FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Yuan, NY
   Tsai, RY
   Ho, MH
   Wang, DM
   Lai, JY
   Hsieh, HJ
AF Yuan, Nai-Yi
   Tsai, Ruei-Yi
   Ho, Ming-Hwa
   Wang, Da-Ming
   Lai, Juin-Yih
   Hsieh, Hsyue-Jen
TI Fabrication and characterization of chondroitin sulfate-modified
   chitosan membranes for biomedical applications
SO DESALINATION
LA English
DT Article; Proceedings Paper
CT 4th Conference of the Aseanian-Membrane-Society
CY AUG 16-18, 2007
CL Taipei, TAIWAN
SP Aseanian Membrane Soc
DE Biomaterial; Chitosan; Chondroitin sulfate; Freeze-gelation; Porous
   membrane
ID POROUS SCAFFOLDS; STATE CHARACTERIZATION; CROSS-LINKING; DESIGN
AB Chitosan (CH) is a biomaterial with antiseptic, bioactive, and biocompatible properties. To further enhance the performance of chitosan membranes, chondroitin Sulfate (CS) was utilized to modify the porous chitosan membranes fabricated by the freeze-gelation method. The cross-linking of CS to CH was mediated by ionic interaction and covalent cross-linking using EDC/NHS coupling reagents. The pore structures, mechanical properties, and surface hydrophilicity of the porous chondroitin sulfate-modified chitosan (CH/CS) membranes could be altered by varying the weight ratio of CS to CH. The membranes had interconnected stratiform pore structure with surface pore size ranging from 10 to 40 mu m. Among various CH/CS membranes the one with the weight ratio of 90/10 (CH to CS) possessed the highest mechanical strength (18.61 N/g), about 40% increase as compared with the unmodified CH membrane. The addition of CS improved the hydrophilicity of the membranes. Preliminary cell culture experiments revealed that the proliferation of the gingival fibroblasts on the CH/CS surface was slightly better than that on the CH surface. In summary, the CH/CS membranes (especially the 90/10 membrane), due to their higher mechanical strength, hydrophilicity, and better cell compatibility, are promising biomaterials for tissue engineering applications.
C1 [Yuan, Nai-Yi; Tsai, Ruei-Yi; Wang, Da-Ming; Hsieh, Hsyue-Jen] Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
   [Ho, Ming-Hwa] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 106, Taiwan.
   [Lai, Juin-Yih] Chung Yuan Christian Univ, Res & Dev Ctr Membrane Technol, Chungli 320, Taiwan.
RP Hsieh, HJ (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
EM hjhsieh@ntu.edu.tw
RI Lai, Juin-Yih/B-4461-2011
CR Chen YL, 2006, BIOMATERIALS, V27, P2222, DOI 10.1016/j.biomaterials.2005.10.029
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   FLETCHER M, 1982, APPL ENVIRON MICROB, V44, P184
   GOOZEN M, 1997, APPL CHITIN CHITOSAN
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Khalid MN, 2002, EUR J PHARM SCI, V15, P425, DOI 10.1016/S0928-0987(02)00029-5
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   Rhoades J, 2000, APPL ENVIRON MICROB, V66, P80, DOI 10.1128/AEM.66.1.80-86.2000
   SAMUELS RJ, 1981, J POLYM SCI POL PHYS, V19, P1081, DOI 10.1002/pol.1981.180190706
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   YUI T, 1994, MACROMOLECULES, V27, P7601, DOI 10.1021/ma00104a014
   Zaia J, 2001, ANAL CHEM, V73, P6030, DOI 10.1021/ac015577t
NR 18
TC 22
Z9 23
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0011-9164
J9 DESALINATION
JI Desalination
PD DEC 31
PY 2008
VL 234
IS 1-3
BP 166
EP 174
DI 10.1016/j.desal.2007.09.083
PG 9
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA 381WK
UT WOS:000261566400021
DA 2018-10-20
ER

PT J
AU Li, YC
   Cai, YR
   Kong, XD
   Yao, JM
AF Li, Yucheng
   Cai, Yurong
   Kong, Xiangdong
   Yao, Juming
TI Anisotropic growth of hydroxyapatite on the silk fibroin films
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Hydroxyapatite; Silk fibroin films; Biomineralization;
   Pre-calcification; Simulated body fluid (SBF)
ID MATRIX PROTEIN; NANOCRYSTALS; SCAFFOLDS; ORGANIZATION; BIOMATERIAL;
   COMPOSITES; CRYSTALS; SYSTEM; BONE
AB Bombyx mori silk fibroin is of practical interest for its excellent intrinsic properties utilizable in the biotechnological and biomedical fields. Here, the silk fibroin films were pretreated with different methods and then used as the template for the hydroxyapatite (HA) crystal growth. To study the effect of silk films' surface structure on the protein biomineralization, the films were immersed into 1.5 times simulated body fluid (1.5 x SBF) to induce the HA deposition at 37 degrees C. The results showed that an anisotropic growth of HA crystals was observed on the different films as judging from XRD, TEM and HRTEM data. This was thought that the positions and density of carboxyl groups, C = O and amino groups on the surface of SF films may be different, which play the key effect on HA crystal growth. (C) 2008 Elsevier B. V. All rights reserved.
C1 [Li, Yucheng; Cai, Yurong; Yao, Juming] Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
   [Kong, Xiangdong] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Peoples R China.
RP Yao, JM (reprint author), Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Xiasha Higher Educ Pk, Hangzhou 310018, Peoples R China.
EM yaoj@zstu.edu.cn
RI Yao, Juming/N-7886-2014
FU Program for Changjiang Scholars and Innovative Research Team in
   University [IRT0654]; Program for New Century Excellent Talents in
   University [NCET070763]; National Natural Science Foundation of China
   [10672145]; Key Project of Chinese Ministry of Education [207042]
FX The work is financially supported by the Program for Changjiang Scholars
   and Innovative Research Team in University (IRT0654), Program for New
   Century Excellent Talents in University (NCET070763), National Natural
   Science Foundation of China (No. 10672145) and the Key Project of
   Chinese Ministry of Education (No. 207042).
CR Alivisatos AP, 2000, SCIENCE, V289, P736, DOI 10.1126/science.289.5480.736
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   Chen JD, 2007, BIOMATERIALS, V28, P2275, DOI 10.1016/j.biomaterials.2007.01.033
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Ehrlich H, 2006, J MEMBRANE SCI, V273, P124, DOI 10.1016/j.memsci.2005.11.050
   He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945
   Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Lee SM, 2003, ADV MATER, V15, P441, DOI 10.1002/adma.200390102
   LEGEROS RZ, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P3
   Lin F, 2008, MATER CHEM PHYS, V111, P92, DOI 10.1016/j.matchemphys.2008.03.019
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Nemoto R, 2004, J AM CERAM SOC, V87, P1014, DOI 10.1111/j.1551-2916.2004.01014.x
   Riman RE, 2002, SOLID STATE IONICS, V151, P393, DOI 10.1016/S0167-2738(02)00545-3
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang L, 2004, J EUR CERAM SOC, V24, P2707, DOI 10.1016/j.jeurceramsoc.2003.09.006
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WEINER S, 1986, FEBS LETT, V206, P262, DOI 10.1016/0014-5793(86)80993-0
   Yang M, 2008, BIOMACROMOLECULES, V9, P416, DOI 10.1021/bm700665m
   Yao J., 2004, ENCY BIOMATERIALS BI, P1363
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
   Zhang D, 2003, ORG LETT, V5, P3221, DOI 10.1021/o1035012e
   Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i
NR 27
TC 27
Z9 35
U1 0
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 30
PY 2008
VL 255
IS 5
BP 1681
EP 1685
DI 10.1016/j.apsusc.2008.06.009
PN 1
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 377TS
UT WOS:000261274100008
DA 2018-10-20
ER

PT J
AU Ao, YH
   Xu, JJ
   Shen, XW
   Fu, DG
   Yuan, CW
AF Ao, Yanhui
   Xu, Jingjing
   Shen, Xunwei
   Fu, Degang
   Yuan, Chunwei
TI Magnetically separable composite photocatalyst with enhanced
   photocatalytic activity
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Magnetic activated carbon; Magnetically separable; Photocatalysis;
   Titania; Phenol
ID ACTIVATED CARBON; BIOMATERIAL SYSTEM; NANOPARTICLES; TITANIA; WATER;
   DEGRADATION; ANATASE; PHENOL; SHELL; CORE
AB A novel magnetically separable composite photocatalyst, anatase titania-coated magnetic activated carbon (TMAC), was prepared in this article. In the synthesis, magnetic activated carbon (MAC) was firstly obtained by adsorbing magnetic Fe(3)O(4) nanoparticles onto the activated carbon (AC),and then the obtained MAC was directly coated by anatase titania nanoparticles prepared at low temperature (i.e. 75 degrees C). The prepared samples were characterized by XRD, SEM and vibrating sample magnetometer (VSM). The composite photocatalyst can be easily separated from solution by a magnet, its photocatalytic activity in degradation of phenol in aqueous solution also has dramatic enhancement compared to that of the neat titania. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Ao, Yanhui; Xu, Jingjing; Fu, Degang] SE Univ, Sch Chem & Chem Engn, Nanjing 210096, Peoples R China.
   [Ao, Yanhui; Xu, Jingjing; Shen, Xunwei; Fu, Degang; Yuan, Chunwei] SE Univ, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
   [Ao, Yanhui; Xu, Jingjing; Fu, Degang] SE Univ, Key Lab Environm & Biosafety Suzhou, Res Inst, Suzhou 215123, Peoples R China.
RP Fu, DG (reprint author), SE Univ, Sch Chem & Chem Engn, Nanjing 210096, Peoples R China.
EM andyao@seu.edu.cn; fudegang@seu.edu.cn
RI Fu, DG/G-4750-2012
OI Fu, DG/0000-0002-0113-5308
FU National Natural Science Foundation of China [60121101]; Hi-Tech
   Research and Development Program (863 Program) of China [2002AA302304]
FX This work was supported by the National Natural Science Foundation of
   China (No. 60121101) and Hi-Tech Research and Development Program (863
   Program) of China (No. 2002AA302304). We are also very grateful to Prof.
   Zhang Yu and Dr. Liu Ji-wei in Southeast University for their help in
   VSM experiments.
CR Beydoun D, 2000, J PHYS CHEM B, V104, P4387, DOI 10.1021/jp992088c
   Bickley RI, 1997, MATER CHEM PHYS, V51, P47, DOI 10.1016/S0254-0584(97)80265-9
   Carpio E, 2005, J MOL CATAL A-CHEM, V228, P293, DOI 10.1016/j.molcata.2004.09.066
   Chen F, 2001, CHEMOSPHERE, V44, P1159, DOI 10.1016/S0045-6535(00)00277-0
   Chung YS, 2004, MATER CHEM PHYS, V86, P375, DOI 10.1016/j.matchemphys.2004.03.027
   FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   HOFFMANN MR, 1995, CHEM REV, V95, P96
   HOWE RF, 1987, J PHYS CHEM-US, V91, P3906, DOI 10.1021/j100298a035
   Huang J., 1997, ZAIRYO TO KANKYO, V469, P651
   LITTER MI, 1994, J PHOTOCH PHOTOBIO A, V84, P183, DOI 10.1016/1010-6030(94)03858-9
   MADHUSUDHAN RP, 1995, J MATER SCI, V30, P4980
   Matos J, 1998, APPL CATAL B-ENVIRON, V18, P281, DOI 10.1016/S0926-3373(98)00051-4
   MATTHEWS RW, 1990, WATER RES, V24, P653, DOI 10.1016/0043-1354(90)90199-G
   MILIS A, 1994, J MOL CATAL, V87, P67, DOI 10.1016/0304-5102(93)E0213-Z
   Mills A, 1997, J PHOTOCH PHOTOBIO A, V108, P1, DOI 10.1016/S1010-6030(97)00118-4
   NAVIO JA, 1992, J MATER SCI, V27, P3036, DOI 10.1007/BF01154116
   OLLIS DF, 1985, ENVIRON SCI TECHNOL, V19, P480, DOI 10.1021/es00136a002
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Pera-Titus M, 2004, APPL CATAL B-ENVIRON, V47, P219, DOI 10.1016/j.apcatb.2003.09.010
   Pozzo RL, 1997, CATAL TODAY, V39, P219, DOI 10.1016/S0920-5861(97)00103-X
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Toyoda M, 2003, DESALINATION, V159, P273, DOI 10.1016/S0011-9164(03)90079-8
   Tryba B, 2003, APPL CATAL B-ENVIRON, V41, P427, DOI 10.1016/S0926-3373(02)00173-X
   Xie YB, 2003, APPL CATAL B-ENVIRON, V46, P251, DOI 10.1016/S0926-3373(03)00211-X
   Yuan J.N., 1995, ZAIRYO TO KANKYO, V44, P534
NR 29
TC 32
Z9 36
U1 2
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD DEC 30
PY 2008
VL 160
IS 2-3
BP 295
EP 300
DI 10.1016/j.jhazmat.2008.02.114
PG 6
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 377ML
UT WOS:000261255200005
PM 18406055
DA 2018-10-20
ER

PT J
AU Park, D
   Ahn, CK
   Kim, YM
   Yun, YS
   Park, JM
AF Park, Donghee
   Ahn, Chi Kyu
   Kim, Young Mi
   Yun, Yeoung-Sang
   Park, Jong Moon
TI Enhanced abiotic reduction of Cr(VI) in a soil slurry system by natural
   biomaterial addition
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Hexavalent chromium; Remediation; Reduction; Soil slurry system; Organic
   reductant; Pine bark
ID IN-SITU REMEDIATION; HEXAVALENT CHROMIUM; CONTAMINATED SOILS; ACTIVATED
   CARBONS; BIOMASS; KINETICS; REMOVAL
AB Among various plant-based natural biomaterials, pine bark was chosen as an efficient biomaterial capable of removing toxic Cr(VI) from aqueous solution. XPS spectra indicated that Cr(VI) was abiotically reduced to Cr(III) in both liquid and solid phases. The Cr(VI)-reducing capacity of pine bark was determined as 545 (+/- 1.3) mg-Cr(VI) g(-1) of it, which was 8.7 times higher than that of a common chemical Cr(VI)-reductant, FeSO(4)center dot 7H(2)O. Because pine bark could completely reduce toxic Cr(VI) to less toxic or nontoxic Cr(III) even at neutral pH, it was used as an organic reductant to remediate Cr(VI)-contaminated soil in this study. Soil slurry system using a bottle roller was applied to ex situ slurry-phase remediation experiments. In the soil slurry system, pine bark completely reduced Cr(VI) to Cr(III) and adsorbed the reduced-Cr(III) on its surface. Abiotic remediation rate of Cr(Vi)-contaminated soil increased with the increase of pine bark dosage and with the decreases of Cr(VI) and water contents. In conclusion, pine bark can be used to remediate Cr(VI)-contaminated soil efficiently and environmentally friendly. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Park, Donghee; Ahn, Chi Kyu; Kim, Young Mi; Park, Jong Moon] Pohang Univ Sci & Technol, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, Sch Environm Sci & Engn, Pohang 790784, South Korea.
   [Yun, Yeoung-Sang] Chonbuk Natl Univ, Div Environm & Chem Engn, Ind Technol Res Inst, Jeonju 561756, South Korea.
RP Park, JM (reprint author), Pohang Univ Sci & Technol, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, Sch Environm Sci & Engn, San 31, Pohang 790784, South Korea.
EM jmpark@postech.ac.kr
RI Yun, Yeoung-Sang/F-8340-2011
OI Yun, Yeoung-Sang/0000-0002-2583-8278
FU KOSEF through the AEBRC; Program for Advanced Education of Chemical
   Engineers at POSTECH; MCCIE; KOTEF through the Human Resource Training
   Project for Regional Innovation at Chonbuk National University
FX This work was financially supported by the KOSEF through the AEBRC and
   the Program for Advanced Education of Chemical Engineers at POSTECH.
   This work was also partially supported by the MCCIE and KOTEF through
   the Human Resource Training Project for Regional Innovation at Chonbuk
   National University.
CR Argun ME, 2005, ENVIRON TECHNOL, V26, P479, DOI 10.1080/09593332608618532
   Barnhart J, 1997, REGUL TOXICOL PHARM, V26, pS3, DOI 10.1006/rtph.1997.1132
   Blowes DW, 1997, ENVIRON SCI TECHNOL, V31, P3348, DOI 10.1021/es960844b
   Bras IP, 1999, ENVIRON SCI TECHNOL, V33, P631, DOI 10.1021/es980402v
   Clesceri L. S., 1998, STANDARD METHODS EXA, P366
   Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032
   Deng BL, 1996, ENVIRON SCI TECHNOL, V30, P2484, DOI 10.1021/es950780p
   Kamaludeen SPB, 2003, REV ENVIRON CONTAM T, V178, P93, DOI 10.1007/0-387-21728-2_4
   Kozuh N, 2000, ENVIRON SCI TECHNOL, V34, P112, DOI 10.1021/es981162m
   LOSI ME, 1994, ENVIRON TOXICOL CHEM, V13, P1727, DOI 10.1897/1552-8618(1994)13[1727:FACABR]2.0.CO;2
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Park D, 2006, IND ENG CHEM RES, V45, P2405, DOI 10.1021/ie0509387
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   Park D, 2007, CHEMOSPHERE, V66, P939, DOI 10.1016/j.chemosphere.2006.05.068
   Proctor D. M., 1997, CHROMIUM SOIL PERSPE
   Seaman JC, 1999, ENVIRON SCI TECHNOL, V33, P938, DOI 10.1021/es980546+
   Szulczewski MD, 2001, ENVIRON SCI TECHNOL, V35, P1134, DOI 10.1021/es001301b
   Szulczewski MD, 1997, ENVIRON SCI TECHNOL, V31, P2954, DOI 10.1021/es9701772
   Thornton EC, 1999, ENVIRON SCI TECHNOL, V33, P4096, DOI 10.1021/es9812507
   Tokunaga TK, 2003, J ENVIRON QUAL, V32, P1641, DOI 10.2134/jeq2003.1641
NR 22
TC 22
Z9 23
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD DEC 30
PY 2008
VL 160
IS 2-3
BP 422
EP 427
DI 10.1016/j.jhazmat.2008.03.044
PG 6
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 377ML
UT WOS:000261255200024
PM 18434006
DA 2018-10-20
ER

PT J
AU O'Brien, CP
   Stuart, SJ
   Bruce, DA
   Latour, RA
AF O'Brien, C. P.
   Stuart, S. J.
   Bruce, D. A.
   Latour, R. A.
TI Modeling of Peptide Adsorption Interactions with a Poly(lactic acid)
   Surface
SO LANGMUIR
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN ADSORPTION; FREE-ENERGY;
   CONFORMATIONAL-CHANGES; SOLID-SURFACES; DISTRIBUTIONS; POLY(L-LACTIDE);
   ENERGETICS; MECHANICS; POLYMERS
AB The biocompatibility of implanted materials and devices is governed by the conformation, orientation, and composition of the layer of proteins that adsorb to the surface of the material immediately upon implantation, so an understanding of this adsorbed protein layer is essential to the rigorous and methodical design of implant materials. In this study, novel molecular dynamics techniques were employed in order to determine the change in free energy for the adsorption of a solvated nine-residue peptide (GGGG-K-GGGG) to a crystalline polylactide surface in an effort to elucidate the fundamental mechanisms that govern protein adsorption. This system, like many others, involves two distinct types of sampling problems: a spatial sampling problem, which arises due to entropic effects creating barriers in the free energy profile, and a conformational sampling problem, which occurs due to barriers in the potential energy landscape. In a two-step process that addresses each sampling problem in turn, the technique of biased replica exchange molecular dynamics was refined and applied in order to overcome these sampling problems and, using the information available at the atomic level of detail afforded by molecular simulation, both quantify and characterize the interactions between the peptide and a relevant biomaterial surface. The results from these simulations predict a fairly strong adsorption response with an adsorption free energy of -2.5 +/- 0.6 kcal/mol (mean +/- 95% confidence interval), with adsorption primarily due to hydrophobic interactions between the nonpolar groups of the peptide and the PLA surface. As part of a larger and ongoing effort involving both simulation and experimental investigations, this work contributes to the goal of transforming the engineering of biomaterials from one dominated by trial-and-error to one which is guided by an atomic-level understanding of the interactions that occur at the tissue-biomaterial interface.
C1 [O'Brien, C. P.; Latour, R. A.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
   [Stuart, S. J.] Clemson Univ, Dept Chem, Clemson, SC 29634 USA.
   [Bruce, D. A.] Clemson Univ, Dept Chem & Biomol Engn, Clemson, SC 29634 USA.
RP Latour, RA (reprint author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RI Stuart, Steven/H-1111-2012; Bruce, David/E-9572-2011
FU National Science Foundation [EEC-9731680]; Center for Advanced
   Engineering Fibers and Films (CAEFF); NIH [R01 EB006163, R01 GM074511];
   NJ Center for Biomaterials RESBIO [P41 EB001046]; Clemson University
FX This work was supported by the ERC pro,gram of the National Science
   Foundation under Award Number EEC-9731680 as part of the Center for
   Advanced Engineering Fibers and Films (CAEFF). Partial support was also
   provided by NIH R01 EB006163, R01 GM074511, and the NJ Center for
   Biomaterials RESBIO (NIH, P41 EB001046). We would like to thank the
   Department of Mathematical Sciences at Clemson University for the use of
   their computational cluster environment. The authors would also like to
   acknowledge the support of the staff from the Cyberinfrastructure
   Technology Integration group, and the use of the advanced computational
   resources deployed and maintained by Clemson Computing and Information
   Technology.
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   [Anonymous], 2008, ENCY BIOMATERIALS BI, P270
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   Branden C.-I., 1998, INTRO PROTEIN STRUCT
   BRASH JL, 1995, PROTEINS INTERFACES, V2, P1
   BROOKS BR, 1983, J COMPUT CHEM, V4, P217
   CLAESSON PM, 1995, ADV COLLOID INTERFAC, V57, P161, DOI 10.1016/0001-8686(95)00241-H
   Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005
   GROSSFIELD A, 2006, IMPLEMENTATION WHAM
   GUNSTEREN WF, 1989, COMPUTER SIMULATION, V1
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA, P246
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657
   KUMAR S, 1995, J COMPUT CHEM, V16, P1339, DOI 10.1002/jcc.540161104
   Lamoureux G, 2003, J CHEM PHYS, V119, P5185, DOI 10.1063/1.1598191
   LEACH AR, 2001, MOL MODELLING PRINCI, P179
   Lennard-Jones JE, 1931, P PHYS SOC, V43, P461, DOI 10.1088/0959-5309/43/5/301
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Martyna GJ, 1996, MOL PHYS, V87, P1117, DOI 10.1080/00268979600100761
   McAliley JH, 2008, J PHYS CHEM A, V112, P7244, DOI 10.1021/jp712114q
   Mezei M, 1989, MOL SIMULAT, V3, P301, DOI 10.1080/08927028908031382
   NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201
   OBRIEN CP, 2005, THESIS CLEMSON U
   OVERBEEK JTG, 1977, J COLLOID INTERF SCI, V58, P408, DOI 10.1016/0021-9797(77)90151-5
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6
   Rathore N, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1831273
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Raut VP, 2005, LANGMUIR, V21, P1629, DOI 10.1021/la047807f
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   SADANA A, 1992, CHEM REV, V92, P1799, DOI 10.1021/cr00016a006
   Sasaki S, 2003, MACROMOLECULES, V36, P8385, DOI 10.1021/ma0348674
   Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9
   Thanki PN, 2006, APPL SURF SCI, V253, P2758, DOI DOI 10.1016/J.APSUSC.2006.05.047
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   Vernekar V. N., 2005, MATER RES INNOV, V9, P337
   Wang F, 2008, BIOINTERPHASES, V3, P9, DOI 10.1116/1.2840054
   Wei Y, 2008, LANGMUIR, V24, P6721, DOI 10.1021/la8005772
   Zhang J, 2007, POLYMER, V48, P4900, DOI 10.1016/j.polymer.2007.06.030
NR 52
TC 35
Z9 36
U1 0
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 16
PY 2008
VL 24
IS 24
BP 14115
EP 14124
DI 10.1021/la802588n
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 382UU
UT WOS:000261631700043
PM 19360943
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mise, T
   Ishikawa, M
   Nishimoto, K
   Meguro, T
AF Mise, Takaya
   Ishikawa, Makishi
   Nishimoto, Kensaku
   Meguro, Takashi
TI A new approach for preventing charging up of soft material samples by
   coating with conducting polymers in SIMS analysis
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 16th International Conference on Secondary Ion Mass Spectrometry (SIMS )
CY OCT 29-NOV 02, 2007
CL Kanazawa, JAPAN
DE Secondary ion mass spectroscopy; Soft material; Sensitivity; Ion beam
AB Dynamic secondary ion mass spectroscopy (SIMS) analysis of soft materials such as polymer or biomaterial is one of challenging subjects due to the charge up effect brought from the irradiation of a primary ion beam, hampering the collection of secondary ions. Conventional methods against the charging up are the electron beam irradiation for charge compensation and surface coating with metal, normally gold. Those methods require a compromise analytical condition, reducing the primary ion beam current to suppress the range of the charging, which degrading the performances of the SIMS analyses. We have proposed that a thicker conductive layer, capable of delocalizing the charge onto the surface, should be put on a soft insulator sample to avoid charging up. The depth pro. le of the hair sample coated wholly with a polythiophen-based conducting polymer was successfully measured in longer time without any charging up even in the maximum current of the oxygen primary ion beam (O(2)(+): 7.5 keV, 400 nA) or using an electron beam compensation system. Thus, the proposed method coating with a conductive organic polymer against the charging issue would be expected as a breakthrough on SIMS analysis. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Mise, Takaya; Meguro, Takashi] RIKEN, Wako, Saitama 3510198, Japan.
   [Ishikawa, Makishi; Nishimoto, Kensaku] CAMECA Instruments Japan, Chiyoda Ku, Tokyo 1010021, Japan.
RP Mise, T (reprint author), RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM tmise@riken.jp
CR Shibahara K, 2003, APPL SURF SCI, V203, P387, DOI 10.1016/S0169-4332(02)00682-7
NR 1
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 15
PY 2008
VL 255
IS 4
BP 1113
EP 1115
DI 10.1016/j.apsusc.2008.05.040
PG 3
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 377OB
UT WOS:000261259400083
DA 2018-10-20
ER

PT J
AU Al-Ahmad, A
   Wiedmann-Al-Ahmad, M
   Carvalho, C
   Lang, M
   Follo, M
   Braun, G
   Wittmer, A
   Mulhaupt, R
   Hellwig, E
AF Al-Ahmad, A.
   Wiedmann-Al-Ahmad, M.
   Carvalho, C.
   Lang, M.
   Follo, M.
   Braun, G.
   Wittmer, A.
   Muelhaupt, R.
   Hellwig, E.
TI Bacterial and Candida albicans adhesion on rapid prototyping-produced
   3D-scaffolds manufactured as bone replacement materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE rapid prototyping; tissue engineering; bacterial colonization; dental
   pathogens; saliva
ID TISSUE REGENERATION MEMBRANES; IN-VIVO; STAPHYLOCOCCUS-EPIDERMIDIS;
   PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-MUTANS; POLYMER SURFACES;
   SCAFFOLDS; CELLS; VITRO; HYDROXYAPATITE
AB Rapid prototyping (RP)-produced scaffolds are gaining increasing importance in scaffold-guided tissue engineering. Microbial adhesion on the surface of replacement materials has a strong influence on healing and long-term Outcome. Consequently, it is important to examine the adherence of microorganisms on RP-produced scaffolds. This research focussed on manufacturing of scaffolds by 3D-bioplotting and examination of their microbial adhesion characteristics. Tricalciumphosphate (TCP), calcium/sodium alginate, and poly(lactide-co-glycolic acid) (PLGA) constructs were produced and used to study the adhesion of dental pathogens. Six oral bacterial strains, one Candida strain and human saliva were used for the adhesion studies. The number of colony forming units (CFU) were determined and scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) were performed. Microorganisms adhered to all scaffolds. All strains, except for Streptococcus oralis, adhered best to PLGA scaffolds. Streptococcus oralis adhered to each of the biomaterials equally. Streptococcus mutans and Enterococcus faecalis adhered best to PLGA scaffolds, followed by alginate and TCP. Prevotella nigrescens, Porphyromonas gingivalis, Streptococcus sanguis, and Candida albicans showed the highest adherence to PLGA, followed by TCP and alginate. In contrast, the microorganisms of saliva adhered significantly better to TCP, followed by PLGA and alginate. SEM observations correlated with the results of the CFU determinations. CLSM detected bacteria within deeper sheets of alginate. In Conclusion, because of the high adherence rate of oral pathogens to the scaffolds, the application of these biomaterials for bone replacement in oral surgery Could result in biomaterial-related infections. Strategies to decrease microbial adherence and to prevent infections due to oral pathogens are discussed. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 933-943, 2008
C1 [Al-Ahmad, A.; Lang, M.; Braun, G.; Hellwig, E.] Univ Freiburg, Dept Operat Dent & Periodontol, Freiburg, Germany.
   [Wiedmann-Al-Ahmad, M.] Univ Freiburg, Dept Oral & Maxillofacial Surg, Freiburg, Germany.
   [Carvalho, C.; Muelhaupt, R.] Univ Freiburg, Freiburg Mat Res Ctr, Freiburg, Germany.
   [Carvalho, C.; Muelhaupt, R.] Univ Freiburg, Inst Macromol Chem, D-7800 Freiburg, Germany.
   [Follo, M.] Univ Freiburg, Dept Hematol & Oncol, Freiburg, Germany.
   [Wittmer, A.] Univ Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany.
RP Al-Ahmad, A (reprint author), Univ Freiburg, Dept Operat Dent & Periodontol, Freiburg, Germany.
EM ali.al-ahmad@uniklinik-freiburg.de
OI Follo, Marie/0000-0002-3090-7442
CR Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0
   Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   de Resende MA, 2006, MYCOPATHOLOGIA, V162, P39, DOI 10.1007/s11046-006-0029-6
   Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053
   BAUMGARTNER JN, 1996, ASAIO J, V42, P476
   Beikler T, 2006, J PERIODONTOL, V77, P1323, DOI 10.1902/jop.2006.050204
   Carlen A, 2003, ORAL MICROBIOL IMMUN, V18, P203, DOI 10.1034/j.1399-302X.2003.00043.x
   Carlen A, 1998, CARIES RES, V32, P447, DOI 10.1159/000016486
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Ciardelli G, 2004, J MATER SCI-MATER M, V15, P305, DOI 10.1023/B:JMSM.0000021092.03087.d4
   Cohen SR, 2006, J CRANIOFAC SURG, V17, P40, DOI 10.1097/01.scs.0000200411.22583.4e
   Dexter SJ, 2001, J BIOMED MATER RES, V56, P222, DOI 10.1002/1097-4636(200108)56:2<222::AID-JBM1087>3.0.CO;2-L
   Foster JS, 2004, APPL ENVIRON MICROB, V70, P4340, DOI 10.1128/AEM.70.7.4340-4348.2004
   Garvin K, 2005, CLIN ORTHOP RELAT R, P105, DOI 10.1097/01.blo.0000175720.99118.fe
   GIBBONS RJ, 1989, J DENT RES, V68, P750, DOI 10.1177/00220345890680050101
   GIBBONS RJ, 1989, J DENT RES, V68, P1303, DOI 10.1177/00220345890680090201
   Golecka M, 2006, TRANSPLANT P, V38, P155, DOI 10.1016/j.transproceed.2005.12.078
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Hung SL, 2002, J PERIODONTOL, V73, P843, DOI 10.1902/jop.2002.73.8.843
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Landes CA, 2006, PLAST RECONSTR SURG, V117, P2347, DOI 10.1097/01.prs.0000218787.49887.73
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   MAEKAWA S, 1992, MICROBIOL IMMUNOL, V36, P671, DOI 10.1111/j.1348-0421.1992.tb02070.x
   Makinen TJ, 2005, BONE, V36, P292, DOI 10.1016/j.bone.2004.11.009
   Malaisrie SC, 1998, LARYNGOSCOPE, V108, P1733, DOI 10.1097/00005537-199811000-00026
   MARSH P, 1999, ORALE MIKROBIOLOGIE, P15
   Matsuno T, 2006, DENT MATER J, V25, P138, DOI 10.4012/dmj.25.138
   NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281
   Otten JE, 2005, J BIOMED MATER RES B, V74B, P627, DOI 10.1002/jbm.b.30250
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Sanchez-Salcedo S, 2006, TISSUE ENG, V12, P279, DOI 10.1089/ten.2006.12.279
   Schirrmeister JF, 2007, J ENDODONT, V33, P536, DOI 10.1016/j.joen.2007.01.012
   Sela MN, 2003, CLIN ORAL IMPLAN RES, V14, P263, DOI 10.1034/j.1600-0501.2003.140302.x
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
   STEMBERGER A, 1997, NEW ANTICOAGULANTS C, P377
   Tan KH, 2005, P I MECH ENG H, V219, P183, DOI 10.1243/095441105X9345
   Tan KH, 2003, BIOMATERIALS, V24, P3115, DOI 10.1016/S0142-9612(03)00131-5
   Teng LJ, 2002, J CLIN MICROBIOL, V40, P3172, DOI 10.1128/JCM.40.9.3172-3178.2002
   THOMSON RC, 2000, PRINCIPLES TISSUE EN, P251
   Triandafillu K, 2003, BIOMATERIALS, V24, P1507, DOI 10.1016/S0142-9612(02)00515-X
   Wagner M, 2007, J BIOMED MATER RES A, V83A, P1154, DOI 10.1002/jbm.a.31416
   Weng YL, 2006, TISSUE ENG, V12, P1503, DOI 10.1089/ten.2006.12.1503
   WILSON M, 1989, J DENT, V17, P166, DOI 10.1016/0300-5712(89)90069-9
   Wu-Yuan C D, 1995, J Oral Implantol, V21, P207
   Yenice I, 2002, INT J PHARM, V242, P271, DOI 10.1016/S0378-5173(02)00186-2
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
NR 48
TC 12
Z9 12
U1 0
U2 26
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2008
VL 87A
IS 4
BP 933
EP 943
DI 10.1002/jbm.a.31832
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 374WY
UT WOS:000261075600010
PM 18228269
DA 2018-10-20
ER

PT J
AU Serrano, MC
   Pagani, R
   Ameer, GA
   Vallet-Regi, M
   Portoles, MT
AF Serrano, M. Concepcion
   Pagani, Raffaella
   Ameer, Guillermo A.
   Vallet-Regi, Maria
   Portoles, M. Teresa
TI Endothelial cells derived from circulating progenitors as an effective
   source to functional endothelialization of NaOH-treated
   poly(epsilon-caprolactone) films
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE endothelial progenitor cell; poly(epsilon-caprolactone); nitric oxide;
   endothelial cell markers; tissue engineering
ID TISSUE PLASMINOGEN-ACTIVATOR; HUMAN UMBILICAL VEIN; NITRIC-OXIDE;
   IN-VITRO; CULTURED HUMAN; EPSILON-CAPROLACTONE; VASCULAR GRAFTS;
   RELAXING FACTOR; PROLIFERATION; ANGIOGENESIS
AB Biomaterials have been widely used to prepare synthetic vascular grafts over the past thirty years, but the inherent thrombogenicity of their Surface can lead to graft failure. Endothelial progenitor cells (EPC) are circulating premature cells able to differentiate in either myocardial or endothelial cells (EC). The therapeutic potential of these cells and its easy obtaining technique are important reasons why these cells Could be used to improve the performance of vascular grafts. In this study, two different stages of differentiation of EC derived from EPC (EC1 and EC2) were characterized and Cultured on poly(E-caprolactone) (PCL) films treated with NaOH (PCL-NaOH). We investigated by immunolabeling the expression of CD31, von Willebrand factor (vWF), and endothelial nitric oxide synthase (eNOS) in these cells during the differentiation process. The proliferation, cell cycle, and mitochondrial function of EC2 cultured on PCL-NaOH were evaluated at different times. The effect of this biomaterial on the nitric oxide (NO) content was also measured. The mature EC obtained from circulating progenitor cells (EC,) showed an appropriate growth and functionality on NaOH-treated films. They conserved their capacity to define vessel-like structures in culture and increased their basal NO production. These results underline the potential usefulness of these EC, to,et a functional endothelialization of polymers with applications in vascular tissue engineering. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 964-971,2008
C1 [Serrano, M. Concepcion; Pagani, Raffaella; Portoles, M. Teresa] Univ Complutense, Fac Chem, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain.
   [Ameer, Guillermo A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Vallet-Regi, Maria] Univ Complutense, Fac Pharm, Dept Inorgan & Bioinorg Chem, E-28040 Madrid, Spain.
RP Portoles, MT (reprint author), Univ Complutense, Fac Chem, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain.
EM portoles@quim.ucm.es
RI Ameer, Guillermo/B-6765-2009; Portoles, Maria Teresa/U-1678-2017;
   Serrano, Maria Concepcion/D-7442-2014; Vallet-Regi, Maria/M-3378-2014
OI Portoles, Maria Teresa/0000-0002-9681-0184; Serrano, Maria
   Concepcion/0000-0002-5010-644X; Vallet-Regi, Maria/0000-0002-6104-4889
FU Fundacion MMA; Comuniclad de Madrid [0505/MAT/0324]
FX Contract grant sponsor: Fundacion MMA [(2004-033), coordinated by Dr. J.
   V. Comas (Pediatric Heart Institute, Hospital Universitario "12 de
   Octubre", Madrid, Spain)]; Contract grant sponsor: Comuniclad de Madrid;
   contract grant number: S-0505/MAT/0324
CR ALLEN J, TISSUE ENG IN PRESS, DOI DOI 10.1089/TEN.2007.0265
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Badorff C, 2003, CIRCULATION, V107, P1024, DOI 10.1161/01.CIR.0000051460.85800.BB
   CALLOW AD, 1982, SURG CLIN N AM, V62, P501
   DAVIE EW, 1995, THROMB HAEMOSTASIS, V74, P1
   DEGRAAF JC, 1992, CIRCULATION, V85, P2284, DOI 10.1161/01.CIR.85.6.2284
   DELISSER HM, 1994, IMMUNOL TODAY, V15, P490, DOI 10.1016/0167-5699(94)90195-3
   Deutsch M, 1997, J VASC SURG, V25, P757, DOI 10.1016/S0741-5214(97)70307-0
   DICHEK D, 1989, BLOOD, V74, P222
   Donnelly R, 2002, LANCET, V359, P2048, DOI 10.1016/S0140-6736(02)08946-8
   EICKHOFF JH, 1987, J VASC SURG, V6, P506, DOI 10.1067/mva.1987.avs0060506
   ESMON CT, 1987, SCIENCE, V235, P1348, DOI 10.1126/science.3029867
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   GIMBRONE MA, 1990, ANN NY ACAD SCI, V598, P77, DOI 10.1111/j.1749-6632.1990.tb42279.x
   HANSON SR, 1993, J CLIN INVEST, V92, P2003, DOI 10.1172/JCI116795
   HARKER LA, 1992, THROMBOSIS CARDIOVAS, P1
   HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015
   HERRING M, 1978, SURGERY, V84, P498
   Heyligers JMM, 2005, ANN VASC SURG, V19, P448, DOI 10.1007/s10016-005-0026-0
   Hristov M, 2003, TRENDS CARDIOVAS MED, V13, P201, DOI 10.1016/S1050-1738(03)00077-X
   IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265
   Khang G, 2002, J APPL POLYM SCI, V85, P1253, DOI 10.1002/app.10680
   Khor HL, 2002, MAT SCI ENG C-BIO S, V20, P71, DOI 10.1016/S0928-4931(02)00015-2
   LEVIN EG, 1983, P NATL ACAD SCI-BIOL, V80, P6804, DOI 10.1073/pnas.80.22.6804
   Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333
   MONCADA S, 1982, ARTERIOSCLEROSIS, V2, P193, DOI 10.1161/01.ATV.2.3.193
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296
   Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2
   PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0
   PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0
   Perego G, 2003, J BIOMAT SCI-POLYM E, V14, P1057, DOI 10.1163/156856203769231565
   Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005
   Riha GM, 2005, TISSUE ENG, V11, P1535, DOI 10.1089/ten.2005.11.1535
   Serrano MC, 2006, BIOMATERIALS, V27, P4706, DOI 10.1016/j.biomaterials.2006.05.007
   Serrano MC, 2005, BIOMATERIALS, V26, P5827, DOI 10.1016/j.biomaterials.2005.02.039
   Serrano MC, 2005, MACROMOL BIOSCI, V5, P415, DOI 10.1002/mabi.200400214
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361
   STANHOPE SJ, 1994, GAIT POSTURE, V2, P54
   Walenta K, 2005, BIOCHEM BIOPH RES CO, V333, P476, DOI 10.1016/j.bbrc.2005.05.153
   WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 49
TC 24
Z9 24
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2008
VL 87A
IS 4
BP 964
EP 971
DI 10.1002/jbm.a.31728
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 374WY
UT WOS:000261075600013
PM 18257077
DA 2018-10-20
ER

PT J
AU Jarmar, T
   Palmquist, A
   Brnemark, R
   Hermansson, L
   Engqvist, H
   Thomsen, P
AF Jarmar, Tobias
   Palmquist, Anders
   Brnemark, Rickard
   Hermansson, Leif
   Engqvist, Hakan
   Thomsen, Peter
TI Technique for preparation and characterization in cross-section of oral
   titanium implant surfaces using focused ion beam and transmission
   electron microscopy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE SEM; FIB and TEM analysis; dental implant; titanium oxide; surface
   analysis; interface
ID SPECTROSCOPIC CHARACTERIZATION; TEETH
AB The surface properties of materials are believed to control most of the biological reactions toward implanted materials. To study the surface structure, elemental distribution, and morphology, using transmission electron microscopy (TEM) techniques, thin foils of the surface (in cross-section) are needed. These have been cumbersome to produce, in particular, from the normally irregular screw-shaped metal implants. Focused ion beam (FIB) microscopy has been developed partly for TEM sample preparation, mainly within the microelectronics industry. Our study describes a method based on FIB for producing electron transparent foils/sections from a metal implant for TEM analysis. Using a screw-shaped titanium dental implant, it wash demonstrated that thin foils can be prepared With submicron specificity and from almost any surface geometry. A comparison of different lift-out techniques showed that the in situ lift-out preparation technique allowed plasma cleaning and produced particularly good samples with excellent yield. The titanium oxide on the implant Surface was analyzed using energy-filtered TEM (EFTEM) and high-resolution TEM (HRTEM) and the TiO(2) rutile phase being determined via the lattice parameters. This study provides the first set of data for the optimization of a new route for preparation and analysis of biomaterial surfaces and interfaces. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 1003-1009, 2008
C1 [Jarmar, Tobias; Palmquist, Anders; Thomsen, Peter] Inst Biomat & Cell Therapy, Gothenburg, Sweden.
   [Jarmar, Tobias; Hermansson, Leif; Engqvist, Hakan] Doxa AB, SE-75421 Uppsala, Sweden.
   [Jarmar, Tobias; Hermansson, Leif; Engqvist, Hakan] Uppsala Univ, Dept Engn Sci, SE-75121 Uppsala, Sweden.
   [Palmquist, Anders; Brnemark, Rickard] Integrum AB, SE-41104 Gothenburg, Sweden.
   [Palmquist, Anders; Thomsen, Peter] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, SE-40530 Gothenburg, Sweden.
   [Brnemark, Rickard] Univ Gothenburg, Sahlgrenska Acad, Dept Orthopaed, SE-40530 Gothenburg, Sweden.
RP Palmquist, A (reprint author), Inst Biomat & Cell Therapy, Gothenburg, Sweden.
EM anders.palmquist@biomaterials.gu.se
RI Palmquist, Anders/D-2171-2014
OI Thomsen, Peter/0000-0003-3910-6665; Engqvist, Hakan/0000-0001-9529-650X
FU VINNOVA VinnVaxt Program Biomedical Development in Western Sweden;
   Swedish Research Council [K2006-73X-09495-16-3]; Goran Gustafsson
   Foundation; Doxa AB; Integrum AB
FX Contract grant sponsor: VINNOVA VinnVaxt Program Biomedical Development
   in Western Sweden; Contract grant sponsor: Swedish Research Council;
   contract grant number: K2006-73X-09495-16-3; Contract grant sponsor:
   Goran Gustafsson Foundation, Doxa AB, and Integrum AB
CR Beste U, 2006, INT J REFRACT MET H, V24, P168, DOI 10.1016/j.ijrmhm.2005.05.003
   Bicais-Lepinay N, 2002, MICROELECTRON RELIAB, V42, P1747, DOI 10.1016/S0026-2714(02)00224-X
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P596, DOI 10.1016/0142-9612(90)90085-5
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Engqvist H, 2006, J BIOMED MATER RES A, V78A, P20, DOI 10.1002/jbm.a.30696
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   ERICSON LE, 1991, BONE-BIOMATERIAL INTERFACE, P425
   *JCPDS, 2005, 0211272 PDF JCPDS IN
   *JCPDS, 2005, 0441294 PDF JCPDS IN
   *JCPDS, 2005, 0291360 PDF JCPDS IN
   *JCPDS, 2005, 0211276 PDF JCPDS IN
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Langford RM, 2001, J VAC SCI TECHNOL A, V19, P2186, DOI 10.1116/1.1378072
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   PALMQUIST A, 2008, ACTA ORTHOP IN PRESS
   RADEGRAN G, 1991, J ELECTRON MICR TECH, V19, P99, DOI 10.1002/jemt.1060190110
   THOMSEN P, 1985, BIOMATERIALS, V6, P421, DOI 10.1016/0142-9612(85)90104-8
   WIESLER DG, 1992, SURF SCI, V268, P57, DOI 10.1016/0039-6028(92)90950-B
   Williams D. B., 1996, TRANSMISSION ELECT M
NR 21
TC 42
Z9 42
U1 0
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 15
PY 2008
VL 87A
IS 4
BP 1003
EP 1009
DI 10.1002/jbm.a.31856
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 374WY
UT WOS:000261075600018
PM 18257067
DA 2018-10-20
ER

PT J
AU Brummer, F
   Pfannkuchen, M
   Baltz, A
   Hauser, T
   Thiel, V
AF Bruemmer, Franz
   Pfannkuchen, Martin
   Baltz, Alexander
   Hauser, Thomas
   Thiel, Vera
TI Light inside sponges
SO JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY
LA English
DT Article
DE Aplysina; light conduction; porifera; spicula; sponges; Tethya
ID MARINE SPONGE; SUBERITES-DOMUNCULA; SILICATEIN; PORIFERA; CYANOBACTERIA;
   EVOLUTION; SPICULES; DEMOSPONGIAE; MYOTROPHIN; PHYLOGENY
AB Sponges are the most basal metazoan organisms. As sessile filter feeders in marine or freshwater habitats, they often live in close association with phototrophic microorganisms. Active photosynthesis by the associated microorganisms has been believed to be restricted to the outer tissue portion of the sponge hosts. However, phototrophic microorganisms have also been detected in deeper tissue regions. In many cases they are found around spicules, siliceous skelettal elements of demosponges and hexactinellids. The finding of phototrophic organisms seemingly assembled around spicules led to the hypothesis of a siliceous light transmission system in sponges. The principle ability to conduct light was already shown for sponge derived, explanted spicules. However it was not shown until now, that in deed sponges have a light transmission system, and can harbour photosynthetically active microorganisms in deeper tissue regions.
   Here we show for the first time, that, as hypothesized 13 year ago, sponge spicules in living specimens transmit light into deeper tissue regions. Our results demonstrate that in opposite to the actual opinion, photosynthetically active microorganisms can also live in deeper tissue regions, and not only directly beneath the surface, when a light transmission system (spicules) is present.
   Our results show the possibility of massive or globular sponges being supplied with photosynthetic products or pathways throughout their whole body, implying not only a more important role of these endobioses. Our findings also elucidate the in-situ function of a recently more and more interesting biomaterial, which is unique not only for its mechanical, electrical and optical properties. Biosilica is of special interest for the possibility to produce it enzymatically under environmental conditions. (C) 2008 Published by Elsevier B.V.
C1 [Bruemmer, Franz; Pfannkuchen, Martin; Baltz, Alexander; Hauser, Thomas] Univ Stuttgart, Inst Biol, Abt Zool, D-70569 Stuttgart, Germany.
   [Thiel, Vera] IFM GEOMAR, Leibniz Inst Marine Sci, D-24105 Kiel, Germany.
RP Brummer, F (reprint author), Univ Stuttgart, Inst Biol, Abt Zool, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.
EM franz.bruemmer@bio.uni-stuttgart.de
RI Pfannkuchen, Martin/A-9173-2012
OI Pfannkuchen, Martin/0000-0002-6253-4716
FU Federal Ministry of Education and Reseach (BMBF) [03F0414D]; Universitat
   Stuttgart, Germany
FX This work is dedicated to Elda Gaino and Michele SarA for asking the
   right questions already years ago, as well as Werner E.G. Muller for his
   continuous, stimulating work on sponges. [SS]
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101
   Bergquist PR, 1978, SPONGES
   Boury-Esnault N, 2006, CAN J ZOOL, V84, P205, DOI 10.1139/Z06-003
   BRUMMER F, 2004, B MUS 1 BIOL U GENOV, V68, P219
   CattaneoVietti R, 1996, NATURE, V383, P397, DOI 10.1038/383397b0
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   GAINO E, 1994, MAR ECOL PROG SER, V108, P147, DOI 10.3354/meps108147
   Gaino E, 2006, INVERTEBR BIOL, V125, P281, DOI 10.1111/j.1744-7410.2006.00061.x
   Gupta S, 2006, FOLIA MICROBIOL, V51, P121, DOI 10.1007/BF02932166
   Hill MS, 2005, MAR ECOL PROG SER, V291, P93, DOI 10.3354/meps291093
   Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x
   Muller WEG, 2003, PROG MOLEC, V33, P195
   MULLER WEG, 2005, BIOSENS BIOELECTRON, V21, P1149
   Mullineaux CW, 2005, J EXP BOT, V56, P389, DOI 10.1093/jxb/eri064
   Nickel M, 2006, ZOOMORPHOLOGY, V125, P225, DOI 10.1007/s00435-006-0022-0
   Perry CC, 2003, REV MINERAL GEOCHEM, V54, P291, DOI 10.2113/0540291
   Reiswig HM, 2006, CAN J ZOOL, V84, P195, DOI 10.1139/Z05-174
   Sara M., 2002, SYSTEMA PORIFERA GUI, V1, P245
   Sarikaya M, 2001, J MATER RES, V16, P1420, DOI 10.1557/JMR.2001.0198
   Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234
   Steindler L, 2005, APPL ENVIRON MICROB, V71, P4127, DOI 10.1128/AEM.71.7.4127-4131.2005
   TABACHNICK KR, 2002, SYSTEMA PORIFERA GUI, P1264
   Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06
   Thiel V, 2007, FEMS MICROBIOL ECOL, V59, P47, DOI 10.1111/j.1574-6941.2006.00217.x
   UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100
   VACELET J, 1995, NATURE, V377, P296, DOI 10.1038/377296a0
   WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0
   WILKINSON CR, 1980, ENDOCYTOBIOLOGY ENDO, P553
   Xiao SH, 2005, PALAEOGEOGR PALAEOCL, V220, P89, DOI 10.1016/j.palaeo.2002.02.001
NR 30
TC 23
Z9 25
U1 1
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0981
J9 J EXP MAR BIOL ECOL
JI J. Exp. Mar. Biol. Ecol.
PD DEC 15
PY 2008
VL 367
IS 2
BP 61
EP 64
DI 10.1016/j.jembe.2008.06.036
PG 4
WC Ecology; Marine & Freshwater Biology
SC Environmental Sciences & Ecology; Marine & Freshwater Biology
GA 385XM
UT WOS:000261846900001
DA 2018-10-20
ER

PT J
AU Muthutantri, A
   Huang, J
   Edirisinghe, M
AF Muthutantri, Anushini
   Huang, Jie
   Edirisinghe, Mohan
TI Novel preparation of graded porous structures for medical engineering
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE bioceramic; microstructure; sintering; biomedical; electrohydrodynamic
   spraying
ID HYDROXYAPATITE CERAMICS; MECHANICAL-PROPERTIES; POLYLACTIDE FOAMS;
   POROSITY; COMPOSITE; BIOGLASS(R); FABRICATION; SCAFFOLDS; BONE
AB The gradation of porosity in a biomaterial can be very useful for a variety of medical engineering applications such as filtration, bone replacement and implant development. However, the preparation of such structures is not a technologically trivial task and replication methods do not offer an easy solution. In this work, we elucidate the preparation of structures having a graded porosity by electrohydrodynamic spraying, using zirconia (ZrO(2)), which is widely used in biomedical and other applications. The processes are generic and can be achieved using other bioactive ceramics with similar particle characteristics. The pores on the sprayed surface, the innermost surface and lengthwise cross sections have been analysed in addition to the change in depth of penetration as a function of spraying time. Control of porosity, pore size and depth of penetration has been obtained by varying parameters such as the spraying time, sintering temperature and the sacrificial template. It has been possible to obtain structures with interconnected pore networks of pore size greater than 100 mu m as well as scattered pores smaller than 10 mu m in size.
C1 [Muthutantri, Anushini; Huang, Jie; Edirisinghe, Mohan] UCL, Dept Mech Engn, London WC1E 7JE, England.
RP Edirisinghe, M (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.
EM m.edirisinghe@ucl.ac.uk
FU EPSRC [GR/S 97880]; Royal Society, UK; Engineering and Physical Sciences
   Research Council [GR/S97880/02, GR/S97880/01]
FX EPSRC grant GR/S 97880 and the Royal Society, UK (Brian Mercer Fund) are
   gratefully acknowledged for funding the research.
CR Becker BS, 1997, J MATER SCI-MATER M, V8, P793, DOI 10.1023/A:1018525015421
   Boccaccini AR, 2003, J MATER SCI-MATER M, V14, P443, DOI 10.1023/A:1023266902662
   Castillo M, 2003, ADV SPACE RES, V32, P265, DOI 10.1016/S0273-1177(03)00392-2
   Chen QZ, 2006, J AM CERAM SOC, V89, P1534, DOI 10.1111/j.1551-2916.2006.00935.x
   Christel P, 1988, BIOCERAMICS MAT CHAR, V523, P234
   Corbin SF, 1999, MAT SCI ENG A-STRUCT, V262, P192, DOI 10.1016/S0921-5093(98)01019-3
   Dariel MP, 2001, MATER CHEM PHYS, V67, P192, DOI 10.1016/S0254-0584(00)00438-7
   GOMEZ A, 1994, PHYS FLUIDS, V6, P404, DOI 10.1063/1.868037
   Grigoriev DA, 2002, J APPL PHYS, V91, P437, DOI 10.1063/1.1420762
   Hartmann R. P. A., 1996, J AEROSOL SCI, V27, pS177, DOI DOI 10.1016/0021-8502(96)00161-9
   Helmer J. D., 1969, S US CER SURG IMPL C
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   Holtappels P, 2006, FUEL CELLS, V6, P113, DOI 10.1002/fuce.200500116
   Jayasinghe SN, 2004, J EUR CERAM SOC, V24, P2203, DOI 10.1016/j.jeurcernsoc.2003.07.001
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P270, DOI 10.1002/jbm.b.30032
   Lu WW, 2003, J MATER SCI-MATER M, V14, P1039, DOI 10.1023/B:JMSM.0000004000.56814.9e
   Luyten J, 2005, ADV APPL CERAM, V104, P4, DOI 10.1179/174367605225010990
   MIAO X, 2003, BIOCERAMICS, V15, P595
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Muthutantri A, 2008, J MATER SCI-MATER M, V19, P1485, DOI 10.1007/s10856-008-3379-4
   Okii N, 2001, NEUROL MED-CHIR, V41, P100, DOI 10.2176/nmc.41.100
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Robinson JH, 2008, KEY ENG MATER, V361-363, P3, DOI 10.4028/www.scientific.net/KEM.361-363.3
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Steffens HD, 1999, J THERM SPRAY TECHN, V8, P517, DOI 10.1361/105996399770350197
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Tulliani JM, 1999, J AM CERAM SOC, V82, P961, DOI 10.1111/j.1151-2916.1999.tb01860.x
   Vaz L, 1999, J MATER SCI-MATER M, V10, P239, DOI 10.1023/A:1008910213166
   Werner J, 2002, BIOMATERIALS, V23, P4285, DOI 10.1016/S0142-9612(02)00191-6
   Yoshida K, 2006, J EUR CERAM SOC, V26, P515, DOI 10.1016/j.jeurceramsoc.2005.07.047
   Zeschky J, 2005, ACTA MATER, V53, P927, DOI 10.1016/j.actamat.2004.10.039
NR 31
TC 20
Z9 20
U1 0
U2 14
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD DEC 6
PY 2008
VL 5
IS 29
BP 1459
EP 1467
DI 10.1098/rsif.2008.0092
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 382YY
UT WOS:000261642500007
PM 18426768
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Rimola, A
   Corno, M
   Zicovich-Wilson, CM
   Ugliengo, P
AF Rimola, Albert
   Corno, Marta
   Marcelo Zicovich-Wilson, Claudio
   Ugliengo, Piero
TI Ab Initio Modeling of Protein/Biomaterial Interactions: Glycine
   Adsorption at Hydroxyapatite Surfaces
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SOLID-STATE NMR; DRUG-DELIVERY; AMINO-ACIDS; GAS-PHASE; STATHERIN;
   CRYSTALS; PROTEIN; RECOGNITION; ZWITTERION; AMELOGENIN
AB How does glycine adsorb at hydroxyapatite surfaces? Ab initio simulations based on periodic B3LYP GTO calculations reveal the detailed mechanism of binding to the (001) and (010) Surfaces by shedding light on how acid and basic amino acid residues of proteins interact with hydroxyapatite based biomaterials.
C1 [Rimola, Albert; Corno, Marta; Ugliengo, Piero] Univ Turin, IFM, Dipartimento Chim, NIS Ctr Excellence,Natl Consortium, I-10125 Turin, Italy.
   [Rimola, Albert; Corno, Marta; Ugliengo, Piero] Univ Turin, INSTM Mat Sci & Technol, I-10125 Turin, Italy.
   [Marcelo Zicovich-Wilson, Claudio] Univ Autonoma Estado Morelos, Fac Ciencias, Cuernavaca 62209, Morelos, Mexico.
RP Ugliengo, P (reprint author), Univ Turin, IFM, Dipartimento Chim, NIS Ctr Excellence,Natl Consortium, Via P Giuria 7, I-10125 Turin, Italy.
EM piero.ugliengo@unito.it
RI Rimola, Albert/K-1813-2014; ugliengo, piero/H-6373-2015;
   zicovich-wilson, claudio/B-7789-2015; Corno, Marta/I-4310-2012
OI Rimola, Albert/0000-0002-9637-4554; ugliengo, piero/0000-0001-8886-9832;
   zicovich-wilson, claudio/0000-0001-6116-9166; Corno,
   Marta/0000-0001-7248-2705
FU CONACYT [46983]; MIUR [COFIN2006, Prot. 2006032335005]
FX A.R. is indebted to the Ramon Areces Foundation for a postodoctoral
   fellowship. C.Z.W. thanks CONACYT (Project 46983) for financial support.
   Financial support from MIUR (Project COFIN2006, Prot. 2006032335005) and
   from the Regione Piemonte (Bando ricerca scientifica Piemonte 2004,
   Settore: Nanotecnologie e nanoscienze, "Materiali nanostrutturati
   biocompatibili per applicazioni biomediche") is gratefully acknowledged.
   Roberto Orlando is acknowledged for critically reading the
CR Bertozzi C. R., 2006, Publication No. WO/2006/062776, Patent No. 2006062776
   Capriotti LA, 2007, J AM CHEM SOC, V129, P5281, DOI 10.1021/ja070356b
   Chen PH, 2008, J AM CHEM SOC, V130, P2862, DOI 10.1021/ja076607y
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   CORNO M, LANGMUIR UNPUB
   Corno M, 2007, EUR J MINERAL, V19, P757, DOI 10.1127/0935-1221/2007/0019-1764
   Corral I, 2006, CHEM-EUR J, V12, P6787, DOI 10.1002/chem.200600127
   Gibson JM, 2006, J AM CHEM SOC, V128, P5364, DOI 10.1021/ja056731m
   Goobes R, 2007, BIOCHEMISTRY-US, V46, P4725, DOI 10.1021/bi602345a
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hijon N, 2004, CHEM MATER, V16, P1451, DOI 10.1021/cm031164s
   JENSEN JH, 1995, J AM CHEM SOC, V117, P8159, DOI 10.1021/ja00136a013
   Kirkham J, 2002, CURR OPIN COLLOID IN, V7, P124, DOI 10.1016/S1359-0294(02)00017-1
   Kokubo T., 1990, BIOMED MAT RES, V24, P721, DOI DOI 10.1002/JBM.820240607
   Long JR, 2001, BIOCHEMISTRY-US, V40, P15451, DOI 10.1021/bi010864c
   Makrodimitris K, 2007, J AM CHEM SOC, V129, P13713, DOI 10.1021/ja074602v
   Palazzo B, 2005, MAT SCI ENG C-BIO S, V25, P207, DOI 10.1016/j.msec.2005.01.011
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   Ratner B. D., 2004, BIOMATERIAL SCI INTR
   Rimola A, 2006, LANGMUIR, V22, P6593, DOI 10.1021/la0610203
   Schroder E, 2003, ANAL BIOCHEM, V313, P176, DOI 10.1016/S0003-2697(02)00567-5
   Shaw WJ, 2004, J BIOL CHEM, V279, P40263, DOI 10.1074/jbc.C400322200
   Shaw WJ, 2000, J AM CHEM SOC, V122, P1709, DOI 10.1021/ja9842823
   SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701
   Song J, 2005, J AM CHEM SOC, V127, P3366, DOI 10.1021/ja043776z
   Strittmatter EF, 2000, J PHYS CHEM A, V104, P9793, DOI 10.1021/jp002970e
   Tomsia AP, 2005, ADV ENG MATER, V7, P999, DOI 10.1002/adem.200500143
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   VoDinh T, 2007, NANOTECHNOLOGY IN BIOLOGY AND MEDICINE: METHODS, DEVICES, AND APPLICATIONS, P1
   Wallwork ML, 2001, LANGMUIR, V17, P2508, DOI 10.1021/la001281r
   Wierzbicki A, 2000, J MOL STRUC-THEOCHEM, V529, P73, DOI 10.1016/S0166-1280(00)00534-0
NR 33
TC 69
Z9 69
U1 6
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD DEC 3
PY 2008
VL 130
IS 48
BP 16181
EP +
DI 10.1021/ja806520d
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 406UG
UT WOS:000263319800028
PM 18989958
DA 2018-10-20
ER

PT J
AU Palestino, G
   Agarwal, V
   Aulombard, R
   Perez, E
   Gergely, C
AF Palestino, Gabriela
   Agarwal, Vivechana
   Aulombard, Roger
   Perez, Elias
   Gergely, Csilla
TI Biosensing and Protein Fluorescence Enhancement by Functionalized Porous
   Silicon Devices
SO LANGMUIR
LA English
DT Article
ID DIRECT ELECTRON-TRANSFER; HYDROGEN-PEROXIDE; MESOPOROUS SILICA; OXIDASE;
   MICROCAVITIES; STABILITY; IMMOBILIZATION
AB Porous silicon (PSi) is a promising biomaterial presenting the advantage of being biocompatible and bioresorbable. Due to the large specific surface area and unique optical features, these microporous structures are excellent candidates for biosensing applications. Investigating device functionality and developing simple Si-based transducers need to be addressed in novel biological detection. Our work demonstrates that, among the various PSi configurations for molecular detection, PSi microcavity structure demonstrates the best biosensing performance, reflected through the enhanced luminescence response and the changes in the refractive index. For successful immobilization, molecular infiltration and confinement are the two key factors that are controlled by the pore size distribution of the PSi microcavities and by the surface modification obtained by silane-glutaraldehyde chemistry. Enhancement of the fluorescence emission of confined fluorescent biomolecules in the active layer of PSi microcavities was observed for a nonlabeled protein with a natural green fluorescence, the glucose oxidase enzyme (GOX). An increase in the fluorescence emission was also observed when functionalized PSi material was used to detect specific binding between biotin and a low concentration of labeled streptavidin. Evidence for the enzymatic activity of GOX in its adsorbed form is also presented. Use of smart silicon devices, enabling enhancement of fluorescence emission of biomolecules, offers easy-to-use biosensing, based on the luminescence response of the molecules to be detected.
C1 [Palestino, Gabriela; Aulombard, Roger; Gergely, Csilla] Univ Montpellier 2, CNRS, UMR 5650, Etud Semicond Grp, F-34095 Montpellier 5, France.
   [Palestino, Gabriela] Univ Autonoma San Luis Potosi, Fac Ciencias Quim, San Luis Potosi 78000, Mexico.
   [Perez, Elias] Univ Autonoma San Luis Potosi, Inst Fis, San Luis Potosi 78000, Mexico.
   [Agarwal, Vivechana] CIICAP UAEM, Cuernavaca, Morelos, Mexico.
RP Gergely, C (reprint author), Univ Montpellier 2, CNRS, UMR 5650, Etud Semicond Grp, Pl Eugene Bataillon, F-34095 Montpellier 5, France.
EM gergely@ges.univ-montp2.fr
RI Perez, Elias/D-3281-2011
OI Perez, Elias/0000-0003-3002-7100
FU Phoremost European Network of Excellence [511616]; Nano-Photonics to
   Realise Molecular Scale Technologies; Ecos-North French-Mexican program
   [M06P01]; CONACyT [57631]
FX This work was supported by the Phoremost European Network of Excellence,
   Project Nr. 511616: "Nano-Photonics to Realise Molecular Scale
   Technologies" and the M06P01 Ecos-North French-Mexican program. Authors
   thank E. Estephan and M. Saab for help with the AFM images. Thanks are
   going to F. Cuisinier and L. Zimanyi for valuable discussions. G.P.
   thanks PROMEP support. V.A. acknowledges the financial support from the
   CONACyT (57631) project and the technical support from D. Becerra.
CR Agarwal V, 2007, J PHYS D APPL PHYS, V40, P3203, DOI 10.1088/0022-3727/40/10/026
   Agarwal V, 2003, APPL PHYS LETT, V82, P1512, DOI 10.1063/1.1559420
   Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t
   Bengtsson M, 2000, PHYS STATUS SOLIDI A, V182, P533, DOI 10.1002/1521-396X(200011)182:1<533::AID-PSSA533>3.0.CO;2-W
   CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561
   Canham LT, 1999, ADV MATER, V11, P1505, DOI 10.1002/(SICI)1521-4095(199912)11:18<1505::AID-ADMA1505>3.3.CO;2-3
   Chan S, 2001, MAT SCI ENG C-BIO S, V15, P277, DOI 10.1016/S0928-4931(01)00219-3
   Chan S, 2001, J AM CHEM SOC, V123, P11797, DOI 10.1021/ja016555r
   Chan S, 2001, OPT MATER, V17, P31, DOI 10.1016/S0925-3467(01)00016-7
   Chin V, 2001, ADV MATER, V13, P1877, DOI 10.1002/1521-4095(200112)13:24<1877::AID-ADMA1877>3.0.CO;2-4
   Dai ZH, 2004, BIOSENS BIOELECTRON, V19, P861, DOI 10.1016/j.bios.2003.08.024
   DeLouise LA, 2004, ANAL CHEM, V76, P6915, DOI 10.1021/ac0488208
   Han KC, 2005, BIOCHEM ENG J, V22, P161, DOI 10.1016/j.bej.2004.09.011
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   He F, 2006, ADV FUNCT MATER, V16, P91, DOI 10.1002/adfm.200500602
   Ivnitski D, 2008, SMALL, V4, P357, DOI 10.1002/smll.200700725
   KILLIAN KA, 2007, ADV FUNCT MATER, P1
   Lees IN, 2003, LANGMUIR, V19, P9812, DOI 10.1021/la035197y
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Lu YJ, 2007, ADV FUNCT MATER, V17, P2160, DOI 10.1002/adfm.200600505
   Matveeva EG, 2007, ANAL BIOCHEM, V363, P239, DOI 10.1016/j.ab.2007.01.030
   MUNOLLI V, 1999, 2 SCI TECHNOL, V14, P1052
   Orth RN, 2003, BIOMED MICRODEVICES, V5, P29, DOI 10.1023/A:1024459215654
   Ouyang H, 2005, ADV FUNCT MATER, V15, P1851, DOI 10.1002/adfm.200500218
   Ouyang H, 2005, P SPIE, V6005
   Palestino AG, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2786596
   PALESTINO G, 2008, SPIE, V6991
   Pickup JC, 2005, BIOSENS BIOELECTRON, V20, P2555, DOI 10.1016/j.bios.2004.10.002
   Sapelkin AV, 2006, BIOMATERIALS, V27, P842, DOI 10.1016/j.biomaterials.2005.06.023
   Setzu S., 1999, J LUMIN, V80, P129
   Yoshimoto M, 2006, BIOCHEM ENG J, V30, P158, DOI 10.1016/j.bej.2006.03.004
   Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391
NR 32
TC 43
Z9 43
U1 1
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 2
PY 2008
VL 24
IS 23
BP 13765
EP 13771
DI 10.1021/la8015707
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 376XO
UT WOS:000261216500077
PM 18959435
DA 2018-10-20
ER

PT J
AU Hook, F
   Kasemo, B
   Grunze, M
   Zauscher, S
AF Hook, Fredrik
   Kasemo, Bengt
   Grunze, Michael
   Zauscher, Stefan
TI Quantitative Biological Surface Science: Challenges and Recent Advances
SO ACS NANO
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; SELF-ASSEMBLED MONOLAYERS; SINGLE-MOLECULE
   DETECTION; LIPID-MEMBRANES; WATER; ADSORPTION; CONVERSATION;
   COADSORPTION; INTERFACE; PROTEINS
AB Biological surface science is a broad, interdisciplinary subfield of surface science, where properties and processes at biological and synthetic surfaces and interfaces are investigated, and where biofunctional surfaces are fabricated. The need to study and to understand biological surfaces and interfaces in liquid environments provides sizable challenges M, as well as fascinating opportunities. Here, we report on recent progress in biological surface E. science that was described within the program assembled by the Biomaterial Interface Division of the Science and Technology of Materials, Interfaces and Processes (www.avs.org) during their 55th International Symposium and Exhibition held in Boston, October 19-24, 2008. The selected examples show that the rapid progress in nanoscience and nanotechnology, hand-in-hand with theory and simulation, provides increasingly sophisticated methods and tools to unravel the mechanisms and details of complex processes at biological surfaces and in-depth understanding of biomolecular surface interactions.
C1 [Hook, Fredrik; Kasemo, Bengt] Chalmers, Dept Appl Phys, SE-41296 Gothenburg, Sweden.
   [Grunze, Michael] Univ Heidelberg, D-69120 Heidelberg, Germany.
   [Zauscher, Stefan] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA.
RP Hook, F (reprint author), Chalmers, Dept Appl Phys, SE-41296 Gothenburg, Sweden.
EM fredrik.hook@chalmers.se
RI Hook, Fredrik/F-6701-2010; Grunze, Michael/H-1600-2013
CR Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002
   BRUCKBAUER A, 2007, BIOPHYS J, V93, P3210
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cho NJ, 2007, J AM CHEM SOC, V129, P10050, DOI 10.1021/ja0701412
   Dahlin AB, 2008, ACS NANO, V2, P2174, DOI 10.1021/nn800254h
   DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826
   Gunnarsson A, 2008, NANO LETT, V8, P183, DOI 10.1021/nl072401j
   HANSMA PK, 1989, SCIENCE, V243, P641, DOI 10.1126/science.2464851
   Heydt M, 2007, J ADHESION, V83, P417, DOI 10.1080/00218460701377388
   JONSSON M, 2008, ANAL CHEM, V71, P2174
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Knoll W, 2008, ELECTROCHIM ACTA, V53, P6680, DOI 10.1016/j.electacta.2008.02.121
   Luthgens E, 2005, CHEMPHYSCHEM, V6, P444, DOI 10.1002/cphc.200400446
   Maccarini M, 2007, BIOINTERPHASES, V2, pMR1, DOI 10.1116/1.2768902
   Mamatkulov SI, 2004, LANGMUIR, V20, P4756, DOI 10.1021/la036036x
   Mamdouh W, 2008, J AM CHEM SOC, V130, P695, DOI 10.1021/ja076832f
   MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483
   Reimhult E, 2004, ANAL CHEM, V76, P7211, DOI 10.1021/ac0492970
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Schiller SM, 2003, ANGEW CHEM INT EDIT, V42, P208, DOI 10.1002/anie.200390080
   Schilp S, 2007, BIOINTERPHASES, V2, P143, DOI 10.1116/1.2806729
   Schmitt EK, 2008, SOFT MATTER, V4, P250, DOI 10.1039/b716723g
   Schmitt EK, 2006, BIOPHYS J, V91, P2163, DOI 10.1529/biophysj.106.083592
   Schwendel D, 2003, LANGMUIR, V19, P2284, DOI 10.1021/la026716k
   Sebba DS, 2008, APPL PHYS B-LASERS O, V93, P69, DOI 10.1007/s00340-008-3212-2
   Shevchuk AI, 2006, ANGEW CHEM INT EDIT, V45, P2212, DOI 10.1002/anie.200503915
   WANG G, 2008, REV SCI INSTRUM, V79
   Wang RLC, 2000, PHYS CHEM CHEM PHYS, V2, P1721, DOI 10.1039/a909598e
   Weiskopf D, 2007, LANGMUIR, V23, P9134, DOI 10.1021/la701080u
   Weiss PS, 2008, ACS NANO, V2, P1979, DOI 10.1021/nn800663f
   Weiss PS, 2007, ACS NANO, V1, P3, DOI 10.1021/nn7001294
   Xu SL, 2006, NANO LETT, V6, P1434, DOI 10.1021/nl060563u
   2008, BIOINTERPHASES, V3, pFA1
NR 34
TC 40
Z9 40
U1 0
U2 42
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
J9 ACS NANO
JI ACS Nano
PD DEC
PY 2008
VL 2
IS 12
BP 2428
EP 2436
DI 10.1021/nn800800v
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 388MJ
UT WOS:000262023600005
PM 19206275
DA 2018-10-20
ER

PT J
AU Wollensak, G
   Iomdina, E
AF Wollensak, Gregor
   Iomdina, Elena
TI Long-term biomechanical properties after collagen crosslinking of sclera
   using glyceraldehyde
SO ACTA OPHTHALMOLOGICA
LA English
DT Article
DE collagen crosslinking; glyceraldehyde; myopia; sclera
ID MYOPIA PROGRESSION; MAILLARD REACTION; OCULAR-TISSUES; GLYCATION;
   KERATOCONUS; COMPLICATIONS; ORGANIZATION; PRODUCTS; PROTEINS; GELATIN
AB Chemical crosslinking by glyceraldehyde has been shown to increase significantly the biomechanical rigidity of sclera. It might therefore become an option for a sclera-based treatment of progressive myopia. The present pilot study was designed to test the long-term biomechanical efficiency of the new crosslinking method.
   Six Chinchilla rabbits were treated with sequential sub-Tenon's injections of 0.15 ml 0.5 m glyceraldehyde, which were given in the supero-nasal quadrant of the right eye (OD) five times over 14 days. The rabbits were killed 4 months and 8 months after crosslinking treatment, respectively. Biomechanical stress-strain measurements of scleral strips from the treatment area were performed and compared to non-treated contralateral control sclera using a microcomputer-controlled biomaterial testing device. In addition, the eyes were examined histologically by light microscopy to evaluate possible side-effects.
   Following the crosslinking treatment, the ultimate stress was 10.2 +/- 2.3 MPa after 4 months and 8.5 +/- 2.2 MPa after 8 months versus 2.4 +/- 0.3 MPa in the controls (increases of 325% and 254.17%, respectively); Young's modulus was 104.6 +/- 13.7 MPa after 4 months and 53.2 +/- 5.2 MPa after 8 months versus 9.6 +/- 1.3 MPa in the controls (increases of 989.6% and 554.17%, respectively); and ultimate strain was 15.8 +/- 1.5% after 4 months and 24.1 +/- 0.7% after 8 months versus 38.4 +/- 4.6% in the controls (decreases of 58.84% and 37.24%, respectively). Histologically, no side-effects were found.
   Our new method of scleral collagen crosslinking proved very efficient in increasing scleral biomechanical strength over a period of up to 8 months. Glyceraldehyde can be applied easily by sequential parabulbar injections. Before clinical application in myopic patients, a study in an animal myopia model is recommended.
C1 [Wollensak, Gregor] Univ Halle Wittenberg, Dept Ophthalmol, Halle, Germany.
   [Iomdina, Elena] Moscow Helmholtz Res Inst Eye Dis, Moscow, Russia.
RP Wollensak, G (reprint author), Wildentensteig 4, D-14195 Berlin, Germany.
EM gwollens@hotmail.com
CR Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1181
   Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618
   AWETISSOW ES, 1980, KLIN MONATSBL AUGENH, V176, P777, DOI 10.1055/s-2008-1057552
   BAI PM, 1992, CONNECT TISSUE RES, V28, P1, DOI 10.3109/03008209209014224
   Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5
   BAILEY AJ, 1987, EYE-T OPHTH SOC UK, V1, P175, DOI 10.1038/eye.1987.34
   Bell G R, 1993, J Am Optom Assoc, V64, P332
   BELL GR, 1978, J AM OPTOM ASSOC, V49, P1399
   Bullimore MA, 2002, INVEST OPHTH VIS SCI, V43, P2110
   Edwards MH, 1996, ACTA OPHTHALMOL SCAN, V74, P213
   FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314
   Gerrard JA, 2002, FOOD CHEM, V79, P343, DOI 10.1016/S0308-8146(02)00174-7
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   Iomdina E.N., 1993, P 14 C BIOM PAR INT, P616
   Kosmala JD, 2000, BIOMATERIALS, V21, P2019, DOI 10.1016/S0142-9612(00)00057-0
   Kumar CM, 2003, EYE, V17, P1003, DOI 10.1038/sj.eye.6700501
   Lee KW, 1999, BBA-MOL BASIS DIS, V1453, P141, DOI 10.1016/S0925-4439(98)00097-0
   LEE RE, 1981, EXP EYE RES, V32, P737, DOI 10.1016/0014-4835(81)90023-3
   MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133
   McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0
   MECHANIC G, 1972, BIOCHEM BIOPH RES CO, V47, P267, DOI 10.1016/S0006-291X(72)80038-X
   Paul RG, 1996, INT J BIOCHEM CELL B, V28, P1297, DOI 10.1016/S1357-2725(96)00079-9
   Pierro L, 1999, RETINA-J RET VIT DIS, V19, P401, DOI 10.1097/00006982-199909000-00005
   Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009
   SADY C, 1995, BIOCHEM BIOPH RES CO, V214, P793, DOI 10.1006/bbrc.1995.2356
   Saw SM, 2002, BRIT J OPHTHALMOL, V86, P1306, DOI 10.1136/bjo.86.11.1306
   Seiler T, 2000, GRAEF ARCH CLIN EXP, V238, P822, DOI 10.1007/s004179900111
   Tano Y, 2002, AM J OPHTHALMOL, V134, P645, DOI 10.1016/S0002-9394(02)01883-4
   Tessier FJ, 2003, BIOCHEM J, V369, P705, DOI 10.1042/BJ20020668
   Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P1201, DOI 10.1167/iovs.06-0737
   Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5
   Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4
   Weale RA, 2003, SURV OPHTHALMOL, V48, P515, DOI 10.1016/S0039-6257(03)00086-9
   Wildsoet CF, 1999, OPTOMETRY VISION SCI, V76, P341, DOI 10.1097/00006324-199906000-00001
   Wollensak G, 2005, ACTA OPHTHALMOL SCAN, V83, P477, DOI 10.1111/j.1600-0420.2005.00447.x
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   WOLLENSAK G, 2008, J CATARACT IN PRESS
   Wollensak G, 2006, CURR OPIN OPHTHALMOL, V17, P356, DOI 10.1097/01.icu.0000233954.86723.25
   Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071
   ZUCLICH JA, 1989, HEALTH PHYS, V56, P671, DOI 10.1097/00004032-198905000-00012
NR 41
TC 24
Z9 29
U1 2
U2 7
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1755-375X
J9 ACTA OPHTHALMOL
JI Acta Ophthalmol.
PD DEC
PY 2008
VL 86
IS 8
BP 887
EP 893
DI 10.1111/j.1755-3768.2007.01156.x
PG 7
WC Ophthalmology
SC Ophthalmology
GA 377IA
UT WOS:000261243700015
PM 18537936
OA Bronze
DA 2018-10-20
ER

PT J
AU Kretlow, JD
   Mikos, AG
AF Kretlow, James D.
   Mikos, Antonios G.
TI From Material to Tissue: Biomaterial Development, Scaffold Fabrication,
   and Tissue Engineering
SO AICHE JOURNAL
LA English
DT Review
DE biomaterials; tissue engineering; drug delivery; polymer scaffolds;
   hydrogels; biomimetics; bioreactors
ID MARROW STROMAL CELLS; OLIGO(POLY(ETHYLENE GLYCOL) FUMARATE); CO-ETHYLENE
   GLYCOL); IN-VITRO DEGRADATION; FLOW PERFUSION BIOREACTOR;
   POLY(DL-LACTIC-CO-GLYCOLIC ACID) FOAMS; BIODEGRADABLE POLYMER
   MICROPARTICLES; CATIONIZED GELATIN MICROSPHERES; CROSS-LINKING
   CHARACTERISTICS; BONE MORPHOGENETIC PROTEIN-2
AB The need for techniques to facilitate the regeneration of failing or destroyed tissues remains great with the aging of the worldwide population and the continued incidence of trauma and diseases such as cancer. A 16-year history in biomaterial scaffold development and tissue engineering is examined, beginning with the synthesis of novel materials and fabrication of 3D porous scaffolds. Exploring cell-scaffold interactions and subsequently cellular delivery using biomaterial carriers, we have developed a variety of techniques for bone and cartilage engineering. In addition to delivering cells, we have utilized growth factors, DNA, and peptides to improve the in vitro and in vivo regeneration of tissues. This review covers important developments and discoveries within our laboratory, and the increasing breadth in the scope of our work within the expanding field of tissue engineering is presented. (C) 2008 American Institute of Chemical Engineers AIChE J, 54: 3048-3067, 2008
C1 [Kretlow, James D.; Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   [Mikos, Antonios G.] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77251 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
EM mikos@rice.edu
FU National Institutes of Health; National Science Foundation; NASA;
   Whitaker Foundation; Rice University Institute of Biosciences and
   Bioengineering through the Biotechnology Training [T32 GM008362];
   National Institute of General Medical Sciences [T32 GM007330]
FX The authors acknowledge financial support by the National Institutes of
   Health, National Science Foundation, NASA, Whitaker Foundation, and
   other agencies and companies for research towards the development of new
   biomaterials (AGM). They thank all the current and past undergraduate
   students, graduate students, and postdoctoral fellows for their hard
   work during the past 16 years. They also thank their colleagues at Rice
   University and their collaborators around the world for their
   significant contributions over the years. JDK acknowledges support by
   the National Institutes of Health and Rice University Institute of
   Biosciences and Bioengineering through the Biotechnology Training Grant
   (T32 GM008362). JDK is a student in the Baylor College of Medicine
   Medical Scientist Training Program and was also supported by the
   National Institute of General Medical Sciences (T32 GM007330).
CR Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   Ambrose CG, 2003, CLIN ORTHOP RELAT R, P279, DOI 10.1097/01.blo.0000093920.26658.ae
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Behravesh E, 2003, BIOMATERIALS, V24, P4365, DOI 10.1016/S0142-9612(03)00338-7
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P153, DOI 10.1021/bm010137x
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P1263, DOI 10.1021/bm020067
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P374, DOI 10.1021/bm010158r
   Blum JS, 2004, BIOMATERIALS, V25, P5809, DOI 10.1016/j.biomaterials.2004.01.035
   Blum JS, 2004, J ORTHOPAED RES, V22, P411, DOI 10.1016/j.orthres.2003.08.006
   Blum JS, 2003, HUM GENE THER, V14, P1689, DOI 10.1089/104303403322611719
   Blum JS, 2001, J CELL BIOCHEM, V80, P532, DOI 10.1002/1097-4644(20010315)80:4<532::AID-JCB1007>3.0.CO;2-B
   Bodde EWH, 2008, J BIOMED MATER RES A, V85A, P206, DOI 10.1002/jbm.a.31549
   BODDE EW, J BIOMED A IN PRESS
   Botchwey EA, 2003, J BIOMED MATER RES A, V67A, P357, DOI 10.1002/jbm.a.10111
   BUCK BE, 1989, CLIN ORTHOP RELAT R, P129
   Burkus JK, 2002, SPINE, V27, P2396, DOI 10.1097/01.BRS.0000030193.26290.DD
   Butler D, 1998, NATURE, V391, P320
   Cheng MH, 2006, PLAST RECONSTR SURG, V118, p1E, DOI 10.1097/01.prs.0000221120.11128.1a
   Christenson EM, 2007, BIOMACROMOLECULES, V8, P3806, DOI 10.1021/bm7007235
   Cleek RL, 1997, J BIOMED MATER RES, V35, P525, DOI 10.1002/(SICI)1097-4636(19970615)35:4<525::AID-JBM12>3.0.CO;2-A
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   Dean D, 2003, TISSUE ENG, V9, P495, DOI 10.1089/107632703322066679
   Eaglstein WH, 1997, CLIN THER, V19, P894, DOI 10.1016/S0149-2918(97)80043-4
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1327, DOI 10.1021/bm030028d
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2004, J BIOMED MATER RES A, V68A, P428, DOI 10.1002/jbm.a.20073
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976
   Godbey WT, 2000, J BIOMED MATER RES, V51, P321, DOI 10.1002/1097-4636(20000905)51:3<321::AID-JBM5>3.0.CO;2-R
   Godbey WT, 2001, BIOMATERIALS, V22, P471, DOI 10.1016/S0142-9612(00)00203-9
   Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q
   Godbey WT, 1999, P NATL ACAD SCI USA, V96, P5177, DOI 10.1073/pnas.96.9.5177
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Goodship AE, 1998, ACTA ASTRONAUT, V43, P65, DOI 10.1016/S0094-5765(98)00144-1
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Habraken WJEM, 2006, J BIOMAT SCI-POLYM E, V17, P1057, DOI 10.1163/156856206778366004
   HABRAKEN WJ, J BIOMED A IN PRESS
   Habraken WJEM, 2008, BIOMATERIALS, V29, P2464, DOI 10.1016/j.biomaterials.2008.02.012
   HACKER MC, J BIOMED A IN PRESS
   Hacker M, 2007, BIOMATERIALS, V28, P3497, DOI 10.1016/j.biomaterials.2007.04.018
   Hacker MC, 2008, BIOMACROMOLECULES, V9, P1558, DOI 10.1021/bm8000414
   Hacker MC, 2006, TISSUE ENG, V12, P2049, DOI 10.1089/ten.2006.12.2049
   Haesslein A, 2008, ACTA BIOMATER, V4, P1, DOI 10.1016/j.actbio.2007.08.011
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Healthcare Cost and Utilization Project (HCUP), HEALTHC COST UT PROJ
   Hedberg EL, 2005, TISSUE ENG, V11, P1356, DOI 10.1089/ten.2005.11.1356
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   Hedberg EL, 2005, J BIOMED MATER RES A, V72A, P343, DOI 10.1002/jbm.a.30265
   Hedberg EL, 2005, BIOMATERIALS, V26, P3215, DOI 10.1016/j.biomaterials.2004.09.012
   Hedberg EL, 2002, J CONTROL RELEASE, V84, P137, DOI 10.1016/S0168-3659(02)00261-4
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Holtorf HL, 2005, BIOMATERIALS, V26, P6208, DOI 10.1016/j.biomaterials.2005.04.006
   Holtorf HL, 2005, J BIOMED MATER RES A, V74A, P171, DOI 10.1002/jbm.a.30330
   Horch RA, 2004, BIOMACROMOLECULES, V5, P1990, DOI 10.1021/bm049768s
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Jo S, 2001, BIOMACROMOLECULES, V2, P255, DOI 10.1021/bm000107e
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   Kajikawa Y, 2007, J CELL PHYSIOL, V210, P684, DOI 10.1002/jcp.20876
   Kasper FK, 2006, J BIOMED MATER RES A, V78A, P823, DOI 10.1002/jbm.a.30736
   Kasper FK, 2006, J BIOMED MATER RES A, V78A, P335, DOI 10.1002/jbm.a.30698
   Kasper FK, 2005, J CONTROL RELEASE, V107, P547, DOI 10.1016/j.jconrel.2005.07.005
   Kasper FK, 2005, J CONTROL RELEASE, V104, P521, DOI 10.1016/j.jconrel.2005.03.008
   Kessler P, 2005, BRIT J ORAL MAX SURG, V43, P51, DOI 10.1016/j.bjoms.2004.08.026
   KLOUDA L, 2008, TRANSLATIONAL APPROA, P325
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEACH CS, 1990, ACTA ASTRONAUT, V21, P659, DOI 10.1016/0094-5765(90)90077-X
   Leeuwenburgh SCG, 2007, J BIOMAT SCI-POLYM E, V18, P1547
   Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137
   Link DP, 2008, BIOMATERIALS, V29, P675, DOI 10.1016/j.biomaterials.2007.10.029
   LINK DP, 2008, J BIOMED MAT RES A
   Liu GZ, 2001, J CELL BIOCHEM, V83, P129, DOI 10.1002/jcb.1208
   Liu Q, 2000, BIOMATERIALS, V21, P2163, DOI 10.1016/S0142-9612(00)00137-X
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu LC, 2001, J BONE JOINT SURG AM, V83A, pS82
   Lu LC, 1998, J BIOMAT SCI-POLYM E, V9, P1187
   Lu LC, 1999, BIOMATERIALS, V20, P2351, DOI 10.1016/S0142-9612(99)00164-7
   Lu LC, 2001, BIOMATERIALS, V22, P291, DOI 10.1016/S0142-9612(00)00179-4
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   Mauney JR, 2004, CALCIFIED TISSUE INT, V74, P458, DOI 10.1007/s00223-003-0104-7
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Miller M J, 1996, Tissue Eng, V2, P51, DOI 10.1089/ten.1996.2.51
   Mistry AS, 2007, J BIOMED MATER RES A, V83A, P940, DOI 10.1002/jbm.a.31280
   MISTRY AS, 2007, THESIS RICE U HOUSTO
   Mofid MM, 2002, PLAST RECONSTR SURG, V109, P1621, DOI 10.1097/00006534-200204150-00020
   Murphy MB, 2007, BIOMACROMOLECULES, V8, P2237, DOI 10.1021/bm070121s
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   Oshima Y, 2005, J HISTOCHEM CYTOCHEM, V53, P207, DOI 10.1369/jhc.4A6280.2005
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   PARK H, J BIOMED A IN PRESS
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1
   PATEL ZS, BONE IN PRESS
   Payne RG, 2002, BIOMATERIALS, V23, P4381, DOI 10.1016/S0142-9612(02)00186-2
   Payne RG, 2002, BIOMATERIALS, V23, P4359, DOI 10.1016/S0142-9612(02)00184-9
   Payne RG, 2002, BIOMATERIALS, V23, P4373, DOI 10.1016/S0142-9612(02)00185-0
   Peppas NA, 2004, AICHE J, V50, P536, DOI 10.1002/aic.10048
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Peter SJ, 1999, J BIOMAT SCI-POLYM E, V10, P363, DOI 10.1163/156856299X00423
   Peter SJ, 1997, J BIOMAT SCI-POLYM E, V8, P893, DOI 10.1163/156856297X00074
   Peter SJ, 1998, J CELL BIOCHEM, V71, P55, DOI 10.1002/(SICI)1097-4644(19981001)71:1<55::AID-JCB6>3.0.CO;2-0
   PHAM QP, 2008, J BIOMED A IN PRESS
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Purdue Gary F., 1997, Journal of Burn Care and Rehabilitation, V18, P52, DOI 10.1097/00004630-199701000-00009
   Ruhe PQ, 2006, TISSUE ENG, V12, P789, DOI 10.1089/ten.2006.12.789
   Ruhe PQ, 2005, J BIOMED MATER RES A, V74A, P533, DOI 10.1002/jbm.a.30341
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Saraf A, 2008, BIOMACROMOLECULES, V9, P818, DOI 10.1021/bm701146f
   Shi XF, 2005, NANOTECHNOLOGY, V16, pS531, DOI 10.1088/0927-4484/16/7/030
   Shi XF, 2008, J BIOMED MATER RES A, V86A, P813, DOI 10.1002/jbm.a.31671
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Shin H, 2005, BIOMATERIALS, V26, P3645, DOI 10.1016/j.biomaterials.2004.09.050
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin H, 2003, BIOMACROMOLECULES, V4, P552, DOI 10.1021/bm020121m
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Shung AK, 2003, TISSUE ENG, V9, P243, DOI 10.1089/107632703764664710
   Shung AK, 2002, J BIOMAT SCI-POLYM E, V13, P95, DOI 10.1163/156856202753525963
   Sikavitsas VI, 2005, ANN BIOMED ENG, V33, P63, DOI 10.1007/s10439-005-8963-x
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Sitharaman B, 2007, J BIOMAT SCI-POLYM E, V18, P655, DOI 10.1163/156856207781034133
   Sitharaman B, 2007, CONTRAST MEDIA MOL I, V2, P139, DOI 10.1002/cmmi.140
   Suggs LJ, 1998, J BIOMAT SCI-POLYM E, V9, P653, DOI 10.1163/156856298X00073
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   Suggs LJ, 1998, J BIOMED MATER RES, V42, P312, DOI 10.1002/(SICI)1097-4636(199811)42:2<312::AID-JBM17>3.0.CO;2-K
   Suggs LJ, 1999, BIOMATERIALS, V20, P683, DOI 10.1016/S0142-9612(98)00226-9
   Suggs LJ, 1999, CELL TRANSPLANT, V8, P345, DOI 10.1177/096368979900800402
   Tanahashi K, 2003, J BIOMED MATER RES A, V67A, P1148, DOI 10.1002/jbm.a.10147
   Tanahashi K, 2003, J BIOMED MATER RES A, V67A, P448, DOI 10.1002/jbm.a.10077
   Tanahashi K, 2002, J BIOMED MATER RES, V62, P558, DOI 10.1002/jbm.10284
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Temenoff JS, 2003, BIOMACROMOLECULES, V4, P1605, DOI 10.1021/bm030056w
   Temenoff JS, 2004, J BIOMED MATER RES A, V70A, P235, DOI 10.1002/jbm.a.30064
   Temenoff JS, 2003, J BIOMAT SCI-POLYM E, V14, P989, DOI 10.1163/156856203322381465
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Thomson RC, 1996, BIOMATERIALS, V17, P321, DOI 10.1016/0142-9612(96)85570-0
   Timmer MD, 2003, BIOMACROMOLECULES, V4, P1026, DOI 10.1021/bm0300150
   Timmer MD, 2003, BIOMATERIALS, V24, P4707, DOI 10.1016/S0142-9612(03)00364-8
   Timmer MD, 2003, J BIOMED MATER RES A, V66A, P811, DOI 10.1002/jbm.a.10011
   Timmer MD, 2003, J BIOMAT SCI-POLYM E, V14, P369, DOI 10.1163/156856203321478874
   Timmer MD, 2002, MACROMOLECULES, V35, P4373, DOI 10.1021/ma020028q
   Timmer MD, 2003, BIOMATERIALS, V24, P571, DOI 10.1016/S0142-9612(02)00368-X
   Ueda H, 2007, J BIOMED MATER RES A, V83A, P656, DOI 10.1002/jbm.a.31226
   Vaccaro AR, 2004, SPINE, V29, P1885, DOI 10.1097/01.brs.0000137062.79201.98
   Vaccaro AR, 2005, SPINE, V30, P2709, DOI 10.1097/01.brs.0000190812.08447.ba
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   van den Dolder J, 2003, J BIOMED MATER RES A, V64A, P235, DOI 10.1002/jbm.a.10365
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   WAKE MC, 1995, CELL TRANSPLANT, V4, P275, DOI 10.1177/096368979500400305
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Wolfe MS, 2002, J BIOMED MATER RES, V61, P159, DOI 10.1002/jbm.10058
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   YOUNG S, 2008, THESIS RICE U HOUSTO
   Young S, 2008, TISSUE ENG PT B-REV, V14, P295, DOI 10.1089/ten.teb.2008.0153
   Young S, 2008, J BIOMED MATER RES A, V86A, P182, DOI 10.1002/jbm.a.31639
   Zimmermann C E, 2001, Clin Oral Investig, V5, P214
NR 210
TC 72
Z9 74
U1 4
U2 86
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-1541
EI 1547-5905
J9 AICHE J
JI AICHE J.
PD DEC
PY 2008
VL 54
IS 12
BP 3048
EP 3067
DI 10.1002/aic.11610
PG 20
WC Engineering, Chemical
SC Engineering
GA 375ZX
UT WOS:000261153400002
PM 19756176
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Uygur, F
   Ulkur, E
   Pehlivan, O
   Celikoz, B
AF Uygur, Fatih
   Ulkur, Ersin
   Pehlivan, Oezcan
   Celikoz, Bahattin
TI Soft tissue necrosis following using calcium phosphate cement in
   calcaneal bone cyst: case report
SO ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
LA English
DT Article
DE Calcium phosphate cements; Soft tissue necrosis; Calcenous bone cyst
ID HYDROXYAPATITE CEMENT; IN-VIVO; CERAMICS; MONOXIDE; GRAFT;
   RECONSTRUCTION; AUGMENTATION; SUBSTITUTES; DEFECTS; MARROW
AB Calcium phosphate cements have received widespread attention for their possible role as bone-grafting material and bone fillers in skeletal defects. They were evaluated as a biomaterial in many aspects. No serious harmful effects such as foreign body reaction and tissue necrosis against to calcium phosphate cements have been reported yet. They were accepted as highly biocompatible materials. In this paper, we represent a patient who had soft tissue necrosis around lateral malleolar region, following using percutaneous calcium phosphate cement as a filler bone substitute in calcenous bone cyst. The possible mechanisms were discussed.
C1 [Uygur, Fatih] Haydarpasha Training Hosp, Gulhane Mil Med Acad, Dept Plast & Reconstruct Surg, TR-34668 Istanbul, Turkey.
   Haydarpasha Training Hosp, Gulhane Mil Med Acad, Burn Unit, Istanbul, Turkey.
   Haydarpasha Training Hosp, Fac Med, Istanbul, Turkey.
   [Pehlivan, Oezcan] Haydarpasha Training Hosp, Gulhane Mil Med Acad, Dept Orthoped & Traumatol, Istanbul, Turkey.
   [Pehlivan, Oezcan] Haydarpasha Training Hosp, Fac Med, Istanbul, Turkey.
RP Uygur, F (reprint author), Haydarpasha Training Hosp, Gulhane Mil Med Acad, Dept Plast & Reconstruct Surg, Selimiye Mahallesi Tibbiye, TR-34668 Istanbul, Turkey.
EM fatihuygur@hotmail.com
CR Baker SB, 2002, PLAST RECONSTR SURG, V109, P1789, DOI 10.1097/00006534-200205000-00003
   Bloemers FW, 2003, J BIOMED MATER RES B, V66B, P526, DOI 10.1002/jbm.b.10045
   CHAIN M, 1997, THESIS U ALABAMA BIR
   CHIGIRA M, 1983, J BONE JOINT SURG BR, V65, P633
   Csizy M, 2001, FOOT ANKLE INT, V22, P507, DOI 10.1177/107110070102200610
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P99
   dos Santos LA, 2002, BIOMATERIALS, V23, P2035, DOI 10.1016/S0142-9612(01)00333-7
   FARBER JM, 1990, ORTHOPEDICS, V13, P25
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Geurtsen W, 2001, Aust Endod J, V27, P12
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   HIRANO M, 1998, JPN PHARMACOL THER, V26, P189
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jackson IT, 2000, BRIT J PLAST SURG, V53, P24, DOI 10.1054/bjps.1999.3236
   Jaffe HL, 1942, ARCH SURG-CHICAGO, V44, P1004, DOI 10.1001/archsurg.1942.01210240043003
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Killian JT, 1998, J PEDIATR ORTHOPED, V18, P621, DOI 10.1097/00004694-199809000-00013
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.0.CO;2-J
   KURASHINA K, 1995, J MATER SCI-MATER M, V6, P340, DOI 10.1007/BF00120302
   Kurashina K, 1997, BIOMATERIALS, V18, P147, DOI 10.1016/S0142-9612(96)00173-1
   Kurashina K, 1997, BIOMATERIALS, V18, P539, DOI 10.1016/S0142-9612(96)00162-7
   LEGEROS RZ, 1996, BIOCERAMICS, V9, P7
   Liu CS, 1997, J BIOMED MATER RES, V35, P75, DOI 10.1002/(SICI)1097-4636(199704)35:1<75::AID-JBM7>3.0.CO;2-J
   MIRTCHI AA, 1990, BIOMATERIALS, V11, P83, DOI 10.1016/0142-9612(90)90121-6
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P634, DOI 10.1016/0142-9612(89)90120-8
   Noetzel Jorn, 2005, Schweiz Monatsschr Zahnmed, V115, P1148
   Okada E, 2004, J CRANIOFAC SURG, V15, P102, DOI 10.1097/00001665-200401000-00028
   OSBORN JF, 1991, BIOMATERIALS DEGRADA, P185
   Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1
   Rougraff BT, 2002, J BONE JOINT SURG AM, V84A, P921, DOI 10.2106/00004623-200206000-00005
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   Schildhauer TA, 2000, J ORTHOP TRAUMA, V14, P309, DOI 10.1097/00005131-200006000-00001
   STJOHN KR, 1995, J APPL BIOMATER, V6, P89
   Sugawara A, 1992, Dent Mater J, V11, P11
   Turk J B, 2000, Facial Plast Surg, V16, P7, DOI 10.1055/s-2000-7321
   Verheggen R, 2001, ACTA NEUROCHIR, V143, P919, DOI 10.1007/s007010170022
   Wilkins R M, 2000, J Am Acad Orthop Surg, V8, P217
   Yandow SM, 1998, J PEDIATR ORTHOPED, V18, P616, DOI 10.1097/00004694-199809000-00012
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
NR 43
TC 5
Z9 6
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0936-8051
J9 ARCH ORTHOP TRAUM SU
JI Arch. Orthop. Trauma Surg.
PD DEC
PY 2008
VL 128
IS 12
BP 1397
EP 1401
DI 10.1007/s00402-007-0534-1
PG 5
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 367AE
UT WOS:000260524100009
PM 18058113
DA 2018-10-20
ER

PT J
AU Maus, U
   Andereya, S
   Gravius, S
   Siebert, CH
   Ohnsorge, JAK
   Niedhart, C
AF Maus, Uwe
   Andereya, Stefan
   Gravius, Sascha
   Siebert, Christian H.
   Ohnsorge, Joerg A. K.
   Niedhart, Christopher
TI Lack of effect on bone healing of injectable BMP-2 augmented hyaluronic
   acid
SO ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
LA English
DT Article
DE Hyaluronic acid; Osteogenesis; BMP-2; Biomaterial; Bone substitute
ID MORPHOGENETIC PROTEIN-2; POLYMER SCAFFOLD; IN-VITRO; CELLS; STIMULATION;
   SUBSTITUTE; DEFECTS; MODEL; SHEEP
AB Introduction Autologous bone graft is the gold standard for the filling of large osseous defects. Because of its limited supply and complications such as pain, bleeding or infection, the development of alternative bone substitutes has been the subject of several studies. In clinical practice, the most commonly used bone substitutes are calcium phosphates like hydroxyapatite or tricalcium phosphate. With the aim to improve the osseointegration of these materials, growth factors such as bone morphogenetic protein-2 (BMP-2) have been added. Preferably, an injectable bone substitute should be made available. Hyaluronic acid is a component of the extracellular matrix of many tissues, including bone. We examined the bone regenerative effect of commercially available, injectable hyaluronic acid (Hyalart(R)) with and without addition of bone morphogenetic protein-2 (BMP-2).
   Materials and methods Trepanation defects of 9.4 mm diameter in the intercondylar groove of sheep femora were filled with pure and augmented (200 mu g BMP-2) hyaluronic acid. As controls, empty defects and defects treated with autologous bone graft harvested from the contralateral side were used. After 3 months, the defects were analysed by fluorescence microscopy after intravital fluorescence staining, contact microradiography, histology and histomorphometry.
   Results Treatment of the defects with loaded and unloaded hyaluronic acid resulted in a significant lack of bone formation inside the defects. Untreated defects showed an amount of 5.1% newly formed bone, and defects treated with autologous bone graft revealed a bone content of 20%. The difference between both groups was statistically significant (P < 0.05). Furthermore, there was neither a remarkable effect in the periphery of the defects nor ectopic bone formation.
   Conclusion The application of the used injectable hyaluronic acid (Hyalart(R)) with and without BMP-2 is not advantageous as sole bone substitute for the filling of osseous defects.
C1 [Maus, Uwe; Andereya, Stefan; Gravius, Sascha; Ohnsorge, Joerg A. K.; Niedhart, Christopher] Rhein Westfal TH Aachen, Univ Hosp, Dept Orthopaed Surg, D-52074 Aachen, Germany.
   [Siebert, Christian H.] Annastift eV, Orthopaed Clin 1, D-30625 Hannover, Germany.
RP Maus, U (reprint author), Rhein Westfal TH Aachen, Univ Hosp, Dept Orthopaed Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
EM umaus@ukaachen.de
CR Aebli N, 2005, J BIOMED MATER RES A, V73A, P295, DOI 10.1002/jbm.a.30299
   Arosarena O, 2005, Orthod Craniofac Res, V8, P267, DOI 10.1111/j.1601-6343.2005.00349.x
   Aslan M, 2006, J BIOMATER APPL, V20, P209, DOI 10.1177/0885328206051047
   BALAZS EA, 1989, CIBA F SYMP, V143, P265
   Cao JJ, 2005, J BONE MINER RES, V20, P30, DOI 10.1359/JBMR.041014
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   FEINBERG RN, 1983, SCIENCE, V220, P1177, DOI 10.1126/science.6857242
   FRASER JRE, 1989, CHIBA FDN S, V143, P41
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Hunt DR, 2001, J PERIODONTOL, V72, P651, DOI 10.1902/jop.2001.72.5.651
   KIKUCHI T, 1993, 18 IL C RHEUM BARC J
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   LAURENT TC, 1995, ANN RHEUM DIS, V54, P429, DOI 10.1136/ard.54.5.429
   Lisignoli G, 2002, BIOMATERIALS, V23, P1043, DOI 10.1016/S0142-9612(01)00216-2
   Lisignoli G, 2001, BIOMATERIALS, V22, P2095, DOI 10.1016/S0142-9612(00)00398-7
   Niedhart C, 2004, J BIOMED MATER RES B, V71B, P123, DOI 10.1002/jbm.b.30071
   Niedhart C, 2003, J BIOMED MATER RES A, V65A, P17, DOI 10.1002/jbm.a.10362
   OAKES DA, 2003, CLIN ORTHOP RELAT R, V413, P281
   Ohyama T, 2004, NEUROL MED-CHIR, V44, P234, DOI 10.2176/nmc.44.234
   PILLONI A, 1992, Journal of Dental Research, V71, P574
   Radomsky ML, 1999, J ORTHOPAED RES, V17, P607, DOI 10.1002/jor.1100170422
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   SASAKI T, 1995, BONE, V16, P9, DOI 10.1016/S8756-3282(94)00001-8
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   TOOLE BP, 1971, DEV BIOL, V26, P28, DOI 10.1016/0012-1606(71)90104-7
   Wiedmann-Al-Ahmad M, 2005, J MATER SCI-MATER M, V16, P57, DOI 10.1007/s10856-005-6447-z
NR 27
TC 19
Z9 22
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0936-8051
EI 1434-3916
J9 ARCH ORTHOP TRAUM SU
JI Arch. Orthop. Trauma Surg.
PD DEC
PY 2008
VL 128
IS 12
BP 1461
EP 1466
DI 10.1007/s00402-008-0608-8
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 367AE
UT WOS:000260524100020
PM 18330583
DA 2018-10-20
ER

PT J
AU Sezer, AD
   Cevher, E
   Hatipoglu, F
   Ogurtan, Z
   Bas, AL
   Akbuga, J
AF Sezer, Ali Demir
   Cevher, Erdal
   Hatipoglu, Fatih
   Ogurtan, Zeki
   Bas, Ahmet Levent
   Akbuga, Juelide
TI Preparation of Fucoidan-Chitosan Hydrogel and Its Application as Burn
   Healing Accelerator on Rabbits
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE fucoidan chitosan; burn healing; hydrogel; bioadhesion; texture analyzer
ID MUCOADHESIVE PROPERTIES; FUCUS-VESICULOSUS; DRUG DELIVERY; DERMAL BURN;
   FORMULATIONS; PH; POLYSACCHARIDES; IRRADIATION; MODULATION; POLYMERS
AB Treatment of dermal wounds with macromolecular agents such as natural polymers is one of the research areas of the biomaterial science. Fucoidan is a sulphated polysaccharide which is commonly obtained from seaweeds. The great number of studies on the different pharmacological properties of fucoidan is present, but there is limited information about using of fucoidan in the treatment of dermal burns. The aim of this study was to prepare fucoidan-chitosan hydrogels and to investigate their treatment efficiency on dermal burns. Hydrogels were prepared by swelling the polymers in acidic solution and their swelling, mechanical (hardness, cohesiveness and adhesiveness) and bioadhesive properties were investigated. The viscosity and water absorption capacity of formulations increased with increase in the polymer concentration. In contrast to the cohesiveness results, the adhesiveness of hydrogels increased with the polymer concentration. The bioadhesion was changed between 0.012-0.142 mJ.cm(-2) and enhanced with addition of fucoidan into gel formulations. It was formed dermal burns on seven adult male New Zealand white rabbits and the optimum gel formulation applied on the wounds. Control and treatment group biopsy samples were taken on days 7, 14 and 21 and each burn wound site was evaluated histopathollogically. No edema was seen in tested groups except control after 3 d treatment. After 7 of treatment, fibroplasia and scar were fixed on wounds treated with fucoidan-chitosan gel and fucoidan solution. The best regeneration on dermal papillary formation and the fastest closure of the wounds were observed in fucoidan-chitosan hydrogels after 14 d treatment.
C1 [Sezer, Ali Demir; Akbuga, Juelide] Marmara Univ, Fac Pharm, Dept Pharmaceut Biotechnol, TR-34668 Istanbul, Turkey.
   [Cevher, Erdal] Istanbul Univ, Fac Pharm, Dept Pharmaceut Technol, TR-34116 Istanbul, Turkey.
   [Hatipoglu, Fatih] Selcuk Univ, Fac Vet, Dept Pathol, Konya, Turkey.
   [Ogurtan, Zeki] Selcuk Univ, Fac Vet, Dept Surg, Konya, Turkey.
   [Bas, Ahmet Levent] Selcuk Univ, Fac Vet, Dept Pharmacol, TR-42075 Konya, Turkey.
RP Sezer, AD (reprint author), Marmara Univ, Fac Pharm, Dept Pharmaceut Biotechnol, TR-34668 Istanbul, Turkey.
EM adsezer@marmara.edu.tr
RI Hatipoglu, Fatih/M-8076-2014
FU Commission of Marmara University Scientific Research Project
   [SAG-060/131102]
FX This study was supported by Commission of Marmara University Scientific
   Research Project (BAPKO, SAG-060/131102).
CR Atiyeh BS, 2005, BURNS, V31, P944, DOI 10.1016/j.burns.2005.08.023
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Cevher E, 2008, DRUG DELIV, V15, P57, DOI [10.1080/10717540701829234, 10.1080/10717540701829234 ]
   DESHPANDE AA, 1992, DRUG DEV IND PHARM, V18, P1225, DOI 10.3109/03639049209046329
   El-Sherbiny IM, 2005, EUR POLYM J, V41, P2584, DOI 10.1016/j.eurpolymj.2005.05.035
   Fujimura T, 2000, BIOL PHARM BULL, V23, P1180
   Gerentes P, 2002, BIOMATERIALS, V23, P1295, DOI 10.1016/S0142-9612(01)00247-2
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jones DS, 1997, INT J PHARM, V151, P223, DOI 10.1016/S0378-5173(97)04904-1
   Jones DS, 1999, J PHARM SCI, V88, P592, DOI 10.1021/js9803095
   Jurjus A, 2007, BURNS, V33, P892, DOI 10.1016/j.burns.2006.10.406
   Kellouche S, 2007, BIOCHEM BIOPH RES CO, V363, P472, DOI 10.1016/j.bbrc.2007.08.155
   KIYOZUMI T, 2006, J BIOMED MATER RES B, V79, P126
   Kiyozumi T, 2007, BURNS, V33, P642, DOI 10.1016/j.burns.2006.09.010
   Knabl JS, 1999, BURNS, V25, P715, DOI 10.1016/S0305-4179(99)00086-8
   Kondo Toshikazu, 2007, Legal Medicine, V9, P109, DOI 10.1016/j.legalmed.2006.11.009
   Leary RO, 2004, BIOL PHARM BULL, V27, P266
   Leung MYK, 2006, IMMUNOL LETT, V105, P101, DOI 10.1016/j.imlet.2006.01.009
   Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007
   Martineau L, 2006, BURNS, V32, P70, DOI 10.1016/j.burns.2005.08.009
   Noble L, 1999, INT J PHARM, V192, P173, DOI 10.1016/S0378-5173(99)00306-3
   PATANKAR MS, 1993, J BIOL CHEM, V268, P21770
   Peng P, 2007, BIOINTERPHASES, V2, P95, DOI 10.1116/1.2751126
   Pereira MS, 1999, J BIOL CHEM, V274, P7656, DOI 10.1074/jbc.274.12.7656
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   RICHARDSON JL, 1992, ADV DRUG DELIVER REV, V8, P341, DOI 10.1016/0169-409X(92)90008-E
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Ruperez P, 2002, J AGR FOOD CHEM, V50, P840, DOI 10.1021/jf010908o
   Sezer AD, 2008, EUR J PHARM BIOPHARM, V69, P189, DOI 10.1016/j.ejpb.2007.09.004
   SEZER AD, 2005, 12 EUR C BIOT COP DE, P77
   Sezer AD, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0802039
   Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tacheau C, 2007, EUR J PHARMACOL, V573, P65, DOI 10.1016/j.ejphar.2007.07.030
   TAN YTF, 2000, AAPS PHARMSCITECH, V1, P1
   Trere D, 2000, MICRON, V31, P127, DOI 10.1016/S0968-4328(99)00069-4
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Varshney L, 2007, NUCL INSTRUM METH B, V255, P343, DOI 10.1016/j.nimb.2006.11.101
   Vogt PM, 2006, BURNS, V32, P698, DOI 10.1016/j.burns.2006.01.007
   Whitney JD, 2003, J WOUND OSTOMY CONT, V30, P199
   Wong CF, 1999, INT J PHARM, V180, P47, DOI 10.1016/S0378-5173(98)00402-5
   Xie YJ, 2007, CARBOHYD POLYM, V69, P142, DOI 10.1016/j.carbpol.2006.09.010
   Zhao L, 2006, CARBOHYD POLYM, V64, P473, DOI 10.1016/j.carbpol.2005.12.014
   Zhao L, 2008, J BIOACT COMPAT POL, V23, P319, DOI 10.1177/0883911508092302
NR 45
TC 61
Z9 64
U1 3
U2 44
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD DEC
PY 2008
VL 31
IS 12
BP 2326
EP 2333
DI 10.1248/bpb.31.2326
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 376SZ
UT WOS:000261204600027
PM 19043221
OA Bronze
DA 2018-10-20
ER

PT J
AU Ghasemi-Mobarakeh, L
   Prabhakaran, MP
   Morshed, M
   Nasr-Esfahani, MH
   Ramakrishna, S
AF Ghasemi-Mobarakeh, Laleh
   Prabhakaran, Molamma P.
   Morshed, Mohammad
   Nasr-Esfahani, Mohammad-Hossein
   Ramakrishna, Seeram
TI Electrospun poly(epsilon-caprolactone)/gelatin nanofibrous scaffolds for
   nerve tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Nerve tissue engineering; Electrospinning; Nanofiber; PCL; Gelatin
ID CONTROLLED FIBER ORIENTATION; FIBROUS SCAFFOLDS; STEM-CELLS; GELATIN;
   PROLIFERATION; REGENERATION; FABRICATION; STRATEGIES; MEMBRANES;
   GUIDANCE
AB Nerve tissue engineering is one of the most promising methods to restore nerve systems in human health care. Scaffold design has pivotal role in nerve tissue engineering. Polymer blending is one of the most effective methods for providing new, desirable biocomposites for tissue-engineering applications. Random and aligned PCL/gelatin biocomposite scaffolds were fabricated by varying the ratios of PCL and gelatin concentrations. Chemical and mechanical properties of PCL/gelatin nanofibrous scaffolds were measured by FFIR, porometry, contact angle and tensile measurements, while the in vitro biodegradability of the different nanofibrous scaffolds were evaluated too. PCL/gelatin 70:30 nanofiber was found to exhibit the most balanced properties to meet all the required specifications for nerve tissue and was used for in vitro culture of nerve stem cells (C17.2 cells). MTS assay and SEM results showed that the biocomposite of PCL/gelatin 70:30 nanofibrous scaffolds enhanced the nerve differentiation and proliferation compared to PCL nanofibrous scaffolds and acted as a positive cue to support neurite outgrowth. It was found that the direction of nerve cell elongation and neurite outgrowth on aligned nanofibrous scaffolds is parallel to the direction of fibers. PCL/gelatin 70:30 nanofibrous scaffolds proved to be a promising biomaterial suitable for nerve regeneration.
C1 [Ghasemi-Mobarakeh, Laleh; Prabhakaran, Molamma P.; Ramakrishna, Seeram] Natl Univ Singapore, NUS Nanosci & Nanotechnol Initiat, Singapore 117576, Singapore.
   [Ghasemi-Mobarakeh, Laleh] Islamic Azad Univ, Najafabad Branch, Esfahan, Iran.
   [Ghasemi-Mobarakeh, Laleh; Morshed, Mohammad] Isfahan Univ Technol, Dept Text Engn, Esfahan, Iran.
   [Ghasemi-Mobarakeh, Laleh; Nasr-Esfahani, Mohammad-Hossein] ACECR, Royan Inst, Dept Cell Sci Res Ctr, Tehran, Iran.
RP Ramakrishna, S (reprint author), Natl Univ Singapore, NUS Nanosci & Nanotechnol Initiat, 9 Engn Dr 1, Singapore 117576, Singapore.
EM seeram@nus.edu.sg
RI Prabhakaran, Molamma/M-8630-2013
FU National Medical Research Council [NMRC/1015/2005, R397000625213]
FX We would like to express our thanks to National Medical Research Council
   (grant number: NMRC/1015/2005, R397000625213), Singapore for their
   financial support.
CR ASHAMMAKHI N, 2008, EUROPEAN J PLASTIC S
   BELLAMKONDA R, 1994, BIOTECHNOL BIOENG, V43, P543, DOI 10.1002/bit.260430703
   Bini TB, 2006, J MATER SCI, V41, P6453, DOI 10.1007/s10853-006-0714-3
   BORDENAVE L, 1989, BIOMATERIALS, V10, P235, DOI 10.1016/0142-9612(89)90099-9
   Catledge SA, 2007, BIOMED MATER, V2, P142, DOI 10.1088/1748-6041/2/2/013
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Kim CH, 2006, J BIOMED MATER RES B, V78B, P283, DOI 10.1002/jbm.b.30484
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Lackie JM, 2007, DICT CELL MOL BIOL
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Li DP, 2006, J MEMBRANE SCI, V286, P104, DOI 10.1016/j.memsci.2006.09.020
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Ma ZW, 2002, J BIOMED MATER RES, V63, P838, DOI 10.1002/jbm.10470
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Teo WE, 2005, NANOTECHNOLOGY, V16, P918, DOI 10.1088/0957-4484/16/6/049
   WAROCQUIERCLEROUT R, 1990, CYTOTECHNOLOGY, V3, P259, DOI 10.1007/BF00365490
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yang F, 2004, J BIOMAT SCI-POLYM E, V15, P1483, DOI 10.1163/1568562042459733
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   Zeng J, 2003, J APPL POLYM SCI, V89, P1085, DOI 10.1002/app.12260
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 39
TC 557
Z9 577
U1 33
U2 371
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 34
BP 4532
EP 4539
DI 10.1016/j.biomaterials.2008.08.007
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 368KH
UT WOS:000260619500007
PM 18757094
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Linsmeier, CE
   Wallman, L
   Faxius, L
   Schouenborg, J
   Bjursten, LM
   Danielsen, N
AF Linsmeier, Cecilia E.
   Wallman, Lars
   Faxius, Linda
   Schouenborg, Jens
   Bjursten, Lars M.
   Danielsen, Nils
TI Soft tissue reactions evoked by implanted gallium phosphide
SO BIOMATERIALS
LA English
DT Article
DE GaP; Foreign-body response; In vivo test; Soft tissue;
   Immunohistochemistry; Nanowires
ID INTRACORTICAL ELECTRODE ARRAY; SILICON MICROELECTRODE ARRAYS;
   BRAIN-TISSUE; TITANIUM IMPLANTS; RAT; CAPABILITY; NANOWIRES; SUBSTRATE;
   ALUMINUM; NEURONS
AB Neural devices may play an important role in the diagnosis and therapy of several clinical conditions, such as stroke, trauma or neurodegenerative disorders, by facilitating motor and pain control. Such interfaces, chronically implanted in the CNS, need to be biocompatible and have the ability to stimulate and record nerve signals. However, neural devices of today are not fully optimized. Nanostructured surfaces may improve electrical properties and lower evoked tissue responses. Vertical gallium phosphide (GaP) nanowires epitaxially grown from a GaP surface is one way of creating nanostructured electrodes. Thus, we chose to study the soft tissue reactions evoked by GaP surfaces. GaP and the control material titanium (Ti) were implanted in the rat abdominal wall for evaluation of tissue reactions after 1, 6, or 12 weeks. The foreign-body response was evaluated by measuring the reactive capsule thickness and by quantification of ED1-positive macrophages and total cells in the capsule. Furthermore, the concentration of Ga was measured in blood, brain, liver and kidneys. Statistically significant differences were noticed between GaP and Ti at 12 weeks for total and ED1-positive cell densities in the capsule. The chemical analysis showed that the concentration of Ga in brain, liver and kidneys increased during 12 weeks of implantation, indicating loss of Ga from the implant. Taken together, our results show that the biocompatible properties of GaP are worse than those of the well-documented biomaterial Ti. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Linsmeier, Cecilia E.; Wallman, Lars; Schouenborg, Jens; Danielsen, Nils] Lund Univ, Neuronano Res Ctr, SE-22184 Lund, Sweden.
   [Faxius, Linda; Bjursten, Lars M.] Lund Univ, Dept Clin Sci, SE-20502 Malmo, Sweden.
   [Wallman, Lars] Lund Univ, Dept Elect Measurements, SE-22100 Lund, Sweden.
RP Linsmeier, CE (reprint author), Lund Univ, Neuronano Res Ctr, BMC F10, SE-22184 Lund, Sweden.
EM cecilia.eriksson_linsmeier@med.lu.se
RI Eriksson LInsmeier, Cecilia/N-2212-2015
OI Schouenborg, Jens/0000-0002-2815-6918
FU The Royal Physiographic Society in Lund; The Knut and Alice Wallenberg
   Foundation [KAW 2004-0119]; Swedish Research Council [600012701]
FX This project was sponsored by The Royal Physiographic Society in Lund,
   The Knut and Alice Wallenberg Foundation (project number: KAW
   2004-0119), and a Linne grant (project number: 600012701) from the
   Swedish Research Council.
CR ALLEN DD, 1992, J NEUROCHEM, V58, P903, DOI 10.1111/j.1471-4159.1992.tb09342.x
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138
   Hallstrom W, 2007, NANO LETT, V7, P2960, DOI 10.1021/nl070728e
   Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970
   HOLGERS KM, 1995, BIOMATERIALS, V16, P83, DOI 10.1016/0142-9612(95)98267-I
   Kim JR, 2004, NANOTECHNOLOGY, V15, P1397, DOI 10.1088/0957-4484/15/11/002
   KIPKE DR, 2004, P IEEE ENG MED BIOL, V7, P5344
   Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0
   Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100
   Otto KJ, 2005, J NEURAL ENG, V2, P42, DOI 10.1088/1741-2560/2/2/005
   Otto KJ, 2005, HEARING RES, V210, P112, DOI 10.1016/j.heares.2005.08.004
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   Rosengren A, 1996, BIOMATERIALS, V17, P1779, DOI 10.1016/0142-9612(95)00358-4
   Rosengren A, 2002, IEEE T BIO-MED ENG, V49, P392, DOI 10.1109/10.991167
   Rosengren A, 1998, J MATER SCI-MATER M, V9, P415, DOI 10.1023/A:1013239731256
   Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4
   Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800
   Siegel S., 1956, NONPARAMETRIC STAT B
   Silva GA, 2006, NAT REV NEUROSCI, V7, P65, DOI 10.1038/nrn1827
   SONG YK, 2007, P IEEE ENG MED BIOL, V1, P445
   Tanaka A, 2004, TOXICOL APPL PHARM, V198, P405, DOI 10.1016/j.taap.2003.10.019
   THOMSEN P, 1986, SCAND J PLAST RECONS, V20, P173, DOI 10.3109/02844318609006316
   Westby GWM, 1997, J NEUROSCI METH, V76, P123, DOI 10.1016/S0165-0270(97)00088-5
   WISE KD, 1991, SCIENCE, V254, P1335, DOI 10.1126/science.1962192
   Young TH, 2006, BIOMATERIALS, V27, P3361, DOI 10.1016/j.biomaterials.2006.02.001
NR 28
TC 25
Z9 27
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4598
EP 4604
DI 10.1016/j.biomaterials.2008.08.028
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400004
PM 18801568
DA 2018-10-20
ER

PT J
AU Zhang, X
   Zheng, ZZ
   Liu, P
   Ma, Y
   Lin, L
   Lang, N
   Fu, X
   Zhang, JY
   Ma, KT
   Chen, P
   Zhou, CY
   Ao, YF
AF Zhang, Xin
   Zheng, Zhuozhao
   Liu, Ping
   Ma, Yong
   Lin, Lin
   Lang, Ning
   Fu, Xin
   Zhang, Jiying
   Ma, Kangtao
   Chen, Ping
   Zhou, Chunyan
   Ao, Yingfang
TI The synergistic effects of microfracture, perforated decalcified
   cortical bone matrix and adenovirus-bone morphogenetic protein-4 in
   cartilage defect repair
SO BIOMATERIALS
LA English
DT Article
DE Articular cartilage; Decalcified cortical bone matrix (DCBM); Bone
   morphogenetic protein-4 (BMP4)
ID FULL-THICKNESS DEFECTS; STEM-CELL NICHE; ARTICULAR-CARTILAGE;
   CHONDROGENIC DIFFERENTIATION; IN-VITRO; REGENERATION; VIVO;
   HYDROXYAPATITE; ALGINATE; ADIPOSE
AB We reported a technique for articular cartilage repair, consisting of microfracture, a biomaterial scaffold of perforated decalcified cortical bone matrix (DCBM) and adenovirus-bone morphogenetic protein-4 (Ad-BMP4) gene therapy. In the present study, we evaluated its effects on the quality and quantity for induction of articular cartilage regeneration. Full-thickness defects were created in the articular cartilage of the trochlear groove of rabbits. Four groups were assigned: Ad-BMP4/perforated DCBM composite (group I); perforated DCBM alone without Ad-BMP4 (group II); DCBM without perforated (group III) and microfracture alone (group IV). Animals were sacrificed 6, 12 and 24 weeks postoperation. The harvested tissues were analyzed by magnetic resonance image, scanning electron microscope, histological examination and immunohistochemistry. Group I showed vigorous and rapid repair leading to regeneration of hyaline articular cartilage at 6 weeks and to complete repair of articular cartilage and subchondral bone at 12 weeks. Groups II and III completely repaired the defect with hyaline cartilage at 24 weeks, but group II was more rapid than group III in the regeneration of repair tissue. In group IV the defects were concave and filled with fibrous tissue at 24 weeks. These findings demonstrated that this composite biotechnology can rapidly repair large areas of cartilage defect with regeneration of native hyaline articular cartilage. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Zhang, Xin; Liu, Ping; Ma, Yong; Lin, Lin; Fu, Xin; Zhang, Jiying; Ao, Yingfang] Peking Univ, Third Hosp, Dept Sports Med, Beijing 100083, Peoples R China.
   [Ma, Kangtao; Chen, Ping; Zhou, Chunyan] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100083, Peoples R China.
   [Zheng, Zhuozhao; Lang, Ning] Peking Univ, Third Hosp, Dept Diagnost Radiol, Beijing 100083, Peoples R China.
RP Ao, YF (reprint author), Peking Univ, Third Hosp, Dept Sports Med, Beijing 100083, Peoples R China.
EM chunyanzhou@bjmu.edu.cn; yingfang.ao@vip.sina.com
FU Chinese National Science and Technology
FX This work was supported by the Chinese National Science and Technology
   Supporting Plan.
CR BERT JM, 1993, RHEUM DIS CLIN N AM, V19, P725
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   Catanese J, 1999, J BIOMECH, V32, P1365, DOI 10.1016/S0021-9290(99)00128-1
   CHIROFF RT, 1977, J BIOMED MATER RES, V11, P165, DOI 10.1002/jbm.820110203
   Cohen SB, 2003, BIOMATERIALS, V24, P2653, DOI 10.1016/S0142-9612(03)00058-9
   Gelse K, 2003, ARTHRITIS RHEUM, V48, P430, DOI 10.1002/art.10759
   Glansbeek HL, 1997, ARTHRITIS RHEUM, V40, P1020, DOI 10.1002/art.1780400605
   JOHNSON L L, 1986, Arthroscopy, V2, P54, DOI 10.1016/S0749-8063(86)80012-3
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Kumai T, 1999, J BONE JOINT SURG AM, V81A, P1229, DOI 10.2106/00004623-199909000-00004
   Kuo AC, 2006, OSTEOARTHR CARTILAGE, V14, P1126, DOI 10.1016/j.joca.2006.04.004
   Kuroda R, 2006, ARTHRITIS RHEUM, V54, P433, DOI 10.1002/art.21632
   Lee CR, 2003, J ORTHOPAED RES, V21, P272, DOI 10.1016/S0736-0266(02)00153-5
   Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525
   Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952
   Minas T, 1997, ORTHOPEDICS, V20, P525
   MORALES TI, 1988, J BIOL CHEM, V263, P12828
   MUCKLE DS, 1990, J BONE JOINT SURG BR, V72, P60
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Reddi AH, 2003, ANN RHEUM DIS, V62, P73
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   Semba I, 2000, DEV DYNAM, V217, P401, DOI 10.1002/(SICI)1097-0177(200004)217:4<401::AID-DVDY7>3.0.CO;2-D
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Shen HC, 2004, BONE, V34, P982, DOI 10.1016/j.bone.2004.01.028
   Sitnicka E, 1996, BLOOD, V88, P82
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Steinert A, 2003, J ORTHOPAED RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1
   Suominen E, 1996, J BIOMED MATER RES, V32, P543, DOI 10.1002/(SICI)1097-4636(199612)32:4<543::AID-JBM7>3.0.CO;2-R
   Tan CF, 2003, TRANSPLANT P, V35, P3105, DOI 10.1016/j.transproceed.2003.10.019
   Tan TCF, 1996, SKELETAL RADIOL, V25, P749, DOI 10.1007/s002560050173
   Ushida T, 2002, CELL TRANSPLANT, V11, P489
   van Susante JLC, 1998, BIOMATERIALS, V19, P2367, DOI 10.1016/S0142-9612(98)00158-6
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Zhang X, 2006, CALCIFIED TISSUE INT, V79, P169, DOI 10.1007/s00223-006-0083-6
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 37
TC 33
Z9 35
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4616
EP 4629
DI 10.1016/j.biomaterials.2008.07.051
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400006
PM 18793797
DA 2018-10-20
ER

PT J
AU Lovett, ML
   Cannizzaro, CM
   Vunjak-Novakovic, G
   Kaplan, DL
AF Lovett, Michael L.
   Cannizzaro, Christopher M.
   Vunjak-Novakovic, Gordana
   Kaplan, David L.
TI Gel spinning of silk tubes for tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Silk; Vascular grafts; Arterial tissue engineering; Mechanical
   properties; Endothelial cells; Smooth muscle cells
ID FIBROIN AQUEOUS-SOLUTION; HUMAN SAPHENOUS-VEIN; BOMBYX-MORI;
   STRUCTURAL-CHARACTERIZATION; BIOMATERIAL COATINGS; BLOOD-VESSELS;
   SCAFFOLDS; FIBERS; GRAFTS; REGENERATION
AB Tubular vessels for tissue engineering are typically fabricated using a molding, dipping, or electrospinning technique. While these techniques provide some control over inner and outer diameters of the tube, they lack the ability to align the polymers or fibers of interest throughout the tube. This is an important aspect of biomaterial composite structure and function for mechanical and biological impact of tissue outcomes. We present a novel aqueous process system to spin tubes from biopolymers and proteins such as silk fibroin. Using silk as an example, this method of winding an aqueous solution around a reciprocating rotating mandrel offers substantial improvement in the control of the tube properties, specifically with regard to winding pattern, tube porosity, and composite features. Silk tube properties are further controlled via different post-spinning processing mechanisms such as methanol treatment, air-drying, and lyophilization. This approach to tubular scaffold manufacture offers numerous tissue engineering applications such as complex composite biomaterial matrices, blood vessel grafts and nerve guides, among others. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Lovett, Michael L.; Cannizzaro, Christopher M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI vunjak-novakovic, gordana/J-9279-2012
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU Tissue Engineering Resource Center (TERC); NIH [EB002520]; National
   Institute of Biomedical Imaging and Bioengineering
FX We acknowledge funding from the Tissue Engineering Resource Center
   (TERC) through the NIH - grant EB002520 from the National Institute of
   Biomedical Imaging and Bioengineering. We would also like to acknowledge
   the assistance of Jonathan Kluge in the mechanical testing of the silk
   tubes and the Tufts machine shop (in particular, Larry McMaster, Scott
   MacCorkle, and Denis DuPuis) in the construction of the silk winding
   apparatus.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asakura T, 2007, BIOMACROMOLECULES, V8, P175, DOI 10.1021/bm060874z
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   DONOVAN DL, 1990, J VASC SURG, V12, P531, DOI 10.1067/mva.1990.22707
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Fukae R, 2005, POLYMER, V46, P11193, DOI 10.1016/j.polymer.2005.10.001
   Girard A, 2005, POINT VET, V36, P8
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Han DW, 2005, TISSUE ENG, V11, P1054, DOI 10.1089/ten.2005.11.1054
   Hoenig MR, 2005, ARTERIOSCL THROM VAS, V25, P1128, DOI 10.1161/01.ATV.0000158996.03867.72
   Isenberg BC, 2006, ANN BIOMED ENG, V34, P971, DOI 10.1007/s10439-006-9101-0
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jin HJ, 2006, BIONANOTECHNOLOGY: PROTEINS TO NANODEVICES, P189, DOI 10.1007/978-1-4020-4375-8_10
   Kannan RY, 2006, BIOMATERIALS, V27, P4618, DOI 10.1016/j.biomaterials.2006.04.024
   Kim SH, 2006, J BIOMAT SCI-POLYM E, V17, P1359, DOI 10.1163/156856206778937244
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liivak O, 1998, MACROMOLECULES, V31, P2947, DOI 10.1021/ma971626l
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747
   Notin L, 2006, ACTA BIOMATER, V2, P387, DOI 10.1016/j.actbio.2006.03.003
   Phillips DM, 2005, J MATER CHEM, V15, P4206, DOI 10.1039/b510069k
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   Santana Daniel Bia, 2007, Cell and Tissue Banking, V8, P43, DOI 10.1007/s10561-006-9000-5
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860
   Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Xie F, 2006, INT J BIOL MACROMOL, V38, P284, DOI 10.1016/j.ijbiomac.2006.03.021
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
NR 38
TC 73
Z9 76
U1 6
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4650
EP 4657
DI 10.1016/j.biomaterials.2008.08.025
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400009
PM 18801570
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Acharya, C
   Hinz, B
   Kundu, SC
AF Acharya, Chitrangada
   Hinz, Boris
   Kundu, Subhas C.
TI The effect of lactose-conjugated silk biomaterials on the development of
   fibrogenic fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE Film; Scaffold; Lactose; Silk fibroin; Myofibroblast
ID SMOOTH MUSCLE ACTIN; OSTEOBLAST IN-VITRO; POLY(D,L-LACTIC ACID);
   CHEMICAL-MODIFICATION; TGF-BETA; FIBROIN; MYOFIBROBLAST; CELLS;
   ADHESION; GROWTH
AB Surface properties of implanted biomaterials can cause fibrotic tissue reactions by stimulating differentiation of host fibroblasts into contractile myofibroblasts. Silk fibroin (SF) protein has been used as biomaterial in pure and blended form. however, its effect on myofibroblast differentiation remains elusive. We here conjugated SF with lactose using cyanuric chloride as coupling spacer. NMR spectroscopy and the conjugates ability to agglomerate Abrus precatorius agglutinin verified efficient conjugation. Two-dimensional films and three-dimensional scaffolds produced from pure and lactose-conjugated SF solutions were tested as culture substrates for subcutaneous fibroblasts and myofibroblasts. Lactose-conjugated SF substrates mediated higher adhesion, proliferation and viability of fibroblastic cells than pure SF. This SF film composition promotes better attachment of fibroblasts than myofibroblasts. Profibrotic cytokine TGF beta 1 was ineffective in inducing fibroblast-to-myofibroblast differentiation on such substrates. Pre-differentiated myofibroblasts lost their contractile phenotype within a few days of being cultured on lactose-conjugated SF. Myofibroblast differentiation was also suppressed by growth in three-dimensional lactose-conjugated SF scaffolds that, however, support population with fibroblasts, We propose that this biomaterial will promote tissue integration without causing a fibrotic host reaction. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Hinz, Boris] Ecole Polytech Fed Lausanne, LCB, CH-1015 Lausanne, Switzerland.
   [Acharya, Chitrangada; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Hinz, B (reprint author), Ecole Polytech Fed Lausanne, LCB, Batiment SG-AA-B 143,Stn 15, CH-1015 Lausanne, Switzerland.
EM boris.hinz@epfl.ch; kundu@hijli.iitkgp.ernet.in
OI Kundu, Subhas C./0000-0002-7170-2291; Hinz, Boris/0000-0002-0526-393X
FU Swiss National Science Foundation [3100A0-102150/1, 3100A0-11373311];
   Gebert-Ruf Stiftung, Switzerland
FX We are grateful to J. Smith-Clerc for excellent technical assistance, to
   the staff of the Biolmaging and Optics platform of the EPFL for
   providing image facilities and training, and to J.-J. Meister for
   providing laboratory facilities. This work was financially supported by
   the Department of Biotechnology, Council of Scientific and Industrial
   Research, Government of India, New Delhi. CA and SCK are grateful for
   receiving a short-term research fellowship from the
   IIT-Kharagpur-EPFL-Lausanne exchange program which was kindly
   coordinated by Dr. P. Rastogi (EPFL). BH acknowledges support from the
   Swiss National Science Foundation (grants #3100A0-102150/1 and
   #3100A0-11373311) and the Gebert-Ruf Stiftung, Switzerland for this
   work.
CR ACHARYA C, J BIOMATER IN PRESS
   ACHARYA C, J MAT SCI P IN PRESS
   Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Acharya Chitrangada, 2008, Biotechnol J, V3, P226, DOI 10.1002/biot.200700120
   Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Dal Pra I, 2006, INT J MOL MED, V18, P241
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   GOTOH Y, 1993, BIOCONJUGATE CHEM, V4, P554, DOI 10.1021/bc00024a020
   Gotoh Y, 1996, INT J BIOL MACROMOL, V18, P19, DOI 10.1016/0141-8130(95)01039-4
   Heckmann D, 2007, METHOD ENZYMOL, V426, P463, DOI 10.1016/S0076-6879(07)26020-3
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hinz B, 2006, EUR J CELL BIOL, V85, P175, DOI 10.1016/j.ejcb.2005.09.004
   Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730
   Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Kawaguchi T, 1999, J COLLOID INTERF SCI, V210, P290, DOI 10.1006/jcis.1998.5976
   KIM HJ, 2008, BONE
   KUNDU J, MAT SCI ENG IN PRESS
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Ma XL, 2006, J BIOMED MATER RES B, V78B, P89, DOI 10.1002/jbm.b.30466
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MURPHY AR, 2008, BIOMATERIALS
   Roche AC, 2003, CELL MOL LIFE SCI, V60, P288, DOI 10.1007/s000180300024
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   Schneider A, 2006, BIOMACROMOLECULES, V7, P2882, DOI 10.1021/bm0605208
   Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208
   SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97
   Wang JX, 2006, EXP CELL RES, V312, P205, DOI 10.1016/j.yexcr.2005.11.004
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042
   Yamamoto K, 2007, BIOMATERIALS, V28, P1838, DOI 10.1016/j.biomaterials.2006.11.045
   Yoon JJ, 2002, BIOTECHNOL BIOENG, V78, P1, DOI 10.1002/bit.10239
   Zhang YQ, 2006, J BIOMED MATER RES B, V79B, P275, DOI 10.1002/jbm.b.30539
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 62
TC 33
Z9 36
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4665
EP 4675
DI 10.1016/j.biomaterials.2008.08.033
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400011
PM 18804860
DA 2018-10-20
ER

PT J
AU Antoci, V
   Adams, CS
   Parvizi, J
   Davidson, HM
   Composto, RJ
   Freeman, TA
   Wickstrom, E
   Ducheyne, P
   Jungkind, D
   Shapiro, IM
   Hickok, NJ
AF Antoci, Valentin, Jr.
   Adams, Christopher S.
   Parvizi, Javad
   Davidson, Helen M.
   Composto, Russell J.
   Freeman, Theresa A.
   Wickstrom, Eric
   Ducheyne, Paul
   Jungkind, Donald
   Shapiro, Irving M.
   Hickok, Noreen J.
TI The inhibition of Staphylococcus epidermidis biofilm formation by
   vancomycin-modified titanium alloy and implications for the treatment of
   periprosthetic infection
SO BIOMATERIALS
LA English
DT Article
DE Antibacterial; Bacterial adhesion; Biofilm; Metal surface treatment;
   Bacteria; Surface modification; Titanium alloy
ID BACTERIAL-COLONIZATION; AUREUS; IMPLANTS; PROVIDES
AB Peri-prosthetic infections are notoriously difficult to treat as the biomaterial implant is ideal for bacterial adhesion and biofilm formation, resulting in decreased antibiotic sensitivity. Previously, we reported that vancomycin covalently attached to a Ti alloy surface (Vanc-Ti) could prevent bacterial colonization. Herein we examine the effect of this Vanc-Ti surface on Staphylococci epidermidis, a Gram-positive organism prevalent in orthopaedic infections. By direct colony counting and fluorescent visualization of live bacteria, S. epidermidis colonization was significantly inhibited on Vanc-Ti implants. In contrast, the gram-negative organism Escherichia coli readily colonized the Vanc-Ti rod, suggesting retention of antibiotic specificity. By histochemical and SEM analysis, Vanc-Ti prevented S. epidermidis biofilm formation, even in the presence of serum. Furthermore, when challenged multiple times with S. epidermidis, Vanc-Ti rods resisted bacterial colonization. Finally, when S. epidermidis was continuously cultured in the presence of Vanc-Ti, the bacteria maintained a Vanc sensitivity equivalent to the parent strain. These findings indicate that antibiotic derivatization of implants can result in a surface that can resist bacterial colonization. This technology holds great promise for the prevention and treatment of periprosthetic infections. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Antoci, Valentin, Jr.; Adams, Christopher S.; Parvizi, Javad; Davidson, Helen M.; Freeman, Theresa A.; Shapiro, Irving M.; Hickok, Noreen J.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.
   [Parvizi, Javad] Rothman Inst, Philadelphia, PA USA.
   [Composto, Russell J.; Ducheyne, Paul; Shapiro, Irving M.] Univ Penn, Sch Engn & Appl Sci, Ctr Bioact Mat & Tissue Engn, Philadelphia, PA 19104 USA.
   [Composto, Russell J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Wickstrom, Eric; Shapiro, Irving M.; Hickok, Noreen J.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.
   [Ducheyne, Paul] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Jungkind, Donald] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
RP Hickok, NJ (reprint author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1015 Walnut St,Suite 501, Philadelphia, PA 19107 USA.
EM noreen.hickok@jefferson.edu
OI Freeman, Theresa/0000-0002-5959-5884; Adams,
   Christopher/0000-0003-2100-4417
FU NIAMS NIH HHS [R01 AR051303-01A2, AR-051303, R01 AR051303]; NIDCR NIH
   HHS [DE-10875, R01 DE010875-13, R01 DE010875, DE-13319, R01 DE013319,
   R01 DE013319-06]
CR Antoci V, 2007, CLIN ORTHOP RELAT R, P81, DOI 10.1097/BLO.0b013e3181123a50
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Bahar Gul, 2002, Mikrobiyoloji Bulteni, V36, P343
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Biemer J J, 1973, Ann Clin Lab Sci, V3, P135
   BOYLE VJ, 1973, ANTIMICROB AGENTS CH, V3, P418, DOI 10.1128/AAC.3.3.418
   Burny F, 2000, MED ENG PHYS, V22, P469, DOI 10.1016/S1350-4533(00)00062-X
   *CLIN LAB STAND I, 2008, 18 INF JAN S, V28
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI20365
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Edupuganti OP, 2007, BIOORG MED CHEM LETT, V17, P2692, DOI 10.1016/j.bmcl.2007.03.005
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Kilgus DJ, 2002, CLIN ORTHOP RELAT R, P116, DOI 10.1097/01.blo.0000030492.43495.63
   Nelson CL, 2004, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.bio.0000143741.92384.18
   O'Toole GA, 1999, METHOD ENZYMOL, V310, P91
   Oliveira M, 2006, VET MICROBIOL, V118, P133, DOI 10.1016/j.vetmic.2006.07.008
   Peersman G, 2001, CLIN ORTHOP RELAT R, P15
   Radin S, 2001, J BIOMED MATER RES, V57, P313, DOI 10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705
   Toms AD, 2006, J BONE JOINT SURG BR, V88B, P149, DOI 10.1302/0301-620X.88B2.17058
   van der Laan MJ, 2006, STAT APPL GENET MOL, V5
   Vodna L, 2007, MACROMOL BIOSCI, V7, P629, DOI 10.1002/mabi.200600290
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
NR 30
TC 132
Z9 133
U1 1
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4684
EP 4690
DI 10.1016/j.biomaterials.2008.08.016
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400013
PM 18814909
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Wieghaus, KA
   Nickerson, MM
   Aronin, CEP
   Sefcik, LS
   Price, RJ
   Paige, MA
   Brown, ML
   Botchwey, EA
AF Wieghaus, Kristen A.
   Nickerson, Meghan M.
   Aronin, Caren E. Petrie
   Sefcik, Lauren S.
   Price, Richard J.
   Paige, Mikell A.
   Brown, Milton L.
   Botchwey, Edward A.
TI Expansion of microvascular networks in vivo by phthalimide neovascular
   factor 1 (PNF1)
SO BIOMATERIALS
LA English
DT Article
DE Small molecule delivery; Controlled release; Microvascular remodeling;
   Monocyte recruitment
ID ENDOTHELIAL GROWTH-FACTOR; CORONARY-ARTERY DISEASE; THERAPEUTIC
   ANGIOGENESIS; 1-MATRIX METALLOPROTEINASE; ENDOMETRIOTIC LESIONS;
   ARTERIOGENESIS; TISSUE; RELEASE; REVASCULARIZATION; REGRESSION
AB Phthalimide neovascular factor (PNF1, formerly SC-3-149) is a potent stimulator of proangiogenic signaling pathways in endothelial cells. In this study, we evaluated the in vivo effects of sustained PNF1 release to promote ingrowth and expansion of microvascular networks surrounding biomaterial implants. The dorsal skinfold window chamber was used to evaluate the structural remodeling response of the local microvasculature. PNF1 was released from poly(lactic-co-glycolic acid) (PLAGA) films, and a transport model was utilized to predict PNF1 penetration into the surrounding tissue. PNF1 significantly expanded microvascular networks within a 2 mm radius from implants after 3 and 7 days by increasing microvessel length density and lumenal diameter of local arterioles and venules. Staining of histological sections with CD11b showed enhanced recruitment of circulating white blood cells, including monocytes, which are critical for the process of vessel enlargement through arteriogenesis. As PNF1 has been shown to modulate MT1-MMP, a facilitator of CCL2 dependent leukocyte transmigration, aspects of window chamber experiments were repeated in CCR2(-/-) (CCL2 receptor) mouse chimeras to more fully explore the critical nature of monocyte recruitment on the therapeutic benefits of PNF1 function in vivo. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Wieghaus, Kristen A.; Nickerson, Meghan M.; Aronin, Caren E. Petrie; Sefcik, Lauren S.; Price, Richard J.; Botchwey, Edward A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.
   [Price, Richard J.] Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.
   [Paige, Mikell A.; Brown, Milton L.] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr,Drug Discovery Progr, Washington, DC 20057 USA.
RP Botchwey, EA (reprint author), Univ Virginia, Dept Biomed Engn, Box 800759, Charlottesville, VA 22908 USA.
EM eab6e@virginia.edu
FU National Institute of Arthritis and Musculoskeletal Disease (NIAMS)
   [K01AR052352-01A1]; US Department of Education's Graduate Assistance in
   Areas of National Need (GAANN); University of Virginia Biotechnology
   [5T32GM008715-08]; National Science Foundation
FX Sources for support of these studies include the National Institute of
   Arthritis and Musculoskeletal Disease (NIAMS) grant K01AR052352-01A1 to
   Dr. Botchwey. Dr. Kristen Wieghaus is supported by the US Department of
   Education's Graduate Assistance in Areas of National Need (GAANN)
   funding. Dr. Caren Petrie Aronin is also supported by GAANN funding and
   by the University of Virginia Biotechnology Training Program grant
   5T32GM008715-08. Lauren Sefcik is supported by a National Science
   Foundation Graduate Research Fellowship.
CR Barnard GC, 2005, APPL ENVIRON MICROB, V71, P5735, DOI 10.1128/AEM.71.10.5735-5742.2005
   Berglund JD, 2003, BRIT J PHARMACOL, V140, P627, DOI 10.1038/sj.bjp.0705457
   Bernas Gloria Castro, 2003, Clin Hemorheol Microcirc, V29, P199
   Bezemer JM, 2000, J CONTROL RELEASE, V64, P179, DOI 10.1016/S0168-3659(99)00127-3
   Blau HM, 2001, NAT MED, V7, P532, DOI 10.1038/87850
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Brey EM, 2005, TISSUE ENG, V11, P567, DOI 10.1089/ten.2005.11.567
   Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906
   Faisant N, 2006, INT J PHARMACEUT, V314, P189, DOI 10.1016/j.ijpharm.2005.07.030
   Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   Freedman SB, 2002, ANN INTERN MED, V136, P54, DOI 10.7326/0003-4819-136-1-200201010-00011
   Freedman SB, 2001, J MOL CELL CARDIOL, V33, P379, DOI 10.1006/jmcc.2000.1329
   Friesenecker BE, 2006, CRIT CARE, V10, DOI 10.1186/cc4922
   Fung LK, 1996, PHARM RES-DORDR, V13, P671, DOI 10.1023/A:1016083113123
   Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200
   Gazit Y, 1997, MICROCIRCULATION-LON, V4, P395, DOI 10.3109/10739689709146803
   GAZIT Y, 1995, PHYS REV LETT, V75, P2428, DOI 10.1103/PhysRevLett.75.2428
   Heil M, 2004, CIRC RES, V94, P671, DOI 10.1161/01.RES.0000122041.73808.B5
   Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A
   Hershey JC, 2001, CARDIOVASC RES, V49, P618, DOI 10.1016/S0008-6363(00)00232-7
   HIRSCHI KK, REPARATIVE MED GROWI, P223
   HOCKEL M, 1993, ARCH SURG-CHICAGO, V128, P423
   Hoefer IE, 2002, CIRCULATION, V105, P1639, DOI 10.1161/01.CIR.0000014987.32865.8E
   Hughes GC, 2004, ANN THORAC SURG, V77, P812, DOI 10.1016/j.athorasur.2003.09.060
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   KEIFER FN, 2003, CURR PHARM DESIGN, V9, P1733
   King TW, 2000, J BIOMED MATER RES, V51, P383, DOI 10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Laschke MW, 2006, BRIT J PHARMACOL, V149, P137, DOI 10.1038/sj.bjp.0706857
   Laschke MW, 2007, FERTIL STERIL, V87, P163, DOI 10.1016/j.fertnstert.2006.05.068
   Laschke MW, 2006, HUM REPROD, V21, P262, DOI 10.1093/humrep/dei308
   Lei Y, 2004, BASIC RES CARDIOL, V99, P121, DOI 10.1007/s00395-004-0447-x
   Qian F, 2002, J CONTROL RELEASE, V83, P427, DOI 10.1016/S0168-3659(02)00217-1
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Ruel M, 2003, CIRCULATION, V108, P335, DOI 10.1161/01.cir.0000087903.75204.ad
   Sefcik LS, 2008, BIOMATERIALS, V29, P2869, DOI 10.1016/j.biomaterials.2008.03.017
   Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F
   Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407
   Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200
   Steinstraesser L, 2006, ANN PLAS SURG, V56, P93, DOI 10.1097/01.sap.0000190883.30005.91
   Strasser JF, 1995, J PHARMACOL EXP THER, V275, P1647
   Strieth S, 2006, INT J CANCER, V119, P423, DOI 10.1002/ijc.21838
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   van Royen N, 2001, CARDIOVASC RES, V49, P543, DOI 10.1016/S0008-6363(00)00206-6
   WIEGHAUS KA, 2008, BIOINFORMATICS  0821
   Wieghaus KA, 2007, TISSUE ENG, V13, P2561, DOI 10.1089/ten.2007.0023
   Wieghaus KA, 2006, TISSUE ENG, V12, P1903, DOI 10.1089/ten.2006.12.1903
   Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102
NR 49
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 35
BP 4698
EP 4708
DI 10.1016/j.biomaterials.2008.08.029
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 386EF
UT WOS:000261864400015
PM 18804278
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bruggeman, JP
   de Bruin, BJ
   Bettinger, CJ
   Langer, R
AF Bruggeman, Joost P.
   de Bruin, Berend-Jan
   Bettinger, Christopher J.
   Langer, Robert
TI Biodegradable poly(polyol sebacate) polymers
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Poly(polyol sebacate); Polyol; Polymer; Biodegradable
ID POLY(GLYCEROL SEBACATE); IN-VITRO; TISSUE; ELASTOMER; NERVE;
   DEGRADATION; SEGMENTS; XYLITOL; VIVO
AB We have developed a family of synthetic biodegradable polymers that are composed of structural units endogenous to the human metabolism, designated poly(polyol sebacate) (PPS) polymers. Material properties of PPS polymers can be tuned by altering the polyol monomer and reacting stiochiometric ratio of sebacic acid. These thermoset networks exhibited tensile Young's modiali ranging from 0.37 +/- 0.08 to 378 +/- 33 MPa with maximum elongations at break from 10.90 +/- 1.37% to 205.16 +/- 55.76%, and glass transition temperatures ranging from similar to 7-46 degrees C. In vitro degradation under physiological conditions was slower than in vivo degradation rates observed for some PPS polymers. PPS polymers demonstrated similar in vitro and in vivo biocompatibility compared to poly(L-lactic-co-glycolic acid) (PLGA). (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Bruggeman, Joost P.; de Bruin, Berend-Jan; Bettinger, Christopher J.; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Bruggeman, Joost P.; de Bruin, Berend-Jan] Erasmus Univ, Erasmus Sch Ctr, Dept Plast & Reconstruct Surg, NL-3015 GE Rotterdam, Netherlands.
   [Bettinger, Christopher J.] Charles Stark Draper Lab Inc, Ctr Biomed Engn, Cambridge, MA 02139 USA.
RP Langer, R (reprint author), MIT, Dept Chem Engn, 45 Carleton St,E25-342, Cambridge, MA 02139 USA.
EM rlanger@mit.edu
RI Bettinger, Christopher/A-3895-2009
FU J.F.S. Esser Stichting; Stichting Prof. Michael-Van Vloten Fonds;
   Charles Stark Draper Laboratory Fellowship; NIH [HL060435]
FX JPB acknowledges financial support from the J.F.S. Esser Stichting and
   the Stichting Prof. Michael-Van Vloten Fonds. CJB was funded by a
   Charles Stark Draper Laboratory Fellowship. This work was funded by NIH
   grant HL060435 and through a gift from Richard and Gail Siegal.
CR Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   BRUGGEMAN JP, THERMOSET BIOD UNPUB
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Clerin V, 2003, TISSUE ENG, V9, P461, DOI 10.1089/107632703322066642
   den Dunnen WFA, 2000, J BIOMED MATER RES, V51, P575, DOI 10.1002/1097-4636(20000915)51:4<575::AID-JBM5>3.3.CO;2-Q
   ELLWOOD KC, 1995, AM J CLIN NUTR, V62, P1169
   Firoozbakhsh K, 2002, CLIN ORTHOP RELAT R, P240, DOI 10.1097/01.blo.0000022170.66847.1c
   Flory P. J., 1953, PRINCIPALS POLYM CHE
   Ha SK, 2006, MED ENG PHYS, V28, P534, DOI 10.1016/j.medengphy.2005.09.006
   Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105
   MAINILVARLET P, 1996, J BIOMED MATER RES A, V7, P6713
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Natah SS, 1997, AM J CLIN NUTR, V65, P947
   NIJST CLE, 2007, BIOMACROMOLECULES
   RYDEVIK BL, 1990, J ORTHOPAED RES, V8, P694, DOI 10.1002/jor.1100080511
   Schmalenberg KE, 2005, BIOMATERIALS, V26, P1423, DOI 10.1016/j.biomaterials.2004.04.046
   SESTOFT L, 1985, ACTA ANAESTH SCAND, V29, P19, DOI 10.1111/j.1399-6576.1985.tb02336.x
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   THURSTON G, 1988, CYTOMETRY, V9, P411, DOI 10.1002/cyto.990090502
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P129, DOI 10.1016/j.joca.2004.10.015
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
NR 27
TC 129
Z9 130
U1 4
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 36
BP 4726
EP 4735
DI 10.1016/j.biomaterials.2008.08.037
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 372YV
UT WOS:000260939100002
PM 18824260
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, F
   Zhang, ZB
   Zhu, XL
   Kang, ET
   Neoh, KG
AF Zhang, Fan
   Zhang, Zhengbiao
   Zhu, Xiulin
   Kang, En-Tang
   Neoh, Koon-Gee
TI Silk-functionalized titanium surfaces for enhancing osteoblast functions
   and reducing bacterial adhesion
SO BIOMATERIALS
LA English
DT Article
DE Titanium; Silk; Surface-initiated ATRP; Methacrylic acid sodium salt;
   Osteoblast; Bacterial adhesion
ID POLYELECTROLYTE MULTILAYERS; RADICAL POLYMERIZATION; SERICIN;
   PROLIFERATION; ANTIBACTERIAL; ATTACHMENT; COPOLYMERS; POLYMERS; GROWTH;
   BIOMATERIALS
AB It would be ideal to have implants which can simultaneously inhibit bacterial adhesion and promote osteoblast functions. In this work, titanium surfaces were modified with poly(methacrylic acid) (P(MAA)) followed by immobilization of silk sericin. Firstly a trichlorosifane coupling agent, which is an atom transfer radical polymerization (ATRP) initiator, was immobilized on the oxidized titanium surface to facilitate the surface-initiated ATRP of methacrylic acid sodium salt (MAAS). The pendant carboxyl end groups of the grafted and partially protonated MAA chains were subsequently Coupled with silk sericin via carbodiimide chemistry. The functionalized Ti surfaces were characterized by X-ray photoelectron spectroscopy, and assayed for osteoblast cell functions and bacterial adhesion. The covalently immobilized MAA brushes significantly reduce the adhesion of the two bacterial strains (Staphylococcus aureus and Staphylococcus epidermidis) tested. The silk sericin-immobilized surfaces, at the same time, promote osteoblast cells' adhesion, proliferation, and alkaline phosphatase activity. Thus, the P(MAA) and silk sericin functionalized Ti surfaces have potential applications combating biomaterial-centered infection and promoting osseointegration. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Zhang, Fan; Zhang, Zhengbiao; Kang, En-Tang; Neoh, Koon-Gee] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 119260, Singapore.
   [Zhang, Zhengbiao; Zhu, Xiulin] Suzhou Univ, Sch Chem & Chem Engn, Suzhou 215006, Peoples R China.
RP Neoh, KG (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Kent Ridge, Singapore 119260, Singapore.
EM chenkg@nus.edu.sg
RI Kang, En-Tang/G-8522-2012
OI Kang, En-Tang/0000-0003-0599-7834; Neoh, Koon Gee/0000-0002-2700-1914
FU Ministry of Education under the National University of Singapore
   [R279000202112]
FX The authors gratefully acknowledge the financial support from the
   Ministry of Education under the National University of Singapore Grant
   NO.: R279000202112.
CR Anagnostou F, 2006, BIOMATERIALS, V27, P3912, DOI 10.1016/biomaterials.2006.03.004
   Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243
   Ashford EJ, 1999, CHEM COMMUN, P1285, DOI 10.1039/a903773j
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Cai K, 2007, J BIOMED MATER RES A, V82A, P927, DOI 10.1002/jbm.a.31233
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   DAVIES JE, 2000, BONE ENG
   Dong R, 2007, BIOMACROMOLECULES, V8, P3082, DOI 10.1021/bm700493v
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   El Khadali F, 2002, BIOMACROMOLECULES, V3, P51, DOI 10.1021/bm015563x
   Gray JE, 2003, BIOMATERIALS, V24, P2759, DOI 10.1016/S0142-9612(03)00057-7
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Montanaro L, 2007, BIOMATERIALS, V28, P5155, DOI 10.1016/j.biomaterials.2007.08.003
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   Osborne VL, 2002, CHEM COMMUN, P1838, DOI 10.1039/b204737c
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   Shi ZL, 2007, IND ENG CHEM RES, V46, P439, DOI 10.1021/ie0608096
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Yang JM, 2003, J APPL POLYM SCI, V90, P1331, DOI 10.1002/app.12787
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Zhang F, 2007, IND ENG CHEM RES, V46, P9077, DOI 10.1021/ie070795j
   Zhang YQ, 2006, J CHEM TECHNOL BIOT, V81, P136, DOI 10.1002/jctb.1370
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhang YQ, 2006, J CONTROL RELEASE, V115, P307, DOI 10.1016/j.jconrel.2006.08.019
NR 40
TC 110
Z9 113
U1 4
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 36
BP 4751
EP 4759
DI 10.1016/j.biomaterials.2008.08.043
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 372YV
UT WOS:000260939100004
PM 18829101
DA 2018-10-20
ER

PT J
AU Ren, PG
   Lee, SW
   Biswal, S
   Goodman, SB
AF Ren, Pei-Gen
   Lee, Sheen-Woo
   Biswal, Sandip
   Goodman, Stuart B.
TI Systemic trafficking of macrophages induced by bone cement particles in
   nude mice
SO BIOMATERIALS
LA English
DT Article
DE Macrophage; Polymethylmethacrylate; Wear debris; Non-invasive imaging;
   Animal model; In vivo test
ID TOTAL HIP-ARTHROPLASTY; NECROSIS-FACTOR-ALPHA; DEBRIS IN-VITRO;
   PERIPROSTHETIC OSTEOLYSIS; WEAR DEBRIS; BIOMATERIAL PARTICLES;
   GENE-EXPRESSION; GROWTH-FACTOR; LAK CELLS; MODEL
AB Macrophages play an important role in the biological response to wear particles, which can result in periprosthetic osteolysis and implant loosening. In this study, we demonstrate that polymer particles induce systemic trafficking of macrophages by non-invasive in vivo imaging and immunohistochemistry. The distal femora of nude mice were injected with 10% (w/v) Simplex bone cement (BC) suspensions or saline (PBS). Reporter RAW264.7 macrophages which stably expressed the bioluminescent reporter gene fluc, and the fluorescence reporter gene gfp, were injected intravenously. Bioluminescence imaging was performed immediately and periodically at 2-day intervals until day 14. Compared to the non-operated contralateral femora, the bioluminescent signal of femora injected with BC Suspension increased 4.7 +/- 1.6 and 7.8 +/- 2.9-fold at day 6 and 8, respectively. The same values for PBS group were 1.2 +/- 0.2 and 1.4 +/- 0.5, respectively. The increase of bioluminescence of the BC group was significantly greater than the PBS group at day 8 (p < 0.05) and day 6 (p < 0.1). Histological Study confirmed the presence of reporter macrophages within the medullary canal of mice that received cement particles. Modulation of the signaling mechanisms that regulate systemic macrophage trafficking may provide a new strategy for mitigating the chronic inflammatory response and osteolysis associated with wear debris. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Ren, Pei-Gen; Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA.
   [Lee, Sheen-Woo; Biswal, Sandip] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.
RP Goodman, SB (reprint author), Stanford Univ, Sch Med, Dept Orthopaed Surg, R153,300 Pasteur Dr, Stanford, CA 94305 USA.
EM goodbone@stanford.edu
RI Ren, Pei-Gen/A-4099-2009
FU National Institute of Health, the Ellenburg Chair in Surgery [R21
   AR053189, R01 AR055650-01]
FX We gratefully acknowledge Dr. Gobalakrishnan Sundaresan who supplied the
   fluc and gfp expressing RAW264.7 macrophage cell line. This study was
   supported in part by Grants R21 AR053189 and R01 AR055650-01 from the
   National Institute of Health, the Ellenburg Chair in Surgery.
CR Akisue T, 2002, J BIOMED MATER RES, V59, P507, DOI 10.1002/jbm.1264
   Archibeck M J, 2001, Instr Course Lect, V50, P185
   ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336
   DAVIS RG, 1993, J BIOMED MATER RES, V27, P1039, DOI 10.1002/jbm.820270809
   De A, 2003, MOL THER, V7, P681, DOI 10.1016/S1525-0016(03)00070-4
   Decaris E, 1999, ARTHRITIS RHEUM, V42, P1951, DOI 10.1002/1529-0131(199909)42:9<1951::AID-ANR22>3.3.CO;2-4
   DONALDSON LF, 1993, J NEUROSCI METH, V49, P5, DOI 10.1016/0165-0270(93)90103-X
   Drees P, 2007, NAT CLIN PRACT RHEUM, V3, P165, DOI 10.1038/ncprheum0428
   Epstein NJ, 2005, J ORTHOP RES, V23, P501, DOI 10.1016/j.orthres.2004.10.004
   FELGAR RE, 1990, CELL IMMUNOL, V129, P288, DOI 10.1016/0008-8749(90)90205-6
   Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Goodman SB, 2005, CLIN ORTHOP RELAT R, P39, DOI 10.1097/01/blo.0000149998.88218.05
   HOROWITZ SM, 1995, J BIOMED MATER RES, V29, P477, DOI 10.1002/jbm.820290407
   JONES LC, 1987, CLIN ORTHOP RELAT R, P192
   Kelly S, 2007, EUR J NEUROSCI, V26, P935, DOI 10.1111/j.1460-9568.2007.05737.x
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   Kinov P, 2006, J ORTHOP RES, V24, P55, DOI 10.1002/jor.20013
   Kumagai K, 2008, J ORTHOP RES, V26, P165, DOI 10.1002/jor.20477
   KUPPEN PJK, 1992, INT J CANCER, V52, P266, DOI 10.1002/ijc.2910520219
   LINDER L, 1983, CLIN ORTHOP RELAT R, P93
   LOTZE MT, 1980, J IMMUNOL, V125, P1487
   MAGHAZACHI A A, 1988, Cellular Immunology, V115, P179
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2
   Miyanishi K, 2003, J BONE MINER RES, V18, P1573, DOI 10.1359/jbmr.2003.18.9.1573
   Nakashima Y, 1998, J BONE JOINT SURG BR, V80B, P694, DOI 10.1302/0301-620X.80B4.8374
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b
   QUINN J, 1992, J BONE JOINT SURG BR, V74, P652
   Quinn JMW, 1998, CALCIFIED TISSUE INT, V62, P527, DOI 10.1007/s002239900473
   RICHARDSON DR, 1976, BASIC CIRCULATORY PH, P101
   Rocchetta HL, 2001, ANTIMICROB AGENTS CH, V45, P129, DOI 10.1128/AAC.45.1.129-137.2001
   Sabokbar A, 1998, ARCH ORTHOP TRAUM SU, V117, P136, DOI 10.1007/s004020050213
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   Talmo CT, 2006, CLIN ORTHOP RELAT R, P254, DOI 10.1097/01.blo.0000246531.59876.a8
   Wang ML, 2004, J ARTHROPLASTY, V19, P1028, DOI 10.1016/j.arth.2004.03.024
   Zilber S, 2008, J BIOMED MATER RES B, V84B, P286, DOI 10.1002/jbm.b.30872
NR 39
TC 28
Z9 29
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 36
BP 4760
EP 4765
DI 10.1016/j.biomaterials.2008.09.004
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 372YV
UT WOS:000260939100005
PM 18824259
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gilbert, TW
   Wognum, S
   Joyce, EM
   Freytes, DO
   Sacks, MS
   Badylak, SF
AF Gilbert, Thomas W.
   Wognum, Silvia
   Joyce, Erinn M.
   Freytes, Donald O.
   Sacks, Michael S.
   Badylak, Stephen F.
TI Collagen fiber alignment and biaxial mechanical behavior of porcine
   urinary bladder derived extracellular matrix
SO BIOMATERIALS
LA English
DT Article
DE Extracellular matrix; Scaffold; Collagen fiber alignment; Biaxial
   mechanical behavior
ID SMALL-INTESTINAL SUBMUCOSA; INPLANE SHEAR; TENDON REPAIR; DOG-MODEL;
   SCAFFOLDS; TISSUE; CELLS; QUANTIFICATION; RECONSTRUCTION; BIOMATERIAL
AB The collagen fiber alignment and biomechanical behavior of naturally occurring extracellular matrix (ECM) scaffolds are important considerations for the design of medical devices from these materials. Both should be considered in order to produce a device to meet tissue specific mechanical requirements (e.g., tendon vs. urinary bladder), and Could ultimately affect the remodeling response in vivo. The present study evaluated the collagen fiber alignment and biaxial mechanical behavior of ECM scaffold material harvested from porcine urinary bladder tunica mucosa and basement membrane (together referred to as urinary bladder matrix (UBM)) and ECM harvested from urinary bladder submucosa (UBS). Since the preparation of UBM allows for control of the direction of delamination, the effect of the delamination method on the mechanical behavior of UBM was determined by delaminating the submucosa and other abluminal layers by scraping along the longitudinal axis of the bladder (apex to neck) (UBML) or along the circumferential direction (UBMC). The processing of UBS does not allow for similar directional control. UBML and UBS had similar collagen fiber distributions, with a preferred collagen fiber alignment along the longitudinal direction. UBMC showed a more homogenous collagen fiber orientation. All samples showed a stiffer mechanical behavior in the longitudinal direction. Despite similar collagen fiber distributions, UBML and UBS showed quite different mechanical behavior for the applied loading patterns with UBS showing a much more pronounced toe region. The mechanical behavior for UBMC in both directions was similar to the mechanical behavior of UBML. There are distinct differences in the mechanical behavior of different layers of ECM from the porcine urinary bladder, and the processing methods can substantially alter the mechanical behavior observed. (c) 2008 Elsevier Ltd. All rights Feserved.
C1 [Gilbert, Thomas W.; Freytes, Donald O.; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Wognum, Silvia; Joyce, Erinn M.; Sacks, Michael S.] Univ Pittsburgh, Dept Bioengn, Engineered Tissue Mech & Mechanobiol Lab, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, 100 Technol Dr,Suite 200, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
FU NIBIB NIH HHS [R01 EB000506, R01 EB000506-02]
CR Androjna C, 2007, TISSUE ENG, V13, P233, DOI 10.1089/ten.2006.0050
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   BEATTIE AJ, TISSUE ENG IN PRESS
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Coburn JC, 2007, J BIOMED MATER RES A, V81A, P250, DOI 10.1002/jbm.a.30943
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   FREYTES DO, 2008, J BIOMED MAT A  0128
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Freytes DO, 2006, J BIOMED MATER RES B, V78B, P327, DOI 10.1002/jbm.b.30491
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Gilbert TW, 2007, TISSUE ENG, V13, P1313, DOI 10.1089/ten.2006.0318
   Gilbert TW, 2006, J BIOMECH ENG-T ASME, V128, P890, DOI 10.1115/1.2354200
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   Gloeckner DC, 2002, J UROLOGY, V167, P2247, DOI 10.1016/S0022-5347(05)65137-3
   KOCHUPURA PV, 2005, CIRCULATION, V112, P1144
   Li F, 2004, ENDOTHELIUM-J ENDOTH, V11, P199, DOI 10.1080/10623320490512390
   Nagatomi J, 2005, ANN BIOMED ENG, V33, P1078, DOI 10.1007/s10439-005-5776-x
   Nieponice A, 2006, ANN THORAC SURG, V82, P2050, DOI 10.1016/j.athoracsur.2006.06.036
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   REING JE, 2008, TISSUE ENG A    0724
   ROBINSON KA, 2005, CIRCULATION, V112, P1135
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Sacks MS, 1999, J BIOMECH ENG-T ASME, V121, P551, DOI 10.1115/1.2835086
   Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671
   Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   Sun W, 2003, J BIOMECH ENG-T ASME, V125, P372, DOI 10.1115/1.1572518
   Vande Geest JP, 2004, J BIOMECH ENG-T ASME, V126, P815, DOI 10.1115/1.1824121
   Wallis MC, 2008, TISSUE ENG PT A, V14, P339, DOI 10.1089/tea.2006.0398
   Zantop T, 2006, J ORTHOP RES, V24, P1299, DOI 10.1002/jor.20071
NR 40
TC 78
Z9 81
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 36
BP 4775
EP 4782
DI 10.1016/j.biomaterials.2008.08.022
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 372YV
UT WOS:000260939100007
PM 18801572
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rockwood, DN
   Akins, RE
   Parrag, IC
   Woodhouse, KA
   Rabolt, JF
AF Rockwood, Danielle N.
   Akins, Robert E., Jr.
   Parrag, Ian C.
   Woodhouse, Kimberly A.
   Rabolt, John F.
TI Culture on electrospun polyurethane scaffolds decreases atrial
   natriuretic peptide expression by cardiomyocytes in vitro
SO BIOMATERIALS
LA English
DT Article
DE Cardiac tissue engineering; Electrospinning; Biodegradable polyurethane;
   Atrial natriuretic peptide (ANP); Cardiomyocyte
ID GENE-EXPRESSION; CARDIAC-MUSCLE; VENTRICULAR MYOCYTES; TISSUE
   ARCHITECTURE; MESSENGER-RNA; HEART; SKELETAL; CELLS; ARRANGEMENT;
   ALIGNMENT
AB The function of the mammalian heart depends on the functional alignment of cardiomyocytes, and controlling cell alignment is an important consideration in biomaterial design for cardiac tissue engineering and research. The physical cues that guide functional cell alignment in vitro and the impact of substrate-imposed alignment on cell phenotype, however, are only partially understood. In this report, primary cardiac ventricular cells were grown on electrospun, biodegradable polyurethane (ES-PU) with either aligned or unaligned microfibers. ES-PU scaffolds supported high-density cultures and cell subpopulations remained intact over two weeks in culture. ES-PU cultures contained electricall-coupled y cardiomyocytes with connexin-43 localized to points of cell:cell contact. Multi-cellular organization correlated with rnicrofiber orientation and aligned materials yielded highly oriented cardiomyocyte groupings. Atrial natriuretic peptide, a molecular marker that shows decreasing expression during ventricular cell maturation, was significantly lower in cultures grown on ES-PU scaffolds than in those grown on tissue culture polystyrene. Cells grown on aligned ES-PU had significantly lower steady state levels of ANP and constitutively released less ANP over time indicating that scaffold-imposed cell organization resulted in a shift in cell phenotype to a more mature state. We conclude that the physical organization of microfibers in ES-PU scaffolds impacts both multi-cellular architecture and cardiac cell phenotype in vitro. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Akins, Robert E., Jr.] Alfred I DuPont Hosp Children, Wilmington, DE 19803 USA.
   [Rockwood, Danielle N.; Rabolt, John F.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19711 USA.
   [Parrag, Ian C.; Woodhouse, Kimberly A.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
RP Akins, RE (reprint author), Alfred I DuPont Hosp Children, 1600 Rockland Rd, Wilmington, DE 19803 USA.
EM rakins@nemours.org
OI Akins, Robert/0000-0001-9706-0752
FU NSF [DMR - 0315461]; National Center for Research Resources at NIH [1
   P20-RR020173-01]; Nemours Foundation (REA); Canadian Institutes for
   Health Research (KAW); Natural Science and Engineering Research Council
   - Canada (KAW)
FX The authors would like to thank Therese McLaughlin for the help with
   cell culture, Frank Kriss and Dr. Chao Ni for assistance in electron
   microscopy, and Melissa Rhodes, Steve Beard, Alfred Lance and Dave
   Cowgill for the help in manufacturing the mandrel used for aligning the
   fibers during electrospinning. In addition, the authors greatly
   appreciate the help of Dr. Chuanzhao Li and Robert Long with flow
   cytometry data collection. This work was funded through NSF (NIRT and
   DMR - 0315461 to JFR), the National Center for Research Resources at NIH
   (RPG# 1 P20-RRO20173-01 to REA), the Nemours Foundation (REA), the
   Canadian Institutes for Health Research (KAW), and the Natural Science
   and Engineering Research Council - Canada (KAW).
CR Akins RE, 2007, DNA CELL BIOL, V26, P425, DOI 10.1089/dna.2006.0543
   Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005
   Barth AS, 2005, PFLUG ARCH EUR J PHY, V450, P201, DOI 10.1007/s00424-005-1404-8
   Baudino TA, 2008, MICROSC MICROANAL, V14, P117, DOI 10.1017/S1431927608080021
   BLOCH KD, 1986, CELL, V47, P695, DOI 10.1016/0092-8674(86)90512-X
   Cameron VA, 2003, ENDOCRINOLOGY, V144, P2191, DOI 10.1210/en.2003-0127
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   CLAYCOMB WC, 1988, BIOCHEM J, V255, P617
   DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2
   Fink C, 2000, FASEB J, V14, P669
   Guenet JL, 1996, MAMM GENOME, V7, P13, DOI 10.1007/s003359900004
   HARDING SE, 1994, EUR HEART J, V15, P35, DOI 10.1093/eurheartj/15.suppl_D.35
   Hooks DA, 2007, CIRC RES, V101, pE103, DOI 10.1161/CIRCRESAHA.107.161075
   HORI K, 2000, SCAND J GASTROENTERO, V35, P24
   IRONS CE, 1993, AM J PHYSIOL, V264, pH282
   Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.000026193.13269.bf
   LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571
   LU L, 1996, MRS BULL, V31, P28
   Matsuda T, 2005, BIOCHEM BIOPH RES CO, V326, P228, DOI 10.1016/j.bbrc.2004.11.019
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   McDevitt TC, 2002, J BIOMED MATER RES, V60, P472, DOI 10.1002/jbm.1292
   McGrath MF, 2005, PEPTIDES, V26, P933, DOI 10.1016/j.peptides.2004.12.022
   Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005
   Opie L. H., 2004, HEART PHYSL CELL CIR
   Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024
   Reinecke H, 2000, J CELL BIOL, V149, P731, DOI 10.1083/jcb.149.3.731
   Riboldi SA, 2008, J BIOMED MATER RES A, V84A, P1094, DOI 10.1002/jbm.a.31534
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Rockwood DN, 2007, J BIOMAT SCI-POLYM E, V18, P743, DOI 10.1163/156856207781034115
   SCHULTE R, 2000, BIOMED TECH, V45, P97
   SIMPSON DG, 1994, J CELL PHYSIOL, V161, P89, DOI 10.1002/jcp.1041610112
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   SPERELAKIS N, 1978, ENVIRON HEALTH PERSP, V26, P243, DOI 10.2307/3428847
   Vandenburgh HH, 1996, AM J PHYSIOL-CELL PH, V270, pC1284
   WOLLENBERGER A, 1985, BASIC RES CARDIOL, V80, P9
   Wu CF, 1997, J BIOL CHEM, V272, P14860, DOI 10.1074/jbc.272.23.14860
   Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104
   Yamane M, 2007, BIOCHEM BIOPH RES CO, V353, P1023, DOI 10.1016/j.bbrc.2006.12.144
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 40
TC 78
Z9 80
U1 0
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2008
VL 29
IS 36
BP 4783
EP 4791
DI 10.1016/j.biomaterials.2008.08.034
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 372YV
UT WOS:000260939100008
PM 18823659
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Qiu, JJ
   He, ZX
   Liu, CM
   Guo, XD
   Zheng, QX
AF Qiu, Jin-Jun
   He, Zhao-Xuan
   Liu, Cheng-Mei
   Guo, Xiao-Dong
   Zheng, Qi-Xing
TI Crosslinking property of an oligomeric unsaturated phosphoester used as
   a potential injectable biomaterial
SO BIOMEDICAL MATERIALS
LA English
DT Article; Proceedings Paper
CT 5th China-Korea Symposium on Biomaterials and Nano-Biotechnology
CY OCT 14-18, 2007
CL Wuhan, PEOPLES R CHINA
ID IN-VIVO DEGRADATION; ORTHOPEDIC BIOMATERIALS; MECHANICAL-PROPERTIES;
   BONE-CEMENT; POLY(PHOSPHOESTER); SITU; POLYPHOSPHOESTER; COMPOSITE;
   POLYANHYDRIDES; DELIVERY
AB An unsaturated polyphosphoester (UPPE) that has double bonds in repeatable units could crosslink with a vinyl monomer. A study of how the crosslinking temperature, setting time and mechanical properties are affected by the UPPE molecular weight, N-vinyl pyrrolidinone (NVP)/UPPE ratio and benzoyl peroxide (BPO)/UPPE ratio was conducted. The results of the study indicated that the maximum crosslinking temperature is between 41.1 degrees C and 82.3 degrees C, which is lower than the 97 degrees C of poly(methyl methacrylate) bone cement. The BPO concentration strongly affected the maximum temperature and setting time. High concentration of BPO gives a rapid polymerization rate, causing reaction heat to be released immediately. The compressive strength and compressive modulus will be enhanced with an increase in the NVP/UPPE ratio, the UPPE molecular weight and the BPO concentration. For all formulations, the compressive strength values are between 3.3 MPa and 11.0 MPa and the compressive modulus values are between 4.9 MPa and 101.9 MPa. These initial studies suggest that UPPE is one kind of potential injectable bone tissue engineering scaffold material.
C1 [Qiu, Jin-Jun; He, Zhao-Xuan; Liu, Cheng-Mei] Huazhong Univ Sci & Technol, Dept Chem & Chem Engn, Wuhan 430074, Peoples R China.
   [Guo, Xiao-Dong; Zheng, Qi-Xing] Huazhong Univ Sci & Technol, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
RP Qiu, JJ (reprint author), Huazhong Univ Sci & Technol, Dept Chem & Chem Engn, Wuhan 430074, Peoples R China.
EM liukui@hust.edu.cn
RI guo, xiaodong/K-2600-2013
CR Burdick JA, 2001, J BIOMAT SCI-POLYM E, V12, P1253, DOI 10.1163/156856201753395789
   Burdick JA, 2002, J BIOMED MATER RES, V63, P484, DOI 10.1002/jbm.10298
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   Chaubal MV, 2003, J BIOMAT SCI-POLYM E, V14, P45, DOI 10.1163/15685620360511137
   DAHIYAT BI, 1995, J CONTROL RELEASE, V33, P13, DOI 10.1016/0168-3659(94)00039-W
   Frazier DD, 1997, J BIOMED MATER RES, V35, P383, DOI 10.1002/(SICI)1097-4636(19970605)35:3<383::AID-JBM12>3.0.CO;2-G
   GOLDSTEIN SA, 1991, J BIOMECH, V24, P135, DOI 10.1016/0021-9290(91)90384-Y
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Huang SW, 2004, BIOMACROMOLECULES, V5, P306, DOI 10.1021/bm034241l
   JEFFERISS CD, 1975, J BONE JOINT SURG BR, V57, P511
   KE TY, 1998, GAODENG XUEXIAO HUAX, V19, P1335
   Kumar N, 2002, ADV DRUG DELIVER REV, V54, P889, DOI 10.1016/S0169-409X(02)00050-9
   Leong KW, 1995, CHINESE J POLYM SCI, V13, P289
   Pascual B, 1996, BIOMATERIALS, V17, P509, DOI 10.1016/0142-9612(96)82725-6
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Qiu JJ, 2006, J APPL POLYM SCI, V102, P3095, DOI 10.1002/app.23720
   Salem AK, 2003, ADV MATER, V15, P210, DOI 10.1002/adma.200390047
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Wan ACA, 2004, J BIOMED MATER RES B, V70B, P91, DOI 10.1002/jbm.b.30022
   Wan ACA, 2001, BIOMATERIALS, V22, P1147, DOI 10.1016/S0142-9612(00)00355-0
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
   Wang J, 2001, J AM CHEM SOC, V123, P9480, DOI 10.1021/ja016062m
   Wang S, 2001, BIOMATERIALS, V22, P1157, DOI 10.1016/S0142-9612(00)00356-2
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
   Zhao Z, 2003, ADV DRUG DELIVER REV, V55, P483, DOI 10.1016/S0169-409X(03)00040-1
NR 26
TC 4
Z9 8
U1 0
U2 15
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD DEC
PY 2008
VL 3
IS 4
AR 044107
DI 10.1088/1748-6041/3/4/044107
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 376TX
UT WOS:000261207000011
PM 19029608
DA 2018-10-20
ER

PT J
AU Tang, XJ
   Gui, L
   Lu, XY
AF Tang, Xiao-Jun
   Gui, Lai
   Lue, Xiao-Ying
TI Hard tissue compatibility of natural hydroxyapatite/chitosan composite
SO BIOMEDICAL MATERIALS
LA English
DT Article; Proceedings Paper
CT 5th China-Korea Symposium on Biomaterials and Nano-Biotechnology
CY OCT 14-18, 2007
CL Wuhan, PEOPLES R CHINA
ID BONE-GRAFT SUBSTITUTES; IN-VITRO; CHITOSAN; OSTEOCONDUCTION;
   REGENERATION; BIOMATERIAL; REPAIR; PASTE
AB The natural hydroxyapatite/chitosan (NHC) composite is a new synthesized material. The aim of this experiment was to assess the bone tissue compatibility of this NHC composite in vivo. Twenty-four healthy New Zealand rabbits were included in this study. Of those, 20 were used as the experimental group and four as the control group. In the experimental group, animals receive a cranium defect procedure and NHC composite repair. In the control group, animals underwent the cranium defect procedure without NHC composite repair. At 1, 4, 12, 24, and 40 weeks after surgery, the animals were sacrificed and samples were taken and assessed by gross observation, three-dimensional (3D) computerized tomographic (CT) reconstruction, histology and scanning electron microscope. Our results showed that at 1 week after repairing the bone defect with the NHC composite in the experimental group, new bone appeared around the composite and matured gradually. At 24 weeks after surgery, there were little collagenous tissues present between the material and surrounding bones. At 40 weeks after surgery, new bone had grown into the mature bone and total osseointegration had occurred. In the control group, however, no bone defect healing was observed at 40 weeks after surgery. All these results of the present in vivo work suggest that the NHC composite has a good hard tissue biocompatibility and an excellent osteoconductivity. It is suitable for artificial bone implants and frame materials of tissue engineering.
C1 [Tang, Xiao-Jun; Gui, Lai] Chinese Acad Med Sci, Plast Surg Hosp, Dept Craniomaxillofacial Sur, Beijing 100144, Peoples R China.
   [Tang, Xiao-Jun; Gui, Lai] Peking Union Med Coll, Beijing 100144, Peoples R China.
   [Lue, Xiao-Ying] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
RP Tang, XJ (reprint author), Chinese Acad Med Sci, Plast Surg Hosp, Dept Craniomaxillofacial Sur, 33 Ba Da Chu Rd, Beijing 100144, Peoples R China.
EM laiguiplastic@tom.com; luxy@seu.edu.cn
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Arts JJC, 2006, BIOMATERIALS, V27, P1110, DOI 10.1016/j.biomaterials.2005.07.024
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Carvalho Alexandre L, 2007, J Oral Implantol, V33, P267, DOI 10.1563/1548-1336(2007)33[267:EOGSOT]2.0.CO;2
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DING YH, 2001, CHIN J MARINE DRUGS, V20, P32
   Gardiner A, 2007, SPORTS MED ARTHROSC, V15, P158, DOI 10.1097/JSA.0b013e31805c090b
   HEIMKE G, 1987, BIOMATERIALS CLIN AP, V9, P93
   Janes KA, 2003, J APPL POLYM SCI, V88, P2769, DOI 10.1002/app.12016
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   Kofron MD, 2004, CURR OPIN BIOTECH, V15, P399, DOI 10.1016/j.copbio.2004.07.004
   Kuo SM, 2006, J BIOMED MATER RES A, V76A, P408, DOI 10.1002/jbm.a.30534
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   LU XY, 2005, 3 INT S AP CORR BIOM
   Lue XY, 2007, KEY ENG MATER, V342-343, P213, DOI 10.4028/www.scientific.net/KEM.342-343.213
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Manjubala I, 2000, J MATER SCI-MATER M, V11, P705, DOI 10.1023/A:1008915510976
   Mukherjee DP, 2003, J BIOMED MATER RES B, V67B, P603, DOI 10.1002/jbm.b.10050
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P39, DOI 10.1016/0142-9612(93)90073-B
   Pang EK, 2005, J PERIODONTOL, V76, P1526, DOI 10.1902/jop.2005.76.9.1526
   PANTALEONE D, 1992, CARBOHYD RES, V237, P325, DOI 10.1016/S0008-6215(92)84256-R
   Park JB, 2007, IMPLANT DENT, V16, P246, DOI 10.1097/ID.0b013e3181237926
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Seo DS, 2008, ANN BIOMED ENG, V36, P132, DOI 10.1007/s10439-007-9394-7
   Takagi S, 2003, DENT MATER, V19, P797, DOI 10.1016/S0109-5641(03)00028-9
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
   ZHENG BZ, 2004, THESIS SE U NANJING, P39
NR 32
TC 14
Z9 18
U1 1
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD DEC
PY 2008
VL 3
IS 4
AR 044115
DI 10.1088/1748-6041/3/4/044115
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 376TX
UT WOS:000261207000019
PM 19029618
DA 2018-10-20
ER

PT J
AU Fozdar, DY
   Wu, X
   Patrick, CW
   Chen, S
AF Fozdar, David Y.
   Wu, Xuemei
   Patrick, Charles W., Jr.
   Chen, Shaochen
TI Micro-well texture printed into PEG hydrogels using the FILM
   nanomanufacturing process affects the behavior of preadipocytes
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE adipose tissue engineering; nanomanufacturing; polyethylene glycol;
   preadipocyte; tissue scaffold
ID FLAP; FAT; DIFFERENTIATION; TRANSPLANTATION; NANOSTRUCTURES;
   RECONSTRUCTION; ADHESION; ATROPHY; TENSION; CELLS
AB To date, biomaterial scaffolds for adipose tissue engineering have focused on macro- and upper micro-scale fabrication, biocompatibility, and biodegradation, but have failed to recapitulate the sub-micron dimensions of native extracellular matrix (ECM) and, therefore, have not optimized material-cell interactions. Here, we report the findings from a study investigating the effects of a quasi-mimetic sub-micron (< 1 mu m) surface texture on the qualitative behavior of preadipocytes (PAs). We found that PAs in contact with tread-like micro-well structures exhibit a different morphology relative to PAs seeded onto control smooth glass surfaces. Additionally, the micro-well topography induced isolated PAs to undergo adipogenesis, which usually occurs in the presence of aggregates of contact-inhibited PAs. The micro-well structures were printed into polyethylene glycol dimethacrylate (PEGDMA) using the recently reported nanomanufacturing process called Flash Imprint Lithography Using a Mask Aligner (FILM). FILM is a simple process that can be utilized to fabricate micro- and nanostructures in UV-curable materials (D.Y. Fozdar, W. Zhang, M. Palard, C.W. Patrick Jr., S.C. Chen, Flash Imprint Lithography Using A Mask Aligner (FILM): A Method for Printing Nanostructures in Photosensitive Hydrogels for Tissue Engineering. Nanotechnology 19, 2008). We demonstrate the utilization of the FILM process for a tissue engineering application for the first time. The micro-well topographical theme is characterized by contact angle and surface energy analysis and the results were compared with those for smooth glass and unpatterned PEGDMA surfaces. Based on our observations, we believe that the micro-well texture may ultimately be beneficial on implantable tissue scaffolds.
C1 [Fozdar, David Y.; Chen, Shaochen] Univ Texas Austin, Dept Mech Engn, Ctr Nano Mol Sci & Technol, Microelect Res Ctr, Austin, TX 78712 USA.
   [Wu, Xuemei; Patrick, Charles W., Jr.] Univ Texas MD Anderson Canc Ctr, Dept Biomed Engn, Houston, TX 77030 USA.
RP Chen, S (reprint author), Univ Texas Austin, Dept Mech Engn, Ctr Nano Mol Sci & Technol, Microelect Res Ctr, 1 Univ Stn,C2200, Austin, TX 78712 USA.
EM davidfozdar@mail.utexas.edu; scchen@mail.utexas.edu
FU Office of Naval Research to SCC; Susan G. Komen Foundation; NCI
   [CA16672]; M. D. Anderson Cancer Center; NSF at UT-Austin
FX We acknowledge the technical assistance of Ms. Krithi Mittakanti during
   her summer internship. This work is supported in part by a grant from
   the Office of Naval Research to SCC. CWP acknowledges the grant from the
   Susan G. Komen Foundation and a NCI grant CA16672 awarded to M. D.
   Anderson Cancer Center. Work was performed in part at the Center for
   Nano and Molecular Science and Technology (CNM) and at the
   Microelectronics Research Center (MRC), a part of the National
   Microfabrication Infrastructure Network supported by NSF at UT- Austin.
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004
   ADAMSON AW, 1970, J COLLOID INTERF SCI, V34, P461, DOI 10.1016/0021-9797(70)90206-7
   ADAMSON AW, 1982, PHYS CHEM SURFACES
   Andreas JM, 1938, J PHYS CHEM-US, V42, P1001, DOI 10.1021/j100903a002
   Asai S, 2006, ANN PLAS SURG, V57, P154, DOI 10.1097/01.sap.0000216243.91162.c2
   BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Colburn M, 1999, P SOC PHOTO-OPT INS, V3676, P379, DOI 10.1117/12.351155
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P219, DOI 10.1097/00006534-199102000-00001
   Fowkes FM, 1940, J AM CHEM SOC, V62, P3377, DOI 10.1021/ja01869a029
   FOZDAR DY, 2008, NANOTECHNOLOGY, V19, DOI DOI 10.1088/0957-4484/19/21/215303
   GIRIFALCO LA, 1957, J PHYS CHEM-US, V61, P904, DOI 10.1021/j150553a013
   Hunt JA, 2003, PLAST RECONSTR SURG, V111, P1497, DOI 10.1097/01.PRS.0000049646.25757.BE
   Kim P, 2005, NANOTECHNOLOGY, V16, P2420, DOI 10.1088/0957-4484/16/10/072
   Patel PN, 2005, TISSUE ENG, V11, P1498, DOI 10.1089/ten.2005.11.1498
   Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139
   Patrick CW, 2000, SEMIN SURG ONCOL, V19, P302, DOI 10.1002/1098-2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Patrick CW, 2002, TISSUE ENG, V8, P283, DOI 10.1089/107632702753725049
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Steinberg T, 2007, NANO LETT, V7, P287, DOI 10.1021/nl06227z
   Vaienti L, 2005, PLAST RECONSTR SURG, V116, P699, DOI 10.1097/01.prs.0000177449.12366.48
   Wang XC, 2005, ANN PLAS SURG, V55, P617, DOI 10.1097/01.sap.0000189659.76694.e2
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
NR 25
TC 8
Z9 8
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2008
VL 10
IS 6
BP 839
EP 849
DI 10.1007/s10544-008-9198-z
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA 348YQ
UT WOS:000259246400008
PM 18561027
DA 2018-10-20
ER

PT J
AU Park, D
   Lim, SR
   Yun, YS
   Park, JM
AF Park, Donghee
   Lim, Seong-Rin
   Yun, Yeoung-Sang
   Park, Jong Moon
TI Development of a new Cr(VI)-biosorbent from agricultural biowaste
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Biosorption; Chromium; Cr(VI)-biosorbent; Reduction; Agricultural
   biowaste
ID HEXAVALENT CHROMIUM REMOVAL; DEAD FUNGAL BIOMASS; AQUEOUS-SOLUTIONS;
   TRIVALENT CHROMIUM; ACTIVATED CARBONS; CR(VI) REMOVAL; WASTE-WATER;
   BIOSORPTION; MECHANISM; SORPTION
AB Among useless but abundant agricultural biowastes such as banana skin, green tea waste, oak leaf, walnut shell, peanut shell and rice husk, in this study, banana skin was screened as the most efficient biomaterial to remove toxic Cr(VI) from aqueous solution. X-ray photoelectron spectroscopy (XPS) study revealed that the mechanism of Cr(VI) biosorption by banana skin was its complete reduction into Cr(III) in both aqueous and solid phases and partial binding of the reduced-Cr(III), in the range of pH 1.5-4 tested. One gram of banana skin Could reduce 249.6 (+/- 4.2) mg of Cr(VI) at initial pH 1.5. Namely, Cr(VI)-reducing capacity of banana skin was four times higher than that of a common chemical Cr(VI)-reductant, FeSO4 center dot 7H(2)O. To diminish undesirable/serious organic leaching from the biomaterial and to enhance removal efficiency of total Cr, its powder was immobilized within Ca-alginate bead. The developed Cr(VI)-biosorbent Could completely reduce toxic Cr(VI) to less toxic Cr(Ill) and Could remove almost of the reduced-Cr(III) from aqueous phase. On the basis of removal mechanisms of Cr(VI) and total Cr by the Cr(VI)-biosorbent, a kinetic model was derived and could be Successfully used to predict their removal behaviors in aqueous phase. In conclusion, Our Cr(VI)-biosorbent must be a potent candidate to substitute for chemical reductants as well as adsorbents for treating Cr(VI)-bearing wastewaters. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Park, Donghee; Park, Jong Moon] Pohang Univ Sci & Technol, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, Sch Environm Sci & Engn, Pohang 790784, South Korea.
   [Lim, Seong-Rin] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN 55108 USA.
   [Yun, Yeoung-Sang] Chonbuk Natl Univ, Ind Technol Res Inst, Div Environm & Chem Engn, Jeonju 561756, South Korea.
RP Park, JM (reprint author), Pohang Univ Sci & Technol, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, Sch Environm Sci & Engn, San 31,Hyoja Dong, Pohang 790784, South Korea.
EM jmpark@postech.ac.kr
RI Yun, Yeoung-Sang/F-8340-2011
OI Yun, Yeoung-Sang/0000-0002-2583-8278; Lim, Seong-Rin/0000-0002-5192-0486
FU KOSEF; Program for Advanced Education of Chemical Engineers at POSTECH;
   Korea Ministry of Environment
FX This work was financially Supported by the KOSEF through the AEBRC and
   the Program for Advanced Education of Chemical Engineers at POSTECH.
   This work was also partially supported by Korea Ministry of Environment
   as "The Eco-technopia 21 project".
CR ABBAS M, 2008, WATER AIR SOIL POLL, DOI DOI 10.1007/S11270-007-9613-8
   Anderson RA, 1997, REGUL TOXICOL PHARM, V26, pS35, DOI 10.1006/rtph.1997.1136
   Araujo MM, 1997, INT BIODETER BIODEGR, V40, P63, DOI 10.1016/S0964-8305(97)00064-4
   Baral A., 2002, ENVIRON SCI POLICY, V5, P121, DOI DOI 10.1016/S1462-9011(02)00028-X
   Barnhart J, 1997, REGUL TOXICOL PHARM, V26, pS3, DOI 10.1006/rtph.1997.1132
   Clesceri L. S., 1998, STANDARD METHODS EXA, P366
   Copello GJ, 2008, BIORESOURCE TECHNOL, V99, P6538, DOI 10.1016/j.biortech.2007.11.055
   Costa LG, 2003, BIOMARKERS, V8, P1, DOI 10.1080/13547500210148315
   Dambies L, 2001, COLLOID SURFACE A, V177, P203, DOI 10.1016/S0927-7757(00)00678-6
   Deng SB, 2005, ENVIRON SCI TECHNOL, V39, P8490, DOI 10.1021/es050697u
   Dupont L, 2003, ENVIRON SCI TECHNOL, V37, P4235, DOI 10.1021/es0342345
   ELANGOVAN R, 2008, J HAZARD MATER, DOI DOI 10.1016/J.JHAZMAR.2007.06.06
   ELANGOVAN R, 2008, CHEM ENG J, DOI DOI 10.1016/J.CEJ.2007.10.102
   ERTUGAY N, 2008, J HAZARD MATER, DOI DOI 10.1016/J.JHAZMAT.2007.10.07
   Gao H, 2008, J HAZARD MATER, V150, P446, DOI 10.1016/j.jhazmat.2007.04.126
   Gode F, 2005, J HAZARD MATER, V119, P175, DOI 10.1016/j.jhazmat.2004.12.004
   Gode F, 2008, J HAZARD MATER, V152, P1201, DOI 10.1016/j.jhazmat.2007.07.104
   Gokhale SV, 2008, BIORESOURCE TECHNOL, V99, P3600, DOI 10.1016/j.biortech.2007.07.039
   GUPTA VK, 2008, J HAZARD MATER, DOI DOI 10.1016/J.JHAZMAT.2007.10.03
   HAMEED BH, 2008, J HAZARD MATER, DOI DOI 10.1016/JJHAZMAT.2008.01.19
   KUMAR PA, 2008, CEHM ENG J, DOI DOI 10.1016/J.CEJ.2007.11.004
   Li HD, 2008, BIORESOURCE TECHNOL, V99, P6271, DOI 10.1016/j.biortech.2007.12.002
   Liu CC, 2006, IND ENG CHEM RES, V45, P8891, DOI 10.1021/ie060978q
   LOW KS, 1995, BIORESOURCE TECHNOL, V51, P227, DOI 10.1016/0960-8524(94)00123-I
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Nakano Y, 2001, WATER RES, V35, P496, DOI 10.1016/S0043-1354(00)00279-7
   Noeline BF, 2005, SEP PURIF TECHNOL, V45, P131, DOI 10.1016/j.seppur.2005.03.004
   Park D, 2006, IND ENG CHEM RES, V45, P2405, DOI 10.1021/ie0509387
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   PARK D, 2006, IND ENG CHEM RES, V46, P5059
   Park D, 2008, BIORESOURCE TECHNOL, V99, P1141, DOI 10.1016/j.biortech.2007.02.025
   Park D, 2007, CHEMOSPHERE, V66, P939, DOI 10.1016/j.chemosphere.2006.05.068
   Park HG, 2004, J CHEM TECHNOL BIOT, V79, P1080, DOI 10.1002/jctb.1080
   PEHLIVAN E, 2008, J HAZARD MATER, DOI DOI 10.1016/J.JHAZMAT.2007.11.07
   Qin G, 2005, ENVIRON SCI TECHNOL, V39, P6321, DOI 10.1021/es050486p
   RAWAJFIH Z, 2008, J CHEM THERMODYN, DOI DOI 10.1016/J.JCT.2008.01.00
   Shibi IG, 2006, J CHEM TECHNOL BIOT, V81, P433, DOI 10.1002/jctb.1423
   SRIVASTAVA HCP, 1986, ENVIRON TECHNOL LETT, V7, P55, DOI 10.1080/09593338609384391
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   VOLESKY B, 2007, WATER RES, P4017
   WANG XS, 2008, J ENVIRON MANAGE, DOI DOI 10.1016/J.JENVM.2008.01.01
   Yang L, 2008, BIORESOURCE TECHNOL, V99, P297, DOI 10.1016/j.biortech.2006.12.021
   Yun YS, 2001, ENVIRON SCI TECHNOL, V35, P4353, DOI 10.1021/es010866k
   ZUBAIR A, 2008, WATER AIR SOIL POLL, DOI DOI 10.1017/S11270-008-9626-Y
NR 47
TC 143
Z9 153
U1 2
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD DEC
PY 2008
VL 99
IS 18
BP 8810
EP 8818
DI 10.1016/j.biortech.2008.04.042
PG 9
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 358AN
UT WOS:000259888700044
PM 18511265
DA 2018-10-20
ER

PT J
AU Ip, AWM
   Barford, JP
   Mckay, G
AF Ip, A. W. M.
   Barford, J. P.
   McKay, G.
TI Production and comparison of high surface area bamboo derived active
   carbons
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Bamboo; Activated carbon; Phosphoric acid activation; Adsorption; Acid
   dye
ID PORE-SIZE DISTRIBUTION; REACTIVE DYES; BONE CHAR; ADSORPTIVE PROPERTIES;
   CHEMICAL ACTIVATION; COMPONENT SYSTEMS; TEXTILE EFFLUENT;
   AQUEOUS-SOLUTION; PHOSPHORIC-ACID; REMOVAL
AB High surface area activated carbons have been produced from the natural biomaterial bamboo, using phosphoric acid as the activating agent. The effects of phosphoric acid impregnation ratio, activation temperature, heating rate on the carbon surface area, porosity and mass yield are presented. Three of these bamboo derived active carbons, surface areas 1337,1628 and 2123 m(2)/g were assessed for their ability to adsorb Acid Red 18 dye from aqueous solution; these results were compared with three conventional adsorbents: activated carbon F400, bone char and peat. Isotherm data were analysed using Langmuir. Freundlich, Redlich-Peterson and Langmuir-Freundlich isotherms. Different isotherms provided the best fit correlations to the adsorption experimental data but the Langmuir-Freundlich equation provided the best overall correlation of data. The adsorption capacities of two of the selected bamboo derived carbons were much greater than the capacities of the other three adsorbents. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Ip, A. W. M.; Barford, J. P.; McKay, G.] Hong Kong Univ Sci & Technol, Dept Chem Engn, Kowloon, Hong Kong, Peoples R China.
RP Mckay, G (reprint author), Hong Kong Univ Sci & Technol, Dept Chem Engn, Kowloon, Hong Kong, Peoples R China.
EM kemckayg@ust.hk
OI Barford, John/0000-0003-0494-4837
CR Abe I, 2004, J COLLOID INTERF SCI, V275, P35, DOI 10.1016/j.jcis.2003.12.031
   Adinata D, 2007, BIORESOURCE TECHNOL, V98, P145, DOI 10.1016/j.biortech.2005.11.006
   Al-Degs Y, 2000, WATER RES, V34, P927, DOI 10.1016/S0043-1354(99)00200-6
   Al-Degs YS, 2004, SEPAR SCI TECHNOL, V39, P97, DOI 10.1081/SS-120027403
   Allen SJ, 2004, J COLLOID INTERF SCI, V280, P322, DOI 10.1016/j.jcis.2004.08.078
   Asada T, 2002, J HEALTH SCI, V48, P473, DOI 10.1248/jhs.48.473
   Asada T, 2006, J HEALTH SCI, V52, P585, DOI 10.1248/jhs.52.585
   BROWN MA, 1993, CRIT REV ENV SCI TEC, V23, P249, DOI 10.1080/10643380490434119
   Cheung CW, 2000, SEP PURIF TECHNOL, V19, P55, DOI 10.1016/S1383-5866(99)00073-8
   Cheung CW, 2001, WATER RES, V35, P605, DOI 10.1016/S0043-1354(00)00306-7
   Choy KKH, 1999, RESOUR CONSERV RECY, V27, P57, DOI 10.1016/S0921-3449(98)00085-8
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Easton J, 1995, COLOUR DYEHOUSE EFFL, P9
   El-Hendawy ANA, 2003, CARBON, V41, P713, DOI 10.1016/S0008-6223(03)00029-0
   Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Girgis BS, 1997, ADSORPT SCI TECHNOL, V15, P277, DOI 10.1177/026361749701500403
   Guo YP, 2007, BIORESOURCE TECHNOL, V98, P1513, DOI 10.1016/j.biortech.2006.06.027
   Ho YS, 1998, CHEM ENG J, V70, P115, DOI 10.1016/S0923-0467(98)00076-1
   Ho YS, 2002, WATER AIR SOIL POLL, V141, P1, DOI 10.1023/A:1021304828010
   Jagtoyen M, 1998, CARBON, V36, P1085, DOI 10.1016/S0008-6223(98)00082-7
   Juang RS, 2001, ADSORPTION, V7, P65, DOI 10.1023/A:1011225001324
   KANEKO K, 1994, J MEMBRANE SCI, V96, P59, DOI 10.1016/0376-7388(94)00126-X
   Kim YJ, 2006, CARBON, V44, P1592, DOI 10.1016/j.carbon.2006.02.011
   Koutcheiko S, 2007, BIORESOURCE TECHNOL, V98, P2459, DOI 10.1016/j.biortech.2006.09.038
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Lima IM, 2005, BIORESOURCE TECHNOL, V96, P699, DOI 10.1016/j.biortech.2004.06.021
   LOWELL S, 2004, CHARACTERIZATION POR, P67
   Mizuta K, 2004, BIORESOURCE TECHNOL, V95, P255, DOI 10.1016/j.biortech.2004.02.015
   Moreno-Castilla C, 1997, CARBON, V35, P1619, DOI 10.1016/S0008-6223(97)00121-8
   Mudoga HL, 2008, BIORESOURCE TECHNOL, V99, P3528, DOI 10.1016/j.biortech.2007.07.058
   NEWCOMBE G, 1997, CARBON, V33, P15
   Pereira MFR, 2003, CARBON, V41, P811, DOI 10.1016/S0008-6223(02)00406-2
   Puziy AM, 2002, APPL SURF SCI, V200, P196, DOI 10.1016/S0169-4332(02)00883-8
   Rahman IA, 2005, BIORESOURCE TECHNOL, V96, P1578, DOI 10.1016/j.biortech.2004.12.015
   REDLICH O, 1959, J PHYS CHEM-US, V63, P1024, DOI 10.1021/j150576a611
   Reife A., 1994, ENV CHEM DYES PIGMEN, P265
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Rouquerol F., 1999, ADSORPTION POWDERS P, P439
   San Miguel G, 2006, J CHEM TECHNOL BIOT, V81, P1685, DOI 10.1002/jctb.1600
   Santhy K, 2006, BIORESOURCE TECHNOL, V97, P1329, DOI 10.1016/j.biortech.2005.05.016
   SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922
   Sudaryanto Y, 2006, BIORESOURCE TECHNOL, V97, P734, DOI 10.1016/j.biortech.2005.04.029
   Suzuki RM, 2007, BIORESOURCE TECHNOL, V98, P1985, DOI 10.1016/j.biortech.2006.08.001
   Tsang DCW, 2007, WATER AIR SOIL POLL, V184, P141, DOI 10.1007/s11270-007-9404-2
   Tseng RL, 2006, J HAZARD MATER, V136, P671, DOI 10.1016/j.jhazmat.2005.12.048
   Walker GM, 2001, CHEM ENG J, V83, P201, DOI 10.1016/S1385-8947(00)00257-6
   Wang L, 2006, STROKE, V37, P679
   Wu FC, 1999, J ENVIRON SCI HEAL A, V34, P1753, DOI 10.1080/10934529909376927
NR 49
TC 69
Z9 70
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD DEC
PY 2008
VL 99
IS 18
BP 8909
EP 8916
DI 10.1016/j.biortech.2008.04.076
PG 8
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 358AN
UT WOS:000259888700059
PM 18572403
DA 2018-10-20
ER

PT J
AU Speziale, P
   Visai, L
   Rindi, S
   Pietrocola, G
   Provenza, G
   Provenzano, M
AF Speziale, Pietro
   Visai, Livia
   Rindi, Simonetta
   Pietrocola, Giampiero
   Provenza, Giulio
   Provenzano, Maria
TI Prevention and Treatment of Staphylococcus Biofilms
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE Staphylococcus; biofilm; biomaterials; therapeutic strategies
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; ACCUMULATION-ASSOCIATED PROTEIN;
   POLY-N-ACETYLGLUCOSAMINE; WALL TEICHOIC-ACIDS; EPIDERMIDIS BIOFILMS;
   MONOCLONAL-ANTIBODIES; AUREUS BIOFILM; ARTIFICIAL SURFACES; BINDING
   PROTEINS; MATRIX-MOLECULES
AB Staphylococcus growth on medical devices represents a common occurrence that can lead to serious illness and death. Biomaterial-associated infection, mostly caused by Staphylococcus epidermidis and Staphylococcus aureus, is fairly complicated by the organism'development of a biofilm, which provides a microenvironment that protects from attack by the host immune system and antibiotics. In this review we present recent insights regarding S. aureus and S. epidermidis structural and functional factors that are effective in biofilm development and describe the regulation of their expression. On the basis of the knowledge gained, we also present the potential and limits of current biochemical and biophysical strategies aimed at preventing biofilm formation or at the treatment of established mature biofilms.
C1 [Speziale, Pietro] Univ Pavia, Fac Med & Surg, Dept Biochem, I-27100 Pavia, Italy.
RP Speziale, P (reprint author), Univ Pavia, Fac Med & Surg, Dept Biochem, Viale Taramelli 3-B, I-27100 Pavia, Italy.
EM pspeziale@unipv.it
OI PIETROCOLA, GIAMPIERO/0000-0002-7069-8155
FU Italian Ministry of Health [RF-IOR-2006-349032]
FX This work was supported by a grant from the Italian Ministry of Health
   to P. S. (Identification code: RF-IOR-2006-349032. Opportunistic
   bacteria in orthopaedic implant infections; new strategies of molecular
   and gene therapies).
CR Allignet J, 2001, INFECT IMMUN, V69, P712, DOI 10.1128/IAI.69.2.712-718.2001
   Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06
   Boelens JJ, 2000, J INFECT DIS, V181, P1167, DOI 10.1086/315344
   Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052
   Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200
   Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0
   Bowden MG, 2002, J BIOL CHEM, V277, P43017, DOI 10.1074/jbc.M207921200
   Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Burton E, 2006, ANTIMICROB AGENTS CH, V50, P1835, DOI 10.1128/AAC.50.5.1835-1840.2006
   CERCA N, 2007, INFECT IMMUN, V75, P2406
   Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306
   Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Doherty N, 2006, J BACTERIOL, V188, P2885, DOI 10.1128/JB.188.8.2885-2897.2006
   Domanski PJ, 2005, INFECT IMMUN, V73, P5229, DOI 10.1128/IAI.73.8.5229-5232.2005
   Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0
   Frank KL, 2007, INFECT IMMUN, V75, P4728, DOI 10.1128/IAI.00640-07
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001
   Gu J, 2005, J HOSP INFECT, V61, P342, DOI 10.1016/j.jhin.2005.04.017
   Gyimesi E, 2004, IMMUNOL LETT, V95, P185, DOI 10.1016/j.imlet.2004.07.007
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Hell W, 2003, FEMS MICROBIOL LETT, V227, P47, DOI 10.1016/S0378-1097(03)00647-5
   Hennig S, 2008, J BACTERIOL, V190, P1488, DOI 10.1128/JB.01290-07
   Illingworth B, 2000, J HEART VALVE DIS, V9, P135
   Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07
   Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027
   Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6
   Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07
   Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430
   Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   Karchmer Adolf W., 1994, P213
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004
   Kockro RA, 2000, J MED MICROBIOL, V49, P441, DOI 10.1099/0022-1317-49-5-441
   Kong H, 2008, LANGMUIR, V24, P2051, DOI 10.1021/la703085e
   Kreikemeyer B, 2002, INT J MED MICROBIOL, V292, P283, DOI 10.1078/1438-4221-00212
   Kristian SA, 2008, J INFECT DIS, V197, P1028, DOI 10.1086/528992
   Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002
   Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mack D, 1999, INFECT IMMUN, V67, P1004
   Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200
   Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823
   Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x
   O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08
   O'Seaghdha M, 2006, FEBS J, V273, P4831, DOI 10.1111/j.1742-4658.2006.05482.x
   Otto M, 2008, CURR TOP MICROBIOL, V322, P207
   Palmer RJ, 2007, J BACTERIOL, V189, P7948, DOI 10.1128/JB.00787-07
   Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531
   Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233
   Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0
   Rodrigues LR, 2006, J APPL MICROBIOL, V100, P470, DOI 10.1111/j.1365-2672.2005.02826.x
   Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Sadovskaya I, 2004, CARBOHYD RES, V339, P1467, DOI 10.1016/j.carres.2004.03.017
   Sass P, 2007, APPL ENVIRON MICROB, V73, P347, DOI 10.1128/AEM.01616-06
   Schlag S, 2007, J BACTERIOL, V189, P7911, DOI 10.1128/JB.00598-07
   Sharma M, 2008, ANTIMICROB AGENTS CH, V52, P299, DOI 10.1128/AAC.00988-07
   Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005
   Tormo MA, 2005, J BACTERIOL, V187, P2348, DOI 10.1128/JB.187.7.2348-2356.2005
   Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0
   TUROS E, 2007, BIOORG MED CHEM LETT, V17, P3466
   van der Borden AJ, 2004, APPL ENVIRON MICROB, V70, P6871, DOI 10.1128/AEM.70.11.6871-6874.2004
   Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0
   Visai L, 2000, J BIOL CHEM, V275, P39837, DOI 10.1074/jbc.M005297200
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239
   Vuong C, 2008, J INFECT DIS, V198, P258, DOI 10.1086/589307
   Walencka E, 2008, FOLIA MICROBIOL, V53, P61, DOI 10.1007/s12223-008-0009-y
   Walencka E, 2007, Z NATURFORSCH C, V62, P433
   Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863
   Weigel LM, 2007, ANTIMICROB AGENTS CH, V51, P231, DOI 10.1128/AAC.00576-06
   Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0
   WITHCHURCH CB, 2002, SCIENCE, V295, P1487
   Wu JA, 2003, ANTIMICROB AGENTS CH, V47, P3407, DOI 10.1128/AAC.47.11.3407-3414.2003
   Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945
   Zhu Y, 2007, INFECT IMMUN, V75, P4219, DOI 10.1128/IAI.00509-07
NR 93
TC 29
Z9 35
U1 0
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
J9 CURR MED CHEM
JI Curr. Med. Chem.
PD DEC
PY 2008
VL 15
IS 30
BP 3185
EP 3195
DI 10.2174/092986708786848442
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 386OK
UT WOS:000261892300004
PM 19075662
DA 2018-10-20
ER

PT J
AU Suzuki, K
AF Suzuki, Kaoru
TI Free electron laser induced forward transfer method of biomaterial for
   marking
SO ELECTRICAL ENGINEERING IN JAPAN
LA English
DT Article
DE direct write marking; biomaterial; free electron laser induced forward
   transfer
ID FILMS
AB Biomaterial, Such its chitosan and poly lactic acid, containing a fluorescence agent was deposited onto biologic hard tissue, Such as teeth, the claws of-dogs or cats, or a sapphire Substrate by free electron laser induced forward transfer method for direct write marking. Spin-coated biomaterial with the fluorescence agent Rhodamin 613 or zinc phthalocyanine target on it sapphire plate was ablated by a free electron laser (resonance absorption wavelength of biomaterial: 3380 nm). In particular, the influence of the spin-coating film-forming temperature on hardness and adhesion strength of the biomaterial is Studied. The effect of resonance excitation of the biomaterial target by turning the free electron laser is discussed with respect to damage in terms of biomaterial, rhodamin-6G, or zinc phthalocyanine For direct write marking. (C) 2008 Wiley Periodicals, Inc.
C1 Nihon Univ, Tokyo 102, Japan.
RP Suzuki, K (reprint author), Nihon Univ, Tokyo 102, Japan.
FU Ministry of Education, Culture, Sports, Science, and Technology
FX This study has been financially supported by a grant from the Ministry
   of Education, Culture, Sports, Science, and Technology to promote the
   multi-disciplinary research project "Academic Frontier"; and "High Tech
   Research Center."
CR BOHANDY J, 1988, J APPL PHYS, V63, P1158, DOI 10.1063/1.340023
   FRABIAN J, 1992, CHEM REV, V92, P1197
   Gattin R, 2001, J POLYM ENVIRON, V9, P11, DOI 10.1023/A:1016036302871
   *HARD TISS RES GRO, 2005, HARD TISS RES HDB MA, P335
   Ishihara M, 2002, TRENDS GLYCOSCI GLYC, V14, P331, DOI 10.4052/tigg.14.331
   Stark DA, 2005, DEV DYNAM, V233, P983, DOI 10.1002/dvdy.20385
   Suzuki K, 2005, P SOC PHOTO-OPT INS, V5713, P610, DOI 10.1117/12.590972
   TABATA Y, 2003, BIOMATERIALS, P1
   TUAN VD, 2003, BIOMEDICAL PHOTONICS, P833
   WROBEL JJ, 1982, APPL PHYS LETT, V40, P928, DOI 10.1063/1.92957
NR 10
TC 3
Z9 3
U1 2
U2 8
PU SCRIPTA TECHNICA-JOHN WILEY & SONS
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158 USA
SN 0424-7760
J9 ELECTR ENG JPN
JI Electr. Eng. Jpn.
PD DEC
PY 2008
VL 165
IS 4
BP 60
EP 66
DI 10.1002/eej.20795
PG 7
WC Engineering, Electrical & Electronic
SC Engineering
GA 343MH
UT WOS:000258857400007
DA 2018-10-20
ER

PT J
AU Sunil, P
   Goel, SC
   Rastogi, A
   Aryya, NC
AF Sunil, P.
   Goel, S. C.
   Rastogi, A.
   Aryya, N. C.
TI Incorporation and biodegradation of hydroxyapatite-tricalcium phosphate
   implanted in large metaphyseal defects-An animal study
SO INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE Bioactive ceramics; Bone substitutes; Hydroxyapatite; Metaphyseal
   defects; Tricalcium phosphate
ID BONE-GRAFT SUBSTITUTE; POROUS HYDROXYAPATITE; CALCIUM; CERAMICS; SURGERY
AB Incorporation and biodegradation of hydroxyapatite(HA)-tricalcium phosphate(TCP) granules implanted in 5 x 5 x 5 mm distal femoral metaphyseal defects created in 18 adult rabbits were studied. In two rabbits, the defects were left to heal spontaneously without any implant. Roentgenographic and histological study by light microscopy was done on silver nitrate stained undecalcified sections as well as haematoxylin-eosin stained decalcified sections. The synthetic HA-TCP was biocompatible and produced no adverse reactions. The implant was osteoconductive and allowed good new bone formation to occur, mainly from periphery to center, but mature trabeculae could be delineated only at 4-6 months. The HA-TCP biomaterial had very low biodegradability with marked amount of intact implant still present at final follow up. Bonding between implant and bone, though a close biological bond, was not uniformly strong. Rate of bone ingrowth was very slow and large areas of implant at center did not show new bone formation at 12 months.
C1 [Sunil, P.; Goel, S. C.; Rastogi, A.] Banaras Hindu Univ, Dept Orthopaed, Varanasi 221005, Uttar Pradesh, India.
   [Aryya, N. C.] Banaras Hindu Univ, Inst Med Sci, Dept Pathol, Varanasi 221005, Uttar Pradesh, India.
RP Sunil, P (reprint author), Flat 201,Plot G-47,Pride Dream House Apartments,P, Hyderabad 500008, Andhra Pradesh, India.
EM sunilortho@yahoo.com
CR BUCHOLZ R, 1988, CLIN ORTHOP RELAT R, V240, P53
   Bucholz R, 1989, ORTHOP CLIN N AM, V18, P323
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   FLATLEY TJ, 1983, CLIN ORTHOP RELAT R, P246
   HOLMES R, 1984, CLIN ORTHOP RELAT R, P252
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   LANE JM, 1999, CLIN ORTHOP S, V367, P107
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   LEGEROS RZ, 1995, BIOCERAMICS, V8, P81
   NICHOLAS RW, 1994, CLIN ORTHOP RELAT R, V306, P107
   Oonishi H, 1997, J BONE JOINT SURG BR, V79B, P87, DOI 10.1302/0301-620X.79B1.1290
   Takaoka T, 1996, BIOMATERIALS, V17, P1499, DOI 10.1016/0142-9612(96)89774-2
   THOMAS WB, 2002, CLIN ORTHOP RELAT R, V395, P11
   UCHIDA A, 1984, J BONE JOINT SURG BR, V66, P269
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   Yamamoto T, 2000, J BONE JOINT SURG BR, V82B, P1117, DOI 10.1302/0301-620X.82B8.11194
NR 19
TC 8
Z9 8
U1 0
U2 2
PU NATL INST SCIENCE COMMUNICATION
PI NEW DELHI
PA DR K S KRISHNAN MARG, NEW DELHI 110 012, INDIA
SN 0019-5189
J9 INDIAN J EXP BIOL
JI Indian J. Exp. Biol.
PD DEC
PY 2008
VL 46
IS 12
BP 836
EP 841
PG 6
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 382TE
UT WOS:000261627500006
PM 19245181
DA 2018-10-20
ER

PT J
AU Nejadnik, MR
   Engelsman, AF
   Fernandez, ICS
   Busscher, HJ
   Norde, W
   van der Mei, HC
AF Nejadnik, M. Reza
   Engelsman, Anton F.
   Fernandez, Isabel C. Saldarriaga
   Busscher, Henk J.
   Norde, Willem
   van der Mei, Henny C.
TI Bacterial colonization of polymer brush-coated and pristine silicone
   rubber implanted in infected pockets in mice
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS; TISSUE
AB Curing biomaterial-associated infection (BAI) frequently includes antibiotic treatment, implant removal and re-implantation. However, revision implants are at a greater risk of infection as they may attract bacteria from their infected surroundings. Polymer brush-coatings attract low numbers of bacteria, but the virtue of polymer brush-coatings in vivo has seldom been investigated. Here, we determine the possible benefits of polymer brush-coated versus pristine silicone rubber in revision surgery, using a murine model.
   BAI was induced in 26 mice by subcutaneous implantation of silicone rubber discs with a biofilm of Staphylococcus aureus Xen29. During the development of BAI, half of the mice received rifampicin/vancomycin treatment. After 5 days, the infected discs were removed from all mice, and either a polymer brush-coated or pristine silicone rubber disc was re-implanted. Revision discs were explanted after 5 days, and the number of cfu cultured from the discs and the surrounding tissue was determined.
   None of the polymer brush-coated discs after antibiotic treatment appeared colonized by staphylococci, whereas 83% of the pristine silicone rubber discs were re-infected. Polymer brush-coated discs also showed reduced colonization rates in the absence of antibiotic treatment when compared with pristine silicone rubber discs. Tissue surrounding the discs was culture-positive in all cases.
   Polymer brush-coatings are less prone to re-infection than pristine silicone rubber when used in revision surgery, i.e. when implanted in a subcutaneous pocket infected by a staphylococcal BAI. Antibiotic pre-treatment during the development of BAI hardly had any effect in preventing the colonization of pristine silicone rubber.
C1 [Nejadnik, M. Reza; Engelsman, Anton F.; Fernandez, Isabel C. Saldarriaga; Busscher, Henk J.; Norde, Willem; van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Nejadnik, M. Reza; Engelsman, Anton F.; Fernandez, Isabel C. Saldarriaga; Busscher, Henk J.; Norde, Willem; van der Mei, Henny C.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Norde, Willem] Wageningen Univ, Lab Phys Chem & Colloid Sci, NL-6703 HB Wageningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
FU University of Groningen-University Medical Center Groningen, Groningen,
   The Netherlands
FX This research was funded by the University of Groningen-University
   Medical Center Groningen, Groningen, The Netherlands.
CR Broekhuizen CAN, 2008, J BIOMED MATER RES A, V85A, P498, DOI 10.1002/jbm.a.31528
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003
   Liu VA, 2002, J BIOMED MATER RES, V60, P126, DOI 10.1002/jbm.10005
   Nejadnik MR, 2008, APPL ENVIRON MICROB, V74, P916, DOI 10.1128/AEM.01557-07
   QUESADA ET, 1993, J UROLOGY, V149, P46, DOI 10.1016/S0022-5347(17)35995-5
NR 10
TC 18
Z9 18
U1 5
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD DEC
PY 2008
VL 62
IS 6
BP 1323
EP 1325
DI 10.1093/jac/dkn395
PG 3
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 373MH
UT WOS:000260975500030
PM 18812426
OA Bronze
DA 2018-10-20
ER

PT J
AU Willcox, MDP
   Hume, EBH
   Aliwarga, Y
   Kumar, N
   Cole, N
AF Willcox, M. D. P.
   Hume, E. B. H.
   Aliwarga, Y.
   Kumar, N.
   Cole, N.
TI A novel cationic-peptide coating for the prevention of microbial
   colonization on contact lenses
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE antimicrobial cationic peptides; biomaterial; contact lens; Pseudomonas;
   Staphylococcus
ID CENTRAL VENOUS CATHETERS; CONTROLLED-TRIAL; IN-VITRO; INFECTION;
   ANTIBACTERIAL; MELITTIN; BIOFILMS; MORPHOLOGY; VIABILITY; BACTERIA
AB To develop an antimicrobial peptide with broad spectrum activity against bacteria implicated in biomaterial infection of low toxicity to mammalian cells and retaining its antimicrobial activity when covalently bound to a biomaterial surface.
   A synthetic peptide (melimine) was produced by combining portions of the antimicrobial cationic peptides mellitin and protamine. In contrast to the parent peptide melittin which lysed sheep red blood cells at > 10 mu g ml(-1), melimine lysed sheep red blood cells only at concentrations > 2500 mu g ml(-1), well above bactericidal concentrations. Additionally, melimine was found to be stable to heat sterilization. Evaluation by electron microscopy showed that exposure of both Pseudomonas aeruginosa and Staphylococcus aureus to melimine at the minimal inhibitory concentration (MIC) produced changes in the structure of the bacterial membranes. Further, repeated passage of these bacteria in sub-MIC concentrations of melimine did not result in an increase in the MIC. Melimine was tested for its ability to reduce bacterial adhesion to contact lenses when adsorbed or covalently attached. Approximately 80% reduction in viable bacteria was seen against both P. aeruginosa and S. aureus for 500 mu g per lens adsorbed melimine. Covalently linked melimine (18 +/- 4 mu g per lens) showed > 70% reduction of these bacteria to the lens.
   We have designed and tested a synthetic peptide melimine incorporating active regions of protamine and mellitin which may represent a good candidate for development as an antimicrobial coating for biomaterials.
   Infection associated with the use of biomaterials remains a major barrier to the long-term use of medical devices. The antimicrobial peptide melimine is an excellent candidate for development as an antimicrobial coating for such devices.
C1 [Willcox, M. D. P.; Hume, E. B. H.; Aliwarga, Y.; Cole, N.] Univ New S Wales, Eye Res Inst, Sydney, NSW 2052, Australia.
   [Hume, E. B. H.; Cole, N.] Vis Cooperat Res Ctr, Sydney, NSW, Australia.
   [Willcox, M. D. P.; Hume, E. B. H.; Cole, N.] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW 2052, Australia.
   [Kumar, N.] Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.
RP Willcox, MDP (reprint author), Univ New S Wales, Eye Res Inst, Level 4,North Wing,Rupert Myers Bldg,Gate 14,Bark, Sydney, NSW 2052, Australia.
EM m.willcox@ier.org.au
OI cole, nerida/0000-0002-9866-4694
FU Australian Research Council's [DP0663368]
FX This research was supported under Australian Research Council's
   Discovery Projects funding scheme (Project number DP0663368). The
   authors thank Dr Judith Flanagan for assistance with the preparation of
   this manuscript.
CR Bach A, 1996, INTENS CARE MED, V22, P1066, DOI 10.1007/BF01699229
   BANDYK DF, 1984, ARCH SURG-CHICAGO, V119, P102
   Bechinger B, 1997, J MEMBRANE BIOL, V156, P197, DOI 10.1007/s002329900201
   BOMAN HG, 1989, FEBS LETT, V259, P103, DOI 10.1016/0014-5793(89)81505-4
   Bong JJ, 2003, J CLIN PATHOL, V56, P731, DOI 10.1136/jcp.56.10.731
   Bryers JD, 2006, BIOMATERIALS, V27, P5039, DOI 10.1016/j.biomaterials.2006.05.034
   Ciresi DL, 1996, AM SURGEON, V62, P641
   COLE N, 1994, J BIOCH, V8, P971
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1981, ANNU REV MICROBIOL, V35, P299, DOI 10.1146/annurev.mi.35.100181.001503
   Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Douglas J.L., 1992, INFECT ENDOCARDITIS, P375
   FLOWERS RH, 1989, JAMA-J AM MED ASSOC, V261, P878, DOI 10.1001/jama.261.6.878
   Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Jones JR, 2006, J MATER SCI-MATER M, V17, P989, DOI 10.1007/s10856-006-0434-x
   Juvvadi P, 1996, J AM CHEM SOC, V118, P8989, DOI 10.1021/ja9542911
   KAMAL GD, 1991, JAMA-J AM MED ASSOC, V265, P2364, DOI 10.1001/jama.265.18.2364
   Lam PK, 2004, BRIT J BIOMED SCI, V61, P125, DOI 10.1080/09674845.2004.11732656
   Leung D, 2005, BIOMATERIALS, V26, P7145, DOI 10.1016/j.biomaterials.2005.05.014
   MAKI DG, 1988, AM J MED, V85, P307, DOI 10.1016/0002-9343(88)90579-7
   Mangoni ML, 2004, BIOCHEM J, V380, P859, DOI 10.1042/BJ20031975
   MASUR H, 1980, J THORAC CARDIOV SUR, V80, P31
   MOR A, 1994, J BIOL CHEM, V269, P31635
   NEU HC, 1992, SCIENCE, V257, P1073
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2
   NosBarbera S, 1997, CORNEA, V16, P101
   Ravikumar T, 2006, BIOMACROMOLECULES, V7, P2762, DOI 10.1021/bm060476w
   SHIMODA M, 1995, INFECT IMMUN, V63, P2886
   Subbalakshmi C, 1999, FEBS LETT, V448, P62, DOI 10.1016/S0014-5793(99)00328-2
   Thornton J, 1996, ANAESTHESIA, V51, P1018, DOI 10.1111/j.1365-2044.1996.tb14994.x
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
   Williams TJ, 2003, CURR EYE RES, V27, P227, DOI 10.1076/ceyr.27.4.227.16602
NR 35
TC 93
Z9 95
U1 2
U2 44
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1364-5072
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD DEC
PY 2008
VL 105
IS 6
BP 1817
EP 1825
DI 10.1111/j.1365-2672.2008.03942.x
PG 9
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 375PH
UT WOS:000261125300010
PM 19016975
OA Bronze
DA 2018-10-20
ER

PT J
AU Sadykov, MR
   Olson, ME
   Halouska, S
   Zhu, YF
   Fey, PD
   Powers, R
   Somerville, GA
AF Sadykov, Marat R.
   Olson, Michael E.
   Halouska, Steven
   Zhu, Yefei
   Fey, Paul D.
   Powers, Robert
   Somerville, Greg A.
TI Tricarboxylic Acid Cycle-Dependent Regulation of Staphylococcus
   epidermidis Polysaccharide Intercellular Adhesin Synthesis
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID CHAIN AMINO-ACIDS; COAGULASE-NEGATIVE STAPHYLOCOCCI; BACILLUS-SUBTILIS;
   BIOFILM FORMATION; STATIONARY-PHASE; GENE-EXPRESSION; ESCHERICHIA-COLI;
   LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURE; GLOBAL REGULATOR
AB Staphylococcus epidermidis is a major nosocomial pathogen primarily infecting immunocompromised individuals or those with implanted biomaterials (e. g., catheters). Biomaterial-associated infections often involve the formation of a biofilm on the surface of the medical device. In S. epidermidis, polysaccharide intercellular adhesin (PIA) is an important mediator of biofilm formation and pathogenesis. Synthesis of PIA is regulated by at least three DNA binding proteins (IcaR, SarA, and sigma(B)) and several environmental and nutritional conditions. Previously, we observed the environmental conditions that increased PIA synthesis decreased tricarboxylic acid (TCA) cycle activity. In this study, S. epidermidis TCA cycle mutants were constructed, and the function of central metabolism in PIA biosynthesis was examined. TCA cycle inactivation altered the metabolic status of S. epidermidis, resulting in a massive derepression of PIA biosynthetic genes and a redirection of carbon from growth into PIA biosynthesis. These data demonstrate that the bacterial metabolic status is a critical regulatory determinant of PIA synthesis. In addition, these data lead us to propose that the TCA cycle acts as a signal transduction pathway to translate external environmental cues into intracellular metabolic signals that modulate the activity of transcriptional regulators.
C1 [Sadykov, Marat R.; Zhu, Yefei; Somerville, Greg A.] Univ Nebraska, Dept Vet & Biomed Sci, Lincoln, NE 68583 USA.
   [Olson, Michael E.; Fey, Paul D.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
   [Halouska, Steven; Powers, Robert] Univ Nebraska, Dept Chem, Lincoln, NE 68522 USA.
RP Somerville, GA (reprint author), Univ Nebraska, Dept Vet & Biomed Sci, 155 VBS,Fair St & E Campus Loop, Lincoln, NE 68583 USA.
EM gsomerville3@unl.edu
RI Sadykov, Marat/H-3147-2011; Somerville, Greg/B-1326-2013; Zhu,
   Yefei/F-8940-2013
OI Somerville, Greg/0000-0002-0991-8737; 
FU Hatch Act; National Institute of General Medical Sciences [GM076585];
   American Heart Association [0760005Z, 0860033Z]
FX This article is a contribution of the University of Nebraska
   Agricultural Research Division, supported in part by funds provided
   through the Hatch Act, the National Institute of General Medical
   Sciences (GM076585), and the American Heart Association (0760005Z) to G.
   A. S. and the American Heart Association (0860033Z) to R. P.
CR Baughn AD, 2002, P NATL ACAD SCI USA, V99, P4662, DOI 10.1073/pnas.052710199
   Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057
   Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004
   Brekasis D, 2003, EMBO J, V22, P4856, DOI 10.1093/emboj/cdg453
   Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1
   Chatterjee I, 2006, APPL ENVIRON MICROB, V72, P2627, DOI 10.1128/AEM.72.4.2627-2636.2006
   Cho SH, 2002, INT J ANTIMICROB AG, V19, P570, DOI 10.1016/S0924-8579(02)00101-2
   COLLINS FM, 1962, J GEN MICROBIOL, V29, P531, DOI 10.1099/00221287-29-3-531
   Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004
   Conlon KM, 2002, FEMS MICROBIOL LETT, V216, P171, DOI 10.1016/S0378-1097(02)01031-5
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Craig JE, 1997, J BACTERIOL, V179, P7351, DOI 10.1128/jb.179.23.7351-7359.1997
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162
   DEAN BA, 1973, J HYG-CAMBRIDGE, V71, P261, DOI 10.1017/S0022172400022737
   DEIGHTON M, 1993, INFECT IMMUN, V61, P4473
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dobinsky S, 2003, J BACTERIOL, V185, P2879, DOI 10.1128/JB.185.9.2879-2886.2003
   Foster TJ, 1998, METHOD MICROBIOL, V27, P433
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Gaudu P, 2003, MOL MICROBIOL, V50, P183, DOI 10.1046/j.1365-2958.2003.03700.x
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gracia E, 1999, LUMINESCENCE, V14, P23, DOI 10.1002/(SICI)1522-7243(199901/02)14:1<23::AID-BIO513>3.0.CO;2-M
   GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x
   Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x
   Handke LD, 2007, CAN J MICROBIOL, V53, P82, DOI 10.1139/W06-108
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   HENKIN TM, 1991, MOL MICROBIOL, V5, P575, DOI 10.1111/j.1365-2958.1991.tb00728.x
   Jeng WY, 2008, NUCLEIC ACIDS RES, V36, P1567, DOI 10.1093/nar/gkm1176
   Jourlin-Castelli C, 2000, J MOL BIOL, V295, P865, DOI 10.1006/jmbi.1999.3420
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892
   Kim HJ, 2002, MOL MICROBIOL, V45, P179, DOI 10.1046/j.1365-2958.2002.03003.x
   Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049
   Kornmann H, 2003, APPL MICROBIOL BIOT, V62, P168, DOI 10.1007/s00253-003-1299-2
   Kozitskaya S, 2004, INFECT IMMUN, V72, P1210, DOI 10.1128/IAI.72.2.1210-1215.2004
   Lamb HK, 2003, J BIOL CHEM, V278, P32107, DOI 10.1074/jbc.M304104200
   Lauble H, 1996, P NATL ACAD SCI USA, V93, P13699, DOI 10.1073/pnas.93.24.13699
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002
   Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07
   MCCOMBIE H, 1946, NATURE, V158, P382, DOI 10.1038/158382a0
   MEKALANOS JJ, 1992, J BACTERIOL, V174, P1
   NOVICK RP, 1991, METHOD ENZYMOL, V204, P587
   Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c
   PROJAN SJ, 1989, J BACTERIOL, V171, P1841, DOI 10.1128/jb.171.4.1841-1845.1989
   Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   RUPP ME, 1997, STAPHYLOCOCCI HUMAN, P379
   Sambrook J, 1989, MOL CLONING LAB MANU
   SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133
   Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08
   Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x
   Somerville G, 1999, J BACTERIOL, V181, P1072
   Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003
   Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002
   Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002
   Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772
   Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Stephenson K, 2001, P NATL ACAD SCI USA, V98, P15251, DOI 10.1073/pnas.251408398
   STRASTERS KC, 1963, J GEN MICROBIOL, V33, P213, DOI 10.1099/00221287-33-2-213
   Throup JP, 2001, BIOCHEMISTRY-US, V40, P10392, DOI 10.1021/bi0102959
   Tojo S, 2005, MOL MICROBIOL, V56, P1560, DOI 10.1111/j.1365-2958.2005.04635.x
   TOMLINS RI, 1971, CAN J MICROBIOL, V17, P759, DOI 10.1139/m71-121
   Tormo MA, 2005, J BACTERIOL, V187, P2348, DOI 10.1128/JB.187.7.2348-2356.2005
   Tramonti A, 2006, J BACTERIOL, V188, P8118, DOI 10.1128/JB.01044-06
   Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2005, J BACTERIOL, V187, P2967, DOI 10.1128/JB.187.9.2967-2973.2005
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Wu SW, 1996, J BACTERIOL, V178, P6036, DOI 10.1128/jb.178.20.6036-6042.1996
   Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
   2004, AM J INFECT CONTROL, V32, P470
NR 84
TC 34
Z9 35
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD DEC
PY 2008
VL 190
IS 23
BP 7621
EP 7632
DI 10.1128/JB.00806-08
PG 12
WC Microbiology
SC Microbiology
GA 371VP
UT WOS:000260860500005
PM 18820013
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Ferraz, N
   Nilsson, B
   Hong, J
   Ott, MK
AF Ferraz, Natalia
   Nilsson, Bo
   Hong, Jaan
   Ott, Marjam Karlsson
TI Nanoporesize affects complement activation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nanotopography; nanoporous alumina; complement; whole blood; protein
   adsorption
ID SURFACES IN-VITRO; ARTIFICIAL SURFACES; PROTEIN ADSORPTION; WHOLE-BLOOD;
   MODEL; NANOTOPOGRAPHY; OSTEOBLASTS; TOPOGRAPHY; BEHAVIOR; ALUMINA
AB In the present study, we have shown the vast importance of biomaterial nanotexture when evaluating inflammatory response. For the first time in an in vitro whole blood system, we have proven that a small increase in nanoporesize, specifically 180 nm (from 20 to 200 nm), has a huge effect on the complement system. The study was done using nanoporous aluminiumoxide, a material that previously has been evaluated for potential implant use, showing good biocompatibility. This material can easily be manufactured with different pore sizes making it an excellent candidate to govern specific protein and cellular events at the tissue-material interface. We performed whole blood studies, looking at complement activation after blood contact with two pore size alumina membranes (pore diameters, 20 and 200 nm). The fluid phase was analyzed for complement soluble components, C3a and sC5b-9. In addition, surface adsorbed proteins were eluted and dot blots were performed to detect IgG, IgM, C1q, and C3. All results point to the fact that 200 nm pore size membranes are more complement activating. Significantly, higher values of complement soluble components were found after whole blood contact with 200 nm alumina and all studied proteins adsorbed more readily to this membrane than to the 20 nm pore size membrane. We hypothesize that the difference in complement activation between our two test materials is caused by the type and the amount of adsorbed proteins, as well as their conformation and orientation. The different protein patterns created on the two alumina membranes are most likely a consequence of the material topography. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 575-581, 2008
C1 [Ferraz, Natalia; Ott, Marjam Karlsson] Uppsala Univ, Dept Phys & Analyt Chem, Div Surface Biotechnol, S-75123 Uppsala, Sweden.
   [Nilsson, Bo; Hong, Jaan] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Div Clin Immunol, S-75123 Uppsala, Sweden.
RP Ott, MK (reprint author), Uppsala Univ, Dept Phys & Analyt Chem, Div Surface Biotechnol, S-75123 Uppsala, Sweden.
EM marjam.ott@ytbioteknik.uu.se
RI Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
FU National Institute of Health [GM-62134, EB-003968, AI-066343-01];
   Swedish Research Council [5647, 15244]
FX Contract grant sponsor: National Institute of Health; contract grant
   numbers: GM-62134, EB-003968, Al-066343-01; Contract grant sponsor:
   Swedish Research Council; contract grant numbers: 5647, 15244
CR Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   ANDERSSON J, 2003, THESIS UPPSALA U UPP
   CHEUNG AK, 1990, KIDNEY INT, V37, P1055, DOI 10.1038/ki.1990.85
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Eriksson C, 2001, BIOMATERIALS, V22, P1987, DOI 10.1016/S0142-9612(00)00382-3
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Horbett Thomas A., 1996, P133
   Karlsson M, 2004, MICROSC RES TECHNIQ, V63, P259, DOI 10.1002/jemt.20040
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   Kasemo B, 1999, Adv Dent Res, V13, P8
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson UR, 2001, MOL IMMUNOL, V38, P151, DOI 10.1016/S0161-5890(01)00039-6
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Price RL, 2003, MED BIOL ENG COMPUT, V41, P372, DOI 10.1007/BF02348445
   Rasband WS, 1997, IMAGEJ
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Sutherland DS, 2001, MACROMOL BIOSCI, V1, P270, DOI 10.1002/1616-5195(20010801)1:6<270::AID-MABI270>3.3.CO;2-V
   Tengvall P, 1998, BIOMATERIALS, V19, P935, DOI 10.1016/S0142-9612(98)00005-2
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   Wettero J, 2001, J BIOMED MATER RES, V57, P550, DOI 10.1002/1097-4636(20011215)57:4<550::AID-JBM1201>3.0.CO;2-T
   WETTERO J, 2002, THESIS LINKOPING U L
   Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872
   Wieneke H, 2003, CATHETER CARDIO INTE, V60, P399, DOI 10.1002/ccd.10664
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
NR 40
TC 20
Z9 20
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 575
EP 581
DI 10.1002/jbm.a.31818
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800002
PM 18186072
DA 2018-10-20
ER

PT J
AU Changotade, SIT
   Korb, G
   Bassil, J
   Barroukh, B
   Willig, C
   Colliec-Jouault, S
   Durand, P
   Godeau, G
   Senni, K
AF Changotade, S. Igondjo Tchen
   Korb, G.
   Bassil, J.
   Barroukh, B.
   Willig, C.
   Colliec-Jouault, S.
   Durand, P.
   Godeau, G.
   Senni, K.
TI Potential effects of a low-molecular-weight fucoidan extracted from
   brown algae on bone biomaterial osteoconductive properties
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fucoidan; osteoblast; bone; biomaterial; heparan mimetics
ID IN-VITRO; CELLS; SUBSTITUTES; RELEASE; CULTURE; MODEL
AB In this work, we first tested the influence of low-molecular-weight (LMW) fucoidan extracted from pheophicae cell wall on bidimensional cultured normal human osteoblasts' behaviors. Second, by impregnation procedure with LMW fucoidan of bone biomaterial (Lubboc (R)), we explored in this bone extracellular matrix context its capabilities to support human osteoblastic behavior in 3D culture. In bidimensionnal cultures, we evidenced that LMW fucoidan promotes human osteoblast proliferation and collagen type I expression and favors precocious alkaline phosphatase activity. Furthermore, with LMW fucoidan, von Kossa's staining was positive at 30 days and positive only at 45 days in the absence of LMW fucoidan. In our three-dimensional culture models with the biomaterial pretreated with LMW fucoidan, osteoblasts promptly overgrew the pretreated biomaterial. We also evidenced that osteoblasts increased proliferation with pretreated biomaterial when compared with untreated biomaterial. Osteoblasts secreted osteocalcin and expressed BMP2 receptor on control material as well as with LMW fucoidan impregnated biomaterial. In conclusion, in our experimental conditions, LMW fucoidan stimulated expression of osteoblastic markers differentiation such as alkaline phosphatase activity, collagen type I expression, and mineral deposition; furthermore, cell proliferation was favored. These findings suggest that fucoidan could be clinically useful for bone regeneration and bone substitute design. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 666-675, 2008
C1 [Changotade, S. Igondjo Tchen; Korb, G.; Bassil, J.; Barroukh, B.; Willig, C.; Godeau, G.; Senni, K.] Univ Paris 05, Lab Physiopathol Tissus Non Mineralises, Fac Chirurg Dent Montrouge, Paris, France.
   [Colliec-Jouault, S.; Durand, P.] IFREMER, Nantes, France.
RP Godeau, G (reprint author), Univ Paris 05, Lab Physiopathol Tissus Non Mineralises, Fac Chirurg Dent Montrouge, Paris, France.
EM godeau_g@yahoo.fr
OI Colliec-Jouault, Sylvia/0000-0002-2449-5410
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   Basle MF, 1998, J BIOMED MATER RES, V40, P350, DOI 10.1002/(SICI)1097-4636(19980605)40:3<350::AID-JBM2>3.0.CO;2-E
   BEGLEY CT, 1993, BONE, V14, P661, DOI 10.1016/8756-3282(93)90089-S
   BERESFORD JN, 1993, AM J MED GENET, V45, P163, DOI 10.1002/ajmg.1320450205
   BUCK BE, 1994, CLIN ORTHOP RELAT R, P8
   Chabut D, 2004, THROMB RES, V113, P93, DOI 10.1016/j.thromres.2004.01.013
   Feige J J, 1995, Kidney Int Suppl, V49, pS15
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hartl A, 2004, ACTA ORTHOP SCAND, V75, P217, DOI 10.1080/00016470412331294485
   HOLDEN C M, 1990, Journal of Oral Implantology, V16, P86
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jager M, 2006, J BIOMED MATER RES A, V76A, P310, DOI 10.1002/jbm.a.30515
   Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   Logeart D, 1996, J BIOMED MATER RES, V30, P501, DOI 10.1002/(SICI)1097-4636(199604)30:4<501::AID-JBM8>3.3.CO;2-F
   Luyt CE, 2003, J PHARMACOL EXP THER, V305, P24, DOI 10.1124/jpet.102.046144
   Matou S, 2002, THROMB RES, V106, P213, DOI 10.1016/S0049-3848(02)00136-6
   MCCAFFREY TA, 1994, J CELL PHYSIOL, V159, P51, DOI 10.1002/jcp.1041590108
   Millet J, 1999, THROMB HAEMOSTASIS, V81, P391
   Nardella A, 1996, CARBOHYD RES, V289, P201, DOI 10.1016/0008-6215(96)00110-3
   Nefussi JR, 1997, J HISTOCHEM CYTOCHEM, V45, P493, DOI 10.1177/002215549704500402
   POUMARAT G, 1993, BIOMATERIALS, V14, P337, DOI 10.1016/0142-9612(93)90051-3
   PROLO DJ, 1985, CLIN ORTHOP RELAT R, P322
   SCHOETERS G, 1992, CELL PROLIFERAT, V25, P587, DOI 10.1111/j.1365-2184.1992.tb01462.x
   Senni K, 2006, ARCH BIOCHEM BIOPHYS, V445, P56, DOI 10.1016/j.abb.2005.11.001
   SENNI K, 2003, Patent No. 6559131
NR 28
TC 34
Z9 34
U1 2
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 666
EP 675
DI 10.1002/jbm.a.31819
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800012
PM 18189302
DA 2018-10-20
ER

PT J
AU Chang, DT
   Jones, JA
   Meyerson, H
   Colton, E
   Kwon, IK
   Matsuda, T
   Anderson, JM
AF Chang, David T.
   Jones, Jacqueline A.
   Meyerson, Howard
   Colton, Erica
   Kwon, Il Keun
   Matsuda, Takehisa
   Anderson, James M.
TI Lymphocyte/macrophage interactions: Biomaterial surface-dependent
   cytokine, chemokine, and matrix protein production
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PET biomaterials; lymphocytes; macrophages; cytokines; matrix
   metalloproteinases
ID FOREIGN-BODY RESPONSE; GIANT-CELL FORMATION; T-CELL; IN-VITRO; ADHERENT
   MACROPHAGES; ADHESION BEHAVIOR; TISSUE INHIBITORS; HUMAN MONOCYTES; B7
   FAMILY; LYMPHOCYTES
AB The role of lymphocytes in the biological response to synthetic polymers is poorly understood despite the transient appearance of lymphocytes at the biomaterial implant site. To investigate cytokines, chemokines, and extracellular matrix (ECM) proteins produced by lymphocytes and macrophages in response to biomaterial surfaces, human peripheral blood monocytes and lymphocytes were co-cultured on polyethylene terephthalate (PET)-based material surfaces displaying distinct hydrophobic, hydrophilic/neutral, hydrophilic/anionic, and hydrophilic/cationic chemistries. Antibody array screening showed the majority of detected proteins are inflammatory mediators that guide the early inflammatory phases of wound healing. Proteomic ELISA quantification and adherent cell analysis were performed after 3, 7, and 10 days of culture. IL-2 and IFN-gamma were not detected in any co-cultures suggesting lack of lymphocyte activation. The hydrophilic/neutral surfaces increased IL-8 relative to the hydrophobic PET surface (p < 0.05). The hydrophilic/anionic surfaces promoted increased TNF-alpha over hydrophobic and cationic surfaces and increased MIP-1 beta compared to hydrophobic surfaces (p < 0.05). Since enhanced macrophage fusion was observed on hydrophilic/anionic surfaces, the production of these cytokines likely plays an important role in the fusion process. The hydrophilic/cationic surface promoted IL-10 production and increased matrix metalloproteinase (MMP)-9/tissue inhibitor of MMP (TIMP) relative to hydrophilic/neutral and anionic surfaces (p < 0.05). These results suggest hydrophilic/neutral and anionic surfaces promote pro-inflammatory responses and reduced degradation of the ECM, whereas the hydrophilic/cationic surfaces induce an anti-inflammatory response and greater MMP-9/TIMP with an enhanced potential for ECM breakdown. The study also underscores the usefulness of protein arrays in assessing the role of soluble mediators in the inflammatory response to biomaterials. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 676-687, 2008
C1 [Chang, David T.; Jones, Jacqueline A.; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Meyerson, Howard; Colton, Erica; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Meyerson, Howard] Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA.
   [Kwon, Il Keun] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA.
   [Kwon, Il Keun] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   [Matsuda, Takehisa] Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Wolstein Res Bldg Room W5104,2103 Cornell Rd, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU National Institutes of Health (NIH); National Institute of Biomedical
   Imaging and Bioengineering (NIBIB) [EB-000275, EB-000282, T32 GM07250]
FX Contract grant sponsors: National Institutes of Health (NIH), National
   Institute of Biomedical Imaging and Bioengineering (NIBIB); contract
   grant numbers: EB-000275, EB-000282, T32 GM07250
CR Anderson J.M., 1994, PROB GEN SURG, V11, P147
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902
   Bergman AJ, 1999, BIOMATERIALS, V20, P2235, DOI 10.1016/S0142-9612(99)00154-4
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Burger D, 2002, ARTHRITIS RES THER, V4, pS169, DOI 10.1186/ar558
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DING L, 1993, J IMMUNOL, V151, P1224
   Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611
   GROTH T, 1994, BIOMATERIALS, V15, P423, DOI 10.1016/0142-9612(94)90220-8
   Groux H, 2003, J AUTOIMMUN, V20, P281, DOI 10.1016/S0896-8411(03)00044-1
   Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19
   HOUSSIAU FA, 1989, J IMMUNOL, V143, P2520
   Hoves S, 2006, J IMMUNOL, V177, P2691, DOI 10.4049/jimmunol.177.4.2691
   JONES JA, 2007, J BIOMED MAT RES A
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   LE JM, 1988, P NATL ACAD SCI USA, V85, P8643, DOI 10.1073/pnas.85.22.8643
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   MAEDA M, 1986, J BIOMED MATER RES, V20, P25, DOI 10.1002/jbm.820200104
   Maghazachi AA, 1996, EUR J IMMUNOL, V26, P315, DOI 10.1002/eji.1830260207
   MALEFYT RD, 1991, J EXP MED, V174, P1209
   Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Mott JD, 2000, J BIOL CHEM, V275, P1384, DOI 10.1074/jbc.275.2.1384
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Nakayama Y, 2000, J BIOMED MATER RES, V53, P584, DOI 10.1002/1097-4636(200009)53:5<584::AID-JBM19>3.0.CO;2-0
   Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975
   OSTHUES A, 1992, FEBS LETT, V296, P16, DOI 10.1016/0014-5793(92)80393-U
   Romagnani S, 1999, INFLAMM BOWEL DIS, V5, P285, DOI 10.1097/00054725-199911000-00009
   Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x
   SCHALL TJ, 1994, CYTOKINE HDB, P419
   Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1
   Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3
   STETLERSTEVENSON WG, 1993, FASEB J, V7, P1434
   Trindade MCD, 2001, BIOMATERIALS, V22, P253, DOI 10.1016/S0142-9612(00)00181-2
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   WARD SG, 1998, BIOCH J 3, V333, P4577
   Xue ML, 2005, INT J BIOCHEM CELL B, V37, P2406, DOI 10.1016/j.biocel.2005.06.003
   YOKOYAMA M, 1986, J BIOMED MATER RES, V20, P867, DOI 10.1002/jbm.820200702
NR 47
TC 40
Z9 40
U1 0
U2 27
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 676
EP 687
DI 10.1002/jbm.a.31630
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800013
PM 18200554
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Fassina, L
   Saino, E
   Visai, L
   Silvani, G
   De Angelis, MGC
   Mazzini, G
   Benazzo, F
   Magenes, G
AF Fassina, Lorenzo
   Saino, Enrica
   Visai, Livia
   Silvani, Giulia
   De Angelis, Maria Gabriella Cusella
   Mazzini, Giuliano
   Benazzo, Francesco
   Magenes, Giovanni
TI Electromagnetic enhancement of a culture of human SAOS-2 osteoblasts
   seeded onto titanium fiber-mesh scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE electromagnetic stimulation; osteoblast; cell proliferation; calcified
   extracellular matrix; decorin; osteopontin; type-I collagen; surface
   modification; biomimetics
ID MARROW STROMAL CELLS; ECTOPIC BONE-FORMATION; POLYURETHANE POROUS
   SCAFFOLD; CALCIFIED MATRIX PRODUCTION; COMBINED MAGNETIC-FIELDS;
   PERFUSION BIOREACTOR; CALCIUM-PHOSPHATE; OSTEOGENIC CELLS; FOLLOW-UP;
   IN-VITRO
AB The surface properties of a biomaterial are fundamental to determine the response of the host tissue. In the present study, we have followed a particular biomimetic strategy where electromagnetically stimulated SAOS-2 human osteoblasts proliferated and built a calcified extracellular matrix on a titanium fiber-mesh surface. In comparison with control conditions, the electromagnetic stimulation (magnetic field intensity, 2 mT; frequency, 75 Hz) caused higher cell proliferation and increased surface coating with type-l collagen, decorin, and osteopontin (9.8-fold, 11.3-fold, and 9.5-fold, respectively). Reverse transcriptase-polymerase analysis revealed the electromagnetically upregulated transcription specific for the foregoing matrix proteins and for the growth factor TGF-beta 1. The immunofluorescence of type-I collagen, decorin, and osteopontin showed their colocalization in the cell-rich areas. The use of an electromagnetic bioreactor aimed at obtaining the surface modification of the biocompatible metallic scaffold in terms of cell colonization and coating with calcified extracellular matrix. The superficially modified biomaterial could be used, in clinical applications, as an implant for bone repair. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 750-759, 2008
C1 [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy.
   [Fassina, Lorenzo; Saino, Enrica; Visai, Livia; Silvani, Giulia; De Angelis, Maria Gabriella Cusella; Mazzini, Giuliano; Benazzo, Francesco; Magenes, Giovanni] Univ Pavia, CIT, I-27100 Pavia, Italy.
   [Saino, Enrica; Visai, Livia] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy.
   [Silvani, Giulia; De Angelis, Maria Gabriella Cusella] Univ Pavia, Dipartimento Med Sperimentale, I-27100 Pavia, Italy.
   [Mazzini, Giuliano] Univ Pavia, IGM CNR Istochim & Citometria, Dipartimento Biol Anim, I-27100 Pavia, Italy.
   [Benazzo, Francesco] Univ Pavia, Dipartimento SMEC, IRCCS San Matteo, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, Via Palestro 3, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it
RI Magenes, Giovanni/C-4202-2012; Fassina, Lorenzo/K-9283-2015
OI Magenes, Giovanni/0000-0002-7558-1490; Fassina,
   Lorenzo/0000-0002-5587-4632; Cusella De Angelis, Maria
   Gabriella/0000-0003-2642-3346
FU Fondazione Cariplo [2004.1424/10.8485]; Italian Ministry of Education,
   University and Research [FIRBRBIP06FH7J]; University of Pavia
FX Contract grant sponsor: Fondazione Cariplo; contract grant number:
   2004.1424/10.8485; Contract grant sponsor: Italian Ministry of
   Education, University and Research (PRIN 2006 to L.V.); Contract grant
   sponsor: Italian Ministry of Education, University and Research
   (FIRBRBIP06FH7J)); Contract grant sponsor: University of Pavia (FAR
   2006)
CR Aaron RK, 1996, J ORTHOPAED RES, V14, P582, DOI 10.1002/jor.1100140412
   Aaron RK, 2004, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000118698.46535.83
   Akita S, 2004, TISSUE ENG, V10, P789, DOI 10.1089/1076327041348338
   Banerjee AG, 2003, CANCER RES, V63, P7769
   BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616
   Bodamyali T, 1998, BIOCHEM BIOPH RES CO, V250, P458, DOI 10.1006/bbrc.1998.9243
   Callaghan JJ, 1996, CLIN ORTHOP RELAT R, P118
   CANE V, 1993, J ORTHOPAED RES, V11, P664, DOI 10.1002/jor.1100110508
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chang WHS, 2004, BIOELECTROMAGNETICS, V25, P457, DOI 10.1002/bem.20016
   CIOMBOR DM, 1993, J CELL BIOCHEM, V52, P37, DOI 10.1002/jcb.240520106
   Clohisy JC, 1999, J BONE JOINT SURG AM, V81A, P66, DOI 10.2106/00004623-199901000-00010
   DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0
   Duan YR, 2004, J MATER SCI-MATER M, V15, P1205, DOI 10.1007/s10856-004-5673-0
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2005, TISSUE ENG, V11, P685, DOI 10.1089/ten.2005.11.685
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Fisher L W, 1995, Acta Orthop Scand Suppl, V266, P61
   FISHER LW, 1989, J BIOL CHEM, V264, P4571
   FITZSIMMONS RJ, 1994, CLIN PLAST SURG, V21, P401
   FITZSIMMONS RJ, 1994, CALCIFIED TISSUE INT, V55, P376, DOI 10.1007/BF00299318
   FITZSIMMONS RJ, 1995, J BONE MINER RES, V10, P812
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   Heermeier K, 1998, BIOELECTROMAGNETICS, V19, P222, DOI 10.1002/(SICI)1521-186X(1998)19:4<222::AID-BEM4>3.0.CO;2-3
   Holland NB, 1998, NATURE, V392, P799
   Holtorf HL, 2005, BIOMATERIALS, V26, P6208, DOI 10.1016/j.biomaterials.2005.04.006
   Holtorf HL, 2005, J BIOMED MATER RES A, V74A, P171, DOI 10.1002/jbm.a.30330
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Iwata M, 2004, BLOOD, V103, P4496, DOI 10.1182/blood-2004-01-0256
   Krout A, 2005, J BIOMED MATER RES A, V73A, P377, DOI 10.1002/jbm.a.30310
   Lohmann CH, 2000, J ORTHOP RES, V18, P637, DOI 10.1002/jor.1100180417
   Lohmann CH, 2003, J ORTHOP RES, V21, P326, DOI 10.1016/S0736-0266(02)00137-7
   MAKELA JK, 1990, BIOCHIM BIOPHYS ACTA, V1049, P171, DOI 10.1016/0167-4781(90)90037-3
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   Otter MW, 1998, CLIN ORTHOP RELAT R, pS90
   Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   van den Dolder J, 2003, J BIOMED MATER RES A, V64A, P235, DOI 10.1002/jbm.a.10365
   van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
   Vehof JWM, 2001, PLAST RECONSTR SURG, V108, P434, DOI 10.1097/00006534-200108000-00024
   VOGEL KG, 1987, J BIOL CHEM, V262, P13607
   ZOU X, 2003, APMIS S, V109, P127
NR 54
TC 27
Z9 28
U1 1
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 750
EP 759
DI 10.1002/jbm.a.31827
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800021
PM 18200542
DA 2018-10-20
ER

PT J
AU Bodde, EWH
   Boerman, OC
   Russel, FGM
   Mikos, AG
   Spauwen, PHM
   Jansen, JA
AF Bodde, Esther W. H.
   Boerman, Otto C.
   Russel, Frans G. M.
   Mikos, Antonios G.
   Spauwen, Paul H. M.
   Jansen, John A.
TI The kinetic and biological activity of different loaded rhBMP-2 calcium
   phosphate cement implants in rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE BMP; drug release; calcium phosphate cement; PLGA; bone regeneration
ID BONE MORPHOGENETIC PROTEIN-2; BIODEGRADABLE POLYMER MICROPARTICLES;
   GROWTH-FACTOR BETA-1; DELIVERY SYSTEMS; IN-VIVO; BIOMATERIAL CARRIERS;
   CONTROLLED-RELEASE; ECTOPIC MODEL; DEFECTS; REPAIR
AB The healing of large bone defects can be improved by osteogenic bone graft substitutes, due to growth factor inclusion. A sustained release of these growth factors provides more efficient bioactivity when compared with burst release and might reduce the dose required for bone regeneration, which is desirable for socioeconomical and safety reasons. In this study, we compared different rhBMP-2 loadings in a sustained release system of CaP cement and PLGA-microparticles and were able to couple kinetic to biological activity data. Fifty-two rats received a critical-size cranial defect, which was left open or filled with the cement composites. The implants consisted of plain, high, and five-fold lower dose rhBMP-2 groups. Implantation time was 4 and 12 weeks. Longitudinal in vivo release was monitored by scintigraphic imaging of 131 I-labeled rhBMP-2. Quantitative analysis of the scintigraphic images revealed a sustained release of I-131-rhBMP-2 for both doses, with different release profiles between the two loadings. However, around 70% of the initial dose was retained in both implant formulations. Although low amounts of rhBMP-2 were released (2.4 +/- 0.8 mu g in 5 weeks), histology showed defect bridging in the high-dose implants. Release out of the low-dose implants was not sufficient to enhance bone formation. Implant degradation was limited in all formulations, but was mainly seen in the high-dose group. Low amounts of sustained released rhBMP-2 were sufficient to bridge critically sized defects. A substantial amount of rhBMP-2 was retained in the implants because of the slow release rate and the limited degradation. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 780-791, 2008
C1 [Bodde, Esther W. H.; Jansen, John A.] Radboud Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, NL-6525 ED Nijmegen, Netherlands.
   [Boerman, Otto C.] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6525 ED Nijmegen, Netherlands.
   [Russel, Frans G. M.] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands.
   [Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX USA.
   [Spauwen, Paul H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Plast & Reconstruct Surg, NL-6525 ED Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, NL-6525 ED Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Jansen, John/H-8055-2014; Russel, Frans/B-3184-2014; Boerman,
   Otto/A-8112-2014
OI Russel, Frans/0000-0002-7959-2314; Boerman, Otto/0000-0001-6832-101X
CR Andrade J. D., 1996, INTERFACIAL PHENOMEN, P19
   Arnaud E, 1999, BIOMATERIALS, V20, P1909, DOI 10.1016/S0142-9612(99)00090-3
   Barnes B, 2005, SPINE, V30, P1127, DOI 10.1097/01.brs.0000162623.48058.8c
   BURKINSHAW L, 1958, PHYS MED BIOL, V2, P255, DOI 10.1088/0031-9155/2/3/305
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004
   Cleek RL, 1997, J BIOMED MATER RES, V35, P525, DOI 10.1002/(SICI)1097-4636(19970615)35:4<525::AID-JBM12>3.0.CO;2-A
   del Real RP, 2003, J BIOMED MATER RES A, V65A, P30, DOI 10.1002/jbm.a.10432
   Ebara S, 2002, SPINE, V27, pS10, DOI 10.1097/01.BRS.0000020727.98493.20
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Habraken WJEM, 2006, J BIOMAT SCI-POLYM E, V17, P1057, DOI 10.1163/156856206778366004
   Hoshino M, 2006, BIOMATERIALS, V27, P4934, DOI 10.1016/j.biomaterials.2006.04.044
   Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656
   Jansen J, 2005, ORTHOP CLIN N AM, V36, P89, DOI 10.1016/j.ocl.2004.06.014
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Kamakura S, 2004, J BIOMED MATER RES A, V71A, P299, DOI 10.1002/jbm.a.30157
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Niedhart C, 2003, J BIOMED MATER RES A, V65A, P17, DOI 10.1002/jbm.a.10362
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Rodeo SA, 2003, J BONE JOINT SURG AM, V85A, P2054, DOI 10.2106/00004623-200310000-00035
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2005, J BIOMED MATER RES A, V74A, P533, DOI 10.1002/jbm.a.30341
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Seeherman HJ, 2006, J BONE JOINT SURG AM, V88A, P1553, DOI 10.2106/JBJS.E.01006
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Wang J, 1999, CALCIFIED TISSUE INT, V65, P486, DOI 10.1007/s002239900737
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
   Wozney JM, 2002, SPINE, V27, pS2, DOI 10.1097/01.BRS0000020725.01916.7E
   Wurzler KK, 1998, J CRANIOFAC SURG, V9, P131
   Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
NR 41
TC 69
Z9 70
U1 2
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 780
EP 791
DI 10.1002/jbm.a.31830
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800024
PM 18200544
DA 2018-10-20
ER

PT J
AU Li, XT
   Sun, J
   Chen, S
   Chen, GQ
AF Li, Xiao-Tao
   Sun, Jie
   Chen, Song
   Chen, Guo-Qiang
TI In vitro investigation of maleated poly
   (3-hydroxybutyrate-co-3-hydroxyhexanoate) for its biocompatibility to
   mouse fibroblast L929 and human microvascular endothelial cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PHB; maleated PHBHHx; maleic anhydride; L929; HMEC
ID INDUCED GRAFT-POLYMERIZATION; ARTICULAR-CARTILAGE CHONDROCYTES; TISSUE
   ENGINEERING APPLICATIONS; SURFACE WETTABILITY; ACRYLIC-ACID;
   POLY(3-HYDROXYBUTYRATE); POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE);
   POLYHYDROXYALKANOATES; BIODEGRADATION; COPOLYMER
AB Poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx), a polyester with strong mechanical properties and biocompatibility, is a member of microbial polyhydroxyalkanoates (PHA) family. Maleic anhydride was used to graft PHBHHx to form maleated PHBHHx (Ma-PHBHHx). Ma-PHBHHx with a graft degree of 0.59% was found to be more thermo-stable in comparison with PHBHHx. In vitro study demonstrated that the biocompatibility to mouse fibroblast L929 and human microvascular endothelial cells (HMEC) was improved in different degrees on Ma-PHBHHx films and scaffolds. Compared with their growth on PHBHHx, L929 and HMEC grown on Ma-PHBHHx films and scaffolds showed similar to 120% and 260% more in proliferation rates, respectively. Morphology study suggested that fine whorl-like surface structures with porosities on Ma-PHBHHx films attributed to MA grafting would be better for cell attachment and proliferation. Ma-PHBHHx scaffolds prepared by thermally induced phase separation (TIPS) with increased porosity, hydrophilicity, surface energy, and charges also were more favorable for cell growth. In addition, Ma-PHBHHx showed an accelerated degradation incubation in SBF at 37 degrees C, losing 21.4% of its original weight after 21 weeks while PHBHHx just lost 7.3%. Based on the improved biocompatibility, reasonable mechanical properties as well as accelerated biodegradation, Ma-PHBHHx has shown advantages over PHBHHx as a biomaterial for biomedical applications. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 87A: 832-842,2008
C1 [Li, Xiao-Tao; Sun, Jie; Chen, Guo-Qiang] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
   [Chen, Song; Chen, Guo-Qiang] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.
RP Chen, GQ (reprint author), Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
EM chengq@stu.edu.cn
RI Chen, Song/H-3174-2011
FU Li ka Sheng Foundation; National High Tech 863 [2006AA02Z242]; State
   Basic Science Foundation 973 [2007CB707804]
FX Contract grant sponsor: Li ka Sheng Foundation; Contract grant sponsor:
   National High Tech 863; contract grant number: 2006AA02Z242; Contract
   grant sponsor: State Basic Science Foundation 973; contract grant
   number: 2007CB707804
CR Bahari K, 1997, ANGEW MAKROMOL CHEM, V250, P31, DOI 10.1002/apmc.1997.052500103
   BARHAM PJ, 1986, J POLYM SCI POL PHYS, V24, P69, DOI 10.1002/polb.1986.180240108
   Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3
   Chen C, 2003, J APPL POLYM SCI, V88, P659, DOI 10.1002/app11771
   Chen C, 2002, EUR POLYM J, V38, P1663, DOI 10.1016/S0014-3057(02)00046-0
   Chen C, 2002, J APPL POLYM SCI, V84, P1789, DOI 10.1002/app.10463
   Chen FZ, 2004, J AEROSOL SCI, V35, P47, DOI 10.1016/S0021-8502(03)00383-5
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Deng Y, 2003, BIOMATERIALS, V24, P4273, DOI 10.1016/S0142-9612(03)00367-3
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   Doi Y., 2002, BIOPOLYMERS
   Dziubla TD, 2004, J BIOMED MATER RES A, V68A, P603, DOI 10.1002/jbm.a.20023
   Evans MDM, 1998, J BIOMED MATER RES, V40, P621, DOI 10.1002/(SICI)1097-4636(19980615)40:4<621::AID-JBM14>3.0.CO;2-I
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8
   Hu SG, 2003, BIOMATERIALS, V24, P2685, DOI 10.1016/S0142-9612(03)00079-6
   KENONG GJ, 1993, POLYMER, V34, P4089
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Luciano RM, 2003, J MATER SCI-MATER M, V14, P87, DOI 10.1023/A:1021509722296
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Mei N, 2006, J MATER SCI-MATER M, V17, P749, DOI 10.1007/s10856-006-9686-8
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Mitomo H, 1996, SEN-I GAKKAISHI, V52, P623, DOI 10.2115/fiber.52.11_623
   MITOMO H, 1995, J MACROMOL SCI PURE, VA32, P429, DOI 10.1080/10601329508013674
   MITOMO H, 1995, RADIAT PHYS CHEM, V46, P233, DOI 10.1016/0969-806X(95)00018-S
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Plackett D, 2004, J POLYM ENVIRON, V12, P131, DOI 10.1023/B:JOOE.0000038544.75554.0e
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9
   Shangguan YY, 2006, BIOMATERIALS, V27, P2349, DOI 10.1016/j.biomaterials.2005.11.024
   Steinbuchel A, 1991, BIOMATERIALS NOVEL M, P124
   Tesema Y, 2004, J APPL POLYM SCI, V93, P2445, DOI 10.1002/app.20787
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Wang YW, 2004, POLYM DEGRAD STABIL, V85, P815, DOI 10.1016/j.polymdegradstab.2004.02.010
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Xu J, 2003, J POLYM SCI POL PHYS, V41, P2128, DOI 10.1002/polb.10556
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
   ZOU B, 2006, CHINA BIOTECHNOL, V26, P43
NR 42
TC 15
Z9 18
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2008
VL 87A
IS 3
BP 832
EP 842
DI 10.1002/jbm.a.31890
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 373PR
UT WOS:000260984800029
PM 18306313
DA 2018-10-20
ER

PT J
AU Liu, J
   Wang, FH
   Wang, LL
   Xiao, SY
   Tong, CY
   Tang, DY
   Liu, XM
AF Liu Jun
   Wang Feng-hua
   Wang Ling-ling
   Xiao Su-yao
   Tong Chun-yi
   Tang Dong-ying
   Liu Xuan-ming
TI Preparation of fluorescence starch-nanoparticle and its application as
   plant transgenic vehicle
SO JOURNAL OF CENTRAL SOUTH UNIVERSITY OF TECHNOLOGY
LA English
DT Article
DE fluorescence nanoparticle; plant; gene vehicle; ultrasound-mediation;
   transformation
ID GENE DELIVERY; MAMMALIAN-CELLS; DNA PROTECTION; ULTRASOUND;
   TRANSFORMATION; BOMBARDMENT; CARRIER; TOOL
AB Starch-nanoparticles were synthesized in water-in-oil microemusion at room temperature, and the starch-nanoparticles were coated with poly-L-lysine. The surface of the starch-nanoparticles was combined with fluorescence material Ru(bpy)(3)(2+) center dot 6H(2)O, and then the particles were characterized via transmission electron microscope. The fluorescence nanoparticles were conjugated with plasmid DNA to form complexes, and then treated with ultrasound and DNase I. pEGAD plasmid DNA-nanoparticle complexes were co-cultured with plant suspension cells of Dioscrea Zigiberensis G H Wright, and treated with ultrasound. The results show that the diameter of the fluorescence starch-nanoparticles is 50-100 nm. DNA-nanoparticle complexes can protect DNA from ultrasound damage as well as from DNase I cleavage. Mediated by ultrasound, pEGAD plasmid DNA-nanoparticle complexes can pierce into the cell wall, cell membrane and nucleus membrane of plant suspension cells. The green fluorescence protein(GFP) gene at a high frequency exceeds 5%. This nano-biomaterial can efficiently solve the problem that exterior genes cannot traverse the plant cell wall easily.
C1 [Liu Jun; Wang Feng-hua; Xiao Su-yao; Tong Chun-yi; Tang Dong-ying; Liu Xuan-ming] Hunan Univ, Coll Life Sci & Biotechnol, Changsha 410082, Hunan, Peoples R China.
   [Liu Jun] Hunan Univ, Coll Mat Sci & Engn, Changsha 410082, Hunan, Peoples R China.
   [Wang Ling-ling] Hunan Univ, Sch Phys & Microelect Sci, Changsha 410082, Hunan, Peoples R China.
RP Liu, XM (reprint author), Hunan Univ, Coll Life Sci & Biotechnol, Changsha 410082, Hunan, Peoples R China.
EM sw_xml@hnu.cn
FU "985" Program of China [200501]
FX Project(200501) supported the "985" Program of China
CR BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Chai LY, 2006, J CENT SOUTH UNIV T, V13, P17, DOI 10.1007/s11771-006-0099-0
   Chowdhury EH, 2004, GENE, V341, P77, DOI 10.1016/j.gene.2004.07.015
   Deng CX, 2004, ULTRASOUND MED BIOL, V30, P519, DOI 10.1016/j.ultrasmedbio.2004.01.005
   Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003
   He XX, 2003, J AM CHEM SOC, V125, P7168, DOI 10.1021/ja034450d
   Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200
   Liu J, 2005, ANAL SCI, V21, P193, DOI 10.2116/analsci.21.193
   Liu J, 2005, CHEM J CHINESE U, V26, P634
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Men S, 2003, PLANT CELL REP, V21, P592, DOI 10.1007/s00299-002-0559-4
   MILLER DL, 1993, ULTRASOUND MED BIOL, V19, P343, DOI 10.1016/0301-5629(93)90106-X
   Roy I, 2005, P NATL ACAD SCI USA, V102, P279, DOI 10.1073/pnas.0408039101
   STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0
   Taylor NJ, 2002, DNA CELL BIOL, V21, P963, DOI 10.1089/104454902762053891
   Thomas M, 2003, P NATL ACAD SCI USA, V100, P9138, DOI 10.1073/pnas.1233634100
   Xiao SY, 2005, SCI CHINA SER B, V48, P162, DOI 10.1360/04yb0010
   Yu DM, 2007, CHINESE SCI BULL, V52, P2913, DOI 10.1007/s11434-007-0388-5
NR 18
TC 28
Z9 29
U1 0
U2 41
PU JOURNAL OF CENTRAL SOUTH UNIV TECHNOLOGY
PI HUNAN
PA EDITORIAL OFFICE, CHANGSHA, HUNAN 410083, PEOPLES R CHINA
SN 1005-9784
J9 J CENT SOUTH UNIV T
JI J. Cent. South Univ. Technol.
PD DEC
PY 2008
VL 15
IS 6
BP 768
EP 773
DI 10.1007/s11771-008-0142-4
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 384OA
UT WOS:000261752900006
DA 2018-10-20
ER

PT J
AU Shen, XR
   Nagai, N
   Murata, M
   Nishimura, D
   Sugi, M
   Munekata, M
AF Shen, XuanRi
   Nagai, Nobuhiro
   Murata, Masaru
   Nishimura, Daisuke
   Sugi, Masahito
   Munekata, Masanobu
TI Development of salmon milt DNA/salmon collagen composite for wound
   dressing
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID UV-IRRADIATION; DNA; GEL; PROLIFERATION; ATELOCOLLAGEN; FIBROBLASTS;
   BIOMATERIAL; ADENOSINE; GROWTH; FILMS
AB This study aims to develop a novel wound dressing comprising salmon milt DNA (sDNA) and salmon collagen (SC). The sDNA/SC composites were prepared by incubating a mixture of an acidic SC solution, an sDNA solution, and a collagen fibrillogenesis inducing buffer (pH 6.8) containing a crosslinking agent (water-soluble carbodiimide) for gelation, and a subsequent ventilation-drying process to give sDNA/SC films. The conjugation between sDNA and SC were confirmed by sDNA-elution assay and fluorescence microscopy. The sDNA/SC films with various doses of sDNA (sDNA/SC weight ratios of 1:5, 1:10, and 1:20) were used for in vitro cell cultures to evaluate their growth potentials of normal human dermal fibroblasts (NHDF) and normal human epidermal keratinocytes (NHEK). It was found that NHDF proliferation was increased by sDNA conjugation, whereas NHEK proliferation was dose-dependently inhibited. In light of the in vitro results, the appropriate dose of sDNA for in vivo study was determined to be the ratio of 1:10. For the implantation in full-thickness skin defects in rat dorsal region, the sDNA/SC films were reinforced by incorporating them on a porous SC sponge, because the sDNA/SC films exhibited early contraction and inadequate morphologic stability when implanted in vivo. The regenerated tissue in the sDNA/SC sponge group showed similar morphology to native dermis, while the SC sponge group without sDNA showed epithelial overgrowth, indicating that additional sDNA could reduce epidermal overgrowth. Furthermore, blood capillary formation was significantly enhanced in the sDNA/SC sponge group when compared to the SC sponge group. In conclusion, the results suggest that the sDNA/SC composite could be a potential wound dressing for clinical applications.
C1 [Shen, XuanRi; Munekata, Masanobu] Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan.
   [Nagai, Nobuhiro] Hokkaido Univ, Creat Res Initiat Sousei, Sapporo, Hokkaido 0010021, Japan.
   [Murata, Masaru] Hlth Sci Univ Hokkaido, Sch Dent, Div Oral & Maxillofacial Surg, Tobetsu Cho, Hokkaido 0610293, Japan.
   [Nishimura, Daisuke; Sugi, Masahito] Inst Nissei Bio Co Ltd, Eniwa, Hokkaido 0611374, Japan.
RP Shen, XR (reprint author), Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Kita Ku, N13-W8, Sapporo, Hokkaido 0608628, Japan.
EM sxrcg@yahoo.co.jp
FU Japan Society for the Promotion of Science (JSPS)
FX Shen thanks the Japan Society for the Promotion of Science (JSPS) for a
   post-doctoral fellowship for foreign researchers.
CR COOK PW, 1995, J INVEST DERMATOL, V104, P976, DOI 10.1111/1523-1747.ep12606228
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   Falabella AF, 2006, DERMATOL THER, V19, P317, DOI 10.1111/j.1529-8019.2006.00090.x
   Fukushima T, 2004, BIOMATERIALS, V25, P5491, DOI 10.1016/j.biomaterials.2004.01.006
   Giraud-Guille MM, 2000, BIOMATERIALS, V21, P899, DOI 10.1016/S0142-9612(99)00244-6
   Holen E, 2006, NUTRITION, V22, P90, DOI 10.1016/j.nut.2006.01.001
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   KALDLER KE, 1996, BIOCH J 1, V316, P1
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Liu WG, 2005, BIOMATERIALS, V26, P2705, DOI 10.1016/j.biomaterials.2004.07.038
   MIAN M, 1992, INT J TISSUE REACT, V14, P1
   Montesinos MC, 2002, AM J PATHOL, V160, P2009, DOI 10.1016/S0002-9440(10)61151-0
   Nagai N, 2004, J BIOSCI BIOENG, V98, P493, DOI 10.1016/S1389-1723(05)00319-1
   Nagai N, 2004, J BIOSCI BIOENG, V97, P389, DOI 10.1263/jbb.97.389
   Nagai N, 2007, J BIOMED MATER RES A, V82A, P395, DOI 10.1002/jbm.a.31110
   Purna S K, 2000, Burns, V26, P54
   Queen Douglas, 2004, Int Wound J, V1, P59, DOI 10.1111/j.1742-4801.2004.0009.x
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Thellung S, 1999, LIFE SCI, V64, P1661, DOI 10.1016/S0024-3205(99)00104-6
   van den Beucken JJJP, 2006, BIOMATERIALS, V27, P691, DOI 10.1016/j.biomaterials.2005.06.015
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Yamada M, 2001, BIOMATERIALS, V22, P3121, DOI 10.1016/S0142-9612(01)00061-8
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
NR 25
TC 16
Z9 18
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2008
VL 19
IS 12
BP 3473
EP 3479
DI 10.1007/s10856-008-3512-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 353LZ
UT WOS:000259570800001
PM 18592347
DA 2018-10-20
ER

PT J
AU Vohra, S
   Hennessy, KM
   Sawyer, AA
   Zhuo, Y
   Bellis, SL
AF Vohra, Shikhar
   Hennessy, Kristin M.
   Sawyer, Amber A.
   Zhuo, Ya
   Bellis, Susan L.
TI Comparison of mesenchymal stem cell and osteosarcoma cell adhesion to
   hydroxyapatite
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ADSORBED SERUM-PROTEINS; GROWTH-FACTOR-BETA; BONE-MARROW-CELLS;
   OSTEOBLASTIC DIFFERENTIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION;
   PRECURSOR CELLS; RGD PEPTIDES; I COLLAGEN; FIBRONECTIN
AB Immortalized cells are often used to model the behavior of osteogenic cells on orthopaedic and dental biomaterials. In the current study we compared the adhesive behavior of two osteosarcoma cell lines, MG-63 and Saos-2, with that of mesenchymal stem cells (MSCs) on hydroxyapatite (HA). It was found that osteosarcoma cells demonstrated maximal binding to fibronectin-coated HA, while MSCs alternately preferred HA coated with collagen-I. Interesting, the binding of MG-63 and Saos-2 cells to fibronectin was mediated by both alpha 5 and alpha v-containing integrin heterodimers, whereas only alpha v integrins were used by MSCs. Cell spreading was also markedly different for the three cell types. Osteosarcoma cells exhibited optimal spreading on fibronectin, but poor spreading on HA disks coated with fetal bovine serum. In contrast, MSCs spread very well on serum-coated surfaces, but less extensively on fibronectin. Finally, we evaluated integrin expression and found that MSCs have higher levels of alpha 2 integrin subunits relative to MG-63 or Saos-2 cells, which may explain the enhanced adhesion of MSCs on collagen-coated HA. Collectively our results suggest that osteosarcoma cells utilize different mechanisms than MSCs during initial attachment to protein-coated HA, thereby calling into question the suitability of these cell lines as in vitro models for cell/biomaterial interactions.
C1 [Vohra, Shikhar; Bellis, Susan L.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
RP Bellis, SL (reprint author), Univ Alabama Birmingham, Dept Physiol & Biophys, MCLM 982A,1918 Univ Blvd, Birmingham, AL 35294 USA.
EM bellis@physiology.uab.edu
FU NIAMS [R01AR51539]; NIBIB
FX The authors gratefully acknowledge support from NIAMS grant R01AR51539
   (SLB) and a predoctoral NRSA from NIBIB (KMH).
CR AKIYAMA SK, 1987, J BIOL CHEM, V262, P17536
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.3.CO;2-3
   DASTYCH J, 1994, J IMMUNOL, V152, P213
   Davies JE, 1996, ANAT REC, V245, P426
   Duan XP, 2004, CLIN EXP METASTAS, V21, P747, DOI 10.1007/s10585-005-0599-6
   Dumbleton J, 2004, J BONE JOINT SURG AM, V86A, P2526, DOI 10.2106/00004623-200411000-00028
   Geesink RGT, 2002, CLIN ORTHOP RELAT R, P53, DOI 10.1097/00003086-200202000-00007
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   HEINO J, 1989, J BIOL CHEM, V264, P380
   Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014
   Karrholm J, 1997, J PEDIATR ORTHOP B, V6, P91
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Kinashi T, 1999, J IMMUNOL, V162, P2850
   LENTER M, 1994, J BIOL CHEM, V269, P12263
   LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805
   Marco RAW, 2003, J CELL BIOCHEM, V88, P1038, DOI 10.1002/jcb.10465
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Sawyer AA, 2007, BIOMATERIALS, V28, P383, DOI 10.1016/j.biomaterials.2006.08.031
   Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Soballe K, 2003, ACTA ORTHOP SCAND, V74, P239
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   Suzawa M, 2002, J BONE MINER RES, V17, P240, DOI 10.1359/jbmr.2002.17.2.240
   Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   Tang CH, 2004, TOXICON, V43, P11, DOI 10.1016/j.toxicon.2003.01.008
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
NR 39
TC 27
Z9 27
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2008
VL 19
IS 12
BP 3567
EP 3574
DI 10.1007/s10856-008-3525-z
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 353LZ
UT WOS:000259570800012
PM 18626747
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wu, YZ
   Hu, Y
   Cai, JY
   Ma, SY
   Wang, XP
AF Wu, Yangzhe
   Hu, Yi
   Cai, Jiye
   Ma, Shuyuan
   Wang, Xiaoping
TI Coagulation property of hyaluronic acid-collagen/chitosan complex film
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; IN-VITRO; PLATELET-ADHESION; RECEPTOR
   EXPRESSION; STEM-CELLS; CHITOSAN; COLLAGEN; SCAFFOLDS; ACTIVATION;
   BIOCOMPATIBILITY
AB Biomacromolecule has been widely used as biomedical material. Because different biomacromolecules possess different properties, how to exhibit the respective advantages of different components on one type of biomaterial becomes the hot spot in the field of biomaterial studying. This work reported a type of complex film that consisted of hyaluronic acid (HA), type I collagen (Col-I), and chitosan (CS) (HA-Col-I/CS, HCC). Then, a series of experiments were performed, such as inverted microscopic observation, atomic force microscopic (AFM) imaging, flow cytometry (FCM) measurement, MTT assay, and MIC assay. In the present work, we observed the growing condition of 3T3 fibroblasts on the surface of the HCC complex film, visualized the morphological changes of platelets during the coagulation process, and discovered microparticles on the platelet membrane. Moreover, we confirmed the microparticles are the platelet-derived microparticles (PMPs) using the FCM. In addition, the minimal inhibitory concentration (MIC) of HCC against Escherichia coli (E. coli) 8099 was 0.025 mg/ml, against Staphylococcus aureus (S. aureus) ATCC 6538 was 0.1 mg/ml. The results together indicated that the HCC film possessed promising coagulation property, cell compatibility and anti-bacteria property, and the potential in future clinical application such as wound healing and bandage.
C1 [Wu, Yangzhe; Hu, Yi; Cai, Jiye] Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China.
   [Ma, Shuyuan; Wang, Xiaoping] Jinan Univ, Affiliated Hosp 1, Guangzhou 510632, Guangdong, Peoples R China.
RP Cai, JY (reprint author), Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China.
EM tjycai@jnu.edu.cn
RI Wu, Yangzhe/C-4435-2012
FU NSFC [60578025, 30540420311]
FX We thank associate professor Meiying Zhang (Biomedicine Research &
   Development Center, Jinan University) for her warm help in cell culture
   techniques. This work is supported by the NSFC (No. 60578025,
   30540420311).
CR Abatangelo G, 1997, BIOMATERIALS, V18, P1411, DOI 10.1016/S0142-9612(97)00089-6
   Alberio Lorenzo J, 2004, Curr Hematol Rep, V3, P338
   Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6
   Aurigemma C, 2007, THROMB RES, V120, P901, DOI 10.1016/j.thromres.2007.01.009
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Blinc A, 2000, FIBRINOLYSIS PROTEOL, V14, P288, DOI 10.1054/fipr.2000.0085
   CATANI L, 2006, EXP HEMATOL, V134, P879
   Cauwenberghs S, 2006, FEBS LETT, V580, P5313, DOI 10.1016/j.febslet.2006.08.082
   Chan BP, 2005, J BIOMED MATER RES A, V75A, P689, DOI 10.1002/jbm.a.30469
   Choi W, 2008, ACTA ODONTOL SCAND, V66, P31, DOI 10.1080/00016350701884612
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   Feng Q, 2005, COLLOID SURFACE A, V257-58, P85, DOI 10.1016/j.colsurfa.2004.10.099
   Fernandez-Barbero JE, 2006, CLIN ORAL IMPLAN RES, V17, P687, DOI 10.1111/j.1600-0501.2006.01179.x
   Fungaloi P, 2002, PHOTOCHEM PHOTOBIOL, V75, P412, DOI 10.1562/0031-8655(2002)075<0412:PATPTT>2.0.CO;2
   Garrison MD, 1997, ANN NY ACAD SCI, V831, P101
   Haque T, 2005, INT J ARTIF ORGANS, V28, P631
   Horber JKH, 2003, SCIENCE, V302, P1002, DOI 10.1126/science.1067410
   Hu Y, 2007, INT J MOL SCI, V8, P1, DOI 10.3390/i8010001
   Ilveskero S, 2001, ARTERIOSCL THROM VAS, V21, P628, DOI 10.1161/01.ATV.21.4.628
   Jiansu C., 2005, ARTIFI ORGANS, V29, P104
   Kalsch T, 2007, THROMB RES, V120, P703, DOI 10.1016/j.thromres.2006.12.022
   Kalsch T, 2006, INT J CARDIOL, V111, P217, DOI 10.1016/j.ijcard.2005.08.001
   Kang I, 2007, THROMB RES, V119, P731, DOI 10.1016/j.thromres.2006.06.010
   Kanno M, 2002, J BIOMED MATER RES, V60, P53, DOI 10.1002/jbm.1280
   Li B, 2006, CARBOHYD POLYM, V65, P488, DOI 10.1016/j.carbpol.2006.02.006
   Linden MD, 2004, SEMIN THROMB HEMOST, V30, P501, DOI 10.1055/s-2004-835671
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Nan Liu, 2006, Carbohydrate Polymers, V64, P60, DOI 10.1016/j.carbpol.2005.10.028
   Qu CX, 2006, J CLIN LAB ANAL, V20, P250, DOI 10.1002/jcla.20150
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Serebruany V, 2007, THROMB RES, V119, P175, DOI 10.1016/j.thromres.2006.02.004
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Siedlecki CA, 1999, BIOMATERIALS, V20, P1521, DOI 10.1016/S0142-9612(99)00065-4
   Stuhlmeier KM, 2006, WIEN MED WOCHENSCHR, V156, P563, DOI 10.1007/s10354-006-0351-0
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Toes GJ, 1999, BIOMATERIALS, V20, P1951, DOI 10.1016/S0142-9612(99)00100-3
   Vidovic A, 2007, PSYCHIAT RES, V150, P211, DOI 10.1016/j.psychres.2006.05.004
   Wang J, 2006, NUCL INSTRUM METH B, V242, P12, DOI 10.1016/j.nimb.2005.08.100
   Wang XY, 2008, J BIOMED MATER RES A, V84A, P384, DOI 10.1002/jbm.a.31326
   Yamada T, 2005, J BIOSCI BIOENG, V99, P521, DOI 10.1263/jbb.99.521
   YANO Y, 1994, BIOCHEM J, V299, P303, DOI 10.1042/bj2990303
NR 44
TC 19
Z9 20
U1 3
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2008
VL 19
IS 12
BP 3621
EP 3629
DI 10.1007/s10856-008-3477-3
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 353LZ
UT WOS:000259570800018
PM 18642062
DA 2018-10-20
ER

PT J
AU Shafqat, F
   Bhatti, HN
   Hanif, MA
   Zubair, A
AF Shafqat, Faiza
   Bhatti, Haq Nawaz
   Hanif, Muhammad Asif
   Zubair, Ammara
TI KINETIC AND EQUILIBRIUM STUDIES OF CR(III) AND CR(VI) SORPTION FROM
   AQUEOUS SOLUTION USING ROSA GRUSS AN TEPLITZ (RED ROSE) WASTE BIOMASS
SO JOURNAL OF THE CHILEAN CHEMICAL SOCIETY
LA English
DT Article
DE biosorption; pretreatment; Cr(III); Cr(VI); biomass
ID HEAVY-METAL BIOSORPTION; ASPERGILLUS-NIGER; HEXAVALENT CHROMIUM; ALGAL
   BIOMASS; REMOVAL; IONS; LEAD; PB(II); COPPER; ZINC
AB The biosorption of Cr(III) and Cr(VI) from synthetic solution using dried untreated and pretreated Rosa gruss an teplitz waste biomass was evaluated in this study. The results showed that initial pH, biosorbent dose, sorbent particle size, initial metal concentration, time and temperature affected chromium uptake capacity of rose biomass. The effect of twenty different pretreatments including gaseous and Other reagents on Cr(III) and Cr(VI) uptake capacity of Rosa gruss an teplitz waste biomass was comprehensively described. Uptake capacity of Rosa grass an teplitz waste biomass was significantly affected after pretreatment. The metal uptake capacity of biomass was not only found related to nature of pretreatment but also found strongly related to oxidation state of chromium. The estimation of the correlation coefficients for Cr(VI) showed that the experimental data fit better to Freundlich model. The Langmuir isotherm provided the best correlation for Cr(III) onto the rose waste biomass. The biosorption phenomenon was dependent on the temperature with maximum adsorption at 30 degrees C. Biosorption of Cr(III) and Cr(VI) ions on to biomass followed pseudo 2(nd) order adsorption kinetic model. The results Confirmed that rose waste biomass is a potential biomaterial to remove Cr(III) and Cr(VI) ions with a high biosorption capacity 45.03 mg/g and 48.75 mg/g for Cr(III) and Cr(VI) respectively.
C1 [Shafqat, Faiza; Bhatti, Haq Nawaz; Hanif, Muhammad Asif; Zubair, Ammara] Univ Agr Faisalabad, Dept Chem & Biochem, Ind Biotechnol Lab, Faisalabad 38040, Pakistan.
   [Hanif, Muhammad Asif] Univ Agr Faisalabad, Inst Hort Sci, Rose Lab, Faisalabad 38040, Pakistan.
RP Shafqat, F (reprint author), Univ Agr Faisalabad, Dept Chem & Biochem, Ind Biotechnol Lab, Faisalabad 38040, Pakistan.
EM hnbhatti2005@yahoo.com
RI Hanif, Muhammad Asif/G-7242-2015; Bhatti, Haq Nawaz/I-2069-2015
CR Ahalya N, 2005, ELECTRON J BIOTECHN, V8, DOI 10.2225/vol8-issue3-fulltext-10
   Ahluwalia SS, 2005, ENG LIFE SCI, V5, P158, DOI 10.1002/elsc.200420066
   Ashkenazy R, 1997, BIOTECHNOL BIOENG, V5, P1
   Bai S, 2001, BIORESOURCE TECHNOL, V79, P73, DOI 10.1016/S0960-8524(00)00107-3
   BHATTACHARYYA KG, 2004, J HAZARD MAT, V97
   Bhatti HN, 2007, PROCESS BIOCHEM, V42, P547, DOI 10.1016/j.procbio.2006.11.009
   Bishnoi NR, 2007, J HAZARD MATER, V145, P142, DOI 10.1016/j.jhazmat.2006.10.093
   Bishnoi NR, 2004, J SCI IND RES INDIA, V63, P813
   Boddu VM, 2003, ENVIRON SCI TECHNOL, V37, P4449, DOI 10.1021/es021013a
   BRIERLEY JA, 1985, Patent No. 85112810
   Cabuk Ahmet, 2005, Turkish Journal of Biology, V29, P23
   CELEYA RJ, 2000, BIOPROCESS ENG, V22, P539
   Chand Shri, 1994, Indian Journal of Environmental Health, V36, P151
   Conrad K, 2007, BIORESOURCE TECHNOL, V98, P89, DOI 10.1016/j.biortech.2005.11.018
   Cordero B, 2004, ENVIRON CHEM, V1, P180, DOI 10.1071/EN04039
   Deng SB, 2005, WATER RES, V39, P2167, DOI 10.1016/j.watres.2005.03.033
   Deo N., 1992, INDIAN J ENV PROTECT, V12, P828
   DOW JM, 1997, J GEN MICROBIOL, V99, P29
   Fourest E, 1996, ENVIRON SCI TECHNOL, V30, P277, DOI 10.1021/es950315s
   GALUN M, 1987, WATER AIR SOIL POLL, V33, P359, DOI 10.1007/BF00294204
   Gupta VK, 2001, WATER RES, V35, P4079, DOI 10.1016/S0043-1354(01)00138-5
   Hanif MA, 2007, J HAZARD MATER, V139, P345, DOI 10.1016/j.jhazmat.2006.06.040
   HELLAWELL JM, 1989, NY POLLUTION MONITOR, P546
   HOLAN ZR, 1995, APPL BIOCHEM BIOTECH, V53, P133, DOI 10.1007/BF02788603
   HUANG C, 1996, WATER RES, V30, P985
   Javed MA, 2007, SEPAR SCI TECHNOL, V42, P3641, DOI 10.1080/01496390701710794
   Kapoor A, 1999, BIORESOURCE TECHNOL, V70, P95, DOI 10.1016/S0960-8524(98)00192-8
   Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2
   Kapoor A, 1998, BIORESOURCE TECHNOL, V63, P109, DOI 10.1016/S0960-8524(97)00118-1
   KAUFMAN DB, 1970, AM J DIS CHILD, V119, P374, DOI 10.1001/archpedi.1970.02100050376021
   Kratochvil D, 1998, ENVIRON SCI TECHNOL, V32, P2693, DOI 10.1021/es971073u
   Lazaro N, 2003, WATER RES, V37, P2118, DOI 10.1016/S0043-1354(02)00575-4
   LEONARD A, 1980, MUTAT RES, V76, P227, DOI 10.1016/0165-1110(80)90018-4
   Loaec M, 1997, WATER RES, V31, P1171, DOI 10.1016/S0043-1354(96)00375-2
   LUEF E, 1991, APPL MICROBIOL BIOT, V34, P688, DOI 10.1007/BF00167924
   MCGAHREN WJ, 1984, PROCESS BIOCHEM, V19, P88
   MITTELMAN MW, 1985, APPL ENVIRON MICROB, V49, P846
   Mungasavalli DP, 2007, COLLOID SURFACE A, V301, P214, DOI 10.1016/j.colsurfa.2006.12.060
   MURALEEDHARAN TR, 1990, BIOTECHNOL BIOENG, V35, P320, DOI 10.1002/bit.260350314
   Niu H, 2003, HYDROMETALLURGY, V71, P209, DOI 10.1016/S0304-386X(03)00158-0
   Nomanbhay S. M., 2005, ELE J BIOTECHNOL, V8, P44
   Nriega JO, 1988, CHROMIUM NATURAL HUM, P44
   Ozer A, 2003, J HAZARD MATER, V100, P219, DOI 10.1016/S0304-3894(03)00109-2
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Quek SY, 1998, WATER SA, V24, P251
   RAUF A, 2008, J HAZARD MATER, DOI DOI 10.1016/J.HAZMAT.2008.04.040
   Sag Y, 2000, PROCESS BIOCHEM, V36, P157, DOI 10.1016/S0032-9592(00)00200-4
   Saravanane R, 2002, Indian J Environ Health, V44, P78
   Schiewer S, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P329
   TAPIA J, 2002, B SOC CHIL QUIM, V4, P469
   Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011
   TOBIN JM, 1990, ENZYME MICROB TECH, V12, P591, DOI 10.1016/0141-0229(90)90132-A
   Tsui MTK, 2006, CHEMOSPHERE, V65, P51, DOI 10.1016/j.chemosphere.2006.03.002
   Veglio F, 2003, PROCESS BIOCHEM, V38, P953, DOI 10.1016/S0032-9592(02)00235-2
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Volesky B., 2003, SORPTION BIOSORPTION, P316
   Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6
   Yan GY, 2000, WATER SA, V26, P119
   Zafar MN, 2007, J HAZARD MATER, V143, P478, DOI 10.1016/j.jhazmat.2006.09.055
   ZUBAIR A, 2008, WATER AIR SOIL POLL, V191, P308
NR 60
TC 17
Z9 17
U1 0
U2 2
PU SOC CHILENA QUIMICA
PI CONCEPCION
PA CASILLA 2613, CONCEPCION, 00000, CHILE
SN 0717-9324
J9 J CHIL CHEM SOC
JI J. Chil. Chem. Soc.
PD DEC
PY 2008
VL 53
IS 4
BP 1667
EP 1672
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 391GT
UT WOS:000262222500005
OA Other Gold, Bronze
DA 2018-10-20
ER

PT J
AU Jaworski, R
   Pierlot, C
   Pawlowski, L
   Bigan, M
   Quivrin, M
AF Jaworski, Roman
   Pierlot, Christel
   Pawlowski, Lech
   Bigan, Muriel
   Quivrin, Maxime
TI Synthesis and Preliminary Tests of Suspension Plasma Spraying of Fine
   Hydroxyapatite Powder
SO JOURNAL OF THERMAL SPRAY TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT International Thermal Spray Conference (ITSC 2008)
CY JUN 02-04, 2008
CL Maastricht, NETHERLANDS
SP ASM Thermal Spray Soc, German Welding Soc, Int Inst Welding
DE biomedical coatings; hydroxyapatite; powder manufacturing; suspension
   plasma spraying
ID COATINGS; MICROSTRUCTURE; PARAMETERS
AB The synthetic hydroxyapatite (HA, Ca(10)(PO(4))(6)(OH)(2)) is a very useful biomaterial for numerous applications in medicine, such as e. g., fine powder for suspension plasma spraying. The powder was synthesized using aqueous solution of ammonium phosphate (H(2)(PO(4))NH(4)) and calcium nitrate (Ca(NO(3))center dot 4H(2)O) in the carefully controlled experiments. The synthesized fine powder was characterized by X-ray diffraction (XRD) and scanning electron microscope (SEM). The powder was formulated into water and alcohol based suspension and used to carry out the initial tests of plasma spraying onto titanium substrate. The phase analysis of sprayed coating was made with the XRD.
C1 [Jaworski, Roman; Pawlowski, Lech] Ecole Natl Super Chim Lille, Serv Thermal Spraying, F-59650 Villeneuve Dascq, France.
   [Pierlot, Christel; Bigan, Muriel; Quivrin, Maxime] ENSCL, UMR CNRS 8009, LCOM, F-59652 Villeneuve Dascq, France.
RP Jaworski, R (reprint author), Ecole Natl Super Chim Lille, Serv Thermal Spraying, BP 90180,8 Ave Mendeleiev, F-59650 Villeneuve Dascq, France.
EM lech.pawlowski@ensc-lille.fr
RI Pawlowski, Lech/G-9383-2016
OI Pawlowski, Lech/0000-0002-9716-4700
CR *AFNOR, 1993, S94067 AFNOR
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Bouyer E, 1997, IEEE T PLASMA SCI, V25, P1066, DOI 10.1109/27.649627
   Dyshlovenko S, 2006, SURF COAT TECH, V200, P3845, DOI 10.1016/j.surfcoat.2004.11.037
   Dyshlovenko S, 2006, SURF COAT TECH, V200, P3757, DOI 10.1016/j.surfcoat.2005.04.002
   FAUCHAIS P, 2007, 1 SCI WORKSH THERM S
   Gitzhofer F., 1997, Suspension Plasma Spraying, Patent No. [US5609921, 5609921]
   Heimann RB, 2006, SURF COAT TECH, V201, P2012, DOI 10.1016/j.surfcoat.2006.04.052
   Hornez JC, 2007, BIOMOL ENG, V24, P505, DOI 10.1016/j.bioeng.2007.08.015
   Jaworski R, 2007, MATERIALWISS WERKST, V38, P125, DOI 10.1002/mawe.200600120
   JAWORSKI R, SURF COAT TECH UNPUB
   JAWORSKI R, 2008, SURF COAT TECH, V202, P2544
   Jaworski R, 2008, J THERM SPRAY TECHN, V17, P73, DOI 10.1007/s11666-007-9147-z
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   PAWLOWSKI L, 2008, SCI ENG THERMAL SPRA, P101
   Pawlowski L, 2008, SURF COAT TECH, V202, P4318, DOI 10.1016/j.surfcoat.2008.04.004
   Prevey PS, 2000, J THERM SPRAY TECHN, V9, P369, DOI 10.1361/105996300770349827
   SANTOS C, 1995, MAT CLIN APPL, P11
   Wittmann-Teneze K, 2008, SURF COAT TECH, V202, P4349, DOI 10.1016/j.surfcoat.2008.04.008
NR 19
TC 10
Z9 10
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9630
J9 J THERM SPRAY TECHN
JI J. Therm. Spray Technol.
PD DEC
PY 2008
VL 17
IS 5-6
BP 679
EP 684
DI 10.1007/s11666-008-9220-2
PG 6
WC Materials Science, Coatings & Films
SC Materials Science
GA 379QQ
UT WOS:000261411700014
DA 2018-10-20
ER

PT J
AU Peretz, H
   Blinder, P
   Baranes, D
   Vago, R
AF Peretz, H.
   Blinder, P.
   Baranes, D.
   Vago, R.
TI Aragonite crystalline matrix as an instructive microenvironment for
   neural development
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE tissue engineering; aragonite skeleton; cell-material interactions;
   biomaterials; calcium uptake; neural bioengineering
ID RAT CORTICAL-NEURONS; NEURITE OUTGROWTH; EXTRACELLULAR-MATRIX; SYNAPSE
   FORMATION; SCHWANN-CELLS; COLLAGEN GEL; MARROW-CELLS; OPTIC TRACT;
   IN-VITRO; TISSUE
AB The ability to mimic cell-matrix interactions in a way that closely resembles the natural environment is of a great importance for both basic neuroscience and for fabrication of potent scaffolding materials for nervous tissue engineering. Such scaffolding materials should not only facilitate cell attachment but also create a microenvironment that provides essential developmental and survival cues. We previously found that porous aragonite crystalline matrices of marine origin are an adequate and active biomaterial that promotes neural cell growth and tissue development. Here we studied the mechanism underlying these neural cell-material interactions, focusing on the three-dimensional (31)) surface architecture and matrix activity of these scaffolds. We introduced a new cloning technique of the hydrozoan Millepora dichotoma, through which calcein or (45)Ca(2+) were incorporated into the organism's growing skeleton and neuronal cells could then be cultured on the labelled matrices. Herein, we describe the role of matrix 3D architecture on neural cell type composition and survival in culture, and report for the first time on the capacity of neurons and astrocytes to exploit calcium ions from the supporting biomatrix. We found that hippocampal cells growing on the prelabelled aragonite lattice took up aragonite-derived Ca(2+), and even enhanced this uptake when extracellular calcium ions were chelated by EGTA. When the aragonite-derived Ca2+ uptake was omitted by culturing the cells on coral skeletons coated with gold, cell survival was reduced but not arrested, suggesting a role for matrix architecture in neural survival. in addition, we found that the effects of scaffold architecture and chemistry on cell survival were more profound for neurons than for astrocytes. We submit that translocation of calcium from the biomaterial to the cells activates a variety of membrane-bound signalling molecules and leads to the subsequent cell behaviour. This kind of cell-material interaction possesses great potential for fabricating advanced biomaterials for neural tissue-engineering applications. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Vago, R.] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   [Peretz, H.; Blinder, P.; Baranes, D.] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.
   [Peretz, H.; Blinder, P.; Baranes, D.] Ben Gurion Univ Negev, Nat Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.
RP Vago, R (reprint author), Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
EM rvago@bgu.ac.il
RI Blinder, Pablo/D-2472-2009
OI Blinder, Pablo/0000-0002-4042-214X
FU National Institute for Biotechnology in the Negev grant; Horowitz
   Foundation; Bionational Science Foundation (BSF) [2001045]
FX The authors wish to thank the staff of the Intertiniversity Institute
   for Marine Science, Eilat, for their field, administrative and technical
   support during this study. We thank Ms Rina Jeger and Ms Yona
   Lichtenfeld for technical assistance, and Ms Inez Murinek for her
   fruitful discussions and comments on the manuscript. This research was
   partially supported by the National Institute for Biotechnology in the
   Negev grant, by the Horowitz Foundation ('Establishment of the Israeli
   Cellome Network') and by the Bionational Science Foundation (BSF), Grant
   No. 2001045.
CR ABBOTT A, 2003, NATURE, V424, P70
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ATALA A, 2002, METHODS TISSUE ENG
   Baranes D, 2007, TISSUE ENG, V13, P473, DOI 10.1089/ten.2006.0052
   Baranes D, 1996, P NATL ACAD SCI USA, V93, P4706, DOI 10.1073/pnas.93.10.4706
   Baum BJ, 2000, J AM DENT ASSOC, V131, P309, DOI 10.14219/jada.archive.2000.0174
   Birk RZ, 2006, TISSUE ENG, V12, P21, DOI 10.1089/ten.2006.12.21
   Bolz H, 2002, ADV EXP MED BIOL, V514, P399
   Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   DOWLING JE, 1992, NEURONS NETWORKS INT
   Edelman DB, 2005, EXP NEUROL, V192, P1, DOI 10.1016/j.expneurol.2004.10
   Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   Gil ML, 1996, INFECT IMMUN, V64, P5239
   Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844
   Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P274
   GOTTLIBABRAMOWI.L, 2006, TISSUE ENG, V12, P729
   GRD E, 2000, SEMIN SURG ONCOL, V19, P312
   Hayman MW, 2005, J BIOCHEM BIOPH METH, V62, P231, DOI 10.1016/j.jbbm.2004.12.001
   Hayman MW, 2004, BIOCHEM BIOPH RES CO, V314, P483, DOI 10.1016/j.bbrc.2003.12.135
   Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   HYAFIL F, 1981, CELL, V26, P447, DOI 10.1016/0092-8674(81)90214-2
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kelm JM, 2006, J BIOTECHNOL, V121, P86, DOI 10.1016/j.jbiotec.2005.07.009
   LETOURNEAU PC, 1994, J NEUROSCI, V14, P915
   Lin PW, 2005, J BIOMED MATER RES B, V75B, P146, DOI 10.1002/jbm.b.30276
   O'Connor SM, 2000, BIOSENS BIOELECTRON, V14, P871
   O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4
   O'Connor SM, 2001, NEUROSCI LETT, V304, P189, DOI 10.1016/S0304-3940(01)01769-4
   O'Shaughnessy TJ, 2003, NEUROSCI LETT, V340, P169, DOI 10.1016/S0304-3940(03)00083-1
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   PERETZ H, 2007, TISSUE ENG, V113, P461
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611
   Plant GW, 2000, CELL TRANSPLANT, V9, P759, DOI 10.1177/096368970000900603
   PLANT GW, 1995, BRAIN RES, V671, P119, DOI 10.1016/0006-8993(94)01312-6
   POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x
   RADICE GL, 2001, CELL ADHESION, P63
   ROUDIER M, 1995, J BIOMED MATER RES, V29, P909, DOI 10.1002/jbm.820290802
   SCHUGENS C, 1995, J BIOMED MATER RES, V29, P1349, DOI 10.1002/jbm.820291106
   Shany B, 2006, TISSUE ENG, V12, P1763, DOI 10.1089/ten.2006.12.1763
   Shany B, 2005, TISSUE ENG, V11, P585, DOI 10.1089/ten.2005.11.585
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Vago R, 2002, J BIOCHEM BIOPH METH, V50, P253, DOI 10.1016/S0165-022X(01)00235-4
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
NR 51
TC 9
Z9 9
U1 0
U2 8
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD DEC
PY 2008
VL 2
IS 8
BP 463
EP 471
DI 10.1002/term.118
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 391ZO
UT WOS:000262272900002
PM 18924122
DA 2018-10-20
ER

PT J
AU Deng, C
   Weng, J
   Lu, X
   Zhou, SB
   Wan, JX
   Qu, SX
   Feng, B
   Li, XH
AF Deng, C.
   Weng, J.
   Lu, X.
   Zhou, S. B.
   Wan, J. X.
   Qu, S. X.
   Feng, B.
   Li, X. H.
TI Preparation and in vitro bioactivity of poly(D,L-lactide) composite
   containing hydroxyapatite nanocrystals
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Preparation; In vitro bioactivity; Composite; Thin film
ID MECHANICAL-PROPERTIES; APATITE; BIOMATERIALS; REPLACEMENT; TISSUE; BONE
AB The nano-sized hydroxyapatite (n-HA) was incorporated into poly(D,L-Lactide) (PDLLA) to form a bioactive and biodegradable composite for application in hard tissue replacement and regeneration. Thin film of PDLLA composite containing 20 mass% of n-HA fillers was successfully developed through integration of solvent co-blending and hot pressing techniques. firstly, n-HA and PDLLA were chemically synthesized, respectively, then mixed together and homogeneously dispersed in N,N-dimethyl formamide(DMF) solvent, finally, the dried blended hybrid containing PDLLA matrix and n-HA fillers was put into the mould and compacted by hot-pressing machine under 8 MPa pressure at 110 degrees C for 15 min. In vitro studies were conducted using the simulated body fluid(SBF). Composite specimens were soaked in SBF from I day to 21 days prior to surface analysis. Results obtained from scanning electron microscopy(SEM) examination, Energy dispersive X-ray detector(EDX) analysis and Xray diffraction (XRD) analysis showed that a layer of non-stoichiometric apatite formed within 7 days on HA/PDLLA composite surface after its immersion in SBF, demonstrating moderate in vitro bioactivity of n-HA/PDLLA composite, though a moderate rate of apatite formation in SBF was found on initial stage of immersion periods for n-HA/PDLLA composite, compared to the other biomaterial composite. This type of composite film exhibited certain desirable bioactive characteristics, and they are promising bone candidates to develop novel bioactive composites for biomedical application. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Deng, C.; Weng, J.; Lu, X.; Zhou, S. B.; Wan, J. X.; Qu, S. X.; Feng, B.; Li, X. H.] SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
RP Weng, J (reprint author), SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM jweng@home.swjtu.edu.cn
RI LU, xiong/B-3092-2010; QU, SHU XIN/H-3036-2011; Feng, Bo/B-3498-2010;
   Weng, Jie/B-3005-2010; zhou, shaobing/B-3148-2010
OI LU, xiong/0000-0001-6367-430X; 
FU Chinese Ministry of Education
FX This project is supported by Trans-Century Training Program Foundation
   for the Talents by Chinese Ministry of Education.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   HENCH LL, 1993, INTRO BIOCERAMICS, P11
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Kim HM, 2001, KEY ENG MATER, V192-195, P47, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.47
   Leonor IB, 2003, BIOMATERIALS, V24, P579, DOI 10.1016/S0142-9612(02)00371-X
   Li Y. B., 1994, J MATER SCI-MATER M, V5, P252, DOI DOI 10.1007/BF00122393)
   Liu Q, 1998, BIOMATERIALS, V19, P1067, DOI 10.1016/S0142-9612(98)00033-7
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   NENAD I, 2004, APPL SURF SCI, V238, P314
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   Ni J, 2002, MAT SCI ENG C-BIO S, V20, P101, DOI 10.1016/S0928-4931(02)00019-X
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Silvio L.D., 1998, J MATER SCI-MATER M, V9, P845
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Wang M, 2001, J MATER SCI-MATER M, V12, P821, DOI 10.1023/A:1017933220894
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Yu SC, 2005, BIOMATERIALS, V26, P2343, DOI 10.1016/j.biomaterials.2004.07.028
NR 19
TC 17
Z9 17
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD DEC 1
PY 2008
VL 28
IS 8
BP 1304
EP 1310
DI 10.1016/j.msec.2008.01.003
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 385YD
UT WOS:000261848600017
DA 2018-10-20
ER

PT J
AU Weng, YJ
   Ren, JR
   Huang, N
   Wang, J
   Chen, JY
   Leng, YX
   Liu, HQ
AF Weng, Y. J.
   Ren, J. R.
   Huang, N.
   Wang, J.
   Chen, J. Y.
   Leng, Y. X.
   Liu, H. Q.
TI Surface engineering of Ti-O films by photochemical immobilization of
   gelatin
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Gelatin; Ti-O film; Photochemical immobilization; Cell growth
ID VEIN ENDOTHELIAL-CELLS; IMMERSION ION-IMPLANTATION; COVALENT
   IMMOBILIZATION; IN-VITRO; PLASMA DEPOSITION; CARBON-FILMS; TITANIUM;
   BIOMATERIALS; BEHAVIOR; ADHESION
AB Crystalline Ti-O films were prepared by unbalanced magnetron sputtering and the structure was confirmed by XRD. An organic layer of 3-aminopropylphosphonic acid (APP) was first introduced on the Ti-O films by self-assembling. The stability of the APP on Ti-O films was confirmed by XPS and FTIR analysis. Simultaneously, azido group was introduced in gelatin molecule to act as photoreactive point. The derivated gelatin was spin-coated onto the self-assembled layer and immobilized by UV irradiating. Chemical patterned surface was obtained by using a photomask when irradiating and confirmed by sirius red staining and surface profile analysis. Measured by surface profilometer, the thickness of the immobilized gelatin was about 5-20 nm. The adhering of human endothelial EVC304 cells on APP modified surface was enhanced in the cell culture test. Moreover, the adherence and growth of cells were prior on gelatin-immobilized region visually seen on the patterned surface. This result indicated gelatin-immobilized Ti-O Surface can serve as a biocompatible biomaterial for endothelialization. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Weng, Y. J.; Ren, J. R.; Huang, N.; Wang, J.; Chen, J. Y.; Leng, Y. X.; Liu, H. Q.] SW Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
   [Weng, Y. J.; Ren, J. R.; Huang, N.; Wang, J.; Chen, J. Y.; Leng, Y. X.; Liu, H. Q.] SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Peoples R China.
EM nhuang@263.net
RI Leng, Yongxiang/G-5488-2010; Leng, Y.X./C-2278-2012
OI Leng, Y.X./0000-0001-6823-1233
FU Key Basic Research [2005CB623904]; Natural Science Foundation of China
   [30300087, 30670564]; NSFCRGC [30318006]
FX This work was financially supported by Key Basic Research Project No.
   2005CB623904, Natural Science Foundation of China No. 30300087# and
   30670564#, and NSFCRGC 30318006#.
CR Backer MV, 2006, BIOMATERIALS, V27, P5452, DOI 10.1016/j.biomaterials.2006.06.025
   Barbucci R, 2003, BIOMATERIALS, V24, P915, DOI 10.1016/S0142-9612(02)00425-8
   Chen JY, 2006, NUCL INSTRUM METH B, V242, P26, DOI 10.1016/j.nimb.2005.08.098
   Chen JY, 2004, SURF COAT TECH, V186, P270, DOI 10.1016/j.surfcoat.2004.02.050
   Chu PK, 2007, SURF COAT TECH, V201, P8076, DOI 10.1016/j.surfcoat.2005.12.053
   Gao XY, 1998, EUR J PHARM BIOPHARM, V45, P275, DOI 10.1016/S0939-6411(98)00010-1
   Gawalt ES, 2003, LANGMUIR, V19, P200, DOI 10.1021/la0203436
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Harsch A, 2000, J NEUROSCI METH, V98, P135, DOI 10.1016/S0165-0270(00)00196-5
   Hasebe T, 2007, DIAM RELAT MATER, V16, P1343, DOI 10.1016/j.diamond.2006.12.009
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HUANG Y, 2005, BIOMATERIALS, V26, P761
   Ito Y, 2000, J INORG BIOCHEM, V79, P77, DOI 10.1016/S0162-0134(99)00159-2
   Jing FJ, 2007, DIAM RELAT MATER, V16, P550, DOI 10.1016/j.diamond.2006.11.051
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Konno T, 2005, BIOMATERIALS, V26, P1381, DOI 10.1016/j.biomaterials.2004.04.047
   Kouvroukoglou S, 2000, BIOMATERIALS, V21, P1725, DOI 10.1016/S0142-9612(99)00205-7
   Kuijpers AJ, 2000, BIOMATERIALS, V21, P1763, DOI 10.1016/S0142-9612(00)00064-8
   Leng YX, 2006, SURF COAT TECH, V201, P157, DOI 10.1016/j.surfcoat.2005.11.074
   [刘敬肖 Liu Jingxiao], 2002, [材料研究学报, Chinese Journal of Materials Research], V16, P529
   Lu G, 2000, SURF SCI, V458, P80, DOI 10.1016/S0039-6028(00)00420-9
   Muller R, 2006, BIOMATERIALS, V27, P4059, DOI 10.1016/j.biomaterials.2006.03.019
   Nilsing M, 2005, SURF SCI, V582, P49, DOI 10.1016/j.susc.2005.02.044
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Wang AF, 2005, COLLOID SURFACE B, V43, P245, DOI 10.1016/j.colsurfb.2005.04.015
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
   Zhu YB, 2002, BIOMATERIALS, V23, P4889, DOI 10.1016/S0142-9612(02)00247-8
NR 28
TC 9
Z9 9
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD DEC 1
PY 2008
VL 28
IS 8
BP 1495
EP 1500
DI 10.1016/j.msec.2008.04.004
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 385YD
UT WOS:000261848600045
DA 2018-10-20
ER

PT J
AU Kurella, AK
   Hu, MZ
   Dahotre, NB
AF Kurella, Anil K.
   Hu, Michael Z.
   Dahotre, Narendra B.
TI Effect of microstructural evolution on wettability of laser coated
   calcium phosphate on titanium alloy
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE Laser; Wettability; Biocompatibility; Calcium phosphate; Titanium alloy;
   Biomaterial
ID COATINGS; HYDROXYAPATITE; BIOMATERIALS; CO2-LASER; ZIRCONIA
AB Surface engineering of synthetic implant materials provides an exciting opportunity to mimic natural biomaterials. Surface that are bioactive and textured at multi-scale have the potential for easier osseointegration. Ti alloy surfaces known for their biocompatibility are coated with bioactive calcium phosphate using a laser source at multiple processing speeds. The resulting surface has multi-scale morphology and multi-phase chemical nature. Faster processing speeds showed improved wettability to water along with higher degree of crystallinity in the phases present. Furthermore. decreased laser processing speeds induced formation of increased amount of glassy phases that are expected to provide increased biocompatibility. The combination of these opposing effects Suggested that optimum crystallinity leading to optimum wettability can be produced at intermediate speeds for improved biocompatibility. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kurella, Anil K.; Dahotre, Narendra B.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   [Hu, Michael Z.] Oak Ridge Natl Lab, Nucl Sci & Technol Div, Oak Ridge, TN 37831 USA.
   [Dahotre, Narendra B.] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA.
RP Dahotre, NB (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM ndahotre@utk.edu
OI Hu, Michael/0000-0001-8461-9684
FU Division of Materials Science [KC 02 03 010]; Office of Science; U.S.
   Department of Energy at Oak Ridge National Laboratory
   [DE-AC05-00OR22725]
FX This work is partially supported by the Division of Materials Science
   (KC 02 03 010), Office of Science, the U.S. Department of Energy at Oak
   Ridge National Laboratory managed by UT-Battelle, LLC, for the U.S.
   Department of Energy under contract DE-AC05-00OR22725.
CR Agathopoulos S, 1996, J MATER SCI-MATER M, V7, P629, DOI 10.1007/BF00058203
   Bento AC, 1996, J APPL PHYS, V79, P6848, DOI 10.1063/1.362650
   CHIANG M, 1997, PRINCIPLES CERAMICS, P1
   Cui CX, 2005, MATER LETT, V59, P3144, DOI 10.1016/j.matlet.2005.05.037
   DIASA AG, 2005, J NONCRYST SOLIDS, P810
   EUSTATHOPOULOS MG, 1999, WETTABILITY HIGH TEM, P36
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   Harimkar SP, 2007, J APPL PHYS, V101, DOI 10.1063/1.2710288
   Harimkar SP, 2006, J PHYS D APPL PHYS, V39, P1642, DOI 10.1088/0022-3727/39/8/025
   Khor KA, 2004, BIOMATERIALS, V25, P4009, DOI 10.1016/j.biomaterials.2003.10.089
   Kurella A, 2006, J MATER SCI-MATER M, V17, P565, DOI 10.1007/s10856-006-8941-3
   KURELLA A, 2006, ACTABIOMATERIALIA, V2, P777
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Lusquinos F, 2003, J BIOMED MATER RES A, V64A, P630, DOI 10.1002/jbm.a.10440
   Moritz N, 2004, J MATER SCI-MATER M, V15, P787, DOI 10.1023/B:JMSM.0000032819.64994.42
   Sun LM, 2003, MAT SCI ENG A-STRUCT, V360, P70, DOI 10.1016/S0921-5093(03)00439-8
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Tian YS, 2005, APPL SURF SCI, V242, P177, DOI 10.1016/j.apsusc.2004.08.011
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Webster TJ, 2003, J BIOMED MATER RES A, V67A, P975, DOI 10.1002/jbm.a.10160
NR 20
TC 10
Z9 10
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD DEC 1
PY 2008
VL 28
IS 8
BP 1560
EP 1564
DI 10.1016/j.msec.2008.04.015
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 385YD
UT WOS:000261848600054
DA 2018-10-20
ER

PT J
AU Popovici, A
   Fodor, O
   Moldovan, M
   Roman, A
   Borzea, D
AF Popovici, A.
   Fodor, O.
   Moldovan, M.
   Roman, A.
   Borzea, D.
TI "In vitro" study of a new composite biomaterial for indirect
   restorations
SO OPTOELECTRONICS AND ADVANCED MATERIALS-RAPID COMMUNICATIONS
LA English
DT Article
DE Advanced materials; Composite resin; Inlay; Scanning electron microscopy
ID MECHANICAL-PROPERTIES; MARGINAL ADAPTATION; AGENTS; INLAY
AB The purpose of this study was to evaluate the ability of a new Romanian composite biomaterial to be used for indirect restorations ( inlays). In this purpose, 40 standardized class II cavities were prepared on freshly extracted, sound third molars and restored with composite inlays using the Romanian composite Barodent as well as a well known trademark composite. The restored teeth were sectioned mesio-distally and then analysed. The structure of the inlays and the adhesion to the dental tissues were investigated by using scanning electron microscopy and X-ray dispersive energy analysis. The SEM micrographs showed a rather homogeneous structure of the Romanian composite, as well as its quality of adhesion to the dental hard tissues.
C1 [Popovici, A.; Roman, A.; Borzea, D.] Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca, Romania.
   [Fodor, O.] Univ Oradea, Fac Med & Pharm, Oradea, Romania.
   [Moldovan, M.] Univ Babes Bolyai, Raluca Ripan Inst Res Chem, R-3400 Cluj Napoca, Romania.
RP Popovici, A (reprint author), Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca, Romania.
EM andrapopovici@yahoo.com
RI Moldovan, Marioara/N-6387-2017; Soanca, Andrada/O-5008-2014
OI Roman, Alexandra/0000-0002-0649-9426
CR BOWEN RL, 1992, J AM DENT ASSOC, V123, P33
   BRYANT RW, 2002, PRESERVATION RESTAUR
   COLCERIU A, 2007, ADV MAT RAPID COMM, V1, P231
   Craig RG, 2002, RESTORATIVE DENT MAT
   de Andrade OS, 2007, DENT MATER, V23, P279, DOI 10.1016/j.dental.2006.01.028
   DOUGLAS AT, 2001, PRACT P AESTHET DENT, V13, P51
   FERRARI M, 2001, QUINTESSENCE PUBL, V1, P95
   Gerdolle DA, 2005, J PROSTHET DENT, V93, P563, DOI 10.1016/j.prosdent.2005.04.004
   Irie M, 2001, DENT MATER, V17, P347, DOI 10.1016/S0109-5641(00)00093-2
   KOUBI S, 2006, INFORM DENT, V5, P194
   Miara P, 1998, Pract Periodontics Aesthet Dent, V10, P423
   Moldovan M, 2007, J OPTOELECTRON ADV M, V9, P3415
   Popovici A., 2005, ENG BIOMATERIALS, V47-53, P15
   RASKIN A, 2005, REALITES CLIN, V16, P297
   RASKIN H, 2005, REALITES CLIN, V16, P313
   Rosin Michael, 2003, Clin Oral Investig, V7, P20
   Soares CJ, 2003, OPER DENT, V28, P689
   TASSERY H, 1998, INFORM DENT, V6, P365
   WEISROCK G, 2003, FACULTE ODONTOLOGIE, P25
NR 19
TC 5
Z9 5
U1 0
U2 6
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1842-6573
J9 OPTOELECTRON ADV MAT
JI Optoelectron. Adv. Mater.-Rapid Commun.
PD DEC
PY 2008
VL 2
IS 12
BP 891
EP 894
PG 4
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA 389KG
UT WOS:000262090700033
DA 2018-10-20
ER

PT J
AU Kim, IY
   Chung, JH
   Choi, YJ
   Cho, CS
AF Kim, In-yong
   Chung, Jong-hoon
   Choi, Yun-jaie
   Cho, Chong-su
TI Protein and Gene Delivery in Tissue Engineering
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE Tissue engineering; protein delivery; gene delivery; scaffold;
   biomaterial
ID PLASMA GLOW-DISCHARGE; DNA DELIVERY; CONTROLLED-RELEASE; DRUG-DELIVERY;
   GROWTH-FACTOR; IMMOBILIZED POLYURETHANES; COLLAGEN HYDROGELS; IN-VIVO;
   SCAFFOLDS; POLYMER
AB In regenerative medicine, growing demand for tissues and organs has led to the rapid development of tissue engineering as an alternative. To improve functional scaffold, many biomaterials serve dual purposes; in addition to providing cell support, cutting-edge scaffolds biologically interact with adhering and invading cells and effectively guide cellular growth and development by releasing bioactive proteins and genes. For achieving the ambitious goal of tissue regeneration and replacement, it is more important to understand the basic principles of protein and gene delivery as well as design of the system required by using proper biomaterials. This review covered the requirement in the materials choice, the strategies, the main techniques for producing proteins and genes releasing scaffolds.
C1 [Kim, In-yong; Choi, Yun-jaie; Cho, Chong-su] Seoul Natl Univ, Dept Agr Biotech, Seoul 151921, South Korea.
   [Kim, In-yong] Univ Illinois, Dept Mat Sci Eng, Urbana, IL 61801 USA.
   [Chung, Jong-hoon] Seoul Natl Univ, Dept Biosyst & Biomat Eng, Seoul 151921, South Korea.
RP Kim, IY (reprint author), Seoul Natl Univ, Dept Agr Biotech, Seoul 151921, South Korea.
EM chocs@plaza.snu.ac.kr
RI Choi, Yunjaie/B-4697-2014
FU National Research Laboratory of Korean Science and Engineering
   Foundation [ROA-2008-000-20024-0]
FX This work was supported from National Research Laboratory of Korean
   Science and Engineering Foundation(ROA-2008-000-20024-0).
CR Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   BIRAN R, 2000, J BIOMED MATER RES, V55, P1
   Bleiziffer O, 2007, J CELL MOL MED, V11, P206, DOI 10.1111/j.1582-4934.2007.00027.x
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cadee JA, 2002, J CONTROL RELEASE, V78, P1, DOI 10.1016/S0168-3659(01)00483-7
   Chen CS, 2000, METH MOL B, V139, P209
   Chun KW, 2005, BIOMATERIALS, V26, P3319, DOI 10.1016/j.biomaterials.2004.07.055
   CHUNG E, 2006, TISSUE ENG REGEN MED, V3, P39
   Cohen-Sacks H, 2004, J CONTROL RELEASE, V95, P309, DOI 10.1016/j.jconrel.2003.11.001
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   DRUMHELLER PD, 1995, BIOMEDICAL ENG HDB, P1583
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   GLASS J, 1994, ANN NY ACAD SCI, V745, P177
   Hacker M, 2003, BIOMATERIALS, V24, P4459, DOI 10.1016/S0142-9612(03)00346-6
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   Huang YC, 2003, J BIOMED MATER RES A, V67A, P1384, DOI 10.1002/jbm.a.20036
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   JANG JW, 2005, TISSUE ENG REGEN MED, V2, P34
   Jewell CM, 2006, BIOMACROMOLECULES, V7, P2483, DOI 10.1021/bm0604808
   Ji J, 2004, BIOMATERIALS, V25, P1859, DOI 10.1016/j.biometerials.2003.08.031
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   Kasper FK, 2005, J CONTROL RELEASE, V104, P521, DOI 10.1016/j.jconrel.2005.03.008
   KHANG G, 2004, TISSUE ENG REGEN MED, V1, P9
   Khang Gilson, 2006, [Tissue Engineering and Regenerative Medicine, 조직공학과 재생의학], V3, P376
   Kim EJ, 1998, BIOMATERIALS, V19, P239, DOI 10.1016/S0142-9612(98)00203-8
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   KIM SK, 2005, TISSUE ENG REGEN MED, V2, P130
   Kim SH, 2008, TISSUE ENG REGEN MED, V5, P351
   Kuhl PR, 1997, NAT MED, V3, P93, DOI 10.1038/nm0197-93
   Laham RJ, 1999, CIRCULATION, V100, P1865, DOI 10.1161/01.CIR.100.18.1865
   Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   LEE JE, 2005, TISSUE ENG REGEN MED, V2, P41
   Leonard M, 2004, J CONTROL RELEASE, V98, P395, DOI 10.1016/j.jconrel.2004.05.009
   Liang DH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gnil171
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Mikulec LJ, 1996, J BIOMED MATER RES, V32, P203, DOI 10.1002/(SICI)1097-4636(199610)32:2<203::AID-JBM8>3.0.CO;2-X
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   Nie Y, 2006, DRUG DELIV, V13, P441, DOI 10.1080/10717540600640302
   Nobs L, 2003, INT J PHARM, V250, P327, DOI 10.1016/S0378-5173(02)00542-2
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pannier AK, 2008, ACTA BIOMATER, V4, P26, DOI 10.1016/j.actbio.2007.08.008
   PARK IK, 2004, TISSUE ENG REGEN MED, V1, P164
   Park JS, 2007, TISSUE ENG REGEN MED, V4, P347
   Quick DJ, 2003, PHARM RES, V20, P1730, DOI 10.1023/B:PHAM.0000003368.66471.6a
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Roy K, 2003, MOL THER, V7, P401, DOI 10.1016/1525-0016(03)00008-X
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Schek RM, 2004, MOL THER, V9, P130, DOI 10.1016/j.ymthe.2003.10.002
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Seo SJ, 2006, BIOMATERIALS, V27, P1487, DOI 10.1016/j.biomaterials.2005.09.018
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Sohier J, 2006, J CONTROL RELEASE, V111, P95, DOI 10.1016/j.conrel.2005.11.016
   Sohier J, 2003, J CONTROL RELEASE, V87, P57, DOI 10.1016/S0168-3659(02)00350-4
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Whang K, 2000, BIOMATERIALS, V21, P2545, DOI 10.1016/S0142-9612(00)00122-8
   Wieland JA, 2007, J CONTROL RELEASE, V120, P233, DOI 10.1016/j.jconrel.2007.04.015
   Wozney JM, 2004, CURR OPIN BIOTECH, V15, P392, DOI 10.1016/j.copbio.2004.08.001
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zheng J, 2000, BIOTECHNOL PROGR, V16, P254, DOI 10.1021/bp990150h
NR 80
TC 10
Z9 10
U1 2
U2 9
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JEONJU
PA CHONBUK NATIONAL UNIV, DEPT POLYMER-NANO SCIENCE & TECH, 664-14,
   DUCKJIN, JEONJU, 561-756, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD DEC
PY 2008
VL 5
IS 4-6
BP 671
EP 677
PG 7
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 379EY
UT WOS:000261380700019
DA 2018-10-20
ER

PT J
AU Jin, Z
   Gong, YQ
   Qin, XC
   Zhang, J
   Zhu, YC
   Lin, GT
   Lue, TF
   Xin, ZC
AF Jin, Zhe
   Gong, Yan-Qing
   Qin, Xin-Cheng
   Zhang, Jian
   Zhu, Yi-Chen
   Lin, Gui-ting
   Lue, Tom F.
   Xin, Zhong-Cheng
TI Biodegradable Poly(lactic-co-glycolic acid) Maxpol-T/S as Novel Scaffold
   for Adipose Derived Stem Cells and Fibroblast Growth In Vitro
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE Adipose-derived stem cells; fibroblasts; GFP; PLGA mesh; cell adhesion;
   tissue engineering
ID VENOUS PATCH GRAFT; PEYRONIES-DISEASE; DIFFERENTIATION; REGENERATION
AB To explore the ability of MaxPol-T/S, a novelbiodegradable poly-lactic-co-glycolic acid(PLGA) scaffold, in providing a cell-matrix interaction interface for cell growth, we generated GFP positive adipose derived stem cell(ADSC(GFP+)) and fibroblasts(FCGFP+) for investigating the cellular growth on this biomaterial. The MaxPol-T/S was produced through salt-leaching/particulate-leaching technology for tissue engineering, which provides a modified surface for the best cellular attachment sites and nutrient supply and waste exchange conditions. The morphological features of MaxPol-T/S were studied with a scanning electron microscope and the ADSC(GFP+) and FCGFP+ were confirmed by auto-fluorescence microscopy and flow cytometry assay. Being seeded onto the MaxPol-T/S in vitro, the growth and morphology of ADSC(GFP+) and FCGFP+ were further verified by auto-fluorescence microscopy and MMT test. The ADSCs and fibroblasts, expressed strong GFP signals in the cytoplasm and nucleus, adhered and proliferated on the surface of scaffold MaxPol-T/S. Both cell lines survived on the scaffold more than 21 days in vitro and formed three-dimensional colonies on the surface of the MaxPol-T. In conclusion, MaxPol-T/S is a novel PLGA scaffold for ADSC(GFP+) and FCGFP+ and implies a promising technique for tissue engineering.
C1 [Jin, Zhe; Gong, Yan-Qing; Qin, Xin-Cheng; Zhang, Jian; Xin, Zhong-Cheng] Peking Univ, Androl Ctr, Hosp 1, Beijing 100034, Peoples R China.
   [Lin, Gui-ting; Lue, Tom F.] Univ Calif San Francisco, Dept Urol, Sch Med, San Francisco, CA 94143 USA.
RP Jin, Z (reprint author), Peking Univ, Androl Ctr, Hosp 1, Beijing 100034, Peoples R China.
EM xinzc@bjmu.edu.cn
CR Bhatnagar RS, 2004, P ANN INT IEEE EMBS, V26, P5021
   BROCK G, 1993, J UROLOGY, V150, P1306, DOI 10.1016/S0022-5347(17)35766-X
   Choi YS, 2006, BIOCHEM BIOPH RES CO, V345, P631, DOI 10.1016/j.bbrc.2006.04.128
   El-Sakka AI, 1998, J UROLOGY, V160, P2050, DOI 10.1016/S0022-5347(01)62240-7
   FOURNIER GR, 1993, J UROLOGY, V149, P1321, DOI 10.1016/S0022-5347(17)36382-6
   Hirsch A, 2005, J PERIODONTOL, V76, P1323, DOI 10.1902/jop.2005.76.8.1323
   Kim M, 2006, BIOCHEM BIOPH RES CO, V348, P386, DOI 10.1016/j.bbrc.2006.07.063
   Lue TF, 1998, J UROLOGY, V160, P2047, DOI 10.1016/S0022-5347(01)62239-0
   Ning HX, 2006, DIFFERENTIATION, V74, P510, DOI 10.1111/j.1432-0436.2006.00081.x
   Rahmani M E, 2006, J Contemp Dent Pract, V7, P63
   Shen Francis H, 2006, Spine J, V6, P615, DOI 10.1016/j.spinee.2006.03.006
   Strem BM, 2005, TRENDS BIOTECHNOL, V23, P64, DOI 10.1016/j.tibtech.2004.12.003
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
   Zigdon H, 2006, Refuat Hapeh Vehashinayim (1993), V24, P19
NR 15
TC 1
Z9 1
U1 0
U2 4
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD DEC
PY 2008
VL 5
IS 4-6
BP 869
EP 876
PG 8
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 379EY
UT WOS:000261380700045
DA 2018-10-20
ER

PT J
AU Chou, AI
   Reza, AT
   Nicoll, SB
AF Chou, Alice I.
   Reza, Anna T.
   Nicoll, Steven B.
TI Distinct Intervertebral Disc Cell Populations Adopt Similar Phenotypes
   in Three-Dimensional Culture
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; LONG-TERM CULTURE; HYDROSTATIC-PRESSURE;
   ANULUS FIBROSUS; IN-VITRO; EXTRACELLULAR-MATRIX; NUCLEUS PULPOSUS;
   CHONDROCYTES; EXPRESSION; CARTILAGE
AB Tissue engineering strategies have the potential to improve upon current techniques for intervertebral disc repair. However, determining a suitable biomaterial scaffold for disc regeneration is difficult due to the complex fibrocartilaginous structure of the tissue. In this study, cells isolated from three distinct regions of the intervertebral disc, the outer and inner annulus fibrosus and nucleus pulposus, were expanded and seeded on resorbable polyester fiber meshes and encapsulated in calcium crosslinked alginate hydrogels, both chosen to approximate the native tissue architecture. Three-dimensional (3D) constructs were cultured for 14 days in vitro and evaluated histologically and quantitatively for gene expression and production of types I and II collagen and proteoglycans. During monolayer expansion, the cell populations maintained their distinct phenotypic morphology and gene expression profiles. However, after 14 days in 3D culture, there were no significant differences in morphology, gene expression, or protein production between all three cell populations grown in either alginate or polyester fiber meshes. The results of this study indicate that the culture environment may have a greater impact on cellular behavior than the intrinsic origin of the cells, and suggest that only a single-cell type may be required for intervertebral disc regenerative therapies.
C1 [Chou, Alice I.; Reza, Anna T.; Nicoll, Steven B.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Nicoll, Steven B.] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.
RP Nicoll, SB (reprint author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.
EM nicoll@seas.upenn.edu
FU NIH [EB002425]; National Science Foundation
FX This work was supported by NIH grant EB002425 and a National Science
   Foundation graduate fellowship (A R.). The II-II6B3 antibody developed
   by TF Linsenmayer was obtained from the Developmental Studies Hybridoma
   Bank developed under the auspices of the NICHD and maintained by the
   University of Iowa, Department of Biological Sciences, Iowa City, IA
   52242.
CR Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   An H, 2003, SPINE, V28, pS24, DOI 10.1097/00007632-200308011-00005
   Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884
   Aoki M, 2004, J BIOMED MATER RES B, V71B, P252, DOI 10.1002/jbm.b.30084
   BAYLISS MT, 1988, SPINE, V13, P972, DOI 10.1097/00007632-198809000-00003
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Cao DJ, 2006, TISSUE ENG, V12, P1369, DOI 10.1089/ten.2006.12.1369
   CAO Y, 1994, TRANSPLANT P, V26, P3390
   Caruso AB, 2005, J BIOMED MATER RES A, V73A, P388, DOI 10.1002/jbm.a.30233
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   Chou AI, 2006, SPINE, V31, P1875, DOI 10.1097/01.brs.0000229222.98051.9a
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1
   Gruber HE, 1997, MATRIX BIOL, V16, P285, DOI 10.1016/S0945-053X(97)90016-0
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X
   Guilak F, 1999, SPINE, V24, P2475, DOI 10.1097/00007632-199912010-00009
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Horner HA, 2002, SPINE, V27, P1018, DOI 10.1097/00007632-200205150-00004
   Huang Russel C, 2006, Spine J, V6, P242, DOI 10.1016/j.spinee.2005.04.013
   Hutton WC, 1999, SPINE, V24, P1507, DOI 10.1097/00007632-199908010-00002
   Hutton WC, 2001, CLIN BIOMECH, V16, P728, DOI 10.1016/S0268-0033(01)00080-8
   Kasra M, 2003, J ORTHOPAED RES, V21, P597, DOI 10.1016/S0736-0266(03)00027-5
   Kim DJ, 2003, SPINE, V28, P2679, DOI 10.1097/01.BRS.0000101445.46487.16
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F
   MALDONADO BA, 1992, J ORTHOP RES, V10, P677, DOI 10.1002/jor.1100100510
   MARCHAND F, 1990, SPINE, V15, P402, DOI 10.1097/00007632-199005000-00011
   Melrose J, 2003, EUR SPINE J, V12, P57, DOI 10.1007/s00586-002-0434-6
   Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042
   Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27
   NEIDLINGERWILKE C, 2006, EUR SPINE J S15, V15, P372
   OEGEMA TR, 1993, CLIN SPORT MED, V12, P419
   Rannou F, 2000, J LAB CLIN MED, V136, P412, DOI 10.1067/mlc.2000.109755
   Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6
   Seidel JO, 2004, BIORHEOLOGY, V41, P445
   Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177
   Tsai TT, 2007, SPINE, V32, P495, DOI 10.1097/01.brs.0000257341.88880.f1
   URBAN JPG, 1993, MUSCULOSKELETAL SOFT-TISSUE AGING: IMPACT ON MOBILITY, P391
   VACANTI CA, 1994, CLIN PLAST SURG, V21, P445
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wang JY, 2001, SPINE, V26, P1747, DOI 10.1097/00007632-200108150-00003
   Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4
   Yoon ST, 2003, SPINE, V28, P1773, DOI 10.1097/01.BRS.0000083204.44190.34
NR 47
TC 35
Z9 40
U1 3
U2 6
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC
PY 2008
VL 14
IS 12
BP 2079
EP 2087
DI 10.1089/ten.tea.2007.0337
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 379NN
UT WOS:000261403500015
PM 18636941
OA Green Published
DA 2018-10-20
ER

PT J
AU Georgakoudi, I
   Rice, WL
   Hronik-Tupaj, M
   Kaplan, DL
AF Georgakoudi, Irene
   Rice, William L.
   Hronik-Tupaj, Marie
   Kaplan, David L.
TI Optical Spectroscopy and Imaging for the Noninvasive Evaluation of
   Engineered Tissues
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID LIGHT-SCATTERING SPECTROSCOPY; MESENCHYMAL STEM-CELLS; ADHESION CONTACT
   DYNAMICS; MODE CONFOCAL MICROSCOPY; COHERENCE TOMOGRAPHY; IN-VITRO;
   MULTIPHOTON MICROSCOPY; 2ND-HARMONIC GENERATION; 2-PHOTON EXCITATION;
   OSTEOGENIC DIFFERENTIATION
AB Optical spectroscopy and imaging approaches offer the potential to noninvasively assess different aspects of the cellular, extracellular matrix, and scaffold components of engineered tissues. In addition, the combination of multiple imaging modalities within a single instrument is highly feasible, allowing acquisition of complementary information related to the structure, organization, biochemistry, and physiology of the sample. The ability to characterize and monitor the dynamic interactions that take place as engineered tissues develop promises to enhance our understanding of the interdependence of processes that ultimately leads to functional tissue outcomes. It is expected that this information will impact significantly upon our abilities to optimize the design of biomaterial scaffolds, bioreactors, and cell systems. Here, we review the principles and performance characteristics of the main methodologies that have been exploited thus far, and we present examples of corresponding tissue engineering studies.
C1 [Georgakoudi, Irene; Rice, William L.; Hronik-Tupaj, Marie; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Georgakoudi, I (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM Irene.Georgakoudi@tufts.edu
FU NSF [BES 0547292]; NIH [P41 EB002520]
FX Funding for the development of optical spectroscopic imaging approaches
   for tissue engineering applications has been provided in our
   laboratories by NSF (BES 0547292) and NIH (P41 EB002520 Tissue
   Engineering Resource Center).
CR Allen J, 2007, BIOMATERIALS, V28, P162, DOI 10.1016/j.biomaterials.2006.07.002
   Arifler D, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2398932
   Ashjian P, 2004, TISSUE ENG, V10, P411, DOI 10.1089/107632704323061771
   Azrad E, 2006, J RAMAN SPECTROSC, V37, P480, DOI 10.1002/jrs.1420
   Backman V, 2001, IEEE J SEL TOP QUANT, V7, P887, DOI 10.1109/2944.983289
   Bagnaninchi PO, 2007, TISSUE ENG, V13, P323, DOI 10.1089/ten.2006.0168
   Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chen F, 2007, MAT SCI ENG C-BIO S, V27, P325, DOI 10.1016/j.msec.2006.05.004
   CHENG PC, 2005, HDB BIOL CONFOCAL MI, P703
   CHRIS X, 1996, BIOIMAGING, V4, P198
   COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x
   de Boer JF, 2003, OPT LETT, V28, P2067, DOI 10.1364/OL.28.002067
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Dennis T, 2007, PROC SPIE, V6446, DOI 10.1117/12.699244
   Drezek RA, 2003, CANCER, V98, P2015, DOI 10.1002/cncr.11678
   Du M, 2003, J BIOL CHEM, V278, P6002, DOI 10.1074/jbc.M209606200
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Dumas D, 2004, BIORHEOLOGY, V41, P459
   Fang H, 2003, IEEE J SEL TOP QUANT, V9, P267, DOI 10.1109/JSTQE.2003.812515
   Fang N, 2005, MACROMOL BIOSCI, V5, P1022, DOI 10.1002/mabi.200500123
   Fawzi-Grancher S, 2006, ANN BIOMED ENG, V34, P1767, DOI 10.1007/s10439-006-9180-y
   Feng QL, 2005, MATER SCI FORUM, V475-479, P2391, DOI 10.4028/www.scientific.net/MSF.475-479.2391
   Georgakoudi I, 2002, AM J OBSTET GYNECOL, V186, P374, DOI 10.1067/mob.2002.121075
   Georgakoudi I, 2001, GASTROENTEROLOGY, V120, P1620, DOI 10.1053/gast.2001.24842
   Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gonzalez S., 2008, International Journal of Cosmetic Science, V30, P1, DOI 10.1111/j.1468-2494.2008.00406.x
   Gupta S, 2008, BIOMATERIALS, V29, P2359, DOI 10.1016/j.biomaterials.2008.01.034
   Holzer W, 2005, CHEM PHYS, V308, P69, DOI 10.1016/j.chemphys.2004.08.006
   Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X
   Huzaira M, 2001, J INVEST DERMATOL, V116, P846, DOI 10.1046/j.0022-202x.2001.01337.x
   INOUE S, 2005, HDB BIOL CONFOCAL MI, P1
   Jacques SL, 1998, PHOTOCHEM PHOTOBIOL, V67, P23
   Kierdaszuk B, 1996, BIOPHYS CHEM, V62, P1, DOI 10.1016/S0301-4622(96)02182-5
   Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009
   Kim YL, 2003, IEEE J SEL TOP QUANT, V9, P243, DOI 10.1109/JSTQE.2003.814183
   Ko HJ, 2006, TISSUE ENG, V12, P63, DOI 10.1089/ten.2006.12.63
   Konig K, 2005, BIOMATERIALS, V26, P495, DOI 10.1016/j.biomaterials.2004.02.059
   Kostyuk O, 2004, BIOPHYS J, V87, P648, DOI 10.1529/biophysj.103.038976
   Kostyuk O, 2004, J PHYSIOL-LONDON, V554, P791, DOI 10.1113/physiol.2004.054809
   LAKOWICZ JR, 1995, BIOPHYS CHEM, V56, P263, DOI 10.1016/0301-4622(95)00040-5
   Landis FA, 2006, BIOMACROMOLECULES, V7, P1751, DOI 10.1021/bm0600466
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780
   Lee HS, 2006, TISSUE ENG, V12, P2835, DOI 10.1089/ten.2006.12.2835
   Leong DT, 2006, CELLS TISSUES ORGANS, V182, P1, DOI 10.1159/000091713
   Lu CW, 2008, OPT LETT, V33, P416, DOI 10.1364/OL.33.000416
   Luong LN, 2006, BIOMATERIALS, V27, P1175, DOI 10.1016/j.biomaterials.2005.07.043
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Martina M, 2005, BIOMATERIALS, V26, P5609, DOI 10.1016/j.biomaterials.2005.02.011
   Mason C, 2004, PHYS MED BIOL, V49, P1097, DOI 10.1088/0031-9155/49/7/002
   Mason C, 2004, BIOSENS BIOELECTRON, V20, P414, DOI 10.1016/j.bios.2004.03.035
   Mujat C, 2008, INT J CANCER, V122, P363, DOI 10.1002/ijc.23120
   Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202
   Nadiarnykh O, 2007, OPT EXPRESS, V15, P3348, DOI 10.1364/OE.15.003348
   Navarro FA, 2004, PLAST RECONSTR SURG, V114, P121, DOI 10.1097/01.PRS.0000128374.20913.4B
   Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720
   Opitz F, 2004, CARDIOVASC RES, V63, P719, DOI 10.1016/j.cardiores.2004.05.002
   Palero JA, 2007, BIOPHYS J, V93, P992, DOI 10.1529/biophysj.106.099457
   Pancrazio JJ, 2007, BIOSENS BIOELECTRON, V22, P2803, DOI 10.1016/j.bios.2006.12.023
   Patterson GH, 2000, BIOPHYS J, V78, P2159, DOI 10.1016/S0006-3495(00)76762-2
   Peretti GM, 2006, CONNECT TISSUE RES, V47, P190, DOI 10.1080/03008200600809935
   Petroll WM, 2006, SCANNING, V28, P305
   Pierce MC, 2004, J INVEST DERMATOL, V123, P458, DOI 10.1111/j.0022-202X.2004.23404.x
   Rice WL, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2823019
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   Schenke-Layland K, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1896966
   Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004
   SCOTT TG, 1970, J AM CHEM SOC, V92, P687, DOI 10.1021/ja00706a043
   Skala MC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717503
   Smith IO, 2006, J BIOMED MATER RES B, V79B, P185, DOI 10.1002/jbm.b.30529
   Spoler F, 2006, SKIN RES TECHNOL, V12, P261, DOI 10.1111/j.0909-752X.2006.00163.x
   Squirrell JM, 2003, MICROSC MICROANAL, V9, P190, DOI 10.1017/S1431927603030174
   Sun S, 2006, BIOELECTROCHEMISTRY, V69, P133, DOI 10.1016/j.bioelechem.2005.11.007
   SZUTS EZ, 1991, ARCH BIOCHEM BIOPHYS, V287, P297, DOI 10.1016/0003-9861(91)90482-X
   Tamariz E, 2002, MOL BIOL CELL, V13, P3915, DOI 10.1091/mbc.E02-05-0291
   Tan W, 2004, TISSUE ENG, V10, P1747, DOI 10.1089/ten.2004.10.1747
   Tan W, 2006, OPT EXPRESS, V14, P7159, DOI 10.1364/OE.14.007159
   Tan WJ, 2005, BIOMATERIALS, V26, P891, DOI 10.1016/j.biomaterials.2004.03.041
   Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   Wang AMJ, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1989335
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wenger A, 2004, TISSUE ENG, V10, P1536, DOI 10.1089/1076327042500283
   Wu J, 2003, MICROSC MICROANAL, V9, P574, DOI [10.1017/S1431927603030277, 10.1017/S14319276030302777]
   Xu CY, 2006, OPT LETT, V31, P1079, DOI 10.1364/OL.31.001079
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
   Xu XQ, 2003, EUR BIOPHYS J BIOPHY, V32, P355, DOI 10.1007/s00249-003-0285-z
   Yang Y, 2006, PHYS MED BIOL, V51, P1649, DOI 10.1088/0031-9155/51/7/001
   Yeh AT, 2004, J BIOMED OPT, V9, P248, DOI 10.1117/1-16486461
   Zhao YS, 2005, J HEART LUNG TRANSPL, V24, P1091, DOI 10.1016/j.healun.2004.07.010
   Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100
   Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799
   Zoumi A, 2004, BIOPHYS J, V87, P2778, DOI 10.1529/biophysj.104.042887
NR 97
TC 60
Z9 60
U1 0
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD DEC
PY 2008
VL 14
IS 4
BP 321
EP 340
DI 10.1089/ten.teb.2008.0248
PG 20
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 382TI
UT WOS:000261627900001
PM 18844604
OA Green Published
DA 2018-10-20
ER

PT J
AU Singh, M
   Berkland, C
   Detamore, MS
AF Singh, Milind
   Berkland, Cory
   Detamore, Michael S.
TI Strategies and Applications for Incorporating Physical and Chemical
   Signal Gradients in Tissue Engineering
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID NERVE GROWTH-FACTOR; IMMOBILIZED CONCENTRATION GRADIENTS;
   HIGH-THROUGHPUT CHARACTERIZATION; COMBINATORIAL MATERIALS SCIENCE;
   FUNCTIONALLY GRADED MATERIAL; FREQUENCY PLASMA DISCHARGE; GUIDED NEURITE
   OUTGROWTH; PORE-SIZE GRADIENT; WETTABILITY GRADIENT; PLATELET-ADHESION
AB From embryonic development to wound repair, concentration gradients of bioactive signaling molecules guide tissue formation and regeneration. Moreover, gradients in cellular and extracellular architecture as well as in mechanical properties are readily apparent in native tissues. Perhaps tissue engineers can take a cue from nature in attempting to regenerate tissues by incorporating gradients into engineering design strategies. Indeed, gradient-based approaches are an emerging trend in tissue engineering, standing in contrast to traditional approaches of homogeneous delivery of cells and/or growth factors using isotropic scaffolds. Gradients in tissue engineering lie at the intersection of three major paradigms in the field-biomimetic, interfacial, and functional tissue engineering-by combining physical (via biomaterial design) and chemical (with growth/differentiation factors and cell adhesion molecules) signal delivery to achieve a continuous transition in both structure and function. This review consolidates several key methodologies to generate gradients, some of which have never been employed in a tissue engineering application, and discusses strategies for incorporating these methods into tissue engineering and implant design. A key finding of this review was that two-dimensional physicochemical gradient substrates, which serve as excellent high-throughput screening tools for optimizing desired biomaterial properties, can be enhanced in the future by transitioning from two dimensions to three dimensions, which would enable studies of cell-protein-biomaterial interactions in a more native tissue-like environment. In addition, biomimetic tissue regeneration via combined delivery of graded physical and chemical signals appears to be a promising strategy for the regeneration of heterogeneous tissues and tissue interfaces. In the future, in vivo applications will shed more light on the performance of gradient-based mechanical integrity and signal delivery strategies compared to traditional tissue engineering approaches.
C1 [Singh, Milind; Berkland, Cory; Detamore, Michael S.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA.
   [Berkland, Cory] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA.
RP Detamore, MS (reprint author), Univ Kansas, Dept Chem & Petr Engn, 1530 W 15th St,Learned Hall,Room 4132, Lawrence, KS 66045 USA.
EM detamore@ku.edu
FU NIH/NIDCR [1 R21 DE017673-01A1]; Juvenile Diabetes Research Foundation;
   University of Kansas General Research Fund
FX The present work was supported by NIH/NIDCR grant 1 R21 DE017673-01A1,
   the Juvenile Diabetes Research Foundation and the University of Kansas
   General Research Fund.
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Alberts B, 2002, MOL BIOL CELL
   Alexander MR, 2004, J MATER CHEM, V14, P408, DOI 10.1039/b311256j
   Beauregard G P, 1999, Biomed Sci Instrum, V35, P415
   Bhat RR, 2005, J POLYM SCI POL PHYS, V43, P3384, DOI 10.1002/polb.20640
   Bhat RR, 2004, MACROMOL RAPID COMM, V25, P270, DOI 10.1002/marc.200300163
   Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Boughton P, 2001, CERAM ENG SCI PROC, V22, P593
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Caelen I, 2000, LANGMUIR, V16, P9125, DOI 10.1021/la000851k
   Cao X, 2003, NEUROSCIENCE, V122, P381, DOI 10.1016/j.neuroscience.2003.08.018
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539
   Chen CC, 2006, J BIOMED MATER RES B, V78B, P146, DOI 10.1002/jbm.b.30465
   Chen GP, 2001, BIOMATERIALS, V22, P2453, DOI 10.1016/S0142-9612(00)00432-4
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Choee JH, 2004, J APPL POLYM SCI, V92, P599, DOI 10.1002/app.20048
   Clark R. A. F., 1996, WOUND REPAIR OVERVIE
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Eichmann A, 2005, CURR OPIN NEUROBIOL, V15, P108, DOI 10.1016/j.conb.2005.01.008
   Eidelman N, 2004, J RES NATL INST STAN, V109, P219, DOI 10.6028/jres.109.014
   ELWING H, 1987, J BIOMED MATER RES, V21, P1023, DOI 10.1002/jbm.820210808
   ELWING H, 1987, J COLLOID INTERF SCI, V119, P203, DOI 10.1016/0021-9797(87)90260-8
   ELWING H, 1987, PROG COLLOID POLYM S, V74, P103
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Eufinger H, 2007, BIOMATERIALS, V28, P475, DOI 10.1016/j.biomaterials.2006.08.055
   FISHER PR, 1989, J CELL BIOL, V108, P973, DOI 10.1083/jcb.108.3.973
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   FOCUS W, 2003, EMBO J, V22, P2318
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Gerstenfeld LC, 2002, J BONE MINER RES, V17, P221, DOI 10.1359/jbmr.2002.17.2.221
   GOLANDER CG, 1990, BIOMATERIALS, V11, P32, DOI 10.1016/0142-9612(90)90048-U
   GOLANDER CG, 1989, COLLOID SURFACE, V42, P165, DOI 10.1016/0166-6622(89)80084-8
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   GRUNER H, 1987, CHEM ABSTR, V106
   Gunawan RC, 2006, LANGMUIR, V22, P4250, DOI 10.1021/la0531493
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500
   Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654
   Halfter W, 1996, J NEUROSCI, V16, P4389
   Harley BA, 2006, BIOMATERIALS, V27, P866, DOI 10.1016/j.biomaterials.2005.07.012
   Harris BP, 2006, LANGMUIR, V22, P4467, DOI 10.1021/la053417x
   Harris BP, 2006, MACROMOLECULES, V39, P2764, DOI 10.1021/ma0512051
   Hedia HS, 2004, BIO-MED MATER ENG, V14, P133
   Herbert CB, 1997, CHEM BIOL, V4, P731, DOI 10.1016/S1074-5521(97)90311-2
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HLADY V, 1991, APPL SPECTROSC, V45, P246, DOI 10.1366/0003702914337533
   Horb ME, 2000, BIOESSAYS, V22, P599
   Hsu YH, 2007, J MATER SCI-MATER M, V18, P2251, DOI 10.1007/s10856-007-3126-2
   Hypolite CL, 1997, BIOCONJUGATE CHEM, V8, P658, DOI 10.1021/bc9701252
   Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018
   Ingber DE, 2006, TISSUE ENG, V12, P3265, DOI 10.1089/ten.2006.12.3265
   Iqbal P, 2007, J MATER CHEM, V17, P5097, DOI 10.1039/b712687e
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Jacot JG, 2006, J BIOMED MATER RES A, V79A, P485, DOI 10.1002/jbm.a.30812
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   Jandeleit B, 1999, ANGEW CHEM INT EDIT, V38, P2495
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Jeong BJ, 1996, J COLLOID INTERF SCI, V178, P757, DOI 10.1006/jcis.1996.0174
   Julthongpiput D, 2005, NANO LETT, V5, P1535, DOI 10.1021/nl050612n
   Kang CE, 2004, J BIOMED MATER RES A, V71A, P403, DOI 10.1002/jbm.a.30137
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Khang G, 1999, BIO-MED MATER ENG, V9, P179
   Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015
   Kieback B, 2003, MAT SCI ENG A-STRUCT, V362, P81, DOI 10.1016/S0921-5093(03)00578-1
   Kim HM, 2000, J MATER SCI-MATER M, V11, P555, DOI 10.1023/A:1008924102096
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P270, DOI 10.1002/jbm.b.30032
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364
   Kramer S, 2004, J AM CHEM SOC, V126, P5388, DOI 10.1021/ja031674n
   Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009
   Lagoa ALC, 2008, J MATER SCI-MATER M, V19, P417, DOI 10.1007/s10856-006-0022-0
   Lapizco-Encinas BH, 2007, ELECTROPHORESIS, V28, P4521, DOI 10.1002/elps.200700303
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   LEE JH, 1992, J COLLOID INTERF SCI, V151, P563, DOI 10.1016/0021-9797(92)90504-F
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   Lee JH, 1999, J BIOMAT SCI-POLYM E, V10, P283
   Lee SJ, 2003, J COLLOID INTERF SCI, V259, P228, DOI 10.1016/S0021-9797(02)00163-7
   Li B, 2005, BIOMATERIALS, V26, P4956, DOI 10.1016/j.biomaterials.2005.01.018
   Li B, 2005, BIOMATERIALS, V26, P1487, DOI 10.1016/j.biomaterials.2004.05.004
   Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340
   Lin-Gibson S, 2006, BIOMATERIALS, V27, P1711, DOI 10.1016/j.biomaterials.2005.10.040
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Malda J, 2004, BIOMATERIALS, V25, P5773, DOI 10.1016/j.biomaterials.2004.01.028
   Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z
   Mei Y, 2006, J BIOMED MATER RES A, V79A, P974, DOI 10.1002/jbm.a.30883
   Meier MAR, 2004, J MATER CHEM, V14, P3289, DOI 10.1039/b406497f
   Meier MAR, 2004, MACROMOL RAPID COMM, V25, P21, DOI 10.1002/marc.200300147
   Meredith JC, 2000, MACROMOLECULES, V33, P5760, DOI 10.1021/ma0004662
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Meredith JC, 2000, MACROMOLECULES, V33, P9747, DOI 10.1021/ma001298g
   Messersmith PB, 2008, SCIENCE, V319, P1767, DOI 10.1126/science.1155122
   MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Morgenthaler S, 2003, LANGMUIR, V19, P10459, DOI 10.1021/la0347071
   Morgenthaler S, 2006, BIOINTERPHASES, V1, P156, DOI 10.1116/1.2431704
   Moritz T, 2000, J MATER SCI, V35, P2235, DOI 10.1023/A:1004774809436
   Mortensen A, 1995, INT MATER REV, V40, P239, DOI 10.1179/imr.1995.40.6.239
   Muratoglu OK, 2002, BIOMATERIALS, V23, P717, DOI 10.1016/S0142-9612(01)00176-4
   Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008
   NELSON RD, 1975, J IMMUNOL, V115, P1650
   NIINO M, 1990, ISIJ INT, V30, P699, DOI 10.2355/isijinternational.30.699
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765
   Parry KL, 2006, SURF INTERFACE ANAL, V38, P1497, DOI 10.1002/sia.2400
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   PITT WG, 1989, J COLLOID INTERF SCI, V133, P223, DOI 10.1016/0021-9797(89)90295-6
   Plummer ST, 2002, LANGMUIR, V18, P4142, DOI 10.1021/la011742o
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Righetti PG, 2005, J CHROMATOGR A, V1079, P24, DOI 10.1016/j.chroma.2005.01.018
   Roberson S, 2003, APPL SURF SCI, V203, P855, DOI 10.1016/S0169-4332(02)00822-X
   RODBARD D, 1971, ANAL BIOCHEM, V40, P135, DOI 10.1016/0003-2697(71)90087-X
   Rosoff WJ, 2005, BIOTECHNOL BIOENG, V91, P754, DOI 10.1002/bit.20564
   Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259
   Roy TD, 2003, J BIOMED MATER RES A, V66A, P283, DOI 10.1002/jbm.a.10582
   Ruardy TG, 1997, SURF SCI REP, V29, P3, DOI 10.1016/S0167-5729(97)00008-3
   Schwarz K, 1998, MACROMOL RAPID COMM, V19, P613, DOI 10.1002/(SICI)1521-3927(19981201)19:12<613::AID-MARC613>3.3.CO;2-D
   Schwarz U, 2007, SOFT MATTER, V3, P263, DOI 10.1039/b606409d
   Shen FW, 2005, CLIN ORTHOP RELAT R, P80, DOI 10.1097/01.blo.0000149999.17123.e8
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Singh M, 2008, TISSUE ENG PART C-ME, V14, P299, DOI 10.1089/ten.tec.2008.0167
   Smith AP, 2003, MACROMOL RAPID COMM, V24, P131, DOI 10.1002/marc.200390001
   Smith AP, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015503
   Smith AP, 2001, J POLYM SCI POL PHYS, V39, P2141, DOI 10.1002/polb.1188
   Spijker HT, 2002, J ADHES SCI TECHNOL, V16, P1703, DOI 10.1163/156856102320396094
   Spijker HT, 2002, BIOMATERIALS, V23, P757, DOI 10.1016/S0142-9612(01)00181-8
   Suciati T, 2006, J MATER SCI-MATER M, V17, P1049, DOI 10.1007/s10856-006-0443-9
   Sung FJ, 2005, BIOMATERIALS, V26, P4557, DOI 10.1016/j.biomaterials.2004.11.034
   Suresh S, 2001, SCIENCE, V292, P2447, DOI 10.1126/science.1059716
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   Tomkoria S, 2004, MED ENG PHYS, V26, P815, DOI 10.1016/j.medengphy.2004.07.006
   UEDAYUKOSHI T, 1995, LANGMUIR, V11, P4135, DOI 10.1021/la00010a080
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Vaz L, 1999, J MATER SCI-MATER M, V10, P239, DOI 10.1023/A:1008910213166
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Vunjak-Novakovic G, 2006, TISSUE ENG, V12, P3261, DOI 10.1089/ten.2006.12.3261
   Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k
   Wang M, 1999, J MATER SCI-MATER M, V10, P269, DOI 10.1023/A:1008901428552
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   Weeber HA, 2007, GRAEF ARCH CLIN EXP, V245, P1357, DOI 10.1007/s00417-007-0537-1
   Werner J, 2002, BIOMATERIALS, V23, P4285, DOI 10.1016/S0142-9612(02)00191-6
   Whittle JD, 2003, CHEM COMMUN, P1766, DOI 10.1039/b305445b
   WIJESUNDARA MBJ, 1987, J COLLOID INTERF SCI, V119, P203
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   Wu T, 2003, J MATER SCI, V38, P4471, DOI 10.1023/A:1027373216389
   Xu HHK, 2007, BIOMATERIALS, V28, P3786, DOI 10.1016/j.biomaterials.2007.05.015
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yang J, 2007, J BIOMECH, V40, P2377, DOI 10.1016/j.jbiomech.2006.11.019
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zhao B, 2004, LANGMUIR, V20, P11748, DOI 10.1021/la047681m
   Zhu L, 2006, J BIOMED MATER RES A, V78A, P515, DOI 10.1002/jbm.e.30745
   ZICHA D, 1991, J CELL SCI, V99, P769
   ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 185
TC 107
Z9 108
U1 4
U2 62
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD DEC
PY 2008
VL 14
IS 4
BP 341
EP 366
DI 10.1089/ten.teb.2008.0304
PG 26
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 382TI
UT WOS:000261627900002
PM 18803499
OA Green Published, Green Accepted
DA 2018-10-20
ER

PT J
AU Zawaneh, PN
   Putnam, D
AF Zawaneh, Peter N.
   Putnam, David
TI Materials in Surgery: A Review of Biomaterials in Postsurgical Tissue
   Adhesion and Seroma Prevention
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID OXIDIZED-REGENERATED CELLULOSE; PROSPECTIVE RANDOMIZED-TRIAL; TEX
   SURGICAL MEMBRANE; UTERINE HORN MODEL; MODIFIED RADICAL-MASTECTOMY;
   BREAST-CANCER SURGERY; POSTOPERATIVE ABDOMINAL ADHESIONS; LINKED
   HYALURONIC-ACID; LATISSIMUS-DORSI FLAP; AXILLARY NODE DISSECTION
AB Postoperative tissue adhesion is a complex inflammatory disorder in which tissues that normally remain separated in the body grow into each other. Seroma is a common postoperative complication that arises when serous fluid collects in the space generated following surgeries that require extensive dissection and that create large empty spaces. Postsurgical tissue adhesion and seroma formation are two serious surgical complications that have received more attention recently from the biomaterials community. This paper provides a review of the pathogenesis and treatment of these surgical complications, with a thorough overview of biomaterial-based treatment and prevention methods.
C1 [Putnam, David] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
   [Zawaneh, Peter N.; Putnam, David] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
RP Putnam, D (reprint author), Cornell Univ, Dept Biomed Engn, 270 Olin Hall, Ithaca, NY 14853 USA.
EM dap43@cornell.edu
OI Putnam, David/0000-0002-0794-4915
FU Coulter Foundation
FX The authors would like to acknowledge the Coulter Foundation for
   funding. We would also like to acknowledge Careless and Henry 195 for
   allowing us to publish Table 3.
CR Ackroyd R, 1997, BREAST, V6, P271, DOI 10.1016/S0960-9776(97)90003-5
   Acunzo G, 2003, HUM REPROD, V18, P1918, DOI 10.1093/humrep/deg368
   Adwani A, 2006, INT J CLIN PRACT, V60, P562, DOI 10.1111/j.1368-5031.2005.00689.x
   Agrawal A, 2006, ANZ J SURG, V76, P1088, DOI 10.1111/j.1445-2197.2006.03949.x
   AITKEN DR, 1983, SURG CLIN N AM, V63, P1331
   AITKEN DR, 1984, SURG GYNECOL OBSTET, V158, P327
   Akhtar S, 2005, PLAST RECONSTR SURG, V116, P347, DOI 10.1097/01.PRS.0000173545.11707.ED
   Al-Musawi D, 2001, GYNAECOL ENDOSC, V10, P123, DOI 10.1046/j.1365-2508.2001.00422.x
   Albala DM, 2003, CARDIOVASC SURG, V11, P5, DOI 10.1016/S0967-2109(03)00065-6
   Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Almond A, 2007, CELL MOL LIFE SCI, V64, P1591, DOI 10.1007/s00018-007-7032-z
   ALVANDY LJ, 1991, AUST NZ J SURG, V9, P670
   Andrades P, 2007, AESTHET PLAST SURG, V31, P514, DOI 10.1007/s00266-007-0078-3
   ARRAJAB A, 1995, EUR J SURG, V161, P341
   ARRAJAB A, 1991, J SURG RES, V50, P212, DOI 10.1016/0022-4804(91)90180-T
   Avital S, 2005, DIS COLON RECTUM, V48, P153, DOI 10.1007/s10350-004-0748-z
   AZZIZ R, 1993, SURG GYNECOL OBSTET, V177, P135
   Bae J, 2005, ANN SURG, V241, P534, DOI 10.1097/01.sla.0000154281.79639.89
   Banerjee D, 2001, ANN ROY COLL SURG, V83, P268
   BAROUDI R, 1988, AESTHETIC SURG J, V18, P440
   Barwell J, 1997, ANN ROY COLL SURG, V79, P435
   Beck DE, 1997, EUR J SURG, V163, P49
   Beck DE, 2003, DIS COLON RECTUM, V46, P1310, DOI 10.1097/01.DCR.0000089117.62296.E4
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   Bennett SL, 2003, J CARDIAC SURG, V18, P494, DOI 10.1046/j.0886-0440.2003.00303.x
   Berger A, 2001, BREAST CANCER RES TR, V67, P9, DOI 10.1023/A:1010671209279
   BEST CL, 1991, OBSTET GYNECOL, V78, P858
   BEST CL, 1992, FERTIL STERIL, V58, P817
   Binda MM, 2006, FERTIL STERIL, V86, P166, DOI 10.1016/j.fertnstert.2005.11.079
   Boland GM, 2006, J SURG RES, V132, P3, DOI 10.1016/j.jss.2005.12.002
   Bold EL, 1996, AM J OTOLARYNG, V17, P27, DOI 10.1016/S0196-0709(96)90039-3
   Bonnema J, 1999, EUR J SURG, V165, P9, DOI 10.1080/110241599750007441
   Bonnema J, 1997, AM J SURG, V173, P76, DOI 10.1016/S0002-9610(96)00416-3
   BONNEMA J, 1994, BRIT J SURG, V81, P1693, DOI 10.1002/bjs.1800811144
   BOURKE JB, 1976, BRIT J SURG, V63, P67, DOI 10.1002/bjs.1800630115
   BOYERS SP, 1990, PROG CLIN BIOL RES, V358, P93
   BOYERS SP, 1988, FERTIL STERIL, V49, P1066
   Bristow RE, 2007, GYNECOL ONCOL, V104, P739, DOI 10.1016/j.ygyno.2006.09.029
   Brown CB, 2007, FERTIL STERIL, V88, P1413, DOI 10.1016/j.fertnstert.2006.12.084
   Browse DJ, 1996, EUR J SURG ONCOL, V22, P569, DOI 10.1016/S0748-7983(96)92164-2
   Brunelli G, 2005, J ORTHOP RES, V23, P1377, DOI 10.1016/j.orthres.2005.05.001
   BRYANT M, 1987, BRIT J SURG, V74, P1187, DOI 10.1002/bjs.1800741239
   Buckenmaier CC, 1999, AM SURGEON, V65, P274
   BUDD DC, 1978, AM J SURG, V135, P218, DOI 10.1016/0002-9610(78)90103-4
   Burak WE, 1997, J SURG ONCOL, V64, P27, DOI 10.1002/(SICI)1096-9098(199701)64:1<27::AID-JSO6>3.3.CO;2-9
   Burkhard MJ, 1996, VET CLIN PATH, V25, P114, DOI 10.1111/j.1939-165X.1996.tb00978.x
   Burns JW, 1997, EUR J SURG, V163, P40
   CANIS M, 1992, FERTIL STERIL, V58, P617
   Carcoforo P, 2003, J AM COLL SURGEONS, V196, P365, DOI 10.1016/S1072-7515(02)01757-X
   Carless PA, 2006, BRIT J SURG, V93, P810, DOI 10.1002/bjs.5432
   Cashman J, 2004, INFLAMM RES, V53, P355, DOI 10.1007/s00011-004-1272-2
   Cheong YC, 2001, HUM REPROD UPDATE, V7, P556, DOI 10.1093/humupd/7.6.556
   CHILSON TR, 1992, AM SURGEON, V58, P750
   CHMIELEWSKI GW, 1992, AM SURGEON, V58, P590
   Chung TL, 2006, BREAST J, V12, P442, DOI 10.1111/j.1075-122X.2006.00300.x
   Coveney E C, 1993, Eur J Surg Oncol, V19, P143
   DAWSON I, 1989, BRIT J SURG, V76, P311, DOI 10.1002/bjs.1800760329
   De Iaco PA, 2001, SURGERY, V130, P60, DOI 10.1067/msy.2001.115102
   De Iaco PA, 1998, FERTIL STERIL, V69, P318
   Del Rosso G, 2000, NEPHROL DIAL TRANSPL, V15, P927
   DEVIRGILIO C, 1990, ARCH SURG-CHICAGO, V125, P1378
   DIAMOND M, 1996, J GYNECOL SURG, V7, P1
   DIAMOND M, 1984, INFERTILITY, V39, P7
   DIAMOND M P, 1987, Microsurgery, V8, P197, DOI 10.1002/micr.1920080406
   DIAMOND MP, 1991, FERTIL STERIL, V55, P700
   DIAMOND MP, 1991, FERTIL STERIL, V55, P389
   Diamond MP, 1998, FERTIL STERIL, V69, P1067, DOI 10.1016/S0015-0282(98)00057-0
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   DIAMOND MP, 1988, INT J FERTIL, V33, P278
   DIAMOND MP, 1988, INT J FERTIL, V33, P372
   DIAMOND MP, 1984, FERTIL STERIL, V42, P717
   DINEEN P, 1976, SURG GYNECOL OBSTET, V142, P481
   Dinsmore RC, 2000, AM SURGEON, V66, P982
   diZerega GS, 2007, FERTIL STERIL, V87, P485, DOI 10.1016/j.fertnstert.2006.07.1505
   Dizerega GS, 2007, J BIOMED MATER RES B, V81B, P239, DOI 10.1002/jbm.b.30659
   diZerega GS, 2002, HUM REPROD, V17, P1031, DOI 10.1093/humrep/17.4.1031
   DIZEREGA GS, 1994, FERTIL STERIL, V61, P219
   DLUGI AM, 1984, SEMIN REPROD ENDOCR, V2, P125, DOI 10.1055/s-2007-1023838
   Dunn R, 2001, FERTIL STERIL, V75, P411, DOI 10.1016/S0015-0282(00)01677-0
   Elbert DL, 1998, J BIOMED MATER RES, V42, P55, DOI 10.1002/(SICI)1097-4636(199810)42:1<55::AID-JBM8>3.0.CO;2-N
   ELLIS H, 1965, BRIT J SURG, V52, P471, DOI 10.1002/bjs.1800520616
   ELLIS H, 1990, SURG GYNECOL OBSTET, V171, P521
   Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4
   Eroglu E, 1996, EUR J SURG ONCOL, V22, P137, DOI 10.1016/S0748-7983(96)90567-3
   FABRI PJ, 1983, SURGERY, V94, P336
   Fazio VW, 2006, DIS COLON RECTUM, V49, P1, DOI 10.1007/s10350-005-0268-5
   Ferland R, 2001, HUM REPROD, V16, P2718, DOI 10.1093/humrep/16.12.2718
   FILMAR S, 1989, AM J OBSTET GYNECOL, V160, P1062, DOI 10.1016/0002-9378(89)90161-0
   FILMAR S, 1989, AM J OBSTET GYNECOL, V160, P1068, DOI 10.1016/0002-9378(89)90162-2
   FLEW TJ, 1979, BRIT J SURG, V66, P302, DOI 10.1002/bjs.1800660503
   FOWLER JM, 1991, GYNECOL ONCOL, V43, P141, DOI 10.1016/0090-8258(91)90060-I
   FRANKLIN R, 1995, FERTIL STERIL, V63, P491
   Galatius H, 2003, BREAST, V12, P338, DOI 10.1016/S0960-9776(03)00110-3
   GAUWERKY JFH, 1986, BIOL RES PREG PERIN, V7, P93
   Gilly FN, 1998, EUR SURG RES, V30, P439, DOI 10.1159/000008611
   GOLDBERG JM, 1987, OBSTET GYNECOL, V70, P846
   Gomel V, 1996, J REPROD MED, V41, P35
   Gonzalez Ernest A, 2003, Breast J, V9, P385, DOI 10.1046/j.1524-4741.2003.09504.x
   Guida M, 2004, HUM REPROD, V19, P1461, DOI 10.1093/humrep/deh238
   Gupta R, 2001, EUR J SURG ONCOL, V27, P26, DOI 10.1053/ejso.2000.1054
   GURGAN T, 1991, FERTIL STERIL, V56, P1176
   HANEY AF, 1995, FERTIL STERIL, V63, P1021, DOI 10.1016/S0015-0282(16)57541-4
   HANEY AF, 1992, FERTIL STERIL, V57, P202
   HANEY AF, 1993, FERTIL STERIL, V60, P550
   HARADA RN, 1992, SURG GYNECOL OBSTET, V175, P450
   HARRIS JM, 1997, AM CHEM SOC S SERIES
   Hashemi Esmat, 2004, World J Surg Oncol, V2, P44, DOI 10.1186/1477-7819-2-44
   HAYES JA, 1984, AUST NZ J SURG, V54, P25, DOI 10.1111/j.1445-2197.1984.tb06680.x
   HILLWEST JL, 1994, FERTIL STERIL, V62, P630
   HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59
   HIRAIZUMI Y, 1995, SPINE, V20, P2272, DOI 10.1097/00007632-199511000-00002
   HOLTZ G, 1982, FERTIL STERIL, V37, P494
   *INT TC7 ADH BARR, 1989, FERTIL STERIL, V51, P933
   INWANG R, 1991, ANN ROY COLL SURG, V73, P326
   Ito T, 2007, BIOMATERIALS, V28, P3418, DOI 10.1016/j.biomaterials.2007.04.017
   Ito T, 2007, BIOMATERIALS, V28, P1778, DOI 10.1016/j.biomaterials.2006.12.012
   Ito T, 2007, BIOMATERIALS, V28, P975, DOI 10.1016/j.biomaterials.2006.10.021
   Jackson JK, 2002, PHARM RES-DORDR, V19, P411, DOI 10.1023/A:1015175108183
   Jain PK, 2004, BRIT J SURG, V91, P54, DOI 10.1002/bjs.4435
   JANSEN RPS, 1985, AM J OBSTET GYNECOL, V153, P363, DOI 10.1016/0002-9378(85)90072-9
   JEFFREY SS, 1995, ARCH SURG-CHICAGO, V130, P909
   Johns DA, 2003, J AM ASSOC GYN LAP, V10, P334, DOI 10.1016/S1074-3804(05)60257-5
   Johns DB, 1997, FERTIL STERIL, V68, P37, DOI 10.1016/S0015-0282(97)81472-0
   Johnson L, 2005, AM J SURG, V189, P319, DOI 10.1016/j.amjsurg.2005.01.004
   Keogh GW, 1998, BREAST, V7, P39, DOI 10.1016/S0960-9776(98)90050-9
   Kerin MJ, 1996, EUR J SURG ONCOL, V22, P571, DOI 10.1016/S0748-7983(96)92190-3
   KEYES EL, 1953, AMA ARCH SURG, V66, P446, DOI 10.1001/archsurg.1953.01260030461012
   Komatsu K, 2007, THORAC CARDIOV SURG, V55, P385, DOI 10.1055/s-2007-965174
   Kopelman D, 1999, EUR J SURG, V165, P117
   KRINSKY AH, 1984, FERTIL STERIL, V41, P647
   Kudo FA, 2004, SURG TODAY, V34, P648, DOI 10.1007/s00595-004-2792-7
   Kulber DA, 1997, PLAST RECONSTR SURG, V99, P842, DOI 10.1097/00006534-199703000-00034
   Kumar S, 1995, J R Coll Surg Edinb, V40, P292
   Kuroi Katsumasa, 2005, Breast Cancer, V12, P288, DOI 10.2325/jbcs.12.288
   Lang RA, 2007, FERTIL STERIL, V88, P1180, DOI 10.1016/j.fertnstert.2007.01.108
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Langer S, 2003, AM SURGEON, V69, P77
   LARSEN BB, 1955, JAMA-J AM MED ASSOC, V159, P24, DOI 10.1001/jama.1955.02960180026006
   Larsson B, 1996, J REPROD MED, V41, P27
   Laverson S, 1999, PLAST RECONSTR SURG, V104, P1212, DOI 10.1097/00006534-199909040-00082
   LEACH RE, 1990, AM J OBSTET GYNECOL, V162, P1317, DOI 10.1016/0002-9378(90)90044-8
   Lee JH, 2005, J APPL POLYM SCI, V96, P1138, DOI 10.1002/app.21558
   LINDSEY WH, 1995, LARYNGOSCOPE, V105, P241, DOI 10.1288/00005537-199503000-00003
   LINDSEY WH, 1990, ARCH SURG-CHICAGO, V125, P305
   LINKSY CB, 1988, INFERTILITY, V11, P273
   LINSKY CB, 1987, J REPROD MED, V32, P17
   Liu CD, 1997, AM SURGEON, V63, P868
   Liu YC, 2007, FERTIL STERIL, V87, P940, DOI 10.1016/j.fertnstert.2006.07.1532
   LOTZE MT, 1981, ANN SURG, V193, P288, DOI 10.1097/00000658-198103000-00007
   Lumachi F, 2004, EJSO, V30, P526, DOI 10.1016/j.ejso.2004.03.003
   Lumachi F, 2004, AM SURGEON, V70, P80
   Lundorff P, 2005, HUM REPROD, V20, P514, DOI 10.1093/humrep/deh651
   Lundorff P, 2001, HUM REPROD, V16, P1982, DOI 10.1093/humrep/16.9.1982
   Mais V, 1995, HUM REPROD, V10, P3133, DOI 10.1093/oxfordjournals.humrep.a135873
   Mais V, 2006, HUM REPROD, V21, P1248, DOI 10.1093/humrep/dei488
   MAIS V, 1995, OBSTET GYNECOL, V86, P512, DOI 10.1016/S0029-7844(95)80007-7
   MARCH CM, 1992, FERTIL STERIL, V57, P921
   MARIANNE D, 2005, SOUTH MED J, V98, P1039
   Matsuda S, 2002, BIOMATERIALS, V23, P2901, DOI 10.1016/S0142-9612(01)00418-5
   MCCARTHY PM, 1986, SURG GYNECOL OBSTET, V162, P418
   McCaul JA, 2000, BREAST, V9, P144, DOI 10.1054/brst.1999.0126
   MCDONALD MN, 1988, J REPROD MED, V33, P436
   McLeod R, 2006, DIS COLON RECTUM, V49, P1234, DOI 10.1007/s10350-006-0621-3
   Menon NG, 2003, ANN PLAS SURG, V50, P639, DOI 10.1097/01.SAP.0000054182.47311.17
   Mensitieri M, 1996, J MATER SCI-MATER M, V7, P695, DOI 10.1007/BF00123409
   Menzies D, 2006, ANN ROY COLL SURG, V88, P375, DOI 10.1308/003588406X114730
   Mettler L, 2004, FERTIL STERIL, V82, P398, DOI 10.1016/j.fertnstert.2003.12.046
   Mohri Y, 2005, AM SURGEON, V71, P861
   MOLL HD, 1991, AM J VET RES, V52, P88
   MONTZ FJ, 1992, GYNECOL ONCOL, V45, P290, DOI 10.1016/0090-8258(92)90306-4
   Moore M, 2001, J AM COLL SURGEONS, V192, P591, DOI 10.1016/S1072-7515(01)00827-4
   Moore MM, 1997, AM SURGEON, V63, P97
   MORRIS AM, 1973, BRIT J SURG, V60, P357, DOI 10.1002/bjs.1800600509
   MOSS JP, 1981, SURG GYNECOL OBSTET, V152, P517
   Muller SA, 2005, EUR J OBSTET GYN R B, V120, P222, DOI 10.1016/j.ejorgb.2004.09.011
   Muller SA, 2003, ARCH SURG-CHICAGO, V138, P286, DOI 10.1001/archsurg.138.3.286
   Muller SA, 2002, FERTIL STERIL, V77, P1269, DOI 10.1016/S0015-0282(02)03094-7
   Murphy DJ, 2002, AM J VET RES, V63, P1448, DOI 10.2460/ajvr.2002.63.1448
   Nehez L, 2006, SCAND J GASTROENTERO, V41, P1110, DOI 10.1080/00365520600554550
   NICHTER LS, 1983, ANN PLAS SURG, V11, P233, DOI 10.1097/00000637-198309000-00010
   Nur I, 2005, EUR SURG RES, V37, P159, DOI 10.1159/000085963
   O'Hea BJ, 1999, AM J SURG, V177, P450, DOI 10.1016/S0002-9610(99)00089-6
   ODWYER PJ, 1991, SURG GYNECOL OBSTET, V172, P55
   OSTEEN RT, 1994, CANCER, V73, P1994, DOI 10.1002/1097-0142(19940401)73:7<1994::AID-CNCR2820730735>3.0.CO;2-O
   PAGIDAS K, 1992, FERTIL STERIL, V57, P199
   PARIKH HK, 1992, J SURG ONCOL, V51, P266, DOI 10.1002/jso.2930510413
   Peacock KE, 2006, FERTIL STERIL, V85, P1261, DOI 10.1016/j.fertnstert.2005.07.1337
   Pellicano M, 2003, FERTIL STERIL, V80, P441, DOI 10.1016/S0015-0282(03)00597-1
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   PETREK JA, 1992, SURG GYNECOL OBSTET, V175, P405
   PETREK JA, 1990, ARCH SURG-CHICAGO, V125, P378
   Pogson CJ, 2003, EUR J SURG ONCOL, V29, P711, DOI 10.1016/S0748-7983(03)00096-9
   POLISHUK WZ, 1971, J OBSTET GYN BR COMM, V78, P724
   Porter KA, 1998, AM J SURG, V176, P8, DOI 10.1016/S0002-9610(98)00093-2
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Ray NF, 1998, J AM COLL SURGEONS, V186, P1, DOI 10.1016/S1072-7515(97)00127-0
   Reichel W, 2001, PERITON DIALYSIS INT, V21, P414
   Reid R L, 1993, Prog Clin Biol Res, V381, P261
   Reijnen MMPJ, 2003, BRIT J SURG, V90, P533, DOI 10.1002/bjs.4141
   Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170
   Rice DC, 2000, J SURG ONCOL, V73, P224, DOI 10.1002/(SICI)1096-9098(200004)73:4<224::AID-JSO7>3.0.CO;2-0
   Ridings P, 1998, ANN ROY COLL SURG, V80, P61
   Rodgers KE, 1997, FERTIL STERIL, V67, P553, DOI 10.1016/S0015-0282(97)80085-4
   Rodgers KE, 2000, FERTIL STERIL, V73, P831, DOI 10.1016/S0015-0282(99)00642-1
   RODIER JF, 1987, INT SURG, V72, P166
   Roses DF, 1999, ANN SURG, V230, P194, DOI 10.1097/00000658-199908000-00009
   RYAN CK, 1995, AM J SURG, V169, P154, DOI 10.1016/S0002-9610(99)80125-1
   Sanders RP, 1996, J SURG RES, V61, P65, DOI 10.1006/jsre.1996.0082
   Saravelos HG, 1996, J REPROD MED, V41, P42
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   SAY CC, 1974, SURG GYNECOL OBSTET, V138, P370
   Schafer M, 1998, DIGEST SURG, V15, P148, DOI 10.1159/000018609
   Schuijtvlot M, 2002, BREAST, V11, P94, DOI 10.1054/brst.2001.0366
   Schultz I, 1997, ANN SURG ONCOL, V4, P293, DOI 10.1007/BF02303577
   Schwabegger A, 1997, ANN PLAS SURG, V38, P594, DOI 10.1097/00000637-199706000-00005
   SCHWARTZ LB, 1991, SEMIN REPROD ENDOCR, V9, P89, DOI 10.1055/s-2007-1019398
   SEKIBA K, 1992, OBSTET GYNECOL, V79, P518
   Shamley DR, 2005, BREAST CANCER RES TR, V90, P263, DOI 10.1007/s10549-004-4727-9
   SHEPPARD BB, 1993, AM SURGEON, V59, P786
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P531, DOI 10.1097/00006534-199902000-00025
   SITZMANN JV, 1983, SURGERY, V93, P345
   SOMERS RG, 1992, ANN SURG, V215, P146, DOI 10.1097/00000658-199202000-00009
   STEINLEITER A, 1993, PROG CLIN BIOL RES, V381, P325
   STEINLEITNER A, 1991, OBSTET GYNECOL, V77, P48
   *SURG MEMBR STUD G, 1991, FERTIL STERIL, V57, P921
   Talbot ML, 2002, ANZ J SURG, V72, P488, DOI 10.1046/j.1445-2197.2002.02456.x
   Tang CL, 2006, ANN SURG, V243, P449, DOI 10.1097/01.sla.0000207837.71831.a2
   TEJLER G, 1985, BRIT J SURG, V72, P542, DOI 10.1002/bjs.1800720714
   Tekin E, 2001, EUR SURG RES, V33, P245, DOI 10.1159/000049713
   TERRELL GS, 1992, SURG GYNECOL OBSTET, V175, P437
   Thornton MH, 1998, HUM REPROD, V13, P1480, DOI 10.1093/humrep/13.6.1480
   Tingstedt B, 2007, EUR SURG RES, V39, P259, DOI 10.1159/000102591
   Titley OG, 1997, BRIT J PLAST SURG, V50, P106, DOI 10.1016/S0007-1226(97)91321-7
   Tomita K, 2007, ANN PLAS SURG, V59, P149, DOI 10.1097/SAP.0b013e31802c54ef
   Tsuji S, 2005, EUR J OBSTET GYN R B, V123, P244, DOI 10.1016/j.ejogrb.2005.04.012
   TULANDI T, 1994, FERTIL STERIL, V61, P548
   Uchida K, 2005, SURG TODAY, V35, P1054, DOI 10.1007/s00595-005-3085-5
   UDEN P, 1993, EUR J SURG, V159, P263
   ULIBARRI JI, 1990, LANCET, V336, P258, DOI 10.1016/0140-6736(90)91793-A
   Ulusoy Ali Naki, 2003, Breast J, V9, P393, DOI 10.1046/j.1524-4741.2003.09506.x
   Unalp HR, 2007, BREAST J, V13, P588, DOI 10.1111/j.1524-4741.2007.00509.x
   URMAN B, 1991, FERTIL STERIL, V56, P568
   VANHEURN LWE, 1995, BRIT J SURG, V82, P931, DOI 10.1002/bjs.1800820725
   VAXMAN F, 1995, EUR SURG RES, V27, P346, DOI 10.1159/000129419
   VEMER HM, 1982, BRIT J OBSTET GYNAEC, V89, P473, DOI 10.1111/j.1471-0528.1982.tb03639.x
   Verco S, 2002, FERTIL STERIL, V78, pS114, DOI 10.1016/S0015-0282(02)03681-6
   Verco SJS, 2000, HUM REPROD, V15, P1764, DOI 10.1093/humrep/15.8.1764
   Wang JY, 1996, ANN PLAS SURG, V37, P400, DOI 10.1097/00000637-199610000-00009
   WATTBOOLSEN S, 1989, DAN MED BULL, V36, P487
   WATTBOOLSEN S, 1988, ACTA ONCOL, V27, P663, DOI 10.3109/02841868809091765
   Wedderburn A, 2000, EUR J SURG ONCOL, V26, P142, DOI 10.1053/ejso.1999.0757
   Weinrach JC, 2004, ANN PLAS SURG, V53, P12, DOI 10.1097/01.sap.0000112286.30212.12
   Weis C, 2004, J BIOMED MATER RES B, V70B, P191, DOI 10.1002/jbm.b.30007
   WEST JL, 1995, BIOMATERIALS, V16, P1153, DOI 10.1016/0142-9612(95)93579-3
   West JL, 1996, J REPROD MED, V41, P149
   Wiener M, 2007, J PLAST RECONSTR AES, V60, P573, DOI 10.1016/j.bjps.2006.11.021
   Wilson MS, 2002, COLORECTAL DIS, V4, P355
   Wiseman DM, 1998, FERTIL STERIL, V70, P702, DOI 10.1016/S0015-0282(98)00270-2
   Wiseman DM, 1999, J INVEST SURG, V12, P141
   WISEMAN DM, 1992, J REPROD MED, V37, P766
   Wiseman DM, 1999, J REPROD MED, V44, P325
   Woodworth PA, 2000, AM SURGEON, V66, P444
   WURSTER SH, 1995, J SURG RES, V59, P97, DOI 10.1006/jsre.1995.1138
   WYMAN A, 1993, BRIT J SURG, V80, P871, DOI 10.1002/bjs.1800800722
   YAACOBI Y, 1993, J SURG RES, V55, P422, DOI 10.1006/jsre.1993.1163
   Yea Y, 2007, J CONTROL RELEASE, V120, P178, DOI 10.1016/j.jconrel.2007.04.016
   Yeo Y, 2007, BIOMATERIALS, V28, P3704, DOI 10.1016/j.biomaterials.2007.04.033
   Yeo Y, 2007, ANN SURG, V245, P819, DOI 10.1097/01.sla.0000251519.49405.55
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
   Young P, 2005, FERTIL STERIL, V84, P1450, DOI 10.1016/j.fertnstert.2005.04.055
   Zeng QQ, 2007, WORLD J SURG, V31, P2125, DOI 10.1007/s00268-007-9242-9
NR 271
TC 17
Z9 17
U1 1
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD DEC
PY 2008
VL 14
IS 4
BP 377
EP 391
DI 10.1089/ten.teb.2008.0226
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 382TI
UT WOS:000261627900004
PM 18816187
DA 2018-10-20
ER

PT J
AU Jones, KS
AF Jones, Kim S.
TI Assays on the Influence of Biomaterials on Allogeneic Rejection in
   Tissue Engineering
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID KAPPA-B ACTIVATION; DELAYED-TYPE HYPERSENSITIVITY; MESENCHYMAL
   STEM-CELLS; REGULATORY T-CELLS; RENAL-TRANSPLANT RECIPIENTS;
   FOREIGN-BODY RESPONSE; ANTI-HLA ANTIBODIES; TOLL-LIKE RECEPTORS;
   IN-VITRO CULTURE; DENDRITIC CELLS
AB In tissue engineering, innate responses to biomaterial scaffolds will affect rejection of allogeneic cells. Biomaterials directly influence innate and adaptive immune cell adhesion, reactive oxygen intermediate production, cytokine secretion, nuclear factor-kappa B nuclear translocation, gene expression, and cell surface markers, all of which are likely to affect allogeneic rejection responses. A major goal in tissue engineering is to induce transplant tolerance, potentially by manipulating the biomaterial component. This review describes methods of measuring responses of macrophages, dendritic cells, and T cells stimulated in vitro and in vivo and addresses key factors in assay development. Such tests include mixed leukocyte reactions, enzyme-linked immunosorbent spot assays, trans-vivo delayed-type hypersensitivity assays, and measurement of dendritic cell subsets and anti-donor antibodies; we propose extending these studies to tissue engineering.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RP Jones, KS (reprint author), McMaster Univ, Dept Chem Engn, 1280 Main St W, Hamilton, ON L8S 4L7, Canada.
EM kjones@mcmaster.ca
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x
   Ainslie KM, 2007, LANGMUIR, V23, P747, DOI 10.1021/la060948s
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   ARRAJAB A, 1994, CELL TRANSPLANT, V3, P493, DOI 10.1177/096368979400300606
   Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731
   Arredouani MS, 2006, AM J RESP CELL MOL, V35, P474, DOI 10.1165/rcmb.0128OC
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Bickerstaff AA, 2000, TRANSPLANTATION, V69, P1517, DOI 10.1097/00007890-200004150-00055
   Borges O, 2007, INT J PHARM, V337, P254, DOI 10.1016/j.ijpharm.2007.01.021
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Burlingham WJ, 2007, AM J TRANSPLANT, V7, P466, DOI 10.1111/j.1600-6143.2006.01627.x
   Butler LM, 2007, THROMB HAEMOSTASIS, V97, P814, DOI 10.1160/TH06-08-0439
   Canton I, 2007, TISSUE ENG, V13, P1013, DOI 10.1089/ten.2006.0357
   Carrodeguas L, 1999, HUM IMMUNOL, V60, P640, DOI 10.1016/S0198-8859(99)00002-6
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Chockalingam K, 2007, PROTEIN ENG DES SEL, V20, P155, DOI 10.1093/protein/gzm008
   COLIGAN JE, 2001, CURRENT PROTOCOLS IM
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Csencsits KL, 2003, AM J TRANSPLANT, V3, P107, DOI 10.1034/j.1600-6143.2003.00036.x
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   Derks RA, 2005, CURR OPIN IMMUNOL, V17, P560, DOI 10.1016/j.coi.2005.07.011
   Ding TT, 2007, J MATER SCI-MATER M, V18, P2233, DOI 10.1007/s10856-007-3014-9
   Drukker M, 2008, SEMIN IMMUNOL, V20, P123, DOI 10.1016/j.smim.2007.11.002
   Endres S, 2008, J MATER SCI-MATER M, V19, P1209, DOI 10.1007/s10856-007-3104-8
   Garrigues GE, 2005, BIOMATERIALS, V26, P2933, DOI 10.1016/j.biomaterials.2004.06.034
   Geissler F, 2001, TRANSPLANT P, V33, P1377, DOI 10.1016/S0041-1345(00)02517-3
   Gemmell CH, 1996, J BIOMED MATER RES, V32, P29, DOI 10.1002/(SICI)1097-4636(199609)32:1<29::AID-JBM4>3.0.CO;2-R
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Giavaresi G, 2006, J BIOMAT SCI-POLYM E, V17, P1405, DOI 10.1163/156856206778937226
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GOULMY E, 1989, TRANSPLANTATION, V48, P559, DOI 10.1097/00007890-198910000-00004
   Grandjean-Laquerriere A, 2004, BIOMATERIALS, V25, P5921, DOI 10.1016/j.biomaterials.2004.02.003
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Guardino AE, 2006, CYTOTHERAPY, V8, P277, DOI 10.1080/14653240600735701
   Hamdy S, 2007, J BIOMED MATER RES A, V81A, P652, DOI 10.1002/jbm.a.31019
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Holan V, 1996, TRANSPLANTATION, V62, P1050
   Ishido N, 1999, TRANSPLANT P, V31, P2880, DOI 10.1016/S0041-1345(99)00600-4
   Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007
   Jeong HJ, 2006, CLIN EXP ALLERGY, V36, P785, DOI 10.1111/j.1365-2222.2006.02508.x
   Jiang SP, 2006, HUM IMMUNOL, V67, P765, DOI 10.1016/j.humimm.2006.07.013
   Jiang SQ, 2004, CURR OPIN IMMUNOL, V16, P550, DOI 10.1016/j.coi.2004.07.011
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones KS, 2006, TRANSPLANTATION, V82, P415, DOI 10.1097/01.tp.0000228917.57323.ec
   Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007
   Kang CM, 2005, AM J RESP CELL MOL, V33, P290, DOI 10.1165/rcmb.2005-0003OC
   Kao WYJ, 2001, BIOMATERIALS, V22, P2901, DOI 10.1016/S0142-9612(01)00037-0
   Keyser KA, 2007, CELL TRANSPLANT, V16, P555, DOI 10.3727/000000007783464939
   Ko IK, 2007, ANN BIOMED ENG, V35, P101, DOI 10.1007/s10439-006-9204-7
   Kobayashi T, 2003, TRANSPLANTATION, V75, P619, DOI 10.1097/01.TP.0000053749.36365.7E
   Korbutt GS, 2004, DIABETOLOGIA, V47, P1810, DOI 10.1007/s00125-004-1531-3
   KUMAR RK, 1990, IMMUNOL INVEST, V19, P363, DOI 10.3109/08820139009050776
   Lepthien S, 2006, APPL MICROBIOL BIOT, V73, P740, DOI 10.1007/s00253-006-0665-2
   Lewis JB, 2003, J BIOMED MATER RES A, V64A, P217, DOI 10.1002/jbm.a.10352
   Liu GW, 2007, IMMUNOLOGY, V122, P149, DOI 10.1111/j.1365-2567.2007.02651.x
   Longhi MP, 2006, TRENDS IMMUNOL, V27, P102, DOI 10.1016/j.it.2005.12.008
   Lucarelli M, 2004, EUR CYTOKINE NETW, V15, P339
   Luzardo-Alvarez A, 2005, J CONTROL RELEASE, V109, P62, DOI 10.1016/j.jconrel.2005.09.015
   LYNCH I, 2006, SCI STKE, pE14
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Marques AP, 2005, J MATER SCI-MATER M, V16, P1029, DOI 10.1007/s10856-005-4757-9
   Maskarinec SA, 2005, CURR OPIN BIOTECH, V16, P422, DOI 10.1016/j.copbio.2005.06.009
   Matheson LA, 2007, BIOTECHNIQUES, V42, P744, DOI 10.2144/000112460
   Matheson LA, 2006, BIOCHEM CELL BIOL, V84, P763, DOI 10.1139/O06-093
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   Mazariegos GV, 2005, AM J TRANSPLANT, V5, P314, DOI 10.1111/j.1600-6143.2004.00672.x
   Mazariegos GV, 2003, AM J TRANSPLANT, V3, P689, DOI 10.1034/j.1600-6143.2003.00109.x
   McKenna RM, 2000, TRANSPLANTATION, V69, P319, DOI 10.1097/00007890-200002150-00001
   Mebouta-Nkamgueu E, 2001, J MATER SCI-MATER M, V12, P351, DOI 10.1023/A:1011255406438
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132
   Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333
   Osborne JL, 2008, ACTA BIOMATER, V4, P49, DOI 10.1016/j.actbio.2007.07.007
   Otsuka H, 2006, EUR CELLS MATER, V12, P36, DOI 10.22203/eCM.v012a04
   Pleiss J, 2006, APPL MICROBIOL BIOT, V73, P735, DOI 10.1007/s00253-006-0664-3
   Rasmusson I, 2007, J LEUKOCYTE BIOL, V82, P887, DOI 10.1189/jlb.0307140
   Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028
   Rocha PN, 2003, IMMUNOL REV, V196, P51, DOI 10.1046/j.1600-065X.2003.00090.x
   Sabokbar A, 2003, J MATER SCI-MATER M, V14, P731, DOI 10.1023/A:1025088418878
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Sefton MV, 2001, J BIOMED MATER RES, V55, P447, DOI 10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
   Stabler CL, 2005, TISSUE ENG, V11, P404, DOI 10.1089/ten.2005.11.404
   Strober S, 2000, TRANSPLANTATION, V69, P1549
   SUCIUFOCA N, 1991, TRANSPLANTATION, V51, P593, DOI 10.1097/00007890-199103000-00011
   THOMAS J, 1977, SURGERY, V81, P125
   VanBuskirk AM, 2000, J CLIN INVEST, V106, P145, DOI 10.1172/JCI9171
   Walsh PT, 2004, J CLIN INVEST, V114, P1398, DOI 10.1172/JCI200423238
   Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010
   Wu GJ, 2007, FOOD CHEM TOXICOL, V45, P250, DOI 10.1016/j.fct.2006.07.025
   Xu QY, 2007, J IMMUNOL, V178, P3983, DOI 10.4049/jimmunol.178.6.3983
   Yamamoto Ken-ichiro, 2005, J Artif Organs, V8, P257, DOI 10.1007/s10047-005-0315-y
   Yamamoto Y, 2007, BIOSCI BIOTECH BIOCH, V71, P238, DOI 10.1271/bbb.60416
   YANG D, 2008, J BIOMED MAT A  0603
   Yates SF, 2007, J IMMUNOL, V179, P967, DOI 10.4049/jimmunol.179.2.967
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yoon HJ, 2007, BIOCHEM BIOPH RES CO, V358, P954, DOI 10.1016/j.bbrc.2007.05.042
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2007, J BIOMED MATER RES A, V80A, P7, DOI 10.1002/jbm.a.30832
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Yoshida M, 2006, J BIOMAT SCI-POLYM E, V17, P893, DOI 10.1163/156856206777996844
   Zhai Y, 1999, CRIT REV IMMUNOL, V19, P155
NR 111
TC 9
Z9 9
U1 0
U2 18
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD DEC
PY 2008
VL 14
IS 4
BP 407
EP 417
DI 10.1089/ten.teb.2008.0264
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 382TI
UT WOS:000261627900006
PM 18826337
DA 2018-10-20
ER

PT J
AU Chen, J
   Zeng, RC
   Huang, WJ
   Zheng, ZQ
   Wang, ZL
   Wang, J
AF Chen Jun
   Zeng Rong-chang
   Huang Wei-jiu
   Zheng Zi-qing
   Wang Zhen-lin
   Wang Jun
TI Characterization and wear resistance of macro-arc oxidation coating on
   magnesium alloy AZ91 in simulated body fluids
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE magnesium alloy; macro-arc oxidation; coating; erosion corrosion;
   biomaterial; simulated body fluid
ID CORROSION BEHAVIOR
AB The mechanical characteristics of the macro-arc oxidation (MAO) coating on Mg alloy AZ91 were examined by means of nano scratch tester. The corrosion and erosion corrosion behavior of AZ91 with and without MAO coating were investigated by using potentiodynamic electrochemical technique and micro-abrasion tribometer in simulated body fluids, respectively. The influence of HCO(3)(-) ions on the erosion corrosion was discussed. The results show that the coating and its substrate are in a pronounced bond. The MAO coating increases 1-2 orders of magnitude of the corrosion resistance of AZ91 alloy. HCO(3)(-) ions enhance the corrosion rates of the AZ91 alloys more significantly than the alloys with MAO coating. However, there exists an obvious passivation process of AZ91 without coating in the HCO(3)(-) solutions. Moreover, an MgCO(3) film formed in HCO(3)(-) containing solutions leads to an enhancement in micro-wear resistance. MAO coating deteriorates the erosion corrosion resistance of AZ91 alloy due to the formation of oxidation debris resulted from the broken MAO coating.
C1 [Chen Jun; Zeng Rong-chang; Huang Wei-jiu; Zheng Zi-qing; Wang Zhen-lin; Wang Jun] Chongqing Inst Technol, Sch Mat Sci & Engn, Chongqing 400050, Peoples R China.
RP Zeng, RC (reprint author), Chongqing Inst Technol, Sch Mat Sci & Engn, Chongqing 400050, Peoples R China.
EM rczeng2001@yahoo.com.cn
RI Zeng, Rong-Chang/H-4154-2011
OI Zeng, Rong-Chang/0000-0002-5945-3851
FU National Natural Science Foundation of China [50405005]; New Century
   Excellent Talents in University, China [NCET-05-0777]; Natural Science
   Foundation of Chongqing Science and Technology Commission, China
   [2008BB0063]
FX Project(50405005) supported by the National Natural Science Foundation
   of China; Project(NCET-05-0777) supported by the New Century Excellent
   Talents in University, China; Project(8655, CSTC 2008BB0063) supported
   by the Natural Science Foundation of Chongqing Science and Technology
   Commission, China
CR ABDULLAT YA, 2001, MAT T, V42, P1777
   Gao Jia-cheng, 2004, Chinese Journal of Nonferrous Metals, V14, P1508
   GULBRANDSEN E, 1992, ELECTROCHIM ACTA, V37, P1403, DOI 10.1016/0013-4686(92)87014-Q
   Hara N, 2007, CORROS SCI, V49, P166, DOI 10.1016/j.corsci.2006.05.033
   Huang WJ, 2006, T NONFERR METAL SOC, V16, pS1827
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Muller L, 2006, ACTA BIOMATER, V2, P181, DOI 10.1016/j.actbio.2005.11.001
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xin YC, 2007, J MATER RES, V22, P2004, DOI 10.1557/JMR.2007.0233
   Zeng RC, 2007, T NONFERR METAL SOC, V17, pS166
   Zeng RC, 2007, J MATER SCI TECHNOL, V23, P353
   Zhang XP, 2007, J MATER SCI, V42, P8523, DOI 10.1007/s10853-007-1738-z
   Zhao H, 2006, T NONFERR METAL SOC, V16, pS1814
NR 15
TC 24
Z9 24
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD DEC
PY 2008
VL 18
BP S361
EP S364
DI 10.1016/S1003-6326(10)60232-4
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 390HP
UT WOS:000262155200070
DA 2018-10-20
ER

PT J
AU Alfaro, MP
   Pagni, M
   Vincent, A
   Atkinson, J
   Hill, MF
   Cates, J
   Davidson, JM
   Rottman, J
   Lee, E
   Young, PP
AF Alfaro, Maria P.
   Pagni, Matthew
   Vincent, Alicia
   Atkinson, James
   Hill, Michael F.
   Cates, Justin
   Davidson, Jeffrey M.
   Rottman, Jeffrey
   Lee, Ethan
   Young, Pampee P.
TI The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment,
   granulation tissue formation and myocardial repair
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE regeneration; wound healing
ID SIGNALING PATHWAY; BONE-MARROW; STROMAL CELLS; MRL MOUSE; HEART;
   DIFFERENTIATION; FIBROSIS; MURINE; TARGET; MODEL
AB Cell-based therapies, using multipotent mesenchymal stem cells (MSCs) for organ regeneration, are being pursued for cardiac disease, orthopedic injuries and biomaterial fabrication. The molecular pathways that regulate MSC-mediated regeneration or enhance their therapeutic efficacy are, however, poorly understood. We compared MSCs isolated from MRL/MpJ mice, known to demonstrate enhanced regenerative capacity, to those from C57BL/6 (WT) mice. Compared with WT-MSCs, MRL-MSCs demonstrated increased proliferation, in vivo engraftment, experimental granulation tissue reconstitution, and tissue vascularity in a murine model of repair stimulation. The MRL-MSCs also reduced infarct size and improved function in a murine myocardial infarct model compared with WT-MSCs. Genomic and functional analysis indicated a downregulation of the canonical Writ pathway in MRL-MSCs characterized by significant up-regulation of specific secreted frizzled-related proteins (sFRPs). Specific knockdown of sFRP2 by shRNA in MRL-MSCs decreased their proliferation and their engraftment in and the vascular density of MRL-MSC-generated experimental granulation tissue. These results led us to generate WT-MSCs overexpressing sFRP2 (sFRP2-MSCs) by retroviral transduction. sFRP2-MSCs maintained their ability for multilineage differentiation in vitro and, when implanted in vivo, recapitulated the MRL phenotype. Peri-infarct intramyocardial injection of sFRP2-MSCs resulted in enhanced engraftment, vascular density, reduced infarct size, and increased cardiac function after myocardial injury in mice. These findings implicate sFRP2 as a key molecule for the biogenesis of a superior regenerative phenotype in MSCs.
C1 [Alfaro, Maria P.; Pagni, Matthew; Vincent, Alicia; Atkinson, James; Cates, Justin; Davidson, Jeffrey M.; Young, Pampee P.] Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37232 USA.
   [Hill, Michael F.; Rottman, Jeffrey; Young, Pampee P.] Vanderbilt Univ, Dept Internal Med, Sch Med, Nashville, TN 37232 USA.
   [Lee, Ethan] Vanderbilt Univ, Dept Cell & Dev Biol, Sch Med, Nashville, TN 37232 USA.
   [Pagni, Matthew; Vincent, Alicia; Atkinson, James; Davidson, Jeffrey M.; Rottman, Jeffrey; Young, Pampee P.] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA.
RP Young, PP (reprint author), Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37232 USA.
EM pampee.young@vanderbilt.edu
OI Cates, Justin/0000-0002-7336-5196
FU National Institutes of Health [HL088424, P40RR017447]; Veterans Affairs
   ARCD award; American Heart Association; Vanderbilt Discovery Award;
   National Institute of Diabetes and Digestive and Kidney Diseases [U24
   DK-59637]
FX This work was supported National Institutes of Health Grant HL088424,
   Veterans Affairs ARCD award, American Heart Association and Vanderbilt
   Discovery Award to PPY. All microarray experiments were performed in the
   Vanderbilt Microarray Shared Resource. Some of the materials used were
   provided by the Tulane Center for Gene Therapy through National
   Institutes of Health National Center for Research Resources Grant
   P40RR017447. Echocardiography and MI surgery were performed in the
   Cardiovascular Pathophysiology and Complications Core (CPCC) of the
   Vanderbilt Mouse Metabolic Phenotyping Center (MMPQ which is supported
   by the National Institute of Diabetes and Digestive and Kidney Diseases
   Grant U24 DK-59637.
CR Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   BADOO M, 2003, J CELL BIOCHEM, V89, P1235
   Bedelbaeva K, 2004, CLONING STEM CELLS, V6, P352, DOI 10.1089/clo.2004.6.352
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698
   Cooney R, 1997, J TRAUMA, V42, P415, DOI 10.1097/00005373-199703000-00008
   CSELENYI CS, 2008, SCI SIGNALI IN PRESS
   DUFOURCQ P, 2007, AM J PATHOL, V172, P37
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200
   Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200
   GREGORY CA, 2005, J BIOL CHEM, V280, P33132
   Heber-Katz E, 2004, PHILOS T ROY SOC B, V359, P785, DOI 10.1098/rstb.2004.1468
   Heber-Katz E, 1999, SEMIN CELL DEV BIOL, V10, P415, DOI 10.1006/scdb.1999.0328
   Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623
   Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57
   KRUMMEL TM, 1988, J PEDIATR SURG, V23, P647, DOI 10.1016/S0022-3468(88)80638-9
   Lescher B, 1998, DEV DYNAM, V213, P440, DOI 10.1002/(SICI)1097-0177(199812)213:4<440::AID-AJA9>3.0.CO;2-6
   Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578
   Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200
   McBrearty BA, 1998, P NATL ACAD SCI USA, V95, P11792, DOI 10.1073/pnas.95.20.11792
   Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104
   Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859
   Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030
   Van Raay TJ, 2005, NEURON, V46, P23, DOI 10.1016/j.neuron.2005.02.023
   Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9
   Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069
   Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041
   Zimmet JM, 2005, BASIC RES CARDIOL, V100, P471, DOI 10.1007/s00395-005-0553-4
NR 36
TC 110
Z9 118
U1 0
U2 7
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 25
PY 2008
VL 105
IS 47
BP 18366
EP 18371
DI 10.1073/pnas.0803437105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 380TY
UT WOS:000261489300060
PM 19017790
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Tsuji, H
   Yamamura, Y
   Ono, T
   Saeki, T
   Daimon, H
   Fujie, K
AF Tsuji, Hideto
   Yamamura, Yoshiko
   Ono, Tomoyuki
   Saeki, Takashi
   Daimon, Hiroyuki
   Fujie, Koichi
TI Hydrolytic Degradation and Monomer Recovery of Poly(butylene succinate)
   and Poly(butylene succinate/adipate) in the Melt
SO MACROMOLECULAR REACTION ENGINEERING
LA English
DT Article
DE biodegradable; hydrolysis; hydrolytic degradation; monomer recovery;
   recycling
ID LACTIC-ACID; HYDROTHERMAL CONDITIONS; POLY(L-LACTIC ACID); SUPERCRITICAL
   WATER; PET WASTE; POLY(ETHYLENE-TEREPHTHALATE); DEPOLYMERIZATION;
   POLY(EPSILON-CAPROLACTONE); BIOMATERIAL; COPOLYMERS
AB Aliphatic dicarboxylic acid/aliphatic diol-derived polyesters, poly(butylene succinate) and poly(butylene succinate/adipate), have been hydrolytically degraded in the melt in high-temperature and high-pressure water over a wide temperature range of 180-300 degrees C for periods of up to 30 min. The formation/decomposition of succinic acid (SA), adipic acid (AA), and butane-1,4-diol (BD), plus the molecular weight change of PBS and PBSA were then investigated. SA and AA were recovered at maximum yields of 65-80%, whereas BD was recovered at a maximum yield of only 30%, probably because of its decomposition. The obtained results were compared with those reported for aliphatic hydroxycarboxylic acid-derived polyesters and aromatic dicarboxylic acid/aliphatic diol-derived polyesters.
C1 [Tsuji, Hideto; Yamamura, Yoshiko; Ono, Tomoyuki; Saeki, Takashi; Daimon, Hiroyuki; Fujie, Koichi] Toyohashi Univ Technol, Dept Ecol Engn, Fac Engn, Aichi 4418580, Japan.
   [Fujie, Koichi] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan.
RP Tsuji, H (reprint author), Toyohashi Univ Technol, Dept Ecol Engn, Fac Engn, Tempaku Cho, Aichi 4418580, Japan.
EM tsuji@eco.tut.ac.jp
RI Tsuji, Hideto/M-3665-2014
OI Tsuji, Hideto/0000-0001-9986-5933; Fujie, Koichi/0000-0002-8540-6469
FU Ministry of Education, Culture, Sports, Science and Technology (Japan)
FX The authors thank Yoshikazu Hosoda and Yashiro Okino at Showa High
   Polymer Co. Ltd., for supplying PBS and PBSA. This research was
   supported by The 21st Century COE Program, "Ecological Engineering for
   Homeostatic Human Activities", of the Ministry of Education, Culture,
   Sports, Science and Technology (Japan).
CR Adschiri T, 1997, KAGAKU KOGAKU RONBUN, V23, P505, DOI 10.1252/kakoronbunshu.23.505
   Ahn BD, 2001, J APPL POLYM SCI, V82, P2808
   ALBERTSSON AC, 2002, ADV POLYM SCI, V157
   Avadanei L, 2002, MATER PLAST, V39, P234
   Awaja F, 2005, EUR POLYM J, V41, P1453, DOI 10.1016/j.eurpolymj.2005.02.005
   CAMPANELLI JR, 1993, J APPL POLYM SCI, V48, P443, DOI 10.1002/app.1993.070480309
   Cho K, 2001, J APPL POLYM SCI, V79, P1025
   DOI Y, 2002, POLYESTERS 1 3 BIOPO, V2
   DOI Y, 1994, BIODEGRADABLE PLASTI
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   Du J, 2006, POLYM DEGRAD STABIL, V91, P3281, DOI 10.1016/j.polymdegradstab.2006.06.006
   FAISAL M, 2006, WASTE MANAGEMENT ENV, V3, P225
   Faisal M, 2007, ASIAN J CHEM, V19, P1714
   Han SI, 2005, ADV FUNCT MATER, V15, P367, DOI 10.1002/adfm.200400079
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   Kaplan D.L., 1998, BIOPOLYMERS RENEWABL
   Karayannidis GP, 2007, MACROMOL MATER ENG, V292, P128, DOI 10.1002/mame.200600341
   Kint DPR, 2003, POLYMER, V44, P1321, DOI 10.1016/S0032-3861(02)00938-2
   Kozlowski M, 2003, POLIMERY-W, V48, P606
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   Li LX, 1999, IND ENG CHEM RES, V38, P2599, DOI 10.1021/ie980520r
   Lorenzetti C, 2006, J POLYM ENVIRON, V14, P89, DOI 10.1007/s10924-005-8711-1
   Lyoo WS, 2000, POLYMER, V41, P9055, DOI 10.1016/S0032-3861(00)00154-3
   Mobley D., 1994, PLASTICS MICROBES
   MOK WSL, 1989, J ORG CHEM, V54, P4596, DOI 10.1021/jo00280a027
   Nikles DE, 2005, MACROMOL MATER ENG, V290, P13, DOI 10.1002/mame.200400186
   Paszun D, 1997, IND ENG CHEM RES, V36, P1373, DOI 10.1021/ie960563c
   Saeki T, 2005, POLYMER, V46, P2157, DOI 10.1016/j.polymer.2005.01.030
   Saeki T, 2004, KOBUNSHI RONBUNSHU, V61, P561, DOI 10.1295/koron.61.561
   Scheirs J, 1998, WILEY SERIES POLYM S
   Scott G., 2002, BIODEGRADABLE POLYM
   Shinoda H, 2003, POLYM DEGRAD STABIL, V80, P241, DOI 10.1016/S0141-3910(02)00404-4
   Taniguchi I, 2002, MACROMOL BIOSCI, V2, P447, DOI 10.1002/mabi.200290002
   Tsuji H, 2000, J APPL POLYM SCI, V77, P1452, DOI 10.1002/1097-4628(20000815)77:7<1452::AID-APP7>3.0.CO;2-S
   Tsuji H, 2005, POLYM DEGRAD STABIL, V89, P336, DOI 10.1016/j.polymdegradstab.2005.01.018
   Tsuji H, 2003, BIOMACROMOLECULES, V4, P835, DOI 10.1021/bm034060j
   Uesaka T, 2002, J APPL POLYM SCI, V83, P1750, DOI 10.1002/app.10104
   Vert M., 1992, BIODEGRADABLE POLYM
   VERT M, 1995, MACROMOL SCI PURE A, V32, P787
   Yang Y, 2001, PROG CHEM, V13, P65
NR 40
TC 7
Z9 7
U1 0
U2 20
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1862-832X
J9 MACROMOL REACT ENG
JI Macromol. React. Eng.
PD NOV 21
PY 2008
VL 2
IS 6
BP 522
EP 528
DI 10.1002/mren.200800027
PG 7
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 380CT
UT WOS:000261444100004
DA 2018-10-20
ER

PT J
AU Huang, Y
   Lue, XY
   Ma, JW
   Huang, N
AF Huang Yan
   Lue Xiaoying
   Ma Jingwu
   Huang Nan
TI In vitro investigation of protein adsorption and platelet adhesion on
   inorganic biomaterial surfaces
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Surface and Interfaces of Biomaterials
CY OCT 05-07, 2007
CL SW Jiaotong Univ, Chengdu, PEOPLES R CHINA
HO SW Jiaotong Univ
DE DLC and Ti; Surface property; Protein adsorption; Platelet adhesion;
   Blood compatibility
ID CARBON; ALBUMIN; FILMS; ASSAY; DLC
AB The aim of this paper was to study the surface properties, protein adsorption and platelet adhesion behaviors of diamond-like carbon (DLC) and titanium (Ti) films. The surface energy and microstructures of these films were characterized by contact angle measurement and atomic force microscopy (AFM). A modified Coomassie brilliant blue (CBB) protein assay was used to study the amount of adsorbed proteins. Platelet adhesion was assessed by scanning electron microscopy (SEM). The AFM results show that the DLC film is smoother than Ti. Protein adsorption results from CBB protein assay show that the ratio of adsorbed albumin (Alb) to IgG (R(A/I)) on DLC is larger than Ti, which coincide with the sequence of the ratio of interfacial tension between solid surface and Alb (gamma(S,Alb)) to interfacial tension between surface and IgG (gamma(S,IgG)) (gamma(S,Alb)/gamma(S,IgG)). The DLC film has a preferential adsorption for Alb. The results suggest that the ratio of gamma(S,Alb)/gamma(S,IgG) may indicate an Alb/IgG affinity ratio of materials. More platelets adhere on Ti film than on DLC, which may correspond to the surface roughness of materials. The conclusion is the blood compatibility of DLC seems to be better than Ti. (C) 2008 Elsevier B. V. All rights reserved.
C1 [Huang Yan; Lue Xiaoying; Ma Jingwu] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
   [Huang Nan] SW Jiaotong Univ, Inst Biomat & Surface Engn, Chengdu 610031, Peoples R China.
RP Lue, XY (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
EM luxy@seu.edu.cn; nhuang@263.com
CR AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   FORBES CD, 1994, THROMBOSIS ARTIFICIA, P84712
   GOODMAN SL, 1984, SEM 1984, V1, P279
   GU HQ, 1993, BIOMEDICAL MAT, P84712
   Huang Y, 2007, KEY ENG MATER, V330-332, P893
   Lu XY, 2007, SURF COAT TECH, V201, P6843, DOI 10.1016/j.surfcoat.2006.09.019
   PAUL L, 1981, J COLLOID INTERF SCI, V84, P546, DOI 10.1016/0021-9797(81)90245-9
   Wang XH, 2003, COLLOID SURFACE B, V30, P111, DOI 10.1016/S0927-7765(03)00078-X
NR 10
TC 19
Z9 19
U1 3
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2008
VL 255
IS 2
BP 257
EP 259
DI 10.1016/j.apsusc.2008.06.192
PG 3
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 366VD
UT WOS:000260510600002
DA 2018-10-20
ER

PT J
AU Li, X
   Yao, J
   Yang, X
   Tian, W
   Liu, L
AF Li, Xiaoyu
   Yao, Jinfeng
   Yang, Xiaojuan
   Tian, Weidong
   Liu, Lei
TI Surface modification with fibronectin or collagen to improve the cell
   adhesion
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Surface and Interfaces of Biomaterials
CY OCT 05-07, 2007
CL SW Jiaotong Univ, Chengdu, PEOPLES R CHINA
HO SW Jiaotong Univ
DE Surface modification; Cellular attachment; Proliferation
ID ACRYLIC-ACID; FILMS; POLYHYDROXYALKANOATES; PLASMA; PHBHHX
AB Objective: The surface of biomaterials plays a critical role in determining bioactivity. The aim of this study was to evaluate the cell adhesion and proliferation of ADSCs on the surface of biomaterial which is modified with fibronectin or collagen.
   Materials and methods: Adipose-derived stromal cells (ADSCs) were obtained from SD rats, expanded in culture, and seeded onto scaffold surface-modified with fibronectin or collagen. To characterize cellular attachment, cells were incubated on scaffold for 1 and 2 h and then counted the cells attached onto the scaffold. The MTT assay was chosen to evaluate the proliferation at days 1, 4, 7 and 14. After 7 d of culture, scanning electron microscope was chosen to observe cell morphology and attachment of ADSCs on the scaffolds.
   Results: Attachment at 1 and 2 h of cells on scaffold modified with fibronectin was significantly greater than in control, but not with collagen. The MTT assay revealed that ADSCs proliferation tendency was nearly parallel to that in control. The scanning electron microscope (SEM) showed that ADSCs in experiment expanded thoroughly and excreted much extracellular materials. Conclusions: Surface modification with fibronectin or collagen can enhance the attachment of cultured ADSCs on the scaffold, but it had not evident effect to proliferation. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Liu, Lei] Sichuan Univ, W China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu 610041, Peoples R China.
   [Yao, Jinfeng; Tian, Weidong] State Key Lab Oral Dis, Chengdu 610044, Peoples R China.
RP Liu, L (reprint author), Sichuan Univ, W China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu 610041, Peoples R China.
EM drtwd@sina.com; drliulei@163.com
RI liu, lei/B-2263-2012; Yu, Mei/G-4994-2015
OI Yu, Mei/0000-0003-0306-6817
CR Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Dennis J E, 1993, J Oral Implantol, V19, P106
   Faucheux N, 1999, BIOMATERIALS, V20, P159, DOI 10.1016/S0142-9612(98)00156-2
   GRINNELL F, 1983, J CELL PHYSIOL, V116, P289, DOI 10.1002/jcp.1041160305
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Kang ET, 1997, J PHYS CHEM B, V101, P10744, DOI 10.1021/jp9727052
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   Li J, 2005, J BIOMED MATER RES A, V75A, P985, DOI 10.1002/jbm.a.30504
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292
   Ruoslahti E, 1996, TUMOR BIOL, V17, P117, DOI 10.1159/000217975
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Zhang DM, 2000, SURF COAT TECH, V131, P350, DOI 10.1016/S0257-8972(00)00810-0
NR 14
TC 8
Z9 9
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2008
VL 255
IS 2
BP 459
EP 461
DI 10.1016/j.apsusc.2008.06.105
PG 3
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 366VD
UT WOS:000260510600057
DA 2018-10-20
ER

PT J
AU Poole-Warren, LA
   Farrugia, B
   Fong, N
   Hume, E
   Simmons, A
AF Poole-Warren, L. A.
   Farrugia, B.
   Fong, N.
   Hume, E.
   Simmons, A.
TI Controlling cell-material interactions with polymer nanocomposites by
   use of surface modifying additives
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Surface and Interfaces of Biomaterials
CY OCT 05-07, 2007
CL SW Jiaotong Univ, Chengdu, PEOPLES R CHINA
HO SW Jiaotong Univ
DE Polyurethane; Organosilicate; Biomaterial; Antibacterial; Platelet
   adhesion; Fibroblast adhesion
AB Polymer nanocomposites (NC) are fabricated by incorporating well dispersed nanoscale particles within a polymer matrix. This study focuses on elastomeric polyurethane (PU) based nanocomposites, containing organically modified silicates (OMS), as bioactive materials. Nanocomposites incorporating chlorhexidine diacetate as an organic modifier (OM) were demonstrated to be antibacterial with a dose dependence related to both the silicate loading and the loading of OM. When the non-antibacterial OM dodecylamine was used, both cell and platelet adhesion were decreased on the nanocomposite surface. These results suggest that OM is released from the polymer and can impact on cell behaviour at the interface. Nanocomposites have potential use as bioactive materials in a range of biomedical applications. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Poole-Warren, L. A.; Farrugia, B.; Fong, N.; Hume, E.; Simmons, A.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
RP Poole-Warren, LA (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
EM l.poolewarren@unsw.edu.au
OI Simmons, Anne/0000-0002-3758-7306; Farrugia, Brooke/0000-0003-1303-4165;
   Poole-Warren, Laura/0000-0002-4414-022X
CR Cormio L, 2001, EUR UROL, V40, P354, DOI 10.1159/000049799
   FARRUGIA B, 2007, ESB              SEP, P84712
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P937, DOI 10.1002/jbm.820250803
   PITT WG, 1988, BIOMATERIALS, V9, P36, DOI 10.1016/0142-9612(88)90067-1
   Styan KE, 2008, J BIOMED MATER RES A, V86A, P571, DOI 10.1002/jbm.a.31667
   Wang XP, 2007, ACTA BIOMATER, V3, P757, DOI 10.1016/j.actbio.2007.01.004
NR 6
TC 11
Z9 11
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2008
VL 255
IS 2
BP 519
EP 522
DI 10.1016/j.apsusc.2008.06.062
PG 4
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 366VD
UT WOS:000260510600074
DA 2018-10-20
ER

PT J
AU Oudadesse, H
   Derrien, AC
   Martin, S
   Chaair, H
   Cathelineau, G
AF Oudadesse, H.
   Derrien, A. C.
   Martin, S.
   Chaair, H.
   Cathelineau, G.
TI Surface and interface investigation of aluminosilicate biomaterial by
   the "in vivo'' experiments
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 1st International Symposium on Surface and Interfaces of Biomaterials
CY OCT 05-07, 2007
CL SW Jiaotong Univ, Chengdu, PEOPLES R CHINA
HO SW Jiaotong Univ
DE Composite; In vivo; Bone-graft interface; Surface; Interface
AB Porous mixtures of aluminosilicate/calcium phosphate have been studied for biomaterials applications. Aluminosilicates formed with an inorganic polymeric constitution present amorphous zeolites because of their 3D network structure and present the ability to link to bone matrix. Amorphous geopolymers of the potassium-poly(sialate)-nanopolymer type were synthesised at low temperature and studied for their use as potential biomaterials. They were mixed with 13% weight of calcium phosphate like biphasic hydroxyapatite and beta-tricalcium phosphate. In this study, "in vivo'' experiments were monitored to evaluate the biocompatibility, the surface and the interface behaviour of these composites when used as bone implants. Moreover, it has been demonstrated using histological and physicochemical studies that the developed materials exhibited a remarkable bone bonding when implanted in a rabbit's thighbone for a period of 1 month. The easy synthesis conditions (low temperature) of this composite and the fast intimate links with bone constitute an improvement of synthetic bone graft biomaterial. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Oudadesse, H.; Derrien, A. C.; Martin, S.; Cathelineau, G.] Univ Rennes 1, CNRS, SCR, UMR 6226, F-35042 Rennes, France.
   [Chaair, H.] Univ Hassan 2, Fac Sci & Tech, FSTM LGP, Mohammadia, Morocco.
RP Oudadesse, H (reprint author), Univ Rennes 1, CNRS, SCR, UMR 6226, 263 Gen Leclerc, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
CR Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Irigaray JL, 2001, BIOMATERIALS, V22, P629, DOI 10.1016/S0142-9612(00)00172-1
   KIM HW, 2005, J BIOMED MATER RES B, V77, P323
   NI GX, 2005, J BIOMED RES B, V77, P409
   Oudadesse H, 2007, J MATER SCI, V42, P3092, DOI 10.1007/s10853-006-0524-7
   Oudadesse H, 2005, EUR PHYS J-APPL PHYS, V31, P217, DOI 10.1051/epjap:2005062
   OUDADESSE H, 2006, JTAC, V82, P323
   OUDADESSE H, 2007, BIOMED MATER, V2, P59
   OUDADESSE H, 2007, J RADIOANAL NUCL CHE, V274, P431
   YAMAGUCHI M, 1988, BIOCHEM PHARMACOL, V37, P4075, DOI 10.1016/0006-2952(88)90098-6
NR 10
TC 7
Z9 7
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 15
PY 2008
VL 255
IS 2
BP 593
EP 596
DI 10.1016/j.apsusc.2008.06.086
PG 4
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 366VD
UT WOS:000260510600094
DA 2018-10-20
ER

PT J
AU Xia, H
   Suo, ZY
   Qiang, GJ
   Chang, CJ
AF Xia, Huang
   Suo, Zheng Yuan
   Qiang, Gao Ji
   Chang, Cheng Jia
TI Synthesis, characterization, and degradation of a novel
   L-tyrosine-derived polycarbonate for potential biomaterial applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biodegradable; degradation; polycarbonate
ID PSEUDO-POLY(AMINO ACIDS); POLYARYLATES; COPOLYMERS; RELAXATION;
   CURRENTS; DESIGN
AB A novel class of pseudo-poly(amino acid)s was synthesized with a cyclic dipeptide as new diphenole. Nonpeptide bonds alternating with a peptide bond structure were introduced into the backbone of the pseudopoly(amino acid)s. The cyclic dipeptide in this study was obtained from natural L-tyrosine. L-tyrosine is a major nutrient amino acid with a phenolic hydroxyl group, so a polycarbonate derived from the cyclic dipeptide should possess more optimum mechanical properties, bioactivity, and biocompatibility. The hydrolytic specimen of the resulting polycarbonate was prepared by a modified solvent evaporation process. Under strongly alkaline conditions, degradation testing was performed. The tyrosine-derived polycarbonate possessed a low glass-transition temperature value and a high thermal decomposition temperature value, which formed a broad mean thermal processing range. The most important results of our study were the effects of the polycarbonate degradation on the local pH values, which were smaller than those of other biodegradable polymers [e.g., poly(lactic acid), poly(glycolic acid), and poly(lactic glycolic acid)]. The synthesized polymer and cyclic dipeptide were characterized with Fourier transform infrared, C-13-NMR, and H-1-NMR spectroscopy to determine their chemical structures; by differential scanning calorimetry and thermoogravimetric analysis to determine the thermal properties of the polymer; by gel permeation chromatography to determine the polymer's molecular weight; and by X-ray diffraction to determine the polymer's morphology. (C) 2008 Wiley Periodicals, Inc.
C1 [Xia, Huang; Qiang, Gao Ji; Chang, Cheng Jia] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
   [Suo, Zheng Yuan] Xi An Jiao Tong Univ, Sch Sci, Xian 710049, Peoples R China.
RP Xia, H (reprint author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
EM happyhxia@163.com
CR Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3
   Cabrele C, 1999, J ORG CHEM, V64, P4353, DOI 10.1021/jo982402j
   COOK B, 1992, J CHEM SOC PERK T 1, P1199, DOI 10.1039/p19920001199
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   GOLDBERG EP, 1964, J POLYM SCI C, V4, P707
   Kimura Y, 1996, PHYTOCHEMISTRY, V41, P665, DOI 10.1016/0031-9422(95)00693-1
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1993, TRENDS POLYM SCI, V1, P206
   KOHN J, 1984, POLYM MAT SCI ENG, V51, P119
   LI T, 2004, J CHEM IND TIMES, V18, P37
   MAO H, 1999, Patent No. 5912225
   MERRILL SH, 1961, J POLYM SCI, V55, P343, DOI 10.1002/pol.1961.1205516133
   ODonnell PB, 1997, ADV DRUG DELIVER REV, V28, P25, DOI 10.1016/S0169-409X(97)00049-5
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Puma M, 1999, J POLYM SCI POL PHYS, V37, P3504, DOI 10.1002/(SICI)1099-0488(19991215)37:24<3504::AID-POLB11>3.0.CO;2-Y
   Sen Gupta A, 2005, POLYMER, V46, P2133, DOI 10.1016/j.polymer.2005.01.023
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Suarez N, 2001, POLYMER, V42, P8671, DOI 10.1016/S0032-3861(01)00437-2
   Tangpasuthadol V, 1996, BIOMATERIALS, V17, P463, DOI 10.1016/0142-9612(96)89665-7
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2371, DOI 10.1016/S0142-9612(00)00104-6
   WIPF P, 1995, CHEM REV, V95, P2115, DOI 10.1021/cr00038a013
NR 22
TC 5
Z9 5
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD NOV 15
PY 2008
VL 110
IS 4
BP 2168
EP 2178
DI 10.1002/app.28755
PG 11
WC Polymer Science
SC Polymer Science
GA 356CC
UT WOS:000259755300035
DA 2018-10-20
ER

PT J
AU Dos Santos, I
   Mazeres, S
   Freche, M
   Lacout, JL
   Sautereau, AM
AF Dos Santos, Isabelle
   Mazeres, Serge
   Freche, Michele
   Lacout, Jean-Louis
   Sautereau, Anne-Marie
TI FRET: A tool to study the interaction between apatite and collagen?
SO MATERIALS LETTERS
LA English
DT Article
DE FRET; luminescence; composite materials; apatite; collagen; molecular
   interaction
ID SELF-ORGANIZATION MECHANISM; HYDROXYAPATITE; COMPOSITE; NANOCOMPOSITES;
   NANOCRYSTALS
AB Fluorescence Resonance Energy Transfer, FRET, is largely used in biology to demonstrate the occurrence of molecular interactions. In order to investigate the vicinity between collagen and calcium phosphate in bone substitute biomaterial, composites constituted of autofluorescent collagen and apatite doped by europium were synthesized by a precipitation method. The first results show a fluorescence energy transfer between the two fluorescent components and are very promising. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Dos Santos, Isabelle; Sautereau, Anne-Marie] Univ Toulouse 3, Fac Pharm, Serv Pharm Galen, Inst Carnot,CIRIMAT,PPB,UMR 5085, F-31062 Toulouse 4, France.
   [Mazeres, Serge] CNRS, IPBS, F-31077 Toulouse, France.
   [Freche, Michele; Lacout, Jean-Louis] ENSIACET INPT, UMR 5085, CIRIMAT, Inst Carnot,PPB, F-31077 Toulouse, France.
RP Sautereau, AM (reprint author), Univ Toulouse 3, Fac Pharm, Serv Pharm Galen, Inst Carnot,CIRIMAT,PPB,UMR 5085, 118 Route Narbonne, F-31062 Toulouse 4, France.
EM serge.mazeres@ipbs.fr; Michele.Freche@ensiacet.fr;
   jeanLouis.Lacout@ensiacet.fr; asautere@cict.fr
CR Bazin H, 2001, SPECTROCHIM ACTA A, V57, P2197, DOI 10.1016/S1386-1425(01)00493-0
   Doat A, 2004, J SOLID STATE CHEM, V177, P1179, DOI 10.1016/j.jssc.2003.10.023
   FUJIMOTO D, 1978, J BIOCHEM-TOKYO, V83, P863, DOI 10.1093/oxfordjournals.jbchem.a131983
   Hallworth R, 2006, BRAIN RES, V1091, P122, DOI 10.1016/j.brainres.2006.02.076
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Lin XY, 2004, MATER LETT, V58, P3569, DOI 10.1016/j.matlet.2004.06.044
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Rhee SH, 2000, J AM CERAM SOC, V83, P2890
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Wang YJ, 2006, ADV ENG MATER, V8, P97, DOI 10.1002/adem.200500220
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
NR 13
TC 3
Z9 3
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD NOV 15
PY 2008
VL 62
IS 28
BP 4377
EP 4379
DI 10.1016/j.matlet.2008.07.035
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 351JJ
UT WOS:000259420300022
DA 2018-10-20
ER

PT J
AU Zhang, H
   Wei, YT
   Tsang, KS
   Sun, CR
   Li, J
   Huang, H
   Cui, FZ
   An, YH
AF Zhang, Han
   Wei, Yue Teng
   Tsang, Kam Sze
   Sun, Chong Ran
   Li, Jin
   Huang, Hua
   Cui, Fu Zhai
   An, Yi Hua
TI Implantation of neural stem cells embedded in hyaluronic acid and
   collagen composite conduit promotes regeneration in a rabbit facial
   nerve injury model
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
ID CULTURED SCHWANN-CELLS; EXTRACELLULAR-MATRIX; PERIPHERAL-NERVES;
   PROGENITOR CELLS; SPINAL-CORD; TRANSPLANTATION; GRAFTS; DIFFERENTIATION;
   ENHANCEMENT; ALLOGRAFT
AB The implantation of neural stem cells (NSCs) in artificial scaffolds for peripheral nerve injuries draws much attention. NSCs were ex-vivo expanded in hyaluronic acid (HA)-collagen composite with neurotrophin-3, and BrdU-labeled NSCs conduit was implanted onto the ends of the transected facial nerve of rabbits. Electromyography demonstrated a progressive decrease of current threshold and increase of voltage amplitude in de-innervated rabbits after implantation for one, four, eight and 12 weeks compared to readouts derived from animals prior to nerve transection. The most remarkable improvement, observed using Electrophysiology, was of de-innervated rabbits implanted with NSCs conduit as opposed to de-innervated counterparts with and without the implantation of HA-collagen, NSCs and HA-collagen, and HA-collagen and neurotrophin-3. Histological examination displayed no nerve fiber in tissue sections of de-innervated rabbits. The arrangement and S-100 immunoreactivity of nerve fibers in the tissue sections of normal rabbits and injured rabbits after implantation of NSCs scaffold for 12 weeks were similar, whereas disorderly arranged minifascicles of various sizes were noted in the other three arms. BrdU(+) cells were detected at 12 weeks post-implantation. Data suggested that NSCs embedded in HA-collagen biomaterial could facilitate re-innervations of damaged facial nerve and the artificial conduit of NSCs might offer a potential treatment modality to peripheral nerve injuries.
C1 [Zhang, Han; Sun, Chong Ran; Li, Jin; Huang, Hua; An, Yi Hua] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China.
   [Wei, Yue Teng; Cui, Fu Zhai] Tsinghua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   [Tsang, Kam Sze; Li, Jin] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China.
   [Tsang, Kam Sze; Li, Jin] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.
   [Sun, Chong Ran] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China.
RP An, YH (reprint author), Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China.
EM meishazhang@yahoo.com.cn; yeting_smth@hotmail.com; tsangks@cuhk.edu.hk;
   sunfootprint@yahoo.com.cn; flintli@yahoo.com.cn; ama_225@sina.com;
   cuifz@tsinghua.edu.cn; riveran@163.com
RI Wei, Yueteng/B-4653-2012
FU National Science Foundation of Beijing, China [7042014]; National
   Natural Science Foundation of China [50573044]; National Basic Research
   Program of China [2005CB623905]
FX Research support: This study is supported in part by the grants from the
   7042014 of the National Science Foundation of Beijing, China, the
   50573044 of the National Natural Science Foundation of China and the
   2005CB623905 of the National Basic Research Program of China.
CR BAIN JR, 1992, PLAST RECONSTR SURG, V90, P1036, DOI 10.1097/00006534-199212000-00015
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Fansa H, 2001, PLAST RECONSTR SURG, V107, P485, DOI 10.1097/00006534-200102000-00026
   Fansa H, 2004, NEUROL RES, V26, P167, DOI 10.1179/016164104225013842
   Fong SP, 2007, J NEUROSCI RES, V85, P1851, DOI 10.1002/jnr.21319
   Francel PC, 1997, J NEUROSURG, V87, P887, DOI 10.3171/jns.1997.87.6.0887
   Frerichs O, 2002, MICROSURG, V22, P311, DOI 10.1002/micr.10056
   Heath CA, 2000, TRENDS BIOTECHNOL, V18, P17, DOI 10.1016/S0167-7799(99)01396-7
   Hori J, 2007, OCUL IMMUNOL INFLAMM, V15, P261, DOI 10.1080/09273940701382242
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hudson TW, 2000, ORTHOP CLIN N AM, V31, P485, DOI 10.1016/S0030-5898(05)70166-8
   Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F
   Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101
   Le Belle JE, 2004, J NEUROSCI RES, V76, P174, DOI 10.1002/jnr.20035
   Lin WL, 2005, J NEUROCYTOL, V34, P397, DOI 10.1007/s11068-006-8726-0
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016
   Mackinnon SE, 2001, PLAST RECONSTR SURG, V107, P1419, DOI 10.1097/00006534-200105000-00016
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   Millesi H, 2000, HAND CLIN, V16, P73
   Mligiliche N, 2002, J BIOMED MATER RES, V63, P591, DOI 10.1002/jbm.10349
   Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x
   Routsellis-Theotokis Andreas, 2008, V438, P31, DOI 10.1007/978-1-59745-133-8_4
   Tang SQ, 2007, J BIOMED MATER RES A, V82A, P323, DOI 10.1002/jbm.a.30974
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
NR 27
TC 32
Z9 37
U1 0
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD NOV 5
PY 2008
VL 6
AR 67
DI 10.1186/1479-5876-6-67
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 393KU
UT WOS:000262373000002
PM 18986538
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chaa, L
   Joly, N
   Lequart, V
   Faugeron, C
   Mollet, JC
   Martin, P
   Morvan, H
AF Chaa, Lahouari
   Joly, Nicolas
   Lequart, Vincent
   Faugeron, Celine
   Mollet, Jean-Claude
   Martin, Patrick
   Morvan, Henri
TI Isolation, characterization and valorization of hemicelluloses from
   Aristida pungens leaves as biomaterial
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE arabinoxylan; Aristida pungens; hemicelluloses; plastic films
ID WHEAT-STRAW HEMICELLULOSES; STRUCTURAL-CHARACTERIZATION;
   QUANTITATIVE-DETERMINATION; PLASTIC FILMS; RICE STRAW; CELLULOSE;
   POLYSACCHARIDES; DERIVATIVES; ALKALI; XYLAN
AB Aristida pungens, a perennial grass widely distributed on the Algerian and regions, may potentially be the source of raw cell wall material to promote a local development in North Africa. Hemicelluloses the main, matrix cell wall polymers of this species were isolated from leaves with 14% KOH aqueous solution characterized and converted as plastic material. The extraction procedure yielded two hemicellulose fractions (A and B) accounting for 3.5 and 10.1% of the starting leaf material, respectively. GC and C-13 NMR showed the presence of xylose as the main component with arabinosyl residues. Both analyses indicate that hemicelluloses from A. pungens leaves are arabinoxylans. Arabinoxylans were transformed into hydrophobic plastics by grafting of lauroyl chloride. The resulting materials were characterized by FT-IR and H-1 NMR spectroscopies, with both mechanical and thermogravimetric analysis. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Joly, Nicolas; Lequart, Vincent; Martin, Patrick] IUT Bethune, Dept Chim, Unite Catalyse & Chim Solide, UMR CNRS 8181, F-62408 Bethune, France.
   [Chaa, Lahouari] Univ Sci & Tech Lille Flandres Artois, EA 2465, Lab Physiopathol Barriere Hematho Encephal, Fac Jean Perrin, F-62307 Lens, France.
   Univ Sci & Tech Lille Flandres Artois, Lab Glycobiol & Physiol Vegetale, Fac Jean Perrin, F-62307 Lens, France.
   [Faugeron, Celine] Fac Sci & Tech, EA 1069, Lab Chim Substances Nat, F-87060 Limoges, France.
   [Mollet, Jean-Claude] Univ Rouen, IFRMP23, FRE CNRS 3090, Lab Glycobiol & Transports Chez Vegetaux, F-76821 Mont St Aignan, France.
RP Joly, N (reprint author), IUT Bethune, Dept Chim, Unite Catalyse & Chim Solide, UMR CNRS 8181, 1230 Rue Univ,BP 819, F-62408 Bethune, France.
EM nicolas.joly@univ-artois.fr
RI Joly, Nicolas/O-5749-2016
OI Joly, Nicolas/0000-0003-0516-2466; Patrick, Martin/0000-0001-7507-5910;
   girard, celine/0000-0003-1923-546X
FU "Institut Universitaire de Technologie" of Bethune
FX We thank the "Institut Universitaire de Technologie" of Bethune for
   financial support. The authors are also grateful to Dr. Emmanuel Maes
   (UMR CNRS 8576, Unite de Glycobiologie Structurale et Fonctionnelle,
   Lille, France) for <SUP>13</SUP>C NMR analysis.
CR Bechet G., 1982, BIOCENOSES B ECOLOGI, V1, P79
   Bendahou A, 2007, CARBOHYD POLYM, V68, P601, DOI 10.1016/j.carbpol.2006.10.016
   BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1
   BUCHALA AJ, 1972, PHYTOCHEMISTRY, V11, P1249, DOI 10.1016/S0031-9422(00)90071-2
   Buckeridge MS, 2004, CEREAL CHEM, V81, P115, DOI 10.1094/CCHEM.2004.81.1.115
   Chaikumpollert O, 2004, CARBOHYD POLYM, V57, P191, DOI 10.1016/j.carbpol.2004.04.011
   DUBOIS M, 1956, ANAL CHEM, V28, P356, DOI DOI 10.1021/AC60111A017
   DUSTERHOFT EM, 1992, J SCI FOOD AGR, V59, P151, DOI 10.1002/jsfa.2740590204
   Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542
   FONTANILLE M, 2002, CHIM PHYSICO CHIM PO, P586
   FORD CW, 1986, CARBOHYD RES, V147, P101, DOI 10.1016/0008-6215(86)85010-8
   Gabrielii I, 1998, J APPL POLYM SCI, V69, P1661, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1661::AID-APP19>3.3.CO;2-K
   Gabrielii I, 2000, CARBOHYD POLYM, V43, P367, DOI 10.1016/S0144-8617(00)00181-8
   Gontard N, 1994, FOOD PACKAGING PRESE, P159
   GRANDTNER G, 2005, POLYM B, V4, P235
   HATFIELD RD, 1989, AGRON J, V81, P39, DOI 10.2134/agronj1989.00021962008100010007x
   Hoije A, 2005, CARBOHYD POLYM, V61, P266, DOI 10.1016/j.carbpol.2005.02.009
   Joly N, 2005, J APPL POLYM SCI, V97, P1266, DOI 10.1002/app.21783
   JOLY N, 2006, E-POLYMERS, V70, P1
   Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X
   Kayserilioglu BS, 2003, BIORESOURCE TECHNOL, V87, P239, DOI 10.1016/S0960-8524(02)00258-4
   MOINE C, 2004, J ENV SCI HLTH B, V39, P4627
   Rantanen H, 2007, CARBOHYD POLYM, V68, P350, DOI 10.1016/j.carbpol.2006.11.022
   Satge C, 2002, CARBOHYD POLYM, V49, P373, DOI 10.1016/S0144-8617(02)00004-8
   Satge C, 2004, CR CHIM, V7, P135, DOI 10.1016/j.crci.2003.11.003
   Sun RC, 1996, CARBOHYD POLYM, V29, P325, DOI 10.1016/S0144-8617(96)00018-5
   Sun RC, 2000, CARBOHYD POLYM, V42, P111, DOI 10.1016/S0144-8617(99)00136-8
   Sun RC, 2002, CARBOHYD POLYM, V50, P263, DOI 10.1016/S0144-8617(02)00037-1
   Sun RC, 2002, CARBOHYD POLYM, V49, P415, DOI 10.1016/S0144-8617(01)00349-6
   Sun RC, 1999, IND CROP PROD, V10, P209, DOI 10.1016/S0926-6690(99)00025-4
   Verbruggen MA, 1998, CARBOHYD RES, V306, P275, DOI 10.1016/S0008-6215(97)10065-9
   VICKEN JP, 2003, PLANT PHYSIOL, V132, P1781
   WHISTLER RL, 1993, IND GUMS, P295
   Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X
   Zanetta JP, 1999, GLYCOBIOLOGY, V9, P255, DOI 10.1093/glycob/9.3.255
NR 35
TC 24
Z9 26
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD NOV 4
PY 2008
VL 74
IS 3
BP 597
EP 602
DI 10.1016/j.carbpol.2008.04.017
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 355KQ
UT WOS:000259708200038
DA 2018-10-20
ER

PT J
AU Shim, J
   Hagerman, E
   Wu, B
   Gupta, V
AF Shim, Jaewoo
   Hagerman, Elizabeth
   Wu, Ben
   Gupta, Vijay
TI Measurement of the tensile strength of cell-biomaterial interface using
   the laser spallation technique
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cell adhesion; Laser spallation experiment; Tensile strength; Osteoblast
   adhesion; Fibroblasts
ID NB SAPPHIRE INTERFACES; ADHESION STRENGTH; SURFACE-ROUGHNESS;
   SHEAR-STRESS; SHOCK-WAVES; FIBRONECTIN; DETACHMENT; PULSES; ENERGY;
   FORCE
AB A previously developed laser spallation technique to determine the tensile strength of thin film interfaces was successfully adopted to determine the tensile strength of interfaces between three different live mammalian cells (osteoblast, chondrocyte and fibroblast) and polystyrene (untreated and fibronectin coated) and titanium surfaces. No noticeable differences in the interfacial tensile strength values were found across the three cell types on the same substrate although osteoblasts showed slightly lower adhesion strength when cultured on untreated polystyrene surfaces. Significant differences were, however, measured for cells treated on different surfaces. Use of fibronectin increased the interfacial tensile strength for all cell types, kind cells bonded much better to titanium than to untreated polystyrene surfaces. Cell interfacial strength was higher when cultured with serum than in a serum-free environment. The results demonstrate the remarkable sensitivity of the laser spallation experiment in determining the effects of local interfacial microstructure and chemistry on cell adhesion. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Shim, Jaewoo; Hagerman, Elizabeth; Wu, Ben; Gupta, Vijay] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
   [Wu, Ben; Gupta, Vijay] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA.
   [Gupta, Vijay] Univ Calif Los Angeles, Dept Mech Engn, Los Angeles, CA 90095 USA.
RP Gupta, V (reprint author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
EM vgupta@seas.ucla.edu
CR ANDERHOL.NC, 1970, APPL PHYS LETT, V16, P113, DOI 10.1063/1.1653116
   ANDRES J, 1998, J BIOL CHEM, V273, P10988
   Antoun T, 2003, SPALL FRACTURE
   BARKER LM, 1970, J APPL PHYS, V41, P4208, DOI 10.1063/1.1658439
   BARKER LM, 1972, EXP MECH, V12, P209, DOI 10.1007/BF02318100
   Berthe L, 1997, J APPL PHYS, V82, P2826, DOI 10.1063/1.366113
   Bolis C, 2007, J PHYS D APPL PHYS, V40, P3155, DOI 10.1088/0022-3727/40/10/019
   Bundy KJ, 2001, CELL BIOL INT, V25, P289, DOI 10.1006/cbir.2000.0648
   Cargill RS, 1999, BIOMATERIALS, V20, P2417, DOI 10.1016/S0142-9612(99)00169-6
   CHEN PC, 1993, MULTIDIMENSIONAL MIC
   COGSWELL CJ, 1994, 3 DIMENSIONAL MICROS
   FABBRO R, 1990, J APPL PHYS, V68, P775, DOI 10.1063/1.346783
   FISHER JC, 1948, J APPL PHYS, V19, P1062, DOI 10.1063/1.1698012
   Garcia AJ, 2003, CELL BIOCHEM BIOPHYS, V39, P61, DOI 10.1385/CBB:39:1:61
   Goldstein AS, 2002, J BIOMED MATER RES, V59, P665, DOI 10.1002/jbm.1276
   GUPTA V, 1992, J MECH PHYS SOLIDS, V40, P141, DOI 10.1016/0022-5096(92)90296-E
   GUPTA V, 1994, J ADHES SCI TECHNOL, V8, P713, DOI 10.1163/156856194X00447
   Gupta V, 1997, J AM CERAM SOC, V80, P3172
   GUPTA V, 1993, REV SCI INSTRUM, V64, P1611, DOI 10.1063/1.1144034
   Hagerman E, 2007, J BIOMED MATER RES A, V82A, P852, DOI 10.1002/jbm.a.31011
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X
   KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3
   Lev LC, 1996, J APPL PHYS, V80, P529, DOI 10.1063/1.362757
   Mal A, 2002, P SOC PHOTO-OPT INS, V4702, P339, DOI 10.1117/12.469894
   MAL AK, 2005, P 2 INT S MECH SCI B
   Matsumoto B, 1993, CELL BIOL APPL CONFO
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   MONCHALIN JP, 1986, MATER EVAL, V44, P1231
   PRONIN A, 1993, REV SCI INSTRUM, V64, P2233, DOI 10.1063/1.1144452
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Richards RG, 1995, CELL BIOL INT, V19, P1015, DOI 10.1006/cbir.1995.1044
   Scheffer L, 2001, EUR BIOPHYS J BIOPHY, V30, P83, DOI 10.1007/s002490000122
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   VANKOOTEN TG, 1994, MED ENG PHYS, V16, P506, DOI 10.1016/1350-4533(94)90077-9
   Vossen J. L., 1978, Adhesion Measurement of Thin Films, Thick Films and Bulk Coatings, P122, DOI 10.1520/STP38629S
   Williams PR, 1998, PHYS MED BIOL, V43, P3101, DOI 10.1088/0031-9155/43/10/028
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
   YUAN J, 1993, J APPL PHYS, V74, P2388, DOI 10.1063/1.354698
   YUAN J, 1993, J APPL PHYS, V74, P2405, DOI 10.1063/1.354700
   YUAN J, 1995, ACTA METALL MATER, V43, P781, DOI 10.1016/0956-7151(94)00258-J
   YUAN J, 1995, ACTA METALL MATER, V43, P769, DOI 10.1016/0956-7151(94)00257-I
   YUAN J, 1994, THESIS DARTMOUTH COL
NR 44
TC 9
Z9 9
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2008
VL 4
IS 6
BP 1657
EP 1668
DI 10.1016/j.actbio.2008.06.001
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377LT
UT WOS:000261253400009
PM 18640086
DA 2018-10-20
ER

PT J
AU Zalfen, AM
   Nizet, D
   Jerome, C
   Frankenne, F
   Foidart, JM
   Maquet, V
   Lecomte, F
   Hubert, P
   Evrard, B
AF Zalfen, A. M.
   Nizet, D.
   Jerome, C.
   Frankenne, F.
   Foidart, J. M.
   Maquet, V.
   Lecomte, F.
   Hubert, P.
   Evrard, B.
TI Controlled release of drugs from multi-component biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Drug delivery; Controlled release; Hydrogel; Poly(2-hydroxyethyl
   methacrylate); Microspheres
ID POLY(2-HYDROXYETHYL METHACRYLATE) HYDROGELS; DELIVERY SYSTEMS;
   INJECTABLE MICROSPHERES; EPSILON-CAPROLACTONE; SWELLING BEHAVIORS;
   POLY(EPSILON-CAPROLACTONE); PERMEABILITY; FORMULATIONS; MECHANISMS;
   COPOLYMERS
AB In order to control their release, drugs are encapsulated into systems which are expected to provide a certain site with a predetermined amount of drug over a well-defined period of time. Here we report on a multi-component drug delivery biomaterial that consists of a hydrogel matrix in which drug-loaded biodegradable microcarriers are dispersed, and whose potential applications could be found in the design of implantable devices with long-term activity, as required by contraceptive and hormone replacement treatments. The release profile of the drug can actually be tuned by the complex interplay of several release mechanisms, including the permeability and eventually the degradation rate of the microcarriers and the diffusion through the hydrogel. The hydrogel consisted of 2-hydroxyethyl methacrylate cross-linked by ethylene glycol dimethacrylate. The microcarriers were biodegradable poly-epsilon-caprolactone (PCL) microspheres in which active molecules, such as levonorgestrel (LNG), were encapsulated. The hydrogels were characterized by water swelling, thermal properties, LNG diffusion through drug-free and drug-depleted hydrogel membranes and LNG release from devices with drug dispersed in the hydrogel. The PCL microspheres were observed by scanning electron microscopy; their size distribution, LNG loading and release were also investigated. The hydrogel-microsphere assemblies were characterized in terms of the distribution of the microspheres within the hydrogel, water swelling and the release of the encapsulated molecules. The developed device, due to its composite structure, has the ability to combine several release mechanisms, leading to drug release obeying zero-order kinetics for most of the time. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zalfen, A. M.; Jerome, C.; Frankenne, F.] Univ Liege, Ctr Educ & Res Macromol, B-4000 Liege, Belgium.
   [Nizet, D.; Evrard, B.] Univ Liege, Inst Pharm, Pharmaceut Technol Lab, B-4000 Liege, Belgium.
   [Frankenne, F.; Foidart, J. M.] Univ Liege, Lab Biol Tumeurs & Dev, B-4000 Liege, Belgium.
   [Maquet, V.] KitoZyme, B-4040 Herstal, Belgium.
   [Lecomte, F.; Hubert, P.] Univ Liege, Analyt Chem Lab, B-4000 Liege, Belgium.
RP Zalfen, AM (reprint author), Univ Liege, Ctr Educ & Res Macromol, B-4000 Liege, Belgium.
EM Alina.Zalfen@ulg.ac.be
FU Walloon Region Ministry; IAP program
FX The authors wish to thank to the Walloon Region Ministry for the
   financial support accorded in the framework of the IMPUT project through
   the DGTRE. C.J. thanks the IAP program "Functional Supramolecular
   Systems" for financial support.
CR Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f
   BENOIT JP, 1986, INT J PHARM, V29, P95, DOI 10.1016/0378-5173(86)90106-7
   Bhattachar SN, 2002, INT J PHARM, V236, P135, DOI 10.1016/S0378-5173(02)00027-3
   Brazel CS, 1999, POLYMER, V40, P3383, DOI 10.1016/S0032-3861(98)00546-1
   Buntner B, 1998, J CONTROL RELEASE, V56, P159, DOI 10.1016/S0168-3659(98)00085-6
   Chen DR, 2000, POLYM DEGRAD STABIL, V67, P455, DOI 10.1016/S0141-3910(99)00145-7
   Dalton PD, 2001, BIOMATERIALS, V22, P2661, DOI 10.1016/S0142-9612(01)00008-4
   Dash AK, 1997, J MICROENCAPSUL, V14, P101, DOI 10.3109/02652049709056471
   Dhanaraju MD, 2006, J BIOMED MATER RES A, V76A, P63, DOI 10.1002/jbm.a.30458
   Dhanaraju MD, 2004, CHEM PHARM BULL, V52, P976, DOI 10.1248/cpb.52.976
   Dhanaraju MD, 2003, INT J PHARM, V268, P23, DOI 10.1016/j.ijpharm.2003.08.011
   Dziubla TD, 2001, BIOMATERIALS, V22, P2893, DOI 10.1016/S0142-9612(01)00035-7
   Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015
   Garcia O, 2000, EUR POLYM J, V36, P111, DOI 10.1016/S0014-3057(99)00037-3
   Gehrke SH, 1997, ANN NY ACAD SCI, V831, P179
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   He HY, 2004, J CONTROL RELEASE, V95, P391, DOI 10.1016/j.jconrel.2003.12.004
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6
   Jeong JC, 2003, J CONTROL RELEASE, V92, P249, DOI 10.1016/S0168-3659(03)00367-5
   Kishida A., 2002, POLYM BIOMATERIALS, P133
   Lee WF, 1998, POLYM GELS NETW, V6, P493, DOI 10.1016/S0966-7822(99)00002-7
   Liu Q, 2000, BIOMATERIALS, V21, P2163, DOI 10.1016/S0142-9612(00)00137-X
   Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4
   OKADA H, 1995, CRIT REV THER DRUG, V12, P1
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   PINCHUK L, 1984, J BIOMED MATER RES, V18, P671, DOI 10.1002/jbm.820180608
   Pitt C. G., 1980, BIODEGRADABLE DELIVE, P17
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   REFOJO MF, 1967, J POLYM SCI A1, V5, P3103, DOI 10.1002/pol.1967.150051211
   Rosca ID, 2004, J CONTROL RELEASE, V99, P271, DOI 10.1016/j.jconrel.2004.07.007
   Siewert M., 2003, AAPS PHARMSCITECH, V4, P1
   SINCLAIR GW, 1984, J MEMBRANE SCI, V17, P329, DOI 10.1016/S0376-7388(00)83223-8
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   SONG SZ, 1981, J PHARM SCI, V70, P216, DOI 10.1002/jps.2600700226
   Venter JP, 2001, EUR J PHARM SCI, V13, P169, DOI 10.1016/S0928-0987(01)00110-5
   Wang JQ, 2005, EUR POLYM J, V41, P1143, DOI 10.1016/j.europolymj.2004.11.034
   WASHINGTON C, 1990, INT J PHARM, V58, P1, DOI 10.1016/0378-5173(90)90280-H
   Weldemeersch D, 2003, ANN NY ACAD SCI, V997, P174, DOI 10.1196/annals.1290.020
   Yoo JW, 2006, J CONTROL RELEASE, V112, P1, DOI 10.1016/j.jconrel.2006.01.021
   Zahedi P, 2007, EUR J PHARM BIOPHARM, V65, P320, DOI 10.1016/j.ejpb.2006.10.025
NR 43
TC 27
Z9 29
U1 3
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2008
VL 4
IS 6
BP 1788
EP 1796
DI 10.1016/j.actbio.2008.05.021
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377LT
UT WOS:000261253400023
PM 18583206
DA 2018-10-20
ER

PT J
AU Wu, F
   Wei, J
   Guo, H
   Chen, FP
   Hong, H
   Liu, CS
AF Wu, Fan
   Wei, Jie
   Guo, Han
   Chen, Fangping
   Hong, Hua
   Liu, Changsheng
TI Self-setting bioactive calcium-magnesium phosphate cement with high
   strength and degradability for bone regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Magnesium phosphate; Calcium phosphate; Calcium-magnesium phosphate
   cement; Biodegradability; Biocompatibility
ID BETA-TRICALCIUM PHOSPHATE; IN-VITRO BIOACTIVITY; MECHANICAL-PROPERTIES;
   GRAFT SUBSTITUTES; TISSUE-RESPONSE; REPAIR; VIVO; RESORPTION; DIHYDRATE;
   CONCRETE
AB Calcium phosphate cement (CPC) has been successfully used in clinics as bone repair biomaterial for many years. However, poor mechanical properties and a low biodegradation rate limit any further applications. Magnesium phosphate cement (MPC) is characterized by fast setting, high initial strength and relatively rapid degradation in vivo. In this study, MPC was combined with CPC to develop novel calcium-magnesium phosphate cement (CMPC). The setting time, compressive strength, phase composition of hardened cement, degradation in vitro, cells responses in vitro by MG-63 cell culture and tissue responses in vivo by implantation of CMPC in bone defect of rabbits were investigated. The results show that CMPC has a shorter setting time and markedly better mechanical properties than either CPC or MPC. Moreover, CMPC showed significantly improved degradability compared to CPC in simulated body fluid. Cell culture results indicate that CMPC is biocompatible and could support cell attachment and proliferation. To investigate the in vivo biocompatibility and osteogenesis, the CMPC samples were implanted into bone defects in rabbits. Histological evaluation showed that the introduction of MPC into CPC enhanced the efficiency of new bone formation. CMPC also exhibited good biocompatibility, biodegradability and osteoconductivity with host bone in vivo. The results obtained suggest that CMPC, having met the basic requirements of bone tissue engineering, might have a significant clinical advantage over CPC, and may have the potential to be applied in orthopedic, reconstructive and maxillofacial surgery. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wu, Fan; Wei, Jie; Guo, Han; Chen, Fangping; Hong, Hua; Liu, Changsheng] E China Univ Sci & Technol, Engn Res Ctr Biomed Mat, Key Lab Ultrafine Mat, Minist Educ, Shanghai 200237, Peoples R China.
RP Liu, CS (reprint author), E China Univ Sci & Technol, Engn Res Ctr Biomed Mat, Key Lab Ultrafine Mat, Minist Educ, 130 Meilong Rd, Shanghai 200237, Peoples R China.
EM csliu@sh163.net
FU National Science Fund for Distinguished Young Scholars of China
   [20425621]; Major State Basic Research Program of China [2005CCA01000];
   Basic Research Foundation of the Shanghai Science and Technology
   Committee [05DJ14005]; Nano special program of Science and Technology
   Development of Shanghai [0652nm021]
FX The authors appreciate financial support from the National Science Fund
   for Distinguished Young Scholars of China (Grant No. 20425621), the
   Major State Basic Research Program of China (No. 2005CCA01000) and the
   Basic Research Foundation of the Shanghai Science and Technology
   Committee (05DJ14005), and Nano special program of Science and
   Technology Development of Shanghai (No. 0652nm021).
CR Abdelrazig B, 1984, P BR CERAM SOC, V35, P141
   ABDELRAZIG BEI, 1989, CEMENT CONCRETE RES, V19, P247, DOI 10.1016/0008-8846(89)90089-6
   Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Bodde EWH, 2007, J BIOMED MATER RES B, V83B, P161, DOI 10.1002/jbm.b.30780
   Bohner M, 2004, BIOMATERIALS, V25, P741, DOI 10.1016/S0142-9612(03)00573-8
   Brown PW, 1986, CEMENTS RES PROGR, P352
   BURGUERA E, 2004, J BIOMED MATER RES A, V71, P272
   Burguera EF, 2006, J BIOMED MATER RES B, V77B, P126, DOI 10.1002/jbm.b.30403
   Burguera EF, 2005, J BIOMED MATER RES A, V75A, P966, DOI 10.1002/jbm.a.30497
   Carey LE, 2005, BIOMATERIALS, V26, P5002, DOI 10.1016/j.biomaterials.2005.01.015
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   del Real RP, 2003, J BIOMED MATER RES A, V65A, P30, DOI 10.1002/jbm.a.10432
   Fernandez E, 1998, J BIOMED MATER RES, V41, P560, DOI 10.1002/(SICI)1097-4636(19980915)41:4<560::AID-JBM7>3.0.CO;2-A
   Guo DG, 2006, J BIOMED MATER RES A, V77A, P313, DOI 10.1002/jbm.a.30629
   Hall DA, 1998, J AM CERAM SOC, V81, P1550
   Hipedinger NE, 2004, CEMENT CONCRETE RES, V34, P157, DOI 10.1016/S0008-8846(03)00256-4
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Huan Z, 2007, ACTA BIOMATER, V3, P952, DOI 10.1016/j.actbio.2007.05.003
   JAZAIRI BEI, 1987, CONCRETE, V21, P25
   Julien M, 2007, BIOMATERIALS, V28, P956, DOI 10.1016/j.biomaterials.2006.10.018
   KENT JN, 1986, J ORAL MAXIL SURG, V44, P597, DOI 10.1016/S0278-2391(86)80069-6
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Komaki H, 2006, BIOMATERIALS, V27, P5118, DOI 10.1016/j.biomaterials.2006.05.031
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Liu CS, 2006, BIOMATERIALS, V27, P5003, DOI 10.1016/j.biomaterials.2006.05.043
   Liu CS, 2003, BIOMATERIALS, V24, P2995, DOI 10.1016/S0142-9612(03)00125-X
   LIU CS, Patent No. 7094286
   LIU CS, 1996, THESIS E CHINA U SCI
   Niedhart C, 2001, J BIOMED MATER RES, V55, P530, DOI 10.1002/1097-4636(20010615)55:4<530::AID-JBM1046>3.0.CO;2-D
   Ogose A, 2002, J BIOMED MATER RES, V63, P601, DOI 10.1002/jbm.10380
   Ohura K, 1996, J BIOMED MATER RES, V30, P193, DOI 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M
   Ooms EM, 2003, BIOMATERIALS, V24, P749, DOI 10.1016/S0142-9612(02)00408-8
   POPOVICS S, 1987, ACI MATER J, V84, P64
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   SARKAR AK, 1990, AM CERAM SOC BULL, V69, P234
   SEEHRA SS, 1993, CEMENT CONCRETE RES, V23, P254, DOI 10.1016/0008-8846(93)90090-V
   Soudee E, 2002, CEMENT CONCRETE RES, V32, P153, DOI 10.1016/S0008-8846(01)00647-0
   Soudee E, 2000, CEMENT CONCRETE RES, V30, P315, DOI 10.1016/S0008-8846(99)00254-9
   Stevenson S, 1996, CLIN ORTHOP RELAT R, P66
   Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056
   Ueyama Y, 2001, J BIOMED MATER RES, V55, P652, DOI 10.1002/1097-4636(20010615)55:4<652::AID-JBM1060>3.0.CO;2-K
   WU JG, 2006, SHANGHAI MED J, V29, P230
   Wu Jian-guo, 2005, Fudan Xuebao (Yixuekexueban), V32, P707
   Wu Z. Z., 2005, CLIN MED J CHINA, V12, P261
   Wu Zizheng, 2006, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V20, P912
   Xu HHK, 2004, J BIOMED MATER RES A, V68A, P725, DOI 10.1002/jbm.a.20093
   Xu HHK, 2002, J DENT RES, V81, P219, DOI 10.1177/154405910208100315
   Xu HHK, 2007, DENT MATER, V23, P433, DOI 10.1016/j.dental.2006.02.014
   Yang QB, 1999, CEMENT CONCRETE RES, V29, P389, DOI 10.1016/S0008-8846(98)00230-0
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
NR 53
TC 106
Z9 121
U1 4
U2 111
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2008
VL 4
IS 6
BP 1873
EP 1884
DI 10.1016/j.actbio.2008.06.020
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377LT
UT WOS:000261253400032
PM 18662897
DA 2018-10-20
ER

PT J
AU Xin, YC
   Huo, KF
   Tao, H
   Tang, GY
   Chu, PK
AF Xin, Yunchang
   Huo, Kaifu
   Tao, Hu
   Tang, Guoyi
   Chu, Paul K.
TI Influence of aggressive ions on the degradation behavior of biomedical
   magnesium alloy in physiological environment
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Magnesium alloys; Biomaterial; Degradation; Aggressive ions
ID SULFATE-SOLUTIONS; CORROSION; MECHANISMS; IMPLANTS; CHLORIDE
AB Various electrochemical approaches, including potentiodynamic polarization, open circuit potential evolution and electrochemical impedance spectroscopy (EIS), are employed to investigate the degradation behavior of biomedical magnesium alloy under the influence of aggressive ions, such as chloride, phosphate, carbonate and sulfate, in a physiological environment. The synergetic effects and mutual influence of these ions on the degradation behavior of Mg are revealed. Our results demonstrate that chloride ions can induce porous pitting corrosion. In the presence of phosphates, the corrosion rate decreases and the formation of pitting corrosion is significantly delayed due to precipitation of magnesium phosphate. Hydrogen carbonate ions are observed to stimulate the corrosion of magnesium alloy during the early immersion stage but they can also induce rapid passivation on the surface. This surface passivation behavior mainly results from the fast precipitation of magnesium carbonate in the corrosion product layer that can subsequently inhibit pitting corrosion completely. Sulfate ions are also found to stimulate magnesium dissolution. These results improve our understanding on the degradation mechanism of surgical magnesium in the physiological environment. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Xin, Yunchang; Huo, Kaifu; Tao, Hu; Chu, Paul K.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   [Xin, Yunchang; Tang, Guoyi] Tsinghua Univ, Shenzhen Grad Sch, Adv Mat Inst, Shenzhen 518055, Peoples R China.
   [Huo, Kaifu] Wuhan Univ Sci & Technol, Coll Mat & Met, Hubei Prov Key Lab Refractories & Ceram, Wuhan 430081, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI HUO, Kaifu/C-3246-2016; Chu, Paul/B-5923-2013; Xin,
   Yunchang/M-3976-2016; Xin, Yunchang/C-7315-2008; Hu, Tao/H-5137-2011
OI HUO, Kaifu/0000-0001-5670-8233; Chu, Paul/0000-0002-5581-4883; Hu,
   Tao/0000-0001-6937-4017
FU City University of Hong Kong Applied Research Grant [9667002]; Key Grant
   Project of Educational Commission of Hubei Province [Z200711001]; Key
   Project of Chinese Ministry of Education [208087]
FX The Project was supported by a City University of Hong Kong Applied
   Research Grant (ARG, No. 9667002), the Key Grant Project of Educational
   Commission of Hubei Province (Z200711001) and the Key Project of Chinese
   Ministry of Education (No. 208087).
CR Baril G, 2007, J ELECTROCHEM SOC, V154, pC108, DOI 10.1149/1.2401056
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Gao Jia-cheng, 2004, Chinese Journal of Nonferrous Metals, V14, P1508
   Lindstrom R, 2004, CORROS SCI, V46, P1141, DOI 10.1016/j.corsci.2003.09.010
   Mathieu S, 2003, CORROS SCI, V45, P2741, DOI 10.1016/S0010-938X(03)00109-4
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   Morks MF, 2004, MATER LETT, V58, P3316, DOI 10.1016/j.matlet.2004.06.027
   Revell PA, 2004, KEY ENG MAT, V254-2, P447, DOI 10.4028/www.scientific.net/KEM.254-256.447
   Shao CL, 2006, J MATER SCI, V41, P3821, DOI 10.1007/s10853-005-5623-3
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tongamp W, 2007, J MATER SCI, V42, P9210, DOI 10.1007/s10853-007-1866-5
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   WILTE F, 2006, BIOMATERIALS, V27, P1013
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Zhang YJ, 2005, CORROS SCI, V47, P2816, DOI 10.1016/j.corsci.2005.01.010
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 21
TC 178
Z9 184
U1 2
U2 79
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2008
VL 4
IS 6
BP 2008
EP 2015
DI 10.1016/j.actbio.2008.05.014
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377LT
UT WOS:000261253400045
PM 18571486
DA 2018-10-20
ER

PT J
AU Liu, YY
   Liu, DM
   Chen, SY
   Tung, TH
   Liu, TY
AF Liu, Yen-Yu
   Liu, Dean-Mo
   Chen, San-Yuan
   Tung, Tsan-Hua
   Liu, Tse-Ying
TI In situ synthesis of hybrid nanocomposite with highly order arranged
   amorphous metallic copper nanoparticle in poly(2-hydroxyethyl
   methacrylate) and its potential for blood-contact uses
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Copper nanoparticles; Cupric oxide; pHEMA; Hybrid; Surface charge
ID NITRIC-OXIDE; HEMOCOMPATIBILITY; COMPATIBILITY; PLASMA; BIOMATERIALS;
   REDUCTION; PLATELETS; MEMBRANE; COATINGS; COMPLEX
AB A hybrid consisting of a highly ordered nanostructure of metallic Cu(0) nanoparticles embedded in a poly(2-hydroxyethyl methacrylate) (pHEMA) matrix was successfully synthesized by in situ photopolymerization, followed by in situ chemical reduction. The evolution of an ordered nanostructure of Cu(0) showing a nearly amorphous nature is discussed, and it is proposed that it is due to a coupling interaction between the Cu precursor and the unpaired O of the COOR group, associated with water molecules, among pHEMA molecules. The hybrids showed a negative surface charge and considerable improvement in blood compatibility compared to neat pHEMA and the widely used biomaterial polysulfonate. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Liu, Yen-Yu; Liu, Dean-Mo; Chen, San-Yuan; Tung, Tsan-Hua] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu, Taiwan.
   [Liu, Tse-Ying] Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
RP Liu, DM (reprint author), Natl Chiao Tung Univ, Dept Mat Sci & Engn, 1001 Ta Hsueh Rd, Hsinchu, Taiwan.
EM deanmo_liu@yahoo.ca; sanyuanchen@mail.nctu.edu.tw
FU National Science Council of the Republic of China, Taiwan
   [NSC96-2113-M-009-027-MY2]
FX This work was financially supported by the National Science Council of
   the Republic of China, Taiwan under Contract of No.
   NSC96-2113-M-009-027-MY2.
CR BAURSCHMIDT P, 1977, J BIOENG, V1, P261
   Bolz A, 1996, TEX HEART I J, V23, P162
   Dey RK, 2005, J MACROMOL SCI PURE, VA42, P351, DOI 10.1081/MA-200050470
   Goda T, 2006, EXPERT REV MED DEVIC, V3, P167, DOI 10.1586/17434440.3.2.167
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   Hirota E, 2006, J BIOMED MATER RES A, V76A, P540, DOI 10.1002/jbm.a.30563
   Hu CC, 2006, J CHEM ENG JPN, V39, P1283, DOI 10.1252/jcej.39.1283
   Huang C, 1999, APPL PHYS LETT, V74, P1692, DOI 10.1063/1.123657
   Kong DY, 1999, BIOORG MED CHEM LETT, V9, P1087
   Kung FC, 2007, POLYM ADVAN TECHNOL, V18, P286, DOI 10.1002/pat.863
   Liu Y, 2007, SURF COAT TECH, V201, P6851, DOI 10.1016/j.surfcoat.2006.09.021
   Merga G, 2007, J PHYS CHEM C, V111, P12220, DOI 10.1021/jp074257w
   Oh BK, 2004, BIOMATERIALS, V25, P283, DOI 10.1016/S0142-9612(03)00530-1
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Shih CC, 2005, J BIOMED MATER RES A, V74A, P325, DOI 10.1002/ibm.a.30255
   Skarja GA, 1997, J BIOMED MATER RES, V34, P439, DOI 10.1002/(SICI)1097-4636(19970315)34:4<439::AID-JBM5>3.0.CO;2-L
   Topala I, 2007, PLASMA CHEM PLASMA P, V27, P95, DOI 10.1007/s11090-006-9046-y
   Tsyganov IA, 2007, NUCL INSTRUM METH B, V257, P122, DOI 10.1016/j.nimb.2006.12.169
   Wang J, 2007, COLLOID SURFACE A, V302, P494, DOI 10.1016/j.colsurfa.2007.03.021
   Wu YD, 2007, SENSOR ACTUAT B-CHEM, V121, P36, DOI 10.1016/j.snb.2006.09.025
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
NR 21
TC 16
Z9 17
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2008
VL 4
IS 6
BP 2052
EP 2058
DI 10.1016/j.actbio.2008.05.022
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 377LT
UT WOS:000261253400050
PM 18585991
DA 2018-10-20
ER

PT J
AU Duran, N
   Alvarenga, MA
   Da Silva, EC
   Melo, PS
   Marcato, PD
AF Duran, N.
   Alvarenga, M. A.
   Da Silva, E. C.
   Melo, P. S.
   Marcato, P. D.
TI Microencapsulation of Antibiotic Rifampicin in
   Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
SO ARCHIVES OF PHARMACAL RESEARCH
LA English
DT Article
DE Controlled release/delivery; Emulsion/microemulsion; Biomaterial;
   Microparticles; Biodegradable polymers;
   Poly(3-hydroxybutyrate-co-3-hydroxyvalerate); Rifampicin; Antibacterial
   Activity; Cytotoxicity
ID ANTIBACTERIAL ACTIVITY EVALUATION; LOADED PLGA MICROSPHERES;
   EXPERIMENTAL TUBERCULOSIS; V79 FIBROBLASTS; DRUG-DELIVERY; RELEASE;
   NANOPARTICLES; POLY(EPSILON-CAPROLACTONE); MICROPARTICLES; CYTOTOXICITY
AB The aim of this study was the preparation of microparticles containing rifampicin using a biodegradable polymer poly(3-hydroxybutyrate-co-3-hydroxyvalerate) for oral administration produced by a bacteria. The poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microparticles with and without rifampicin were prepared by the emulsification and solvent evaporation method, in which chloroform and polyvinyl alcohol are used as the solvent and emulsifier, respectively. Microparticles were obtained within a size range of 20-60 mu m by changing the initial poly(3-hydroxybutyrate-co-3-hydroxyvalerate), polyvinyl alcohol and rifampicin concentrations. An encapsulation efficiency value of 14% was obtained. The optimized total yield of 60% of the poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/rifampicin was obtained. A load of 0.035 mg/l mg of PHBV was reached. Almost 90% of the drug loaded in the microparticles was released after 24 h. The size, encapsulation efficiency and ribampicin release of the microparticles varied as a function of the initial poly(3-hydroxybutyrate-co-3-hydroxyvalerate), polyvinyl alcohol and rifampicin concentrations. It was demonstrated that the microencapsulated rifampicin, although was not totally available in the medium, exhibited a similar inhibition value as free rifampicin at 24 h of incubation with S. aureus. Cytotoxicity assays demonstrated a reduction of the toxicity when rifampicin was microencapsulated in poly(3-hydroxybutyrate-co-3-hydroxyvalerate) while maintaining its antibacterial activity.
C1 [Duran, N.; Marcato, P. D.] Univ Estadual Campinas, Inst Quim, Biol Chem Lab, BR-13083970 Campinas, SP, Brazil.
   [Alvarenga, M. A.; Da Silva, E. C.] Univ Mogi das Cruzes, Biol Chem & Biotechnol Lab, Nucleo Ciencias Ambientais, Mogi Das Cruzes, SP, Brazil.
   [Melo, P. S.] Univ Estadual Campinas, Inst Biol, Dept Bioquim, BR-13083970 Campinas, SP, Brazil.
   [Melo, P. S.] Metropolitam Integrated Fac Campinas METROCAMP, Campinas, SP, Brazil.
RP Duran, N (reprint author), Univ Estadual Campinas, Inst Quim, Biol Chem Lab, CP 6154, BR-13083970 Campinas, SP, Brazil.
EM duran@iqm.unicamp.br
RI Marcato, Priscyla/D-4371-2012
OI Duran, Nelson/0000-0001-8372-5143
FU CNPq; FAPESP; Brazilian Network in Nanobiotechnology and Brazilian
   Network in Nanocosmetics (MCT/CNPq)
FX We acknowledge the financial support from CNPq, FAPESP, Brazilian
   Network in Nanobiotechnology and Brazilian Network in Nanocosmetics
   (MCT/CNPq).
CR Anisimova YV, 2000, J NANOPART RES, V2, P165, DOI 10.1023/A:1010061013365
   BIANCHI V, 1990, TOXICOL IN VITRO, V4, P9, DOI 10.1016/0887-2333(90)90003-C
   Borenfreunds E, 1984, J TISSUE CULTURE MET, V9, P7
   Borin A, 2007, ANAL BIOANAL CHEM, V387, P1105, DOI 10.1007/s00216-006-0971-7
   Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0
   Celikkaya E, 1996, ARTIF ORGANS, V20, P743
   Chen J, 2002, J MICROENCAPSUL, V19, P191, DOI 10.1080/02652040110065431
   CINGI MR, 1991, TOXICOL IN VITRO, V5, P119, DOI 10.1016/0887-2333(91)90031-8
   Coccoli V, 2008, J MATER SCI-MATER M, V19, P1703, DOI 10.1007/s10856-007-3253-9
   Coimbra PA, 2008, J MICROENCAPSUL, V25, P170, DOI [10.1080/02652040701814140, 10.1080/02652040701814140 ]
   Correa DHA, 2005, EUR J PHARMACOL, V510, P17, DOI 10.1016/j.ejphar.2005.01.016
   Dang MH, 1997, J ENVIRON POLYM DEGR, V5, P49
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Duran N, 2007, PHARMAZIE, V62, P287, DOI 10.1691/ph.2007.4.6058
   Duran N, 2006, J CHEMOTHERAPY, V18, P473, DOI 10.1179/joc.2006.18.5.473
   Esmaeili F, 2007, NANOMED-NANOTECHNOL, V3, P161, DOI 10.1016/j.nano.2007.03.003
   FUMORI I, 2004, COLLOID SURFACE B, V39, P17
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3
   HARMA R, 2001, PHARM RES, V18, P1405
   Kamath M. P., 2000, Indian Journal of Experimental Biology, V38, P113
   Kassab AC, 1997, J BIOMAT SCI-POLYM E, V8, P947, DOI 10.1163/156856297X00119
   Labana S, 2002, INT J ANTIMICROB AG, V20, P301, DOI 10.1016/S0924-8579(02)00175-9
   Marcato PD, 2008, J NANOSCI NANOTECHNO, V8, P2216, DOI 10.1166/jnn.2008.274
   Pandey R, 2006, DRUG DELIV, V13, P287, DOI 10.1080/10717540500398076
   Pandey R, 2005, TUBERCULOSIS, V85, P415, DOI 10.1016/j.tube.2005.08.009
   Pandey R, 2003, J ANTIMICROB CHEMOTH, V52, P981, DOI 10.1093/jac/dkg477
   Pandey Rajesh, 2006, Indian Journal of Experimental Biology, V44, P459
   Petrelli D, 2008, J MED MICROBIOL, V57, P364, DOI 10.1099/jmm.0.47621-0
   Pich A, 2006, POLYMER, V47, P1912, DOI 10.1016/j.polymer.2006.01.038
   Schaffazick SR, 2003, QUIM NOVA, V26, P726, DOI 10.1590/S0100-40422003000500017
   Sendil D, 1999, J CONTROL RELEASE, V59, P207, DOI 10.1016/S0168-3659(98)00195-3
   Sharma R, 2007, J ANTIMICROB CHEMOTH, V59, P499, DOI 10.1093/jac/dkl533
   Takenaga M, 2008, DRUG DELIV, V15, P169, DOI 10.1080/10717540801952530 
   Tomoda K, 2005, COLLOID SURFACE B, V45, P1, DOI 10.1016/j.colsurfb.2005.06.014
   Tomoda K, 2007, COLLOID SURFACE B, V55, P115, DOI 10.1016/j.colsurfb.2006.11.030
   ULAIN Q, 2003, J ANTIMICROB CHEMOTH, V51, P931
   Zahoor A, 2005, INT J ANTIMICROB AG, V26, P298, DOI 10.1016/j.ijantimicag.2005.07.012
   ZAHOOR A, 2007, NANOMEDICINE NBM, V3, P239
NR 39
TC 25
Z9 27
U1 1
U2 19
PU PHARMACEUTICAL SOC KOREA
PI SEOUL
PA 1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA
SN 0253-6269
J9 ARCH PHARM RES
JI Arch. Pharm. Res.
PD NOV
PY 2008
VL 31
IS 11
BP 1509
EP 1516
DI 10.1007/s12272-001-2137-7
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 387GC
UT WOS:000261938700018
PM 19023549
DA 2018-10-20
ER

PT J
AU de Mel, A
   Jell, G
   Stevens, MM
   Seifalian, AM
AF de Mel, Achala
   Jell, Gavin
   Stevens, Molly M.
   Seifalian, Alexander M.
TI Biofunctionalization of Biomaterials for Accelerated in Situ
   Endothelialization: A Review
SO BIOMACROMOLECULES
LA English
DT Review
ID COLONY-STIMULATING FACTOR; STEM-CELL FACTOR; EXTRACELLULAR-MATRIX
   PROTEINS; RANDOMIZED CONTROLLED-TRIAL; SYNTHETIC VASCULAR GRAFTS;
   PACLITAXEL-ELUTING STENT; CORONARY-ARTERY-DISEASE; PROGENITOR CELLS;
   NITRIC-OXIDE; NEOINTIMAL HYPERPLASIA
AB The higher patency rates of cardiovascular implants, including vascular bypass grafts, stents, and heart valves are related to their ability to inhibit thrombosis, intimal hyperplasia, and calcification. In native tissue, the endothelium plays a major role in inhibiting these processes. Various bioengineering research strategies thereby aspire to induce endothelialization of graft surfaces either prior to implantation or by accelerating in situ graft endothelialization. This article reviews potential bioresponsive molecular components that can be incorporated into (and/or released from) biomaterial surfaces to obtain accelerated in situ endothelialization of vascular grafts. These molecules could promote in situ endothelialization by the mobilization of endothelial progenitor cells (EPC) from the bone marrow, encouraging cell-specific adhesion (endothelial cells (EC) and/or EPC) to the graft and, once attached, by controlling the proliferation and differentiation of these cells. EC and EPC interactions with the extracellular matrix continue to be a principal source of inspiration for material biofunctionalization, and therefore, the latest developments in understanding these interactions will be discussed.
C1 [de Mel, Achala; Seifalian, Alexander M.] UCL, Ctr Nanotechnol Biomat & Tissue Engn, UCL Div Surg & Intervent Sci, London, England.
   [Jell, Gavin; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
   [Jell, Gavin; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London, England.
   [Seifalian, Alexander M.] Royal Free Hampstead NHS Trust Hosp, Univ Dept Surg, London, England.
RP Seifalian, AM (reprint author), UCL, Ctr Nanotechnol Biomat & Tissue Engn, UCL Div Surg & Intervent Sci, London, England.
EM a.seifalian@ucl.ac.uk
RI Jell, Gavin/C-4893-2009; Seifalian, Alexander/I-6028-2013; Jell,
   Gavin/B-7855-2010
OI Seifalian, Alexander/0000-0002-1180-3322; 
FU Engineering and Physical Sciences Research Council [EP/D064872/1]
CR Aicher A, 2005, HYPERTENSION, V45, P321, DOI 10.1161/01.HYP.0000154789.28695.ea
   ALLENDER S, 2007, BRIT EART FDN ANN RE
   Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Alobaid N, 2005, CLIN HEMORHEOL MICRO, V33, P209
   Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048
   Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X
   Baguneid M, 2004, BIOTECHNOL APPL BIOC, V39, P151, DOI 10.1042/BA20030148
   Bahlmann FH, 2003, KIDNEY INT, V64, P1648, DOI 10.1046/j.1523-1755.2003.00279.x
   Bhat VD, 1998, J BIOMED MATER RES, V40, P57, DOI 10.1002/(SICI)1097-4636(199804)40:1<57::AID-JBM7>3.3.CO;2-6
   Blindt R, 2006, J AM COLL CARDIOL, V47, P1786, DOI 10.1016/j.jacc.2005.11.081
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Brewster LP, 2007, BIOMATERIALS, V28, P5028, DOI 10.1016/j.biomaterials.2007.07.048
   BUNTING S, 1977, LANCET, V2, P1075
   Cagiannos C, 2005, J VASC SURG, V42, P980, DOI 10.1016/j.jvs.2005.06.018
   Cavallaro G, 2007, J SURG RES, V137, P122, DOI 10.1016/j.jss.2006.07.038
   Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CHENG S, 1994, J MED CHEM, V37, P1, DOI 10.1021/jm00027a001
   Cho CS, 2006, BIOMATERIALS, V27, P576, DOI 10.1016/j.biomaterials.2005.06.008
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   COYLE CH, 2006, J BIOMATER APPL
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Daub K, 2007, SEMIN THROMB HEMOST, V33, P173, DOI 10.1055/s-2007-969031
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dentelli P, 2007, BLOOD, V109, P4264, DOI 10.1182/blood-2006-06-029603
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Doyle B, 2005, TRENDS BIOTECHNOL, V23, P444, DOI 10.1016/j.tibtech.2005.05.013
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   FERNANDEZ P, 2007, TISSUE ENG
   Frost MC, 2005, J BIOMED MATER RES A, V72A, P409, DOI 10.1002/jbm.a.30275
   Frost MC, 2004, J AM CHEM SOC, V126, P1348, DOI 10.1021/ja039466i
   Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE
   Gasteier P, 2007, MACROMOL BIOSCI, V7, P1010, DOI 10.1002/mabi.200700064
   Gauvreau V, 2005, BIOCONJUGATE CHEM, V16, P1088, DOI 10.1021/bc049717s
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   George J, 2005, CARDIOVASC RES, V68, P299, DOI 10.1016/j.cardiores.2005.06.022
   GREISLER HP, 1987, J VASC SURG, V5, P393, DOI 10.1067/mva.1987.avs0050393
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   GROTE K, 2007, BLOOD
   GROVES JT, 2005, SCI STKE, pE45
   Han DK, 2006, ARTIF ORGANS, V30, P955, DOI 10.1111/j.1525-1594.2006.00327.x
   Hasegawa T, 2007, J THORAC CARDIOV SUR, V133, P1268, DOI 10.1016/j.jtcvs.2006.12.049
   Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354
   Heilshorn SC, 2005, BIOMACROMOLECULES, V6, P318, DOI 10.1021/bm049627q
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   Hoffmann J, 2006, J BIOMAT SCI-POLYM E, V17, P985, DOI 10.1163/156856206778366059
   Hollenbeck ST, 2004, J SURG RES, V120, P288, DOI 10.1016/j.jss.2004.01.008
   Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68
   Hsu SH, 2004, J BIOTECHNOL, V111, P143, DOI 10.1016/j.jbiotec.2004.03.014
   Hsu SH, 2003, ARTIF ORGANS, V27, P1068, DOI 10.1111/j.1525-1594.2003.07141.x
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Hunter WL, 2006, ADV DRUG DELIVER REV, V58, P347, DOI 10.1016/j.addr.2006.01.013
   Hynd MR, 2007, J NEUROSCI METH, V162, P255, DOI 10.1016/j.jneumeth.2007.01.024
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Inoguchi H, 2007, BIOMATERIALS, V28, P486, DOI 10.1016/j.biomaterials.2006.09.020
   Ishizawa K, 2004, BIOCHEM BIOPH RES CO, V324, P276, DOI 10.1016/j.bbrc.2004.09.049
   Jevon M, 2008, CELL PROLIFERAT, V41, P146, DOI 10.1111/j.1365-2184.2008.00488.x
   Jiang XS, 2006, BIOMATERIALS, V27, P2723, DOI 10.1016/j.biomaterials.2005.12.001
   Jun HW, 2005, TISSUE ENG, V11, P1133, DOI 10.1089/ten.2005.11.1133
   Jun HW, 2005, BIOMACROMOLECULES, V6, P838, DOI 10.1021/bm049419y
   Kang HJ, 2004, LANCET, V363, P751, DOI 10.1016/S0140-6736(04)15689-4
   Kannan RY, 2006, BIOMATERIALS, V27, P4618, DOI 10.1016/j.biomaterials.2006.04.024
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Karrer L, 2005, INT J ARTIF ORGANS, V28, P993
   Kaul S, 2000, J AM COLL CARDIOL, V35, P493, DOI 10.1016/S0735-1097(99)00543-4
   KHADEMHOSSEINI A, 2007, NANOBIOTECHNOL DRUG
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kidane AG, 2006, J BIOMED MATER RES A, V79A, P606, DOI 10.1002/jbm.a.30817
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265
   Kojima N, 2006, BIOMATERIALS, V27, P4904, DOI 10.1016/j.biomaterials.2006.05.026
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Kown MH, 2001, J THORAC CARDIOV SUR, V121, P971, DOI 10.1067/mtc.2001.112532
   Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017
   Krijgsman B, 2002, TISSUE ENG, V8, P673, DOI 10.1089/107632702760240580
   Kumar TRS, 2001, BIOMATERIALS, V22, P2769
   Lahtinen M, 2007, EUR J CARDIO-THORAC, V31, P383, DOI 10.1016/j.ejcts.2006.11.048
   Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e
   Langer HF, 2007, SEMIN THROMB HEMOST, V33, P136, DOI 10.1055/s-2007-969026
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Larsen CC, 2007, BIOMATERIALS, V28, P3537, DOI 10.1016/j.biomaterials.2007.04.026
   Letourneur D, 2002, J BIOMED MATER RES, V60, P94, DOI 10.1002/jbm.10072
   Lev EI, 2006, THROMB HAEMOSTASIS, V96, P498, DOI 10.1160/TH06-05-0250
   Li C, 2005, J BIOMAT SCI-POLYM E, V16, P875, DOI 10.1163/1568562054255754
   Lin X, 2006, BBA-GEN SUBJECTS, V1760, P1403, DOI 10.1016/j.bbagen.2006.05.010
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mart RJ, 2006, SOFT MATTER, V2, P822, DOI 10.1039/b607706d
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   McMillan R, 2001, J BIOMED MATER RES, V54, P272, DOI 10.1002/1097-4636(200102)54:2<272::AID-JBM15>3.0.CO;2-3
   Meinhart JG, 2005, TISSUE ENG, V11, P887, DOI 10.1089/ten.2005.11.887
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   Moore MAS, 2001, ANN NY ACAD SCI, V938, P36
   Mougin K, 2005, LANGMUIR, V21, P4809, DOI 10.1021/la050613v
   Ochsenhirt SE, 2006, BIOMATERIALS, V27, P3863, DOI 10.1016/j.biomaterials.2005.12.012
   Olbrich M, 2007, J BIOMAT SCI-POLYM E, V18, P453, DOI 10.1163/156856207780425059
   Park K, 2000, J BIOMAT SCI-POLYM E, V11, P1121, DOI 10.1163/156856200744228
   PATEL S, 2007, J BIOMED MAT RES A
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   Plouffe BD, 2007, LANGMUIR, V23, P5050, DOI 10.1021/la0700220
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Qin GJ, 2006, J EXP MED, V203, P153, DOI 10.1084/jem.20050459
   RADOMSKI MW, 1987, LANCET, V2, P1057
   Randone B, 2005, J SURG RES, V127, P70, DOI 10.1016/j.jss.2004.09.005
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reynolds MM, 2006, BIOMACROMOLECULES, V7, P987, DOI 10.1021/bm060028o
   Rodenberg EJ, 2007, TISSUE ENG, V13, P2653, DOI 10.1089/ten.2007.0037
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Ruegg C, 2004, BBA-REV CANCER, V1654, P51, DOI 10.1016/j.bbcan.2003.09.003
   Salacinski HJ, 2003, J BIOMED MATER RES A, V66A, P688, DOI 10.1002/jbm.a.10020
   Salacinski HJ, 2000, EUR J VASC ENDOVASC, V20, P342, DOI 10.1053/ejvs.2000.1185
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Sarkar S, 2007, MED BIOL ENG COMPUT, V45, P327, DOI 10.1007/s11517-007-0176-z
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   Schachner M, 2000, NATURE, V405, P747, DOI 10.1038/35015648
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5
   Seifalian AM, 2002, ARTIF ORGANS, V26, P209, DOI 10.1046/j.1525-1594.2002.00878.x
   Shin JH, 2007, J AM CHEM SOC, V129, P4612, DOI 10.1021/ja0674338
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smadja DM, 2007, CELL BIOL TOXICOL, V23, P223, DOI 10.1007/s10565-007-0177-6
   SMITH JW, 1990, J BIOL CHEM, V265, P2168
   SMITH JW, 1990, J BIOL CHEM, V265, P12267
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215
   Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441
   TAITE LJ, 2007, J BIOMED MAT RES B
   Takamiya M, 2006, ARTERIOSCL THROM VAS, V26, P751, DOI 10.1161/01.ATV.0000205607.98538.9a
   Tan YH, 2007, CARDIOVASC RES, V73, P823, DOI 10.1016/j.cardiores.2006.12.015
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Thebaud NB, 2007, J MATER SCI-MATER M, V18, P339, DOI 10.1007/s10856-006-0698-1
   Thomas AC, 2003, CARDIOVASC PATHOL, V12, P271, DOI 10.1016/S1054-8807(03)00086-3
   Tigue CC, 2007, BONE MARROW TRANSPL, V40, P185, DOI 10.1038/sj.bmt.1705722
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P325, DOI 10.1053/ejvs.2002.1854
   Urao N, 2006, CIRC RES, V98, P1405, DOI 10.1161/01.RES.0000224117.59417.f3
   Urban P, 2007, LANCET, V369, P619, DOI 10.1016/S0140-6736(07)60289-X
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   VANE JR, 1991, WIEN KLIN WOCHENSCHR, V103, P403
   Vats A, 2005, LANCET, V366, P592, DOI 10.1016/S0140-6736(05)66879-1
   Veiseh M, 2007, LANGMUIR, V23, P4472, DOI 10.1021/la062849k
   Verma S, 2005, NEW ENGL J MED, V353, P730, DOI 10.1056/NEJMcibr052030
   Walpoth BH, 2007, J THORAC CARDIOV SUR, V133, P1163, DOI 10.1016/j.jtcvs.2007.01.029
   Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55
   Wang CH, 2006, CIRC RES, V99, P617, DOI 10.1161/01.RES.0000243210.79654.fd
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wojakowski W, 2006, EUR HEART J, V27, P1013, DOI 10.1093/eurheartj/ehi889
   Woolfson DN, 2006, CURR OPIN CHEM BIOL, V10, P559, DOI 10.1016/j.cbpa.2006.09.019
   Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Yin ZL, 1997, CLIN EXP PHARMACOL P, V24, P436, DOI 10.1111/j.1440-1681.1997.tb01218.x
   Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 173
TC 202
Z9 203
U1 9
U2 117
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2008
VL 9
IS 11
BP 2969
EP 2979
DI 10.1021/bm800681k
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 371UM
UT WOS:000260856900001
PM 18831592
DA 2018-10-20
ER

PT J
AU Strand, SP
   Issa, MM
   Christensen, BE
   Varum, KM
   Artursson, P
AF Strand, Sabina P.
   Issa, Mohamed M.
   Christensen, Bjorn E.
   Varum, Kjell M.
   Artursson, Per
TI Tailoring of Chitosans for Gene Delivery: Novel Self-Branched
   Glycosylated Chitosan Oligomers with Improved Functional Properties
SO BIOMACROMOLECULES
LA English
DT Article
ID ADMINISTRATION IN-VIVO; TRANSFECTION EFFICIENCY; PHYSICOCHEMICAL
   PROPERTIES; INTRACELLULAR TRAFFICKING; CHEMICAL-MODIFICATION;
   LIGHT-SCATTERING; MOLECULAR-WEIGHT; VITRO; DNA; CYTOTOXICITY
AB Chitosan is a promising biomaterial with an attractive safety profile; however, its application potential for gene delivery is hampered by poor compatibility at physiological pH values. Here we have tailored the molecular architecture of chitosan to improve the functional properties and gene transfer efficacy of chitosan oligomers and have developed self-branched glycosylated chitosan oligomer (SB-TCO) substituted with a trisaccharide containing N-acetylglucosamine, AAM. SB-TCO was prepared by controlled depolymerization of chitosan, followed by simultaneous branching and AAM substitution. The product was fully soluble at physiological pH and complexed plasmid DNA into polyplexes of high colloidal and physical stability. SB-TCO displayed high transfection efficacy in HEK293 cells, reaching transfection efficiencies of up to 70%, and large amounts of transgene were produced. Gene transfer efficacy was confirmed in HepG2 cells, where gene expression levels mediated by SB-TCO were up to 10 and 4 times higher than those obtained with unsubstituted and substituted linear oligomers, respectively. The rapid onset of transgene expression in both cell lines indicates efficient DNA release and transcription from SB-TCO polyplexes. In comparison with 22 kDa linear PEI-based transfection reagent used as the control, SB-TCO possessed higher gene transfer efficacy, significantly lower cytotoxicity, and improved serum compatibility.
C1 [Strand, Sabina P.; Christensen, Bjorn E.; Varum, Kjell M.] Norwegian Univ Sci & Technol NTNU, Norwegian Biopolymer Lab NOBIPOL, Dept Biotechnol, N-7491 Trondheim, Norway.
   [Strand, Sabina P.; Issa, Mohamed M.; Artursson, Per] Uppsala Univ, Dept Pharm, S-75123 Uppsala, Sweden.
RP Strand, SP (reprint author), Norwegian Univ Sci & Technol NTNU, Norwegian Biopolymer Lab NOBIPOL, Dept Biotechnol, N-7491 Trondheim, Norway.
EM sabina.strand@biotech.ntnu.no
RI Christensen, Bjorn E./G-6033-2015
OI Christensen, Bjorn E./0000-0002-1135-9815
FU Norwegian University of Science and Technology; Novamatrix/FMC
   Biopolymer AS (Oslo, Norway)
FX This work was supported by a post doc fellowship from Norwegian
   University of Science and Technology to S.P.S. and a grant from
   Novamatrix/FMC Biopolymer AS (Oslo, Norway).
CR Akinc A, 2003, BIOCONJUGATE CHEM, V14, P979, DOI 10.1021/bc034067y
   Arote R, 2007, BIOMATERIALS, V28, P735, DOI 10.1016/j.biomaterials.2006.09.028
   Bowman K, 2006, INT J NANOMED, V1, P117, DOI 10.2147/nano.2006.1.2.117
   Breunig M, 2004, J NANOSCI NANOTECHNO, V4, P512, DOI 10.1166/jnn.2004.080
   Breunig M, 2007, P NATL ACAD SCI USA, V104, P14454, DOI 10.1073/pnas.0703882104
   Christensen BE, 2008, CARBOHYD POLYM, V74, P559, DOI 10.1016/j.carbpol.2008.04.012
   Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Danielsen S, 2005, BBA-GEN SUBJECTS, V1721, P44, DOI 10.1016/j.bbagen.2004.10.011
   Danielsen S, 2004, BIOMACROMOLECULES, V5, P928, DOI 10.1021/bm034502r
   Dash PR, 2000, J BIOL CHEM, V275, P3793, DOI 10.1074/jbc.275.6.3793
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
   Germershaus O, 2008, J CONTROL RELEASE, V125, P145, DOI 10.1016/j.jconrel.2007.10.013
   Hashimoto M, 2006, BIOCONJUGATE CHEM, V17, P309, DOI 10.1021/bc050228h
   Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004
   Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008
   Issa MM, 2006, J CONTROL RELEASE, V115, P103, DOI 10.1016/j.jconrel.2006.06.029
   Issa Mohamed M, 2005, Drug Discov Today Technol, V2, P1, DOI 10.1016/j.ddtec.2005.05.008
   Jiang X, 2006, J GENE MED, V8, P477, DOI 10.1002/jgm.868
   Jon S, 2003, BIOMACROMOLECULES, V4, P1759, DOI 10.1021/bm034176f
   Kean T, 2005, J CONTROL RELEASE, V103, P643, DOI 10.1016/j.jconrel.2004.01.001
   Kim TH, 2007, PROG POLYM SCI, V32, P726, DOI 10.1016/j.progpolymsci.2007.05.001
   Koping-Hoggard M, 2004, GENE THER, V11, P1441, DOI 10.1038/sj.gt.3302312
   Koping-Hoggard M, 2003, J GENE MED, V5, P130, DOI 10.1002/jgm.327
   Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492
   Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029
   Lee D, 2007, PHARM RES, V24, P157, DOI 10.1007/s11095-006-9136-9
   Lee KY, 2007, MACROMOL RES, V15, P195, DOI 10.1007/BF03218774
   Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014
   Mao SR, 2004, INT J PHARM, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019
   Merdan T, 2005, BIOCONJUGATE CHEM, V16, P785, DOI 10.1021/bc049743q
   Mishra S, 2004, EUR J CELL BIOL, V83, P97, DOI 10.1078/0171-9335-00363
   Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.mythe.2005.02.010
   Nagasaki T, 2004, BIOCONJUGATE CHEM, V15, P249, DOI 10.1021/bc034178x
   Park IK, 2003, J DISPER SCI TECHNOL, V24, P489, DOI 10.1081/DIS-120021804
   Romoren K, 2003, INT J PHARM, V261, P115, DOI 10.1016/S0378-5173(03)00301-6
   Srinivasachari S, 2007, BIOMATERIALS, V28, P2885, DOI 10.1016/j.biomaterials.2007.01.037
   Srinivasachari S, 2006, J AM CHEM SOC, V128, P8176, DOI 10.1021/ja0585580
   Strand SP, 2005, BIOMACROMOLECULES, V6, P3357, DOI 10.1021/bm0503726
   Strand SP, 2001, BIOMACROMOLECULES, V2, P1310, DOI 10.1021/bm015598x
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014
   Tommeraas K, 2001, CARBOHYD RES, V333, P137, DOI 10.1016/S0008-6215(01)00130-6
   Tommeraas K, 2002, CARBOHYD RES, V337, P2455, DOI 10.1016/S0008-6215(02)00334-8
   Varum K. M., 2004, POLYSACCHARIDES STRU, P625
   VARUM KM, 1994, CARBOHYD POLYM, V25, P65, DOI 10.1016/0144-8617(94)90140-6
   Zhang YQ, 2007, BIOTECHNOL APPL BIOC, V46, P197, DOI 10.1042/BA2060163
NR 48
TC 65
Z9 69
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2008
VL 9
IS 11
BP 3268
EP 3276
DI 10.1021/bm800832u
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 371UM
UT WOS:000260856900040
PM 18834173
DA 2018-10-20
ER

PT J
AU Liu, Y
   Strauss, J
   Camesano, TA
AF Liu, Yatao
   Strauss, Joshua
   Camesano, Terri A.
TI Adhesion forces between Staphylococcus epidermidis and surfaces bearing
   self-assembled monolayers in the presence of model proteins
SO BIOMATERIALS
LA English
DT Article
DE Bacterial adhesion; Atomic force microscopy; Adhesion; Biofouling
ID FIBRONECTIN-BINDING PROTEIN; BIOFILM FORMATION; BACTERIAL ADHESION;
   MICROBIAL BIOFILMS; OPTICAL TWEEZERS; POLYMER BRUSHES; AUREUS; SILVER;
   INFECTIONS; INHIBITION
AB Self-assembled monolayers (SAMs) are being developed into coatings to reduce microbial biofilm formation on biomaterials. To test anti-adhesion properties, SAMs can be easily constructed on gold, and used to represent a coated biomaterial. However, coatings that prevent bacterial adhesion must also resist protein adsorption. We explored the competitive effects of bacteria and protein for adsorption to SAMs, choosing fetal bovine serum (FBS) to represent protein non-specific binding, and fibronectin (FN) to evaluate ligand/receptor binding. Staphylococcus epidermidis were immobilized on an atomic force microscope (AFM) tip and used as a force probe to detect the interaction forces between bacteria and gold-coated SAMs. The SAMs tested were alkanethiol molecules terminating in isophthalic acid (IPA) or isophthalic acid with silver (IAG). While S. epidermidis showed weak interactions with FBS, the bacteria showed strong adhesion with FN, due to ligand/receptor binding. Bacterial retention and viability experiments were correlated with the force measurements. S. epidermidis interacting with IAG SAMs showed a loss of viability, due to the mobility of silver ions. For most substrata, there was a link between high adhesion forces with bacteria and a high percentage of dead cells being retained on that substratum (even in the absence of a specific biocidal effect, such as silver). This may suggest that high adhesion forces can cause stress to the bacteria which contributed to their death. The relationship between highly adhesive SAMs and bacterial inactivation may be useful in future biomaterial design. When evaluating coatings for biomaterials, it is important to consider the interplay between bacteria, proteins, and the coating material. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Liu, Yatao; Strauss, Joshua; Camesano, Terri A.] Worcester Polytech Inst, Dept Chem Engn, Life Sci & Bioengn Ctr, Worcester, MA 01609 USA.
RP Camesano, TA (reprint author), Worcester Polytech Inst, Dept Chem Engn, Life Sci & Bioengn Ctr, Gateway Pk,100 Inst Rd, Worcester, MA 01609 USA.
EM terric@wpi.edu
RI Liu, Yatao/D-1702-2010
OI Liu, Yatao/0000-0003-3623-1030
FU National Science Foundation [BES 0238627]
FX This work was supported in part by the National Science Foundation
   through grant BES 0238627. We are grateful to Prof. W. Grant McGimpsey
   and Mr. Eftim Milkani for their assistance with SAMs preparation, and to
   Ms. Xiaoshu Dai and Prof. Satya Shivkumar for their assistance with SEM
   measurements. We also thank Dr. Stephen Heard, Dr. Ray Emerson, and Mr.
   Pete Driscoll for helpful discussions throughout the course of these
   studies.
CR Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   Bahna P, 2007, INT J ANTIMICROB AG, V29, P593, DOI 10.1016/j.ijantimicag.2006.12.013
   Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053
   Barthelson R, 1998, INFECT IMMUN, V66, P1439
   Bechert T, 1999, INFECTION, V27, pS24, DOI 10.1007/BF02561613
   Bologna RA, 1999, UROLOGY, V54, P982, DOI 10.1016/S0090-4295(99)00318-0
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Bruinsma GM, 2001, J MICROBIOL METH, V45, P95, DOI 10.1016/S0167-7012(01)00238-X
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   Burnham NA, 2003, NANOTECHNOLOGY, V14, P1, DOI 10.1088/0957-4484/14/1/301
   Busscher HJ, 2008, APPL ENVIRON MICROB, V74, P2559, DOI 10.1128/AEM.02839-07
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   CAMESANO TA, 2007, Patent No. 2007109689
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Dufrene YF, 2001, ULTRAMICROSCOPY, V86, P113, DOI 10.1016/S0304-3991(00)00079-6
   Emerson RJ, 2006, LANGMUIR, V22, P11311, DOI 10.1021/la061984u
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   GAO XP, 1992, J PHYS CHEM-US, V96, P4156, DOI 10.1021/j100190a011
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X
   HEILMANN C, 2003, MED IMPLICATIONS BIO, P110
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   Hou SY, 2007, APPL ENVIRON MICROB, V73, P4300, DOI 10.1128/AEM.02633-06
   Huesca M, 2000, INFECT IMMUN, V68, P1156, DOI 10.1128/IAI.68.3.1156-1163.2000
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   Jarvis RA, 2005, J BIOMED MATER RES A, V75A, P41, DOI 10.1002/jbm.a.30404
   Joh D, 1998, EUR J BIOCHEM, V258, P897, DOI 10.1046/j.1432-1327.1998.2580897.x
   Keane FM, 2007, BIOCHEMISTRY-US, V46, P7226, DOI 10.1021/bi700454x
   Kinnari TJ, 2004, LARYNGOSCOPE, V114, P2038, DOI 10.1097/01.mlg.0000147944.20676.17
   Lee S, 2005, LANGMUIR, V21, P11957, DOI 10.1021/la051932p
   Liu Y, 2008, COLLOID SURFACE B, V65, P35, DOI 10.1016/j.colsurfb.2008.02.012
   Liu YT, 2007, LANGMUIR, V23, P7134, DOI 10.1021/la700575u
   Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   Mack D, 1999, J HOSP INFECT, V43, pS113, DOI 10.1016/S0195-6701(99)90074-9
   Melaiye A, 2005, EXPERT OPIN THER PAT, V15, P125, DOI 10.1517/13543776
   Melchior MB, 2006, VET J, V171, P398, DOI 10.1016/j.tvjl.2005.01.006
   MENDEZVILAS M, 2008, COLLOID SURFACE B, V63, P101
   Montanaro L, 1999, MICROBIOLOGICA, V22, P331
   MOSHER DF, 1980, SCIENCE, V209, P927, DOI 10.1126/science.7403857
   Nienow AW, 2005, INZ CHEM PROCESOWA, V26, P395
   Oliveira M, 2006, VET MICROBIOL, V118, P133, DOI 10.1016/j.vetmic.2006.07.008
   Ostaci RV, 2008, LANGMUIR, V24, P2732, DOI 10.1021/la703086x
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Qiu Y, 2007, INT J ARTIF ORGANS, V30, P828
   Rodriguez JA, 2003, J AM CHEM SOC, V125, P276, DOI 10.1021/ja021007e
   Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061
   Sahoo S, 2006, BIOTECHNOL BIOENG, V94, P118, DOI 10.1002/bit.20835
   Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature0189
   Shi JX, 2004, ANAL CHEM, V76, P632, DOI 10.1021/ac020796f
   SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699
   Simpson KH, 2004, BIOMOL ENG, V21, P105, DOI 10.1016/j.bioeng.2004.08.00l
   Simpson KH, 2003, J BACTERIOL, V185, P2031, DOI 10.1128/JB.185.6.2031-2035.2003
   Sone H, 2004, JPN J APPL PHYS 1, V43, P4663, DOI 10.1143/JJAP.43.4663
   Steenackers M, 2007, SMALL, V3, P1764, DOI 10.1002/smll.200700187
   Stewart PS, 1996, ANTIMICROB AGENTS CH, V40, P2517, DOI 10.1128/AAC.40.11.2517
   Stobie N, 2008, BIOMATERIALS, V29, P963, DOI 10.1016/j.biomaterials.2007.10.057
   STRAUSS J, 2008, ACS SYM SER, V984, P79
   Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   Vericat C, 2006, J PHYS-CONDENS MAT, V18, pR867, DOI 10.1088/0953-8984/18/48/R01
   Vericat C, 2000, J PHYS CHEM B, V104, P302, DOI 10.1021/jp9927451
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
   Woodyard LL, 1996, J CONTROL RELEASE, V40, P23, DOI 10.1016/0168-3659(95)00135-2
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yongsunthon R, 2006, J ELECTRON SPECTROSC, V150, P228, DOI 10.1016/j.elspec.2005.06.012
   Yongsunthon R, 2007, LANGMUIR, V23, P2289, DOI 10.1021/la063117v
NR 76
TC 59
Z9 59
U1 1
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2008
VL 29
IS 33
BP 4374
EP 4382
DI 10.1016/j.biomaterials.2008.07.044
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 361WL
UT WOS:000260158100002
PM 18760835
DA 2018-10-20
ER

PT J
AU Ju, DJ
   Byun, IG
   Park, JJ
   Lee, CH
   Ahn, GH
   Park, TJ
AF Ju, D. J.
   Byun, I. G.
   Park, J. J.
   Lee, C. H.
   Ahn, G. H.
   Park, T. J.
TI Biosorption of a reactive dye (Rhodamine-B) from an aqueous solution
   using dried biomass of activated sludge
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE biosorption; dried activated sludge; Rhodamine-B; swelling; pretreatment
ID EFFLUENT; REMOVAL
AB Low cost, locally available biomaterial was tested for its ability to remove reactive dyes from aqueous solution. Granules prepared from dried activated Sludge (DAS) were utilized as a sorbent for the uptake of Rhodamine-B (Rh-B) dye. The effects of various experimental parameters (dye concentration, sludge concentrations, swelling, pretreatment and other factors) were investigated and optimal experimental conditions were ascertained. Nearly 15 min was required for the equilibrium adsorption, and Rh-B dyes could be removed effectively. Dye removal performance of Rh-B and DAS increased with increasing concentrations. The acid pretreated biomass exhibited a slightly better biosorption capacity that, alkali pretreated or non-pretreated biomass. The optimum swelling time for dye adsorption of the DAS within the swelling time range studied was 12 h. Both the Freundlich and Langmuir isotherm models Could describe the adsorption equilibrium of the reactive dye onto the activated sludge with the Langmuir isotherm showing the better agreement of the two. Second-order kinetic models confirmed the agreement. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Ju, D. J.; Byun, I. G.; Park, J. J.; Park, T. J.] Pusan Natl Univ, Dept Environm Engn, Pusan 609735, South Korea.
   [Lee, C. H.; Ahn, G. H.] Catholic Univ, Dept Environm Engn, Pusan 609323, South Korea.
RP Ju, DJ (reprint author), Pusan Natl Univ, Dept Environm Engn, Pusan 609735, South Korea.
EM ju123c@pusan.ac.kr
CR Aksu Z, 2001, BIOCHEM ENG J, V7, P79, DOI 10.1016/S1369-703X(00)00098-X
   Annadurai G, 2003, ADV ENVIRON RES, V7, P739, DOI 10.1016/S1093-0191(02)00044-8
   Bai RS, 2002, WATER RES, V36, P1224, DOI 10.1016/S0043-1354(01)00330-X
   Carliell CM, 1996, WATER SA, V22, P225
   Choy KKH, 1999, RESOUR CONSERV RECY, V27, P57, DOI 10.1016/S0921-3449(98)00085-8
   Gong RM, 2007, BIORESOURCE TECHNOL, V98, P1319, DOI 10.1016/j.biortech.2006.04.034
   Hu TL, 1996, WATER RES, V30, P2522, DOI 10.1016/0043-1354(96)00123-6
   Huang BR, 1999, MATER CHEM PHYS, V59, P143, DOI 10.1016/S0254-0584(99)00036-X
   Ju D. J., 2006, WATER PRACTICE TECHN, V1
   Largergren S., 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Liversidge RM, 1997, PROCESS BIOCHEM, V32, P473, DOI 10.1016/S0032-9592(96)00107-0
   Morais LC, 1999, WATER RES, V33, P979, DOI 10.1016/S0043-1354(98)00294-2
   Moran C, 1997, J SOC DYERS COLOUR, V113, P272
   Mukhopadhyay M, 2007, BIORESOURCE TECHNOL, V98, P1781, DOI 10.1016/j.biortech.2006.06.025
   PONNUSAMI V, 2006, J HAZARD MATER, P7
   Robinson T, 2002, ENVIRON INT, V28, P29, DOI 10.1016/S0160-4120(01)00131-3
   Tunali S, 2005, MINER ENG, V18, P681, DOI 10.1016/j.mineng.2004.11.002
   Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6
   YEH CF, 1993, J CHROMATOGR A, V630, P2
   ZHOU WC, 1993, FEMS MICROBIOL LETT, V107, P157, DOI 10.1111/j.1574-6968.1993.tb06023.x
NR 20
TC 54
Z9 60
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD NOV
PY 2008
VL 99
IS 17
BP 7971
EP 7975
DI 10.1016/j.biortech.2008.03.061
PG 5
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 341TT
UT WOS:000258738700008
PM 18511271
DA 2018-10-20
ER

PT J
AU Yu, H
   Tyo, K
   Alper, H
   Klein-Marcuschamer, D
   Stephanopoulos, G
AF Yu, Huimin
   Tyo, Keith
   Alper, Hal
   Klein-Marcuschamer, Daniel
   Stephanopoulos, Gregory
TI A High-Throughput Screen for Hyaluronic Acid Accumulation in Recombinant
   Escherichia coli Transformed by Libraries of Engineered Sigma Factors
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE Hyaluronic acid; high throughput screening; translucent colony
   identification; alcian blue staining; global transcriptional machinery
   engineering; sigma factor engineering
ID TRANSCRIPTION MACHINERY; STREPTOCOCCUS; CULTURE; BIOSYNTHESIS; GROWTH;
   MUTANT; RPOS; CELL
AB Hyaluronic acid (HA) is an important biomaterial with functional medical and cosmetic applications. As its synthesis has been recently reported in recombinant bacteria, it is of interest to develop a high throughput screening method for the rapid isolation of HA accumulating strains transformed by combinatorial libraries. Here we report a novel two-step screening strategy to select for better HA-producing recombinant Escherichia coli strains transformed by mutation libraries of rpoD and rpoS, coding for the sigma(D) and sigma(s) factors of the RNA polymerase, respectively. The first screen, based on translucent colony morphology identification, was used to qualitatively distinguish HA-producing strains on agar plates from non-HA producing strains that exhibit dense colony morphology. The second screen was based on the photometric measurement of an alcian blue staining solution that precipitates with HA, creating an inverse relationship between HA concentration and alcian blue absorbance. The color attenuation fitted a second-order polynomial between HA concentration and OD540 absorbance. Using the alcian blue absorbance quantification, 74 translucent colonies from the HA-rpoD library and 78 translucent colonies from the HA-rpoS library were isolated and cultured for optimal strain selection. Three representative superior recombinants with high, medium and low increase of HA accumulation, respectively, were identified by the screen from the HA-rpoD and HA-rpoS mutant library. Further flask culture confirmed that results of the library screen were reliable and the superior recombinant D72 highly accumulated HA of 561.4 mg/L with a productivity of similar to 265 mg HA/g dry cell. Sequencing results showed that the mutant rpoD gene in D72 is in a truncated D protein that lacks the conserved regions 3 and 4 of the a Generally, this two-step high throughput screen presents a promising strategy for selecting superior HA-producing strains from large scale mutation libraries.
C1 [Yu, Huimin; Tyo, Keith; Alper, Hal; Klein-Marcuschamer, Daniel; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Yu, Huimin] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China.
RP Stephanopoulos, G (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM gregstep@mit.edu
RI Tyo, Keith/H-6227-2012; Tyo, Keith/D-1817-2009
FU Singapore-MIT Alliance [SMA-2]; National Key Basic Research Project 973
   of China [2007CB714304]
FX Contract grant sponsor Singapore-MIT Alliance Contract grant number:
   SMA-2 Contract grant sponsor: National Key Basic Research Project 973 of
   China Contract grant number: 2007CB714304
CR Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002
   Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969
   BELLEMANN P, 1994, INT J BIOL MACROMOL, V16, P290, DOI 10.1016/0141-8130(94)90058-2
   Chong BF, 2003, J BIOTECHNOL, V100, P33, DOI 10.1016/S0168-1656(02)00239-0
   DEANGELIS PL, 1993, J BIOL CHEM, V268, P14568
   Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x
   FERRANTE ND, 1956, J BIOL CHEM, V220, P303
   Follstad BD, 1999, BIOTECHNOL BIOENG, V63, P675, DOI 10.1002/(SICI)1097-0290(19990620)63:6<675::AID-BIT5>3.0.CO;2-R
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Gregory BD, 2005, MOL MICROBIOL, V56, P1208, DOI 10.1111/j.1365-2958.2005.04624.x
   HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203
   Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43
   Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003
   Jin YS, 2005, APPL ENVIRON MICROB, V71, P8249, DOI 10.1128/AEM.71.12.8249-8256.2005
   Kakizaki I, 2002, EUR J BIOCHEM, V269, P5066, DOI 10.1046/j.1432-1033.2002.03217.x
   Kim JH, 1996, ENZYME MICROB TECH, V19, P440, DOI 10.1016/S0141-0229(96)00019-1
   KISS RD, 1991, BIOTECHNOL PROGR, V7, P501, DOI 10.1021/bp00012a004
   Kumari K, 1997, J BIOL CHEM, V272, P32539, DOI 10.1074/jbc.272.51.32539
   LAUREN TC, 1998, CHEM BIOL MED APPL H
   LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992
   NEIDHARDT FC, 1974, J BACTERIOL, V119, P736
   Ogrodowski CS, 2005, APPL BIOCHEM BIOTECH, V121, P753
   Penney DP, 2002, BIOTECH HISTOCHEM, V77, P237, DOI 10.1080/714028210
   Sambrook J, 1988, MOL CLONING LAB MANU
   SAN KY, 1984, BIOTECHNOL BIOENG, V26, P1209, DOI 10.1002/bit.260261009
   Stephanopoulos G, 1997, CHEM ENG SCI, V52, P2607, DOI 10.1016/S0009-2509(97)00077-8
   STEPHANOPOULOS G, 1993, TRENDS BIOTECHNOL, V11, P392, DOI 10.1016/0167-7799(93)90099-U
   STEPHANOPOULOS G, 1979, AICHE J, V25, P863, DOI 10.1002/aic.690250515
   Stephanopoulos G, 2001, SCIENCE, V292, P2024, DOI 10.1126/science.1062556
   VALLINO JJ, 1994, BIOTECHNOL PROGR, V10, P320, DOI 10.1021/bp00027a013
   Venturi V, 2003, MOL MICROBIOL, V49, P1, DOI 10.1046/j.1365-2958.2003.03547.x
   Wang FL, 1998, BIOTECHNOL BIOENG, V58, P325, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<325::AID-BIT33>3.0.CO;2-8
   Widner B, 2005, APPL ENVIRON MICROB, V71, P3747, DOI 10.1128/AEM.71.7.3747-3752.2005
   Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4
   Yu HM, 2008, METAB ENG, V10, P24, DOI 10.1016/j.ymben.2007.09.001
NR 35
TC 39
Z9 41
U1 1
U2 30
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD NOV 1
PY 2008
VL 101
IS 4
BP 788
EP 796
DI 10.1002/bit.21947
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 360AY
UT WOS:000260030600014
PM 18500764
DA 2018-10-20
ER

PT J
AU Tyndall, A
   Ladner, UM
   Matucci-Cerinic, M
AF Tyndall, Alan
   Ladner, Ulf M.
   Matucci-Cerinic, Marco
TI The EULAR Scleroderma Trials And Research group (EUSTAR): an
   international framework for accelerating scleroderma research
SO CURRENT OPINION IN RHEUMATOLOGY
LA English
DT Review
DE EUSTAR; minimal essential data set; scleroderma; systemic sclerosis;
   teaching
ID DISEASE-ACTIVITY CRITERIA; PULMONARY ARTERIAL-HYPERTENSION; ENDOTHELIAL
   GROWTH-FACTOR; SYSTEMIC-SCLEROSIS; EUROPEAN MULTICENTER; DOUBLE-BLIND;
   FIBROSIS; BOSENTAN; SURVIVAL; REGISTRY
AB Purpose of review Systemic sclerosis has a complex pathogenesis and a multifaceted clinical spectrum without a specific treatment. Under the auspices of the European League Against Rheumatism, the European League Against Rheumatism Scleroderma Trials And Research group (EUSTAR) has been founded in Europe to foster the study of systemic sclerosis with the aim of achieving equality of assessment and care of systemic sclerosis patients throughout the world according to evidence-based principles.
   Recent findings EUSTAR created the minimal essential data set, a simple two-page form with basic demographics and mostly yes/no answers to clinical and laboratory parameters, to track patients throughout Europe. Currently, over 7000 patients are registered from 150 centres in four continents, and several articles have been published with the data generated by the minimal essential data set. A commitment of EUSTAR is also to teaching and educating, and for this reason there are two teaching courses and a third is planned for early in 2009. These courses have built international networks among young investigators improving the quality of multicentre clinical trials. EUSTAR has organized several rounds of 'teach the teachers' to further standardize the skin scoring.
   Summary EUSTAR activities have extended beyond European borders, and EUSTAR now includes expert,,, from several nations. The growth of data and biomaterial might ensure many further fruitful multicentre studies, but the financial sustainability of EUSTAR remains an issue that may jeopardize the existence of this group as well as that of other organizations in the world.
C1 [Tyndall, Alan] Univ Basel, Dept Rheumatol, Basel, Switzerland.
   [Ladner, Ulf M.] Univ Giessen, Dept Internal Med & Rheumatol, Giessen, Germany.
   [Matucci-Cerinic, Marco] Univ Florence, Div Rheumatol AOUC, Dept Biomed, Denothe Ctr, I-50139 Florence, Italy.
RP Matucci-Cerinic, M (reprint author), Univ Florence, Div Rheumatol AOUC, Dept Biomed, Denothe Ctr, Villa Monna Tessa,Viale Pieraccini 18, I-50139 Florence, Italy.
EM cerinic@unifi.it
FU EULAR
FX A.T. is the Secretary and founding member of EUSTAR, U.M.L. is the
   Treasurer and founding member of EUSTAR and M.M.-C. is the Chairman and
   founding member of EUSTAR. The authors are indebted to EULAR for
   continuous support and funding.
CR Abraham DJ, 2005, TRENDS IMMUNOL, V26, P587, DOI 10.1016/j.it.2005.09.004
   Allanore Y, 2007, ANN RHEUM DIS, V66, P257, DOI 10.1136/ard.2006.054346
   Bryan C, 1999, ARTHRITIS RHEUM, V42, P2660, DOI 10.1002/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N
   Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X
   Clements PJ, 1999, ARTHRITIS RHEUM, V42, P1194, DOI 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7
   Czirjak L, 2007, ANN RHEUM DIS, V66, P966, DOI 10.1136/ard.2006.066530
   Della Rossa A, 2001, ANN RHEUM DIS, V60, P585, DOI 10.1136/ard.60.6.585
   Distler JHW, 2007, ARTHRITIS RHEUM, V56, P311, DOI 10.1002/art.22314
   Distler O, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar596
   Farge D, 2004, ANN RHEUM DIS, V63, P974, DOI 10.1136/ard.2003.011205
   Hoyles RK, 2006, ARTHRITIS RHEUM, V54, P3962, DOI 10.1002/art.22204
   Manetti M, 2007, ARTHRITIS RHEUM, V56, P3442, DOI 10.1002/art.22940
   Mukerjee D, 2003, ANN RHEUM DIS, V62, P1088, DOI 10.1136/ard.62.11.1088
   ROZMAN B, 2007, ANN RHEUM DIS
   Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
   Steen VD, 2000, ARTHRITIS RHEUM, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U
   Tashkin DP, 2007, AM J RESP CRIT CARE, V176, P1026, DOI 10.1164/rccm.200702-3260C
   Tyndall A, 2005, Ann Rheum Dis, V64, P1107, DOI 10.1136/ard.2005.036038
   TYNDALL A, 2008, NAT CLIN PR IN PRESS
   Valentini G, 2003, ANN RHEUM DIS, V62, P901, DOI 10.1136/ard.62.9.901
   Valentini G, 2001, ANN RHEUM DIS, V60, P592, DOI 10.1136/ard.60.6.592
   Walker UA, 2007, ANN RHEUM DIS, V66, P754, DOI 10.1136/ard.2006.062901
   Williams MH, 2006, HEART, V92, P926, DOI 10.1136/hrt.2005.069484
NR 23
TC 3
Z9 3
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1040-8711
J9 CURR OPIN RHEUMATOL
JI Curr. Opin. Rheumatol.
PD NOV
PY 2008
VL 20
IS 6
BP 703
EP 706
DI 10.1097/BOR.0b013e328311f841
PG 4
WC Rheumatology
SC Rheumatology
GA 374LW
UT WOS:000261045900011
PM 18946332
DA 2018-10-20
ER

PT J
AU Griffiths, LG
   Choe, L
   Lee, KH
   Reardon, KF
   Orton, EC
AF Griffiths, Leigh G.
   Choe, Leila
   Lee, Kelvin H.
   Reardon, Kenneth F.
   Orton, E. Christopher
TI Protein extraction and 2-DE of water- and lipid-soluble proteins from
   bovine pericardium, a low-cellularity tissue
SO ELECTROPHORESIS
LA English
DT Article
DE Biological scaffold; Bovine pericardium; 2-DE; Protein extraction
ID 2-DIMENSIONAL GEL-ELECTROPHORESIS; PORCINE HEART-VALVES;
   MASS-SPECTROMETRIC IDENTIFICATION; IMMOBILIZED PH GRADIENTS; PROTEOMIC
   ANALYSIS; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; XENOGENEIC
   TISSUE; ESCHERICHIA-COLI; DECELLULARIZATION
AB Bovine pericardium. (BP) is an important biomaterial used in the production of glutaraldehyde-fixed heart valves and tissue-engineering applications. The ability to perform proteomic analysis on BP is useful for a range of studies, including investigation of immune rejection after implantation. However, proteomic analysis of fibrous tissues such as BP is challenging due to their relative low-cellularity and abundance of extracellular matrix. A variety of methods for tissue treatment, protein extraction, and;fractionation were investigated with the aim of producing high-quality 2-DE gels for both water- and lipid-soluble BP proteins. Extraction of water-soluble proteins with 3-(benzyldimethylammonio)-propanesulfonate followed by n-dodecyl beta-D-maltoside extraction and ethanol precipitation for lipid-soluble proteins provided the best combination of yield, spot number, and resolution on 2-DE gels (Protocol E2). ESI-quadrupole/ion trap or MALDI-TOF/TOF MS protein identifications were performed to confirm bovine origin and appropriate subcellular prefractionation of resolved proteins. Twenty-five unique, predominantly cytoplasmic bovine proteins were identified from the water-soluble fraction. Thirty-two unique, predominantly membrane bovine proteins were identified from the lipid-soluble fraction. These results demonstrated that the final protocol produced high-quality proteomic data from this important tissue for both cytoplasmic and membrane proteins.
C1 [Reardon, Kenneth F.] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
   [Griffiths, Leigh G.; Orton, E. Christopher] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA.
   [Choe, Leila; Lee, Kelvin H.] Univ Delaware, Dept Chem Engn, Newark, DE USA.
   [Choe, Leila; Lee, Kelvin H.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA.
RP Reardon, KF (reprint author), Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
EM kenneth.reardon@colostate.edu
RI Crozier, Laura/C-2170-2011; Reardon, Kenneth/A-1952-2016
OI Reardon, Kenneth/0000-0002-7753-4049
FU National Heart Lung and Blood Institute (NHLBI) at the National
   Institutes of Health [HL081107]
FX The authors thank Carla Lacerda for her technical advice. This research
   was supported by grant number HL081107 from the National Heart Lung and
   Blood Institute (NHLBI) at the National Institutes of Health. Contents
   are solely the responsibility of the authors and do not necessarily
   represent the official views of NIH.
CR Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Bierczynska-Krzysik A, 2006, NEUROCHEM INT, V49, P245, DOI 10.1016/j.neuint.2006.01.013
   Bunai K, 2005, J CHROMATOGR B, V815, P227, DOI 10.1016/j.chromb.2004.08.030
   Bunai K, 2003, PROTEOMICS, V3, P1738, DOI 10.1002/pmic.200300529
   Butt RH, 2006, J PROTEOME RES, V5, P437, DOI 10.1021/pr0503634
   Catterall JB, 2006, RHEUMATOLOGY, V45, P1101, DOI 10.1093/rheumatology/kel060
   Cebotari S, 2002, CIRCULATION S1, V106, P163
   Choe LH, 2005, ELECTROPHORESIS, V26, P2437, DOI 10.1002/elps.200410336
   Churchward Matthew A, 2005, Proteome Sci, V3, P5, DOI 10.1186/1477-5956-3-5
   ELSHOURBAGY NA, 1987, J BIOL CHEM, V262, P7973
   Erdbrugger W, 2006, TISSUE ENG, V12, P2059, DOI 10.1089/ten.2006.12.2059
   Finehout EJ, 2004, ELECTROPHORESIS, V25, P2564, DOI 10.1002/elps.200406012
   Frayne J, 1999, CELL TISSUE RES, V298, P415, DOI 10.1007/s004410050064
   Gan CS, 2005, PROTEOMICS, V5, P2468, DOI 10.1002/pmic.200401266
   Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje
   Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6
   Goncalves A, 2003, CIRCULATION, V108, P436
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V
   Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031
   Gorg A., 2000, PROTEOME RES 2 DIMEN
   HANSSON SF, 2004, PROTEOME SCI, V2
   Heeger PS, 2003, AM J TRANSPLANT, V3, P525, DOI 10.1034/j.1600-6143.2003.00123.x
   Helling S, 2006, PROTEOMICS, V6, P4506, DOI 10.1002/pmic.200600169
   Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200
   Hess JL, 2005, J CHROMATOGR B, V815, P65, DOI 10.1016/j.jchromb.2004.07.047
   Hopkinson A, 2005, PROTEOMICS, V5, P1967, DOI 10.1002/pmic.200401073
   Human P, 2001, J Long Term Eff Med Implants, V11, P199
   ISHIHARA T, 1981, J THORAC CARDIOV SUR, V81, P747
   Jarrold B, 2005, ELECTROPHORESIS, V26, P2269, DOI 10.1002/gel.200410367
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421
   KOVACIC RT, 1991, BIOCHEMISTRY-US, V30, P9015, DOI 10.1021/bi00101a015
   Krah Alexander, 2004, Methods Mol Med, V94, P19
   Lacerda CMR, 2007, J PROTEOME RES, V6, P1145, DOI 10.1021/pr060477v
   Lammi MJ, 2006, ELECTROPHORESIS, V27, P2687, DOI 10.1002/elps.200600004
   Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251
   Maestro MM, 2006, ACTA BIOMATER, V2, P213, DOI 10.1016/j.actbio.2005.11.004
   MANCHESTER KL, 1995, BIOTECHNIQUES, V19, P208
   Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311
   Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4
   Mitra SK, 2007, J PROTEOME RES, V6, P1933, DOI 10.1021/pr060525b
   Mol A, 2004, J HEART VALVE DIS, V13, P272
   MONTECUCCO C, 1983, EUR J BIOCHEM, V132, P189, DOI 10.1111/j.1432-1033.1983.tb07346.x
   Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200
   O'Brien M F, 1999, Semin Thorac Cardiovasc Surg, V11, P194
   Oh-Ishi M, 2007, J CHROMATOGR B, V849, P211, DOI 10.1016/j.jchromb.2006.10.064
   Pedersen SK, 2003, J PROTEOME RES, V2, P303, DOI 10.1021/pr025588i
   Puvimanasinghe JPA, 2006, EUR J CARDIO-THORAC, V29, P374, DOI 10.1016/j.ejcts.2005.11.037
   Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303
   RABILLOUD T, 2000, PROTEOME RES 2 DIMEN
   Ruiz-Romero C, 2005, PROTEOMICS, V5, P3048, DOI 10.1002/pmic.200402106
   Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962
   Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228
   Shaw MM, 2003, PROTEOMICS, V3, P1408, DOI 10.1002/pmic.200300471
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Song J, 2006, ELECTROPHORESIS, V27, P3144, DOI 10.1002/elps.200500921
   Sprenger J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S3
   Stanley BA, 2003, PROTEOMICS, V3, P815, DOI 10.1002/pmic.200300388
   Stock UA, 2006, BIOMATERIALS, V27, P1, DOI 10.1016/j.biomaterials.2005.05.100
   Terasaki PI, 2005, CURR OPIN IMMUNOL, V17, P541, DOI 10.1016/j.coi.2005.07.018
   Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004
   Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107
   Ueda Y, 2006, INT J ARTIF ORGANS, V29, P781
   Vincent D, 2006, ELECTROPHORESIS, V27, P1853, DOI 10.1002/elps.200500698
   von Oppell U O, 2001, J Long Term Eff Med Implants, V11, P105
   Vuillard L, 1998, EUR J BIOCHEM, V256, P128, DOI 10.1046/j.1432-1327.1998.2560128.x
   Wilcox HE, 2005, J HEART VALVE DIS, V14, P228
   WILCOX HE, 2005, J HEART VALVE DIS, V14, P236
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6
   YU WH, 1995, J BIOL CHEM, V270, P13998, DOI 10.1074/jbc.270.23.13998
   Zilla P, 2004, BIOTECHNOL APPL BIOC, V40, P57, DOI 10.1042/BA20030211
NR 73
TC 10
Z9 11
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD NOV
PY 2008
VL 29
IS 22
BP 4508
EP 4515
DI 10.1002/elps.200800108
PG 8
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 384JM
UT WOS:000261741100009
PM 18985661
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, Z
   Peng, J
   Wang, GJ
   Yang, Q
   Yu, HL
   Guo, QY
   Wang, AY
   Zhao, B
   Lu, SB
AF Li, Zhi
   Peng, Jiang
   Wang, Guanjun
   Yang, Qiang
   Yu, Hailong
   Guo, Quanyi
   Wang, Aiyuan
   Zhao, Bin
   Lu, Shibi
TI Effects of local release of hepatocyte growth factor on peripheral nerve
   regeneration in acellular nerve grafts
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Hepatocyte growth factor; Acellular nerve; Peripheral nerve; Nerve
   regeneration
ID FACTOR-SCATTER FACTOR; RAT SCIATIC-NERVE; NEUROTROPHIC FACTOR;
   SCHWANN-CELLS; GENE-THERAPY; PURIFICATION; NEURONS; REPAIR; EXPRESSION;
   ALLOGRAFTS
AB Options for reconstructing peripheral nerve gaps after trauma are limited. The acellular nerve is a new kind of biomaterial used to reconstruct the Peripheral nerve defect, but its use Could be improved upon. We aimed to investigate the effect of adenoviral transfection with hepatocyte growth factor (HGF) on the functional recovery of transected sciatic nerves repaired by acellular nerve grafting. 30 Rats were divided into three groups (10/group) for autografting and acellular grafting, as well as acellular grafting with adenovirus transfection of HGF (1 x 10(8) pfu) injected in muscles around the proximal and distal allograft coapation, Sciatic functional index (SFI) was evaluated every 4 weeks to week 16 by measuring rat footprints on walking-track testing. The three groups presented initial complete functional loss, followed by slow but steady recovery, with final similar SFIs. Weight of the gastrocnemius and soleus muscles, histologic and morphometric study and neovascularization in the nerve grafts were evaluated at week 16. Autografting gave the best functional recovery, but HGF-treated acellular grafting gave better recovery than acellular grafting alone. Neovascularization was greater with HGF-treated acellular grafting than with autografting and acellular grafting alone. Axonal regeneration distance of autografting on the 20th postoperative day was the longest in the three groups,while that of acellular grafting alone was the smallest. Acellular nerve grafting may be useful for functional peripheral nerve regeneration, and with human HGF gene transfection may improve on acellular grafting alone in functional recovery. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Li, Zhi; Peng, Jiang; Wang, Guanjun; Yang, Qiang; Yu, Hailong; Guo, Quanyi; Wang, Aiyuan; Zhao, Bin; Lu, Shibi] Chinese Peoples Liberat Army Gen Hosp, Key Lab Peoples Liberat Army, Inst Orthoped, Beijing 100853, Peoples R China.
RP Lu, SB (reprint author), Chinese Peoples Liberat Army Gen Hosp, Key Lab Peoples Liberat Army, Inst Orthoped, Beijing 100853, Peoples R China.
EM shibilu301@gmail.com
FU Nature Science Foundation of China [30571875]
FX This study was funded by Nature Science Foundation of China (30571875).
   The authors thank technicians Yoe Tian, Li Zhang, Xiang Sui and
   Jingxiang Huang for help with histology examination and animal
   operation. The recombinant replication-defective adenovirus carrying HGF
   (Ad-HGF) or GFP (Ad-GFP) IS Courtesy of the Department of Experimental
   Hematology, Beijing Institute of Radiation Medicine.
CR ANDERSON WF, 1992, SCIENCE, V256, P808, DOI 10.1126/science.1589762
   BRUNELLI GA, 1994, MICROSURG, V15, P176, DOI 10.1002/micr.1920150307
   CARLTON J M, 1986, Surgical Forum (Chicago), V37, P611
   Chattopadhyay M, 2002, ANN NEUROL, V51, P19, DOI 10.1002/ana.10061
   Davey F, 2000, MOL CELL NEUROSCI, V15, P79, DOI 10.1006/mcne.1999.0803
   DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5
   Dumont CE, 1997, TRANSPLANTATION, V63, P1210, DOI 10.1097/00007890-199705150-00004
   Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0
   EVANS PJ, 1994, PROG NEUROBIOL, V43, P187, DOI 10.1016/0301-0082(94)90001-9
   FAWCETT JW, 1986, J NEUROSURG, V65, P354, DOI 10.3171/jns.1986.65.3.0354
   FoidartDessalle M, 1997, EXP NEUROL, V148, P236, DOI 10.1006/exnr.1997.6542
   GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334
   HAASE G, 1998, J NEUROL SCI, V160, P97
   HAASE SC, 2000, SURG FORUM, V51, P607
   Hashimoto N, 2001, NEUROREPORT, V12, P1403, DOI 10.1097/00001756-200105250-00022
   Hudson TW, 2004, TISSUE ENG, V10, P1641, DOI 10.1089/ten.2004.10.1641
   JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485
   KIM DH, 1993, J RECONSTR MICROSURG, V9, P415, DOI 10.1055/s-2007-1006750
   KRAMER H, 1955, J HISTOCHEM CYTOCHEM, V3, P227, DOI 10.1177/3.3.227
   KRASNOSELSKY A, 1994, J NEUROSCI, V14, P7284
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   MACKINNON S E, 1990, Journal of Reconstructive Microsurgery, V6, P117, DOI 10.1055/s-2007-1006810
   Maina F, 1999, NAT NEUROSCI, V2, P213, DOI 10.1038/6310
   Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591
   NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489
   NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1
   Navarro X, 1996, J Peripher Nerv Syst, V1, P53
   Newman JP, 1996, ARCH OTOLARYNGOL, V122, P399
   Okura Y, 1999, EUR J NEUROSCI, V11, P4139, DOI 10.1046/j.1460-9568.1999.00832.x
   Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8
   RESTREPO Y, 1983, Microsurgery, V4, P105, DOI 10.1002/micr.1920040207
   Rubin A, 2003, LARYNGOSCOPE, V113, P985, DOI 10.1097/00005537-200306000-00013
   Sondell M, 1998, BRAIN RES, V795, P44, DOI 10.1016/S0006-8993(98)00251-0
   Terzis JK, 1997, J RECONSTR MICROSURG, V13, P215, DOI 10.1055/s-2007-1006407
   WEBER RA, 1993, MICROSURG, V14, P323, DOI 10.1002/micr.1920140507
   Yang XM, 1998, J NEUROSCI, V18, P8369
   ZALEWSKI AA, 1995, EXP NEUROL, V133, P189, DOI 10.1006/exnr.1995.1021
NR 38
TC 32
Z9 41
U1 1
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
J9 EXP NEUROL
JI Exp. Neurol.
PD NOV
PY 2008
VL 214
IS 1
BP 47
EP 54
DI 10.1016/j.expneurol.2008.07.007
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA 368JM
UT WOS:000260617400006
PM 18680744
DA 2018-10-20
ER

PT J
AU Rosa, AL
   de Oliveira, PT
   Beloti, MM
AF Rosa, Adalberto Luiz
   de Oliveira, Paulo Tambasco
   Beloti, Marcio Mateus
TI Macroporous scaffolds associated with cells to construct a hybrid
   biomaterial for bone tissue engineering
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biomaterial; bone; osteoblastic cell; scaffold; tissue engineering
ID EMBRYONIC STEM-CELLS; IN-VITRO OSTEOGENESIS; MARROW STROMAL CELLS;
   OF-THE-ART; OSTEOBLAST PHENOTYPE; BIOACTIVE GLASS; CULTURE PERIOD;
   GROWTH-FACTORS; DIFFERENTIATION; REPAIR
AB Bone tissue has the ability to heal without a scar and to remodel, which promotes three basic functions: locomotion, protection of internal organs and mineral homeostasis. Although bone regeneration is highly efficient, some clinical situations - such as large bone defects - require specific treatments in order to promote bone healing. Allogenic or autologous bone grafts have been used in these procedures with limited success and, based on this, bone tissue-engineering approaches have been investigated extensively. Tissue engineering has been defined as the application of principles and techniques of the life sciences and engineering to the design, modification and growth of living tissues using biomaterials, cells and growth factors, alone or in combination. The association of cells with porous scaffolds to produce 3D hybrid osteogenic constructs is a common subject in bone tissue-engineering research and will be the focus of this review. We will present some aspects of bone biology, the cells and scaffolds used to engineer bone, and techniques to fabricate the hybrid biomaterial.
C1 [Rosa, Adalberto Luiz; de Oliveira, Paulo Tambasco; Beloti, Marcio Mateus] Univ Sao Paulo, Cell Culture Lab, Sch Dent, BR-14040904 Ribeirao Preto, SP, Brazil.
RP Beloti, MM (reprint author), Univ Sao Paulo, Cell Culture Lab, Sch Dent, Av Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM adalrosa@forp.usp.br; tambasco@usp.br; mmbeloti@usp.br
RI Rosa, Adalberto/A-6314-2008; Tambasco de Oliveira, Paulo/F-9749-2010;
   Beloti, Marcio/E-7473-2012
OI Rosa, Adalberto/0000-0002-6495-2778; Tambasco de Oliveira,
   Paulo/0000-0002-6662-0486; Beloti, Marcio/0000-0003-0149-7189
CR Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526
   Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285
   Becker W, 1996, J PERIODONTOL, V67, P1025, DOI 10.1902/jop.1996.67.10.1025
   Beloti MM, 2006, J BIOMED MATER RES A, V79A, P282, DOI 10.1002/jbm.a.30801
   Beloti MM, 2008, CLIN ORAL IMPLAN RES, V19, P48, DOI 10.1111/j.1600-0501.2007.01420.x
   Beloti Márcio Mateus, 2005, Braz. Dent. J., V16, P156, DOI 10.1590/S0103-64402005000200013
   Beloti MM, 2009, J BIOMATER APPL, V23, P481, DOI 10.1177/0885328208094082
   Beloti Marcio Mateus, 2008, J Biomed Mater Res A, V84, P435, DOI 10.1002/jbm.a.31344
   Beloti MM, 2005, BIOMATERIALS, V26, P4245, DOI 10.1016/j.biomaterials.2004.10.039
   Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518
   BOSKEY AL, 1985, CALCIFIED TISSUE INT, V37, P57, DOI 10.1007/BF02557680
   Buckwalter J A, 1996, Instr Course Lect, V45, P387
   Buckwalter J A, 1996, Instr Course Lect, V45, P371
   Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   Charles-Harris M, 2007, BIOMATERIALS, V28, P4429, DOI 10.1016/j.biomaterials.2007.06.029
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   CITARDI MJ, 1994, OTOLARYNG CLIN N AM, V27, P891
   Costantino PD, 2001, ARCH OTOLARYNGOL, V127, P588, DOI 10.1001/archotol.127.5.588
   de la Piedra C, 2008, J ORTHOP RES, V26, P200, DOI 10.1002/jor.20466
   de Oliveira PT, 2008, J HISTOCHEM CYTOCHEM, V56, P629, DOI 10.1369/jhc.2008.950758
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   Downey PA, 2006, PHYS THER, V86, P77, DOI 10.1093/ptj/86.1.77
   Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299
   Duplomb L, 2007, STEM CELLS, V25, P544, DOI 10.1634/stemcells.2006-0395
   Eberli D, 2006, METHOD ENZYMOL, V420, P287, DOI 10.1016/S0076-6879(06)20013-2
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Gao YB, 2006, J BIOMED MATER RES A, V79A, P193, DOI 10.1002/jbm.a.30761
   Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   HABAL MB, 1994, CLIN PLAST SURG, V21, P349
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Handschel J, 2006, INT J ORAL MAX IMPL, V21, P890
   Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jain KK, 2005, EXPERT OPIN BIOL TH, V5, P153, DOI 10.1517/14712598.5.2.153
   Jonsson KB, 1999, ACTA ORTHOP SCAND, V70, P365, DOI 10.3109/17453679908997826
   Karner E, 2007, STEM CELLS DEV, V16, P39, DOI 10.1089/scd.2006.0010
   Karsenty G, 2001, Novartis Found Symp, V232, P6
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Lane JM, 1999, CLIN ORTHOP RELAT R, P216
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Lickorish D, 2007, BIOMATERIALS, V28, P1495, DOI 10.1016/j.biomaterials.2006.11.025
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   LOVERIDGE N, 1999, J ANIM SCI S, V77, pS190
   Liporaci JL, 2008, J MATER SCI-MATER M, V19, P833, DOI 10.1007/s10856-007-3081-y
   Mao X, 2005, TISSUE CELL, V37, P349, DOI 10.1016/j.tice.2005.05.003
   Navarro M, 2004, J MATER SCI-MATER M, V15, P419, DOI 10.1023/B:JMSM.0000021113.88702.9d
   Ng AMH, 2008, J BIOMED MATER RES A, V85A, P301, DOI 10.1002/jbm.a.31324
   Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169
   Polak JM, 2006, ANN NY ACAD SCI, V1068, P352, DOI 10.1196/annals.1346.001
   Ranly DM, 2007, J BONE JOINT SURG AM, V89A, P139, DOI 10.2106/JBJS.F.00388
   Ren J, 2007, J BIOMAT SCI-POLYM E, V18, P505, DOI 10.1163/156856207780852578
   ROBEY PG, 1993, J BONE MINER RES, V2, pS483
   Roussy Y, 2007, CLIN ORAL IMPLAN RES, V18, P639, DOI 10.1111/j.1600-0501.2007.01385.x
   Ruhe PQ, 2005, J BIOMED MATER RES A, V74A, P533, DOI 10.1002/jbm.a.30341
   Sabolinski ML, 1996, BIOMATERIALS, V17, P311, DOI 10.1016/0142-9612(96)85569-4
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schantz JT, 2002, CELL TRANSPLANT, V11, P125
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Fo HOS, 2007, CLIN ORAL IMPLAN RES, V18, P333, DOI 10.1111/j.1600-0501.2006.01313.x
   Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744
   Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05
   Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002
   Siggelkow H, 1999, J CELL BIOCHEM, V75, P22, DOI 10.1002/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.3.CO;2-Y
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0
   Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283
   Sreerekha PR, 2006, CELL PROLIFERAT, V39, P301, DOI 10.1111/j.1365-2184.2006.00389.x
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   VACANTI JP, 1999, LANCET S1, V354, pS132
   Wiesmann HP, 2004, INT J ORAL MAX SURG, V33, P523, DOI 10.1016/j.ijom.2004.04.005
   Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761
   Yang TH, 2001, J BIOMED MATER RES, V55, P379, DOI 10.1002/1097-4636(20010605)55:3<379::AID-JBM1026>3.0.CO;2-Z
   Yao J, 2005, J BIOMED MATER RES A, V75A, P794, DOI 10.1002/jbm.a.30494
   Yao J, 2005, BIOMATERIALS, V26, P1935, DOI 10.1016/j.biomaterials.2004.06.027
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zaidi N, 2007, ANN NY ACAD SCI, V1117, P62, DOI 10.1196/annals.1402.074
   Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.3.CO;2-6
   Zhang Y, 2004, J MATER SCI-MATER M, V15, P255, DOI 10.1023/B:JMSM.0000015485.94665.25
   zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x
NR 87
TC 20
Z9 21
U1 1
U2 20
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD NOV
PY 2008
VL 5
IS 6
BP 719
EP 728
DI 10.1586/17434440.5.6.719
PG 10
WC Engineering, Biomedical
SC Engineering
GA 380HR
UT WOS:000261457300015
PM 19025348
DA 2018-10-20
ER

PT J
AU Pulkkinen, HJ
   Tiitu, V
   Valonen, P
   Hamalainen, ER
   Lammi, MJ
   Kiviranta, I
AF Pulkkinen, H. J.
   Tiitu, V.
   Valonen, P.
   Hamalainen, E-R
   Lammi, M. J.
   Kiviranta, I.
TI Recombinant human type II collagen as a material for cartilage tissue
   engineering
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Bovine chondrocyte; Cartilage tissue engineering; Collagen gel; Human
   type II collagen
ID BOVINE ARTICULAR-CARTILAGE; IN-VITRO; PROTEOGLYCAN SYNTHESIS;
   EXTRACELLULAR-MATRIX; DEDIFFERENTIATED CHONDROCYTES; BIODEGRADABLE
   HYDROGELS; ALLOGRAFT CHONDROCYTES; MECHANICAL COMPRESSION; BIOSYNTHETIC
   RESPONSE; DYNAMIC COMPRESSION
AB Purpose: Collagen type II is the major component of cartilage and would be an optimal scaffold material for reconstruction of injured cartilage tissue. In this study, the feasibility of recombinant human type II collagen gel as a 3-dimensional culture system for bovine chondrocytes was evaluated in vitro.
   Methods: Bovine chondrocytes (4x10(6) cells) were seeded within collagen gels and cultivated for up to 4 weeks. The gels were investigated with confocal microscopy, histology, and biochemical assays.
   Results: Confocal microscopy revealed that the cells maintained their viability during the entire cultivation period. The chondrocytes were evenly distributed inside the gels, and the number of cells and the amount of the extracellular matrix increased during cultivation. The chondrocytes maintained their round phenotype during the 4-week cultivation period. The glycosaminoglycan levels of the tissue increased during the experiment. The relative levels of aggrecan and type II collagen mRNA measured with real-time polymerase chain reaction (PCR) showed an increase at 1 week.
   Conclusion: Our results imply that recombinant human type II collagen is a promising biomaterial for cartilage tissue engineering, allowing homogeneous distribution in the gel and biosynthesis of extracellular matrix components. (Int J Artif Organs 2008; 31: 960-9)
C1 [Pulkkinen, H. J.; Tiitu, V.; Valonen, P.; Lammi, M. J.] Univ Kuopio, Dept Anat, Inst Biomed, FIN-70211 Kuopio, Finland.
   [Pulkkinen, H. J.; Tiitu, V.; Valonen, P.; Kiviranta, I.] Jyvaskyla Cent Hosp, Dept Orthopaed & Traumatol, Jyvaskyla, Finland.
   [Hamalainen, E-R] Univ Oulu, Bioproc Engn Lab, Oulu, Finland.
   [Lammi, M. J.] Univ Kuopio, Dept Biosci, FIN-70211 Kuopio, Finland.
   [Kiviranta, I.] Helsinki Univ Hosp, Dept Orthopaed & Traumatol, Helsinki, Finland.
RP Pulkkinen, HJ (reprint author), Univ Kuopio, Dept Anat, Inst Biomed, POB 1627, FIN-70211 Kuopio, Finland.
EM hertta.pulkkinen@uku.fi
RI Lammi, Mikko/B-9291-2008; Kuopio, Dept Biosci/A-4529-2010
OI Lammi, Mikko/0000-0002-6181-9904; 
FU TEKES COMBIO project, Sigrid Juselius Foundation, and by the Academy of
   Finland [107605]
FX The recombinant human type II collagen was donated by Fibrogen Europe,
   Helsinki, Finland. This work was funded by the TEKES COMBIO project,
   Sigrid Juselius Foundation, and by the Academy of Finland (project no.
   107605).
CR BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   CHARRIERE G, 1989, J AM ACAD DERMATOL, V21, P1203, DOI 10.1016/S0190-9622(89)70330-3
   Chen MY, 2006, BIORHEOLOGY, V43, P337
   Dausse Y, 2003, OSTEOARTHR CARTILAGE, V11, P16, DOI 10.1053/joca.2002.0859
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   Freyria AM, 2005, TISSUE ENG, V11, P674, DOI 10.1089/ten.2005.11.674
   Galois L, 2006, BIOMATERIALS, V27, P79, DOI 10.1016/j.biomaterials.2005.05.098
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   HOLMDAHL R, 1986, ARTHRITIS RHEUM, V29, P400, DOI 10.1002/art.1780290314
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Hunter CJ, 2002, BIOMATERIALS, V23, P1249, DOI 10.1016/S0142-9612(01)00245-9
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200
   Kiraly K, 1996, HISTOCHEM J, V28, P99, DOI 10.1007/BF02331414
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kopakkala-Tani M, 2006, BIORHEOLOGY, V43, P271
   Lammi MJ, 2004, J RHEUMATOL, V31, P2449
   Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443
   Lemare F, 1998, J CELL PHYSIOL, V176, P303, DOI 10.1002/(SICI)1097-4652(199808)176:2<303::AID-JCP8>3.0.CO;2-S
   Malemud C J, 1994, Osteoarthritis Cartilage, V2, P29, DOI 10.1016/S1063-4584(05)80004-4
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Mukaida T, 2005, J ORTHOP SCI, V10, P521, DOI 10.1007/s00776-005-0930-8
   Nehrer S, 1998, BIOMATERIALS, V19, P2313, DOI 10.1016/S0142-9612(98)00143-4
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   PARKKINEN JJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P458, DOI 10.1006/abbi.1993.1062
   PARKKINEN JJ, 1992, J ORTHOPAED RES, V10, P610, DOI 10.1002/jor.1100100503
   Pulkkinen H, 2006, BIO-MED MATER ENG, V16, pS29
   Pulliainen O, 2007, TISSUE ENG, V13, P1347, DOI 10.1089/ten.2006.0347
   Qu CJ, 2007, CONNECT TISSUE RES, V48, P27, DOI 10.1080/03008200601044128
   SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502
   SALTER DM, 1992, BRIT J RHEUMATOL, V31, P231
   SCHUMAN L, 1995, BIOMATERIALS, V16, P809, DOI 10.1016/0142-9612(95)99644-2
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SPEER DP, 1979, CLIN ORTHOP RELAT R, P326
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Toyras J, 2003, ULTRASOUND MED BIOL, V29, P447, DOI 10.1016/S0301-5629(02)00708-1
   Vasara AI, 2004, CALCIFIED TISSUE INT, V74, P107, DOI 10.1007/s00223-002-2153-8
   Veilleux NH, 2004, TISSUE ENG, V10, P119, DOI 10.1089/107632704322791763
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Weiser L, 1999, TISSUE ENG, V5, P533, DOI 10.1089/ten.1999.5.533
   Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
NR 62
TC 18
Z9 19
U1 0
U2 7
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD NOV
PY 2008
VL 31
IS 11
BP 960
EP 969
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 405SU
UT WOS:000263245300006
PM 19089798
DA 2018-10-20
ER

PT J
AU Liang, YS
   Zhao, W
   Chen, GQ
AF Liang, Yan-Sheng
   Zhao, Wei
   Chen, Guo-Qiang
TI Study on the biocompatibility of novel terpolyester
   poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PHB; terpolyester; polyhydroxyalkanoates; PHA; 3-hydroxyvalerate;
   3-hydroxyhexanoate; fibroblast L929; osteoblast MC3T3
ID IN-VITRO; CELL-ADHESION; DIFFERENT ROUGHNESS; SURFACE-ROUGHNESS;
   TISSUE-REACTIONS; PROLIFERATION; ATTACHMENT;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); POLYHYDROXYALKANOATES;
   BIODEGRADATION
AB Terpolyester poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) (PHBVHHx) containing 5.3 mol% 3-hydroxyvalerate (3-HV) and 10.2 mol % 3-hydroxyhexanoate was obtained via microbial synthesis using recombinant Aeromonas hydrophila. For the first time in vitro biocompatibility of the terpolyester was evaluated in comparison with poly(L-lactic acid), poly (3-hydroxybutyrate), poly(3-hydroxybutyrate-co-3-hydroxyvalerate), and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx). Scanning electron microscopy showed whorls-like morphology only on PHBVHHx film Surface. Methylthiazol tetrazolium assay demonstrated that PHBVHHx was better than the above four materials in promoting cell attachment and proliferation of fibroblast cell line L929 and osteciblast cell line MC3T3, respectively. Histological study using rabbits proved that PHBVHHx was a fairly harmless implantable biomaterial. Thus, PHBVHHx with an adjustable mechanical properties, combined with its biocompatibility, are in the process of developing into a new generation of bioimplant material. (c) 2008 Wiley Periodicals, Inc.
C1 [Liang, Yan-Sheng; Zhao, Wei; Chen, Guo-Qiang] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
RP Chen, GQ (reprint author), Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
EM chengq@stu.edu.cn
FU Li Ka Shing Foundation; State High Tech Project (863) [2006AA02Z242]
FX Contract grant sponsor: Li Ka Shing Foundation; Contract grant sponsor:
   State High Tech Project (863), contract grant number: 2006AA02Z242
CR Akhtar S., 1990, THESIS U BATH
   Andrade J D, 1973, Med Instrum, V7, P110
   BARBARA DB, 1996, BIOMATERIALS, V17, P137
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Campoccia D, 2003, BIOMATERIALS, V24, P587, DOI 10.1016/S0142-9612(02)00373-3
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chou L, 1999, BIOMATERIALS, V20, P977, DOI 10.1016/S0142-9612(98)00254-3
   Davis DH, 2002, BIOMATERIALS, V23, P4019, DOI 10.1016/S0142-9612(02)00152-7
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   GREENBERG JH, 1981, DEV BIOL, V87, P259, DOI 10.1016/0012-1606(81)90149-4
   Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Lu XY, 2005, FEMS MICROBIOL LETT, V243, P149, DOI 10.1016/j.femsle.2004.11.051
   MENG V, 2007, J BIOMAT SCI-POLYM E, V18, P81
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Parkins W M, 1943, Ann Surg, V118, P193, DOI 10.1097/00000658-194308000-00004
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   Pol BJM, 1996, J BIOMED MATER RES, V32, P307
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Qu XH, 2006, J BIOMAT SCI-POLYM E, V17, P1107, DOI 10.1163/156856206778530704
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Tsai CC, 2001, BIOMATERIALS, V22, P523, DOI 10.1016/S0142-9612(00)00206-4
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   WILLIAMS SF, 2001, BIOPOLYMERS POLYESTE, V3, P91
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
NR 32
TC 9
Z9 10
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2008
VL 87A
IS 2
BP 441
EP 449
DI 10.1002/jbm.a.31801
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 360PF
UT WOS:000260068900017
PM 18186048
DA 2018-10-20
ER

PT J
AU Sieminski, AL
   Semino, CE
   Gong, H
   Kamm, RD
AF Sieminski, A. L.
   Semino, C. E.
   Gong, H.
   Kamm, R. D.
TI Primary sequence of ionic self-assembling peptide gels affects
   endothelial cell adhesion and capillary morphogenesis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE capillary morphogenesis; endothelial cell; biomaterial; self-assembling;
   adhesion
ID COMPLEMENTARY OLIGOPEPTIDE; IN-VITRO; MECHANICAL-PROPERTIES; MATRICES;
   SCAFFOLDS; MICROENVIRONMENTS; ANGIOGENESIS; MICROVESSELS; GENERATION;
   OUTGROWTH
AB Appropriate choice of biomaterial Supports is critical for the study of capillary morphogenesis in vitro as well as to support vascularization of engineered tissues in vivo. Self-assembling peptides are a class of synthetic, ionic, oligopeptides that spontaneously assemble into gets with an ECM-like microarchitecture when exposed to salt. In this paper, the ability of four different self-assembling peptide gels to promote endothelial cell adhesion and capillary morphogenesis is explored. Human umbilical vein endothelial cells (HUVECs) were cultured within ionic self-assembling peptide family members, RAD16-I ((RADA)(4), RAD16-II ((RARADADA)(2)), KFE-8 ((FKFE)(2)), or KLD-12 ((KLDL)(3)). HUVECs SLIspended in RAD16-I or RAD16-II gels elongated and formed interconnected capillary-like networks resembling in vivo capillaries, while they remained round and formed clusters within KFE-8 Or KLD-12 gels. As HUVECs attach to RAD16-I and RAD16-II significantly better than the other peptides, these differences appear to be explained by differences in cell adhesion. Although adhesion likely occurs via bound adhesion proteins, there appears to be no difference in protein binding to the peptides investigated. Results indicate that, although these oligopeptides have similar mechanisms of self-assembly, their primary sequence can greatly affect cell adhesion. Additionally, a Subset of these biomimetic ECM-like materials Support capillary morphogenesis and thus may be useful for supporting vascularization. (C) 2008 Wiley Periodicals, Inc.
C1 [Sieminski, A. L.; Semino, C. E.; Kamm, R. D.] MIT, Biol Engn Div, Cambridge, MA 02139 USA.
   [Semino, C. E.] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   [Gong, H.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.
RP Kamm, RD (reprint author), MIT, Biol Engn Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM rdkamm@mit.edu
OI Gong, Haiyan/0000-0002-7204-5019; /0000-0002-7232-304X
FU National Institutes of Health [R01-EB003805]; Draper Laboratory
   University IRD [DL-H-550151]; National Institutes of Health
FX The authors thank 3DM for the generous gift of RAD16-I (BD PuraMatrix);
   Keith Gooch, Mike DiMicco, John Kisiday, Wonmuk Hwang, and Lisa Spirio
   for insightful discussions; and Yamilee Toussaint and Estevan Martinez
   for their technical assistance. The authors also gratefully acknowledge
   funding from the National Institutes of Health grant R01-EB003805
   (R.D.K.), Draper Laboratory University IR&D grant DL-H-550151, and the
   National Institutes of Health Ruth L. Kirschstein National Research
   Service Award (A.L.S).
CR Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   DAVIS GE, 1995, EXP CELL RES, V216, P113, DOI 10.1006/excr.1995.1015
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   DVORAK HF, 1987, LAB INVEST, V57, P673
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Gong HY, 2002, EXP EYE RES, V75, P347, DOI 10.1006/exer.2002.2010
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hall Heike, 2004, Angiogenesis, V7, P213, DOI 10.1007/s10456-004-1328-5
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Korff T, 1999, J CELL SCI, V112, P3249
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Nor JE, 2001, LAB INVEST, V81, P453
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Sieminski AL, 2005, TISSUE ENG, V11, P1332, DOI 10.1089/ten.2005.11.1332
   Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035
   Sieminski AL, 2002, TISSUE ENG, V8, P1057, DOI 10.1089/107632702320934155
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yang JW, 2001, NAT BIOTECHNOL, V19, P219, DOI 10.1038/85655
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 36
TC 82
Z9 82
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2008
VL 87A
IS 2
BP 494
EP 504
DI 10.1002/jbm.a.31785
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 360PF
UT WOS:000260068900023
PM 18186067
DA 2018-10-20
ER

PT J
AU Yildirim, ED
   Yin, X
   Nair, K
   Sun, W
AF Yildirim, Eda D.
   Yin, Xi
   Nair, Kalyani
   Sun, Wei
TI Fabrication, Characterization, and Biocompatibility of Single-Walled
   Carbon Nanotube-Reinforced Alginate Composite Scaffolds Manufactured
   Using Freeform Fabrication Technique
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE tissue scaffold; tissue engineering; alginate; single-walled carbon
   nanotube (SWCNT); freeform fabrication
ID TISSUE ENGINEERED CONSTRUCTS; ENHANCED OSTEOBLAST ADHESION;
   PERIPHERAL-NERVE REPAIR; NANOPHASE CERAMICS; PULMONARY TOXICITY;
   HEALTH-RISKS; NEURONAL GROWTH; HIPCO PROCESS; DEPOSITION; POLYMER
AB Composite polymeric scaffolds from alginate and single-walled carbon nanotube (SWCNT) were produced using a freeform fabrication technique. The scaffolds were characterized for their structural, mechanical, and biological properties by scanning electron microscopy, Raman spectroscopy, tensile testing, and cell-scaffold interaction study. Three-dimensional hybrid alginate/SWCNT tissue scaffolds were fabricated in a multinozzle biopolymer deposition system, which makes possible to disperse and align SWCNTs in the alginate matrix. The structure of the resultant scaffolds was significantly altered due to SWCNT reinforcement, which was confirmed by Raman spectroscopy. Microtensile testing presented a reinforcement effect of SWCNT to the mechanical strength of the alginate struts. Ogden constitutive modeling was utilized to predict the stress-strain relationship of the alginate scaffold, which compared well with the experimental data. Cellular study by rat heart endothelial cell showed that the SWCNT incorporated in the alginate structure improved cell adhesion and proliferation. Our study suggests that hybrid alginate/SWCNT scaffolds are a promising biomaterial for tissue engineering applications. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 87B: 406-414, 2008
C1 [Yildirim, Eda D.; Yin, Xi; Nair, Kalyani; Sun, Wei] Drexel Univ, Dept Mech Engn & Mech, Lab Comp Aided Tissue Engn, Philadelphia, PA 19104 USA.
RP Sun, W (reprint author), Drexel Univ, Dept Mech Engn & Mech, Lab Comp Aided Tissue Engn, Philadelphia, PA 19104 USA.
EM sunwei@drexel.edu
FU NSF [0427216, 0219176]
FX Contract grant sponsor: NSF; contract grant numbers: 0427216, 0219176
CR *ABAQUS, ABAQUS AN VERS 6 5 U
   ADAMS D, 1978, J BIOMED MATER RES, V12, P35, DOI 10.1002/jbm.820120104
   Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   Andrews R, 2004, CURR OPIN SOLID ST M, V8, P31, DOI 10.1016/j.cossms.2003.10.006
   AYAD L, 1994, EXTRACELLULAR MATRIX
   Biercuk MJ, 2002, APPL PHYS LETT, V80, P2767, DOI 10.1063/1.1469696
   Bronikowski MJ, 2001, J VAC SCI TECHNOL A, V19, P1800, DOI 10.1116/1.1380721
   Carter FJ, 2001, MED IMAGE ANAL, V5, P231, DOI 10.1016/S1361-8415(01)00048-2
   Chiang IW, 2001, J PHYS CHEM B, V105, P8297, DOI 10.1021/jp0114891
   Cooper CA, 2002, COMPOS SCI TECHNOL, V62, P1105, DOI 10.1016/S0266-3538(02)00056-8
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   DRESSELHAUS MS, 1996, SCI FULLERENES CARBO, P756
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hudson TW, 2000, ORTHOP CLIN N AM, V31, P485, DOI 10.1016/S0030-5898(05)70166-8
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   KHALIL SA, 1986, INT J FRACTURE, V31, P37, DOI 10.1007/BF00033928
   Khalil S, 2007, MAT SCI ENG C-BIO S, V27, P469, DOI 10.1016/j.msec.2006.05.023
   KHAN S, 2002, CARBON NANOTUBE BASE
   Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANGONE F, 1995, BIOMATERIALS, V16, P347, DOI 10.1016/0142-9612(95)93851-4
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li RH, 1996, BIOTECHNOL BIOENG, V50, P365, DOI 10.1002/(SICI)1097-0290(19960520)50:4<365::AID-BIT3>3.0.CO;2-J
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Ounaies Z, 2003, COMPOS SCI TECHNOL, V63, P1637, DOI 10.1016/S0266-3538(03)00067-8
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Siegel RW, 1996, SCI AM, V275, P74, DOI 10.1038/scientificamerican1296-74
   Stichel CC, 1999, EUR J NEUROSCI, V11, P632, DOI 10.1046/j.1460-9568.1999.00466.x
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   Vacanti JP, 1999, LANCET, V354, pSI32
   Warheit D, 2003, ABSTR PAP AM CHEM S, V225, pU955
   Warheit DB, 2006, CARBON, V44, P1064, DOI 10.1016/j.carbon.2005.10.013
   Warheit DB, 2004, ABSTR PAP AM CHEM S, V227, pU1232
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Weber W. H., 2000, RAMAN SCATTERING MAT
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, NANOSTRUCT MATER, V12, P983, DOI 10.1016/S0965-9773(99)00283-4
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wilson CE, 2002, J MATER SCI-MATER M, V13, P1265, DOI 10.1023/A:1021139415528
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yakobson BI, 1997, AM SCI, V85, P324
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
NR 56
TC 44
Z9 45
U1 3
U2 39
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2008
VL 87B
IS 2
BP 406
EP 414
DI 10.1002/jbm.b.31118
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 364SG
UT WOS:000260355000013
PM 18506813
DA 2018-10-20
ER

PT J
AU Nagai, N
   Nakayama, Y
   Zhou, YM
   Takamizawa, K
   Mori, K
   Munekata, M
AF Nagai, Nobuhiro
   Nakayama, Yasuhide
   Zhou, Yue-Min
   Takamizawa, Keiichi
   Mori, Kazuo
   Munekata, Masanobu
TI Development of Salmon Collagen Vascular Graft: Mechanical and Biological
   Properties and Preliminary Implantation Study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE vascular graft; salmon collagen; biodegradable scaffold; implantation;
   regenerative medicine
ID HUMAN BLOOD-VESSEL; BIODEGRADABLE POLYMER; FIBRIL FORMATION;
   CROSS-LINKING; IN-VITRO; CELLS; BIOMATERIAL; ARTERIES; SCAFFOLD; MODEL
AB Elastic salmon collagen (SC) vascular grafts were prepared by incubating a mixture of acidic SC solution and a fibrillogenesis-inducing buffer containing a crosslinking agent [water-soluble carbodiiimide (WSC)] in a tubular mold at 4 degrees C for 24 h and then at 60 degrees C for 5 min. Subsequently, re-crosslinking in ethanol solution containing WSC was performed. The dimension of the SC grafts was easily controlled by changing the size of the mold used. The compliance (stiffness parameter: beta) and burst strength of the SC grafts (internal diameter, 2 mm; length, 20 mm; and wall thickness, 0.75 mm) that were prepared for implantation were 18.2 and 1434 mmHg, respectively; both these values were comparable with those of native vessels. Upon placement in rat subcutaneous pouches, the SC grafts were gradually biodegraded with little inflammatory reaction. The SC grafts were preliminarily implanted in rat abdominal aortas by using specially designed vascular connecting system. This system was used because the graft exhibited easy tearing and thus inadequate suturability. There was neither aneurysm formation nor graft rupture, but mild thrombus formation was seen within the 4-week observation period. These grafts may be ideal for use in regenerative medicine because we believe that SC would be completely replaced with native vascular tissues after implantation, although further improvement in the mechanical properties of the graft is needed for anastomosis. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part 13: Appl Biomater 87B: 432-439, 2008
C1 [Nagai, Nobuhiro] Hokkaido Univ, CRIS, Sapporo, Hokkaido 0010021, Japan.
   [Nakayama, Yasuhide; Zhou, Yue-Min; Takamizawa, Keiichi] Natl Cardiovasc Ctr, Res Inst, Adv Med Engn Ctr, Dept Bioengn, Osaka 5658565, Japan.
   [Nakayama, Yasuhide; Munekata, Masanobu] Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Sapporo, Hokkaido 0608628, Japan.
   [Mori, Kazuo] Ihara & Co Ltd, Otaru, Hokkaido 0470261, Japan.
RP Nagai, N (reprint author), Hokkaido Univ, CRIS, Sapporo, Hokkaido 0010021, Japan.
EM nagai491@yahoo.co.jp; nakayama@ri.ncvc.go.jp
CR BASSIOUNY HS, 1992, J VASC SURG, V15, P708, DOI 10.1016/0741-5214(92)90019-5
   Bassiouny HS, 1992, J VASC SURG, V15, P716
   Damink LHHO, 1996, BIOMATERIALS, V17, P679, DOI 10.1016/0142-9612(96)86737-8
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   HAYASHI K, 1985, Journal of Biomedical Materials Research, V19, P133, DOI 10.1002/jbm.820190204
   HAYASHI K, 1980, J BIOMECH, V13, P175, DOI 10.1016/0021-9290(80)90191-8
   HAYASHI K, 1986, NEW APPROACHES CARDI, P258
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Iwai S, 2005, ANN THORAC SURG, V80, P1821, DOI 10.1016/j.athoracsur.2005.03.139
   Iwai S, 2004, J THORAC CARDIOV SUR, V128, P472, DOI 10.1016/j.jtcvs.2004.04.013
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   L'Heureux N, 1998, FASEB J, V12, P47
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lepidi S, 2006, EUR J VASC ENDOVASC, V32, P411, DOI 10.1016/j.ejvs.2006.02.012
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Nagai N, 2004, J BIOSCI BIOENG, V97, P389, DOI 10.1263/jbb.97.389
   Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828
   Polanowska-Grabowska R, 1999, THROMB HAEMOSTASIS, V81, P118
   Sakai Osamu, 2005, J Artif Organs, V8, P119, DOI 10.1007/s10047-005-0294-z
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   TAKAMIZAWA K, 1987, J BIOMECH, V20, P7, DOI 10.1016/0021-9290(87)90262-4
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WILDEVUUR CRH, 1987, BIOMATERIALS, V8, P418, DOI 10.1016/0142-9612(87)90076-7
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Yunoki S, 2003, J BIOSCI BIOENG, V96, P575, DOI 10.1016/S1389-1723(04)70152-8
   Yunoki S, 2007, J MATER SCI-MATER M, V18, P1369, DOI 10.1007/s10856-007-0121-6
NR 27
TC 14
Z9 14
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2008
VL 87B
IS 2
BP 432
EP 439
DI 10.1002/jbm.b.31121
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 364SG
UT WOS:000260355000016
PM 18478534
DA 2018-10-20
ER

PT J
AU Ban, S
   Sato, H
   Suehiro, Y
   Nakanishi, H
   Nawa, M
AF Ban, Seiji
   Sato, Hideo
   Suehiro, Yasuhiko
   Nakanishi, Hideo
   Nawa, Masahiro
TI Biaxial Flexure Strength and Low Temperature Degradation of Ce-TZP/Al2O3
   Nanocomposite and Y-TZP as Dental Restoratives
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE zirconia; dental/craniofacial material; degradation; surface
   characteristics
ID TRANSFORMATION-TOUGHENED ZIRCONIA; TETRAGONAL ZRO2 POLYCRYSTALS;
   YTTRIA-STABILIZED ZIRCONIA; MECHANICAL-PROPERTIES; HEAT-TREATMENT;
   GRAIN-SIZE; CERAMICS; WATER; BIOMATERIAL; STRESS
AB The purpose of the present study was to evaluate the mechanical durability of a zirconia/alumina nanocomposite stabilized with cerium oxide (Ce-TZP/Al2O3 nanocomposite) in comparison to yttria-stabilized tetragonal zirconia polycrystals (Y-TZP) and discuss its application on ceramic dental restorations. The disk-shaped specimens of both materials were stored in physiological saline solution at 80 degrees C for 30 days, in 4% acetic acid at 80 degrees C for 30 days, and in an autoclave at 121 degrees C for 10 days. Before and after storage, specimens were subjected to the biaxial flexure test and to the determination of the monoclinic zirconia content. After autoclaving, Y-TZP showed remarkable increasing of the content of monoclinic zirconia: 0.3 vol% before and 49.9 vol% after, and slight decreasing of biaxial flexure strength: 1046 MPa before and 892 MPa after; whereas Ce-TZP/Al2O3 nanocomposite showed no significant difference in the monoclinic content (4.8-5.5 vol%) and the biaxial flexure strength (1371-1422 MPa) after storage in any conditions. It is concluded that, compared to Y-TZP, the Ce-TZP/Al2O3 nanocomposite has a high biaxial flexure strength along with a satisfactory durability in terms of low-temperature aging degradation in above conditions. This study indicates that the Ce-TZP/Al2O3 nanocomposite demonstrates excellent mechanical durability for dental restorations such as all-ceramic bridges. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 87B: 492-498, 2008
C1 [Ban, Seiji; Sato, Hideo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biomat Sci, Kagoshima 8900145, Japan.
   [Suehiro, Yasuhiko; Nakanishi, Hideo; Nawa, Masahiro] Matsushita Elect Works, Adv Technol Fus Lab, Kadoma, Osaka 5718686, Japan.
RP Ban, S (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biomat Sci, Kagoshima 8900145, Japan.
EM sban@denta.hal.kagoshima-u.ac.jp
FU Japan Society for the Promotion of Science [18390521]
FX Contract grant sponsor: Japan Society for the Promotion of Science
   (Grant-in-Aid for General Scientific Research): contract grant number:
   18390521
CR Anusavice KJ, 2003, PHILLIPS SCI DENT MA, P655
   Ardlin BI, 2002, DENT MATER, V18, P590, DOI 10.1016/S0109-5641(01)00095-1
   Ban S, 2007, KEY ENG MATER, V330-332, P353, DOI 10.4028/www.scientific.net/KEM.330-332.353
   Ban S, 2006, KEY ENG MAT, V309-311, P1219, DOI 10.4028/www.scientific.net/KEM.309-311.1219
   BAN S, 1990, J DENT RES, V69, P1791, DOI 10.1177/00220345900690120201
   BAN S, 2005, DENT MATER J, V24, P70
   BASU D, 1995, CERAM INT, V21, P277, DOI 10.1016/0272-8842(95)99794-C
   Blaine L., 2001, KEY ENG MATER, V192, P553
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   DRUMMOND JL, 1989, J AM CERAM SOC, V72, P675, DOI 10.1111/j.1151-2916.1989.tb06194.x
   FRANGINI S, 2001, KEY ENG MATER, V192, P557
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GUPTA TK, 1978, J MATER SCI, V13, P1464, DOI 10.1007/BF00553200
   Kosmac T, 2004, KEY ENG MAT, V254-2, P683, DOI 10.4028/www.scientific.net/KEM.254-256.683
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Lin J-D, 2002, MATER CHEM PHYS, V77, P808
   LU HY, 1987, J AM CERAM SOC, V70, P537, DOI 10.1111/j.1151-2916.1987.tb05701.x
   MENDELSON MI, 1969, J AM CERAM SOC, V52, P443, DOI 10.1111/j.1151-2916.1969.tb11975.x
   Nawa M, 1998, CERAM INT, V24, P497, DOI 10.1016/S0272-8842(97)00048-5
   Nawa M, 1998, J EUR CERAM SOC, V18, P209, DOI 10.1016/S0955-2219(97)00116-7
   Niihara K., 1991, J CERAM SOC JPN, V99, P974, DOI DOI 10.2109/JCERSJ.99.974
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sato H, 2008, DENT MATER J, V27, P408, DOI 10.4012/dmj.27.408
   SATO T, 1985, AM CERAM SOC BULL, V64, P1382
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   SHIMIZU K, 1993, J BIOMED MATER RES, V27, P729, DOI 10.1002/jbm.820270605
   SWAIN MV, 1986, J AM CERAM SOC, V69, P511, DOI 10.1111/j.1151-2916.1986.tb04785.x
   Tanaka K, 2003, J BIOMED MATER RES A, V67A, P200, DOI 10.1002/jbm.a.10006
   Tanaka K, 2002, J BIOMED MATER RES, V63, P262, DOI 10.1002/jbm.10182
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   TSUKUMA K, 1985, J MATER SCI, V20, P1178, DOI 10.1007/BF01026311
   WURST JC, 1972, J AM CERAM SOC, V55, P109, DOI 10.1111/j.1151-2916.1972.tb11224.x
NR 35
TC 75
Z9 76
U1 2
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2008
VL 87B
IS 2
BP 492
EP 498
DI 10.1002/jbm.b.31131
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 364SG
UT WOS:000260355000024
PM 18491411
DA 2018-10-20
ER

PT J
AU Martineau, L
   Davis, SC
   Peng, HT
   Hung, A
AF Martineau, Lucie
   Davis, Stephen C.
   Peng, Henry T.
   Hung, Andy
TI Controlling Methicillin Resistant Staphyloccocus aureus and Pseudomonas
   aeruginosa Wound Infections with a Novel Biomaterial (vol 20, pg 217,
   2007)
SO JOURNAL OF INVESTIGATIVE SURGERY
LA English
DT Correction
C1 [Martineau, Lucie] DRDC, Valcartier, PQ, Canada.
   [Davis, Stephen C.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Peng, Henry T.; Hung, Andy] DRDC, Toronto, ON, Canada.
RP Martineau, L (reprint author), DRDC, Valcartier, PQ, Canada.
CR Martineau L, 2007, J INVEST SURG, V20, P217, DOI 10.1080/10717540701481275
NR 1
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0894-1939
J9 J INVEST SURG
JI J. Invest. Surg.
PD NOV-DEC
PY 2008
VL 21
IS 6
BP 375
EP 375
DI 10.1080/08941930802584576
PG 1
WC Surgery
SC Surgery
GA 400DL
UT WOS:000262848100012
OA Bronze
DA 2018-10-20
ER

PT J
AU Lawrence, BD
   Omenetto, F
   Chui, K
   Kaplan, DL
AF Lawrence, Brian D.
   Omenetto, Fiorenzo
   Chui, Katherine
   Kaplan, David L.
TI Processing methods to control silk fibroin film biomaterial features
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID CORNEAL EPITHELIAL-CELLS; CONFORMATION TRANSITION KINETICS; TRANSFORM
   INFRARED-SPECTROSCOPY; POLY(ETHYLENE OXIDE); CYTOSKELETAL ORGANIZATION;
   NANOSCALE TOPOGRAPHY; THERMAL-PROPERTIES; HIGH-PRESSURE; BETA-SHEET;
   IN-VITRO
AB Control of silk structural and morphological features is reported for fibroin protein films via all aqueous processing, with and without polyethylene oxide (PEO). Silk films with thicknesses from 500 nm to 50 mu m were generated with controllable surface morphologies by employing soft-lithography surface patterning or by adjusting PEO concentrations. FTIR analysis indicated that water-annealing, used to cure or set the films, resulted in increased beta-sheet and alpha-helix content within the films. Steam sterilization provided an additional control point by increasing beta-sheet content, while reducing random coil and turn structures, yet retaining film transparency and material integrity. Increased PEO concentration used during processing resulted in decreased sizes of surface globule structures, while simultaneously increasing uniformity of these features. The above results indicate that both surface and bulk morphologies and structures can be controlled by adjusting PEO concentration. The combined tool set for controlling silk film geometry and structure provides a foundation for further study of novel silk film biomaterial systems. These silk film biomaterials have potential applicability for a variety of optical and regenerative medicine applications due to their optical clarity, impressive mechanical properties, slow degradability, and biocompatibility.
C1 [Lawrence, Brian D.; Omenetto, Fiorenzo; Chui, Katherine; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA USA.
EM David.Kaplan@tufts.edu
FU NIH P41 Tissue Engineering Resource Center; U. S. Army Research
   Laboratory; U. S. Army Research Office [W911NF-07-1-0618]; DARPA-DSO
FX The authors thank the NIH P41 Tissue Engineering Resource Center for
   support for this work. Additionally, the authors would like to thank
   Mark Cronin-Golomb for technical assistance with AFM imaging, Xiao Hu
   for technical assistance with FTIR, and Katherine Chui for providing
   technical assistance in material processing. This material is based upon
   work supported in part by the U. S. Army Research Laboratory and the U.
   S. Army Research Office under contract number W911NF-07-1-0618 and by
   the DARPA-DSO.
CR Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012
   Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Crabb RAB, 2006, TISSUE ENG, V12, P1565, DOI 10.1089/ten.2006.12.1565
   CUNIBERTI C, 1972, POLYMER, V13, P379, DOI 10.1016/0032-3861(72)90058-4
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022
   DUNN GA, 1986, J CELL SCI, V83, P313
   FINK AL, 1998, FOLD DES, V3, DOI DOI 10.1016/S1359-0278(98)00005-4
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Hammouda B, 2004, MACROMOLECULES, V37, P6932, DOI 10.1021/ma049623d
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jung C, 2000, J MOL RECOGNIT, V13, P325, DOI 10.1002/1099-1352(200011/12)13:6<325::AID-JMR507>3.0.CO;2-C
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kardestuncer T, 2006, CLIN ORTHOP RELAT R, P234, DOI 10.1097/01.blo.0000205879.50834.fe
   Karlon WJ, 1999, ANN BIOMED ENG, V27, P712, DOI 10.1114/1.226
   Karuri NW, 2006, IEEE T NANOBIOSCI, V5, P273, DOI 10.1109/TNB.2006.886570
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   MEARS DR, 1969, J APPL PHYS, V40, P4229, DOI 10.1063/1.1657180
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Nakafuku C, 2003, J APPL POLYM SCI, V87, P1962, DOI 10.1002/app.11601
   NAKAFUKU C, 1993, POLYMER, V34, P4166, DOI 10.1016/0032-3861(93)90684-3
   *NIH, IM J
   *NIH, 1 37C
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   PARK J, 2004, THESIS TUFTS U MEDFO, P56
   Smith CK, 1997, ACCOUNTS CHEM RES, V30, P153, DOI 10.1021/ar9601048
   Speare JO, 2003, BIOPOLYMERS, V72, P193, DOI 10.1002/bip.10337
   Suh KY, 2004, ADV MATER, V16, P584, DOI 10.1002/adma.200306180
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Valluzzi R, 2004, BIOMACROMOLECULES, V5, P696, DOI 10.1021/bm0343085
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Zhao DB, 2007, CLEAN-SOIL AIR WATER, V35, P42, DOI 10.1002/clen.200600015
NR 63
TC 83
Z9 86
U1 3
U2 73
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD NOV
PY 2008
VL 43
IS 21
BP 6967
EP 6985
DI 10.1007/s10853-008-2961-y
PG 19
WC Materials Science, Multidisciplinary
SC Materials Science
GA 367AU
UT WOS:000260525700020
DA 2018-10-20
ER

PT J
AU Zhang, HP
   Lu, X
   Fang, LM
   Weng, J
   Huang, N
   Leng, Y
AF Zhang, Hong-Ping
   Lu, Xiong
   Fang, Li-Ming
   Weng, Jie
   Huang, Nan
   Leng, Yang
TI Molecular dynamics simulation of RGD peptide adsorption on titanium
   oxide surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FORCE-FIELD; AB-INITIO; IN-VIVO; IMPLANTS; ADHESION; COMPASS; BLOOD
AB Peptide Arg-Gly-Asp (RGD) sequence is a ubiquitous adhesive motif found in various bone extracellular matrix proteins and is crucial in the biomaterial surface/interface reaction. This study analyzed the adsorption of RGD on different titanium oxide surfaces with molecular dynamics simulation. The simulation results indicate that the RGD peptide binds strongly with anatase (001) and rutile (010). RGD conformation changes due to the variation of the backbone torsion angle in the middle of the RGD chain. Pair correlation function analysis indicates that the interaction of the RGD peptide and the titanium oxide results from hydrogen bonding and the groups in RGD play different roles during the adsorption process. This study provides useful information on how to design titanium surfaces in order to modulate peptide or protein adsorption.
C1 [Zhang, Hong-Ping; Lu, Xiong; Weng, Jie; Huang, Nan] SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Sichuan, Peoples R China.
   [Fang, Li-Ming] S China Univ Technol, Dept Polymer Sci & Engn, Sch Mat Sci & Engn, Guangzhou 510641, Peoples R China.
   [Fang, Li-Ming; Leng, Yang] Hong Kong Univ Sci & Technol, Dept Engn Mech, Kowloon, Hong Kong, Peoples R China.
RP Lu, X (reprint author), SW Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Sichuan, Peoples R China.
EM luxiong_2004@163.com
RI Leng, Yang/B-3187-2010; Weng, Jie/B-3005-2010; LU, xiong/B-3092-2010
OI LU, xiong/0000-0001-6367-430X; Fang, Liming/0000-0003-4263-8478
FU National Natural Science Foundation of China [30700172]; Specialized
   Research [20070613019]; MSTC [2006BAI16B01]
FX This project was financially supported by the National Natural Science
   Foundation of China (No. 30700172), Specialized Research Fund for the
   Doctoral Program of Higher Education for Young Teacher (20070613019) and
   National Key Project of Scientific and Technical Supporting Programs
   Fund from MSTC (2006BAI16B01).
CR Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Iucci G, 2007, MAT SCI ENG C-BIO S, V27, P1201, DOI 10.1016/j.msec.2006.09.038
   Kantarci N, 2005, POLYMER, V46, P4307, DOI 10.1016/j.polymer.2005.03.016
   Monti S, 2007, J PHYS CHEM C, V111, P7765, DOI 10.1021/jp071095v
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Rybolt TR, 2007, J COLLOID INTERF SCI, V314, P434, DOI 10.1016/j.jcis.2007.05.083
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   Sun H, 2005, J COMPUT CHEM, V26, P169, DOI 10.1002/jcc.20153
   Sun H, 1998, COMPUT THEOR POLYM S, V8, P229, DOI 10.1016/S1089-3156(98)00042-7
   Sun H, 1998, J PHYS CHEM B, V102, P7338, DOI 10.1021/jp980939v
   Thor A, 2007, BIOMATERIALS, V28, P966, DOI 10.1016/j.biomaterials.2006.10.020
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Toth R, 2006, BIOMACROMOLECULES, V7, P1714, DOI 10.1021/bm050937y
   Wang YM, 2007, SURF SCI, V601, P63, DOI 10.1016/j.susc.2006.09.005
   WILFRED HJC, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI DOI 10.1002/ANIE.199009921
   Yang ZY, 2007, ENG ANAL BOUND ELEM, V31, P402, DOI 10.1016/j.enganabound.2006.07.012
   Zhao BH, 2005, CURR APPL PHYS, V5, P407, DOI 10.1016/j.cap.2005.01.002
NR 20
TC 11
Z9 11
U1 3
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2008
VL 19
IS 11
BP 3437
EP 3441
DI 10.1007/s10856-008-3498-y
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 347FY
UT WOS:000259127200014
PM 18584123
DA 2018-10-20
ER

PT J
AU He, J
   Zhou, W
   Zhou, XJ
   Zhong, XX
   Zhang, XL
   Wan, PB
   Zhu, BS
   Chen, WT
AF He, Jie
   Zhou, Wei
   Zhou, Xiaojian
   Zhong, Xiaoxia
   Zhang, Xiuli
   Wan, Pengbo
   Zhu, Bangshang
   Chen, Wantao
TI The anatase phase of nanotopography titania plays an important role on
   osteoblast cell morphology and proliferation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ORTHOPEDIC APPLICATIONS; BIOLOGICAL RESPONSES; PROTEIN ADSORPTION;
   IN-VITRO; ADHESION; WETTABILITY; TOPOGRAPHY; COATINGS; TIO2;
   BIOMATERIALS
AB The surface properties of biomaterials play a vital role in cell morphology and behaviors such as cell adhesion, migration, proliferation and differentiation. Three different crystal phases of titania film (rutile, anatase and amorphous titania) with similar roughness were successfully synthesized by DC reactive magnetron sputtering. The surface roughness of each film was about 8-10 nm. Primary rat osteoblasts were used to observe changes in morphology and to evaluate cell behavior at the film surface. The number of the osteoblasts on anatase film was significantly higher than rutile and amorphous films after 36 and 72 h incubation. More importantly, synthesis of alkaline phosphatase was significantly greater by osteoblasts cultured on anatase film than on rutile and amorphous films after 7 and 14 days. In addition, the cells grown on the anatase phase film had the largest spreading area; the actin filaments in cells with regular directions were well defined and fully spreaded. The results indicate that the anatase phase of titania with nanoscale topography yield the best biological effects for cell adhesion, spreading, proliferation and differentiation. There are strong therapeutic prospects for this biomaterial film for osteoblast proliferation, with possible applications for orthopedic and dental implant.
C1 [He, Jie; Zhou, Wei; Wan, Pengbo; Chen, Wantao] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200011, Peoples R China.
   [Zhou, Wei; Zhang, Xiuli] Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200030, Peoples R China.
   [Zhou, Xiaojian; Zhong, Xiaoxia; Chen, Wantao] Shanghai Key Lab Stomatol, Shanghai 200011, Peoples R China.
   [Zhu, Bangshang] Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai 200030, Peoples R China.
RP Chen, WT (reprint author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200011, Peoples R China.
EM chenwantao2002@hotmail.com
RI zhong, xiaoxia/O-1081-2015; zhou, wei/D-2312-2017
OI zhong, xiaoxia/0000-0002-5371-7932; zhou, wei/0000-0002-5257-3885
FU National Natural Science Foundation of China [30572053]; Shanghai
   Science and Technology Committee [0452nm063, 0652nm018]
FX The authors would like to thank Mrs. QH Lu (Analysis and Measurement
   Center of Shanghai JiaoTong University) for AFM measurement and
   modification of the manuscript. The project was financially supported by
   the National Natural Science Foundation of China (30572053) and Shanghai
   Science and Technology Committee (0452nm063 and 0652nm018).
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Black J, 1998, HDB BIOMATERIAL PROP, P179
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   BOYD DA, 2006, NANO LETT, V11, P2592, DOI DOI 10.1021/N1062061M
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Chen XB, 2006, J NANOSCI NANOTECHNO, V6, P906, DOI 10.1166/jnn.2006.160
   Eisenbarth E, 2007, BIOMOL ENG, V24, P27, DOI 10.1016/j.bioeng.2006.05.016
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   Kriparamanan R, 2006, J NANOSCI NANOTECHNO, V6, P1905, DOI 10.1166/jnn.2006.330
   Lee TM, 2002, J MATER SCI-MATER M, V13, P281, DOI 10.1023/A:1014010901423
   Leeuwenburgh S, 2005, J BIOMED MATER RES A, V74A, P275, DOI 10.1002/jbm.a.30420
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Perla V, 2005, J BIOMED MATER RES A, V75A, P356, DOI 10.1002/jbm.a.30423
   Rabady R, 2005, APPL OPTICS, V44, P378, DOI 10.1364/AO.44.000378
   Sato M, 2004, EXPERT REV MED DEVIC, V1, P105, DOI 10.1586/17434440.1.1.105
   Sato M, 2005, BIOMATERIALS, V26, P1349, DOI 10.1016/j.biomaterials.2004.04.044
   Suzuki O, 2006, J BIOMED MATER RES B, V77B, P201, DOI 10.1002/jbm.b.30407
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yao C, 2006, J NANOSCI NANOTECHNO, V6, P2682, DOI 10.1166/jnn.2006.447
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Zhou W, 2006, SURF COAT TECH, V200, P6155, DOI 10.1016/j.surfcoat.2005.09.029
   Zhou W, 2007, J BIOMED MATER RES A, V81A, P453, DOI 10.1002/jbm.a.30987
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
NR 33
TC 99
Z9 102
U1 1
U2 38
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2008
VL 19
IS 11
BP 3465
EP 3472
DI 10.1007/s10856-008-3505-3
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 347FY
UT WOS:000259127200017
PM 18592349
DA 2018-10-20
ER

PT J
AU Garmendia, N
   Bilbao, L
   Munoz, R
   Imbuluqueta, G
   Garcia, A
   Bustero, I
   Calvo-Barrio, L
   Arbiol, J
   Obieta, I
AF Garmendia, N.
   Bilbao, L.
   Munoz, R.
   Imbuluqueta, G.
   Garcia, A.
   Bustero, I.
   Calvo-Barrio, L.
   Arbiol, J.
   Obieta, I.
TI Zirconia Coating of Carbon Nanotubes by a Hydrothermal Method
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Nanozirconia; Carbon Nanotubes; Nanocomposites; Hydrothermal; Coating
ID STABILIZED ZIRCONIA; IN-SITU; COMPOSITES; TEMPERATURE; NANOCOMPOSITES;
   SIMULATION
AB Carbon nanotubes have unique mechanical properties that open attractive possibilities in many fields, such as the biomedical one. Currently, zirconia ceramics are widely used as femoral heads, but case studies show that delayed failure can occur in vivo due to crack propagation. Nanotubes could avoid the slow crack propagation and enhance the toughness of the ceramic material used for prostheses fabrication. In this work, single-wall carbon nanotubes and multi-wall carbon nanotubes have been partially coated with nanozirconia via hydrothermal synthesis and characterized by several techniques: X-ray diffraction, infrared spectroscopy, scanning electron microscope, transmission electron microscope, electron energy loss spectra, X-ray photoelectronic spectroscopy and atomic force microscopy. By means of these techniques, the existence of bonds between zirconium and the carbon nanotube has been proved. The as covered nanotubes should offer a better wettability in the ceramic matrix and improve the dispersion of the carbon nanotubes, to obtain the desired new ceramic biomaterial with a longer lifetime and better reliability.
C1 [Garmendia, N.; Bilbao, L.; Munoz, R.; Imbuluqueta, G.; Garcia, A.; Bustero, I.; Obieta, I.] INASMET TECNALIA, E-20009 San Sebastian, Spain.
   [Calvo-Barrio, L.; Arbiol, J.] Univ Barcelona, TEM MAT, Serv Cient Tecnis, E-08028 Barcelona, Spain.
   [Calvo-Barrio, L.; Arbiol, J.] Univ Barcelona, EME CeRMAE IN2 UB, Dept Elect, E-08028 Barcelona, Spain.
RP Garmendia, N (reprint author), INASMET TECNALIA, Mikeletegi Pasealekua 2,Parque Tecnol, E-20009 San Sebastian, Spain.
RI Calvo-Barrio, Lorenzo/F-3123-2016; Obieta, Isabel/A-7137-2011; Arbiol,
   Jordi/B-6048-2008; Munoz Gomez, Roberto/Q-5768-2017
OI Calvo-Barrio, Lorenzo/0000-0002-6993-1482; Arbiol,
   Jordi/0000-0002-0695-1726; Munoz Gomez, Roberto/0000-0002-7668-6681
FU Basque Government [PI-2004-2, BF105.R2.555]
FX The authors thank the Basque Government (PI-2004-2, BF105.R2.555 and
   Etortek: Nanornaterials) for its financial support.
CR An JW, 2002, J CERAM PROCESS RES, V3, P174
   [Anonymous], 1997, 13356 ISO
   Arbiol J, 2002, MAT SCI ENG B-SOLID, V91, P534, DOI 10.1016/S0921-5107(01)01067-4
   CHEN F, 2005, J AM CERAM SOC, V88, P2469
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   COCKE DL, 1988, APPL SURF SCI, V31, P471, DOI 10.1016/0169-4332(88)90009-8
   Curtin WA, 2004, MATER TODAY, V7, P44, DOI 10.1016/S1369-7021(04)00508-5
   DAUSKARDT RH, 1989, J AM CERAM SOC, V72, P1124, DOI 10.1111/j.1151-2916.1989.tb09694.x
   Deville S, 2005, J AM CERAM SOC, V88, P1273, DOI 10.1111/j.1551-2916.2005.00221.x
   Deville S, 2005, J BIOMED MATER RES B, V72B, P239, DOI 10.1002/jbm.b.30123
   Garcia A, 2006, PHYS STATUS SOLIDI A, V203, P1117, DOI 10.1002/pssa.200566149
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Gremillard L, 2002, J AM CERAM SOC, V85, P401
   Hernadi K, 2003, ACTA MATER, V51, P1447, DOI 10.1016/S1359-6454(02)00539-6
   Huang YL, 2004, J UNIV SCI TECHNOL B, V11, P13
   Lupo F, 2004, CARBON, V42, P1995, DOI 10.1016/j.carbon.2004.03.037
   Matsui K, 2003, J AM CERAM SOC, V86, P1401, DOI 10.1111/j.1151-2916.2003.tb03483.x
   Peigney A, 2002, CHEM PHYS LETT, V352, P20, DOI 10.1016/S0009-2614(01)01441-5
   Rul S, 2003, J EUR CERAM SOC, V23, P1233, DOI 10.1016/S0955-2219(02)00286-8
   Seeger T, 2001, CHEM PHYS LETT, V339, P41, DOI 10.1016/S0009-2614(01)00256-1
   Seeger T, 2002, CHEM COMMUN, P34, DOI 10.1039/b109441f
   Shan Y, 2005, NANOTECHNOLOGY, V16, P625, DOI 10.1088/0957-4484/16/6/001
   Xia B, 2000, J AM CERAM SOC, V83, P1077
   Zhao LP, 2004, CARBON, V42, P423, DOI 10.1016/j.carbon.2003.10.024
NR 24
TC 5
Z9 6
U1 3
U2 18
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD NOV
PY 2008
VL 8
IS 11
BP 5678
EP 5683
DI 10.1166/jnn.2008.211
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 379IV
UT WOS:000261390800010
PM 19198288
DA 2018-10-20
ER

PT J
AU Zietek, M
   Gedrange, T
   Mikulewicz, M
AF Zietek, M.
   Gedrange, T.
   Mikulewicz, M.
TI LONG TERM EVALUATION OF BIOMATERIAL APPLICATION IN SURGICAL TREATMENT OF
   PERIODONTITIS
SO JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article; Proceedings Paper
CT 2nd Dental Continuing Education Meeting on Regenerative Medicine
CY MAR 10-14, 2008
CL South Tyrol, ITALY
DE periodontitis; biomaterials; bone graft material
ID BONE; DEFECTS; HYDROXYAPATITE; SUBSTITUTES; DISEASES
AB Regenerative treatment of periodontally damaged teeth is a demanding task. Advantages which comes With use of biomaterials are mainly connected with fact that traditional, surgical treatment protocols often do not lead to bone regeneration. The aim of this research was to evaluate clinical and radiological effectiveness of Surgical periodontal treatment (with application of HA-Biocer, Biogramu, Bio-Oss) after eight years prior to surgical protocol. Clinical evaluation consisted of measuring depths with perio probe, than evaluation of API (approximal plaque-index) hygiene index (%). Calculation Of Modified sulcus bleeding index - SBI (%) by Muhlemann and Son was done. Engelberger, Marthaler and Rateitschak index on x-rays was calculated. Routine check up eight years after Surgical treatment of periodontitis with use of biomaterials was conducted on 32 patients (20 woman, 12 men). The group of patients was divided into: 28 patients with chronic periodontitis (CP), and 4 patients with general aggressive periodontitis (GAP). Eight years after surgical treatment increase of bleeding areas were observed - in all applied biomaterials. For Bio-Oss average percent of SBI 45.2% (+/- 24.3), for Biogran 62% (+/- 36.2) and respectively for HA-Bioccr 51% (+/- 33.2) API index (%) oil teeth proximal surfaces was estimated for Biogran 47%, BioOss - 46.5% and for HA-Biocer 45.6%. Mean pocket depth (mm) has decreased - in case of all applied biomaterials. Radiological index was also calculated. Decrease of index value was stated. Outcomes of 8 years study indicate, decrease of oral hygiene, increase bleeding, decrease of Engelberger, Marthaler, Rateitchak index. It is necessary to perform routine check up of and control on oral hygiene. It seems to be important to mobilize patients to preserve high oral hygiene.
C1 [Zietek, M.] Wroclaw Med Univ, Dept Periodontol, PL-50425 Wroclaw, Poland.
   [Gedrange, T.] Ernst Moritz Arndt Univ Greifswald, Dept Orthodont Prevent & Pediat Dent, Greifswald, Germany.
   [Mikulewicz, M.] Wroclaw Med Univ, Individual Lab Facial Growth Defects, Dept Dentofacial Orthoped & Orthodont, Wroclaw, Poland.
RP Zietek, M (reprint author), Wroclaw Med Univ, Dept Periodontol, Krakowska 26, PL-50425 Wroclaw, Poland.
EM paradont@stom.am.wroc.pl
CR Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1
   CALLAN DP, 1993, J PERIODONTOL, V64, P575, DOI 10.1902/jop.1993.64.6.575
   Czesnikiewicz-Guzik M, 2007, J PHYSIOL PHARMACOL, V58, P5
   Gonciarz M, 2006, J PHYSIOL PHARMACOL, V57, P155
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENKEL KO, 2005, KEY ENG MATER, P885
   Mai R, 2007, ANN ANAT, V189, P350, DOI 10.1016/j.aanat.2007.02.023
   Mai R, 2006, J CRANIO MAXILL SURG, V34, P101, DOI 10.1016/S1010-5182(06)60022-X
   MELHER AH, 1962, ORAL SURG ORAL MED O, V15, P996
   Nasr HF, 1999, PERIODONTOL 2000, V19, P74, DOI 10.1111/j.1600-0757.1999.tb00148.x
   OHAZAMA A, 1999, J JAPAN SOC PERIODON, V41, P153
   OONISHI H, 1997, CLIN ORTHOP RELAT R, V334, P316
   Persson GR, 2000, J CLIN PERIODONTOL, V27, P104, DOI 10.1034/j.1600-051x.2000.027002104.x
   Proff P, 2006, ANN ANAT, V188, P353, DOI 10.1016/j.aanat.2006.02.003
   Richardson CR, 1999, J CLIN PERIODONTOL, V26, P421, DOI 10.1034/j.1600-051X.1999.260702.x
NR 16
TC 20
Z9 20
U1 2
U2 3
PU POLISH PHYSIOLOGICAL SOC
PI GRZEGORZECKA
PA JAGIELLONIAN UNIV SCHOOL MED, INST PHYSIOLOGY, 31-531 KRAKOW, 16
   GRZEGORZECKA, POLAND
SN 0867-5910
J9 J PHYSIOL PHARMACOL
JI J. Physiol. Pharmacol.
PD NOV
PY 2008
VL 59
SU 5
BP 81
EP 86
PG 6
WC Physiology
SC Physiology
GA 388CG
UT WOS:000261997300010
PM 19075328
DA 2018-10-20
ER

PT J
AU Chuo, CB
   Thomas, SS
AF Chuo, C. B.
   Thomas, S. S.
TI Absorbable mesh and topical negative pressure therapy for closure of
   abdominal dehiscence with exposed bowel
SO JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY
LA English
DT Article
DE Abdominal wall reconstruction; Abdominal dehiscence; Porcine dermis
   mesh; Permacol; Topical negative pressure therapy
ID WALL RECONSTRUCTION; RAT MODEL; PERMACOL(TM); REPAIR; DEFECTS; IMPLANT
AB Permacol (TM) mesh is a porcine dermis-derived biomaterial used for the repair of abdominal incisional and inguinal hernia. It has been found to be a safe and effective alternative to non-absorbable mesh for application over exposed bowel. This mesh has also been successfully applied over contaminated abdominal, wound beds and around stomas. Topical. negative pressure therapy has been used for the management of wound complications after surgical implantation of Permacol (TM) mesh. We describe our experience with the combined use of Permacol (TM) mesh and simultaneous application of topical negative pressure therapy to aid wound contraction and granulation in a patient with abdominal dehiscence and exposed bowel. (C) 2007 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Chuo, C. B.; Thomas, S. S.] Univ Hosp Birmingham Fdn Trust, Dept Burns & Plast Surg, Selly Oak Hosp, Birmingham, W Midlands, England.
RP Chuo, CB (reprint author), Univ Hosp Birmingham Fdn Trust, Dept Burns & Plast Surg, Selly Oak Hosp, Birmingham, W Midlands, England.
EM chuocb@rcsed.ac.uk
CR Adedeji OA, 2002, BRIT J PLAST SURG, V55, P85, DOI 10.1054/bjps.2001.3711
   DAYTON MT, 1986, ARCH SURG-CHICAGO, V121, P954
   Hammond TM, 2006, BRIT J SURG, V93, P39
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   Holl-Allen R T, 1984, J R Coll Surg Edinb, V29, P151
   Holl-Allen R T, 1984, J R Coll Surg Edinb, V29, P154
   Liyanage SH, 2006, J PLAST RECONSTR AES, V59, P553, DOI 10.1016/j.bjps.2005.06.008
   Macleod TM, 2005, BRIT J PLAST SURG, V58, P518, DOI 10.1016/j.bjps.2004.12.012
   MacLeod TM, 2003, BRIT J PLAST SURG, V56, P775, DOI 10.1016/S0007-1226(03)00383-7
   Mathes SJ, 2000, ANN SURG, V232, P586, DOI 10.1097/00000658-200010000-00014
   SARMAH BD, 1984, BRIT J SURG, V71, P524, DOI 10.1002/bjs.1800710717
   VANDERLEI B, 1989, BRIT J SURG, V76, P803, DOI 10.1002/bjs.1800760813
   VOYLES CR, 1981, ANN SURG, V194, P219, DOI 10.1097/00000658-198108000-00017
NR 13
TC 11
Z9 13
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-6815
J9 J PLAST RECONSTR AES
JI J. Plast. Reconstr. Aesthet. Surg.
PD NOV
PY 2008
VL 61
IS 11
BP 1378
EP 1381
DI 10.1016/j.bjps.2007.04.012
PG 4
WC Surgery
SC Surgery
GA 374AC
UT WOS:000261013600018
PM 17544349
DA 2018-10-20
ER

PT J
AU Schneider, J
   Begand, S
   Kriegel, R
   Kaps, C
   Glien, W
   Oberbach, T
AF Schneider, Jens
   Begand, Sabine
   Kriegel, Ralf
   Kaps, Christian
   Glien, Wilfried
   Oberbach, Thomas
TI Low-Temperature Aging Behavior of Alumina-Toughened Zirconia
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID MONOCLINIC PHASE-TRANSFORMATION; CERAMIC FEMORAL-HEAD; JOINT PROSTHESES;
   Y-TZP; DIFFRACTION DATA; DEGRADATION; YTTRIA; HIP; POLYCRYSTALS;
   BIOMATERIAL
AB The corrosion of alumina-toughened zirconia (ATZ) as a consequence of hydrothermal treatment was investigated, especially the transformation kinetics from tetragonal zirconia to the monoclinic phase. For this purpose, polished ATZ specimens (R(a)< 5 nm) were aged in water vapor at different temperatures ranging from 70 degrees to 134 degrees C. The fraction of the monoclinic phase was determined using X-ray diffraction and Rietveld refinement. The isothermal transformation curves obtained were fitted to the Mehl-Johnson-Avrami equation by least squares. An Arrhenius plot of the fitted transformation rates was used to determine the activation energy and the pre-exponential factor. Following this procedure, the kinetic parameters of the phase transformation were extrapolated down to body temperature and the formation of the monoclinic phase was simulated. In addition, optical interferometry on well-polished specimens (R(a)< 2 nm) was alternatively used to calculate the monoclinic fraction from the histogram dataset. The results agree very well with those of the X-ray measurements. Additionally, the development of surface roughness with increasing aging time is discussed.
C1 [Schneider, Jens; Kaps, Christian] Bauhaus Univ Weimar, D-99423 Weimar, Germany.
   [Glien, Wilfried; Oberbach, Thomas] Mathys Orthopad GmbH, D-07646 Morsdorf, Germany.
   [Kriegel, Ralf] Hermsdorfer Inst Tech Keram, D-07629 Hermsdorf Thuringia, Germany.
RP Schneider, J (reprint author), Bauhaus Univ Weimar, D-99423 Weimar, Germany.
EM jens.schneider@bauing.uni-weimar.de
OI Kriegel, Ralf/0000-0001-8326-6004; Begand, Sabine/0000-0001-5877-8227
CR Begand S, 2006, KEY ENG MAT, V309-311, P1261, DOI 10.4028/www.scientific.net/KEM.309-311.1261
   Begand S, 2005, KEY ENG MAT, V284-286, P1019, DOI 10.4028/www.scientific.net/KEM.284-286.1019
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 1997, BIOCERAMICS, P10
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   CHRISTIAN JW, 2002, THEORY PHASE TRANSFO, V1, P529
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   DEVILLE S, 1999, BIOMED MAT RES B, V72, P139
   DEVILLE S, 2005, BIOMATERIALS, V27, P2186
   Gremillard L, 2004, J EUR CERAM SOC, V24, P3483, DOI 10.1016/j.jeurceramsoc.2003.11.025
   HARAGUCHI K, 2003, J BONE JOINT SURG BR, V85, P996
   Heinicke G., 1984, TRIBOCHEMISTRY, P111
   Hernigou P, 2003, J BONE JOINT SURG BR, V85B, P504, DOI 10.1302/0301-620X.85B4.13397
   HOWARD CJ, 1991, J MATER SCI, V26, P127, DOI 10.1007/BF00576042
   Hummer CD, 1995, J ARTHROPLASTY, V10, P848, DOI 10.1016/S0883-5403(05)80085-3
   JANSEN E, 1994, J APPL CRYSTALLOGR, V27, P492, DOI 10.1107/S0021889893012348
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   LANGE FF, 1982, J MATER SCI, V17, P225, DOI 10.1007/BF00809057
   Maccauro G, 2004, J BONE JOINT SURG BR, V86B, P1192, DOI 10.1302/0301-620X.86B8.15012
   Masonis JL, 2004, J ARTHROPLASTY, V19, P898, DOI 10.1016/j.arth.2004.02.045
   Panagiotopoulos EC, 2007, CLIN BIOMECH, V22, P856, DOI 10.1016/j.clinbiomech.2007.04.007
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rahaman MN, 2007, J AM CERAM SOC, V90, P1965, DOI 10.1111/j.1551-2916.2007.01725.x
   RUHLE M, 1988, PHYSICA B & C, V150, P86, DOI 10.1016/0378-4363(88)90110-6
   Santos EM, 2004, J ARTHROPLASTY, V19, P30, DOI 10.1016/j.arth.2004.06.017
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   SCHMAUDER S, 1986, J AM CERAM SOC, V69, P534, DOI 10.1111/j.1151-2916.1986.tb04789.x
   THIESSEN PA, 1967, GRUNDLAGEN TRIBOCHEM, P25
   TSUBAKINO H, 1991, J AM CERAM SOC, V74, P440, DOI 10.1111/j.1151-2916.1991.tb06905.x
   TSUBAKINO H, 1994, SOLID SOLID PHASE TR, P749
   Winter M, 1992, CLIN ORTHOP RELAT R, V282, P73
   Yasuda K, 1999, J MATER SCI, V34, P3597, DOI 10.1023/A:1004630800871
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
NR 34
TC 40
Z9 40
U1 0
U2 24
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD NOV
PY 2008
VL 91
IS 11
BP 3613
EP 3618
DI 10.1111/j.1551-2916.2008.02700.x
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 374SI
UT WOS:000261063600022
DA 2018-10-20
ER

PT J
AU Long, LH
   Zhang, FM
   Chen, L
   Chen, LD
   Chang, J
AF Long, Lihua
   Zhang, Faming
   Chen, Lei
   Chen, Lidong
   Chang, Jiang
TI Preparation and properties of beta-CaSiO3/ZrO2 (3Y) nanocomposites
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE nanocomposites; mechanical properties; ZrO2
ID CERAMICS; ZIRCONIA; BIOMATERIAL; BIOACTIVITY
AB beta-CaSiO3/ZrO2 (3Y) nanocomposites were successfully fabricated by spark plasma sintering (SPS) technique. The addition of nanocrystalline ZrO2 could inhibit the phase transition of micrometer sized CaSiO3 and increase its phase transitional temperature. The relative densities of the dense beta-CaSiO3/ZrO2 nanocomposites were above 98%. Nanocrystalline ZrO2 has formed a network structure in the nanocomposites, which could improve the mechanical properties of nanocomposites. The fracture strength and fracture toughness of the nanocomposites were as high as 395 MPa and 4.08 MPa m(1/2) respectively. The nanocomposites showed good in vitro bioactivity with hydroxyapatite (HA) layer formation on the ZrO2 network of the nanocomposites in simulated body fluid. The spark plasma sintered beta-CaSiO3/ZrO2 (3Y) nanocomposite may provide a new bone graft for load bearing applications. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Zhang, Faming; Chen, Lei; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China.
   [Long, Lihua; Chen, Lidong] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Long, Lihua] Chinese Acad Sci, Grad Sch, Shanghai 200050, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn
RI Chen, Lidong/F-2705-2010; Zhang, Faming/G-2804-2013
OI Zhang, Faming/0000-0001-7653-8163; Chen, Lidong/0000-0002-9683-037X
FU National Basic Science Research Program of China (973 Program)
   [2005CB522704]; Funds of the Chinese Academy of Sciences [KGCX2-YW-207];
   Funds of the Shanghai Institute of Ceramics Chinese Academy of Sciences
   for Innovation of Science and Technology [SCX0606]
FX This work is supported by the National Basic Science Research Program of
   China (973 Program) (Grant No.: 2005CB522704), the Funds of the Chinese
   Academy of Sciences for Key Topics in Innovation Engineering (Grant No.:
   KGCX2-YW-207) and the Funds of the Shanghai Institute of Ceramics
   Chinese Academy of Sciences for Innovation of Science and Technology
   (Grant No.: SCX0606).
CR Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   Hazar ABY, 2007, CERAM INT, V33, P687, DOI 10.1016/j.ceramint.2006.12.013
   Kutty MG, 2001, CERAM ENG SCI PROC, V22, P601
   LI LK, 2005, J INORG MATER, V20, P692
   Lin KL, 2005, CERAM INT, V31, P323, DOI 10.1016/j.ceramint.2004.05.023
   Long LH, 2006, J EUR CERAM SOC, V26, P1701, DOI 10.1016/j.eurceramsoc.2005.03.247
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rice RW, 1996, J MATER SCI, V31, P1969, DOI 10.1007/BF00356616
   Shi JL, 1999, J MATER RES, V14, P1398, DOI 10.1557/JMR.1999.0190
   Silva VV, 2001, COMPOS SCI TECHNOL, V61, P301, DOI 10.1016/S0266-3538(00)00222-0
   SIYU N, 2006, J BIOMED MATER RES A, V76, P196
   Tadashi Kokubo, 2006, BIOMATERIALS, V27, P2907
NR 13
TC 13
Z9 14
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD NOV
PY 2008
VL 28
IS 15
BP 2883
EP 2887
DI 10.1016/j.jeurceramsoc.2008.05.006
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 356DL
UT WOS:000259758800009
DA 2018-10-20
ER

PT J
AU Carvalho, V
   Domingues, L
   Gama, M
AF Carvalho, Vera
   Domingues, Lucilia
   Gama, Miguel
TI The Inhibitory Effect of an RGD-Human Chitin-Binding Domain Fusion
   Protein on the Adhesion of Fibroblasts to Reacetylated Chitosan Films
SO MOLECULAR BIOTECHNOLOGY
LA English
DT Article
DE Human chitin-binding module (ChBM); RGD; Fibroblasts; Cell adhesion;
   Reacetylated chitosan (RC) films
ID CELL-ADHESION; BIOMATERIALS; PURIFICATION; POLYMERS; CHITOTRIOSIDASE;
   BIOTECHNOLOGY; FIBRONECTIN; ACETYLATION; ATTACHMENT; SCAFFOLDS
AB Biomaterials used for tissue engineering applications must provide a structural support for the tissue development and also actively interact with cells, promoting adhesion, proliferation, and differentiation. To achieve this goal, adhesion molecules may be used, such as the tripeptide Arg-Gly-Asp (RGD). A method based on the use of a carbohydrate-binding module, with affinity for chitin, was tested as an alternative approach to the chemical grafting of bioactive peptides. This approach would simultaneously allow the production of recombinant peptides (alternatively to peptide synthesis) and provide a simple way for the specific and strong adsorption of the peptides to the biomaterial.
   A fusion recombinant protein, containing the RGD sequence fused to a human chitin-binding module (ChBM), was expressed in E. coli. The adhesion of fibroblasts to reacetylated chitosan (RC) films was the model system selected to analyze the properties of the obtained proteins. Thus, the evaluation of cell attachment and proliferation on polystyrene surfaces and reacetylated chitosan films, coated with the recombinant proteins, was performed using mouse embryo fibroblasts 3T3. The results show that the recombinant proteins affect negatively fibroblasts anchorage to the materials surface, inhibiting its adhesion and proliferation. We also conclude that this negative effect is fundamentally due to the human chitin-binding domain.
C1 [Carvalho, Vera; Domingues, Lucilia; Gama, Miguel] Univ Minho, Ctr Biol Engn, Inst Biotechnol & Bioengn, IBB, P-4710057 Braga, Portugal.
RP Gama, M (reprint author), Univ Minho, Ctr Biol Engn, Inst Biotechnol & Bioengn, IBB, Campus Gualtar, P-4710057 Braga, Portugal.
EM fmgama@deb.uminho.pt
RI Domingues, Lucilia/B-2191-2010; Gama, Miguel/I-3140-2015
OI Domingues, Lucilia/0000-0003-1089-7627; Gama,
   Miguel/0000-0002-5655-0015; Carvalho, Vera/0000-0003-1468-0433
FU Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/27359/2006]; 
   [POCTI/BIO/45356/2002]
FX Vera Carvalho was supported by the grant SFRH/BD/27359/2006 from
   Fundacao para a Ciencia e Tecnologia, Portugal. This study was supported
   by the Portuguese grant POCTI/BIO/45356/2002: "FUNCARB-FUNcionalizacao
   de materiais biome medicos usando um dominio de ligacao a
   CARBohidratos''.
CR ANDRADE FK, 2008, J BIOMEDICAL MAT R A
   Babu KS, 2008, PROTEIN EXPRES PURIF, V57, P201, DOI 10.1016/j.pep.2007.10.004
   BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252
   CARVALHO V, 2007, AUSTR J BIOTECHNOL S, V131, pS254
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chiba M, 1996, J IMMUNOL METHODS, V191, P55, DOI 10.1016/0022-1759(96)00021-X
   Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Hamilton V, 2006, J MATER SCI-MATER M, V17, P1373, DOI 10.1007/s10856-006-0613-9
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Hsu SH, 2004, J BIOTECHNOL, V111, P143, DOI 10.1016/j.jbiotec.2004.03.014
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   ILUM L, 1994, PHARM RES, V11, P1186
   Khatuntseva SA, 2008, J BIOTECHNOL, V133, P123, DOI 10.1016/j.jbiotec.2007.08.044
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MOREIRA S, 2008, DEV STRATEGY F UNPUB
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198
   RUIZHERRERA J, 1978, P 1 INT C CHIT CHIT, P11
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tjoelker LW, 2000, J BIOL CHEM, V275, P514, DOI 10.1074/jbc.275.1.514
   Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1
   UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   Wang TW, 2006, J BIOMED MATER RES B, V79B, P379, DOI 10.1002/jbm.b.30552
   WIERZBA A, 1995, BIOTECHNOL BIOENG, V46, P185, DOI 10.1002/bit.260460302
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
NR 40
TC 7
Z9 10
U1 1
U2 5
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1073-6085
J9 MOL BIOTECHNOL
JI Mol. Biotechnol.
PD NOV
PY 2008
VL 40
IS 3
BP 269
EP 279
DI 10.1007/s12033-008-9089-9
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 360OZ
UT WOS:000260068300007
PM 18677572
DA 2018-10-20
ER

PT J
AU Wessels, QB
   Pretorius, E
AF Wessels, Q. B.
   Pretorius, E.
TI Enhanced stabilization of collagen-based dermal regeneration scaffolds
   through the combination of physical and chemical crosslinking
SO SOUTH AFRICAN JOURNAL OF SCIENCE
LA English
DT Article
ID PORE-SIZE; POROUS SCAFFOLDS; MAMMALIAN SKIN; TISSUE; MATRIX;
   GLUTARALDEHYDE; BIOMATERIALS; DEPOSITION; MORPHOLOGY; GROWTH
AB The use of collagen in the biomedical device Industry has led to major advances In soft tissue repair. This Is attributed largely to the favourable biological and physiochemical properties of collagen. Regenerative medicine and tissue engineering favoured the use of this biomaterial and various commercial products have become available In the past few decades. This study alms to develop a collagen and chondroitin-6-sulphate dermal regeneration scaffold with enhanced resistance against enzymatic degradation. Frozen slurries (0.5% collagen) were dried under vacuum, coated with silicone, crosslinked and then thoroughly rinsed. The scaffolds were subjected to a range of quantitative and qualitative tests that Included: scanning electron microscopy analysis, collagenase enzymatic degradation, and cytotoxicity assessment. Scaffold resistance to enzymatic degradation was manipulated after dehydrothermal treatment by employing combinations of crosslinking agents, such as glutaraldehyde and/or carbodiimide, with or without the presence of L-lysine. Results indicate that highly porous (mean pore diameter of 87.3 mu m), bioactive, non-cytotoxic tissue engineering matrices were obtained. Enhanced stability of these scaffolds was achieved through extensive crosslinking and suggests the potential to prevent in vivo wound contraction sufficiently.
C1 [Wessels, Q. B.; Pretorius, E.] Univ Pretoria, Fac Hlth Sci, Dept Anat, ZA-0001 Pretoria, South Africa.
RP Wessels, QB (reprint author), So Biotech Pty Ltd, POB 17198, ZA-0410 Lyttolton, South Africa.
EM quenton.w@southmod.co.za
CR Bansky R, 2005, Bratisl Lek Listy, V106, P221
   BILLIGHARM L, 1951, J EXP BIOL, V28, P385
   BILLINGHAM RE, 1955, J ANAT, V89, P114
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Hara M, 2006, J ORAL TISSUE ENG, V3, P118
   HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008
   Kuberka M, 2002, INT J ARTIF ORGANS, V25, P67
   LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Ma L, 2003, J BIOMAT SCI-POLYM E, V14, P861
   MANDL I, 1953, J CLIN INVEST, V32, P1323, DOI 10.1172/JCI102861
   MOORE S, 1948, J BIOL CHEM, V176, P367
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Paddle-Ledinek JE, 2006, PLAST RECONSTR SURG, V117, P110
   PAGGIARO AO, 2003, MICROSC ACTA, V21, P205
   Pek YS, 2004, BIOMATERIALS, V25, P473, DOI 10.1016/S0142-9612(03)00541-6
   PIEZ KA, 1967, TREATISE COLLAGEN, V1, P207
   Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   STEFFEN C, 1968, IMMUNOLOGY, V15, P135
   Vacanti CA, 2006, TISSUE ENG, V12, P1137, DOI 10.1089/ten.2006.12.1137
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   WILLIAMS W, 2002, TOTAL, P783
   Yannas Ioannis V., 1998, Wound Repair and Regeneration, V6, P518, DOI 10.1046/j.1524-475X.1998.60604.x
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yannas IV, 2005, J R SOC INTERFACE, V2, P403, DOI 10.1098/rsif.2005.0062
   YANNAS IV, 2002, ANN NY ACAD SCI, V961, P280
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 38
TC 7
Z9 7
U1 0
U2 1
PU ACAD SCIENCE SOUTH AFRICA A S S AF
PI LYNWOOD RIDGE
PA PO BOX 72135, LYNWOOD RIDGE 0040, SOUTH AFRICA
SN 0038-2353
EI 1996-7489
J9 S AFR J SCI
JI S. Afr. J. Sci.
PD NOV-DEC
PY 2008
VL 104
IS 11-12
BP 513
EP 516
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 417QE
UT WOS:000264090400026
DA 2018-10-20
ER

PT J
AU Krenning, G
   Moonen, JRAJ
   van Luyn, MJA
   Harmsen, MC
AF Krenning, Guido
   Moonen, Jan-Renier A. J.
   van Luyn, Marja J. A.
   Harmsen, Martin C.
TI Generating New Blood Flow: Integrating Developmental Biology and Tissue
   Engineering
SO TRENDS IN CARDIOVASCULAR MEDICINE
LA English
DT Review
ID ENDOTHELIAL PROGENITOR CELLS; SMOOTH-MUSCLE-CELLS;
   EPITHELIAL-MESENCHYMAL TRANSFORMATION; EMBRYONIC STEM-CELLS; GROWTH
   FACTOR-BB; IN-VITRO; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX;
   PHENOTYPIC MODULATION; PARACRINE MECHANISMS
AB Vascular tissue engineering aims to restore blood flow by seeding artificial tubular scaffolds with endothelial and smooth muscle cells, thus creating bioartificial blood vessels. Herein, the progenitors of smooth muscle and endothelial cells hold great promise because they efficiently differentiate and harbor longevity. In this review, we describe a novel tissue engineering approach that uses current insights from developmental biology, that is, progenitor cell plasticity, and the latest advances in biomaterial design. We focus specifically on developmental processes that regulate progenitor cell (trans)differentiation and offer a platform for the integration of these molecular clues into biomaterial design. We propose a novel engineering paradigm for the creation of a small-diameter blood vessel wherein progenitor cell differentiation and tissue organization are instructed by the biomaterial solely. With this review, we emphasize the power of integrating developmental biology and material science for vascular tissue engineering. (Trends Cardiovasc Med 2008;18:312-323) (C) 2008, Elsevier Inc.
C1 [Krenning, Guido; Moonen, Jan-Renier A. J.; van Luyn, Marja J. A.; Harmsen, Martin C.] Univ Groningen, Stem Cell & Tissue Engn Res Grp, Div Med Biol, Univ Med Ctr Groningen,Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands.
RP Harmsen, MC (reprint author), Univ Groningen, Stem Cell & Tissue Engn Res Grp, Div Med Biol, Univ Med Ctr Groningen,Dept Pathol & Med Biol, Hanzepl 1,EA11, NL-9713 GZ Groningen, Netherlands.
EM m.c.harm-sen@med.umcg.nl
RI Krenning, Guido/B-2704-2008
CR Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Arciniegas E, 2006, DIFFERENTIATION, V74, P277, DOI 10.1111/j.1432-0436.2006.00079.x
   Arciniegas E, 2000, ANAT RECORD, V258, P47, DOI 10.1002/(SICI)1097-0185(20000101)258:1<47::AID-AR6>3.0.CO;2-W
   Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006
   Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003
   Botta R, 2004, FASEB J, V18, P1392, DOI 10.1096/fj.03-0879fje
   Brody S, 2006, TISSUE ENG, V12, P413, DOI 10.1089/ten.2006.12.413
   Calera MR, 2004, EXP CELL RES, V300, P248, DOI 10.1016/j.yexcr.2004.07.007
   Camoretti-Mercado B, 2006, J BIOL CHEM, V281, P20383, DOI 10.1074/jbc.M602748200
   Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510913103
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Couet F, 2007, MACROMOL BIOSCI, V7, P701, DOI 10.1002/mabi.200700002
   Deguchi J, 1999, GENE THER, V6, P956, DOI 10.1038/sj.gt.3300918
   Deissler H, 2006, INT J MOL MED, V18, P577
   Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465
   Feng YZ, 2004, BIOCHEMISTRY-US, V43, P15811, DOI 10.1021/bi049174+
   Ferrari G, 2006, P NATL ACAD SCI USA, V103, P17260, DOI 10.1073/pnas.0605556103
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Frank R, 1996, J INVEST DERMATOL, V106, P36, DOI 10.1111/1523-1747.ep12327182
   Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Gong YH, 2007, J BIOMED MATER RES B, V82B, P192, DOI 10.1002/jbm.b.30721
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   Ha CH, 2008, J BIOL CHEM, V283, P7261, DOI 10.1074/jbc.M702881200
   Hall SM, 2002, AM J RESP CELL MOL, V26, P333, DOI 10.1165/ajrcmb.26.3.4698
   Hao H, 2002, ARTERIOSCL THROM VAS, V22, P1093, DOI 10.1161/01.ATV.0000022407.91111.E4
   Hautmann MB, 1997, J BIOL CHEM, V272, P10948
   Herbrig K, 2004, AM J KIDNEY DIS, V44, P840, DOI 10.1053/j.ajkd.2004.08.001
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241
   Hyman KM, 2002, SURGERY, V132, P173, DOI 10.1067/msy.2002.125304
   Igreja C, 2008, EXP HEMATOL, V36, P193, DOI 10.1016/j.exphem.2007.09.001
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Isenberg BC, 2008, BIOMATERIALS, V29, P2565, DOI 10.1016/j.biomaterials.2008.02.023
   Ishihara H, 2008, J NEUROPATH EXP NEUR, V67, P435, DOI 10.1097/NEN.0b013e31816fd622
   Ishisaki A, 2003, J BIOL CHEM, V278, P1303, DOI 10.1074/jbc.M207329200
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kawamoto A, 2008, TRENDS CARDIOVAS MED, V18, P33, DOI 10.1016/j.tcm.2007.11.004
   Kawamoto A, 2007, CATHETER CARDIO INTE, V70, P477, DOI 10.1002/ccd.21292
   Kilian O, 2004, EUR J MED RES, V9, P337
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Koshida R, 2005, ARTERIOSCL THROM VAS, V25, P2548, DOI 10.1161/01.ATV.0000188511.84138.9b
   KRENNING G, 2008, J CELL MOL IN PRESS
   Krenning G, 2008, BIOMATERIALS, V29, P3703, DOI 10.1016/j.biomaterials.2008.05.034
   Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017
   KRUG EL, 1987, DEV BIOL, V120, P348, DOI 10.1016/0012-1606(87)90237-5
   Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080
   Young HL, 2007, AM J RESP CELL MOL, V37, P485, DOI 10.1165/rcmb.2006-0439OC
   Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849
   Li XM, 1997, BIOCHEM J, V327, P709, DOI 10.1042/bj3270709
   Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050
   Lin YK, 2007, J BIOMATER APPL, V21, P265, DOI 10.1177/0885328206063502
   Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200
   Mercado-Pimentel ME, 2007, DEV BIOL, V304, P420, DOI 10.1016/j.ydbio.2006.12.038
   Miyata T, 2005, J CELL PHYSIOL, V204, P948, DOI 10.1002/jcp.20362
   Moonen JRAJ, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2283
   Nagai R, 2001, ANN NY ACAD SCI, V947, P56
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9
   O'Riordan E, 2007, AM J PHYSIOL-HEART C, V292, pH285, DOI 10.1152/ajpheart.00560.2006
   OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002
   Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
   Paranya G, 2001, AM J PATHOL, V159, P1335, DOI 10.1016/S0002-9440(10)62520-5
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Pollman MJ, 1999, CIRCULATION, V99, P2019, DOI 10.1161/01.CIR.99.15.2019
   Reddy K, 2003, TISSUE CELL, V35, P260, DOI 10.1016/S0040-8166(03)00039-9
   Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963
   Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072
   Sakao S, 2007, FASEB J, V21, P3640, DOI 10.1096/fj.07-8432com
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Shadwick RE, 1999, J EXP BIOL, V202, P3305
   Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004
   Smadja DM, 2008, J CELL MOL MED, V12, P975, DOI 10.1111/j.1582-4934.2007.00161.x
   Song WM, 2000, DEV BIOL, V227, P606, DOI 10.1006/dbio.2000.9919
   Taipale J, 1997, FASEB J, V11, P51
   Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006
   Tanaka T, 2004, MOL VIS, V10, P462
   TEI K, 2008, STEM CELLS, P2007
   Thomas V, 2006, J BIOMAT SCI-POLYM E, V17, P969, DOI 10.1163/156856206778366022
   TSILIBARY EC, 1990, J CELL BIOL, V111, P1583, DOI 10.1083/jcb.111.4.1583
   Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   YAMAMOTO M, 1993, EXP CELL RES, V204, P121, DOI 10.1006/excr.1993.1016
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
   Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433
   ZAMORA PO, 1993, BIOCHIM BIOPHYS ACTA, V1182, P197, DOI 10.1016/0925-4439(93)90141-M
   Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613
   Zentilin L, 2006, BLOOD, V107, P3546, DOI 10.1182/blood-2005-08-3215
   Zhang SJ, 2006, CELL RES, V16, P577, DOI 10.1038/sj.cr.7310075
   Zhang XF, 2005, J CELL PHYSIOL, V202, P205, DOI 10.1002/jcp.20106
   Zilberman A, 1998, CIRC RES, V82, P566, DOI 10.1161/01.RES.82.5.566
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 97
TC 15
Z9 16
U1 1
U2 15
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1050-1738
J9 TRENDS CARDIOVAS MED
JI Trends Cardiovasc. Med.
PD NOV
PY 2008
VL 18
IS 8
BP 312
EP 323
AR PII S1050-1738(09)00026-7
DI 10.1016/j.tcm.2009.01.004
PG 12
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 434HA
UT WOS:000265264600006
PM 19345319
DA 2018-10-20
ER

PT J
AU McCann, L
   Udofia, I
   Graindorge, S
   Ingham, E
   Jin, Z
   Fisher, J
AF McCann, L.
   Udofia, I.
   Graindorge, S.
   Ingham, E.
   Jin, Z.
   Fisher, J.
TI Tribological testing of articular cartilage of the medial compartment of
   the knee using a friction simulator
SO TRIBOLOGY INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT 34th Leeds-Lyon Symposium on Tribology
CY SEP 04-07, 2007
CL Inst Natl Sci Appliquees, Lyon, FRANCE
HO Inst Natl Sci Appliquees
DE articular cartilage; friction; wear; contact stress; hemiarthroplasty;
   knee
ID INNOVATIVE CHONDROPLASTY MATERIALS; HEMIARTHROPLASTY; REGENERATION;
   THICKNESS; LOADS; TIME; WEAR
AB The aim of this study was to develop a tribological simulation of a unicondylar natural knee, to measure the friction and wear of articular cartilage (AC) against itself (AC-vs-AC) and against stainless steel (SS) simulating a hemiarthroplasty (AC-vs-SS). AC-vs-AC produced low levels of friction and no wear was found. AC-vs-SS showed higher levels of friction and significant AC wear. Using AC-vs-SS with elevated loading, the wear of AC was accelerated and through to bone. This study demonstrated the importance of contact stress in the design of a spacer hemiarthroplasty for the medial compartmental knee. Initial results showed the importance of contact mechanics, stress and biomaterial type in determining short-term tribological function and long-term clinical outcome of hemiarthroplasty. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.
C1 [McCann, L.; Udofia, I.; Graindorge, S.; Ingham, E.; Jin, Z.; Fisher, J.] Univ Leeds, Inst Med & Biol Engn, Sch Mech Engn, Leeds LS2 9JT, W Yorkshire, England.
RP McCann, L (reprint author), Univ Leeds, Inst Med & Biol Engn, Sch Mech Engn, Leeds LS2 9JT, W Yorkshire, England.
EM menimc@leeds.ac.uk
CR AMSTUTZ HC, 1994, J BONE JOINT SURG BR, V76B, P423
   Ateshian GA, 1998, J TRIBOL-T ASME, V120, P241, DOI 10.1115/1.2834416
   Baliunas AJ, 2002, OSTEOARTHR CARTILAGE, V10, P573, DOI 10.1053/joca.2002.0797
   Bell CJ, 2006, P I MECH ENG H, V220, P23, DOI 10.1243/095441105X69060
   DARCY J, 1976, J BONE JOINT SURG BR, V58, P279
   FINLAY JB, 1986, J BIOMECH, V19, P703, DOI 10.1016/0021-9290(86)90194-6
   Forster H, 1996, Proc Inst Mech Eng H, V210, P109, DOI 10.1243/PIME_PROC_1996_210_399_02
   FORSTER H, 1995, P LUBR LUBR S
   Freeman ME, 2000, WEAR, V241, P129, DOI 10.1016/S0043-1648(00)00387-2
   Hallock RH, 2003, CLIN ORTHOP RELAT R, P154, DOI 10.1097/01.blo.0000093031.56370.90
   Katta J, 2007, P I MECH ENG J-J ENG, V221, P175, DOI 10.1243/13506501JET240
   Kawalec JS, 1998, J BIOMED MATER RES, V41, P534, DOI 10.1002/(SICI)1097-4636(19980915)41:4<534::AID-JBM4>3.0.CO;2-D
   KIM Y-H, 1989, Yonsei Medical Journal, V30, P280
   Koo S, 2007, J BIOMECH, V40, P2961, DOI 10.1016/j.jbiomech.2007.02.005
   KOSASHVILI, 2008, INJURY, V39, P232
   MacIntosh D L, 1972, J Bone Joint Surg Br, V54, P244
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   MOW VC, 1997, BASIC ORTHOPAEDIC BI
   Northwood E, 2007, P I MECH ENG H, V221, P263, DOI 10.1243/09544119JEIM178
   NORTHWOOD E, 2006, P ORTH RES SOC ORS
   Northwood E, 2007, CLIN BIOMECH, V22, P834, DOI 10.1016/j.clinbiomech.2007.03.008
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   Schwartz CJ, 2007, WEAR, V262, P1315, DOI 10.1016/j.wear.2007.01.007
   SCOTT RD, 1985, J BONE JOINT SURG AM, V67A, P203, DOI 10.2106/00004623-198567020-00004
   Sisto DJ, 2005, J BONE JOINT SURG AM, V87A, P1706, DOI 10.2106/JBJS.D.02339
   van der Meulen MCH, 2002, J ORTHOPAED RES, V20, P669, DOI 10.1016/S0736-0266(01)00182-6
NR 26
TC 19
Z9 19
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-679X
J9 TRIBOL INT
JI Tribol. Int.
PD NOV
PY 2008
VL 41
IS 11
BP 1126
EP 1133
DI 10.1016/j.triboint.2008.03.012
PG 8
WC Engineering, Mechanical
SC Engineering
GA 337JX
UT WOS:000258433500021
DA 2018-10-20
ER

PT J
AU Zini, E
   Gazzano, M
   Scandola, M
   Wallner, SR
   Gross, RA
AF Zini, Elisa
   Gazzano, Massimo
   Scandola, Mariastella
   Wallner, Sabine R.
   Gross, Richard A.
TI Glycolipid Biomaterials: Solid-State Properties of a Poly(sophorolipid)
SO MACROMOLECULES
LA English
DT Article
ID TEMPERATURE MODULATED DSC; MELTING BEHAVIOR; OLEIC-ACID; SOPHOROLIPIDS;
   SOPHOROSE; PHASE
AB Structural complexity inherited from a microbial synthesis of glycolipids was translated into unique poly(sophorolipid) biomaterials. ROMP polymerization of natural diacetylated lactonic sophorolipids gave a high molecular weight polymer with asymmetric bola-amphiphilic repeating units. The poly(sophorolipid) chain alternates C18 oleic-like aliphatic segments (90% cis-configured double bonds) with bulky diacetylated disaccharide moieties. The solid-state properties were investigated by means of TGA, DSC, TMDSC, and variable-temperature X-ray diffraction. The poly(sophorolipid) is a solid at room temperature that undergoes the glass transition at 61 degrees C and melts at 123 degrees C. The crystal phase is associated with ordered packing of the aliphatic chain segments. The semicrystalline poly(sophorolipid) also displays a long-range order (d = 2.44 nm) involving sophorose groups that is found to persist after crystal phase melting (in high-T diffractograms) with a slightly shortened distance (2.27 nm). Upon annealing at 80 degrees C the poly(sophorolipid) recrystallizes and concomitantly the disaccharide units space out again at 2.44nm. An exothermal phenomenon that immediately follows melting and is revealed by TMDSC might be associated with the observed adjustment of sophorose units spacing in the melt. The peculiar structural organization of this novel biomaterial is discussed.
C1 [Zini, Elisa; Scandola, Mariastella] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy.
   [Zini, Elisa; Scandola, Mariastella] UdR Bologna, INSTM, Natl Consoritum Mat Sci & Technol, I-40126 Bologna, Italy.
   [Gazzano, Massimo] ISOF CNR, Dept Chem G Ciamician, I-40126 Bologna, Italy.
   [Wallner, Sabine R.; Gross, Richard A.] Polytech Univ, Six Metrotech Ctr, Dept Chem & Biol Sci, NSF 1,UCRC Ctr Biocatalysis & Bioproc Macromol, Brooklyn, NY 11201 USA.
RP Scandola, M (reprint author), Univ Bologna, Dept Chem G Ciamician, Via Selmi 2, I-40126 Bologna, Italy.
RI Gazzano, Massimo/D-9880-2012
OI Gazzano, Massimo/0000-0003-1352-9547
FU Italian Ministry for University and Research (MUR); National Science
   Foundation Industrial/University Cooperative Research Center for
   Biocatalysis; Polytechnic University
FX We thank the Italian Ministry for University and Research (MUR) and the
   National Science Foundation Industrial/University Cooperative Research
   Center for Biocatalysis and Bioprocessing of Macromolecules at
   Polytechnic University for their financial support to this work.
CR Bluth MH, 2006, CRIT CARE MED, V34, P188, DOI 10.1097/01.CCM.0000196212.56885.50
   Focarete ML, 2002, MACROMOLECULES, V35, P8066, DOI 10.1021/ma0205966
   Fuhrhop AH, 2004, CHEM REV, V104, P2901, DOI 10.1021/cr030602b
   Gao W, 2007, MACROMOLECULES, V40, P145, DOI 10.1021/ma0620159
   Guilmanov V, 2002, BIOTECHNOL BIOENG, V77, P489, DOI 10.1002/bit.10177
   Kaneko F, 1997, J PHYS CHEM B, V101, P1803, DOI 10.1021/jp963400a
   Klemm D., 1998, COMPREHENSIVE CELLUL, V1
   Liu T, 2001, POLYMER, V42, P6453, DOI 10.1016/S0032-3861(01)00173-2
   OHANESSIAN J, 1978, ACTA CRYSTALLOGR B, V34, P3666, DOI 10.1107/S0567740878014788
   Okazaki I, 1997, MACROMOLECULES, V30, P1758, DOI 10.1021/ma961539d
   Qiu ZB, 2003, POLYMER, V44, P7781, DOI 10.1016/j.polymer.2003.10.045
   RAFF RA, 1965, HIGH POLYM 1, V20
   Ribeiro M, 1999, J THERM ANAL CALORIM, V57, P253, DOI 10.1023/A:1010112801307
   Sahoo B, 2006, BIOMACROMOLECULES, V7, P1042, DOI 10.1021/bm050703e
   Sauer BB, 2000, POLYMER, V41, P1099, DOI 10.1016/S0032-3861(99)00258-X
   Shah V, 2005, ANTIMICROB AGENTS CH, V49, P4093, DOI 10.1128/AAC.49.10.4093-4100.2005
   Singh SK, 2003, J ORG CHEM, V68, P5466, DOI 10.1021/jo0204395
   Tandon P, 2000, J MOL STRUCT, V524, P201, DOI 10.1016/S0022-2860(00)00378-1
   Van Bogaert INA, 2007, APPL MICROBIOL BIOT, V76, P23, DOI 10.1007/s00253-007-0988-7
   Wunderlich B., 1980, MACROMOLECULAR PHYS, V3
   Zhou SQ, 2004, LANGMUIR, V20, P7926, DOI 10.1021/la048590s
   Zini E, 2003, BIOMACROMOLECULES, V4, P821, DOI 10.1021/bm034040h
NR 22
TC 17
Z9 17
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
EI 1520-5835
J9 MACROMOLECULES
JI Macromolecules
PD OCT 28
PY 2008
VL 41
IS 20
BP 7463
EP 7468
DI 10.1021/ma800496f
PG 6
WC Polymer Science
SC Polymer Science
GA 363GM
UT WOS:000260255800032
DA 2018-10-20
ER

PT J
AU Kang, C
   Weiss, SM
AF Kang, Christopher
   Weiss, Sharon M.
TI Photonic crystal with multiple-hole defect for sensor applications
SO OPTICS EXPRESS
LA English
DT Article
ID SILICON WAVE-GUIDE; SLOW-LIGHT; BENDS; LASER; TRANSMISSION; NANOCAVITY;
   DOMAIN; SLABS
AB A photonic crystal defect consisting of several subwavelength holes was investigated as a means to increase the surface area of the defect region without compromising the quality factor of the structure. Finite-difference time-domain calculations were performed to determine the relationships between the size of the multi-hole defect (MHD) region, resonance frequency, quality factor, and refractive index of the defect holes. The advantage of using the MHD for sensing applications is demonstrated through a comparison with a single hole defect (SHD) photonic crystal structure. Assuming the same monolayer thickness of biomaterial coats the defect hole walls of the MHD and SHD, the MHD has a three times larger change in resonance frequency and two times larger quality factor. (C) 2008 Optical Society of America
C1 [Kang, Christopher; Weiss, Sharon M.] Vanderbilt Univ, Interdisciplinary Grad Program Mat Sci, Nashville, TN 37235 USA.
   [Weiss, Sharon M.] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37235 USA.
RP Kang, C (reprint author), Vanderbilt Univ, Interdisciplinary Grad Program Mat Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM chris.kang@vanderbilt.edu
RI Weiss, Sharon/B-4806-2012
CR Akahane Y, 2003, NATURE, V425, P944, DOI 10.1038/nature02063
   Asano T, 2006, IEEE J SEL TOP QUANT, V12, P1123, DOI 10.1109/JSTQE.2006.881639
   Assefa S, 2006, OPT LETT, V31, P745, DOI 10.1364/OL.31.000745
   Baba T, 1999, ELECTRON LETT, V35, P654, DOI 10.1049/el:19990438
   BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159
   Chutinan A, 2000, PHYS REV B, V62, P4488, DOI 10.1103/PhysRevB.62.4488
   Farjadpour A, 2006, OPT LETT, V31, P2972, DOI 10.1364/OL.31.002972
   Garnett JCM, 1904, PHILOS T R SOC LOND, V203, P385, DOI 10.1098/rsta.1904.0024
   Imada M, 1999, APPL PHYS LETT, V75, P316, DOI 10.1063/1.124361
   Jiang YQ, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2138367
   Johnson SG, 2001, OPT EXPRESS, V8, P173, DOI 10.1364/OE.8.000173
   Kang C, 2008, PROC SPIE, V7031, DOI 10.1117/12.798277
   Lee M, 2007, OPT EXPRESS, V15, P4530, DOI 10.1364/OE.15.004530
   Levy O, 1997, PHYS REV B, V56, P8035, DOI 10.1103/PhysRevB.56.8035
   Loncar M, 2003, APPL PHYS LETT, V82, P4648, DOI 10.1063/1.1586781
   Mandelshtam VA, 1998, J CHEM PHYS, V109, P4128, DOI 10.1063/1.477013
   Mekis A, 1996, PHYS REV LETT, V77, P3787, DOI 10.1103/PhysRevLett.77.3787
   Morton KJ, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/34/345301
   Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819
   Rong G, 2008, BIOSENS BIOELECTRON, V23, P1572, DOI 10.1016/j.bios.2008.01.017
   Schmidt B, 2004, APPL PHYS LETT, V85, P4854, DOI 10.1063/1.1819997
   Soljacic M, 2002, J OPT SOC AM B, V19, P2052, DOI 10.1364/JOSAB.19.002052
   Taflove A, 2000, COMPUTATIONAL ELECTR
NR 23
TC 28
Z9 28
U1 0
U2 7
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD OCT 27
PY 2008
VL 16
IS 22
BP 18188
EP 18193
DI 10.1364/OE.16.018188
PG 6
WC Optics
SC Optics
GA 371XL
UT WOS:000260865900102
PM 18958096
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Cheung, CY
   McCartney, SJ
   Anseth, KS
AF Cheung, Charles Y.
   McCartney, Suzanne J.
   Anseth, Kristi S.
TI Synthesis of Polymerizable Superoxide Dismutase Mimetics to Reduce
   Reactive Oxygen Species Damage in Transplanted Biomedical Devices
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID BETA-CELL DESTRUCTION; HYDROGEN-PEROXIDE; IN-VITRO; MANGANESE PORPHYRIN;
   DIABETES-MELLITUS; ISLET GRAFTS; T-CELLS; RADICALS; ANION;
   METALLOPORPHYRINS
AB A new polymerizable superoxide dismutase (SOD) mimetic metalloporphyrin macromer was synthesized to minimize inflammatory damage associated with tissue transplantation and biomaterial implantation, such as the use of encapsulated pancreatic islets for the treatment of type I diabetes mellitus (TIDM). This functional SOD mimetic, Mn(III) Tetrakis[1-(3-acryloxy-propyl)-4-pyridyl] porphyrin (MnTPPyP-Acryl), was copolymerized and crosslinked with poly(ethylene glycol) diacrylate (PEGDA) to form hydrogel networks that may actively reduce reactive oxygen species (ROS) damage associated with biomaterial implantation. Solution phase activity assays with MnTPPyP-Acryl macromers showed comparable SOD activity to MnTMPyP, a non-polymerizable commercially available SOD mimetic. This work also describes the development of a new, simple, and inexpensive solid phase assay system that was developed to assess the activity of MnTPPyP-Acryl macromers polymerized within PEGDA hydrogels, which has the potential to fulfill an existing void with the biochemical tools available for testing other immobilized ROS antagonists. With this new assay system, hydrogels containing up to 0.25 mol% MnTPPyP-Acryl showed significantly higher levels of SOD activity, whereas control hydrogels polymerized with inactive MnTPPyP-Acryl macromers showed only background levels of activity. The potential for repeated use of such hydrogel devices to consistently reduce superoxide anion concentrations was demonstrated upon retention of 100% SOD activity for at least 72 h post-polymerization. These results demonstrate the potential that polymerizable SOD mimetics may have for integration into medical devices for the minimization of inflammatory damage upon transplantation, such as during the delivery of encapsulated pancreatic islets.
C1 [Cheung, Charles Y.; McCartney, Suzanne J.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Cheung, CY (reprint author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
EM kristi.anseth@colorado.edu
FU NSF [EEC0444771]
FX This work was partially supported by the NSF (EEC0444771).
CR Ali SS, 2004, FREE RADICAL BIO MED, V37, P1191, DOI 10.1016/j.freeradbiomed.2004.07.002
   ASAYAMA K, 1986, J LAB CLIN MED, V107, P459
   Asayama S, 2004, BIOCONJUGATE CHEM, V15, P1360, DOI 10.1021/bc049865i
   Batinic-Haberle I, 1999, INORG CHEM, V38, P4011, DOI 10.1021/ic990118k
   Batinic-Haberle I, 1998, J BIOL CHEM, V273, P24521, DOI 10.1074/jbc.273.38.24521
   Benaglia M, 2002, ORG LETT, V4, P4229, DOI 10.1021/ol0267230
   Benov L, 2005, FREE RADICAL RES, V39, P81, DOI 10.1080/10715760400022368
   BUTLER J, 1975, Biochimica et Biophysica Acta, V408, P215
   Cheung CY, 2006, BIOCONJUGATE CHEM, V17, P1036, DOI 10.1021/bc060023o
   Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341
   Emregul E, 2005, ANAL BIOANAL CHEM, V383, P947, DOI 10.1007/s00216-005-0102-x
   Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014
   FAULKNER KM, 1994, J BIOL CHEM, V269, P23471
   GRANKVIST K, 1986, INT J BIOCHEM, V18, P109, DOI 10.1016/0020-711X(86)90141-2
   GRANKVIST K, 1981, NATURE, V294, P158, DOI 10.1038/294158a0
   HASEGAWA E, 1978, EUR POLYM J, V14, P123, DOI 10.1016/0014-3057(78)90076-9
   Ho E, 1999, P SOC EXP BIOL MED, V222, P205, DOI 10.1046/j.1525-1373.1999.d01-137.x
   HORIO F, 1994, DIABETOLOGIA, V37, P22
   KAJIWARA A, 1994, POLYM J, V26, P215, DOI 10.1295/polymj.26.215
   KAMACHI M, 1987, MACROMOLECULES, V20, P2665, DOI 10.1021/ma00177a005
   Kawakami H, 1999, POLYM ADVAN TECHNOL, V10, P270, DOI 10.1002/(SICI)1099-1581(199905)10:5<270::AID-PAT873>3.0.CO;2-C
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430
   NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3
   NOMIKOS IN, 1989, IMMUNOL CELL BIOL, V67, P85, DOI 10.1038/icb.1989.12
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   Ohse T, 1999, J BIOMAT SCI-POLYM E, V10, P917, DOI 10.1163/156856299X00531
   PACKER E, 1997, HDB SYNTHETIC ANTIOX
   PAPACCIO G, 1993, HISTOL HISTOPATHOL, V8, P751
   PASTERNACK RF, 1981, J INORG BIOCHEM, V15, P261, DOI 10.1016/S0162-0134(00)80161-0
   Pastor I, 2004, ANAL BIOCHEM, V334, P335, DOI 10.1016/j.ab.2004.08.012
   Piganelli JD, 2002, DIABETES, V51, P347, DOI 10.2337/diabetes.51.2.347
   Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9
   RAO UM, 1989, FREE RADICAL BIO MED, V7, P513
   Rogers CJ, 2005, TETRAHEDRON, V61, P12140, DOI 10.1016/j.tet.2005.07.115
   SALINAS CN, 2008, UNPUB
   Salvemini D, 2002, NAT REV DRUG DISCOV, V1, P367, DOI 10.1038/nrd796
   Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365
   Tay T, 2007, REACT FUNCT POLYM, V67, P999, DOI 10.1016/j.reactfunctpolym.2007.06.003
   TSUCHIDA E, 1978, MACROMOLECULES, V11, P947, DOI 10.1021/ma60065a021
   Tyrberg B, 1999, PHARMACOL TOXICOL, V85, P269, DOI 10.1111/j.1600-0773.1999.tb02021.x
   Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025
   Weber LM, 2007, CELL TRANSPLANT, V16, P1049, DOI 10.3727/000000007783472336
   WERINGER EJ, 1986, AM J PATHOL, V125, P107
   Yoon JW, 1998, AUTOIMMUNITY, V27, P109, DOI 10.3109/08916939809008041
   Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391
NR 46
TC 32
Z9 32
U1 4
U2 19
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD OCT 23
PY 2008
VL 18
IS 20
BP 3119
EP 3126
DI 10.1002/adfm.200800566
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 369PV
UT WOS:000260707300003
DA 2018-10-20
ER

PT J
AU Velzenberger, E
   Pezron, I
   Legeay, G
   Nagel, MD
   El Kirat, K
AF Velzenberger, Elodie
   Pezron, Isabelle
   Legeay, Gilbert
   Nagel, Marie-Danielle
   El Kirat, Karim
TI Probing Fibronectin-Surface Interactions: A Multitechnique Approach
SO LANGMUIR
LA English
DT Article
ID HUMAN PLASMA FIBRONECTIN; MARROW STROMAL CELLS; PROTEIN ADSORPTION;
   POLYMER SURFACES; DRUG-DELIVERY; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS;
   MELANOMA-CELLS; ADHESION; SUBSTRATUM
AB The development of adhesive as well as antiadhesive surfaces is essential in various biomaterial applications. In this study, we have used a multidisciplinary approach that combines biological and physicochemical methods to progress in our understanding of cell-surface interactions. Four model surfaces have been used to investigate fibronectin (Fn) adsorption and the subsequent morphology and adhesion of preosteoblasts. Such experimental conditions lead us to distinguish between anti- and proadhesive substrata. Our results indicate that Fn is not able to induce cell adhesion on antiadhesive materials. On adhesive substrata, Fn did not increase the number of adherent cells but favored their spreading. This work also examined Fn-surface interactions using ELISA immunoassays, fluorescent labeling of Fn, and force spectroscopy with Fn-modified tips. The results provided clear evidence of the advantages and limitations of each technique. All of the techniques confirmed the important adsorption of Fn on proadhesive surfaces for cells. By contrast, antiadhesive substrata for cells avoided Fn adsorption. Furthermore, ELISA experiments enabled us to verify the accessibility of cell binding sites to adsorbed Fn molecules.
C1 [Velzenberger, Elodie; Nagel, Marie-Danielle; El Kirat, Karim] Univ Technol Compiegne, CNRS, UMR Biomecan & Bioingn 6600, F-60205 Compiegne, France.
   [Pezron, Isabelle] Univ Technol Compiegne, EA Transformat Integrees Mat Renouvelable, F-60205 Compiegne, France.
RP Velzenberger, E (reprint author), Univ Technol Compiegne, CNRS, UMR Biomecan & Bioingn 6600, BP 20529, F-60205 Compiegne, France.
EM elodie.velzenberger@utc.fr
RI EL KIRAT, Karim/A-4590-2017; EL KIRAT, Karim/C-5136-2009
OI EL KIRAT, Karim/0000-0003-4884-7270; pezron,
   isabelle/0000-0002-1083-3343
FU Universite de Technologie de Compiegne
FX The support of the Universite de Technologie de Compiegne [UTC, Plan de
   Pluriformation (PPF Nanobiotechnologies)] is gratefully acknowledged. We
   thank the Service d'Analyses Physico-Chimiques of UTC for the use of the
   atomic force microscope and Statice Santd Company for the culture device
   packaging and sterilization.
CR AKIYAMA SK, 1994, COLLOID SURFACE B, V2, P241, DOI 10.1016/0927-7765(94)80038-3
   Alsteens D, 2007, LANGMUIR, V23, P11977, DOI 10.1021/la702765c
   Barbucci R, 2004, J BIOMAT SCI-POLYM E, V15, P607, DOI 10.1163/156856204323046870
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Beck D E, 1997, Eur J Surg Suppl, P49
   BENTLEY KL, 1985, J BIOMED MATER RES, V19, P757, DOI 10.1002/jbm.820190704
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Blanco EM, 2008, LANGMUIR, V24, P2284, DOI 10.1021/la702957f
   Buckenmaier CC, 2000, AM SURGEON, V66, P1041
   Caruso DM, 2006, J BURN CARE RES, V27, P298, DOI 10.1097/01.BCR.0000216741.21433.66
   Cha P, 2008, LANGMUIR, V24, P2553, DOI 10.1021/la703310k
   Chiumiento A, 2006, J MATER SCI-MATER M, V17, P427, DOI 10.1007/s10856-006-8470-0
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   El Kirat K, 2005, J BIOMED NANOTECHNOL, V1, P39, DOI 10.1166/jbn.2005.011
   ERICKSON HP, 1983, J BIOL CHEM, V258, P4539
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Fuse Y, 2007, DENT MATER J, V26, P814, DOI 10.4012/dmj.26.814
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Guest JF, 2005, CURR MED RES OPIN, V21, P281, DOI 10.1185/030079905X25532
   Guest JF, 2005, CURR MED RES OPIN, V21, P81, DOI 10.1185/030079904X15219
   Hindie A, 2005, BIOMOL ENG, V22, P205, DOI 10.1016/j.bioeng.2005.07.002
   Hindie M, 2006, J CELL BIOCHEM, V99, P96, DOI 10.1002/jcb.20833
   Hoffmann C, 2008, ANAL BIOCHEM, V372, P62, DOI 10.1016/j.ab.2007.07.027
   Karp JM, 2007, CURR OPIN BIOTECH, V18, P454, DOI 10.1016/j.copbio.2007.09.008
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Kim MS, 2007, TISSUE ENG, V13, P2095, DOI 10.1089/ten.2006.0062
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   KOWALCZYNSKA HM, 1994, COLLOID SURFACE B, V2, P291, DOI 10.1016/0927-7765(94)80043-X
   Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273
   LEE JH, 1991, BIOMATERIALS, V12, P443
   Lipson MJ, 2007, OPTOMETRY VISION SCI, V84, P593, DOI 10.1097/OPX.0b013e31811ece4a
   Liu LS, 2007, CELLULOSE, V14, P15, DOI 10.1007/s10570-006-9095-7
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Meyer EE, 2005, P NATL ACAD SCI USA, V102, P6839, DOI 10.1073/pnas.0502110102
   MIKLAVIC SJ, 1994, J PHYS CHEM-US, V98, P9022, DOI 10.1021/j100087a034
   Nonckreman CJ, 2007, J BIOMED MATER RES A, V81A, P791, DOI 10.1002/jbm.a.31111
   Ravenscroft MJ, 2006, ANN ROY COLL SURG, V88, P18, DOI 10.1308/003588406X82989
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rothenfluh DA, 2008, NAT MATER, V7, P248, DOI 10.1038/nmat2116
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Saika S, 2003, J CATARACT REFR SURG, V29, P1198, DOI 10.1016/S0886-3350(02)01988-0
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Sousa SR, 2007, LANGMUIR, V23, P7046, DOI 10.1021/la062956e
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   Szabo A, 2000, EUR SURG RES, V32, P125, DOI 10.1159/000008751
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996
   Vallieres K, 2007, LANGMUIR, V23, P9745, DOI 10.1021/la701323q
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   van der Zijpp YJT, 2003, J BIOMED MATER RES A, V65A, P51, DOI 10.1002/jbm.a.10327
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
   VELZENBERGER E, 2008, CELLULOSE, P347
   Versura P, 1999, J CATARACT REFR SURG, V25, P527
   Williams D, 2008, MED DEVICE TECHNOL, V19, P10
   Wu PC, 1998, DRUG DEV IND PHARM, V24, P179, DOI 10.3109/03639049809085604
NR 59
TC 15
Z9 15
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 21
PY 2008
VL 24
IS 20
BP 11734
EP 11742
DI 10.1021/la801727p
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 360HT
UT WOS:000260049300057
PM 18816077
DA 2018-10-20
ER

PT J
AU Tiong, WHC
   Damodaran, G
   Naik, H
   Kelly, JL
   Pandit, A
AF Tiong, William H. C.
   Damodaran, Gopinath
   Naik, Hemantkumar
   Kelly, John L.
   Pandit, Abhay
TI Enhancing Amine Terminals in an Amine-Deprived Collagen Matrix
SO LANGMUIR
LA English
DT Article
ID CROSS-LINKED COLLAGEN; NMR RELAXATION PARAMETERS; DERMAL SHEEP COLLAGEN;
   IN-VITRO; PAMAM DENDRIMERS; POLYAMIDOAMINE DENDRIMERS; MICROBIAL
   TRANSGLUTAMINASE; BIOLOGICAL EVALUATION; CHAIN DYNAMICS; CELL VIABILITY
AB Collagen, though widely used as a core biomaterial in many clinical applications, is often limited by its rapid degradability which prevents full exploitation of its potential in vivo. Polyamidoamine (PAMAM) dendrimer, a highly branched macromolecule, possesses versatile multiterminal amine surface groups that enable them to be tethered to collagen molecules and enhance their potential. In this study, we hypothesized that incorporation of PAMAM dendrimer in a collagen matrix through cross-linking will result in a durable, cross-linked collagen biomaterial with free -NH2 groups available for further multi-biomolecular tethering. The aim of this study was to assess the physicochemical properties of a G1 PAMAM cross-linked collagen matrix and its cellular sustainability in vitro. Different amounts of G I PAMAM dendrimer (5 or 10 mg) were integrated into bovine-derived collagen matrices through a cross-linking process, mediated by 5 or 25 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) in 5 mM N-hydroxysuccinimide (NHS) and 50 mM 2-morpholinoethane sulfonic acid buffer at pH 5.5. The physicochemical properties of resultant matrices were investigated with scanning electron microscopy (SEM), collagenase degradation assay, differential scanning calorimetry (DSC), Fourier transform infrared (FTIR) spectra, and ninhydrin assay. Cellular sustainability of the matrices was assessed with Alamar Blue assay and SEM. There was no significant difference in cellular behavior between the treated and nontreated groups. However, the benefit of incorporating PAMAM in the cross-linking reaction was limited when higher concentrations of either agent were used. These results confirm the hypothesis that PAMAM dendrimer can be incorporated in the collagen cross-linking process in order to modulate the properties of the resulting cross-linked collagen biomaterial with free -NH2 groups available for multi-biomolecular tethering.
C1 [Tiong, William H. C.; Damodaran, Gopinath; Naik, Hemantkumar; Pandit, Abhay] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland.
   [Kelly, John L.] Univ Hosp Galway, Dept Plast Reconstruct & Hand Surg, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008; Tiong, William/G-6010-2018; Naik,
   Hemantkumar/G-1101-2011
OI Pandit, Abhay/0000-0002-6292-4933; Tiong, William/0000-0002-1254-8490;
   Damodaran, Gopinath/0000-0002-1697-0357
FU Enterprise Ireland
FX The authors gratefully acknowledge the financial support from Enterprise
   Ireland (Technology Development Grant).
CR Baek MG, 2002, BIOORGAN MED CHEM, V10, P11, DOI 10.1016/S0968-0896(01)00248-6
   BARTH A, 2002, C Q REV BIOPHYS, V35, P369
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   Boas U, 2001, J ORG CHEM, V66, P2136, DOI 10.1021/jo001573x
   Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Chan JCY, 2008, BIOMACROMOLECULES, V9, P528, DOI 10.1021/bm701055k
   Chen P, 2005, TISSUE ENG, V11, P1436, DOI 10.1089/ten.2005.11.1436
   Chen RN, 2005, BIOMATERIALS, V26, P4229, DOI 10.1016/j.biomaterials.2004.11.012
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DAMODARAN G, J BIOMED MAT RES A
   Domanski DM, 2004, BIOELECTROCHEMISTRY, V63, P193, DOI 10.1016/j.bioelechem.2003.09.024
   Duan X, 2007, J BIOMAT SCI-POLYM E, V18, P701, DOI 10.1163/156856207781034151
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Duan X, 2005, J BIOMED MATER RES A, V75A, P510, DOI 10.1002/jbm.a.30475
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019
   Everaerts F, 2008, J BIOMED MATER RES A, V85A, P547, DOI 10.1002/jbm.a.31524
   Fail CA, 2002, LANGMUIR, V18, P264, DOI 10.1021/la0111598
   Fini M, 2007, J ORTHOP RES, V25, P98, DOI 10.1002/jor.20295
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   FISHER J, 1987, LIFE SUPPORT SYST, V5, P189
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Garcia Y, 2007, J MATER SCI-MATER M, V18, P1991, DOI 10.1007/s10856-007-3091-9
   Gingras M, 2008, GLIA, V56, P354, DOI 10.1002/glia.20617
   Gopinath D, 2005, J BIOMED MATER RES A, V73A, P320, DOI 10.1002/jbm.a.30303
   Hanthamrongwit M, 1996, BIOMATERIALS, V17, P775, DOI 10.1016/0142-9612(96)81414-1
   Hong MY, 2003, LANGMUIR, V19, P416, DOI 10.1021/a1020431q
   Jevprasesphant R, 2003, PHARM RES-DORDR, V20, P1543, DOI 10.1023/A:1026166729873
   Jevprasesphant R, 2003, INT J PHARM, V252, P263, DOI 10.1016/S0378-5173(02)00623-3
   Kobayashi H, 2001, MAGNET RESON MED, V46, P781, DOI 10.1002/mrm.1257.abs
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Malik N, 2000, J CONTROL RELEASE, V65, P133, DOI 10.1016/S0168-3659(99)00246-1
   Malik N, 1999, ANTI-CANCER DRUG, V10, P767, DOI 10.1097/00001813-199909000-00010
   Maraval V, 2003, J ORG CHEM, V68, P6043, DOI 10.1021/jo0344438
   MELTZER AD, 1992, MACROMOLECULES, V25, P4549, DOI 10.1021/ma00044a014
   MELTZER AD, 1992, MACROMOLECULES, V25, P4541, DOI 10.1021/ma00044a013
   Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Nourse A, 2000, BIOPOLYMERS, V53, P316, DOI 10.1002/(SICI)1097-0282(20000405)53:4<316::AID-BIP4>3.3.CO;2-A
   O Halloran DM, 2006, TISSUE ENG, V12, P1467, DOI 10.1089/ten.2006.12.1467
   OBRIEN TK, 1984, T AM SOC ART INT ORG, V30, P440
   Ohan MP, 2003, J BIOMED MATER RES A, V67A, P1188, DOI 10.1002/jbm.a.20018
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   PETITE H, 1994, J BIOMED MATER RES, V28, P159, DOI 10.1002/jbm.820280204
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   Roberts JC, 1990, BIOCONJUGATE CHEM, V1, P305, DOI 10.1021/bc00005a001
   Rodkey WG, 1999, CLIN ORTHOP RELAT R, pS281
   Sanchez-Sancho F, 2002, BIOCONJUGATE CHEM, V13, P647, DOI 10.1021/bc0155824
   Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5
   Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028
   Shanmugasundaram N, 2004, J BIOMATER APPL, V18, P247, DOI 10.1177/0885328204040945
   Shaunak S, 2004, NAT BIOTECHNOL, V22, P977, DOI 10.1038/nbt995
   Shukla S, 2003, BIOCONJUGATE CHEM, V14, P158, DOI 10.1021/bc025586o
   STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Wu P, 2004, ANGEW CHEM INT EDIT, V43, P3928, DOI 10.1002/anie.200454078
   Wu XY, 2004, MACROMOL BIOSCI, V4, P71, DOI 10.1002/mabi.200300041
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
NR 69
TC 14
Z9 15
U1 1
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 21
PY 2008
VL 24
IS 20
BP 11752
EP 11761
DI 10.1021/la801913c
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 360HT
UT WOS:000260049300059
PM 18774827
DA 2018-10-20
ER

PT J
AU Yang, T
   Zaman, MH
AF Yang, Tianyi
   Zaman, Muhammad H.
TI Cell Adhesion to Nanoligands: Effects of Ligand Size and Concentration
   in Solution
SO LANGMUIR
LA English
DT Article
ID MUTATIONS; DISEASE; SURFACES; KINETICS; FAMILY; LAYERS; MODEL; FLOW
AB Cells interact with both tethered and motile ligands in their extracellular environment to initiate and regulate signaling, adhesion, and migration. A quantitative and fundamental understanding of these receptor-ligand interactions is necessary for drug discovery, tissue engineering, and biomaterial fabrication. In this paper, we present a mean field approach to quantify the fundamental thermodynamics of interaction between the cell surface receptors and motile ligands in solvent. Our studies show that the free energy of interaction between the receptors and the nanosized ligands depends strongly on the ligand size and the effects at lower and higher concentrations show completely opposite trends that cannot be explained by simple scaling laws. In addition, we also observe various regimes of strong and weak adhesion as a function of ligand size and concentration. Our calculations provide insights into understanding cell-matrix interactions at a fundamental level as well as to identify potential avenues for fabrication of nanoligands for therapeutic and biotechnological purposes.
C1 [Zaman, Muhammad H.] Univ Texas Austin, Dept Biomed Engn, Inst Theoret Chem, Austin, TX 78712 USA.
   [Yang, Tianyi] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA.
RP Zaman, MH (reprint author), Univ Texas Austin, Dept Biomed Engn, Inst Theoret Chem, Austin, TX 78712 USA.
EM mhzaman@mail.utexas.edu
FU Robert A. Welch Foundation [F-1677]; Cockrell School of Engineering
FX M.H.Z. gratefully acknowledges the support of a Robert A. Welch
   Foundation Grant (F-1677) and faculty startup funds from the Cockrell
   School of Engineering at UT Austin. The authors would like to thank
   Prof. Igal Szleifer (Northwestern) for his support and guidance during
   early stages of model development. We are also deeply grateful to the
   reviewers of our manuscript for their detailed and insightful comments
   and suggestions.
CR Alberts B, 2002, MOL BIOL CELL
   Bodian DL, 2008, BIOCHEMISTRY-US, V47, P5424, DOI 10.1021/bi800026k
   CARIGNANO MA, 1993, J CHEM PHYS, V98, P5006, DOI 10.1063/1.464954
   DESIMONE DW, 1987, BIOCHEM SOC T, V15, P789
   Gao M, 2002, J MUSCLE RES CELL M, V23, P513, DOI 10.1023/A:1023466608163
   Gensure RC, 2005, J CLIN INVEST, V115, P1250, DOI 10.1172/JCI200522760
   HAMMER DA, 1993, BLOOD CELLS, V19, P261
   HAMMER DA, 1989, CELL BIOPHYS, V14, P139, DOI 10.1007/BF02797131
   HAMMER DA, 1987, BIOPHYS J, V52, P475, DOI 10.1016/S0006-3495(87)83236-8
   Huang YB, 2002, MACROMOLECULES, V35, P1373, DOI 10.1021/ma011294r
   Huang YB, 2001, J CHEM PHYS, V114, P3809, DOI 10.1063/1.1345723
   Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89
   Hynes RO, 2004, MATRIX BIOL, V23, P333, DOI 10.1016/j.matbio.2004.08.001
   Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351
   Longo G, 2005, LANGMUIR, V21, P11342, DOI 10.1021/la051685p
   Lupo I, 2005, BRIT J DERMATOL, V153, P1019, DOI 10.1111/j.1365-2133.2005.06842.x
   Miyamoto Y, 2007, HUM GENET, V121, P625, DOI 10.1007/s00439-007-0354-y
   Press W. H., 2007, NUMERICAL RECIPES C
   Segev F, 2006, INVEST OPHTH VIS SCI, V47, P565, DOI 10.1167/iovs.05-0771
   VIKKULA M, 1994, ANN MED, V26, P107
   WARD MD, 1993, BIOPHYS J, V64, P936, DOI 10.1016/S0006-3495(93)81456-5
   WARD MD, 1995, ANN BIOMED ENG, V23, P322, DOI 10.1007/BF02584432
   WILLIAMS CJ, 1995, J RHEUMATOL, V22, P28
   Yang TY, 2008, CHEM PHYS LETT, V454, P362, DOI 10.1016/j.cplett.2008.01.088
   Yang TY, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2424985
   Zaman MH, 2007, BIOPHYS J, V92, pL17, DOI 10.1529/biophysj.106.097519
   Zhu C, 2000, J BIOMECH, V33, P23, DOI 10.1016/S0021-9290(99)00163-3
NR 27
TC 2
Z9 2
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 21
PY 2008
VL 24
IS 20
BP 11819
EP 11827
DI 10.1021/la801885c
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 360HT
UT WOS:000260049300067
PM 18816080
DA 2018-10-20
ER

PT J
AU Zisch, AH
   Zimmermann, R
AF Zisch, Andreas H.
   Zimmermann, Roland
TI Bioengineering of foetal membrane repair
SO SWISS MEDICAL WEEKLY
LA English
DT Article
DE spontaneous PPROM; iatrogenic PPROM; tissue sealants; foetoscopy;
   injectable hydrogel; scaffolds
ID PRETERM PREMATURE RUPTURE; FETOSCOPIC ACCESS SITES; RABBIT MODEL;
   STRUCTURAL CHARACTERISTICS; GENETIC AMNIOCENTESIS; CLOSURE TECHNIQUES;
   MESENCHYMAL CELLS; GELATIN SPONGE; EXPERIENCE; DELIVERY
AB Preterm premature rupture of the foetal membranes (fruber vorzeitiger Blasensprung) has remained a devastating complication of pregnancy with very high risk of pregnancy loss. Several methods of sealing spontaneously ruptured membranes to stop amniotic fluid leakage and prolong pregnancy have been tested, but no one of them has achieved a clinical breakthrough. Also, needle and foetoscopic puncture of membranes for diagnostic or surgical interventions in the amniotic cavity carry a significant risk of persistent membrane leakage and subsequent rupture - thus limiting the developing field of intrauterine foetal surgery. Efforts are concentrated on taking action before rupture rather than reacting after rupture: one avenue of research concerns prophylactic plugging of foetoscopic access sites in foetal membranes at the time of intervention, thus inhibiting leakage and rupture. Foetal membrane injuries, spontaneous or iatrogenic, constitute extreme challenges to repair: thinness of foetal membrane tissue, difficult localisation and accessibility of the rupture site, the need for injectable sealants, vet gluing conditions and poor wound healing in this tissue all complicate repair. The goal is to achieve immediate and at the same time long-lasting closure of the membrane leak. Here we review approaches to closure of foetal membrane defects with liquid sealants or solid biomaterial scaffolds, with the focus on prophylactic plugging of foetoscopic access sites.
C1 [Zisch, Andreas H.; Zimmermann, Roland] Univ Zurich Hosp, Dept Obstet, CH-8091 Zurich, Switzerland.
   [Zisch, Andreas H.] Swiss Fed Inst Technol, Dept Mat, CH-1015 Lausanne, Switzerland.
   [Zisch, Andreas H.] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.
RP Zisch, AH (reprint author), Univ Zurich Hosp, Dept Obstet, Frauenklinikstr 10, CH-8091 Zurich, Switzerland.
EM andreas.zisch@usz.ch
CR Bilic G, 2005, AM J OBSTET GYNECOL, V193, P1724, DOI 10.1016/j.ajog.2005.04.005
   Bilic G, 2004, AM J OBSTET GYNECOL, V190, P87, DOI 10.1016/j.ajog.2003.07.011
   Deprest JA, 1997, PRENATAL DIAG, V17, P1247, DOI 10.1002/(SICI)1097-0223(199712)17:13<1247::AID-PD329>3.0.CO;2-W
   Deprest JA, 1999, HUM REPROD, V14, P1730, DOI 10.1093/humrep/14.7.1730
   Deprest J, 2006, SEMIN FETAL NEONAT M, V11, P398, DOI 10.1016/j.siny.2006.09.003
   Devlieger R, 2003, AM J OBSTET GYNECOL, V188, P844, DOI 10.1067/mob.2003.213
   DEVLIEGER R, 2006, AM J OBSTET GVNECOL
   Ghezzi F, 2002, AM J OBSTET GYNECOL, V186, P268, DOI 10.1067/mob.2002.119628
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gratacos E, 2000, AM J OBSTET GYNECOL, V182, P142, DOI 10.1016/S0002-9378(00)70503-5
   Gratacos E, 2006, PLACENTA, V27, P452, DOI 10.1016/j.placenta.2005.03.008
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Luks FI, 1999, AM J OBSTET GYNECOL, V181, P995, DOI 10.1016/S0002-9378(99)70338-8
   MALAK TM, 1994, BRIT J OBSTET GYNAEC, V101, P375, DOI 10.1111/j.1471-0528.1994.tb11908.x
   Mallik AS, 2007, OBSTET GYNECOL, V110, P1121, DOI 10.1097/01.AOG.0000284624.23598.7c
   McLaren J, 1999, HUM REPROD, V14, P237, DOI 10.1093/humrep/14.1.237
   Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9
   O'Brien JM, 2002, AM J OBSTET GYNECOL, V187, P1143, DOI 10.1067/mob.2002.127124
   Ochsenbein-Kolble N, 2007, AM J OBSTET GYNECOL, V196, P263, DOI 10.1016/j.ajog.2006.10.904
   Ochsenbein-Kolble N, 2003, J PERINAT MED, V31, P287, DOI 10.1515/JPM.2003.040
   Papadopulos NA, 1998, AM J OBSTET GYNECOL, V178, P938, DOI 10.1016/S0002-9378(98)70527-7
   Papadopulos NA, 2006, FETAL DIAGN THER, V21, P494, DOI 10.1159/000095660
   Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006
   Portmann-Lanz CB, 2007, PLACENTA, V28, P6, DOI 10.1016/j.placenta.2006.01.004
   Quintero RA, 1998, AM J OBSTET GYNECOL, V179, P71, DOI 10.1016/S0002-9378(98)70252-2
   Quintero RA, 2001, CLIN PERINATOL, V28, P861, DOI 10.1016/S0095-5108(03)00083-6
   Quintero RA, 1999, AM J OBSTET GYNECOL, V181, P744, DOI 10.1016/S0002-9378(99)70522-3
   Quintero RA, 2002, AM J OBSTET GYNECOL, V186, P155, DOI 10.1067/mob.2002.119185
   Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6
   Sciscione AC, 2001, AM J OBSTET GYNECOL, V184, P368, DOI 10.1067/mob.2001.111796
   Sener T, 1997, AM J OBSTET GYNECOL, V177, P1535, DOI 10.1016/S0002-9378(97)70104-2
   Wenstrom KD, 1998, AM J OBSTET GYNECOL, V178, P546, DOI 10.1016/S0002-9378(98)70436-3
   West JL, 1996, P NATL ACAD SCI USA, V93, P13188, DOI 10.1073/pnas.93.23.13188
   Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1162, DOI 10.1067/mob.2001.117678
   Young B K, 2004, J Matern Fetal Neonatal Med, V16, P235
   Young BK, 2004, FETAL DIAGN THER, V19, P296, DOI 10.1159/000076715
NR 36
TC 5
Z9 5
U1 0
U2 7
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD OCT 18
PY 2008
VL 138
IS 41-42
BP 596
EP 601
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 362YM
UT WOS:000260233100001
PM 18941945
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Yang, H
   Zhang, L
   Xu, KW
AF Yang, Hui
   Zhang, Lin
   Xu, Ke-Wei
TI Effect of fabrication processes on orientation growth of La/HAP crystal
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE crystal orientation; lanthanum; hydroxyapatite; biomaterial;
   nanomaterial
ID HYDROXYAPATITE CRYSTALS; COLLAGEN; BONE
AB Hydroxyapatite doped with lanthanum (La/HAP) was prepared using co-precipitation method in this study. The effects of the concentration of La3+, stirring, aging time, hydrothermal treatment and calcination temperature on orient growth of the La/HAP were investigated. The phase composition of the La/HAP was analyzed by means of X-ray diffraction (XRD). The parameter (c/a) values of the orient growth of the La/HAP were calculated based on XRD data. The results show that the orient growth of La/HAP crystal is slightly affected by the concentration of La3+ in reaction solution whereas the growth of the crystal is closely related to the aging time and the calcination temperature. As the calcination temperature changes from 100 degrees C to 750 degrees C, the La/HAP crystal tends to grow along a-axis. The tendency of the crystal growth in the direction of c-axis becomes obvious at 70 degrees C as aging time extends. However, stirring appears to restrain the growth of crystal in c-axis. The hydrothermal treatment at 125 degrees C seems helpful for getting a low c/a value crystal and changes the La/HAP from needle shape to rod one. The direction of the c-axis of the La/HAP lattice seems to be the same as that of the long-axis of the La/HAP nanoparticles. The assynthesized La/HAP powder mainly consists of HAP phase with slight La2O3 phase and has good thermostability. (C) 2008 Published by Elsevier B.V.
C1 [Yang, Hui; Xu, Ke-Wei] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
   [Yang, Hui; Zhang, Lin] Shaanxi Univ Sci & Technol, Life Coll Sci & Engn, Xianyang 712081, Peoples R China.
RP Xu, KW (reprint author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
EM kwxu@xjtu.edu.cn
FU Bureau of Science Technology [GG 200354]; Natural Science Foundation
   [2004B24]; Shaanxi University of Science Technology [sust-B104]
FX This work was financially supported by the Key Research item of
   Technology of Bureau of Science & Technology of Xi'an city, Shaanxi
   Province of China (Grant no. GG 200354) and partially supported by the
   Natural Science Foundation of Shaanxi Province of China (Grant no.
   2004B24) and the Research Team Foundation of Shaanxi University of
   Science & Technology (sust-B104).
CR Aizawa M, 2005, BIOMATERIALS, V26, P3427, DOI 10.1016/j.biomaterials.2004.09.044
   Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   CAO XZ, 1984, INORG CHEM, P173
   Feng QL, 1999, J MATER SCI LETT, V18, P559, DOI 10.1023/A:1006686713882
   Fraser AC, 1999, BRIT POULTRY SCI, V40, P626, DOI 10.1080/00071669987016
   Kaneko T, 2004, CHEM MATER, V16, P5596, DOI 10.1021/cm0490975
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Lee BT, 2006, MAT SCI ENG A-STRUCT, V429, P348, DOI 10.1016/j.msea.2006.05.090
   Liu Rong fang, 2003, Journal of the Chinese Ceramic Society, V31, P615
   Massa EA, 2002, MATER RES SOC SYMP P, V711, P257
   Matsuda A, 2004, MAT SCI ENG C-BIO S, V24, P717, DOI 10.1016/j.msec.2004.08.048
   Oktar F.N., 2006, KEY ENG MATER, V18, P101
   Park SS, 2005, KEY ENG MAT, V277-279, P113, DOI 10.4028/www.scientific.net/KEM.277-279.113
   Rodriguez-Lorenzo LM, 2000, CHEM MATER, V12, P2460, DOI 10.1021/cm001033g
   Rokita E, 2005, NUCL INSTRUM METH B, V240, P69, DOI 10.1016/j.nimb.2005.06.089
   SHAW WJ, 2004, J BIOL CHEM, V279, P40236
   TIAN CX, 1999, J PANZHIHUA U, V16, P77
   Ueshima M, 2002, SOLID STATE IONICS, V151, P29, DOI 10.1016/S0167-2738(02)00600-8
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Zhai Y, 2005, CURR APPL PHYS, V5, P429, DOI 10.1016/j.cap.2005.01.004
   ZHANG LJ, 2004, THIN SOLID FILMS, V458, P287, DOI DOI 10.1016/J.TSF.2003.11.296
NR 21
TC 5
Z9 6
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD OCT 16
PY 2008
VL 207
IS 1-3
BP 276
EP 282
DI 10.1016/j.jmatprotec.2007.12.079
PG 7
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 356NZ
UT WOS:000259786200034
DA 2018-10-20
ER

PT J
AU Wheeldon, IR
   Gallaway, JW
   Barton, SC
   Banta, S
AF Wheeldon, Ian R.
   Gallaway, Joshua W.
   Barton, Scott Calabrese
   Banta, Scott
TI Bioelectrocatalytic hydrogels from electron-conducting
   metallopolypeptides coassembled with bifunctional enzymatic building
   blocks
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biocatalysis; biofuel cell; biomaterial; laccase; protein
ID BIOFUEL CELLS; STREPTOMYCES-COELICOLOR; CIRCULAR-DICHROISM; SMALL
   LACCASE; PROTEIN; DESIGN; BIOSENSORS; SECONDARY; KINETICS; MODEL
AB Here, we present two bifunctional protein building blocks that coassemble to form a bioelectrocatalytic hydrogel that catalyzes the reduction of dioxygen to water. One building block, a metallopolypeptide based on a previously designed triblock polypeptide, is electron-conducting. A second building block is a chimera of artificial alpha-helical leucine zipper and random coil domains fused to a polyphenol oxidase, small laccase (SLAC). The metallopolypeptide has a helix-random-helix secondary structure and forms a hydrogel via tetrameric coiled coils. The helical and random domains are identical to those fused to the polyphenol oxidase. Electron-conducting functionality is derived from the divalent attachment of an osmium bis-bipyrdine complex to histidine residues within the peptide. Attachment of the osmium moiety is demonstrated by mass spectroscopy (MS-MALDI-TOF) and cyclic voltammetry. The structure and function of the alpha-helical domains are confirmed by circular dichroism spectroscopy and by rheological measurements. The metallopolypeptide shows the ability to make electrical contact to a solid-state electrode and to the redox centers of modified SLAC. Neat samples of the modified SLAC form hydrogels, indicating that the fused alpha-helical domain functions as a physical cross-linker. The fusion does not disrupt dimer formation, a necessity for catalytic activity. Mixtures of the two building blocks coassemble to form a continuous supramolecular hydrogel that, when polarized, generates a catalytic current in the presence of oxygen. The specific application of the system is a biofuel cell cathode, but this protein-engineering approach to advanced functional hydrogel design is general and broadly applicable to biocatalytic, biosensing, and tissue-engineering applications.
C1 [Wheeldon, Ian R.; Gallaway, Joshua W.; Banta, Scott] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
   [Barton, Scott Calabrese] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.
RP Banta, S (reprint author), Columbia Univ, Dept Chem Engn, 500 W 120th St, New York, NY 10027 USA.
EM sbanta@cheme.columbia.edu
OI Gallaway, Joshua/0000-0002-6798-7781
FU Air Force Office of Scientific Research Multidisciplinary University
   Research Initiative [FA9550-06-1-0264]
FX We thank D. Tirrell (Caffech) for the kind gift of the expression
   plasmid pQE9AC10Atrp, G. Canters (Leiden University, The Netherlands)
   for his gift of pSLAC, and Y. Itagaki for his help with the MS-MALDI
   experiments. This work was supported by Air Force Office of Scientific
   Research Multidisciplinary University Research Initiative
   (FA9550-06-1-0264).
CR BARTLETT PN, 1993, J ELECTROANAL CHEM, V362, P1
   Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k
   Bullen RA, 2006, BIOSENS BIOELECTRON, V21, P2015, DOI 10.1016/j.bios.2006.01.030
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Chockalingam K, 2007, PROTEIN ENG DES SEL, V20, P155, DOI 10.1093/protein/gzm008
   Ehrick JD, 2005, NAT MATER, V4, P298, DOI 10.1038/nmat1352
   Gallaway J, 2008, BIOSENS BIOELECTRON, V23, P1229, DOI 10.1016/j.bios.2007.11.004
   Gallaway JW, 2008, J AM CHEM SOC, V130, P8527, DOI 10.1021/ja0781543
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Heller A, 2006, CURR OPIN CHEM BIOL, V10, P664, DOI 10.1016/j.cbpa.2006.09.018
   HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007
   Ikeda T, 2003, BBA-PROTEINS PROTEOM, V1647, P121, DOI 10.1016/S1570-9639(03)00075-X
   Iwasaki Y, 2002, BIOSENS BIOELECTRON, V17, P783, DOI 10.1016/S0956-5663(02)00054-4
   JOHNSON WC, 1990, PROTEIN-STRUCT FUNCT, V7, P214
   Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   LAU SYM, 1984, J BIOL CHEM, V259, P3253
   Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104
   Maciejewska M, 2006, ELECTROCHEM COMMUN, V8, P1119, DOI 10.1016/j.elecom.2006.04.021
   Mano N, 2002, J PHYS CHEM B, V106, P8842, DOI 10.1021/jp025955d
   Mano N, 2006, J PHYS CHEM B, V110, P11180, DOI 10.1021/jp055654e
   Murphy WL, 2007, ANGEW CHEM INT EDIT, V46, P3066, DOI 10.1002/anie.200604808
   Newman JD, 2006, MOL BIOTECHNOL, V32, P249, DOI 10.1385/MB:32:3:249
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573
   Shen W, 2005, MACROMOLECULES, V38, P3909, DOI 10.1021/ma048348s
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Ulijn RV, 2007, MATER TODAY, V10, P40, DOI 10.1016/S1369-7021(07)70049-4
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wheeldon IR, 2007, BIOMACROMOLECULES, V8, P2990, DOI 10.1021/bm700858p
NR 31
TC 46
Z9 46
U1 1
U2 27
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 7
PY 2008
VL 105
IS 40
BP 15275
EP 15280
DI 10.1073/pnas.0805249105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 364UI
UT WOS:000260360500014
PM 18824691
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Yamada, M
   Aono, H
AF Yamada, Masanori
   Aono, Hirofumi
TI DNA-inorganic hybrid material as selective absorbent for harmful
   compounds
SO POLYMER
LA English
DT Article
DE Biopolymers; Organic-inorganic hybrid materials; DNA
ID DOUBLE-STRANDED DNA; CALF THYMUS DNA; NUCLEIC-ACIDS; METAL-IONS;
   DEOXYRIBONUCLEIC-ACID; POLYMER ELECTROLYTES; FUNCTIONAL MATERIALS;
   CIRCULAR-DICHROISM; GEL; COMPOSITE
AB Double-stranded DNA is one of functional polymers, but the large amounts of DNA sources, such as salmon milt and shellfish gonads, have been discarded as industrial wastes. Therefore, conversion of this discarded DNA to be a useful material would be beneficial to utilize the unique property of DNA. These materials including DNA have been prepared by mixing with the organic polymers, such as alginic acid, collagen, and chitosan. However, since these materials have consisted from entirely organic components, these do not have the mechanical strength for a material. So, we prepared the organic-inorganic hybrid materials by mixing DNA with silane coupling reagents bis(trimethoxysilylpropyl)amine or bis[(3-trimethoxysilyl)propyl]ethylenediamine. These hybrid materials with the flexibility were water-insoluble and resistant to hydrolysis by nuclease. In addition, the mechanical strength of this hybrid material was approximately twice as high as that of DNA without mixing with silane coupling reagents. Furthermore, the double-stranded DNA in the hybrid materials has been maintained in a B-form structure in aqueous solution. Thus, we demonstrated the utilization of DNA as a functional material. As a result, this material could selectively accumulate harmful DNA-intercalating compounds with the planar structure, such as dibenzo-p-dioxin, dibenzofuran, and ethidium bromide. Organic-inorganic hybrid material including double-stranded DNA has potential to serve as a useful biomaterial for medical, engineering, and environmental applications. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Yamada, Masanori; Aono, Hirofumi] Okayama Univ Sci, Fac Sci, Dept Chem, Okayama 7000005, Japan.
RP Yamada, M (reprint author), Okayama Univ Sci, Fac Sci, Dept Chem, Okayama 7000005, Japan.
EM myamada@chem.ous.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [19750187]
FX This work was supported by the Grants-in-Aid for Scientific Research
   from the Ministry of Education, Culture, Sports, Science and Technology
   of Japan (No. 19750187).
CR ALLEN FS, 1972, BIOPOLYMERS, V11, P853, DOI 10.1002/bip.1972.360110410
   Arakawa H, 2000, J BIOL CHEM, V275, P10150, DOI 10.1074/jbc.275.14.10150
   ARMSTRONG RW, 1970, J AM CHEM SOC, V92, P3174, DOI 10.1021/ja00713a041
   Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8
   Coradin T, 2007, ACCOUNTS CHEM RES, V40, P819, DOI 10.1021/ar068129m
   GEACINTOV NE, 1976, J AM CHEM SOC, V98, P6444, DOI 10.1021/ja00437a002
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P469, DOI 10.1016/S0167-7799(00)01493-1
   Hackl EV, 2005, INT J BIOL MACROMOL, V35, P175, DOI 10.1016/j.ijbiomac.2005.01.011
   Honma I, 2003, SOLID STATE IONICS, V162, P237, DOI 10.1016/S0167-2738(03)00260-1
   Honma I, 2003, J ELECTROCHEM SOC, V150, pA616, DOI 10.1149/1.1566018
   Honma I, 2002, ELECTROCHEMISTRY, V70, P920
   Iwata K, 1996, INT J BIOL MACROMOL, V18, P149, DOI 10.1016/0141-8130(95)01073-4
   Kandimalla VB, 2006, CHEM-EUR J, V12, P1074, DOI 10.1002/chem.200500178
   Lee SL, 2004, J PHYS CHEM B, V108, P3098, DOI 10.1021/jp0311409
   LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1
   Liu XD, 2003, INT J BIOL MACROMOL, V32, P121, DOI 10.1016/S0141-8130(03)00045-X
   Liu XD, 2007, ADV POLYM SCI, V209, P149, DOI 10.1007/12_2006_106
   McManus JJ, 2004, J AM CHEM SOC, V126, P15966, DOI 10.1021/ja046105+
   MOORE DS, 1974, BIOPOLYMERS, V13, P977, DOI 10.1002/bip.1974.360130512
   NAGATA C, 1967, B CHEM SOC JPN, V40, P2564, DOI 10.1246/bcsj.40.2564
   Nishikawa O, 2004, ELECTROCHIM ACTA, V50, P667, DOI 10.1016/j.electacta.2003.12.069
   Pereira APV, 2000, J NON-CRYST SOLIDS, V273, P180, DOI 10.1016/S0022-3093(00)00166-6
   SAENGER W, 1987, PRINCIPLES NUCL ACID
   Satoh S, 2005, POLYM J, V37, P94, DOI 10.1295/polymj.37.94
   Shinkai S, 2005, SUPRAMOL CHEM, V17, P181, DOI 10.1080/10610270412331328925
   TAJMIRRIAHI HA, 1993, BIOPOLYMERS, V33, P1819, DOI 10.1002/bip.360331208
   TSO POP, 1964, P NATL ACAD SCI USA, V51, P17, DOI 10.1073/pnas.51.1.17
   Umeno D, 1998, BIOCONJUGATE CHEM, V9, P719, DOI 10.1021/bc980019f
   Uragami T., 2005, BIOMACROMOLECULES, V6, P368
   Vince J, 2006, LANGMUIR, V22, P6489, DOI 10.1021/la060694a
   Wang LL, 2001, CHEM MATER, V13, P1273, DOI 10.1021/cm000869g
   Wang ZJ, 2006, TALANTA, V69, P686, DOI 10.1016/j.talanta.2005.11.004
   WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Yamada M, 2005, POLYMER, V46, P10102, DOI 10.1016/j.polymer.2005.07.086
   Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r
   Yamada M, 2008, INT J BIOL MACROMOL, V42, P478, DOI 10.1016/j.ijbiomac.2008.03.005
   Yamada M, 2008, POLYM J, V40, P327, DOI 10.1295/polymj.PJ2007215
   Yang KG, 2005, DESALINATION, V175, P297, DOI 10.1016/j.desal.2004.08.046
   Yoshinaga I, 1996, J SOL-GEL SCI TECHN, V6, P151, DOI 10.1007/BF00425972
NR 40
TC 20
Z9 20
U1 2
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD OCT 6
PY 2008
VL 49
IS 21
BP 4658
EP 4665
DI 10.1016/j.polymer.2008.08.027
PG 8
WC Polymer Science
SC Polymer Science
GA 360MZ
UT WOS:000260062900024
DA 2018-10-20
ER

PT J
AU Xiao, YM
   Li, DX
   Chen, XN
   Lu, J
   Fan, HS
   Zhang, XD
AF Xiao, Yumei
   Li, Dongxiao
   Chen, Xuening
   Lu, Jian
   Fan, Hongsong
   Zhang, Xingdong
TI Preparation and cytocompatibility of chitosan-modified polylactide
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polylactide; chitosan; microspheres; surface modification;
   cytocompatibility
ID LACTIC ACID MEMBRANE; POLY(L-LACTIC ACID); COLLAGEN; SURFACE;
   IMMOBILIZATION; SCAFFOLD; GROWTH
AB Chitosan-modified PLA (CMPLA) was fabricated to improve cytocompatibility of polylactide (PLA). PMAA-grafted PLA (PMAA-PLA) was obtained through alpha-methacrylic acid (MAA) grafted polymerization on PLA surface with photooxidization and UV irradiation. Steady PMAA-PLA microparticle Suspension with an average size as 172.8 +/- 3.6 nm and zeta potential as -95.0 +/- 0.6 mV was prepared through solvent volatilization. By static electricity interaction and other interactions between PMAA-PLA microsparticles and chitosan molecules, CMPLA was obtained. FTIR, XPS, SEM, and zeta potential analyses indicated that CMPLA was modified with chitosan molecules uniformly. Compared with the PLA control, CMPLA adapted to supporting the attachment and proliferation of L929 cells better. The obtained CMPLA was expected to be used as perfect biomaterial for tissue regeneration. (C) 2008 Wiley Periodicals, Inc.
C1 [Xiao, Yumei; Li, Dongxiao; Chen, Xuening; Lu, Jian; Fan, Hongsong; Zhang, Xingdong] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610041, Peoples R China.
   [Li, Dongxiao] Sichuan Inst Chinese Mat Med, Chengdu 610041, Peoples R China.
RP Xiao, YM (reprint author), Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610041, Peoples R China.
EM xymzl2000@126.com
RI Lu, Jian/G-5407-2010
CR Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   Ide A, 2001, MAT SCI ENG C-BIO S, V17, P95, DOI 10.1016/S0928-4931(01)00315-0
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Ma ZW, 2002, J BIOMED MATER RES, V63, P838, DOI 10.1002/jbm.10470
   Ma ZW, 2002, EUR POLYM J, V38, P2279, DOI 10.1016/S0014-3057(02)00119-2
   Malvern Instruments Ltd, 2004, ZET NAN US MAN
   MAO YM, 2007, MATER LETT, V61, P59
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Sato T, 2004, MAT SCI ENG C-BIO S, V24, P365, DOI 10.1016/j.msec.2003.12.010
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Xiao YM, 2007, MATER LETT, V61, P2601, DOI 10.1016/j.matlet.2006.10.006
   Yang Y, 2003, NUCL INSTRUM METH B, V207, P165, DOI 10.1016/S0168-583X(03)00456-7
   Zhu YB, 2003, BIOMACROMOLECULES, V4, P446, DOI 10.1021/bm025723k
NR 14
TC 11
Z9 14
U1 4
U2 26
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 5
PY 2008
VL 110
IS 1
BP 408
EP 412
DI 10.1002/app.28493
PG 5
WC Polymer Science
SC Polymer Science
GA 340GJ
UT WOS:000258633800050
DA 2018-10-20
ER

PT J
AU Yliperttula, M
   Chung, BG
   Navaladi, A
   Manbachi, A
   Urtti, A
AF Yliperttula, Marjo
   Chung, Bong Geun
   Navaladi, Akshay
   Manbachi, Amir
   Urtti, Arto
TI High-throughput screening of cell responses to biomaterials
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Review
DE high-throughput screening; biomaterial; tissue engineering;
   biocompatibility; cell culture; microarray; microfluidics; drug
   discovery
ID EMBRYONIC STEM-CELLS; MICROSCALE TECHNOLOGIES; DIFFERENTIATION;
   MICROARRAYS; ARRAYS; FABRICATION; ADHESION; SURFACE; PROLIFERATION;
   MICROWELLS
AB Biomaterials have emerged as powerful regulators of the cellular microenvironment for drug discovery, tissue engineering research and chemical testing. Although biomaterial-based matrices control the cellular behavior, these matrices are still far from being optimal. In principle, efficacy of biomaterial development for the cell cultures can be improved by using high-throughput techniques that allow screening of a large number of materials and manipulate microenvironments in a controlled manner. Several cell responses such as toxicity, proliferation, and differentiation have been used to evaluate the biomaterials thus providing basis for further selection of the lead biomimetic materials or microenvironments. Although high-throughput techniques provide an initial screening of the desired properties, more detailed follow-up studies of the selected materials are required to understand the true value of a 'positive hit'. High-throughput methods may become important tools in the future development of biomaterials-based cell cultures that will enable more realistic pre-clinical prediction of pharmacokinetics, pharmacodynamics, and toxicity. This is highly important, because predictive pre-clinical methods are needed to improve the high attrition rate of drug candidates during clinical testing. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Yliperttula, Marjo] Univ Helsinki, Div Biopharm & Pharmacokinet, FIN-00014 Helsinki, Finland.
   [Yliperttula, Marjo; Chung, Bong Geun; Navaladi, Akshay; Manbachi, Amir] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Chung, Bong Geun] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Biomed Engn,Dept Med, Boston, MA 02115 USA.
   [Navaladi, Akshay] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Manbachi, Amir] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada.
   [Urtti, Arto] Univ Helsinki, Drug Discovery & Dev Technol Ctr, FIN-00014 Helsinki, Finland.
RP Yliperttula, M (reprint author), Univ Helsinki, Div Biopharm & Pharmacokinet, Viikinkaari 5E, FIN-00014 Helsinki, Finland.
EM marjo.yliperttula@helsinki.fi
OI Manbachi, Amir/0000-0003-0206-5230
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   ALLEN LT, 2003, INTERACTION SOFT CON
   Anderson DG, 2004, P NATL ACAD SCI USA, V101, P16028, DOI 10.1073/pnas.0407218101
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Bailey SN, 2004, P NATL ACAD SCI USA, V101, P16144, DOI 10.1073/pnas.0404425101
   Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t
   CALDWELL JS, 2006, ADV CANCER RES, V96, P145
   Castel D, 2006, DRUG DISCOV TODAY, V11, P616, DOI 10.1016/j.drudis.2006.05.015
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k
   DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1
   Diaz-Mochon JJ, 2007, CHEM SOC REV, V36, P449, DOI 10.1039/b511848b
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erfle H, 2004, BIOTECHNIQUES, V37, P454, DOI 10.2144/04373RT01
   Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618
   Goodman SL, 1996, BIOMATERIALS, V17, P2087, DOI 10.1016/0142-9612(96)00016-6
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Haney SA, 2006, DRUG DISCOV TODAY, V11, P889, DOI 10.1016/j.jdrudis.2006.08.015
   Hirsch LR, 2006, ANN BIOMED ENG, V34, P15, DOI 10.1007/s10439-005-9001-8
   Hubbell JA, 2004, NAT BIOTECHNOL, V22, P828, DOI 10.1038/nbt0704-828
   Ito Y, 2005, BIOMATERIALS, V26, P211, DOI 10.1016/j.biomaterials.2004.02.019
   James K, 1996, MRS BULL, V21, P22, DOI 10.1557/S0883769400031808
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Khademhosseini A, 2005, LAB CHIP, V5, P1380, DOI 10.1039/b508096g
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khademhosseini A, 2006, J BIOMAT SCI-POLYM E, V17, P1221, DOI 10.1163/156856206778667488
   Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035
   Kudelska-Mazur Dorota, 2005, Cell and Tissue Banking, V6, P55, DOI 10.1007/s10561-005-1911-z
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lavik EB, 2005, BIOMATERIALS, V26, P3187, DOI 10.1016/j.biomaterials.2004.08.022
   Lysaght MJ, 2000, ASAIO J, V46, P515, DOI 10.1097/00002480-200009000-00001
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Mei Y, 2007, CURR OPIN CHEM BIOL, V11, P388, DOI 10.1016/j.cbpa.2007.07.006
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030
   Paasonen L, 2007, J CONTROL RELEASE, V122, P86, DOI 10.1016/j.jconrel.2007.06.009
   Pihl J, 2005, ANAL CHEM, V77, P3897, DOI 10.1021/ac050218+
   Pinaud F, 2006, BIOMATERIALS, V27, P1679, DOI 10.1016/j.biomaterials.2005.11.018
   Ratner Buddy D., 1996, P1, DOI 10.1016/B978-012582460-6/50002-5
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Stevens MM, 2005, BIOMATERIALS, V26, P7636, DOI 10.1016/j.biomaterials.2005.05.001
   Tan WJ, 2005, BIOMATERIALS, V26, P891, DOI 10.1016/j.biomaterials.2004.03.041
   Tanase M, 2005, LAB CHIP, V5, P598, DOI 10.1039/b500243e
   Wang ZH, 2007, LAB CHIP, V7, P740, DOI 10.1039/b618734j
   Weng JF, 2006, CURR MED CHEM, V13, P897, DOI 10.2174/092986706776361076
   Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L
   Yang X, 2006, COMB CHEM HIGH T SCR, V9, P123, DOI 10.2174/138620706775541891
NR 58
TC 47
Z9 47
U1 2
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD OCT 2
PY 2008
VL 35
IS 3
BP 151
EP 160
DI 10.1016/j.ejps.2008.04.012
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 358VC
UT WOS:000259944600001
PM 18586092
DA 2018-10-20
ER

PT J
AU Moisel, M
   de Mele, MAFL
   Muller, WD
AF Moisel, Marion
   Fernandez Lorenzo de Mele, Monica Alicia
   Mueller, Wolf-Dieter
TI Biomaterial Interface Investigated by Electrochemical Impedance
   Spectroscopy
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID IN-VITRO CORROSION; SELF-ASSEMBLED MONOLAYERS; OSTEOBLAST-LIKE CELLS;
   BOVINE SERUM-ALBUMIN; BY-LAYER ADSORPTION; STAINLESS-STEEL; TITANIUM
   SURFACES; TI-6AL-4V ALLOY; ALTERNATING POLYCATION; CELLULAR BEHAVIOR
AB Application of a biomaterial requires profound knowledge about the features and structure of the biomaterial - tissue interface. Electrochemical techniques, especially electrochemical impedance spectroscopy (EIS) enable a fast non-destructive characterization of the interface. This review summarizes the application of EIS in different biological environments.
C1 [Moisel, Marion; Mueller, Wolf-Dieter] Univ Sch Dent Med, Charite, D-14197 Berlin, Germany.
   [Fernandez Lorenzo de Mele, Monica Alicia] Univ Nacl La Plata, INIFTA, La Plata, Buenos Aires, Argentina.
RP Moisel, M (reprint author), Univ Sch Dent Med, Charite, Assinannshauserstr 4-6, D-14197 Berlin, Germany.
RI Fernandez Lorenzo de Mele, Monica/I-1388-2015
OI Fernandez Lorenzo de Mele, Monica/0000-0002-8093-7551
CR Aas V, 2002, ANN NY ACAD SCI, V967, P506
   Aguey-Zinsou KF, 2003, J AM CHEM SOC, V125, P530, DOI 10.1021/ja028293e
   Arndt S, 2004, BIOSENS BIOELECTRON, V19, P583, DOI 10.1016/S0956-5663(03)00269-0
   Assis SL, 2005, J BIOMED MATER RES B, V73B, P109, DOI 10.1002/jbm.b.30205
   Atanasov V, 2006, BIOCONJUGATE CHEM, V17, P631, DOI 10.1021/bc050328n
   Bjorefors F, 2007, ANAL CHEM, V79, P8391, DOI 10.1021/ac071399d
   Bouafsoun A, 2007, MACROMOL BIOSCI, V7, P599, DOI 10.1002/mabi.200600263
   Bouafsoun A, 2007, BIOELECTROCHEMISTRY, V70, P401, DOI 10.1016/j.bioelechem.2006.05.012
   Busalmen JP, 2003, BIOTECHNOL BIOENG, V82, P619, DOI 10.1002/bit.10600
   Busalmen JP, 2001, APPL ENVIRON MICROB, V67, P3188, DOI 10.1128/AEM.67.7.3188-3194.2001
   Cabilio NR, 2000, LANGMUIR, V16, P8480, DOI 10.1021/la0003948
   Chen HJ, 2007, BIOSENS BIOELECTRON, V22, P1811, DOI 10.1016/j.bios.2006.08.013
   Cho S, 2008, SENSORS-BASEL, V8, P1198, DOI 10.3390/s8021198
   Choi H. J., 2005, NANOTECHNOLOGY, V16, P143
   Contu F, 2003, J BIOMED MATER RES A, V67A, P246, DOI 10.1002/jbm.a.10113
   Crespo GA, 2008, ANAL CHEM, V80, P1316, DOI 10.1021/ac071156l
   Ehret R, 1997, BIOSENS BIOELECTRON, V12, P29, DOI 10.1016/0956-5663(96)89087-7
   Friedrich MG, 2008, J PHYS CHEM B, V112, P3193, DOI 10.1021/jp709717k
   Garcia-Alonso MC, 2003, BIOMATERIALS, V24, P19, DOI 10.1016/S0142-9612(02)00237-5
   Gawad S, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2737751
   GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0
   GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896
   Gimsa J, 2005, J NEUROSCI METH, V142, P251, DOI 10.1016/j.jneumeth.2004.09.001
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Guan JG, 2004, J BIOSCI BIOENG, V97, P219
   Handrea M, 2003, BIOELECTROCHEMISTRY, V61, P1, DOI 10.1016/S1567-5394(03)00047-1
   Hang TC, 2004, BIOSENS BIOELECTRON, V19, P1537, DOI 10.1016/j.bios.2003.12.014
   Herzog G, 2007, ANALYST, V132, P615, DOI 10.1039/b701472d
   Hiromoto S, 2002, CORROS SCI, V44, P955, DOI 10.1016/S0010-938X(01)00110-X
   Huang HH, 2005, DENT MATER, V21, P749, DOI 10.1016/j.dental.2005.01.009
   Huang HH, 2004, BIOCHEM BIOPH RES CO, V314, P787, DOI 10.1016/j.bbrc.2003.12.173
   HUIQI H, 2008, BIOELECTROCHEMISTRY, V72, P161
   Jacquot BC, 2008, BIOSENS BIOELECTRON, V23, P1503, DOI 10.1016/j.bios.2008.01.006
   JEYKUMARI D, 2008, BIOSENS BIOELECTRON
   Ji JA, 2004, COLLOID SURFACE B, V34, P185, DOI 10.1016/j.colsurfb.2003.12.015
   Jia NQ, 2005, ELECTROCHIM ACTA, V51, P611, DOI 10.1016/j.electacta.2005.05.032
   Jie M, 1999, ELECTROCHEM COMMUN, V1, P425, DOI 10.1016/S1388-2481(99)00071-5
   K'Owino IO, 2005, ELECTROANAL, V17, P2101, DOI 10.1002/elan.200503371
   Kai M, 2008, J PEPT SCI, V14, P192, DOI 10.1002/psc.974
   Karpagavalli R, 2007, J BIOMED MATER RES A, V83A, P1087, DOI 10.1002/jbm.a.31447
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   LEWIS G, 1993, J APPL BIOMATER, V4, P47, DOI 10.1002/jab.770040106
   Lewis G, 2007, BIO-MED MATER ENG, V17, P97
   Li XM, 2003, NANOTECHNOLOGY, V14, P1064, DOI 10.1088/0957-4484/14/10/302
   Lu HY, 2006, ELECTROANAL, V18, P1511, DOI 10.1002/elan.200603557
   Luong JHT, 2001, ANAL CHEM, V73, P1844, DOI 10.1021/ac0011585
   Mantzila AG, 2008, ANAL CHEM, V80, P1169, DOI [10.1021/ac071570l, 10.1021/ac071570I]
   MITRA P, 1991, BIOTECHNIQUES, V11, P504
   Moulton SE, 2005, LANGMUIR, V21, P316, DOI 10.1021/la0487242
   Mustafa K, 2002, J BIOMED MATER RES, V59, P655, DOI 10.1002/jbm.1275
   Naumowicz M, 2003, BIOELECTROCHEMISTRY, V61, P21, DOI 10.1016/S1567-5394(03)00056-2
   Omanovic S, 1999, LANGMUIR, V15, P8315, DOI 10.1021/la990474f
   Pan J, 1998, J BIOMED MATER RES, V40, P244, DOI 10.1002/(SICI)1097-4636(199805)40:2<244::AID-JBM9>3.0.CO;2-L
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   Pei RJ, 2001, BIOMACROMOLECULES, V2, P463, DOI 10.1021/bm0001289
   Pei RJ, 2001, BIOSENS BIOELECTRON, V16, P355, DOI 10.1016/S0956-5663(01)00150-6
   Phillips RKR, 2001, LANGMUIR, V17, P2471, DOI 10.1021/la0007729
   Qiu YL, 2008, ANAL CHEM, V80, P990, DOI 10.1021/ac701745c
   Rondelli G, 2006, J BIOMED MATER RES B, V79B, P320, DOI 10.1002/jbm.b.30545
   Sapper A, 2006, ANAL CHEM, V78, P5184, DOI 10.1021/ac060094g
   Scharnweber D, 2002, J MATER SCI-MATER M, V13, P1215, DOI 10.1023/A:1021118811893
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   Shih CC, 2005, J BIOMED MATER RES A, V74A, P325, DOI 10.1002/ibm.a.30255
   SILVA MPD, 2003, J MATER SCI-MATER M, V14, P511
   Smiechowski MF, 2006, BIOSENS BIOELECTRON, V22, P670, DOI 10.1016/j.bios.2006.02.008
   Sun YY, 2006, BIOMATERIALS, V27, P4042, DOI 10.1016/j.biomaterials.2006.03.014
   Takhistov P, 2004, BIOSENS BIOELECTRON, V19, P1445, DOI 10.1016/j.bios.2003.08.015
   Tang DP, 2005, BIOSENS BIOELECTRON, V21, P539, DOI 10.1016/j.bios.2004.11.024
   TAYLOR GT, 1993, APPL SPECTROSC, V47, P1140, DOI 10.1366/0003702934068053
   TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919
   Wang CX, 2003, BIOMATERIALS, V24, P3069, DOI 10.1016/S0142-9612(03)00154-6
   Wang Y, 2008, ANAL CHEM, V80, P2255, DOI 10.1021/ac7024688
   Wegener J, 1999, PFLUG ARCH EUR J PHY, V437, P925, DOI 10.1007/s004240050864
   Wegener J, 2000, BRAIN RES, V853, P115, DOI 10.1016/S0006-8993(99)02317-3
   Weikart CM, 2001, J BIOMED MATER RES, V54, P597, DOI 10.1002/1097-4636(20010315)54:4<597::AID-JBM170>3.3.CO;2-J
   WILLIAMS R, 1988, BIOMATERIALS, V40, P181
   Xiao CD, 2002, ANAL CHEM, V74, P5748, DOI 10.1021/ac025848f
   Xie QJ, 2003, J COLLOID INTERF SCI, V262, P107, DOI 10.1016/S0021-9797(03)00196-6
   Yun YH, 2007, NANOTECHNOLOGY, V18, P1
   Zhang H, 2006, J PHYS CHEM B, V110, P2171, DOI 10.1021/jp055301f
NR 80
TC 26
Z9 26
U1 0
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD OCT
PY 2008
VL 10
IS 10
BP B33
EP B46
DI 10.1002/adem.200800184
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA 374GK
UT WOS:000261031600014
DA 2018-10-20
ER

PT J
AU Malasoma, A
   Fritsch, A
   Kohlhauser, C
   Brynk, T
   Vitale-Brovarone, C
   Pakiela, Z
   Eberhardsteiner, J
   Hellmich, C
AF Malasoma, A.
   Fritsch, A.
   Kohlhauser, C.
   Brynk, T.
   Vitale-Brovarone, C.
   Pakiela, Z.
   Eberhardsteiner, J.
   Hellmich, C.
TI Micromechanics of bioresorbable porous CEL2 glass ceramic scaffolds for
   bone tissue engineering
SO ADVANCES IN APPLIED CERAMICS
LA English
DT Article; Proceedings Paper
CT EUROMAT 2007 Conference
CY SEP, 2007
CL Nurnberg, GERMANY
SP Federat European Mat Soc
DE Continuum micromechanics; Bioactive glass ceramic scaffolds; Elasticity;
   Strength; Porosity
ID STRENGTH CRITERION; ELASTIC PROPERTIES; HYDROXYAPATITE; INCLUSIONS;
   HOMOGENIZATION; COMPOSITES
AB Owing to their stimulating effects on bone cells, ceramics are identified as expressly promising materials for fabrication of tissue engineering (TE) scaffolds. To ensure the mechanical competence of TE scaffolds, it is of central importance to understand the impact of pore shape and volume on the mechanical behaviour of the scaffolds, also under complex loading states. Therefore, the theory of continuum micromechanics is used as basis for a material model predicting relationships between porosity and elastic/strength properties. The model, which mathematically expresses the mechanical behaviour of a ceramic matrix (based on a glass system of the type SiO(2)-P(2)O(5)-CaO-MgO-Na(2)O-K(2)O; called CEL2) in which interconnected pores are embedded, is carefully validated through a wealth of independent experimental data. The remarkably good agreement between porosity based model predictions for the elastic and strength properties of CEL2-based porous scaffolds and corresponding experimentally determined mechanical properties underlines the great potential of micromechanical modelling for speeding up the biomaterial and tissue engineering scaffold development process-by delivering reasonable estimates for the material behaviour, also beyond experimentally observed situations.
C1 [Fritsch, A.; Kohlhauser, C.; Eberhardsteiner, J.; Hellmich, C.] Vienna Univ Technol, Inst Mech Mat & Struct, A-1040 Vienna, Austria.
   [Malasoma, A.; Vitale-Brovarone, C.] Politecn Torino, Dept Mat Sci & Chem Engn, Turin, Italy.
   [Brynk, T.; Pakiela, Z.] Warsaw Univ Technol, Fac Mat Sci & Engn, Warsaw, Poland.
RP Hellmich, C (reprint author), Vienna Univ Technol, Inst Mech Mat & Struct, A-1040 Vienna, Austria.
EM christian.hellmich@tuwien.ac.at
RI Vitale Brovarone, Chiara/G-9630-2012
OI Vitale Brovarone, Chiara/0000-0003-2413-5594; Brynk,
   Tomasz/0000-0002-5825-4789; Eberhardsteiner, Josef/0000-0001-9030-6107
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   Barthelemy JF, 2004, INT J NUMER ANAL MET, V28, P565, DOI 10.1002/nag.368
   Barthelemy JF, 2003, CR MECANIQUE, V331, P271, DOI 10.1016/S1631-0721(03)00063-9
   Boccaccini AR, 2005, MAT SCI ENG C-BIO S, V25, P23, DOI 10.1016/j.msec.2004.03.002
   BOUCHER S, 1976, REV M, V22, P31
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   Dormieux L, 2002, J MECH PHYS SOLIDS, V50, P2203, DOI 10.1016/S0022-5096(02)00008-X
   Dormieux L, 2001, J ENG MECH-ASCE, V127, P1267, DOI 10.1061/(ASCE)0733-9399(2001)127:12(1267)
   Dormieux L, 2006, MICROPOROMECHANICS
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   ESHELBY JD, 1957, P ROY SOC LOND A MAT, V241, P396
   Fedorov F. I, 1968, THEORY ELASTIC WAVES
   Fritsch A, 2007, WOODHEAD PUBL MATER, P529, DOI 10.1533/9781845693817.2.529
   Fritsch A, 2007, J MATER SCI, V42, P8824, DOI 10.1007/s10853-007-1859-4
   Fritsch A, 2009, J BIOMED MATER RES A, V88A, P149, DOI 10.1002/jbm.a.31727
   Hashin Z, 1962, J APPL MECH, V29, P143, DOI DOI 10.1115/1.3636446
   HILL R, 1963, J MECH PHYS SOLIDS, V11, P357, DOI 10.1016/0022-5096(63)90036-X
   Jones J.R., 2005, BIOMATERIALS ARTIFIC
   KOHLHAUSER C, 2008, STRAIN
   KREHER W, 1990, J MECH PHYS SOLIDS, V38, P115, DOI 10.1016/0022-5096(90)90023-W
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MCLAUGHLIN R, 1977, INT J ENG SCI, V15, P237, DOI 10.1016/0020-7225(77)90058-1
   Molinari A, 1996, INT J SOLIDS STRUCT, V33, P3131, DOI 10.1016/0020-7683(95)00275-8
   SUQUET P, 1997, CONTINUUM MICROMECHA
   Verma D, 2006, J BIOMED MATER RES A, V78A, P772, DOI 10.1002/jbm.a.30774
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
   WALSH JB, 1965, J AM CERAM SOC, V48, P605, DOI 10.1111/j.1151-2916.1965.tb14687.x
   Zaoui A, 2002, J ENG MECH-ASCE, V128, P808, DOI 10.1061/(ASCE)0733-9399(2002)128:8(808)
   ZIMMERMAN RW, 1991, MECH MATER, V12, P17, DOI 10.1016/0167-6636(91)90049-6
NR 31
TC 9
Z9 9
U1 1
U2 5
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1743-6753
J9 ADV APPL CERAM
JI Adv. Appl. Ceram.
PD OCT
PY 2008
VL 107
IS 5
BP 277
EP 286
DI 10.1179/174367508X306488
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA 370RH
UT WOS:000260779900008
DA 2018-10-20
ER

PT J
AU Rowlands, AS
   George, PA
   Cooper-White, JJ
AF Rowlands, Andrew S.
   George, Peter A.
   Cooper-White, Justin J.
TI Directing osteogenic and myogenic differentiation of MSCs: interplay of
   stiffness and adhesive ligand presentation
SO AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
LA English
DT Article
DE mesenchymal stem cells; extracellular matrix proteins; substrate
   elasticity
ID MESENCHYMAL STEM-CELLS; CYTOSKELETAL TENSION; SUBSTRATE; INTEGRINS;
   MATRIX; MECHANISMS; CROSSTALK; MOLECULES; SHAPE; RHOA
AB The mechanical properties of the extracellular matrix (ECM) can exert significant influence in determining cell fate. Human mesenchymal stem cells (MSCs) grown on substrates with varying stiffness have been shown to express various cell lineage markers, without the use of toxic DNA demethylation agents or complex cocktails of expensive growth factors. Here we investigated the myogenic and osteogenic potential of various polyacrylamide gel substrates that were coated with covalently bound tissue-specific ECM proteins (collagen I, collagen IV, laminin, or fibronectin). The gel-protein substrates were shown to support the growth and proliferation of MSCs in a stiffness-dependent manner. Higher stiffness substrates encouraged up to a 10-fold increase in cell number over lower stiffness gels. There appears to be definitive interplay between substrate stiffness and ECM protein with regard to the expression of both osteogenic and myogenic transcription factors by MSCs. Of the 16 gel-protein combinations investigated, osteogenic differentiation was found to occur significantly only on collagen I-coated gels with the highest modulus gel tested (80 kPa). Myogenic differentiation occurred on all gel-protein combinations that had stiffnesses >9 kPa but to varying extents as ascertained by MyoD1 expression. Peak MyoD1 expression was seen on gels with a modulus of 25 kPa coated in fibronectin, with similar levels of expression observed on 80-kPa collagen I-coated gels. The modulation of myogenic and osteogenic transcription factors by various ECM proteins demonstrates that substrate stiffness alone does not direct stem cell lineage specification. This has important implications in the development of tailored biomaterial systems that more closely mimic the microenvironment found in native tissues.
C1 [Rowlands, Andrew S.; George, Peter A.; Cooper-White, Justin J.] Univ Queensland, Tissue Engn & Microfluid Lab, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
RP Cooper-White, JJ (reprint author), Univ Queensland, Tissue Engn & Microfluid Lab, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
EM j.cooperwhite@uq.edu.au
RI Cooper-White, Justin/B-2567-2010
OI Cooper-White, Justin/0000-0002-1920-8229
FU Australian Research Council Discovery Grants Scheme; The University of
   Queensland; Australian Institute for Bioengineering and Nanotechnology
FX This study was supported by the Australian Research Council Discovery
   Grants Scheme, The University of Queensland and the Australian Institute
   for Bioengineering and Nanotechnology.
CR ARNOLD IC, 2007, J CELL PHYSL, V213, P341
   Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011
   Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002
   Brooke G, 2007, SEMIN CELL DEV BIOL, V18, P846, DOI 10.1016/j.semcdb.2007.09.012
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   GUMBINER BM, 1993, NEURON, V11, P551, DOI 10.1016/0896-6273(93)90068-3
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   HANTAI D, 1983, COLLAGEN REL RES, V3, P381
   Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jones JL, 1999, J CLIN PATHOL-MOL PA, V52, P208
   LIGHT N, 1984, BIOCHEM J, V219, P1017, DOI 10.1042/bj2191017
   Magne D, 2005, TRENDS MOL MED, V11, P519, DOI 10.1016/j.molmed.2005.09.002
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Palsson B.O., 2004, TISSUE ENG
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65
   Segers VFM, 2006, AM J PHYSIOL-HEART C, V290, pH1370, DOI 10.1152/ajpheart.00523.2005
   Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328
   Tao H, 2005, DEV GROWTH DIFFER, V47, P423
   Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 30
TC 283
Z9 288
U1 2
U2 67
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6143
J9 AM J PHYSIOL-CELL PH
JI Am. J. Physiol.-Cell Physiol.
PD OCT
PY 2008
VL 295
IS 4
BP C1037
EP C1044
DI 10.1152/ajpcell.67.2008
PG 8
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA 358NW
UT WOS:000259925800019
PM 18753317
OA Bronze
DA 2018-10-20
ER

PT J
AU Marcal, H
   Wanandy, NS
   Sanguanchaipaiwong, V
   Woolnough, CE
   Lauto, A
   Mahler, SM
   Foster, LJR
AF Marcal, Helder
   Wanandy, Nico S.
   Sanguanchaipaiwong, Vorapat
   Woolnough, Catherine E.
   Lauto, Antonio
   Mahler, Stephen M.
   Foster, L. John R.
TI BioPEGylation of Polyhydroxyalkanoates: Influence on Properties and
   Satellite-Stem Cell Cycle
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYHYDROXYOCTANOATE-DIETHYLENE GLYCOL; IN-VIVO; BIOSYNTHESIS;
   BIOCOMPATIBILITY; REGENERATION; DEGRADATION; MORPHOLOGY; APOPTOSIS;
   PRODUCTS; HYBRIDS
AB The addition of poly(ethylene glycol), PEG, to bioprocessing systems producing polyhydroxyalkanoates (PHAs), has been reported as a means of their molecular weight control and can also support bioPEGylation, resulting in hybrids with amphiphillic properties. However, the study of such natural-synthetic hybrids of PHA-b-PEG is still in its infancy. In this study, we report the influence of bioPEGylation of polyhydroxyoctanoate (PHO) on its physiochemical, material, and biological properties. Consistent with previous studies, bioPEGylation with diethylene glycol (DEG) showed a significant reduction in PHA molecular weight (57%). In comparison to solvent cast films of PHO, PHO-b-DEG films possessed a noticeable X-ray diffraction peak at 9.82 degrees and increased Young's modulus of 11 Gpa (83%). Potential biocompatibility was investigated by measuring the early phase of apoptosis in myoblastic satellite-stem cells (C2C12). Comparative analysis of cell proliferation and progression in the presence of the mcl-PHA and its hybrid showed that the latter induced significant cell cycle progression: the first time a biomaterial has been shown to do so. Microtopographies of the film surfaces demonstrated that these differences were not due to changes in surface morphology; both polymers possessed average surface rugosities of 1.4 +/- 0.2 mu m. However, a slight decrease in surface hydrophobicity (3.5 +/- 0.9 degrees) due to the hydrophilic DEG may have exerted an influence. The results support the further study of bioPEGylated PHAs as potential biomaterials in the field of tissue engineering.
C1 [Marcal, Helder; Wanandy, Nico S.; Sanguanchaipaiwong, Vorapat; Woolnough, Catherine E.; Lauto, Antonio; Foster, L. John R.] Univ New S Wales, BioPolymer Res Grp, Sydney, NSW 2052, Australia.
   [Marcal, Helder; Wanandy, Nico S.; Sanguanchaipaiwong, Vorapat; Woolnough, Catherine E.; Lauto, Antonio; Foster, L. John R.] Univ New S Wales, Ctr Adv Macromol Design, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
   [Mahler, Stephen M.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
RP Foster, LJR (reprint author), Univ New S Wales, BioPolymer Res Grp, Sydney, NSW 2052, Australia.
EM J.Foster@unsw.edu.au
RI Mahler, Stephen/B-4824-2009; Marcal, Helder/A-7690-2008
CR Ausubel R. M., 1995, CURRENT PROTOCOLS MO
   BENNET AM, 1999, SCIENCE, V278, P1288
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Bucci DZ, 2005, POLYM TEST, V24, P564, DOI 10.1016/j.polymertesting.2005.02.008
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Cheng S, 2006, BIOMATERIALS, V27, P3758, DOI 10.1016/j.biomaterials.2006.02.046
   Chinga G, 2004, J PULP PAP SCI, V30, P222
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Foster LJR, 2008, BIOMACROMOLECULES, V9, P314, DOI 10.1021/bm7006289
   Foster LJR, 2007, APPL MICROBIOL BIOT, V75, P1241, DOI 10.1007/s00253-007-0976-y
   Foster LJR, 2005, POLYMER, V46, P6587, DOI 10.1016/j.polymer.2005.05.012
   Foster LJR, 2001, J BIOMAT SCI-POLYM E, V12, P317, DOI 10.1163/156856201750180843
   Foster LJR, 1995, BIOMATERIALS, V16, P314
   GROSS RA, 1989, MACROMOLECULES, V22, P1106, DOI 10.1021/ma00193a018
   Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x
   Kim S S, 1999, Semin Pediatr Surg, V8, P119
   Lee SY, 1999, APPL ENVIRON MICROB, V65, P2762
   Marois Y, 1999, TISSUE ENG, V5, P369, DOI 10.1089/ten.1999.5.369
   MARTIN SJ, 1996, ANNEXIN, V5
   Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Sanguanchaipaiwong V, 2004, BIOMACROMOLECULES, V5, P643, DOI 10.1021/bm0344708
   SCHLEGEL HG, 1961, NATURE, V19, P15
   STEINBUCHEL A, 1996, BIOTECHNOLOGY
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   WILLIAMS SF, 2001, Patent No. 819447
   Xiao XQ, 2007, BIOMATERIALS, V28, P3608, DOI 10.1016/j.biomaterials.2007.04.046
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   Zanzig J, 2003, J BIOACT COMPAT POL, V18, P339, DOI 10.1177/088391103038229
   Zhao K, 2003, BIOCHEM ENG J, V16, P115, DOI 10.1016/S1369-703X(03)00029-9
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 33
TC 13
Z9 13
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD OCT
PY 2008
VL 9
IS 10
BP 2719
EP 2726
DI 10.1021/bm800418e
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 360HV
UT WOS:000260049500023
PM 18754686
DA 2018-10-20
ER

PT J
AU Lipski, AM
   Pino, CJ
   Haselton, FR
   Chen, IW
   Shastri, VP
AF Lipski, Anna M.
   Pino, Christopher J.
   Haselton, Frederick R.
   Chen, I-Wei
   Shastri, V. Prasad
TI The effect of silica nanoparticle-modified surfaces on cell morphology,
   cytoskeletal organization and function
SO BIOMATERIALS
LA English
DT Article
DE focal adhesions; F-actin fibers; nanoroughness; endothelial cells;
   preosteoblasts; nano-mechanotransduction
ID ENHANCED OSTEOBLAST ADHESION; SERUM VITRONECTIN; ENDOTHELIAL-CELLS;
   FIBRONECTIN; TISSUE; DIFFERENTIATION; PROLIFERATION; FIBROBLASTS;
   ATTACHMENT; ELASTICITY
AB Chemical and morphological characteristics of a biomaterial surface are thought to play an important role in determining cellular differentiation and apoptosis. In this report, we investigate the effect of nanoparticle (NP) assemblies arranged on a flat substrate on cytoskeletal organization, proliferation and metabolic activity on two cell types, Bovine aortic endothelial cells (BAECs) and mouse calvarial pre-osteoblasts (MC3T3-E1). To vary roughness without altering chemistry, glass substrates were coated with monodispersed silica nanoparticles of 50, 100 and 300 nm in diameter. The impact of surface roughness at the nanoscale on cell morphology was studied by quantifying cell spreading, shape, cytoskeletal F-actin alignment, and recruitment of focal adhesion complexes (FAC) using image analysis. Metabolic activity was followed using a thiazolyl blue tetrazolium bromide assay. In the two cell types tested, surface roughness introduced by nanoparticles had cell type specific effects on cell morphology and metabolism. While BAEC on NP-modified substrates exhibited smaller cell areas and fewer focal adhesion complexes compared to BAEC grown on glass, MC3T3-E1 cells in contrast exhibited larger cell areas on NP-modified surfaces and an increased number of FACs, in comparison to unmodified glass. However, both cell types on 50 nm NP had the highest proliferation rates (comparable to glass control) whereas cells grown on 300 nm NP exhibited inhibited proliferation. Interestingly, for both cell types surface roughness promoted the formation of long, thick F-actin fibers, which aligned with the long axis of each cell. These findings are consistent with our earlier result that osteogenic differentiation of human mesenchymal progenitor cells is enhanced on NP-modified surfaces. Our finding that nanoroughness, as imparted by nanoparticle assemblies, effects cellular processes in a cell specific manner, can have far reaching consequences on the development of "smart" biomaterials especially for directing stem cell differentiation. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Shastri, V. Prasad] Vanderbilt Univ, Dept Biomed Engn, Stevenson Ctr 5824, Nashville, TN 37235 USA.
   [Lipski, Anna M.; Chen, I-Wei; Shastri, V. Prasad] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
RP Shastri, VP (reprint author), Vanderbilt Univ, Dept Biomed Engn, Stevenson Ctr 5824, Stn B 351631, Nashville, TN 37235 USA.
EM prasad.shastri@vanderbilt.edu
RI Zhou, Feng/E-9510-2011
OI Chen, I-Wei/0000-0002-4045-4467; Pino, Christopher/0000-0003-4063-9215
FU National Institutes of Health [R24 AI-47739-03]; NSF IGERT Fellowship;
   Ada I. Pressman Memorial Scholarship; Society of Women Engineers; The
   Nanotechnology Institute; Ben-Franklin Technology Partners of
   Northeastern Pennsylvania; National Institute of Health Vascular
   Training Grant [NIH HL 0775]
FX This work was supported in part by National Institutes of Health (R24
   AI-47739-03) sub-award to VPS, an NSF IGERT Fellowship and an Ada I.
   Pressman Memorial Scholarship given by the Society of Women Engineers to
   AML, The Nanotechnology Institute, through the Ben-Franklin Technology
   Partners of Northeastern Pennsylvania, and graduate fellowship to CJP
   through National Institute of Health Vascular Training Grant (NIH HL
   0775).
CR Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   AUGUSTINVOSS HG, 1993, J CELL PHYSIOL, V157, P279, DOI 10.1002/jcp.1041570210
   BASSELL GJ, 1994, J CELL BIOL, V126, P863, DOI 10.1083/jcb.126.4.863
   Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9
   BOURKE BM, 1986, J VASC SURG, V4, P257, DOI 10.1067/mva.1986.avs0040257
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Eisenbarth E, 2002, BIOMOL ENG, V19, P233, DOI 10.1016/S1389-0344(02)00028-X
   Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335
   Engler AJ, 2007, METHOD CELL BIOL, V83, P521, DOI 10.1016/S0091-679X(07)83022-6
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360
   Itala A, 2002, J BIOMED MATER RES, V62, P404, DOI 10.1002/jbm.10273
   JAYAGOPAL A, 2008, NANOTECHNOLOGIES LIF, P461
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617
   Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x
   Mandrekar SJ, 2003, STAT METHODS MED RES, V12, P505, DOI 10.1191/0962280203sm346oa
   Maniotis AJ, 1997, J CELL BIOCHEM, V65, P114
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   MARTIN JY, 1995, J BIOMED MAT RES MAR, P29
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   NORRIS WD, 1990, J CELL SCI, V95, P255
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   SCHWING C, 2002, KLINIKMANAG AKTUELL, V4, P8
   Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Wu MH, 2003, J COLLOID INTERF SCI, V265, P304, DOI 10.1016/S0021-9797(03)00311-4
NR 40
TC 120
Z9 121
U1 2
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2008
VL 29
IS 28
BP 3836
EP 3846
DI 10.1016/j.biomaterials.2008.06.002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 345SN
UT WOS:000259017000010
PM 18606447
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Paula, NE
   Skazik, C
   Harwardt, M
   Bartneck, M
   Denecke, B
   Klee, D
   Salber, J
   Zwadlo-Klarwasser, G
AF Paula, Nora E.
   Skazik, Claudia
   Harwardt, Marc
   Bartneck, Matthias
   Denecke, Bernd
   Klee, Doris
   Salber, Jochen
   Zwadlo-Klarwasser, Gabriele
TI Topographical control of human macrophages by a regularly micro
   structured polyvinylidene fluoride surface
SO BIOMATERIALS
LA English
DT Article
DE Microstructure; Nanotopography; Macrophage; Inflammation; Cytokine; Gene
   expression
ID FOREIGN-BODY REACTION; HUMAN-MONOCYTES; MONOCLONAL-ANTIBODY; EXPRESSION;
   CYTOKINES; CELLS; DIFFERENTIATION; ACTIVATION; POLARIZATION; CHEMOKINES
AB In this study we investigated the influence of surface topography on the inflammatory response of human macrophages. We generated different polyvinylidene fluoride (PVDF) surfaces including (i) a smooth surface of PVDF spherulites as a control, (ii) a randomly nanotextured surface with alumina particles, and (iii) a microstructure using laser ablation. The identical chemistry of all PVDF surfaces was demonstrated by X-ray photoelectron spectroscopy. The topography was evaluated by white light interferometry and X-profile analysis. Macrophages were cultured on the different surfaces including lipopolysaccharide (LPS) treatment as an inflammatory activator. Our results demonstrate that the microstructured surface but not the nanotexured significantly affects the activation of primary human macrophages by inducing a specific cytokine and gene expression pattern. This activation resulted in a subtype of macrophages with pro- but also anti-inflammatory properties. Interestingly, the response on the topography differed from that triggered by LPS, pointing to a different activation state of the cells. Our data clearly show that a particular topography induces an inflammatory response. This suggests that the modification of topography could influence the inflammatory potency of a biomaterial and hence could affect the biocompatibility of implants. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Paula, Nora E.; Bartneck, Matthias; Denecke, Bernd; Zwadlo-Klarwasser, Gabriele] Rhein Westfal TH Aachen, Univ Hosp, IZKF Biomat, D-52074 Aachen, Germany.
   [Skazik, Claudia] Rhein Westfal TH Aachen, Univ Hosp, Dept Dermatol, D-52074 Aachen, Germany.
   [Harwardt, Marc; Klee, Doris; Salber, Jochen] Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, D-52074 Aachen, Germany.
   [Harwardt, Marc; Klee, Doris; Salber, Jochen] Rhein Westfal TH Aachen, DWI, D-52074 Aachen, Germany.
RP Paula, NE (reprint author), Rhein Westfal TH Aachen, Univ Hosp, IZKF Biomat, Pauwelsstr 30, D-52074 Aachen, Germany.
EM npaul@ukaachen.de
FU Interdisciplinary Centre for Clinical Research (IZKF-BIOMAT) [TVB105];
   "Biointerface" [GRK1035]
FX Supported by a grant from the Interdisciplinary Centre for Clinical
   Research (IZKF-BIOMAT) within the faculty of Medicine at the RWTH Aachen
   (TVB105) and a grant from the DFG research training group "Biointerface"
   (GRK1035).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   Andrew DP, 1998, J IMMUNOL, V161, P5027
   BHARDWAJ RS, 1992, EUR J IMMUNOL, V22, P1891, DOI 10.1002/eji.1830220732
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   DIEGELMANN RF, 1981, PLAST RECONSTR SURG, V68, P107, DOI 10.1097/00006534-198107000-00025
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Graziano A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000496
   Hogger P, 1998, J IMMUNOL, V161, P1883
   HUANG R, 1993, SCAND J IMMUNOL, V38, P359, DOI 10.1111/j.1365-3083.1993.tb01738.x
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   JUNGNICKEL BJ, 1996, POLY VINYLIDENE FLUO
   Kenis G, 2002, CYTOKINE, V19, P228, DOI 10.1016/S1043-4666(02)91961-7
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4
   Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Polentarutti N, 1997, EUR CYTOKINE NETW, V8, P271
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rinaldo Jr G., 1994, J POLYM SCI B, V32, P859
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SKAZIK C, EXP DERMATO IN PRESS
   SRIKANTH S, 1994, J BIOL CHEM, V269, P32626
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   ZWADLO G, 1987, EXP CELL BIOL, V55, P295
   ZWADLO G, 1986, J IMMUNOL, V137, P512
NR 32
TC 62
Z9 62
U1 3
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2008
VL 29
IS 30
BP 4056
EP 4064
DI 10.1016/j.biomaterials.2008.07.010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359YV
UT WOS:000260025100004
PM 18667233
DA 2018-10-20
ER

PT J
AU Wittmer, CR
   Phelps, JA
   Lepus, CM
   Saltzman, WM
   Harding, MJ
   Van Tassel, PR
AF Wittmer, Corinne R.
   Phelps, Jennifer A.
   Lepus, Christin M.
   Saltzman, William M.
   Harding, Martha J.
   Van Tassel, Paul R.
TI Multilayer nanofilms as substrates for hepatocellular applications
SO BIOMATERIALS
LA English
DT Article
DE Layer-by-layer; Multilayer film; Nanofilm biomaterial; Hepatocyte; Liver
ID POLYELECTROLYTE MULTILAYER; CELL-ADHESION; ONCOSTATIN-M;
   EXTRACELLULAR-MATRIX; SURFACE-MODIFICATION; GRATING COUPLERS; PROTEIN
   ADSORPTION; FETAL HEPATOCYTES; IN-VITRO; FILMS
AB Multilayer nanofilms, formed by the layer-by-layer (LbL) adsorption of positively and negatively charged polyelectrolytes, are promising substrates for tissue engineering. We investigate here the attachment and function of hepatic cells on multilayer films in terms of film composition, terminal layer, rigidity, charge, and presence of biofunctional species. Human hepatocellular carcinoma (HepG2) cells, adult rat hepatocytes (ARH), and human fetal hepatoblasts (HFHb) are studied on films composed of the polysaccharides chitosan (CHI) and alginate (ALG), the polypeptides poly(L-lySine) (PLL) and poly(L-glutamic acid) (PGA), and the synthetic polymers poly(allylamine hydrochloride) (PAH) and poly(styrene sulfonate) (PSS). The influence of chemical cross-linking following LbL assembly is also investigated. We find HepG2 to reach confluence after 7 days of culture on only 2 of 18 candidate multilayer systems: (PAH-PSS)(n) (i.e. nPAH-PSS bilayers) and cross-linked (PLL-ALG)(n)-PLL. Cross-linked PLL-ALG and PLL-PGA films support attachment and function of ARH, independently of the terminal layer, Provided collagen is adsorbed to the top of the film. (PAH-PSS),, cross-linked (PLL-ALG),, and cross-linked (PLL-PCA)(n)-PLL films all support attachment, layer confluence, and function of HFHb, with the latter film promoting the greatest level of function at 8 days. Overall, film composition, terminal layer, and rigidity are key variables in promoting attachment and function of hepatic cells, while film charge and biofunctionality are somewhat less important. These studies reveal optimal candidate multilayer biomaterials for human liver tissue engineering applications. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Wittmer, Corinne R.; Phelps, Jennifer A.; Van Tassel, Paul R.] Yale Univ, Dept Chem Engn, New Haven, CT 06520 USA.
   [Lepus, Christin M.; Harding, Martha J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA.
   [Saltzman, William M.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.
RP Van Tassel, PR (reprint author), Yale Univ, Dept Chem Engn, 9 Hillhouse Ave, New Haven, CT 06520 USA.
EM paul.vantassel@yale.edu
RI Van Tassel, Paul/D-1087-2017
FU National Institutes of Health [R01-EB00258]
FX We are grateful to jean Wilson for assistance with the albumin ELISA
   analysis, Kathy Harry and the Yale Liver Center (#DK-P30-34989) for
   providing adult rat hepatocytes, and the National Institutes of Health
   for financial support (through grant R01-EB00258).
CR Allen JW, 2002, TISSUE ENG, V8, P725, DOI 10.1089/10763270260424097
   Benkirane-Jessel N, 2005, ADV FUNCT MATER, V15, P648, DOI 10.1002/adfm.200400129
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Berthiaume F, 1996, FASEB J, V10, P1471
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   BOYER JL, 1990, METHOD ENZYMOL, V192, P501
   Chan C, 2004, LIVER TRANSPLANT, V10, P1331, DOI 10.1002/lt.20229
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   CIMA LG, 1991, BIOTECHNOL BIOENG, V38, P145, DOI 10.1002/bit.260380207
   CIMA LG, 1991, T ASME, V113, P143
   Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   Deurholt T, 2006, CELL TRANSPLANT, V15, P811, DOI 10.3727/000000006783464417
   Hammond JS, 2006, EXPERT REV MED DEVIC, V3, P21, DOI 10.1586/17434440.3.1.21
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Kamiya A, 2002, HEPATOLOGY, V35, P1351, DOI 10.1053/jhep.2002.33331
   Kamiya A, 2001, FEBS LETT, V492, P90, DOI 10.1016/S0014-5793(01)02140-8
   Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127
   Khopade AJ, 2003, LANGMUIR, V19, P6219, DOI 10.1021/la030016d
   Kidambi S, 2004, J AM CHEM SOC, V126, P16286, DOI 10.1021/ja046188u
   Kidambi S, 2007, MACROMOL BIOSCI, V7, P344, DOI 10.1002/mabi.200600205
   Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265
   Kreke MR, 2005, BIOMATERIALS, V26, P2975, DOI 10.1016/j.biomaterials.2004.08.013
   Kulig KM, 2004, TRANSPL IMMUNOL, V12, P303, DOI 10.1016/j.trim.2003.12.005
   Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448
   LUKOSZ W, 1991, BIOSENS BIOELECTRON, V6, P227, DOI 10.1016/0956-5663(91)80007-K
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   NELLEN PM, 1988, SENSOR ACTUATOR, V15, P285, DOI 10.1016/0250-6874(88)87017-3
   Park IK, 2003, BIOMATERIALS, V24, P2331, DOI 10.1016/S0142-9612(03)00108-X
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   RAMSDEN JJ, 1993, J STAT PHYS, V73, P853, DOI 10.1007/BF01052813
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Rodahl M, 1996, SENSOR ACTUAT B-CHEM, V37, P111, DOI 10.1016/S0925-4005(97)80077-9
   Rodahl M, 1996, ANAL CHEM, V68, P2219, DOI 10.1021/ac951203m
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q
   Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328
   Semler EJ, 2001, BIOTECHNOL BIOENG, V75, P510, DOI 10.1002/bit.10113
   Tan W, 2005, J BIOMED MATER RES A, V72A, P146, DOI 10.1002/jbm.a.30182
   TIEFENTHALER K, 1989, J OPT SOC AM B, V6, P209, DOI 10.1364/JOSAB.6.000209
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Voros J, 2002, BIOMATERIALS, V23, P3699, DOI 10.1016/S0142-9612(02)00103-5
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
NR 53
TC 76
Z9 76
U1 2
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2008
VL 29
IS 30
BP 4082
EP 4090
DI 10.1016/j.biomaterials.2008.06.027
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359YV
UT WOS:000260025100007
PM 18653230
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Osathanon, T
   Linnes, ML
   Rajachar, RM
   Ratner, BD
   Somerman, MJ
   Giachelli, CM
AF Osathanon, Thanaphum
   Linnes, Michael L.
   Rajachar, Rupak M.
   Ratner, Buddy D.
   Somerman, Martha J.
   Giachelli, Cecilia M.
TI Microporous nanofibrous fibrin-based scaffolds for bone tissue
   engineering
SO BIOMATERIALS
LA English
DT Article
DE Fibrin; Calcium phosphate; Hydroxyapatite; Bone tissue engineering
ID CALCIUM-PHOSPHATE GRANULES; MESENCHYMAL STEM-CELLS; OF-THE-ART;
   IN-VITRO; OCTACALCIUM PHOSPHATE; INORGANIC-PHOSPHATE; MINERALIZED
   COLLAGEN; TRICALCIUM PHOSPHATE; CALVARIAL DEFECTS; GENE-EXPRESSION
AB The fibrotic response of the body to synthetic polymers limits their success in tissue engineering and other applications. Though porous polymers have demonstrated improved healing, difficulty in controlling their pore sizes and pore interconnections has clouded the understanding of this phenomenon. In this study, a novel method to fabricate natural polymer/calcium phosphate composite scaffolds with tightly controllable pore size, Pore interconnection, and calcium phosphate deposition was developed. Microporous, nanofibrous fibrin scaffolds were fabricated using sphere-templating methods. Composite scaffolds were created by solution deposition of calcium phosphate on fibrin Surfaces OF by direct incorporation of nanocrystalline hydroxyapatite (nHA). The SEM results showed that fibrin scaffolds exhibited a highly porous and interconnected structure. Osteoblast-like cells, obtained from murine calvaria, attached, Spread and showed a polygonal morphology on the Surface of the biomaterial. Multiple cell layers and fibrillar Matrix deposition were observed. Moreover, cells seeded on mineralized fibrin scaffolds exhibited significantly higher alkaline phosphatase activity as well as osteoblast marker gene expression compared to fibrin scaffolds and nHA incorporated fibrin scaffolds (0.25 and 0.5 g). All types of scaffolds were degraded both in vitro and in vivo. Furthermore, these scaffolds promoted bone formation in a mouse calvarial defect model and the bone formation was enhanced by addition of FhBMP-2. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Osathanon, Thanaphum; Somerman, Martha J.; Giachelli, Cecilia M.] Univ Washington, Sch Dent, Dept Oral Biol, Seattle, WA 98195 USA.
   [Osathanon, Thanaphum; Linnes, Michael L.; Rajachar, Rupak M.; Ratner, Buddy D.; Giachelli, Cecilia M.] Univ Washington, Coll Engn, Dept Bioengn, Seattle, WA 98195 USA.
   [Somerman, Martha J.] Univ Washington, Sch Dent, Dept Periodont, Seattle, WA 98195 USA.
RP Giachelli, CM (reprint author), Univ Washington, Dept Bioengn, POB 355061,Foege Hall,Room N330L, Seattle, WA 98192 USA.
EM ceci@u.washington.edu
OI Linnes, Michael/0000-0003-0504-7177
FU NSF [EEC-9872882, EEC-9529161]; School of Dentistry Research Funding;
   University of Washington [NIH/NIDCR DE15109]; Anandamahidol Foundation
FX The authors gratefully acknowledge the UWEB Optical Microscopy and Image
   Analysis Shared Resource (NSF Grants EEC-9872882 and EEC-9529161), the
   UW center of Nanotechnology. This study was funded in part by the School
   of Dentistry Research Funding, University of Washington, NIH/NIDCR
   DE15109 (MS), and unrestricted funds to CG. TO is supported by a
   scholarship from the Anandamahidol Foundation, under the Royal Patronage
   of His Majesty the King of Thailand.
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200
   Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269
   CHENG PT, 1987, CALCIFIED TISSUE INT, V40, P339, DOI 10.1007/BF02556696
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059
   Cronin KJ, 2007, J BIOMED MATER RES B, V82B, P122, DOI 10.1002/jbm.b.30713
   Datta NS, 2005, J BONE MINER RES, V20, P1051, DOI 10.1359/JBMR.050106
   Foster BL, 2006, CALCIFIED TISSUE INT, V78, P103, DOI 10.1007/s00223-005-0184-7
   FOWLER BO, 1993, CHEM MATER, V5, P1417, DOI 10.1021/cm00034a009
   Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1
   Hirata K, 2003, BONE, V32, P502, DOI 10.1016/S8756-3282(03)00054-1
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Itaka K, 2007, MOL THER, V15, P1655, DOI 10.1038/sj.mt.6300218
   Jegoux F, 2005, ARCH ORTHOP TRAUM SU, V125, P153, DOI 10.1007/s00402-004-0748-4
   Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   KIM SS, 2008, J BIOMED MAT RES A
   Le Guehennec L, 2005, J MATER SCI-MATER M, V16, P29, DOI 10.1007/s10856-005-6443-3
   Lee YJ, 2006, BIOMATERIALS, V27, P3738, DOI 10.1016/j.biomaterials.2006.02.032
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lynch MP, 1998, J CELL BIOCHEM, V68, P31
   Mankani MH, 2004, RADIOLOGY, V230, P369, DOI 10.1148/radiol.2302011529
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   NANCOLLAS GH, 1992, PURE APPL CHEM, V64, P1673, DOI 10.1351/pac199264111673
   Niemeyer P, 2004, CELLS TISSUES ORGANS, V177, P68, DOI 10.1159/000079182
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schliephake H, 2004, CLIN ORAL IMPLAN RES, V15, P112, DOI 10.1111/j.1600-0501.2004.00992.x
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Siebers MC, 2006, J BIOMED MATER RES A, V78A, P258, DOI 10.1002/jbm.a.30700
   TADDEI P, 2000, BIOPOLYMERS, P57
   TAKEI A, 1995, IN VITRO CELL DEV-AN, V31, P467
   Tarasevich BJ, 2003, J PHYS CHEM B, V107, P10367, DOI 10.1021/jp027445p
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   ZHOU H, 2007, J BIOL CHEM
NR 44
TC 94
Z9 101
U1 2
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2008
VL 29
IS 30
BP 4091
EP 4099
DI 10.1016/j.biomaterials.2008.06.030
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359YV
UT WOS:000260025100008
PM 18640716
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Crawford, A
   Hatton, PV
AF Crawford, A.
   Hatton, P. V.
TI Cell-Biomaterial Interactions in Skeletal Tissue Engineering.
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Meeting Abstract
CT 7th International Congress on Progress in Bioengineering
CY OCT 27-30, 2008
CL Pisa, ITALY
C1 [Crawford, A.; Hatton, P. V.] Univ Sheffield, Ctr Biomat & Tissue Engn, Sheffield, S Yorkshire, England.
EM a.crawford@sheffield.ac.uk
NR 0
TC 0
Z9 0
U1 1
U2 5
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD OCT
PY 2008
VL 62
IS 8
BP 493
EP 494
DI 10.1016/j.biopha.2008.07.014
PG 2
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 370CA
UT WOS:000260739100014
DA 2018-10-20
ER

PT J
AU Vozzi, G
   Chiono, V
   Vozzi, F
   Salvadori, C
   Dini, F
   Carlucci, F
   Arispici, M
   Burchielli, S
   Ciardelli, G
   Giusti, P
AF Vozzi, G.
   Chiono, V.
   Vozzi, F.
   Salvadori, C.
   Dini, F.
   Carlucci, F.
   Arispici, M.
   Burchielli, S.
   Ciardelli, G.
   Giusti, P.
TI Nerve regeneration using novel biomaterial supports
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Meeting Abstract
CT 7th International Congress on Progress in Bioengineering/7th
   International Congress on Vascular Endothelium/9the International
   Congress on Advances in Management of Malignancies
CY OCT 27-30, 2008
CL Pisa, ITALY
C1 [Vozzi, G.; Giusti, P.] Univ Pisa, Dept Chem Engn Ind Chem & Mat Sci, I-56126 Pisa, Italy.
   [Vozzi, G.; Vozzi, F.] Univ Pisa, Interdepartmental Res Ctr E Piaggio, I-56126 Pisa, Italy.
   [Chiono, V.; Ciardelli, G.] Politecn Torino, Dept Mech, I-10129 Turin, Italy.
   [Vozzi, F.; Burchielli, S.] CNR, Inst Clin Physiol, I-56126 Pisa, Italy.
   [Salvadori, C.; Arispici, M.] Univ Pisa, Dept Anim Pathol Prophylaxis & Hyg Aliments, I-56126 Pisa, Italy.
   [Dini, F.; Carlucci, F.] Univ Pisa, Fac Vet, Dept Vet Clin, I-56126 Pisa, Italy.
EM g.vozzi@ing.unipi.it
RI Vozzi, Giovanni/F-9787-2014; Chiono, Valeria/G-3631-2014
OI Vozzi, Giovanni/0000-0002-9414-9994; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD OCT
PY 2008
VL 62
IS 8
BP 495
EP 496
DI 10.1016/j.biopha.2008.07.018
PG 2
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 370CA
UT WOS:000260739100018
DA 2018-10-20
ER

PT J
AU Hui, FFC
   Chan, CW
   Qin, L
   Li, G
   Lee, KM
   Hu, YY
   Leung, KS
   Cheng, CYJ
AF Hui, Fan Fong Celine
   Chan, Chun Wai
   Qin, Ling
   Li, Gang
   Lee, Kwong Man
   Hu, Yun Yu
   Leung, Kwok Sui
   Cheng, Chun Yiu Jack
TI Low intensity pulsed ultrasound enhances spinal fusion supplemented with
   tissue engineered biomaterial composite
SO BONE
LA English
DT Meeting Abstract
CT International Conference on Osteoporosis and Bone Research
CY OCT 22-25, 2008
CL Beijing, PEOPLES R CHINA
SP Chinese Med Assoc, Int Bone & Mineral Soc, Int Chinese Hard Tissue Soc
C1 [Hui, Fan Fong Celine; Chan, Chun Wai; Qin, Ling; Leung, Kwok Sui; Cheng, Chun Yiu Jack] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   [Li, Gang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.
   [Lee, Kwong Man] Chinese Univ Hong Kong, Lee Hysan Clin Res Labs, Hong Kong, Hong Kong, Peoples R China.
   [Hu, Yun Yu] Inst Orthopaed & Traumatol, Xian, Peoples R China.
RI Qin, Ling/J-9047-2018; Chan, Chun Wai/B-5889-2015; Li, Gang/J-7830-2018
OI Qin, Ling/0000-0001-6173-6167; Li, Gang/0000-0002-3981-2239
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD OCT
PY 2008
VL 43
SU 1
BP S44
EP S44
DI 10.1016/j.bone.2008.08.020
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 360TT
UT WOS:000260081500084
DA 2018-10-20
ER

PT J
AU Finotelli, PV
   Sampaio, DA
   Morales, MA
   Rossi, AM
   Rocha-Leao, MH
AF Finotelli, P. V.
   Sampaio, D. A.
   Morales, M. A.
   Rossi, A. M.
   Rocha-Leao, M. H.
TI Ca ALGINATE AS SCAFFOLD FOR IRON OXIDE NANOPARTICLES SYNTHESIS
SO BRAZILIAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE Alginate; Nanotechnology and Magnetite
ID CONTRAST AGENTS; PARTICLES; FE3O4; HYPERTHERMIA; DEXTRAN
AB Recently, nanotechnology has developed to a stage that makes it possible to process magnetic nanoparticles for the site-specific delivery of drugs. To this end, it has been proposed as biomaterial for drug delivery system in which the drug release rates would be activated by a magnetic external stimuli. Alginate has been used extensively in the food, pharmaceutical and biomedical industries for their gel forming properties in the presence of multivalent cations. In this study, we produced iron oxide nanoparticles by coprecipitation of Fe(III) and Fe(II). The nanoparticles were entrapped in Ca alginate beads before and after alginate gelation. XRD analysis showed that particles should be associated to magnetite or maghemite with crystal size of 9.5 and 4.3 nm, respectively. Studies using Mossbauer spectroscopy corroborate the superparamagnetic behavior. The combination of magnetic properties and the biocompatibility of alginate suggest that this biomaterial may be used as biomimetic system.
C1 [Finotelli, P. V.; Morales, M. A.; Rocha-Leao, M. H.] Univ Fed Rio de Janeiro, Inst Quim, Ctr Technol, BR-21949900 Rio De Janeiro, Brazil.
   [Rossi, A. M.] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, Brazil.
RP Rocha-Leao, MH (reprint author), Univ Fed Rio de Janeiro, Inst Quim, Ctr Technol, BR-21949900 Rio De Janeiro, Brazil.
EM mhrl@eq.ufrj.br
RI Morales, Marco/G-1229-2012
OI Morales, Marco/0000-0002-3098-5731
FU Brazilian Council for Scientific and Technological Development
   (CNPq/Pronex); CAPES
FX This study was supported by the Brazilian Council for Scientific and
   Technological Development (CNPq/Pronex). The first author is grateful to
   CAPES for the financial support. The alginate was kindly supplied by ISP
   Alginates Inc.
CR BAHADUR D, 2003, BIOMATER MAGNET, V28, P639
   Bergemann C, 1999, J MAGN MAGN MATER, V194, P45, DOI 10.1016/S0304-8853(98)00554-X
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   Cheng FY, 2005, BIOMATERIALS, V26, P729, DOI 10.1016/j.biomaterials.2004.03.016
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA
   DIONNE GF, 1975, P IEEE, V63, P77
   Dyal A, 2003, J AM CHEM SOC, V125, P1684, DOI 10.1021/ja021223n
   Fried T, 2001, ADV MATER, V13, P1158, DOI 10.1002/1521-4095(200108)13:15<1158::AID-ADMA1158>3.0.CO;2-6
   Hafeli UO, 2004, INT J PHARM, V277, P19, DOI 10.1016/j.ijpharm.2003.03.002
   Hong CY, 1997, J APPL PHYS, V81, P4275, DOI 10.1063/1.364800
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Kang YS, 1996, CHEM MATER, V8, P2209, DOI 10.1021/cm960157j
   Kim DK, 2001, J MAGN MAGN MATER, V225, P256, DOI 10.1016/S0304-8853(00)01255-5
   Lubbe AS, 1996, CANCER RES, V56, P4686
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Matsumoto M., 1991, IEEE Translation Journal on Magnetics in Japan, V6, P648, DOI 10.1109/TJMJ.1991.4565229
   MORISAKO A, 1987, IEEE T MAGN, V23, P56, DOI 10.1109/TMAG.1987.1064821
   Pardoe H, 2001, J MAGN MAGN MATER, V225, P41, DOI 10.1016/S0304-8853(00)01226-9
   Reynolds CH, 2000, J AM CHEM SOC, V122, P8940, DOI 10.1021/ja001426g
   Saiyed Z., 2003, BIOMAGN RES TECHNOL, V1, P2, DOI DOI 10.1186/1477-044X-1-2
   SAPIESZKO RS, 1980, J COLLOID INTERF SCI, V74, P405, DOI 10.1016/0021-9797(80)90210-6
   Thode K, 1997, J DRUG TARGET, V5, P35, DOI 10.3109/10611869708995856
   Vandenberghe RE, 2000, HYPERFINE INTERACT, V126, P247, DOI 10.1023/A:1012603603203
   Vijayakumar R, 2000, MAT SCI ENG A-STRUCT, V286, P101, DOI 10.1016/S0921-5093(00)00647-X
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
NR 25
TC 13
Z9 13
U1 0
U2 10
PU BRAZILIAN SOC CHEMICAL ENG
PI SAO PAULO
PA RUA LIBERO BADARO 152-11 ANDAR, CEP 01008-90 SAO PAULO, BRAZIL
SN 0104-6632
J9 BRAZ J CHEM ENG
JI Braz. J. Chem. Eng.
PD OCT-DEC
PY 2008
VL 25
IS 4
BP 759
EP 764
DI 10.1590/S0104-66322008000400013
PG 6
WC Engineering, Chemical
SC Engineering
GA 376UE
UT WOS:000261207700013
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Vucurovic, V
   Razmovski, R
   Rebic, M
AF Vucurovic, Vesna
   Razmovski, Radojka
   Rebic, Mario
TI A CORN STEM AS BIOMATERIAL FOR SACCHAROMYCES CEREVISIAE CELLS
   IMMOBILIZATION FOR THE ETHANOL PRODUCTION
SO CHEMICAL INDUSTRY & CHEMICAL ENGINEERING QUARTERLY
LA English
DT Article
DE corn stem; yeast immobilization; fermentation; ethanol yield
ID FERMENTATION; BAGASSE
AB This study provides a preliminary contribution to the development of a bioprocess for the production of ethanol using Saccharomyces cerevisiae cells immobilized onto a corn stem. For this purpose, the yeast cells were submitted to the batch tests in situ adsorption onto 0.5 cm long corn stem. Cells immobilization was analyzed by optical microscopy The number of the yeast cells, fermentation kinetics, the ethanol yield in the presence or the absence of the support in the fermentation medium was investigated. It was determined that the addition of the corn stem led to the abrupt increase of the yeast cells number in substrate, ethanol yield pH value, a total dissolved salts content and substrate conductivity. The addition of 5 and 10g of the corn stem pith per liter of the medium decreased the amount of residual sugar. The results indicate that a corn stem might be a good carder for the yeast cell immobilization, and also a cheap alternative recourse of mineral components with the possibility of application for improving ethanol productivites.
C1 [Vucurovic, Vesna; Razmovski, Radojka; Rebic, Mario] Univ Novi Sad, Fac Technol, Novi Sad 21000, Serbia.
RP Vucurovic, V (reprint author), Univ Novi Sad, Fac Technol, Bul Cara Lazara 1, Novi Sad 21000, Serbia.
FU Ministry of Science and Technological Development of Serbia [BTN 20009]
FX The final support from the Ministry of Science and Technological
   Development of Serbia is highly acknowledged (BTN 20009).
CR Anderson WF, 2008, J IND MICROBIOL BIOT, V35, P355, DOI 10.1007/s10295-007-0291-8
   Bai FW, 2008, BIOTECHNOL ADV, V26, P89, DOI 10.1016/j.biotechadv.2007.09.002
   BATTACHARYA AK, 2006, J MATER SCI, V41, P2443
   Beltran-Garcia M. J., 2001, J MEX CHEM SOC, V45, P77
   BRANYIK T, 2005, P 2 MERC C CHEM ENG
   CAPUTI A, 1968, AM J ENOL VITICULT, V19, P160
   de Vasconcelos JN, 2004, BRAZ J CHEM ENG, V21, P357, DOI 10.1590/S0104-66322004000300002
   Fujii N, 1999, PROCESS BIOCHEM, V34, P147, DOI 10.1016/S0032-9592(98)00085-5
   Jung HG, 2006, CROP SCI, V46, P1793, DOI 10.2135/cropsci2005.02-0085
   PARMANIK K, 2004, J CH, V85, P31
   Plessas S, 2007, BIORESOURCE TECHNOL, V98, P860, DOI 10.1016/j.biortech.2006.03.014
   Reddy N, 2005, POLYMER, V46, P5494, DOI 10.1016/j.polymer.2005.04.073
   Santos DT, 2008, J FOOD ENG, V86, P542, DOI 10.1016/j.jfoodeng.2007.11.004
   Thamae T, 2008, J MATER SCI, V43, P4057, DOI 10.1007/s10853-008-2495-3
   Verbelen PJ, 2006, BIOTECHNOL LETT, V28, P1515, DOI 10.1007/s10529-006-9132-5
   Yu JL, 2007, J BIOTECHNOL, V129, P415, DOI 10.1016/j.jbiotec.2007.01.039
NR 16
TC 7
Z9 7
U1 0
U2 9
PU ASSOC CHEMICAL ENG
PI BELGRADE
PA KNEZA MILOSO 9-I, BELGRADE, 11000, SERBIA
SN 1451-9372
J9 CHEM IND CHEM ENG Q
JI Chem. Ind. Chem. Eng. Q.
PD OCT-DEC
PY 2008
VL 14
IS 4
BP 235
EP 238
DI 10.2298/CICEQ0804235V
PG 4
WC Chemistry, Applied; Engineering, Chemical
SC Chemistry; Engineering
GA 392BO
UT WOS:000262278100007
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Choi, JH
   Bischof, JC
AF Choi, Jeung Hwan
   Bischof, John C.
TI A quantitative analysis of the thermal properties of porcine liver with
   glycerol at subzero and cryogenic temperatures
SO CRYOBIOLOGY
LA English
DT Article
DE Thermal property; Subzero; Liver; Glycerol
ID DIFFERENTIAL SCANNING CALORIMETRY; CONDUCTIVITY; H2O-NACL-GLYCEROL;
   CRYSTALLIZATION; BIOMATERIALS; SULFOXIDE; KINETICS; SOLIDS; MELTS; ICE
AB There is a lack of information on the effect of cryoprotective agents (CPAs) on the thermal properties of biomaterials at cryobiologically relevant temperatures (i.e. <233.15 K, -40 degrees C). Thermal properties that are of most interest include: thermal conductivity, density, specific heat, and latent heat resulting from phase change in tissue systems. Availability of such information would be beneficial for accurate mathematical modeling of cryobiological applications. Recently, we reported these thermal properties in phosphate buffered saline (PBS) with varying concentrations of glycerol, a widely used cryoprotective agent. In this study we extend these results by assessing the effects of glycerol on the thermal properties of porcine liver at subzero temperatures. Differential scanning calorimeter (DSC) was used to measure the specific heat and the latent heat release of porcine liver immersed in PBS and varying concentrations of glycerol. The specific heat data obtained from the DSC experiments were also used to predict the bulk thermal conductivity. This was done using a transient heat transfer model with a thermistor probe technique. Results show that the introduction of glycerol significantly alters thermal properties from known values for H2O and non-treated liver. Therefore, inaccuracies in thermal predictions can be expected due to the application of measured vs. predicted thermal properties such as from weight averaging. This supports the need for these and other measurements of biomaterial thermal properties, with and without CPA addition, in the cryogenic regime. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Choi, Jeung Hwan; Bischof, John C.] Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA.
   [Bischof, John C.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.
   [Bischof, John C.] Univ Minnesota, Dept Urol Surg, Minneapolis, MN 55455 USA.
RP Bischof, JC (reprint author), Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55455 USA.
EM bischof@umn.edu
FU United States National Science Foundation (NSF) [CTS 0313934]
FX Statement of funding: This work was supported by the United States
   National Science Foundation (NSF) under Grant No. CTS 0313934.
CR ASHWORTH T, 1972, P 4 INT CRYOG ENG C, P24
   BAI XM, 1991, J BIOMECH ENG-T ASME, V113, P423, DOI 10.1115/1.2895422
   Balasubramaniam TA, 1997, J BIOMECH ENG-T ASME, V99, P148
   BALD WB, 1982, REP PROG PHYS, V45, P1381, DOI 10.1088/0034-4885/45/12/001
   BIRGE NO, 1986, PHYS REV B, V34, P1631, DOI 10.1103/PhysRevB.34.1631
   Bischof JC, 2007, ANN BIOMED ENG, V35, P292, DOI 10.1007/s10439-006-9176-7
   BOUTRON P, 1979, CRYOBIOLOGY, V16, P372, DOI 10.1016/0011-2240(79)90050-6
   BOUTRON P, 1986, CRYOBIOLOGY, V23, P88, DOI 10.1016/0011-2240(86)90022-2
   BOWMAN HF, 1975, ANNU REV BIOPHYS BIO, V4, P43, DOI 10.1146/annurev.bb.04.060175.000355
   CAHILL DG, 1987, PHYS REV B, V35, P4067, DOI 10.1103/PhysRevB.35.4067
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   Chato JC, 1985, HEAT TRANSFER MED BI, P167
   CHEN MM, 1981, J BIOMECH ENG-T ASME, V103, P253
   CHIU J, 1979, THERMOCHIM ACTA, V34, P267, DOI 10.1016/0040-6031(79)87116-6
   CHOI JH, 2007, INT J HEAT IN PRESS
   COCKS FH, 1975, J APPL PHYS, V46, P3444, DOI 10.1063/1.322066
   COOPER TE, 1972, J HEAT TRANSFER, P133
   Fennema O. R., 1973, LOW TEMPERATURE PRES
   Hey JM, 1998, CRYOBIOLOGY, V37, P119, DOI 10.1006/cryo.1998.2108
   Hobbs P. V., 1974, ICE PHYS
   Hohne GWH, 1996, DIFFERENTIAL SCANNIN
   JOCHEM M, 1987, CRYOBIOLOGY, V24, P513, DOI 10.1016/0011-2240(87)90055-1
   KEATING MY, 1990, THERMOCHIM ACTA, V166, P69, DOI 10.1016/0040-6031(90)80170-4
   KHANNA YP, 1988, POLYM ENG SCI, V28, P1034, DOI 10.1002/pen.760281604
   Klinger J., 1973, PHYS CHEM ICE, P114
   LIDE DR, 2006, HDB CHEM PHYS, P6
   Luyet B, 1968, Biodynamica, V10, P167
   NEWMAN AA, 1968, PHYS PROPERTIES GLYC, P21
   OWEN MS, 2002, ASHRAE HDB REFRIGERA, P81
   OZISIK MN, 1993, HEAT CONDUCTION, P214
   Poppendiek H. F., 1966, CRYOBIOLOGY, V3, P318
   RUBINSKY B, 1984, CRYOBIOLOGY, V21, P303, DOI 10.1016/0011-2240(84)90326-2
   SHEPARD ML, 1976, CRYOBIOLOGY, V13, P9, DOI 10.1016/0011-2240(76)90154-1
   VALVANO JW, 1988, LOW TEMPERATURE BIOT, P331
   Zhang A, 2004, CELL PRESERV TECHNOL, V2, P157, DOI 10.1089/153834404774101990
   Zhang H., 2002, CELL PRESERV TECHNOL, V1, P141
NR 36
TC 14
Z9 15
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
J9 CRYOBIOLOGY
JI Cryobiology
PD OCT
PY 2008
VL 57
IS 2
BP 79
EP 83
DI 10.1016/j.cryobio1.2008.05.004
PG 5
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA 365LD
UT WOS:000260407000001
PM 18656857
DA 2018-10-20
ER

PT J
AU Witte, F
   Hort, N
   Vogt, C
   Cohen, S
   Kainer, KU
   Willumeit, R
   Feyerabend, F
AF Witte, Frank
   Hort, Norbert
   Vogt, Carla
   Cohen, Smadar
   Kainer, Karl Ulrich
   Willumeit, Regine
   Feyerabend, Frank
TI Degradable biomaterials based on magnesium corrosion
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
DE Magnesium alloy; Biodegradable; Corrosion; In vivo; In vitro; Animal
   model; Implant
ID PLASMA-MASS SPECTROMETRY; IN-VIVO CORROSION; ATOMIC-ABSORPTION
   SPECTROMETRY; OPTICAL-EMISSION-SPECTROMETRY; PORCINE CORONARY-ARTERIES;
   BONE IMPLANT APPLICATION; BLOOD-FLOW DISTRIBUTION; BROWN ADIPOSE-TISSUE;
   MECHANICAL-PROPERTIES; ALLOY STENTS
AB Biodegradable metals are breaking the current paradigm in biomaterial science to develop only corrosion resistant metals. In particular, metals which consist of trace elements existing in the human body are promising candidates for temporary implant materials. These implants would be temporarily needed to provide mechanical support during the healing process of the injured or pathological tissue. Magnesium and its alloys have been investigated recently by many authors as a suitable biodegradable biomaterial. In this investigative review we would like to summarize the latest achievements and comment on the selection and use, test methods and the approaches to develop and produce magnesium alloys that are intended to perform clinically with an appropriate host response. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Witte, Frank] Hannover Med Sch, Lab Biomech & Biomat, D-30625 Hannover, Germany.
   [Witte, Frank; Cohen, Smadar] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   [Hort, Norbert; Kainer, Karl Ulrich; Willumeit, Regine; Feyerabend, Frank] GKSS Forschungszentrum Geesthacht GmbH, Inst Mat Res, D-21502 Geesthacht, Germany.
   [Vogt, Carla] Leibniz Univ Hannover, Inst Inorgan Chem, D-30167 Hannover, Germany.
RP Witte, F (reprint author), Hannover Med Sch, Lab Biomech & Biomat, Anna von Borries Str 1-7, D-30625 Hannover, Germany.
EM fwitte@web.de; norbert.hort@gkss.de; vogt@acc.uni-hannover.de;
   s.cohen@bgu.il.co; karl.kai-ner@gkss.de; regine.willumeit@gkss.de;
   frank.feyer-abend@gkss.de
RI Kainer, Karl/D-6417-2011; Hort, Norbert/G-1913-2011; Willumeit,
   Regine/I-8029-2013; Feyerabend, Frank/A-1124-2010; COHEN,
   SMADAR/F-1901-2012
OI Kainer, Karl/0000-0002-9630-0985; Hort, Norbert/0000-0002-6636-1568;
   Willumeit, Regine/0000-0002-6004-6946; Feyerabend,
   Frank/0000-0001-9532-0207; Witte, Frank/0000-0001-9154-6217
CR ABOUSHAKRA FR, 1989, TRACE ELEM MED, V6, P142
   Ambard Alberto J, 2006, J Prosthodont, V15, P321, DOI 10.1111/j.1532-849X.2006.00129.x
   Ambat R, 2000, CORROS SCI, V42, P1433, DOI 10.1016/S0010-938X(99)00143-2
   An YH, 1999, ANIMAL MODELS ORTHOP
   Anetzberger H, 2004, J APPL PHYSIOL, V96, P1928, DOI 10.1152/japplphysiol.00904.2003
   Aral H, 2008, ECOTOX ENVIRON SAFE, V70, P349, DOI 10.1016/j.ecoenv.2008.02.026
   ARMSTRONG RB, 1984, AM J PHYSIOL, V246, pH59
   Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001
   *ASM INT, 1988, MAGN BIN PHAS DIAGR
   *ASTM B, STAND PRACT TEMP DES
   *ASTM B, STAND PRACT COD UN M
   Avedesian M. M., 1999, MAGNESIUM MAGNESIUM
   Bach FW, 2003, MATER SCI FORUM, V419-4, P1037, DOI 10.4028/www.scientific.net/MSF.419-422.1037
   BANKS RA, 1981, CLIN EXP PHARMACOL P, V8, P543, DOI 10.1111/j.1440-1681.1981.tb00764.x
   BARUTHIO F, 1988, CLIN CHEM, V34, P227
   BAUCCIO ML, 2001, ASM METALS REFERENCE
   Becker JS, 2005, ANAL CHEM, V77, P3208, DOI 10.1021/ac040184q
   Begerow J, 2000, J ANAL ATOM SPECTROM, V15, P347, DOI 10.1039/a909056h
   Bell G, 1968, TXB PHYSL BIOCH
   Benes B, 2000, BIOL TRACE ELEM RES, V75, P195, DOI 10.1385/BTER:75:1-3:195
   Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y
   Bichet DG, 2006, J AM SOC NEPHROL, V17, P920, DOI 10.1681/ASN.2006020135
   Bock NA, 2008, BRAIN RES, V1198, P160, DOI 10.1016/j.brainres.2007.12.065
   BOYER HE, 1985, METALLS HDB
   Brewer GJ, 2007, EXP BIOL MED, V232, P323
   Browse DJ, 1997, EUR J PHARMACOL, V320, P139, DOI 10.1016/S0014-2999(96)00887-4
   CROSBY WH, 1974, JAMA-J AM MED ASSOC, V227, P310, DOI 10.1001/jama.227.3.310
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Emley E. F., 1966, PRINCIPLES MAGNESIUM
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   EVANS FG, 1976, ANAT REC, V185, P1, DOI 10.1002/ar.1091850102
   Ferreira PC, 2008, REV LAT-AM ENFERM, V16, P151, DOI 10.1590/S0104-11692008000100023
   FEYERABEND F, 2008, BIOMED MAT RES A, DOI DOI 10.1002/JBM.A.32151
   Feyerabend F, 2006, TISSUE ENG, V12, P3545, DOI 10.1089/ten.2006.12.3545
   FOERSTER GS, 1975, GT75112
   FRIEDRICH HE, 2006, MORDIKE BL MAGNESIUM
   Garcia EE, 2001, J ANAL ATOM SPECTROM, V16, P825, DOI 10.1039/b100779n
   Gelinas Y, 1997, BIOL TRACE ELEM RES, V59, P63, DOI 10.1007/BF02783231
   Ghazi AM, 2000, J ANAL ATOM SPECTROM, V15, P1335, DOI 10.1039/b001888k
   Gilca M, 2007, J POSTGRAD MED, V53, P207, DOI 10.4103/0022-3859.33869
   Giles JJ, 2006, CURR PHARM DESIGN, V12, P1531, DOI 10.2174/138161206776389804
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Gordon T, 2003, MUTAT RES-FUND MOL M, V533, P99, DOI 10.1016/j.mrfmmm.2003.08.022
   Gruhl S, 2009, J ANAL ATOM SPECTROM, V24, P181, DOI 10.1039/b813734j
   GRZESIAK JJ, 1995, J CLIN INVEST, V95, P227, DOI 10.1172/JCI117644
   Grzesiak JJ, 2008, INT J CANCER, V122, P2199, DOI 10.1002/ijc.23368
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   HAFSTROM L, 1980, CANCER RES, V40, P481
   HAMILTON E I, 1976, Science of the Total Environment, V5, P1, DOI 10.1016/0048-9697(76)90023-1
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   HASSEL T, 2007, MAGNESIUM TECHNOLOGY, P359
   HEIM T, 1966, J PHYSIOL-LONDON, V186, P42, DOI 10.1113/jphysiol.1966.sp008019
   Hongchun X., 2000, J ANAL SPECTROM, V15, P759
   Hyder F, 2000, J CEREBR BLOOD F MET, V20, P485, DOI 10.1097/00004647-200003000-00007
   Iwase M, 2000, HYPERTENS RES, V23, P503, DOI 10.1291/hypres.23.503
   JACKSON BP, 2006, PLASM WINT C 2006 TU
   Janssens K, 1999, FRESEN J ANAL CHEM, V363, P413, DOI 10.1007/s002160051212
   Ji YJ, 2000, BIOMED ENVIRON SCI, V13, P287
   JOHNSON JRK, 1968, CLIN CHEM, V14, P1218
   KAESE V, 2002, BEITRAG KORROSIONSSC
   Kammer C., 2000, MAGNESIUM TASCHENBUC
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kaya RA, 2007, J NEUROSURG-SPINE, V6, P141, DOI 10.3171/spi.2007.6.2.141
   KIILERICH S, 1980, CLIN CHIM ACTA, V105, P231, DOI 10.1016/0009-8981(80)90465-9
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KNOOP FM, 1994, ERZEUGUNG KONSOLIDIE
   Koganezawa T, 2006, BRIT J PHARMACOL, V148, P579, DOI 10.1038/sj.bjp.0706765
   Kostova Irena, 2007, Metal-Based Drugs, P15925, DOI 10.1155/2007/15925
   Kraft R, 2005, PFLUG ARCH EUR J PHY, V451, P204, DOI 10.1007/s00424-005-1428-0
   KRAUSE C, 2007, MAGNESIUM TECHNOLOGY, P329
   Krejcova A, 2001, J ANAL ATOM SPECTROM, V16, P1002, DOI 10.1039/b101941o
   Kuper C, 2007, CURR GENOMICS, V8, P209
   KURIHARA T, 1992, LIFE SCI, V51, P6
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Lango T, 1996, UNDERSEA HYPERBAR M, V23, P247
   Larsen M, 2008, J ORTHOP RES, V26, P746, DOI 10.1002/jor.20561
   Lastra MD, 2001, J TRACE ELEM MED BIO, V15, P5, DOI 10.1016/S0946-672X(01)80019-5
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   Loghin Felicia, 1999, Metal-Based Drugs, V6, P87, DOI 10.1155/MBD.1999.87
   Magda D, 2006, SEMIN CANCER BIOL, V16, P466, DOI 10.1016/j.semcancer.2006.09.002
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   MAKINO T, 1981, CLIN CHEM, V27, P1445
   MARTIN B, 1998, SKELETAL TISSUE MECH
   Martinez R, 2001, J ANAL ATOM SPECTROM, V16, P250, DOI 10.1039/b009469m
   Matheson PJ, 2008, AM J SURG, V196, P293, DOI 10.1016/j.amjsurg.2007.11.013
   *MEL, 2005, MAGN EL DAT
   *MEL, 2005, MAGN DAT 497
   Milavec-Puretic V, 1998, ARCH ORTHOP TRAUM SU, V117, P383, DOI 10.1007/s004020050272
   Morant C, 2003, APPL SURF SCI, V220, P79, DOI 10.1016/S0169-4332(03)00746-3
   MOUREN S, 1994, ANESTHESIOLOGY, V80, P634, DOI 10.1097/00000542-199403000-00021
   Müller Wolf Dieter, 2007, Mat. Res., V10, P5, DOI 10.1590/S1516-14392007000100003
   NEITE G, 1996, MAT SCI TECHNOLOGY
   NIXON DE, 1989, ANALYST, V114, P1671, DOI 10.1039/an9891401671
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Perna L, 2002, J ANAL ATOM SPECTROM, V17, P1166, DOI 10.1039/b202451a
   PIIPER J, 1962, J APPL PHYSIOL, V17, P268
   Post JI, 2008, AMYOTROPH LATERAL SC, V9, P149, DOI 10.1080/17482960801934015
   Reinoso RF, 1997, J PHARMACOL TOXICOL, V38, P87, DOI 10.1016/S1056-8719(97)00053-1
   Ren YB, 2005, ACTA METALL SIN, V41, P1228
   Renkema KY, 2008, ANN MED, V40, P82, DOI 10.1080/07853890701689645
   RENNER F, 2004, EINLFUSSGROSSEN SCHW
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Revie R. Winston, 2000, UHLIGS CORROSION HDB
   RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189
   Rokhlin L.L., 2003, MAGNESIUM ALLOYS CON
   ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C
   Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397
   Rousselle AV, 2002, HISTOL HISTOPATHOL, V17, P1025, DOI 10.14670/HH-17.1025
   Rubin H, 2005, P NATL ACAD SCI USA, V102, P9276, DOI 10.1073/pnas.0503688102
   Rubin H, 2005, BIOESSAYS, V27, P311, DOI 10.1002/bies.20183
   Sahin O, 2006, PATHOLOGY, V38, P58, DOI 10.1080/00313020500464904
   SALTMAN PD, 1993, J AM COLL NUTR, V12, P384, DOI 10.1080/07315724.1993.10718327
   Schlingmann KP, 2005, J PHYSIOL-LONDON, V566, P301, DOI 10.1113/jphysiol.2004.080200
   Seifert EL, 2006, BIOL NEONATE, V90, P104, DOI 10.1159/000092069
   SHAW BA, 2003, ASM HDB A, V13
   Shingde M, 2005, MED J AUSTRALIA, V183, P145
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   SPEICH M, 1981, CLIN CHEM, V27, P246
   STATLAND BE, 1976, CLIN BIOCHEM, V9, P26, DOI 10.1016/S0009-9120(76)80008-2
   TAHAN JE, 1994, ANAL CHIM ACTA, V295, P187, DOI 10.1016/0003-2670(94)80350-1
   VAUPEL P, 1976, PFLUG ARCH EUR J PHY, V361, P201, DOI 10.1007/BF00583467
   Villaneuva M, 2000, J ANAL ATOM SPECTROM, V15, P877, DOI 10.1039/a907603d
   Von der Hoeh N, 2006, DEUT TIERARZTL WOCH, V113, P439
   Waksman R, 2005, EUR HEART J, V26, P417
   Waksman R, 2006, J AM COLL CARDIOL, V47, p23B
   Waksman R, 2005, CIRCULATION, V112, pU539
   Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Wambach PF, 2008, J CHEM HEALTH SAF, V15, P5, DOI 10.1016/j.jchas.2008.01.012
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Wang QD, 2001, J MATER SCI, V36, P3035
   Wen CE, 2004, MATER LETT, V58, P357, DOI 10.1016/S0167-577X(03)004500-7
   WILLIAMS LR, 1989, CLIN PHYS PHYSIOL M, V10, P187, DOI 10.1088/0143-0815/10/3/001
   Wintermantel E, 2002, MEDIZINTECHNIK BIOKO
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, MATERIALWISS WERKST, V37, P504, DOI 10.1002/mawe.200600027
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   WITTE F, 2006, PROGR BIOMEDICAL OPT
   Witte F, 2008, J BIOMED MATER RES A, V86A, P1041, DOI 10.1002/jbm.a.31713
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Zhang GD, 2007, ACTA METALL SIN, V43, P1186
NR 150
TC 825
Z9 861
U1 28
U2 399
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
EI 1879-0348
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD OCT-DEC
PY 2008
VL 12
IS 5-6
BP 63
EP 72
DI 10.1016/j.cossms.2009.04.001
PG 10
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 462YD
UT WOS:000267394000001
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Smith, CD
   Masouros, S
   Hill, AM
   Wallace, AL
   Amis, AA
   Bull, AMJ
AF Smith, Christopher D.
   Masouros, Spyros
   Hill, Adam M.
   Wallace, Andrew L.
   Amis, Andrew A.
   Bull, Anthony M. J.
TI Mechanical testing of intra-articular tissues. Relating experiments to
   physiological function
SO CURRENT ORTHOPAEDICS
LA English
DT Article
DE Cartilage; Labrum; Meniscus; Ligament; Biomechanical properties; Testing
ID ANTERIOR CRUCIATE LIGAMENT; HUMAN ARTICULAR-CARTILAGE; INFERIOR
   GLENOHUMERAL LIGAMENT; IMPLANTABLE FORCE TRANSDUCER; MEDIAL COLLATERAL
   LIGAMENT; CROSS-SECTIONAL AREA; ROTATOR CUFF MUSCLES; IN-VIVO;
   KNEE-JOINT; HIP-JOINT
AB There is a wealth of data published on the biomechanical properties of intra-articular tissues. However, much of this information is not intuitively applicable to clinical practice due to both methodological disparity between studies and the relevance of the methodology used to test the biomaterial. This inevitably results in comparison difficulties with other experimental data produced for the same tissue, or indeed different tissues.
   Therefore, this review highlights the salient issues that need to be considered when trying to interpret biomechanical testing scenarios and how they influence clinical practice. As such, different testing protocols and their clinical relevance are scrutinised. The importance of recreating the physiological loading conditions and the interpretation of the functional anatomy are highlighted. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Smith, Christopher D.; Masouros, Spyros; Hill, Adam M.; Bull, Anthony M. J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.
   [Smith, Christopher D.; Masouros, Spyros; Amis, Andrew A.] Univ London Imperial Coll Sci Technol & Med, Dept Mech Engn, London, England.
   [Wallace, Andrew L.; Amis, Andrew A.] Univ London Imperial Coll Sci Technol & Med, Dept Musculoskeletal Surg, London, England.
RP Bull, AMJ (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.
EM a.bull@imperial.ac.uk
RI Masouros, Spyros/S-7151-2017; Bull, Anthony/C-2317-2008
OI Masouros, Spyros/0000-0003-1700-5548; Bull, Anthony/0000-0002-4473-8264
CR AMIS AA, 1980, J BIOMECH, V13, P765, DOI 10.1016/0021-9290(80)90238-9
   AMIS AA, 1979, J ENG MED H, P41
   ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   ASPDEN RM, 1985, J ANAT, V140, P371
   Ballard RE, 1998, J APPL PHYSIOL, V84, P1976
   Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9
   BERGMANN G, 1984, J BIOMECH, V17, P907, DOI 10.1016/0021-9290(84)90004-6
   BERGMANN G, 2006, J BIOMECH S1, V39, pS134
   BEYNNON B, 1992, INT ORTHOP, V16, P1
   Beynnon BD, 1998, J BIOMECH, V31, P519, DOI 10.1016/S0021-9290(98)00044-X
   Bull AMJ, 2005, KNEE SURG SPORT TR A, V13, P145, DOI 10.1007/s00167-004-0556-y
   BUTLER DL, 1992, J BIOMECH, V25, P511, DOI 10.1016/0021-9290(92)90091-E
   Cerulli G, 2003, KNEE SURG SPORT TR A, V11, P307, DOI 10.1007/s00167-003-0403-6
   Chae Y, 2003, LASER SURG MED, V32, P271, DOI 10.1002/lsm.10167
   CHAI BF, 1990, CHINESE MED J-PEKING, V103, P290
   Chang YW, 2000, J SHOULDER ELB SURG, V9, P188, DOI 10.1067/mse.2000.105135
   CHIMICH D, 1992, J BIOMECH, V25, P831, DOI 10.1016/0021-9290(92)90223-N
   COOPER DE, 1992, J BONE JOINT SURG AM, V74A, P46, DOI 10.2106/00004623-199274010-00007
   Daniel M, 2001, MED ENG PHYS, V23, P347, DOI 10.1016/S1350-4533(01)00051-0
   DAVY DT, 1988, J BONE JOINT SURG AM, V70A, P45, DOI 10.2106/00004623-198870010-00008
   Dennerlein JT, 1998, J BIOMECH, V31, P295, DOI 10.1016/S0021-9290(98)00006-2
   Duda GN, 1997, J BIOMECH, V30, P933, DOI 10.1016/S0021-9290(97)00057-2
   Edwards A, 2007, ARTHROSCOPY, V23, P284, DOI 10.1016/j.arthro.2006.11.005
   Elisa JJ, 2006, J BIOMECH, V39, P865, DOI 10.1016/j.jbiomech.2005.01.030
   ENGLISH TA, 1979, J BIOMED ENG     APR, P111
   Ferguson SJ, 2001, J ORTHOPAED RES, V19, P887, DOI 10.1016/S0736-0266(01)00007-9
   FISHER IA, 2000, MATH INVESTIGATION I
   FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19
   FUKASHIRO S, 1995, EUR J APPL PHYSIOL O, V71, P453, DOI 10.1007/BF00635880
   Gabrion A, 2005, SURG RADIOL ANAT, V27, P507, DOI 10.1007/s00276-005-0031-6
   GLOS DL, 1993, J BIOMECH ENG-T ASME, V115, P335, DOI 10.1115/1.2895495
   Gupte CM, 2002, J BIOMECH, V35, P1623, DOI 10.1016/S0021-9290(02)00238-5
   Hara H, 1996, J Shoulder Elbow Surg, V5, P263, DOI 10.1016/S1058-2746(96)80052-8
   Haut TL, 1997, J BIOMECH, V30, P79, DOI 10.1016/S0021-9290(96)00108-X
   Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2
   HIROTANI H, 1975, Anatomischer Anzeiger, V138, P29
   HODGE WA, 1989, J BONE JOINT SURG AM, V71A, P1378, DOI 10.2106/00004623-198971090-00015
   HOERNING EK, 2005, J BONE JOINT SURG S1, V87, pC162
   HOLDEN JP, 1994, J BIOMECH, V27, P517, DOI 10.1016/0021-9290(94)90063-9
   Huang CY, 2005, J BIOMECH, V38, P799, DOI 10.1016/j.jbiomech.2004.05.006
   Hughes HE, 1996, BEHAV BRAIN RES, V75, P83, DOI 10.1016/0166-4328(96)00175-1
   Iglic Ales, 2002, Comput Methods Biomech Biomed Engin, V5, P185, DOI 10.1080/10255840290010300
   Jurvelin J S, 2003, Proc Inst Mech Eng H, V217, P215, DOI 10.1243/095441103765212712
   Juul-Kristensen B, 2000, CELLS TISSUES ORGANS, V167, P214, DOI 10.1159/000016784
   KAPITONOVA MY, 2003, J PATHOL, V25, P15
   KEATING JF, 1993, J BONE JOINT SURG BR, V75, P137
   KEMPSON GE, 1968, NATURE, V220, P1127, DOI 10.1038/2201127b0
   KENNEDY JC, 1976, J BONE JOINT SURG AM, V58, P350, DOI 10.2106/00004623-197658030-00009
   KIM YT, 1995, CLIN ORTHOP RELAT R, P176
   Lechner K, 2000, J ORTHOPAED RES, V18, P945, DOI 10.1002/jor.1100180614
   Lee TQ, 1999, CLIN BIOMECH, V14, P471, DOI 10.1016/S0268-0033(99)00007-8
   Leslie BW, 2000, P I MECH ENG H, V214, P631, DOI 10.1243/0954411001535651
   Lisi AJ, 2006, J APPL BIOMECH, V22, P234, DOI 10.1123/jab.22.3.234
   McGibbon CA, 1997, ARTHRIT CARE RES, V10, P300, DOI 10.1002/art.1790100504
   McMahon PJ, 1999, J BONE JOINT SURG BR, V81B, P406, DOI 10.1302/0301-620X.81B3.9153
   McMahon PJ, 2001, J SHOULDER ELB SURG, V10, P482, DOI 10.1067/mse.2001.116870
   MERKEL KHH, 1980, ARCH ORTHOP TRAUM SU, V97, P185, DOI 10.1007/BF00389725
   Mine T, 2000, ARCH ORTHOP TRAUM SU, V120, P201, DOI 10.1007/s004020050044
   Montella Andrea, 1992, Archivio Italiano di Anatomia e di Embriologia, V97, P1
   Muehleman C, 2004, OSTEOARTHR CARTILAGE, V12, P97, DOI 10.1016/j.joca.2003.10.001
   NEURATH M, 1992, UNFALLCHIRURG, V95, P17
   Nishida K, 1996, J Shoulder Elbow Surg, V5, P132, DOI 10.1016/S1058-2746(96)80008-5
   NOYES FR, 1984, J BONE JOINT SURG AM, V66A, P344, DOI 10.2106/00004623-198466030-00005
   OZKAYA N, 1999, FUNDAMENTALS BIOMECH, P125
   Park S, 1999, GAIT POSTURE, V10, P211, DOI 10.1016/S0966-6362(99)00033-8
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   Petersen W, 2003, ARCH ORTHOP TRAUM SU, V123, P283, DOI 10.1007/s00402-003-0527-7
   Petersen W, 1998, ANAT EMBRYOL, V197, P317, DOI 10.1007/s004290050141
   Pioletti DP, 1999, MED ENG PHYS, V21, P95, DOI 10.1016/S1350-4533(99)00028-4
   Provenzano PP, 2002, J APPL PHYSIOL, V92, P362
   Putz R, 1998, ORTHOPADE, V27, P675, DOI 10.1007/PL00003452
   Race A, 2000, SPINE, V25, P662, DOI 10.1097/00007632-200003150-00003
   REEVES B, 1968, Journal of Bone and Joint Surgery British Volume, V50-B, P858
   Robinson JR, 2005, J BIOMECH, V38, P1067, DOI 10.1016/j.jbiomech.2004.05.034
   Schatzmann L, 1998, Knee Surg Sports Traumatol Arthrosc, V6 Suppl 1, pS56, DOI 10.1007/s001670050224
   Seldes RM, 2001, CLIN ORTHOP RELAT R, P232
   Shepherd DET, 1999, RHEUMATOLOGY, V38, P124, DOI 10.1093/rheumatology/38.2.124
   Shepherd DET, 1997, P I MECH ENG H, V211, P155, DOI 10.1243/0954411971534278
   TISSAKHT M, 1995, J BIOMECH, V28, P411, DOI 10.1016/0021-9290(94)00081-E
   Toshiaki A, 2005, ACTA ORTHOP, V76, P509, DOI 10.1080/17453670510041493
   VANGSNESS CT, 1995, ARTHROSCOPY, V11, P180, DOI 10.1016/0749-8063(95)90064-0
   VIIDIK A, 1972, Z ANAT ENTWICKLUNGS, V136, P204, DOI 10.1007/BF00519178
   Wilke HJ, 2001, CLIN BIOMECH, V16, pS111, DOI 10.1016/S0268-0033(00)00103-0
   Wren TAL, 2003, ANN BIOMED ENG, V31, P710, DOI 10.1114/1.1569267
   XU WS, 1992, J BIOMECH ENG-T ASME, V114, P170, DOI 10.1115/1.2891368
   Zhao D, 2007, J ORTHOP RES, V25, P593, DOI 10.1002/jor.20362
NR 86
TC 5
Z9 6
U1 0
U2 8
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0268-0890
J9 CURR ORTHOPAED
JI Curr. Orthop.
PD OCT
PY 2008
VL 22
IS 5
BP 341
EP 348
DI 10.1016/j.cuor.2008.07.010
PG 8
WC Orthopedics
SC Orthopedics
GA 386JP
UT WOS:000261879800005
DA 2018-10-20
ER

PT J
AU Balamurugan, A
   Balossier, G
   Laurent-Maquin, D
   Pina, S
   Rebelo, AHS
   Faure, J
   Ferreira, JMF
AF Balamurugan, A.
   Balossier, G.
   Laurent-Maquin, D.
   Pina, S.
   Rebelo, A. H. S.
   Faure, J.
   Ferreira, J. M. F.
TI An in vitro biological and anti-bacterial study on a sol-gel derived
   silver-incorporated bioglass system
SO DENTAL MATERIALS
LA English
DT Article
DE sol-gel; bacteriostatic; silver; biomaterial
ID BIOACTIVE GLASS; SURFACE; TISSUE; COMPOSITES; BACTERIA; IONS; CELL
AB Objectives. The purpose of this study was to evaluate the in vitro antibacterial and biological activity of silver-incorporated bioactive glass system SiO2-CaO-P2O5-Ag2O (AgBG). The bacteriostatic and bactericidal proper-ties of this new quaternary glass system along with the ternary sol-gel glass system SiO2-CaO-P2O5 (BG) have been studied using Escherichia coli as a test micro-organism. The AGBG system thus appears to be a promising material for dental applications, since similar effects might be produced on a film of bacteria and mucous that grows on the teeth.
   Methods. The SiO2-CaO-P2O5-Ag2O and SiO2-CaO-P2O5 glass systems were synthesized by the sol-gel technique and characterized for their physicho-chemical properties. The antibacterial activity and biological properties were evaluated by determining the minimum inhibitory concentrations (MICs). Release of Ag+ into the culture medium was measured by inductively coupled plasma (ICP) analysis.
   Results. The in vitro antibacterial action of the SiO2-CaO-P2O5-Ag2O was compared with that of its ternary counterpart glass system. The concentrations of Ag-bioglass, in the range of 0.02-0.20 mg of Ag-bioglass per millilitre of culture medium, were found to inhibit the growth of these bacteria. The Ag-bioglass not only acts bacteriostatically but it also elicited a rapid bactericidal action. A complete bactericidal effect was elicited in the early stages of the incubation at Ag-bioglass concentration of 20mg/ml and the ternary glass system had no effect on bacterial growth or viability. The antibacterial action of Ag-bioglass was exclusively attributed to the leaching of Ag+ ions from the glass matrix.
   Significance. One of the major advantages of incorporating silver ions into a gel glass system is that the porous glass matrix can allow for controlled sustained delivery of the antibacterial agent to dental material, used even under anaerobic conditions such as deep in the periodontal pocket. This glass system also provides long-term action required for systems which are constantly at risk of microbial contamination. (C) 2008 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Balamurugan, A.; Pina, S.; Rebelo, A. H. S.; Ferreira, J. M. F.] Univ Aveiro, Dept Ceram & Glass Engn, CICECO, P-3810193 Aveiro, Portugal.
   [Balossier, G.; Faure, J.] Univ Reims, INSERM, Lab Microscopie Elect Analyt, ERM 0203, F-51685 Reims 2, France.
   [Laurent-Maquin, D.] Univ Reims, INSERM, ERM 0203, F-51096 Reims 2, France.
RP Ferreira, JMF (reprint author), Univ Aveiro, Dept Ceram & Glass Engn, CICECO, P-3810193 Aveiro, Portugal.
EM jmf@cv.ua.pt
RI Pina, Sandra/H-8133-2013
OI Pina, Sandra/0000-0002-4361-1253; Ferreira, Jose/0000-0002-7520-2809
FU CICECO; INSERM ERM0203; University of Reims, France
FX The work was supported by CICECO, University of Aveiro, Portugal. The
   authors would like to acknowledge the support and technical assistance
   of L. Wortham and S. Bouthors INSERM ERM0203, Centre for Bioactive
   Materials and Tissue Engineering, University of Reims, France.
CR Adams AP, 1999, VET SURG, V28, P219, DOI 10.1053/jvet.1999.0219
   *AM SOC MICR, 1981, MAN METH GEN BACT
   [Anonymous], 92771995E ISO
   Balabas MV, 2007, NAT PHYS, V3, P2, DOI 10.1038/nphys496
   Blaker JJ, 2004, BIOMATERIALS, V25, P1319, DOI 10.1016/j.biomaterials.2003.08.007
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   CARLISLE EM, 1996, SILICON BIOCH, P123
   CHU CS, 1988, J TRAUMA, V28, P1488, DOI 10.1097/00005373-198810000-00016
   DEITCH EA, 1987, J TRAUMA, V27, P301
   Efrima S, 1998, J PHYS CHEM B, V102, P5947, DOI 10.1021/jp9813903
   FILGUEIRAS MR, 1993, J BIOMED MATER RES, V27, P445, DOI 10.1002/jbm.820270405
   George N, 1997, BURNS, V23, P493, DOI 10.1016/S0305-4179(97)00047-8
   Gillam DG, 2002, J ORAL REHABIL, V29, P305, DOI 10.1046/j.1365-2842.2002.00824.x
   Grier N., 1983, DISINFECTION STERILI
   Hattar S, 2005, BIOMATERIALS, V26, P839, DOI 10.1016/j.biomaterials.2004.03.026
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hench LL, 1998, J SOL-GEL SCI TECHN, V13, P245, DOI 10.1023/A:1008643303888
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lee BS, 2005, DENT MATER J, V24, P562, DOI 10.4012/dmj.24.562
   Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x
   Marcolongo M, 1998, J BIOMED MATER RES, V39, P161, DOI 10.1002/(SICI)1097-4636(199801)39:1<161::AID-JBM18>3.0.CO;2-I
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Perez-Pariente J, 1999, J BIOMED MATER RES, V47, P170, DOI 10.1002/(SICI)1097-4636(199911)47:2<170::AID-JBM6>3.0.CO;2-J
   Saravanapavan P, 2004, KEY ENG MATER, V254-2, P1087, DOI 10.4028/www.scientific.net/KEM.254-256.1087
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   Sepulveda P, 2001, J BIOMED MATER RES, V58, P734, DOI 10.1002/jbm.10026
   SILHAVY TJ, 1984, EXPT GENE FUSION
   Slawson R M, 1990, Biol Met, V3, P151, DOI 10.1007/BF01140573
   SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217
   Stamboulis AG, 2002, ADV ENG MATER, V4, P105, DOI 10.1002/1527-2648(200203)4:3<105::AID-ADEM105>3.3.CO;2-C
   THOMPSON M, 1989, HDB INDUCTIVELY COUP
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   WELLS TNC, 1995, BIOCHEMISTRY-US, V34, P7896, DOI 10.1021/bi00024a014
   Zamet JS, 1997, J CLIN PERIODONTOL, V24, P410, DOI 10.1111/j.1600-051X.1997.tb00205.x
NR 38
TC 141
Z9 148
U1 2
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD OCT
PY 2008
VL 24
IS 10
BP 1343
EP 1351
DI 10.1016/j.dental.2008.02.015
PG 9
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 350NQ
UT WOS:000259359800008
PM 18405962
DA 2018-10-20
ER

PT J
AU Lattanzi, W
   Parrilla, C
   Fetoni, A
   Logroscino, G
   Straface, G
   Pecorini, G
   Stigliano, E
   Tampieri, A
   Bedini, R
   Pecci, R
   Michetti, F
   Gambotto, A
   Robbins, PD
   Pola, E
AF Lattanzi, W.
   Parrilla, C.
   Fetoni, A.
   Logroscino, G.
   Straface, G.
   Pecorini, G.
   Stigliano, E.
   Tampieri, A.
   Bedini, R.
   Pecci, R.
   Michetti, F.
   Gambotto, A.
   Robbins, P. D.
   Pola, E.
TI Ex vivo-transduced autologous skin fibroblasts expressing human Lim
   mineralization protein-3 efficiently form new bone in animal models
SO GENE THERAPY
LA English
DT Article
DE LMP; autologous transplantation; skin fibroblasts; bone formation;
   animal models
ID MARROW STROMAL CELLS; REGIONAL GENE-THERAPY; MUSCLE-DERIVED CELLS;
   IN-VIVO; STEM-CELLS; OSTEOBLAST DIFFERENTIATION; COMPUTED-TOMOGRAPHY;
   VITRO; REGENERATION; LMP-1
AB Local gene transfer of the human Lim mineralization protein (LMP), a novel intracellular positive regulator of the osteoblast differentiation program, can induce efficient bone formation in rodents. To develop a clinically relevant gene therapy approach to facilitate bone healing, we have used primary dermal fibroblasts transduced ex vivo with Ad. LMP-3 and seeded on a hydroxyapatite/collagen matrix prior to autologous implantation. Here, we demonstrate that genetically modified autologous dermal fibroblasts expressing Ad. LMP-3 are able to induce ectopic bone formation following implantation of the matrix into mouse triceps and paravertebral muscles. Moreover, implantation of the Ad. LMP-3-modified dermal fibroblasts into a rat mandibular bone critical size defect model results in efficient healing, as determined by X-rays, histology and three-dimensional microcomputed tomography (3DmCT). These results demonstrate the effectiveness of the non-secreted intracellular osteogenic factor LMP-3 in inducing bone formation in vivo. Moreover, the utilization of autologous dermal fibroblasts implanted on a biomaterial represents a promising approach for possible future clinical applications aimed at inducing new bone formation.
C1 [Lattanzi, W.; Michetti, F.] Univ Cattolica Sacro Cuore, Dept Anat & Cell Biol, I-168 Rome, Italy.
   [Parrilla, C.; Fetoni, A.] Univ Cattolica Sacro Cuore, Dept Otolaryngol, I-168 Rome, Italy.
   [Logroscino, G.; Pola, E.] Univ Cattolica Sacro Cuore, Dept Orthopaed, Sch Med, I-168 Rome, Italy.
   [Straface, G.; Pecorini, G.] Univ Cattolica Sacro Cuore, Dept Internal Med, Sch Med, I-168 Rome, Italy.
   [Stigliano, E.] Univ Cattolica Sacro Cuore, Dept Pathol, Sch Med, I-168 Rome, Italy.
   [Tampieri, A.] CNR Natl Res Council, Dept Sci & Technol Ceram ISTEC, Faenza, Italy.
   [Bedini, R.; Pecci, R.] Ist Super Sanita, Technol & Hlth Dept, I-00161 Rome, Italy.
   [Michetti, F.] Latium Musculoskeletal Tissue Bank, Rome, Italy.
   [Gambotto, A.; Robbins, P. D.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA USA.
RP Pola, E (reprint author), Univ Cattolica Sacro Cuore, Dept Orthopaed & Traumatol, Sch Med, Lgo Gemelli 8, I-168 Rome, Italy.
EM enrico.pola@rm.unicatt.it
RI Bedini, Rossella/B-2465-2013; Pecci, Raffaella/B-2508-2013
OI FETONI, ANNA RITA/0000-0001-5405-4301; LOGROSCINO,
   GIANDOMENICO/0000-0003-1301-5343; Bedini, Rossella/0000-0002-0830-6632
FU Italian Society of Orthopaedics and Traumatology
FX Enrico Pola was supported by a grant of the Italian Society of
   Orthopaedics and Traumatology. We thank Kaori Okada and Sun Huijie
   (Department of Surgery, University of Pittsburgh School of Medicine,
   Pittsburgh, PA, USA), and Alessandro Sbriccoli (Institute of Anatomy and
   Cell Biology, Universita` Cattolica del Sacro Cuore, Rome, Italy), for
   their invaluable technical assistance.
CR Baltzer AWA, 2000, CLIN ORTHOP RELAT R, pS120
   Blum JS, 2003, HUM GENE THER, V14, P1689, DOI 10.1089/104303403322611719
   Boden SD, 1998, SPINE, V23, P2486, DOI 10.1097/00007632-199812010-00003
   Boden SD, 1998, ENDOCRINOLOGY, V139, P5125, DOI 10.1210/en.139.12.5125
   Chang SCN, 2003, GENE THER, V10, P2013, DOI 10.1038/sj.gt.3302106
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Gugala Z, 2003, GENE THER, V10, P1289, DOI 10.1038/sj.gt.3302006
   Hirata K, 2003, BONE, V32, P502, DOI 10.1016/S8756-3282(03)00054-1
   Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Lattanzi W, 2005, Eur Rev Med Pharmacol Sci, V9, P167
   Lee JY, 2002, HUM GENE THER, V13, P1201, DOI 10.1089/104303402320138989
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Liu YS, 2002, J BONE MINER RES, V17, P406, DOI 10.1359/jbmr.2002.17.3.406
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005
   Minamide A, 2003, J BONE JOINT SURG AM, V85A, P1030, DOI 10.2106/00004623-200306000-00007
   Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Nussenbaum B, 2003, HUM GENE THER, V14, P1107, DOI 10.1089/104303403322124819
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Pola E, 2004, GENE THER, V11, P683, DOI 10.1038/sj.gt.3302207
   Rutherford RB, 2002, TISSUE ENG, V8, P441, DOI 10.1089/107632702760184709
   Sangadala S, 2006, J BIOL CHEM, V281, P17212, DOI 10.1074/jbc.M511013200
   SASOV AY, 1987, J MICROSC-OXFORD, V147, P169, DOI 10.1111/j.1365-2818.1987.tb02829.x
   Shen HC, 2004, BONE, V34, P982, DOI 10.1016/j.bone.2004.01.028
   Sugiyama O, 2005, MOL THER, V11, P390, DOI 10.1016/j.ymthe.2004.10.019
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Tsuda H, 2005, J GENE MED, V7, P1322, DOI 10.1002/jgm.777
   Viggeswarapu M, 2001, J BONE JOINT SURG AM, V83A, P364, DOI 10.2106/00004623-200103000-00008
   Wang JC, 2003, J BONE JOINT SURG AM, V85A, P905, DOI 10.2106/00004623-200305000-00020
   Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944
   Yang M, 2005, CYTOTHERAPY, V7, P273, DOI 10.1080/14653240510027244
   Yoon ST, 2004, SPINE, V29, P2603, DOI 10.1097/01.brs.0000146103.94600.85
   Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332
   Zhang XS, 2004, J GENE MED, V6, P4, DOI 10.1002/jgm.477
NR 38
TC 42
Z9 46
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0969-7128
J9 GENE THER
JI Gene Ther.
PD OCT
PY 2008
VL 15
IS 19
BP 1330
EP 1343
DI 10.1038/gt.2008.116
PG 14
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Research & Experimental Medicine
GA 348PN
UT WOS:000259222500005
PM 18633445
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Weir, C
   Morel-Kopp, MC
   Gill, A
   Tinworth, K
   Ladd, L
   Hunyor, SN
   Ward, C
AF Weir, Christopher
   Morel-Kopp, Marie-Christine
   Gill, Anthony
   Tinworth, Kellie
   Ladd, Leigh
   Hunyor, Stephen N.
   Ward, Christopher
TI Mesenchymal stem cells: Isolation, characterisation and in vivo
   fluorescent dye tracking
SO HEART LUNG AND CIRCULATION
LA English
DT Article
DE mesenchymal stem cells (MSC); CM-DiI; cell division and differentiation;
   sheep; biomaterials; scaffold
ID BONE-MARROW; MULTILINEAGE DIFFERENTIATION; TRANSPLANTATION;
   CARDIOMYOCYTES; MYOCARDIUM; DISEASE; REPAIR; HEART
AB Cell therapies have been used to regenerate the heart by direct myocardial delivery, by coronary infusion and by surface attached scaffolds. Multipotent mesenchymal stem cells (MSC) with capacity to differentiate into cardiomyocytes and other cell lines have been predominantly trialled in rodents. However, large animal models are increasingly needed to translate basic research into new, safe regenerative therapies. Understanding the mode of action of cell therapies in the mammalian heart has been limited by cell tracking capability. This study examined the ability to track the fate of allogeneic MSC in sheep using various fluorescent dyes.
   MSC isolated from sheep bone marrow were grown in culture following extraction and flow cytometric characterisation. After labelling with fluorescent tracking dyes (e.g. CFSE and DiI) cells were tested for in vitro and in vivo signal up to six weeks. Labelling effect on cell division and differentiation was studied.
   Several dyes lost fluorescence and slowed cell division. However, the thiol reactive dye CM-DiI showed detectable in vivo fluorescence in labelled MSC six weeks after injection into sheep skeletal muscle and two weeks after implantation of an MSC coated biomaterial scaffold. CM-DiI labelled MSC differentiated in vitro showed label retention over four weeks.
   The fluorescent membrane dye CM-DiI tracks implanted sheep MSC and provides an alternative to traditional cell markers such as gene modified GFP.
C1 [Hunyor, Stephen N.] Univ Sydney, Royal N Shore Hosp, Cardiac Technol Ctr, Dept Cardiol, Sydney, NSW 2065, Australia.
   [Weir, Christopher; Tinworth, Kellie; Ladd, Leigh; Hunyor, Stephen N.] Kolling Inst, Sydney, NSW, Australia.
   [Weir, Christopher; Morel-Kopp, Marie-Christine; Ward, Christopher] Northern Blood Res Ctr, Sydney, NSW, Australia.
   [Weir, Christopher; Morel-Kopp, Marie-Christine; Ward, Christopher] St Vincents Hosp, Dept Haematol, Sydney, NSW 2010, Australia.
   [Gill, Anthony] Dept Anat Pathol, Sydney, NSW, Australia.
RP Hunyor, SN (reprint author), Univ Sydney, Royal N Shore Hosp, Cardiac Technol Ctr, Dept Cardiol, Sydney, NSW 2065, Australia.
EM stephenh@med.usyd.edu.au
RI Gill, Anthony/D-4215-2015; Morel-Kopp, Marie-Christine/A-7470-2015
OI Gill, Anthony/0000-0002-9447-1967; Morel-Kopp,
   Marie-Christine/0000-0003-4795-1746; Ladd, Leigh/0000-0001-5997-9637
FU North Shore Heart Research Foundation [13-04/05]
FX This project was supported by North Shore Heart Research Foundation
   Grant # 13-04/05.
CR Bosnakovski D, 2005, CELL TISSUE RES, V319, P243, DOI 10.1007/s00441-004-1012-5
   Choi D, 2002, J NEUROSCI METH, V117, P167, DOI 10.1016/S0165-0270(02)00098-5
   Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937
   Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x
   Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369
   Hassink RJ, 2003, J AM COLL CARDIOL, V41, P711, DOI 10.1016/S0735-1097(02)02933-9
   HAUGLAND R, 2005, MOL PROBES INVITROGE, P670
   Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488
   Kovacic JC, 2005, INTERN MED J, V35, P348, DOI 10.1111/j.1445-5994.2005.00840.x
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004
   LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Piao H, 2005, EUR J HEART FAIL, V7, P730, DOI 10.1016/j.ejheart.2004.09.019
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Povysil C, 2005, Cesk Patol, V41, P133
   Rhodes NP, 2004, J MATER SCI-MATER M, V15, P391, DOI 10.1023/B:JMSM.0000021108.74004.7e
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034
   Weber A, 2004, EUR J CARDIO-THORAC, V26, P137, DOI 10.1016/j.ejcts.2004.03.024
   Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730
NR 22
TC 67
Z9 76
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1443-9506
J9 HEART LUNG CIRC
JI Heart Lung Circ.
PD OCT
PY 2008
VL 17
IS 5
BP 395
EP 403
DI 10.1016/j.hlc.2008.01.006
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 350MK
UT WOS:000259356400008
PM 18396458
DA 2018-10-20
ER

PT J
AU Hoover-Plow, JL
   Gong, Y
   Shchurin, A
   Busuttil, SJ
   Schneeman, TA
   Hart, E
AF Hoover-Plow, J. L.
   Gong, Y.
   Shchurin, A.
   Busuttil, S. J.
   Schneeman, T. A.
   Hart, E.
TI Strain and model dependent differences in inflammatory cell recruitment
   in mice
SO INFLAMMATION RESEARCH
LA English
DT Article
DE Leukocyte recruitment; Peritoneal inflammation; Inbred mouse strains;
   Metalloproteinase-9; Cytokines
ID INDUCED AIRWAY INFLAMMATION; MATRIX METALLOPROTEINASES; MURINE MODEL;
   MATRIX-METALLOPROTEINASE-9; PLASMINOGEN; RESPONSES; BIOMATERIALS;
   POLYMORPHISMS; INFILTRATION; PATHOGENESIS
AB Objective and design: The objective of this study was to determine genetic differences in inflammation in these distinct inbred mouse strains.
   Methods: Peritoneal leukocyte recruitment, matrix metalloproteinases and cytokines were quantified in A/J, 129/svJ, C57BL/6J. using thioglycollate or biomaterial implants as inflammatory stimuli.
   Results: In response to thioglycollate, A/J had significant decreases compared to C57BL/6J in both neutrophil (86%) and macrophage (62%) recruitment, and 129/svJ had a significant (43%) decrease compared to C57BL/6J in macrophage recruitment. The reduced leukocyte recruitment corresponded to reduced matrix metalloproteinase-9. In the bioimplant model, 129/svJ had a 2-fold increase in neutrophil and macrophage recruitment compared to C57BL/6J, and the increased leukocyte recruitment corresponded to elevated cytok-ines, monocyte inhibitory protein-2 and monocyte chemoattractant protein-1, in the lavage compared to the values for C57BL/6J.
   Conclusion: Not only was leukocyte recruitment strain dependent, but the three strains had marked differences in metalloproteinases and cytokine response. In addition, there were model specific differences in the metalloproteinase and cytokine response to the two inflammatory stimuli. Thus, inflammatory cell recruitment is genetically determined and stimulus specific and may determine the susceptibility to complex diseases.
C1 [Hoover-Plow, J. L.; Gong, Y.; Hart, E.] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc Med, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA.
   [Hoover-Plow, J. L.; Gong, Y.; Hart, E.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA.
   [Busuttil, S. J.] Div Vasc Surg, Baltimore, MD 21201 USA.
   [Schneeman, T. A.] Cleveland Publ Sch, Cleveland, OH 44114 USA.
   [Shchurin, A.] Oakwood Hlth Care Syst, Med Educ Int Med, Dearborn, MI 48133 USA.
RP Hoover-Plow, JL (reprint author), Cleveland Clin, Lerner Res Inst, Dept Cardiovasc Med, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM hooveri@ccf.org
FU NIH [T32 HL07914, H1.17964, HL65205, HL078701]
FX The authors thank Dr. Edward Plow for his helpful discussion and review
   of the manuscript and Dr. Yelena Shchurina for assistance with the
   thioglycollate model, and R. Lewis and N. Klimczak for assistance with
   manuscript preparation. This study was supported by Prants from NIH. T32
   HL07914 (AS). H1.17964, HL65205, HL078701 Julp).
CR Abou-Raya A, 2006, AUTOIMMUN REV, V5, P331, DOI 10.1016/j.autrev.2005.12.006
   Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR
   Betsuyaku T, 1999, AM J RESP CELL MOL, V20, P1303, DOI 10.1165/ajrcmb.20.6.3558
   Bhatt DL, 2003, AM J CARDIOL, V92, P136, DOI 10.1016/S0002-9149(03)00527-7
   Bjarnadottir K, 2006, ATHEROSCLEROSIS, V188, P341, DOI 10.1016/j.atherosclerosis.2005.11.014
   Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x
   CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0
   Cataldo DD, 2002, AM J PATHOL, V161, P491, DOI 10.1016/S0002-9440(10)64205-8
   Delano DL, 2005, INFLAMMATION, V29, P1, DOI 10.1007/s10753-006-8962-6
   Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103
   GREENBERGER MJ, 1995, J IMMUNOL, V155, P722
   HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022
   Hoover-Plow Jane, 2006, BMC Blood Disord, V6, P6, DOI 10.1186/1471-2326-6-6
   Imahara Scott D, 2004, Curr Opin Crit Care, V10, P318, DOI 10.1097/01.ccx.0000140942.42247.7e
   Kolaczkowska E, 2006, IMMUNOBIOLOGY, V211, P137, DOI 10.1016/j.imbio.2005.08.004
   Kurzawski M, 2005, INT J IMMUNOGENET, V32, P285, DOI 10.1111/j.1744-313X.2005.00524.x
   Liu Z, 2005, J CLIN INVEST, V115, P879, DOI 10.1172/JCI200523977
   Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601
   McMillan SJ, 2004, J IMMUNOL, V172, P2586, DOI 10.4049/jimmunol.172.4.2586
   NADEAU JH, 1995, J INFLAMM, V45, P27
   Nakashima K, 2006, BIOCHEM BIOPH RES CO, V344, P300, DOI 10.1016/j.bbrc.2006.03.102
   Natividad A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-40
   Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001
   Ploplis VA, 1998, BLOOD, V91, P2005
   Ramos CDL, 2006, EUR J IMMUNOL, V36, P2025, DOI 10.1002/eji.200636057
   Renckens R, 2006, J IMMUNOL, V176, P3735, DOI 10.4049/jimmunol.176.6.3735
   Roche JK, 2007, AM J PATHOL, V170, P526, DOI 10.2353/ajpath.2007.060366
   Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 2002, J BIOMED MATER RES, V62, P471, DOI 10.1002/jbm.10271
   Tarlton JF, 2000, AM J PATHOL, V157, P1927, DOI 10.1016/S0002-9440(10)64831-6
   TORRES JL, 1988, ARCH BIOCHEM BIOPHYS, V267, P271, DOI 10.1016/0003-9861(88)90032-X
   Van den Steen PE, 2001, BBA-GEN SUBJECTS, V1528, P61, DOI 10.1016/S0304-4165(01)00190-8
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869
NR 36
TC 19
Z9 19
U1 0
U2 1
PU BIRKHAUSER VERLAG AG
PI BASEL
PA VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND
SN 1023-3830
J9 INFLAMM RES
JI Inflamm. Res.
PD OCT
PY 2008
VL 57
IS 10
BP 457
EP 463
DI 10.1007/s00011-008-7062-5
PG 7
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA 387XL
UT WOS:000261984800003
PM 18827970
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Dubois, G
   Segers, VFM
   Bellamy, V
   Sabbah, L
   Peyrard, S
   Bruneval, P
   Hagege, AA
   Lee, RT
   Menasche, P
AF Dubois, Gilbert
   Segers, Vincent F. M.
   Bellamy, Valerie
   Sabbah, Laurent
   Peyrard, Severine
   Bruneval, Patrick
   Hagege, Albert A.
   Lee, Richard T.
   Menasche, Philippe
TI Self-assembling peptide nanofibers and skeletal myoblast transplantation
   in infarcted myocardium
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE allogeneic cell; cardiac tissue engineering; cell proliferation; muscle;
   peptide; scaffold
ID DELIVERY; SCAFFOLDS; HEART
AB Cell transplantation is currently limited by poor graft retention and survival in the postinfarction scar. Because this issue could potentially be addressed by embedding cells in bioinjectable scaffolds and boosting cell survival pathways, we induced a myocardial infarction in 72 rats to assess the effects of different self-assembling peptides with or without platelet-derived growth factor (PDGF-BB) on survival of transplanted skeletal myoblasts. Two weeks after coronary artery ligation, rats were randomized to receive in-scar injections of culture medium (controls, n = 11), self-assembling peptide (RAD16-I) nanofibers (NF, n = 9), skeletal myoblasts (it = 12), or skeletal myoblasts in combination with NF (n = 8). In separate experiments with different self-assembling peptides (RAD16-II), rats received in-scar injections of culture medium (controls, n = 6), skeletal myoblasts (n = 10), PDGF-loaded peptides (n = 7), or skeletal myoblasts (5 X 106) in combination with PDGF-loaded peptides (n = 9). After I month, left ventricullar function, as assessed by echocardiography, was not improved in either of the experimental groups compared with controls. This correlated with the failure of RAD16-I peptides or PDGF-loaded RAD16-II peptides to improve myoblast survival despite a greater angiogenesis. In vitro experiments confirmed that the number of myoblasts decreased over time when seeded on nanofiber gels. These data suggest that the optimal use of biomaterial scaffolds for survival of transplanted cells will require specific tailoring of the biomaterial to the cell type. (C) 2008 Wiley Periodicals, Inc.
C1 [Sabbah, Laurent; Hagege, Albert A.; Menasche, Philippe] INSERM, Lab Biosurg Res, U633, F-75015 Paris, France.
   [Dubois, Gilbert] AP HP, Ecole Chirurg, F-75005 Paris, France.
   [Segers, Vincent F. M.; Lee, Richard T.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Cardiovasc Div,Dept Med, Boston, MA 02115 USA.
   [Bellamy, Valerie] INSERM, Lab Biosurg Res, U633, F-75014 Paris, France.
   [Sabbah, Laurent; Hagege, Albert A.] Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, F-75015 Paris, France.
   [Sabbah, Laurent; Bruneval, Patrick; Hagege, Albert A.; Menasche, Philippe] Univ Paris 05, Fac Med, Paris, France.
   [Peyrard, Severine] Hop Europeen Georges Pompidou, AP HP, Epidemiol & Clin Res Unit, F-75015 Paris, France.
   [Peyrard, Severine] INSERM, CIE4, F-75015 Paris, France.
   [Bruneval, Patrick] Hopital Europeen Georges Pompiclou, AP HP, Dept Pathol, F-75015 Paris, France.
   [Bruneval, Patrick] INSERM, U430, F-75015 Paris, France.
   [Menasche, Philippe] Hop Europeen Georges Pompidou, AP HP, Dept Cardiovasc Surg, F-75015 Paris, France.
RP Menasche, P (reprint author), INSERM, Lab Biosurg Res, U633, F-75015 Paris, France.
EM philippe.menasche@egp.aphp.fr
OI HAGEGE, Albert/0000-0003-4685-6077; Segers, Vincent/0000-0001-7796-2222
FU Research Foundation - Flanders (FWO); Belgian American Educational
   Foundation; National Heart, Lung, and Blood Institute; LeDucq Foundation
   (CaPTAA network)
FX Research Foundation - Flanders (FWO); Belgian American Educational
   Foundation; National Heart, Lung, and Blood Institute; LeDucq Foundation
   (CaPTAA network)
CR Azarnoush K, 2005, J THORAC CARDIOV SUR, V130, P173, DOI 10.1016/j.jtcvs.2004.11.044
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Edelberg JM, 2002, CIRCULATION, V105, P608, DOI 10.1161/hc0502.103672
   Gelain F, 2007, J NANOSCI NANOTECHNO, V7, P424, DOI 10.1166/jnn.2007.154
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Maurel A, 2005, TRANSPLANTATION, V80, P660, DOI 10.1097/01.tp.0000172178.35488.31
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Segers VFM, 2007, DRUG DISCOV TODAY, V12, P561, DOI 10.1016/j.drudis.2007.05.003
   Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
NR 15
TC 42
Z9 42
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2008
VL 87B
IS 1
BP 222
EP 228
DI 10.1002/jbm.b.31099
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 350CA
UT WOS:000259328900029
PM 18386833
DA 2018-10-20
ER

PT J
AU Abraham, LC
   Zuena, E
   Perez-Ramirez, B
   Kaplan, DL
AF Abraham, Leah C.
   Zuena, Erin
   Perez-Ramirez, Bernardo
   Kaplan, David L.
TI Guide to collagen characterization for biomaterial studies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE collagen; characterization; denatured; structure; biomaterials
ID DIFFERENTIAL SCANNING CALORIMETRY; ATOMIC-FORCE MICROSCOPY; IN-VITRO
   CHARACTERIZATION; HUMAN-DIPLOID FIBROBLASTS; MARROW STROMAL CELLS;
   CIRCULAR-DICHROISM; AMINO-ACIDS; THERMAL-STABILITY; TRIPLE-HELIX;
   QUANTITATIVE-ANALYSIS
AB The structure and remodeling of collagen in vivo is critical to the pathology and healing of many human diseases, as well as to normal tissue development and regeneration. In addition, collagen matrices in the form of fibers, coatings, and films are used extensively in biomaterial and biomedical applications. The specific properties of these matrices, both in terms of physical and chemical characteristics, have a direct impact on cellular adhesion, spreading, and proliferation rates, and ultimately on the rate and extent of new extracellular matrix formation in vitro or in vivo. In recent studies, it has also been shown that collagen matrix structure has a major impact on cell and tissue outcomes related to cellular aging and differentiation potential. Collagen structure is complex because of both diversity of source materials, chemistry, and structural hierarchy. With such significant impact of collagen features on biological outcomes, it becomes essential to consider an appropriate set of analytical tools, or guide, so that collagens attained from commercial vendors are characterized in a comparative manner as an integral part of studies focused on biological parameters. The analysis should include as a starting point: (a) structural detail-mainly focused on molecular mass, purity, helical content, and bulk thermal properties, (b) chemical features-mainly focused on surface elemental analysis and hydrophobicity, and (c) morphological features at different length scales. The application of these analytical techniques to the characterization of collagen biomaterial matrices is critical in order to appropriately correlate biological responses from different studies with experimental outcomes in vitro or in vivo. As a case study, the analytical tools employed for collagen biomaterial studies are reviewed in the context of collagen remodeling by fibroblasts. The goal is to highlight the necessity of understanding collagen biophysical and chemical features as a prerequisite to (a) studies with cells and tissue formation, and (b) suggest modes to establish comparative outcomes for studies conducted in different laboratories. (C) 2008 Wiley Periodicals, Inc.
C1 [Abraham, Leah C.; Zuena, Erin; Kaplan, David L.] Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   [Abraham, Leah C.; Zuena, Erin; Kaplan, David L.] Tufts Univ, Dept Biol Engn, Medford, MA 02155 USA.
   [Abraham, Leah C.; Zuena, Erin; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
   [Perez-Ramirez, Bernardo] Genzyme Corp, BioFormulat Dev, Framingham, MA 01701 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
CR Abraham LC, 2004, J BIOMED MATER RES A, V70A, P39, DOI 10.1002/jbm.a.30057
   Abraham LC, 2007, EXP CELL RES, V313, P1045, DOI 10.1016/j.yexcr.2006.12.019
   Abraham LC, 2007, BIOMATERIALS, V28, P151, DOI 10.1016/j.biomaterials.2006.07.001
   Alberts B, 2002, MOL BIOL CELL
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Awad HA, 2000, J BIOMED MATER RES, V51, P233, DOI 10.1002/(SICI)1097-4636(200008)51:2<233::AID-JBM12>3.0.CO;2-B
   Babu IR, 2001, J AM CHEM SOC, V123, P2079, DOI 10.1021/ja002165d
   Badii F, 2003, J AGR FOOD CHEM, V51, P1440, DOI 10.1021/jf020492u
   Baguneid M, 2004, BIOTECHNOL APPL BIOC, V39, P151, DOI 10.1042/BA20030148
   Basle MF, 1998, J BIOMED MATER RES, V40, P350, DOI 10.1002/(SICI)1097-4636(19980605)40:3<350::AID-JBM2>3.0.CO;2-E
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Blair HC, 2002, BIOCHEM J, V364, P329, DOI 10.1042/BJ20020165
   BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191
   BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x
   BORNSTEIN MB, 1958, LAB INVEST, V7, P134
   BORNSTEIN P, 1979, CHEM BIOL COLLAGEN
   Brandt J, 1999, CLIN CHEM, V45, P47
   Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0
   Briggs D., 1998, SURFACE ANAL POLYM X
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brown EM, 1997, J AM LEATHER CHEM AS, V92, P225
   Buijtenhuijs P, 2004, BIOTECHNOL APPL BIOC, V39, P141, DOI 10.1042/BA20030105
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, V282, P250
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   CHEN KY, 1986, J CELL PHYSIOL, V128, P27, DOI 10.1002/jcp.1041280106
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Cherubino P, 2003, J Orthop Surg (Hong Kong), V11, P10
   Cochran DAE, 2001, PROTEIN SCI, V10, P1305, DOI 10.1110/ps.50701
   Consonni R, 2000, BIOPOLYMERS, V53, P99, DOI 10.1002/(SICI)1097-0282(200001)53:1<99::AID-BIP9>3.3.CO;2-4
   CRISTOFALO VJ, 1988, EXP GERONTOL, V23, P297, DOI 10.1016/0531-5565(88)90032-0
   CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617
   Day JS, 2004, BIORHEOLOGY, V41, P359
   Demers Laurence M., 2000, Cancer, V88, P2919, DOI 10.1002/1097-0142(20000615)88:12+<2919::AID-CNCR7>3.0.CO;2-Z
   Detamore MS, 2005, MATRIX BIOL, V24, P45, DOI 10.1016/j.matbio.2004.11.006
   Dewez JL, 1996, J BIOMED MATER RES, V30, P373
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Dreisewerd K, 2004, ANAL CHEM, V76, P3482, DOI 10.1021/ac049928q
   Dunn CA, 2005, MOL THER, V11, P294, DOI 10.1016/j.ymthe.2004.10.005
   Eaglstein W H, 1998, Cutis, V62, P1
   Ehlers EM, 1999, ANN ANAT, V181, P513, DOI 10.1016/S0940-9602(99)80055-7
   EINBINDER J, 1951, J BIOL CHEM, V188, P335
   Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200
   Ellerbroek SM, 2001, ARCH BIOCHEM BIOPHYS, V390, P51, DOI 10.1006/abbi.2001.2345
   Eriksen HA, 2004, BONE, V34, P720, DOI 10.1012/j.bone.2003.12.009
   Ferrando JM, 2001, WORLD J SURG, V25, P840, DOI 10.1007/s00268-001-0038-z
   FLANDIN F, 1984, BIOCHIM BIOPHYS ACTA, V791, P205, DOI 10.1016/0167-4838(84)90010-4
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 2003, ADV DRUG DELIVER REV, V55, P1529, DOI 10.1016/j.addr.2003.08.001
   GALLOP PM, 1963, METHOD ENZYMOL, V6, P635, DOI 10.1016/0076-6879(63)06233-9
   Garfinkel S, 1996, BBA-MOL CELL RES, V1314, P109, DOI 10.1016/S0167-4889(96)00105-X
   Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084
   GUSEV AI, 1995, ANAL CHEM, V67, P1034, DOI 10.1021/ac00102a003
   Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1
   Hanley L, 1999, J MASS SPECTROM, V34, P705, DOI 10.1002/(SICI)1096-9888(199907)34:7<705::AID-JMS845>3.0.CO;2-B
   Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024
   HAY ED, 1991, CELL BIOL EXTRACELLU, pR17
   HAYASHI T, 1979, BIOCHEMISTRY-US, V18, P4182, DOI 10.1021/bi00586a022
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Hickman D, 2000, J BIOTECHNOL, V79, P245, DOI 10.1016/S0168-1656(00)00241-8
   Higuchi A, 2000, J BIOMAT SCI-POLYM E, V11, P149, DOI 10.1163/156856200743625
   HILDEBRAN JN, 1981, BIOCHEM J, V198, P249, DOI 10.1042/bj1980249
   Hsu SH, 2002, ARTIF ORGANS, V26, P647, DOI 10.1046/j.1525-1594.2002.06889.x
   Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6
   JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308
   Jiang FZ, 2004, MICROSC RES TECHNIQ, V64, P435, DOI 10.1002/jemt.20101
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   Knott L, 1999, BRIT POULTRY SCI, V40, P371, DOI 10.1080/00071669987476
   KNOWLES GC, 1991, J CELL SCI, V98, P551
   Kordula T, 2002, INFECT IMMUN, V70, P419, DOI 10.1128/IAI.70.1.419-421.2002
   Kubisz L, 2003, INT J BIOL MACROMOL, V33, P89, DOI 10.1016/S0141-8130(03)00071-0
   KULJU KS, 1995, EXP CELL RES, V217, P336, DOI 10.1006/excr.1995.1095
   Kumar TR, 2003, J BIOMAT SCI-POLYM E, V14, P689, DOI 10.1163/156856203322274941
   Kwok DY, 1997, LANGMUIR, V13, P2880, DOI 10.1021/la9608021
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   LOW RB, 1986, CONNECT TISSUE RES, V14, P179, DOI 10.3109/03008208609014258
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005
   Merrett K, 2002, J BIOMAT SCI-POLYM E, V13, P593, DOI 10.1163/156856202320269111
   MICHALOPOULOS G, 1975, EXP CELL RES, V94, P70, DOI 10.1016/0014-4827(75)90532-7
   Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X
   MILLER EJ, 1971, BIOCHEMISTRY-US, V10, P1652, DOI 10.1021/bi00785a024
   Mizuno K, 2004, J BIOL CHEM, V279, P38072, DOI 10.1074/jbc.M402953200
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   MU XC, 1995, J CELL PHYSIOL, V165, P647, DOI 10.1002/jcp.1041650324
   Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0
   Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058
   NIYIBIZI C, 1984, J BIOL CHEM, V259, P4170
   Paige MF, 2001, MICRON, V32, P341, DOI 10.1016/S0968-4328(00)00037-8
   Pamula E, 2004, J COLLOID INTERF SCI, V271, P80, DOI 10.1016/j.jcis.2003.11.012
   Patankar NA, 2004, LANGMUIR, V20, P8209, DOI 10.1021/la048629t
   Patino Maria G, 2002, Implant Dent, V11, P280, DOI 10.1097/00008505-200207000-00014
   PELTONEN L, 1980, P NATL ACAD SCI-BIOL, V77, P162, DOI 10.1073/pnas.77.1.162
   Qiu Q, 1998, J BIOMED MATER RES, V42, P117, DOI 10.1002/(SICI)1097-4636(199810)42:1<117::AID-JBM15>3.3.CO;2-0
   Ricard-Blum S., 2000, UNCONVENTIONAL COLLA
   Rochdi A, 1999, BIOPOLYMERS, V50, P690, DOI 10.1002/(SICI)1097-0282(199912)50:7<690::AID-BIP2>3.0.CO;2-P
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Sionkowska A, 1999, INT J BIOL MACROMOL, V24, P337, DOI 10.1016/S0141-8130(99)00047-1
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   SYKES B, 1976, BIOCHEM BIOPH RES CO, V72, P1472, DOI 10.1016/S0006-291X(76)80180-5
   Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   Torkian Behrooz A, 2004, Arch Facial Plast Surg, V6, P180, DOI 10.1001/archfaci.6.3.180
   TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857
   Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com
   Viravaidya K, 2002, BIOTECHNOL BIOENG, V78, P454, DOI 10.1002/bit.10219
   Volloch V, 2002, MATRIX BIOL, V21, P533, DOI 10.1016/S0945-053X(02)00038-0
   Vomund AN, 2004, MOL GENET METAB, V82, P144, DOI 10.1016/j.ymgme.2004.03.004
   VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044
   Wang X, 2002, CALCIFIED TISSUE INT, V71, P186, DOI 10.1007/s00223-001-1082-2
   Wei L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1891
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Yamauchi K, 2001, BIOMATERIALS, V22, P855, DOI 10.1016/S0142-9612(00)00249-0
   Zambonin G, 2000, J BIOMED MATER RES, V49, P120, DOI 10.1002/(SICI)1097-4636(200001)49:1<120::AID-JBM15>3.0.CO;2-Q
   Zhang J, 2005, BIOMATERIALS, V26, P3353, DOI 10.1016/j.biomaterials.2004.08.019
   Zhang LH, 2002, ARTIF CELL BLOOD SUB, V30, P319, DOI 10.1081/BIO-120006122
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
NR 125
TC 55
Z9 58
U1 2
U2 42
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2008
VL 87B
IS 1
BP 264
EP 285
DI 10.1002/jbm.b.31078
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 350CA
UT WOS:000259328900034
PM 18386843
DA 2018-10-20
ER

PT J
AU Agarwal, V
   Lal, P
   Pruthi, P
   Pruthi, V
AF Agarwal, Vishnu
   Lal, Priyanka
   Pruthi, Parul
   Pruthi, Vikas
TI Studies of Candida albicans biofilm formed on biomaterial surfaces
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Meeting Abstract
C1 [Agarwal, Vishnu; Lal, Priyanka; Pruthi, Vikas] IIT Roorkee, Dept Biotechnol, Mol Microbiol Lab, Roorkee 247667, Uttar Pradesh, India.
   [Pruthi, Parul] HNB Garhwal Univ, HAPPRC, Garhwal, UA, India.
EM Vishnu_agarwal02@rediffmail.com
CR Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
NR 2
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD OCT
PY 2008
VL 136
SU S
MA V4-P-132
BP S451
EP S451
DI 10.1016/j.jbiotec.2008.07.1048
PG 1
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA V32VT
UT WOS:000208979402019
DA 2018-10-20
ER

PT J
AU Agnarsson, I
   Boutry, C
   Blackledge, TA
AF Agnarsson, Ingi
   Boutry, Cecilia
   Blackledge, Todd A.
TI Spider silk aging: Initial improvement in a high performance material
   followed by slow degradation
SO JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-ECOLOGICAL GENETICS AND
   PHYSIOLOGY
LA English
DT Article
ID MECHANICAL-PROPERTIES; CAPTURE-SILK; FLAGELLIFORM SILK; FIBERS SPUN;
   DESIGN; BIOMATERIAL; DIFFRACTION; POLYMERS; BEHAVIOR; THREADS
AB Spider silk possesses a unique combination of high tensile strength and elasticity resulting in extraordinarily tough fibers, compared with the best synthetic materials. However, the potential application of spider silk and biomimetic fibers depends upon retention of their high performance under a variety of conditions. Here, we report on changes in the mechanical properties of dragline and capture silk fibers from several spider species over periods tip to 4 years of benign aging. We find an improvement in mechanical performance of silk fibers during the first year of aging. Fibers rapidly decrease in diameter, suggesting an increase in structural alignment and organization of molecules. One-year old silk also is stiffer and has higher stress at yield than fresh silk, whereas breaking force, elasticity, and toughness either improve or are unaffected by early aging. However, 4-year old silk shows signs of degradation as the breaking load, elasticity, and toughness are all lower than in fresh silk. Aging, however, does not reduce the tensile strength of silk. These data suggest initially rapid reorganization and tighter packaging of molecules within the fiber, followed by longer-term decomposition. We hypothesize that possibly the breakdown of amino acids via emission of ammonia gas, as is seen in long-term aging of museum silkworm fabrics, may contribute. Degradation of spider silk under benign conditions may be a concern for efforts to construct and utilize biomimetic silk analogs. However, our findings suggest an initial improvement in mechanical performance and that even old spider silk still retains impressive mechanical performance. J. Exp. Zool. 309A:494-504, 2008. (C) 2008 Wiley-Liss, Inc.
C1 [Agnarsson, Ingi; Boutry, Cecilia; Blackledge, Todd A.] Univ Akron, Dept Biol, Akron, OH 44325 USA.
   [Agnarsson, Ingi; Boutry, Cecilia; Blackledge, Todd A.] Univ Akron, Integrated Biolsci Program, Akron, OH 44325 USA.
   [Agnarsson, Ingi] Smithsonian Inst, Dept Entomol, Washington, DC 20560 USA.
RP Agnarsson, I (reprint author), Univ Akron, Dept Biol, Akron, OH 44325 USA.
EM iagnarsson@gmail.com
FU National Science Foundation [DEB-0516038, DBI-0521261]; Integrated
   Bioscience Program at University of Akron
FX This research was funded by DEB-0516038 and DBI-0521261 from the
   National Science Foundation and by the Integrated Bioscience Program at
   University of Akron. Taylor Gondek assisted with silk diameter
   measurements.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   BECKER MA, 1995, J AM INST CONSERV, V34, P141, DOI 10.2307/3179736
   Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x
   Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001
   Booth C., 1989, COMPREHENSIVE POLYM
   Boukezzi L, 2006, ANN CHIM-SCI MAT, V31, P561, DOI 10.3166/acsm.31.561-569
   CLOUGH RL, 1996, POLYM DURABILIT DEGR
   Davis CR, 1996, J APPL POLYM SCI, V62, P2237
   DENNY M, 1976, J EXP BIOL, V65, P483
   El Shafee E, 2003, POLYMER, V44, P3727, DOI 10.1016/S0032-3861(03)00282-9
   Elices M, 2005, JOM-US, V57, P60, DOI 10.1007/s11837-005-0218-7
   GELLYNCK K, 2006, THESIS U GENT GENT
   Gillen KT, 1996, ADV CHEM SER, V249, P557
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   GRIFFITHS JR, 1980, J MATER SCI, V15, P491, DOI 10.1007/BF00551703
   Guan ZB, 2007, POLYM INT, V56, P467, DOI 10.1002/pi.2245
   Guinea GV, 2006, BIOMACROMOLECULES, V7, P2173, DOI 10.1021/bm060138v
   GUMARGALIEVA KZ, 1996, KINETIC THERMODYNAMI, P145
   Hayashi CY, 2001, BIOESSAYS, V23, P750, DOI 10.1002/bies.1105
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Hermes AC, 2006, BIOMACROMOLECULES, V7, P777, DOI 10.1021/bm0508313
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Opell BD, 2008, J EXP ZOOL PART A, V309A, P11, DOI 10.1002/jez.426
   Osaki S, 2004, POLYM J, V36, P623, DOI 10.1295/polymj.36.623
   Perez-Rigueiro J, 2007, J POLYM SCI POL PHYS, V45, P786, DOI 10.1002/polb.21118
   Riekel C, 1999, INT J BIOL MACROMOL, V24, P179, DOI 10.1016/S0141-8130(98)00084-1
   RIGBY BJ, 1974, J MACROMOL SCI PHYS, VB 10, P255, DOI 10.1080/00222347408260829
   ROBINSON MS, 1981, TEXT RES J, V51, P637, DOI 10.1177/004051758105101004
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   TOWNLEY MA, 1991, J EXP ZOOL, V259, P154, DOI 10.1002/jez.1402590203
   VADLAMUDI S, 1995, THESIS U WYOMING LAR
   Van Nimmen E, 2003, INT J MATER PROD TEC, V18, P344
   Vlasveld DPN, 2005, POLYMER, V46, P12539, DOI 10.1016/j.polymer.2005.10.120
   Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4
   VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   Vollrath F, 2002, IN VIVO, V16, P229
   VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Vollrath F., 2000, REV MOL BIOTECHNOL, V74, P67, DOI DOI 10.1016/S1389-0352(00)00006-4)
   Yanagi Y, 2000, TEXT RES J, V70, P871, DOI 10.1177/004051750007001005
NR 47
TC 21
Z9 21
U1 0
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1932-5223
J9 J EXP ZOOL PART A
JI J. Exp. Zool. Part A
PD OCT 1
PY 2008
VL 309A
IS 8
BP 494
EP 504
DI 10.1002/jez.480
PG 11
WC Zoology
SC Zoology
GA 355PB
UT WOS:000259719700007
PM 18626974
DA 2018-10-20
ER

PT J
AU Hu, WW
   Lang, MW
   Krebsbach, PH
AF Hu, Wei-Wen
   Lang, Michael W.
   Krebsbach, Paul H.
TI Development of adenovirus immobilization strategies for in situ gene
   therapy
SO JOURNAL OF GENE MEDICINE
LA English
DT Article
DE adenovirus; avidin/biotin; chitosan; gene delivery; surface
   modification; tissue engineering
ID BONE MORPHOGENETIC PROTEIN-2; ANTIBODY IMMOBILIZATION; TARGET-CELLS;
   CHITOSAN; DELIVERY; VECTOR; SURFACES; VIVO; SCAFFOLDS; TRANSDUCTION
AB Background Regenerative gene therapy using viral vectors enables transduced cells to express bioactive factors in vivo. Viral delivery with spatial control can enhance transduction efficiency and may limit systemic infection. Consequently, we tethered biotinylated adenovirus via interactions with avidin on chitosan surfaces to gain robust control for in situ transduction.
   Methods Avidin was either directly conjugated to chitosan (virus-biotin-avidin-material; VBAM) or indirectly clocked on biotinylated chitosan surfaces (virus-biotin-avidin-biotin-material; VBABM) to tether biotinylated adenovirus. Enzyme-linked immunosorbent assay (ELISA) and spectroscopic analysis were performed to demonstrate the binding profiles. Biotin-alkaline phosphatase and biotinylated adenovirus were used as different sized particles to evaluate binding efficiencies and were compared by the Sips isotherm adsorption method. Scanning electron microscopy (SEM) examination illustrated virus distribution, and the transduction efficiency was determined by in vitro cell transduction.
   Results ELISA and spectroscopic analysis both demonstrated that the VBAM system led to multilayer avidin formation on biomaterial surfaces, whereas VBABM formed a monolayer of avidin. Sips isotherm adsorption indicated that the VBAM method increased heterogeneity and steric hindrance of binding sites. By contrast, the VBABM method docked avidin on chitosan surfaces and orientated the binding sites to facilitate ligand binding. In addition, SFM images illustrated that the VBABM method led to more even viral distribution. In vitro cell infection experiments also demonstrated that the VBABM system enhanced virus immobilization and thus improved cell transduction efficiency over the VBAM system.
   Conclusions The VBABM strategy is a superior method for in situ transduction from biomaterials. This strategy could be adapted for use with a variety of biomaterials as well as vital vectors, and thus may be an alternative method for in vivo regenerative gene therapy. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Hu, Wei-Wen; Lang, Michael W.; Krebsbach, Paul H.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   [Hu, Wei-Wen; Krebsbach, Paul H.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Krebsbach, PH (reprint author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, K1030,1011 N Univ Ave, Ann Arbor, MI 48109 USA.
EM paulk@umich.edu
FU AO Foundation [16-2004]
FX The research was supported by a grant from the AO Foundation (16-2004).
CR Ahmed SR, 2006, J MEMBRANE SCI, V280, P553, DOI 10.1016/j.memsci.2006.02.009
   Alden TD, 1999, HUM GENE THER, V10, P2245, DOI 10.1089/10430349950017220
   Anderson GP, 1997, BIOSENS BIOELECTRON, V12, P329, DOI 10.1016/S0956-5663(96)00074-7
   Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o
   Bajaj B, 2001, BIOTECHNOL PROGR, V17, P587, DOI 10.1021/bp010039n
   Beer SJ, 1998, GENE THER, V5, P740, DOI 10.1038/sj.gt.3300647
   Bengali Z, 2007, J GENE MED, V9, P668, DOI 10.1002/jgm.1058
   DIMMOCK NJ, 1994, INTRO MODERN VIROLOG, P345
   Firestone MA, 1996, J AM CHEM SOC, V118, P9033, DOI 10.1021/ja961046o
   GREEN NM, 1963, BIOCHEM J, V89, P585, DOI 10.1042/bj0890585
   Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876
   Hobson DA, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-4
   Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   KASSEISLER A, 1994, GENE THER, V1, P395
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Lu B, 1996, ANALYST, V121, pR29, DOI 10.1039/an996210029r
   Lu B, 1996, ANAL CHIM ACTA, V331, P97, DOI 10.1016/0003-2670(96)00191-2
   Mei L, 2006, J GENE MED, V8, P690, DOI 10.1002/jgm.912
   Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Ochiya Takahiro, 2001, Current Gene Therapy, V1, P31, DOI 10.2174/1566523013348887
   Okubo Y, 2000, BIOCHEM BIOPH RES CO, V267, P382, DOI 10.1006/bbrc.1999.1975
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Parrott MB, 2003, MOL THER, V8, P688, DOI 10.1016/S1525-0016(03)00213-2
   Pickles RJ, 1998, J VIROL, V72, P6014
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Shriver-Lake LC, 1997, BIOSENS BIOELECTRON, V12, P1101, DOI 10.1016/S0956-5663(97)00070-5
   SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Vijayendran RA, 2001, ANAL CHEM, V73, P471, DOI 10.1021/ac000523p
   Yao DC, 2003, ANAL CHIM ACTA, V478, P23, DOI 10.1016/S0003-2670(02)01484-8
   Yeung C, 1997, LANGMUIR, V13, P6746, DOI 10.1021/la970830z
   Yeung C, 1999, LANGMUIR, V15, P6829, DOI 10.1021/la990019j
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
NR 37
TC 17
Z9 17
U1 1
U2 12
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1099-498X
J9 J GENE MED
JI J. Gene. Med.
PD OCT
PY 2008
VL 10
IS 10
BP 1102
EP 1112
DI 10.1002/jgm.1233
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 367YD
UT WOS:000260587600005
PM 18618417
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Nielsen, VG
   Kirklin, JK
   Holman, WL
   George, JF
   Ellis, TC
   Steenwyk, BL
AF Nielsen, Vance G.
   Kirklin, James K.
   Holman, William L.
   George, James F.
   Ellis, Truitt C.
   Steenwyk, Brad L.
TI Patient with hypofibrinolysis-mediated thromboembolism converted to a
   hypercoagulable/hyperfibrinolytic state via ventricular assist device
   placement
SO JOURNAL OF HEART AND LUNG TRANSPLANTATION
LA English
DT Article
ID ACTIVATABLE FIBRINOLYSIS INHIBITOR; HEART-FAILURE; HUMAN PLASMA;
   HYPERCOAGULABILITY; THROMBOSIS
AB Mechanical circulatory support with ventricular assist devices (VADs) for end-stage heart failure has been a focus of intense interest for nearly four decades. Despite improvements in VAD design and biomaterial composition, it is common to administer anti-coagulation (e.g., warfarin, anti-platelet agents) to prevent both device thrombosis and thromboembolism. We present a patient with pre-operative thrombophilia (pulmonary embolism, intracardiac thrombus) and hypofibrinolysis, who subsequently developed hypercoagulability with hyperfibrinolysis with normalization of clot lifespan after left VAD placement. Such complex patient-VAD-hemostatic-state interactions serve as the rationale for continuing investigation of the effects of mechanical circulation on the fibrinolytic system and thrombophilia.
C1 [Nielsen, Vance G.; Ellis, Truitt C.; Steenwyk, Brad L.] Univ Alabama, Dept Anesthesiol, Birmingham, AL 35249 USA.
   [Nielsen, Vance G.; Kirklin, James K.; Holman, William L.; George, James F.] Univ Alabama, Dept Surg, Birmingham, AL 35249 USA.
RP Nielsen, VG (reprint author), Univ Alabama, Dept Anesthesiol, Basic Med Res 2,Room 206901,S 19th St, Birmingham, AL 35249 USA.
EM vnielsen@uab.edu
FU Departments of Anesthesiology and Surgery, University of Alabama at
   Birmingham
FX Supported by the Departments of Anesthesiology and Surgery, University
   of Alabama at Birmingham.
CR De Lorenzo F, 2003, DRUGS, V63, P565, DOI 10.2165/00003495-200363060-00004
   Jafri SM, 1997, SEMIN THROMB HEMOST, V23, P543, DOI 10.1055/s-2007-996133
   Marcucci R, 2006, J THROMB HAEMOST, V4, P1017, DOI 10.1111/j.1538-7836.2006.01916.x
   Nielsen VG, 2008, ASAIO J, V54, P351, DOI 10.1097/MAT.0b013e31817f3e03
   Nielsen VG, 2008, BLOOD COAGUL FIBRIN, V19, P283, DOI 10.1097/MBC.0b013e3282ff76c3
   Nielsen VG, 2007, BLOOD COAGUL FIBRIN, V18, P29, DOI 10.1097/MBC.0b013e3280129afe
   Nielsen VG, 2006, J HEART LUNG TRANSPL, V25, P1247, DOI 10.1016/j.healun.2006.06.009
   Schafer Andreas, 2004, Clin Lab, V50, P559
   Steenwyk BL, 2007, ANESTH ANALG, V104, P538, DOI 10.1213/01.ane.0000255155.87860.94
   Tschirkov A, 2007, J HEART LUNG TRANSPL, V26, P553, DOI 10.1016/j.healun.2007.01.030
NR 10
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1053-2498
J9 J HEART LUNG TRANSPL
JI J. Heart Lung Transplant.
PD OCT
PY 2008
VL 27
IS 10
BP 1169
EP 1171
DI 10.1016/j.healun.2008.06.009
PG 3
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery;
   Transplantation
SC Cardiovascular System & Cardiology; Respiratory System; Surgery;
   Transplantation
GA 358WI
UT WOS:000259947800018
PM 18926412
DA 2018-10-20
ER

PT J
AU Das, I
   Agrawal, NR
   Verma, S
   Ansari, SA
AF Das, Ishwar
   Agrawal, Namita R.
   Verma, Smriti
   Ansari, Shoeb A.
TI Non-equilibrium growth patterns in a reaction between thiamine and
   glucose
SO JOURNAL OF THE INDIAN CHEMICAL SOCIETY
LA English
DT Article
DE Growth pattern; fractal; biomaterial; Schiff base
ID MAILLARD REACTION; SCHIFF-BASE; COMPLEXES; COPPER; METAL
AB Reaction between glucose and thiamine has been studied in aqueous solution containing gel matrix. Growth patterns of the reactants and the product have been studied. Glucose crystallizes in the form of fractal with fractal dimension 1.74 and thiamine as spherulitic when observed under polarized light microscope. Glucose-thiamine reaction product crystallized in different morphologies. Following transitions were observed on increasing the concentration.
   Spherulite -> Ringed spherulite -> Revert spaced concentric rings
   Besides change in the morphology of the reaction product, XRD, IR and DSC studies also revealed the formation of a new product. During the reaction glucose was continuously consumed on addition of thiamine, obeying the relation [G](-1) = m log V + c, where m and c are slope and intercept respectively. Heat of fusion Delta H of the product was calculated using the expression Delta H.m = KA, where m is the mass of the substance, K and A are the calibration constant and area under the curve respectively. The value was found to be 1.36 kcal/mol, which was lower than those of the individual reactants.
C1 [Das, Ishwar; Verma, Smriti; Ansari, Shoeb A.] DDU Gorakhpur Univ, Dept Chem, Gorakhpur 273009, Uttar Pradesh, India.
   [Agrawal, Namita R.] St Andreas Coll, Dept Chem, Gorakhpur 273009, Uttar Pradesh, India.
RP Das, I (reprint author), DDU Gorakhpur Univ, Dept Chem, Gorakhpur 273009, Uttar Pradesh, India.
EM ishwar_das@rediffmail.com
FU Department of Science and Technology, New Delhi
FX Authors wish to thank Prof. K. D. S. Yadav, Head, Chemistry Department,
   DDU Gorakhpur University, Gorakhpur, for providing necessary laboratory
   facilities. We are grateful to Department of Science and Technology, New
   Delhi for providing financial support.
CR Achary G, 2007, INDIAN J CHEM TECHN, V14, P16
   Ajandouz EH, 1999, J AGR FOOD CHEM, V47, P1786, DOI 10.1021/jf980928z
   Ben-Jacob E, 1994, FRACTALS, V2, P15, DOI 10.1142/S0218348X9400003X
   BENJACOB E, 1990, NATURE, V343, P523, DOI 10.1038/343523a0
   BENJACOB E, 1994, NATURE, V368, P46, DOI 10.1038/368046a0
   Chandra D, 2007, CHEM MATER, V19, P5347, DOI 10.1021/cm701918t
   Chandra D, 2007, MICROPOR MESOPOR MAT, V101, P348, DOI 10.1016/j.micromeso.2006.11.027
   DACCORD G, 1986, PHYS REV LETT, V56, P336, DOI 10.1103/PhysRevLett.56.336
   DAS I, 1991, Indian Journal of Experimental Biology, V29, P1109
   Das I, 1997, INDIAN J CHEM A, V36, P197
   Das I, 1997, INDIAN J CHEM A, V36, P1018
   DELANGE P, 1954, NATURE, V29, P1040
   FAMILY F, 1989, PHYSICA D, V38, P98, DOI 10.1016/0167-2789(89)90178-4
   FIELDEN J, 2007, EUR J INORG CHEM, P3930
   Karaoglan GK, 2007, INDIAN J CHEM A, V46, P1273
   Komatsu H, 2007, J MOL CATAL A-CHEM, V273, P289, DOI 10.1016/j.molcata.2007.04.016
   Mandelbrot B. B, 1982, FRACTAL GEOMETRY NAT
   Nagaraj RH, 1996, J BIOL CHEM, V271, P19338, DOI 10.1074/jbc.271.32.19338
   Nawale RB, 2006, INDIAN J BIOCHEM BIO, V43, P337
   Purakayastha A, 1999, NEW J CHEM, V23, P1141, DOI 10.1039/a907123g
   RASTOGI RP, 1993, J PHYS CHEM-US, V97, P4871, DOI 10.1021/j100120a046
   RASTOGI RP, 1993, INDIAN J CHEM A, V32, P749
   RASTOGI RP, 1993, J CHEM EDUC, V71, P694
   RASTOGI RP, 1991, CHEM PHYS LETT, V1, P186
   RASTOGI RP, 1992, J CHEM ED A, V69, P48
   RIEPPEL O, 1993, NATURE, V362, P216, DOI 10.1038/362216b0
   SANDER LM, 1986, NATURE, V322, P789, DOI 10.1038/322789a0
   Saracovan I, 1999, MACROMOLECULES, V32, P8918, DOI 10.1021/ma9911602
   SCHAEFFER DW, 1989, SCIENCE, V243, P1043
   SHAKLAI N, 1984, J BIOL CHEM, V259, P3812
   STANLEY HE, 1989, PHYSICA D, V38, P330, DOI 10.1016/0167-2789(89)90215-7
   VISHNOI NK, 1982, ADV PRACTICAL ORGANI, P438
NR 32
TC 0
Z9 0
U1 0
U2 2
PU SCIENTIFIC PUBL-INDIA
PI JODHPUR
PA 5-A, NEW PALI RD, PO BOX 91, NEAR HOTEL TAJ HARI MAHAL, JODHPUR, 342
   003, INDIA
SN 0019-4522
J9 J INDIAN CHEM SOC
JI J. Indian Chem. Soc.
PD OCT
PY 2008
VL 85
IS 10
BP 1004
EP 1009
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 376TW
UT WOS:000261206900006
DA 2018-10-20
ER

PT J
AU Stylianopoulos, T
   Bashur, CA
   Goldstein, AS
   Guelcher, SA
   Barocas, VH
AF Stylianopoulos, Triantafyllos
   Bashur, Chris A.
   Goldstein, Aaron S.
   Guelcher, Scott A.
   Barocas, Victor H.
TI Computational predictions of the tensile properties of electrospun fibre
   meshes: Effect of fibre diameter and fibre orientation
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Fibrous mesh; Network architecture; Multiscale modelling; Tissue
   microstructure
ID STRUCTURAL CONSTITUTIVE MODEL; BIAXIAL MECHANICAL-PROPERTIES; STOCHASTIC
   FIBROUS NETWORKS; AORTIC-VALVE CUSP; BIOMEDICAL APPLICATIONS; COLLAGEN
   NETWORKS; ARTIFICIAL GRAFT; MEDIA EQUIVALENT; AVERAGING THEORY; VASCULAR
   GRAFT
AB The mechanical properties of biomaterial scaffolds are crucial for their efficacy in tissue engineering and regenerative medicine. At the microscopic scale, the scaffold must be sufficiently rigid to support cell adhesion, spreading, and normal extracellular matrix deposition. Concurrently, at the macroscopic scale the scaffold must have mechanical properties that closely match those of the target tissue. The achievement of both goals may be possible by careful control of the scaffold architecture. Recently, electrospinning has emerged as an attractive means to form fused fibre scaffolds for tissue engineering. The diameter and relative orientation of fibres affect cell behaviour, but their impact on the tensile properties of the scaffolds has not been rigorously characterized. To examine the structure-property relationship, electrospun meshes were made from a polyurethane elastomer with different fibre diameters and orientations and mechanically tested to determine the dependence of the elastic modulus on the mesh architecture. Concurrently, a multiscale modelling strategy developed for type I collagen networks was employed to predict the mechanical behaviour of the polyurethane meshes. Experimentally, the measured elastic modulus of the meshes varied from 0.56 to 3.0 MPa depending on fibre diameter and the degree of fibre alignment. Model predictions for tensile loading parallel to fibre orientation agreed well with experimental measurements for a wide range of conditions when a fitted fibre modulus of 18 MPa was used. Although the model predictions were less accurate in transverse loading of anisotropic samples, these results indicate that computational modelling can assist in design of electrospun artificial tissue scaffolds. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Barocas, Victor H.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.
   [Stylianopoulos, Triantafyllos] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA.
   [Bashur, Chris A.; Goldstein, Aaron S.] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
   [Guelcher, Scott A.] Vanderbilt Univ, Dept Chem Engn, Nashville, TN 37235 USA.
RP Barocas, VH (reprint author), Univ Minnesota, Dept Biomed Engn, 7-105 Hasselmo Hall,312 Church St SE, Minneapolis, MN 55455 USA.
EM baroc001@umn.edu
OI Bashur, Chris/0000-0002-2637-9149; Stylianopoulos,
   Triantafyllos/0000-0002-3093-1696
FU NIH [1 R01 EB005813-01]; Charles E. Culpeper Foundation [03130];
   Institute for Critical Technologies and Sciences at Virginia Tech;
   Doctoral Dissertation Fellowship from the University of Minnesota;
   University of Minnesota Supercomputing institute
FX This work was supported by NIH grant 1 R01 EB005813-01 to VHB, and
   grants from the Charles E. Culpeper Foundation (03130) and the Institute
   for Critical Technologies and Sciences at Virginia Tech to ASG. TS was
   also supported by a Doctoral Dissertation Fellowship from the University
   of Minnesota. Simulations were made possible by resources grants from
   the University of Minnesota Supercomputing institute.
CR Agoram B, 2001, J BIOMECH ENG-T ASME, V123, P362, DOI 10.1115/1.1385843
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005
   Berhan L, 2003, J COMPOS MATER, V37, P715, DOI 10.1177/002199803029725
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P327, DOI 10.1115/1.1287158
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P23, DOI 10.1115/1.429624
   Boland ED, 2006, ACS SYM SER, V918, P188
   Boland ED, 2005, ACTA BIOMATER, V1, P115, DOI 10.1016/j.actbio.2004.09.003
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Chandran PL, 2006, J BIOMECH ENG-T ASME, V128, P259, DOI 10.1115/1.2165699
   Chandran PL, 2007, J BIOMECH ENG-T ASME, V129, P137, DOI 10.1115/1.2472369
   DREW DA, 1971, STUD APPL MATH, V50, P133
   Driessen NJB, 2005, J BIOMECH ENG-T ASME, V127, P494, DOI 10.1115/1.1894373
   Enever PAJ, 2002, J SURG RES, V105, P160, DOI 10.1006/jsre.2002.6372
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107
   Gu SY, 2005, MACROMOL RAPID COMM, V26, P716, DOI 10.1002/marc.200400667
   Guelcher SA, 2005, ACTA BIOMATER, V1, P471, DOI 10.1016/j.actbio.2005.02.007
   Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021
   HAYASHI K, 1980, J BIOMECH, V13, P175, DOI 10.1016/0021-9290(80)90191-8
   HAYASHI K, 1989, J BIOMED MATER RES-A, V23, P229
   Head DA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061907
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Humphrey JD, 2003, P ROY SOC A-MATH PHY, V459, P3, DOI 10.1098/rspa.2002.1060
   Inoguchi H, 2006, BIOMATERIALS, V27, P1470, DOI 10.1016/j.biomaterials.2005.08.029
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Macosko C. W., 1994, RHEOLOGY PRINCIPLES
   Matsuda T, 2005, J BIOMED MATER RES A, V73A, P125, DOI 10.1002/jbm.a.30260
   Moran JM, 2003, TISSUE ENG, V9, P63, DOI 10.1089/107632703762687546
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   Nemat-Nasser S, 1999, MICROMECHANICS OVERA
   Oda M, 1999, MECH GRANULAR MAT
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681
   Sonoda H, 2002, J BIOMED MATER RES, V60, P191, DOI 10.1002/jbm.10055
   Stylianopoulos T, 2007, J BIOMECH ENG-T ASME, V129, P611, DOI 10.1115/1.2746387
   Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   Wang CW, 2000, J ENG MATER-T ASME, V122, P460, DOI 10.1115/1.1288768
   Wang CW, 2000, J ENG MATER-T ASME, V122, P450, DOI 10.1115/1.1288769
   WHITAKER S, 1986, TRANSPORT POROUS MED, V1, P3, DOI 10.1007/BF01036523
   White JA, 2002, BIOPHYS J, V82, P2081, DOI 10.1016/S0006-3495(02)75555-0
   Wilhelm J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108103
   WILKES GL, 2003, COMPREHENSIVE DESK R, P624
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
   Zulliger MA, 2004, J BIOMECH, V37, P989, DOI 10.1016/j.jbiomech.2003.11.026
NR 51
TC 76
Z9 76
U1 1
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD OCT
PY 2008
VL 1
IS 4
BP 326
EP 335
DI 10.1016/j.jmbbm.2008.01.003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 359PT
UT WOS:000260001300006
PM 19627797
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Shingel, KI
   Faure, MP
   Azoulay, L
   Roberge, C
   Deckelbaum, RJ
AF Shingel, Kirill I.
   Faure, Marie-Pierre
   Azoulay, Laurent
   Roberge, Christophe
   Deckelbaum, Richard J.
TI Solid emulsion get as a vehicle for delivery of polyunsaturated fatty
   acids: implications for tissue repair, dermal angiogenesis and wound
   heating
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE solid emulsion gel; omega-3 (n-3) polyunsaturated fatty acids;
   angiogenesis; wound healing; gene expression; vascular endothelial
   growth factor
ID ENDOTHELIAL GROWTH-FACTOR; DIFFERENTIATION-RELATED PROTEIN;
   DOCOSAHEXAENOIC ACID; NITRIC-OXIDE; IN-VITRO; HEME OXYGENASE-1;
   CUTANEOUS WOUNDS; ADRP EXPRESSION; CELL-GROWTH; SKIN
AB The paper describes preparation and biological characterization of the solid hybrid biomaterial that was designed for cell-targeted lipid delivery in healing tissues. The material referred to as 'solid emulsion gel' combines a protein-stabilized lipid emulsion and a hydrogel structure in a single compartment. The potential of the omega-3 (n-3)-fatty acids rich solid emulsion gel for tissue repair applications was investigated at the macro-, micro-, molecular and gene expression levels, using human fibroblasts and endothelial cells and a porcine model of full-thickness wounds. Being non-cytotoxic in vitro and in vivo, the biomaterial was found to affect cell metabolism, modulate expression of certain genes, stimulate early angiogenesis and promote wound repair in vivo. The neovascular response in vivo was correlated with upregulated expression of the genes involved in lipid transport (e.g. adipophilin), anti-apoptosis (e.g. heat shock proteins, haem oxygenase 1) and angiogenesis (vascular endothelial growth factor, placental growth factor). Collectively, the results of this study provide first evidence that the angiogenic response provided by solid emulsion gel-mediated delivery of n-3 fatty acids is an alternative to the topical administration of exogenous growth factors or gene therapy, and can be advantageously used for the stimulation of tissue repair in complex wounds. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Shingel, Kirill I.; Faure, Marie-Pierre; Roberge, Christophe] BioArtificial Gel Technol BAGTECH Inc, Montreal, PQ H3A 1L4, Canada.
   [Azoulay, Laurent] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada.
   [Deckelbaum, Richard J.] Columbia Univ, Dept Pediat, Inst Human Nutr, New York, NY 10027 USA.
RP Shingel, KI (reprint author), BioArtificial Gel Technol BAGTECH Inc, 400 Moisonneuve Ouest,Suite 1156, Montreal, PQ H3A 1L4, Canada.
EM kirill.shingel@bagtech.com
FU NIH [HL 40404]
FX The authors are grateful to Dr Zabeida from the Department of
   Engineering Physics, Ecole Polytechnique, for help in materials
   characterization. The technical assistance of Ludmila Anohina and
   Jessica Elkouby (both from Bioartificial Gel Technologies Inc.) is also
   gratefully acknowledged. Dr Deckelbaum's laboratory is supported in part
   by NIH Grant No. HL 40404.
CR Akay G, 2004, BIOMATERIALS, V25, P3991, DOI 10.1016/j.biomaterials.2003.10.086
   Arend A, 2000, ANN NUTR METAB, V44, P217, DOI 10.1159/000046687
   Brasaemle DL, 1997, J LIPID RES, V38, P2249
   Braund Rhiannon, 2007, Current Drug Delivery, V4, P195
   BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375
   Bussolati B, 2006, ANTIOXID REDOX SIGN, V8, P1153, DOI 10.1089/ars.2006.8.1153
   Cardoso CRB, 2004, WOUND REPAIR REGEN, V12, P235
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Danesch U, 1996, J CELL PHYSIOL, V168, P618, DOI 10.1002/(SICI)1097-4652(199609)168:3<618::AID-JCP14>3.0.CO;2-V
   DIJKE P, 1989, BIOTECHNOLOGY, V7, P793
   DYSON M, 1992, J INVEST DERMATOL, V99, P729, DOI 10.1111/1523-1747.ep12614460
   FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607
   Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825
   Gao J, 2000, J CELL PHYSIOL, V182, P297
   Gercek A, 2007, JPEN-PARENTER ENTER, V31, P161, DOI 10.1177/0148607107031003161
   Hankenson KD, 2000, P SOC EXP BIOL MED, V223, P88, DOI 10.1046/j.1525-1373.2000.22312.x
   Hentze H. P., 2002, REV MOL BIOTECHNOL, V90, P27, DOI [DOI 10.1016/S1389-0352(01)00046-0, 10.1016/S1389-0352(01)00046-0]
   HINMAN CD, 1963, NATURE, V200, P377, DOI 10.1038/200377a0
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Horch RE, 2005, J CELL MOL MED, V9, P592, DOI 10.1111/j.1582-4934.2005.tb00491.x
   Jazwa A, 2006, FREE RADICAL BIO MED, V40, P1250, DOI 10.1016/j.freeradbiomed.2005.11.016
   Jia Yi, 2005, Lipids Health Dis, V4, P14, DOI 10.1186/1476-511X-4-14
   Kashyap N, 2005, CRIT REV THER DRUG, V22, P107, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i2.10
   Kim HJ, 2005, J CELL PHYSIOL, V204, P881, DOI 10.1002/jcp.20351
   Liu J, 1999, J BIOL CHEM, V274, P15781, DOI 10.1074/jbc.274.22.15781
   MARGOLIS DJ, 1995, DERMATOL SURG, V21, P145, DOI 10.1111/j.1524-4725.1995.tb00128.x
   NISHIGAKI I, 1980, BIOCHEM MED METAB B, V24, P185, DOI 10.1016/0006-2944(80)90010-1
   Nissen NN, 1998, AM J PATHOL, V152, P1445
   O'Donnell VB, 2001, CIRC RES, V88, P12, DOI 10.1161/01.RES.88.1.12
   Oliveira FLC, 1997, JPEN-PARENTER ENTER, V21, P224, DOI 10.1177/0148607197021004224
   Pae HO, 2005, ENDOCRINOLOGY, V146, P2229, DOI 10.1210/en.2004-1431
   Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004
   Pratt VC, 2001, LIPIDS, V36, P675, DOI 10.1007/s11745-001-0772-y
   Robson M. C., 1998, AM J SURG, V176, P80
   Rose DP, 1999, INT J ONCOL, V15, P1011
   Ruthig DJ, 1999, J NUTR, V129, P1791
   Scardino MS, 1999, VET DERMATOL, V10, P283, DOI 10.1046/j.1365-3164.1999.00148.x
   Seo T, 2005, CURR OPIN LIPIDOL, V16, P11, DOI 10.1097/00041433-200502000-00004
   Shingel KI, 2005, BIOMACROMOLECULES, V6, P1635, DOI 10.1021/bm0492475
   Shingel Kirill I, 2006, Int Wound J, V3, P332, DOI 10.1111/j.1742-481X.2006.00262.x
   Silverstein MS, 2005, POLYMER, V46, P6682, DOI 10.1016/j.polymer.2005.05.022
   Snyders R, 2007, J BIOMED MATER RES A, V83A, P88, DOI 10.1002/jbm.a.31217
   Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x
   TILL GO, 1985, AM J PATHOL, V119, P376
   Tobin KAR, 2006, J LIPID RES, V47, P815, DOI 10.1194/jlr.M500527-JLR200
   Tsuzuki T, 2007, BIOSCI BIOTECH BIOCH, V71, P1902, DOI 10.1271/bbb.70114
   Vogt PM, 1998, CHIRURG, V69, P1197, DOI 10.1007/s001040050557
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
   Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103
   Zhang SM, 2007, POLYMER, V48, P3021, DOI 10.1016/j.polymer.2007.04.009
NR 50
TC 17
Z9 18
U1 3
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD OCT
PY 2008
VL 2
IS 7
BP 383
EP 393
DI 10.1002/term.101
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 360ZB
UT WOS:000260096200001
PM 18642392
DA 2018-10-20
ER

PT J
AU Sen, MY
   Puskas, JE
   Ummadisetty, S
   Kennedy, JP
AF Sen, Mustafa Y.
   Puskas, Judit E.
   Ummadisetty, Subramanyam
   Kennedy, Joseph P.
TI Green Polymer Chemistry: II Enzymatic Synthesis of
   Methacrylate-Terminated Polyisobutylenes
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE enzymes; esterification; functionalization of polymers; green chemistry;
   polyisobutylene
ID TRANSFER AGENTS INIFERS; SEQUENTIAL CO-POLYMERS; ANTARCTICA-LIPASE-B;
   TELECHELIC POLYMERS; NETWORKS
AB Methacrylate-terminated polyisobutylenes (PIB-MAs) were synthesized by trans esterification of vinyl methacrylate by hydroxyl-terminated polyisobutylenes (PIB-OH) using Candida antarctica lipase B (Novozyme 435) catalyst in hexane at 50 degrees C. PIB-CH2-CH2-CH2-OH and Glissopal-OH, synthesized by anti-Markovnikov hydrobromination of allyl-terminated PIB and Glissopal (R) 2300 followed by hydrolysis, were quantitatively converted into the corresponding PIB-MAs. H-1 and C-13 NMR spectroscopy verified the formation of the expected structures. This "green" chemistry is a very promising methodology for polymer functionalization in general, and biomaterial synthesis in particular.
C1 [Sen, Mustafa Y.; Puskas, Judit E.; Ummadisetty, Subramanyam; Kennedy, Joseph P.] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
RP Puskas, JE (reprint author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
EM jpuskas@uakron.edu
FU National Science Foundation [DMR-0509687]
FX This material is based upon work supported by the National Science
   Foundation under DMR-0509687.
CR FABER K, 1992, SYNTHESIS-STUTTGART, P895
   Georgiou TK, 2007, MACROMOLECULES, V40, P2335, DOI 10.1021/ma062307+
   Gotor-Fernandez V, 2006, ADV SYNTH CATAL, V348, P797, DOI 10.1002/adsc.200606057
   Kasper J. R., 2008, POLYM PREP-ACS, V49, P1161
   KENNEDY JP, 1983, J POLYM SCI POL CHEM, V21, P1033, DOI 10.1002/pol.1983.170210411
   KENNEDY JP, 1993, J BIOMAT SCI-POLYM E, V4, P445
   KENNEDY JP, 1983, POLYM BULL, V10, P146
   Keszler B, 2000, POLYM BULL, V43, P511, DOI 10.1007/s002890050009
   Lee GS, 2006, BIOTECHNOL LETT, V28, P581, DOI 10.1007/s10529-006-0019-2
   Leonard V, 2007, CHEMBIOCHEM, V8, P662, DOI 10.1002/cbic.200600479
   OTERA J, 2003, ESTERIFICATION METHO, P55
   Puskas JE, 2008, J POLYM SCI POL CHEM, V46, P3024, DOI 10.1002/pola.22640
   SEN MY, 2008, POLYM PREP-ACS, V49, P487
   Ummadisetty S, 2008, J POLYM SCI POL CHEM, V46, P4236, DOI 10.1002/pola.22716
   Yadav GD, 2003, ENZYME MICROB TECH, V32, P783, DOI 10.1016/S0141-0229(03)00064-4
NR 15
TC 12
Z9 12
U1 1
U2 9
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1336
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD OCT 1
PY 2008
VL 29
IS 19
BP 1598
EP 1602
DI 10.1002/marc.200800359
PG 5
WC Polymer Science
SC Polymer Science
GA 369SN
UT WOS:000260714300006
DA 2018-10-20
ER

PT J
AU Zhou, B
   Liu, Y
   Wei, W
   Mao, J
AF Zhou, Bin
   Liu, Yan
   Wei, Wei
   Mao, Jing
TI GEPIs-HA hybrid: A novel biomaterial for tooth repair
SO MEDICAL HYPOTHESES
LA English
DT Article
ID MOLECULAR BIOMIMETICS; HYDROXYAPATITE; NUCLEATION; AMELOGENIN; PEPTIDE;
   ENAMEL; GROWTH
AB Dental caries are slowly progressive and infectious disease, which result in localized dissolution and destruction of the calcified tissues. In routine clinical treatments, microleakage following with secondary caries usually occurs due to the discrepancy in physico-chemical property between fitted materials and tooth. Idea( filling materials for tooth defect should be similar to the structure and chemical composition of natural tooth. Recently, molecular biomimetics developed a novel nanotechnology through biology, which fabricate materials based on molecular recognition between genetically engineered peptides for inorganics (GEPIs) and inorganic crystal. Since GEPIs can be used in the assembly of functional nanostructures, we hypothesis that an analogue of dental hard tissue, hybrid of GEPIs and HA crystal, might be engineered using the recognition properties between GEPIs and HA crystal. (c) 2008 Published by Elsevier Ltd.
C1 [Zhou, Bin; Liu, Yan; Wei, Wei; Mao, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Stomatol, Wuhan 430030, Hubei, Peoples R China.
RP Mao, J (reprint author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Stomatol, 1095 Jiefang Rd, Wuhan 430030, Hubei, Peoples R China.
EM bzhou@tjh.tjmu.edu.cn; mao-jing1999@yahoo.com
FU National Science Foundation of China [30700957]
FX Funded by National Science Foundation of China which is conferred to Dr.
   B. Zhou (NSFC No.30700957).
CR Andersson Anita, 2007, Oral Health Prev Dent, V5, P229
   Bader J D, 2001, J Dent Educ, V65, P960
   Chen HF, 2005, J COLLOID INTERF SCI, V288, P97, DOI 10.1016/j.jcis.2005.02.064
   Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200
   Habelitz S, 2006, EUR J ORAL SCI, V114, P315, DOI 10.1111/j.1600-0722.2006.00312.x
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   KENNETH RS, 2007, DENT CLIN N AM, V51, P747
   Moradian-Oldak J, 2007, J DENT RES, V86, P487, DOI 10.1177/154405910708600603
   MUSTAFA G, 2008, BIOMACROMOLECULES, DOI DOI 10.1021/BM701037X
   Onuma K, 2005, J CRYST GROWTH, V282, P199, DOI 10.1016/j.jcrysgro.2005.04.085
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Tamerler C, 2007, ACTA BIOMATER, V3, P289, DOI 10.1016/j.actbio.2006.10.009
   Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001
   Vollenweider M, 2007, ACTA BIOMATER, V3, P936, DOI 10.1016/j.actbio.2007.04.003
   Yamagishi K, 2005, NATURE, V433, P819, DOI 10.1038/433819a
NR 15
TC 4
Z9 6
U1 1
U2 13
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD OCT
PY 2008
VL 71
IS 4
BP 591
EP 593
DI 10.1016/j.mehy.2008.04.024
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 361RW
UT WOS:000260145800020
PM 18657914
DA 2018-10-20
ER

PT J
AU Soman, P
   Rice, Z
   Siedlecki, CA
AF Soman, Pranav
   Rice, Zachary
   Siedlecki, Christopher A.
TI Immunological identification of fibrinogen in dual-component protein
   films by AFM imaging
SO MICRON
LA English
DT Review
DE AFW; fibrinogen; protein adsorption immunochemistry; biomaterials; gold
   labeling; biocompatibility; polymers
ID ATOMIC-FORCE MICROSCOPY; SUPPORTED PHOSPHOLIPID-BILAYERS;
   SURFACE-PLASMON RESONANCE; ION MASS-SPECTROMETRY; VOLUMETRIC
   INTERPRETATION; PLATELET-ADHESION; BINDING-SITES; ADSORPTION;
   LOCALIZATION; BIOMATERIALS
AB The success of long-term blood-contacting implanted devices is largely dependent upon the interaction of the blood components with the device biomaterial surface. The ability to study these interactions has been hindered by a lack of methods to measure single-molecule interactions in complex multi-protein environments similar to the environment found in vivo. In this paper, we demonstrate the use of atomic force microscopy (AFM) in conjunction with gold nanolabels to detect the protein fibrinogen under aqueous conditions without the topographical clues usually necessary for high resolution visualization. BSA was patterned onto both muscovite mica and plasma-treated polydimethylsiloxane (PDMS) substrates and these test substrates were subsequently backfilled with fibrinogen to yield a featureless protein layer. The fibrinogen in this dual-protein layer was detected using high resolution AFM imaging following infusion of anti-fibrinogen conjugated with nanogold particles. This AFM immuno-detection technique will potentially be applicable to complex multi-component protein films adsorbed on clinically relevant polymers used in medical devices. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Rice, Zachary; Siedlecki, Christopher A.] Penn State Univ, Coll Med, Dept Surg, Inst Biomed Engn, Hershey, PA 17033 USA.
   [Soman, Pranav; Siedlecki, Christopher A.] Penn State Univ, Coll Med, Dept Bioengn, Inst Biomed Engn, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Coll Med, Dept Surg, Inst Biomed Engn, Mail Code H151,500 Univ Dr, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
FU National Heart, Lung, and Blood Institute [N01HV48191]; National
   Institute of Health; National Science Foundation [NSF EEC-0234026];
   Pennsylvania Department of Health
FX Financial support for this work was provided by National Heart, Lung,
   and Blood Institute Contract N01HV48191, the Penn State University BBSI
   program through a grant from the National Institute of Health and the
   National Science Foundation (Funding #: NSF EEC-0234026), the Dorothy
   Foehr Huck and J. Lloyd Huck Institutes of the Life Sciences, and by a
   grant from the Pennsylvania Department of Health. The Pennsylvania
   Department of Health specifically disclaims responsibility for any
   analyses, interpretations or conclusions. The authors thank Dr. Keith
   Milner for preparing the silicone stamps for micro-contact printing and
   Dr. John Flanagan for assistance with HPLC purification. The authors
   would also like to thank Dr. Li-Chong Xu and Dr. Aashiish Agnihotri for
   valuable technical discussions.
CR Agnihotri A, 2006, J BIOMAT SCI-POLYM E, V17, P227, DOI 10.1163/156856206774879036
   Agnihotri A, 2005, ULTRAMICROSCOPY, V102, P257, DOI 10.1016/j.ultramic.2004.10.006
   Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Argaman M, 1997, NUCLEIC ACIDS RES, V25, P4379, DOI 10.1093/nar/25.21.4379
   Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Bar G, 1997, LANGMUIR, V13, P3807, DOI 10.1021/la970091m
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1
   Calvete JJ, 1999, P SOC EXP BIOL MED, V222, P29, DOI 10.1111/j.1525-1373.1999.09993.x
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   EPPELL SJ, 1995, BIOPHYS J, V68, P671, DOI 10.1016/S0006-3495(95)80228-6
   FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729
   Glasmastar K, 2002, J COLLOID INTERF SCI, V246, P40, DOI 10.1006/jcis.2001.8060
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   HAINFELD JF, 1997, CELL VISION, V4, P408
   Hantgan R. R., 2001, HEMOSTASIS THROMBOSI, P203
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Hussain MA, 2005, LANGMUIR, V21, P6979, DOI 10.1021/la046943h
   Krishnan A, 2006, BIOMATERIALS, V27, P3187, DOI 10.1016/j.biomaterials.2005.12.032
   Lassen B, 1996, J COLLOID INTERF SCI, V179, P470, DOI 10.1006/jcis.1996.0239
   Lin H, 2000, BIOCHEMISTRY-US, V39, P3192, DOI 10.1021/bi991624o
   Marchant RE, 2002, CURR PROTEIN PEPT SC, V3, P249, DOI 10.2174/1389203023380611
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   Montesano-Roditis L, 2001, J BIOL CHEM, V276, P14117, DOI 10.1074/jbc.M008430200
   Noh H, 2006, BIOMATERIALS, V27, P5801, DOI 10.1016/j.biomaterials.2006.08.005
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   Osada T, 2003, ULTRAMICROSCOPY, V97, P353, DOI 10.1016/S0304-3991(03)00060-3
   Pickering JP, 1998, POLYM BULL, V40, P549, DOI 10.1007/s002890050289
   Plow E. F., 2001, HEMOSTASIS THROMBOSI, P479
   PUTNAM CAJ, 1993, ULTRAMICROSCOPY, V48, P177
   Radmacher M, 1997, IEEE ENG MED BIOL, V16, P47, DOI 10.1109/51.582176
   Raghavachari M, 2000, THROMB RES, V98, P351, DOI 10.1016/S0049-3848(00)00185-7
   Reviakine I, 2000, LANGMUIR, V16, P1806, DOI 10.1021/la9903043
   Reviakine I, 2000, LANGMUIR, V16, P1473, DOI 10.1021/la990806g
   Thibault C, 2005, J Nanobiotechnology, V3, P7, DOI 10.1186/1477-3155-3-7
   Toscano A, 2006, LANGMUIR, V22, P2588, DOI 10.1021/la051641g
   Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x
   Truong C. Ta., 1998, LANGMUIR, V14, P2435
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1017, DOI 10.1002/jbm.820290814
   Wagner MS, 2003, BIOMATERIALS, V24, P1897, DOI 10.1016/S0142-9612(02)00612-9
   Wagner MS, 2003, J BIOMED MATER RES A, V64A, P1, DOI 10.1002/jbm.a.10263
   WAKAKO S, 2006, NEUROSCI LETT, V391, P102
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Yang RB, 2000, J COMP NEUROL, V425, P139, DOI 10.1002/1096-9861(20000911)425:1<139::AID-CNE12>3.0.CO;2-#
NR 49
TC 18
Z9 18
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD OCT
PY 2008
VL 39
IS 7
BP 832
EP 842
DI 10.1016/j.micron.2007.12.013
PG 11
WC Microscopy
SC Microscopy
GA 351KI
UT WOS:000259422800011
PM 18294855
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Engberg, A
   Rosengren-Holmberg, J
   Nicholls, I
   Ekdahl, KN
AF Engberg, Anna
   Rosengren-Holmberg, Jenny
   Nicholls, Ian
   Ekdahl, Kristina Nilsson
TI Development of novel biomaterial surfaces and evaluation of their
   hemocompatibility
SO MOLECULAR IMMUNOLOGY
LA English
DT Meeting Abstract
CT 22nd International Complement Workshop
CY SEP 28-OCT 02, 2008
CL Basel, SWITZERLAND
C1 [Engberg, Anna; Rosengren-Holmberg, Jenny; Nicholls, Ian; Ekdahl, Kristina Nilsson] Univ Kalmar, Sch Pure & Appl Nat Sci, Kalmar, Sweden.
RI Nicholls, Ian/A-1976-2009
OI Nicholls, Ian/0000-0002-0407-6542; Rosengren Holmberg,
   Jenny/0000-0003-2417-9175
NR 0
TC 1
Z9 1
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD OCT
PY 2008
VL 45
IS 16
SI SI
MA P262
BP 4182
EP 4182
DI 10.1016/j.molimm.2008.08.261
PG 1
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 363DB
UT WOS:000260245000268
DA 2018-10-20
ER

PT J
AU He, QH
   Zhang, ZX
   Xiong, JW
   Xiong, YY
   Xiao, H
AF He, Qinghang
   Zhang, Zhenxi
   Xiong, Jianwen
   Xiong, Yuying
   Xiao, Hua
TI A novel biomaterial - Fe3O4:TiO2 core-shell nano particle with magnetic
   performance and high visible light photocatalytic activity
SO OPTICAL MATERIALS
LA English
DT Article
DE Fe3O4:TiO2 core-shell NP; Malignant tumor therapy; Photocatalytic
   activity; Homogeneous precipitation method
ID TIO2; DISINFECTION; DEGRADATION; FILMS; DYE
AB Aiming at some disadvantages of TiO2 nano particle (TiO2 NP), this paper successfully prepared Fe3O4: TiO2 core-shell nano particle (Fe3O4:TiO2 core-shell NP) using homogeneous precipitation method. The prepared Fe3O4:TiO2 core-shell NP was characterized using XRD, TEM. UV-vis DRS, FT-IR, and VSM, respectively: the results show that Fe3O4:TiO2 core-shell NP is single dispersed with the diameter of 20 nm on average. In contrast to the traditional TiO2 NP, Fe3O4:TiO2 core-shell NP generates red shift, and has higher absorption in visible region and greater photocatalytic activity, plus additional superpara-magetism. In order to demonstrate the benefits of Fe3O4:TiO2 core-shell NP, we adopted Hela cells as a model to investigate the killing efficiency. The results show that Fe3O4:TiO2 core-shell NP is non-toxic, and much more efficient than traditional TiO2 NP combined with extra magnetic field. This shows that Fe3O4:TiO2 core-shell NP is a novel biomaterial with magnetic performance and high visible light photocatalytic activity. It would be a promising candidate in the field of malignant tumor therapy in future. (C) 2008 Elsevier B.V. All rights reserved.
C1 [He, Qinghang; Zhang, Zhenxi] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China.
   [He, Qinghang; Zhang, Zhenxi] Xi An Jiao Tong Univ, Inst Biomed Analyt Technol & Instrumentat, Sch Life Sci & Technol, Xian 710049, Peoples R China.
   [He, Qinghang] Xiamen Food & Drug Adm, Xiamen 361004, Peoples R China.
   [Xiong, Jianwen; Xiong, Yuying; Xiao, Hua] S China Normal Univ, Dept Phys, Guangzhou 510631, Guangdong, Peoples R China.
RP Zhang, ZX (reprint author), Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China.
EM zxzhang@mail.xjtu.edu.cn
FU National Natural Science Foundation of China [60578026]
FX The authors are grateful for the financial support provided by the
   National Natural Science Foundation of China (Grant Number: 60578026).
CR Behnajady MA, 2007, CHEM ENG J, V127, P167, DOI 10.1016/j.cej.2006.09.013
   Choi H., 2007, DESALINATION, V202, P200
   Christensen PA, 2003, APPL CATAL B-ENVIRON, V41, P371, DOI 10.1016/S0926-3373(02)00172-8
   Dadjour MF, 2006, WATER RES, V40, P1137, DOI 10.1016/j.watres.2005.12.047
   FUJISHIMA A, 2000, J PHOTOCHEM PHOTOBIO, V1, P12
   GUAN B, 2007, J AM SOC SPECTROM, V81, P519
   Kleiman A, 2007, SURF COAT TECH, V201, P6358, DOI 10.1016/j.surfcoat.2006.12.002
   Li JY, 2007, J MOL CATAL A-CHEM, V261, P131, DOI 10.1016/j.molcata.2006.08.018
   Murphy AB, 2007, SOL ENERG MAT SOL C, V91, P1326, DOI 10.1016/j.solmat.2007.05.005
   OH ST, 2007, J MOL CATAL A-CHEM, V267, P118
   OKADA K, 2007, MAT RES B, V42, P1922
   SANG LX, 2003, CHEM J CHIN U CHIN, V246, P165
   Sichel C, 2007, APPL CATAL B-ENVIRON, V74, P152, DOI 10.1016/j.apcatb.2007.02.005
   Tachibana Y, 2007, SOL ENERG MAT SOL C, V91, P201, DOI 10.1016/j.solmat.2006.09.001
   XIE YB, 2006, ELECTROCHIM ACTA, V51, P3406
   Yamazaki S, 2007, J PHOTOCH PHOTOBIO A, V185, P150, DOI 10.1016/j.jphotochem.2006.05.024
   Zallen R, 2006, SOLID STATE COMMUN, V137, P154, DOI 10.1016/j.ssc.2005.10.024
   ZHAO Y, 2007, MATER LETT, V61, P83
NR 18
TC 96
Z9 104
U1 4
U2 127
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-3467
J9 OPT MATER
JI Opt. Mater.
PD OCT-DEC
PY 2008
VL 31
IS 2
BP 380
EP 384
DI 10.1016/j.optmat.2008.05.011
PG 5
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA 385NZ
UT WOS:000261822200051
DA 2018-10-20
ER

PT J
AU Falco, EE
   Patel, M
   Fisher, JP
AF Falco, Erin E.
   Patel, Minal
   Fisher, John P.
TI Recent developments in cyclic acetal biomaterials for tissue engineering
   applications
SO PHARMACEUTICAL RESEARCH
LA English
DT Review
DE biomaterial; cyclic acetal; polyacetal; polyketal; tissue engineering
ID POLY(PROPYLENE FUMARATE)-BASED NETWORKS; SYNTHETIC BIODEGRADABLE
   POLYMERS; PH-DEPENDENT DEGRADATION; DRUG-DELIVERY SYSTEMS; IN-VITRO;
   MECHANICAL-PROPERTIES; POLY(L-LACTIC ACID); SURFACE-MORPHOLOGY;
   POLYACETAL; HYDROGELS
AB At an ever increasing pace, synthetic biomaterials are being developed with specific functionalities for tissue engineering applications. These biomaterials possess properties including biocompatibility, mechanical strength, and degradation as well as functionalities such as specific cell adhesion and directed cell migration. However, synthetic polymers are often not completely biologically inert and may non-specifically react with the surrounding in vivo environment. An example of this reactivity is the release of acidic degradation products from hydrolytically degradable polymers based upon an ester moiety. In order to address this concern, a novel class of biomaterials based upon a cyclic acetal unit has been developed. Scaffolds suitable for the replacement of both hard and soft tissues have been successfully fabricated from cyclic acetals and a detailed characterization of scaffold properties has been performed. Cyclic acetal based biomaterials have also been used to repair bone defects and promote bone growth, displaying a minimal inflammatory response. This review will discuss the most recent research of current biomaterials and cyclic acetals, and particularly focus on the tissue engineering applications of these materials. Finally, this review will also briefly discuss polyacetals and polyketals for drug delivery applications.
C1 [Patel, Minal; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Falco, Erin E.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg 225, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
FU Arthritis Foundation; National Science Foundation [0448684]; State of
   Maryland Department of Business and Economic Development
FX This work was supported by the Arthritis Foundation through an Arthritis
   Investigator Award to JPF, the National Science Foundation through a
   CAREER Award to JPF (#0448684), and the State of Maryland Department of
   Business and Economic Development.
CR Al Malyan M, 2006, J CRANIOFAC SURG, V17, P302, DOI 10.1097/00001665-200603000-00018
   Allen C, 2002, BIOSCIENCE REP, V22, P225, DOI 10.1023/A:1020186505848
   An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Behravesh E, 1999, CLIN ORTHOP RELAT R, pS118
   BETZ MW, 2007, J BIOMED MAT A  1116
   BETZ MW, 2008, J BIOMED A IN PRESS
   Bohner M, 2001, EUR SPINE J, V10, pS114, DOI 10.1007/s005860100276
   Bramfeldt H, 2007, J BIOMED MATER RES A, V83A, P503, DOI 10.1002/jbm.a.31300
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Brem H, 1995, J NEURO-ONCOL, V26, P111, DOI 10.1007/BF01060217
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   CASCONE MG, 1995, BIOMATERIALS, V16, P569, DOI 10.1016/0142-9612(95)91131-H
   Cohen SR, 2006, J CRANIOFAC SURG, V17, P40, DOI 10.1097/01.scs.0000200411.22583.4e
   Daniels A. U., 1992, T ORTHOP RES SOC, V17, P88
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Delie F, 2005, MOLECULES, V10, P65, DOI 10.3390/10010065
   FALCO EE, 2007, J SURG RES      0918
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gilbert TW, 2007, BIOMATERIALS, V28, P147, DOI 10.1016/j.biomaterials.2006.08.022
   Gillies ER, 2004, J AM CHEM SOC, V126, P11936, DOI 10.1021/ja0463738
   Gunatillake P, 2006, BIOTECHNOL ANN REV, V12, P301, DOI 10.1016/S1387-2656(06)12009-8
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   Heffernan MJ, 2005, BIOCONJUGATE CHEM, V16, P1340, DOI 10.1021/bc050176w
   Heller J, 2004, BIOMACROMOLECULES, V5, P1625, DOI 10.1021/bm040049n
   HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Il Lee K, 2007, J ACOUST SOC AM, V121, pEL263, DOI 10.1121/1.2719046
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kaihara S, 2007, NAT PROTOC, V2, P2767, DOI 10.1038/nprot.2007.391
   Kaihara S, 2007, MACROMOLECULES, V40, P7625, DOI 10.1021/ma071297p
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Khaja SD, 2007, BIOMACROMOLECULES, V8, P1391, DOI 10.1021/bm061234z
   Kim TG, 2007, INT J PHARM, V338, P276, DOI 10.1016/j.ijpharm.2007.01.040
   Kumar N, 2002, ADV DRUG DELIVER REV, V54, P889, DOI 10.1016/S0169-409X(02)00050-9
   Kurtz SM, 2000, J BIOMED MATER RES, V52, P447
   LAM KH, 1995, J BIOMED MATER RES, V29, P929, DOI 10.1002/jbm.820290804
   LAM KH, 1993, J BIOMED MATER RES, V27, P1569, DOI 10.1002/jbm.820271214
   Lee S, 2007, BIOCONJUGATE CHEM, V18, P4, DOI 10.1021/bc060259s
   Lemcoff NG, 2002, ORG LETT, V4, P731, DOI 10.1021/ol017230i
   Lendlein A, 2005, Med Device Technol, V16, P12
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mistry AS, 2007, J BIOMED MATER RES A, V83A, P940, DOI 10.1002/jbm.a.31280
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Mundargi RC, 2007, J CONTROL RELEASE, V119, P59, DOI 10.1016/j.jconrel.2007.01.008
   Nakabayashi N, 2003, BIOMATERIALS, V24, P2437, DOI 10.1016/S0142-9612(03)00112-1
   Nomura M, 2003, BIOORGAN MED CHEM, V11, P2453, DOI 10.1016/S0968-0896(03)00104-4
   Papisov MI, 2005, BIOMACROMOLECULES, V6, P2659, DOI 10.1021/bm0502157
   Patel M, 2008, PEDIATR RES, V63, P497, DOI 10.1203/01.PDR.0b013e318165eb3e
   Periti P, 2002, CLIN PHARMACOKINET, V41, P485, DOI 10.2165/00003088-200241070-00003
   Poletto FS, 2007, INT J PHARMACEUT, V345, P70, DOI 10.1016/j.ijpharm.2007.05.040
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2003, EUR CELLS MATER, V5, P39
   Sartor O, 2003, UROLOGY, V62, P319, DOI 10.1016/S0090-4295(03)00330-3
   Schacht E, 2006, J CONTROL RELEASE, V116, P219, DOI 10.1016/j.jconrel.2006.07.026
   Schlosser M, 2005, J BIOMED MATER RES A, V72A, P317, DOI 10.1002/jbm.a.30240
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   Sitharaman B, 2007, J BIOMAT SCI-POLYM E, V18, P655, DOI 10.1163/156856207781034133
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   STENZL A, 2007, INT BRAZ J UROL, V33, P871
   Strazar K, 2006, BIOMACROMOLECULES, V7, P2507, DOI 10.1021/bm060239t
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   Takada S, 1998, Nihon Rinsho, V56, P675
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Thompson MS, 2001, J MATER SCI-MATER M, V12, P883, DOI 10.1023/A:1012815822323
   Timmer MD, 2003, J BIOMED MATER RES A, V66A, P811, DOI 10.1002/jbm.a.10011
   Timmer MD, 2003, J BIOMAT SCI-POLYM E, V14, P369, DOI 10.1163/156856203321478874
   Timmer MD, 2003, BIOMATERIALS, V24, P571, DOI 10.1016/S0142-9612(02)00368-X
   Tomlinson R, 2003, BIOCONJUGATE CHEM, V14, P1096, DOI 10.1021/bc030028a
   Tomlinson R, 2002, MACROMOLECULES, V35, P473, DOI 10.1021/ma0108867
   UPPAL P, 1994, J OCUL PHARMACOL, V10, P471, DOI 10.1089/jop.1994.10.471
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Vicent MJ, 2004, J DRUG TARGET, V12, P491, DOI 10.1080/10611860400011885
NR 77
TC 34
Z9 35
U1 0
U2 40
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD OCT
PY 2008
VL 25
IS 10
BP 2348
EP 2356
DI 10.1007/s11095-008-9620-5
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 348CE
UT WOS:000259187800018
PM 18536870
OA Bronze
DA 2018-10-20
ER

PT J
AU Romer, L
   Scheibel, T
AF Roemer, Lin
   Scheibel, Thomas
TI The elaborate structure of spider silk Structure and function of a
   natural high performance fiber
SO PRION
LA English
DT Reprint
DE biomimetics; biotechnology; protein folding; protein assembly; spinning
ID CONSERVED C-TERMINI; DRAGLINE SILK; MECHANICAL-PROPERTIES; FLAGELLIFORM
   SILK; ESCHERICHIA-COLI; PROTEINS; SUPERCONTRACTION; DESIGN; ORIENTATION;
   SEQUENCE
AB Biomaterials, having evolved over millions of years, often exceed man-made materials in their properties. Spider silk is one outstanding fibrous biomaterial which consists almost entirely of large proteins. Silk fibers have tensile strengths comparable to steel and some silks are nearly as elastic as rubber on a weight to weight basis. In combining these two properties, silks reveal a toughness that is two to three times that of synthetic fibers like Nylon or Kevlar. Spider silk is also antimicrobial, hypoallergenic and completely biodegradable.
   This article focuses on the structure-function relationship of the characterized highly repetitive spider silk spidroins and their conformational conversion from solution into fibers. Such knowedge is of crucial importance to understanding the intrinsic properties of spider silk and to get insight into the sophisticated assembly processes of silk proteins. This review further outlines recent progress in recombinant production of spider silk proteins and their assembly into distinct polymer materials as a basis for novel products.
C1 [Roemer, Lin; Scheibel, Thomas] Univ Bayreuth, Fak Angew Nat Wissensch, Lehrstuhl Biomat, D-95447 Bayreuth, Germany.
RP Scheibel, T (reprint author), Univ Bayreuth, Fak Angew Nat Wissensch, Lehrstuhl Biomat, Univ Str 30, D-95447 Bayreuth, Germany.
EM thomas.scheibel@uni-bayreuth.de
RI Scheibel, Thomas/I-1170-2014
OI Scheibel, Thomas/0000-0002-0457-2423
CR Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100
   Ayoub N. A., 2007, PLOS ONE, V2, P514
   Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng1011
   Dicko C, 2004, BIOCHEMISTRY-US, V43, P14080, DOI 10.1021/bi0483413
   Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a
   Emile O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.167402
   Exler JH, 2007, ANGEW CHEM INT EDIT, V46, P3559, DOI 10.1002/anie.200604718
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Fraser R., 1973, CONFORMATION FIBROUS
   Gao HJ, 2004, P NATL ACAD SCI USA, V101, P7851, DOI 10.1073/pnas.0400757101
   GERRITSEN V. B., 2000, PROTEIN SPOTLIGHT, V24, P1
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 2001, BIOESSAYS, V23, P750, DOI 10.1002/bies.1105
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   Hu XY, 2007, BIOCHEMISTRY-US, V46, P3294, DOI 10.1021/bi602507e
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Ittah S, 2007, BIOMACROMOLECULES, V8, P2768, DOI 10.1021/bm7004559
   Jelinski LW, 1999, INT J BIOL MACROMOL, V24, P197, DOI 10.1016/S0141-8130(98)00085-3
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KAPLAN D, 1993, ACS S SERIES
   Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x
   Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099
   Kubik S, 2002, ANGEW CHEM INT EDIT, V41, P2721, DOI 10.1002/1521-3773(20020802)41:15<2721::AID-ANIE2721>3.0.CO;2-3
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmet1534
   Metwalli E, 2007, APPL PHYS A-MATER, V89, P655, DOI 10.1007/s00339-007-4265-5
   Miao YG, 2006, APPL MICROBIOL BIOT, V71, P192, DOI 10.1007/s00253-005-0127-2
   Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b
   NENTWIG W, 1982, OECOLOGIA, V53, P412, DOI 10.1007/BF00389023
   Padgett KA, 1996, GENE, V168, P31, DOI 10.1016/0378-1119(95)00731-8
   Perez-Rigueiro J, 2003, POLYMER, V44, P3733, DOI 10.1016/S0032-3861(03)00245-3
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Riekel C, 1999, INT J BIOL MACROMOL, V24, P179, DOI 10.1016/S0141-8130(98)00084-1
   Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Scheibel T, 2005, CURR OPIN BIOTECH, V16, P427, DOI 10.1016/j.copbio.2005.05.005
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Schmidt M, 2007, BIOTECHNOL LETT, V29, P1741, DOI 10.1007/s10529-007-9461-z
   Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880
   Sengupta S., 2007, PROTEIN FOLDING MISF, P1
   Shao Z, 1999, POLYMER, V40, P2493, DOI 10.1016/S0032-3861(98)00475-3
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Slotta U, 2007, MACROMOL BIOSCI, V7, P183, DOI 10.1002/mabi.200600201
   Slotta U, 2006, SUPRAMOL CHEM, V18, P465, DOI 10.1080/10610270600832042
   Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048
   Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b
   TERMONIA Y, 1994, PHYS REV LETT, V72, P3678, DOI 10.1103/PhysRevLett.72.3678
   Townley MA, 2006, J EXP BIOL, V209, P1463, DOI 10.1242/jeb.02147
   TRIVEDI BP, LAB SPINS ARTIFICIAL
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vendrely Charlotte, 2008, V474, P3, DOI 10.1007/978-1-59745-480-3_1
   VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447
   Vollrath F, 2000, J Biotechnol, V74, P67
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Wilding M. A., 1996, POLYM MAT ENCY, V11, P8307
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yang ZT, 2000, J AM CHEM SOC, V122, P9019, DOI 10.1021/ja0017099
   ZSCHOKKE S, 1993, B BR ARACHNOL SOC, V9, P167
NR 74
TC 100
Z9 104
U1 2
U2 59
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1002 WEST AVENUE, 2ND FLOOR, AUSTIN, TX 78701 USA
SN 1933-6896
J9 PRION
JI Prion
PD OCT-DEC
PY 2008
VL 2
IS 4
BP 154
EP 161
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 415DB
UT WOS:000263913400005
PM 19221522
DA 2018-10-20
ER

PT J
AU Kundu, SC
   Dash, BC
   Dash, R
   Kaplan, DL
AF Kundu, Subhas C.
   Dash, Biraja C.
   Dash, Rupesh
   Kaplan, David L.
TI Natural protective glue protein, sericin bioengineered by silkworms:
   Potential for biomedical and biotechnological applications
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Silk proteins; Sericin; Fibroin; Cosmetics; Anticancer drugs;
   Biomaterial
ID TROPICAL TASAR SILKWORM; SECRETES RECOMBINANT PROTEINS; REDUCING
   OXIDATIVE STRESS; ACUTE SERUM DEPRIVATION; BOMBYX-MORI SILKGLAND;
   LIGHT-CHAIN GENE; ANTHERAEA-MYLITTA; MOLECULAR PHYLOGENY; FIBROBLAST
   CELLS; L-ASPARAGINASE
AB Silk proteins consist of a fibrous core protein, fibroin, and glue proteins called sericins, which envelop the fibroin fiber with successive sticky layers that help in the formation of a cocoon by cementing together the silk fibers. This system is essentially a protein-fiber composite system, with fibers of the high-molecular-weight fibroin proteins surrounded by the gluelike continuous phase of the sericin. In mulberry silk produced by Bombyx man, Ser1 and Ser2 are the two major genes encoding for sericin. Ser1 is the most abundant silk sericin of B. moli and consists of repeats of a 38-amino acid motif that contributes towards the hydrophilicity of sericin. The protein has partially been characterized from non-mulberry silkworms like the tropical tasar Antheraea mylitta, and studied for various potential applications because of its unique biochemical and biophysical properties. These applications include the skincare and food industries, as coating material for biomedical applications like anticoagulants, in anticancer drugs, for drug delivery, and in tissue engineering. Sericin promotes proliferation of cells when used as a constituent of cell culture in serum-free media. Sericin also supports cell adhesion and proliferation when used in pure form and/or blended in matrices. Sericin films, 3D scaffolds, nanoparticles, composites, conjugated drugs, and recombinant sericins offer potential future options for these needs. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Kundu, Subhas C.; Dash, Biraja C.; Dash, Rupesh] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI DASH, BIRAJA/B-3966-2018
OI DASH, BIRAJA/0000-0002-1795-3284; Kundu, Subhas C./0000-0002-7170-2291;
   dash, rupesh/0000-0001-5740-7053
FU Department of Science and Technology, Department of Biotechnology [BR/PR
   6035/MED/14/733/05, BT/PR 9552/ICD/16/755/06]; Council of Scientific and
   Industrial Research, Govt. of India; Indo-US Scientific and Technology
   Foundation, New Delhi; Department of Biotechnology, Indian Institute of
   Technology, Kharagpur; the Department of Biomedical Engineering, Tufts
   University; NIH Tissue Engineering Resource Center [P41 EB002520]
FX The Department of Science and Technology, Department of Biotechnology
   (BR/PR 6035/MED/14/733/05; BT/PR 9552/ICD/16/755/06), and Council of
   Scientific and Industrial Research, Govt. of India, Indo-US Scientific
   and Technology Foundation, New Delhi supported this work at the
   Department of Biotechnology, Indian Institute of Technology, Kharagpur.
   S.C.K. wishes to thank to the Department of Biomedical Engineering,
   Tufts University for hospitality during his short visit. Support from
   the NIH Tissue Engineering Resource Center (P41 EB002520) is
   acknowledged. We appreciate the assistance of Sakya Sarkar and Ishan
   Chaturvedi during video clipping.
CR Ahmad R, 2004, DNA CELL BIOL, V23, P149, DOI 10.1089/104454904322964742
   Ahn JS, 2001, J APPL POLYM SCI, V80, P274, DOI 10.1002/1097-4628(20010411)80:2<274::AID-APP1096>3.0.CO;2-G
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anghileri A, 2007, J BIOTECHNOL, V127, P508, DOI 10.1016/j.jbiotec.2006.07.021
   Bindu PC, 2006, BIOCHEM SYST ECOL, V34, P698, DOI 10.1016/j.bse.2006.05.003
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cheng TC, 2004, INSECT BIOCHEM MOLEC, V34, P523, DOI 10.1016/j.ibmb.2004.02.004
   CHEVILLARD M, 1986, NUCLEIC ACIDS RES, V14, P6341, DOI 10.1093/nar/14.15.6341
   Chevillard M, 1986, SERICOLOGIA, V26, P435
   Cho KY, 2003, INT J BIOL MACROMOL, V32, P36, DOI 10.1016/S0141-8130(03)00023-0
   CORTEZ J, 2006, ENZYME MICROB TECHNO, V40, P1698
   COUBLE P, 1985, NUCLEIC ACIDS RES, V13, P1801, DOI 10.1093/nar/13.5.1801
   COUBLE P, 1983, DEV BIOL, V97, P398, DOI 10.1016/0012-1606(83)90096-9
   COUBLE P, 1987, DEV BIOL, V124, P431, DOI 10.1016/0012-1606(87)90496-9
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   Dash R, 2008, BMB REP, V41, P236, DOI 10.5483/BMBRep.2008.41.3.236
   Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   Datta A, 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI 10.1016/S0965-1748(01)00049-2
   DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9
   ENGEL W, 1987, Patent No. 3603595
   Evans W.C, 1996, TREASE EVANS PHARMAC
   Fabiani C, 1996, DESALINATION, V105, P1, DOI 10.1016/0011-9164(96)00050-1
   Fraga DW, 1998, TRANSPLANTATION, V65, P1060, DOI 10.1097/00007890-199804270-00009
   FUKUTA M, 1993, J BIOL CHEM, V268, P19471
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2
   GAREL A, 1994, GENETICA, V93, P125, DOI 10.1007/BF01435245
   GEIER P. W., 1963, AUSTRALIAN JOUR ZOOL, V11, P323, DOI 10.1071/ZO9630323
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   GRZELAK K, 1995, COMP BIOCH PHYSL B, V110, P61
   HAMADA Y, 1987, CELL DIFFER DEV, V20, P65, DOI 10.1016/0045-6039(87)90466-0
   HENNE W, 1985, Patent No. 3408406
   Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028
   HIRABAYASHI K, 1989, NIPPON SANSHIGAKU ZA, V58, P81
   HOPPE U, 1984, Patent No. 3233388
   HU G, 1997, GONGXUEYUAN XUEBAO, V14, P154
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   HUI CC, 1990, J MOL BIOL, V213, P395, DOI 10.1016/S0022-2836(05)80201-3
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   ISHIKAWA E, 1985, DEV GROWTH DIFFER, V27, P73
   JAFFE N, 1973, CANCER RES, V33, P1
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Johnson CD, 2001, COLEOPTS BULL, V55, P37, DOI 10.1649/0010-065X(2001)055[0037:EOACRC]2.0.CO;2
   Jolly M. S., 1969, Bulletin of Entomology Entomological Society of India, V10, P32
   Jolly M. S, 1970, Entomologist, V103, P18
   Jolly M. S., 1974, TASAR CULTURE
   JOLLY MS, 1987, FAO AGR SERVICES  29, V4, P1
   JONES D, 1985, J COMP PHYSIOL B, V155, P235, DOI 10.1007/BF00685218
   JUN L, 1997, CANYE KEXE, V23, P47
   Kaplan D, 1994, SILK POLYM MAT SCI B
   KAPLAN DL, 1992, MATER RES SOC S P, V255, P19
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kato N., 1998, BIOSCI BIOTECH BIOCH, V62, P45
   KAUFFMAN WC, 1989, J CHEM ECOL, V15, P2051, DOI 10.1007/BF01207437
   KIKUCHI Y, 1992, GENE, V110, P151, DOI 10.1016/0378-1119(92)90642-3
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   KIMURA K, 1985, EXPERIENTIA, V41, P1167, DOI 10.1007/BF01951711
   KIRIKAWA M, 2000, Patent No. 2000044598
   Kweon HY, 2000, MACROMOL RAPID COMM, V21, P1302, DOI 10.1002/1521-3927(20001201)21:18<1302::AID-MARC1302>3.3.CO;2-Y
   Li AL, 2005, J GENET, V84, P137, DOI 10.1007/BF02715839
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   Lucas F., 1968, Comprehensive Biochem, V26, P475
   MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340
   MAEKAWA H, 1980, DEV BIOL, V78, P394, DOI 10.1016/0012-1606(80)90343-7
   Mahendran B, 2006, J GENET, V85, P31, DOI 10.1007/BF02728967
   Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010
   Mahendran B., 2005, CURR SCI, V90, P100
   Mahendran B, 2006, J BIOCHEM MOL BIOL, V39, P522
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mathe G, 1970, Recent Results Cancer Res, V33, P278
   MATSUNO K, 1990, NUCLEIC ACIDS RES, V18, P1853, DOI 10.1093/nar/18.7.1853
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   MICHAILLE JJ, 1989, INSECT BIOCHEM, V19, P19, DOI 10.1016/0020-1790(89)90005-X
   MICHAILLE JJ, 1986, BIOCHIMIE, V68, P1165, DOI 10.1016/S0300-9084(86)80060-8
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MIYASHITA T, 1999, Patent No. 11152206
   Monti P, 2007, J MOL STRUCT, V834, P202, DOI 10.1016/j.molstruc.2006.11.009
   MOROOKA H, 2006, SEN-I GAKKAISHI, V62, P48
   Nagaraju J, 2002, MOL CELL PROBE, V16, P67, DOI 10.1006/mcpr.2001.0404
   NAGURA M, 2004, T 7 WORLD BIOM C, P1207
   Nagura Masanobu, 2001, Journal of Insect Biotechnology and Sericology, V70, P149
   Nakamura K, 1984, SEN-I GAKKAISHI, V40, P327
   Nakamura K., 2001, Japan Patent, Patent No. [2001106794, 2001-106794A]
   Ogawa A, 2004, J BIOSCI BIOENG, V98, P217
   Ogawa A, 1999, Japan Patent Publication Number, Patent No. [11193210 A2, 11193210]
   Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019
   OKAMOTO H, 1982, J BIOL CHEM, V257, P5192
   Osamu H., 1987, Japan Patent, Patent No. [JP62036308, 62036308]
   Padamwar M. N., 2003, INDIAN DRUGS, V40, P526
   Padamwar MN, 2004, J SCI IND RES INDIA, V63, P323
   PADAMWAR MN, 2002, 62 WORLD C FIP NIC
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Prasad MD, 2005, GENETICS, V169, P197, DOI 10.1534/gentics.104.031005
   PRUDHOMME JC, 1985, COMPREHENSIVE INSECT, V17, P571
   Reddy KD, 1999, GENOME, V42, P1057, DOI 10.1139/gen-42-6-1057
   Saha M, 2006, BIOCHEM GENET, V44, P72, DOI 10.1007/s10528-006-9007-4
   SAKAMOTO K, 2000, Patent No. 2000073090
   Sasaki M, 2000, NUTR RES, V20, P1505, DOI 10.1016/S0271-5317(00)80031-7
   Sasaki M, 2005, BIOTECHNOL APPL BIOC, V42, P183, DOI 10.1042/BA20050019
   Sasaki M, 2000, ONCOL REP, V7, P1049
   Sasaki M., 2000, FOOD SCI TECHNOL RES, V6, P280
   SEHNAL F, 1990, INT J INSECT MORPHOL, V19, P79, DOI 10.1016/0020-7322(90)90022-H
   SHIMADA T, 1995, MOL PHYLOGENET EVOL, V4, P223, DOI 10.1006/mpev.1995.1021
   SHIMURA K, 1976, J BIOCHEM-TOKYO, V80, P693, DOI 10.1093/oxfordjournals.jbchem.a131328
   SHIMURA K, 1982, Journal of Sericultural Science of Japan, V51, P20
   SINHA AK, 1994, P C CYTOL GENET, V4, P7
   SINOHARA H, 1979, COMP BIOCHEM PHYS B, V63, P87, DOI 10.1016/0305-0491(79)90239-6
   SINOHARA H, 1971, BIOCHIM BIOPHYS ACTA, V237, P273, DOI 10.1016/0304-4165(71)90317-5
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Song Y, 2006, POLYM POLYM COMPOS, V14, P169, DOI 10.1177/096739110601400206
   Song Y, 2006, POLYM INT, V55, P1350, DOI 10.1002/pi.2093
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   SOUCHE YS, 2000, J BIOSCIENCE, V25, P361
   SPRAGUE KU, 1975, BIOCHEMISTRY-US, V14, P925, DOI 10.1021/bi00676a008
   Suzuki N, 2004, BIOFACTORS, V21, P329, DOI 10.1002/biof.552210164
   Takahashi M, 2005, BIOTECHNOL LETT, V27, P893, DOI 10.1007/s10529-005-7177-5
   Takahashi M, 2003, BIOTECHNOL LETT, V25, P1805, DOI 10.1023/A:1026284620236
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Takasu Y, 2007, INSECT BIOCHEM MOLEC, V37, P1234, DOI 10.1016/j.ibmb.2007.07.009
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Takeuchi A, 2004, KEY ENG MAT, V254-2, P403, DOI 10.4028/www.scientific.net/KEM.254-256.403
   Tamada Y, 2004, J BIOMAT SCI-POLYM E, V15, P971, DOI 10.1163/1568562041526469
   TAN YD, 2001, GENETICS, V157, P1227
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
   Tao W, 2005, MACROMOL MATER ENG, V290, P188, DOI 10.1002/mame.200400306
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Teramoto H, 2006, MACROMOLECULES, V39, P6, DOI 10.1021/ma0521147
   Teramoto H, 2005, BIOMACROMOLECULES, V6, P2049, DOI 10.1021/bm0500547
   Teramoto H, 2005, BIOSCI BIOTECH BIOCH, V69, P845, DOI 10.1271/bbb.69.845
   Teramoto H, 2007, MACROMOLECULES, V40, P1562, DOI 10.1021/ma062604e
   TOKUTAKE S, 1980, BIOCHEM J, V187, P413, DOI 10.1042/bj1870413
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Tomita M, 2007, TRANSGENIC RES, V16, P449, DOI 10.1007/s11248-007-9087-x
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   Tsubouchi K, 1999, Japan patent, Patent No. [11-070160A, 11070160]
   Tsukada M., 1981, B SCI I TEXT FR, V10, P141
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Veronese FM, 1999, FARMACO, V54, P497, DOI 10.1016/S0014-827X(99)00066-X
   Vicent MJ, 2006, TRENDS BIOTECHNOL, V24, P39, DOI 10.1016/j.tibtech.2005.11.006
   Voegeli R., 1993, COSMET TOILETRIES, V108, P101
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang Su, 1998, Journal of Sericultural Science of Japan, V67, P295
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wei DQ, 1989, ACTA POLYM SIN, V6, P740
   Wu JH, 2007, FOOD CHEM, V103, P1255, DOI 10.1016/j.foodchem.2006.10.042
   Wu W, 2006, POLYM INT, V55, P513, DOI 10.1002/pi.1993
   Xie RJ, 2007, KEY ENG MATER, V342-343, P241, DOI 10.4028/www.scientific.net/KEM.342-343.241
   YAMADA H, 2001, Patent No. 2001015660
   Yamada H, 1998, Japan Patent Publication Number, Patent No. [10226653 A2, 10226653]
   YAMADA H, 2001, Patent No. 2001064148
   Yamada H., 2001, INT J WILD SILKMOTH, V6, P17
   YAMADA H, 1998, Patent No. 10226626
   Yang JB, 2007, SURF INTERFACE ANAL, V39, P375, DOI 10.1002/sia.2549
   Yao YQ, 2003, CHEM J CHINESE U, V24, P2327
   YASUDA N, 1998, Patent No. 10245345
   Yoshii F, 2000, Japan Patent Publication Number, Patent No. [2000-169736, 2000169736]
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
   Zhang YQ, 2006, J CHEM TECHNOL BIOT, V81, P136, DOI 10.1002/jctb.1370
   Zhang YQ, 2004, BIOMATERIALS, V25, P3751, DOI 10.1016/j.biomaterials.2003.10.019
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhang YQ, 2006, J CONTROL RELEASE, V115, P307, DOI 10.1016/j.jconrel.2006.08.019
   Zhao HP, 2007, ENG FRACT MECH, V74, P1953, DOI 10.1016/j.engfracmech.2006.06.010
   Zhaorigetu S, 2003, J PHOTOCH PHOTOBIO B, V71, P11, DOI 10.1016/S1011-1344(03)00092-7
   Zhaorigetu S, 2001, BIOSCI BIOTECH BIOCH, V65, P2181, DOI 10.1271/bbb.65.2181
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhu Liang Jun, 1995, Journal of Sericultural Science of Japan, V64, P415
   ZHU LJ, 1991, CANYE KEXUE, V17, P33
   Zurovec M, 1998, J BIOL CHEM, V273, P15423, DOI 10.1074/jbc.273.25.15423
NR 173
TC 148
Z9 156
U1 6
U2 92
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD OCT
PY 2008
VL 33
IS 10
BP 998
EP 1012
DI 10.1016/j.progpolymsci.2008.08.002
PG 15
WC Polymer Science
SC Polymer Science
GA 384BR
UT WOS:000261719100003
DA 2018-10-20
ER

PT J
AU Ni, M
   Ratner, BD
AF Ni, Ming
   Ratner, Buddy D.
TI Differentiating calcium carbonate polymorphs by surface analysis
   techniques - an XPS and TOF-SIMS study
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE calcium carbonate; calcite; aragonite; vaterite; X-ray photoelectron
   spectroscopy; time-of-flight secondary ion mass spectroscopy; principal
   component analysis
ID ION MASS-SPECTROMETRY; HYDROXYAPATITE; MORPHOLOGY; CACO3; WATER
AB Calcium carbonate has evoked interest owing to its use as a biomaterial, and for its potential in biomineralization. Three polymorphs of calcium carbonate, i.e. calcite, aragonite, and vaterite were synthesized. Three conventional bulk analysis techniques, Fourier transform infrared (FTIR), X-ray diffraction (XRD), and SEM, were used to confirm the crystal phase of each polymorphic calcium carbonate. Two surface analysis techniques, X-ray photoelectron spectroscopy (XPS) and time-of-flight secondary ion mass spectroscopy (TOF-SIMS), were used to differentiate the surfaces of these three polymorphs of calcium carbonate. XPS results clearly demonstrate that the surfaces of these three polymorphs are different as seen in the Ca(2p) and O(1s) core-level spectra. The different atomic arrangement in the crystal lattice, which provides for a different chemical environment, can explain this surface difference. Principal component analysis (PCA) was used to analyze the TOF-SIMS data. Three polymorphs of calcium carbonate cluster into three different groups by PCA scores. This suggests that surface analysis techniques are as powerful as conventional bulk analysis to discriminate calcium carbonate polymorphs. Copyright (c) 2008 John Wiley & Sons, Ltd.
C1 [Ratner, Buddy D.] Univ Washington, UWEB, Dept Bioengn, Seattle, WA 98195 USA.
   [Ni, Ming; Ratner, Buddy D.] Univ Washington, UWEB, Dept Chem Engn, Seattle, WA 98195 USA.
RP Ratner, BD (reprint author), Univ Washington, UWEB, Dept Bioengn, Seattle, WA 98195 USA.
EM ratner@uweb.engr.washington.edu
FU NSF [EEC-9529161]; NIH [RR01296]
FX We thank Deborah Leach-Scampavia for her help with XPS and TOF-SIMS.
   This work was supported by NSF EEC-9529161 (LIWEB) and NIH RR01296
   (NESAC/BIO).
CR BAER DR, 1991, SURF INTERFACE ANAL, V17, P25, DOI 10.1002/sia.740170108
   Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5
   Castner DG, 1996, LANGMUIR, V12, P5083, DOI 10.1021/la960465w
   Chakrabarty D, 1999, J MATER CHEM, V9, P2953
   Chusuei CC, 1999, ANAL CHEM, V71, P149, DOI 10.1021/ac9806963
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   Feng QL, 2000, J CRYST GROWTH, V216, P459, DOI 10.1016/S0022-0248(00)00396-1
   Gopinath CS, 2002, MATER RES BULL, V37, P1323, DOI 10.1016/S0025-5408(02)00763-8
   Grasby SE, 2003, GEOCHIM COSMOCHIM AC, V67, P1659, DOI 10.1016/S0016-7037(00)01304-2
   Long JR, 1998, P NATL ACAD SCI USA, V95, P12083, DOI 10.1073/pnas.95.21.12083
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   Lucas A, 2001, INT J INORG MATER, V3, P87, DOI 10.1016/S1466-6049(00)00058-1
   MANN S, 1983, STRUCT BONDING BERLI, V54, P127
   MCELHANEY RD, 1990, METALLIZATION POLYM
   Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9
   Pang P, 2001, IND ENG CHEM RES, V40, P2445, DOI 10.1021/ie000846b
   SIMKISS K, 1964, NATURE, V201, P492, DOI 10.1038/201492a0
   Stipp SLS, 1997, SURF INTERFACE ANAL, V25, P959, DOI 10.1002/(SICI)1096-9918(199712)25:13<959::AID-SIA321>3.0.CO;2-W
   Vickerman J. C., 1997, SURFACE ANAL PRINCIP
   VUOLA J, 2000, NATURAL CORAL HYDROX
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
NR 21
TC 95
Z9 96
U1 8
U2 70
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD OCT
PY 2008
VL 40
IS 10
BP 1356
EP 1361
DI 10.1002/sia.2904
PG 6
WC Chemistry, Physical
SC Chemistry
GA 367ZW
UT WOS:000260592100007
PM 25031482
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Oliveira, JT
   Correlo, VM
   Sol, PC
   Costa-Pinto, AR
   Malafaya, PB
   Salgado, AJ
   Bhattacharya, M
   Charbord, P
   Neves, NM
   Reis, RL
AF Oliveira, Joao T.
   Correlo, Vitor M.
   Sol, Paula C.
   Costa-Pinto, Ana R.
   Malafaya, Patricia B.
   Salgado, Antonio J.
   Bhattacharya, Mrinal
   Charbord, Pierre
   Neves, Nuno M.
   Reis, Rui L.
TI Assessment of the Suitability of Chitosan/PolyButylene Succinate
   Scaffolds Seeded with Mouse Mesenchymal Progenitor Cells for a Cartilage
   Tissue Engineering Approach
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID CHONDROCYTE DIFFERENTIATION; CHITOSAN; BONE; REGENERATION; REPAIR;
   FIBROBLASTS; DEGRADATION; OSTEOBLASTS; FABRICATION; COMPOSITES
AB In this work, scaffolds derived from a new biomaterial originated from the combination of a natural material and a synthetic material were tested for assessing their suitability for cartilage tissue engineering applications. In order to obtain a better outcome result in terms of scaffolds' overall properties, different blends of natural and synthetic materials were created. Chitosan and polybutylene succinate (C-PBS) 50/50 (wt%) were melt blended using a twin-screw extruder and processed into 5 x 5 x 5 mm scaffolds by compression moulding with salt leaching. Micro-computed tomography analysis calculated an average of 66.29% porosity and 92.78% interconnectivity degree for the presented scaffolds. The salt particles used ranged in size between 63 and 125 mu m, retrieving an average pore size of 251.28 mu m. Regarding the mechanical properties, the compressive modulus was of 1.73 +/- 0.4 MPa (E-sec 1%). Cytotoxicity evaluation revealed that the leachables released by the developed porous structures were not harmful to the cells and hence were noncytotoxic. Direct contact assays were carried out using a mouse bone marrow-derived mesenchymal progenitor cell line (BMC9). Cells were seeded at a density of 5 x 10(5) cells/scaffold and allowed to grow for periods up to 3 weeks under chondrogenic differentiating conditions. Scanning electron microscopy analysis revealed that the cells were able to proliferate and colonize the scaffold structure, and MTS test demonstrated cell viability during the time of the experiment. Finally, Western blot performed for collagen type II, a natural cartilage extracellular matrix component, showed that this protein was being expressed by the end of 3 weeks, which seems to indicate that the BMC9 cells were being differentiated toward the chondrogenic pathway. These results indicate the adequacy of these newly developed C-PBS scaffolds for supporting cell growth and differentiation toward the chondrogenic pathway, suggesting that they should be considered for further studies in the cartilage tissue engineering field.
C1 [Oliveira, Joao T.; Correlo, Vitor M.; Sol, Paula C.; Costa-Pinto, Ana R.; Malafaya, Patricia B.; Neves, Nuno M.; Reis, Rui L.] Univ Minho, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4710057 Braga, Portugal.
   [Oliveira, Joao T.; Correlo, Vitor M.; Sol, Paula C.; Costa-Pinto, Ana R.; Malafaya, Patricia B.; Neves, Nuno M.; Reis, Rui L.] Inst Biotechnol & Bioengn, PT Associated Lab, Braga, Portugal.
   [Salgado, Antonio J.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, P-4710057 Braga, Portugal.
   [Bhattacharya, Mrinal] Univ Minnesota, Dept Biosyst Engn, St Paul, MN 55108 USA.
   [Charbord, Pierre] Univ Tours, Fac Med, Equipe ESPRI EA 3855, INSERM, Tours, France.
RP Oliveira, JT (reprint author), Univ Minho, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, Campus Gualtar, P-4710057 Braga, Portugal.
EM Joao.oliveira@dep.uminho.pt
RI Salgado, Antonio/J-4129-2013; Group, 3Bs/E-4374-2012; Malafaya,
   Patricia/M-3994-2013; Reis, Rui L./A-8938-2008; Neves, Nuno/B-4685-2008;
   Correlo, Vitor/O-4227-2015; Pinto, Ana Rita/I-7483-2013
OI Salgado, Antonio/0000-0003-3806-9823; Group, 3Bs/0000-0002-5195-3456;
   Malafaya, Patricia/0000-0002-7916-5910; Reis, Rui
   L./0000-0002-4295-6129; Neves, Nuno/0000-0003-3041-0687; Correlo,
   Vitor/0000-0002-5516-7583; Pinto, Ana Rita/0000-0002-4764-8539; Sol,
   Paula/0000-0003-0512-0928
FU Portuguese Foundation for Science and Technology (FCT) [SFRH/
   BD17135/2004]; European NoE EXPERTISSUES [NMP3-CT-2004-500283]; European
   Project GENOSTEM [LSHB-CT-2003-503161]; FCT Project CartiScaff
   [POCTI/SAU-BMA/58991/2004]
FX J. T. Oliveira would like to acknowledge the grant (SFRH/ BD17135/2004)
   from Portuguese Foundation for Science and Technology (FCT). The authors
   would like to thank Fernanda Marques, at the Institute for Health and
   Life Sciences (ICVS), University of Minho, Braga, Portugal, for her help
   with the Western blot analysis, as well as the staff at ICVS for
   allowing to use their facilities. The monoclonal antibody for collagen
   type II was obtained from the Developmental Studies Hybridoma Bank
   developed under the auspices of the NICHD and maintained by the
   Department of Biological Sciences, University of Iowa (Iowa City, IA).
   This work was carried out under the scope of the European NoE
   EXPERTISSUES (NMP3-CT-2004-500283), and partially supported by the
   European Project GENOSTEM (LSHB-CT-2003-503161) and the FCT Project
   CartiScaff (POCTI/SAU-BMA/58991/2004).
CR Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Correlo VM, 2005, MAT SCI ENG A-STRUCT, V403, P57, DOI 10.1016/j.msea.2005.04.055
   Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700
   Devlieghere F, 2004, FOOD MICROBIOL, V21, P703, DOI 10.1016/j.fm.2004.02.008
   Duda GN, 2005, J BIOMECH, V38, P843, DOI 10.1016/j.jbiomech.2004.04.034
   Estrada LE, 2001, OSTEOARTHR CARTILAGE, V9, P169, DOI 10.1053/joca.2000.0373
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Fuss M, 2000, ANN ANAT, V182, P303
   Gartland A, 2005, BONE, V37, P530, DOI 10.1016/j.bone.2005.04.034
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gross AE, 2003, J ARTHROPLASTY, V18, P14, DOI 10.1054/arth.2003.50084
   HENRY EW, 1985, EXP NEUROL, V90, P652, DOI 10.1016/0014-4886(85)90162-1
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   *ISO, 1099312003 ISO
   Jung Y, 2005, BIOMATERIALS, V26, P6314, DOI 10.1016/j.biomaterials.2005.04.007
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Koegler WS, 2004, BIOMATERIALS, V25, P2819, DOI 10.1016/j.biomaterials.2003.09.064
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lyoo WS, 2000, POLYMER, V41, P9055, DOI 10.1016/S0032-3861(00)00154-3
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mahmoudifar N, 2005, BIOMATERIALS, V26, P7012, DOI 10.1016/j.biomaterials.2005.04.062
   Malafaya PB, 2003, KEY ENG MAT, V240-2, P39, DOI 10.4028/www.scientific.net/KEM.240-242.39
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Richardson JB, 1999, J BONE JOINT SURG BR, V81B, P1064, DOI 10.1302/0301-620X.81B6.9343
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Silva RM, 2003, KEY ENG MAT, V240-2, P423
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yang Y, 2005, BIOMATERIALS, V26, P2585, DOI 10.1016/j.biomaterials.2004.07.046
   Zammaretti P, 2004, CURR OPIN BIOTECH, V15, P430, DOI 10.1016/j.copbio.2004.08.007
NR 39
TC 34
Z9 36
U1 0
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD OCT
PY 2008
VL 14
IS 10
BP 1651
EP 1661
DI 10.1089/ten.tea.2007.0307
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 359OS
UT WOS:000259998000007
PM 18611147
DA 2018-10-20
ER

PT J
AU Sun, H
   Ye, F
   Wang, J
   Shi, Y
   Tu, Z
   Bao, J
   Qin, M
   Bu, H
   Li, Y
AF Sun, H.
   Ye, F.
   Wang, J.
   Shi, Y.
   Tu, Z.
   Bao, J.
   Qin, M.
   Bu, H.
   Li, Y.
TI The Upregulation of Osteoblast Marker Genes in Mesenchymal Stem Cells
   Prove the Osteoinductivity of Hydroxyapatite/Tricalcium Phosphate
   Biomaterial
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article
ID DIFFERENTIATION IN-VITRO; EXPRESSION; PROLIFERATION; SUBSTITUTES
AB Background. Calcium phosphate (Ca-P), mainly concerning hydroxyapatite (HA), is the main inorganic component of the body's hard tissue. It is acknowledged that Ca-P biomaterial not only has osteoconduction but also can form bone bonding to host bone, making an ideal tissue-engineering scaffold. However, whether Ca-P biomaterial possesses osteoinductivity is still debated. The present study was performed to explore the expression level of osteoblast maker genes in human mesenchymal stem cells (hMSCs) grown on a Ca-P biomaterial.
   Materials and methods. hMSCs were cultured on the HA/tricalcium phosphate-(TCP) double-phase ceramic. After coculture for 5, 10, 15, or 20 days, the cells were digested for isolation of total RNA. Fluorescence quantitative polymerase chain reaction was used to detect the relative mRNA levels of Runx2, collagen type 1, osteopontin, and osteocalcin, all of which are the marker genes for osteoblasts. The mg63 cell was recruited as the reference and un-cocultured hMSCs as the negative controls. Alkaline phosphatase (ALP) activity in the cells was also examined after culture for 10 or 20 days.
   Results. Our results showed that the expression levels of all four genes continued to rise during the first 10 days. Then, both collagen type I and Runx2 decreased. In contrast, osteocalcin mRNA reached its maximum at day 15 and osteopontin mRNA kept increasing throughout the whole experimental period. Additionally, ALP activity increased in a time-dependent manner.
   Conclusion. The up-regulation of all four osteoblast marker genes in hMSCs grown on Ca-P biomaterial suggested that HA/TCP biomaterials possess osteoinductivity on hMSCs, cells a mechanism that requires further investigation.
C1 [Sun, H.; Ye, F.; Wang, J.; Shi, Y.; Tu, Z.; Bao, J.; Qin, M.; Bu, H.; Li, Y.] Sichuan Univ, W China Hosp, Minist Hlth, Key Lab Transplant Engn & Immunol, Chengdu 610041, Peoples R China.
RP Shi, Y (reprint author), Sichuan Univ, W China Hosp, Minist Hlth, Key Lab Transplant Engn & Immunol, Chengdu 610041, Peoples R China.
EM shiyujun1128@hotmail.com
FU Key Basic Research Project of China [2005CB623901]
FX This work was supported by the Key Basic Research Project of China
   (2005CB623901).
CR Bao Chongyun, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P442
   BURSTONE MS, 1960, ANN NY ACAD SCI, V85, P431, DOI 10.1111/j.1749-6632.1960.tb49972.x
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Duan Yourong, 2003, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V20, P22
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   DUEY P, 1997, CELL, V89, P747
   Fan HS, 2007, J NANOSCI NANOTECHNO, V7, P808, DOI 10.1166/jnn.2007.501
   Goessler UR, 2005, CELL MOL BIOL LETT, V10, P345
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Moscoso I, 2005, TRANSPL P, V37, P481, DOI 10.1016/j.transproceed.2004.12.247
   Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3
   Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094
   Wei Xiang-yang, 2005, Zhonghua Wai Ke Za Zhi, V43, P1198
NR 18
TC 34
Z9 40
U1 1
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
EI 1873-2623
J9 TRANSPL P
JI Transplant. Proc.
PD OCT
PY 2008
VL 40
IS 8
BP 2645
EP 2648
DI 10.1016/j.transproceed.2008.07.096
PG 4
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 361NL
UT WOS:000260134300061
PM 18929827
DA 2018-10-20
ER

PT J
AU Leterrier, M
   Holappa, LD
   Broglie, KE
   Beckles, DM
AF Leterrier, Marina
   Holappa, Lynn D.
   Broglie, Karen E.
   Beckles, Diane M.
TI Cloning, characterisation and comparative analysis of a starch synthase
   IV gene in wheat: functional and evolutionary implications
SO BMC PLANT BIOLOGY
LA English
DT Article
ID COLI GLYCOGEN-SYNTHASE; GLUCOSE-BINDING-SITE; GLY-GLY SEQUENCE;
   ESCHERICHIA-COLI; ACTIVE-SITE; ARABIDOPSIS-THALIANA; ADP-GLUCOSE;
   OLIGOSACCHARIDE SUBSTRATE; STRUCTURE PREDICTION; EXPRESSION ANALYSIS
AB Background: Starch is of great importance to humans as a food and biomaterial, and the amount and structure of starch made in plants is determined in part by starch synthase (SS) activity. Five SS isoforms, SSI, II, III, IV and Granule Bound SSI, have been identified, each with a unique catalytic role in starch synthesis. The basic mode of action of SSs is known; however our knowledge of several aspects of SS enzymology at the structural and mechanistic level is incomplete. To gain a better understanding of the differences in SS sequences that underscore their specificity, the previously uncharacterised SSIVb from wheat was cloned and extensive bioinformatics analyses of this and other SSs sequences were done.
   Results: The wheat SSIV cDNA is most similar to rice SSIVb with which it shows synteny and shares a similar exon-intron arrangement. The wheat SSIVb gene was preferentially expressed in leaf and was not regulated by a circadian clock. Phylogenetic analysis showed that in plants, SSIV is closely related to SSIII, while SSI, SSII and Granule Bound SSI clustered together and distinctions between the two groups can be made at the genetic level and included chromosomal location and intron conservation. Further, identified differences at the amino acid level in their glycosyltransferase domains, predicted secondary structures, global conformations and conserved residues might be indicative of intragroup functional associations.
   Conclusion: Based on bioinformatics analysis of the catalytic region of 36 SSs and 3 glycogen synthases (GSs), it is suggested that the valine residue in the highly conserved K-X-G-G-L motif in SSIII and SSIV may be a determining feature of primer specificity of these SSs as compared to GBSSI, SSI and SSII. In GBSSI, the Ile485 residue may partially explain that enzyme's unique catalytic features. The flexible 380s Loop in the starch catalytic domain may be important in defining the specificity of action for each different SS and the G-X-G in motif VI could define SSIV and SSIII action particularly.
C1 [Leterrier, Marina; Holappa, Lynn D.; Beckles, Diane M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.
   [Broglie, Karen E.] Dupont Pioneer, Crop Genet Res, Expt Stn, Wilmington, DE 19808 USA.
   [Holappa, Lynn D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.
RP Beckles, DM (reprint author), Univ Calif Davis, Dept Plant Sci, 1 Peter Shield Ave, Davis, CA 95616 USA.
EM msleterrier@ucdavis.edu; lholappa@oeb.harvard.edu;
   Karen.E.Broglie@cgr.dupont.com; dmbeckles@ucdavis.edu
OI Beckles, Diane/0000-0001-6336-1186
CR Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927
   BARFORD D, 1992, PROTEIN SCI, V1, P472
   Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263
   Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3
   Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324
   Busi MV, 2008, PROTEINS, V70, P31, DOI 10.1002/prot.21469
   BUSI MV, 2007, PROTEINS STRUCTURE F, V9999
   CLUSTAL W, MULTIPLE SEQUENCE AL
   Cuff JA, 1999, PROTEINS, V34, P508, DOI 10.1002/(SICI)1097-0134(19990301)34:4<508::AID-PROT10>3.0.CO;2-4
   de Souza SJ, 1997, GENE, V205, P141, DOI 10.1016/S0378-1119(97)00401-0
   Denyer K, 1997, PLANT CELL ENVIRON, V20, P1566, DOI 10.1046/j.1365-3040.1997.d01-48.x
   Denyer K, 1999, BIOCHEM J, V342, P647, DOI 10.1042/0264-6021:3420647
   Denyer K, 1999, BIOCHEM J, V340, P183, DOI 10.1042/0264-6021:3400183
   Denyer K, 2001, J PLANT PHYSIOL, V158, P479, DOI 10.1078/0176-1617-00360
   deSouza SJ, 1996, P NATL ACAD SCI USA, V93, P14632, DOI 10.1073/pnas.93.25.14632
   Dian WM, 2005, J EXP BOT, V56, P623, DOI 10.1093/jxb/eri065
   Dian WM, 2003, PLANTA, V218, P261, DOI 10.1007/s00425-003-1101-9
   Edwards A, 1999, PLANT J, V17, P251, DOI 10.1046/j.1365-313X.1999.00371.x
   Edwards A, 1999, EUR J BIOCHEM, V266, P724, DOI 10.1046/j.1432-1327.1999.00861.x
   Ellis RP, 1998, J SCI FOOD AGR, V77, P289, DOI 10.1002/(SICI)1097-0010(199807)77:3<289::AID-JSFA38>3.3.CO;2-4
   Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978
   Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845
   FURUKAWA K, 1993, J BIOL CHEM, V268, P23837
   FURUKAWA K, 1990, J BIOL CHEM, V265, P2086
   FURUKAWA K, 1994, J BIOL CHEM, V269, P868
   Gao M, 1998, PLANT CELL, V10, P399, DOI 10.1105/tpc.10.3.399
   Gao Z, 2004, ARCH BIOCHEM BIOPHYS, V427, P1, DOI 10.1016/j.abb.2004.01.010
   Guan HP, 1998, TRENDS GLYCOSCI GLYC, V10, P307, DOI 10.4052/tigg.10.307
   Hare MP, 2003, MOL BIOL EVOL, V20, P969, DOI 10.1093/molbev/msg111
   HENNENBIERWAGEN T, 2008, PLANT PHYSIOL, P146
   Henrissat B, 2001, PLANT MOL BIOL, V47, P55, DOI 10.1023/A:1010667012056
   Hirose T, 2004, PLANTA, V220, P9, DOI 10.1007/s00425-004-1314-6
   Hitz WD, 2002, PLANT PHYSIOL, V128, P650, DOI 10.1104/pp.128.2.650
   Imparl-Radosevich JM, 1999, FEBS LETT, V457, P357, DOI 10.1016/S0014-5793(99)01066-2
   Imparl-Radosevich JM, 1998, ARCH BIOCHEM BIOPHYS, V353, P64, DOI 10.1006/abbi.1998.0613
   JENKINS JPJ, 1993, STARCH-STARKE, V45, P417
   Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Labesse G, 1998, BIOINFORMATICS, V14, P206, DOI 10.1093/bioinformatics/14.2.206
   Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079
   Li Zhongyi, 2003, Functional & Integrative Genomics, V3, P76
   Li ZY, 2000, PLANT PHYSIOL, V123, P613, DOI 10.1104/pp.123.2.613
   Lloyd JR, 1999, BIOCHEM J, V338, P515, DOI 10.1042/0264-6021:3380515
   MacGregor EA, 2002, J PROTEIN CHEM, V21, P297, DOI 10.1023/A:1019701621256
   MARTIN C, 1995, PLANT CELL, V7, P971
   Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999
   Morell MK, 2005, CURR OPIN PLANT BIOL, V8, P204, DOI 10.1016/j.pbi.2005.01.009
   *NCBI, NCBI BAS LOC AL SEAR
   Nichols DJ, 2000, BIOCHEMISTRY-US, V39, P7820, DOI 10.1021/bi000407g
   Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292
   OReilly M, 1997, NAT STRUCT BIOL, V4, P405, DOI 10.1038/nsb0597-405
   Patron NJ, 2005, J PHYCOL, V41, P1131, DOI 10.1111/j.1529-8817.2005.00135.x
   *PFAM, PFAM DAT PROT FAM HM
   Ral JP, 2004, PLANT PHYSIOL, V136, P3333, DOI 10.1104/pp.104.044131
   Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118
   Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X
   Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x
   Rujan T, 2001, TRENDS GENET, V17, P113, DOI 10.1016/S0168-9525(00)02209-5
   Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857
   SEARS ER, 1953, AM NAT, V87, P245, DOI 10.1086/281780
   TETLOW I, 2008, PLANT PHYSIOL, P146
   Tetlow IJ, 2006, CAN J BOT, V84, P1167, DOI 10.1139/B06-089
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tomasik P, 2004, ADV CARBOHYD CHEM BI, V59, P175, DOI 10.1016/S0065-2318(04)59005-4
   Vrinten PL, 2000, PLANT PHYSIOL, V122, P255, DOI 10.1104/pp.122.1.255
   Wang SJ, 2001, PLANT SCI, V161, P635, DOI 10.1016/S0168-9452(01)00449-6
   Watson KA, 1999, EMBO J, V18, P4619, DOI 10.1093/emboj/18.17.4619
   Yep A, 2004, BIOCHEM BIOPH RES CO, V316, P960, DOI 10.1016/j.bbrc.2004.02.136
   Yep A, 2004, J BIOL CHEM, V279, P8359, DOI 10.1074/jbc.M312686200
   Yep A, 2006, ARCH BIOCHEM BIOPHYS, V453, P188, DOI 10.1016/j.abb.2006.07.003
   TITO TOOLS INCREMENT
   SPIDEY MRNA TO GENOM
   SAM T02 HMM BASED PR
   JNET NEURAL NETWORK
NR 74
TC 49
Z9 52
U1 5
U2 24
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2229
J9 BMC PLANT BIOL
JI BMC Plant Biol.
PD SEP 30
PY 2008
VL 8
AR 98
DI 10.1186/1471-2229-8-98
PG 21
WC Plant Sciences
SC Plant Sciences
GA 371JR
UT WOS:000260828100001
PM 18826586
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hung, J
   Solis, J
   Guerrero, JL
   Braithwaite, GJC
   Muratoglu, OK
   Chaput, M
   Fernandez-Friera, L
   Handschumacher, MD
   Wedeen, VJ
   Houser, S
   Vlahakes, GJ
   Levine, RA
AF Hung, Judy
   Solis, Jorge
   Guerrero, J. Luis
   Braithwaite, Gavin J. C.
   Muratoglu, Orhun K.
   Chaput, Miguel
   Fernandez-Friera, Leticia
   Handschumacher, Mark D.
   Wedeen, Van J.
   Houser, Stuart
   Vlahakes, Gus J.
   Levine, Robert A.
TI A novel approach for reducing ischemic mitral regurgitation by injection
   of a polymer to reverse remodel and reposition displaced papillary
   muscles
SO CIRCULATION
LA English
DT Article; Proceedings Paper
CT 80th Annual Scientific Session of the American-Heart-Association
CY NOV 04-07, 2007
CL Orlando, FL
SP Amer Heart Assoc
DE coronary artery disease; left ventricular remodeling; mitral
   regurgitation
ID 3-DIMENSIONAL ECHOCARDIOGRAPHY; VALVULAR REGURGITATION;
   MYOCARDIAL-INFARCTION; CELL TRANSPLANTATION; COLLAGEN INJECTION;
   IN-VIVO; REPAIR; RECONSTRUCTION; ANNULOPLASTY; REPLACEMENT
AB Background-Ischemic mitral regurgitation (MR) relates to displacement of the papillary muscles from ischemic ventricular distortion. We tested the hypothesis that repositioning of the papillary muscles can be achieved by injection of polyvinyl-alcohol (PVA) polymer, a biologically inert biomaterial that has been specially formulated to produce an encapsulated, stable, resilient gel once injected into the myocardium. The purpose is to materially support the infarcted myocardium while at the same time repositioning the papillary muscles that become apically tethered in MR.
   Methods and Results-Nine sheep underwent ligation of circumflex branches to produce acute ischemic MR. PVA polymer was then injected by echo guidance into the myocardium underlying the infarcted papillary muscle. Hemodynamic data, left ventricular ejection fraction, elastance, tau (relaxation constant), left ventricular stiffness coefficient, and 2-dimensional and 3-dimensional echocardiograms were obtained post-MR and post-PVA injection. One animal died after coronary ligation and 2 did not develop MR. In the remaining 6, moderate MR developed. With PVA injection, the MR decreased significantly from moderate to trace-mild (vena contracta: 5 +/- 0.4 mm versus 2 +/- 0.7 mm, post-MR versus post-PVA injection; P < 0.0001). This was associated with a decrease in infarcted papillary muscle-to-mitral annulus tethering distance (27 +/- 4 to 24 +/- 4 mm, post-MR versus post-PVA, P < 0.001). Importantly, PVA injection was not associated with significant decreases in left ventricular ejection fraction (43 +/- 6% versus 37 +/- 4%, post-MR versus post-PVA, P=nonsignificant), elastance (3.5 +/- 1.4 versus 2.9 +/- 1.3; post-MR versus post-PVA injection, P=nonsignificant). Measures of left ventricular diastolic function, tau (100 +/- 51 ms to 84 +/- 37 ms, post-MR versus post-PVA; P=nonsignificant), and left ventricular stiffness coefficient (0.18 +/- 0.12 versus 0.14 +/- 0.08, post-MR versus post-PVA; P=nonsignificant) did not increase post-PVA.
   Conclusions-PVA polymer injection resulted in acute reverse remodeling of the ventricle with papillary muscle repositioning to decrease MR. This was not associated with an adverse effect on left ventricular systolic and diastolic function. This new approach to alter pathological anatomy after infarction may offer an alternative strategy for relieving ischemic MR by correcting the position of the affected papillary muscle, thus relieving apical tethering.
C1 [Hung, Judy] Massachusetts Gen Hosp, Cardiac Ultrasound Lab, Boston, MA 02114 USA.
   [Braithwaite, Gavin J. C.] Cambridge Polymer Inc, Boston, MA USA.
RP Hung, J (reprint author), Massachusetts Gen Hosp, Cardiac Ultrasound Lab, Blake 256,55 Fruit St, Boston, MA 02114 USA.
EM jhung@partners.org
RI Fernandez Friera, Leticia/E-9931-2015; Solis, Jorge/E-2709-2018
OI Fernandez Friera, Leticia/0000-0002-4237-2166; Solis,
   Jorge/0000-0002-4227-7062; Braithwaite, Gavin/0000-0002-6239-0046
FU NIBIB NIH HHS [R21 EB005294, R21 EB005294-02]; NHLBI NIH HHS [R01
   HL038176-14, K24 HL67434, K24 HL067434-07, R01 HL038176, K24 HL067434];
   PHS HHS [R01 038176]
CR Allen MJ, 2004, SPINE, V29, P515, DOI 10.1097/01.BRS.0000113871.67305.38
   Calafiore AM, 2001, ANN THORAC SURG, V71, P1146, DOI 10.1016/S0003-4975(00)02650-3
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Grayburn PA, 1996, CIRCULATION, V94, P119, DOI 10.1161/01.CIR.94.2.119
   Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759
   Guy TS, 2004, J AM COLL CARDIOL, V43, P377, DOI 10.1016/j.jacc.2003.07.045
   Hadlock T A, 1998, Facial Plast Surg, V14, P197, DOI 10.1055/s-2008-1064345
   Hamraoui K, 2002, J AM COLL CARDIOL, V39, P1297, DOI 10.1016/S0735-1097(02)01752-7
   HANDSCHUMACHER MD, 1993, J AM COLL CARDIOL, V21, P743, DOI 10.1016/0735-1097(93)90108-D
   He SQ, 1997, CIRCULATION, V96, P1826, DOI 10.1161/01.CIR.96.6.1826
   Hung J, 2002, CIRCULATION, V106, P2594, DOI 10.1161/01.CIR.0000038363.83133.6D
   HUNG J, 2007, CIRCULATION, V116, P259
   HUNG J, 2004, CIRCULATION S2, V110, P85
   Kershen RT, 1999, UROL CLIN N AM, V26, P81, DOI 10.1016/S0094-0143(99)80008-1
   Komeda M, 1997, J THORAC CARDIOV SUR, V113, P292, DOI 10.1016/S0022-5223(97)70326-X
   KU DB, 1999, REINFORCED UNCROSSLI
   Lamas GA, 1997, CIRCULATION, V96, P827
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161
   Liel-Cohen N, 2000, CIRCULATION, V101, P2756, DOI 10.1161/01.CIR.101.23.2756
   LLANERAS MR, 1994, ANN THORAC SURG, V57, P432, DOI 10.1016/0003-4975(94)91012-X
   Maselli D, 2006, CIRCULATION, V114, P377, DOI 10.1161/CIRCULATIONAHA.105.609883
   McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037
   MELE D, 1995, CIRCULATION, V91, P746, DOI 10.1161/01.CIR.91.3.746
   Messas E, 2006, J AM COLL CARDIOL, V47, P2086, DOI 10.1016/j.jacc.2005.12.063
   Mishra YK, 2006, ANN THORAC SURG, V81, P42, DOI 10.1016/j.athoracsur.2005.06.023
   Nasseri BA, 2001, SURGERY, V130, P781, DOI 10.1067/msy.2001.112960
   Niimi Y, 1997, NEUROSURGERY, V40, P675, DOI 10.1097/00006123-199704000-00004
   Niimi Y, 1997, NEUROSURGERY, V40, P682
   Orr TE, 1999, J BIOMED MATER RES, V44, P308, DOI 10.1002/(SICI)1097-4636(19990305)44:3<308::AID-JBM9>3.3.CO;2-H
   Otsuji Y, 1997, CIRCULATION, V96, P1999, DOI 10.1161/01.CIR.96.6.1999
   PAGEL PS, 1991, ANESTHESIOLOGY, V74, P1103, DOI 10.1097/00000542-199106000-00019
   PEPPAS N, 1973, REINFORCED UNCROSSLI
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   RADOVAN C, 1984, PLAST RECONSTR SURG, V74, P482, DOI 10.1097/00006534-198410000-00005
   Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314
   Tahta SA, 2002, J HEART VALVE DIS, V11, P11
   Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8
   Tseng WI, 1999, MAGNET RESON MED, V42, P393, DOI 10.1002/(SICI)1522-2594(199908)42:2<393::AID-MRM22>3.0.CO;2-F
   URUSHIZAKI F, 1990, INT J PHARM, V58, P135
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wedeen VJ, 2005, MAGNET RESON MED, V54, P1377, DOI 10.1002/mrm.20642
   Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3
NR 45
TC 21
Z9 21
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD SEP 30
PY 2008
VL 118
IS 14
SU 1
BP S263
EP S269
DI 10.1161/CIRCULATIONAHA.107.756502
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 354OJ
UT WOS:000259648600038
PM 18824765
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Kim, WC
   Kim, JG
   Lee, JY
   Seok, HK
AF Kim, Woo-Cheol
   Kim, Jung-Gu
   Lee, Ji-Young
   Seok, Hyun-Kwang
TI Influence of Ca on the corrosion properties of magnesium for
   biomaterials
SO MATERIALS LETTERS
LA English
DT Article
DE magnesium; calcium galvanic corrosion; Hank's solution; biomaterial
   hydrogen evolution
ID IN-VIVO CORROSION; ALUMINUM ALLOYS; BONE; BEHAVIOR; MATRIX
AB The corrosion properties of a Mg alloy with Ca in Hank's solution were investigated by the hydrogen evolution test. In the test results, the hydrogen evolution rate increased with increasing Ca content. This phenomenon was caused by the precipitation of Mg(2)Ca phase in large amounts on the Mg matrix. In the case of Mg-Ca alloy, the formation of a micro-galvanic cell between the Mg(2)Ca phase and Mg matrix accelerated the preferred dissolution of the matrix. These results demonstrated that the corrosion resistance and hydrogen evolution rate are controlled by the Mg(2)Ca phase distribution in the Mg-Ca alloy system. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kim, Woo-Cheol; Kim, Jung-Gu] Sungkyunkwan Univ, Dept Adv Mat Engn, Suwon 440746, South Korea.
   [Lee, Ji-Young; Seok, Hyun-Kwang] Korea Inst Sci & Technol, Seoul 136791, South Korea.
RP Kim, JG (reprint author), Sungkyunkwan Univ, Dept Adv Mat Engn, 300 Chunchun Dong, Suwon 440746, South Korea.
EM kimjg@skku.ac.kr
FU U&I corporation and the research program of the Short-Term Core
   Technology Development Program [10029643]
FX This work was supported by a grant from the U&I corporation and the
   research program of the Short-Term Core Technology Development Program
   (No. 10029643) of the Ministry of Commerce, Industry and Energy,
   Republic of Korea.
CR CLAES L E, 1992, Clinical Materials, V10, P41, DOI 10.1016/0267-6605(92)90083-6
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   Jones D., 1996, PRINCIPLES PREVENTIO
   Kim JG, 2003, CORROSION, V59, P228, DOI 10.5006/1.3277555
   Lee CD, 2000, MET MATER-KOREA, V6, P441, DOI 10.1007/BF03028133
   Lee CD, 2000, MET MATER-KOREA, V6, P351, DOI 10.1007/BF03028082
   LEE CD, 2000, J KOREAN INST MET MA, V38, P10
   LEE SH, 2004, J KOR SOC TREAT, V17, P173
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   MAKAR GL, 1990, J ELECTROCHEM SOC, V137, P414, DOI 10.1149/1.2086455
   Mark P. S., 2006, BIOMATERIALS, V27, P1728
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Uhlig H.H., 1985, CORROSION CORROSION
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0
NR 21
TC 104
Z9 115
U1 0
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD SEP 30
PY 2008
VL 62
IS 25
BP 4146
EP 4148
DI 10.1016/j.matlet.2008.06.028
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 344ZR
UT WOS:000258966300028
DA 2018-10-20
ER

PT J
AU Silva, EA
   Kim, ES
   Kong, HJ
   Mooney, DJ
AF Silva, Eduardo A.
   Kim, Eun-Suk
   Kong, Hyun Joon
   Mooney, David J.
TI Material-based deployment enhances efficacy of endothelial progenitor
   cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; cell therapy; ischemic diseases; neovascularization;
   regenerative medicine
ID GROWTH-FACTOR; MYOCARDIAL-INFARCTION; STEM-CELLS; ANGIOGENESIS; THERAPY;
   TRANSPLANTATION; DISEASE; SCAFFOLDS; ALGINATE; LEPTIN
AB Cell-based therapies are attractive for revascularizing and regenerating tissues and organs, but clinical trials of endothelial progenitor cell transplantation have not resulted in consistent benefit. We propose a different approach in which a material delivery system is used to create a depot of vascular progenitor cells in vivo that exit over time to repopulate the damaged tissue and participate in regeneration of a vascular network. Microenvironmental conditions sufficient to maintain the viability and outward migration of outgrowth endothelial cells (OECs) have been delineated, and a material incorporating these signals improved engraftment of transplanted cells in ischemic murine hindlimb musculature, and increased blood vessel densities from 260 to 670 vessels per mm(2), compared with direct cell injection. Further, material deployment dramatically improved the efficacy of these cells in salvaging ischemic murine limbs, whereas bolus OEC delivery was ineffective in preventing toe necrosis and foot loss. Finally, material deployment of a combination of OECs with another cell population commonly isolated from peripheral or cord blood, endothelial progenitor cells (EPCs) returned perfusion to normal levels in 40 days, and prevented toe and foot necrosis. Direct injection of an EPC/OEC combination was minimally effective in improving limb perfusion, and untreated limbs underwent autoamputation in 3 days. These results demonstrate that vascular progenitor cell utility is highly dependent on the mode of delivery, and suggest that one can create new vascular beds for a variety of applications with this material-controlled deployment of cells.
C1 [Silva, Eduardo A.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02139 USA.
   [Silva, Eduardo A.] Univ Porto, Fac Engn, P-4099002 Oporto, Portugal.
   [Kim, Eun-Suk] Chungnam Natl Univ, Coll Med, Dept Dent, Taejon 301747, South Korea.
   [Kong, Hyun Joon] Univ Illinois, Inst Genom Biol, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02139 USA.
EM mooneyd@seas.harvard.edu
RI Silva, Eduardo/M-2711-2015
OI Silva, Eduardo/0000-0003-3173-7622
FU National Institutes of Health [R01 HL069957]; Fundacao para Ciencia e
   Tecnologia Predoctoral Fellowship [SFRH/BD/9613/2002]
FX We thank the Biological Resources Branch of National Cancer Institute
   for generously providing VEGF<INF>165</INF> used in our studies. This
   work was supported by National Institutes of Health Grant R01 HL069957.
   E.A.S. is a student of the Gulbenkian PhD Program in Biomedicine,
   Portugal, and was supported by Fundacao para Ciencia e Tecnologia
   Predoctoral Fellowship SFRH/BD/9613/2002.
CR Akar AR, 2006, ARTIF ORGANS, V30, P213, DOI 10.1111/j.1525-1594.2006.00209.x
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904
   Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638
   Couzin J, 2004, SCIENCE, V304, P192, DOI 10.1126/science.304.5668.192
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Fuchs JR, 2003, J PEDIATR SURG, V38, P984, DOI 10.1016/S0022-3468(03)00139-8
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248
   Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Hou D, 2005, CIRCULATION, V112, P1150
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335
   Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI [10.1016/j.biomaterials.2007.12.031, 10.1016/j.biomaterials.2007.12-031]
   Koch R James, 2002, Facial Plast Surg, V18, P59, DOI 10.1055/s-2002-19828
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lunde ME, 2006, EPILEPSY BEHAV, V9, P355, DOI 10.1016/j.yebeh.2006.06.013
   March KL, 2004, AM J PHYSIOL-HEART C, V287, pH458, DOI 10.1152/ajpheart.00343.2004
   Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313
   Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Sales VL, 2007, CIRCULATION, V116, P155
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Shi Q, 1998, BLOOD, V92, P362
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683
   Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059
   Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F
   Srivastava D, 2006, NATURE, V441, P1097, DOI 10.1038/nature04961
   Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340
   Thebaud NB, 2007, J MATER SCI-MATER M, V18, P339, DOI 10.1007/s10856-006-0698-1
   Thornton AJ, 2004, TRANSPLANTATION, V77, P1798, DOI 10.1097/01.tp.0000131152.71117.0e
   Welt FGP, 2006, CIRCULATION, V113, P1272, DOI 10.1161/CIRCULATIONAHA.105.613034
   Wolk R, 2005, ATHEROSCLEROSIS, V183, P131, DOI 10.1016/j.athersclerosis.2005.03.048
   Woywodt A, 2006, J THROMB HAEMOST, V4, P671, DOI 10.1111/j.1538-7836.2006.01794.x
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
NR 54
TC 130
Z9 133
U1 3
U2 21
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 23
PY 2008
VL 105
IS 38
BP 14347
EP 14352
DI 10.1073/pnas.0803873105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 353TY
UT WOS:000259592400024
PM 18794520
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Eydelnant, IA
   Tufenkji, N
AF Eydelnant, Irwin Adam
   Tufenkji, Nathalie
TI Cranberry derived proanthocyanidins reduce bacterial adhesion to
   selected biomaterials
SO LANGMUIR
LA English
DT Article
ID FIMBRIATED ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA STRAINS; SECONDARY
   ENERGY MINIMUM; SURFACE-PROPERTIES; INHIBIT ADHERENCE; CELL SURFACES;
   GROWTH-MEDIUM; POROUS-MEDIA; JUICE; INFECTIONS
AB Catheter associated urinary tract infections (CAUTI) linked with the uropathogens Escherichia coli (E. coli) and Enterococcus faecalis(E. faecalis) account for the majority of nosocomial infections acquired in the clinical environment. Because these infections develop following initial adhesion of the bacteria] pathogens to the catheter surface, there is increased interest in developing effective methods to inhibit attachment of cells to biomaterials used in the manufacture of indwelling devices. High molecular weight proanthocyanidins (PAC) extracted from the North American cranberry (Vaccinium macrocarpon) were examined for their potential to reduce the initial adhesion of uropathogenic bacteria (E. coli CFF073 and E. faecalis 29212) to two model biomaterials, poly(vinyl chloride) (PVC) and polytetrafluoroethylene (PTFE). Well-controlled experiments conducted in a parallel-plate flow chamber (PPFC) demonstrated decreased attachment of both bacteria to PVC and PTFE when either the bacteria, biomaterial or both surfaces were treated with PAC. Most significant inhibition of bacterial adhesion was observed for the condition where both the bacteria and biomaterial surfaces were coated with PAC. Additional experiments conducted with nonbiological model particles demonstrate comparable extents of adhesion inhibition, supporting a nonbiospecific mechanism of PAC action. The results of this study are promising for the implementation of PAC in the clinical milieu for prevention of device associated infection as the proposed functional modification is independent of antibacterial mechanisms that may give rise to resistant strains.
C1 [Eydelnant, Irwin Adam; Tufenkji, Nathalie] McGill Univ, Dept Chem Engn, Montreal, PQ H3A 2B2, Canada.
RP Tufenkji, N (reprint author), McGill Univ, Dept Chem Engn, Montreal, PQ H3A 2B2, Canada.
EM nathalie.tufenkji@mcgill.ca
RI Eydelnant, Irwin Adam/A-9548-2008
FU NSERC; Cranberry institute; Wisconsin Cranberry Board; CRC; CFI Programs
FX This research was supported by NSERC (Discovery Grant), the Cranberry
   institute, the Wisconsin Cranberry Board and the CRC and CFI Programs.
   The authors acknowledge A. B. Howell (Rutgers) for providing cranberry
   derived proanthocyanidins, A. Manges (McGill) for providing E. coli
   CFT073, K. Harmidy for assistance with bacteria characterization, and S.
   Khan for assistance with material characterization. We thank two
   anonymous reviewers for comments that improved the manuscript.
CR Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o
   Ahuja S, 1998, J UROLOGY, V159, P559, DOI 10.1016/S0022-5347(01)63983-1
   Allison DG, 2000, J BASIC MICROB, V40, P3, DOI 10.1002/(SICI)1521-4028(200002)40:1<3::AID-JOBM3>3.3.CO;2-C
   Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Burger O, 2000, FEMS IMMUNOL MED MIC, V29, P295, DOI 10.1016/S0928-8244(00)00220-0
   Burks GA, 2003, LANGMUIR, V19, P2366, DOI 10.1021/la026375a
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Castro FD, 2007, ENVIRON SCI TECHNOL, V41, P4332, DOI 10.1021/es0701558
   Considine RF, 2001, LANGMUIR, V17, P6325, DOI 10.1021/la001459+
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   de Kerchove AJ, 2007, LANGMUIR, V23, P12301, DOI 10.1021/la701936x
   DERJAGUIN BV, 1941, ACTA PHYSICOCHIM URS, V14, P733, DOI DOI 10.1016/0079-6816(93)90013-1
   Di Martino P, 2006, WORLD J UROL, V24, P21, DOI 10.1007/s00345-005-0045-z
   Duguid J. L., 1980, BACTERIAL ADHERENCE, V6, P185
   Elimelech M., 1995, PARTICLE DEPOSITION, P441
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718
   Foo LY, 2000, PHYTOCHEMISTRY, V54, P173, DOI 10.1016/S0031-9422(99)00573-7
   Gallardo-Moreno AM, 2003, J ADHES SCI TECHNOL, V17, P1877, DOI 10.1163/156856103770572034
   Gupta K, 2007, J UROLOGY, V177, P2357, DOI 10.1016/j.juro.2007.01.114
   Habash MB, 1999, CAN J MICROBIOL, V45, P691, DOI 10.1139/cjm-45-8-691
   Hahn MW, 2004, ENVIRON SCI TECHNOL, V38, P5915, DOI 10.1021/es049746d
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Howell AB, 2005, PHYTOCHEMISTRY, V66, P2281, DOI 10.1016/j.phytochem.2005.05.022
   Howell AB, 2002, JAMA-J AM MED ASSOC, V287, P3082, DOI 10.1001/jama.287.23.3082
   Howell AB, 1998, NEW ENGL J MED, V339, P1085, DOI 10.1056/NEJM199810083391516
   Howell AB, 2007, MOL NUTR FOOD RES, V51, P732, DOI 10.1002/mnfr.200700038
   Hunter R. J., 2001, FDN COLLOID SCI, P806
   Jacobs A, 2007, COLLOID SURFACE B, V59, P35, DOI 10.1016/j.colsurfb.2007.04.008
   Johnson-White B, 2006, ANAL CHEM, V78, P853, DOI 10.1021/ac051700v
   Jucker BA, 1998, ENVIRON SCI TECHNOL, V32, P2909, DOI 10.1021/es980211s
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Kuznar ZA, 2007, COLLOID SURFACE A, V294, P156, DOI 10.1016/j.colsurfa.2006.08.007
   Litton GM, 1996, COLLOID SURFACE A, V107, P273, DOI 10.1016/0927-7757(95)03343-2
   Liu YT, 2006, BIOTECHNOL BIOENG, V93, P297, DOI 10.1002/bit.20675
   Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240
   NAPPER DH, 1977, J COLLOID INTERF SCI, V58, P390, DOI 10.1016/0021-9797(77)90150-3
   Redman JA, 2004, ENVIRON SCI TECHNOL, V38, P1777, DOI 10.1021/es0348871
   Rijnaarts HHM, 1999, COLLOID SURFACE B, V14, P179, DOI 10.1016/S0927-7765(99)00035-1
   RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P191, DOI 10.1016/0927-7765(94)01164-Z
   Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0
   Salerno MB, 2004, LANGMUIR, V20, P10625, DOI 10.1021/la048372z
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Simoni SF, 2000, ENVIRON SCI TECHNOL, V34, P1011, DOI 10.1021/es990476m
   Trautner BW, 2004, AM J INFECT CONTROL, V32, P177, DOI 10.1016/j.ajilc.2003.08.005
   Triandafillu K, 2003, BIOMATERIALS, V24, P1507, DOI 10.1016/S0142-9612(02)00515-X
   Tufenkji N, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004851
   Tufenkji N, 2006, WATER RES, V40, P3315, DOI 10.1016/j.watres.2006.07.036
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   VANOSS CJ, 2006, INTERFACIAL FORCES A
   VERWEY EJW, 1948, THEORY STABILITY LYO
   Walker SL, 2002, LANGMUIR, V18, P2193, DOI 10.1021/la011284j
   Walker SL, 2004, LANGMUIR, V20, P7736, DOI 10.1021/la049511f
   Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C
   ZAFRIRI D, 1989, ANTIMICROB AGENTS CH, V33, P92, DOI 10.1128/AAC.33.1.92
NR 59
TC 41
Z9 41
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD SEP 16
PY 2008
VL 24
IS 18
BP 10273
EP 10281
DI 10.1021/la801525d
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 347DJ
UT WOS:000259120500054
PM 18698853
DA 2018-10-20
ER

PT J
AU Califano, V
   Bloisi, F
   Vicari, LRM
   Colombi, P
   Bontempi, E
   Depero, LE
AF Califano, Valeria
   Bloisi, Francesco
   Vicari, Luciano R. M.
   Colombi, Paolo
   Bontempi, Elza
   Depero, Laura E.
TI MAPLE deposition of biomaterial multilayers
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE MAPLE; surface morphology; thin films; polyethylene glycol
ID PULSED-LASER EVAPORATION; GRAFTED POLY(ETHYLENE GLYCOL);
   POLYETHYLENE-GLYCOL; FORCE MICROSCOPY; THIN-FILMS; ABLATION; POLYMER;
   MATRIX; WATER; MORPHOLOGY
AB Double layers of polyethylene glycol (PEG) and 3-(3,4-dihydroxyphenyl)-2-methyl-L-alanine (m-DOPA) thin films were obtained by matrix assisted pulsed laser evaporation (MAPLE) technique, by depositing a first layer of m-DOPA on Si substrate and a second layer of PEG on top of it. The films were characterized by low angle X-ray diffraction (LAXRD), X-ray reflectivity (XRR), atomic force microscopy (AFM), and micro-Raman spectroscopy. From these analyses it resulted that PEG was deposited without any relevant damage both in terms of chemical structure and molecular weight. Furthermore, PEG chains were mostly in the extended conformation, although PEG micelles appeared. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Califano, Valeria; Bloisi, Francesco; Vicari, Luciano R. M.] Univ Naples Federico 2, CNR, INFM Coherentia, I-80125 Naples, Italy.
   [Bloisi, Francesco; Vicari, Luciano R. M.] Univ Naples Federico 2, Dipartimento Sci Fisiche, Fac Ingn, I-80125 Naples, Italy.
   [Colombi, Paolo; Bontempi, Elza; Depero, Laura E.] Univ Brescia, Lab Chim Tecnol, I-25123 Brescia, Italy.
RP Califano, V (reprint author), Univ Naples Federico 2, CNR, INFM Coherentia, Piazzale Tecchio 80, I-80125 Naples, Italy.
EM valeriacalifano@hotmail.com
RI Bloisi, Francesco/A-4296-2008; Depero, Laura/A-3176-2009; Colombi,
   Paolo/G-3588-2013; VICARI, Luciano Rosario Mari/L-6131-2015; Bontempi,
   Elza/F-3216-2010
OI Bloisi, Francesco/0000-0002-9714-9244; Depero,
   Laura/0000-0001-7818-3212; VICARI, Luciano Rosario
   Mari/0000-0003-1835-6411; Bontempi, Elza/0000-0003-1656-7506; COLOMBI,
   Paolo/0000-0002-0136-4442
CR Adya AK, 2005, J INDIAN CHEM SOC, V82, P1133
   Alessandri I, 2005, MAT SCI ENG C-BIO S, V25, P560, DOI 10.1016/j.msec.2005.07.006
   Alessi ML, 2005, MACROMOLECULES, V38, P9333, DOI 10.1021/ma051339e
   BLANCHET GB, 1993, APPL PHYS LETT, V62, P1026, DOI 10.1063/1.108514
   BLANDAMER MJ, 1967, MAKROMOL CHEM, V49, P124
   Bloisi F, 2007, MAT SCI ENG C-BIO S, V27, P1185, DOI 10.1016/j.msec.2006.12.005
   BONTEMPI E, 2004, RECENT RES DEV CHEM, P461
   Bozzini B, 2006, J MATER SCI-MATER EL, V17, P915, DOI 10.1007/s10854-006-0044-x
   Bubb DM, 2006, APPL PHYS A-MATER, V83, P147, DOI 10.1007/s00339-005-3478-8
   Bubb DM, 2001, APPL PHYS A-MATER, V73, P121, DOI 10.1007/s003390100884
   Bubb DM, 2002, J APPL PHYS, V91, P9809, DOI 10.1063/1.1478136
   Bubb DM, 2002, J APPL PHYS, V91, P2055, DOI 10.1063/1.1427138
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   CHRISEY DB, 1991, THIN SOLID FILMS, V206, P111, DOI 10.1016/0040-6090(91)90402-J
   Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w
   Dalsin JL, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71079-8
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   DEGENNES PG, 1993, CR HEBD ACAD SCI, V313, P1117
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   Doraiswamy A, 2007, MAT SCI ENG C-BIO S, V27, P409, DOI 10.1016/j.msec.2006.05.026
   Ebner A, 2004, MICROSC RES TECHNIQ, V65, P246, DOI 10.1002/jemt.20124
   Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.
   Hoffmann MM, 2005, J COLLOID INTERF SCI, V287, P712, DOI 10.1016/j.jcis.2005.02.044
   Itina TE, 2001, NUCL INSTRUM METH B, V180, P238, DOI 10.1016/S0168-583X(01)00423-2
   Kaewpirom S, 2006, EUR POLYM J, V42, P1609, DOI 10.1016/j.eurpolymj.2006.01.010
   Leveugle E, 2007, J APPL PHYS, V102, DOI 10.1063/1.2783898
   Lippert T, 2003, CHEM REV, V103, P453, DOI 10.1021/cr010460q
   Lowndes DH, 1996, SCIENCE, V273, P898, DOI 10.1126/science.273.5277.898
   Mahlin D, 2005, POLYMER, V46, P12210, DOI 10.1016/j.polymer.2005.10.091
   Papra A, 2001, LANGMUIR, V17, P1457, DOI 10.1021/la000609d
   Qiu YJ, 2007, J APPL POLYM SCI, V103, P2464, DOI 10.1002/app.25362
   Rodrigo K, 2006, APPL SURF SCI, V252, P4824, DOI 10.1016/j.apsusc.2005.07.143
   Rundqvist J, 2005, LANGMUIR, V21, P2981, DOI 10.1021/la0471792
   Sanderson LAW, 1998, J COLLOID INTERF SCI, V207, P180, DOI 10.1006/jcis.1998.5727
   Sasahara K, 1998, COLLOID POLYM SCI, V276, P643, DOI 10.1007/s003960050292
   Toftmann B, 2005, APPL SURF SCI, V247, P211, DOI 10.1016/j.apsusc.2005.01.175
   Turner K, 1996, COLLOID POLYM SCI, V274, P622, DOI 10.1007/BF00653058
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   Zhigilei LV, 2003, CHEM REV, V103, P321, DOI 10.1021/cr010459r
NR 39
TC 24
Z9 24
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD SEP 15
PY 2008
VL 254
IS 22
BP 7143
EP 7148
DI 10.1016/j.apsusc.2008.05.295
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 345LQ
UT WOS:000258998700005
DA 2018-10-20
ER

PT J
AU Mami, M
   Lucas-Girot, A
   Oudadesse, H
   Dorbez-Sridi, R
   Mezahi, F
   Dietrich, E
AF Mami, Mohamed
   Lucas-Girot, Anita
   Oudadesse, Hassane
   Dorbez-Sridi, Rachida
   Mezahi, Fatima
   Dietrich, Elodie
TI Investigation of the surface reactivity of a sol-gel derived glass in
   the ternary system SiO(2)-CaO-P(2)O(5)
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE sol-gel processing; exchange; surface; body fluid
ID IN-VITRO SYNTHESIS; BIOACTIVE GLASS; COMPOSITIONAL DEPENDENCE; MEDICAL
   APPLICATIONS; POROSITY; LAYER; CERAMICS; GROWTH; BONE; BIOMATERIALS
AB A new glass formulation, with themolar composition 60% SiO(2)-35% CaO-5% P(2)O(5), was synthesized using the sol-gel process, for applications as biomaterial in orthopaedic or maxillo facial surgery. Pellets, made of glass powder, were uniaxially compacted and soaked in simulated body fluid (SBF) for up to 7 days at 37 degrees C to evaluate glass bioactivity. Ionic exchanges at the interface glass-SBF were evaluated by studying evolutions of calcium, phosphorus and silicon concentrations in SBF using ICP-OES. Changes in glass surface, and the formation of crystalline phases were analyzed using XRD, SEM, EDS and FTIR methods. Results form ICP-OES showed a high reactivity of the glass surface with a very high and continuous release of calcium, a limited glass dissolution and an uptake of phosphorous from SBF. Results from both FTIR and XRD analysis indicated that the glass surface was progressively covered by two different phases: CaCO(3) as calcite and a carbonated apatite layer. The formation of these phases, following two different schemas, was observed after 2 h of immersion and confirmed after 7 days. SEM micrographs and EDS analysis demonstrated that the main phase, a carbonated apatite, was present as micro-spheroids and the secondary phase, calcite, was materialized by agglomerates which have diameters up to 10-15 mm. These results are in accordance with a bioactive feature of the glass studied. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Mami, Mohamed; Lucas-Girot, Anita; Oudadesse, Hassane; Mezahi, Fatima; Dietrich, Elodie] Equipe Chim Solide & Mat, UMR Sci Chim Rennes 6226, F-35042 Rennes, France.
   [Mami, Mohamed; Dorbez-Sridi, Rachida] Fac Sci Monastir, Dept Phys, Lab Physicochim Mat, Monastir 5019, Tunisia.
RP Mami, M (reprint author), Equipe Chim Solide & Mat, UMR Sci Chim Rennes 6226, Campus Beaulieu,Bat 10B,Ave Gen Leclerc, F-35042 Rennes, France.
EM mohamed_fsm@yahoo.fr
CR ANDERSSON OH, 1994, BIOCERAMICS, V7, P3
   Brink M, 1997, J BIOMED MATER RES, V37, P114, DOI 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   DAVIDOVITS J, 1996, Patent No. 0815064
   Derrien AC, 2004, NUCL INSTRUM METH B, V226, P281, DOI 10.1016/j.nimb.2004.06.014
   DUCHEYNE P, 1994, J CELL BIOCHEM, V56, P162, DOI 10.1002/jcb.240560207
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   FARMER VC, 1974, SW75HR MIN SOC
   FILGUEIRAS MR, 1993, J BIOMED MATER RES, V27, P445, DOI 10.1002/jbm.820270405
   GROSS U, 1988, CRC CRITICAL REV BIO, V4, P2
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HEUGHEBAERT M, 1988, J BIOMED MATER RES, V23, P258
   *JCPDS INT CTR DIF, 2002, 5586 JCPDS INT CTR D
   *JCPDS INT CTR DIF, 2002, 090432 JCPDS INT CTR
   KIM CY, 1992, J BIOMED MATER RES, V26, P1147, DOI 10.1002/jbm.820260905
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kokubo T., 1999, ADV SERIES CERAMICS, V1, P75
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   LEGEROS RZ, 1990, HDB BIOACTIVE CERAMI, V2, P17
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Lucas A, 2001, INT J INORG MATER, V3, P87, DOI 10.1016/S1466-6049(00)00058-1
   Lucas-Girot A, 2005, J BIOMED MATER RES B, V73B, P164, DOI 10.1002/jbm.b.30210
   Lucas-Girot A, 2002, BIOMATERIALS, V23, P503, DOI 10.1016/S0142-9612(01)00132-6
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   Oudadesse H, 2007, J MATER SCI, V42, P3092, DOI 10.1007/s10853-006-0524-7
   Oudadesse H, 2004, INSTRUM SCI TECHNOL, V32, P545, DOI 10.1081/CI-200029803
   OUDADESSE H, 2007, BIOMED MATER, V2, P65
   Padilla S, 2005, BIOMATERIALS, V26, P475, DOI 10.1016/j.biomaterials.2004.02.054
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   Ramila A, 2002, CHEM MATER, V14, P542, DOI 10.1021/cm0110876
   Rehman I, 1998, J BIOMED MATER RES, V41, P162, DOI 10.1002/(SICI)1097-4636(199807)41:1<162::AID-JBM19>3.0.CO;2-P
   Roman J, 2003, CHEM MATER, V15, P798, DOI 10.1021/cm021325c
   SEPULVEDA P, 2001, J BIOMED MATER RES, V2, P301
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Smith B, 1999, INFRARED SPECTRA INT
   Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b
   Vallet-Regi M, 1999, J BIOMED MATER RES, V44, P416, DOI 10.1002/(SICI)1097-4636(19990315)44:4<416::AID-JBM7>3.0.CO;2-S
   Vallet-Regi M, 2000, J BIOMED MATER RES, V51, P23, DOI 10.1002/(SICI)1097-4636(200007)51:1<23::AID-JBM4>3.0.CO;2-B
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Wanpeng C., 1996, CERAM INT, V22, P493
   ZARZYCKI J, 1982, ETAT VITREUX
   Zoulgami M, 2002, EUR PHYS J-APPL PHYS, V19, P173, DOI 10.1051/epjap:2002063
   Zoulgami M, 2001, BIOMATERIALS, V22, P1933, DOI 10.1016/S0142-9612(00)00384-7
NR 46
TC 63
Z9 63
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD SEP 15
PY 2008
VL 254
IS 22
BP 7386
EP 7393
DI 10.1016/j.apsusc.2008.05.340
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 345LQ
UT WOS:000258998700047
DA 2018-10-20
ER

PT J
AU Yu, SH
   Wu, YB
   Mi, FL
   Shyu, SS
AF Yu, Shu-Huei
   Wu, Yu-Bey
   Mi, Fwu-Long
   Shyu, Shin-Shing
TI Polysaccharide-based artificial extracellular matrix: Preparation and
   characterization of three-dimensional macroporous chitosan, and heparin
   composite scaffold
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE chitosan; heparin; artificial extracellular matrix; glutaraldehyde;
   scaffold
ID TISSUE; FABRICATION; HYDROGELS; COMPLEX; SPONGE; GROWTH
AB Scaffold-guided tissue engineering based on synthetic and natural occurring polymers has gained many interests in recent year. In this study, the development of a chitosan-heparin artificial extracellular matrix (AECM) is reported. Three-dimensional, macroporous composite AECMs composed of heparin (Hep) and chitosan (Chito) were prepared by an interpolyelectrolyte complex/lyophilization method. The Chito-Hep composite AECMs were respectively, crosslinked with glutaraldehyde, as well as cocrosslinked with N,N-(3-dimethylaminopropyl)-N'-ethyl carbodiimide (EDC/NHS) and N-hydroxysuccinimide (NHS). The crosslinking reactions were examined by FT-IR analysis. In physiological buffer solution (PBS), the EDC/NHS-crosslinked Chito-Hep composite AECM showed a relative lower water retention ratio than its glutaraldehyde-crosslinked counterparts. The EDC/NHS-crosslinked Chito-Hep composite AECMs showed excellent biocompatibility, according to the results of the in vitro cytotoxic test. This result suggested that the EDC/NHS-crosslinked Chito-Hep composite AECMs might be a potential biomaterial for scaffold-guided tissue engineering applications. (c) 2008 Wiley Periodicals, Inc. J Appl Polym Sci 109: 3639-3644, 2008.
C1 [Shyu, Shin-Shing] Vanung Univ, Ctr Polymer Mat Res, Chungli, Taiwan.
   [Shyu, Shin-Shing] Vanung Univ, Dept Cosmet Sci, Chungli, Taiwan.
   [Yu, Shu-Huei] Vanung Univ, Dept Polymer Mat, Chungli, Taiwan.
   [Wu, Yu-Bey] Natl Cent Univ, Dept Chem & Mat Engn, Chungli 32054, Taiwan.
   [Mi, Fwu-Long] Dept Biotechnol, Tao Yuan 320, Taiwan.
RP Shyu, SS (reprint author), Vanung Univ, Ctr Polymer Mat Res, Chungli, Taiwan.
EM ssshyu@msa.vnu.edu.tw
CR FLINT N, 1994, J CELL SCI, V107, P401
   Gilbert TW, 2005, BIOMATERIALS, V26, P1431, DOI 10.1016/j.biomaterials.2004.04.042
   Gong YH, 2006, J APPL POLYM SCI, V101, P3336, DOI 10.1002/app.23931
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Kweon DK, 2003, J APPL POLYM SCI, V87, P1784, DOI 10.1002/app.11592
   LANGER R, 1993, TISSUE ENG SCI, V260, P920
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   MCPHERSON JM, 1988, COLLAGEN REL RES, V8, P83
   Mi FL, 2006, J BIOMED MATER RES A, V76A, P1, DOI 10.1002/jbm.a.30298
   Mi FL, 2005, J POLYM SCI POL CHEM, V43, P1985, DOI 10.1002/pla.20669
   Mi FL, 2005, BIOMACROMOLECULES, V6, P975, DOI 10.1021/bm049335p
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2003, BIOMATERIALS, V24, P5023, DOI 10.1016/S0142-9612(03)00413-7
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Ozturk E, 2006, J APPL POLYM SCI, V101, P1602, DOI 10.1002/app.23563
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   VACANTI JP, 1999, TISSUE ENG, V354, P32
   Zhou QL, 2005, J APPL POLYM SCI, V98, P1373, DOI 10.1002/app.22289
NR 21
TC 9
Z9 11
U1 0
U2 16
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 15
PY 2008
VL 109
IS 6
BP 3639
EP 3644
DI 10.1002/app.28494
PG 6
WC Polymer Science
SC Polymer Science
GA 327JH
UT WOS:000257724900027
DA 2018-10-20
ER

PT J
AU Shi, ZL
   Neoh, KG
   Kang, ET
   Poh, C
   Wang, W
AF Shi, Zhilong
   Neoh, K. G.
   Kang, E. T.
   Poh, Chyekhoon
   Wang, W.
TI Bacterial adhesion and osteoblast function on titanium with
   surface-grafted chitosan and immobilized RGD peptide
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium alloy; chitosan; bacterial adhesion; osteoblast; peptide
ID STAPHYLOCOCCUS-EPIDERMIDIS; ANTIBACTERIAL ACTIVITY; CELL-ADHESION;
   IN-VITRO; CHEMICAL-MODIFICATION; IMPLANT INFECTIONS; OXIDE SURFACES;
   MINERALIZATION; ATTACHMENT; BIOMATERIALS
AB Biomaterials-associated infections remain a source of serious complications in modern medicine. Mien a biomaterial is implanted in the body, the result of successful tissue integration or implant infection depends on the race for the surface between bacteria and tissue cells. One promising strategy to reduce the incidence of infection is the functionalization of the biomaterial surface to inhibit bacterial adhesion and encourage the growth of cells. In this in vitro study, the surface of titanium alloy substrates was first functionalized by covatently grafted chitosan (CS). The cell-adhesive Arg-Gly-Asp (RGD) peptide was then immobilized oil the CS-grafted surface through covalent binding of peptide to the free NH2 groups of CS. Both these functionalized surfaces showed a decrease in adhesion of Staphylococcus aureus (S. aureus) and Staphylococcus epidermis (S. epidermidis) compared with the pristine substrate. A Significant increase in osteoblast cell attachment, proliferation, and alkaline phosphatase activity x-vas observed on the surface with the immobilized Arg-Gly-Asp peptide. Thus, utilizing surface-grafted chitosan in conjunction with the cell-adhesive peptide to modify the metal surface provides a promising means for enhancing tissue integration of implants by reducing bacterial adhesion rend promoting osteoblast functions. (C) 2007 Wiley Periodicals, Inc.
C1 [Shi, Zhilong; Neoh, K. G.; Kang, E. T.] Natl Univ Singapore, Dept Chem & Biomol Engn, Kent Ridge 119260, Singapore.
   [Poh, Chyekhoon; Wang, W.] Natl Univ Singapore, Dept Orthopaed Surg, Kent Ridge 119260, Singapore.
RP Neoh, KG (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Kent Ridge 119260, Singapore.
EM chenkg@nus.edu.sg
RI Kang, En-Tang/G-8522-2012
OI Kang, En-Tang/0000-0003-0599-7834; Neoh, Koon Gee/0000-0002-2700-1914
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032
   Holgers KM, 1999, BIOMATERIALS, V20, P1319, DOI 10.1016/S0142-9612(99)00033-2
   Hu SG, 2003, BIOMATERIALS, V24, P2685, DOI 10.1016/S0142-9612(03)00079-6
   Huh MW, 2001, J APPL POLYM SCI, V81, P2769, DOI 10.1002/app.1723
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1993, J BIOL CHEM, V268, P8053
   Matsunaga T, 2006, J BIOMED MATER RES A, V76A, P711, DOI 10.1002/jbm.a.30588
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Patel S, 2006, BIOMATERIALS, V27, P2890, DOI 10.1016/j.biomaterials.2005.12.009
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 1999, LANGMUIR, V15, P6931, DOI 10.1021/la990024n
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   Shi ZL, 2005, BIOMATERIALS, V26, P501, DOI 10.1016/j.biomaterials.2004.02.060
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   TURKSEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P1339, DOI 10.1177/40.9.1506671
   Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Yamada S, 2003, J BIOMED MATER RES A, V66A, P500, DOI 10.1002/jbm.a.10009
   Zhang H, 2004, BIOMACROMOLECULES, V5, P2461, DOI 10.1021/bm0496211
NR 43
TC 82
Z9 83
U1 2
U2 55
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2008
VL 86A
IS 4
BP 865
EP 872
DI 10.1002/jbm.a.31648
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 340HQ
UT WOS:000258637100002
PM 18041731
DA 2018-10-20
ER

PT J
AU Raffaelli, L
   Iommetti, PR
   Piccioni, E
   Toesca, A
   Serini, S
   Resci, F
   Missori, M
   De Spirito, M
   Manicone, PF
   Calviello, G
AF Raffaelli, Luca
   Iommetti, Pierfrancesco Rossi
   Piccioni, Elisabetta
   Toesca, Amelia
   Serini, Simona
   Resci, Federica
   Missori, Mauro
   De Spirito, Marco
   Manicone, Paolo F.
   Calviello, Gabriella
TI Growth, viability, adhesion potential, and fibronectin expression in
   fibroblasts cultured on zirconia or feldspatic ceramics in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE zirconia; fixed partial dentures; cellular adhesion; cellular growth
   rate; fibronectin
ID PARTIALLY-STABILIZED ZIRCONIA; HUMAN GINGIVAL FIBROBLASTS; DENTAL
   ALLOYS; MECHANICAL-PROPERTIES; CYTOTOXICITY; CELLS; PROLIFERATION;
   APOPTOSIS; INVITRO; ALUMINA
AB Zirconia, a biomaterial wideley used ill dentistry, has recently attracted much attention for its mechanical strength and toughness. Previously, its lack of mutagenic and carcinogenic power was reported. We describe here other essential aspects to be taken into account to define in vitro the biocompatibility of a material: the growth rate, viability, and adhesion capacity of normal stabilized cells grooving on it. To this aim, immortalized RAT-1 fibroblasts, growing either oil zirconia and on feldspatic (FE) ceramics were compared. In particular, the level of expression and the intra- and extra-cellular organization of fibronectill, a glycoprotein involved in Cellular adhesion and migration during tissue repair, was analyzed. Fibroblasts cultured on zirconia showed a higher growth rate, and underwent necrosis at lower levels than cells on FE ceramic, whereas either Materials did not stimulate apoptosis. Adhesion capacity of fibroblasts was evaluated measuring adherent cell nucleic acids with the flurometric CyQuant (R) assay, and it was found significantly higher in cells cultured on zirconia than on FE ceramic. This finding may be explained by the higher and more precocious expression of the adhesion protein fibronectin observed by indirect immunofluorescence in fibroblasts oil zirconia. Overall, the results suggest that zirconia, exerting low cytotoxicity and strongly inducing adhesion capacity, increases cellular growth rate of fibroblasts. All these features suggest that zirconia could represent a more suitable biomaterial than FE ceramic for prosthesis in dentistry. (C) 2007 Wiley Periodicals, Inc.
C1 [Piccioni, Elisabetta; Serini, Simona; Resci, Federica; Calviello, Gabriella] Catholic Univ, Inst Gen Pathol, I-00168 Rome, Italy.
   [Raffaelli, Luca; Iommetti, Pierfrancesco Rossi; Manicone, Paolo F.] Catholic Univ, Inst Clin Dent, I-00168 Rome, Italy.
   [Toesca, Amelia] Catholic Univ, Inst Human Anat, I-00168 Rome, Italy.
   [Missori, Mauro; De Spirito, Marco] Catholic Univ, Inst Phys, I-00168 Rome, Italy.
RP Calviello, G (reprint author), Catholic Univ, Inst Gen Pathol, Lgo F Vito 1, I-00168 Rome, Italy.
EM g.calviello@rm.unicatt.it
RI Missori, Mauro/H-4355-2012; De Spirito, Marco/C-5386-2008
OI De Spirito, Marco/0000-0003-4260-5107; SERINI,
   Simona/0000-0002-6894-1443; Manicone, Paolo
   Francesco/0000-0003-0283-2903; CALVIELLO, Gabriella/0000-0002-2117-5534
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   BARBER S, 1984, J ORAL PATHOL MED, V13, P221, DOI 10.1111/j.1600-0714.1984.tb01420.x
   Briggs S L, 2005, J Wound Care, V14, P284
   CALES B, 1994, J MATER SCI-MATER M, V5, P376, DOI 10.1007/BF00058967
   Calviello G, 2003, CARCINOGENESIS, V24, P427, DOI 10.1093/carcin/24.3.427
   CAPUTO AA, 1980, DENT CLIN N AM, V24, P331
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Coli P, 2004, INT J PROSTHODONT, V17, P59
   COUCHMAN JR, 1982, J CELL BIOL, V93, P402, DOI 10.1083/jcb.93.2.402
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   CRAIG RG, 1990, J DENT RES, V69, P1539, DOI 10.1177/00220345900690081801
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   FARDAL O, 1986, J CLIN PERIODONTOL, V13, P735, DOI 10.1111/j.1600-051X.1986.tb00874.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Griggs JA, 2003, DENT MATER, V19, P353, DOI 10.1016/S0109-5641(02)00066-0
   Grill V, 1997, ARCH ORAL BIOL, V42, P641, DOI 10.1016/S0003-9969(97)00055-1
   Grill V, 2000, QUINTESSENCE INT, V31, P741
   GRILL V, 1996, J BIOL RES, V72, P87
   GUPTA TK, 1978, J MATER SCI, V13, P1464, DOI 10.1007/BF00553200
   Helmer J, 1969, S US CER SURG IMPL S
   Hickman JA, 1997, BRIT MED BULL, V53, P632
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Kuru L, 1998, J DENT RES, V77, P555, DOI 10.1177/00220345980770040801
   Lohaman C.H., 2002, BIOMATERIALS, V23, P1855
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   MACCAURO G, 1992, P 8 ESB M ROM IT JUN, P110
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   McLaren E A, 1999, Pract Periodontics Aesthet Dent, V11, P985
   Milleding P, 2001, BIOMATERIALS, V22, P2545, DOI 10.1016/S0142-9612(00)00445-2
   Neff T, 2002, J ENDODONT, V28, P811, DOI 10.1097/00004770-200212000-00005
   PAPI M, 2006, APPL PHYS LETT, V88, DOI UNSP 194102-194104
   Persson BNJ, 2005, J PHYS-CONDENS MAT, V17, pR1, DOI 10.1088/0953-8984/17/1/R01
   Phipps RP, 1997, J PERIODONTAL RES, V32, P159, DOI 10.1111/j.1600-0765.1997.tb01398.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Potiket N, 2004, J PROSTHET DENT, V92, P491, DOI 10.1016/j.prosdent.2004.09.001
   RIETH PH, 1976, AM CERAM SOC BULL, V55, P717
   Sadi AY, 2006, J MATER SCI-MATER M, V17, P407, DOI 10.1007/s10856-006-8467-8
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   SIMION M, 1991, International Journal of Prosthodontics, V4, P543
   Sjogren G, 2000, J PROSTHET DENT, V84, P229, DOI 10.1067/mpr.2000.107227
   Solary E, 2001, THERAPIE, V56, P511
   SORENSEN JA, 2003, QUINTESSENCE DENT TE, V26, P57
   SYRJANEN S, 1985, BIOMATERIALS, V6, P169, DOI 10.1016/0142-9612(85)90005-5
   TERRANOVA VP, 1986, J PERIODONTAL RES, V21, P330, DOI 10.1111/j.1600-0765.1986.tb01467.x
   Tinschert J, 2001, INT J PROSTHODONT, V14, P231
   Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0
   Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155
NR 49
TC 17
Z9 17
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2008
VL 86A
IS 4
BP 959
EP 968
DI 10.1002/jbm.a.31693
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 340HQ
UT WOS:000258637100012
PM 18067158
DA 2018-10-20
ER

PT J
AU Arshad, M
   Zafar, MN
   Younis, S
   Nadeem, R
AF Arshad, Mamoona
   Zafar, Muhammad Nadeem
   Younis, Sadaf
   Nadeem, Raziya
TI The use of Neem biomass for the biosorption of zinc from aqueous
   solutions
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE biosorption; Neem; zinc; waste water; kinetics; Gibbs free energy
ID HEAVY-METALS; AZADIRACHTA-INDICA; ADSORPTION; REMOVAL; IONS; WASTE;
   KINETICS; COPPER; EQUILIBRIUM; PESTICIDES
AB An adsorbent was developed from mature leaves and stem bark of the Neem (Azadirachta indica) tree for removing zinc from water. Adsorption was carried out in a batch process with several different concentrations of zinc by varying pH. The uptake of metal was very fast initially, but gradually slowed down indicating penetration into the interior of the adsorbent particles. The data showed that optimum pH for efficient biosorption of zinc by Neem leaves and stem bark was 4 and 5, respectively. The maximum adsorption capacity showed that the Neem biomass had a mass capacity for zinc (147.08 mg Zn/g for Neem leaves and 137.67 mg Zn/g Neem bark). The experimental results were analyzed in terms of Langmuir and Freundlich isotherms. The adsorption followed pseudo-second-order kinetic model. The thermodynamic assessment of the metal ion-Neem tree biomass system indicated the feasibility and spontaneous nature of the process and Delta G degrees values were evaluated as ranging from -26.84 to -32.75 (Neem leaves) kJ/mol and -26.04 to -29.50 (Neem bark) kJ/mol for zinc biosorption. Due to its outstanding zinc uptake capacity, the Neem tree was proved to be an excellent biomaterial for accumulating zinc from aqueous solutions. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Arshad, Mamoona; Zafar, Muhammad Nadeem; Younis, Sadaf; Nadeem, Raziya] Univ Agr Faisalabad, Dept Chem, Faisalabad 38040, Pakistan.
   [Zafar, Muhammad Nadeem] Lund Univ, Dept Analyt Chem, SE-22100 Lund, Sweden.
   [Arshad, Mamoona] Natl Inst Biotechnol & Genet Engn, Bioproc Technol Div, Faisalabad, Pakistan.
RP Zafar, MN (reprint author), Univ Agr Faisalabad, Dept Chem, Faisalabad 38040, Pakistan.
EM MNadeem.Zafar@analykem.lu.se
RI Zafar, Muhammad/B-9827-2008; Zafar, Muhammad/E-8849-2010
OI Zafar, Muhammad/0000-0002-2109-7601
FU University of Agriculture, Faisalabad, Pakistan
FX Authors are thankful to Prof. Dr. Munir Ahmad Sheikh (Chairman,
   Department of Chemistry, University of Agriculture, Faisalabad,
   Pakistan) for financial support.
CR Agrawal A, 2004, COLLOID SURFACE A, V237, P133, DOI 10.1016/j.colsurfa.2004.01.034
   ASCHER KRS, 1993, ARCH INSECT BIOCHEM, V22, P433, DOI 10.1002/arch.940220311
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Chen JP, 1997, SEPAR SCI TECHNOL, V32, P51, DOI 10.1080/01496399708003186
   Chu KH, 2002, J HAZARD MATER, V90, P77, DOI 10.1016/S0304-3894(01)00332-6
   Cordero B, 2004, ENVIRON CHEM, V1, P180, DOI 10.1071/EN04039
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   Davis TA, 2000, WATER RES, V34, P4270, DOI 10.1016/S0043-1354(00)00177-9
   Fourest E, 1996, ENVIRON SCI TECHNOL, V30, P277, DOI 10.1021/es950315s
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   GOMES NCM, 1996, REV MICROBIOLOGIA, V27, P67
   GOSSET T, 1986, WATER RES, V20, P21, DOI 10.1016/0043-1354(86)90209-5
   GROSSE DW, 1986, JAPCA J AIR WASTE MA, V36, P603, DOI 10.1080/00022470.1986.10466099
   Ho Y. S., 1995, ADSORPTION HEAVY MET
   Janson C.E., 1982, ENVIRON PROG, V1, P212
   Jnr M. H., 2004, EUR J BIOTECHNOL, V7, P313
   Kargi F, 2007, J ENVIRON MANAGE, V85, P883, DOI 10.1016/j.jenvman.2006.10.017
   Lagergren S., 1898, VETENSKAPSAKAD HANDL, V24, P1
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   MCKAY G, 1980, WATER RES, V14, P15, DOI 10.1016/0043-1354(80)90037-8
   Mellah A, 1997, WATER RES, V31, P621, DOI 10.1016/S0043-1354(96)00294-1
   Mohan D, 2002, WATER RES, V36, P2304, DOI 10.1016/S0043-1354(01)00447-X
   *NAT RES COUNC, 1992, NEEM TREE SOLV GLOB
   Norton L, 2004, ADV ENVIRON RES, V8, P629, DOI 10.1016/S1093-0191(03)00035-2
   Padmavathy V, 2003, PROCESS BIOCHEM, V38, P1389, DOI 10.1016/S0032-9592(02)00168-1
   Quek SY, 1998, WATER SA, V24, P251
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Rudresh H. B., 1977, J ENV SCI TECHNOL, V122, P251
   Sag Y, 1998, HYDROMETALLURGY, V50, P297, DOI 10.1016/S0304-386X(98)00065-6
   SAG Y, 1995, PROCESS BIOCHEM, V30, P169, DOI 10.1016/0032-9592(95)95716-V
   Sanchez-Polo M., 2002, Environmental Science and Technology, V36, P3850, DOI 10.1021/es0255610
   SCHMUTTERER H, 1990, ANNU REV ENTOMOL, V35, P271, DOI 10.1146/annurev.en.35.010190.001415
   SHARMA DC, 1994, BIORESOURCE TECHNOL, V49, P31, DOI 10.1016/0960-8524(94)90170-8
   Sing C, 1998, WATER RES, V32, P2746, DOI 10.1016/S0043-1354(98)00024-4
   TIEN CT, 1991, TRACE METALS ENV, V1, P295
   Tran HH, 1999, WATER RES, V33, P2992, DOI 10.1016/S0043-1354(99)00017-2
   USDHHS Toxicological Profile for Zinc, 1993, TOX PROF ZINC
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Volesky B., 2003, SORPTION BIOSORPTION
   Volesky B., 1990, BIOSORPTION HEAVY ME, P3
   Weber W. J., 1962, P INT C WAT POLL S, V2, P231
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
NR 43
TC 42
Z9 43
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD SEP 15
PY 2008
VL 157
IS 2-3
BP 534
EP 540
DI 10.1016/j.jhazmat.2008.01.017
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 337HK
UT WOS:000258425900041
PM 18289783
DA 2018-10-20
ER

PT J
AU Lin, F
   Li, YC
   Jin, J
   Cai, YR
   Wei, KM
   Yao, JM
AF Lin, Feng
   Li, Yucheng
   Jin, Jun
   Cai, Yurong
   Wei, Kemin
   Yao, Juming
TI Deposition behavior and properties of silk fibroin scaffolds soaked in
   simulated body fluid
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE microporous materials; polymers; crystal growth; mechanical properties
ID SOLID-STATE NMR; BOMBYX-MORI; BONE-FORMATION; MICROSTRUCTURE;
   NANOCOMPOSITES; BIOMATERIAL; COMPOSITE; CARTILAGE; FIBERS
AB Porous 3D silk fibroin (SF) scaffolds were prepared directly from the SF solution with the addition of methanol and glutaralclehyde by a freeze-drying method. The scaffolds were then soaked in the simulated body fluid (SBF) for the deposition of hydroxyapatite (HA) crystals. The XRD and MR results showed that the SF were in P-sheet structure, resulting in the high thermal stability and mechanical properties of scaffolds. The XRD and AAS data revealed that the SF scaffolds could induce the continuous growth and enrichment ofHA crystals onto the scaffolds with the extension ofsoaking time. The mechanical properties of scaffolds increased first with the HA-deposition within 3 d of soaking, then it declined. During the full soaking period, no significant change was observed on the porosity and water-binding ability, which were kept at about 84% and 800%, respectively. The cell cultivation results showed that the scaffolds have the satisfied cell biocompatibility, which was promoted after the HA-deposition. This work suggests that the porous 3D SF scaffolds may be a potential candidate in the bone engineering. (c) 2008 Elsevier BY. All rights reserved.
C1 [Lin, Feng; Li, Yucheng; Jin, Jun; Cai, Yurong; Yao, Juming] Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
   [Wei, Kemin] Zhejiang Acad Tradit Chinese Med, Hangzhou 310007, Zhejiang, Peoples R China.
RP Yao, JM (reprint author), Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Xiasha Higher Educ Pk, Hangzhou 310018, Peoples R China.
EM yaoj@zstu.edu.cn
RI Yao, Juming/N-7886-2014
CR Akari T., 2003, J BIOMED MATER RES A, V65, P283
   Asakura T, 2001, J MOL BIOL, V306, P291, DOI 10.1006/jmbi.2000.4394
   Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chang MC, 2001, J MATER SCI LETT, V20, P1199, DOI 10.1023/A:1010914621089
   Choi DW, 2004, MATER RES BULL, V39, P417, DOI 10.1016/j.materresbull.2003.10.013
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Furuzono T, 2000, J BIOMED MATER RES, V50, P344, DOI 10.1002/(SICI)1097-4636(20000605)50:3<344::AID-JBM8>3.0.CO;2-D
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Jalota S, 2006, J MATER SCI-MATER M, V17, P697, DOI 10.1007/s10856-006-9680-1
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li L, 2008, J MATER SCI-MATER M, V19, P577, DOI 10.1007/s10856-007-3004-y
   Liu YC, 2002, TISSUE ENG, V8, P709, DOI 10.1089/107632702760240616
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tsukada M, 1996, J APPL POLYM SCI, V60, P1619, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-#
   Uchida M, 2004, ADV MATER, V16, P1071, DOI 10.1002/adma.200400152
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang L, 2002, J NANOPART RES, V4, P535, DOI 10.1023/A:1022841507932
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F
   Yao J., 2004, ENCY BIOMATERIALS BI, P1363
   Yao JM, 2004, BIOMACROMOLECULES, V5, P680, DOI 10.1021/bm034285u
   Yao JM, 2002, MACROMOLECULES, V35, P6, DOI 10.1021/ma011335j
   Yao JM, 2007, ACTA CHIM SINICA, V65, P635
   ZHAO M, 2006, INT J BIOMED ENG, V29, P1
   Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i
NR 33
TC 33
Z9 37
U1 1
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD SEP 15
PY 2008
VL 111
IS 1
BP 92
EP 97
DI 10.1016/j.matchemphys.2008.03.019
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 323MN
UT WOS:000257450300020
DA 2018-10-20
ER

PT J
AU Corno, M
   Pedone, A
   Dovesi, R
   Ugliengo, P
AF Corno, Marta
   Pedone, Alfonso
   Dovesi, Roberto
   Ugliengo, Piero
TI B3LYP simulation of the full vibrational spectrum of 45S5 bioactive
   silicate glass compared to nu-silica
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATIONS; LOCALIZED WANNIER FUNCTIONS; EFFECTIVE
   CORE POTENTIALS; HARTREE-FOCK GRADIENTS; AB-INITIO; VITREOUS-SILICA;
   ELASTIC PROPERTIES; PERIODIC-SYSTEMS; CRYSTAL CODE;
   ELECTRONIC-PROPERTIES
AB The IR spectrum of the Bioglass 45S5 (of composition 46.1 SiO2, 24.4 Na2O, 26.9 CaO. and 2.6 P2O5 mol %) has been simulated by means of periodic ab initio B3LYP calculations. The initial glass structure unit cell envisaging 78 atoms was generated through a melt quench process by means of classical molecular dynamics simulations. The molecular mechanics optimized unit cell has then been fully reoptimized (both unit-cell parameters and internal coordinates) at B3LYP level in a periodic approach using Gaussian basis sets of double-xi quality by means of the CRYSTAL06 code. Although long-range structural properties cannot be modeled by using this ab initio approach because of the intrinsic amorphous nature of the glass, the quantum mechanical simulation proved to be extremely effective in predicting and analyzing the vibrational features of this biomaterial. The effect of modifiers Na and Ca cations on the network dynamics has been assessed by comparing the 45S5 vibrational spectrum with that of amorphous nu-SiO2, both simulated at the B3LYP level. A detailed assignment of each spectral peak to the corresponding vibrational mode of the two glasses has been addressed and the role of cation modifiers on the vibrational features has been analyzed in greater details. This may be useful to support further IR and Raman investigations of the bulk structure of these materials.
C1 [Corno, Marta; Dovesi, Roberto; Ugliengo, Piero] Univ Turin, NIS Ctr Excellence, Dept IFM Chem, Turin, Italy.
   [Corno, Marta; Dovesi, Roberto; Ugliengo, Piero] Univ Turin, INSTM Mat Sci & Technol, Natl Consortium, Turin, Italy.
   [Pedone, Alfonso] Univ Modena & Reggio Emilia, Dept Chem, I-41100 Modena, Italy.
RP Ugliengo, P (reprint author), Univ Turin, NIS Ctr Excellence, Dept IFM Chem, Via P Giuria 7, Turin, Italy.
EM piero.ugliengo@unito.it
RI Corno, Marta/I-4310-2012; ugliengo, piero/H-6373-2015; Pedone,
   Alfonso/C-6286-2014
OI Corno, Marta/0000-0001-7248-2705; ugliengo, piero/0000-0001-8886-9832;
   Pedone, Alfonso/0000-0003-3772-7222
FU Italian Ministry MIUR [2006032335_005]; Regione Piemonte (Bando ricerca
   scientifica Piemonte 2004, Settore: Nanotecriologie e nanoscienze,
   "Materiali nanostrutturati biocompatibili per applicazioni biomediche")
FX Financial support from the Italian Ministry MIUR (Project COFIN2006,
   Prot. 2006032335_005 led by Prof. C. Morterra) and from the Regione
   Piemonte (Bando ricerca scientifica Piemonte 2004, Settore:
   Nanotecriologie e nanoscienze, "Materiali nanostrutturati biocompatibili
   per applicazioni biomediche", led by Prof. C. Morterra) is gratefully
   acknowledged. We thank Prof. S. Pantelides for kindly providing the
   coordinates of the starting structure of the nu-SiO<INF>2</INF> glass.
CR AHMAD N, 1988, PHILOS MAG B, V57, P677, DOI 10.1080/13642818808211238
   APRA E, 1993, J PHYS-CONDENS MAT, V5, P2969, DOI 10.1088/0953-8984/5/18/019
   Arai M., 1991, T AM CRYSTALLOGR ASS, V27, P113
   Bakos T, 2002, IEEE T NUCL SCI, V49, P2713, DOI 10.1109/TNS.2002.805342
   Bakos T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.055508
   Baranek P, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125102
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Bell R., 1970, DISCUSS FARADAY SOC, V50, P55, DOI DOI 10.1039/DF9705000055
   BELL RJ, 1972, PHILOS MAG, V25, P1381, DOI 10.1080/14786437208223861
   CARPENTER JM, 1985, PHYS REV LETT, V54, P441, DOI 10.1103/PhysRevLett.54.441
   Civalleri B, 2001, CHEM PHYS LETT, V348, P131, DOI 10.1016/S0009-2614(01)01081-8
   Clark TM, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.064202
   Clayden NJ, 2005, J NON-CRYST SOLIDS, V351, P195, DOI 10.1016/j.jnoncrysol.2004.11.009
   Cora F, 2004, STRUCT BOND, V113, P171, DOI 10.1007/b97944
   Corno M, 2006, PHYS CHEM CHEM PHYS, V8, P2464, DOI 10.1039/b602419j
   Doll K, 2001, COMPUT PHYS COMMUN, V137, P74, DOI 10.1016/S0010-4655(01)00172-2
   Doll K, 2001, INT J QUANTUM CHEM, V82, P1, DOI 10.1002/1097-461X(2001)82:1<1::AID-QUA1017>3.0.CO;2-W
   Donadio D, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.214205
   Dovesi R, 2005, REV COMP CH, V21, P1, DOI 10.1002/0471720895.ch1
   Dovesi R, 2005, Z KRISTALLOGR, V220, P571, DOI 10.1524/zkri.220.5.571.65065
   DOVESI R, 1992, PHILOS T ROY SOC A, V341, P203, DOI 10.1098/rsta.1992.0094
   DOVESI R, 1991, CHEM PHYS, V156, P11, DOI 10.1016/0301-0104(91)87032-Q
   DOVESI R, 2006, CRYSTAL2006 USERS MA
   Du JC, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2345060
   ElBatal HA, 2003, MATER CHEM PHYS, V80, P599, DOI 10.1016/S0254-0584(03)00082-8
   Elgayar I, 2005, J NON-CRYST SOLIDS, V351, P173, DOI 10.1016/j.jnoncrysol.2004.07.067
   EXARHOS GJ, 1972, SOLID STATE COMMUN, V11, P755, DOI 10.1016/0038-1098(72)90502-9
   FEUSTON BP, 1988, J CHEM PHYS, V89, P5818, DOI 10.1063/1.455531
   FEUSTON BP, 1989, J CHEM PHYS, V91, P564, DOI 10.1063/1.457440
   Gale JD, 2003, MOL SIMULAT, V29, P291, DOI 10.1080/0892702031000104887
   GALEENER FL, 1983, PHYS REV B, V27, P1052, DOI 10.1103/PhysRevB.27.1052
   GALEENER FL, 1984, PHYS REV LETT, V53, P2429, DOI 10.1103/PhysRevLett.53.2429
   GERVAIS F, 1990, J NON-CRYST SOLIDS, V119, P79, DOI 10.1016/0022-3093(90)90243-F
   GRIMLEY DI, 1990, J NON-CRYST SOLIDS, V119, P49, DOI 10.1016/0022-3093(90)90240-M
   GUTTMAN L, 1986, PHYS REV B, V33, P1506, DOI 10.1103/PhysRevB.33.1506
   Habas MP, 1998, J PHYS-CONDENS MAT, V10, P6897, DOI 10.1088/0953-8984/10/31/008
   HANDKE M, 1994, J MOL STRUCT, V325, P129, DOI 10.1016/0022-2860(94)80028-6
   HAURET G, 1995, J NON-CRYST SOLIDS, V191, P85, DOI 10.1016/0022-3093(95)00322-3
   HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975
   HENCH L, 1993, INTRO BIOCERAMICS
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695
   Ispas S, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevLett.87.214206
   JIN W, 1993, PHYS REV B, V48, P9359, DOI 10.1103/PhysRevB.48.9359
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LAUGHLIN RB, 1977, PHYS REV B, V16, P2942, DOI 10.1103/PhysRevB.16.2942
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   LI D, 1995, J NON-CRYST SOLIDS, V188, P181, DOI 10.1016/0022-3093(95)00100-X
   LICHANOT A, 1993, PHYS STATUS SOLIDI B, V177, P157, DOI 10.1002/pssb.2221770111
   Lin CC, 2005, J NON-CRYST SOLIDS, V351, P3195, DOI 10.1016/j.jnoncrysol.2005.08.020
   Linati L, 2005, J PHYS CHEM B, V109, P4989, DOI 10.1021/jp046631n
   Linati L, 2008, J NON-CRYST SOLIDS, V354, P84, DOI 10.1016/j.jnoncrysol.2007.06.076
   LOCKYER MWG, 1995, J NON-CRYST SOLIDS, V188, P207, DOI 10.1016/0022-3093(95)00188-3
   Lusvardi G, 2005, J PHYS CHEM B, V109, P21586, DOI 10.1021/jp0546857
   LUSVARDI G, 2008, J BIOMATER IN PRESS
   Malavasi G, 2007, THEOR CHEM ACC, V117, P933, DOI 10.1007/s00214-006-0214-1
   MASATOSHI A, 1991, T AM CRYSTALLOGR ASS, V27, P113
   Monkhrost H. J., 1976, PHYS REV B, V8, P5188
   Noel Y, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.014111
   Oliveira JM, 2002, BIOMATERIALS, V23, P371, DOI 10.1016/S0142-9612(01)00115-6
   Pascale F, 2005, J PHYS CHEM B, V109, P18522, DOI 10.1021/jp052991e
   Pascale F, 2004, J COMPUT CHEM, V25, P888, DOI 10.1002/jcc.20019
   Pascale F, 2002, J CHEM PHYS, V117, P5337, DOI 10.1063/1.1499477
   PEDONE A, CHEM MAT UNPUB
   PEDONE A, J PHYS CHEM UNPUB
   PEDONE A, 2008, THESIS U MODENA R EM
   Pedone A, 2008, THEOR CHEM ACC, V120, P557, DOI 10.1007/s00214-008-0434-7
   Pedone A, 2007, CHEM MATER, V19, P3144, DOI 10.1021/cm062619r
   Pedone A, 2006, J PHYS CHEM B, V110, P11780, DOI 10.1021/jp0611018
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Prencipe M., 2004, PHYS CHEM MINER, V31, P1
   Rahmani A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.184202
   SANDERS MJ, 1984, J CHEM SOC CHEM COMM, V1271, P1984
   Sarnthein J, 1997, SCIENCE, V275, P1925, DOI 10.1126/science.275.5308.1925
   SEN PN, 1977, PHYS REV B, V15, P4030, DOI 10.1103/PhysRevB.15.4030
   Taraskin SN, 1997, PHYS REV B, V56, P8605, DOI 10.1103/PhysRevB.56.8605
   Tilocca A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.224202
   Tilocca A, 2007, J PHYS CHEM B, V111, P14256, DOI 10.1021/jp075677o
   Tilocca A, 2006, J PHYS CHEM B, V110, P25810, DOI 10.1021/jp065146k
   Tilocca A, 2007, FARADAY DISCUSS, V136, P45, DOI 10.1039/b617540f
   Tilocca A, 2007, CHEM MATER, V19, P95, DOI 10.1021/cm061631g
   Tilocca A, 2006, J MATER CHEM, V16, P1950, DOI [10.1039/b517362k, 10.1039/B517362K]
   UGLIENGO P, 2005, MOLDRAW MOL GRAPHICS
   van Santen R. A., 1989, ADV SOLID STATE CHEM, V1, P151
   VANGINHOVEN RM, 2005, PHYS REV B, V71
   WADT WR, 1985, J CHEM PHYS, V82, P284, DOI 10.1063/1.448800
   WILLSON M, 1996, PHYS REV LETT, V77, P4023
   Zicovich-Wilson CM, 2007, J AM CHEM SOC, V129, P11512, DOI 10.1021/ja0730361
   Zicovich-Wilson CM, 2004, J COMPUT CHEM, V25, P1873, DOI 10.1002/jcc.20120
   Zicovich-Wilson CM, 2002, J CHEM PHYS, V116, P1120, DOI 10.1063/1.1425406
   Zicovich-Wilson CM, 2001, J CHEM PHYS, V115, P9708, DOI 10.1063/1.1415745
NR 94
TC 32
Z9 32
U1 2
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD SEP 9
PY 2008
VL 20
IS 17
BP 5610
EP 5621
DI 10.1021/cm801164u
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 344QC
UT WOS:000258941400020
DA 2018-10-20
ER

PT J
AU Yi, F
   Lavan, DA
AF Yi, Feng
   LaVan, David A.
TI Poly(glycerol sebacate) nanofiber scaffolds by core/shell
   electrospinning
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; coaxial electrospinning; nanofibers; poly(glycerol
   sebacate); scaffold; tissue engineering
ID POLYMER BLENDS
AB The novel biomaterial poly(glycerol sebacate) (PGS) holds great promise for tissue engineering and regenerative medicine. PGS is a rubbery, degradable polymer much like elastin; however, it has been limited to cast structures. This work reports on the formation of PGS nanofibers in random non-woven mats for use as tissue engineering scaffolds by coaxial core/shell electrospinning. PGS nanofibers are an inexpensive and synthetic material that mimics the chemical and mechanical environment provided by elastin fibers. Poly(lactide) was used as the shell material to constrain the PGS during the curing process and was removed before cell seeding. Human microvascular endothelial cells from skin (HDMEC) were used to evaluate the in-vitro cellular compatibility of the PGS nanofiber scaffolds.
C1 [Yi, Feng; LaVan, David A.] Yale Univ, New Haven, CT 06511 USA.
RP Lavan, DA (reprint author), Yale Univ, 9Hillhouse Ave,Mason Labs Room M3, New Haven, CT 06511 USA.
EM david.lavan@yale.edu
RI LaVan, David/C-3943-2012
OI LaVan, David/0000-0002-1952-0028
CR Bhattarai N, 2006, ADV MATER, V18, P1463, DOI 10.1002/adma.200502537
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Gao J, 2007, J BIOMED MATER RES A, V83A, P1070, DOI 10.1002/jbm.a.31434
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Liao S, 2006, BIOMED MATER, V1, pR45, DOI 10.1088/1748-6041/1/3/R01
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wei M, 2005, MACROMOL RAPID COMM, V26, P1127, DOI 10.1002/marc.200500212
   Wei M, 2006, MACROMOL MATER ENG, V291, P1307, DOI 10.1002/mame.200600284
   Yi F, 2004, MACROMOL RAPID COMM, V25, P1038, DOI 10.1002/marc.200400021
NR 11
TC 65
Z9 65
U1 4
U2 57
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD SEP 9
PY 2008
VL 8
IS 9
BP 803
EP 806
DI 10.1002/mabi.200800041
PG 4
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 352YQ
UT WOS:000259533700001
PM 18504802
DA 2018-10-20
ER

PT J
AU Mandal, BB
   Kundu, SC
AF Mandal, Biman B.
   Kundu, Subhas C.
TI Non-bioengineered silk fibroin protein 3D scaffolds for potential
   biotechnological and tissue engineering applications
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; fibroin; nonmulberry silk; scaffolds; tissue engineering
ID TROPICAL TASAR SILKWORM; SODIUM DODECYL-SULFATE; MESENCHYMAL STEM-CELLS;
   ANTHERAEA-MYLITTA; IN-VITRO; MOLECULAR PHYLOGENY; 3-D SCAFFOLDS;
   BIOMATERIALS; MATRICES; INSECTS
AB This paper describes a new source for fabricating high-strength, non-bioengineered silk gland fibroin 3D scaffolds from Indian tropical tasar silkworm, Antheraea mylitta using SDS for dissolution. The scaffolds were fabricated by freeze drying at different prefreezing temperatures for pore size and porosity optimization. Superior mechanical properties with compressive strength in the range of 972 kPa were observed. The matrices were degraded by proteases within 28 d of incubation. Biocompatibility was assessed by feline fibroblast culture in vitro and confocal microscopy further confirmed adherence, spreading, and proliferation of primary dermal fibroblasts. Results indicate nonmulberry 3D silk gland fibroin protein as an inexpensive, high-strength, slow biodegradable, biocompatible, and alternative natural biomaterial.
C1 [Mandal, Biman B.; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
OI Kundu, Subhas C./0000-0002-7170-2291
FU Department of Biotechnology [BT/PR6035/MED/14/733/2005,
   BT/PR9552/ICD/16/755/2006]; Council of Scientoc Industrial Research
FX Department of Biotechnology (BT/PR6035/ MED/14/733/2005 and
   BT/PR9552/ICD/16/755/2006) and Council of Scientoc Industrial Research
   (for fellowship to B. B. M.), Government of India, New Delhi financially
   supported this work. Financial support through the IIT-Kharagpur and
   EPFL-Lausanne program, which was coordinated by Professor Promod Rastogi
   (EPFL), is gratefully acknowledged. We are indebted to Professor Jeffrey
   Alan Hubbell (EPFL), Switzerland for permitting us to use his
   laboratory, primary human dermal fibroblasts, confocal laser microscopy
   facilities, and for his kind and excellent hospitality during our short
   stay.
CR Adeloew C, 2008, BIOMATERIALS, V29, P314, DOI 10.1016/j.biomaterials.2007.09.036
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARAND M, 1992, ANAL BIOCHEM, V207, P73, DOI 10.1016/0003-2697(92)90502-X
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   DASH R, 2008, BMB REP, V31, P236
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   Domb A, 2007, ADV DRUG DELIVER REV, V59, P185, DOI 10.1016/j.addr.2007.05.001
   DUTTA A, 2001, COMP BIOCH PHYSL B, V129, P197
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   *ICH, Q3C R3 GUID RES SOLV
   IIZUKA E, 1985, J APPL POLYM SCI APP, V41, P173
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kundu S.C., 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI DOI 10.1016/S0965-1748(01)00049-2
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Li MZ, 2003, POLYM ADVAN TECHNOL, V14, P694, DOI 10.1002/pat.409
   Li MZ, 2003, INT J BIOL MACROMOL, V32, P159, DOI 10.1016/S0141-8130(03)00049-7
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   MAGOSHI J, 1981, J POLYM SCI POL PHYS, V19, P185, DOI 10.1002/pol.1981.180190117
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   Magoshi J., 1996, POLYM MAT ENCY, V1, P667
   Mahendran B, 2006, J GENET, V85, P31, DOI 10.1007/BF02728967
   Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010
   Mahendran B, 2006, J BIOCHEM MOL BIOL, V39, P522
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   MINGZHONG L, 1999, J APPL POLYM SCI, V79, P2185
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   MUGA A, 1993, ARCH BIOCHEM BIOPHYS, V300, P451, DOI 10.1006/abbi.1993.1061
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Saha M, 2006, BIOCHEM GENET, V44, P72, DOI 10.1007/s10528-006-9007-4
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   TANFORD C, 1976, BIOCHIM BIOPHYS ACTA, V457, P133, DOI 10.1016/0304-4157(76)90009-5
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P1407, DOI 10.1002/polb.1994.090320812
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 55
TC 97
Z9 101
U1 0
U2 19
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD SEP 9
PY 2008
VL 8
IS 9
BP 807
EP 818
DI 10.1002/mabi.200800113
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 352YQ
UT WOS:000259533700002
PM 18702171
DA 2018-10-20
ER

PT J
AU Barrett, DG
   Yousaf, MN
AF Barrett, Devin G.
   Yousaf, Muhammad N.
TI Poly(triol alpha-ketoglutarate) as biodegradable, chemoselective, and
   mechanically tunable elastomers
SO MACROMOLECULES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; ALIPHATIC POLYESTERS; SURFACES; LIGANDS;
   BIOSYNTHESIS; COPOLYMERS; SCAFFOLDS; CHEMISTRY; STRATEGY; DELIVERY
AB We report the design of several elastomers based on the thermal polycondensation of alpha-ketoglutaric acid and one of three triols: glycerol, 1,2,4-butanetriol, or 1,2,6-hexanetriol. By varying the curing temperature and the duration of the curing process, a wide range of mechanical properties was achieved. The values of the Young's modulus (0.1 - 657.4 MPa), ultimate stress (0.2 - 30.8 MPa), and ultimate strain (22 - 583%) encompass the mechanical properties of many biological materials, increasing the probability of success for the use of poly(triol alpha-ketoglutarate) as a biomaterial. Furthermore, the poly(triol alpha-ketoglutarate) series hydrolytically degraded in as fast as 2 days and as long as 28 days in phosphate-buffered saline solutions. For postpolymerization modifications, the repeat units contain ketones, which are capable of reacting with a variety of oxyamine--terminated molecules to generate stable oxime linkages. Finally, the versatility and utility of these elastomers were demonstrated by creating micropatterned structures and films for biospecific cell scaffold supports.
C1 [Yousaf, Muhammad N.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA.
RP Yousaf, MN (reprint author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.
EM mnyousaf@email.unc.edu
FU Carolina Center for Cancer Nanotechnology Excellence; NIH; Burroughs
   Wellcome Foundation
FX The authors thank the Ashby and DeSimone research groups for insightful
   discussions. This work was supported by the Carolina Center for Cancer
   Nanotechnology Excellence, grants from the NIH to M.N.Y., and the
   Burroughs Wellcome Foundation (Interface Career Award).
CR Barrett DG, 2008, BIOMACROMOLECULES, V9, P2029, DOI 10.1021/bm800271f
   Barrett DG, 2008, CHEMBIOCHEM, V9, P62, DOI 10.1002/cbic.200700550
   Brown AH, 2007, MACROMOLECULES, V40, P4848, DOI 10.1021/ma070185v
   Chan EWL, 2006, J AM CHEM SOC, V128, P15542, DOI [10.1021/ja065828l, 10.1021/ja0658281]
   Chung IS, 2003, MACROMOLECULES, V36, P2995, DOI 10.1021/ma034029+
   Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488
   Jagur-Grodzinski J, 2006, POLYM ADVAN TECHNOL, V17, P395, DOI 10.1002/pat.729
   Kim YB, 2004, MACROMOL MATER ENG, V289, P923, DOI 10.1002/mame.200400163
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Lazny R, 2005, J COMB CHEM, V7, P109, DOI 10.1021/cc049874y
   Lee DP, 2001, J LIPID RES, V42, P1979
   LEE MC, 1992, J BIOMECH, V25, P925, DOI 10.1016/0021-9290(92)90232-P
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Odelius K, 2005, BIOMACROMOLECULES, V6, P2718, DOI 10.1021/bm050190b
   Olson DA, 2006, J AM CHEM SOC, V128, P13625, DOI 10.1021/ja063092m
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RISSE W, 1990, MACROMOLECULES, V23, P4029, DOI 10.1021/ma00220a001
   Riva R, 2007, MACROMOLECULES, V40, P796, DOI 10.1021/ma0624090
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sanda F, 2001, J POLYM SCI POL CHEM, V39, P265, DOI 10.1002/1099-0518(20010115)39:2<265::AID-POLA20>3.0.CO;2-D
   Shastri V. Prasad, 2003, Current Pharmaceutical Biotechnology, V4, P331, DOI 10.2174/1389201033489694
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Taniguchi I, 2005, MACROMOLECULES, V38, P216, DOI 10.1021/ma0487554
   Van Horn BA, 2008, MACROMOLECULES, V41, P1618, DOI 10.1021/ma7026963
   Wang F, 1998, MACROMOL RAPID COMM, V19, P135, DOI 10.1002/(SICI)1521-3927(19980201)19:2<135::AID-MARC135>3.0.CO;2-7
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Westcott NP, 2008, LANGMUIR, V24, P2261, DOI 10.1021/la703744v
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang SK, 2008, MACROMOLECULES, V41, P346, DOI 10.1021/ma702052k
   Younes HM, 2004, BIOMATERIALS, V25, P5261, DOI 10.1016/j.biomaterials.2003.12.024
   Zugates GT, 2006, J AM CHEM SOC, V128, P12726, DOI 10.1021/ja061570n
NR 35
TC 35
Z9 39
U1 1
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 9
PY 2008
VL 41
IS 17
BP 6347
EP 6352
DI 10.1021/ma8009728
PG 6
WC Polymer Science
SC Polymer Science
GA 344EL
UT WOS:000258909000015
DA 2018-10-20
ER

PT J
AU Park, SH
   Choi, BG
   Joo, MK
   Han, DK
   Sohn, YS
   Jeong, B
AF Park, So Hyun
   Choi, Bo Gyu
   Joo, Min Kyung
   Han, Dong Kenn
   Sohn, Youn Soo
   Jeong, Byeongmoon
TI Temperature-sensitive poly (caprolactone-co-trimethylene
   carbonate)-poly(ethylene glycol)-poly(caprolactone-co-trimethylene
   carbonate) as in situ gel-forming biomaterial
SO MACROMOLECULES
LA English
DT Article
ID COPOLYMER AQUEOUS-SOLUTIONS; HUMAN ARTICULAR CHONDROCYTES; POLY(ETHYLENE
   GLYCOL); TRIBLOCK COPOLYMERS; POLY(1,3-TRIMETHYLENE CARBONATE);
   MULTIBLOCK COPOLYMERS; GELATION; DEGRADATION; OXIDE); ARCHITECTURE
AB We are reporting a new thermogelling poly(caprolactone-co-trimethylene carbonate)-poly(ethylene glycol) -poly(caprolactone-co-trimethylene carbonate) (PCTC-PEG-PCTC) triblock copolymer. By incorporating the comonomer (trimethylene carbonate) up to 25-40 wt % in the polycaprolactone block, the resulting PCTC-PEG-PCTC triblock copolymer achieved so] stability while keeping the thermogelling property in a physiologically important temperature range of 10-50 degrees C. The precipitation of the polymer in water at 20 degrees C was a concern for a poly(caprolactone)-poly(ethylene glycol) -poly(caprolactone) (PCL-PEG-PCL) system for practical applications (Macromolecules 2006, 39, 4873). The PCTC-PEG-PCTC triblock copolymer thermogel did not show the characteristic peaks of the polycaprolactone crystalline domain at 2 theta = 21.5 degrees and 23.5 degrees in the X-ray diffraction spectra. The sol-to-gel transition temperature of PCTC-PEG-PCTC aqueous solution could be controlled in a range of 15-30 degrees C by varying the composition and molecular weight of PCTC. The PCTC-PEG-PCTC was not degraded in a phosphate buffer saline for 50 days, whereas significant changes in molecular weight and composition of the polymer were observed for the polymer implanted in the subcutaneous layer of rats over the same period of time. The in situ formed hydrogel of PCTC-PEG-PCTC was investigated as a three-dimensional cell culture medium. Compared with the traditional culture on a plate (two-dimensional culture), the chondrocytes cultured in the in situ formed PCTC-PEG-PCTC hydrogel (three-dimensional culture) showed a higher expression of collagen type 11 and aggrecan and suppression of collagen type I (fibroblastic gene), suggesting the excellent differentiation of the cell in the PCTC-PEG-PCTC hydrogel.
C1 [Park, So Hyun; Choi, Bo Gyu; Joo, Min Kyung; Sohn, Youn Soo; Jeong, Byeongmoon] Ewha Womans Univ, Dept Chem, Div Nano Sci, Seoul 120750, South Korea.
   [Han, Dong Kenn] Korea Adv Inst Sci & Technol, Biomat Res Ctr, Seoul 130650, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem, Div Nano Sci, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
OI Han, Dong Keun/0000-0003-4641-7883
CR ALEXANDRIDIS P, 1994, MACROMOLECULES, V27, P2414, DOI 10.1021/ma00087a009
   ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   ASHWELL MS, 2008, OSTEOARTHRITIS CARTI
   Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m
   Bae SJ, 2006, MACROMOLECULES, V39, P4873, DOI 10.1021/ma060153s
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P153, DOI 10.1021/bm010137x
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Booth C, 2000, MACROMOL RAPID COMM, V21, P501, DOI 10.1002/1521-3927(20000601)21:9<501::AID-MARC501>3.0.CO;2-R
   CHASIN M, 1990, BIODEGRADABLE POLYM, P3
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CHUNG YM, 2002, BIOMACROMOLECULES, V3, P512
   Huang K, 2002, BIOMACROMOLECULES, V3, P397, DOI 10.1021/bm015650p
   Jeong B, 2003, J PHYS CHEM B, V107, P10032, DOI 10.1021/jp027339n
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Kim SY, 2007, MACROMOLECULES, V40, P5519, DOI 10.1021/ma070190z
   Kulkarni A, 2007, LANGMUIR, V23, P12202, DOI 10.1021/la701523e
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lee J, 2006, POLYMER, V47, P3760, DOI 10.1016/j.polymer.2006.03.109
   Lee J, 2006, BIOMACROMOLECULES, V7, P1729, DOI 10.1021/bm0600062
   Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Odian G., 2004, PRINCIPLES POLYM, P40
   OHKURA M, 1992, POLYMER, V33, P5044, DOI 10.1016/0032-3861(92)90056-3
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   Park JS, 2007, J CONTROL RELEASE, V124, P51, DOI 10.1016/j.jconrel.2007,08.030
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pego AP, 2002, MACROMOL BIOSCI, V2, P411, DOI 10.1002/mabi.200290000
   Sosnik A, 2005, BIOMATERIALS, V26, P349, DOI 10.1016/j.biomaterials.2004.02.041
   Sun KH, 2006, BIOMACROMOLECULES, V7, P2871, DOI 10.1021/bm060512r
   SYFTESTAD GT, 1985, DEV BIOL, V110, P275, DOI 10.1016/0012-1606(85)90087-9
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Zhang Z, 2005, BIOMACROMOLECULES, V6, P3404, DOI 10.1021/bm050460q
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
   Zwicky R, 2000, HISTOCHEM CELL BIOL, V114, P363
   Zwingmann J, 2007, TISSUE ENG, V13, P2335, DOI 10.1089/ten.2006.0393
NR 37
TC 51
Z9 51
U1 3
U2 58
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 9
PY 2008
VL 41
IS 17
BP 6486
EP 6492
DI 10.1021/ma800562s
PG 7
WC Polymer Science
SC Polymer Science
GA 344EL
UT WOS:000258909000032
DA 2018-10-20
ER

PT J
AU Zhang, H
   Yu, L
   Ding, JD
AF Zhang, Huan
   Yu, Lin
   Ding, Jiandong
TI Roles of hydrophilic homopolymers on the hydrophobic-association-induced
   physical gelling of amphiphilic block copolymers in water
SO MACROMOLECULES
LA English
DT Article
ID PEO TRIBLOCK COPOLYMERS; DRUG-DELIVERY SYSTEMS; AQUEOUS-SOLUTIONS;
   POLY(ETHYLENE GLYCOL); PHASE-BEHAVIOR; PLA HYDROGELS; GELATION; GEL;
   PLGA; RELEASE
AB Recently, the addition of poly(ethylene glycol) (PEG) homopolymers was found to significantly lower the sol-gel transition temperature T-gel of the aqueous system of a block copolymer composed of poly(lactic acid-co-glycolic acid) (PLGA) and PEG, different from the "normal" phenomenon of a T-gel increase for Pluronic hydrogels of block copolymers of PEG and poly(propylene glycol) (PPG). While such an effect is useful for applications of PLGA-PEG-PLGA physical hydrogels as an injectable biomaterial, it is puzzling why the addition of a hydrophilic homopolymer probably enhances the hydrophobic-association-induced physical gelation of ail amphiphilic block copolymer. A series of PEG homopolymers with different molecular weights and concentrations were examined in the aqueous systems of PEG/PLGA block copolymers with three compositions in the present paper. An immiscibility mechanism was put forward by us to account for the earlier spontaneous thermogelling under the assumption of the structure of a randomly percolated micelle network. Meanwhile, the late physical gelling of Pluronics in the presence of PEG homopolymers was interpreted by an order-interfering mechanism. We further found that the immiscibility mechanism might also work for Pluronics upon addition of ethylene glycol and oligo(ethylene glycol).
C1 [Zhang, Huan; Yu, Lin; Ding, Jiandong] Fudan Univ, Minist Educ, Dept Macromol Sci, Adv Mat Lab,Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Minist Educ, Dept Macromol Sci, Adv Mat Lab,Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
RI Zhang, Huan/O-7352-2014
OI Zhang, Huan/0000-0001-8625-8050
FU NSF of China [50533010, 20574013, 20774020]; Chinese Ministry of Science
   and Technology [973 Project 2005CB522700]; Chinese Ministry of Education
   [305004]; Science and Technology Developing Foundation of Shanghai
   [07JC14005, 074319117]; Shanghai Education Committee [Project B 112]
FX This work was supported by NSF of China (Grants 50533010, 20574013, and
   20774020), Chinese Ministry of Science and Technology (973 Project
   2005CB522700), Chinese Ministry of Education (Key Grant 305004), Science
   and Technology Developing Foundation of Shanghai (Grants 07JC14005 and
   074319117), and Shanghai Education Committee (Project B 112).
CR Agrawal SK, 2007, LANGMUIR, V23, P5039, DOI 10.1021/la063390x
   ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   He YY, 2007, CHEM COMMUN, P2732, DOI 10.1039/b704490a
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Hyun H, 2007, BIOMACROMOLECULES, V8, P1093, DOI 10.1021/bm060771u
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 2002, BIOMACROMOLECULES, V3, P865, DOI 10.1021/bm025536m
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong B, 2000, MACROMOLECULES, V33, P8317, DOI 10.1021/ma000638v
   Kwon KW, 2002, POLYMER, V43, P3353, DOI 10.1016/S0032-3861(02)00155-6
   Li F, 2005, MACROMOL BIOSCI, V5, P1125, DOI 10.1002/mabi.200500143
   Li SM, 2003, MACROMOLECULES, V36, P8008, DOI 10.1021/ma034734i
   LI YQ, 2005, J CHEM PHYS, V122
   MALMSTEN M, 1993, MACROMOLECULES, V26, P2905, DOI 10.1021/ma00063a040
   MALMSTEN M, 1993, MACROMOLECULES, V26, P1282, DOI 10.1021/ma00058a014
   Malmsten M, 2006, SOFT MATTER, V2, P760, DOI 10.1039/b608348j
   Mortensen K, 1995, MACROMOLECULES, V28, P8829, DOI 10.1021/ma00130a016
   Nie T, 2003, MACROMOLECULES, V36, P8825, DOI 10.1021/ma035131+
   Pandit N, 2000, J COLLOID INTERF SCI, V222, P213, DOI 10.1006/jcis.1999.6628
   Pandit N K, 1997, Pharm Dev Technol, V2, P181, DOI 10.3109/10837459709022623
   Park MJ, 2004, LANGMUIR, V20, P2456, DOI 10.1021/la035573e
   Prudhomme RK, 1996, LANGMUIR, V12, P4651, DOI 10.1021/la951506b
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Shim WS, 2005, BIOMACROMOLECULES, V6, P2930, DOI 10.1021/bm050521k
   Singh P, 2007, GREEN CHEM, V9, P254, DOI 10.1039/b603210a
   Tew GN, 2005, SOFT MATTER, V1, P253, DOI 10.1039/b509800a
   TUNG CYM, 1982, J APPL POLYM SCI, V27, P569, DOI 10.1002/app.1982.070270220
   WANKA G, 1994, MACROMOLECULES, V27, P4145, DOI 10.1021/ma00093a016
   YANG Z, 2008, MACROMOL RAPID COMM, V66, P509
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Zhang J, 2007, MACROMOLECULES, V40, P5537, DOI 10.1021/ma070554n
   ZHOU Z, 1994, MACROMOLECULES, V27, P2025, DOI 10.1021/ma00086a008
NR 39
TC 84
Z9 86
U1 4
U2 101
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 9
PY 2008
VL 41
IS 17
BP 6493
EP 6499
DI 10.1021/ma7026484
PG 7
WC Polymer Science
SC Polymer Science
GA 344EL
UT WOS:000258909000033
DA 2018-10-20
ER

PT J
AU Jian, PCJ
   Liu, TF
   Tsai, CM
   Tsai, MS
   Chang, CC
AF Jian, Peng-Chung Jang
   Liu, Tzeng-Feng
   Tsai, Chuan-Mei
   Tsai, Ming-Shih
   Chang, Chia-Ching
TI Ni2+ doping DNA: a semiconducting biopolymer
SO NANOTECHNOLOGY
LA English
DT Article
ID AC-IMPEDANCE SPECTROSCOPY; SELF-ASSEMBLED MONOLAYERS; SINGLE-BASE
   MISMATCH; DIVALENT METAL-IONS; GOLD ELECTRODES; MOLECULAR WIRE;
   HYBRIDIZATION; DUPLEX
AB DNA is a one-dimensional nanowire in nature, and it may not be used in nanodevices due to its low conductivity. In order to improve the conducting property of DNA, divalent Ni2+ are incorporated into the base pairs of DNA at pH >= 8.5 and nickel DNA (Ni-DNA) is formed. Conducting scanning probe microscopy (SPM) analysis reveals that the Ni-DNA is a semiconducting biopolymer and the Schottky barrier of Ni-DNA reduces to 2 eV. Meanwhile, electrochemical analysis by cyclic voltammetry and AC impedance shows that the conductance of Ni-DNA is better than that of native DNA by a factor of approximately 20-fold. UV spectroscopy and DNA base pair mismatch analyses show that the conducting mechanism of Ni-DNA is due to electrons hopping through the pi-pi stacking of DNA base pairs. This biomaterial is a designable one-dimensional semiconducting polymer for usage in nanodevices.
C1 [Jian, Peng-Chung Jang; Liu, Tzeng-Feng] Natl Chiao Tung Univ, Dept Mat Sci & Engn, Hsinchu 30050, Taiwan.
   [Tsai, Chuan-Mei] Natl Nano Device Labs, Hsinchu 30071, Taiwan.
   [Tsai, Ming-Shih] Chupei, Cabot Microelect, Hsinchu Hsien 302, Taiwan.
   [Chang, Chia-Ching] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30050, Taiwan.
   [Chang, Chia-Ching] Acad Sinica, Inst Phys, Taipei 11529, Taiwan.
RP Chang, CC (reprint author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30050, Taiwan.
EM ccchang01@faculty.nctu.edu.tw
OI Chang, Chia-Ching/0000-0002-3444-0894
CR Aich P, 1999, J MOL BIOL, V294, P477, DOI 10.1006/jmbi.1999.3234
   Chi QJ, 2006, J PHYS CHEM B, V110, P1102, DOI 10.1021/jp056356k
   CHIDSEY CED, 1991, SCIENCE, V251, P919, DOI 10.1126/science.251.4996.919
   de Pablo PJ, 2000, PHYS REV LETT, V85, P4992, DOI 10.1103/PhysRevLett.85.4992
   Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873
   ELEY DD, 1962, T FARADAY SOC, V58, P411, DOI 10.1039/tf9625800411
   FINKLEA HO, 1993, LANGMUIR, V9, P3660, DOI 10.1021/la00036a050
   Hall DB, 1996, NATURE, V382, P731, DOI 10.1038/382731a0
   Ito T, 2007, BIOSENS BIOELECTRON, V22, P1816, DOI 10.1016/j.bios.2006.08.008
   Janek RP, 1998, LANGMUIR, V14, P3011, DOI 10.1021/la970980+
   Kelley SO, 1999, NUCLEIC ACIDS RES, V27, P4830, DOI 10.1093/nar/27.24.4830
   LEE JS, 1993, BIOCHEM CELL BIOL, V71, P162, DOI 10.1139/o93-026
   Lee TY, 2001, ANAL CHEM, V73, P5629, DOI 10.1021/ac015572w
   Li CZ, 2003, J PHYS CHEM B, V107, P2291, DOI 10.1021/jp026792w
   Long YT, 2003, BIOPHYS J, V84, P3218, DOI 10.1016/S0006-3495(03)70046-0
   MILLER C, 1991, J PHYS CHEM-US, V95, P877, DOI 10.1021/j100155a072
   Moreno-Herrero F, 2003, NANOTECHNOLOGY, V14, P128, DOI 10.1088/0957-4484/14/2/305
   Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163
   Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029
   RANDLES JEB, 1947, DISCUSS FARADAY SOC, V1, P11, DOI 10.1039/df9470100011
   Irit N, 2007, J AM CHEM SOC, V129, P84, DOI 10.1021/ja064919f
   SIMONE SA, 2006, PHYS REV B, V73
   Steichen M, 2007, BIOSENS BIOELECTRON, V22, P2237, DOI 10.1016/j.bios.2006.10.041
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Wettig SD, 2003, ANAL SCI, V19, P23, DOI 10.2116/analsci.19.23
   Wilson E.K., 1997, CHEM ENG NEWS, V24, P33
   Wood DO, 2002, NUCLEIC ACIDS RES, V30, P2244, DOI 10.1093/nar/30.10.2244
NR 27
TC 8
Z9 8
U1 2
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD SEP 3
PY 2008
VL 19
IS 35
AR 355703
DI 10.1088/0957-4484/19/35/355703
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 329CG
UT WOS:000257843900024
PM 21828857
DA 2018-10-20
ER

PT J
AU Waldeck, H
   Kao, WJ
AF Waldeck, Heather
   Kao, Weiyuan John
TI Extended interaction of beta 1 integrin subunit-deficient cells (GD25)
   with surfaces modified with fibronectin-derived peptides: Culture
   optimization, adhesion and cytokine panel studies
SO ACTA BIOMATERIALIA
LA English
DT Article
DE biological response; polymeric biomaterial; tissue engineering; cellular
   growth; surface structure
ID POLY(ETHYLENE GLYCOL) DIACRYLATE; GELATIN-BASED HYDROGELS;
   INTERPENETRATING NETWORKS; PHYSICOCHEMICAL ANALYSIS; INTEGRIN
   ACTIVATION; PEGYLATED RGD; CROSS-LINKING; GROWTH-FACTOR; BETA-1;
   EXPRESSION
AB The modification of biomaterials with extracellular matrix-mimicking factors is a common technique used to influence the cellular response through integrin-mediated signaling. The inherent limitations of antibody-inhibition studies necessitate the use of complementary methods to block integrin function to confirm cell-surface interaction. In this study, we employed a beta 1 integrin-deficient cell line, GD25, to investigate the role of beta 1 subunit in cell adhesion and subsequent cytokine (granulocyte macrophage colony stimulating factor; interleukin (IL)-1 alpha; IL-1 beta; IL-6; monocyte chemoattractant protein-l regulated upon activation, normal T-cell expressed, and secreted; tumor necrosis factor-alpha) release kinetics in the presence of tissue culture polystyrene (TCPS) and semi-interpenetrating polymer networks (sIPN) modified with fibronectin (FN)-mimic peptides (RGD, PHSRN). Culture conditions (i.e. seeding density, medium, serum supplementation) were optimized for long-term observation. Differences in cell adhesion, cell viability and cytokine release behavior were dependent on the presence of the beta 1 integrin subunit, FN, sIPN cast method and peptide identity. By comparing two complementary techniques for assaying integrin function, we observed both similarities (i.e. decreased adhesion to FN-absorbed TCPS and increased IL-1 beta release at 96 h) and differences (i.e. no difference in adhesion or IL-1 beta release in the presence of different sIPN surfaces) when the function of the beta 1 subunit was blocked in cell adhesion and signaling in the presence of biomaterials. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kao, Weiyuan John] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   [Waldeck, Heather; Kao, Weiyuan John] Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU NIH [HL077825]
FX This work was supported by the NIH grant HL077825. The authors thank the
   laboratories of Dean Mosher, Ph.D. (University of Wisconsin-Madison) and
   Reinhard Fassler, Ph.D. (Max-Planck Institute of Biochemistry) for their
   generous donation of the GD25 and GD25 beta 1A cell lines, Amy Chung,
   Sean Zuckerman, Dave Schmidt and Becky Bader, Ph.D.
CR Alimenti E, 2004, BBA-MOL CELL RES, V1693, P73, DOI 10.1016/j.bbamrc.2004.05.007
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Armulik A, 2004, MOL BIOL CELL, V15, P2558, DOI 10.1091/mbc.E03-09-0700
   BALZAC F, 1993, J CELL BIOL, V121, P171, DOI 10.1083/jcb.121.1.171
   BALZAC F, 1994, J CELL BIOL, V127, P557, DOI 10.1083/jcb.127.2.557
   Burmania JA, 2003, J BIOMED MATER RES A, V67A, P224, DOI 10.1002/jbm.a.10106
   Burmania JA, 2003, BIOMATERIALS, V24, P3921, DOI 10.1016/S0142-9612(03)00270-9
   Chen YM, 2005, BIOMATERIALS, V26, P4588, DOI [10.1016/j.biomaterials.2004.11.025, 10.1016/j.bomaterials.2004.11.025]
   Chung AS, 2007, J BIOMAT SCI-POLYM E, V18, P713, DOI 10.1163/156856207781034179
   COELHO AL, 2005, CYTOKINE GROWTH F R, V16, P552
   Cordes N, 2006, ONCOGENE, V25, P1378, DOI 10.1038/sj.onc.1209164
   Einerson NJ, 2003, BIOMATERIALS, V24, P509, DOI 10.1016/S0142-9612(02)00369-1
   *EMD BIOSC, 2007, FMOC RES CLEAV DEPR
   FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979
   Gattas-Asfura KM, 2005, BIOMACROMOLECULES, V6, P1503, DOI 10.1021/bm049238w
   Grundstrom G, 2003, EXP CELL RES, V291, P463, DOI 10.1016/j.yexcr.2003.07.010
   Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3
   Haringman JJ, 2004, ANN RHEUM DIS, V63, P1186, DOI 10.1136/ard.2004.020529
   Huebsch N, 2005, J BIOMED MATER RES B, V74B, P440, DOI 10.1002/jbm.b.30155
   Kikkawa Y, 2004, EXP CELL RES, V300, P94, DOI 10.1016/j.yexcr.2004.06.031
   LANGUINO LR, 1992, J BIOL CHEM, V267, P23439
   Li J, 2003, BIOMACROMOLECULES, V4, P1055, DOI 10.1021/bm034069l
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   Nilsson S, 2006, EXP CELL RES, V312, P844, DOI 10.1016/j.yexcr.2005.12.001
   Ofner CM, 1996, PHARM RES-DORDR, V13, P1821
   Peng Q, 2005, J IMMUNOL, V174, P2258, DOI 10.4049/jimmunol.174.4.2258
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Phillips JM, 2005, TISSUE ENG, V11, P964, DOI 10.1089/ten.2005.11.964
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sakai T, 1999, J BIOL CHEM, V274, P15480, DOI 10.1074/jbc.274.22.15480
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563
   SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096
   Tillet E, 2002, J CELL BIOCHEM, V86, P726, DOI 10.1002/jcb.10268
   VANDERFLIER A, 1995, FEBS LETT, V369, P340, DOI 10.1016/0014-5793(95)00814-P
   Waldeck H, 2007, J BIOMED MATER RES A, V82A, P861, DOI 10.1002/jbm.a.31054
   Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227
   Wennerberg K, 2000, MOL CELL BIOL, V20, P5758, DOI 10.1128/MCB.20.15.5758-5765.2000
   Witte RP, 2004, J BIOMED MATER RES A, V71A, P508, DOI 10.1002/jbm.a.30179
   Zhang QH, 1999, J BIOL CHEM, V274, P368, DOI 10.1074/jbc.274.1.368
   ZHIDKOVA NI, 1995, BIOCHEM BIOPH RES CO, V214, P279, DOI 10.1006/bbrc.1995.2285
   Zilinski JL, 2004, J BIOMED MATER RES A, V68A, P392, DOI 10.1002/jbm.a.20079
NR 47
TC 4
Z9 4
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2008
VL 4
IS 5
BP 1172
EP 1186
DI 10.1016/j.actbio.2008.03.020
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 355WQ
UT WOS:000259740400005
PM 18514047
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Tamimi, F
   Kumarasami, B
   Doillon, C
   Gbureck, U
   Le Nihouannen, D
   Cabarcos, EL
   Barralet, JE
AF Tamimi, Faleh
   Kumarasami, Balamurugan
   Doillon, Charles
   Gbureck, Uwe
   Le Nihouannen, Damien
   Lopez Cabarcos, Enrique
   Barralet, Jake E.
TI Brushite-collagen composites for bone regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE cell adhesion; cohesion; calcium phosphate cement; XRD; brushite
ID BETA-TRICALCIUM PHOSPHATE; I COLLAGEN; CEMENTS; DIFFERENTIATION;
   OSTEOBLASTS; OSTEOCALCIN; FRACTURES; CALLUS; ACID
AB Brushite-based biomaterials are of special interest in bone regeneration due to their biocompatibility and biodegradability oil the other hand, collagen is a well-known osteoconductive biomaterial. In the present Study a new brushite-collagen composite biomaterial is reported. This new biomaterial was prepared by combining citric acid/collagen type I solutions with it brushite cement powder. The obtained biomaterial was a cement paste, with improved handling properties. The effect of collagen oil the setting reaction of brushite cement was studied, and was found to speed up the cement setting reaction. The cement paste set into a hard ceramic material within 18.5 +/- 2.1 min and had compressive strength similar to that of spongeous bone (48.9 +/- 5.9 MPa in dry conditions and 12.7 +/- 1.5 MPa in humid conditions). The combination of collagen with citric acid revealed an interesting synergistic effect oil the compressive strength of the composite material. Moreover, this new biomaterial had excellent cohesion properties (ninefold better than brushite cement), and high cellular adhesion capacity (threefold higher than brushite cement). The composite biomaterial described in this study combines good handling properties. compressive strength, cohesion and cell adhesion capacity, along with the osteoconductive and biodegradable properties inherent in brushite and in collagen-based biomaterials. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Tamimi, Faleh; Kumarasami, Balamurugan; Le Nihouannen, Damien; Barralet, Jake E.] McGill Univ, Fac Dent, Montreal, PQ, Canada.
   [Doillon, Charles] CHUL Res Ctr CHUQ, Oncol & Mol Endocrinol Res Ctr T2 32, Quebec City, PQ, Canada.
   [Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
   [Lopez Cabarcos, Enrique] Univ Complutense, Fac Pharm, Dept Phys Chem, E-28040 Madrid, Spain.
RP Tamimi, F (reprint author), McGill Univ, Fac Dent, Montreal, PQ, Canada.
EM faleh.taminimarino@mail.mcgill.ca
RI Lopez Cabarcos, Enrique/L-5802-2014; Gbureck, Uwe/G-1430-2012; barralet,
   jake/A-5820-2008
OI Lopez Cabarcos, Enrique/0000-0003-2939-4130; barralet,
   jake/0000-0003-3543-6042
FU Ministere du Developpement economique, de l'innovation et de
   l'exportation (MDEIE); Bayerische Staatskanzlei [9.035]; DGI-Spanish
   Science and Education Ministry [MAT2006-13646-C03-01]; Canada Research
   Chair; NSERC; Alfonso Martin Escudero Foundation
FX The authors gratefully acknowledge the financial support of Ministere du
   Developpement economique, de l'innovation et de l'exportation (MDEIE),
   (Bavaria Quebec Exchange), Bayerische Staatskanzlei (Bavaria-Quebec
   project Nr. 9.035 "Knochemimplantate"), DGI-Spanish Science and
   Education Ministry project Nr. MAT2006-13646-C03-01 (F.T.), "Canada
   Research Chair" (J.B.), the NSERC Discovery grant (B.K., F.T.) and the
   "Alfonso Martin Escudero Foundation" (F.T.).
CR ALKHRAISAT MH, 2008, J BIOMED MATER RES A, V85, P710
   Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Brodie JC, 2005, J BIOMED MATER RES A, V73A, P409, DOI 10.1002/jbm.a.30279
   Brown PW, 1986, CEMENTS RES PROGR, P352
   Cui FZ, 1996, J STRUCT BIOL, V117, P204, DOI 10.1006/jsbi.1996.0084
   Gbureck U, 2003, BIOMATERIALS, V24, P4123, DOI 10.1016/S0142-9612(03)00283-7
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Hempel U, 2004, J BIOMED MATER RES B, V71B, P130, DOI 10.1002/jbm.b.30082
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Jayaraman Mythili, 2002, Med Sci Monit, V8, pBR481
   KUNTZE RA, 1966, NATURE, V211, P406, DOI 10.1038/211406a0
   Kurdy NMG, 1998, J ORTHOP TRAUMA, V12, P122, DOI 10.1097/00005131-199802000-00010
   LENART G, 1972, CLIN ORTHOP RELAT R, P263
   Marino FT, 2007, J BIOMED MATER RES B, V83B, P571, DOI 10.1002/jbm.b.30830
   MAROUF H A, 1990, International Journal of Oral and Maxillofacial Implants, V5, P148
   Mehlisch D R, 1989, Oral Surg Oral Med Oral Pathol, V68, P505, DOI 10.1016/0030-4220(89)90230-2
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   Ohura K, 1996, J BIOMED MATER RES, V30, P193, DOI 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Schneiders W, 2007, BONE, V40, P1048, DOI 10.1016/j.bone.2006.11.019
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tamimi-Marino F, 2007, J MATER SCI-MATER M, V18, P1195, DOI 10.1007/s10856-007-0139-9
   WEN HB, 1995, J STRUCT BIOL, V114, P115, DOI 10.1006/jsbi.1995.1011
   Zou C, 2005, BIOMATERIALS, V26, P5276, DOI 10.1016/j.biomaterials.2005.01.064
NR 27
TC 51
Z9 54
U1 3
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2008
VL 4
IS 5
BP 1315
EP 1321
DI 10.1016/j.actbio.2008.04.003
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 355WQ
UT WOS:000259740400019
PM 18486574
DA 2018-10-20
ER

PT J
AU Leonor, IB
   Baran, ET
   Kawashita, M
   Reis, RL
   Kokubo, T
   Nakamura, T
AF Leonor, I. B.
   Baran, E. T.
   Kawashita, M.
   Reis, R. L.
   Kokubo, T.
   Nakamura, T.
TI Growth of a bonelike apatite on chitosan microparticles after a calcium
   silicate treatment
SO ACTA BIOMATERIALIA
LA English
DT Article
DE apatite; biomimetic process; calcium silicate; chitosan; microparticles
ID SIMULATED BODY-FLUID; FIBER MESH SCAFFOLDS; TRANSMISSION
   ELECTRON-MICROSCOPY; TISSUE-ENGINEERING APPLICATIONS; MARROW STROMAL
   CELLS; GEL-PREPARED SILICA; IN-VITRO RELEASE; OF-THE-ART; COMPOSITE
   MICROSPHERES; MECHANICAL-PROPERTIES
AB Bioactive chitosan microparticles can be prepared Successfully by treating them with a calcium silicate solution and then subsequently soaking them in simulated body fluid (SBF). Such a combination enables the development of bioactive microparticles that can be used for several applications in the medical field, including injectable biomaterial systems and tissue engineering carrier systems. Chitosan microparticles. 0.6 mu m in average size, were soaked either for 12 h in fresh calcium silicate solution (condition I) or for 1 h in calcium silicate solution that had been aged for 24 h before use (condition II). Afterwards, they were dried in air at 60 degrees C for 24 h. The samples were then soaked in SBF for 1, 3 and 7 days. After the condition I calcium silicate treatment and the Subsequent soaking in SBF, the microparticles formed a dense apatite layer after only 7 days of immersion, which is believed to be due to the formation of silanol (Si-OH) groups effective for apatite formation. For condition II, the microparticles successfully formed an apatite layer oil their Surfaces in SBF within only 1 day of immersion. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Leonor, I. B.; Baran, E. T.; Reis, R. L.] Univ Minho, Dept Polymer Engn, Res Grp 3Bs, P-4710057 Braga, Portugal.
   [Leonor, I. B.; Baran, E. T.; Reis, R. L.] IBB, PT Govt Associated Lab, Braga, Portugal.
   [Kawashita, M.] Tohoku Univ, Ctr Res & Strategy Support, Aoba Ku, Sendai, Miyagi 9808579, Japan.
   [Kokubo, T.] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Aichi 4878501, Japan.
   [Nakamura, T.] Kyoto Univ, Fac Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068506, Japan.
RP Leonor, IB (reprint author), Univ Minho, Dept Polymer Engn, Res Grp 3Bs, Campus Gualtar, P-4710057 Braga, Portugal.
EM belinha@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Kawashita, Masakazu/E-6632-2016; Group,
   3Bs/E-4374-2012; Baran, Erkan/Q-8482-2017; Baran, Erkan/B-1055-2016;
   Leonor, Isabel/B-5260-2011
OI Reis, Rui L./0000-0002-4295-6129; Kawashita,
   Masakazu/0000-0002-4329-9001; Group, 3Bs/0000-0002-5195-3456; Baran,
   Erkan/0000-0002-0563-6943; Baran, Erkan/0000-0002-0563-6943; Leonor,
   Isabel/0000-0002-4319-4883
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/9031/2002]; European Union [NMP3-CT-2003-505758]; European NoE
   EXPERTISSUES [NMP3-CT-2004-500283]
FX I.B.L. thanks the Portuguese Foundation for Science and Technology
   (FCT), for providing her a PhD scholarship (SFRH/BD/9031/2002), the
   European Union funded STREP Project HIPPOCRATES (NMP3-CT-2003-505758)
   and the European NoE EXPERTISSUES (NMP3-CT-2004-500283).
CR AOKI H, 1991, SCI MED APPL HYDROXY
   Berthold A, 1996, J CONTROL RELEASE, V39, P17, DOI 10.1016/0168-3659(95)00129-8
   BERTOLUZZA A, 1982, J NON-CRYST SOLIDS, V48, P117, DOI 10.1016/0022-3093(82)90250-2
   Calvert P, 1996, CHEM MATER, V8, P1715, DOI 10.1021/cm960126o
   Cho SB, 1996, J BIOMED MATER RES, V33, P145, DOI 10.1002/(SICI)1097-4636(199623)33:3<145::AID-JBM4>3.0.CO;2-Q
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Falini G, 2004, TISSUE ENG, V10, P1, DOI 10.1089/107632704322791646
   Gomes Manuela E, 2004, Methods Mol Biol, V238, P65
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Gomes ME, 2004, MACROMOL BIOSCI, V4, P737, DOI 10.1002/mabi.200400094
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Gross KA, 1998, J BIOMED MATER RES, V39, P580, DOI 10.1002/(SICI)1097-4636(19980315)39:4<580::AID-JBM12>3.3.CO;2-Y
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Iooss P, 2001, BIOMATERIALS, V22, P2785, DOI 10.1016/S0142-9612(01)00022-9
   Kim HM, 2003, CURR OPIN SOLID ST M, V7, P289, DOI 10.1016/j.cossms.2003.09.014
   Kim HM, 2001, J CERAM SOC JPN, V109, pS49, DOI 10.2109/jcersj.109.1268_S49
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Kumar G, 2000, POLYMER, V41, P2157, DOI 10.1016/S0032-3861(99)00360-2
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   LI P, 1993, J MATER SCI-MATER M, V4, P127, DOI 10.1007/BF00120381
   LI PJ, 1993, BIOMATERIALS, V14, P963, DOI 10.1016/0142-9612(93)90186-6
   LI PJ, 1995, J BIOMED MATER RES, V29, P325, DOI 10.1002/jbm.820290307
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Malafaya PB, 2006, J MATER SCI-MATER M, V17, P371, DOI 10.1007/s10856-006-8240-z
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Mano JF, 2003, J MATER SCI-MATER M, V14, P127, DOI 10.1023/A:1022015712170
   Morita T, 2001, INT J PHARM, V219, P127, DOI 10.1016/S0378-5173(01)00642-1
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   PERREN SM, 1994, BIODEGRADABLE IMPLAN, P35
   POSNER AS, 1985, CLIN ORTHOP RELAT R, P87
   Ragel CV, 2000, J BIOMED MATER RES, V51, P424, DOI 10.1002/1097-4636(20000905)51:3<424::AID-JBM17>3.0.CO;2-E
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Schaffazick SR, 2003, EUR J PHARM BIOPHARM, V56, P501, DOI 10.1016/S0939-6411(03)00139-5
   Silva GA, 2004, ADV EXP MED BIOL, V553, P283
   Silva GA, 2004, J BIOMED MATER RES A, V70A, P442, DOI 10.1002/jbm.a.30099
   Sivakumar M, 2002, CARBOHYD POLYM, V49, P281, DOI 10.1016/S0144-8617(01)00331-9
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87
   Takadama H, 2002, J AM CERAM SOC, V85, P1933, DOI 10.1111/j.1151-2916.2002.tb00383.x
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8
   Tuzlakoglu K, 2007, J MATER SCI-MATER M, V18, P1279, DOI 10.1007/s10856-006-0063-4
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
NR 59
TC 44
Z9 49
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2008
VL 4
IS 5
BP 1349
EP 1359
DI 10.1016/j.actbio.2008.03.003
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 355WQ
UT WOS:000259740400023
PM 18400572
DA 2018-10-20
ER

PT J
AU Qu, ZH
   Wang, HJ
   Tang, TT
   Zhang, XL
   Wang, JY
   Dai, KR
AF Qu, Zhi-Hu
   Wang, Hua-Jie
   Tang, Ting-Ting
   Zhang, Xiao-Ling
   Wang, Jin-Ye
   Dai, Ke-Rong
TI Evaluation of the zein/inorganics composite on biocompatibility and
   osteoblastic differentiation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE scaffold; zein; hydroxyapatite; mechanical properties; osteogenic
ID POROUS ZEIN SCAFFOLDS; MARROW STROMAL CELLS; MECHANICAL-PROPERTIES;
   IN-VITRO; OSTEOGENIC DIFFERENTIATION; CORN PROTEIN; BONE; PHOSPHATE;
   ADHESION; BIOMATERIAL
AB We have previously Studied the biocompatibility and mechanical properties of porous zein scaffolds. We based the study oil the concept that composite scaffold materials, especially when combined with inorganic materials, are more Suited to the mechanical and physiological demands of the host tissue than individual scaffold materials. We investigated the effect of zein/inorganic composite on the physical and biological properties of porous zein scaffolds, which were fabricated by salt-leaching. The composite was prepared by immersion in simulated body fluid. The hydroxyapatite (HA)-coated zein scaffold had the same porosity as the zein scaffold (over 75%). Using scanning electron microscopy, it was established that the morphology of pores located on the surface and within the porous scaffolds showed equally good pore interconnectivity with zein. However, the compressive Young's modulus decreased from 240.1 +/- 96.8 to 34.4 +/- 12.6 MPa, and compressive strength decreased from 7.8 +/- 1.2 to 4.2 +/- 0.8 MPa. From the in vitro test with human bone marrow stroma. cells, the osteoblastic differentiation on the surface of the HA-coated zein scaffold was increased. Lis expressed by the alkaline phosphatase activity and reverse trail scription-polymerase chain reaction analysis for marker genes. From both the mechanical and biological evaluations, the HA-coated zein scaffold was found to be the optimal biomaterial for bone tissue engineering. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wang, Jin-Ye] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China.
   [Qu, Zhi-Hu; Zhang, Xiao-Ling; Dai, Ke-Rong] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci,Sch Med,Orthopaed Cellular & Mol Bi, Shanghai 200025, Peoples R China.
   [Wang, Hua-Jie; Wang, Jin-Ye] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China.
   [Tang, Ting-Ting; Dai, Ke-Rong] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Orthopaed, Shanghai 200011, Peoples R China.
RP Wang, JY (reprint author), Chinese Acad Sci, Shanghai Inst Organ Chem, 354 Fenglin Rd, Shanghai 200032, Peoples R China.
EM jywang@mail.sioc.ac.cn; krdai@sibs.ac.cn
RI Tang, Tingting/B-1361-2013; Wang, Jin-Ye/H-1450-2011
OI Tang, Tingting/0000-0002-1670-7452; yan, wei/0000-0001-5575-7017
FU National Program on Key Basic Research Projects of China [2005CB522700,
   2005CB724306]; National Natural Science Foundation of China [30700402];
   Science and Technology Commission of Shanghai Municipailty [05JC14034,
   07QA14062]
FX The authors gratefully acknowledge the financial support provided by the
   National Program on Key Basic Research Projects of China (973 Program)
   (Grant Nos. 2005CB522700 and 2005CB724306), National Natural Science
   Foundation of China (Grant No. 30700402), and the Science and Technology
   Commission of Shanghai Municipailty (Grant Nos. 05JC14034 and
   07QA14062).
CR Coelho MD, 2005, J BIOMED MATER RES B, V75B, P451, DOI 10.1002/jbm.b.30354
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Elangovan S, 2007, LANGMUIR, V23, P11200, DOI 10.1021/la7013978
   Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   HARADA Y, 1989, Shikwa Gakuho, V89, P263
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Lucas-Girot A, 2002, BIOMATERIALS, V23, P503, DOI 10.1016/S0142-9612(01)00132-6
   Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109
   Morinobu M, 2003, J BONE MINER RES, V18, P1706, DOI 10.1359/jbmr.2003.18.9.1706
   Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Stucki U, 2001, CLIN ORAL IMPLAN RES, V12, P121, DOI 10.1034/j.1600-0501.2001.012002121.x
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
NR 24
TC 36
Z9 39
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2008
VL 4
IS 5
BP 1360
EP 1368
DI 10.1016/j.actbio.2008.03.006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 355WQ
UT WOS:000259740400024
PM 18439886
DA 2018-10-20
ER

PT J
AU Levine, B
AF Levine, Brett
TI A New Era in Porous Metals: Applications in Orthopaedics
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 5th Biennial International Conference on Porous Metals and Metallic
   Foams
CY SEP, 2007
CL Montreal, CANADA
ID BONE LOSS; TANTALUM IMPLANT; FIXATION; INGROWTH; OSTEONECROSIS;
   ARTHROPLASTY; ATTACHMENT; CONES; HIP
AB The development of porous metals and coatings has revolutionized the field of orthopaedics. However, most implants are fabricated utilizing traditional materials (i.e, sintered beads, fiber metal, plasma spray), which have several inherent limitations. Several new porous metals have been recently introduced to improve upon the biomaterial properties of these traditional metals. Tritanium (Stryker, Mahwah, NJ), Regenerex (Biomet, Warsaw, IN), Stiktite (Smith and Nephew, Memphis, TN), and Trabecular Metal (Zimmer, Warsaw, IN) are currently available for use in orthopaedic surgery, all with a characteristic appearance similar to cancellous bone. The open-cell structure of these materials affords several intriguing properties, including; high volumetric porosity (60-80%), low modulus of elasticity, and high frictional characteristics. The following represents a review of the biomaterial properties and applications in orthopaedic surgery for this new class of highly porous metals.
C1 Midwest Orthopaed Rush, Chicago, IL 60612 USA.
RP Levine, B (reprint author), Midwest Orthopaed Rush, 1725 W Harrison St,Suite 1063, Chicago, IL 60612 USA.
EM brettlevinemd@gmail.com
CR BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   CAMERON HU, 1973, J BIOMED MATER RES, V7, P301, DOI 10.1002/jbm.820070404
   Frenkel SR, 2004, J BIOMED MATER RES B, V71B, P387, DOI 10.1002/jbm.b.30104
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Lombardi AV, 2007, J ARTHROPLASTY, V22, P25, DOI 10.1016/j.arth.2007.02.006
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   *NC, S03001 NC
   Radnay CS, 2006, CLIN ORTHOP RELAT R, P83, DOI 10.1097/01.blo.0000214437.57151.41
   SCHOETTLE T, 2005, P ANN M CSRS DEC 1 3
   Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007
   Sporer SM, 2006, J ARTHROPLASTY, V21, P87, DOI 10.1016/j.arth.2006.05.015
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Weeden SH, 2007, J ARTHROPLASTY, V22, P151, DOI 10.1016/j.arth.2007.04.024
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zou XN, 2005, SPINE, V30, pE392, DOI 10.1097/01.brs.0000170588.80377.3f
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 22
TC 60
Z9 62
U1 1
U2 34
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD SEP
PY 2008
VL 10
IS 9
BP 788
EP 792
DI 10.1002/adem.200800215
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 358RH
UT WOS:000259934700004
DA 2018-10-20
ER

PT J
AU Yavuz, O
   Aldissi, M
AF Yavuz, O.
   Aldissi, M.
TI Biomaterial-based infrared detection
SO BIOINSPIRATION & BIOMIMETICS
LA English
DT Article; Proceedings Paper
CT Conference on Toward Autonomous Robotic Systems 2007
CY SEP, 2007
CL Aberystwyth Univ, Aberystwyth, WALES
HO Aberystwyth Univ
ID LOBSTER SHELL; CRUSTACYANIN; BOLOMETER; ARRAY; ASTAXANTHIN
AB This effort is focused on the use of crustacyanin protein extracted from the lobster shell in IR detection and imaging applications. In addition to the protein's excellent reversible thermo-active response in the IR region of interest, electrical characteristics versus temperature showed that the protein can be used as an electro-optic thermal sensing device as well. The high sensitivity and fast response of the protein layer were further enhanced by the deposition process we used. The thin coatings were prepared by Langmuir -Blodgett and self-assembly techniques. Furthermore, the protein exhibited temperature variation under Ti: sapphire laser excitation at different wavelengths in ambient environment. We have also shown that the protein exhibits fluorescence properties after exposure to IR heat. Stability of the protein, which is important in this type of application, was also demonstrated using the different characterization tech(n)iques after repeated heating/ cooling cycles. We can conclude that this protein represents a formidable candidate for the fabrication of IR sensors and microbolometers for uncooled IR imaging applications.
C1 [Yavuz, O.; Aldissi, M.] Fractal Syst Inc, Safety Harbor, FL 34695 USA.
RP Yavuz, O (reprint author), Fractal Syst Inc, 200 9th Ave N,Suite 100, Safety Harbor, FL 34695 USA.
EM maldissi@fractalsystemsinc.com
CR BERATAN H, 1994, P SOC PHOTO-OPT INS, V2274, P147, DOI 10.1117/12.189240
   BRITTON G, 1982, CAROTENOID CHEM BIOC, P237
   BUCHWALD M, 1968, BIOCHEMISTRY-US, V7, P844, DOI 10.1021/bi00842a043
   BUCHWALD M, 1968, BIOCHEMISTRY-US, V7, P834, DOI 10.1021/bi00842a042
   CHOI IH, 1986, IEEE T ELECTRON DEV, V33, P72
   Cianci M, 2002, P NATL ACAD SCI USA, V99, P9795, DOI 10.1073/pnas.152088999
   Durbeej B, 2003, CHEM PHYS LETT, V375, P30, DOI 10.1016/S0009-2614(03)00800-5
   LIDDIARD KC, 1986, INFRARED PHYS, V26, P43, DOI 10.1016/0020-0891(86)90046-1
   Oliver AD, 1999, SENSOR ACTUAT A-PHYS, V73, P222, DOI 10.1016/S0924-4247(98)00276-3
   QUARMBY R, 1977, COMP BIOCHEM PHYS B, V56, P55, DOI 10.1016/0305-0491(77)90222-X
   Tanaka A, 1997, P SOC PHOTO-OPT INS, V3061, P198, DOI 10.1117/12.280339
   Tanaka A, 1996, IEEE T ELECTRON DEV, V43, P1844, DOI 10.1109/16.543017
   WALD G, 1948, BIOL BULL, V95, P249
   Weesie RJ, 1999, BIOSPECTROSCOPY, V5, P19, DOI 10.1002/(SICI)1520-6343(1999)5:1<19::AID-BSPY4>3.0.CO;2-E
   ZAGALSKY PF, 1976, PURE APPL CHEM, V47, P103, DOI 10.1351/pac197647020103
   ZAGALSKY PF, 1990, COMP BIOCHEM PHYS B, V97, P1, DOI 10.1016/0305-0491(90)90171-O
   Zagalsky PF, 1995, CAROTENOIDS, V1A, P287
NR 17
TC 2
Z9 2
U1 0
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-3182
J9 BIOINSPIR BIOMIM
JI Bioinspir. Biomim.
PD SEP
PY 2008
VL 3
IS 3
AR 035007
DI 10.1088/1748-3182/3/3/035007
PG 10
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 344HM
UT WOS:000258917500012
PM 18667761
DA 2018-10-20
ER

PT J
AU Jing, P
   Rudra, JS
   Herr, AB
   Collier, JH
AF Jing, Peng
   Rudra, Jai S.
   Herr, Andrew B.
   Collier, Joel H.
TI Self-assembling peptide-polymer hydrogels designed from the coiled coil
   region of fibrin
SO BIOMACROMOLECULES
LA English
DT Article
ID ARTIFICIAL PROTEIN HYDROGELS; BURIED POLAR INTERACTION; HYBRID
   BLOCK-COPOLYMERS; GCN4 LEUCINE-ZIPPER; MECHANICAL-PROPERTIES; FIBROUS
   BIOMATERIALS; POLYETHYLENE GLYCOLS; GRAFT-COPOLYMERS; DRUG-DELIVERY;
   TISSUE-REPAIR
AB Biomaterials constructed front self-assembling peptides, peptide derivatives, and peptide-polymer conjugates are receiving increasing attention as defined matrices for tissue engineering, controlled therapeutic release, and in vitro cell expansion, but many are constructed from peptide structures not typically found in the human extracellular matrix. Here we report a self-assembling biomaterial constructed from a designed peptide inspired by the coiled coil domain of human fibrin. the major protein constituent of blood clots and the provisional scaffold of wound healing. Targeted substitutions were made in the residues forming the interface between coiled coil strands for a 37-amino acid peptide front human fibrinogen to stabilize the coiled coil peptide bundle. while the solvent-exposed residues were left unchanged to provide a surface similar to that of the native protein. This peptide, which self-assembled into coiled coil dimers and tetramers, was then used to produce triblock peptide-PEG-peptide bioconjugates that self-assembled into viscoelastic hydrogel biomaterials.
C1 [Rudra, Jai S.; Collier, Joel H.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA.
   [Collier, Joel H.] Univ Chicago, Comm Mol Med, Chicago, IL 60637 USA.
   [Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.
   [Jing, Peng] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH 45221 USA.
RP Collier, JH (reprint author), Univ Chicago, Dept Surg, Chicago, IL 60637 USA.
EM collier@uchicago.edu
RI Jing, Peng/A-8054-2011
OI Herr, Andrew/0000-0002-3598-3399
FU National Institute of Dental and Craniofacial Research [R21DE017703]
FX The authors thank Dale Schaeffer for access to the rheometer, Deb
   Conrady for help with analytical ultracentrifugation, Stephen Macha for
   assistance with mass spectrometry, and Paul Rosevear and Jack Howarth
   for access to the circular dichroism instrument. The project described
   was supported by Grant Number R21DE017703 from the National Institute of
   Dental and Craniofacial Research. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institute of Dental and Craniofacial
   Research or the National Institutes of Health.
CR Alexandridis P, 1997, CURR OPIN COLLOID IN, V2, P478, DOI 10.1016/S1359-0294(97)80095-7
   BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Benkherourou M, 2000, IEEE T BIO-MED ENG, V47, P1465, DOI 10.1109/10.880098
   Boato F, 2007, ANGEW CHEM INT EDIT, V46, P9015, DOI 10.1002/anie.200702805
   Channon K, 2008, SOFT MATTER, V4, P647, DOI 10.1039/b713013a
   Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t
   Collier JH, 2001, J AM CHEM SOC, V123, P9463, DOI 10.1021/ja011535a
   Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047
   Doolittle RF, 2003, J THROMB HAEMOST, V1, P1559, DOI 10.1046/j.1538-7836.2003.00278.x
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fehr T, 1997, J EXP MED, V185, P1785, DOI 10.1084/jem.185.10.1785
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011
   GRADDIS TJ, 1993, BIOCHEMISTRY-US, V32, P12664, DOI 10.1021/bi00210a015
   Guler MO, 2006, BIOMACROMOLECULES, V7, P1855, DOI 10.1021/bm060161g
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   Herr AB, 2003, J MOL BIOL, V327, P645, DOI 10.1016/S0022-2836(03)00149-9
   Herr AB, 1997, J BIOL CHEM, V272, P16382, DOI 10.1074/jbc.272.26.16382
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Kennedy SB, 2005, MACROMOLECULES, V38, P7470, DOI 10.1021/ma0507261
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Law B, 2006, BIOMACROMOLECULES, V7, P1261, DOI 10.1021/bm050920f
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lim YB, 2008, J MATER CHEM, V18, P723, DOI 10.1039/b711188f
   LUMB KJ, 1995, BIOCHEMISTRY-US, V34, P8642, DOI 10.1021/bi00027a013
   Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200
   MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010
   Mart RJ, 2006, SOFT MATTER, V2, P822, DOI 10.1039/b607706d
   Mi LX, 2006, BIOMACROMOLECULES, V7, P38, DOI 10.1021/bm050157p
   Mortensen K, 1998, CURR OPIN COLLOID IN, V3, P12, DOI 10.1016/S1359-0294(98)80036-8
   Mortensen K, 1997, MACROMOLECULES, V30, P503, DOI 10.1021/ma960457m
   NAUTIYAL S, 1995, BIOCHEMISTRY-US, V34, P11645, DOI 10.1021/bi00037a001
   Oakley MG, 1998, BIOCHEMISTRY-US, V37, P12603, DOI 10.1021/bi981269m
   Papapostolou D, 2007, P NATL ACAD SCI USA, V104, P10853, DOI 10.1073/pnas.0700801104
   Pechar M, 2002, MACROMOL BIOSCI, V2, P199, DOI 10.1002/1616-5195(200206)2:5<199::AID-MABI199>3.0.CO;2-2
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Ramachandran S, 2006, BIODRUGS, V20, P263, DOI 10.2165/00063030-200620050-00001
   Rosenberg AS, 2006, AAPS J, V8, pE501
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   Ryadnov MG, 2004, J AM CHEM SOC, V126, P7454, DOI 10.1021/ja048144r
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0
   Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573
   Shen W, 2005, MACROMOLECULES, V38, P3909, DOI 10.1021/ma048348s
   Shen W, 2007, SOFT MATTER, V3, P99, DOI 10.1039/b610986a
   Shen W, 2007, MACROMOLECULES, V40, P689, DOI 10.1021/ma0615194
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith AM, 2006, ADV FUNCT MATER, V16, P1022, DOI 10.1002/adfm.200500568
   SU JY, 1994, BIOCHEMISTRY-US, V33, P15501, DOI 10.1021/bi00255a032
   Vandermeulen GWM, 2005, MACROMOLECULES, V38, P761, DOI 10.1021/ma0485538
   Vandermeulen GWM, 2003, MACROMOLECULES, V36, P4107, DOI 10.1021/ma034124i
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang C, 2001, BIOMACROMOLECULES, V2, P912, DOI 10.1021/bm0155322
   Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606
   Woolfson DN, 2006, CURR OPIN CHEM BIOL, V10, P559, DOI 10.1016/j.cbpa.2006.09.019
   Xu B, 1997, LANGMUIR, V13, P2447, DOI 10.1021/la960799l
   Yang J, 2008, BIOMACROMOLECULES, V9, P510, DOI 10.1021/brn701001f
   Yang JY, 2006, BIOMACROMOLECULES, V7, P1187, DOI 10.1021/bm051002k
   Yang JY, 2006, MACROMOL BIOSCI, V6, P201, DOI 10.1002/mabi.200500208
   Zimmerman SB, 1996, ANAL BIOCHEM, V234, P190, DOI 10.1006/abio.1996.0071
NR 67
TC 63
Z9 64
U1 1
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2008
VL 9
IS 9
BP 2438
EP 2446
DI 10.1021/bm800459v
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 345YH
UT WOS:000259033700021
PM 18712921
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rojo, L
   Barcenilla, JM
   Vazquez, B
   Gonzalez, R
   Roman, JS
AF Rojo, Luis
   Barcenilla, Jose. M.
   Vazquez, Blanca
   Gonzalez, Ramon
   Roman, Julio San
TI Intrinsically antibacterial materials based on polymeric derivatives of
   eugenol for biomedical applications
SO BIOMACROMOLECULES
LA English
DT Article
ID ANTIMICROBIAL ACTIVITY; IN-VITRO; CELL-ADHESION; HYDROPHOBICITY;
   METHACRYLATE; COMPOSITES; MECHANISMS; COPOLYMERS; CARVACROL; SYSTEMS
AB Infections are the most common cause of biomaterial implant failure representing a constant challenge to the more widespread application of medical implants. This study reports on the preparation and characterization of novel hydrophilic copolymeric systems provided with antibacterial properties coming from eugenol residues anchored to the macromolecular chains. Thus, high conversion copolymers were prepared from the hydrophilic monomer 2-hydroxyethyl methacrylate (HEMA) and different eugenol monomeric derivatives, eugenyl methacrylate (EgMA) and ethoxyeugenyl methacrylate (EEgMA), by bulk polymerization reaction. Thermal evaluation revealed glass transition temperature values in the range 95-58 degrees C following the order HEMA-co-EgMA > PHEMA > HEMA-co-EEgMA and a clear increase in thermal stability with the presence of any eugenyl monomer in the system. In vitro wettability studies showed a reduction of water sorption capacity and Surface free energy values with increasing the content of eugenol residues in the copolymer. The antimicrobial activity of copolymeric discs was evaluated by determining their capacity to reduce or inhibit colony formation by different bacterial species. All eugenyl containing materials showed bacteria growth inhibition, this one being higher for the EEgMA derivative copolymers.
C1 [Rojo, Luis; Vazquez, Blanca; Roman, Julio San] CSIC, Inst Polymer Sci & Technol, E-28006 Madrid, Spain.
   [Rojo, Luis; Vazquez, Blanca; Roman, Julio San] CIBER BBN, Madrid 28006, Spain.
   [Barcenilla, Jose. M.; Gonzalez, Ramon] CSIC, Inst Ind Fermentat, E-28006 Madrid, Spain.
RP Rojo, L (reprint author), CSIC, Inst Polymer Sci & Technol, C Juan Cierva 3, E-28006 Madrid, Spain.
EM rojodelolmo@ictp.csic.es
RI Gonzalez, Ramon/G-9281-2011; Rojo, Luis/B-3073-2009
OI Gonzalez, Ramon/0000-0001-7388-1660; Rojo, Luis/0000-0001-6334-6736;
   Vazquez, Blanca/0000-0001-5539-8026
FU Comision Interministerial de Ciencia y Tecnologia; CICYT
   [MAT2007-63355]; NoE EXPERTISSUES [5002832]
FX This research was supported by Comision Interministerial de Ciencia y
   Tecnologia, CICYT, (MAT2007-63355) and NoE EXPERTISSUES (UE Contract No.
   5002832).
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P496
   Ben Arfa A, 2006, LETT APPL MICROBIOL, V43, P149, DOI 10.1111/j.1472-765X.2006.01938.x
   Benencia F, 2000, PHYTOTHER RES, V14, P495, DOI 10.1002/1099-1573(200011)14:7<495::AID-PTR650>3.0.CO;2-8
   Blaszyk M, 1998, INT J FOOD MICROBIOL, V39, P175, DOI 10.1016/S0168-1605(97)00134-7
   Everall N. J., 2007, VIBRATIONAL SPECTROS
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   Good RJ, 1998, J DISPER SCI TECHNOL, V19, P1163, DOI 10.1080/01932699808913235
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Imazato S, 2003, DENT MATER, V19, P449, DOI 10.1016/S0109-5641(02)00102-1
   ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859
   Kaplan AE, 1999, ENDOD DENT TRAUMATOL, V15, P42
   Kenawy ER, 2005, J BIOACT COMPAT POL, V20, P95, DOI 10.1177/0883911505049655
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2
   Ortiz C, 1999, J BIOMED MATER RES, V45, P184, DOI 10.1002/(SICI)1097-4636(19990605)45:3<184::AID-JBM4>3.0.CO;2-8
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Rahim EA, 2004, J MACROMOL SCI PURE, VA41, P133, DOI 10.1081/MA-120027299
   ROJO L, 2008, DENT MAT
   Rojo L, 2008, J MATER SCI-MATER M, V19, P1467, DOI 10.1007/s10856-007-3317-x
   Rojo L, 2006, BIOMACROMOLECULES, V7, P2751, DOI 10.1021/bm0603241
   Schiraldi C, 2004, BIOMATERIALS, V25, P3645, DOI 10.1016/j.biomaterials.2003.10.059
   SIKKEMA J, 1995, MICROBIOL REV, V59, P201
   TAMM C, 1974, FEBS LETT, V48, P7, DOI 10.1016/0014-5793(74)81052-5
   Tashiro T, 2001, MACROMOL MATER ENG, V286, P63
   TYAGI AK, 1992, EUR POLYM J, V28, P419, DOI 10.1016/0014-3057(92)90265-4
   Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002
   Vazquez BI, 2001, INT J FOOD MICROBIOL, V67, P157, DOI 10.1016/S0168-1605(01)00429-9
   VOGL O, 1979, J MACROMOL SCI CHEM, VA13, P415, DOI 10.1080/00222337908068110
   Weber FJ, 1996, BBA-REV BIOMEMBRANES, V1286, P225, DOI 10.1016/S0304-4157(96)00010-X
   Woo GLY, 2002, J BIOMED MATER RES, V59, P35, DOI 10.1002/jbm.1214
NR 32
TC 29
Z9 29
U1 4
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2008
VL 9
IS 9
BP 2530
EP 2535
DI 10.1021/bm800570u
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 345YH
UT WOS:000259033700032
PM 18702543
DA 2018-10-20
ER

PT J
AU Griffiths, LG
   Choe, LH
   Reardon, KF
   Dow, SW
   Orton, EC
AF Griffiths, Leigh G.
   Choe, Leila H.
   Reardon, Kenneth F.
   Dow, Steven W.
   Orton, E. Christopher
TI Immunoproteomic identification of bovine pericardium xenoantigens
SO BIOMATERIALS
LA English
DT Article
DE immunoproteomics; scaffold; tissue engineering; xenoantigens; heart
   valve
ID BIOPROSTHETIC HEART-VALVE; IMMUNE-RESPONSE; PEROXIREDOXIN-I;
   LUNG-CANCER; AUTOIMMUNE-DISEASES; MEMBRANE-PROTEINS; TISSUE FAILURE; CD1
   MOLECULES; TUMOR-ANTIGEN; ALPHA-ENOLASE
AB Bovine pericardium is an important biomaterial with current application in glutaraldehyde-fixed bio-prosthetic heart valves and possible future application as an unfixed biological scaffold for tissue engineering. The importance of both humoral and cell-mediated rejection responses toward fixed and unfixed xenogeneic tissues has become increasingly apparent. However, the full scope and specific identities of bovine pericardium proteins that can elicit an immune response remain largely unknown. in this study, an immunoproteomic approach was used to survey bovine pericardium proteins for their ability to elicit a humoral immune response in rabbits. A two-stage protein extraction protocol was used to separate bovine pericardium proteins into water- and lipid-soluble fractions. Two-dimensional (2-D) gel electrophoresis was performed to separate the proteins from each fraction. Western blots were generated from 2-D gels of both bovine pericardium protein fractions. These blots were probed with serum from rabbits immunized with bovine pericardium and a secondary antibody was used to assess for IgG positivity. Western blots were compared to duplicate 2-D gels and proteins in matched spots were identified by tandem mass spectrometry. Thirty-one putative protein antigens were identified, eight of which are known to be antigenic from previous studies. All of the putative antigens demonstrated progressive staining intensity with increasing days of post-exposure serum. identified antigenic proteins represented a variety of functional and structural protein types, and included both cellular and matrix proteins. The results of this study have implications for the use of bovine pericardium as a biomaterial in bioprostheses and tissue engineering applications, as well as xenotransplantation in general. Published by Elsevier Ltd.
C1 [Griffiths, Leigh G.; Orton, E. Christopher] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA.
   [Reardon, Kenneth F.] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
   [Dow, Steven W.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Choe, Leila H.] Univ Delaware, Dept Chem Engn, Delaware Biotechnol Inst, Newark, DE 19716 USA.
RP Griffiths, LG (reprint author), Univ Calif Davis, Dept Med & Epidemiol, 2103 Tupper Hall,1 Shields Ave, Davis, CA 95616 USA.
EM lggriffiths@ucdavis.edu
RI Reardon, Kenneth/A-1952-2016
OI Reardon, Kenneth/0000-0002-7753-4049
FU NHLBI NIH HHS [R21 HL081107, R21 HL081107-02]
CR Aslan H, 2004, RHEUMATOL INT, V24, P77, DOI 10.1007/s00296-002-0274-z
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Beretta B, 2001, INT ARCH ALLERGY IMM, V126, P188, DOI 10.1159/000049513
   Bertipaglia B, 2003, ANN THORAC SURG, V75, P1274, DOI 10.1016/S0003-4975(02)04706-9
   Bierczynska-Krzysik A, 2006, NEUROCHEM INT, V49, P245, DOI 10.1016/j.neuint.2006.01.013
   Bogdanos DP, 2004, J AUTOIMMUNE DIS, V1, P4
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Bricard G, 2007, CELL MOL LIFE SCI, V64, P1824, DOI 10.1007/s00018-007-7007-0
   Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598
   Cebotari S, 2002, CIRCULATION, V106, pI63, DOI 10.1161/01.cir.0000032900.55215.85
   Chang JW, 2005, FEBS LETT, V579, P2873, DOI 10.1016/j.febslet.2005.04.028
   Choe LH, 2005, ELECTROPHORESIS, V26, P2437, DOI 10.1002/elps.200410336
   DAHM M, 1995, ANN THORAC SURG, V60, pS348, DOI 10.1016/0003-4975(95)00291-R
   DAHM M, 1990, J THORAC CARDIOV SUR, V99, P1082
   Elkins RC, 2001, ANN THORAC SURG, V71, pS428, DOI 10.1016/S0003-4975(01)02503-6
   Ezzelarab M, 2005, IMMUNOL CELL BIOL, V83, P396, DOI 10.1111/j.1440-1711.2005.01344.x
   Fang NT, 2007, CHINESE MED J-PEKING, V120, P696
   Fernandez B, 2003, MOL CELL BIOCHEM, V246, P3, DOI 10.1023/A:1023487424751
   Fujita Y, 2006, CLIN CANCER RES, V12, P6415, DOI 10.1158/1078-0432.CCR-06-1315
   Ge GX, 2004, J BIOL CHEM, V279, P41626, DOI 10.1074/jbc.M406630200
   Goldstein S, 2000, ANN THORAC SURG, V70, P1962, DOI 10.1016/S0003-4975(00)01812-9
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Gumperz JE, 2006, TRAFFIC, V7, P2, DOI 10.1111/j.1600-0854.2006.00364.x
   HANSSON SF, 2004, PROTEOME SCI, V2
   He P, 2007, CANCER SCI, V98, P1234, DOI 10.1111/j.1349-7006.2007.00509.x
   Hess JL, 2005, J CHROMATOGR B, V815, P65, DOI 10.1016/j.jchromb.2004.07.047
   Hopfer U, 2006, J BIOL CHEM, V281, P8645, DOI 10.1074/jbc.M513751200
   Human P, 2001, J Long Term Eff Med Implants, V11, P199
   Human P, 2001, ANN THORAC SURG, V71, pS385, DOI 10.1016/S0003-4975(01)02492-4
   *I LAB AN RES COMM, 1996, GUID CAR US LAB AN
   Iwata Y, 2007, RHEUMATOLOGY, V46, P790, DOI 10.1093/rheumatology/kem010
   Karasawa R, 2005, MICROBIOL IMMUNOL, V49, P57, DOI 10.1111/j.1348-0421.2005.tb03640.x
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Kasimir MT, 2005, TISSUE ENG, V11, P1274, DOI 10.1089/ten.2005.11.1274
   Kearns-Jonker M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-3
   Korossis SA, 2002, J HEART VALVE DIS, V11, P463
   Krah Alexander, 2004, Methods Mol Med, V94, P19
   Lacerda CMR, 2007, J PROTEOME RES, V6, P1145, DOI 10.1021/pr060477v
   Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583
   Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311
   McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Mini R, 2006, J CHROMATOGR B, V833, P63, DOI 10.1016/j.jchromb.2005.12.052
   Mirzaie M, 2000, SCAND CARDIOVASC J, V34, P589
   Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334
   Neuenschwander S, 2004, TRANSPL IMMUNOL, V12, P359, DOI 10.1016/S0966-3274(03)00116-3
   O'Brien M F, 1999, Semin Thorac Cardiovasc Surg, V11, P194
   Oh-Ishi M, 2007, J CHROMATOGR B, V849, P211, DOI 10.1016/j.jchromb.2006.10.064
   Oshima M, 1982, Igaku Kenkyu, V52, P313
   Pedersen SK, 2003, J PROTEOME RES, V2, P303, DOI 10.1021/pr025588i
   RABILLOUD T, 2000, PROTEOME RES 2 DIMEN
   RodriguezGarcia MI, 1996, ANN RHEUM DIS, V55, P895, DOI 10.1136/ard.55.12.895
   SALGALLER ML, 1985, J BIOMED MATER RES, V19, P1, DOI 10.1002/jbm.820190103
   Schenke-Layland K, 2003, CARDIOVASC RES, V60, P497, DOI 10.1016/j.cardiores.2003.09.002
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schmidt D, 2007, PHILOS T R SOC B, V362, P1505, DOI 10.1098/rstb.2007.2131
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Sprenger J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S3
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Taylor PM, 2007, PHILOS T R SOC B, V362, P1313, DOI 10.1098/rstb.2007.2117
   Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004
   Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107
   Ueda Y, 2006, INT J ARTIF ORGANS, V29, P781
   van Duivenvoorde LM, 2004, ARTHRITIS RHEUM, V50, P3354, DOI 10.1002/art.20513
   VESELY I, 1995, ANN THORAC SURG, V60, pS359, DOI 10.1016/0003-4975(95)00206-Z
   Xiang Y, 2004, ARTHRITIS RHEUM, V50, P1511, DOI 10.1002/art.20189
   Xiao Zongwei, 2005, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V22, P1203
   Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6
   Zeng Xi, 2007, Ai Zheng, V26, P1080
   Zhao Dong-e, 2003, Asian Cardiovasc Thorac Ann, V11, P153
NR 70
TC 22
Z9 23
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 26
BP 3514
EP 3520
DI 10.1016/j.biomaterials.2008.05.006
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 336IH
UT WOS:000258357000003
PM 18514307
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Young, TH
   Lee, CY
   Chiu, HC
   Hsu, CJ
   Lin, SJ
AF Young, Tai-Horng
   Lee, Chiao-Yun
   Chiu, Hsien-Ching
   Hsu, Chih-Jung
   Lin, Sung-Jan
TI Self-assembly of dermal papilla cells into inductive spheroidal
   microtissues on poly(ethylene-co-vinyl alcohol) membranes for hair
   follicle regeneration
SO BIOMATERIALS
LA English
DT Article
DE aggregation; dermal papilla; spheroid; tissue engineering; adhesivity;
   biomaterial
ID ADULT-RAT HEPATOCYTES; STEM-CELLS; IN-VITRO; MULTICELLULAR SPHEROIDS;
   MELANOCYTE SPHEROIDS; HOODED RAT; GROWTH; INVITRO; SKIN; SURFACE
AB Self-aggregation is key to hair follicle (HF) induction ability of dermal papilla (DP) cells and neogenesis of HF can be achieved by transplanting DP microtissues. However, there is currently lack of a suitable system that allows efficient production of DP microtissues and analysis of DP self-aggregation in vitro. We demonstrate that, at a higher seeding cell density, poly(ethylene-co-vinyl alcohol) (EVAL) membranes facilitate DP self-assembly into many compact spheroidal microtissues that are able to induce new HFs. This self-assembling process is associated with an enhanced cell movement and a declined cell-substrate adhesivity on EVAL. A compromised cell growth is also revealed on EVAL. On the contrary, a more adherent surface allows faster cell expansion but maintains DP cells in a flat morphology. Dynamically, cell migration, intercellular collision and intercellular adhesion contribute to DP microtissue formation on EVAL. Our results suggest that, for large-scale production of DP microtissues for HF regeneration, an adhesive surface is needed for quick cell expansion and a biomaterial with a lower adhesivity is required for self-aggregation. In addition, this system can be a model for investigation of DP self-aggregation in vitro. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Young, Tai-Horng; Lee, Chiao-Yun; Lin, Sung-Jan] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 100, Taiwan.
   [Young, Tai-Horng; Lee, Chiao-Yun; Lin, Sung-Jan] Natl Taiwan Univ, Coll Engn, Taipei 100, Taiwan.
   [Chiu, Hsien-Ching; Hsu, Chih-Jung; Lin, Sung-Jan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.
RP Lin, SJ (reprint author), Natl Taiwan Univ, Coll Med, Inst Biomed Engn, 1,Sec 1,Jen Ai Rd, Taipei 100, Taiwan.
EM drsjlin@ntu.edu.tw
OI JEE, SHIOU-HWA/0000-0001-6737-6297; Lin, Sung-Jan/0000-0003-1325-3464;
   CHIU, HSIEN-CHING/0000-0002-1409-8470
CR Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357
   Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x
   BUHL AE, 1989, J INVEST DERMATOL, V92, P315, DOI 10.1111/1523-1747.ep12277095
   BURSTONE MS, 1958, J NATL CANCER I, V20, P601
   CHIN HC, 1996, J FORMOS MED ASSOC, V95, P667
   COHEN J, 1961, J EMBRYOL EXP MORPH, V9, P117
   Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376
   Dubessy C, 2000, CRIT REV ONCOL HEMAT, V36, P179, DOI 10.1016/S1040-8428(00)00085-8
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Hamano T, 1998, J BIOMED MATER RES, V41, P257, DOI 10.1002/(SICI)1097-4636(199808)41:2<257::AID-JBM11>3.0.CO;2-I
   Hasskarl J, 2005, J INVEST DERMATOL, V124, P475, DOI 10.1111/j.0022-202X.2004.23574.x
   Hasskarl J, 2006, J INVEST DERMATOL, V126, P1179, DOI 10.1038/sj.jid.5700205
   IHARA S, 1991, CELL TISSUE RES, V266, P65, DOI 10.1007/BF00678712
   Inamatsu M, 1998, J INVEST DERMATOL, V111, P767, DOI 10.1046/j.1523-1747.1998.00382.x
   Ito Y, 2007, J INVEST DERMATOL, V127, P1052, DOI 10.1038/sj.jid.5700665
   JAHODA C, 1981, BRIT J DERMATOL, V105, P623, DOI 10.1111/j.1365-2133.1981.tb00971.x
   JAHODA CAB, 1991, J CELL SCI, V99, P627
   JAHODA CAB, 1993, J INVEST DERMATOL, V101, P584, DOI 10.1111/1523-1747.ep12366039
   JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0
   JAHODA CAB, 1984, J EMBRYOL EXP MORPH, V79, P211
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kelm JM, 2004, TISSUE ENG, V10, P201, DOI 10.1089/107632704322791853
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Khalil M, 2001, J HEPATOL, V34, P68, DOI 10.1016/S0168-8278(00)00080-5
   KOIDE N, 1989, BIOCHEM BIOPH RES CO, V161, P385, DOI 10.1016/0006-291X(89)91609-4
   KOIDE N, 1990, EXP CELL RES, V186, P227, DOI 10.1016/0014-4827(90)90300-Y
   Li Yu, 2005, J Dermatol Sci, V37, P58, DOI 10.1016/j.jdermsci.2004.10.001
   LICHTI U, 1993, J INVEST DERMATOL, V101, pS124, DOI 10.1111/1523-1747.ep12363165
   Lin SJ, 2006, BIOMATERIALS, V27, P1462, DOI 10.1016/j.biomaterials.2005.08.031
   Lin SJ, 2005, BIOMATERIALS, V26, P1413, DOI 10.1016/j.biomaterials.2004.05.002
   Lin SJ, 2006, BIOMATERIALS, V27, P5079, DOI 10.1016/j.biomaterials.2006.05.035
   McElwee KJ, 2003, J INVEST DERMATOL, V121, P1267, DOI 10.1111/j.1523-1747.2003.12568.x
   Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x
   Muller-Rover S, 1998, J HISTOCHEM CYTOCHEM, V46, P1401
   OLIVER R F, 1970, Journal of Embryology and Experimental Morphology, V23, P219
   OLIVER RF, 1967, J EMBRYOL EXP MORPH, V17, P27
   OLIVER RF, 1967, J EMBRYOL EXP MORPH, V18, P43
   ORENTREICH N, 1959, ANN NY ACAD SCI, V83, P463
   Osada A, 2007, TISSUE ENG, V13, P975, DOI 10.1089/ten.2006.0304
   Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2
   PHILPOTT MP, 1992, BRIT J DERMATOL, V127, P600, DOI 10.1111/j.1365-2133.1992.tb14873.x
   PHILPOTT MP, 1990, J CELL SCI, V97, P463
   Philpott MP, 1998, MOL BASIS EPITHELIAL, P75
   REYNOLDS AJ, 1992, DEVELOPMENT, V115, P587
   Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398
   Santini MT, 1999, PATHOBIOLOGY, V67, P148, DOI 10.1159/000028065
   Stenn KS, 2005, CURR OPIN BIOTECH, V16, P493, DOI 10.1016/j.copbio.2005.08.002
   Takeda A, 1998, SCAND J PLAST RECONS, V32, P359, DOI 10.1080/02844319850158435
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
   Young TH, 2005, BIOMATERIALS, V26, P4291, DOI 10.1016/j.biomaterials.2004.10.043
   Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x
NR 52
TC 50
Z9 57
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 26
BP 3521
EP 3530
DI 10.1016/j.biomaterials.2008.05.013
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 336IH
UT WOS:000258357000004
PM 18533254
DA 2018-10-20
ER

PT J
AU Benzaid, R
   Chevalier, J
   Saddaoui, M
   Fantozzi, G
   Nawa, M
   Diaz, LA
   Torrecillas, R
AF Benzaid, Rajaa
   Chevalier, Jerome
   Saddaoui, Malika
   Fantozzi, Gilbert
   Nawa, Masahiro
   Diaz, Luis Antonio
   Torrecillas, Ramon
TI Fracture toughness, strength and slow crack growth in a ceria stabilized
   zirconia-alumina nanocomposite for medical applications
SO BIOMATERIALS
LA English
DT Article
DE mechanical properties; crack; alumina; zirconia; nanocomposite; fatigue
ID CE-TZP/AL2O3 NANOCOMPOSITE; JOINT PROSTHESES; CERAMICS; 3Y-TZP;
   TRANSFORMATION; PROPAGATION; INDENTATION; RESISTANCE; OXIDES; WEAR
AB Mechanical properties and slow crack growth (SCG) behavior of a 10Ce-TZP/Al2O3 nanocomposite currently developed as a biomaterial are considered. Fracture toughness is determined for sharp, long (double torsion) and short (indentation) cracks and a good agreement is found between the two types of Cracks. The main toughening mechanism in the nanocomposite is the tetragonal to monoclinic phase transformation of the ceria-stabilized zirconia (Ce-TZP) phase. Transformation at the surface of ground specimens leads to surface Compressive induced stresses and an increase in strength. Crack velocity curves (V-K-I curves) are obtained under static and cyclic fatigue using the double torsion method. The static V-K-I Curve in air reveals the three stages characteristic Of Stress corrosion with a threshold K-10 similar to 4.5 MPa m(1/2) and a fracture toughness of 8.8 MPa m(1/2) significantly higher than those of currently used inert bioceramics (i.e. alumina and Y-TZP). A Crack growth accelerating effect is shown under cyclic loading, correlated with a decrease in the threshold. However, the cyclic fatigue threshold (4 MPa m(1/2)) still stands above that of current biomedical grade alumina and zirconia. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Benzaid, Rajaa; Chevalier, Jerome; Fantozzi, Gilbert] Univ Lyon 1, Inst Natl Sci Appl Lyon, CNRS, MATEIS,UMR 5510, F-69621 Villeurbanne, France.
   [Benzaid, Rajaa; Saddaoui, Malika] Ecole Mohammadia Ingn, LERSIM, Rabat, Morocco.
   [Nawa, Masahiro] Matsushita Elect Works Ltd, Adv Technol Dev Lab, Kadoma, Osaka 571, Japan.
   [Diaz, Luis Antonio; Torrecillas, Ramon] CINN CSIC, Nanomat & Nanotechnol Res Ctr, Oviedo 33011, Spain.
RP Chevalier, J (reprint author), Univ Lyon 1, Inst Natl Sci Appl Lyon, CNRS, MATEIS,UMR 5510, 20 Ave Albert Einstein,Batiment Blaise Pascal, F-69621 Villeurbanne, France.
EM jerome.chevalier@insa-lyon.fr
RI Torrecillas, Ramon/G-7851-2011
OI Torrecillas, Ramon/0000-0003-3856-0217
CR Affatato S, 2001, BIOMATERIALS, V22, P717, DOI 10.1016/S0142-9612(00)00235-0
   BRAUN LM, 1992, J AM CERAM SOC, V75, P3049, DOI 10.1111/j.1151-2916.1992.tb04385.x
   Burger W., 2001, KEY ENG MATER, p[192, 545], DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.545
   Chevalier J, 1999, J AM CERAM SOC, V82, P3129
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2005, NANO LETT, V5, P1297, DOI 10.1021/nl050492j
   Chevalier J, 1997, CERAM INT, V23, P263, DOI 10.1016/S0272-8842(96)00037-5
   Chevalier J, 1996, CERAM INT, V22, P171, DOI 10.1016/0272-8842(95)00076-3
   Chevalier J, 1996, J MATER SCI, V31, P2711, DOI 10.1007/BF00687305
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   DRANSMANN GW, 1994, J AM CERAM SOC, V77, P1194, DOI 10.1111/j.1151-2916.1994.tb05392.x
   El Attaoui H, 2007, J EUR CERAM SOC, V27, P483, DOI 10.1016/j.jeurceramsoc.2006.04.108
   ELATTAOUI H, 2003, THESIS INSA DE LYON, P138
   Hannink RHJ, 2000, J AM CERAM SOC, V83, P461
   HEROS RJ, 1998, SEMIN ARTHROPLASTY, V9, P114
   Kelly PM, 2002, PROG MATER SCI, V47, P463, DOI 10.1016/S0079-6425(00)00005-0
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Nawa M, 1998, CERAM INT, V24, P497, DOI 10.1016/S0272-8842(97)00048-5
   Niihara K., 1991, J CERAM SOC JPN, V99, P974, DOI DOI 10.2109/JCERSJ.99.974
   Tanaka K, 2003, J BIOMED MATER RES A, V67A, P200, DOI 10.1002/jbm.a.10006
   Tanaka K, 2002, J BIOMED MATER RES, V63, P262, DOI 10.1002/jbm.10182
   Toraya H., 1984, J AM CERAM SOC, V67, P119
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Willmann G, 2000, CLIN ORTHOP RELAT R, P22
NR 25
TC 104
Z9 105
U1 3
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 27
BP 3636
EP 3641
DI 10.1016/j.biomaterials.2008.05.021
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 337MD
UT WOS:000258439300002
PM 18571716
DA 2018-10-20
ER

PT J
AU Li, XT
   Zhang, Y
   Chen, GQ
AF Li, Xiao-Tao
   Zhang, Yan
   Chen, Guo-Qiang
TI Nanofibrous polyhydroxyalkanoate matrices as cell growth supporting
   materials
SO BIOMATERIALS
LA English
DT Article
DE PHB; polyhydroxybutyrate; nanofiber; matrix; HaCat cells;
   biocompatibility; tissue engineering
ID ASSEMBLING PEPTIDE SCAFFOLDS; POLY(L-LACTIC ACID) FOAMS; IN-VITRO;
   TISSUE; REGENERATION; CRYSTALLIZATION; POLY(3-HYDROXYBUTYRATE);
   DIFFERENTIATION; DEGRADATION; BEHAVIOR
AB Polyhydroxyalkanoates (PHAs) have been demonstrated to be a family of biopolymers with good biodegradability and biocompatibility. To mimic the real microenvironment of extracellular matrix (ECM) for cell growth, novel nanofiber matrices based on PHA polymers were prepared via a phase separation process. Three-dimensional interconnected fibrous networks were observed in these matrices with average fiber diameters of 50-500 nm, which are very similar to the major ECM component collagen. Compared with nanofiber matrix made of poly(L-lactide), the mechanical properties of PHA nanofiber matrices were significantly improved, especially those matrices of PHA blends PHB/PHBHHx containing polyhydroxybutyrate (PHB) and copolyesters PHBHHx consisting of 3-hydroxybutyrate and 3-hydroxy-hexanoate, and PHB/P3HB4HB that are PHB blended with copolyesters of 3-hydroxybutyrate and 4-hydroxybutyrate, respectively. More importantly, cell attachment and growth of human keratinocyte cell line HaCat on the nanofiber PHA matrices showed a notable improvement over those on PHA matrices prepared via an Ordinary solution casting method. It was therefore Proposed that PHA nanofiber matrices combined the advantages of biodegradation, improved mechanical Strengths and the nanostructure of a natural extracellular matrix, leading to a better cell compatibility, thus they can be used for future implant biomaterial development. (C) 2008 Published by Elsevier Ltd.
C1 [Li, Xiao-Tao; Zhang, Yan; Chen, Guo-Qiang] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
   [Chen, Guo-Qiang] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.
RP Chen, GQ (reprint author), Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.
EM chengq@stu.edu.cn
CR BARHAM PJ, 1986, J POLYM SCI POL PHYS, V24, P69, DOI 10.1002/polb.1986.180240108
   BARHAM PJ, 1984, J MATER SCI, V19, P2781, DOI 10.1007/BF01026954
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2000, CHINESE J POLYM SCI, V18, P389
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   Chiu JB, 2007, J BIOMED MATER RES A, V83A, P1117, DOI 10.1002/jbm.a.31279
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   GRINNELL F, 1982, METHOD ENZYMOL, V82, P535
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   HAY ED, 1991, CELL BIOL EXTRACELLU, P56
   Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   KENONG GJ, 1993, POLYMER, V34, P4089
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   Luo RC, 2007, J APPL POLYM SCI, V105, P3402, DOI 10.1002/app.26369
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Qu XH, 2006, BIOMATERIALS, V27, P2944, DOI 10.1016/j.biomaterials.2006.01.013
   ROSENBERG MD, 1963, SCIENCE, V139, P411, DOI 10.1126/science.139.3553.411
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shin M, 2008, J BIOMED MATER RES A, V84A, P702, DOI 10.1002/jbm.a.31392
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P719, DOI 10.1023/B:JMSM.0000030215.49991.0d
   Tian F, 2008, J BIOMED MATER RES A, V84A, P291, DOI 10.1002/jbm.a.31304
   Tian G, 2001, APPL SPECTROSC, V55, P888, DOI 10.1366/0003702011952686
   Valappil SP, 2006, EXPERT REV MED DEVIC, V3, P853, DOI 10.1586/17434440.3.6.853
   VONK CG, 1973, J APPL CRYSTALLOGR, V6, P148, DOI 10.1107/S0021889873008332
   WILLIAMS SF, 2002, BIOPOLYMERS, V10, P91
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Xu J, 2003, J POLYM SCI POL PHYS, V41, P2128, DOI 10.1002/polb.10556
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
NR 48
TC 85
Z9 99
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 27
BP 3720
EP 3728
DI 10.1016/j.biomaterials.2008.06.004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 337MD
UT WOS:000258439300012
PM 18585779
DA 2018-10-20
ER

PT J
AU Nakamura, T
   Sekiyama, E
   Takaoka, M
   Bentley, AJ
   Yokoi, N
   Fullwood, NJ
   Kinoshita, S
AF Nakamura, Takahiro
   Sekiyama, Eiichi
   Takaoka, Maho
   Bentley, Adam J.
   Yokoi, Norihiko
   Fullwood, Nigel J.
   Kinoshita, Shigeru
TI The use of trehalose-treated freeze-dried amniotic membrane for ocular
   surface reconstruction
SO BIOMATERIALS
LA English
DT Article
DE trehalose; amniotic membrane; freeze-dry; ocular surface reconstruction;
   biocompatibility
ID LIMBAL EPITHELIAL-CELLS; STEM/PROGENITOR CELLS; TRANSPLANTATION;
   CORNEAL; IDENTIFICATION; SUPPRESSION; MATRIX
AB The aim of this study was to evaluate the efficacy and safety of trehalose-treated freeze-dried amniotic membrane (TT-FDAM) for ocular surface reconstruction. Human AM deprived of amniotic epithelial cells was first incubated with 10% trehalose solution, and then freeze-dried, vacuum-packed, and sterilized with gamma-irradiation. The resultant newly developed TT-FDAM was characterized for its physical, biological, and morphological properties by comprehensive physical assays, immunohistochemistry, electron microscopy, cell adhesion assay, 3D cell culture, and an in vivo biocompatibility test. The adaptability of TT-FDAM was markedly improved as compared to FDAM. Immunohistochemistry for several extracellular matrix molecules revealed that the process of freeze-drying and irradiation apparently did not affect its biological properties, however, electron microscopy revealed that the detailed morphological appearance of TT-FDAM is more similar to that of native AM than to FDAM, Intracorneal and scleral-surface transplantation of TT-FDAM showed excellent biocompatibility with ocular surface tissues. Thus, TT-FDAM retained most of the physical, biological, and morphological characteristics of native AM, consequently it is a useful biomaterial for ocular surface reconstruction. (C) 2008 Published by Elsevier Ltd.
C1 [Nakamura, Takahiro; Sekiyama, Eiichi; Takaoka, Maho; Yokoi, Norihiko; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Ophthalmol, Kamigyo Ku, Kyoto 6020841, Japan.
   [Nakamura, Takahiro] Doshisha Univ, Res Ctr Regenerat Med, Kamigyo Ku, Kyoto 6028580, Japan.
   [Bentley, Adam J.; Fullwood, Nigel J.] Univ Lancaster, Lancaster LA1 4YQ, England.
RP Nakamura, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med, Dept Ophthalmol, Kamigyo Ku, 465 Kawaramachi Hirokoji, Kyoto 6020841, Japan.
EM tnakamur@ophth.kpu-m.ac.jp
OI Fullwood, Nigel James/0000-0002-9405-8515
CR AKLE CA, 1981, LANCET, V2, P1003
   Chen F, 2004, TRANSPLANT P, V36, P2812, DOI 10.1016/j.transproceed.2004.10.005
   Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794
   Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7
   Matsuo T, 2002, OPHTHALMOLOGY, V109, P2024, DOI 10.1016/S0161-6420(02)01219-8
   Nakamura T, 2006, ACTA OPHTHALMOL SCAN, V84, P401, DOI 10.1111/j.1600-0420.2006.00667.x
   Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195
   Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752
   Nakamura T, 2008, STEM CELLS, V26, P1265, DOI 10.1634/stemcells.2007-1067
   Nakamura T, 2007, STEM CELLS, V25, P628, DOI 10.1634/stemcells.2006-0494
   Sekiyama E, 2007, INVEST OPHTH VIS SCI, V48, P1528, DOI 10.1167/iovs.06-1104
   Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
NR 20
TC 28
Z9 30
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 27
BP 3729
EP 3737
DI 10.1016/j.biomaterials.2008.05.023
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 337MD
UT WOS:000258439300013
PM 18547637
DA 2018-10-20
ER

PT J
AU Lee, JY
   Kang, BS
   Hicks, B
   Chancellor, TF
   Chu, BH
   Wang, HT
   Keselowsky, BG
   Ren, F
   Lele, TP
AF Lee, Jiyeon
   Kang, B. S.
   Hicks, Barrett
   Chancellor, Thomas F., Jr.
   Chu, Byung Hwan
   Wang, Hung-Ta
   Keselowsky, Benjamin G.
   Ren, F.
   Lele, Tanmay P.
TI The control of cell adhesion and viability by zinc oxide nanorods
SO BIOMATERIALS
LA English
DT Article
DE nanorods; cell adhesion; cell viability; anti-adhesion
ID CORNEAL EPITHELIAL-CELLS; ENDOTHELIAL-CELLS; FLUORESCENCE DETECTION;
   LIVING CELLS; MUSCLE-CELLS; SCALE; ZNO; NANOTOPOGRAPHY; PROLIFERATION;
   TOPOGRAPHY
AB The ability to control the behavior of cells that interact with implanted biomaterials is desirable for the success of implanted devices such as biosensors or drug delivery devices. There is a need to develop materials that can limit the adhesion and viability of cells on implanted biomaterials. In this study, we investigated the use of zinc oxide (ZnO) nanorods for modulating the adhesion and viability of NIH 3T3 fibroblasts, umbilical vein endothelial cells, and capillary endothelial cells. Cells adhered far less to ZnO nanorods than the corresponding ZnO flat substrate. The few cells that adhered to ZnO nanorods were rounded and not viable compared to the flat ZnO substrate. Cells were unable to assemble focal adhesions and stress fibers on nanorods. Scanning electron microscopy indicated that cells were not able to assemble lamellipodia on nanorods. Time-lapse imaging revealed that cells that initially adhered to nanorods were not able to spread. This suggests that it is the lack of initial spreading, rather than long-term exposure to ZnO that causes cell death. We conclude that ZnO nanorods are potentially useful as an adhesion-resistant biomaterial capable of reducing viability in anchorage-dependent cells. Published by Elsevier Ltd.
C1 [Lee, Jiyeon; Kang, B. S.; Hicks, Barrett; Chancellor, Thomas F., Jr.; Chu, Byung Hwan; Wang, Hung-Ta; Ren, F.; Lele, Tanmay P.] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.
   [Keselowsky, Benjamin G.] Univ Florida, Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP Lele, TP (reprint author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.
EM tlele@che.ufl.edu
RI Keselowsky, Benjamin/A-8000-2009
CR Al-Hilli SM, 2007, J APPL PHYS, V102, DOI 10.1063/1.2798582
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   Dalby M J, 2005, Eur Cell Mater, V9, P1
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Dorfman A, 2006, LANGMUIR, V22, P4890, DOI 10.1021/la053270+
   Dorfman A, 2006, ADV MATER, V18, P2685, DOI 10.1002/adma.200502616
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Garibaldi S, 2006, NANOTECHNOLOGY, V17, P391, DOI 10.1088/0957-4484/17/2/008
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Girard PP, 2007, SOFT MATTER, V3, P307, DOI 10.1039/b614008d
   Gojova A, 2007, ENVIRON HEALTH PERSP, V115, P403, DOI 10.1289/ehp.8497
   Graeter SV, 2007, NANO LETT, V7, P1413, DOI 10.1021/nl070098g
   Greene LE, 2003, ANGEW CHEM INT EDIT, V42, P3031, DOI 10.1002/anie.200351461
   He W, 2008, BIOMEDICAL NANOSTRUCTURES, P25
   Kang BS, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1883330
   KANG BS, 2007, APPL PHYS LETT, V90
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k
   Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Michikawa M, 1998, J NEUROSCI RES, V54, P58, DOI 10.1002/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G
   Pacholski C, 2002, ANGEW CHEM INT EDIT, V41, P1188, DOI 10.1002/1521-3773(20020402)41:7<1188::AID-ANIE1188>3.0.CO;2-5
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Pearton SJ, 2007, TRENDS BIOTECHNOL, V25, P481, DOI 10.1016/j.tibtech.2007.07.011
   RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537
   Spatz JP, 2007, METHOD CELL BIOL, V83, P89, DOI 10.1016/S0091-679X(07)83005-6
   Sun XW, 1999, J APPL PHYS, V86, P408, DOI 10.1063/1.370744
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   XIA N, 2008, FASEB J
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365
NR 43
TC 124
Z9 125
U1 2
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2008
VL 29
IS 27
BP 3743
EP 3749
DI 10.1016/j.biomaterials.2008.05.029
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 337MD
UT WOS:000258439300015
PM 18550161
DA 2018-10-20
ER

PT J
AU Dreesmann, L
   Hajosch, R
   Ahlers, M
   Nuernberger, JV
   Schlosshauer, B
AF Dreesmann, L.
   Hajosch, R.
   Ahlers, M.
   Nuernberger, J. Vaz
   Schlosshauer, B.
TI Permeability testing of biomaterial membranes
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID ENCAPSULATED XENOGENEIC MYOBLASTS; ENDOTHELIAL GROWTH-FACTOR; IN-VITRO
   CHARACTERIZATION; BLOOD-RETINA BARRIER; EPITHELIAL-CELLS; CHROMAFFIN
   CELLS; MODEL; COLLAGEN; REGENERATION; DELIVERY
AB The permeability characteristics of biomaterials are critical parameters for a variety of implants. To analyse the permeability of membranes made from crosslinked ultrathin gelatin membranes and the transmigration of cells across the membranes, we combined three technical approaches: (1) a two-chamber-based permeability assay, (2) cell culturing with cytochemical analysis and (3) biochemical enzyme electrophoresis (zymography). Based on the diffusion of a coloured marker molecule in conjunction with photometric quantification, permeability data for a gelatin membrane were determined in the presence or absence of gelatin degrading fibroblasts. Cytochemical evaluation after cryosectioning of the membranes was used to ascertain whether fibroblasts had infiltrated the membrane inside. Zymography was used to investigate the potential release of proteases from fibroblasts, which are known to degrade collagen derivatives such as gelatin. Our data show that the diffusion equilibrium of a low molecular weight dye across the selected gelatin membrane is approached after about 6-8 h. Fibroblasts increase the permeability due to cavity formation in the membrane inside without penetrating the membrane for an extended time period (> 21 days in vitro). Zymography indicates that cavity formation is most likely due to the secretion of matrix metalloproteinases. In summary, the combination of the depicted methods promises to facilitate a more rational development of biomaterials, because it provides a rapid means of determining permeability characteristics and bridges the gap between descriptive methodology and the mechanistic understanding of permeability alterations due to biological degradation.
C1 [Dreesmann, L.; Hajosch, R.; Nuernberger, J. Vaz; Schlosshauer, B.] Univ Tubingen, NMI Nat & Med Sci Inst, D-72770 Reutlingen, Germany.
   [Ahlers, M.] GELITA AG, D-69412 Eberbach, Germany.
RP Schlosshauer, B (reprint author), Univ Tubingen, NMI Nat & Med Sci Inst, Markwiesenstr 55, D-72770 Reutlingen, Germany.
EM schlosshauer@nmi.de
CR Atkins S, 2006, NEUROREPORT, V17, P1245, DOI 10.1097/01.wnr.0000230519.39456.ea
   Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0
   Bitterle E, 2006, CHEMOSPHERE, V65, P1784, DOI 10.1016/j.chemosphere.2006.04.035
   Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Gabriel D, 2007, BIOCONJUGATE CHEM, V18, P1070, DOI 10.1021/bc060321l
   Giraudier S, 2004, BIOMACROMOLECULES, V5, P1662, DOI 10.1021/bm049670d
   Hillaireau H, 2007, INT J PHARM, V331, P148, DOI 10.1016/j.ijpharm.2006.10.031
   JOSEPH JM, 1994, CELL TRANSPLANT, V3, P355, DOI 10.1177/096368979400300502
   Kim IY, 2007, J BIOCHEM MOL BIOL, V40, P825
   Krzeski P, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2315
   Lalonde RL, 2007, CLIN PHARMACOL THER, V82, P21, DOI 10.1038/sj.clpt.6100235
   Li Yaqing, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P647, DOI 10.1007/s11596-006-0604-6
   LIETZ M, 2006, J BIOTECH BIOENG, V5, P99
   Lindvall O, 2008, EXP NEUROL, V209, P82, DOI 10.1016/j.expneurol.2007.08.019
   Liu YC, 2005, BIOMATERIALS, V26, P4737, DOI 10.1016/j.biomaterials.2005.01.003
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Minuth WW, 2007, BIOMED MATER, V2, pR1, DOI [10.1088/1748-6041/2/2/R01, 10.1088/1748-6041/2/R01]
   Minuth WW, 2005, BIO-MED MATER ENG, V15, P51
   Murua A, 2007, BIOMACROMOLECULES, V8, P3302, DOI 10.1021/bm070194b
   Norton LW, 2005, BIOMATERIALS, V26, P3285, DOI 10.1016/j.biomaterials.2004.07.069
   Ozgenel GY, 2003, MICROSURG, V23, P575, DOI 10.1002/micr.10209
   Peduto G, 2000, TRANSPLANTATION, V70, P78
   Rinsch C, 2002, KIDNEY INT, V62, P1395, DOI 10.1111/j.1523-1755.2002.kid574.x
   Rinsch C, 2001, GENE THER, V8, P523, DOI 10.1038/sj.gt.3301436
   Rinsch C, 2001, TRANSPLANTATION, V71, P345, DOI 10.1097/00007890-200102150-00002
   Rutkowski GE, 2002, BIOTECHNOL PROGR, V18, P362, DOI 10.1021/bp020300f
   SAGEN J, 1993, J NEUROSCI, V13, P2415
   SCHLOSSHAUER B, 2004, ENCY BIOMATERIALS BI, P1043
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Schmidt PG, 2007, EXPERT OPIN BIOL TH, V7, P1427, DOI 10.1517/14712598.7.9.1427
   Steuer H, 2005, INVEST OPHTH VIS SCI, V46, P1047, DOI 10.1167/iovs.04-0925
   Steuer H, 2004, BRAIN RES PROTOC, V13, P26, DOI 10.1016/j.brainresprot.2003.12.002
   STIER H, 1995, DEVELOPMENT, V121, P1443
   Tan Q, 2007, EUR J CARDIO-THORAC, V31, P806, DOI 10.1016/j.ejcts.2007.01.045
   Tchetina EV, 2007, MATRIX BIOL, V26, P247, DOI 10.1016/j.matbio.2007.01.006
   Vessillier S, 2004, PROTEIN ENG DES SEL, V17, P829, DOI 10.1093/protein/gzh097
   Ye SH, 2004, J BIOMAT SCI-POLYM E, V15, P981, DOI 10.1163/1568562041526450
   Zurn AD, 2000, CELL TRANSPLANT, V9, P471, DOI 10.1177/096368970000900404
NR 39
TC 10
Z9 10
U1 0
U2 3
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2008
VL 3
IS 3
AR 034119
DI 10.1088/1748-6041/3/3/034119
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 344HC
UT WOS:000258916500032
PM 18708701
DA 2018-10-20
ER

PT J
AU Fleckman, P
   Olerud, JE
AF Fleckman, P.
   Olerud, J. E.
TI Models for the histologic study of the skin interface with percutaneous
   biomaterials
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID BLOOD-STREAM INFECTION; SURFACE-TOPOGRAPHY; CONNECTIVE-TISSUE; KNOCKOUT
   MICE; TERM DEVICES; IMPLANTS; PREVENTION; ATTACHMENT; TECHNOLOGY;
   PROMISE
AB Percutaneous devices are critical for health care. Access to tissue, vessels and internal organs afforded by these devices provides the means to treat and monitor many diseases. Unfortunately, such access is not restricted, and infection may compromise the usefulness of the device and even the life of the patient. New biomaterials offer the possibility of maintaining internal access while limiting microbial access, but understanding of the cutaneous/biomaterial interface and models to study this area are limited. This paper focuses on models useful for studying the morphology and biology of the intersection of skin and percutaneous biomaterials. An organ culture and a mouse model are described that offer promising possibilities for improved understanding of this critical interface.
C1 [Fleckman, P.; Olerud, J. E.] Univ Washington, Div Dermatol, Sch Med, Seattle, WA 98195 USA.
RP Fleckman, P (reprint author), Univ Washington, Div Dermatol, Sch Med, HSB BB1353,Box 356524, Seattle, WA 98195 USA.
EM fleck@u.washington.edu
FU NSF [EEC 9529161]; NIH [DK 59221]; USPHS NIBIB [1R01 EB004422-03];
   Warren G Magnuson Research Grant; George F Odland Endowed Research Fund;
   Marvin and Judy Young Research Fund
FX This work was supported by NSF EEC 9529161, NIH DK 59221, USPHS NIBIB
   1R01 EB004422-03, the Warren G Magnuson Research Grant, the George F
   Odland Endowed Research Fund and the Marvin and Judy Young Research
   Fund. Special thanks to Marcia Usui for figures.
CR Bockamp E, 2002, PHYSIOL GENOMICS, V11, P115, DOI 10.1152/physiolgenomics.00067.2002
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   Crnich CJ, 2002, CLIN INFECT DIS, V34, P1232, DOI 10.1086/339863
   Crnich CJ, 2002, CLIN INFECT DIS, V34, P1362, DOI 10.1086/340105
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   GANGJEE T, 1985, ANN BIOMED ENG, V13, P451, DOI 10.1007/BF02407772
   Gerritsen M., 2000, Journal of Biomedical Materials Research, V52, P135, DOI 10.1002/1097-4636(200010)52:1<135::AID-JBM17>3.0.CO;2-I
   Grose R, 2004, MOL BIOTECHNOL, V28, P147, DOI 10.1385/MB:28:2:147
   Heaney TG, 1996, J BIOMED MATER RES, V32, P593, DOI 10.1002/(SICI)1097-4636(199612)32:4<593::AID-JBM12>3.0.CO;2-F
   Isenhath SN, 2007, J BIOMED MATER RES A, V83A, P915, DOI 10.1002/jbm.a.31391
   Jansen J A, 1989, J Invest Surg, V2, P29, DOI 10.3109/08941938909016502
   Jansen J A, 1994, J Invest Surg, V7, P123, DOI 10.3109/08941939409015356
   JANSEN JA, 1988, BIOMATERIALS, V9, P268, DOI 10.1016/0142-9612(88)90096-8
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P1535, DOI 10.1002/jbm.820251210
   Kim H, 2006, INT J ORAL MAX IMPL, V21, P354
   Knabe C, 1999, BIOMATERIALS, V20, P503, DOI 10.1016/S0142-9612(98)00195-1
   Knowles NG, 2005, J BIOMED MATER RES A, V74A, P482, DOI 10.1002/jbm.a.30384
   Lundgren D, 1989, J Invest Surg, V2, P17, DOI 10.3109/08941938909016501
   MARSHALL AJ, 2004, POLYM PREPRINTS, V45, P100
   Mermel LA, 2000, ANN INTERN MED, V133, P395
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   MERMEL LA, 1991, AM J MED S3B, V91, P197
   O'Grady Naomi P, 2002, MMWR Recomm Rep, V51, P1
   OKADA T, 1995, J BIOMAT SCI-POLYM E, V7, P171, DOI 10.1163/156856295X00689
   Raad Issam, 1993, Journal of Infectious Diseases, V168, P400
   Reid RR, 2004, J AM COLL SURGEONS, V199, P578, DOI 10.1016/j.jamcollsurg.2004.05.262
   Shin Y, 1997, ARTIF ORGANS, V21, P995
   SQUIER CA, 1981, J PERIODONTAL RES, V16, P434, DOI 10.1111/j.1600-0765.1981.tb00994.x
   TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   VONRECUM AF, 1981, CRC CR REV BIOM ENG, V5, P37
   Walboomers XF, 2005, J BIOMED MATER RES A, V74A, P381, DOI 10.1002/jbm.a.30337
   Weber H P, 1992, Alpha Omegan, V85, P61
   WINTER GD, 1974, J BIOMED MATER RES, V8, P99, DOI 10.1002/jbm.820080311
NR 34
TC 15
Z9 15
U1 0
U2 6
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2008
VL 3
IS 3
AR 034006
DI 10.1088/1748-6041/3/3/034006
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 344HC
UT WOS:000258916500008
PM 18708704
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Fonner, JM
   Forciniti, L
   Nguyen, H
   Byrne, JD
   Kou, YF
   Syeda-Nawaz, J
   Schmidt, CE
AF Fonner, John M.
   Forciniti, Leandro
   Nguyen, Hieu
   Byrne, James D.
   Kou, Yann-Fuu
   Syeda-Nawaz, Jeja
   Schmidt, Christine E.
TI Biocompatibility implications of polypyrrole synthesis techniques
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID PROTEIN ADSORPTION; IN-SITU; MECHANICAL-PROPERTIES; CONDUCTING POLYMERS;
   AQUEOUS-SOLUTIONS; FILMS; MORPHOLOGY; GUIDANCE; ELECTROPOLYMERIZATION;
   FIBRONECTIN
AB Polypyrrole (PPy) is an inherently conducting polymer that has shown great promise for biomedical applications within the nervous system. However, to effectively use PPy as a biomaterial implant, it is important to understand and reproducibly control the electrical properties, physical topography and surface chemistry of the polymer. Although there is much research published on the use of PPy in various applications, there is no systematic study linking the methodologies used for PPy synthesis to PPy's basic polymeric properties ( e. g., hydrophilicity, surface roughness), and to the biological effects these properties have on cells. Electrochemically synthesized PPy films differ greatly in their characteristics depending on synthesis parameters such as dopant, substrate and thickness, among other parameters. In these studies, we have used three dopants (chloride (Cl), tosylate (ToS), polystyrene sulfonate (PSS)), two substrates ( gold and indium tin oxide-coated glass), and a range of thicknesses, to measure and compare the biomedically important characteristics of surface roughness, contact angle, conductivity, dopant stability and cell adhesion (using PC-12 cells and Schwann cells). As predicted, we discovered large differences in roughness depending on the dopant used and the thickness of the film, while substrate choice had little effect. From contact angle measurements, PSS was found to yield the most hydrophilic material, most likely because of free charges from the long PSS chains exposed on the surface of the PPy. ToS-doped PPy films were tenfold more conductive than Cl-or PSS-doped films. X-ray photoelectron spectroscopy studies were used to evaluate dopant concentrations of PPy films stored in water and phosphate buffered saline over 14 days, and conductance studies over the same timeframe measured electrical stability. PSS proved to be the most stable dopant, though all films experienced significant decay in conductivity and dopant concentration. Cell adhesion studies demonstrated the dependence of cell outcome on film thickness and dopant choice. The strengths and weaknesses of different synthesis parameters, as demonstrated by these experiments, are critical design factors that must be leveraged when designing biomedical implants. The results of these studies should provide practical insight to researchers working with conducting polymers, and particularly PPy, on the relationships between synthesis parameters, polymeric properties and biological compatibility.
C1 [Fonner, John M.; Nguyen, Hieu; Byrne, James D.; Kou, Yann-Fuu; Syeda-Nawaz, Jeja; Schmidt, Christine E.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
   [Forciniti, Leandro; Schmidt, Christine E.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.
RP Schmidt, CE (reprint author), Univ Texas Austin, Dept Biomed Engn, 1 Univ Stn,MC C0800, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
OI Nguyen, Hieu/0000-0002-0680-2720
FU National Institutes of Health [R01 EB004529]
FX The authors would like to thank Dr Yangming Sun and Nathalie Guimard for
   their assistance with XPS, and the Center for Nano & Molecular Science &
   Technology for the use of their facilities. This study was financially
   supported by the National Institutes of Health (R01 EB004529).
CR BAILEY SB, 1993, J NEUROCYTOL, V22, P176, DOI 10.1007/BF01246356
   Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2
   BOLTO BA, 1963, AUST J CHEM, V16, P1090, DOI 10.1071/CH9631090
   BRAY D, 1988, ANNU REV CELL BIOL, V4, P43, DOI 10.1146/annurev.cellbio.4.1.43
   Bufon CCB, 2005, J PHYS CHEM B, V109, P19191, DOI 10.1021/jp053516j
   Cai KY, 2006, COLLOID SURFACE B, V50, P1, DOI 10.1016/j.colsurfb.2006.03.016
   Carquigny S, 2008, SYNTHETIC MET, V158, P453, DOI 10.1016/j.synthmet.2008.03.010
   Chainet E, 1998, J ELECTROANAL CHEM, V451, P273
   Chehimi MM, 2004, SYNTHETIC MET, V145, P15, DOI 10.1016/j.synthmet.2004.03.015
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   DIAZ A, 1981, CHEM SCRIPTA, V17, P145
   Diaz A. F., 1982, EXTENDED LINEAR CHAI, V3, P417
   DIAZ AF, 1983, IBM J RES DEV, V27, P342, DOI 10.1147/rd.274.0342
   Dowell-Mesfin NM, 2004, J NEURAL ENG, V1, P78, DOI 10.1088/1741-2560/1/2/003
   EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223
   George PM, 2006, ADV MATER, V18, P577, DOI 10.1002/adma.200501242
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hodgson AJ, 1996, PROC SPIE, V2716, P164, DOI 10.1117/12.232137
   Kang E. T., 1997, HDB ORGANIC CONDUCTI, P121
   Kaynak A, 1997, MATER RES BULL, V32, P271, DOI 10.1016/S0025-5408(96)00200-0
   Khorasani MT, 2006, COLLOID SURFACE B, V51, P112, DOI 10.1016/j.colsurfb.2006.06.002
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   KUHN HH, 1995, SYNTHETIC MET, V71, P2139, DOI 10.1016/0379-6779(94)03198-F
   Mabrouk PA, 2005, SYNTHETIC MET, V150, P101, DOI 10.1016/j.synthmet.2005.01.011
   MADDISON DS, 1989, SYNTHETIC MET, V30, P47, DOI 10.1016/0379-6779(89)90640-1
   Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646
   Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3
   MORENO JS, 2007, BIOELECTROCHEMISTRY, V72, P3
   PINI A, 1994, CURR BIOL, V4, P131, DOI 10.1016/S0960-9822(94)00029-1
   Sadki S, 2000, CHEM SOC REV, V29, P283
   SCHMEISSER D, 1993, SYNTHETIC MET, V59, P211, DOI 10.1016/0379-6779(93)91028-Z
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SKOTHEIM TA, 1986, HDB CONDUCTING POLYM, V2, P3510
   STANKOVIC R, 1994, EUR POLYM J, V30, P385, DOI 10.1016/0014-3057(94)90303-4
   Suarez MF, 1999, J ELECTROANAL CHEM, V462, P211, DOI 10.1016/S0022-0728(98)00414-8
   Vernitskaya TV, 1997, RUSS CHEM REV, V66, P443, DOI DOI 10.1070/RC1997V066N05ABEH000261
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   WYNNE KJ, 1985, MACROMOLECULES, V18, P2361, DOI 10.1021/ma00154a005
   YEKTAFARD M, 1992, J ADHES SCI TECHNOL, V6, P253, DOI 10.1163/156856192X00322
   Yuan YJ, 1999, EUR POLYM J, V35, P1761, DOI 10.1016/S0014-3057(98)00268-7
NR 44
TC 86
Z9 88
U1 0
U2 34
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2008
VL 3
IS 3
AR 034124
DI 10.1088/1748-6041/3/3/034124
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 344HC
UT WOS:000258916500037
PM 18765899
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Pavithra, D
   Doble, M
AF Pavithra, D.
   Doble, Mukesh
TI Biofilm formation, bacterial adhesion and host response on polymeric
   implants - issues and prevention
SO BIOMEDICAL MATERIALS
LA English
DT Review
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   MEDICAL DEVICES; IN-VITRO; STREPTOCOCCUS-PNEUMONIAE; SURFACE
   MODIFICATION; BIOMATERIAL RESEARCH; BLOOD COMPATIBILITY; PROTEIN
   ADSORPTION; CELL-ADHESION
AB Several polymeric materials find application in biomedical implants and devices due to their superior physicochemical properties. The main requirement for these polymers is that they should be biocompatible, which means they prevent bacterial adhesion and are blood compatible. Many parameters contribute to the degree of biocompatibility. This paper discusses the mechanism of the formation of biofilms and lists the factors that influence the bacterial adhesion and haemocompatibility. Polymer surfaces are also modified to enhance adsorption of host cells. The physical, chemical and biological techniques are meant to modify the surface of the biomaterial but at the same time retain the key properties. The various polymer treatment processes have advantages and disadvantages and a few techniques have been proved to be both highly effective at treatment and found suitable for various in vivo environments. The current research focus pertaining to smart materials, biodegradable polymers, combinatorial chemistry, computational modelling and newer analytical techniques to understand polymer-cell interaction holds promise in designing better, cost effective and biocompatible polymers.
C1 [Pavithra, D.; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
RP Pavithra, D (reprint author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
EM mukeshd@iitm.ac.in
OI Doble, Mukeshd/0000-0002-4335-0698
CR Allegrucci M, 2006, J BACTERIOL, V188, P2325, DOI 10.1128/JB.188.7.2325-2335.2006
   ANDERSON JM, 1935, CARDIOVASC PATHOL, V2, P335
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V3, P335
   BAMFORD C H, 1992, Clinical Materials, V10, P243, DOI 10.1016/0267-6605(92)90018-O
   Baquey C, 1999, NUCL INSTRUM METH B, V151, P255, DOI 10.1016/S0168-583X(99)00106-8
   Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06
   Baumgartner JN, 1997, BIOMATERIALS, V18, P831, DOI 10.1016/S0142-9612(96)00197-4
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BORCIA G, 2005, ROM J BIOPHYS, V15, P147
   BORRIELLO G, 2006, ANTIMICROB AGENTS CH, V3, P82
   Burmeister JS, 1998, BIOMATERIALS, V19, P307, DOI 10.1016/S0142-9612(97)00109-9
   BUSSCHER HJ, 1991, CELLS MAT, V1, P234
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   CERCA N, 2005, APPL ENVIRON MICROB, V86, P77
   Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010
   Cho SH, 2002, INT J ANTIMICROB AG, V19, P570, DOI 10.1016/S0924-8579(02)00101-2
   Chokr A, 2006, INT J MED MICROBIOL, V296, P381, DOI 10.1016/j.ijmm.2006.02.018
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Compan V, 2004, BIOMATERIALS, V25, P359, DOI 10.1016/S0142-9612(03)00527-1
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Duan XB, 2002, BIOMATERIALS, V23, P1197, DOI 10.1016/S0142-9612(01)00234-4
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   FREITAS RA, 2003, NANOMEDICINE A, V2, P3510
   Gan BS, 2002, J INFECT DIS, V185, P1369, DOI 10.1086/340126
   Giacometti A, 2003, ANTIMICROB AGENTS CH, V47, P1979, DOI 10.1128/AAC.47.6.1979-1983.2003
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Heath DJ, 2002, BIOMATERIALS, V23, P1519, DOI 10.1016/S0142-9612(01)00282-4
   HOFFMAN A S, 1991, Clinical Materials, V8, P3, DOI 10.1016/0267-6605(91)90003-X
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   HOWARD J, 2004, Patent No. 6727223
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004
   Jagielski J, 2006, SURF COAT TECH, V200, P6355, DOI 10.1016/j.surfcoat.2005.11.005
   Jarry C, 2001, J BIOMED MATER RES, V58, P127, DOI 10.1002/1097-4636(2001)58:1<127::AID-JBM190>3.0.CO;2-G
   Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005
   Johnston EE, 1996, J ELECTRON SPECTROSC, V81, P303, DOI 10.1016/0368-2048(95)02666-5
   Kanamaru S, 2006, INT J ANTIMICROB AG, V28, pS21, DOI 10.1016/j.ijantimicag.2006.05.006
   Kato S, 2000, BIOMATERIALS, V21, P521, DOI 10.1016/S0142-9612(99)00214-8
   Katsaros D, 2004, IEEE INTERNET COMPUT, V8, P37, DOI 10.1109/MIC.2004.1297272
   Kayirhan N, 2001, J APPL POLYM SCI, V81, P1322, DOI 10.1002/app.1557
   Kesler DJ, 1999, J VET MED B, V46, P25, DOI 10.1046/j.1439-0450.1999.00194.x
   Keuren JFW, 2003, BIOMATERIALS, V24, P1917, DOI 10.1016/S0142-9612(02)00620-8
   Khoury A E, 1992, ASAIO J, V38, pM174, DOI 10.1097/00002480-199207000-00013
   Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042
   Koromila G, 2006, BIOMATERIALS, V27, P2525, DOI 10.1016/j.biomaterials.2005.11.017
   Kruft MAB, 1997, BIOMATERIALS, V18, P31, DOI 10.1016/S0142-9612(96)00085-3
   LAMBA NMK, 1998, POLYURETHANES BIOMED, P3510
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006
   Locatelli CI, 2003, BRAZ J MICROBIOL, V34, P203, DOI 10.1590/S1517-83822003000300004
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06
   Nakano K, 2005, MICROBES INFECT, V7, P1246, DOI 10.1016/j.micinf.2005.04.012
   NGUYEN NT, 2006, NANOTECHNOLOGY, V4, P93
   Noh JH, 2007, SURF COAT TECH, V201, P5097, DOI 10.1016/j.surfcoat.2006.07.223
   OJENIJI B, 1991, CHEMOTHERAPY, V44, P13
   Oleschuk RD, 2000, BIOMATERIALS, V21, P1701, DOI 10.1016/S0142-9612(00)00054-5
   Padera RF, 2006, CARDIOVASC PATHOL, V15, P264, DOI 10.1016/j.carpath.2006.04.008
   Park K, 1998, BIOMATERIALS, V19, P387, DOI 10.1016/S0142-9612(97)00111-7
   Plowman TE, 1998, BIOMATERIALS, V19, P341, DOI 10.1016/S0142-9612(97)00113-0
   Poussard L, 2004, BIOMATERIALS, V25, P3473, DOI 10.1016/j.biomaterials.2003.10.069
   Rana N. S. S., 2001, J ELECT SPECTROSC RE, V121, P249
   Rather B.D., 1992, CLIN MAT, V11, P25
   REMICK DG, 1997, CYTOKINES HLTH DIS, P299
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Ruzicka F, 2007, J MICROBIOL METH, V68, P530, DOI 10.1016/j.mimet.2006.10.008
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SCHAKENRAAD JM, 1989, COLLOID SURFACE, V42, P331
   SCHMIDMAIER G, 2007, INJURY, V37, pS105
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   SHALABY WS, 1995, BIOMATERIALS, V16, P1117
   Shangguan YY, 2006, BIOMATERIALS, V27, P2349, DOI 10.1016/j.biomaterials.2005.11.024
   Siedlecki CA, 1998, BIOMATERIALS, V19, P441, DOI 10.1016/S0142-9612(97)00222-6
   Simmons WL, 2007, J BACTERIOL, V189, P1905, DOI 10.1128/JB.01512-06
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   Sodhi RNS, 1996, J ELECTRON SPECTROSC, V81, P269, DOI 10.1016/0368-2048(95)02665-7
   Song B, 2006, MICROBIOL RES, V161, P355, DOI 10.1016/j.micres.2006.01.004
   Sun YC, 2004, ADV DRUG DELIVER REV, V56, P1481, DOI 10.1016/j.addr.2004.02.009
   SUNIKET VF, 2007, J PHARM SCI, V96, P132
   Suzuki Y, 2003, NUCL INSTRUM METH B, V206, P501, DOI 10.1016/S0168-583X(03)00808-5
   SZYCHER M, 2004, BIOMATERIALS PROSTHE, V3, P707
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   Tenke P, 2004, EUA UPDATE SERIES, P106
   TOOMEY R, 2003, EUR CELLS MATER, V6, P24
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Uyama H, 2003, BIOMACROMOLECULES, V4, P211, DOI 10.1021/bm0256092
   Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005
   van Merode AEJ, 2006, J BACTERIOL, V188, P2421, DOI 10.1128/JB.188.7.2421-2426.2006
   VOGLER EA, 1989, COLLOID SURFACE, V42, P233
   Zhang S, 2006, THIN SOLID FILMS, V515, P66, DOI 10.1016/j.tsf.2005.12.037
   Ziats N. P, 1998, BIOMATERIALS, V9, P5
   Zlatanic A, 2004, J POLYM SCI POL PHYS, V42, P809, DOI 10.1002/polb.10737
NR 103
TC 126
Z9 129
U1 3
U2 85
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2008
VL 3
IS 3
AR 034003
DI 10.1088/1748-6041/3/3/034003
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 344HC
UT WOS:000258916500005
PM 18689922
DA 2018-10-20
ER

PT J
AU Yamamichi, N
   Pugdee, K
   Chang, WJ
   Lee, SY
   Yoshinari, M
   Hayakawa, T
   Abiko, Y
AF Yamamichi, Nobuyuki
   Pugdee, Kamolparn
   Chang, Wei-Jen
   Lee, Sheng-Yang
   Yoshinari, Masao
   Hayakawa, Tohru
   Abiko, Yoshimitsu
TI Gene expression monitoring in osteoblasts on titanium coated with
   fibronectin-derived peptide
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Osteoblast; RGD peptide; GeneChip
ID BONE-FORMATION; CELLS; DIFFERENTIATION; ACTIVATION; IMPLANTS; SURFACES
AB Enhanced adhesion and migration of osteoblastic cells on titanium (Ti) surface is believed to increase the success rate of implant therapy. A GRGDSP peptide derived from fibronectin was coated on Ti surfaces using a tresyl chloride activation technique, and then MC3T3-E1 osteoblastic cells were cultured on the Ti surfaces. After 15 days, total RNA was isolated from the cells and gene expression level were analyzed by Affymetrix GeneChip system. The expression levels of many genes in MC3T3-E1 cells cultured on GRGDSP-coated Ti surface were altered when compared to uncoated Ti. In particular, the elevated mRNA levels of bone sialoprotein (BSP) and osteocalcin (OC) were successfully confirmed by reverse transcription-polymerase chain reaction (RT-PCR) and real-time PCR. In light of the results obtained, GRGDSP-coated Ti presented the potential of evolving into a useful biomaterial for successful implant therapy.
C1 [Hayakawa, Tohru] Nihon Univ, Sch Dent Matsuda, Dept Dent Biomat, Chiba, Japan.
   [Yamamichi, Nobuyuki; Pugdee, Kamolparn; Abiko, Yoshimitsu] Nihon Univ, Sch Dent Matsuda, Dept Biochem & Mol Biol, Chiba, Japan.
   [Chang, Wei-Jen; Lee, Sheng-Yang] Taipei Med Univ, Sch Dent, Taipei, Taiwan.
   [Yoshinari, Masao] Tokyo Dent Coll, Oral Hlth Sci Ctr, Div Oral Implants Res, Mihama Ku, Chiba 2618502, Japan.
   [Hayakawa, Tohru; Abiko, Yoshimitsu] Nihon Univ, Sch Dent Matsuda, Res Inst Oral Sci, Chiba, Japan.
RP Hayakawa, T (reprint author), Nihon Univ, Sch Dent Matsuda, Dept Dent Biomat, 2-870-1 Sakaecho Nishi, Chiba, Japan.
EM hayakawa.tohru@nihon-u.ac.jp; abiko.yoshimitsu@nihon-u.ac.jp
FU Japan Society for the Promotion of Science [A1-16209063, C-19592260];
   Ministry of Education, Culture, Sports, Science and Technology
FX This work was supported by a Grant-in-aid for Scientific Research
   (A1-16209063 and C-19592260) from the Japan Society for the Promotion of
   Science and by the "Academic Frontier" Project for Private Universities:
   matching fund subsidy from the Ministry of Education, Culture, Sports,
   Science and Technology, 2007-2011.
CR Abiko Y, 2007, INT J ORAL MED SCI, V6, P97
   Bugel S, 2003, P NUTR SOC, V62, P839, DOI 10.1079/PNS2003305
   DEAN JW, 1995, J ORAL MAXILLOFAC IM, V10, P721
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Gauss B, 1999, CRIT REV ORAL BIOL M, V10, P79
   Hayakawa T, 2003, J BIOMED MATER RES A, V67A, P684, DOI 10.1002/jbm.a.10143
   Hilbig H, 2007, EUR J MED RES, V12, P6
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Pugdee K, 2007, DENT MATER J, V26, P647, DOI 10.4012/dmj.26.647
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Zreiqat H, 2003, J BIOMED MATER RES A, V64A, P105, DOI 10.1002/jbm.a.10376
NR 14
TC 30
Z9 30
U1 2
U2 4
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD SEP
PY 2008
VL 27
IS 5
BP 744
EP 750
DI 10.4012/dmj.27.744
PG 7
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 375US
UT WOS:000261139700015
PM 18972793
OA Bronze
DA 2018-10-20
ER

PT J
AU Kang, SB
   Lee, HN
   Lee, JY
   Park, JS
   Lee, HS
   Lee, JY
AF Kang, Sung-Bum
   Lee, Haet Nim
   Lee, Ji Young
   Park, Jun-Seok
   Lee, Hye Seung
   Lee, Ji Youl
TI Sphincter contractility after muscle-derived stem cells autograft into
   the cryoinjured anal sphincters of rats
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article; Proceedings Paper
CT Conference of the
   Tissue-Engineering-and-Regenerative-Medicine-International-Society
   (TERMIS-EU)
CY SEP 04-07, 2007
CL London, ENGLAND
SP Tissue Engn & Regenerat Med Int Soc, European Chapter, UK Tissue & Cell Engn Soc
DE fecal incontinence; muscle-derived stem cell; anal sphincter; rat;
   cryoinjury; contractility
ID STRESS URINARY-INCONTINENCE; INJECTABLE SILICONE BIOMATERIAL; LEAK POINT
   PRESSURE; FECAL INCONTINENCE; GENE-THERAPY; INJECTION; MODEL;
   DYSFUNCTION; DIFFERENTIATION; TRANSPLANTATION
AB PURPOSE: This study was designed to determine whether the injection of muscle-derived stem cells into the anal sphincter can improve functional properties in a fecal incontinence rat model.
   METHODS: Cryoinjured rats were utilized as a fecal incontinence model. The gastrocnemius muscles of normal three-week-old female Sprague-Dawley rats were used for the purification of the muscle-derived stem cells. The experimental group was divided into three subgroups: normal control; cryoinjured; and muscle-derived stem cells (3x10(6) cells) injection group of cryoinjured rats. All groups were subsequently employed in contractility experiments using muscle strips from the anal sphincter, one week after preparation.
   RESULTS: Contractility in the cryoinjured group was significantly lower than in the control after treatment with acetylcholine and KCl. In the muscle-derived stem cells injection group, contraction amplitude was higher than in the cryoinjured group but not significantly (20.5 +/- 21.3 vs. 17.3 +/- 3.4 g per gram tissue, with acetylcholine (10(-4) mol/l); 31 +/- 14.2 vs. 18.4 +/- 7.9 g per gram tissue, with KCl (10(-4) mol/l)). PKH-26-labeled transplanted cells were detected in all of the grafted sphincters. Differentiated muscle masses stained positively for alpha smooth muscle actin and myosin heavy chain at the muscle-derived stem cells injection sites.
   CONCLUSIONS: This is the first study reporting that autologous muscle-derived stem cell grafts may be a tool for improving anal sphincter function.
C1 [Lee, Haet Nim; Lee, Ji Young; Lee, Ji Youl] Catholic Univ Korea, Dept Urol, Coll Med, Holy Family Hosp, Bucheon Si 420717, Gyonggi Do, South Korea.
   [Kang, Sung-Bum; Park, Jun-Seok] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, Gyonggi Do, South Korea.
   [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, Gyonggi Do, South Korea.
RP Lee, JY (reprint author), Catholic Univ Korea, Dept Urol, Coll Med, Holy Family Hosp, 2 Sosa Dong, Bucheon Si 420717, Gyonggi Do, South Korea.
EM uroljy@catholic.ac.kr
RI Kang, Sung-Bum/J-5361-2012; Seoul National University,
   Pathology/B-6702-2012; Lee, Hye Seung/G-6419-2011
OI Lee, Hye Seung/0000-0002-1667-7986
CR ALAMEDDINE HS, 1994, CELL TRANSPLANT, V3, P3
   Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6
   Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221
   Cannon TW, 2003, UROLOGY, V62, P958, DOI 10.1016/S0090-4295(03)00679-4
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Chermansky CJ, 2004, UROLOGY, V63, P780, DOI 10.1016/j.urology.2003.10.035
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Emans PJ, 2005, J BIOMED MATER RES A, V73A, P430, DOI 10.1002/jbm.a.30293
   Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-0052-6
   Garcia-Olmo D, 2003, INT J COLORECTAL DIS, V18, P451, DOI 10.1007/s00384-003-0490-3
   Guettier-Sigrist S, 2000, EXP CELL RES, V259, P204, DOI 10.1006/excr.2000.4968
   Gulbins H, 2003, THORAC CARDIOV SURG, V51, P295
   Hagege AA, 2003, LANCET, V361, P491, DOI 10.1016/S0140-6736(03)12458-0
   Huard J, 2002, GENE THER, V9, P1617, DOI 10.1038/sj.gt.3301816
   Hwang JH, 2004, MOL CELLS, V17, P57
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044
   Kumar D, 1998, BRIT J SURG, V85, P978
   Kwon D, 2006, UROLOGY, V68, P449, DOI 10.1016/j.urology.2006.03.040
   Lee JY, 2003, INT UROGYNECOL J, V14, P31, DOI 10.1007/s00192-002-1004-5
   Lee JY, 2004, MOL CELLS, V18, P309
   Macmillan AK, 2004, DIS COLON RECTUM, V47, P1341, DOI 10.1007/s10350-004-0593-0
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Pannek J, 2001, J UROLOGY, V166, P1350, DOI 10.1016/S0022-5347(05)65767-9
   Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257
   Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Strasser H, 2007, LANCET, V369, P2179, DOI 10.1016/S0140-6736(07)61014-9
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Yiou R, 2003, TRANSPLANTATION, V76, P1053, DOI 10.1097/01.TP.0000090396.71097.C2
   Yiou R, 2002, BJU INT, V89, P298, DOI 10.1046/j.1464-4096.2001.01618.x
   Yokoyama T, 2000, WORLD J UROL, V18, P56, DOI 10.1007/s003450050010
NR 34
TC 46
Z9 49
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD SEP
PY 2008
VL 51
IS 9
BP 1367
EP 1373
DI 10.1007/s10350-008-9360-y
PG 7
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 339DC
UT WOS:000258557300011
PM 18536965
OA Green Published
DA 2018-10-20
ER

PT J
AU Sommer, F
   Pollinger, K
   Brandl, F
   Weiser, B
   Tessmar, J
   Blunk, T
   Gopferich, A
AF Sommer, Florian
   Pollinger, Klaus
   Brandl, Ferdinand
   Weiser, Barbara
   Tessmar, Joerg
   Blunk, Torsten
   Goepferich, Achim
TI Hyalocyte proliferation and ECM accumulation modulated by bFGF and
   TGF-beta 1
SO GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article
DE hyalocyte; transforming growth factor beta (TGF-beta); basic fibroblast
   growth factor (bFGF); cell-based vitreous substitute; tissue engineering
ID FIBROBLAST-GROWTH-FACTOR; FACTOR-BETA; TGF-BETA; CELL MIGRATION;
   VITREOUS GEL; FACTOR FGF; TISSUE; ACID; DIFFERENTIATION; EXPRESSION
AB Purpose In cases of severe retinal diseases, the vitreous body has to be removed and replaced by a suitable biomaterial. Currently, however, no satisfying long-term vitreous substitute is in clinical use. A novel therapeutic concept represents the combination of hyalocytes with suitable biomaterials. The goal of the present study was to evaluate the potential of bFGF and TGF-beta 1 as tools to control hyalocyte proliferation and the accumulation of extracellular matrix (ECM).
   Methods In vitro investigation on the influence of different concentrations of bFGF and TGF-beta 1 on hyalocyte morphology, proliferation and ECM production.
   Results Both growth factors affected hyalocyte morphology; small, round cells could be observed after bFGF supplementation, whereas the cells appeared more completely spread when cultured with TGF-beta 1. Hyalocyte proliferation was increased 3-fold by 10 ng/ml bFGF; 1 ng/ml TGF-beta 1 in contrast reduced cell proliferation to about 40% of the control. Converse effects of the growth factors could also be observed on the ECM accumulation of hyalocytes; whereas bFGF halved ECM accumulation, TGF-beta 1 enhanced the ECM production up to 3-fold. Precultivation of hyalocytes with bFGF for two passages had no influence on their subsequent accumulation of glycosaminoglycans (GAG). However, cells precultivated with bFGF exhibited a doubled accumulation of collagen compared to controls.
   Conclusions The observed opposite effects of bFGF and TGF-beta 1 on hyalocyte proliferation and ECM accumulation may allow for the control of hyaloycte properties. Therefore, these two growth factors seem to be valuable tools towards the development of a cell-based vitreous substitute.
C1 [Sommer, Florian; Pollinger, Klaus; Brandl, Ferdinand; Weiser, Barbara; Tessmar, Joerg; Blunk, Torsten; Goepferich, Achim] Univ Regensburg, Inst Pharm, Dept Pharmaceut Technol, D-93040 Regensburg, Germany.
RP Gopferich, A (reprint author), Univ Regensburg, Inst Pharm, Dept Pharmaceut Technol, Univ Str 31, D-93040 Regensburg, Germany.
EM achim.goepferich@chemie.uni-regensburg.de
RI Goepferich, Achim/G-1151-2016; Tessmar, Joerg/H-3606-2012
OI Goepferich, Achim/0000-0002-7646-0252; Tessmar,
   Joerg/0000-0001-7057-5369
CR ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020
   ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4
   Badrinath SS, 1999, RETINA-J RET VIT DIS, V19, P51, DOI 10.1097/00006982-199901000-00008
   Benavente CA, 2003, GROWTH FACTORS, V21, P87, DOI 10.1080/08977190310001613789
   BERRADA S, 1995, IN VITRO CELL DEV-AN, V31, P698
   Bishop PN, 2002, EYE, V16, P454, DOI 10.1038/sj.eye.6700199
   Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6
   BLOOM GUNNAR D., 1965, EXP EYE RES, V4, P249, DOI 10.1016/S0014-4835(65)80038-0
   Boltz-Nitulescu G, 1979, Adv Exp Med Biol, V121B, P223
   Borge L, 1997, IN VITRO CELL DEV-AN, V33, P703
   BROWN PD, 1988, J CELL BIOL, V106, P171, DOI 10.1083/jcb.106.1.171
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   DAMICO DJ, 1994, NEW ENGL J MED, V331, P95, DOI 10.1056/NEJM199407143310207
   Dickson C, 2002, MOL CELL ENDOCRINOL, V195, P65, DOI 10.1016/S0303-7207(02)00216-2
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678
   FREEMAN MI, 1978, EXP EYE RES, V29, P479
   Gloor B P, 1978, Adv Ophthalmol, V36, P63
   GLOOR BP, 1973, GRAEFES ARCH CLIN EX, V187, P21
   HAUNER H, 1995, EUR J CLIN INVEST, V25, P90, DOI 10.1111/j.1365-2362.1995.tb01532.x
   Heidenkummer H.-P., 1996, Ophthalmologe, V93, P675, DOI 10.1007/s003470050057
   HENLE J, 1841, LEHRE MISCHUNGS FORM
   INOUE H, 1989, J CELL PHYSIOL, V138, P329, DOI 10.1002/jcp.1041380216
   Kay EP, 1998, CURR EYE RES, V17, P286, DOI 10.1076/ceyr.17.3.286.5212
   KEE NW, 2002, TISSUE ENG, V11, P182
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   KOBUCH K, 2002, INVEST OPHTHALMOL VI, V43
   LANGER R, 1993, TISSUE ENG SCI, V260, P920
   LAZARUS HS, 1994, ARCH OPHTHALMOL-CHIC, V112, P1356, DOI 10.1001/archopht.1994.01090220106031
   Lieb E, 2004, TISSUE ENG, V10, P1399, DOI 10.1089/1076327042500184
   LUTTY GA, 1993, INVEST OPHTH VIS SCI, V34, P477
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121
   McGowan KB, 2002, OSTEOARTHR CARTILAGE, V10, P580, DOI 10.1053/joca.2002.0794
   Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840
   NEWSOME DA, 1976, J CELL BIOL, V71, P59, DOI 10.1083/jcb.71.1.59
   Noda Y, 2004, INVEST OPHTH VIS SCI, V45, P2107, DOI 10.1167/iovs.03-1092
   OSTERLIN SE, 1968, EXP EYE RES, V7, P511, DOI 10.1016/S0014-4835(68)80004-1
   Pangborn CA, 2005, TISSUE ENG, V11, P1141, DOI 10.1089/ten.2005.11.1141
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   Pickering JG, 1997, CIRC RES, V80, P627, DOI 10.1161/01.RES.80.5.627
   Qiao H, 2005, BRIT J OPHTHALMOL, V89, P513, DOI 10.1136/bjo.2004.050658
   Sakamoto Taiji, 2003, Nippon Ganka Gakkai Zasshi, V107, P866
   SALU P, 1985, OPHTHALMIC RES, V17, P125, DOI 10.1159/000265363
   Sebag J., 1989, VITREOUS
   Soman N, 2003, BIO-MED MATER ENG, V13, P59
   Sommer F, 2007, TISSUE ENG, V13, P1281, DOI 10.1089/ten.2006.0274
   Sommer F, 2006, ADV EXP MED BIOL, V585, P413
   Song QH, 2002, J CLIN PATHOL-MOL PA, V55, P164
   Spraul CW, 2004, OPHTHAL RES, V36, P166, DOI 10.1159/000077330
   Stevens MM, 2004, J ORTHOPAED RES, V22, P1114, DOI 10.1016/j.orthres.2003.12.021
   TAYLOR K B, 1969, Histochemical Journal, V1, P199, DOI 10.1007/BF01081408
   Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   WROBLEWSKI J, 1995, J BONE MINER RES, V10, P735
   ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115
   Zhu M, 1997, AUST NZ J OPHTHALMOL, V25, P57
NR 61
TC 5
Z9 6
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0721-832X
J9 GRAEF ARCH CLIN EXP
JI Graefes Arch. Clin. Exp. Ophthalmol.
PD SEP
PY 2008
VL 246
IS 9
BP 1275
EP 1284
DI 10.1007/s00417-008-0846-z
PG 10
WC Ophthalmology
SC Ophthalmology
GA 330HV
UT WOS:000257932500009
PM 18461346
DA 2018-10-20
ER

PT J
AU Covani, U
   Cornelini, R
   Barone, A
AF Covani, Ugo
   Cornelini, Roberto
   Barone, Antonio
TI Buccal Bone Augmentation Around Immediate Implants With and Without Flap
   Elevation: A Modified Approach
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE biomaterial; bone defect; dental implants; extraction sockets;
   mucoperiosteal flap
ID FRESH EXTRACTION SOCKETS; RETROSPECTIVE ANALYSIS; TOOTH EXTRACTION;
   CLINICAL REPORT; PLACEMENT; SURGERY; SITES; DOG
AB Purpose: The aim of this study was to compare the clinical success and bone healing of implants placed in fresh extraction sockets using a flapless procedure compared to those placed with flap elevation. Materials and Methods: Twenty teeth in 20 patients were selected for this study and were scheduled for tooth extraction and immediate implant placement. Ten implants were placed with flap elevation (control group), and 10 implants were placed without flap elevation (test group), All the sites selected showed a complete bone defect at the facial wall. All the implants included in this study were 2-stage implants placed at the level of palatal/lingual bone in augmented bone. Each surgical site was protected with a collagen membrane and, subsequently, a standardized radiograph was taken to evaluate the distance between the implant shoulder and the first bone-implant contact (DIB). Six months after placement, both control and test implants underwent a second-stage surgery and a clinical examination to determine the implant stability quotient, DIB, and the distance between implant shoulder and the crestal bone at the midbuccal aspect (DIC). Results: One implant failed in the test group. Only 1 implant (test group) showed bone growth over the implant neck at the re-entry procedure. Implant stability quotient (ISQ) and DIB did not show any significant differences between the control and test group; however, a higher DIC was found in the test sites compared to the control sites. Conclusion: Data from this study showed that immediate implants with and without a mucoperiosteal flap elevation can be successfully used even in the presence of bone defects requiring augmentation procedures. It was also noted that the bone regenerated reached a higher coronal level in the group with flap elevation than in the group without flap elevation. INT J ORAL MAXILLOFAC IMPLANTS 2008;23: 841-846
C1 [Covani, Ugo; Cornelini, Roberto; Barone, Antonio] Univ Genoa, Sch Dent, Dept Biophys Med & Dent Sci & Technol, Genoa, Italy.
RP Barone, A (reprint author), Piazza Diaz 10, I-55041 Camaiore, Lu, Italy.
EM barosurg@libero.it
RI Barone, Antonio/O-2738-2013
OI Barone, Antonio/0000-0003-1226-7565
CR Al-Ansari BH, 1998, INT J ORAL MAX IMPL, V13, P861
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P33, DOI 10.1034/j.1600-0501.1990.010105.x
   Campelo LD, 2002, INT J ORAL MAX IMPL, V17, P271
   Covani U, 2004, INT J ORAL MAX IMPL, V19, P549
   Covani U, 2004, J PERIODONTOL, V75, P982, DOI 10.1902/jop.2004.75.7.982
   Covani U, 2003, J PERIODONTOL, V74, P268, DOI 10.1902/jop.2003.74.2.268
   Dahlin C, 1989, Int J Oral Maxillofac Implants, V4, P19
   Evian CI, 2004, INT J ORAL MAX IMPL, V19, P393
   Fortin T, 2006, INT J ORAL MAX IMPL, V21, P298
   Nemcovsky CE, 1999, J PERIODONTOL, V70, P926, DOI 10.1902/jop.1999.70.8.926
   NOBUTO T, 1989, J PERIODONTOL, V60, P709, DOI 10.1902/jop.1989.60.12.709
   Nobuto T, 2003, J PERIODONTOL, V74, P521, DOI 10.1902/jop.2003.74.4.521
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Schwartz-Arad D, 1998, J PERIODONTOL, V69, P743, DOI 10.1902/jop.1998.69.7.743
   Schwartz-Arad D, 2000, J PERIODONTOL, V71, P923, DOI 10.1902/jop.2000.71.6.923
   Weber H P, 1992, Clin Oral Implants Res, V3, P181, DOI 10.1034/j.1600-0501.1992.030405.x
   Wilson TG, 2003, J PERIODONTOL, V74, P402, DOI 10.1902/jop.2003.74.3.402
NR 20
TC 32
Z9 35
U1 1
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD SEP-OCT
PY 2008
VL 23
IS 5
BP 841
EP 846
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 364JN
UT WOS:000260332100006
PM 19014153
DA 2018-10-20
ER

PT J
AU Guhathakurta, S
   Balasubramanian, V
   Ananthakrishnan, B
   Veerappan, S
   Balasundari, R
   Tata, BVR
   Cherian, KM
AF Guhathakurta, S.
   Balasubramanian, V.
   Ananthakrishnan, B.
   Veerappan, S.
   Balasundari, R.
   Tata, B. V. R.
   Cherian, K. M.
TI Thrombogenicity studies of three different variants of processed bovine
   pericardium
SO IRBM
LA English
DT Article
DE bovine pericardium; confocal microscopy; decellurization; thrombogenic;
   transmission electron microscopypericarde bovin; microscopie confocale;
   acellurisation; thromboembolie; microscopie electronique
ID PLATELET-COLLAGEN INTERACTIONS; HEPARIN; CELLS
AB Versatile use of bovine pericardium in clinical cardiovascular surgery requires processing, especially cross-linking, to make the tissue non antigenic and mechanically strong. Forty-nine bovine pericardia were made acellular and then cross-linked by two different methods, group A (20) with formalin and group B (29) with heparin and subsequently, as a final measure, five of group B pericardia were gamma-ray sterilized with stipulated dose of 25 kGy and classified as group C. The surface property of thrombogenesis and haemolysis were compared in these three groups to identify a suitable method of processing so that it could be used in the vascular system without any thromboembolic complication. Extensive microscopical examination, mechanical testing and other physical property for biocompatibility studies were conducted on these three different groups with key focus On in Vitro thrombogenicity studies. Heparin treated group B bovine pericardium appeared to be the best method of processing among these three by the above studies and was confirmed by laser confocal microscopy. Heparin cross-linked and heparin sodium treated processing had gained the higher tensile strength, and appeared to be nonthrombogenic, noncalcifiable (by animal experiments), biocompatible biomaterial, which can be used clinically. (c) 2007 Elsevier Masson SAS. All rights reserved.
C1 [Guhathakurta, S.; Balasubramanian, V.; Ananthakrishnan, B.] Indian Inst Technol, Dept Biotechnol, Rehabil Bioengn Grp, Chennai 600036, Tamil Nadu, India.
   [Guhathakurta, S.; Ananthakrishnan, B.; Veerappan, S.; Balasundari, R.; Cherian, K. M.] Frontier Life Line Private Ltd, Int Ctr Cardiothorac & Vasc Dis, Madras 600101, Tamil Nadu, India.
   [Tata, B. V. R.] Indira Gandhi Ctr Atom Res, Kalpakkam 603102, Tamil Nadu, India.
RP Balasubramanian, V (reprint author), Indian Inst Technol, Dept Biotechnol, Rehabil Bioengn Grp, Chennai 600036, Tamil Nadu, India.
EM chanakya@iitm.ac.in
OI Ramesh, Balasundari/0000-0002-0090-2827
CR CHVAPIL M, 1970, INT REV CONNECTIVE T, V6, P1
   CORTELLARO M, 1993, ARTERIOSCLER THROMB, V13, P1412, DOI 10.1161/01.ATV.13.10.1412
   ELIEZER MA, 2005, APPL ENG MECH MED, pA1
   Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068
   FRANSSON LA, 1979, FEBS LETT, V97, P119, DOI 10.1016/0014-5793(79)80065-4
   Gao YG, 2005, MOL CELLS, V19, P350
   GRABENWOGER M, 1992, J BIOMED MATER RES, V26, P1231, DOI 10.1002/jbm.820260912
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Griffin MJ, 2001, ANESTH ANALG, V93, P20
   Guhathakurta S, 2006, CURR SCI INDIA, V91, P1068
   HUANG LLL, 1990, J BIOMED MATER RES, V124, P1185
   ISHIHARA T, 1981, J THORAC CARDIOV SUR, V81, P747
   Kauhanen P, 2000, ARTERIOSCL THROM VAS, V20, pE113, DOI 10.1161/01.ATV.20.11.e113
   Keuren JFW, 2004, ARTERIOSCL THROM VAS, V24, P613, DOI 10.1161/01.ATV.0000116026.18945.66
   Laemmel E, 1998, J BIOMED MATER RES, V39, P446, DOI 10.1002/(SICI)1097-4636(19980305)39:3<446::AID-JBM14>3.0.CO;2-8
   Lassila R, 1997, ARTERIOSCL THROM VAS, V17, P3578, DOI 10.1161/01.ATV.17.12.3578
   Love JW, 1997, PRINCIPLES TISSUE EN, P365
   MENASCHE P, 1984, Life Support Systems, V2, P233
   MENASCHE P, 1986, P 3 INT S BIOL BIOPR
   Poletti LF, 1997, ARTERIOSCL THROM VAS, V17, P925, DOI 10.1161/01.ATV.17.5.925
   REIDY MA, 1992, ARCH PATHOL LAB MED, V116, P1276
   RYGG IH, 1986, P 3 INT S BIOL BIOPR, pCH49
   Vasudev SC, 2000, ARTIF ORGANS, V24, P129, DOI 10.1046/j.1525-1594.2000.06348.x
   WEINBERGER DR, 1986, HDB SCHIZOPHRENIA, V1, P397
   WON LK, 2000, BIOMATERIALS, V21, P2323
   ZACHARIAS RK, 1987, J VASC SURG, V6, P429, DOI 10.1067/mva.1987.avs0060429
NR 26
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1959-0318
EI 1876-0988
J9 IRBM
JI IRBM
PD SEP
PY 2008
VL 29
IS 4
BP 223
EP 230
DI 10.1016/j.rbmret.2007.07.003
PG 8
WC Engineering, Biomedical
SC Engineering
GA 350MF
UT WOS:000259355900001
DA 2018-10-20
ER

PT J
AU Dash, BN
   Nakamura, M
   Sahoo, S
   Kotaki, M
   Nakai, A
   Hamada, H
AF Dash, B. N.
   Nakamura, M.
   Sahoo, S.
   Kotaki, M.
   Nakai, A.
   Hamada, H.
TI Mechanical Properties of Hemp Reinforced Poly(butylene succinate)
   Biocomposites
SO JOURNAL OF BIOBASED MATERIALS AND BIOENERGY
LA English
DT Article
DE Hemp; Shellac; Biopolymer; Biofiber; Surface Modification; Moisture
   Absorption
ID BIODEGRADABLE POLYESTERS; ALIPHATIC POLYESTERS; THERMAL-PROPERTIES;
   COMPOSITES; FIBER; SHELLAC
AB Hemp and poly(butylene succinate) (PBS) composites with 10, 15 and 20 wt% fiber loading were prepared by a film stacking compression molding method, followed by extrusion and injection molding. Inadequate wetting and heterogeneous distribution of fiber was observed in the crushed materials of 20 wt% of fiber loading. Therefore, this composite was reprocessed to investigate whether the fiber-by-matrix impregnation can be improved by repeated compression molding. Composites were prepared using untreated as well as shellac coated hemp and the resulting properties were compared. The main focus of the work is to optimize the fiber loading and to study the effectiveness of shellac, a nontoxic biomaterial as a coating agent for hemp fibers, in order to develop environment friendly low cost composite materials. From the evaluated properties, it is observed that, tensile and flexural properties increased while impact strength decreased with increase in fiber loading in comparison to PBS. Moisture absorption of fibers and the composite specimens (20 wt% fibers loading) were studied. Effect of moisture absorption on the tensile properties of the composites was evaluated. Surface modification of fiber had no significant contribution towards the mechanical behavior of the composites probably due to high processing temperature; however the fiber-matrix adhesion and resistance to moisture absorption improved to some extent. SEM analysis has corroborated the findings.
C1 [Dash, B. N.; Nakamura, M.; Sahoo, S.; Kotaki, M.; Nakai, A.; Hamada, H.] Kyoto Inst Technol, Dept Adv FibroSci, Sakyo Ku, Kyoto 6068585, Japan.
   [Dash, B. N.] G Sc Coll, Dept Chem, Cuttack 754029, Orissa, India.
RP Hamada, H (reprint author), Kyoto Inst Technol, Dept Adv FibroSci, Sakyo Ku, Kyoto 6068585, Japan.
EM hhamada@kit.ac.jp
CR Bismarck A, 2005, NATURAL FIBERS, BIOPOLYMERS, AND BIOCOMPOSITES, P37
   Fujimaki T, 1998, POLYM DEGRAD STABIL, V59, P209, DOI 10.1016/S0141-3910(97)00220-6
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   Kim HS, 2005, J APPL POLYM SCI, V97, P1513, DOI 10.1002/app.21905
   KROSCHWITZ JI, 1989, ENCY POLYM SCI ENG S, pP579
   Lee SM, 2005, COMPOS SCI TECHNOL, V65, P647, DOI 10.1016/j.compscitech.2004.09.023
   Lee SM, 2005, POLYM POLYM COMPOS, V13, P479, DOI 10.1177/096739110501300505
   Mcculloch L, 1943, IND ENG CHEM, V35, P825, DOI 10.1021/ie50403a022
   Mochizuki M, 1997, POLYM ADVAN TECHNOL, V8, P203
   Mohanty AK, 2005, NATURAL FIBERS, BIOPOLYMERS, AND BIOCOMPOSITES, P1
   Mohanty AK, 2001, COMPOS INTERFACE, V8, P313, DOI 10.1163/156855401753255422
   NAKAMURA M, 2006, P 4 INT WORKSH GREEN
   OHKITA T, 2005, J APPL POLYM SCI, V97, P3
   Ray D, 2006, IND ENG CHEM RES, V45, P2722, DOI 10.1021/ie0512800
   Saheb DN, 1999, ADV POLYM TECH, V18, P351, DOI 10.1002/(SICI)1098-2329(199924)18:4<351::AID-ADV6>3.0.CO;2-X
   SAHOO S, 2007, P JCOM 36 JAP SOC CO, P21
   SHARMA N, 2000, INT J POLYM MATER, V47, P351
   SHARMA S, 1983, DEFENCE SCI J, V33, P3
   Shibata M, 2004, J APPL POLYM SCI, V92, P3857, DOI 10.1002/app.20405
   Shibata M, 2003, MACROMOL MATER ENG, V288, P35, DOI 10.1002/mame.200290031
   Siriwardena S, 2003, J REINF PLAST COMP, V22, P1645, DOI 10.1177/073168403027619
   THOMSEN AB, 2000, BIORESOURCE HEMP
   WIENER V, 2003, AUTEX RES J, V3, P20
   XIA W, 2006, FOR STUD CHINA, V8, P1
NR 24
TC 13
Z9 13
U1 1
U2 12
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1556-6560
J9 J BIOBASED MATER BIO
JI J. Biobased Mater. Bioenergy
PD SEP
PY 2008
VL 2
IS 3
BP 273
EP 281
DI 10.1166/jbmb.2008.403
PG 9
WC Chemistry, Applied; Energy & Fuels; Materials Science, Biomaterials
SC Chemistry; Energy & Fuels; Materials Science
GA 373HZ
UT WOS:000260964000011
DA 2018-10-20
ER

PT J
AU Kamath, S
   Bhattacharyya, D
   Padukudru, C
   Timmons, RB
   Tang, LP
AF Kamath, Shwetha
   Bhattacharyya, Dhiman
   Padukudru, Chandana
   Timmons, Richard B.
   Tang, Liping
TI Surface chemistry influences implant-mediated host tissue responses
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE surface modification; inflammation; fibrosis; microsphere; plasma
   polymerization
ID SELF-ASSEMBLED MONOLAYERS; FUNCTIONAL-GROUPS; CELL-ADHESION; FIBROUS
   CAPSULE; PLASMA POLYMERIZATION; PROTEIN ADSORPTION; RELEASE SYSTEMS;
   HYDROXYL-GROUPS; IN-VITRO; BIOMATERIALS
AB Implant-mediated fibrotic reactions are detrimental to the performance of encapsulated cells, implanted drug release devices, and sensors. To improve the implant function and longevity, recent research has emphasized the need for inducing alterations in cellular responses. Although material surface functional groups have been shown to be potent in affecting cellular activity in vitro and short-term in vivo responses, these groups appear to have little influence on long-term in vivo fibrotic reactions, possibly as a result of insufficient interactions between recruited host cells and functional groups on the implants. To maximize the influence of functionality on cells, and to mimic drug release microspheres, functionalized micron-sized particles were created and tested for their ability in modulating tissue responses to biomaterial implants. In this work, the surfaces of polypropylene particles were controllably coated with four different functional groups, specifically -OH, -NH(2), -CF(x), and -COOH, using a radio frequency glow discharge plasma polymerization technique. The effect of these surface functionalities on host tissue responses were then evaluated using a mice subcutaneous implantation model. Major differences were observed in contrasting tissue response to the different chemistries. Surfaces with -OH and -NH(2) surface groups induced the thickest fibrous capsule accompanied with the greatest cellular infiltration into the implants. In contrast, surfaces with -CF(x) and -COOH exhibited the least inflammatory/fibrotic responses and cellular infiltrations. The present results clearly demonstrate that, by increasing the available functionalized surface area and spatial distribution, the effect of surface chemistry on tissue reactivity can be substantially enhanced. (c) 2007 Wiley Periodicals, Inc.
C1 [Tang, Liping] Univ Texas Arlington, Dept Bioengn, Biomed Engn Program, Arlington, TX 76019 USA.
   [Bhattacharyya, Dhiman; Timmons, Richard B.] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, Biomed Engn Program, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
FU NIBIB NIH HHS [R01 EB007271, R01 EB007271-01A2, R01 EB007271-01A2S1];
   NIGMS NIH HHS [R01 GM074021]
CR AMON M, 1994, INT OPHTHALMOL, V18, P9, DOI 10.1007/BF00919407
   AMON M, 1993, J CATARACT REFR SURG, V19, P258, DOI 10.1016/S0886-3350(13)80953-4
   ANDERSON JM, 1981, J BIOMED MATER RES, V15, P889, DOI 10.1002/jbm.820150613
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Barbosa JN, 2005, BIOMATERIALS, V26, P3021, DOI 10.1016/j.biomaterials.2004.09.002
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   BARBOSA JN, 2006, J BIOMED MATER RES, V26, P737
   Beamson G., 1992, HIGH RESOLUTION XPS
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   Butler K, 1997, Biomed Sci Instrum, V34, P18
   Cho J, 2006, CHEM MATER, V18, P2989, DOI 10.1021/cm060212g
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   DESAI NP, 1992, BIOMATERIALS, V13, P505, DOI 10.1016/0142-9612(92)90101-S
   Evans-Nguyen KM, 2005, BIOCHEMISTRY-US, V44, P15561, DOI 10.1021/bi0514358
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Gorbet MB, 2003, J BIOMED MATER RES A, V67A, P792, DOI 10.1002/jbm.a.10155
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   Harsch A, 2000, J NEUROSCI METH, V98, P135, DOI 10.1016/S0165-0270(00)00196-5
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   KUWAHARA T, 1989, CONTRIB NEPHROL, V74, P52
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LENINGER RI, 1978, ANN NY ACAD SCI, V516, P173
   Li ML, 2005, ANAL CHEM, V77, P350, DOI 10.1021/ac0488107
   LINDSAY RM, 1980, T AM SOC ART INT ORG, V26, P603
   NISHI O, 1991, J CATARACT REFR SURG, V17, P471, DOI 10.1016/S0886-3350(13)80854-1
   PANCHALINGAM V, 1993, J BIOMAT SCI-POLYM E, V5, P131
   Panchalingam V, 1993, ASAIO J, V39, pM305
   Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65
   Rinsch CL, 1996, LANGMUIR, V12, P2995, DOI 10.1021/la950685u
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   SAVAGE CR, 1991, CHEM MATER, V3, P575, DOI 10.1021/cm00016a005
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   SHEU MS, 1992, J ADHES SCI TECHNOL, V6, P995, DOI 10.1163/156856192X00890
   SHINODA BA, 1978, BIOMATER ARTIF CELL, V6, P305, DOI 10.3109/10731197809119791
   Socrates G., 1994, INFRARED CHARACTERIS
   SOONSHIONG P, 1991, TRANSPLANT P, V23, P758
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Susut C, 2005, INT J PHARM, V288, P253, DOI 10.1016/j.ijpharm.2004.10.004
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   WOOD RC, 1995, BIOMATERIALS, V16, P957, DOI 10.1016/0142-9612(95)93122-T
   WU Y, 1999, MATER RES SOC S P, V77, P544
   Wu YLJ, 2000, COLLOID SURFACE B, V18, P235, DOI 10.1016/S0927-7765(99)00150-2
   Zhang Z, 2003, LANGMUIR, V19, P4765, DOI 10.1021/la026980d
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 56
TC 57
Z9 57
U1 0
U2 20
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2008
VL 86A
IS 3
BP 617
EP 626
DI 10.1002/jbm.a.31649
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 334RD
UT WOS:000258238000006
PM 18022841
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ball, M
   Grant, DM
   Lo, WJ
   Scotchford, CA
AF Ball, Michael
   Grant, David M.
   Lo, Wei-Jen
   Scotchford, Colin A.
TI The effect of different surface morphology and roughness on
   osteoblast-like cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE surface morphology; surface roughness; osteoblast-like cell; cell
   adhesion; cell differentiation
ID IN-VITRO; MICROMACHINED SURFACES; BONE-CELLS; TITANIUM; HYDROXYAPATITE;
   GROWTH; MG63; 1-ALPHA,25-(OH)(2)D-3; RESPONSIVENESS; PROLIFERATION
AB Increased magnitude of biomaterial surface roughness and micromachined-grooved surfaces has both been shown to stimulate osteoblast activity, but have not been compared in the same study quantitatively. A series of titanium alloy (Ti6Al4V) samples were prepared using simple machining techniques to undertake such a comparison. Samples were either grit blasted (Gb) or shot peened (Sp) to give random discontinuities, or silicon carbide ground (SiC) to produce ordered grooves. These were compared with micropolished samples (Mp). The samples were coated with a 1 mu m continuous coating of hydroxyapatite to remove differences in surface chemistry. Human osteoblast-like cells were seeded onto the materials and metabolic activity, proliferation, alkaline phosphatase activity, and osteocalcin production assessed. Cell responses were highly dependent on the substrate that they were cultured on. Cells cultured on the smooth and ordered (Mp and SiC, respectively) samples had higher metabolic activity and a more elongated morphology than those cultured on the randomly structured Gb or Sp samples. Over 21 days, cell metabolic activity peaked relative to the control between 7 and 14 days on the Mp sample, and between 14 and 21 days on the Gb, Sp, and SiC samples. In common with other researchers, we note that micron scale topography may have potential for influencing osseointegration. More importantly, as the magnitude of the discontinuities on SiC, Gb, and Sp were similar, the differences in cell responses does not appear to lie with the size of the features, but whether the features showed an ordered or disordered structure. (c) 2007 Wiley Periodicals, Inc.
C1 [Ball, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Grant, David M.; Lo, Wei-Jen; Scotchford, Colin A.] Univ Nottingham, Sch Mech Mat Mfg Engn & Management, Nottingham NG7 2RD, England.
RP Ball, M (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
EM m.ball@imperial.ac.uk
OI Scotchford, Colin/0000-0003-1937-6692; Ball,
   Michael/0000-0003-4139-0802; Grant, David/0000-0002-6786-7720
CR AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1
   Aubin Jane E., 1993, P1
   Ball MD, 2001, BIOMATERIALS, V22, P337, DOI 10.1016/S0142-9612(00)00189-7
   BASLE MF, 1993, J MATER SCI-MATER M, V4, P273, DOI 10.1007/BF00122280
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyan BD, 2001, J BIOMED MATER RES, V55, P350, DOI 10.1002/1097-4636(20010605)55:3<350::AID-JBM1023>3.0.CO;2-M
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CHEHROUDI B, 1992, CELL MATER, V2, P89
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   Grant DM, 1996, J MATER SCI-MATER M, V7, P579, DOI 10.1007/BF00122181
   Gray C, 1996, BONE, V18, P115, DOI 10.1016/8756-3282(95)00456-4
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   Lo WJ, 1999, J BIOMED MATER RES, V46, P408, DOI 10.1002/(SICI)1097-4636(19990905)46:3<408::AID-JBM14>3.0.CO;2-Z
   LODISH HB, 2000, MOL CELL BIOL
   Lohmann CH, 1999, J BIOMED MATER RES, V47, P139, DOI 10.1002/(SICI)1097-4636(199911)47:2<139::AID-JBM4>3.0.CO;2-2
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   Pypen CMJM, 1997, J MATER SCI-MATER M, V8, P781, DOI 10.1023/A:1018568830442
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Riehle MO, 2003, MAT SCI ENG C-BIO S, V23, P337, DOI 10.1016/S0928-4931(02)00282-5
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   UNGERSBOCK A, 1995, J MATER SCI-MATER M, V5, P434
   VanKooten TG, 1997, J MATER SCI-MATER M, V8, P835
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
NR 40
TC 53
Z9 53
U1 0
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2008
VL 86A
IS 3
BP 637
EP 647
DI 10.1002/jbm.a.31652
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 334RD
UT WOS:000258238000008
PM 18022800
DA 2018-10-20
ER

PT J
AU Betz, MW
   Modi, PC
   Caccamese, JF
   Coletti, DP
   Sauk, JJ
   Fisher, JP
AF Betz, Martha W.
   Modi, Parth C.
   Caccamese, John F.
   Coletti, Domenick P.
   Sauk, John J.
   Fisher, John P.
TI Cyclic acetal hydrogel system for bone marrow stromal cell encapsulation
   and osteodifferentiation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; bone marrow stromal cells; osteodifferentiation; hydrogel;
   encapsulation
ID MESENCHYMAL STEM-CELLS; POLY(PROPYLENE FUMARATE) SCAFFOLDS; IN-VITRO;
   OSTEOGENIC DIFFERENTIATION; BIOMATERIALS; GROWTH; COLLAGEN; GLYCOL);
   AGAROSE; MODEL
AB Many systems have been proposed for the encapsulation of bone marrow stromal cells (BMSCs) within degradable hydrogels. Here, we use a novel cyclic acetal-based biomaterial formed from 5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD) and poly(ethylene glycol) diacrylate (PEGDA). A cyclic acetal-based hydrogel may be preferred as cyclic acetals hydrolytically degraded into diols and carbonyls as primary degradation products, which may not affect local acidity, unlike other widely investigated polymers. The EHD monomer and PEGDA polymer may be fabricated into a EH-PEG hydrogel by radical polymerization initiated by the ammonium persulfate (APS) and N,N,N',N'-tetramethylethylenediamine (TEMED) system. The objective of this work is to determine whether the components utilized in the fabrication of EH-PEG hydrogels as well as the EH-PEG hydrogels permit BMSC viability, metabolic activity, and osteodifferentiation. Cell viability and metabolic activity were assessed after 30 min, 1 h, and 3 h of exposure to pertinent concentrations of the initiator system (10-20 mM). Osteodifferentiation was assessed by alkaline phosphatase and osteocalcin expression after a short exposure to the initiator system to simulate the encapsulation process. Lastly, cell viability was assessed immediately after encapsulation and after 7 days of culture within the EH-PEG hydrogels. results indicate that the metabolic activity and viability of BMSCs are minimally affected, and that osteodifferentiation is not significantly affected by the APS-TEMED initiator system. Also, encapsulated BMSCs maintained viability within EH-PEG hydrogels for 7 days. This work demonstrates, that the EH-PEG hydrogel is a viable option for the encapsulation and osteodifferentiation of BMSCs. (c) 2007 Wiley Periodicals, Inc.
C1 [Betz, Martha W.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Modi, Parth C.] Univ Maryland, Dept Biol Resources Engn, College Pk, MD 20742 USA.
   [Caccamese, John F.; Coletti, Domenick P.; Fisher, John P.] Univ Maryland, Sch Dent, Dept Oral & Maxillofacial Surg, Baltimore, MD 21201 USA.
   [Sauk, John J.] Univ Maryland, Sch Dent, Dept Pathol, Baltimore, MD 21201 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim,Engn Bldg 225, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z
   Baskaran S, 2002, BIOCONJUGATE CHEM, V13, P1309, DOI 10.1021/bc0255485
   Batorsky A, 2005, BIOTECHNOL BIOENG, V92, P492, DOI 10.1002/bit.20614
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Hong Y, 2006, J BIOMED MATER RES A, V79A, P913, DOI 10.1002/jbm.a.30837
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Jabbari E, 2004, J MICROENCAPSUL, V21, P525, DOI 10.1080/02652040410001729296
   KAIHARA S, EUR J PHARM IN PRESS
   KONG L, 2007, J BIOMATER APPL
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Temenoff JS, 2004, J BIOMED MATER RES A, V70A, P235, DOI 10.1002/jbm.a.30064
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   Vervoort L, 1999, J PHARM SCI, V88, P209, DOI 10.1021/js9802796
   Yoon DM, 2007, BIOMATERIALS, V28, P299, DOI 10.1016/j.biomaterials.2006.08.039
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
NR 31
TC 43
Z9 46
U1 2
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2008
VL 86A
IS 3
BP 662
EP 670
DI 10.1002/jbm.a.31640
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 334RD
UT WOS:000258238000010
PM 18022839
DA 2018-10-20
ER

PT J
AU Nikkola, L
   Vapalahti, K
   Huolman, R
   Seppala, J
   Harlin, A
   Ashammakhi, N
AF Nikkola, L.
   Vapalahti, K.
   Huolman, R.
   Seppala, J.
   Harlin, A.
   Ashammakhi, N.
TI Multilayer Implant with Triple Drug Releasing Properties
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Electrospinning; Nanofibers; Composite; Multicomponent; Intelligent
   Biomaterial; Implant
ID IN-VITRO; DICLOFENAC SODIUM; STAPHYLOCOCCUS-EPIDERMIDIS; BIOABSORBABLE
   FIXATION; BIOFILM FORMATION; ELECTROSPUN; CIPROFLOXACIN; NANOFIBER;
   POLYMER; BISPHOSPHONATE
AB Tissue repair and regeneration is a multistep process. Several drug releasing materials have been developed to help the healing process of tissues after damage. Most of these are loaded with a single agent. In the current study, we developed a composite loaded with three drugs to enhance the control of the healing process of bone. The biodegradable composite comprised two anti-inflammatory agents in a nanofibrous and macrofibrous matrix and bisphosphonates in a solid membrane. Three different multilayers were studied and the release of the agents was compared. Statistical analysis revealed a close correlation of releases between the multilayer implants except the release from the solid membrane. The first phase of release was from the nanofibrous component, followed by a more steady release from the macrofibers and a later release of the agent from the solid membrane. On the basis of these results a developed multilayer composite, releasing different agents, could be adapted for bone repair and regeneration applications.
C1 [Nikkola, L.; Vapalahti, K.; Huolman, R.; Ashammakhi, N.] Tampere Univ Technol, Dept Biomed Engn, FIN-33101 Tampere, Finland.
   [Seppala, J.] Helsinki Univ Technol, Dept Chem Technol, FIN-02150 Espoo, Finland.
   [Harlin, A.] Tampere Univ Technol, Dept Fibre Mat Sci, FIN-33101 Tampere, Finland.
RP Ashammakhi, N (reprint author), Tampere Univ Technol, Dept Biomed Engn, POB 692, FIN-33101 Tampere, Finland.
RI Seppala, Jukka/G-7698-2012
FU European Commission [NMP3-CT2004-500283]
FX This study was carried out within the scope of the European Commission
   network of Excellence on bone and cartilage tissue engineering
   "EXPER-TISSUES" (Project NMP3-CT2004-500283). The authors wish to thank
   Ms. Pirjo Heikkila for her technical support.
CR Ahola N, 2003, J APPL POLYM SCI, V88, P1279, DOI 10.1002/app.11806
   Ashammakhi N, 2007, J NANOSCI NANOTECHNO, V7, P862, DOI 10.1166/jnn.2007.485
   Aspenberg P, 2002, ACTA ORTHOP SCAND, V73, P20, DOI 10.1080/000164702317281350
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Bostman OM, 2000, CLIN ORTHOP RELAT R, P216
   Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6
   Dicko A, 2008, PHARM RES-DORDR, V25, P1702, DOI 10.1007/s11095-008-9561-z
   HALTTUNEN T, 2006, MULT FUNCT GRAD MAT
   Huang ZM, 2006, J BIOMED MATER RES A, V77A, P169, DOI 10.1002/jbm.a.30564
   Jiang HL, 2004, J BIOMAT SCI-POLYM E, V15, P279, DOI 10.1163/156856204322977184
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Makinen TJ, 2005, J ANTIMICROB CHEMOTH, V56, P1063, DOI 10.1093/jac/dki366
   Miyajima M, 1998, J CONTROL RELEASE, V56, P85, DOI 10.1016/S0168-3659(98)00076-5
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Niemela SM, 2006, J CRANIOFAC SURG, V17, P950, DOI 10.1097/01.scs.0000231621.02888.46
   Niemela SM, 2006, J BIOMED MATER RES B, V76B, P8, DOI 10.1002/jbm.b.30414
   Nikkola L, 2006, J NANOSCI NANOTECHNO, V6, P3290, DOI 10.1166/jnn.2006.467
   Nikkola L, 2008, AIP CONF PROC, V973, P766, DOI 10.1063/1.2896878
   OSTOVIC D, 1993, PHARMACEUT RES, V10, P470, DOI 10.1023/A:1018969112754
   PETER B, 2005, J BIOMED MATER RES A, V76, P133
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Sendil D, 2003, BIOMATERIALS, V24, P1969, DOI 10.1016/S0142-9612(02)00567-7
   Tengvall P, 2004, BIOMATERIALS, V25, P2133, DOI 10.1016/j.biomaterials.2003.08.049
   VAPALAHTI K, 2005, THESIS TAMPERE U TEC
   Veiranto M, 2004, ADV EXP MED BIOL, V553, P197
   Veiranto M, 2002, J MATER SCI-MATER M, V13, P1259, DOI 10.1023/A:1021187331458
   VIITANEN P, 2004, THESIS TAMPERE U TEC
   Viitanen P, 2006, J MATER SCI-MATER M, V17, P1267, DOI 10.1007/s10856-006-0601-0
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wedemeyer C, 2005, BIOMATERIALS, V26, P3719, DOI 10.1016/j.biomaterials.2004.09.026
   Weiler A, 1996, J BONE JOINT SURG BR, V78B, P369
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zeng J, 2005, J CONTROL RELEASE, V105, P43, DOI 10.1016/j.j.conrel.2005.02.024
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
NR 39
TC 5
Z9 5
U1 2
U2 13
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD SEP
PY 2008
VL 4
IS 3
SI SI
BP 331
EP 338
DI 10.1166/jbn.2008.337
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 370QB
UT WOS:000260776500012
DA 2018-10-20
ER

PT J
AU Chen, B
   Peng, XH
   Sun, ST
   Fan, JH
AF Chen, Bin
   Peng, Xiang-he
   Sun, Shi-tao
   Fan, Jing-hong
TI Hydroxyapatite-Sheet Parallel Microstructure of Shinbone
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT International Conference on Bionic Engineering (ICBE 2008)
CY OCT 10-12, 2008
CL Changchun, PEOPLES R CHINA
SP Natl Nat Sci Fdn, Minist Educ, Jilin Univ
DE shinbone; hydroxyapatite sheets; parallel microstructure; maximum
   pullout energy; fracture toughness
ID BONE; CRYSTALS
AB Bone is a natural biomaterial. It behaves favorable strength, stiffness and fracture toughness, which arc closely related to its eximious microstructure. Scanning Electron Microscope (SEM) observation on a shinbone showed that the bone is a bioceramic composite consisting of laminated hydroxyapatite and collagen matrix. The hydroxyapatite layers are parallel with the surface of the bone and consist of long and thin hydroxyapatite sheets. The observation also showed that the hydroxyapatite sheets in different hydroxyapatite layers also parallel with each other, which composes a hydroxyapatite-sheet parallel microstructure. The maximum pullout energy of the parallel microstructure was investigated based on its representative model. It was shown that the long and thin shape of the hydroxyapatite sheets in the parallel microstructure is profitable to increase the maximum pullout energy and enhance the fracture toughness of the bone.
C1 [Chen, Bin; Peng, Xiang-he; Sun, Shi-tao; Fan, Jing-hong] Chongqing Univ, Coll Resource & Environm Sci, Dept Engn Mech, Chongqing 400044, Peoples R China.
RP Chen, B (reprint author), Chongqing Univ, Coll Resource & Environm Sci, Dept Engn Mech, Chongqing 400044, Peoples R China.
EM bchen@cqu.cdu.cn
CR Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6
   FRATZL P, 1992, J BONE MINER RES, V7, P329
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Glimcher M.J., 1992, DISORDERS BONE MINER, P265
   LEES S, 1988, CONNECT TISSUE RES, V18, P41, DOI 10.3109/03008208809019071
   Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6
   VINCENT JFV, 2000, HDB ELASTIC PROPERTI, V3
   WEBER M, 2005, MRS P STRUCTURE MECH, V847, P79
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Woesz A, 2005, MAT SCI ENG C-BIO S, V25, P181, DOI 10.1016/j.msec.2005.01.014
NR 10
TC 0
Z9 0
U1 0
U2 3
PU SCIENCE CHINA PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD SEP
PY 2008
VL 5
SU S
BP 9
EP 13
DI 10.1016/S1672-6529(08)60065-7
PG 5
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 361GJ
UT WOS:000260115200003
DA 2018-10-20
ER

PT J
AU Sheu, T
   Sun, W
   Liu, X
   Chen, M
   Fauchet, PM
   Puzas, EJ
AF Sheu, T.
   Sun, W.
   Liu, X.
   Chen, M.
   Fauchet, P. M.
   Puzas, E. J.
TI Towards Development of a Porous Silicon-Based Hybrid Biomaterial with
   Osteoconductivity and Osteoinductivity.
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
CT 30th Annual Meeting of the
   American-Society-for-Bone-and-Mineral-Research
CY SEP 12-16, 2008
CL Montreal, CANADA
SP Amer Soc Bone & Mineral Res
C1 [Sheu, T.; Sun, W.; Liu, X.; Chen, M.; Fauchet, P. M.; Puzas, E. J.] Univ Rochester, Rochester, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD SEP
PY 2008
VL 23
BP S381
EP S381
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 351FX
UT WOS:000259411002165
DA 2018-10-20
ER

PT J
AU Trombelli, L
   Farina, R
AF Trombelli, Leonardo
   Farina, Roberto
TI Clinical outcomes with bioactive agents alone or in combination with
   grafting or guided tissue regeneration
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article; Proceedings Paper
CT 6th European Workshop on Periodontology
CY FEB 02-06, 2008
CL Ittingen, SWITZERLAND
SP European Acad Periodontol, Straumann AG, Swiss Soc Periodontol
DE bioactive agents; furcation defects; growth factors; intra-osseous
   defects; morphogens; periodontal disease; periodontitis; regenerative
   therapy
ID ENAMEL-MATRIX-PROTEINS; PLATELET-RICH PLASMA; INTRABONY PERIODONTAL
   DEFECTS; BOVINE-DERIVED XENOGRAFT; BONE MORPHOGENETIC PROTEIN-2; II
   FURCATION INVOLVEMENT; GROWTH FACTOR-BB; BINDING PEPTIDE P-15; INVASIVE
   SURGICAL TECHNIQUE; UP SPLIT-MOUTH
AB Aim: The purpose of the present review was to determine the clinical effect of the use of bioactive agents (BAs) for the treatment of intra-osseous and furcation defects.
   Material and Methods: The effectiveness of the BAs was evaluated when used in addition to open flap debridement either alone or in association with grafts and/or guided tissue regeneration (GTR). Among the included agents, recombinant human platelet-derived growth factor-BB (rhPDGF-BB), platelet-rich plasma (PRP), commercially available enamel matrix derivative (cEMD) and peptide P-15 (P-15) have been clinically tested for treating periodontal defects.
   Results and Conclusions: The results of the present review indicate that: (1) cEMD either alone or in combination with grafts can be effectively used to treat intra-osseous defects and the clinical results appear to be stable long term; (2) the additional use of a graft seems to enhance the clinical outcome of cEMD; (3) the combined use of rhPDGF-BB and P-15 with a graft biomaterial has shown beneficial effects in intra-osseous defects; (4) contrasting results were reported for PRP and graft combinations; and (5) limited evidence supports the use of BAs either alone or in association with graft/GTR for the treatment of furcation defects.
C1 [Trombelli, Leonardo; Farina, Roberto] Univ Ferrara, Res Ctr Study Periodontal Dis, I-44100 Ferrara, Italy.
RP Trombelli, L (reprint author), Univ Ferrara, Res Ctr Study Periodontal Dis, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM leonardo.trombelli@unife.it
RI Trombelli, Leonardo/I-4671-2015; Farina, Roberto/D-6561-2015
OI Trombelli, Leonardo/0000-0002-1147-2199; Farina,
   Roberto/0000-0002-4621-7809
CR Aghaloo TL, 2006, INT J ORAL MAX IMPL, V21, P535
   Araujo MG, 1998, J CLIN PERIODONTOL, V25, P524, DOI 10.1111/j.1600-051X.1998.tb02482.x
   Barros RRM, 2006, J PERIODONTOL, V77, P1280, DOI 10.1902/jop.2006.050161
   Bateman J, 2005, J PERIODONTOL, V76, P1833, DOI 10.1902/jop.2005.76.11.1833
   Bhatnagar RS, 1997, J BIOMOL STRUCT DYN, V14, P547, DOI 10.1080/07391102.1997.10508155
   Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53
   Bhongade Manohar L, 2007, J Contemp Dent Pract, V8, P25
   Bokan I, 2006, J CLIN PERIODONTOL, V33, P885, DOI 10.1111/j.1600-051X.2006.01010.x
   Bonta H, 2003, QUINTESSENCE INT, V34, P247
   BOSSHARDT DD, 2006, EUROPEAN J ORAL S S1, V114, P222
   BOSSHARDT DD, 2006, EUROPEAN J ORAL S S1, V114, P226
   Bosshardt DD, 2008, J CLIN PERIODONTOL, V35, P87, DOI 10.1111/j.1600-051X.2008.01264.x
   Bosshardt DD, 2006, EUR J ORAL SCI, V114, P225, DOI 10.1111/j.1600-0722.2006.00300.x
   BOWERS G, 1991, J PERIODONTOL, V62, P690, DOI 10.1902/jop.1991.62.11.690
   BOWERS GM, 1989, J PERIODONTOL, V60, P683, DOI 10.1902/jop.1989.60.12.683
   Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018
   Boyne PJ, 1997, INT J PERIODONT REST, V17, P10
   Bratthall G, 2001, J CLIN PERIODONTOL, V28, P923, DOI 10.1034/j.1600-051x.2001.028010923.x
   Camargo PM, 2005, INT J PERIODONT REST, V25, P49
   Camargo PM, 2002, J PERIODONTAL RES, V37, P300, DOI 10.1034/j.1600-0765.2002.01001.x
   Camargo PM, 2001, J CLIN PERIODONTOL, V28, P1016, DOI 10.1034/j.1600-051X.2001.281105.x
   Camelo M, 2003, INT J PERIODONT REST, V23, P213
   Cardaropoli G, 2002, J PERIODONTOL, V73, P501, DOI 10.1902/jop.2002.73.5.501
   CHO MI, 1995, J PERIODONTOL, V66, P522, DOI 10.1902/jop.1995.66.6.522
   Christgau M, 2006, J CLIN PERIODONTOL, V33, P908, DOI 10.1111/j.1600-051X.2006.00999.x
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   Cortellini P, 2005, J PERIODONTOL, V76, P341, DOI 10.1902/jop.2005.76.3.341
   Cortellini P, 2007, J CLIN PERIODONTOL, V34, P1082, DOI 10.1111/j.1600-051X.2007.01144.x
   Cortellini P, 2007, J CLIN PERIODONTOL, V34, P87, DOI 10.1111/j.1600-051X.2006.01020.x
   Czuryszkiewicz-Cyrana J, 2006, Adv Med Sci, V51 Suppl 1, P26
   Demir B, 2007, J CLIN PERIODONTOL, V34, P709, DOI 10.1111/j.1600-051X.2007.01108.x
   Dori F, 2007, J CLIN PERIODONTOL, V34, P254, DOI 10.1111/j.1600-051X.2006.01044.x
   Dori F, 2008, J CLIN PERIODONTOL, V35, P44, DOI 10.1111/j.1600-051X.2007.01161.x
   Donos N, 2004, INT J PERIODONT REST, V24, P363
   Donos N, 2003, J CLIN PERIODONTOL, V30, P1061, DOI 10.1046/j.0303-6979.2003.00429.x
   Donos N, 2003, INT J PERIODONT REST, V23, P507
   Dori F, 2005, J PERIODONTOL, V76, P2236, DOI 10.1902/jop.2005.76.12.2236
   Dori F, 2007, J PERIODONTOL, V78, P983, DOI 10.1902/jop.2007.060349
   DRAGOO MR, 1973, J PERIODONTOL, V44, P599, DOI 10.1902/jop.1973.44.10.599
   Esposito M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003875.pub2
   Farina Roberto, 2007, Oral Health Prev Dent, V5, P307
   Forabosco A, 2003, Minerva Stomatol, V52, P105
   Froum S, 2004, J PERIODONTOL, V75, P1001, DOI 10.1902/jop.2004.75.7.1001
   Froum S, 2001, INT J PERIODONT REST, V21, P437
   Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P685, DOI 10.1111/j.1600-051X.1997.tb00250.x
   Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193
   Guida L, 2007, J PERIODONTOL, V78, P231, DOI 10.1902/jop.2007.060142
   Gurinsky BS, 2004, J PERIODONTOL, V75, P1309, DOI 10.1902/jop.2004.75.10.1309
   Hanna R, 2004, J PERIODONTOL, V75, P1668, DOI 10.1902/jop.2004.75.12.1668
   Harrel SK, 2005, J PERIODONTOL, V76, P380, DOI 10.1902/jop.2005.76.3.380
   Harris R J, 2000, Int J Periodontics Restorative Dent, V20, P510
   Harris RJ, 2007, INT J PERIODONT REST, V27, P171
   HATAKEYAMA M, 2008, ORAL SURG ORAL MED O, V105, P13
   Heard RH, 2000, J PERIODONTOL, V71, P1715, DOI 10.1902/jop.2000.71.11.1715
   Heden G, 2000, INT J PERIODONT REST, V20, P127
   Heden G, 1999, J CLIN PERIODONTOL, V26, P855
   Heden G, 2006, J PERIODONTOL, V77, P295, DOI 10.1902/jop.2006.050071
   Herford Alan S, 2007, J Calif Dent Assoc, V35, P335
   HIATT WH, 1978, J PERIODONTOL, V49, P495, DOI 10.1902/jop.1978.49.10.495
   Hoang AM, 2002, J DENT RES, V81, P497, DOI 10.1177/154405910208100713
   Hoffmann T, 2006, J CLIN PERIODONTOL, V33, P575, DOI 10.1111/j.1600-051X.2006.00947.x
   Howell TH, 1997, INT J PERIODONT REST, V17, P125
   Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186
   Jepsen S, 2008, J CLIN PERIODONTOL, V35, P420, DOI 10.1111/j.1600-051X.2008.01217.x
   Jepsen S, 2004, J PERIODONTOL, V75, P1150, DOI 10.1902/jop.2004.75.8.1150
   Jepsen S, 2002, J CLIN PERIODONTOL, V29, P103, DOI 10.1034/j.1600-051X.29.s3.6.x
   Kassolis JD, 2000, J PERIODONTOL, V71, P1654, DOI 10.1902/jop.2000.71.10.1654
   Keles GC, 2006, ACTA ODONTOL SCAND, V64, P327, DOI 10.1080/00016350600758651
   Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360
   King GN, 1998, J PERIODONTOL, V69, P561, DOI 10.1902/jop.1998.69.5.561
   King GN, 1999, J PERIODONTOL, V70, P1125, DOI 10.1902/jop.1999.70.10.1125
   Kuru B, 2006, CLIN ORAL INVEST, V10, P227, DOI 10.1007/s00784-006-0052-5
   Lallier TE, 2003, J PERIODONTOL, V74, P458, DOI 10.1902/jop.2003.74.4.458
   Lallier TE, 2001, J PERIODONTOL, V72, P990, DOI 10.1902/jop.2001.72.8.990
   Lekovic V, 2003, J CLIN PERIODONTOL, V30, P746, DOI 10.1034/j.1600-051X.2003.00368.x
   Lekovic V, 2002, J PERIODONTOL, V73, P198, DOI 10.1902/jop.2002.73.2.198
   Lekovic V, 2001, J PERIODONTOL, V72, P1157, DOI 10.1902/jop.2000.72.9.1157
   Lekovic V, 2001, J PERIODONTOL, V72, P583, DOI 10.1902/jop.2001.72.5.583
   Lekovic V, 2000, J PERIODONTOL, V71, P1110, DOI 10.1902/jop.2000.71.7.1110
   Leung George, 2003, Prim Dent Care, V10, P41, DOI 10.1308/135576103322500700
   Majzoub Z, 2005, INT J PERIODONT REST, V25, P283
   Manor A, 2000, J Int Acad Periodontol, V2, P44
   Martu S, 2000, Rev Med Chir Soc Med Nat Iasi, V104, P147
   Marx R E, 2001, Implant Dent, V10, P225
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Matos SM, 2007, J PERIODONTOL, V78, P1855, DOI 10.1902/jop.2007.060474
   Mauro S, 2003, Minerva Stomatol, V52, P401
   Maycock J, 2002, CONNECT TISSUE RES, V43, P472, DOI 10.1080/03008200290000880
   McGuire MK, 2006, INT J PERIODONT REST, V26, P223
   MELCHER AH, 1976, J PERIODONTOL, V47, P256, DOI 10.1902/jop.1976.47.5.256
   Mellonig JT, 1999, INT J PERIODONT REST, V19, P9
   Meyle J, 2004, J PERIODONTOL, V75, P1188, DOI 10.1902/jop.2004.75.9.1188
   Miliauskaite A, 2007, J PERIODONTOL, V78, P2043, DOI 10.1902/jop.2007.060492
   Minabe M, 2002, INT J PERIODONT REST, V22, P595
   Mott David A, 2002, J Oral Implantol, V28, P57, DOI 10.1563/1548-1336(2002)028<0057:EOOPIV>2.3.CO;2
   Murakami Shinya, 2007, Clin Calcium, V17, P249
   Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205
   Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282
   Nevins M, 2007, INT J PERIODONT REST, V27, P421
   Nikolopoulos S, 2002, INT J PERIODONT REST, V22, P269
   Okuda K, 2005, J PERIODONTOL, V76, P890, DOI 10.1902/jop.2005.76.6.890
   Okuda K, 2003, J PERIODONTOL, V74, P849, DOI 10.1902/jop.2003.74.6.849
   Onodera H, 2005, BIOMED RES-TOKYO, V26, P69, DOI 10.2220/biomedres.26.69
   Ouyang XY, 2006, CHINESE MED J-PEKING, V119, P1511
   Ozcelik O, 2008, J CLIN PERIODONTOL, V35, P147, DOI 10.1111/j.1600-051X.2007.01176.x
   Ozcelik O, 2007, J CLIN PERIODONTOL, V34, P788, DOI 10.1111/j.1600-051X.2007.01120.x
   Papadopoulos CE, 2003, J PERIODONTOL, V74, P451, DOI 10.1902/jop.2003.74.4.451
   Papli R, 2007, J PERIODONTOL, V78, P185, DOI 10.1902/jop.2007.060052
   Parashis A, 2000, J CLIN PERIODONTOL, V27, P705, DOI 10.1034/j.1600-051x.2000.027009705.x
   Parashis A, 2004, INT J PERIODONT REST, V24, P81
   Parashis AO, 2006, J PERIODONTOL, V77, P103, DOI 10.1902/jop.2006.77.1.103
   PARK JB, 1995, J PERIODONTOL, V66, P462, DOI 10.1902/jop.1995.66.6.462
   Parodi R, 2004, INT J PERIODONT REST, V24, P57
   Parodi R, 2000, INT J PERIODONT REST, V20, P585
   Pietruska M D, 2001, Rocz Akad Med Bialymst, V46, P198
   Pietruska MD, 2001, EUR J ORAL SCI, V109, P178, DOI 10.1034/j.1600-0722.2001.00007.x
   Radhakrishnan Sujatha, 2004, J Int Acad Periodontol, V6, P101
   Rasperini G, 2005, INT J PERIODONT REST, V25, P121
   Rasperini G, 1999, INT J PERIODONT REST, V19, P579
   Ripamonti U, 2006, PERIODONTOL 2000, V41, P73, DOI 10.1111/j.1600-0757.2006.00155.x
   Rosen PS, 2002, J PERIODONTOL, V73, P942, DOI 10.1902/jop.2002.73.8.942
   Saito E, 2003, J PERIODONTOL, V74, P1808, DOI 10.1902/jop.2003.74.12.1808
   Sallum EA, 2004, J PERIODONTOL, V75, P1357, DOI 10.1902/jop.2004.75.10.1357
   Sammartino G, 2005, J ORAL MAXIL SURG, V63, P766, DOI 10.1016/j.jams.2005.02.010
   Sanz M, 2004, J PERIODONTOL, V75, P726, DOI 10.1902/jop.2004.75.5.726
   Scheyer ET, 2002, J PERIODONTOL, V73, P423, DOI 10.1902/jop.2002.73.4.423
   Schwarz F, 2003, J CLIN PERIODONTOL, V30, P975, DOI 10.1034/j.1600-051X.2003.00412.x
   Sculean A, 1999, J PERIODONTOL, V70, P255, DOI 10.1902/jop.1999.70.3.255
   Sculean A, 2000, INT J PERIODONT REST, V20, P375
   Sculean A, 1999, INT J PERIODONT REST, V19, P157
   Sculean A, 2005, INT J PERIODONT REST, V25, P139
   Sculean A, 2005, J CLIN PERIODONTOL, V32, P111, DOI 10.1111/j.1600-051X.2004.00635.x
   Sculean A, 2004, INT J PERIODONT REST, V24, P327
   Sculean A, 2004, J CLIN PERIODONTOL, V31, P545, DOI 10.1111/j.1600-051X.2004.00518.x
   Sculean A, 2003, Clin Oral Investig, V7, P167, DOI 10.1007/s00784-003-0212-9
   Sculean A, 2003, INT J PERIODONT REST, V23, P345
   Sculean A, 2002, INT J PERIODONT REST, V22, P259
   Sculean A, 2002, J PERIODONTOL, V73, P401, DOI 10.1902/jop.2002.73.4.401
   Sculean A, 2001, J PERIODONTOL, V72, P1695, DOI 10.1902/jop.2001.72.12.1695
   Sculean A, 2001, J CLIN PERIODONTOL, V28, P397, DOI 10.1034/j.1600-051x.2001.028005397.x
   Sculean A, 2003, INT J PERIODONT REST, V23, P47
   Sculean A, 1998, J PERIODONTAL RES, V33, P453
   Sculean A, 1999, J PERIODONTAL RES, V34, P310, DOI 10.1111/j.1600-0765.1999.tb02259.x
   Sculean A, 2000, J CLIN PERIODONTOL, V27, P466, DOI 10.1034/j.1600-051x.2000.027007466.x
   Sculean A, 2007, INT J PERIODONT REST, V27, P221
   Sculean A, 2006, J PERIODONTOL, V77, P1879, DOI 10.1902/jop.2006.060002
   Sculean A, 2007, J CLIN PERIODONTOL, V34, P507, DOI 10.1111/j.1600-051X.2007.01084.x
   Sculean A, 2006, J PERIODONTOL, V77, P1167, DOI 10.1902/jop.2006.050300
   Selvig KA, 2002, J PERIODONTOL, V73, P1020, DOI 10.1902/jop.2002.73.9.1020
   Sigurdsson TJ, 1996, INT J PERIODONT REST, V16, P525
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   Silvestri M, 2003, J CLIN PERIODONTOL, V30, P386, DOI 10.1034/j.1600-051X.2003.10146.x
   Sipos PM, 2005, J CLIN PERIODONTOL, V32, P765, DOI 10.1111/j.1600-051X.2005.00754.x
   Sorensen RG, 2004, J CLIN PERIODONTOL, V31, P796, DOI 10.1111/j.1600-051X.2004.00544.x
   St George G, 2006, J CLIN PERIODONTOL, V33, P449, DOI 10.1111/j.1600-051X.2006.00926.x
   STAHL SS, 1983, J PERIODONTOL, V54, P325, DOI 10.1902/jop.1983.54.6.325
   Taba M Jr, 2005, Orthod Craniofac Res, V8, P292
   Tamimi FM, 2007, J ORAL MAXIL SURG, V65, P1084, DOI 10.1016/j.joms.2006.09.012
   Tonetti MS, 2004, J CLIN PERIODONTOL, V31, P1092, DOI 10.1111/j.1600-051X.2004.00615.x
   Trejo PM, 2004, J PERIODONTOL, V75, P1532, DOI 10.1902/jop.2004.75.11.1532
   Trombelli L, 2006, J CLIN PERIODONTOL, V33, P69, DOI 10.1111/j.1600-051X.2005.00865.x
   Trombelli L, 2005, PERIODONTOL 2000, V37, P88, DOI 10.1111/j.1600-0757.2004.03798.x
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P433, DOI 10.1034/j.1600-051X.2002.290508.x
   Tsitoura E, 2004, J CLIN PERIODONTOL, V31, P643, DOI 10.1111/j.1600-051X.2004.00555.x
   Vandana KL, 2004, INT J PERIODONT REST, V24, P185
   Vavouraki H. N., 2003, Cell and Tissue Banking, V4, P17, DOI 10.1023/A:1026383604279
   Velasquez-Plata D, 2002, J PERIODONTOL, V73, P433, DOI 10.1902/jop.2002.73.4.433
   Venezia E, 2004, CRIT REV ORAL BIOL M, V15, P382, DOI 10.1177/154411130401500605
   Walters SP, 2003, J PERIODONTOL, V74, P1161, DOI 10.1902/jop.2003.74.8.1161
   Wang HL, 2005, J PERIODONTOL, V76, P1601
   WANG HL, 1994, J PERIODONTOL, V65, P429, DOI 10.1902/jop.1994.65.5.429
   Weibrich G, 2003, CLIN ORAL IMPLAN RES, V14, P357, DOI 10.1034/j.1600-0501.2003.00810.x
   Wikesjo UME, 2005, CLIN IMPLANT DENT R, V7, P112, DOI 10.1111/j.1708-8208.2005.tb00054.x
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P715, DOI 10.1034/j.1600-051X.2003.00364.x
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P705, DOI 10.1034/j.1600-051X.2003.00363.x
   Wikesjo UME, 1999, J CLIN PERIODONTOL, V26, P392, DOI 10.1034/j.1600-051X.1999.260610.x
   Windisch P, 2002, J PERIODONTOL, V73, P409, DOI 10.1902/jop.2002.73.4.409
   Yamada Y, 2006, INT J PERIODONT REST, V26, P363
   Yassibag-Berkman Z, 2007, J PERIODONTOL, V78, P801, DOI 10.1902/jop.2007.060318
   Yilmaz S, 2007, PLATELETS, V18, P535, DOI 10.1080/09537100701481393
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Yukna RA, 2002, INT J PERIODONT REST, V22, P147
   Yukna RA, 2002, J PERIODONTOL, V73, P123, DOI 10.1902/jop.2002.73.1.123
   Yukna RA, 2000, J PERIODONTOL, V71, P752, DOI 10.1902/jop.2000.71.5.752
   Yukna RA, 2000, J PERIODONTOL, V71, P1671, DOI 10.1902/jop.2000.71.11.1671
   Zetterstrom O, 1997, J CLIN PERIODONTOL, V24, P697, DOI 10.1111/j.1600-051X.1997.tb00252.x
   Zucchelli G, 2003, J PERIODONTOL, V74, P1725, DOI 10.1902/jop.2003.74.12.1725
   Zucchelli G, 2006, J PERIODONTOL, V77, P1788, DOI 10.1902/jop.2006.050333
NR 189
TC 114
Z9 117
U1 0
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD SEP
PY 2008
VL 35
SU 8
BP 117
EP 135
DI 10.1111/j.1600-051X.2008.01265.x
PG 19
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 341SA
UT WOS:000258734000011
PM 18724846
DA 2018-10-20
ER

PT J
AU Ferraz, N
   Carlsson, J
   Hong, J
   Ott, MK
AF Ferraz, Natalia
   Carlsson, Jan
   Hong, Jaan
   Ott, Marjam Karlsson
TI Influence of nanoporesize on platelet adhesion and activation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID VON-WILLEBRAND-FACTOR; PROCOAGULANT ACTIVITY; WHOLE-BLOOD; P-SELECTIN;
   SURFACES; COMPLEMENT; MICROPARTICLES; BIOMATERIALS; FIBRONECTIN;
   VITRONECTIN
AB In this study we have evaluated the influence of biomaterial nano-topography on platelet adhesion and activation. Nano-porous alumina membranes with pore diameters of 20 and 200 nm were incubated with whole blood and platelet rich plasma. Platelet number, adhesion and activation were determined by using a coulter hematology analyzer, scanning electron microscopy, immunocytochemical staining in combination with light microscopy and by enzyme immunoassay. Special attention was paid to cell morphology, microparticle generation, P-selectin expression and beta-TG production. Very few platelets were found on the 200 nm alumina as compared to the 20 nm membrane. The platelets found on the 20 nm membrane showed signs of activation such as spread morphology and protruding filipodia as well as P-selectin expression. However no microparticles were detected on this surface. Despite the fact that very few platelets were found on the 200 nm alumina in contrast to the 20 nm membrane many microparticles were detected on this surface. Interestingly, all microparticles were found inside circular shaped areas of approximately 3 mu m in diameter. Since this is the approximate size of a platelet we speculate that this is evidence of transient, non-adherent platelet contact with the surface, which has triggered platelet microparticle generation. To the authors knowledge, this is the first study that demonstrates how nanotexture can influence platelet microparticle generation. The study highlights the importance of understanding molecular and cellular events on nano-level when designing new biomaterials.
C1 [Ferraz, Natalia; Carlsson, Jan; Ott, Marjam Karlsson] Uppsala Univ, Dept Phys & Analyt Chem, Div Surface Biotechnol, BMC, S-75123 Uppsala, Sweden.
   [Hong, Jaan] Uppsala Univ, Univ Hosp, Dept Oncol Radiol & Clin Immunol, Div Clin Immunol,Rudbeck Lab, S-75185 Uppsala, Sweden.
RP Ott, MK (reprint author), Uppsala Univ, Dept Phys & Analyt Chem, Div Surface Biotechnol, BMC, Husarg 3,Box 577, S-75123 Uppsala, Sweden.
EM Marjam.Ott@ytbioteknik.uu.se
CR ALKHAMIS TM, 1988, T AM SOC ART INT ORG, V34, P868
   BOUCHARD BA, 2002, PLATELETS, P229
   Broberg M, 2002, J LAB CLIN MED, V139, P163, DOI 10.1067/mlc.2002.121604
   Broberg M, 1998, COLLOID SURFACE B, V11, P67, DOI 10.1016/S0927-7765(98)00026-5
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   CURTIS A, 1997, BIOMATERIALS, V18, P573
   Dalby MJ, 2002, IEEE T NANOBIOSCI, V1, P18, DOI 10.1109/TNB.2002.806933
   ERIKSSON C, 1987, BIOMATERIALS, V22, P2001
   FERRAZ N, 2008, J BIOMED MAT RES
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gemmell CH, 2001, J BIOMAT SCI-POLYM E, V12, P933, DOI 10.1163/156856201753113114
   Godo MN, 1999, BIOMATERIALS, V20, P1117, DOI 10.1016/S0142-9612(99)00012-5
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Horstman LL, 1999, CRIT REV ONCOL HEMAT, V30, P111, DOI 10.1016/S1040-8428(98)00044-4
   Hsu SH, 2004, BIOMATERIALS, V25, P5593, DOI 10.1016/j.biomaterials.2004.01.061
   Karlsson M, 2004, MICROSC RES TECHNIQ, V63, P259, DOI 10.1002/jemt.20040
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   KARLSSONPARRA A, 1983, J IMMUNOL METHODS, V64, P85, DOI 10.1016/0022-1759(83)90386-1
   Kikuchi L, 2005, BIOMATERIALS, V26, P5285, DOI 10.1016/j.biomaterials.2005.01.009
   Marcus AJ, 1999, INFLAMMATION BASIC P, P77
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   NOMURA S, 2004, PLATELETS MEGAKARYOC, P260
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   PEERSCHKE EIB, 1993, J EXP MED, V178, P579, DOI 10.1084/jem.178.2.579
   Siedlecki CA, 1999, BIOMATERIALS, V20, P1521, DOI 10.1016/S0142-9612(99)00065-4
   SIMS PJ, 1991, IMMUNOL TODAY, V12, P338, DOI 10.1016/0167-5699(91)90012-I
   SIMS PJ, 1995, SEMIN CELL BIOL, V6, P275, DOI 10.1006/scel.1995.0037
   Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   VALLES J, 1991, BLOOD, V78, P154
   Wieneke H, 2003, CATHETER CARDIO INTE, V60, P399, DOI 10.1002/ccd.10664
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
NR 34
TC 40
Z9 41
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2008
VL 19
IS 9
BP 3115
EP 3121
DI 10.1007/s10856-008-3449-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 316QH
UT WOS:000256964300016
PM 18414999
DA 2018-10-20
ER

PT J
AU Ramtani, S
   Geiger, D
AF Ramtani, S.
   Geiger, D.
TI ANTICYTOSKELETAL DRUGS AND TIME CULTURE EFFECTS UPON THE MECHANICAL
   BEHAVIOR OF DERMAL EQUIVALENT TISSUE SUBMITTED TO UNCONFINED COMPRESSION
   LOADING
SO JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Biomaterial; dermal equivalent; finite strain viscoelasticity;
   unconfined compression; cytoskeletal disrupting agents
ID POPULATED COLLAGEN MICROSPHERE; CONTRACTION; FIBROBLASTS; CELLS;
   TRACTION; ACTIN; MORPHOGENESIS; DEFORMATIONS; MEMBRANE; INVITRO
AB The dermal equivalent ( DE), a dermis substitute consisting of human skin fibroblasts growing into a three-dimensional collagen matrix, is extensively used in many applications: wound-healing response, pharmacological studies, skin grafting, fibroblast proliferation and migration, extracellular matrix remodeling, and efficacy of cosmetic products. The widespread growth of numerical modeling in biomechanical research has placed a heightened emphasis on accurate material property data for soft biological tissues, in particular for equivalent dermis which has not been so thoroughly investigated. Under unconfined compression loading, the effects of the strain rate, time culture, and cytoskeleton-disrupting agents are experimentally investigated. In order to model the observed mechanical behavior of the DE under the above conditions, the internal state variable approach is adopted for finite deformation viscoelasticity and the optimized material parameters are identified with respect to the stated thermodynamic restriction (i.e. positive viscous dissipation).
C1 [Ramtani, S.] Univ Paris 13, Lab Proprietes Mecan & Thermodynam Mat, Inst Galilee, CNRS UPR 9001, F-93430 Villetaneuse, France.
   [Geiger, D.] Univ Paris 12, Fac Sci & Technol, Lab Biomecan Biomat Osteoarticulaires, CNRS SPI UMR 7052, F-94010 Creteil, France.
RP Ramtani, S (reprint author), Univ Paris 13, Lab Proprietes Mecan & Thermodynam Mat, Inst Galilee, CNRS UPR 9001, 99 Ave J-B Clement, F-93430 Villetaneuse, France.
EM ramtani@galilee.univ-paris13.fr
FU CNRS (Centre National de la Recherche Scientifique); DGA; INSERM
   (Institut National de la sante et de la Recherche Medicale)
FX The financial support of CNRS (Centre National de la Recherche
   Scientifique), DGA (Delegation Generale de l'Armement), and INSERM
   (Institut National de la sante et de la Recherche Medicale) are
   gratefully acknowledged.
CR BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BELL E, 1983, J INVEST DERMATOL, V81, P2
   Boehler J. P., 1987, APPL TENSOR FUNCTION
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594
   Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6
   Germain P., 1986, MECANIQUE, VI
   GERMAIN P, 1986, MECANIQUE, V2
   GRINNEL F, 1984, J CELL SCI, V66, P31
   Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X
   GUIDRY C, 1985, J CELL SCI, V79, P67
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   HERLICH HP, 1990, TISSUE CELL, V22, P407
   HERLICH HP, 1988, EYE, V2, P149
   Holzapfel GA, 2000, NONLINEAR SOLID MECH
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0
   KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73
   Martin-Green M, 2000, PRINCIPLES TISSUE EN, P33
   MATSUSHITA T, 2001, RIKEN REV, V41, P67
   MOON AG, 1993, AICHE J, V39, P163, DOI 10.1002/aic.690390116
   Moulin V, 1996, BURNS, V22, P359, DOI 10.1016/0305-4179(95)00167-0
   MURRAY JD, 1984, J MATH BIOL, V19, P265, DOI 10.1007/BF00277099
   NUSGENS B, 1984, COLLAGEN REL RES, V4, P351
   OSBORN M, 1976, P NATL ACAD SCI USA, V73, P867, DOI 10.1073/pnas.73.3.867
   Pioletti DP, 2000, EUR J MECH A-SOLID, V19, P749, DOI 10.1016/S0997-7538(00)00202-3
   Pioletti DP, 1998, J BIOMECH, V31, P753, DOI 10.1016/S0021-9290(98)00077-3
   Ramtani S, 2004, J BIOMECH, V37, P1709, DOI 10.1016/j.jbiomech.2004.01.028
   SAVENJEE R, 1982, J BIOMECH, V15, P107
   STOSSEL TP, 1989, J BIOL CHEM, V264, P18261
   VERONDA DR, 1970, J BIOMECH, V3, P111, DOI 10.1016/0021-9290(70)90055-2
   WAGENSEIL JE, 2001, P ASME BIOENG C, V50, P551
   Wu HW, 1998, SCANNING, V20, P389
NR 34
TC 2
Z9 2
U1 0
U2 4
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-5194
J9 J MECH MED BIOL
JI J. Mech. Med. Biol.
PD SEP
PY 2008
VL 8
IS 3
BP 339
EP 352
DI 10.1142/S0219519408002735
PG 14
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 389LM
UT WOS:000262094100003
DA 2018-10-20
ER

PT J
AU Yang, JM
   Wang, HZ
   Yang, CC
AF Yang, Jen Ming
   Wang, Hung Zen
   Yang, Chun Chen
TI Modification and characterization of semi-crystalline poly(vinyl
   alcohol) with interpenetrating poly(acrylic acid) by UV radiation method
   for alkaline solid polymer electrolytes membrane
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE poly(vinyl alcohol); poly(acrylic acid); ionic conductivity; alkaline
   solid polymer electrolyte membrane
ID SBS-G-VP; DMAEMA COPOLYMER MEMBRANE; POLYVINYL-ALCOHOL; POLYURETHANE
   MEMBRANE; SECONDARY BATTERIES; BIOMATERIAL USAGE; FUEL-CELLS;
   CONDUCTIVITY; PERMEATION; CHITOSAN
AB Semi-crystalline poly(vinyl alcohol) was modified by UV radiation with acrylic acid monomer to get interpenetrating poly(acrylic acid) modified poly(vinyl alcohol), PVAAA, membrane. The stability of various PVAAA membranes in water, 2 M CH(3)OH, 2 M H(2)SO(4), and 40wt% KOH aqueous media were evaluated. It was found that the stability of PVAAA membrane is stable in 40 wt% KOH solution. The PVAAA membranes were characterized by differential scanning calorimetry, X-ray diffraction, and thermogravimetry analysis. These results show that (1) the crystallinity in PVAAA decreased with increasing the content of poly(acrylic acid) in the PVAAA membranes. (2) The melting point of the PVAAA membrane is reduced with increasing the content of poly(acrylic acid) in the membrane. (3)Three stages of thermal degradation were found for pure PVA. Compared to pure PVA, the temperature of thermal degradation increased for the PVAAA membrane. The various PVAAA membranes were immersed in KOH solution to form polymer electrolyte membranes, PVAAA-KOH, and their performances for alkaline solid polymer electrolyte were conducted. At room temperature, the ionic conductivity increased from 0.044 to 0.312 S/cm. The result was due to the formation of interpenetrating polymer chain of poly(acrylic acid) in the PVAAA membrane and resulting in the increase of charge carriers in the PVA polymer matrix. Compared to the data reported for different membranes by other studies, our PVAAA membrane are highly ionic conducting alkaline solid polymer electrolytes membranes.
C1 [Yang, Jen Ming; Wang, Hung Zen] Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
   [Yang, Chun Chen] Ming Chi Univ Technol, Dept Chem Engn, Taipei 243, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
EM jmyang@mail.cgu.edu.tw
FU National Science Council of the Republic of China; Chang Gung Memorial
   Hospital
FX This work was supported by National Science Council of the Republic of
   China and partial financial support of Chang Gung Memorial Hospital.
CR ANDRIEU X, 1995, ELECTROCHIM ACTA, V40, P2295, DOI 10.1016/0013-4686(95)00181-D
   Asensio JA, 2004, ELECTROCHIM ACTA, V49, P4461, DOI 10.1016/j.electacta.2004.05.002
   Bae B, 2003, J MEMBRANE SCI, V220, P75, DOI 10.1016/S0376-7388(03)00216-3
   Carretta N, 2000, J MEMBRANE SCI, V166, P189, DOI 10.1016/S0376-7388(99)00258-6
   FAUVARQUE JF, 1995, ELECTROCHIM ACTA, V40, P2449, DOI 10.1016/0013-4686(95)00212-W
   Guinot S, 1998, ELECTROCHIM ACTA, V43, P1163, DOI 10.1016/S0013-4686(97)10015-9
   Holland BJ, 2001, POLYMER, V42, P6775, DOI 10.1016/S0032-3861(01)00166-5
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   Iwakura C, 2002, SOLID STATE IONICS, V148, P487, DOI 10.1016/S0167-2738(02)00092-9
   Kobayashi T, 1998, SOLID STATE IONICS, V106, P219, DOI 10.1016/S0167-2738(97)00512-2
   Lee HC, 2004, ELECTROCHIM ACTA, V49, P2315, DOI 10.1016/j.electacta.2004.01.012
   Lewandowski A, 2000, SOLID STATE IONICS, V133, P265, DOI 10.1016/S0167-2738(00)00733-5
   Lewandowski A, 2001, ELECTROCHIM ACTA, V46, P2777, DOI 10.1016/S0013-4686(01)00496-0
   MILLER RL, 1989, POLYMER HDB
   Mohamad AA, 2003, SOLID STATE IONICS, V156, P171, DOI 10.1016/S0167-2738(02)00617-3
   PEYSER P, 1989, POLYMER HDB
   Rajendran S, 2004, MATER LETT, V58, P641, DOI 10.1016/S0167-577X(03)00585-8
   Subramania A, 2005, J POWER SOURCES, V141, P188, DOI 10.1016/j.powsour.2004.09.001
   Vassal N, 2000, ELECTROCHIM ACTA, V45, P1527, DOI 10.1016/S0013-4686(99)00369-2
   Wu GM, 2006, J MEMBRANE SCI, V284, P120, DOI 10.1016/j.memsci.2006.07.025
   Yang CC, 2006, J APPL ELECTROCHEM, V36, P655, DOI 10.1007/s10800-006-9117-z
   Yang CC, 2005, J POWER SOURCES, V152, P303, DOI 10.1016/j.jpowsour.2005.03.004
   Yang CC, 2004, MATER LETT, V58, P33, DOI 10.1016/S0167-577X(03)00409-9
   Yang CC, 2003, J POWER SOURCES, V122, P210, DOI 10.1016/S0378-7753(03)00429-4
   Yang CC, 2002, MATER LETT, V57, P873, DOI 10.1016/S0167-577X(02)00888-1
   Yang CC, 2002, J POWER SOURCES, V109, P22, DOI 10.1016/S0378-7753(02)00038-1
   Yang CC, 2002, J POWER SOURCES, V112, P497, DOI 10.1016/S0378-7753(02)00438-X
   Yang CC, 2006, MAT SCI ENG B-SOLID, V131, P256, DOI 10.1016/j.mseb.2006.04.036
   Yang JM, 2003, J APPL POLYM SCI, V90, P1331, DOI 10.1002/app.12787
   Yang JM, 1997, J APPL POLYM SCI, V65, P365, DOI 10.1002/(SICI)1097-4628(19970711)65:2<365::AID-APP17>3.0.CO;2-Z
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 2005, J MEMBRANE SCI, V258, P97, DOI 10.1016/j.memsci.2005.02.033
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
NR 41
TC 38
Z9 40
U1 4
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD SEP 1
PY 2008
VL 322
IS 1
BP 74
EP 80
DI 10.1016/j.memsci.2008.05.035
PG 7
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 345RP
UT WOS:000259014400010
DA 2018-10-20
ER

PT J
AU Sahni, JK
   Chopra, S
   Ahmad, FJ
   Khar, RK
AF Sahni, Jasjeet K.
   Chopra, Shruti
   Ahmad, Farhan J.
   Khar, Roop K.
TI Potential prospects of chitosan derivative trimethyl chitosan chloride
   (TMC) as a polymeric absorption enhancer: synthesis, characterization
   and applications
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Review
ID EPITHELIAL-CELLS CACO-2; IN-VITRO EVALUATION; NASAL DELIVERY-SYSTEM;
   POORLY ABSORBABLE DRUGS; INTESTINAL-ABSORPTION; MOLECULAR-WEIGHT;
   QUATERNIZED CHITOSAN; N-TRIMETHYLCHITOSAN; VIVO; NANOPARTICLES
AB In recent years, researchers have been working extensively on various novel properties of polymers to develop increased efficiency of drug delivery and improve bioavailability of various drug molecules, especially macromolecules. Chitosan, a naturally occurring polysaccharide, because of its protonated/polymeric nature, provides effective and safe absorption of peptide and protein drugs. Its transmucosal absorption is, however, limited to acidic media because of its strong intermolecular hydrogen bonds, A new partially quaternized chitosan derivative, N-trimethyl chitosan chloride (TMC), has been synthesized with improved solubility, safety and effectiveness as an absorption enhancer at neutral pH and in aqueous environment. It enhances the absorption, especially of peptide drugs, by reversible opening of tight junctions in between epithelial cells, thereby facilitating the paracellular diffusion of peptide drugs. This derivative thus opens new perspectives as a biomaterial for various pharmaceutical applications/drug delivery systems. This review deals with the potential use of the quaternized chitosan derivative as a permeation enhancer for the mucosal delivery of macromolecular drugs along with its other biomedical applications.
C1 [Sahni, Jasjeet K.; Chopra, Shruti; Ahmad, Farhan J.; Khar, Roop K.] Hamdard Univ, Fac Pharm, Dept Pharmaceut, New Delhi, India.
RP Sahni, JK (reprint author), Hamdard Univ, Fac Pharm, Dept Pharmaceut, New Delhi, India.
EM jasjeet2975@yahoo.com
OI Ahmad, Farhan/0000-0002-0740-8573
CR Amidi M, 2006, J CONTROL RELEASE, V111, P107, DOI 10.1016/j.conrel.2005.11.014
   Amidi M, 2007, VACCINE, V25, P6818, DOI 10.1016/j.vaceine.2007.05.064
   Amidi M, 2007, VACCINE, V25, P144, DOI 10.1016/j.vaccine.2006.06.086
   ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988
   Atyabi F, 2005, CARBOHYD POLYM, V61, P39, DOI 10.1016/j.carbpol.2005.02.005
   Avadi MR, 2004, EUR POLYM J, V40, P1355, DOI 10.1016/j.europolymj.2004.02.015
   Bernkop-Schnurch A, 2001, ADV DRUG DELIVER REV, V52, P127, DOI 10.1016/S0169-409X(01)00196-X
   Boonyo W, 2007, J CONTROL RELEASE, V121, P168, DOI 10.1016/j.jconrel.2007.05.025
   Borchard G, 1996, J CONTROL RELEASE, V39, P131, DOI 10.1016/0168-3659(95)00146-8
   CHANDY T, 1991, BIOMAT ARTIF CELL IM, V19, P745, DOI 10.3109/10731199109117852
   Chen F, 2008, INT J PHARM, V349, P226, DOI 10.1016/j.ijpharm.2007.07.035
   Chen F, 2007, INT J PHARM, V336, P166, DOI 10.1016/j.ijpharm.2006.11.027
   COLO DG, 2004, J PHARM SCI, V44, P2851
   DOMARD A, 1986, INT J BIOL MACROMOL, V8, P105, DOI 10.1016/0141-8130(86)90007-3
   Dorkoosh FA, 2002, PHARMACEUT RES, V19, P1532, DOI 10.1023/A:1020416918624
   Fini A., 2003, AM J DRUG DELIV, V1, P43
   FIX J A, 1987, Journal of Controlled Release, V6, P151, DOI 10.1016/0168-3659(87)90072-1
   Florea BI, 2006, J CONTROL RELEASE, V110, P353, DOI 10.1016/j.jconrel.2005.10.001
   GUMBINER B, 1987, AM J PHYSIOL, V25, P3749
   Hamman JH, 2002, INT J PHARM, V232, P235, DOI 10.1016/S0378-5173(01)00914-0
   Hamman JH, 2003, DRUG DEV IND PHARM, V29, P161, DOI 10.1081/DDC-120016724
   Heras A, 2001, CARBOHYD POLYM, V44, P1, DOI 10.1016/S0144-8617(00)00195-8
   HOCHMAN J, 1994, J CONTROL RELEASE, V29, P253, DOI 10.1016/0168-3659(94)90072-8
   Hoppe-Seiler F., 1994, BER DTSCH CHEM GES, V27, P3329
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5
   Jonker C, 2002, INT J PHARM, V238, P205, DOI 10.1016/S0378-5173(02)00068-6
   Junginger HE, 1998, PHARM SCI TECHNOL TO, V1, P370, DOI 10.1016/S1461-5347(98)00100-X
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   Kato Yoshinori, 2003, Current Pharmaceutical Biotechnology, V4, P303, DOI 10.2174/1389201033489748
   Kean T, 2005, J CONTROL RELEASE, V103, P643, DOI 10.1016/j.jconrel.2004.01.001
   Kotze AF, 1999, EUR J PHARM SCI, V7, P145, DOI 10.1016/S0928-0987(98)00016-5
   Kotze AF, 1999, J PHARM SCI, V88, P253, DOI 10.1021/js980233c
   Kotze AF, 1999, EUR J PHARM BIOPHARM, V47, P269, DOI 10.1016/S0939-6411(99)00006-5
   Kotze AF, 1997, PHARMACEUT RES, V14, P1197, DOI 10.1023/A:1012106907708
   Murata J, 1997, CARBOHYD POLYM, V32, P105, DOI 10.1016/S0144-8617(96)00154-3
   MUZZARELLI RAA, 1992, CARBOHYD POLYM, V19, P231, DOI 10.1016/0144-8617(92)90074-Z
   Polnok A, 2004, EUR J PHARM BIOPHARM, V57, P77, DOI 10.1016/S0939-6411(03)00151-6
   Sandri G, 2006, J PHARM PHARMACOL, V58, P1327, DOI 10.1211/jpp.58.10.0005
   Sandri G, 2005, INT J PHARM, V297, P146, DOI 10.1016/j.ijpharm.2005.03.017
   Sandri G, 2007, EUR J PHARM BIOPHARM, V65, P68, DOI 10.1016/j.ejpb.2006.07.016
   Schipper NGM, 1999, EUR J PHARM SCI, V8, P335, DOI 10.1016/S0928-0987(99)00032-9
   Schipper NGM, 1996, PHARMACEUT RES, V13, P1686, DOI 10.1023/A:1016444808000
   Sieval AB, 1998, CARBOHYD POLYM, V36, P157, DOI 10.1016/S0144-8617(98)00009-5
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Sinha VR, 2004, INT J PHARM, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026
   Sinha VR, 2001, INT J PHARM, V224, P19, DOI 10.1016/S0378-5173(01)00720-7
   Snyman D, 2002, CARBOHYD POLYM, V50, P145, DOI 10.1016/S0144-8617(02)00008-5
   Snyman D, 2003, DRUG DEV IND PHARM, V29, P61, DOI 10.1081/DDC-120016684
   Thanou M, 2001, ADV DRUG DELIVER REV, V50, pS91, DOI 10.1016/S0169-409X(01)00180-6
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   Thanou M, 2001, ADV DRUG DELIVER REV, V52, P117, DOI 10.1016/S0169-409X(01)00231-9
   Thanou M, 2001, PHARM RES-DORDR, V18, P823, DOI 10.1023/A:1011092613951
   Thanou M, 2000, PHARMACEUT RES, V17, P27, DOI 10.1023/A:1007558206506
   Thanou M, 2000, J PHARM SCI, V89, P951
   Thanou MM, 2000, J CONTROL RELEASE, V64, P15, DOI 10.1016/S0168-3659(99)00131-5
   Thanou MM, 1999, INT J PHARM, V185, P73, DOI 10.1016/S0378-5173(99)00126-X
   van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5
   van der Merwe SM, 2004, EUR J PHARM BIOPHARM, V57, P85, DOI 10.1016/S0939-6411(03)00152-8
   Zambito Y, 2006, EUR J PHARM BIOPHARM, V64, P16, DOI 10.1016/j.ejpb.2006.01.004
NR 61
TC 25
Z9 25
U1 2
U2 19
PU PHARMACEUTICAL PRESS-ROYAL PHARMACEUTICAL SOC GREAT BRITIAN
PI LONDON
PA 1 LAMBETH HIGH ST, LONDON SE1 7JN, ENGLAND
SN 0022-3573
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD SEP
PY 2008
VL 60
IS 9
BP 1111
EP 1119
DI 10.1211/jpp.60.9.0001
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 344PD
UT WOS:000258938900001
PM 18718113
DA 2018-10-20
ER

PT J
AU Falco, EE
   Roth, JS
   Fisher, JP
AF Falco, Erin E.
   Roth, J. Scott
   Fisher, John P.
TI EH networks as a scaffold for skeletal muscle regeneration in abdominal
   wall hernia repair
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE skeletal muscle; abdominal wall hernia; cyclic acetal; prosthetic
   meshes; insulin-like growth factor-1
ID SMALL-INTESTINAL SUBMUCOSA; GROWTH-FACTOR-I; POLY(PROPYLENE FUMARATE)
   SCAFFOLDS; PHOTOINITIATED CROSS-LINKING; SATELLITE CELL; POLYPROPYLENE
   MESH; INSULIN; DIFFERENTIATION; HYPERTROPHY; EXPRESSION
AB Incisional hernias are a common clinical problem occurring in up to 10% of all patients undergoing abdominal procedures. Primary closure, synthetic biomaterials, as well as xenografts and allografts have been used in hernia defect repair. Despite these approaches, the incidence of hernia recurrence ranges from 32% to 63%. To address this high recurrence rate, we propose an incisional hernia treatment that utilizes a functional biomaterial developed for skeletal muscle regeneration. In particular, we have developed a cyclic acetal biomaterial (EH network) based on 5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1,3-dioxane-2- ethanol diacrylate. Initial tests of the scaffold's mechanical properties indicate that the complex modulus of the EH network decreased after a significant increase in initiator concentration. Subsequent studies indicate that EH networks promote myoblastic cell attachment and proliferation as well as delivers functional insulin-like growth factor-1 to an in vitro population of skeletal myoblasts. This work establishes that an EH network, a degradable cyclic acetal biomaterial, can function as a scaffold for skeletal muscle engineering. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Falco, Erin E.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   [Roth, J. Scott] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Bldg, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
FU National Science Foundation [0448684]
FX This work was supported by the National Science Foundation through a
   Career Award to JPF (no. 0448684). The authors acknowledge the editorial
   contributions provided by Rosemary Klein of the Division of General
   Surgery at the University of Maryland Medical Center.
CR Adams GR, 1998, J APPL PHYSIOL, V84, P1716
   ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301
   Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603
   BEGUINOT F, 1985, J BIOL CHEM, V260, P5892
   Borrazzo E C, 2004, Hernia, V8, P108, DOI 10.1007/s10029-003-0181-6
   Burger JWA, 2004, ANN SURG, V240, P578
   CAMPION DR, 1984, INT REV CYTOL, V87, P225, DOI 10.1016/S0074-7696(08)62444-4
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Danino AM, 2005, BRIT J PLAST SURG, V58, P384, DOI 10.1016/j.bjps.2004.06.004
   DEVOL DL, 1990, AM J PHYSIOL, V259, pE89
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1327, DOI 10.1021/bm030028d
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Gonzalez R, 2004, Hernia, V8, P213
   Hashimoto N, 2004, DEVELOPMENT, V131, P5481, DOI 10.1242/dev.01395
   Holterman CE, 2005, SEMIN CELL DEV BIOL, V16, P575, DOI 10.1016/j.semcdb.2005.07.004
   Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066
   KAIHARA S, EUR J PHARM IN PRESS
   KAIHARA S, MACROMOLECU IN PRESS
   Kayaoglu HA, 2005, J INVEST SURG, V18, P89, DOI 10.1080/08941930590926357
   Ko R, 2006, J SURG RES, V135, P9, DOI 10.1016/j.jss.2006.02.007
   Machida S, 2004, EXP GERONTOL, V39, P1521, DOI 10.1016/j.exger.2004.08.009
   Marzaro M, 2002, INT J MOL MED, V10, P177
   Matthews BD, 2003, J SURG RES, V114, P126, DOI 10.1016/S0022-4804(03)00158-6
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Patton JH, 2007, AM J SURG, V193, P360, DOI 10.1016/j.amjsurg.2006.09.021
   Pu LLQ, 2005, PLAST RECONSTR SURG, V115, P2127, DOI 10.1097/01.PRS.0000168883.65715.2F
   Santa Maria L, 2004, EXP CELL RES, V300, P418, DOI 10.1016/j.yexcr.2004.07.017
   Song C, 2006, SURG ENDOSC, V20, P987, DOI 10.1007/s00464-005-0676-6
NR 34
TC 12
Z9 13
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD SEP
PY 2008
VL 149
IS 1
BP 76
EP 83
DI 10.1016/j.jss.2007.08.016
PG 8
WC Surgery
SC Surgery
GA 340GD
UT WOS:000258633200012
PM 18395749
DA 2018-10-20
ER

PT J
AU Larsen, T
   Schultz, K
   Furst, EM
AF Larsen, Travis
   Schultz, Kelly
   Furst, Eric M.
TI Hydrogel microrheology near the liquid-solid transition
SO KOREA-AUSTRALIA RHEOLOGY JOURNAL
LA English
DT Article; Proceedings Paper
CT 9th International Symposium on Applied Rheology
CY MAY   15, 2008
CL Korea Univ, Seoul, SOUTH KOREA
HO Korea Univ
DE hydrogel; peptide; microrheology; particle tracking; superposition;
   critical gel
ID ACTIN-FILAMENT NETWORKS; CROSS-LINKING; GEL POINT; LINEAR
   VISCOELASTICITY; REVERSIBLE HYDROGELS; PARTICLE TRACKING; DESIGNED
   PEPTIDE; DELIVERY; GELATION; CELLS
AB Multiple particle tracking microrheology is used to characterize the viscoelastic properties of biomaterial and synthetic polymer gels near the liquid-solid transition. Probe particles are dispersed in the get precursors, and their dynamics are measured as a function of the extent of reaction during gel formation. We interpret the dynamics using the generalized Stokes-Einstein relationship (GSER), using a form of the GSER that emphasizes the relationship between the probe particle mean-squared displacement and the material creep compliance. We show that long-standing concepts in gel bulk rheology are applicable to microrheological data, including time-cure Superposition to identify the gel point and critical scaling exponents, and the power-law behavior of incipient network's viscoelastic response. These experiments provide valuable insight into the rheology, structure, and kinetics of gelling materials, and are especially powerful for studying the weak incipient networks of dilute gelators, as well as scarce materials, due to the small sample size requirements and rapid data acquisition.
C1 [Furst, Eric M.] Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   Univ Delaware, Ctr Mol & Engn Thermodynam, Newark, DE 19716 USA.
RP Furst, EM (reprint author), Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
EM furst@udel.edu
OI Furst, Eric/0000-0002-8849-4484
CR ADOLF D, 1990, MACROMOLECULES, V23, P3700, DOI 10.1021/ma00217a026
   BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619
   CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955
   Chin K, 2008, BIOTECHNOL PROGR, V24, P358, DOI 10.1021/bp070160f
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   DERRIDA B, 1983, J PHYS LETT-PARIS, V44, pL701
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302
   Grinstaff MW, 2007, BIOMATERIALS, V28, P5205, DOI 10.1016/j.biomaterials.2007.08.041
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   JOANNY JF, 1982, J PHYS-PARIS, V43, P467, DOI 10.1051/jphys:01982004303046700
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Larsen TH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146001
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MARTIN JE, 1988, PHYS REV LETT, V61, P2620, DOI 10.1103/PhysRevLett.61.2620
   MARTIN JE, 1989, PHYS REV A, V39, P1325, DOI 10.1103/PhysRevA.39.1325
   Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Palmer A, 1998, RHEOL ACTA, V37, P97, DOI 10.1007/s003970050095
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]
   Savin T, 2007, SOFT MATTER, V3, P1194, DOI 10.1039/b700434f
   SCANLAN JC, 1991, MACROMOLECULES, V24, P47, DOI 10.1021/ma00001a008
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   STAUFFER D, 1982, ADV POLYM SCI, V44, P103
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tseng Y, 2002, J BIOL CHEM, V277, P18143, DOI 10.1074/jbc.M110868200
   Veerman C, 2006, MACROMOLECULES, V39, P6608, DOI 10.1021/ma0609331
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   Winter HH, 1997, ADV POLYM SCI, V134, P165
   Wu DQ, 2008, BIOMACROMOLECULES, V9, P1155, DOI 10.1021/bm7010328
   Xu CY, 2005, BIOMACROMOLECULES, V6, P1739, DOI 10.1021/bm0500171f
   Zimenkov Y, 2006, J AM CHEM SOC, V128, P6770, DOI 10.1021/ja0605974
NR 42
TC 25
Z9 25
U1 0
U2 12
PU KOREAN SOC RHEOLOGY
PI SEOUL
PA KOREA SCI TECHNOLOGY CENTER, 635-4 YUKSAM-DONG, STE 806, KANGNAM-GOO,
   SEOUL 135-703, SOUTH KOREA
SN 1226-119X
J9 KOREA-AUST RHEOL J
JI Korea-Aust. Rheol. J.
PD SEP
PY 2008
VL 20
IS 3
BP 165
EP 173
PG 9
WC Mechanics; Polymer Science
SC Mechanics; Polymer Science
GA 354XR
UT WOS:000259673700007
DA 2018-10-20
ER

PT J
AU Arata, HF
   Gillot, F
   Nojima, T
   Fujii, T
   Fujita, H
AF Arata, Hideyuki F.
   Gillot, Frederic
   Nojima, Takahiko
   Fujii, Teruo
   Fujita, Hiroyuki
TI Millisecond denaturation dynamics of fluorescent proteins revealed by
   femtoliter container on micro-thermodevice
SO LAB ON A CHIP
LA English
DT Article
ID TOTAL ANALYSIS SYSTEMS; CHROMOPHORE FORMATION; THERMAL-ACTIVATION;
   MOLECULES
AB Real-time observation of biomolecular behavior focusing on high speed temperature response is an essential endeavor for further biological study at the molecular level. This is because most of the important biological functions at the molecular level happen at the sub-second time scale. We used our own on-chip microheaters and microcontainers to observe the denaturation dynamics of fluorescent proteins at the millisecond time scale. The microheater controls the temperature in 1 ms under the microscope. Fluorescent proteins were contained in 28 fL PDMS microcontainers to prevent them from diffusing into the solution. The proteins were denatured by high temperatures and observed by a high speed CCD camera with 5 ms per frame. Hence, denaturation speeds of red fluorescent proteins (rDsRed and rHcRed) were measured to be 5-10 ms. Green fluorescent proteins (rAcGFP and rGFPuv) denatured with bi-exponential decay. rAcGFP denatured with time constants of 5 ms and 75 ms while rGFPuv denatured with 10 ms and 130 ms. This may be the reverse process of a two step renaturation of GFP observed in a previous report. This micro-thermodevice is applicable to other biomaterials such as nucleic acids or other proteins. It does not require any chemical treatment nor mutation to the biomaterial itself. Therefore, the methodology using this general purpose device gives access to biomolecular studies in short time scales and acts as a powerful tool in molecular biology.
C1 [Arata, Hideyuki F.; Gillot, Frederic; Nojima, Takahiko; Fujii, Teruo; Fujita, Hiroyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan.
   [Gillot, Frederic] CNRS, LIMMS, F-75700 Paris, France.
RP Arata, HF (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.
EM Hideyuk.Arata@curie.fr
OI NOJIMA, Takahiko/0000-0001-9873-2856
FU Japan Society of Promotion of Science (JSPS)
FX This work was supported by the Japan Society of Promotion of Science
   (JSPS). We thank Dr C. Yamahata for his help in data analysis. This
   paper was reviewed and revised while HA was working in J-L. Viovy's
   group at the Curie Institute, Paris.
CR Arata HF, 2005, ANAL CHEM, V77, P4810, DOI 10.1021/ac050385+
   ARATA HF, 2006, APPL PHYS LETT, V88, P8392
   Arata HF, 2006, SENSOR ACTUAT B-CHEM, V117, P339, DOI 10.1016/j.snb.2005.11.017
   Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t
   BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0
   Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061
   Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315
   GILLOT F, 2007, LAB CHIP, V7, P1
   Gurskaya NG, 2003, BIOCHEM J, V373, P403, DOI 10.1042/BJ20021966
   Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1
   Kato H, 1999, P NATL ACAD SCI USA, V96, P9602, DOI 10.1073/pnas.96.17.9602
   Kawaguchi K, 2001, CELL MOTIL CYTOSKEL, V49, P41, DOI 10.1002/cm.1019
   Leiderman P, 2006, BIOPHYS J, V90, P1009, DOI 10.1529/biophysj.105.069393
   Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657
   MCDONALD JC, 2002, ACC CHEM RES, V35
   Penna TCV, 2004, LETT APPL MICROBIOL, V38, P135, DOI 10.1111/j.1472-765X.2003.01460.x
   Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w
   Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435
   Rondelez Y, 2005, NAT BIOTECHNOL, V23, P361, DOI 10.1038/nbt1072
   Rondelez Y, 2005, NATURE, V433, P773, DOI 10.1038/nature03277
   Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8
   WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003
NR 24
TC 16
Z9 16
U1 4
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PD SEP
PY 2008
VL 8
IS 9
BP 1436
EP 1440
DI 10.1039/b806749j
PG 5
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 354YO
UT WOS:000259676000003
PM 18818796
OA Bronze
DA 2018-10-20
ER

PT J
AU Silva, CCGE
   Konig, B
   Carbonari, MJ
   Yoshimoto, M
   Allegrini, S
   Bressiani, JC
AF Guedes e Silva, C. C.
   Konig, B., Jr.
   Carbonari, M. J.
   Yoshimoto, M.
   Allegrini, S., Jr.
   Bressiani, J. C.
TI Bone growth around silicon nitride implants - An evaluation by scanning
   electron microscopy
SO MATERIALS CHARACTERIZATION
LA English
DT Article
DE silicon nitride; biomaterial; bone; scanning electron microscopy
ID CERAMICS; CELLS; FIXATION
AB Silicon nitride has demonstrated to be a potential candidate for clinical applications because it is a non-cytotoxic material and has satisfactory fracture toughness, high wear resistance and low friction coefficient. In this paper, samples of silicon nitride, which were kept into rabbits' tibias for 8 weeks, and the adjacentbone tissue were analysed by scanning electron microscopy in order to verify the bone growth around the implants and the interaction between the implant and the bone. Bone growth occurred mainly in the cortical areas, although it has been observed that the newly bone tends to grow toward the marrow cavity. Differences were observed between the implants installed into distal and proximal regions. In the first region, where the distance between the implant and the cortical bone is greater than in the proximal region, the osteoconduction process was evidenced by the presence of a bridge bone formation toward the implant surface. The results showed that silicon nitride can be used as biomaterial since the newly bone grew around the implants. (c) 2007 Elsevier Inc. All rights reserved.
C1 [Guedes e Silva, C. C.] CTMSP, BR-05508000 Sao Paulo, Brazil.
   [Konig, B., Jr.; Yoshimoto, M.; Allegrini, S., Jr.] Univ Sao Paulo, ICB, BR-05508900 Sao Paulo, Brazil.
   [Carbonari, M. J.; Bressiani, J. C.] IPEN, CNEN, SP, BR-05508000 Sao Paulo, Brazil.
RP Silva, CCGE (reprint author), CTMSP, Av Prof Lineu Prestes 2468, BR-05508000 Sao Paulo, Brazil.
EM ceciliacguedes@gmail.com
RI Biofabris, Inct/I-2418-2013; Bressiani, Jose/I-1426-2012; Guedes e
   Silva, Cecilia/A-9658-2014
CR Berroth K, 2005, KEY ENG MAT, V287, P3, DOI 10.4028/www.scientific.net/KEM.287.3
   CARLSSON L, 1988, ACTA ORTHOP SCAND, V59, P272, DOI 10.3109/17453678809149361
   Caudill R F, 1991, Int J Periodontics Restorative Dent, V11, P207
   Chang YS, 1996, J BIOMED MATER RES, V30, P117, DOI 10.1002/(SICI)1097-4636(199601)30:1<117::AID-JBM15>3.0.CO;2-L
   GRISS P, 1980, MECH PROPERTIES BIOM, P217
   HARRIS WH, 1983, CLIN ORTHOP RELAT R, P7
   HOWLETT CR, 1989, CLIN ORTHOP RELAT R, P293
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Silva CCG, 2004, MAT SCI ENG C-BIO S, V24, P643, DOI 10.1016/j.msec.2004.08.007
   Sohrabi A, 2000, J BIOMED MATER RES, V50, P43, DOI 10.1002/(SICI)1097-4636(200004)50:1<43::AID-JBM7>3.0.CO;2-A
   SORRELL C, 2004, P 7 WORD BIOM C SYDN
NR 11
TC 15
Z9 15
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1044-5803
J9 MATER CHARACT
JI Mater. Charact.
PD SEP
PY 2008
VL 59
IS 9
BP 1339
EP 1341
DI 10.1016/j.matchar.2007.11.007
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 344ZF
UT WOS:000258965100029
DA 2018-10-20
ER

PT J
AU Misra, RDK
AF Misra, R. D. K.
TI Magnetic nanoparticle carrier for targeted drug delivery: perspective,
   outlook and design
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
DE magnetic nanocarrier; nanoparticles; targeter drug delivery; stimuli
   response
ID REVERSE MICELLE TECHNIQUE; NANOCRYSTALLINE NICKEL FERRITE; COMPOSITE
   NANOPARTICLES; BIOMATERIAL SYSTEM; CONTROLLED-RELEASE; FOLATE RECEPTORS;
   SHELL; CORE; DOXORUBICIN; BEHAVIOR
AB The primary challenge in the delivery of a drug to a tumour site is to target the anticancer drug specifically into and around tumours at concentrations that will decrease their growth and/or viability. Excellent vehicles to achieve targeted drug delivery are magnetic nanocarriers. A approach to accomplish this objective is to fabricate a novel temperature and pH-responsive magnetic nanocarrier that combines tumour targeting and controlled release. In addition to controlled release, these carriers simultaneously offer the possibility of imaging the delivery process by magnetic resonance imaging. The novel aspect of this approach is the combination of thermal and pH sensitivity of the drug containing shell with magnetic properties of the core in a single unit. Furthermore, application of an external magnetic field will heat the nanoparticles and thus nanoparticle containing cells. The targeted heat will aid in the killing of tumour cells.
C1 Univ Louisiana Lafayette, Ctr Struct & Funct Mat, Lafayette, LA 70504 USA.
RP Misra, RDK (reprint author), Univ Louisiana Lafayette, Ctr Struct & Funct Mat, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Antony AC, 1996, ANNU REV NUTR, V16, P501, DOI 10.1146/annurev.nu.16.070196.002441
   Christie RJ, 2003, ADV DRUG DELIVER REV, V55, P421, DOI 10.1016/S0169-409X(02)00229-6
   Detty MR, 2004, J MED CHEM, V47, P3897, DOI 10.1021/jm040074b
   Etrych T, 2001, J CONTROL RELEASE, V73, P89, DOI 10.1016/S0168-3659(01)00281-4
   Firestone RA, 1996, J CONTROL RELEASE, V39, P251, DOI 10.1016/0168-3659(95)00160-3
   Giri S, 2005, ANGEW CHEM INT EDIT, V44, P5038, DOI 10.1002/anie.200501819
   Grief AD, 2005, J MAGN MAGN MATER, V293, P455, DOI 10.1016/j.jmmm.2005.02.040
   GRINBERG VY, BIOMACROMOLECULES, V2, P871
   Gu HW, 2005, CHEM COMMUN, P4270, DOI 10.1039/b507779f
   Gubbala S, 2004, PHYSICA B, V348, P317, DOI 10.1016/j.physb.2003.12.017
   Gupta A.K, 2004, IEEE T NANOBIOSCI, V41, P4137
   Hafeli UO, 2004, INT J PHARM, V277, P19, DOI 10.1016/j.ijpharm.2003.03.002
   Huh KM, 2001, POLYM J, V33, P108, DOI 10.1295/polymj.33.108
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Kale A, 2004, J MAGN MAGN MATER, V277, P350, DOI 10.1016/j.jmmm.2003.11.015
   King HD, 1999, BIOCONJUGATE CHEM, V10, P279, DOI 10.1021/bc980100i
   Kono K, 2001, ADV DRUG DELIVER REV, V53, P307, DOI 10.1016/S0169-409X(01)00204-6
   Lemarchand C, 2004, EUR J PHARM BIOPHARM, V58, P327, DOI 10.1016/j.ejpb.2004.02.016
   Liu TY, 2006, LANGMUIR, V22, P5974, DOI 10.1021/la060371e
   Lu YJ, 2002, ADV DRUG DELIVER REV, V54, P675, DOI 10.1016/S0169-409X(02)00042-X
   Maziarz KM, 1999, J BIOL CHEM, V274, P11086, DOI 10.1074/jbc.274.16.11086
   Misra RDK, 2004, MAT SCI ENG B-SOLID, V111, P164, DOI 10.1016/j.mseb.2004.04.014
   Nathani H, 2005, MAT SCI ENG B-SOLID, V121, P126, DOI 10.1016/j.mseb.2005.03.016
   Needham D, 2001, ADV DRUG DELIVER REV, V53, P285, DOI 10.1016/S0169-409X(01)00233-2
   Orive G, 2003, CURR OPIN BIOTECH, V14, P659, DOI 10.1016/j.copbio.2003.10.007
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Roux E, 2003, BIOMACROMOLECULES, V4, P240, DOI 10.1021/bm025651x
   Soppimath KS, 2002, DRUG DEV IND PHARM, V28, P957, DOI 10.1081/DDC-120006428
   Trail PA, 1997, CANCER RES, V57, P100
   WEITMAN SD, 1992, CANCER RES, V52, P3396
   WILLNER D, 1993, BIOCONJUGATE CHEM, V4, P521, DOI 10.1021/bc00024a015
   Wu J, 2006, INT J PHARM, V315, P1, DOI 10.1016/j.ijpharm.2006.01.045
   You YZ, 2004, ADV MATER, V16, P1953, DOI 10.1002/adma.200400362
   Zhang J, 2008, ACTA BIOMATER, V4, P40, DOI 10.1016/j.actbio.2007.06.006
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
NR 40
TC 33
Z9 34
U1 3
U2 20
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD SEP
PY 2008
VL 24
IS 9
BP 1011
EP 1019
DI 10.1179/174328408X341690
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 356RT
UT WOS:000259796000002
DA 2018-10-20
ER

PT J
AU Chau, DYS
   Agashi, K
   Shakesheff, KM
AF Chau, D. Y. S.
   Agashi, K.
   Shakesheff, K. M.
TI Microparticles as tissue engineering scaffolds: manufacture,
   modification and manipulation
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Review
DE biomaterial; drug delivery; microparticles; microspheres; polymers;
   tissue engineering
ID SINTERED MICROSPHERE SCAFFOLDS; SUPERCRITICAL CARBON-DIOXIDE; CONTROLLED
   DRUG-RELEASE; LACTIDE-CO-GLYCOLIDE; IN-VITRO EVALUATION; CELL-ADHESION;
   BIODEGRADABLE MICROSPHERES; MECHANICAL-PROPERTIES; SURFACE MODIFICATION;
   SOLVENT EVAPORATION
AB Tissue engineering, a field which focusses on the replacement, repair and regeneration of damaged or diseased tissue by the application of biomaterials, cells and associated biological molecules, has advanced rapidly due to the intense demand for tissue substitutes. A key principle in tissue engineering involves growing the appropriate cells in vitro for the desired application before delivery into the body of a patient. The implantable devices, biological constructs or scaffolds, developed in tissue engineering aim to provide the initial architecture required for supporting the cells as well as define the micro and macrostructure of the final engineered product. Furthermore, these scaffolds may be exploited to release drugs and/or growth factors in a controlled manner, thus facilitating the repair and regeneration of the target tissue. Microparticles, spherical carrier scaffolds, have recently received extensive interest for their potential therapeutic applications in a diverse range of clinical and regenerative medical settings. Not only can these versatile subunits be used as cell culture scaffolds, their innate structure reduces the degradation of encapsulated biologically active molecules and also allows their exploitation as a localised injectable delivery system. The purpose of the present article is to review the tissue engineering applications of these microparticles and to provide a brief overview of the critical factors considered during their formulation and use - including the range of materials used and the different modification protocols and technologies exploited to improve and enhance their mechanical properties and biocompatibility for regenerative medicine.
C1 [Chau, D. Y. S.; Agashi, K.; Shakesheff, K. M.] Univ Nottingham, Sch Pharm, Div Drug Delivery & Tissue Engn, Ctr Biomol Sci, Nottingham NG7 2RD, England.
RP Shakesheff, KM (reprint author), Univ Nottingham, Sch Pharm, Div Drug Delivery & Tissue Engn, Ctr Biomol Sci, Univ Pk, Nottingham NG7 2RD, England.
EM Kevin.Shakesheff@nottingham.ac.uk
RI Shakesheff, Kevin/O-6371-2018
OI Shakesheff, Kevin/0000-0003-3236-2439; Chau, David/0000-0001-9200-6749
CR Abdel-Fattah WI, 2007, ACTA BIOMATER, V3, P503, DOI 10.1016/j.actbio.2006.12.004
   Adamopoulos O, 2007, J MATER SCI-MATER M, V18, P1587, DOI 10.1007/s10856-007-3041-6
   Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Ando S, 1999, J PHARM SCI, V88, P126, DOI 10.1021/js9801687
   ARAR HH, 1992, BIOMED SCI INSTRUM, V28, P173
   BABANSEE JE, 1998, ADV DRUG DELIV RES, V33, P111
   BAJPAI PK, 1988, J BIOMED MATER RES, V22, P1245, DOI 10.1002/jbm.820221212
   Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI 10.1005/adfm.200400562
   BARSOUM MW, 1997, MCGRAW HILL SERIES M, P2
   Berkland C, 2001, J CONTROL RELEASE, V73, P59, DOI 10.1016/S0168-3659(01)00289-9
   Billotte WG, 2003, BIOMATERIALS PRINCIP, P21
   Blomley MJK, 2001, BRIT MED J, V322, P1222, DOI 10.1136/bmj.322.7296.1222
   BODMEIER R, 1988, J PHARM PHARMACOL, V40, P754, DOI 10.1111/j.2042-7158.1988.tb05166.x
   BODMEIER R, 1988, J MICROENCAPSUL, V5, P325, DOI 10.3109/02652048809036729
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Brigham RC, 2000, ARS COMBINATORIA, V54, P3
   Brouwers JRBJ, 1996, PHARM WORLD SCI, V18, P153, DOI 10.1007/BF00820726
   Byrne RS, 2002, INT J PHARM, V246, P61, DOI 10.1016/S0378-5173(02)00357-5
   CANDAU F, 1985, Patent No. 4521317
   CAPLAN AI, 1990, BIOMATERIALS, V11, P44
   Chang SJ, 2006, IEE PROC-NANOBIOTECH, V153, P1, DOI 10.1049/ip-nbt:20050037
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Chau DYS, 2007, TRENDS BIOMATERIALS, P143
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Chickering D, 1996, BIOTECHNOL BIOENG, V52, P96, DOI 10.1002/(SICI)1097-0290(19961005)52:1<96::AID-BIT9>3.0.CO;2-U
   Chung HJ, 2006, PHARM RES, V23, P1835, DOI 10.1007/s11095-006-9039-9
   Coester CJ, 2000, J MICROENCAPSUL, V17, P187
   Cool SM, 2007, J BIOMED MATER RES A, V82A, P599, DOI 10.1002/jbm.a.31174
   Coulembier O, 2006, PROG POLYM SCI, V31, P723, DOI 10.1016/j.progpolymsci.2006.08.004
   DESAI SJ, 1965, J PHARM SCI, V54, P1459, DOI 10.1002/jps.2600541012
   DROBECK HP, 1984, J ORAL MAXIL SURG, V42, P143, DOI 10.1016/S0278-2391(84)80024-5
   EDELMAN R, 1993, VACCINE, V11, P155, DOI 10.1016/0264-410X(93)90012-M
   Eldor J, 1997, ACTA ANAESTH SCAND, V41, P326, DOI 10.1111/j.1399-6576.1997.tb04689.x
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Engwicht A, 2000, BIOMATERIALS, V21, P1587, DOI 10.1016/S0142-9612(00)00045-4
   Engwicht A, 1999, INT J PHARM, V185, P61, DOI 10.1016/S0378-5173(99)00127-1
   Fang LM, 2006, BIOMATERIALS, V27, P3701, DOI 10.1016/j.biomaterials.2006.02.023
   FOLKMAN J, 1964, J Surg Res, V4, P139, DOI 10.1016/S0022-4804(64)80040-8
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gao JM, 1998, J PHARM SCI, V87, P246, DOI 10.1021/js970284u
   Goessler UR, 2004, INT J MOL MED, V13, P505
   Green D, 2003, TISSUE ENG, V9, P1159, DOI 10.1089/10763270360728062
   GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Hao JY, 2004, J PHARM SCI-US, V93, P1083, DOI 10.1002/jps.20002
   Hashimoto M, 2007, J MATER SCI-MATER M, V18, P661, DOI 10.1007/s10856-007-2317-1
   Hem DL, 1998, J BIOMED MATER RES, V39, P266
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HERBERGER JD, 1996, P INT S CONTR REL BI, V23, P835
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Homaeigohar SSH, 2006, J BIOMED MATER RES A, V78A, P129, DOI 10.1002/jbm.a.30691
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ibim SM, 1998, BIOMATERIALS, V19, P941, DOI 10.1016/S0142-9612(98)00019-2
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Jabbarzadeh E, 2007, BIOTECHNOL BIOENG, V98, P1094, DOI 10.1002/bit.21495
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   JALIL R, 1990, J MICROENCAPSUL, V7, P297, DOI 10.3109/02652049009021842
   Jiang J, 2007, CHIM OGGI, V25, P8
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Johnson OL, 1997, PHARM RES-DORDR, V14, P730, DOI 10.1023/A:1012142204132
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   KHAN MA, 1992, P INT S CONTROL REL, V23, P333
   KHAN Y, 2006, P 28 IEEE EMBS ANN I, P529
   Khan YM, 2004, J BIOMED MATER RES A, V69A, P728, DOI 10.1002/jbm.a.30051
   Khan YM, 2007, J MATER SCI, V42, P4183, DOI 10.1007/s10853-006-0636-0
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   KRAJWSKI A, 2000, J MATER SCI-MATER M, V12, P763
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Kreuter J, 1996, J ANAT, V189, P503
   Kuhn K, 1994, Trends Cell Biol, V4, P256, DOI 10.1016/0962-8924(94)90124-4
   Kumbar SG, 2007, J BIOMED MATER RES B, V81B, P91, DOI 10.1002/jbm.b.30641
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   LIM F, 1981, J PHARM SCI, V70, P351, DOI 10.1002/jps.2600700402
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   LU HH, 2005, KEY ENG MATER, V17, P607
   Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652
   Masters K, 1985, SPRAY DRYING HDB
   MATHIOWITZ E, 1987, Journal of Controlled Release, V5, P13, DOI 10.1016/0168-3659(87)90033-2
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Morita T, 2001, INT J PHARM, V219, P127, DOI 10.1016/S0378-5173(01)00642-1
   Muller R, 2006, BIOMATERIALS, V27, P4059, DOI 10.1016/j.biomaterials.2006.03.019
   MULLER BW, 1991, Patent No. 5043280
   Muller M, 2003, J BIOMED MATER RES A, V66A, P55, DOI 10.1002/jbm.a.10502
   Nam YS, 1999, J BIOMAT SCI-POLYM E, V10, P1145
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Niemela T, 2005, ACTA BIOMATER, V1, P235, DOI [10.1016/j.actbio.2004.11.002, 10.1016/j.actbio.2004.11002]
   NIHANT N, 1995, J CONTROL RELEASE, V35, P117, DOI 10.1016/0168-3659(95)00026-5
   OGAWA Y, 1988, CHEM PHARM BULL, V36, P1502
   Pachence JM, 1997, PRINCIPLES TISSUE EN, P273
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Park J. B., 2003, BIOMATERIALS PRINCIP
   PAVANETTO F, 1993, J MICROENCAPSUL, V10, P487, DOI 10.3109/02652049309015325
   Peterson KP, 1998, P SOC EXP BIOL MED, V218, P365
   Qiu QQ, 1999, BIOMATERIALS, V20, P989, DOI 10.1016/S0142-9612(98)00183-5
   Queiroz AC, 2001, BIOMATERIALS, V22, P1393, DOI 10.1016/S0142-9612(00)00296-9
   Rantakyla M, 2002, J SUPERCRIT FLUID, V24, P251, DOI 10.1016/S0896-8446(02)00034-7
   Reis CP, 2006, J MICROENCAPSUL, V23, P245, DOI 10.1080/02652040500286086
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rosca ID, 2004, J CONTROL RELEASE, V99, P271, DOI 10.1016/j.jconrel.2004.07.007
   RUIZ JM, 1989, INT J PHARMACEUT, V49, P69, DOI 10.1016/0378-5173(89)90154-3
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Salem AK, 2003, ADV MATER, V15, P210, DOI 10.1002/adma.200390047
   Sarkari M, 2003, BIOTECHNOL PROGR, V19, P448, DOI 10.1021/bp0255513
   Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65
   Serp D, 2000, BIOTECHNOL BIOENG, V70, P41, DOI 10.1002/1097-0290(20001005)70:1<41::AID-BIT6>3.0.CO;2-U
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shen Francis H, 2006, Spine J, V6, P615, DOI 10.1016/j.spinee.2006.03.006
   Shi SL, 2007, J AM CERAM SOC, V90, P3331, DOI 10.1111/j.1551-2916.2007.01882.x
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Simonoska Crcarevska M., 2008, EUR J PHARM BIOPHARM, V68, P565
   Smith TW, 1997, PSYCHOPHYSIOLOGY, V34, P65, DOI 10.1111/j.1469-8986.1997.tb02417.x
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Taylor NJ, 2002, DNA CELL BIOL, V21, P963, DOI 10.1089/104454902762053891
   Thomasin C, 1997, INT J PHARM, V147, P173, DOI 10.1016/S0378-5173(96)04810-7
   Tjia JS, 1999, BIOMATERIALS, V20, P2223, DOI 10.1016/S0142-9612(99)00153-2
   TOM JW, 1991, BIOTECHNOL PROGR, V7, P403, DOI 10.1021/bp00011a004
   Tse G, 1999, J CONTROL RELEASE, V60, P77, DOI 10.1016/S0168-3659(99)00056-5
   Tsigkou O, 2007, J BIOMED MATER RES A, V80A, P837, DOI 10.1002/jbm.a.30910
   Tsung M J, 2001, AAPS PharmSci, V3, pE11
   Turhani D, 2007, J ORAL MAXIL SURG, V65, P485, DOI 10.1016/j.joms.2005.12.065
   UCHIDA A, 1992, J ORTHOPAED RES, V10, P440, DOI 10.1002/jor.1100100317
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Vallet-Regi M, 2006, DALTON T, P5211, DOI 10.1039/b610219k
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   Vasir JK, 2003, INT J PHARM, V255, P13, DOI 10.1016/S0378-5173(03)00087-5
   Vehring R, 2008, PHARM RES-DORDR, V25, P999, DOI 10.1007/s11095-007-9475-1
   WAGENAAR BW, 1994, BIOMATERIALS, V15, P49, DOI 10.1016/0142-9612(94)90196-1
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Wang SB, 2004, MACROMOL BIOSCI, V4, P27, DOI 10.1002/mabi.200300043
   Watabe M., 2005, WO, Patent No. [2005/023468 Al, 2005023468]
   Watson MS, 2002, ADV MATER, V14, P1802, DOI 10.1002/adma.200290003
   WATTS PJ, 1990, CRIT REV THER DRUG, V7, P235
   Whitaker MJ, 2005, J CONTROL RELEASE, V101, P85, DOI 10.1016/j.jconrel.2004.07.017
   Whittlesey KJ, 2004, EXP NEUROL, V190, P1, DOI 10.1016/j.expneurol.2004.06.020
   Wickline SA, 2006, ARTERIOSCL THROM VAS, V26, P435, DOI 10.1161/01.ATV.0000201069.47550.8b
   WISE DL, 1976, LIFE SCI, V19, P867, DOI 10.1016/0024-3205(76)90314-3
   WITCHI C, 1998, J CONTROL RELEASE, V51, P327
   Wu TJ, 2007, BIOTECHNOL BIOENG, V98, P578, DOI 10.1002/bit.21452
   Wu Xue Shen, 1995, P1151
   Wu Xue Shen, 1995, P1015
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yasuji T, 2006, J PHARM SCI-US, V95, P581, DOI 10.1002/jps.20565
   Yehia Hadi N., 2007, Journal of Nanobiotechnology, V5, P8, DOI 10.1186/1477-3155-5-8
   Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1
   SPHERAMINE
   INJECTABONE
NR 166
TC 8
Z9 9
U1 1
U2 35
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD SEP
PY 2008
VL 24
IS 9
BP 1031
EP 1044
DI 10.1179/174328408X341726
PG 14
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 356RT
UT WOS:000259796000005
DA 2018-10-20
ER

PT J
AU Wang, HJ
   Gong, SJ
   Wang, JY
AF Wang, H. -J.
   Gong, S. -J.
   Wang, J. -Y.
TI Mechanical improvement of zein protein as scaffold for bone tissue
   engineering
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
DE zein; mechanical properties; fatty acids; brittleness; porosity
ID WATER-VAPOR PERMEABILITY; IN-VITRO; SECONDARY STRUCTURE; TENSILE
   PROPERTIES; LINOLEIC ACIDS; CORN PROTEIN; FILMS; BIOCOMPATIBILITY;
   CONFORMATION; POLYMERS
AB Although extensive efforts have been put into the development of porous scaffolds from natural materials for bone regeneration with encouraging results, they still have a common limitation: the inherent lack of strength associated with porosity. That is to say, they are not strong enough to meet the specific requirements of load bearing applications. The authors have reported a series studies on possible application of a natural material, zein protein from maize, as a new kind of biomaterial for tissue engineering. The result showed a good cell compatibility and biodegradability in tissue within eight months. To improve its mechanical property (especially the brittleness), stearic acid or oleic acid was added. The mechanical properties, especially the tensile and flexible properties were improved significantly. The possible mechanism is discussed.
C1 [Wang, J. -Y.] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China.
   [Wang, H. -J.; Gong, S. -J.] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China.
RP Wang, JY (reprint author), Chinese Acad Sci, Shanghai Inst Organ Chem, 354 Fenglin Lu, Shanghai 200032, Peoples R China.
EM jywang@mail.sioc.ac.cn
RI Wang, Jin-Ye/H-1450-2011
FU National Programme on Key Basic Research Projects of China
   [2005CB724306]; National Hi-Tech Research and Development Plan (863
   Project) of China [2002AA327100]
FX The present study was supported by the National Programme on Key Basic
   Research Projects of China (973 Programme, grant no. 2005CB724306), and
   the National Hi-Tech Research and Development Plan ( 863 Project) of
   China (project no. 2002AA327100). It is also grateful that Elsevier
   Limited admits us reproducing the figures in this paper.
CR Belton PS, 2005, J CEREAL SCI, V41, P203, DOI 10.1016/j.jcs.2004.06.003
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Brekke J H, 1996, Tissue Eng, V2, P97, DOI 10.1089/ten.1996.2.97
   Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   Cury-Boaventura MF, 2006, CLIN NUTR, V25, P1004, DOI 10.1016/j.clnu.2006.05.008
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   di Gioia L, 1999, J AGR FOOD CHEM, V47, P1254, DOI 10.1021/jf980976j
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Forato LA, 2004, J AGR FOOD CHEM, V52, P2382, DOI 10.1021/jf035020+
   Forato LA, 2003, BIOPOLYMERS, V72, P421, DOI 10.1002/bip.10481
   Gao CL, 2006, J AGR FOOD CHEM, V54, P4611, DOI 10.1021/jf060611w
   Gao CL, 2005, J AGR FOOD CHEM, V53, P306, DOI 10.1021/jf0492666
   Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029
   Ghanbarzadeh B, 2006, FOOD RES INT, V39, P882, DOI 10.1016/j.foodres.2006.05.011
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Guilbert S, 1986, FOOD PACKAGING PRESE, P371
   Guo YC, 2005, J CEREAL SCI, V41, P277, DOI 10.1016/j.jcs.2004.12.005
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hsu BL, 2005, J AGR FOOD CHEM, V53, P5089, DOI 10.1021/jf0501490
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Jones JR, 2007, BIOMATERIALS, V28, P1404, DOI 10.1016/j.biomaterials.2006.11.014
   Kim S, 2008, J CEREAL SCI, V47, P1, DOI 10.1016/j.jcs.2007.08.004
   Kim S, 2004, IND CROP PROD, V20, P291, DOI 10.1016/j.indcrop.2003.10.013
   Krochta J. M., 1997, FOOD PROTEINS THEIR, P529
   Lai HM, 1997, CEREAL CHEM, V74, P83, DOI 10.1094/CCHEM.1997.74.1.83
   LAWTON JW, 1992, CEREAL CHEM, V69, P351
   Lee JH, 2003, BIOMATERIALS, V24, P2773, DOI 10.1016/S0142-9612(03)00080-2
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Mejia CD, 2007, J CEREAL SCI, V45, P353, DOI 10.1016/j.jcs.2006.09.009
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Paramawati R., 2001, Food Science and Technology Research, V7, P191, DOI 10.3136/fstr.7.191
   PARK JW, 1994, J FOOD SCI, V59, P916, DOI 10.1111/j.1365-2621.1994.tb08157.x
   Parris N, 1997, J AGR FOOD CHEM, V45, P1596, DOI 10.1021/jf960809o
   Parris N, 2000, J AGR FOOD CHEM, V48, P890, DOI 10.1021/jf991079y
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Santosa FXB, 1999, J AGR FOOD CHEM, V47, P2070, DOI 10.1021/jf981154p
   Selling GW, 2004, POLYMER, V45, P4249, DOI 10.1016/j.polymer.2004.03.097
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Tillekeratne M, 2000, POLYM INT, V49, P127, DOI 10.1002/(SICI)1097-0126(200001)49:1<127::AID-PI320>3.3.CO;2-2
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Wang Y, 2005, MACROMOL BIOSCI, V5, P1200, DOI 10.1002/mabi.200500140
   Wang Y, 2003, STARCH-STARKE, V55, P25, DOI 10.1002/star.200390002
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
NR 52
TC 6
Z9 6
U1 1
U2 22
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD SEP
PY 2008
VL 24
IS 9
BP 1045
EP 1052
DI 10.1179/174328408X341735
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 356RT
UT WOS:000259796000006
DA 2018-10-20
ER

PT J
AU Xu, D
   Hein, S
   Wang, K
AF Xu, D.
   Hein, S.
   Wang, K.
TI Chitosan membrane in separation applications
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Review
DE chitosan; membrane; separation; azeotropic; protein
ID ETHANOL-WATER MIXTURES; MOLECULARLY IMPRINTED POLYMERS; COMPLEX
   COMPOSITE MEMBRANES; CHITIN AFFINITY MEMBRANES; HOLLOW-FIBER MEMBRANES;
   DIMETHYL CARBONATE/METHANOL/WATER MIXTURES; BUTYL ETHER/METHANOL
   MIXTURES; GLYCOL AQUEOUS-SOLUTION; SOLID-PHASE EXTRACTION; DRUG-DELIVERY
   SYSTEMS
AB Membrane separation technology, owing to its low energy consumption, operational simplicity, ease of control and scale-up, has gained increasing interest. The rapid development requires highly selective membranes with high through rates and chemical/mechanical stability. Chitosan, a relatively inert biomaterial with film forming ability, has been rapidly recognised for its potential in separation and purification technology in recent decades. Because of its hydrophilicity, cationicity, biocompatibility, ease of modification, remarkable affinity to dyes, metals and proteins, chitosan membranes have become a promising candidate for several applications. In the present review, the pervaporation of azeotropic mixtures and protein purification and separation of gaseous mixtures using chitosan membranes are discussed. The general overview of the preparation of different chitosan membranes, its capabilities in the separation of various solvents, gases and biomacromolecules are presented. Finally, the opportunities, challenges and perspectives in these areas are discussed.
C1 [Xu, D.; Wang, K.] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637459, Singapore.
   [Hein, S.] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark.
   [Hein, S.] Univ Aarhus, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.
RP Wang, K (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637459, Singapore.
EM mkwang@ntu.edu.sg
CR Aburto J, 2004, MACROMOLECULES, V37, P2938, DOI 10.1021/ma049961e
   Ageev EP, 2007, COLLOID J+, V69, P272, DOI 10.1134/S1061933X07030027
   Ahmad AL, 2006, J APPL POLYM SCI, V99, P1740, DOI 10.1002/app.22703
   Ahmad AL, 2005, SEPAR SCI TECHNOL, V40, P3071, DOI 10.1080/01496390500385111
   Ahmed SR, 2006, J MEMBRANE SCI, V280, P553, DOI 10.1016/j.memsci.2006.02.009
   Al Marzouqi MH, 2005, IND ENG CHEM RES, V44, P9273, DOI 10.1021/ie050526y
   Alexander C, 2003, TETRAHEDRON, V59, P2025, DOI 10.1016/S0040-4020(03)00152-2
   Alvarez-Lorenzo C, 2004, J CHROMATOGR B, V804, P231, DOI 10.1016/j.jchromb.2003.12.032
   Ansumali S, 2006, PHYSICA A, V359, P289, DOI 10.1016/j.physa.2005.04.039
   Aravind UK, 2007, J MEMBRANE SCI, V299, P146, DOI 10.1016/j.memsci.2007.04.036
   Arica MY, 2005, PROCESS BIOCHEM, V40, P1433, DOI 10.1016/j.procbio.2004.06.028
   Arica MY, 2004, J MEMBRANE SCI, V240, P167, DOI 10.1016/j.memsci.2004.05.005
   Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Baker RW, 2002, IND ENG CHEM RES, V41, P1393, DOI 10.1021/ie0108088
   BAKER RW, 2004, MEMBRANE TECHNOLOGY, P365
   Bayramoglu G, 2003, J APPL POLYM SCI, V88, P1843, DOI 10.1002/app.11844
   Bayramoglu G, 2003, BIOCHEM ENG J, V13, P35, DOI 10.1016/S1369-703X(02)00098-0
   Bayramoglu G, 2002, COLLOID SURFACE A, V202, P41, DOI 10.1016/S0927-7757(01)01055-X
   Beppu MM, 2004, CHEM ENG COMMUN, V191, P1147, DOI 10.1080/00986440490463968
   Budd PM, 2004, IND ENG CHEM RES, V43, P1863, DOI 10.1021/ie034142o
   Caner C, 2007, J SCI FOOD AGR, V87, P227, DOI 10.1002/jsfa.2698
   Cao SG, 1999, J APPL POLYM SCI, V74, P1452, DOI 10.1002/(SICI)1097-4628(19991107)74:6<1452::AID-APP18>3.0.CO;2-N
   Chanachai A, 2000, J MEMBRANE SCI, V166, P271, DOI 10.1016/S0376-7388(99)00269-0
   Chen JH, 2007, J COLLOID INTERF SCI, V316, P580, DOI 10.1016/j.jcis.2007.09.022
   Chen JH, 2007, J MEMBRANE SCI, V292, P125, DOI 10.1016/j.memsci.2007.01.026
   Chen X, 2001, J APPL POLYM SCI, V79, P1144
   Chen X, 2005, J APPL POLYM SCI, V96, P1267, DOI 10.1002/app.21552
   Chen X, 1999, J APPL POLYM SCI, V73, P975, DOI 10.1002/(SICI)1097-4628(19990808)73:6<975::AID-APP15>3.0.CO;2-#
   Choudhari SK, 2007, J MEMBRANE SCI, V302, P197, DOI 10.1016/j.memsci.2007.06.045
   Chung TS, 2007, PROG POLYM SCI, V32, P483, DOI 10.1016/j.progpolymsci.2007.01.008
   Cong HL, 2007, J MEMBRANE SCI, V294, P178, DOI 10.1016/j.memsci.2007.02.035
   Cunliffe D, 2005, ADV DRUG DELIVER REV, V57, P1836, DOI 10.1016/j.addr.2005.07.015
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Despond S, 2001, J POLYM SCI POL PHYS, V39, P3114, DOI 10.1002/polb.10064
   Devi DA, 2006, J MEMBRANE SCI, V280, P45, DOI 10.1016/j.memsci.2006.01.003
   Devi DA, 2006, J MEMBRANE SCI, V280, P138, DOI 10.1016/j.memsci.2006.01.006
   Devi DA, 2005, J MEMBRANE SCI, V262, P91, DOI 10.1016/j.memsci.2005.03.051
   Dhanuja G, 2005, SEP PURIF TECHNOL, V44, P130, DOI 10.1016/j.seppur.2005.01.001
   Duan SH, 2006, J MEMBRANE SCI, V283, P2, DOI 10.1016/j.memsci.2006.06.026
   Dubey V, 2005, J MEMBRANE SCI, V251, P131, DOI 10.1016/j.memsci.2004.11.009
   Dubois P, 2006, ADV ENG MATER, V8, P147, DOI 10.1002/adem.200500256
   Dutta PK, 2002, J MACROMOL SCI-POL R, VC42, P307, DOI 10.1081/MC-120006451
   El-Azzami LA, 2007, J POLYM SCI POL PHYS, V45, P2620, DOI 10.1002/polb.21236
   Feng XS, 1997, IND ENG CHEM RES, V36, P1048, DOI 10.1021/ie960189g
   Feng XS, 1996, J MEMBRANE SCI, V116, P67, DOI 10.1016/0376-7388(96)00022-1
   Francisco GJ, 2007, J MEMBRANE SCI, V303, P54, DOI 10.1016/j.memsci.2007.06.065
   Fu GQ, 2007, REACT FUNCT POLYM, V67, P442, DOI 10.1016/j.reactfunctpolym.2007.02.006
   Fu YJ, 2006, DESALINATION, V193, P119, DOI 10.1016/j.desa1.2005.07.049
   Gallstedt M, 2001, J POLYM SCI POL PHYS, V39, P985
   Ge JJ, 2000, J MEMBRANE SCI, V165, P75, DOI 10.1016/S0376-7388(99)00228-8
   Gerente C, 2007, CRIT REV ENV SCI TEC, V37, P41, DOI 10.1080/10643380600729089
   Ghosh R, 2002, J CHROMATOGR A, V952, P13, DOI 10.1016/S0021-9673(02)00057-2
   GOTO M, 1994, SEPAR SCI TECHNOL, V29, P1915, DOI 10.1080/01496399408002180
   Guibal E, 2004, SEP PURIF TECHNOL, V38, P43, DOI 10.1016/j.seppur.2003.10.004
   Guibal E, 2006, SEPAR SCI TECHNOL, V41, P2487, DOI 10.1080/01496390600742807
   Gumusderelioglu M, 2004, REACT FUNCT POLYM, V61, P211, DOI 10.1016/j.reactfunctpolym.2004.06.002
   Guo Q. H., 1995, J MEMBRANE SCI, V98, P223
   Guo TY, 2005, CARBOHYD POLYM, V62, P214, DOI 10.1016/j.carbpol.2005.03.012
   Guo TY, 2005, BIOMATERIALS, V26, P5737, DOI 10.1016/j.biomaterials.2005.02.017
   HADWIGER LA, 1994, MOL PLANT MICROBE IN, V7, P531, DOI 10.1094/MPMI-7-0531
   Hein S, 2008, J BIOMED MATER RES B, V86B, P558, DOI 10.1002/jbm.b.31056
   Hillberg AL, 2005, ADV DRUG DELIVER REV, V57, P1875, DOI 10.1016/j.addr.2005.07.016
   Hirano S, 1999, POLYM INT, V48, P732, DOI 10.1002/(SICI)1097-0126(199908)48:8<732::AID-PI211>3.3.CO;2-L
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Holthoff EL, 2007, ANAL CHIM ACTA, V594, P147, DOI 10.1016/j.aca.2007.05.044
   Hoven VP, 2007, CARBOHYD POLYM, V68, P44, DOI 10.1016/j.carbpol.2006.07.008
   Hu CL, 2007, SEP PURIF TECHNOL, V55, P327, DOI 10.1016/j.seppur.2007.01.005
   Hu CL, 2007, J MEMBRANE SCI, V293, P142, DOI 10.1016/j.memsci.2007.02.009
   Huang RYM, 2000, J MEMBRANE SCI, V167, P275, DOI 10.1016/S0376-7388(99)00293-8
   Huang RYM, 2000, J MEMBRANE SCI, V176, P223, DOI 10.1016/S0376-7388(00)00443-9
   Huang RYM, 1999, J MEMBRANE SCI, V160, P17, DOI 10.1016/S0376-7388(99)00074-5
   Ito A, 1997, ANGEW MAKROMOL CHEM, V248, P85, DOI 10.1002/apmc.1997.052480105
   Iwatsubo T, 2002, J APPL POLYM SCI, V86, P265, DOI 10.1002/app.10949
   Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021
   Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017
   Jegal J, 1999, J APPL POLYM SCI, V71, P671, DOI 10.1002/(SICI)1097-4628(19990124)71:4<671::AID-APP19>3.0.CO;2-T
   Jiang XM, 2007, ANAL BIOANAL CHEM, V389, P355, DOI 10.1007/s00216-007-1336-6
   Jiang ZY, 2006, J MEMBRANE SCI, V280, P876, DOI 10.1016/j.memsci.2006.03.006
   Jiraratananon R, 2002, J MEMBRANE SCI, V195, P143, DOI 10.1016/S0376-7388(01)00563-4
   Jiraratananon R, 2002, J MEMBRANE SCI, V199, P211, DOI 10.1016/S0376-7388(01)00699-8
   Jonquieres A, 2002, J MEMBRANE SCI, V206, P87, DOI 10.1016/S0376-7388(01)00768-2
   Kanti P, 2004, SEP PURIF TECHNOL, V40, P259, DOI 10.1016/j.seppur.2004.03.003
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Kim JH, 2003, J MEMBRANE SCI, V213, P273, DOI 10.1016/S0376-7388(02)00534-3
   Kim SG, 2007, J APPL POLYM SCI, V103, P2634, DOI 10.1002/app.25386
   Kim SG, 2002, J APPL POLYM SCI, V85, P714, DOI 10.1002/app.10619
   Kim SG, 2000, J MEMBRANE SCI, V174, P1, DOI 10.1016/S0376-7388(00)00339-2
   Kim SG, 2002, J APPL POLYM SCI, V85, P1832, DOI 10.1002/app.10708
   Kim SK, 2006, FOOD RES INT, V39, P383, DOI 10.1016/j.foodres.2005.10.010
   Kittur AA, 2005, J MEMBRANE SCI, V247, P75, DOI 10.1016/j.memsci.2004.09.010
   KLEIN E, 1994, J MEMBRANE SCI, V95, P199, DOI 10.1016/0376-7388(94)00171-5
   Koczka K, 2007, CHEM ENG PROCESS, V46, P239, DOI 10.1016/j.cep.2006.05.016
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   Kouketsu T, 2007, J MEMBRANE SCI, V287, P51, DOI 10.1016/j.memsci.2006.10.014
   Krajewska B, 2005, SEP PURIF TECHNOL, V41, P305, DOI 10.1016/j.seppur.2004.03.019
   Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013
   Kulkarni SS, 2006, J MEMBRANE SCI, V285, P420, DOI 10.1016/j.memsci.2006.09.021
   Kulkarni SS, 2006, J APPL POLYM SCI, V99, P1380, DOI 10.1002/app.22514
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5
   LEE YM, 1991, J MEMBRANE SCI, V64, P145, DOI 10.1016/0376-7388(91)80085-K
   Lee YM, 1997, J MEMBRANE SCI, V133, P103, DOI 10.1016/S0376-7388(97)00089-6
   LEE YM, 1993, DESALINATION, V90, P277, DOI 10.1016/0011-9164(93)80181-L
   Li BB, 2006, DESALINATION, V193, P171, DOI 10.1016/j.desa1.2005.08.021
   Li F, 2007, TALANTA, V71, P1487, DOI 10.1016/j.talanta.2006.07.023
   Li JH, 2003, J CHROMATOGR B, V791, P55, DOI 10.1016/S1570-0232(03)00203-4
   Liu BB, 2007, J APPL POLYM SCI, V106, P2117, DOI 10.1002/app.26876
   Liu CX, 2005, J MEMBRANE SCI, V267, P68, DOI 10.1016/j.memsci.2005.06.001
   Liu JH, 2003, J APPL POLYM SCI, V90, P1108, DOI 10.1002/app.12841
   Liu YL, 2007, J MEMBRANE SCI, V287, P230, DOI 10.1016/j.memsci.2006.10.040
   Liu YL, 2005, J MEMBRANE SCI, V251, P233, DOI 10.1016/j.memsci.2004.12.003
   Liu YL, 2005, BIOMACROMOLECULES, V6, P368, DOI 10.1021/bm049531w
   Lu LY, 2006, J MEMBRANE SCI, V281, P245, DOI 10.1016/j.memsci.2006.03.041
   Lu LY, 2006, J APPL POLYM SCI, V101, P167, DOI 10.1002/app.23158
   Lucia A, 2006, IND ENG CHEM RES, V45, P8319, DOI 10.1021/ie060035t
   Machado RL, 2006, PROCESS BIOCHEM, V41, P2252, DOI 10.1016/j.procbio.2006.05.015
   Mello RS, 2006, POLYM BULL, V56, P447, DOI 10.1007/s00289-006-0513-7
   Merkel TC, 2002, SCIENCE, V296, P519, DOI 10.1126/science.1069580
   Miller MD, 2004, LANGMUIR, V20, P11545, DOI 10.1021/la0479859
   MOCHIZUKI A, 1989, J APPL POLYM SCI, V37, P3375, DOI 10.1002/app.1989.070371209
   Moon GY, 1999, J MEMBRANE SCI, V156, P17
   Nam SY, 1999, J MEMBRANE SCI, V157, P63
   Nam SY, 1999, J MEMBRANE SCI, V153, P155
   Nam SY, 1997, J MEMBRANE SCI, V135, P161, DOI 10.1016/S0376-7388(97)00144-0
   Nawawi MGM, 1997, J MEMBRANE SCI, V124, P53
   Nicholas JB, 1997, TOP CATAL, V4, P157, DOI 10.1023/A:1019179903977
   Nie HL, 2007, INT J BIOL MACROMOL, V40, P261, DOI 10.1016/j.ijbiomac.2006.08.005
   Pan FS, 2007, CHEM ENG SCI, V62, P703, DOI 10.1016/j.ces.2006.07.046
   Peng FB, 2007, J MEMBRANE SCI, V300, P13, DOI [10.1016/j.memsci.2007.06.008, 10.1016/j.memwasci.2007.06.008]
   Prabaharan M, 2006, CARBOHYD POLYM, V63, P153, DOI 10.1016/j.carbpol.2005.08.051
   Prabaharan M, 2005, DRUG DELIV, V12, P41, DOI 10.1080/10717540590889781
   Prashanth KVH, 2007, TRENDS FOOD SCI TECH, V18, P117, DOI 10.1016/j.tifs.2006.10.022
   Prathab B, 2007, J POLYM SCI POL PHYS, V45, P1260, DOI 10.1002/polb.21109
   Qiao FX, 2006, CHROMATOGRAPHIA, V64, P625, DOI 10.1365/s10337-006-0097-2
   Rao KSVK, 2007, J APPL POLYM SCI, V103, P1918, DOI 10.1002/app.25078
   Rao PS, 2007, IND ENG CHEM RES, V46, P2155, DOI 10.1021/ie061268n
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   ROBESON LM, 1991, J MEMBRANE SCI, V62, P165, DOI 10.1016/0376-7388(91)80060-J
   Ruckenstein E, 1998, J MEMBRANE SCI, V142, P13, DOI 10.1016/S0376-7388(98)00025-8
   Ruckenstein E, 1997, BIOTECHNOL BIOENG, V56, P610, DOI 10.1002/(SICI)1097-0290(19971220)56:6<610::AID-BIT3>3.0.CO;2-Q
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Sebti I, 2007, J AGR FOOD CHEM, V55, P693, DOI 10.1021/jf062013n
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   Shen JN, 2007, J APPL POLYM SCI, V103, P1959, DOI 10.1002/app.24910
   Shi W, 2005, J CHROMATOGR B, V819, P301, DOI 10.1016/j.jchromb.2005.02.018
   Shieh JJ, 1997, J MEMBRANE SCI, V127, P185, DOI 10.1016/S0376-7388(96)00279-7
   Shieh JJ, 1998, J MEMBRANE SCI, V148, P243, DOI 10.1016/S0376-7388(98)00165-3
   Singh DK, 2000, J MACROMOL SCI R M C, VC40, P69, DOI 10.1081/MC-100100579
   Smitha B, 2006, CARBOHYD POLYM, V66, P463, DOI 10.1016/j.carbpol.2006.04.006
   Smitha B, 2004, J MEMBRANE SCI, V241, P1, DOI 10.1016/j.memsci.2004.03.042
   SMITHA B, 2005, J CHEM TECHNOL BIOT, V80, P1416
   Sommer S, 2005, CHEM ENG PROCESS, V44, P1138, DOI 10.1016/j.cep.2005.02.006
   Sridhar S, 2005, SEPAR SCI TECHNOL, V40, P2889, DOI 10.1080/01496390500333186
   Sridhar S, 2005, SEP PURIF REV, V34, P1, DOI 10.1081/SPM-200054949
   Sridhar S, 2001, POLYM INT, V50, P1156, DOI 10.1002/pi.761
   Srinivasa PC, 2007, FOOD REV INT, V23, P53, DOI 10.1080/87559120600998163
   Su HJ, 2006, PROCESS BIOCHEM, V41, P1422, DOI 10.1016/j.procbio.2005.12.024
   Su HJ, 2005, J CHEM TECHNOL BIOT, V80, P439, DOI 10.1002/jctb.1206
   Sun HL, 2008, SEP PURIF TECHNOL, V58, P429, DOI 10.1016/j.seppur.2007.09.012
   Svang-Ariyaskul A, 2006, J MEMBRANE SCI, V280, P815, DOI 10.1016/j.memsci.2006.03.001
   Tada M, 2003, J MOL CATAL A-CHEM, V199, P115, DOI 10.1016/S1381-1169(03)00029-3
   Tamayo FG, 2007, J CHROMATOGR A, V1152, P32, DOI 10.1016/j.chroma.2006.08.095
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   Tarley César Ricardo Teixeira, 2005, Quím. Nova, V28, P1087, DOI 10.1590/S0100-40422005000600025
   Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455
   Tsai HA, 2006, DESALINATION, V193, P129, DOI 10.1016/j.desa1.2005.04.140
   Tsai HA, 2004, J APPL POLYM SCI, V94, P1562, DOI 10.1002/app.20828
   Tsai HA, 2008, J MEMBRANE SCI, V309, P146, DOI 10.1016/j.memsci.2007.10.018
   Tual C, 2000, J POLYM SCI POL PHYS, V38, P1521, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1521::AID-POLB120>3.0.CO;2-#
   Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084
   URAGAMI T, 1990, POLYMER, V31, P668, DOI 10.1016/0032-3861(90)90287-9
   Uragami T, 2004, BIOMACROMOLECULES, V5, P1567, DOI 10.1021/bm0498880
   URAGAMI T, 1992, J MEMBRANE SCI, V74, P183, DOI 10.1016/0376-7388(92)87082-9
   Uragami T, 2002, DESALINATION, V147, P449, DOI 10.1016/S0011-9164(02)00642-2
   Uragami T, 1998, MACROMOL CHEM PHYSIC, V199, P49
   Uragami T, 1997, J MEMBRANE SCI, V124, P203, DOI 10.1016/S0376-7388(96)00238-4
   Varma AJ, 2004, CARBOHYD POLYM, V55, P77, DOI 10.1016/j.carbpol.2003.08.005
   Veerapur RS, 2007, J MEMBRANE SCI, V304, P102, DOI 10.1016/j.memsci.2007.07.006
   Volkov VI, 1998, J MEMBRANE SCI, V138, P221, DOI 10.1016/S0376-7388(97)00232-9
   Wallace DW, 2006, POLYMER, V47, P1207, DOI 10.1016/j.polymer.2005.12.079
   Wang HD, 2007, J MEMBRANE SCI, V297, P262, DOI 10.1016/j.memsci.2007.03.055
   Wang XP, 1999, J APPL POLYM SCI, V73, P1145, DOI 10.1002/(SICI)1097-4628(19990815)73:7<1145::AID-APP6>3.0.CO;2-B
   Wang XP, 2000, POLYM INT, V49, P1426, DOI 10.1002/1097-0126(200011)49:11<1426::AID-PI524>3.0.CO;2-J
   Wang XP, 1996, J MEMBRANE SCI, V119, P191, DOI 10.1016/0376-7388(96)00157-3
   Wang XP, 2000, J APPL POLYM SCI, V75, P740, DOI 10.1002/(SICI)1097-4628(20000207)75:6<740::AID-APP2>3.0.CO;2-3
   Wang XP, 1998, J APPL POLYM SCI, V69, P2035, DOI 10.1002/(SICI)1097-4628(19980906)69:10<2035::AID-APP15>3.0.CO;2-0
   Wang XW, 1998, J APPL POLYM SCI, V67, P513
   Wang YC, 2004, J MEMBRANE SCI, V239, P219, DOI 10.1016/j.memsci.2004.03.037
   Won W, 2002, J MEMBRANE SCI, V209, P493, DOI 10.1016/S0376-7388(02)00367-8
   Won WY, 2003, SEP PURIF TECHNOL, V31, P129, DOI 10.1016/S1383-5866(02)00176-4
   WU LG, 1994, J MEMBRANE SCI, V90, P199, DOI 10.1016/0376-7388(94)80071-5
   Xi FN, 2006, J CHROMATOGR A, V1125, P38, DOI 10.1016/j.chroma.2006.05.016
   Xi FN, 2004, J CHROMATOGR A, V1057, P41, DOI 10.1016/j.chroma.2004.09.059
   Xia BL, 2003, J MEMBRANE SCI, V226, P9, DOI 10.1016/j.memsci.2003.08.007
   Xia YM, 2004, J MOL CATAL B-ENZYM, V31, P111, DOI 10.1016/j.molcatb.2004.08.003
   Xia YQ, 2006, REACT FUNCT POLYM, V66, P1734, DOI 10.1016/j.reactfunctpolym.2006.08.001
   Xia YQ, 2005, BIOMACROMOLECULES, V6, P2601, DOI 10.1021/bm050324l
   Xiao JB, 2007, J APPL POLYM SCI, V103, P3050, DOI 10.1002/app.25465
   Xiao SD, 2007, J MEMBRANE SCI, V306, P36, DOI 10.1016/j.memsci.2007.08.021
   Yang L, 2002, J MEMBRANE SCI, V197, P185, DOI 10.1016/S0376-7388(01)00632-9
   Yang L, 2002, J MEMBRANE SCI, V205, P141, DOI 10.1016/S0376-7388(02)00073-X
   Zeng XF, 1996, J MEMBRANE SCI, V117, P271
   Zeng XF, 1998, J MEMBRANE SCI, V148, P195, DOI 10.1016/S0376-7388(98)00183-5
   Zeng XF, 1998, IND ENG CHEM RES, V37, P159
   Zeng XF, 1996, IND ENG CHEM RES, V35, P4169, DOI 10.1021/ie960270j
   Zeng XF, 1999, J MEMBRANE SCI, V156, P97, DOI 10.1016/S0376-7388(98)00338-X
   Zeng XF, 1999, BIOTECHNOL PROGR, V15, P1003, DOI 10.1021/bp990120e
   Zhang LN, 2000, J APPL POLYM SCI, V77, P610, DOI 10.1002/(SICI)1097-4628(20000718)77:3<610::AID-APP16>3.0.CO;2-B
   Zhang W, 2007, J MEMBRANE SCI, V295, P130, DOI 10.1016/j.memsci.2007.03.001
   Zhao ZP, 2003, J MEMBRANE SCI, V217, P151, DOI 10.1016/S0376-7388(03)00105-4
   Zou HF, 2001, J BIOCHEM BIOPH METH, V49, P199, DOI 10.1016/S0165-022X(01)00200-7
   Zulfikar MA, 2006, J APPL POLYM SCI, V99, P3163, DOI 10.1002/app.22862
NR 213
TC 28
Z9 29
U1 4
U2 96
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD SEP
PY 2008
VL 24
IS 9
BP 1076
EP 1087
DI 10.1179/174328408X341762
PG 12
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 356RT
UT WOS:000259796000009
DA 2018-10-20
ER

PT J
AU Odahara, T
   Matsumoto, H
   Chiba, A
AF Odahara, Tadayoshi
   Matsumoto, Hiroaki
   Chiba, Akihiko
TI Mechanical Properties of Biomedical Co-33Cr-5Mo-0.3N Alloy at Elevated
   Temperatures
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt chromium molybdenum alloy; biomaterial; tensile test; mechanical
   properties; ductility; elongation; fracture; dislocation; dissociated
   dislocation; shockley partials; strain rate sensitivity; dynamic strain
   aging; Portevin-LeChatelier effect
ID STAINLESS-STEEL; STRAIN-RATE; DUCTILITY; BEHAVIOR; COBALT;
   MICROSTRUCTURE; CHROMIUM; FRACTURE
AB In order to examine the mechanical properties of a biomedical Co-33Cr-5Mo-0.3N alloy at elevated temperatures. tensile tests have been conducted in the temperature range from room temperature to 1373 K at initial strain rates of 1.0 x 10(-1) s(-1) and 1.4 x 10(-4) s(-1). The 0.2% proof stress and the tensile strength as a function of temperature have the plateau and the hump, respectively, at intermediate temperatures. The elongation to fracture increases at intermediate temperatures and abruptly decreases at higher temperatures. The decrease of the elongation at higher temperatures arises from the intergranular fracture, possibly caused by the equilibrium segregation of harmful elements such as sulfur. The serrations on the stress-strain curves are observed at intermediate temperatures. The temperature range where the elongation is enhanced and the serrations appear is shifted to lower temperatures at a low strain rate. The 0.2% proof stress does not increase with increasing strain rate and the strain rate sensitivity exhibits negative values at intermediate temperatures. It is considered that a serration leading to large elongation results from the dynamic strain aging. [doi: 10.2320/matertrans.MAW200816]
C1 [Odahara, Tadayoshi; Matsumoto, Hiroaki; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Odahara, T (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RI Chiba, Akihiko/D-1326-2011
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
FX The authors would like to thank to Mr. Yuji Maekawa and Mr. Toshiyuki
   Okubo of Kamaishi Otsuchi Industrial Research Development and Training
   Center for the sample preparations. Thanks are due to Dr. Sang-Hak Lee
   of NHK spring co., ltd., Japan, for the technical supports. This
   research was supported by a Cooperation of Innovative Technology and
   Advanced Research in Evolutional Area from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan.
CR BASKETTER DA, 1993, CONTACT DERMATITIS, V28, P15, DOI 10.1111/j.1600-0536.1993.tb03318.x
   BRINDLEY BJ, 1968, ACTA METALL MATER, V16, P587, DOI 10.1016/0001-6160(68)90133-8
   Chiba A, 1999, PHILOS MAG A, V79, P1533, DOI 10.1080/01418619908210378
   *EM MED SERV, 1996, ANN BOOK ASTM STAND, P4
   Granchi D, 1999, BIOMATERIALS, V20, P1079, DOI 10.1016/S0142-9612(99)00004-6
   Halim H, 2007, ACTA MATER, V55, P4151, DOI 10.1016/j.actamat.2007.03.007
   Haynes DR, 2000, J BIOMED MATER RES, V49, P167, DOI 10.1002/(SICI)1097-4636(200002)49:2<167::AID-JBM3>3.0.CO;2-9
   Huang P, 1999, MATER SCI TECH SER, V15, P1324, DOI 10.1179/026708399101505284
   KANNO M, 1987, MAT T JIM, V28, P742
   KANNO M, 1987, MAT T JIM, V28, P73
   Kim YS, 2007, J MATER PROCESS TECH, V187, P575, DOI 10.1016/j.jmatprotec.2006.11.094
   KLAWITTER JJ, 1977, J DENT RES, V56, P474, DOI 10.1177/00220345770560050501
   KOCKS UF, 1985, METALL TRANS A, V16, P2109, DOI 10.1007/BF02670415
   Lee MH, 2007, J ALLOY COMPD, V428, P99, DOI 10.1016/j.jallcom.2006.03.076
   Lee SH, 2008, MATER TRANS, V49, P260, DOI 10.2320/matertrans.MRA2007220
   Lee SH, 2006, MATER TRANS, V47, P287, DOI 10.2320/matertrans.47.287
   McLean D., 1957, GRAIN BOUNDARIES MET
   Nowosielski R, 2005, J MATER PROCESS TECH, V162, P379, DOI 10.1016/j.jmatprotec.2005.02.119
   Ozgowicz W, 2005, J MATER PROCESS TECH, V162, P392, DOI 10.1016/j.jmatprotec.2005.02.008
   PENG K, 2007, MAT SCI ENG A-STRUCT, V415, P53
   Peng KP, 2004, MAT SCI ENG A-STRUCT, V379, P372, DOI 10.1016/j.msea.2004.03.004
   SHI LQ, 1993, J MATER SCI, V28, P1312, DOI 10.1007/BF01191970
   UEMATSU Y, 1983, TETSU TO HAGANE, V69, P686
   Zhu FL, 2007, MICROELECTRON ENG, V84, P144, DOI 10.1016/j.mee.2006.09.031
NR 24
TC 9
Z9 9
U1 0
U2 2
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD SEP
PY 2008
VL 49
IS 9
BP 1963
EP 1969
DI 10.2320/matertrans.MAW200816
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 365HH
UT WOS:000260396000008
OA Bronze
DA 2018-10-20
ER

PT J
AU Levine, DH
   Ghoroghchian, PP
   Freudenberg, J
   Zhang, G
   Therien, MJ
   Greene, MI
   Hammer, DA
   Murali, R
AF Levine, Dalia Hope
   Ghoroghchian, P. Peter
   Freudenberg, Jaclyn
   Zhang, Geng
   Therien, Michael J.
   Greene, Mark I.
   Hammer, Daniel A.
   Murali, Ramachandran
TI Polymersomes: A new multi-functional tool for cancer diagnosis and
   therapy
SO METHODS
LA English
DT Article
DE Polymersome; Diblock copolymer; Vesicle; Drug delivery; Cancer
   diagnosis; Cancer therapy; Nanoparticle; Targeting; Optical imaging;
   Near-infrared
ID INFRARED-EMISSIVE POLYMERSOMES; BLOCK-COPOLYMER VESICLES; IN-VIVO;
   FUNCTIONALIZED POLYMERSOMES; BIODEGRADABLE POLYMERSOMES; DIBLOCK
   COPOLYMERS; MOLECULAR-WEIGHT; NANOPARTICLES; PACLITAXEL; RELEASE
AB Nanoparticles are being developed as delivery vehicles for therapeutic pharmaceuticals and contrast imaging agents. Polymersomes (mesoscopic polymer vesicles) possess a number of attractive biomaterial properties that make them ideal for these applications. Synthetic control over block copolymer chemistry enables tunable design of polymersome material properties. The polymersome architecture, with its large hydrophilic reservoir and its thick hydrophobic lamellar membrane, provides significant storage capacity for both water soluble and insoluble substances (such as drugs and imaging probes). Further, the brush-like architecture of the polymersome outer shell can potentially increase biocompatibility and blood circulation times. A further recent advance is the development of multi-functional polymersomes that carry pharmaceuticals and imaging agents simultaneously. The ability to conjugate biologically active ligands to the brush surface provides a further means for targeted therapy and imaging. Hence, polymersomes hold enormous potential as nanostructured biomaterials for future in vivo drug delivery and diagnostic imaging applications. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Freudenberg, Jaclyn; Zhang, Geng; Greene, Mark I.; Murali, Ramachandran] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Therien, Michael J.] Duke Univ, Dept Chem, Durham, NC 27706 USA.
   [Levine, Dalia Hope; Hammer, Daniel A.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA.
   [Ghoroghchian, P. Peter; Hammer, Daniel A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Murali, R (reprint author), Univ Penn, Dept Pathol & Lab Med, 243 John Morgan Bldg,36th Hamilton Walk, Philadelphia, PA 19104 USA.
EM murali@mail.med.upenn.edu
FU Health Research Formula Funds; National Institutes of Health
   [EB003457-01, CA115229-01A1]
FX This work is funded, in part, under a grant through the Health Research
   Formula Funds, Commonwealth of Pennsylvania to R.M., M.J.T. and D.A.H.
   The Department specifically disclaims responsibility for any analyses,
   interpretations, or conclusions. This work is also supported, in part,
   under grants from the National Institutes of Health (EB003457-01 and
   CA115229-01A1) to D.A.H. and MJ.T. The authors thank N.A. Christian, and
   G. Robbins for sharing unpublished results and/or recently submitted
   data.
CR Ahmed F, 2004, J CONTROL RELEASE, V96, P37, DOI 10.1016/j.jconrel.2003.12.021
   Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012
   Ahmed F, 2006, MOL PHARMACEUT, V3, P340, DOI 10.1021/mp050103u
   Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010
   Arifin DR, 2005, BIOMACROMOLECULES, V6, P2172, DOI 10.1021/bm0501454
   Bei JZ, 1997, POLYM ADVAN TECHNOL, V8, P693, DOI 10.1002/(SICI)1099-1581(199711)8:11<693::AID-PAT702>3.0.CO;2-B
   Berezov A, 2001, J MED CHEM, V44, P2565, DOI 10.1021/jm000527m
   Bermudez H, 2002, MACROMOLECULES, V35, P8203, DOI 10.1021/ma020669l
   Bolotin Elijah M., 1994, Journal of Liposome Research, V4, P455, DOI 10.3109/08982109409037057
   Borchert U, 2006, LANGMUIR, V22, P5843, DOI 10.1021/la060227t
   Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001
   Cegnar M, 2005, EXPERT OPIN BIOL TH, V5, P1557, DOI 10.1517/14712598.5.12.1557
   Cerritelli S, 2007, BIOMACROMOLECULES, V8, P1966, DOI 10.1021/bm070085x
   Choucair A, 2005, LANGMUIR, V21, P9308, DOI 10.1021/la050710o
   CHRISTIAN NA, 2007, DEV APPL TAT NEAR IN
   Christian NA, 2007, BIOCONJUGATE CHEM, V18, P31, DOI 10.1021/bc0601267
   de Menezes DEL, 1998, CANCER RES, V58, P3320
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838
   DUNCAN R, 2002, POLYM DRUG CONJUGATE, P197
   Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039
   Ghoroghchian PP, 2007, CHEM MATER, V19, P1309, DOI 10.1021/cm062427w
   Ghoroghchian PP, 2006, MACROMOLECULES, V39, P1673, DOI 10.1021/ma0519009
   Ghoroghchian PP, 2005, J AM CHEM SOC, V127, P15388, DOI 10.1021/ja055571b
   Ghoroghchian PP, 2005, P NATL ACAD SCI USA, V102, P2922, DOI 10.1073/pnas.0409394102
   GHOROGHCHIAN PP, 2006, THESIS U PENNSYLVANI
   Gustafson DL, 2005, CANCER LETT, V220, P161, DOI 10.1016/j.canlet.2004.09.007
   HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9
   Hillmyer MA, 1996, SCIENCE, V271, P976, DOI 10.1126/science.271.5251.976
   Hillmyer MA, 1996, MACROMOLECULES, V29, P6994, DOI 10.1021/ma960774t
   Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005
   Kelly KA, 2005, CIRC RES, V96, P327, DOI 10.1161/01.RES.0000155722.17881.dd
   Lee JCM, 2001, BIOTECHNOL BIOENG, V73, P135, DOI 10.1002/bit.1045
   Lee KY, 2007, PROG POLYM SCI, V32, P669, DOI 10.1016/j.progpolymsci.2007.04.001
   Li SL, 2007, BIOTECHNOL PROGR, V23, P278, DOI 10.1021/bp060208+
   Lin JJ, 2006, LANGMUIR, V22, P3975, DOI 10.1021/la052445c
   Lin JJ, 2004, LANGMUIR, V20, P5493, DOI 10.1021/la036417a
   LIN JJ, 2005, PHYS REV LETT, V23
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Meng FH, 2005, J CONTROL RELEASE, V101, P187, DOI 10.1016/j.jconrel.2004.09.026
   Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081
   Napoli A, 2002, LANGMUIR, V18, P8324, DOI 10.1021/la025897n
   Napoli A, 2001, MACROMOLECULES, V34, P8913, DOI 10.1021/ma0108057
   Nobs L, 2004, J PHARM SCI-US, V93, P1980, DOI 10.1002/jps.20098
   O'Reilly RK, 2006, J POLYM SCI POL CHEM, V44, P5203, DOI 10.1002/pola.21602
   O'Reilly RK, 2006, CHEM SOC REV, V35, P1068, DOI 10.1039/b514858h
   Park BW, 2000, NAT BIOTECHNOL, V18, P194, DOI 10.1038/72651
   Perez JM, 2004, NANO LETT, V4, P119, DOI 10.1021/nl034983k
   Photos PJ, 2003, J CONTROL RELEASE, V90, P323, DOI 10.1016/S0168-3659(03)00201-3
   Pressly ED, 2007, BIOMACROMOLECULES, V8, P3126, DOI 10.1021/bm700541e
   Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192
   SHARMA US, 1995, J PHARM SCI, V84, P1223, DOI 10.1002/jps.2600841015
   Sun G, 2007, ADV MATER, V19, P3157, DOI 10.1002/adma.200701973
   Sun J, 2007, LANGMUIR, V23, P8308, DOI 10.1021/la701038f
   Sun XK, 2005, BIOMACROMOLECULES, V6, P2541, DOI 10.1021/bm050260e
   Tsourkas A, 2005, BIOCONJUGATE CHEM, V16, P576, DOI 10.1021/bc050002e
   Valentini M, 2003, LANGMUIR, V19, P4852, DOI 10.1021/la026896y
   Waterhouse Dawn N., 2001, Drug Safety, V24, P903, DOI 10.2165/00002018-200124120-00004
   WEISS RB, 1990, J CLIN ONCOL, V8, P1263, DOI 10.1200/JCO.1990.8.7.1263
   Zhou W, 2006, J CONTROL RELEASE, V116, pE62, DOI 10.1016/j.jconrel.2006.09.051
   Zupancich JA, 2006, MACROMOLECULES, V39, P4286, DOI 10.1021/ma060642s
NR 62
TC 140
Z9 145
U1 0
U2 85
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
J9 METHODS
JI Methods
PD SEP
PY 2008
VL 46
IS 1
BP 25
EP 32
DI 10.1016/j.ymeth.2008.05.006
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 368FP
UT WOS:000260607300005
PM 18572025
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Karnik, R
   Gu, F
   Basto, P
   Cannizzaro, C
   Dean, L
   Kyei-Manu, W
   Langer, R
   Farokhzad, OC
AF Karnik, Rohit
   Gu, Frank
   Basto, Pamela
   Cannizzaro, Christopher
   Dean, Lindsey
   Kyei-Manu, William
   Langer, Robert
   Farokhzad, Omid C.
TI Microfluidic platform for controlled synthesis of polymeric
   nanoparticles
SO NANO LETTERS
LA English
DT Article
ID CDSE NANOCRYSTALS; DRUG-DELIVERY; IN-VIVO; SIZE; PARTICLES; MICROGELS;
   REACTORS; ROUTES
AB A central challenge in the development of drug-encapsulated polymeric nanoparticles is the inability to control the mixing processes required for their synthesis resulting in variable nanoparticle physicochemical properties. Nanoparticles may be developed by mixing and nanoprecipitation of polymers and drugs dissolved in organic solvents with nonsolvents. We used rapid and tunable mixing through hydrodynamic flow focusing in microfluidic channels to control nanoprecipitation of poly(lactic-co-glycolic acid)-b-poly(ethylene glycol) diblock copolymers as a model polymeric biomaterial for drug delivery. We demonstrate that by varying (1) flow rates, (2) polymer composition, and (3) polymer concentration we can optimize the size, improve polydispersity, and control drug loading and release of the resulting nanoparticles. This work suggests that microfluidics may find applications for the development and optimization of polymeric nanoparticles in the newly emerging field of nanomedicine.
C1 [Farokhzad, Omid C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Lab Nanomed & Biomat, Boston, MA 02115 USA.
   [Farokhzad, Omid C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol, Boston, MA 02115 USA.
   [Karnik, Rohit] MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   [Gu, Frank; Basto, Pamela; Cannizzaro, Christopher; Dean, Lindsey; Kyei-Manu, William; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Basto, Pamela; Langer, Robert] Harvard MIT Div Hlth Sci & Technol, MIT, Cambridge, MA 02139 USA.
   [Langer, Robert; Farokhzad, Omid C.] MIT Harvard Ctr Canc Nanotechnol Excellence, MIT, Cambridge, MA 02139 USA.
RP Farokhzad, OC (reprint author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Lab Nanomed & Biomat, Boston, MA 02115 USA.
EM ofarokhzad@zeus.bwh.harvard.edu
OI Basto, Pamela/0000-0002-5446-7963; Gu, Frank/0000-0001-8749-9075;
   Farokhzad, Omid/0000-0003-2009-270X
FU Koch-Prostate Cancer Foundation; Dana Farber Cancer Institute Prostate
   SPORE; NIH [CA119349, EB003647]; Canadian Natural Sciences and
   Engineering Research Council
FX We thank MIT's Microsystems Technology Laboratory and staff for their
   help with device fabrication. We also thank Sangeeta Bhatia (MIT) for
   graciously allowing the use of particle sizing equipment in her
   laboratory. Negative staining sample preparation and electron microscopy
   image acquisition were performed by Eliza Vasile, from the Center for
   Cancer Research, Microscopy and Imaging Core Facility, MIT. This
   research was supported by the Koch-Prostate Cancer Foundation Award in
   Nanotherapeutics (R.L. and O.C.F.), by a Concept Development Grant from
   the Dana Farber Cancer Institute Prostate SPORE (O.C.F.), and by NIH
   Grants CA119349 (R.L. and O.C.F.) and EB003647 (O.C.F.). F.G. was
   supported by a Postdoctoral Fellowship from the Canadian Natural
   Sciences and Engineering Research Council.
CR Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519
   Avgoustakis Konstantinos, 2004, Current Drug Delivery, V1, P321, DOI 10.2174/1567201043334605
   Chan EM, 2005, J AM CHEM SOC, V127, P13854, DOI 10.1021/ja051381p
   Cheng J, 2007, BIOMATERIALS, V28, P869, DOI 10.1016/j.biomaterials.2006.09.047
   Davaran S, 2006, INT J NANOMED, V1, P535, DOI 10.2147/nano.2006.1.4.535
   De Geest BG, 2005, LANGMUIR, V21, P10275, DOI 10.1021/la051527y
   DEMELLO A, 2006, Patent No. 7252814
   deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062
   DeMello J, 2004, LAB CHIP, V4, p11N, DOI 10.1039/b403638g
   Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Johnson BK, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.118302
   Knight JB, 1998, PHYS REV LETT, V80, P3863, DOI 10.1103/PhysRevLett.80.3863
   Krishnadasan S, 2007, LAB CHIP, V7, P1434, DOI 10.1039/b711412e
   Martin-Banderas L, 2005, SMALL, V1, P688, DOI 10.1002/smll.200500087
   Matteucci ME, 2006, LANGMUIR, V22, P8951, DOI 10.1021/1a061122t
   Nguyen NT, 2005, J MICROMECH MICROENG, V15, pR1, DOI 10.1088/0960-1317/15/2/R01
   Nisisako T, 2004, CHEM ENG J, V101, P23, DOI 10.1016/j.cej.2003.11.019
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Quintanar-Guerrero D, 1998, DRUG DEV IND PHARM, V24, P1113, DOI 10.3109/03639049809108571
   Riley T, 2001, LANGMUIR, V17, P3168, DOI 10.1021/la001226i
   Seo M, 2005, LANGMUIR, V21, P11614, DOI 10.1021/la050519e
   Shestopalov I, 2004, LAB CHIP, V4, P316, DOI 10.1039/b403378g
   Wagner J, 2005, NANO LETT, V5, P685, DOI 10.1021/nl050097t
   Xu S, 2005, ANGEW CHEM INT EDIT, V44, P3799, DOI 10.1002/anie.200590085
   Xu SQ, 2005, ANGEW CHEM INT EDIT, V44, P724, DOI 10.1002/anie.200462226
   Yen BKH, 2003, ADV MATER, V15, P1858, DOI 10.1002/adma.200305162
   Zhang H, 2007, MACROMOL RAPID COMM, V28, P527, DOI 10.1002/marc.200600776
NR 28
TC 332
Z9 342
U1 17
U2 296
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD SEP
PY 2008
VL 8
IS 9
BP 2906
EP 2912
DI 10.1021/nl801736q
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 347KQ
UT WOS:000259140200053
PM 18656990
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Thakar, RG
   Chown, MG
   Patel, A
   Peng, L
   Kumar, S
   Desai, TA
AF Thakar, Rahul G.
   Chown, Matthew G.
   Patel, Anqj
   Peng, Lily
   Kumar, Sanjay
   Desai, Tejal A.
TI Contractility-dependent modulation of cell proliferation and adhesion by
   microscale topographical cues
SO SMALL
LA English
DT Article
DE biomaterials; cell adhesion; microfabrication; tissue engineering;
   topographical structures
ID HEPATIC STELLATE CELL; SMOOTH-MUSCLE-CELLS; STRESS FIBERS; RHO-KINASE;
   SOFT LITHOGRAPHY; FOCAL ADHESIONS; EXTRACELLULAR-MATRIX;
   SKELETAL-MUSCLE; GENE-EXPRESSION; DISTINCT ROLES
AB Engineering of cellular assembly on biomaterial scaffolds by utilizing microscale topographical cues has emerged as a powerful strategy in cardiovascular tissue engineering and regenerative medicine. However, the mechanisms through which these cues are processed to yield changes in canonical cell behaviors remain unclear. Previously, we showed that when mixtures of cardiomyocytes and fibroblasts were cultured on polydimethylsiloxane surfaces studded with microscale pillars (micropegs), fibroblast proliferation was dramatically suppressed, which suggests that the micropegs could be exploited to minimize fibrosis and scar formation. Here, we demonstrate that this effect relies on altered adhesive and micro-mechanical interactions between individual cells and micropegs. First, we show that the proliferation of a cell physically attached to a micropeg is significantly lower than that of a cell cultured on a featureless region of the substrate. Micropeg adhesion is accompanied by a marked elongation in cell and nuclear shape. When fibroblast contractility is pharmacologically attenuated through low-dose inhibition of either Rho-associated kinase or myosin light chain kinase, the potency with which micropeg adhesion suppresses cell proliferation is significantly reduced. Together, our results support a model in which cell fate decisions may be directly manipulated within tissue engineering scaffolds by the inclusion of microtopographical structures that alter cellular mechanics.
C1 [Chown, Matthew G.; Patel, Anqj; Kumar, Sanjay] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Thakar, Rahul G.; Desai, Tejal A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.
   [Thakar, Rahul G.; Desai, Tejal A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.
   [Patel, Anqj; Peng, Lily; Kumar, Sanjay; Desai, Tejal A.] UCSF UC Berkeley Joint Grad Grp Bioengn, Berkeley, CA USA.
RP Kumar, S (reprint author), Univ Calif Berkeley, Dept Bioengn, 274A Stanley Hall 1762, Berkeley, CA 94720 USA.
EM skumar@berkeley.edu; tejal.desai@ucsf.edu
FU NSF NSEC; American Heart Association [0765128Y]; Arnold and Mabel
   Beckman Young Investigator Award; UCSF Dean's Health Science Fellowship
FX We appreciate Dr. Kurt Thorn's invaluable training and assistance at the
   Nikon Imaging Center at UCSF-Mission Bay. In addition, we would like to
   express our thanks to Dr. Daniel A. Bernards for his help with SEM image
   collection. We also thank the UCSF Biomedical Micro- and Nanofabrication
   Core for allowing us to fabricate our SU-8 molds, and Dr. James J.
   Norman and Mark Steedman for guidance with the fabrication. This
   research was supported by an NSF NSEC grant to T.A.D., an American Heart
   Association Beginning Grant-in-Aid (0765128Y) and Arnold and Mabel
   Beckman Young Investigator Award to S.K., and a UCSF Dean's Health
   Science Fellowship to L.P. All SEM was performed at the Stanford
   Nanocharacterization Laboratory through the Stanford CIS grant program.
CR Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   BELMONT AS, 1980, CELL BIOPHYS, V2, P165, DOI 10.1007/BF02795842
   Birla RK, 2005, ARTIF ORGANS, V29, P866, DOI 10.1111/j.1525-1594.2005.00148.x
   Biswas G, 2005, CELL DEATH DIFFER, V12, P266, DOI 10.1038/sj.cdd.4401553
   Boateng SY, 2003, AM J PHYSIOL-CELL PH, V285, pC171, DOI 10.1152/ajpcell.00013.2003
   Chaubey A, 2008, J BIOMED MATER RES B, V84B, P70, DOI 10.1002/jbm.b.30846
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   Dennis RG, 2001, AM J PHYSIOL-CELL PH, V280, pC288
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FELDHERR CM, 1990, J CELL BIOL, V111, P1, DOI 10.1083/jcb.111.1.1
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Hu SH, 2004, FRONT BIOSCI, V9, P2177, DOI 10.2741/1352
   Huang Jing, 2004, Human Genomics, V1, P287
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Katoh K, 2001, J CELL BIOL, V153, P569, DOI 10.1083/jcb.153.3.569
   Katoh K, 2007, GENES CELLS, V12, P623, DOI 10.1111/j.1365-2443.2007.01073.x
   Kosnik PE, 2001, TISSUE ENG, V7, P573, DOI 10.1089/107632701753213192
   Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Lang A, 1999, ITAL J GASTROENTEROL, V31, P173
   Lee CJ, 2004, LANGMUIR, V20, P4155, DOI 10.1021/la035467c
   Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550
   Lelievre SA, 2000, CRIT REV EUKAR GENE, V10, P13
   Leor J, 2000, CIRCULATION, V102, P56
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114
   MCMAHON DK, 1994, AM J PHYSIOL, V266, pC1795
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   Motlagh D, 2003, BIOMATERIALS, V24, P2463, DOI 10.1016/S0142-9612(02)00644-0
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896
   Pelletier S, 2005, J CELL PHYSIOL, V204, P412, DOI 10.1002/jcp.20308
   Puddu GM, 2005, J BIOMED SCI, V12, P839, DOI 10.1007/s11373-005-9024-z
   Reiss AB, 2006, J INVEST MED, V54, P123, DOI 10.2310/6550.2006.05051
   Ren Guofeng, 2003, Current Drug Targets - Inflammation and Allergy, V2, P242, DOI 10.2174/1568010033484098
   Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104
   Salber J, 2007, SMALL, V3, P1023, DOI 10.1002/smll.200600596
   Sniadecki NJ, 2007, P NATL ACAD SCI USA, V104, P14553, DOI 10.1073/pnas.0611613104
   Sun Y, 2002, BASIC RES CARDIOL, V97, P343, DOI 10.1007/s00395-002-0365-8
   Takahashi H, 2007, BIOMACROMOLECULES, V8, P3281, DOI 10.1021/bm700540p
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Thakar RG, 2003, BIOCHEM BIOPH RES CO, V307, P883, DOI 10.1016/S0006-291X(03)01285-3
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172
   Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797
   WALLACE CS, 2007, AM J PHYSIOL-HEART C, V3, P1978
   Wang YC, 2004, FASEB J, V18, P525, DOI 10.1096/fj.03-0490fje
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Yanase M, 2003, BIOCHEM BIOPH RES CO, V305, P223, DOI 10.1016/S0006-291X(03)00726-5
NR 55
TC 34
Z9 34
U1 1
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1613-6810
J9 SMALL
JI Small
PD SEP
PY 2008
VL 4
IS 9
BP 1416
EP 1424
DI 10.1002/smll.200701302
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 352ZV
UT WOS:000259536800024
PM 18711756
DA 2018-10-20
ER

PT J
AU Willerth, SM
   Rader, A
   Sakiyama-Elbert, SE
AF Willerth, Stephanie M.
   Rader, Allison
   Sakiyama-Elbert, Shelly E.
TI The effect of controlled growth factor delivery on embryonic stem cell
   differentiation inside fibrin scaffolds
SO STEM CELL RESEARCH
LA English
DT Article
AB The goal of this project was to develop 3-D biomaterial scaffolds that present cues to direct the differentiation of embryonic stem (ES) cell-derived neural progenitor cells, seeded inside the scaffolds, into mature neural phenotypes, specifically neurons and oligodendrocytes. Release studies were performed to determine the appropriate conditions for retention of neurotrophin-3 (NT-3), sonic hedgehog, and platelet-derived growth factor (PDGF) by an affinity-based delivery system incorporated into fibrin scaffolds. Embryoid bodies containing neural progenitors were formed from mouse ES cells, using a 4-/4+ retinoic acid treatment protocol, and then seeded inside fibrin scaffolds containing the drug delivery system. This delivery system was used to deliver various growth factor doses and combinations to the cells seeded inside the scaffolds. Controlled delivery of NT-3 and PDGF simultaneously increased the fraction of neural progenitors, neurons, and oligodendrocytes while decreasing the fraction of astrocytes obtained compared to control cultures seeded inside unmodified fibrin scaffolds with no growth factors present in the medium. These results demonstrate that such a strategy can be used to generate an engineered tissue for the potential treatment of spinal cord injury and could be extended to the study of differentiation in other tissues. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Willerth, Stephanie M.; Rader, Allison; Sakiyama-Elbert, Shelly E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
   [Sakiyama-Elbert, Shelly E.] Washington Univ, Ctr Mat Innovat, St Louis, MO 63130 USA.
RP Sakiyama-Elbert, SE (reprint author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
EM sakiyama@wustl.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851; Willerth,
   Stephanie/0000-0002-1665-7723
FU NIH [R01 NS051454]; NIH Neuroscience Blueprint Interdisciplinary Center
   [P30 NS057105]
FX This work was supported by NIH R01 NS051454. The authors thank Amy
   Boyet, Angela Guzman, Nicole Moore, and Matthew Wood for technical
   support. The authors thank Shengzhou Wu and the Hope Center for
   Neurological Disorders, which is supported by an NIH Neuroscience
   Blueprint Interdisciplinary Center Core grant (P30 NS057105), for use of
   the real-time PCR machine.
CR BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   Bambakidis NC, 2003, J NEUROSURG, V99, P70, DOI 10.3171/spi.2003.99.1.0070
   Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004
   Beckstead BL, 2006, J BIOMED MATER RES A, V79A, P94, DOI 10.1002/jbm.a.30760
   Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exner.2002.7981
   Danesin C, 2006, J NEUROSCI, V26, P5037, DOI 10.1523/JNEUROSCI.0715-06.2006
   Dutton R, 1999, J NEUROSCI, V19, P2601
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Fressinaud C, 2005, GLIA, V49, P555, DOI 10.1002/glia.20136
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   Hiraizumi Y, 1996, SPINAL CORD, V34, P394, DOI 10.1038/sc.1996.71
   HIRAIZUMI Y, 1993, BRAIN RES BULL, V30, P353, DOI 10.1016/0361-9230(93)90264-C
   Hiraizumi Y, 1992, J Am Paraplegia Soc, V15, P7
   Ho JE, 2007, J BIOMED MATER RES A, V83A, P1200, DOI 10.1002/jbm.a.31355
   ICHINOSE A, 1983, FEBS LETT, V153, P369, DOI 10.1016/0014-5793(83)80645-0
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kumar S, 1998, J NEUROSCI RES, V54, P754, DOI 10.1002/(SICI)1097-4547(19981215)54:6<754::AID-JNR3>3.0.CO;2-K
   Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097
   Levenberg S, 2005, TISSUE ENG, V11, P506, DOI 10.1089/ten.2005.11.506
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063
   Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126
   Lobsiger CS, 2000, GLIA, V30, P290, DOI 10.1002/(SICI)1098-1136(200005)30:3<290::AID-GLIA8>3.0.CO;2-6
   McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986
   Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004
   Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127
   Oh S, 2005, DEV DYNAM, V234, P489, DOI 10.1002/dvdy.20422
   Rubin JB, 2002, DEVELOPMENT, V129, P2223
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006
   Soundararajan P, 2007, STEM CELLS, V25, P1697, DOI 10.1634/stemcells.2006-0654
   Taqvi S, 2006, J BIOMED MATER RES A, V79A, P689, DOI 10.1002/jbm.a.30916
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Thomopoulos S, 2007, J ORTHOP RES, V25, P1358, DOI 10.1002/jor.20444
   Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9
   TYLERCROSS R, 1994, PROTEIN SCI, V3, P620
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Wood MD, 2008, J BIOMED MATER RES A, V84A, P300, DOI 10.1002/jbm.a.31269
   Yim EKF, 2005, J BIOMAT SCI-POLYM E, V16, P1193, DOI 10.1163/156856205774269485
   Zhang FM, 2007, BIOCHEMISTRY-US, V46, P3933, DOI 10.1021/bi6025424
NR 57
TC 69
Z9 73
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1873-5061
J9 STEM CELL RES
JI Stem Cell Res.
PD SEP
PY 2008
VL 1
IS 3
BP 205
EP 218
DI 10.1016/j.scr.2008.05.006
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA V12AC
UT WOS:000207571100006
PM 19383401
OA Bronze, Green Accepted
DA 2018-10-20
ER

PT J
AU Nesti, LJ
   Li, WJ
   Shanti, RM
   Jiang, YJ
   Jackson, W
   Freedman, BA
   Kuklo, TR
   Giuliani, JR
   Tuan, RS
AF Nesti, Leon J.
   Li, Wan-Ju
   Shanti, Rabie M.
   Jiang, Yi Jen
   Jackson, Wesley
   Freedman, Brett A.
   Kuklo, Timothy R.
   Giuliani, Jeffrey R.
   Tuan, Rocky S.
TI Intervertebral disc tissue engineering using a novel hyaluronic
   acid-nanofibrous scaffold (HANFS) amalgam
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; INVESTIGATIONAL DEVICE EXEMPTION; NUCLEUS
   PULPOSUS; IN-VITRO; TRANSPLANTATION THERAPY; SOLUTE TRANSPORT; LUMBAR
   FUSION; BACK-PAIN; FOLLOW-UP; DIFFERENTIATION
AB Degeneration of the intervertebral disc (IVD) represents a significant musculoskeletal disease burden. Although spinal fusion has some efficacy in pain management, spine biomechanics is ultimately compromised. In addition, there is inherent limitation of hardware-based IVD replacement prostheses, which underscores the importance of biological approaches to disc repair. In this study, we have seeded multipotent, adult human mesenchymal stem cells (MSCs) into a novel biomaterial amalgam to develop a biphasic construct that consisted of electrospun, biodegradable nanofibrous scaffold (NFS) enveloping a hyaluronic acid (HA) hydrogel center. The seeded MSCs were induced to undergo chondrogenesis in vitro in the presence of transforming growth factor-beta for up to 28 days. The cartilaginous hyaluronic acid nanofibrous scaffold (HANFS) construct architecturally resembled a native IVD, with an outer annulus fibrosus-like region and inner nucleus pulposus-like region. Histological and biochemical analyses, immunohistochemistry, and gene expression profiling revealed the time-dependent development of chondrocytic phenotype of the seeded cells. The cells also maintain the microarchitecture of a native IVD. Taken together, these findings suggest the prototypic potential of MSC-seeded HANFS constructs for the tissue engineering of biological replacements of degenerated IVD.
C1 [Nesti, Leon J.; Li, Wan-Ju; Shanti, Rabie M.; Jiang, Yi Jen; Jackson, Wesley; Tuan, Rocky S.] NIAMSD, NIH, Dept Hlth & Human Serv, Cartilage Biol & Orthopaed Branch, Bethesda, MD 20892 USA.
   [Nesti, Leon J.; Freedman, Brett A.; Kuklo, Timothy R.; Giuliani, Jeffrey R.] Walter Reed Army Med Ctr, Dept Orthopaed & Rehabil, Washington, DC 20307 USA.
   [Shanti, Rabie M.] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA.
RP Tuan, RS (reprint author), NIAMSD, NIH, Dept Hlth & Human Serv, Cartilage Biol & Orthopaed Branch, Bldg 50,Room 1503,MSC 8022, Bethesda, MD 20892 USA.
EM tuanr@mail.nih.gov
OI Li, Wan-Ju/0000-0002-6579-8063
FU NIAMS; NIH [ZO1 AR41131]
FX This work was supported by the Intramural Research Program of the NIAMS,
   NIH (ZO1 AR41131).
CR Abukawa H, 2003, J ORAL MAXIL SURG, V61, P94, DOI 10.1053/joms.2003.50015
   Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Caterson EJ, 2001, J BIOMED MATER RES, V57, P394, DOI 10.1002/1097-4636(20011205)57:3<394::AID-JBM1182>3.0.CO;2-9
   Chen WH, 2006, J CELL PHYSIOL, V209, P744, DOI 10.1002/jcp.20765
   Cowan JA, 2006, NEUROSURGERY, V59, P15, DOI 10.1227/01.NEU.0000219836.54861.CD
   Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fritzell P, 2001, SPINE, V26, P2521, DOI 10.1097/00007632-200112010-00002
   Ganey T, 2003, SPINE, V28, P2609, DOI 10.1097/01.BRS.0000097891.63063.78
   Hallab NJ, 2003, SPINE, V28, pS125, DOI 10.1097/00007632-200310151-00006
   Huang KY, 2007, SPINE, V32, P1174, DOI 10.1097/01.brs.0000263369.95182.19
   Huang RC, 2005, SPINE, V30, P1407, DOI 10.1097/01.brs.0000166528.67425.0e
   Imai Y, 2007, SPINE, V32, P1197, DOI 10.1097/BRS.0b013e3180574d26
   Inkinen RI, 1999, HISTOCHEM J, V31, P579, DOI 10.1023/A:1003898923823
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Huec JC, 2005, ORTHOP CLIN N AM, V36, P315, DOI 10.1016/j.ocl.2005.02.001
   Le Visage C, 2006, SPINE, V31, P2423, DOI 10.1097/01.brs.0000238684.04792.eb
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Leung VYL, 2006, EUR SPINE J, V15, pS406, DOI 10.1007/s00586-006-0183-z
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Li YC, 2007, DEV BIOL, V305, P411, DOI 10.1016/j.ydbio.2007.02.023
   MALDONADO BA, 1992, J ORTHOP RES, V10, P677, DOI 10.1002/jor.1100100510
   Manchikanti L, 2000, Pain Physician, V3, P167
   Masuda K, 2006, EUR SPINE J, V15, pS422, DOI 10.1007/s00586-006-0149-1
   McAfee PC, 2005, SPINE, V30, P1576, DOI 10.1097/01.brs.0000170561.25636.1c
   Meisel HJ, 2006, EUR SPINE J, V15, pS397, DOI 10.1007/s00586-006-0169-x
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   Nesti LJ, 2002, J ORTHOPAED RES, V20, P1042, DOI 10.1016/S0736-0266(02)00020-7
   Nishida K, 2006, SPINE, V31, P1415, DOI 10.1097/01.brs.0000219945.70675.dd
   Paesold G, 2007, EUR SPINE J, V16, P447, DOI 10.1007/s00586-006-0220-y
   Panjabi M, 2007, SPINE, V32, P1311, DOI 10.1097/BRS.0b013e318059af6f
   Pfeiffer M, 2003, EUR SPINE J, V12, P76, DOI 10.1007/s00586-002-0478-7
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Risbud Makarand V, 2004, Spine J, V4, p348S, DOI 10.1016/j.spinee.2004.07.031
   Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f
   Rong Y, 2002, TISSUE ENG, V8, P1037, DOI 10.1089/107632702320934137
   Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3
   Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9
   Sato M, 2003, SPINE, V28, P548, DOI 10.1097/00007632-200303150-00007
   Shuff Charles, 2005, Am J Orthop (Belle Mead NJ), V34, P8
   Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107
   Stern S, 2000, ACTA ORTHOP SCAND, V71, P496, DOI 10.1080/000164700317381207
   Tsai TT, 2007, SPINE, V32, P495, DOI 10.1097/01.brs.0000257341.88880.f1
   URBAN JPG, 1977, CLIN ORTHOP RELAT R, P101
   URBAN JPG, 1982, CLIN ORTHOP RELAT R, P296
   Valdevit Antonio, 2004, Spine J, V4, p276S, DOI 10.1016/j.spinee.2004.07.016
   Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847
   von Knoch M, 2004, J ORTHOPAED RES, V22, P237, DOI 10.1016/j.orthres.2003.08.013
   Wallach CJ, 2003, SPINE, V28, P2331, DOI 10.1097/01.BRS.0000085303.67942.94
   Wallach Corey J, 2006, Spine J, V6, P107, DOI 10.1016/j.spinee.2005.05.002
   Wilda H, 2006, BIOMATERIALS, V27, P5220, DOI 10.1016/j.biomaterials.2006.06.008
   Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x
   Williams KD, 2003, CAMPBELLS OPERATIVE, P1955
   Zigler J, 2007, SPINE, V32, P1155, DOI 10.1097/BRS.0b013e318054e377
NR 61
TC 112
Z9 122
U1 4
U2 28
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2008
VL 14
IS 9
SI SI
BP 1527
EP 1537
DI 10.1089/ten.tea.2008.0215
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 350UG
UT WOS:000259378000010
PM 18707229
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Bakker, AD
   Schrooten, J
   Van Cleynenbreugel, T
   Vanlauwe, J
   Luyten, J
   Schepers, E
   Dubruel, P
   Schacht, E
   Lammens, J
   Luyten, FP
AF Bakker, Astrid D.
   Schrooten, Jan
   Van Cleynenbreugel, Tim
   Vanlauwe, Johan
   Luyten, Jan
   Schepers, Evert
   Dubruel, Peter
   Schacht, Etienne
   Lammens, Johan
   Luyten, Frank P.
TI Quantitative screening of engineered implants in a long bone defect
   model in rabbits
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID PERIOSTEAL CELLS; STEM-CELL; IN-VIVO; LOCALIZATION; VITRO
AB We have standardized a long bone defect model in rabbits to quantitatively compare the bone healing performance of engineered biological implants and have tested the bone healing efficiency of porous cylindrical scaffolds (o-h, 6-20 mm [diameter 6 mm, height 20 mm] porosity, 70%) that were produced from hydroxyapatite (HA), titanium (Ti), and a novel biodegradable polymer-bioceramic composite (PH70 alpha TCP). Scaffolds were perfused with or without 20 x 10(6) rabbit periosteal cells (RPCs) in a bioreactor and implanted in a standardized 2 cm defect in rabbit tibiae. X-rays revealed that new bone had formed at 3 weeks after creation of the defects. At sacrifice after 10 weeks, bone corticalization was observed in the majority of animals. Although PH70 alpha TCP scaffolds did not inhibit callus formation, histomorphometric analysis revealed that there was no bone within the biomaterial, in contrast to HA and Ti scaffolds (bone volume ranging from 10% to 25%). We found that Ti and HA scaffold had good osteoconductive properties, but only HA scaffolds seeded with RPCs contributed to long bone mechanical functionality, with the maximum energy and angle being 308% and 155% greater than in control defects without scaffold.
C1 [Bakker, Astrid D.; Luyten, Frank P.] Katholieke Univ Leuven, Lab Skeletal Dev & Joint Disorders, Leuven, Belgium.
   [Schrooten, Jan] Katholieke Univ Leuven, Dept Met & Mat Engn, Leuven, Belgium.
   [Schrooten, Jan; Schepers, Evert; Lammens, Johan; Luyten, Frank P.] Katholieke Univ Leuven, Div Skeletal Tissue Engn, Leuven, Belgium.
   [Van Cleynenbreugel, Tim] Katholieke Univ Leuven, Dept Mech Engn, Leuven, Belgium.
   [Vanlauwe, Johan; Lammens, Johan] Univ Hosp Pellenberg, Dept Orthopead, Pellenberg, Belgium.
   [Luyten, Jan] Flemish Inst Technol Res, Mol, Belgium.
   [Schepers, Evert] Katholieke Univ Leuven, Dept Prosthet Dent, Leuven, Belgium.
   [Dubruel, Peter; Schacht, Etienne] Univ Ghent, Polymer Mat Res Grp, B-9000 Ghent, Belgium.
RP Luyten, FP (reprint author), UZ Leuven, Dept Rheumatol, Lab Skeletal Dev & Joint Disorders, O&N1,8th Floor,Bus 813, B-3000 Louvain, Belgium.
EM frank.luyten@uzleuven.be
RI Dubruel, Peter/A-3440-2009
OI Vanlauwe, Johan/0000-0003-0593-5414
FU The Institute for the Promotion of Innovation by Science and Technology
   in Flanders (IWT-Flanders) [GBOU-020181]
FX This work is part of the Guided Bone Engineering (GBE) project, an
   interdisciplinary research project funded by The Institute for the
   Promotion of Innovation by Science and Technology in Flanders
   (IWT-Flanders) under the program for strategic basic research
   (GBOU-020181). The scientific GBE-partners are the Department of
   Metallurgy and Materials Engineering, the Division of Biomechanics and
   Engineering Design, and the Department of Rheumatology of the Katholieke
   Universiteit Leuven, the Polymer Materials Research Group of the Ghent
   University; and VITO, the Flemish institute for technology. We thank
   Marina Marechal, Jenny Peeters, Jos Nijs, Erik-Jan Ververs, and Nele
   Bijnens for their technical assistance. We thank Thomasz Gorski for
   preparing the polymer-based scaffolds.
CR De Bari C, 2001, ARTHRITIS RHEUM, V44, P85, DOI 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   EYCKMANS J, 2006, P TERMIS EU M
   Eyckmans J, 2006, TISSUE ENG, V12, P2203, DOI 10.1089/ten.2006.12.2203
   GORSKI T, 2003, 18 EUR C BIOM OCT 1
   HAMADA K, 2007, J BIOMED MATER RES A, P1552
   Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978
   Ito Y, 2001, OSTEOARTHR CARTILAGE, V9, P215, DOI 10.1053/joca.2000.0378
   Kim MS, 2006, TISSUE ENG, V12, P2863, DOI 10.1089/ten.2006.12.2863
   KOJIMOTO H, 1988, J BONE JOINT SURG BR, V70, P543
   KOSHIHARA Y, 1991, J GERONTOL, V46, pB201, DOI 10.1093/geronj/46.5.B201
   Luyten J, 2003, ADV ENG MATER, V5, P715, DOI 10.1002/adem.200300381
   Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787
   NAKAHARA H, 1990, CLIN ORTHOP RELAT R, P223
   Ozaki A, 2000, J Orthop Sci, V5, P64, DOI 10.1007/s007760050010
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   SCHANTZ JT, 2002, CELL TRANSPLANT, V11, P25
   STAFFORD HJ, 1994, J ORTHOP RES, V12, P29, DOI 10.1002/jor.1100120105
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Takushima A, 1998, J SURG RES, V78, P68, DOI 10.1006/jsre.1998.5378
   Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310414
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Van Cleynenbreugel T, 2006, MED BIOL ENG COMPUT, V44, P517, DOI 10.1007/s11517-006-0071-z
   Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014
NR 24
TC 15
Z9 16
U1 1
U2 7
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PT C-METH
JI Tissue Eng. Part C-Methods
PD SEP
PY 2008
VL 14
IS 3
BP 251
EP 260
DI 10.1089/ten.tec.2008.0022
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 354AT
UT WOS:000259612000009
PM 18781837
DA 2018-10-20
ER

PT J
AU Sreenivas, SA
   Pai, KV
AF Sreenivas, S. A.
   Pai, K. V.
TI Thiolated Chitosans: Novel Polymers for Mucoadhesive Drug Delivery - A
   Review
SO TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Review
DE Thiolated chitosan; Thiomers; Mucoadhesion; Permeation enhancement; In
   situ gelation
ID IN-VITRO EVALUATION; POORLY ABSORBABLE DRUGS; SALMON-CALCITONIN;
   ABSORPTION ENHANCEMENT; RHEOLOGICAL EVALUATION; INTESTINAL-ABSORPTION;
   VIVO EVALUATION; ORAL DELIVERY; PERMEABILITY; SYSTEM
AB Chitosan is a natural polycationic copolymer consisting of glucosamine and N-acetylglucosamine units. The polymer has valuable properties as a biomaterial because it is considered to be biocompatible, biodegradable and non-toxic. The purpose of this review article is to provide detailed information about thiolated chitosans which are gaining popularity because of their high mucoadhsiveness and extended drug release properties. The derivatization of the primary amino groups of chitosan with coupling reagents bearing thiol functions leads to the formation of thiolated chitosans. Various properties of chitosan are improved by the immobilization of thiol groups. Due to the formation of disulfide bonds with mucus glycoproteins, mucoadhesiveness is augmented. The permeation of paracellular markers through mucosa can be enhanced by utilizing thiolated instead of unmodified chitosan. Moreover, thiolated chitosans display in situ gelling features due to the pH-dependent formation of inter-as well as intra-molecular disulfide bonds. This latter process provides, strong cohesion and stability of carrier matrices, being based on thiolated chitosans. The in situ gel formation within the pH range of 5 to 6.8 makes the application of thiolated chitosans on vaginal, nasal and ocular mucosa also possible. Thiolated chitosans can guarantee prolonged controlled release of embedded therapeutic ingredients.
C1 [Sreenivas, S. A.] KLESs Coll Pharm, Dept Pharmaceut, Hubli, Karnataka, India.
   [Pai, K. V.] Dept Ind Chem, Shimoga, Karnataka, India.
RP Sreenivas, SA (reprint author), KLESs Coll Pharm, Dept Pharmaceut, Hubli, Karnataka, India.
EM saiseenu7@rediffmail.com
CR Andreas B, 2000, J HIGH ENERGY PHYS
   Andreas B.S., 1998, PHARM RES, V15, P263
   Andreas B. S., 1999, SCI PHARM, V67, P196
   Andreas B.S., 2003, J CONTROL RELEASE, V93, P95
   ANDREAS BS, 2001, SCI PHARM, V69, P109
   Andreas BS, 2003, INT J PHARMACEUT, V260, P229
   ANDRES BS, 1998, J CONTROL RELEASE, V50, P215
   ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988
   Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v
   Baumann H, 2001, CARBOHYD RES, V331, P43, DOI 10.1016/S0008-6215(01)00009-X
   Borchard G, 1996, J CONTROL RELEASE, V39, P131, DOI 10.1016/0168-3659(95)00146-8
   Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3
   Bromberg LE, 2001, J PHARM PHARMACOL, V53, P109, DOI 10.1211/0022357011775082
   Clausen AE, 2002, PHARMACEUT RES, V19, P602, DOI 10.1023/A:1015345827091
   Coppi G, 2001, DRUG DEV IND PHARM, V27, P393, DOI 10.1081/DDC-100104314
   DEASY PB, 1991, INT J PHARM, V73, P117, DOI 10.1016/0378-5173(91)90034-L
   Dodane V, 1999, INT J PHARM, V182, P21, DOI 10.1016/S0378-5173(99)00030-7
   Edsman K, 1998, EUR J PHARM SCI, V6, P105, DOI 10.1016/S0928-0987(97)00075-4
   Felt O, 1999, INT J PHARM, V180, P185, DOI 10.1016/S0378-5173(99)00003-4
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Fini A., 2003, AM J DRUG DELIV, V1, P43
   GRAFSTROM R, 1980, EUR J BIOCHEM, V106, P571, DOI 10.1111/j.1432-1033.1980.tb04605.x
   Guggi D, 2003, PHARM RES-DORDR, V20, P1989, DOI 10.1023/B:PHAM.0000008047.82334.7d
   Guggi D, 2003, J CONTROL RELEASE, V92, P125, DOI 10.1016/S0168-3659(03)00299-2
   Guggi D, 2003, INT J PHARM, V252, P187, DOI 10.1016/S0378-5173(02)00631-2
   Hornof MD, 2003, EUR J PHARM BIOPHARM, V55, P185, DOI 10.1016/S0939-6411(02)00162-5
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Kast CE, 2003, INT J PHARM, V256, P183, DOI 10.1016/S0378-5173(03)00076-0
   Kast CE, 2002, J CONTROL RELEASE, V81, P347, DOI 10.1016/S0168-3659(02)00077-9
   Kast CE, 2001, BIOMATERIALS, V22, P2345, DOI 10.1016/S0142-9612(00)00421-X
   LANGOTH N, 2004, J CONTROL RELEASE, V177, P86
   Lee YH, 2000, ADV DRUG DELIVER REV, V42, P225, DOI 10.1016/S0169-409X(00)00063-6
   Lehr CM, 1996, EUR J DRUG METAB PH, V21, P139, DOI 10.1007/BF03190262
   Leitner VM, 2003, EUR J PHARM BIOPHARM, V56, P207, DOI 10.1016/S0939-6411(03)00061-4
   Leitner VM, 2003, EUR J PHARM SCI, V18, P89, DOI 10.1016/S0928-0987(02)00245-2
   Liu WG, 2002, J CONTROL RELEASE, V83, P1
   Lubben I. M., 2001, BIOMATERIALS, V22, P687
   Luessen HL, 1996, PHARMACEUT RES, V13, P1668, DOI 10.1023/A:1016488623022
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Paulsson M, 1999, EUR J PHARM SCI, V9, P99, DOI 10.1016/S0928-0987(99)00051-2
   Roldo M, 2004, EUR J PHARM BIOPHARM, V57, P115, DOI 10.1016/S0939-6411(03)00157-7
   Schipper NGM, 1999, EUR J PHARM SCI, V8, P335, DOI 10.1016/S0928-0987(99)00032-9
   Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740
   Senel S, 2000, BIOMATERIALS, V21, P2067, DOI 10.1016/S0142-9612(00)00134-4
   Shah RB, 2002, CRIT REV THER DRUG, V19, P135, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i2.20
   SNYDER GH, 1983, BIOCHIM BIOPHYS ACTA, V749, P219, DOI 10.1016/0167-4838(83)90228-5
   STADDON JM, 1995, J CELL SCI, V108, P609
   Takeuchi H, 2001, ADV DRUG DELIVER REV, V47, P39, DOI 10.1016/S0169-409X(00)00120-4
   Thanou M, 2001, J PHARM SCI, V90, P38, DOI 10.1002/1520-6017(200101)90:1<38::AID-JPS5>3.3.CO;2-V
   Thanou M, 2000, PHARMACEUT RES, V17, P27, DOI 10.1023/A:1007558206506
   Torres-Lugo M, 2000, BIOMATERIALS, V21, P1191, DOI 10.1016/S0142-9612(00)00011-9
NR 51
TC 31
Z9 31
U1 0
U2 13
PU PHARMACOTHERAPY GROUP
PI BENIN CITY
PA UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA
SN 1596-5996
J9 TROP J PHARM RES
JI Trop. J. Pharm. Res.
PD SEP
PY 2008
VL 7
IS 3
BP 1077
EP 1088
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 385MO
UT WOS:000261818500010
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Phillips, JE
   Burns, KL
   Le Doux, JM
   Guldberg, RE
   Garcia, AJ
AF Phillips, Jennifer E.
   Burns, Kellie L.
   Le Doux, Joseph M.
   Guldberg, Robert E.
   Garcia, Andres J.
TI Engineering graded tissue interfaces
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE fibroblasts; gene therapy; heterogeneous tissue engineering; Runx2;
   transcription factor gradients
ID IN-VITRO; OSTEOBLAST DIFFERENTIATION; DNA DELIVERY; BONE; RUNX2/CBFA1;
   OSTEOGENESIS; FIBROBLASTS; CONSTRUCTS; MATURATION; RETROVIRUS
AB Interfacial zones between tissues provide specialized, transitional junctions central to normal tissue function. Regenerative medicine strategies focused on multiple cell types and/or bi/tri-layered scaffolds do not provide continuously graded interfaces, severely limiting the integration and biological performance of engineered tissue substitutes. Inspired by the bone-soft tissue interface, we describe a biomaterial-mediated gene transfer strategy for spatially regulated genetic modification and differentiation of primary dermal fibroblasts within tissue-engineered constructs. We demonstrate that zonal organization of osteolblastic and fibroblastic cellular phenotypes can be engineered by a simple, one-step seeding of fibroblasts onto scaffolds containing a spatial distribution of retrovirus encoding the osteogenic transcription factor Runx2/Cbfa1. Gradients of immobilized retrovirus, achieved via deposition of controlled poly(L-lysine) densities, resulted in spatial patterns of transcription factor expression, osteolblastic differentiation, and mineralized matrix deposition. Notably, this graded distribution of mineral deposition and mechanical properties was maintained when implanted in vivo in an ectopic site. Development of this facile and robust strategy is significant toward the regeneration of continuous interfacial zones that mimic the cellular and microstructural characteristics of native tissue.
C1 [Phillips, Jennifer E.; Le Doux, Joseph M.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Burns, Kellie L.; Guldberg, Robert E.; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Phillips, Jennifer E.; Le Doux, Joseph M.; Guldberg, Robert E.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Phillips, Jennifer E.; Le Doux, Joseph M.; Guldberg, Robert E.; Garcia, Andres J.] Georgia Tech Emory Ctr Engn Living Tissues, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), 315 Ferst Dr,Room 2314, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Le Doux, Joseph/D-4876-2018
OI Le Doux, Joseph/0000-0002-6506-3905; Phillips-Cremins,
   Jennifer/0000-0002-4702-0450
FU National Institutes of Health [R01-EB003364]; National Science
   Foundation [EEC-9731643]; National Science Foundation Graduate Research
FX We thank C. Gersbach for helpful discussions and A. Lin for technical
   assistance with microCT image analysis and mechanical testing. This work
   was supported by the National Institutes of Health Grant R01-EB003364,
   the Georgia Tech/Emory Engineering Research Center on the Engineering of
   Living Tissues (National Science Foundation Grant EEC-9731643), and a
   National Science Foundation Graduate Research Fellowship (to J.E.P.).
CR Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Byers BA, 2006, J BIOMED MATER RES A, V76A, P646, DOI 10.1002/jbm.a.30549
   Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Gersbach CA, 2006, GENE THER, V13, P873
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   KUROSAKA M, 1987, AM J SPORT MED, V15, P225, DOI 10.1177/036354658701500306
   Langer R, 1998, NATURE, V392, P5
   Le Doux JM, 2001, HUM GENE THER, V12, P1611, DOI 10.1089/10430340152528110
   Maleki M, 2007, LANGMUIR, V23, P10116, DOI 10.1021/la700822y
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Montcouquiol M, 2003, J NEUROSCI, V23, P9469
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Phillips JE, 2006, J CELL SCI, V119, P581, DOI 10.1242/jcs.02758
   Phillips JE, 2007, TISSUE ENG, V13, P2029, DOI 10.1089/ten.2006.0041
   Phillips JE, 2006, BIOMATERIALS, V27, P5535, DOI 10.1016/j.biomaterials.2006.06.019
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Spalazzi JP, 2006, TISSUE ENG, V12, P3497, DOI 10.1089/ten.2006.12.3497
   Thomopoulos S, 2003, J ORTHOPAED RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3
   Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822
   Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475
   Woo SLY, 2006, J BIOMECH, V39, P1, DOI 10.1016/j.jbiomech.2004.10.025
   Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705
NR 29
TC 135
Z9 134
U1 4
U2 28
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 26
PY 2008
VL 105
IS 34
BP 12170
EP 12175
DI 10.1073/pnas.0801988105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 344DJ
UT WOS:000258905700016
PM 18719120
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Kempen, DHR
   Lu, L
   Classic, KL
   Hefferan, TE
   Creemers, LB
   Maran, A
   Dhert, WJA
   Yaszemski, MJ
AF Kempen, Diederik H. R.
   Lu, Lichun
   Classic, Kelly L.
   Hefferan, Theresa E.
   Creemers, Laura B.
   Maran, Avudaiappan
   Dhert, Wouter J. A.
   Yaszemski, Michael J.
TI Non-invasive screening method for simultaneous evaluation of in vivo
   growth factor release profiles from multiple ectopic bone tissue
   engineering implants
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE controlled drug delivery; non-invasive screening; scintillation
   detector; radiolabelled growth factor; method validation
ID MORPHOGENETIC PROTEIN-2; CALCIUM-PHOSPHATE; DELIVERY-SYSTEMS;
   POLY(PROPYLENE FUMARATE); BIOMATERIAL CARRIERS; SUSTAINED DELIVERY;
   GELATIN HYDROGEL; COLLAGEN SPONGES; MOLECULAR-WEIGHT; RHBMP-2
AB The purpose of this study was to develop and validate a screening method based on scintillation probes for the simultaneous evaluation of in vivo growth factor release profiles of multiple implants in the same animal. First, we characterized the scintillation probes in a series of in vitro experiments to optimize the accuracy of the measurement setup. The scintillation probes were found to have a strong geometric dependence and experience saturation effects at high activities. In vitro simulation of 4 subcutaneous limb implants in a rat showed minimal interference of surrounding implants on local measurements at close to parallel positioning of the probes. These characteristics were taken into consideration for the design of the probe setup and in vivo experiment. The measurement setup was then validated in a rat subcutaneous implantation model using 4 different sustained release carriers loaded with (125)I-BMP-2 per animal. The implants were removed after 42 or 84 days of implantation, for comparison of the non-invasive method to ex vivo radioisotope counting. The non-invasive method demonstrated a good correlation with the ex vivo counting method at both time-points of all 4 carriers. Overall, this study showed that scintillation probes could be successfully used for paired measurement of 4 release profiles with minimal interference of the surrounding implants, and may find use as non-invasive screening tools for various drug delivery applications. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kempen, Diederik H. R.; Lu, Lichun; Hefferan, Theresa E.; Maran, Avudaiappan; Yaszemski, Michael J.] Mayo Clin, Dept Orthoped Surg, Tissue Engn & Biomat Lab, Rochester, MN 55905 USA.
   [Kempen, Diederik H. R.; Lu, Lichun; Hefferan, Theresa E.; Maran, Avudaiappan; Yaszemski, Michael J.] Mayo Clin, Dept Biomed Engn, Rochester, MN 55905 USA.
   [Kempen, Diederik H. R.; Creemers, Laura B.] Univ Med Ctr Utrecht, Dept Orthopaed, NL-3508 GA Utrecht, Netherlands.
RP Yaszemski, MJ (reprint author), Mayo Clin, Dept Orthoped Surg, Tissue Engn & Biomat Lab, 200 1st St SW, Rochester, MN 55905 USA.
EM yaszemski.michael@mayo.edu
OI Creemers, Laura/0000-0002-1585-3052; Kempen,
   Diederik/0000-0002-4504-7756
FU National Institutes of Health [R01 AR45871, R01 EB03060]; Netherlands
   Organization for Health Research and Development ZonMW [920-03-325];
   Stichting Anna Fonds
FX The authors gratefully acknowledge the National Institutes of Health
   (R01 AR45871 and R01 EB03060) and The Netherlands Organization for
   Health Research and Development ZonMW (Agiko 920-03-325) and Stichting
   Anna Fonds for the financial support. The authors thank Dr. Shanfeng
   Wang and Mr. James Greutzmacher from the Tissue Engineering and
   Biomaterials laboratory and Mr. Rodney Landsworth and Mr. Al Amundson
   from Radiation Safety at Mayo Clinic for their contributions to this
   work.
CR Abdiu A, 1998, LIFE SCI, V62, P1911, DOI 10.1016/S0024-3205(98)00159-3
   Boyan BD, 1999, J BIOMED MATER RES, V46, P51, DOI 10.1002/(SICI)1097-4636(199907)46:1<51::AID-JBM6>3.3.CO;2-9
   Delgado JJ, 2006, J CONTROL RELEASE, V114, P223, DOI 10.1016/j.jconrel.2006.05.026
   Duggirala S S, 1996, Pharm Dev Technol, V1, P11, DOI 10.3109/10837459609031413
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Gao TJ, 2001, J BIOMED MATER RES, V57, P92, DOI 10.1002/1097-4636(200110)57:1<92::AID-JBM1146>3.0.CO;2-1
   Hori K, 2007, J CONTROL RELEASE, V118, P169, DOI 10.1016/j.jconrel.2006.12.011
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Kempen DHR, 2006, J BIOMED MATER RES A, V77A, P103, DOI 10.1002/jbm.a.30336
   Kempen DHR, 2003, MATER SCI FORUM, V426-4, P3151, DOI 10.4028/www.scientific.net/MSF.426-432.3151
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Li RH, 2003, J ORTHOP RES, V21, P997, DOI 10.1016/S0736-0266(03)00082-2
   Louis-Ugbo J, 2002, J ORTHOPAED RES, V20, P1050, DOI 10.1016/S0736-0266(02)00011-6
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Ranger NT, 1999, RADIOGRAPHICS, V19, P481, DOI 10.1148/radiographics.19.2.g99mr30481
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Schrier JA, 1999, PHARM DEV TECHNOL, V4, P611, DOI 10.1081/PDT-100101400
   Seeherman H, 2003, J BONE JOINT SURG AM, V85A, P96, DOI 10.2106/00004623-200300003-00016
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Uludag H, 2000, BIOTECHNOL PROGR, V16, P1115, DOI 10.1021/bp000066y
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   Wang SF, 2006, BIOMACROMOLECULES, V7, P1976, DOI 10.1021/bm060096a
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yokota S, 2003, INT J PHARM, V251, P57, DOI 10.1016/S0378-5173(02)00581-1
NR 32
TC 16
Z9 16
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 25
PY 2008
VL 130
IS 1
BP 15
EP 21
DI 10.1016/j.jconrel.2008.05.004
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 352SM
UT WOS:000259517700004
PM 18554743
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yakacki, CM
   Shandas, R
   Safranski, D
   Ortega, AM
   Sassaman, K
   Gall, K
AF Yakacki, Christopher M.
   Shandas, Robin
   Safranski, David
   Ortega, Alicia M.
   Sassaman, Katie
   Gall, Ken
TI Strong, tailored, biocompatible shape-memory polymer networks
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; HYBRID COMPOSITES; DRUG-DELIVERY; POLYURETHANE;
   RECOVERY; THERMOMECHANICS; NANOCOMPOSITES; BEHAVIOR
AB Shape-memory polymers are a class of smart materials that have recently been used in intelligent biomedical devices and industrial applications for their ability to change shape under a predetermined stimulus. In this study, photopolymerized thermoset shape-memory networks with tailored thermomechanics are evaluated to link polymer structure to recovery behavior. Methyl methacrylate (MMA) and poly(ethylene glycol) dimethacrylate (PEGDMA) are copolymerized to create networks with independently adjusted glass transition temperatures (T-g) and rubbery modulus values ranging from 56 to 92 degrees C and 9.3 to 23.0 MPa, respectively. Free-strain recovery under isothermal and transient temperature conditions is highly influenced by the Tg of the networks, while the rubbery moduli of the networks has a negligible effect on this response. The magnitude of stress generation of fixed-strain recovery correlates with network rubbery moduli, while fixed-strain recovery under isothermal conditions shows a complex evolution for varying T, The results are intended to help aid in future shape-memory device design and the MMA-co-PEGDMA network is presented as a possible high strength shape-memory biomaterial.
C1 [Yakacki, Christopher M.; Sassaman, Katie; Gall, Ken] MedShape Solut Inc, Res & Dev, Atlanta, GA 30318 USA.
   [Yakacki, Christopher M.; Safranski, David; Sassaman, Katie; Gall, Ken] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   [Shandas, Robin; Ortega, Alicia M.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
   [Gall, Ken] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Yakacki, CM (reprint author), MedShape Solut Inc, Res & Dev, Atlanta, GA 30318 USA.
EM chris@medshapesolutions.com
OI Shandas, Robin/0000-0002-9473-7542
FU NIH [HL 067393, EB 004481]; NIAMS/NIH [F31AR053466]
FX This work was supported by NIH grants HL 067393 and EB 004481 The
   authors would like to thank Michael Lyons for his help and contributions
   to this work. A. M. Ortega is thankful for the financial support by the
   NIAMS/NIH F31AR053466.
CR Alteheld A, 2005, ANGEW CHEM INT EDIT, V44, P1188, DOI 10.1002/anie.200461360
   Baer G, 2007, J APPL POLYM SCI, V103, P3882, DOI 10.1002/app.25567
   Baer G, 2006, J INVEST MED, V54, pS162
   Baroli B, 2006, J CHEM TECHNOL BIOT, V81, P491, DOI 10.1002/jctb.1468
   Behl M, 2007, SOFT MATTER, V3, P58, DOI 10.1039/b610611k
   Behl M, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70047-0
   Buckley PR, 2006, IEEE T BIO-MED ENG, V53, P2075, DOI 10.1109/TBME.2006.877113
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Frimpong RA, 2007, J BIOMED MATER RES A, V80A, P1, DOI 10.1002/jbm.a.30962
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   HAYASHI S, 1995, PLAST ENG, V51, P29
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, CLIN HEMORHEOL MICRO, V32, P105
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Liang C, 1997, J INTEL MAT SYST STR, V8, P380, DOI 10.1177/1045389X9700800411
   Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k
   Liu C, 2002, J APPL MED POLYM, V6, P47
   Liu YP, 2006, INT J PLASTICITY, V22, P279, DOI 10.1016/j.ijplas.2005.03.004
   Liu YP, 2003, SMART MATER STRUCT, V12, P947, DOI 10.1088/0964-1726/12/6/012
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   Metzger MF, 2002, BIOMED MICRODEVICES, V4, P89, DOI 10.1023/A:1014674912979
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Passy S., 2003, INT J COSMETIC SURG, V5, P193
   Ping P, 2007, J POLYM SCI POL PHYS, V45, P557, DOI 10.1002/polb.20974
   Shmulewitz A, 2006, NAT BIOTECHNOL, V24, P277, DOI 10.1038/nbt0306-277a
   Small W, 2005, OPT EXPRESS, V13, P8204, DOI 10.1364/OPEX.13.008204
   Tobushi H, 1996, SMART MATER STRUCT, V5, P483, DOI 10.1088/0964-1726/5/4/012
   Vallo CI, 2000, POLYM INT, V49, P831, DOI 10.1002/1097-0126(200008)49:8<831::AID-PI462>3.0.CO;2-3
   Wache HM, 2003, J MATER SCI-MATER M, V14, P109, DOI 10.1023/A:1022007510352
   Wang WS, 2006, EUR POLYM J, V42, P1240, DOI 10.1016/j.eurpolymj.2005.11.029
   Wei ZG, 1998, J MATER SCI, V33, P3743, DOI 10.1023/A:1004692329247
   Yakacki CM, 2007, BIOMATERIALS, V28, P2255, DOI 10.1016/j.biomaterials.2007.01.030
NR 36
TC 193
Z9 195
U1 7
U2 141
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD AUG 22
PY 2008
VL 18
IS 16
BP 2428
EP 2435
DI 10.1002/adfm.200701049
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 343ED
UT WOS:000258834600018
PM 19633727
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Moroni, L
   Hamann, D
   Paoluzzi, L
   Pieper, J
   de Wijn, JR
   van Blitterswijk, CA
AF Moroni, Lorenzo
   Hamann, Doreen
   Paoluzzi, Luca
   Pieper, Jeroen
   de Wijn, Joost R.
   van Blitterswijk, Clemens A.
TI Regenerating Articular Tissue by Converging Technologies
SO PLOS ONE
LA English
DT Article
AB Scaffolds for osteochondral tissue engineering should provide mechanical stability, while offering specific signals for chondral and bone regeneration with a completely interconnected porous network for cell migration, attachment, and proliferation. Composites of polymers and ceramics are often considered to satisfy these requirements. As such methods largely rely on interfacial bonding between the ceramic and polymer phase, they may often compromise the use of the interface as an instrument to direct cell fate. Alternatively, here, we have designed hybrid 3D scaffolds using a novel concept based on biomaterial assembly, thereby omitting the drawbacks of interfacial bonding. Rapid prototyped ceramic particles were integrated into the pores of polymeric 3D fiber-deposited (3DF) matrices and infused with demineralized bone matrix (DBM) to obtain constructs that display the mechanical robustness of ceramics and the flexibility of polymers, mimicking bone tissue properties. Ostechondral scaffolds were then fabricated by directly depositing a 3DF structure optimized for cartilage regeneration adjacent to the bone scaffold. Stem cell seeded scaffolds regenerated both cartilage and bone in vivo.
C1 [Moroni, Lorenzo; Hamann, Doreen; de Wijn, Joost R.; van Blitterswijk, Clemens A.] Univ Twente, BMTI, NL-7500 AE Enschede, Netherlands.
   [Paoluzzi, Luca] Univ Politecn Marche, Mech Engn Inst, Ancona, Italy.
   [Pieper, Jeroen] Isotis OrthoBiologics SA, Irvine, CA USA.
   [Moroni, Lorenzo] MuscoloSkeletal Cell & Tissue Bank, Rizzoli Orthopaed Inst, Bologna, Italy.
RP Moroni, L (reprint author), Univ Twente, BMTI, POB 217, NL-7500 AE Enschede, Netherlands.
EM lmoroni@gmail.com
RI Moroni, Lorenzo/D-2826-2014
OI Moroni, Lorenzo/0000-0003-1298-6025; van Blitterswijk,
   Clemens/0000-0003-2371-4615; Paoluzzi, Luca/0000-0002-2656-5224
FU European Community project Intelliscaf [GSRD_2002_00697]
FX This project was funded by the European Community project Intelliscaf
   GSRD_2002_00697.
CR Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6
   Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023
   BEUMER GJ, 1994, BIOMATERIALS, V15, P551, DOI 10.1016/0142-9612(94)90022-1
   BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504
   Bezemer JM, 1999, J CONTROL RELEASE, V62, P393, DOI 10.1016/S0168-3659(99)00170-4
   Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806
   Chakkalakal DA, 2001, TISSUE ENG, V7, P161, DOI 10.1089/107632701300062778
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Demarteau O, 2003, BIOCHEM BIOPH RES CO, V310, P580, DOI 10.1016/j.bbrc.2003.09.099
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Guldberg V. M., 1992, BONE IMPLANT GRAFTIN, P9
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   MARTIN I, 2006, J BIOMECH
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Mensik I., 2002, Cell and Tissue Banking, V3, P245, DOI 10.1023/A:1024674325253
   Moroni L, 2007, TISSUE ENG, V13, P361, DOI 10.1089/ten.2006.0127
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Moroni L, 2006, J BIOMED MATER RES A, V78A, P605, DOI 10.1002/jbm.a.30716
   Moroni L, 2005, J BIOMED MATER RES A, V75A, P957, DOI 10.1002/jbm.a.30499
   Murphy CL, 2001, CONNECT TISSUE RES, V42, P87, DOI 10.3109/03008200109014251
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   REDDI AH, 1981, COLLAGEN REL RES, V1, P209
   Reuss A, 1929, Z ANGEW MATH MECH, V9, P49, DOI 10.1002/zamm.19290090104
   Rice JM, 2003, CALCIFIED TISSUE INT, V72, P726, DOI 10.1007/s00223-002-2045-y
   Schek R M, 2005, Orthod Craniofac Res, V8, P313, DOI 10.1111/j.1601-6343.2005.00354.x
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VONDERMARK K, 1979, CLIN ORTHOP RELAT R, P185
   Wang DW, 2005, J CELL PHYSIOL, V204, P184, DOI 10.1002/jcp.20324
   Wilson CE, 2006, BIOMATERIALS, V27, P302, DOI 10.1016/j.biomaterials.2005.06.041
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 51
TC 16
Z9 16
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 21
PY 2008
VL 3
IS 8
AR e3032
DI 10.1371/journal.pone.0003032
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 422KO
UT WOS:000264426800009
PM 18716660
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Deng, M
   Chen, G
   Cichocki, F
   Burkley, D
   Zhou, J
   Vetrecin, R
AF Deng, Meng
   Chen, Gavin
   Cichocki, Frank
   Burkley, Daniel
   Zhou, Jack
   Vetrecin, Robert
TI POLY 279-Effects of physical form on in vitro degradation of an
   absorbable biomaterial made from poly(glycolide-co-lactide)
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 236th National Meeting of the American-Chemical-Society
CY AUG 17-21, 2008
CL Philadelphia, PA
SP Amer Chem Soc
C1 [Deng, Meng; Chen, Gavin; Cichocki, Frank; Burkley, Daniel; Zhou, Jack; Vetrecin, Robert] Ethicon, Somerville, NJ 08876 USA.
EM mdeng@ethus.jnj.com
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 17
PY 2008
VL 236
MA 279-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 499WD
UT WOS:000270256308060
DA 2018-10-20
ER

PT J
AU Raines, RT
AF Raines, Ronald T.
TI FLUO 18-Fluorinated collagen as a biomaterial and in nanotechnology
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 236th National Meeting of the American-Chemical-Society
CY AUG 17-21, 2008
CL Philadelphia, PA
SP Amer Chem Soc
C1 [Raines, Ronald T.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.
   [Raines, Ronald T.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA.
EM rtraines@wisc.edu
RI Raines, Ronald/A-5009-2013
OI Raines, Ronald/0000-0001-7164-1719
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 17
PY 2008
VL 236
MA 18-FLUO
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 499WD
UT WOS:000270256304588
DA 2018-10-20
ER

PT J
AU Mandal, BB
   Kundu, SC
AF Mandal, Biman B.
   Kundu, Subhas C.
TI Non-bioengineered silk gland fibroin protein: Characterization and
   evaluation of matrices for potential tissue engineering applications
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE non-mulberry silk; gland fibroin; sodium dodecyl sulfate; cell culture
ID TROPICAL TASAR SILKWORM; SODIUM DODECYL-SULFATE; MESENCHYMAL STEM-CELLS;
   ANTHERAEA-MYLITTA; IN-VITRO; MOLECULAR PHYLOGENY; CIRCULAR-DICHROISM;
   BETA-GALACTOSIDASE; MEMBRANE-PROTEINS; BONE-MARROW
AB The possibility of using wild non-mulberry silk protein as a biopolymer remains unexplored compared to domesticated mulberry silk protein. One of the main reasons for this was for not having any suitable method of extraction of silk protein fibroin from cocoons and silk glands. In this study non-bioengineered non-mulberry silk gland fibroin protein from tropical tasar silkworm Antheraca mylitta, is regenerated and characterized using 1% (w/v) sodium dodecyl sulfate (SDS). The new technique is important and unique because it uses a mild surfactant for fibroin dissolution and is advantageous over other previous reported techniques using chaotropic salts. Fabricated fibroin films are smooth as confirmed by atomic force microscopy. Circular dichroism spectrometry along with Fourier transformed infrared spectroscopy and X-ray diffraction reveal random coil/alpha-helix conformations in regenerated fibroin which transform to P-sheets, resulting in crystalline structure and protein insolubility through ethanol treatment. Differential scanning calorimetry shows an increase in glass transition (Tg) temperature and enhanced degradation temperature on alcohol treatment. Enhanced cell attachment and viability of AH927 feline fibroblasts were observed on fibroin matrices. Higher mechanical strength along with controllable water stability of regenerated gland fibroin films make non-mulberry Indian tropical tasar silk gland fibroin protein a promising biomaterial for tissue engineering applications.
C1 [Mandal, Biman B.; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
OI Kundu, Subhas C./0000-0002-7170-2291
CR ACHARYA C, 2007, BIOTECHNOL J, V3, P226
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARAND M, 1992, ANAL BIOCHEM, V207, P73, DOI 10.1016/0003-2697(92)90502-X
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   BUNNING TJ, 1994, ACS S SERIES, V544
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   D'Auria S, 2001, J BIOCHEM-TOKYO, V130, P13, DOI 10.1093/oxfordjournals.jbchem.a002951
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   DASH R, BIOCH MOL B IN PRESS
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   DUTTA A, 2001, COMP BIOCH PHYSL B, V129, P197
   Gil ES, 2006, BIOMACROMOLECULES, V7, P728, DOI 10.1021/bm050622i
   Ha SW, 2003, BIOMACROMOLECULES, V4, P488, DOI 10.1021/bm0255948
   IIZUKA E, 1985, J APPL POLYM SCI APP, V41, P173
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kundu S.C., 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI DOI 10.1016/S0965-1748(01)00049-2
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Lange F, 1907, MONCH MED WOCHENSCHR, V52, P834
   Lange F, 1903, VERH DTSCH ORTHOP GE, V2, P10
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Li MZ, 2003, POLYM ADVAN TECHNOL, V14, P694, DOI 10.1002/pat.409
   Li MZ, 2003, INT J BIOL MACROMOL, V32, P159, DOI 10.1016/S0141-8130(03)00049-7
   Ludloff K., 1927, ZENTRALBL CHIR, V54, P3162
   MAGOSHI J, 1981, J POLYM SCI POL PHYS, V19, P185, DOI 10.1002/pol.1981.180190117
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   Magoshi J., 1996, POLYM MAT ENCY, V1, P667
   Mahendran B, 2006, J GENET, V85, P31, DOI 10.1007/BF02728967
   Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010
   Mahendran B, 2006, J BIOCHEM MOL BIOL, V39, P522
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   MINGZHONG L, 1999, J APPL POLYM SCI, V79, P2185
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   MUGA A, 1993, ARCH BIOCHEM BIOPHYS, V300, P451, DOI 10.1006/abbi.1993.1061
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   Saha M, 2006, BIOCHEM GENET, V44, P72, DOI 10.1007/s10528-006-9007-4
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   TANFORD C, 1976, BIOCHIM BIOPHYS ACTA, V457, P133, DOI 10.1016/0304-4157(76)90009-5
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P1407, DOI 10.1002/polb.1994.090320812
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Wallace BA, 2003, PROTEIN SCI, V12, P875, DOI 10.1110/ps.0229603
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   YANG JT, 1986, METHOD ENZYMOL, V130, P208
NR 61
TC 72
Z9 72
U1 3
U2 31
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD AUG 15
PY 2008
VL 100
IS 6
BP 1237
EP 1250
DI 10.1002/bit.21835
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 330UL
UT WOS:000257968200019
PM 18383269
DA 2018-10-20
ER

PT J
AU Idibie, AC
   Iyuke, ES
AF Idibie, A. Christopher
   Iyuke, E. Sunny
TI Thermodynamics study of linamarin sorption during its isolation from
   cassava
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article
DE cassava; linamarin; adsorption isotherm; activated carbon; thermodynamic
ID CYANIDE
AB Linamarin is an important biomaterial. The removal of linamarin from aqueous solutions at different contact times, temperatures and initial concentration of crude cassava extract during its isolation using activated carbon was investigated. The extent of linamarin removal increases with increase in initial concentration of extract, contact time and temperature of the solution. The adsorption isotherm is described by means of composite isotherm where U-shaped isotherm was observed. The mole of linamarin adsorbed per pore volume of activated carbon (n(1)(s)) at different temperatures (298, 303, 318, 328, and 338 K) was almost equal (0.99, 1.00, 1.01, 1.00 and 1.00 g mol/cm(3)). The activation energy of the system (E.) was calculated as 22.61 kJ/mol. The free energy of the adsorption (Delta G degrees), enthalpy (Delta H degrees), and entropy (AS,) changes were calculated to predict the nature of adsorption. The estimated values of Delta G degrees at 298, 303, 318, 328, and 338 K were -2.45, 1.69, 1.80, 1.70, and 1.73 kJ/mol, respectively, which are relatively high except at 298 K, indicating endothermic and non-spontaneous process. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Idibie, A. Christopher; Iyuke, E. Sunny] Univ Witwatersrand, Sch Chem & Met Engn, Fac Engn, ZA-2050 Wits, Johannesburg, South Africa.
RP Idibie, AC (reprint author), Univ Witwatersrand, Sch Chem & Met Engn, Fac Engn, P Bag 3, ZA-2050 Wits, Johannesburg, South Africa.
EM krisid2007@yahoo.com
FU H.E. Griffin Cancer Trust Foundation
FX The authors wish to acknowledge the H.E. Griffin Cancer Trust Foundation
   for funding this project. We also wish to attest to the immerse support
   extended to us by Prof. Neuse in the School of polymer chemistry, Wits
   University and Dr. Hajierah Davids of the medical school of Wits
   University.
CR ATSDR, 1997, TOX PROF CYAN
   ATSDR, 2006, TOX PROF CYAN
   BRADBURY JH, 1991, J SCI FOOD AGR, V55, P277, DOI 10.1002/jsfa.2740550213
   COOKE RD, 1978, J SCI FOOD AGR, V29, P345, DOI 10.1002/jsfa.2740290408
   Idibie CA, 2007, BIOPROC BIOSYST ENG, V30, P261, DOI 10.1007/s00449-007-0122-3
   ILZA AF, 2000, BRAZ ARCH BIOL TECHN, V43, P2
   Iyuke SE, 2007, IND ENG CHEM RES, V46, P4974, DOI 10.1021/ie061512a
   Kipling J.J., 1965, ADSORPTION SOLUTION
   MANTEL CL, 1951, ADSORPTION
   MICHEAL H, 2005, ELECTRON J BIOTECHN, V8, P1
   SEIGLER DS, 1975, PHYTOCHEMISTRY, V14, P9, DOI 10.1016/0031-9422(75)85001-1
   TREBAL RE, 1981, MASS TRANSFER OPERAT
   YASEMIN B, 2006, DESALINATION, V194, P257
   Yeoh HH, 1998, TRAC-TREND ANAL CHEM, V17, P234, DOI 10.1016/S0165-9936(98)00009-0
NR 14
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD AUG 15
PY 2008
VL 326
IS 1-2
BP 18
EP 22
DI 10.1016/j.colsurfa.2008.05.005
PG 5
WC Chemistry, Physical
SC Chemistry
GA 352UO
UT WOS:000259523100003
DA 2018-10-20
ER

PT J
AU Cui, W
   Hu, QL
   Wu, J
   Li, BQ
   Shen, JC
AF Cui, Wei
   Hu, Qiaoling
   Wu, Jia
   Li, Baoqiang
   Shen, Jiacong
TI Preparation and characterization of magnetite/hydroxyapatite/chitosan
   nanocomposite by in situ compositing method
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE chitosan; magnetism; hydroxyapatite; nanocomposite; in situ compositing;
   magnetic polymers; nanotechnology
ID CHITOSAN; BONE; HYDROXYAPATITE; NANOCRYSTALS; PARTICLES; GELATIN; GROWTH
AB Chitosan is an important kind of biomaterial that is widely used in medical applications. One of the key concerns about its use is the preparation of composites used for bone engineering. Aim of this study concerns the preparation of three-dimensional nanocomposites having potential use in bone repair and regeneration. The magnetite/hydroxyapatite/chitosan nanocomposites were prepared via in situ compositing method by preparing precursor solutions and molds with chitosan membrane. These nanocomposites were characterized by chemical, spectroscopic, magnetic, and morphological methods. X-ray diffraction analysis results demonstrate the formation of magnetite and hydroxyapatite in the chitosan matrix. FTIR analysis indicates that inorganic nanoparticles were chemically bound to the amino and hydroxyl groups in CS molecules. From TG/DTA data, it can be concluded that during preparation raw materials were almost perfectly incorporated into the nanocomposites, and the decrease in decomposition temperatures indicates the formation of chemical bonds between inorganic nanoparticles and chitosan molecules. TEM results show that the maximum size of inorganic particles in the magnetite /hydroxyapatite/chitosan nanocomposites was under 50 nm, and these particles were dispersed homogeneously in the chitosan matrix. From the magnetic measurement, it could be concluded that the nanocomposites were superparamagnetic, which is also the peculiarity of nanomagnetites. (c) 2008 Wiley Periodicals, Inc.
C1 [Cui, Wei; Hu, Qiaoling; Wu, Jia; Li, Baoqiang; Shen, Jiacong] Zhejiang Univ, Inst Polymer Composites, Hangzhou 310027, Peoples R China.
RP Hu, QL (reprint author), Zhejiang Univ, Inst Polymer Composites, Hangzhou 310027, Peoples R China.
EM huql@zju.edu.cn
RI Li, Baoqiang/J-4526-2012
OI Li, Baoqiang/0000-0003-0278-4542
CR AJAY KG, 2005, BIOMATERIALS, V26, P3995
   ANDREW CA, 1997, J BIOMED MATER RES, V38, P235
   Baibekov IM, 2001, B EXP BIOL MED+, V131, P399, DOI 10.1023/A:1017933026086
   Bhatia SC, 2000, BIOMACROMOLECULES, V1, P413, DOI 10.1021/bm0002959
   Bigi A, 2002, J BIOMED MATER RES, V59, P709, DOI 10.1002/jbm.10045
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   INOUE K, 1997, J ION EXCHANGE, V8, P115
   Ito M, 1999, J BIOMED MATER RES, V45, P204, DOI 10.1002/(SICI)1097-4636(19990605)45:3<204::AID-JBM7>3.0.CO;2-4
   Lee DK, 2002, J PHYS CHEM B, V106, P7267, DOI 10.1021/jp014446t
   Lee J, 1996, J COLLOID INTERF SCI, V177, P490, DOI 10.1006/jcis.1996.0062
   Markaki AE, 2004, BIOMATERIALS, V25, P4805, DOI 10.1016/j.biomaterials.2003.11.041
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Muzzarelli C, 2002, J INORG BIOCHEM, V92, P89, DOI 10.1016/S0162-0134(02)00486-5
   Oswald P, 1997, MAGN RESON IMAGING, V15, P1025, DOI 10.1016/S0730-725X(97)00004-0
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   Prashanth KVH, 2002, CARBOHYD POLYM, V50, P27
   RAMAZAN A, 2005, J MAGNETISM MAGNETIC, V292, P108
   Ramesh S., 2001, MALAYS J CHEM, V3, P35
   Rhee SH, 2001, BIOMATERIALS, V22, P2843, DOI 10.1016/S0142-9612(01)00028-X
   Saraswathy G, 2001, B MATER SCI, V24, P415, DOI 10.1007/BF02708641
   Saravanan P, 2003, J MATER SCI LETT, V22, P1283, DOI 10.1023/A:1025470405000
   SUBHASH C, 2003, BIOMACROMOLECULES, V4, P723
   Takegami K, 1998, J BIOMED MATER RES, V43, P210, DOI 10.1002/(SICI)1097-4636(199822)43:2<210::AID-JBM16>3.0.CO;2-L
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   WHITE LR, 1982, J COLLOID INTERF SCI, V90, P536, DOI 10.1016/0021-9797(82)90319-8
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F
NR 26
TC 13
Z9 14
U1 3
U2 43
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 15
PY 2008
VL 109
IS 4
BP 2081
EP 2088
DI 10.1002/app.28013
PG 8
WC Polymer Science
SC Polymer Science
GA 314ZK
UT WOS:000256847500004
DA 2018-10-20
ER

PT J
AU Rodrigues, AP
   Sanchez, EMS
   da Costa, AC
   Moraes, AM
AF Rodrigues, Ana Paula
   Saraiva Sanchez, Elisabete Maria
   da Costa, Aline Carvalho
   Moraes, Angela Maria
TI The influence of preparation conditions on the characteristics of
   chitosan-alginate dressings for skin lesions
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE membranes; biomaterials; polyelectrolytes; hydrogels; mechanical
   properties; chitosan; alginate; wound dressing; coacervates
ID MECHANICAL-PROPERTIES; WOUND DRESSINGS; MEMBRANES; FABRICATION; FILMS
AB In this work, the preparation and characterization of membranes obtained through chitosan and alginate coacervation and designed for use as wound dressings were evaluated. The influence of different stirring rates and rates of addition of chitosan solution to alginate solution on the final characteristics of the biomaterial was analyzed in detail, aiming at a simple and easily scalable membrane production protocol. The results show that membranes with dry thickness from 66 to 80 pm, wet thickness from 106 to 633 mu m, tensile strength varying from 6.86 to 31.14 MPa, elongation at break from 3.97 to 8.42%, and maximum water uptake up to 19 g of water per gram of membrane and that are able to prevent the permeation of bacteria can be obtained in a fairly reproducible way by the procedure established. The membranes prepared at flow ratio of 40 mL/h and stirring equal to 100 rpm showed a high potential for use on highly exuding wounds. (c) 2008 Wiley Periodicals, Inc.
C1 [Rodrigues, Ana Paula; Moraes, Angela Maria] Univ Estadual Campinas, Dept Biotechnol Proc, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
   [Saraiva Sanchez, Elisabete Maria] Univ Estadual Campinas, Dept Mat Engn, Sch Mech Engn, BR-13083970 Campinas, SP, Brazil.
   [da Costa, Aline Carvalho] Univ Estadual Campinas, Dept Chem Proc, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
RP Moraes, AM (reprint author), Univ Estadual Campinas, Dept Biotechnol Proc, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
EM ammoraes@feq.unicamp.br
RI Costa, Aline/E-5931-2011; Moraes, Angela/K-5181-2012
OI Costa, Aline/0000-0002-4586-6882; Moraes, Angela/0000-0002-5813-332X
CR Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   BEHAR D, 1986, J BIOMED MATER RES, V20, P731, DOI 10.1002/jbm.820200607
   Hansen B, 2002, ARCH DERMATOL, V138, P909, DOI 10.1001/archderm.138.7.909
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Knill CJ, 2004, CARBOHYD POLYM, V55, P65, DOI 10.1016/j.carbpol.2003.08.004
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Marreco PR, 2004, J BIOMED MATER RES B, V71B, P268, DOI 10.1002/jbm.b.30081
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   PAUL W, 2004, BIOMATER ARTIF ORGAN, V18, P18
   Wang LH, 2001, J PHARM SCI-US, V90, P1134, DOI 10.1002/jps.1067
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Yan XL, 2000, CHEM PHARM BULL, V48, P941
NR 18
TC 37
Z9 37
U1 0
U2 21
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 15
PY 2008
VL 109
IS 4
BP 2703
EP 2710
DI 10.1002/app.28203
PG 8
WC Polymer Science
SC Polymer Science
GA 314ZK
UT WOS:000256847500078
DA 2018-10-20
ER

PT J
AU Wang, GC
   Liu, XY
   Ding, CX
AF Wang, Guocheng
   Liu, Xuanyong
   Ding, Chuanxian
TI Phase composition and in-vitro bioactivity of plasma sprayed calcia
   stabilized zirconia coatings
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Phase composition; Plasma spraying; Zirconia coating; Bioactivity; SBF
ID SIMULATED BODY-FLUID; APATITE-FORMING ABILITY; Y-TZP; TRANSFORMATION;
   DEPOSITION; HYDROXYAPATITE; SPECTROSCOPY; POLYCRYSTALS; BIOMATERIAL;
   DEGRADATION
AB Zirconia coatings stabilized with different calcia content (12.8 mol%, 16 mol% and 30 mol%) were fabricated on titanium alloy substrates using atmospheric plasma spraying technology. The in-vitro bioactivity of coatings was evaluated by simulated body fluid (SBF) soaking test. The morphology and phase composition of the coatings were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), micro Raman spectroscopy, energy dispersive spectrometry (EDS) and infrared spectroscopy (IR). The results showed that the apatite was formed on the surface of the calcia stabilized zirconia coatings soaked in SBF for 28 days and the formation ability of apatite decreased with the increase in calcia content of the coating. The bioactivity of zirconia coatings was thought to be related to the Zr-OH formed on their surfaces during the phase transformation in the presence of water. Osteoblast-like MG63 cells were Cultured on the surfaces of the coatings to evaluate their cytocompatibility. Results showed that MG63 Cell grew and proliferated well on all coating surfaces, indicating that plasma sprayed calcia stabilized ZrO2 coatings were cytocompatible. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Wang, Guocheng; Liu, Xuanyong; Ding, Chuanxian] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
   [Wang, Guocheng] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China.
RP Liu, XY (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
EM xyliu@mail.sic.ac.cn
RI Wang, Guocheng/P-7551-2014; Liu, Xuanyong/J-2609-2018
OI Wang, Guocheng/0000-0002-8235-4472; 
FU National Basic Research Fund [2005CB623901]; National Natural Science
   Foundation of China [30700170]; Shanghai Science and Technology RD Fund
   [07QH14016, 07JC14057]; Innovation Fund of SICCAS [SCX0606]
FX This work was jointly supported by National Basic Research Fund under
   grant 2005CB623901, National Natural Science Foundation of China
   30700170, Shanghai Science and Technology R&D Fund under grant 07QH14016
   and 07JC14057, Innovation Fund of SICCAS under grant SCX0606.
CR Ashok M, 2003, MATER LETT, V57, P2066, DOI 10.1016/S0167-577X(02)01140-0
   Castkova K, 2004, CERAM-SILIKATY, V48, P85
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   DUWEZ P, 1952, J AM CERAM SOC, V35, P107, DOI 10.1111/j.1151-2916.1952.tb13081.x
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Helmer J. D., 1969, S US CER SURG IMPL C
   Hirst RA, 2002, INFECT IMMUN, V70, P1017, DOI 10.1128/IAI.70.2.1017-1022.2002
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kingery W. D., 1976, INTRO CERAMICS
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   Kosmac T, 2007, INT J APPL CERAM TEC, V4, P164, DOI 10.1111/j.1744-7402.2007.02124.x
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Liu XY, 2006, BIOMATERIALS, V27, P3904, DOI 10.1016/j.biomaterials.2006.03.007
   Orera VM, 1998, J PHYS-CONDENS MAT, V10, P7501, DOI 10.1088/0953-8984/10/33/019
   PERRY CH, 1985, J AM CERAM SOC, V68, pC184
   PHILLIPPI CM, 1971, J AM CERAM SOC, V54, P254, DOI 10.1111/j.1151-2916.1971.tb12283.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   SATO T, 1985, AM CERAM SOC BULL, V64, P1382
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   Scrivani A, 2002, KEY ENG MAT, V218-2, P515, DOI 10.4028/www.scientific.net/KEM.218-220.515
   TAMARI N, 1987, NIPPON SERAM KYO GAK, V95, P806
   Uchida M, 2002, J CERAM SOC JPN, V110, P710, DOI 10.2109/jcersj.110.710
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   Wang XX, 2001, J BIOMED MATER RES, V54, P172, DOI 10.1002/1097-4636(200102)54:2<172::AID-JBM3>3.0.CO;2-#
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Willmann G, 1996, BIOMATERIALS, V17, P2157, DOI 10.1016/0142-9612(96)00042-7
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
   Yan YY, 2007, SURF COAT TECH, V201, P5692, DOI 10.1016/j.surfcoat.2006.07.058
   Yang YZ, 2003, BIOMATERIALS, V24, P619, DOI 10.1016/S0142-9612(02)00376-9
   Yasuda K, 1997, J MATER SCI, V32, P6291, DOI 10.1023/A:1018649530154
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P165
NR 35
TC 27
Z9 29
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 15
PY 2008
VL 202
IS 24
BP 5824
EP 5831
DI 10.1016/j.surfcoat.2008.06.109
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 363KV
UT WOS:000260267100005
DA 2018-10-20
ER

PT J
AU Lao, J
   Jallot, E
   Nedelec, JM
AF Lao, Jonathan
   Jallot, Edouard
   Nedelec, Jean-Marie
TI Strontium-delivering glasses with enhanced bioactivity: A new
   biomaterial for antiosteoporotic applications?
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID SOL-GEL GLASSES; BONE; OSTEOPOROSIS; MAGNESIUM; SCAFFOLDS; RANELATE;
   45S5
AB Bioactive glasses exhibit great performances for bone tissue regeneration. In biological conditions, they spontaneously bond to bone tissues while actively stimulating bone growth. Crucial parameters for the material's bioactivity are the kinetics of formation of the interfacial calcium phosphate layer at the glass surface, as well as the release of critical concentrations of ionic dissolution products capable of stimulating cellular responses. In this paper we report the remarkable bioactivity properties of strontium-delivering sol-gel-derived glasses in the SiO(2)-CaO-SrO system. The glasses were tested in vitro and the interface between the glass and the biological medium was chemically mapped using highly sensitive nuclear microprobes. We prove the ability of our materials to form a phosphocalcic layer at their periphery with increased kinetics of reaction. Our key result is the demonstration that Sr-doped glasses can deliver controlled doses of strontium toward the biological medium. That is the determinant for bone tissue regeneration, as far as strontium is known to positively act on bone remodeling. Sr-delivering glasses could further represent an alternative to the constraining oral administration of strontium in treatment of osteoporosis.
C1 [Nedelec, Jean-Marie] Univ Clermont Ferrand, CNRS, Lab Mat Inorgan, UMR 6002, F-63177 Clermont Ferrand, France.
   [Lao, Jonathan; Jallot, Edouard] Univ Clermont Ferrand, Phys Corpusculaire Lab, CNRS IN2P3, UMR 6533, F-63177 Aubiere, France.
   [Nedelec, Jean-Marie] Ecole Natl Super Chim Clermont Fd, F-63177 Clermont Ferrand, France.
RP Nedelec, JM (reprint author), Univ Clermont Ferrand, CNRS, Lab Mat Inorgan, UMR 6002, F-63177 Clermont Ferrand, France.
EM j-marie.nedelec@univ-bpclermont.fr
RI NEDELEC, jean-marie/A-6920-2008
OI NEDELEC, jean-marie/0000-0002-8243-6849
CR Almoznino-Sarafian D, 2007, EUR J NUTR, V46, P230, DOI 10.1007/s00394-007-0655-x
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1998, J AM CERAM SOC, V81, P511
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Lao J, 2006, NUCL INSTRUM METH B, V245, P511, DOI 10.1016/j.nimb.2005.12.049
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Marie PJ, 2005, CURR OPIN PHARMACOL, V5, P633, DOI 10.1016/j.coph.2005.05.005
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Ortolani S, 2006, BONE, V38, P19, DOI 10.1016/j.bone.2005.10.030
   Padilla S, 2007, J BIOMED MATER RES A, V81A, P224, DOI 10.1002/jbm.a.30934
   Radin S, 2005, J BIOMED MATER RES A, V73A, P21, DOI 10.1002/jbm.a.30241
   Rijkers Ger T., 1993, Magnesium Research, V6, P205
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   Vallet-Regi M, 2005, CHEM MATER, V17, P1874, DOI 10.1021/cm047956j
   WEGLICKI WB, 1992, MOL CELL BIOCHEM, V110, P169, DOI 10.1007/BF02454195
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   Yan HW, 2001, CHEM MATER, V13, P1374, DOI 10.1021/cm000895e
   Yli-Urpo H, 2005, DENT MATER, V21, P201, DOI 10.1016/j.dental.2004.03.006
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
NR 22
TC 67
Z9 68
U1 1
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD AUG 12
PY 2008
VL 20
IS 15
BP 4969
EP 4973
DI 10.1021/cm800993s
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 334MI
UT WOS:000258225500024
DA 2018-10-20
ER

PT J
AU Silva, SS
   Maniglio, D
   Motta, A
   Mano, JF
   Reis, RL
   Migliaresi, C
AF Silva, Simone S.
   Maniglio, Devid
   Motta, Antonella
   Mano, Joao F.
   Reis, Rui L.
   Migliaresi, Claudio
TI Genipin-modified silk-fibroin nanometric nets
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biofibers; electrospinning; genipin; modification; silk fibroin
ID BOMBYX-MORI SILK; TISSUE ENGINEERING APPLICATIONS; ELECTROSPINNING
   METHOD; POLY(ETHYLENE OXIDE); NANOFIBERS; CHITOSAN; BIOMATERIAL;
   STABILITY; CELLS
AB Nanometric silk-fibroin nets were fabricated by electrospinning from regenerated Bombyx mori silk-fibroin (SF)/formic acid solutions with the addition of genipin (GE), 2, 15 and 24 h after the solution preparation. After spinning, the pure fibroin nanofibers were water soluble and needed a further stabilization process, whereas the reaction of fibroin with genipin resulted in water-insoluble fibroin nets due to conformational changes induced in the fibroin by the genipin. SFGE nanofibers presented diameters ranging from 140 to 590 nm and were generally thinner than pure SF nanofibers. The secondary structure of SF into SFGE nanofibers showed the presence of beta-sheet conformation together with beta-turn intermediates (turns and bends). The approach described in this paper provides an alternative method of designing SF nanofibers that are already water insoluble, without any stability post-treatment needed.
C1 [Silva, Simone S.; Mano, Joao F.; Reis, Rui L.] Dept Polymer Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4710057 Braga, Portugal.
   [Silva, Simone S.; Mano, Joao F.; Reis, Rui L.] PT Govt Associated Lab, IBB, Braga, Portugal.
   [Maniglio, Devid; Motta, Antonella; Migliaresi, Claudio] Univ Trent, Dept Mat Engn & Ind Technol, I-38050 Trento, Italy.
   [Maniglio, Devid; Motta, Antonella; Migliaresi, Claudio] Univ Trent, INSTM Res Unit, I-38050 Trento, Italy.
RP Silva, SS (reprint author), Dept Polymer Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Campus Gualtar, P-4710057 Braga, Portugal.
EM simonesilva@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Silva, Simone/F-9757-2011; Group,
   3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Maniglio, Devid/C-4187-2014
OI Reis, Rui L./0000-0002-4295-6129; Silva, Simone/0000-0003-4268-9419;
   Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765;
   Maniglio, Devid/0000-0002-1653-861X; Motta,
   Antonella/0000-0003-4893-6863
FU Portuguese Foundation for Science and Technology (FCT), Portugal
   [SFRH/BD/8658/2002]; EU [NMP3-CT-2003-505758]; European NoE EXPERTISSUES
   [NMP3-CT-2004-500283]
FX We gratefully acknowledge Prof. Rolando Barbucci (Department of Chemical
   and Biosystem Sciences and Technologies, University of Siena, Italy) for
   assistance with the FTIR-spectroscopy studies. The authors acknowledge
   funding from the Portuguese Foundation for Science and Technology (FCT),
   Portugal for SFRH/BD/8658/2002 and the EU-funded Project HIPPOCRATES
   (NMP3-CT-2003-505758). This work was carried out under the scope of the
   European NoE EXPERTISSUES (NMP3-CT-2004-500283).
CR Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Butler MF, 2003, J POLYM SCI POL CHEM, V41, P3941, DOI 10.1002/pola.10960
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Chen C, 2006, POLYMER, V47, P6322, DOI 10.1016/j.polymer.2006.07.009
   Chen HM, 2005, J BIOMED MATER RES A, V75A, P917, DOI 10.1002/jbm.a.30492
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Lu JW, 2006, POLYMER, V47, P8026, DOI 10.1016/j.polymer.2006.09.027
   Mi FL, 2005, J POLYM SCI POL CHEM, V43, P1985, DOI 10.1002/pla.20669
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Sung HW, 2001, J BIOMED MATER RES, V55, P538, DOI 10.1002/1097-4636(20010615)55:4<538::AID-JBM1047>3.3.CO;2-U
   Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
NR 25
TC 45
Z9 45
U1 1
U2 36
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG 11
PY 2008
VL 8
IS 8
BP 766
EP 774
DI 10.1002/mabi.200700300
PG 9
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 340WI
UT WOS:000258675300006
PM 18432596
DA 2018-10-20
ER

PT J
AU Shieh, MJ
   Peng, CL
   Lou, PJ
   Chiu, CH
   Tsai, TY
   Hsu, CY
   Yeh, CY
   Lai, PS
AF Shieh, Ming-Jium
   Peng, Cheng-Liang
   Lou, Pei-Jen
   Chiu, Chieh-Hua
   Tsai, Tsiao-Yu
   Hsu, Chia-Yen
   Yeh, Chen-Yu
   Lai, Ping-Shan
TI Non-toxic phototriggered gene transfection by PAMAM-porphyrin conjugates
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE polyamidoamine dendrimer; photochemical internalization; cytotoxicity;
   transfection
ID PHOTOCHEMICAL INTERNALIZATION; POLYAMIDOAMINE DENDRIMERS; DRUG-DELIVERY;
   PHOTODYNAMIC THERAPY; CANCER-THERAPY; DNA COMPLEXES; CELLS; VECTORS;
   PHOTOSENSITIZER; DISRUPTION
AB Development of controllable and non-toxic gene transfection systems is a core issue in gene therapy. Photochemical internalization, an innovative strategy in cytosolic release, provides us with an opportunity to develop a light-inducible gene delivery system. In this study, a novel photochemical internalization (PCI)-mediated gene delivery system was synthesized by surface modification of polyamidoamine (PAMAM) dendrimers via 5,10,15-tri(4-acetamidophenyl)-20-mono(4-carboxyl-phenyl)porphyrin (TAMCPP) conjugated to the generation 4 PAMAM dendrimer (G4). This water-soluble PAMAM-TAMCPP conjugate was characterized for cell viability, phototoxicity, DNA complexation, and in vitro transfection activity. The results show that TAMCPP conjugation did not increase the cytotoxicity of the PAMAM dendrimer below 20 mu M, but significantly induced cell death after suitable irradiation. Under almost non-toxic G4-TAMCPP-mediated PO treatment, the expression of green fluorescent protein determined by flow cytometry could be markedly enhanced in HeLa cells. Therefore, the G4-TAMCPP conjugate had an inducible and effective gene transfection activity, and showed considerable potential as a bimodal biomaterial for PCI-mediated gene therapy. Crown Copyright (C) 2008 Published by Elsevier B.V. All rights reserved.
C1 [Tsai, Tsiao-Yu; Hsu, Chia-Yen; Yeh, Chen-Yu; Lai, Ping-Shan] Natl Chung Hsing Univ, Dept Chem, Taichung 402, Taiwan.
   [Shieh, Ming-Jium; Peng, Cheng-Liang; Chiu, Chieh-Hua] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 100, Taiwan.
   [Shieh, Ming-Jium; Peng, Cheng-Liang; Chiu, Chieh-Hua] Natl Taiwan Univ, Coll Engn, Taipei 100, Taiwan.
   [Shieh, Ming-Jium] Natl Taiwan Univ Hosp, Dept Oncol, Taipei 100, Taiwan.
   [Shieh, Ming-Jium; Lou, Pei-Jen] Coll Med, Taipei 100, Taiwan.
   [Lou, Pei-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei 100, Taiwan.
RP Lai, PS (reprint author), Natl Chung Hsing Univ, Dept Chem, 250 Kuo Kuang Rd, Taichung 402, Taiwan.
EM f89548003@gmail.com
RI Lai, Ping-Shan/F-1500-2010
OI LOU, PEI-JEN/0000-0002-3383-8593
FU National Science Council of the Republic of China [NSC
   95-2221-E-002-025, NSC 962113-M-005-015]
FX This research was supported by grants from National Science Council of
   the Republic of China (NSC 95-2221-E-002-025 and NSC 962113-M-005-015).
CR ADLER AD, 1967, J ORG CHEM, V32, P476, DOI 10.1021/jo01288a053
   Berg K, 1999, CANCER RES, V59, P1180
   Berg K, 2005, CLIN CANCER RES, V11, P8476, DOI 10.1158/1078-0432.CCR-05.1245
   Caruso JA, 2005, BIOCHEM J, V392, P325, DOI 10.1042/BJ20050313
   De Laporte L, 2006, BIOMATERIALS, V27, P947, DOI 10.1016/j.biomaterials.2005.09.036
   Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889
   Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3
   Feril LB, 2006, CANCER SCI, V97, P1111, DOI 10.1111/j.1349-7006.2006.00286.x
   Folini M, 2003, CANCER RES, V63, P3490
   Han S, 2000, MOL THER, V2, P302, DOI 10.1006/mthe.2000.0142
   Jeong JH, 2007, BIOMATERIALS, V28, P1912, DOI 10.1016/j.biomaterials.2006.12.019
   Kamau SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl035
   Katayose S, 1997, BIOCONJUGATE CHEM, V8, P702, DOI 10.1021/bc9701306
   Kim TI, 2007, BIOMATERIALS, V28, P2061, DOI 10.1016/j.biomaterials.2006.12.013
   Kommareddy S, 2005, BIOCONJUGATE CHEM, V16, P1423, DOI 10.1021/bc050146t
   Kono K, 2005, BIOCONJUGATE CHEM, V16, P208, DOI 10.1021/bc049785e
   Kovacs JR, 2005, BIOMATERIALS, V26, P6754, DOI 10.1016/j.biomaterials.2005.04.022
   KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897
   Kurz T, 2006, FEBS J, V273, P3106, DOI 10.1111/j.1742-4658.2006.05321.x
   Lai PS, 2007, J CONTROL RELEASE, V122, P39, DOI 10.1016/j.jconrel.2007.06.012
   LAI PS, J BIOMED A IN PRESS
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001
   Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036
   Lou PJ, 2006, INT J CANCER, V119, P2692, DOI 10.1002/ijc.22098
   MacDonald L., 2001, J PORPHYR PHTHALOCYA, V5, P105
   MOAN J, 1994, INT J CANCER, V58, P865, DOI 10.1002/ijc.2910580620
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Ndoye A, 2004, J GENE MED, V6, P884, DOI 10.1002/jgm.573
   Nishiyama N, 2005, NAT MATER, V4, P934, DOI 10.1038/nmat1524
   Pandey RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P194, DOI 10.1111/j.1751-1097.1996.tb02442.x
   Plank C, 1996, HUM GENE THER, V7, P1437, DOI 10.1089/hum.1996.7.12-1437
   Prasmickaite L, 2002, BRIT J CANCER, V86, P652, DOI 10.1038/sj/bjc/6600138
   Prasmickaite L, 2006, FEBS LETT, V580, P5739, DOI 10.1016/j.febslet.2006.09.028
   Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q
   Rodal GH, 1998, J PHOTOCH PHOTOBIO B, V45, P150, DOI 10.1016/S1011-1344(98)00175-4
   Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200
   Sun JY, 2003, GENE THER, V10, P964, DOI 10.1038/sj.gt.3302039
   Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630
   Turk M, 2004, J CONTROL RELEASE, V96, P325, DOI 10.1016/j.jconrel.2004.01.013
   Weyergang A, 2006, J CONTROL RELEASE, V111, P165, DOI 10.1016/j.jconrel.2005.12.002
   Yoo H, 2000, NUCLEIC ACIDS RES, V28, P4225, DOI 10.1093/nar/28.21.4225
   Zhou LZ, 2007, J PHARMACEUT BIOMED, V43, P330, DOI 10.1016/j.jpba.2006.06.021
NR 43
TC 69
Z9 72
U1 5
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 7
PY 2008
VL 129
IS 3
BP 200
EP 206
DI 10.1016/j.jconrel.2008.03.024
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 345HH
UT WOS:000258986500008
PM 18541326
DA 2018-10-20
ER

PT J
AU Shi, Q
   Ye, SJ
   Kristalyn, C
   Su, YL
   Jiang, ZY
   Chen, Z
AF Shi, Qing
   Ye, Shuji
   Kristalyn, Cornelius
   Su, Yanlei
   Jiang, Zhongyi
   Chen, Zhan
TI Probing molecular-level surface structures of polyethersulfone/Pluronic
   F127 blends using sum-frequency generation vibrational spectroscopy
SO LANGMUIR
LA English
DT Article
ID PEO-PPO-PEO; POLYSTYRENE/POLY(METHYL METHACRYLATE) BLENDS; SULFONE)
   ULTRAFILTRATION MEMBRANES; ASSISTED GRAFT-POLYMERIZATION; SCANNING FORCE
   MICROSCOPY; CONTACT-ANGLE GONIOMETRY; TRIBLOCK COPOLYMERS;
   POLY(LACTIC/GLYCOLIC ACID); PROTEIN ADSORPTION; CHEMICAL-STRUCTURE
AB We blended Pluronic F127 into polyethersulfone (PES) to improve surface propel-ties of PES, which has been extensively used in biomaterial and other applications. The molecular surface structures of PES/Pluronic F127 blends have been investigated by sum-frequency generation (SFG) vibrational spectroscopy. The molecular orientation of surface functional groups of PES changed significantly when blended with a small amount of Pluornic F127. Pluronic F127 on the blend surface also exhibited different features upon contacting with water. The entanglement of PES chains with Pluronic F127 molecules rendered the blends with long-term Surface stability in water in contrast to the situation where a layer of Pluronic F127 adsorbed on the PES surface. Atomic force microscopy (AFM) and quartz crystal microbalance (QCM) measurements were included to determine the relative amount of protein that adsorbed to the blend Surfaces. The results showed a decreased protein adsorption amount with increasing Pluronic F127 bulk concentration. The correlations between polymer surface properties and detailed molecular structures obtained by SFG would provide insight into the designing and developing of biomedical polymers and functional membranes with improved fouling-resistant properties.
C1 [Shi, Qing; Su, Yanlei; Jiang, Zhongyi] Tianjin Univ, Sch Chem Engn & Technol, Key Lab Green Chem Technol, Tianjin 300072, Peoples R China.
   [Shi, Qing; Ye, Shuji; Kristalyn, Cornelius; Chen, Zhan] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   [Shi, Qing; Ye, Shuji; Kristalyn, Cornelius; Chen, Zhan] Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
RP Chen, Z (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Key Lab Green Chem Technol, Tianjin 300072, Peoples R China.
EM zhyjiang@tju.edu.cn; zhanc@umich.edu
RI Chen, Zhan/G-8312-2016; Ye, Shuji/B-4479-2010
OI Chen, Zhan/0000-0001-8687-8348; 
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   [Anonymous], 2001, HYPERCHEM 7 0
   Briggman KA, 2001, J PHYS CHEM B, V105, P2785, DOI 10.1021/jp0037495
   Casford MTL, 2003, LANGMUIR, V19, P7386, DOI 10.1021/la030106i
   Chen CY, 2003, MACROMOLECULES, V36, P4478, DOI 10.1021/ma025985e
   Chen CY, 2002, MACROMOLECULES, V35, P8093, DOI 10.1021/ma0205717
   Chen CY, 2005, PHYS CHEM CHEM PHYS, V7, P2357, DOI 10.1039/b501910a
   Chen CY, 2004, LANGMUIR, V20, P10186, DOI 10.1021/la049327u
   Chen CY, 2002, MACROMOLECULES, V35, P9130, DOI 10.1021/ma020614j
   Chen Q, 1999, J AM CHEM SOC, V121, P446, DOI 10.1021/ja9831453
   Chen XY, 2007, ANAL BIOANAL CHEM, V388, P65, DOI 10.1007/s00216-006-0999-8
   Chen XY, 2006, J AM CHEM SOC, V128, P2711, DOI 10.1021/ja057029t
   Chen Z, 2000, J AM CHEM SOC, V122, P10615, DOI 10.1021/ja000808j
   Chen Z, 1999, J PHYS CHEM B, V103, P2935, DOI 10.1021/jp984502z
   Chen Z, 2007, POLYM INT, V56, P577, DOI 10.1002/pi.2201
   Clarke ML, 2005, J PHYS CHEM B, V109, P22027, DOI 10.1021/jp054456k
   Dreesen L, 2001, CHEM PHYS LETT, V333, P327, DOI 10.1016/S0009-2614(00)01383-X
   Even MA, 2006, MACROMOLECULES, V39, P9396, DOI 10.1021/ma061785h
   FreijLarsson C, 1996, BIOMATERIALS, V17, P2199, DOI 10.1016/0142-9612(96)00050-6
   Gautam KS, 2000, PHYS REV LETT, V85, P3854, DOI 10.1103/PhysRevLett.85.3854
   Gautam KS, 2001, MACROMOLECULES, V34, P1137, DOI 10.1021/ma0015976
   Gracias DH, 1999, ACCOUNTS CHEM RES, V32, P930, DOI 10.1021/ar990034f
   Green RJ, 1998, J BIOMED MATER RES, V42, P165, DOI 10.1002/(SICI)1097-4636(199811)42:2<165::AID-JBM1>3.0.CO;2-N
   Harp GP, 2003, J AM CHEM SOC, V125, P11283, DOI 10.1021/ja035513v
   HIROSE C, 1992, J CHEM PHYS, V96, P997, DOI 10.1063/1.462120
   JAMES SG, 1993, J POLYM SCI POL PHYS, V31, P221, DOI 10.1002/polb.1993.090310211
   Johnson WC, 2005, J PHYS CHEM B, V109, P6280, DOI 10.1021/jp045647a
   Kim J, 2004, LANGMUIR, V20, P4640, DOI 10.1021/la0498511
   Kim J, 2003, LANGMUIR, V19, P9551, DOI 10.1021/la035496n
   Kim J. T., 2007, J FOOD SCI, V72, P214
   Kiss E, 2003, POLYM ADVAN TECHNOL, V14, P839, DOI 10.1002/pat.404
   Kiss E, 2002, J COLLOID INTERF SCI, V245, P91, DOI 10.1006/jcis.2001.7954
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Liu Y, 2003, J PHYS CHEM B, V107, P9774, DOI 10.1021/jp0277513
   Marsh LH, 2002, J BIOMED MATER RES, V61, P641, DOI 10.1002/jbm.10174
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   NORMAN ME, 1992, BIOMATERIALS, V13, P841, DOI 10.1016/0142-9612(92)90177-P
   Opdahl A, 2002, LANGMUIR, V18, P9409, DOI 10.1021/la020537l
   Pieracci J, 2002, CHEM MATER, V14, P256, DOI 10.1021/cm010565+
   Ratner B. D., 1996, SURFACE MODIFICATION
   RESTOS H, 2001, MACROMOLECULES, V34, P5295
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0
   Shi Q, 2007, J MEMBRANE SCI, V303, P204, DOI 10.1016/j.memsci.2007.07.009
   Silver F., 1989, BIOCOMPATIBILITY INT
   Sprung M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051809
   Susanto H, 2007, LANGMUIR, V23, P7818, DOI 10.1021/la700579x
   Taniguchi M, 2003, CHEM MATER, V15, P3805, DOI 10.1021/cm020283p
   Walton DG, 1996, PHYS REV E, V54, P2811, DOI 10.1103/PhysRevE.54.2811
   Wang J, 2002, J AM CHEM SOC, V124, P7016, DOI 10.1021/ja012387r
   Wang J, 2001, J PHYS CHEM B, V105, P12118, DOI 10.1021/jp013161d
   Wang J, 2003, ANALYST, V128, P773, DOI 10.1039/b212551j
   Wang J, 2001, J AM CHEM SOC, V123, P9470, DOI 10.1021/ja0164071
   Wang J, 2008, J PHYS CHEM B, V112, P2281, DOI 10.1021/jp077556u
   Wang YQ, 2006, J MEMBRANE SCI, V283, P440, DOI 10.1016/j.memsci.2006.07.021
   Wang YQ, 2005, LANGMUIR, V21, P11856, DOI 10.1021/la052052d
   Yang ZH, 2001, LANGMUIR, V17, P6254, DOI 10.1021/la010468v
   Zhang D, 1998, J PHYS CHEM B, V102, P6225, DOI 10.1021/jp981550a
   Zolk M, 2000, LANGMUIR, V16, P5849, DOI 10.1021/la0003239
NR 59
TC 32
Z9 35
U1 6
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 5
PY 2008
VL 24
IS 15
BP 7939
EP 7946
DI 10.1021/la800570a
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 331TC
UT WOS:000258034500044
PM 18616306
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Layer-by-layer biomaterial assemblies
SO ADVANCED MATERIALS
LA English
DT News Item
CR ARIGA K, MACROMOL BIOSCI
NR 1
TC 0
Z9 0
U1 1
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD AUG 4
PY 2008
VL 20
IS 15
BP A1
EP A1
PG 1
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 342MW
UT WOS:000258789200001
DA 2018-10-20
ER

PT J
AU Bao, WW
   Zhang, YZ
   Yin, GB
   Wu, JL
AF Bao Weiwei
   Zhang Youzhu
   Yin Guibo
   Wu Jialin
TI The structure and property of the electrospinning silk fibroin/gelatin
   blend nanofibers
SO E-POLYMERS
LA English
DT Article
ID NORMAL HUMAN KERATINOCYTES; IN-VITRO; FIBROIN; FIBROBLASTS; SCAFFOLDS;
   POLYMER; DESIGN
AB Nanofibers could provide benefits due to high surface area for biomaterial scaffolds. In order to improve both silk fibroin and gelatin performance for potential biomedical applications, in this article the electrospinning of silk fibroin ( SF)/ gelatin ( GT) blends with different composition ratio and concentration was performed with formic acid as a spinning solvent. The nanofibers morphologies and diameters were observed by Scanning electron microscopy ( SEM). Blending with GT could improve the viscosity and spinnability of spinning solution. As- spun SF/ GT blend nanofibers were more homogeneous and non- beaded than pure SF nanofibers. The diameter decreased with higher voltage at same electric field intensity. On increasing the concentrations of spinning solution, the pore diameter of nanofibers decreased, and the porosity increased. In addition, FTIR and DTA analyses showed SF/ GT nanofibers had more alpha- sheets than pure SF nanofibers, which may be caused by an intermolecular interaction between SF and GT. Blending with GT also led to substantial enhancement in mechanical properties of SF nanofibers.
C1 [Bao Weiwei; Zhang Youzhu; Yin Guibo; Wu Jialin] Soochow Univ, Sch Mat Engn, Suzhou 215021, Peoples R China.
   [Bao Weiwei] China Text Informat Ctr, Dept Ind Dev, Beijing 100742, Peoples R China.
RP Zhang, YZ (reprint author), Soochow Univ, Sch Mat Engn, Ganjiang E Rd 178, Suzhou 215021, Peoples R China.
EM baoweiwei@ctic.org.cn; zhangyouzhu@suda.edu.cn
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   HANA SO, 2005, MATER LETT, V59, P2998
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   KAPLAN DL, 1994, MAT SCI BIOTECHNOLOG
   Kim SH, 2003, POLYM J, V35, P185, DOI 10.1295/polymj.35.185
   KOBAYASHI T, 1996, FOODS FOOD INGREDIEN, V170, P82
   Lee KH, 2002, J POLYM SCI POL PHYS, V40, P2259, DOI 10.1002/polb.10293
   MAGOSHI J, 1977, J POLYM SCI POL PHYS, V15, P1675, DOI 10.1002/pol.1977.180150915
   Min BM, 2004, CARBOHYD POLYM, V57, P285, DOI 10.1016/j.carbpol.2004.05.007
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   PARK WH, 2001, FIBER POLYM, V2, P58, DOI DOI 10.1007/BF02875259
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
   ZHENG M, 2004, POLYMER, V45, P5361
NR 22
TC 2
Z9 2
U1 0
U2 5
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD AUG 4
PY 2008
AR 098
PG 9
WC Polymer Science
SC Polymer Science
GA 334HZ
UT WOS:000258214200001
DA 2018-10-20
ER

PT J
AU Stynes, G
   Kiroff, GK
   Morrison, WAJ
   Kirkland, MA
AF Stynes, Gil
   Kiroff, George K.
   Morrison, Wayne A. J.
   Kirkland, Mark A.
TI Tissue compatibility of biomaterials: Benefits and problems of skin
   biointegration
SO ANZ JOURNAL OF SURGERY
LA English
DT Review
DE biocompatible materials; prostheses and implants; reconstructive
   surgical procedure; tantalum; titanium
ID VACUUM-ASSISTED CLOSURE; HUMAN LYMPHOBLASTOID-CELLS; SELF-ASSEMBLED
   MONOLAYERS; OXIDE SURFACES; IN-VITRO; INFLAMMATORY RESPONSE; SOLUBLE
   LAMININ-5; TITANIUM SURFACES; EPITHELIAL-CELLS; IMPLANTS
AB The integration of biomaterials with skin is necessary to enable infection-free access to vasculature and body cavities. Also, integrating plastics and metals with skin increases options for the reconstruction of surgical and traumatic defects and enables the permanent implantation of robotic and electronic devices. Until now, attempts to integrate biomaterials with skin permanently have failed because of epidermal marsupialization and infection. This article reviews the general properties required of biomaterials to optimize integration with body tissues, the modifications that increase biocompatibility, focusing particularly on surface functionalization and the specific requirements for biomaterial integration into skin. Critical pathophysiological processes relating to biocompatibility are discussed with particular emphasis on the skin-biomaterial interface. Future directions are speculated on, in particular, the specific utility of subatmospheric pressure dressings in facilitating tissue integration into biomaterials.
C1 [Stynes, Gil] Geelong Hosp, Dept Clin & Biomed Sci, Geelong, Vic 3220, Australia.
   [Stynes, Gil; Kirkland, Mark A.] Univ Melbourne, Dept Clin & Biomed Sci, Melbourne, Vic, Australia.
   [Stynes, Gil; Kirkland, Mark A.] Deakin Univ, Inst Biotechnol BioDeakin, Geelong, Vic 3217, Australia.
   [Morrison, Wayne A. J.] Bernard OBrien Inst Microsurg, Fitzroy, Vic, Australia.
RP Stynes, G (reprint author), Geelong Hosp, Dept Clin & Biomed Sci, Ryrie St, Geelong, Vic 3220, Australia.
EM gstynes@gmail.com
OI Stynes, Gil/0000-0003-3263-7754
CR ABDALLAH HI, 1994, ANN THORAC SURG, V57, P1017, DOI 10.1016/0003-4975(94)90228-3
   Alton E, 2007, GENE THER, V14, P1555, DOI 10.1038/sj.gt.3303033
   Argenta LC, 2006, PLAST RECONSTR SURG, V117, p127S, DOI 10.1097/01.prs.0000222551.10793.51
   Atagi TA, 2006, PLASTIC SURG, P745
   BADLEY RA, 1978, EXP CELL RES, V117, P231, DOI 10.1016/0014-4827(78)90136-2
   Baker SE, 1996, EXP CELL RES, V228, P262, DOI 10.1006/excr.1996.0325
   BISCHOFF F, 1964, PROG EXP TUMOR RES, V5, P85
   BRAND KG, 1980, PLAST RECONSTR SURG, V66, P591, DOI 10.1097/00006534-198010000-00015
   Brovelli D, 1999, LANGMUIR, V15, P4324, DOI 10.1021/la981758n
   Bruni S, 2005, ACTA BIOMATER, V1, P223, DOI 10.1016/j.actbio.2004.11.001
   BRUNK U, 1971, EXP CELL RES, V67, P407, DOI 10.1016/0014-4827(71)90426-5
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P355, DOI 10.1002/jbm.820210308
   Chen Shao-Zong, 2005, Asian J Surg, V28, P211, DOI 10.1016/S1015-9584(09)60346-8
   CHEN WT, 1982, J CELL BIOL, V95, P205, DOI 10.1083/jcb.95.1.205
   Contreras R, 2007, J BIOMED MATER RES A, V80A, P480, DOI 10.1002/jbm.a.30961
   de Guzman RC, 2008, J BIOMED MATER RES A, V85A, P14, DOI 10.1002/jbm.a.31516
   du Preez L A, 2007, SADJ, V62, P24
   ECONOMIST T, 2007, ECONOMISTCOM
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   Hoiby N, 1994, Ugeskr Laeger, V156, P5998
   HUNT JA, 1994, ANAL CELL PATHOL, V7, P43
   Jansen J A, 1989, J Invest Surg, V2, P29, DOI 10.3109/08941938909016502
   Jeschke MG, 2004, PLAST RECONSTR SURG, V113, P525, DOI 10.1097/01.PRS.0000100813.39746.5A
   Jotterand F, 2007, NANOMEDICINE-UK, V2, P401, DOI 10.2217/17435889.2.4.401
   Kirkland MA, 2004, EXP HEMATOL, V32, P511, DOI 10.1016/j.exphem.2004.02.013
   Knetsch MLW, 2007, J BIOMED MATER RES A, V82A, P947, DOI 10.1002/ibm.a.31212
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Lai JCK, 2007, P I MECH ENG H, V221, P173, DOI 10.1243/09544119JEIM210
   Lai J. C. K., 2005, ENCY BIOMATERIALS BI, P1
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   Lemons J E, 1986, J Arthroplasty, V1, P143, DOI 10.1016/S0883-5403(86)80053-5
   LEW DP, 1989, EUR J CANCER CLIN ON, V25, P1379, DOI 10.1016/0277-5379(89)90091-6
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Molnar JA, 2004, PLAST RECONSTR SURG, V113, P1339, DOI 10.1097/01.PRS.0000112746.67050.68
   MORGAN RW, 1995, J CLIN EPIDEMIOL, V48, P545, DOI 10.1016/0895-4356(94)00211-8
   Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379
   Morykwas MJ, 2006, PLAST RECONSTR SURG, V117, p121S, DOI 10.1097/01.prs.0000225450.12593.12
   Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013
   MURRAY JC, 1979, J CELL BIOL, V80, P197, DOI 10.1083/jcb.80.1.197
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Pendegrass CJ, 2006, BIOMATERIALS, V27, P4183, DOI 10.1016/j.biomaterials.2006.03.041
   Penington DG, 2007, MED J AUSTRALIA, V187, P139
   Pennekamp PH, 2006, J ORTHOP RES, V24, P531, DOI 10.1002/jor.20066
   Pitkin M, 2006, J REHABIL RES DEV, V43, P573, DOI 10.1682/JRRD.2005.05.0160
   Puleo DA, 1997, J BIOMED MATER RES, V37, P222, DOI 10.1002/(SICI)1097-4636(199711)37:2<222::AID-JBM11>3.0.CO;2-G
   REVEL JP, 1973, EXP CELL RES, V78, P1, DOI 10.1016/0014-4827(73)90031-1
   Rushing GD, 2007, J PEDIATR SURG, V42, P93, DOI 10.1016/j.jpedsurg.2006.09.056
   Scheideler L, 2007, DENT MATER, V23, P469, DOI 10.1016/j.dental.2006.03.005
   Sclafani AP, 1997, PLAST RECONSTR SURG, V99, P41, DOI 10.1097/00006534-199701000-00007
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   SLIPMAN CW, 2004, ARCH PHYS MED REHAB, V85, pE33
   Suzuki R, 2003, J BIOMED MATER RES A, V66A, P396, DOI 10.1002/jbm.a.10001
   SUZUKI R, 2000, CLIN ORTOP REL RES, V372, P280
   Tamai  K, 2001, Breast Cancer, V8, P90, DOI 10.1007/BF02967485
   Tamura RN, 1997, J PERIODONTAL RES, V32, P287, DOI 10.1111/j.1600-0765.1997.tb00536.x
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Tosatti S, 2002, LANGMUIR, V18, P3537, DOI 10.1021/la011459p
   Udipi K, 2000, J BIOMED MATER RES, V51, P549, DOI 10.1002/1097-4636(20000915)51:4<549::AID-JBM2>3.0.CO;2-Z
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   Wackenfors A, 2004, WOUND REPAIR REGEN, V12, P600, DOI 10.1111/j.1067-1927.2004.12602.x
   Wang JJ, 2007, MUTAT RES-GEN TOX EN, V628, P99, DOI 10.1016/j.mrgentox.2006.12.003
   Wang JJ, 2007, ENVIRON MOL MUTAGEN, V48, P151, DOI 10.1002/em.20287
   Whitesides George M, 2005, Sci Prog, V88, P17, DOI 10.3184/003685005783238462
   Yamauchi R, 2000, CONTACT DERMATITIS, V42, P52
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   Zuo L, 2007, MED CLIN N AM, V91, P845, DOI 10.1016/j.mcna.2007.05.004
NR 67
TC 7
Z9 7
U1 0
U2 13
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1445-1433
J9 ANZ J SURG
JI ANZ J. Surg.
PD AUG
PY 2008
VL 78
IS 8
BP 654
EP 659
DI 10.1111/j.1445-2197.2008.04609.x
PG 6
WC Surgery
SC Surgery
GA 336GZ
UT WOS:000258353600012
PM 18796021
OA Bronze
DA 2018-10-20
ER

PT J
AU Le Nihouannen, D
   Hacking, SA
   Gbureck, U
   Komarova, SV
   Barralet, JE
AF Le Nihouannen, Damien
   Hacking, S. Adam
   Gbureck, Uwe
   Komarova, Svedana V.
   Barralet, Jake E.
TI The use of RANKL-coated brushite cement to stimulate bone remodelling
SO BIOMATERIALS
LA English
DT Article
DE calcium phosphate cement; brushite; RANKL; osteoclast; controlled drug
   release
ID CALCIUM-PHOSPHATE CEMENT; STRENGTH IMPROVEMENT; HYPODERMIC INJECTION;
   IONIC MODIFICATION; GRAFT; VISCOSITY; DELIVERY; RECEPTOR
AB Calcium phosphate cements were first proposed as synthetic bone substitutes over two decades ago, however, they are characterised by slow chemical or cellular resorption and a slow osteointegration. In contrast, bone autograft has been shown to stimulate osteoclastogenesis and angiogenesis resulting in active bone remodelling and rapid graft incorporation. Therefore, we aimed to develop a biomaterial able to release a key stimulator of the bone remodelling process, cytokine RANKL. Cylinders of brushite cement, hydroxyapatite cement and sodium alginate were loaded with RANKL either by incorporation into the cement or by coating the material with Soluble RANKL. To test the biological activity of these formulations, we assessed their effectiveness in inducing osteoclast formation from RAW 264.7 monocytic cell line. Only brushite and hydroxyapatite cements coated with RANKL allowed for retaining sufficient biological activity to induce osteoclast formation. Most efficient was coating 40 mg cylinder of brushite cement with 800 ng RANKL. We have found that RANKL-coated brushite cement exhibits osteoclastogenic activity for at least 1 month at 37 degrees C. Thus, we developed a formulation of brushite cement with RANKL - a synthetic bone graft that is similar to autografts in its ability to actively induce osteoclastogenesis. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Le Nihouannen, Damien; Komarova, Svedana V.; Barralet, Jake E.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   [Hacking, S. Adam] McGill Univ, Montreal Gen Hosp, Dept Orthoped, Montreal, PQ H3G 1A4, Canada.
   [Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
RP Barralet, JE (reprint author), McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.
EM jake.barralet@mcgill.ca
RI Hacking, Adam/F-3645-2010; Gbureck, Uwe/G-1430-2012; barralet,
   jake/A-5820-2008
OI barralet, jake/0000-0003-3543-6042
CR Bandyopadhyay S, 2006, BIOCHEM PHARMACOL, V72, P184, DOI 10.1016/j.bcp.2006.04.018
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barralet JE, 2004, J MATER SCI-MATER M, V15, P407, DOI 10.1023/B:JMSM.0000021111.48592.ab
   Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   BROWN WE, 1983, J DENT RES, V62, P672
   BURCHARDT H, 1987, ORTHOP CLIN N AM, V18, P187
   Cuckler JM, 2004, J ARTHROPLASTY, V19, P56, DOI 10.1016/j.arth.2004.03.002
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   FEI Z, J MAT SCI M IN PRESS
   Gbureck U, 2004, BIOMATERIALS, V25, P2187, DOI 10.1016/j.biomaterials.2003.08.066
   Gbureck U, 2007, ADV MATER, V19, P795, DOI 10.1002/adma.200601370
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Grover LM, 2006, BIOMATERIALS, V27, P2178, DOI 10.1016/j.biomaterials.2005.11.012
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Komarova SV, 2005, ENDOCRINOLOGY, V146, P3589, DOI 10.1210/en.2004-1642
   Lam J, 2001, J CLIN INVEST, V108, P971, DOI 10.1172/JCI13890
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P343
   Mentaverri R, 2006, FASEB J, V20, P2562, DOI 10.1096/fj.06-6304fje
   Monaco Anthony P, 2004, Exp Clin Transplant, V2, P153
   TAMIMI F, J BIOMED A IN PRESS
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Urban RM, 2007, CLIN ORTHOP RELAT R, P110, DOI 10.1097/BLO.0b013e318059b902
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Vallet-Regi M, 2006, DALTON T, P5211, DOI 10.1039/b610219k
NR 27
TC 37
Z9 37
U1 3
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2008
VL 29
IS 22
BP 3253
EP 3259
DI 10.1016/j.biomaterials.2008.03.035
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 317IG
UT WOS:000257012700011
PM 18455230
DA 2018-10-20
ER

PT J
AU Fan, HB
   Liu, HF
   Wong, EJW
   Toh, SL
   Goh, JCH
AF Fan, Hongbin
   Liu, Haifeng
   Wong, Eugene J. W.
   Toh, Siew L.
   Goh, James C. H.
TI In vivo study of anterior cruciate ligament regeneration using
   mesenchymal stem cells and silk scaffold
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; ligament; silk; regeneration; mesenchyrnal stem
   cells
ID MARROW STROMAL CELLS; HYBRID SCAFFOLD; MECHANICAL STIMULATION; TENDON
   GRAFT; BONE TUNNEL; RECONSTRUCTION; RABBIT; FIBROBLASTS; REPAIR;
   DIFFERENTIATION
AB Although most in vitro studies indicate that silk is a suitable biomaterial for ligament tissue engineering, in vivo studies of implanted silk scaffolds for ligament reconstruction are still lacking. The objective of this study is to investigate anterior cruciate ligament (ACL) regeneration using mesenchymal stem cells (MSCs) and silk scaffold. The scaffold was fabricated by incorporating microporous silk sponges into knitted silk mesh, which mimicked the structures of ligament extracellular matrix (ECM). In vitro culture demonstrated that MSCs on scaffolds proliferated vigorously and produced abundant collagen. The transcription levels of ligament-specific genes also increased with time. Then MSCs/scaffold was implanted to regenerate ACL in vivo. After 24 weeks, histology observation showed that MSCs were distributed throughout the regenerated ligament and exhibited fibroblast morphology. The key ligament ECM components including collagen I, collagen 111, and tenascin-C were produced prominently. Furthermore, direct ligament-bone insertion with typical four zones (bone, mineralized fibrocartilage, fibrocartilage, ligament) was reconstructed, which resembled the native structure of ACL-bone insertion. The tensile strength of regenerated ligament also met the mechanical requirements. Moreover, its histological grading score was significantly higher than that of control. In conclusion, the results imply that silk scaffold has great potentials in future clinical applications. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Fan, Hongbin; Liu, Haifeng; Wong, Eugene J. W.; Toh, Siew L.; Goh, James C. H.] Natl Univ Singapore, Dept Orthopaed Surg, Div Bioengn, Singapore 117548, Singapore.
   [Toh, Siew L.] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.
RP Goh, JCH (reprint author), Natl Univ Singapore, Dept Orthopaed Surg, Div Bioengn, 10 Kent Ridge Crescent, Singapore 117548, Singapore.
EM dosgohj@nus.edu.sg
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman Greg, 2002, FASEB Journal, V16, P270
   AMIEL D, 1984, Journal of Orthopaedic Research, V1, P257
   BALLOCK RT, 1989, J ORTHOP RES, V7, P474, DOI 10.1002/jor.1100070404
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Chen JS, 2006, TISSUE ENG, V12, P3085, DOI 10.1089/ten.2006.12.3085
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Cooper JA, 2007, P NATL ACAD SCI USA, V104, P3049, DOI 10.1073/pnas.0608837104
   Doroski DM, 2007, BIOMATERIALS, V28, P187, DOI 10.1016/j.biomaterials.2006.08.040
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Fan HB, 2008, BIOMATERIALS, V29, P1017, DOI 10.1016/j.biomaterials.2007.10.048
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   GOOD L, 1989, ACTA ORTHOP SCAND, V60, P8, DOI 10.3109/17453678909150080
   GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058
   Gushue DL, 2005, J ORTHOP RES, V23, P735, DOI 10.1016/j.orthres.2005.01.005
   Harner C D, 2001, Instr Course Lect, V50, P463
   Hokugo A, 2006, BIOMATERIALS, V27, P61, DOI 10.1016/j.biomaterials.2005.05.030
   Lim JK, 2004, ARTHROSCOPY, V20, P899, DOI 10.1016/j.arthro.2004.06.035
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Mackie EJ, 1996, J ANAT, V188, P157
   Maletius W, 1997, AM J SPORT MED, V25, P288, DOI 10.1177/036354659702500303
   Miller SL, 2002, ORTHOP CLIN N AM, V33, P675, DOI 10.1016/S0030-5898(02)00027-5
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Moreau JE, 2005, TISSUE ENG, V11, P1887, DOI 10.1089/ten.2005.11.1887
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Petrigliano FA, 2006, ARTHROSCOPY, V22, P441, DOI 10.1016/j.arthro.2006.01.017
   Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91
   Shelburne KB, 2004, J BIOMECH, V37, P797, DOI [10.1016/j.jbiomech.2003.10.010, 10.1016/j.biomech.2003.10.010]
   Strickland SM, 2003, ORTHOP CLIN N AM, V34, P41, DOI 10.1016/S0030-5898(02)00060-3
   Van Eijk F, 2004, TISSUE ENG, V10, P893, DOI 10.1089/1076327041348428
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Weiler A, 2002, ARTHROSCOPY, V18, P124, DOI 10.1053/jars.2002.30657
   Woo SLY, 1999, CLIN ORTHOP RELAT R, pS312
   Yeh WL, 2007, J ORTHOP RES, V25, P636, DOI 10.1002/jor.20360
NR 40
TC 122
Z9 137
U1 7
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2008
VL 29
IS 23
BP 3324
EP 3337
DI 10.1016/j.biomaterials.2008.04.012
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 321ZI
UT WOS:000257344600005
PM 18462787
DA 2018-10-20
ER

PT J
AU Kilian, O
   Wenisch, S
   Karnati, S
   Baumgart-Vogt, E
   Hild, A
   Fuhrmann, R
   Jonuleit, T
   Dingeldein, E
   Schnettler, R
   Franke, RP
AF Kilian, Olaf
   Wenisch, Sabine
   Karnati, Srikanth
   Baumgart-Vogt, Eveline
   Hild, Anne
   Fuhrmann, Rosemarie
   Jonuleit, Tarja
   Dingeldein, Elvira
   Schnettler, Reinhard
   Franke, Ralf-Peter
TI Observations on the microvasculature of bone defects filled with
   biodegradable nanoparticulate hydroxyapatite
SO BIOMATERIALS
LA English
DT Article
DE angiogenesis; endothelial cell; lymphatic vessel; hydroxyapatite
   composite; platelet; animal model
ID ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSEL FORMATION; MOLECULAR-MECHANISMS;
   VASCULAR DEVELOPMENT; POROUS IMPLANTS; ANGIOGENESIS; LYMPHANGIOGENESIS;
   VASCULOGENESIS; VEGF; NEOVASCULARIZATION
AB The microvascularization of metaphyseal bone defects filled with nanoparticulate, biodegradable hydroxyapatite biomaterial with and without platelet factors enrichment was investigated in a minipig model. Results from morphological analysis and PECAM-1 immunohistochemistry showed the formation of new blood vessels into the bone defects by sprouting and intussusception of pre-existing ones. However, no significant differences were observed in the microvascularization of the different biomaterials applied (pure versus platelet factors-enriched hydroxyapatite), concerning the number of vessels and their morphological structure at day 20 after operation. The appearance of VEGFR-2 positive endothelial progenitor cells in the connective tissue between hydroxyapatite particles was also found to be independent from platelet factors enrichment of the hydroxyapatite bone substitute. In both groups formation of lymphatic vessels was detected with a podoplanin antibody. No differences were noted between HA/PLF- and HA/PLF+ implants with respect to the podoplanin expression level, the staining pattern or number of lymphatic vessels. In conclusion, the present study demonstrates different mechanisms of blood and lymphatic vessel formation in hydroxyapatite implants in minipigs. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Kilian, Olaf; Schnettler, Reinhard] Univ Giessen, Dept Trauma Surg, D-35392 Giessen, Germany.
   [Fuhrmann, Rosemarie; Franke, Ralf-Peter] Univ Ulm, Dept Biomat, D-89069 Ulm, Germany.
   [Wenisch, Sabine; Karnati, Srikanth; Baumgart-Vogt, Eveline; Hild, Anne] Univ Giessen, Lab Expt Trauma Surg, Inst Anat & Cell Biol 2, Div Med Cell Biol, D-35390 Giessen, Germany.
   [Jonuleit, Tarja] CellMed AG, Alzenau, Germany.
   [Dingeldein, Elvira] Osartis GmbH, Obernburg, Germany.
   [Franke, Ralf-Peter] Univ Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
RP Kilian, O (reprint author), Univ Giessen, Dept Trauma Surg, Rudolf Buchheim Str 7, D-35392 Giessen, Germany.
EM olaf.kilian@chiru.med.uni-giessen.de
RI Baumgart-Vogt, Eveline/I-5945-2013
OI Baumgart-Vogt, Eveline/0000-0002-8265-3763; Karnati,
   Srikanth/0000-0001-9083-2916
CR Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Al-Rawi MAA, 2005, EJSO, V31, P117, DOI 10.1016/j.ejso.2004.08.015
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Auguste P, 2003, CELL TISSUE RES, V314, P157, DOI 10.1007/s00441-003-0750-0
   Augustin HG, 2001, CIRC RES, V89, P645, DOI 10.1161/res.89.8.645
   Beck L, 1997, FASEB J, V11, P365
   Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069
   BREITENDERGELEF.S, 1999, AM J PATHOL, V154, P386
   BURRI PH, 1990, ANAT REC, V228, P35, DOI 10.1002/ar.1092280107
   Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Cimpean Anca Maria, 2007, Rom J Morphol Embryol, V48, P139
   Crosby JR, 2000, CIRC RES, V87, P728, DOI 10.1161/01.RES.87.9.728
   Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3
   DONATH K, 1982, J ORAL PATHOL, V4, P316
   Edwards JR, 2008, HUM PATHOL, V39, P49, DOI 10.1016/j.humpath.2007.04.022
   Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947
   Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C
   Gerber HP, 1999, NAT MED, V5, P623
   Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   Jeltsch M, 2003, CELL TISSUE RES, V314, P69, DOI 10.1007/s00441-003-0777-2
   Kidd KR, 2002, J BIOMED MATER RES, V59, P366, DOI 10.1002/jbm.1253
   Kilian O, 2007, GROWTH FACTORS, V25, P191, DOI 10.1080/08977190701687585
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018
   Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100
   Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639
   Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002
   Parsons-Wingerter P, 2006, ANAT REC PART A, V288A, P233, DOI 10.1002/ar.a.20309
   Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855
   Ramirez MI, 2002, J HISTOCHEM CYTOCHEM, V50, P33, DOI 10.1177/002215540205000104
   Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Steinbrech D. S., 2000, AM J PHYSIOL-CELL PH, V278, P853
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   Uchida S, 2003, BONE, V32, P491, DOI 10.1016/S8756-3282(03)00053-X
   Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493
   Welter H, 2003, EXP CLIN ENDOCR DIAB, V111, P33, DOI 10.1055/s-2003-37498
   Williams SK, 2006, J BIOMED MATER RES A, V78A, P59, DOI 10.1002/jbm.a.30659
   Zhou AL, 1998, CELL TISSUE RES, V293, P293, DOI 10.1007/s004410051121
NR 44
TC 17
Z9 18
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG-SEP
PY 2008
VL 29
IS 24-25
BP 3429
EP 3437
DI 10.1016/j.biomaterials.2008.05.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 325RS
UT WOS:000257606600005
PM 18501961
DA 2018-10-20
ER

PT J
AU Clem, WC
   Chowdhury, S
   Catledge, SA
   Weimer, JJ
   Shaikh, FM
   Hennessy, KM
   Konovalov, VV
   Hill, MR
   Waterfeld, A
   Bellis, SL
   Vohra, YK
AF Clem, William C.
   Chowdhury, Shaflul
   Catledge, Shane A.
   Weimer, Jeffrey J.
   Shaikh, Faheem M.
   Hennessy, Kristin M.
   Konovalov, Valery V.
   Hill, Michael R.
   Waterfeld, Alfred
   Bellis, Susan L.
   Vohra, Yogesh K.
TI Mesenchymal stem cell interaction with ultra-smooth nanostructured
   diamond for wear-resistant orthopaedic implants
SO BIOMATERIALS
LA English
DT Article
DE diamond; mesenchymal stem cell; biocompatibility; surface treatment;
   protein adsorption; osseointegration
ID VAPOR-DEPOSITED DIAMOND; CARBON COMPOSITE FILMS; BIOMEDICAL
   APPLICATIONS; IN-VITRO; COATINGS; SURFACE; PROTEINS; ADHESION; ALLOY;
   BIOCOMPATIBILITY
AB Ultra-smooth nanostructured diamond (USND) can be applied to greatly increase the wear resistance of orthopaedic implants over conventional designs. Herein we describe surface modification techniques and cytocompatibility studies performed on this new material. We report that hydrogen (H)-terminated USND surfaces supported robust mesenchymal stem cell (MSC) adhesion and survival, while oxygen-(O) and fluorine (F)-terminated surfaces resisted cell adhesion, indicating that USND can be modified to either promote or prevent cell/biomaterial interactions. Given the favorable cell response to H-terminated USND, this material was further compared with two commonly used biocompatible metals, titanium alloy (Ti-6Al-4V) and cobalt chrome (CoCrMo). MSC adhesion and proliferation were significantly improved on USND compared with CoCrMo, although cell adhesion was greatest on Ti-6Al-4V. Comparable amounts of the pro-adhesive protein, fibronectin, were deposited from serum on the three substrates. Finally, MSCs were induced to undergo osteoblastic differentiation on the three materials, and deposition of a mineralized matrix was quantified. Similar amounts of mineral were deposited onto USND and CoCrMo, whereas mineral deposition was slightly higher on Ti-6Al-4V. When coupled with recently published wear studies, these in vitro results suggest that USND has the potential to reduce debris particle release from orthopaedic implants without compromising osseointegration.(c) 2008 Elsevier Ltd. All rights reserved.
C1 [Shaikh, Faheem M.; Hennessy, Kristin M.; Bellis, Susan L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA.
   [Clem, William C.; Chowdhury, Shaflul; Catledge, Shane A.; Konovalov, Valery V.; Hill, Michael R.; Bellis, Susan L.; Vohra, Yogesh K.] Ctr Nanoscale Mat & Biointegrat, Birmingham, AL 35294 USA.
   [Clem, William C.; Hill, Michael R.; Bellis, Susan L.] Univ Alabama, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Chowdhury, Shaflul; Catledge, Shane A.; Konovalov, Valery V.; Vohra, Yogesh K.] Univ Alabama, Dept Phys, Birmingham, AL 35294 USA.
   [Weimer, Jeffrey J.] Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
   [Weimer, Jeffrey J.] Univ Alabama, Dept Chem & Mat Engn, Huntsville, AL 35899 USA.
   [Waterfeld, Alfred] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA.
RP Bellis, SL (reprint author), Univ Alabama, Dept Physiol & Biophys, MCLM 982A, Birmingham, AL 35294 USA.
EM bellis@uab.edu; ykvohra@uab.edu
RI Hill, Michael/N-9461-2017
OI Hill, Michael/0000-0002-7607-9064; Hill, Michael/0000-0002-2379-4240;
   Weimer, Jeffrey/0000-0002-3460-4000
FU NIBIB NIH HHS [T32EB004312, T32 EB004312]; NIAMS NIH HHS [R01AR51539,
   R01 AR051539-03, R01 AR051539]; NIDCR NIH HHS [R01 DE013952, R01
   DE013952-03]
CR Ariano P, 2005, DIAM RELAT MATER, V14, P669, DOI 10.1016/j.diamond.2004.11.021
   Catledge SA, 1999, J APPL PHYS, V86, P698, DOI 10.1063/1.370787
   Catledge SA, 1998, J APPL PHYS, V84, P6469, DOI 10.1063/1.368975
   CATLEDGE SA, 2001, MECH PROPERTIES STRU
   Chakrapani V, 2007, SCIENCE, V318, P1424, DOI 10.1126/science.1148841
   Chowdhury S, 2006, J MATER RES, V21, P2675, DOI 10.1557/JMR.2006.0334
   CHOWDHURY S, 2007, DIAMOND RELATED MAT
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Docheva D, 2007, J CELL MOL MED, V11, P21, DOI 10.1111/j.1582-4934.2007.00001.x
   Faleiro C, 1996, BIOMETALS, V9, P321, DOI 10.1007/BF00140600
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garguilo JM, 2004, DIAM RELAT MATER, V13, P595, DOI 10.1016/j.diamond.2003.10.008
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   HILL MR, 2007, J BIOMEDICAL MAT R B
   Jakubowski W, 2004, DIAM RELAT MATER, V13, P1761, DOI 10.1016/j.diamond.2004.03.003
   Kawarada H, 1996, SURF SCI REP, V26, P205, DOI 10.1016/S0167-5729(97)80002-7
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Konovalov VV, 2006, J NANOSCI NANOTECHNO, V6, P258, DOI 10.1166/jnn.2006.045
   KONOVALOV VV, 2007, PCTUS2006038222
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Maier F, 2000, PHYS REV LETT, V85, P3472, DOI 10.1103/PhysRevLett.85.3472
   Mitura K, 2006, SURF COAT TECH, V201, P2117, DOI 10.1016/j.surfcoat.2005.10.023
   Narayan RJ, 2006, DIAM RELAT MATER, V15, P1935, DOI 10.1016/j.diamond.2006.08.024
   Okroj W, 2006, DIAM RELAT MATER, V15, P1535, DOI 10.1016/j.diamond.2005.12.033
   Popov C, 2007, DIAM RELAT MATER, V16, P735, DOI 10.1016/j.diamond.2006.12.001
   Popov C, 2006, THIN SOLID FILMS, V494, P92, DOI 10.1016/j.tsf.2005.07.163
   Pypen CMJM, 1998, J MATER SCI-MATER M, V9, P761, DOI 10.1023/A:1008919422520
   Raffaini G, 2007, J MATER SCI-MATER M, V18, P309, DOI 10.1007/s10856-006-0694-5
   Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768
   Sawyer AA, 2007, BIOMATERIALS, V28, P383, DOI 10.1016/j.biomaterials.2006.08.031
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
NR 37
TC 49
Z9 49
U1 1
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG-SEP
PY 2008
VL 29
IS 24-25
BP 3461
EP 3468
DI 10.1016/j.biomaterials.2008.04.045
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 325RS
UT WOS:000257606600009
PM 18490051
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, XM
   Cui, YD
AF Li Xinming
   Cui Yingde
TI Study on synthesis and chloramphenicol release of
   poly(2-hydroxyethylmethacrylate-co-acrylamide) hydrogels
SO CHINESE JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE hydrogels; drug delivery; chloramphenicol; pH-sensible
ID OPHTHALMIC DRUG-DELIVERY; SOFT CONTACT-LENSES; HEMA HYDROGEL; TIMOLOL;
   TEAR; FORMULATIONS; MONOMERS; SYSTEMS; EYE
AB In this article, poly(2-hydroxyethylmethacrylate-co-acrylamide) hydrogels were synthesized by bulk free-radical copolymerization of 2-hydroxyethylmethacrylate (HEMA) and acrylamide (AAm) for soft contact lens(SCL)-based ophthalmic drug delivery system. The copolymer was characterized with FT-IR and SEM, the swelling property of the hydrogels were Studied by gravimetrical method, and chloramphenicol was used as a model drug to investigate drug release profile of the hydrogels. The results showed that poly(2-hydroxyethylmethacrylate-co-acrylamide) hydrogels were transparent and useful SCL biomaterial, the water content increased as AAm content increase and pH decrease, and in the same way, hydrogel composition affected chloramphenicol release process too. Migration rate of chloramphenicol increased as the AAm content in the hydrogels increased in the first stage of diffusion process, whereas there was no significant difference thereafter.
C1 [Li Xinming; Cui Yingde] Zhongkai Univ Agr & Engn, Sch Chem & Chem Engn, Guangzhou 510225, Guangdong, Peoples R China.
RP Li, XM (reprint author), Zhongkai Univ Agr & Engn, Sch Chem & Chem Engn, Guangzhou 510225, Guangdong, Peoples R China.
EM lixinming@sina.com
FU Natural Science Foundation of Guangdong Province [5300978]; Zhongkai
   University of Agriculture and Engineering [G2360221]
FX Supported by the Natural Science Foundation of Guangdong Province
   (5300978) and Zhongkai University of Agriculture and Engineering
   (G2360221).
CR Alvarez-Lorenzo C, 2002, J PHARM SCI, V91, P2182, DOI 10.1002/jps.10209
   Alvarez-Lorenzo C., 2006, AM J DRUG DELIV, V4, P131, DOI DOI 10.2165/00137696-200604030-00002
   Alvarez-Lorenzo C, 2006, J CONTROL RELEASE, V113, P236, DOI 10.1016/j.jconrel.2006.05.003
   Andrade-Vivero P, 2007, J PHARM SCI-US, V96, P802, DOI 10.1002/jps.20761
   Bourlais C L, 1998, Prog Retin Eye Res, V17, P33
   Creech JL, 2001, IND ENG CHEM RES, V40, P3015, DOI 10.1021/ie000596z
   DESHPANDE SG, 1989, J PHARM PHARMACOL, V41, P197, DOI 10.1111/j.2042-7158.1989.tb06430.x
   Ding SL, 1998, PHARM SCI TECHNOL TO, V1, P328, DOI 10.1016/S1461-5347(98)00087-X
   Garcia DM, 2004, EUR POLYM J, V40, P1683, DOI 10.1016/j.eurpolymj.2004.03.012
   Gulsen D, 2005, INT J PHARMACEUT, V292, P95, DOI 10.1016/j.ijpharm.2004.11.033
   Gulsen D, 2004, INVEST OPHTH VIS SCI, V45, P2342, DOI 10.1167/iovs.03-0959
   GULSEN D, 2000, CURRENT EYE RES, V30, P1071
   HAROLDO CBP, 2006, J APPL POLYM SCI, V102, P395
   Hiratani H, 2005, MACROMOL BIOSCI, V5, P728, DOI 10.1002/mabi.200500065
   Hiratani H, 2005, BIOMATERIALS, V26, P1293, DOI 10.1016/j.biomaterials.2004.04.030
   Hiratani H, 2004, BIOMATERIALS, V25, P1105, DOI 10.1016/S0142-9612(03)00622-7
   Hiratani H, 2002, J CONTROL RELEASE, V83, P223, DOI 10.1016/S0168-3659(02)00213-4
   Hughes PM, 2005, ADV DRUG DELIVER REV, V57, P2010, DOI 10.1016/j.addr.2005.09.004
   Karlgard CCS, 2003, INT J PHARM, V257, P141, DOI 10.1016/S0378-5173(03)00124-8
   LANG JC, 1995, ADV DRUG DELIVER REV, V16, P39, DOI 10.1016/0169-409X(95)00012-V
   Li CC, 2006, IND ENG CHEM RES, V45, P3718, DOI 10.1021/ie0507934
   Lin HR, 2000, J CONTROL RELEASE, V69, P379, DOI 10.1016/S0168-3659(00)00329-1
   McNamara NA, 1999, AM J OPHTHALMOL, V127, P659, DOI 10.1016/S0002-9394(99)00051-3
   Sano K, 1996, ACTA OPHTHALMOL SCAN, V74, P243
   Sato T, 2005, J APPL POLYM SCI, V98, P731, DOI 10.1002/app.22080
   THYGESEN JEM, 1987, ACTA OPHTHALMOL, V65, P134
   Uchida R, 2003, J CONTROL RELEASE, V92, P259, DOI 10.1016/S0168-3659(03)00368-7
   Venkatesh S, 2007, BIOMATERIALS, V28, P717, DOI 10.1016/j.biomaterials.2006.09.007
   WARLEN M, 1992, INVEST OPHTH VIS SCI, V33, P938
   Wilson CG, 2004, EXP EYE RES, V78, P737, DOI 10.1016/j.exer.2003.10.004
   Winterton LC, 2007, J BIOMED MATER RES B, V80B, P424, DOI 10.1002/jbm.b.30613
NR 31
TC 11
Z9 14
U1 1
U2 11
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
SN 1004-9541
J9 CHINESE J CHEM ENG
JI Chin. J. Chem. Eng.
PD AUG
PY 2008
VL 16
IS 4
BP 640
EP 645
DI 10.1016/S1004-9541(08)60134-2
PG 6
WC Engineering, Chemical
SC Engineering
GA 346WN
UT WOS:000259100400022
DA 2018-10-20
ER

PT J
AU de Oliveira, RC
   de Oliveira, FHG
   Cestari, TM
   Taga, R
   Granjeiro, JM
AF de Oliveira, Rodrigo Cardoso
   Gelonese de Oliveira, Fabio Henrique
   Cestari, Tania Mary
   Taga, Rumio
   Granjeiro, Jose Mauro
TI Morphometric evaluation of the repair of critical-size defects using
   demineralized bovine bone and autogenous bone grafts in rat calvaria
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE bone repair; bovine bone; critical-size defect
ID MORPHOGENETIC PROTEIN; EXTRACELLULAR-MATRIX; REGULATORS; MORBIDITY;
   IMPLANTS; GROWTH
AB Objective: To evaluate the repair of critical-size bone defects in rats treated with demineralized bovine bone (DBB) compared with autogenous bone (AB).
   Material and method: A bone defect of 8 mm in diameter was created in the calvaria of 50 Rattus norvegicus, treated either with DBB or AB. Sub-groups of five rats of each group were killed at 7, 14, 21, 30 and 90 days post-operatively, and the skulls were removed and processed histologically. Histological sections were stained with hematoxylin and eosin.
   Result: Histological analysis showed complete closure of the defects with new bone at 90 days in group AB, and substitution of the biomaterial by fibrotic connective tissue in the DBB group at 21 days. Morphometric analysis showed that DBB was rapidly absorbed at 14 days, with its volume density decreasing from 47%+/- 0.8% at 7 days to 1.2%+/- 0.41% at 14 days. Subsequently, volume densities of the connective tissue and neoformed bone increased from 51.1%+/- 11.17% to 86.8%+/- 7.92% and from 1.9%+/- 1.13% to 12%+/- 8.02%, respectively, for the same time interval. The volume density of AB particles did not change throughout the experimental periods, but the amount of new bone increased markedly between 7 and 90 days, from 4.5%+/- 1.57% to 53.5%+/- 6.42% (P < 0.05).
   Conclusion: DBB did not provide complete repair of the defects, with significantly less new bone formation than in the AB group.
C1 [Granjeiro, Jose Mauro] Univ Fed Fluminense, Inst Biol, Dept Cellular & Mol Biol, BR-24020150 Niteroi, RJ, Brazil.
   [de Oliveira, Rodrigo Cardoso] Univ Sao Paulo, Bauru Dent Sch, UNICAMP, Inst Biol, BR-05508 Sao Paulo, Brazil.
   [Taga, Rumio] Univ Sao Paulo, Bauru Dent Sch, Dept Biol Sci, BR-05508 Sao Paulo, Brazil.
   [Granjeiro, Jose Mauro] Univ Sao Paulo, Cell & Mol Therapy Ctr, BR-05508 Sao Paulo, Brazil.
RP Granjeiro, JM (reprint author), Univ Fed Fluminense, Inst Biol, Dept Cellular & Mol Biol, Outeiro Sao Joao Baptista S-N,Campus Valonguinho, BR-24020150 Niteroi, RJ, Brazil.
EM jmgranjeiro@vm.uff.br
RI Granjeiro, Jose/D-8289-2012; Oliveira, Rodrigo/E-2551-2012; Cestari,
   Tania/E-7060-2012; Taga, Rumio/E-5794-2012
OI Granjeiro, Jose/0000-0002-8027-8293; Oliveira,
   Rodrigo/0000-0003-3070-5960; 
CR Aichelmann-Reidy M E, 1998, Dent Clin North Am, V42, P491
   BECKER W, 1995, J PERIODONTOL, V66, P822, DOI 10.1902/jop.1995.66.9.822
   Damien C J, 1995, J Biomater Appl, V9, P275
   Davies John E, 2003, J Dent Educ, V67, P932
   Gosain AK, 1997, J CRANIOFAC SURG, V8, P506, DOI 10.1097/00001665-199711000-00017
   HAGEN JW, 1992, J BIOMED MATER RES, V26, P897, DOI 10.1002/jbm.820260706
   HAMMONDS RG, 1991, MOL ENDOCRINOL, V5, P149, DOI 10.1210/mend-5-1-149
   Hartl A, 2004, ACTA ORTHOP SCAND, V75, P217, DOI 10.1080/00016470412331294485
   HERCULIANI PP, 2000, REV BRAS IMPLANT, V7, P7
   ISAKSSON S, 1992, J CRANIO MAXILL SURG, V20, P73, DOI 10.1016/S1010-5182(05)80471-8
   Joshi A, 2004, BRIT DENT J, V196, P215, DOI 10.1038/sj.bdj.4810987
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Marins Lucele Vieira, 2004, J. Appl. Oral Sci., V12, P62, DOI 10.1590/S1678-77572004000100012
   PETTIS GY, 1990, J ORAL MAXIL SURG, V48, P1068, DOI 10.1016/0278-2391(90)90291-9
   Pruss A, 2003, BIOLOGICALS, V31, P287, DOI 10.1016/j.biologicals.2003.08.002
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P503, DOI 10.1034/j.1600-0501.2001.120511.x
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   REDDI AH, 1984, EXTRACELLULAR MATRIX, P375
   SAMPATH TK, 1984, J CELL BIOL, V98, P2192, DOI 10.1083/jcb.98.6.2192
   SAMPATH TK, 1983, P NATL ACAD SCI-BIOL, V80, P6591, DOI 10.1073/pnas.80.21.6591
   URIST MR, 1970, CLIN ORTHOP RELAT R, P271
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1982, CLIN ORTHOP RELAT R, P219
   Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Wozney JM, 1998, EUR J ORAL SCI, V106, P160, DOI 10.1111/j.1600-0722.1998.tb02170.x
   Zhao YF, 1999, INT J ORAL MAX IMPL, V14, P889
NR 28
TC 12
Z9 15
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD AUG
PY 2008
VL 19
IS 8
BP 749
EP 754
DI 10.1111/j.1600-0501.2008.01521.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 324JD
UT WOS:000257514000003
PM 18720554
DA 2018-10-20
ER

PT J
AU Slater, N
   Dasmah, A
   Sennerby, L
   Hallman, M
   Piattelli, A
   Sammons, R
AF Slater, Nicola
   Dasmah, Amir
   Sennerby, Lars
   Hallman, Mats
   Piattelli, Adriano
   Sammons, Rachel
TI Back-scattered electron imaging and elemental microanalysis of retrieved
   bone tissue following maxillary sinus floor augmentation with calcium
   sulphate
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE back-scattered electron imaging; calcium sulphate; energy dispersive
   X-ray analysis; maxillary sinus augmentation; resorption
ID CLINICAL REPORT; GRAFT; DEFECT; REGENERATION; HEMIHYDRATE; SUBSTITUTES;
   PARTICLES; MEMBRANES
AB Objectives: To investigate the presence and composition of residual bone graft substitute material in bone biopsies from the maxillary sinus of human subjects, following augmentation with calcium sulphate (CaS).
   Material and methods: Bone cores were harvested from the maxillary sinus of patients who had undergone a sinus lift procedure using CaS G170 granules 4 months after the initial surgery. Samples from seven patients, which contained residual biomaterial particles, were examined by field emission scanning electron microscopy and energy dispersive X-ray spectroscopy was used to determine the composition of the remaining bone graft substitute material.
   Results: Residual graft material occurred in isolated areas surrounded by bone and consisted of individual particles up to 1 mm in length and smaller spherical granules. On the basis of 187 separate point analyses, the residual material was divided into three categories (A, B and C) consisting of: A, mainly CaS (S/P atomic% ratio >= 2.41); B, a heterogeneous mixture of CaS and calcium phosphate (S/P=0.11-2.4) and C, mainly calcium phosphate (S/P <= 0.11; C), which had a mean Ca : P ratio of 1.63 +/- 0.2, consistent with Ca-deficient hydroxyapatite. Linescans and elemental maps showed that type C material was present in areas which appeared dense and surrounded, or were adjacent to, more granular CaS-containing material, and also occurred as spherical particles. The latter could be disintegrating calcium phosphate in the final stages of the resorption process.
   Conclusions: CaS resorption in the human maxillary sinus is accompanied by CaP precipitation which may contribute to its biocompatibility and rapid replacement by bone.
C1 [Slater, Nicola; Sammons, Rachel] Univ Birmingham, Sch Dent, Birmingham B4 6NN, W Midlands, England.
   [Dasmah, Amir; Sennerby, Lars] Univ Gothenburg, Inst Clin Sci, Dept Biomat, Gothenburg, Sweden.
   [Hallman, Mats] Gavle Cent Hosp, Dept Oral & Maxillofacial Surg, S-80187 Gavle, Sweden.
   [Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Pescara, Italy.
RP Sammons, R (reprint author), Univ Birmingham, Sch Dent, St Chads Queensway, Birmingham B4 6NN, W Midlands, England.
EM r.l.sammons@bham.ac.uk
OI Sammons, Rachel/0000-0002-4787-048X
CR Atilgan S, 2007, BIOTECHNOL BIOTEC EQ, V21, P205, DOI 10.1080/13102818.2007.10817446
   Bier S J, 1999, Compend Contin Educ Dent, V20, P655
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   De Leonardis D, 1999, INT J ORAL MAX IMPL, V14, P869
   De Leonardis D, 2000, J PERIODONTOL, V71, P940
   DIBATTISTA P, 1995, J PERIODONTOL, V66, P673, DOI 10.1902/jop.1995.66.8.673
   DUCHEYNE P, 1992, BONE BONDING BIOMATE, P1
   Guarnieri R, 2006, INT J PERIODONT REST, V26, P79
   Guarnieri R, 2004, J PERIODONTOL, V75, P902, DOI 10.1902/jop.2004.75.6.902
   Guarnieri R, 2002, INT J PERIODONT REST, V22, P503
   KOKUBO T, 1992, BONE BONDING BIOMATE, P31
   Lazary A, 2007, BIOMATERIALS, V28, P393, DOI 10.1016/j.biomaterials.2006.09.002
   MacNeill SR, 1999, J CLIN PERIODONTOL, V26, P239, DOI 10.1034/j.1600-051X.1999.260407.x
   Mamidwar SS, 2007, J BIOMED MATER RES B, V81B, P57, DOI 10.1002/jbm.30636
   Maragos P, 2002, INT J PERIODONT REST, V22, P493
   Orsini G, 2004, J BIOMED MATER RES B, V68B, P199, DOI 10.1002/jbm.b.20012
   Orsini M, 2001, J PERIODONTOL, V72, P296, DOI 10.1902/jop.2001.72.3.296
   Pecora G, 2001, INT ENDOD J, V34, P189, DOI 10.1046/j.1365-2591.2001.00369.x
   Pecora G, 1997, Dent Clin North Am, V41, P585
   Pecora G, 1997, ORAL SURG ORAL MED O, V84, P424, DOI 10.1016/S1079-2104(97)90043-3
   Pecora GE, 1998, INT J ORAL MAX IMPL, V13, P866
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   Ricci JL, 2000, BONE ENG, P332
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   SIDQUI M, 1995, BIOMATERIALS, V16, P1327, DOI 10.1016/0142-9612(95)91048-4
   Strocchi Rita, 2002, J Oral Implantol, V28, P273, DOI 10.1563/1548-1336(2002)028<0273:BRWCSE>2.3.CO;2
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   TRAINI T, 2008, CLIN IMPLANT DENTIST
   Turner TM, 2003, ORTHOPEDICS, V26, pS577
   Walsh WR, 2003, CLIN ORTHOP RELAT R, P228, DOI 10.1097/01.blo.0000030062.92399.6a
   Yoshikawa G, 2002, INT ENDOD J, V35, P255, DOI 10.1046/j.1365-2591.2002.00473.x
NR 31
TC 17
Z9 17
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD AUG
PY 2008
VL 19
IS 8
BP 814
EP 822
DI 10.1111/j.1600-0501.2008.01550.x
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 324JD
UT WOS:000257514000012
PM 18705813
DA 2018-10-20
ER

PT J
AU Hryniewicz, T
   Rokicki, R
   Rokosz, K
AF Hryniewicz, T.
   Rokicki, R.
   Rokosz, K.
TI Corrosion characteristics of medical-grade AISI Type 316L stainless
   steel surface after electropolishing in a magnetic field
SO CORROSION
LA English
DT Article
DE corrosion resistance; magnetoelectropolishing; stainless steel
AB Stainless steel materials are widely used for multiple applications because of their good mechanical properties and very good corrosion resistance in a number of environments. They are also used as biomaterials to manufacture conventional and novel medical devices. The stability of the surface oxide layer is one of the most important features of a biomaterial. Electrochemical polishing (EP) is the most extensively used surface technology for stainless steel. We have improved this surface technology by introducing a magnetic field. With a new process called magnetoelectropolishing (MEP) we can improve metal surface properties by making the stainless steel more resistant to halides encountered in a variety of body fluids, such as blood, saliva, urine, etc. Corrosion research results are presented on the behavior of the most commonly used material-medical-grade AISI Type 316L (UNS S31603) stainless steel-applied for human body implants, stents, and devices. Three basic environments have been adopted for the studies: pure distilled water, the Ringer's body fluid, and 3% sodium chloride (NaCl) aqueous solution (the most aggressive environment). The study results cover open-circuit potential and polarization curve characteristics of austenitic stainless steels (Types 304 [UNS S30400], 304L [UNS S30403], 316 [UNS S31600], and 316L), and a ferritic stainless steel (Type 430 [UNS S43000]). The comparison of the corrosion behavior of the stainless steels' surface after two electropolishing processes carried out in the absence (EP) and presence of the magnetic field (MEP) is reported. The experiments were carried out at room temperature (25 degrees C). It has been found that the proposed MEP process shifts the corrosion potentials into the direction of greater corrosion resistance.
C1 [Hryniewicz, T.; Rokosz, K.] Koszalin Univ Technol, PL-75620 Koszalin, Poland.
   [Rokicki, R.] Electrobright, Macungie, PA 18062 USA.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM tadeusz.hryniewicz@tu.koszalin.pl
CR Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz T, 2008, SURF COAT TECH, V202, P1668, DOI 10.1016/j.surfcoat.2007.07.067
   HRYNIEWICZ T, 1989, MONOGRAPH KOSZALIN U, V26, P50
   HRYNIEWICZ T, 2007, P 16 INT MET MAT C M, P1
   HRYNIEWICZ T, 2006, COMP AUGER STUDIES 3
   HRYNIEWICZ T, 2005, ELECTROCHEMISTRY SUR, P127
   Hryniewicz T., 2007, P 15 ANN INT C COMP, P345
   HRYNIEWICZ T, 2007, P 10 SLUPSK AUT FOR, P141
   ROKICKI R, 2006, MED DEVICE DIAGN IND, V3, P1
   ROKICKI R, 2006, Patent No. 2006124472
   Sedriks A.J., 1996, CORROSION STAINLESS, P13
   SELVADURAY G, 2005, P C MAT ALS PROC MED
NR 12
TC 35
Z9 35
U1 2
U2 9
PU NATL ASSOC CORROSION ENG
PI HOUSTON
PA 1440 SOUTH CREEK DRIVE, HOUSTON, TX 77084-4906 USA
SN 0010-9312
J9 CORROSION
JI Corrosion
PD AUG
PY 2008
VL 64
IS 8
BP 660
EP 665
DI 10.5006/1.3279927
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 333UT
UT WOS:000258178800005
DA 2018-10-20
ER

PT J
AU Broekhuizen, CAN
   Schultz, MJ
   van der Wal, AC
   Boszhard, L
   de Boer, L
   Vandenbroucke-Grauls, CMJE
   Zaat, SAJ
AF Broekhuizen, Corine A. N.
   Schultz, Marcus J.
   van der Wal, Allard C.
   Boszhard, Laura
   de Boer, Leonie
   Vandenbroucke-Grauls, Christina M. J. E.
   Zaat, Sebastian A. J.
TI Tissue around catheters is a niche for bacteria associated with medical
   device infection
SO CRITICAL CARE MEDICINE
LA English
DT Article
DE biomaterial-associated infection; pathogenesis; Staphylococcus
   epidermidis; catheter; Enterococcus faecalis; tissue
ID CENTRAL VENOUS CATHETERS; RANDOMIZED CONTROLLED-TRIAL; TRANSMISSION
   ELECTRON-MICROSCOPY; ANTISEPTIC-IMPREGNATED CATHETERS; SUBCUTANEOUS
   ABSCESS FORMATION; CRITICALLY-ILL PATIENTS; FOREIGN-BODY INFECTION;
   INTENSIVE-CARE-UNIT; STAPHYLOCOCCUS-EPIDERMIDIS; SILVER SULFADIAZINE
AB Objective. To investigate whether pericatheter tissue is an additional niche for bacteria potentially causing catheter-associated infections in humans.
   Design: Postmortem patient study.
   Setting: Intensive care unit, autopsy room, and microbiological laboratory in a university hospital.
   Patients: Eighteen deceased patients from whom 35 catheters plus surrounding tissues were collected.
   Interventions: Under axenic conditions catheters and surrounding tissue were excised from deceased intensive care unit patients. The excised parts of the catheters and samples of surrounding tissue were quantitatively cultured and bacteria identified, and tissue histology/immunohistochemistry was performed.
   Measurements and main results. Nine of the 35 (26%) pericatheter tissue samples tested were highly culture positive. The corresponding catheter segments were culture negative or yielded only low numbers of bacteria. Bacteria cultured from different sites of the catheter and surrounding tissues almost all were coagulase-negative staphylococci (predominantly Staphylococcus epidermidis) and Enterococcus faecalis. In histology, bacteria were seen in tissue, intercellularly and associated with host phagocytes.
   Conclusions. Tissue surrounding biomedical devices forms a niche for bacteria. This is an as yet nonrecognized element in the pathogenesis of catheter-associated infections, with possible consequences for strategies of prevention and treatment of these infections.
C1 [Broekhuizen, Corine A. N.; Boszhard, Laura; de Boer, Leonie; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
   [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands.
   [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands.
   [van der Wal, Allard C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.
   [Vandenbroucke-Grauls, Christina M. J. E.] VU Med Ctr, Dept Med Microbiol & Infect Dis, Amsterdam, Netherlands.
RP Broekhuizen, CAN (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM s.a.zaat@amc.uva.nl
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Anderson JM, 2000, INFECT ASS INDWELLIN, P89, DOI 10.1128/9781555818067.ch5
   ARCHER GL, 2005, MANDELL DOUGLAS BENN, P2352
   Beekmann SE, 2005, MANDELL DOUGLAS BENN, P3347
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bouza E, 2005, CRIT CARE MED, V33, P1953, DOI 10.1097/01.CCM.0000171842.63887.C1
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Brun-Buisson C, 2004, INTENS CARE MED, V30, P837, DOI 10.1007/s00134-004-2221-9
   Caplan MJ, 2001, CUMITECH 35 POSTMORT
   COBB DK, 1992, NEW ENGL J MED, V327, P1062, DOI 10.1056/NEJM199210083271505
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2005, ANN SURG, V242, P193, DOI 10.1097/01.sla.0000171874.29934.61
   DEJONGH DS, 1968, AM J CLIN PATHOL, V49, P424
   Dunser MW, 2005, ANESTH ANALG, V101, P1778, DOI 10.1213/01.ANE.0000184200.40689.EB
   El-Azizi Mohamed, 2005, Ann Clin Microbiol Antimicrob, V4, P2, DOI 10.1186/1476-0711-4-2
   Garland JS, 2002, PEDIATRICS, V110, P1009, DOI 10.1542/peds.110.5.1009
   Goetz AM, 1998, INFECT CONT HOSP EP, V19, P842
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gotz F, 2000, INFECT ASS INDWELLIN, P55
   Hannan M, 1999, ANAESTHESIA, V54, P868
   HASLETT TM, 1988, J CLIN MICROBIOL, V26, P696
   Heard SO, 1998, ARCH INTERN MED, V158, P81, DOI 10.1001/archinte.158.1.81
   KURTIN JJ, 1958, AM J CLIN PATHOL, V30, P239, DOI 10.1093/ajcp/30.3.239
   MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301
   MARRIE TJ, 1983, J CLIN MICROBIOL, V18, P1388
   MARRIE TJ, 1984, J CLIN MICROBIOL, V19, P687
   Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700
   Morris JA, 2006, J CLIN PATHOL, V59, P1, DOI 10.1136/jcp.2005.028183
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Osma S, 2006, J HOSP INFECT, V62, P156, DOI 10.1016/j.jhin.2005.06.030
   OSTERHOLM MT, 2005, MANDELL DOUGLAS BENN, P161
   PASSERINI L, 1992, CRIT CARE MED, V20, P665, DOI 10.1097/00003246-199205000-00020
   Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74
   RAAD I, 1995, ANTIMICROB AGENTS CH, V39, P2397, DOI 10.1128/AAC.39.11.2397
   RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501
   REZNICEK MJ, 1994, CLIN LAB MED, P1349
   Safdar N, 2002, MEDICINE, V81, P466, DOI 10.1097/00005792-200211000-00007
   Schmitt SK, 1996, J CLIN MICROBIOL, V34, P508
   SHERERTZ RJ, 1990, J CLIN MICROBIOL, V28, P76
   VIRDEN CP, 1992, AESTHET PLAST SURG, V16, P173, DOI 10.1007/BF00450610
   von Eiff C, 1999, INFECTION, V27, pS7, DOI 10.1007/BF02561610
   Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 46
TC 24
Z9 25
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0090-3493
J9 CRIT CARE MED
JI Crit. Care Med.
PD AUG
PY 2008
VL 36
IS 8
BP 2395
EP 2402
DI 10.1097/CCM.0b013e3181818268
PG 8
WC Critical Care Medicine
SC General & Internal Medicine
GA 335DN
UT WOS:000258271100025
PM 18664789
DA 2018-10-20
ER

PT J
AU Brunot, C
   Grosgogeat, B
   Picart, C
   Lagneau, C
   Jaffrezic-Renault, N
   Ponsonnet, L
AF Brunot, C.
   Grosgogeat, B.
   Picart, C.
   Lagneau, C.
   Jaffrezic-Renault, N.
   Ponsonnet, L.
TI Response of fibroblast activity and polyelectrolyte multilayer films
   coating titanium
SO DENTAL MATERIALS
LA English
DT Article
DE titanium; polyelectrolyte multilayer films; surface roughness; dynamic
   contact angle (DCA); wettability; hysteresis (H); atomic force
   microscopy (AFM); human fibroblasts; cell response
ID QUARTZ-CRYSTAL MICROBALANCE; OSSEOINTEGRATED ORAL IMPLANTS;
   CONTACT-ANGLE HYSTERESIS; CELL-ADHESION PROPERTIES; THIN-FILMS;
   BIOMEDICAL APPLICATIONS; IMPEDANCE MEASUREMENTS; SURFACE MODIFICATION;
   EXPONENTIAL-GROWTH; ENDOTHELIAL-CELLS
AB Objectives. The study of surface properties is a recent and crucial issue in the biomaterial fields applied to Odontology. The reference biomaterial in dental implantology is titanium. The principal objective is a perfect bio-integration in the oral ecosystem, both in terms of mucosal and bone tissues. The aim of this work was to optimize the tissue-titanium interface by applying polyelectrolyte multilayer films on the surface of titanium.
   Methods. The experimental study was undertaken on pure titanium samples. Two types of film ending with polycations or polyanions were selected. Both film types were built with a first poly(ethyleneimine) (PEI) base layer and composed either of poly(styrene sulfonate) (PSS) and poly(allylamine hydrochloride) (PAH) or of hyaluronic acid (HA) and poly(L-lysine) (PLL) layers. Final architectures were as follows: PEI-(PSS/PAH)(10), or PEI-(PSS/PAH)(10)-PSS, or chemically cross-linked PEI-(HA/PLL)(10) or PEI-(HA/PLL)(10)-HA. An analysis of the physicochemical characteristics of the surfaces was carried out by tensiometry measurements (dynamic contact angle, wettability, contact angle hysteresis) and atomic force microscopy. A biological study with human fibroblasts was followed over a 7-day culture period at days 0, 2, 4 and 7 to observe the cellular response in terms of morphology (scanning electron microscopy) and viability (Mosmann's test).
   Results. The results showed that polyelectrolyte multilayer films could be successfully deposited onto titanium as previously described for glass or composite. Fibroblast adhesion and proliferation was strongly dependent on film type. SEM observations of cells on the different films agreed with the viability cell test. Furthermore, films containing PSS/PAH generated a better cellular response than films containing cross-linked HA/PLL.
   Conclusion. PSS/PAH polyelectrolyte films coating titanium could represent a new approach for oral bio-integration with great potential for clinical application in the fields of dental implantology. More particularly, the specific biofunctionalization of PSS/PAH films coating titanium could be envisioned by introducing layers of molecules that encourage the bio-integration process between the films. (c) 2007 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Brunot, C.; Grosgogeat, B.; Lagneau, C.] Univ Lyon 1, Fac Odontol, Lab Multimat & Interfaces, UMR CNRS 5615, F-69372 Lyon 08, France.
   [Brunot, C.; Grosgogeat, B.] Hosp Civils Lyon, Serv Consultat & Traitements Dentaires, F-69365 Lyon, France.
   [Picart, C.] Univ Montpellier 2, Lab Dynam Mol Interact Membranaires, CNRS UMR 5235, F-34095 Montpellier 05, France.
   [Jaffrezic-Renault, N.] Univ Lyon 1, Sci Analyt Lab, UMR CNRS 5180, F-69622 Villeurbanne, France.
   [Ponsonnet, L.] Univ Rouen, Lab Polymeres Biopolymeres Membranes, CNRS UMR 6522, F-76821 Mont St Aignan, France.
RP Brunot, C (reprint author), Univ Lyon 1, Fac Odontol, Lab Multimat & Interfaces, UMR CNRS 5615, Rue Guillaume Paradin, F-69372 Lyon 08, France.
EM cbrunot.gohin@orange.fr; grosgogeat@sante.univ-lyon1.fr
OI PICART, Catherine/0000-0002-4854-6366; PICART,
   Catherine/0000-0003-0130-1000
CR Abrahamsson I, 2002, J CLIN PERIODONTOL, V29, P448, DOI 10.1034/j.1600-051X.2002.290510.x
   Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Ai H, 2003, J NEUROSCI METH, V128, P1, DOI 10.1016/S0165-0270(03)00191-2
   ANDRADE J, 1983, CONTACT ANGLE INTERF, P249
   Antunes FE, 2004, LANGMUIR, V20, P4647, DOI 10.1021/la049783i
   Bearinger JP, 2003, BIOMATERIALS, V24, P1837, DOI 10.1016/S0142-9612(02)00547-1
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026
   Burke SE, 2003, BIOMACROMOLECULES, V4, P1773, DOI 10.1021/bm034184w
   Buron CC, 2006, J COLLOID INTERF SCI, V296, P409, DOI 10.1016/j.jcis.2005.09.034
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Chen JY, 2001, J COLLOID INTERF SCI, V238, P62, DOI 10.1006/jcis.2001.7460
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Duran A, 2004, J MATER CHEM, V14, P2282, DOI 10.1039/b401370k
   Eisenbarth E, 2002, BIOMOL ENG, V19, P243, DOI 10.1016/S1389-0344(02)00032-1
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   Etienne O, 2006, J DENT RES, V85, P44, DOI 10.1177/154405910608500107
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Fussell GW, 2004, BIOMATERIALS, V25, P2971, DOI 10.1016/j.biomaterials.2003.09.062
   Garza JM, 2005, LANGMUIR, V21, P12372, DOI 10.1021/la051465b
   Gergely C, 2004, LANGMUIR, V20, P5575, DOI 10.1021/la049932x
   Halthur TJ, 2004, LANGMUIR, V20, P1739, DOI 10.1021/la035475t
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P169
   Hermitte L, 2004, J COLLOID INTERF SCI, V272, P82, DOI 10.1016/j.jcis.2003.08.055
   Jain R, 2003, J INVEST SURG, V16, P263, DOI 10.1080/08941930390230388
   JAIN R, 2004, J BIOMED MATER RES, V1, P296
   Keller John C, 2003, Implant Dent, V12, P175
   Kim HJ, 2005, LANGMUIR, V21, P8532, DOI 10.1021/la0511182
   Kolasinska M, 2005, BIOELECTROCHEMISTRY, V66, P65, DOI 10.1016/j.bioelechem.2004.03.009
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Mhamdi L, 2006, MAT SCI ENG C-BIO S, V26, P273, DOI 10.1016/j.msec.2005.10.049
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Pavoor PV, 2006, BIOMATERIALS, V27, P1527, DOI 10.1016/j.biomaterials.2005.08.022
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Picart C, 2004, J PHYS CHEM B, V108, P7196, DOI 10.1021/jp037971w
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Ren KF, 2005, COLLOID SURFACE B, V46, P63, DOI 10.1016/j.colsurfb.2005.09.004
   Richards R. G., 1996, Injury, V27, pSC38
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2006, CELL BIOCHEM BIOPHYS, V44, P273, DOI 10.1385/CBB:44:2:273
   Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178
   RUGGE CD, 1993, J PHYS CHEM-US, V97, P8776, DOI 10.1021/j100136a021
   Rupp F, 2002, CHEM ENG TECHNOL, V25, P877, DOI 10.1002/1521-4125(20020910)25:9<877::AID-CEAT877>3.0.CO;2-D
   Sabot A, 2002, ANAL CHEM, V74, P3304, DOI 10.1021/ac0200724
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Schultz P, 2005, BIOMATERIALS, V26, P2621, DOI 10.1016/j.biomaterials.2004.06.049
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   TSUTSUI T, 1973, JPN J MED SCI BIOL, V26, P169, DOI 10.7883/yoken1952.26.169
   van den Beucken JJJP, 2006, J BIOMED MATER RES A, V77A, P202, DOI 10.1002/jbm.a.30583
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Yang SY, 2002, J AM CHEM SOC, V124, P2100, DOI 10.1021/ja017681y
   Zhu YB, 2003, BIOMACROMOLECULES, V4, P446, DOI 10.1021/bm025723k
NR 63
TC 39
Z9 39
U1 0
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD AUG
PY 2008
VL 24
IS 8
BP 1025
EP 1035
DI 10.1016/j.dental.2007.11.022
PG 11
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 330YN
UT WOS:000257978800003
PM 18237774
DA 2018-10-20
ER

PT J
AU Zavan, B
   Vindigni, V
   Lepidi, S
   Iacopetti, I
   Avruscio, G
   Abatangelo, G
   Cortivo, R
AF Zavan, Barbara
   Vindigni, Vincenzo
   Lepidi, Sandro
   Iacopetti, Ilaria
   Avruscio, Giampiero
   Abatangelo, Giovanni
   Cortivo, Roberta
TI Neoarteries grown in vivo using a tissue-engineered hyaluronan-based
   scaffold
SO FASEB JOURNAL
LA English
DT Article
DE elastin; vascular prosthesis; remodeling; surgery
ID SMOOTH-MUSCLE-CELLS; ADULT ARTERIAL REVASCULARIZATION; CULTURED VASCULAR
   CELLS; BLOOD-VESSEL; ENDOTHELIAL-CELLS; ELASTIN; GRAFTS; MORPHOGENESIS;
   AUTOGRAFTS; MODEL
AB Vascular tissue engineering has emerged as a promising technology for the design of an ideal, responsive, living conduit with properties similar to that of native tissue. The missing link in tissue-engineered blood vessels is elastin biosynthesis. Several biomaterials are currently used but few support elastin biosynthesis in a 3-D array. In previous studies, we demonstrated that a hyaluronan-based scaffold (HYAFF-11 (TM)) grafted in the infrarenal rat aorta successfully guided the complete regeneration of a well-functioning small-diameter (2 mm) neoartery. The aim of the present study was to test the ability of HYAFF-11 biodegradable grafts to develop into neovessels of larger size (4 mm) in a porcine model, focusing on extracellular matrix (ECM) remodeling and elastin biosynthesis. HYAFF-11 tubes (diameter 4 mm, length 5 cm) were implanted in an end-to-end fashion in the common carotid artery. Grafts were analyzed for patency with a Duplex scan every 15 days. ECM components were evaluated by histological and molecular biological methods. All the animals survived the observation period without complications. Intimal hyperplasia (initiating at the anastomotic site) and graft thrombosis led to 3 cases of partial or complete occlusion, as demonstrated by histological examination. There were no signs of stenoses or aneurysms in the remaining grafts. After 5 months, the biomaterial was almost completely degraded and replaced by a neoartery segment composed of mature smooth muscle cells, collagen, and elastin fibers organized in layers and was completely covered on the luminal surface by endothelial cells (vWF(+)). Whereas in previous small animal studies, patency rates were not optimal, those obtained in the present study using hyaluronan-based grafts of larger size confirmed the ability of these constructs to guide the development of a well-functioning neoartery, with the remarkable additional attribute of facilitating the formation of organized layers of elastin fibers.
C1 [Vindigni, Vincenzo] Univ Padua, Clin Plast Surg, I-35100 Padua, Italy.
   [Zavan, Barbara; Abatangelo, Giovanni; Cortivo, Roberta] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy.
   [Lepidi, Sandro] Univ Padua, Clin Vasc Surg, I-35100 Padua, Italy.
   [Avruscio, Giampiero] Univ Padua, Unit Angiol, I-35100 Padua, Italy.
   [Iacopetti, Ilaria] Univ Padua, Dept Vet Sci, I-35100 Padua, Italy.
RP Vindigni, V (reprint author), Univ Padua, Clin Plast Surg, Via Giustiniani 2, I-35100 Padua, Italy.
EM vincenzo.vindigni@unipd.it
OI Vindigni, Vincenzo/0000-0001-6638-9010
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Joddar B, 2007, BIOMATERIALS, V28, P3918, DOI 10.1016/j.biomaterials.2007.05.019
   Joddar B, 2006, BIOMATERIALS, V27, P5698, DOI 10.1016/j.biomaterials.2006.07.020
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Kerdjoudj H, 2007, CLIN HEMORHEOL MICRO, V37, P89
   Kielty CM, 2002, J CELL SCI, V115, P2817
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Lepidi S, 2006, EUR J VASC ENDOVASC, V32, P411, DOI 10.1016/j.ejvs.2006.02.012
   LEPIDI S, 2006, FASEB J, V20, P103, DOI DOI 10.1096/FJ.05-4802FJE
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Mann BK, 2001, ANAT REC, V263, P367, DOI 10.1002/ar.1116
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   *NAT RES COUNC, 1996, GUID CAR US LAB
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Ratcliffe A, 2000, MATRIX BIOL, V19, P353, DOI 10.1016/S0945-053X(00)00080-9
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   VESCOVO G, 1996, BASIC APPL MYOL, V6, P183
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P449, DOI 10.1016/S1010-7940(00)00371-7
   Zhang WJ, 2007, J CELL MOL MED, V11, P945, DOI 10.1111/j.1582-4934.2007.00099.x
NR 28
TC 38
Z9 38
U1 0
U2 15
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD AUG
PY 2008
VL 22
IS 8
BP 2853
EP 2861
DI 10.1096/fj.08-107284
PG 9
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 332NI
UT WOS:000258089300025
PM 18385214
DA 2018-10-20
ER

PT J
AU Kim, MS
   Kwon, B
   Park, MS
   Ji, GE
AF Kim, Mi Soon
   Kwon, Bin
   Park, Myeong Soo
   Ji, Geun Eog
TI Isolation of ginsenoside Rh1 and compound K from fermented ginseng and
   efficacy assessment on systemic anaphylactic shock
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Article
DE anaphylactic shock model; compound K; ginsenoside Rh1
ID INTESTINAL BACTERIAL METABOLITE; B-16 MELANOMA-CELLS; PANAX-GINSENG;
   DRACOCEPHALUM-ARGUNENSE; ALLERGIC REACTIONS; METASTASIS; SAPONINS; ACID;
   RB-1; RB1
AB Ginsenosides are responsible for the pharmacological and biological activities of ginseng. In this study, ginsenoside Rh1 and compound K were isolated and purified from fermented ginseng substrate and their anti-allergic effects were assessed in compound 48/80-induced anaphylactic shock model. The fermented ginseng substrate was extracted by methanol and ginsenoside Rh1 and compound K were efficiently purified by preparative high performance liquid chromatography (prep HPLC). Their quality and quantity were analyzed by liquid chromatography-mass spectrometer (LC-MS) and HPLC. Ginsenoside Rh1 showed better anti-allergic effects than compound K in compound 48/80-induced anaphylactic shock model, This study suggested that fermented ginseng extracts with enriched Rh1 may be utilized as a potential biomaterial of functional food for the alleviation of allergic symptoms.
C1 [Kim, Mi Soon; Ji, Geun Eog] Seoul Natl Univ, Dept Food & Nutr, Res Inst Human Ecol, Seoul 151742, South Korea.
   [Kwon, Bin; Park, Myeong Soo; Ji, Geun Eog] Bifido Inc, Res Ctr, Hongcheon 250804, Gangwon, South Korea.
   [Park, Myeong Soo] Anyang Tech Coll, Dept Hotel Culinary Art, Anyang 430749, Gyeonggi, South Korea.
RP Ji, GE (reprint author), Seoul Natl Univ, Dept Food & Nutr, Res Inst Human Ecol, Seoul 151742, South Korea.
EM geji@snu.ac.kr
FU Small & Medium Business Administration; Ministry of Science and
   Technology, Korea [MI-0302-00-0098]
FX This work was supported by the Small & Medium Business Administration
   and the Ministry of Science and Technology (MI-0302-00-0098), Korea.
CR Akao T, 1998, J PHARM PHARMACOL, V50, P1155, DOI 10.1111/j.2042-7158.1998.tb03327.x
   Attele AS, 2002, DIABETES, V51, P1851, DOI 10.2337/diabetes.51.6.1851
   Cheng Y, 2005, ACTA PHARMACOL SIN, V26, P143, DOI 10.1111/j.1745-7254.2005.00034.x
   Chi H, 2006, J MICROBIOL BIOTECHN, V16, P1629
   Hasegawa H, 2004, J PHARMACOL SCI, V95, P153, DOI 10.1254/jphs.FMJ04001X4
   Hasegawa H, 1998, PLANTA MED, V64, P696, DOI 10.1055/s-2006-957560
   Huong NTT, 1998, BIOL PHARM BULL, V21, P978
   Jeong HJ, 2001, IMMUNOPHARM IMMUNOT, V23, P107, DOI 10.1081/IPH-100102572
   Jiang S, 2007, BIOL PHARM BULL, V30, P1707, DOI 10.1248/bpb.30.1707
   Kim SH, 2006, BIOL PHARM BULL, V29, P494, DOI 10.1248/bpb.29.494
   Kim SH, 2006, INT ARCH ALLERGY IMM, V139, P87, DOI 10.1159/000090383
   Kim XY, 2008, FOOD SCI BIOTECHNOL, V17, P184
   Lee JY, 2005, CARCINOGENESIS, V26, P359, DOI 10.1093/carcin/bgh313
   MOCHIZUKI M, 1995, BIOL PHARM BULL, V18, P1197
   ODASHIMA S, 1985, CANCER RES, V45, P2781
   OTA T, 1987, CANCER RES, V47, P3863
   Park EK, 2005, BIOL PHARM BULL, V28, P652, DOI 10.1248/bpb.28.652
   Park EK, 2004, INT ARCH ALLERGY IMM, V133, P113, DOI 10.1159/000076383
   Park M. T., 1998, J GINSENG RES, V22, P216
   SATO K, 1994, BIOL PHARM BULL, V17, P635
   SHIN JE, 2003, J GINSENG RES, V27, P129
   Tawab MA, 2003, DRUG METAB DISPOS, V31, P1065, DOI 10.1124/dmd.31.8.1065
   Wakabayashi C, 1998, BIOCHEM BIOPH RES CO, V246, P725, DOI 10.1006/bbrc.1998.8690
   Yang SO, 2006, FOOD SCI BIOTECHNOL, V15, P363
   Zhang Xin-mu, 2004, Zhongguo Zhongyao Zazhi, V29, P1085
NR 25
TC 6
Z9 6
U1 0
U2 3
PU KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST
PI SEOUL
PA #605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL,
   135-703, SOUTH KOREA
SN 1226-7708
EI 2092-6456
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD AUG
PY 2008
VL 17
IS 4
BP 805
EP 808
PG 4
WC Food Science & Technology
SC Food Science & Technology
GA 343QZ
UT WOS:000258870200021
DA 2018-10-20
ER

PT J
AU Koh, LB
   Rodriguez, I
   Zhou, JJ
AF Koh, Li Buay
   Rodriguez, Isabel
   Zhou, Jijie
TI Platelet adhesion studies on nanostructured
   poly(lactic-co-glycolic-acid)-carbon nanotube composite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE carbon nanotubes; PLGA; platelets; plasma proteins; fibrinogen
ID DIAMOND-LIKE CARBON; MECHANICAL-PROPERTIES; BLOOD COMPATIBILITY;
   POLYELECTROLYTES; BIOCOMPATIBILITY; ASSEMBLIES; SURFACES; COATINGS;
   FILMS; CELL
AB Design of blood-compatible surfaces is required to minimize platelet-surface interactions and increase the thromboresistance of foreign surfaces. Poly(lactic-co-glycolic-acid)-carbon nanotube (PLGA-CNT) composite is studied as a building material to fabricate artificial blood prostheses. This nanocomposite-based biomaterial is prepared by an electrostatic Layer-by-Layer (LbL) deposition technique, in which layers of CNTs are adsorbed onto a PLGA film. Before incubation in nonstimulated platelet-rich plasma (PRP) for platelet studies, fibrinogen is immobilized on PLGA-CNT composite. Interactions between the plasma proteins, e.g. fibrinogen and PRP, are investigated on the prepared PLGA-CNT composite. Contact angle measurements on the PLGA-CNT composite displayed a good resistance of platelets adhesion on a hydrophilic surface with an angle of 64.94 degrees as compared to pristine PLGA control with an angle of 93.43 degrees. A significant reduction of adhesion is observed on the PLGA-CNT composite, as well as the absence of platelet activation. On the contrary, both platelet adhesion and activation are observed on control samples. We inferred this suppression in secretion of granule contents in the platelet by the presence of the CNTs that resulted in the absence of platelet activation and its subsequent inhibition in the release of adhesive membrane receptors on the PLGA-CNT composite. (C) 2007 Wiley Periodicals, Inc.
C1 [Koh, Li Buay; Zhou, Jijie] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore.
   [Rodriguez, Isabel] Inst Mat Res & Engn, Micro & Nano Syst Cluster, Singapore, Singapore.
RP Zhou, JJ (reprint author), 50 Nanyang Ave,N4-1-01, Singapore 639798, Singapore.
EM JjZhou@ntu.edu.sg
RI Zhou, Jijie/A-1962-2012; Rodriguez, Isabel/G-3178-2016; KOH, Li
   Buay/R-8919-2016; Koh, Li Buay/D-7130-2011
OI Rodriguez, Isabel/0000-0002-7178-8275; 
CR Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Calvert P, 1999, NATURE, V399, P210, DOI 10.1038/20326
   Chen JY, 2001, J COLLOID INTERF SCI, V238, P62, DOI 10.1006/jcis.2001.7460
   Cochin D, 1999, MACROMOL CHEM PHYSIC, V200, P609, DOI 10.1002/(SICI)1521-3935(19990301)200:3<609::AID-MACP609>3.0.CO;2-X
   Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Endo M, 2005, NANO LETT, V5, P101, DOI [10.1021/nl0482635, 10.1012/nl0482635]
   FENG L, 1995, STRUCTURE ADSORPTION, P66
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Khang G, 1997, BIO-MED MATER ENG, V7, P357
   KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329
   Kolarik L, 1999, LANGMUIR, V15, P8265, DOI 10.1021/la990413h
   Kong H, 2005, POLYMER, V46, P2472, DOI 10.1016/j.polymer.2005.01.037
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Mamalis AG, 2007, J MATER PROCESS TECH, V181, P52, DOI 10.1016/j.jmatprotec.2006.03.052
   Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747
   MEHRISHI JN, 1970, NATURE, V226, P452, DOI 10.1038/226452a0
   Meng J, 2005, J BIOMED MATER RES A, V74A, P208, DOI 10.1002/jbm.a.30315
   Meng J, 2005, NANOMED-NANOTECHNOL, V1, P136, DOI 10.1016/j.nano.2005.03.003
   Mickelson ET, 1999, J PHYS CHEM B, V103, P4318, DOI 10.1021/jp9845524
   Milthorpe B., 2005, SURFACES INTERFACES, P763
   Sick PB, 2004, AM J CARDIOL, V93, P1351, DOI 10.1016/j.amjcard.2004.02.029
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   Sun TL, 2005, SMALL, V1, P959, DOI 10.1002/smll.200500095
   Tjong SC, 2006, MAT SCI ENG R, V53, P73, DOI 10.1016/j.mser.2006.06.001
   von Klitzing R, 2006, PHYS CHEM CHEM PHYS, V8, P5012, DOI 10.1039/b607760a
   Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299
   Zhu J, 2003, NANO LETT, V3, P1107, DOI 10.1021/nl0342489
NR 28
TC 22
Z9 22
U1 1
U2 20
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2008
VL 86A
IS 2
BP 394
EP 401
DI 10.1002/jbm.a.31605
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 323MM
UT WOS:000257450200011
PM 17969028
DA 2018-10-20
ER

PT J
AU Zhu, AP
   Zhao, F
   Fang, N
AF Zhu, Ai-Ping
   Zhao, Feng
   Fang, Ning
TI Regulation of vascular smooth muscle cells on poly(ethylene
   terephthalate) film by O-carboxymethylchitosan surface immobilization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE PET; surface modification; O-carboxymethylchitosan; regulation; vascular
   smooth muscle cells
ID ADHESION CONTACT DYNAMICS; BEHAVIOR IN-VITRO; PROTEIN ADSORPTION;
   CHITOSAN FILMS; BIOMATERIALS; HYDROPHOBICITY; FIBROBLASTS; APOPTOSIS;
   CULTURE; GROWTH
AB Specifying the chemical environment of cells is a well-established method of controlling cellular behaviors. In this study, poly(ethylene terephthalate) (PET) film was selected as a typical biomaterial to detect the effects of chemical modifications on material surface in controlling cell behaviors. Natural biopolymer chitosan and its biocompatible derivative, O-carboxymethylchitosan (OCMCS) were surface immobilized on PET, respectively, via argon plasma followed by graft copolymerization with acrylic acid (AAc), which was exploited to covalently couple PET with chitosan (CS) and OCMCS molecules. Smooth muscle cells (SMCs) displayed a surface-dependent cell spreading and cytoskeletal organization. The cells spread with a more pronounced elongated spindle shape, smaller cell area, and lower cell shape index (CSI) on OCMCS-modified PET surface than on PET, or the PAA and chitosan-immobilized PET surfaces after 24 h of culture. Cell-culture viability after 5 days showed that all the modified materials possessed good cell proliferation. Our results suggest that cell adhesion, morphology, and growth can be mediated not only by varying the functional groups, electric charge, and wettability of PET surface but also by the specific biological recognition elicited from the biomaterials. These findings strongly support the concept that the microenvironment significantly influences cell behavior, highlighting the importance of environmental material biochemistry in cell-based tissue engineering schemes. (C) 2007 Wiley Periodicals, Inc.
C1 [Zhu, Ai-Ping] Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225002, Peoples R China.
   [Zhao, Feng] Florida State Univ, Dept Chem & Biomed Engn, Tallahassee, FL 32310 USA.
   [Fang, Ning] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
RP Zhu, AP (reprint author), Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225002, Peoples R China.
EM apzhu@yzu.edu.cn
CR Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Cai KY, 2001, J BIOMAT SCI-POLYM E, V12, P1303, DOI 10.1163/156856202753419240
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   CHIOU SH, 2001, J MICROENCAPSUL, V18, P603
   COLEMAN DL, 1982, J BIOMED MATER RES, V16, P381, DOI 10.1002/jbm.820160407
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Fang N, 2005, MACROMOL BIOSCI, V5, P1022, DOI 10.1002/mabi.200500123
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   FOSTER A, 1998, P NOBCCHE, V25, P127
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Halayko AJ, 2001, J APPL PHYSIOL, V90, P358
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Li Song, 2003, FASEB Journal, V17, P97
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   NYGREN H, 1994, BIOPHYS CHEM, V49, P263, DOI 10.1016/0301-4622(93)E0090-R
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   SCHAKENRAAD JM, 1989, COLLOID SURFACE, V42, P331
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Takagi R, 2000, J MEMBRANE SCI, V170, P19, DOI 10.1016/S0376-7388(99)00358-0
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   Thakar RG, 2003, BIOCHEM BIOPH RES CO, V307, P883, DOI 10.1016/S0006-291X(03)01285-3
   Thompson DM, 2001, TISSUE ENG, V7, P247, DOI 10.1089/10763270152044125
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang YC, 2004, FASEB J, V18, P525, DOI 10.1096/fj.03-0490fje
   Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Zhu AP, 2006, BIOMATERIALS, V27, P2566, DOI 10.1016/j.biomaterials.2005.11.039
   Zhu AP, 2005, BIOMACROMOLECULES, V6, P2607, DOI 10.1021/bm050328q
   Zhu AP, 2005, BIOMATERIALS, V26, P6873, DOI 10.1016/j.biomaterials.2005.05.021
   Zhu AP, 2005, COLLOID SURFACE B, V43, P143, DOI 10.1016/j.colsurfb.2005.04.009
   Zhu AP, 2004, POLYM INT, V53, P15, DOI 10.1002/pi.1275
NR 48
TC 10
Z9 11
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2008
VL 86A
IS 2
BP 467
EP 476
DI 10.1002/jbm.a.31567
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 323MM
UT WOS:000257450200019
PM 17975820
DA 2018-10-20
ER

PT J
AU McNally, AK
   Jones, JA
   MacEwan, SR
   Colton, E
   Anderson, JM
AF McNally, Amy K.
   Jones, Jacqueline A.
   MacEwan, Sarah R.
   Colton, Erica
   Anderson, James M.
TI Vitronectin is a critical protein adhesion substrate for IL-4-induced
   foreign body giant cell formation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE adhesion; integrins; monocyte; macrophage; fusion; biomedical polymers
ID BIOMATERIAL SURFACE-CHEMISTRY; HUMAN MACROPHAGE ADHESION; IN-VITRO;
   SERUM-PROTEINS; INTEGRINS; APOPTOSIS; MONOCYTE; FUSION; FIBRONECTIN;
   NEUTROPHILS
AB An in vitro system of interleukin (IL)-4-induced foreign body giant cell (FBGC) formation was utilized to define the adhesion protein substrate(s) that promotes this aspect of the foreign body reaction on biomedical polymers. Human monocytes were cultured on cell culture polystyrene surfaces that had been pre-adsorbed with a synthetic arginine-glycine-aspartate peptide previously found to support optimal FBGC formation, or with various concentrations of potential physiological protein substrates, i.e. complement C3bi, collagen types I or IV, fibrinogen, plasma fibronectin, fibroblast fibronectin, laminin, thrombospondin, vitronectin, or von Willebrand factor. Cultures were evaluated on days 0 (1.5 h), 3, and 7 by May-Griinwald/Giemsa staining. Initial monocyte adhesion occurred on all adsorbed proteins. However, by day 7 of culture, only vitronectin was striking in its ability to support significant macrophage adhesion, development, and fusion leading to FBGC formation. Vitronectin supported high degrees of FBGC formation at an absorption concentration between 5 and 25 mu g/mL. These findings suggest that adsorbed vitronectin is critical in the cotlective events that support and promote FBGC formation on biomedical polymers, and that the propensity for vitronectin adsorption may underlie the material surface chemistry dependency of FBGC formation. (C) 2007 Wiley Periodicals, Inc.
C1 [McNally, Amy K.; Colton, Erica; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Jones, Jacqueline A.; MacEwan, Sarah R.; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP McNally, AK (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
EM amy.mcnally@case.edu
OI MacEwan, Sarah/0000-0002-4365-6232
FU NIBIB NIH HHS [EB 000275, R01 EB000275, R37 EB000275]
CR Anderson J.M., 1999, TISSUE ENG VASCULAR, P197
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   ANDERSON JM, 1988, ASAIO, V11, P101
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   ANDERSSON T, 1991, Drug Investigation, V3, P45
   BAMFORD CH, 1992, VROMAN EFFECT
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003
   CHERNY RC, 1993, J BIOL CHEM, V268, P9725
   Collier TO, 2004, J BIOMED MATER RES A, V69A, P644, DOI 10.1002/jbm.a.30030
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   Duong LT, 2000, CELL MOTIL CYTOSKEL, V47, P174, DOI 10.1002/1097-0169(200011)47:3<174::AID-CM2>3.0.CO;2-N
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gonzalez-Amaro R, 1999, CRIT REV IMMUNOL, V19, P389
   HARBERS GM, 2006, INTRO BIOMATERIALS, P15
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   JONES JA, 2004, J BIOMAT SCI-POLYM E, V15, P576
   Kanse SM, 2004, ARTERIOSCL THROM VAS, V24, P2251, DOI 10.1161/01.ATV.0000146529.68729.8b
   LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417
   McNally AK, 2003, AM J PATHOL, V163, P1147, DOI 10.1016/S0002-9440(10)63474-8
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MCNALLY AK, 1996, 5 WORLD C TOR CAN MA
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9
   Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834
   Tsuji T, 2004, J MEMBRANE BIOL, V200, P115, DOI 10.1007/s00232-004-0696-5
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   Werr J, 2000, J LEUKOCYTE BIOL, V68, P553
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 45
TC 56
Z9 58
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2008
VL 86A
IS 2
BP 535
EP 543
DI 10.1002/jbm.a.31658
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 323MM
UT WOS:000257450200026
PM 17994558
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhou, G
   Li, YB
   Lee, SW
AF Zhou, Gang
   Li, Yu-Bao
   Lee, Soo-Wohn
TI Preparation of a nano-hydroxyapatite/chitosan/konjac glucomannan
   composite as a novel degradable drug delivery system
SO JOURNAL OF CERAMIC PROCESSING RESEARCH
LA English
DT Article
DE n-HA/CS/KGM composite; in vitro test; degradability; drug delivery
ID BONE
AB A Nano-hydroxyapatite (n-HA)/chitosan (CS)/konjac glucomannan (KGM) composite was prepared by integrating composition and molding. Then, X-ray diffraction (XRD), scanning electron microscopy (SEM) and energy dispersive spectroscopy (EDS) were used to analyze the physical, chemical and degradable properties of the composite before and after immersion in simulated body flu id (SBF). Moreover, an in vitro test for drug delivery revealed that the amount of released pentoxifylline (1-[5-oxohexyl]-3, 7-dimethylxanthine)(PTX) reached a plateau and equaled 80% of the drug loaded in an implant. The newly developed n-HAJCS/KGM composite may serve as a good degradable biomaterial for an implantable drug delivery system (IDDS) in bone tissue engineering.
C1 [Zhou, Gang; Lee, Soo-Wohn] Sun Moon Univ, Dept Mat Engn, Asan 336708, Chungnam, South Korea.
   [Zhou, Gang] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China.
   [Zhou, Gang; Li, Yu-Bao] Sichuan Univ, Res Ctr Nanobiomat, Analyt & Testing Ctr, Chengdu 610064, Peoples R China.
RP Lee, SW (reprint author), Sun Moon Univ, Dept Mat Engn, Asan 336708, Chungnam, South Korea.
EM swlee@sunmoon.ac.kr
FU China 973 fund [2007CB936102]
FX The research is supported by China 973 fund (NO. 2007CB936102).
CR ALEKHA KD, 1998, J PHARM TOX METHODS, V41, P1
   Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   DASH AK, 1992, PHARMACEUT RES, V9, P993, DOI 10.1023/A:1015842108772
   Durucan C, 2002, J MATER SCI, V37, P963, DOI 10.1023/A:1014347814241
   HENCH LL, 1993, INTRO BIOCERAMICS, P57
   Jaakkola T, 2004, BIOMATERIALS, V25, P575, DOI 10.1016/S0142-9612(03)00558-1
   JODY R, 2003, J BIOMED MATER RES A, V66, P411
   KEVOR S, 1998, BIOMATERIALS, V19, P2209
   Kim HM, 1999, J BIOMED MATER RES, V46, P228, DOI 10.1002/(SICI)1097-4636(199908)46:2<228::AID-JBM12>3.0.CO;2-J
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   OLEKSIAK JS, 2001, INTERNATIONAL, V27, P767
   SERRO AP, 2000, J BIOMED MATER RES, V49, P345
   SHENG T, 1991, BIOCHEMISTRY-US, P22
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   SZYMURAOLEKSIAK J, 2001, CERAM INT, V7, P767
   WAHLIG H, 1978, J BONE JOINT SURG BR, V60, P270
NR 17
TC 3
Z9 3
U1 0
U2 6
PU KOREAN ASSOC CRYSTAL GROWTH, INC
PI SEOUL
PA SUNGDONG POST OFFICE, P O BOX 27, SEOUL 133-600, SOUTH KOREA
SN 1229-9162
J9 J CERAM PROCESS RES
JI J. Ceram. Process. Res.
PD AUG
PY 2008
VL 9
IS 4
BP 353
EP 357
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 350WE
UT WOS:000259383500005
DA 2018-10-20
ER

PT J
AU Mathur, T
   Singhal, S
   Khan, S
   Bhateja, P
   Pandya, M
   Rattan, A
   Bhatnagar, PK
   Upadhyay, DJ
   Fatma, T
AF Mathur, T.
   Singhal, S.
   Khan, S.
   Bhateja, P.
   Pandya, M.
   Rattan, A.
   Bhatnagar, P. K.
   Upadhyay, D. J.
   Fatma, T.
TI Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of
   staphylococcal adherence to plastic surfaces
SO JOURNAL OF CHEMOTHERAPY
LA English
DT Article
DE RBx 7644; oxazolidinone; Staphylococcus epidermidis; Staphylococcus
   aureus; adherence; biofilms
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; DEVICE-ASSOCIATED INFECTIONS;
   IN-VITRO; BIOFILMS; AUREUS; VANCOMYCIN; RESISTANT; EPIDERMIDIS; AGENTS
AB Adhesion to biomaterial is assumed to be a crucial step in the pathogenesis of foreign body infection. Slime producing Staphylococcus epidermidis and Staphylococcus aureus have emerged as a preeminent cause of nosocomial bacteremia and infections of prosthetic medical devices. We evaluated the time-dependent anti-adhesive effect of RBx 7644 (ranbezolid), vancomycin, linezolid and quinupristin/dalfopristin on two isolates each of S. epidermidis and S. aureus. Linezolid and quinupristin/dalfopristin showed inhibition only at supra-inhibitory concentrations (2 and 4X MIC) following 2 and 4 h delayed treatment, whereas RBx 7644 demonstrated significant activity against adhesion of staphylococcal cells that had been treated with 2 to 6 h delay. When vancomycin treatment was delayed by 4 to 6 h, even concentrations above the MIC were unable to prevent adherence. This study indicates that RBx 7644 has anti-adhesion potential and may emerge as an important antibiotic for prevention and treatment of device-related infections caused by staphylococci.
C1 [Mathur, T.] Ranbaxy Res Labs, New Drug Discovery Res, Dept Infect Dis, Udyog Vihar Ind Area, Gurgaon 122001, Haryana, India.
   [Rattan, A.] SRL, Gurgaon 122001, Haryana, India.
   [Fatma, T.] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India.
RP Mathur, T (reprint author), Ranbaxy Res Labs, New Drug Discovery Res, Dept Infect Dis, Udyog Vihar Ind Area, R & D 3,Plot 20,Sector 18, Gurgaon 122001, Haryana, India.
EM tarun.mathur@ranbaxy.com
CR Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43
   Bana E Costa CA, 1999, MATH MODEL-THEOR APP, V4, P131
   CARSENTIETESSE H, 1993, ANTIMICROB AGENTS CH, V37, P921, DOI 10.1128/AAC.37.4.921
   *CLIN LAB STAND I, 2006, M7A7 CSLI CLIN LAB S, V26
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   CRISTHENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Deighton MA, 2001, METHOD ENZYMOL, V336, P177, DOI 10.1016/S0076-6879(01)36589-8
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Drago L, 2002, ANTIMICROB AGENTS CH, V46, P598, DOI 10.1128/AAC.46.2.598-599.2002
   Drees M, 2006, CURR OPIN INFECT DIS, V19, P544, DOI 10.1097/QCO.0b013e328010683e
   Drew RH, 2007, PHARMACOTHERAPY, V27, P227, DOI 10.1592/phco.27.2.227
   Giacometti A, 2005, ANTIMICROB AGENTS CH, V49, P4042, DOI 10.1128/AAC.49.10.4042-4045.2005
   Hoellman DB, 2003, ANTIMICROB AGENTS CH, V47, P1148, DOI 10.1128/AAC.47.3.1148-1150.2003
   Jones SM, 2001, LANCET, V357, P40, DOI 10.1016/S0140-6736(00)03572-8
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117
   Mathur T, 2004, INT J ANTIMICROB AG, V24, P369, DOI 10.1016/j.ijantimicag.2004.04.012
   MINUTH JN, 1974, ANTIMICROB AGENTS CH, V6, P411, DOI 10.1128/AAC.6.4.411
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Pagano PJ, 2004, INT J ANTIMICROB AG, V23, P226, DOI 10.1016/j.ijantimicag.2003.07.012
   Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X
   RAAD I, 1995, ANTIMICROB AGENTS CH, V39, P741
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Schmitz FJ, 1999, J ANTIMICROB CHEMOTH, V44, P847, DOI 10.1093/jac/44.6.847
   Schwank S, 1998, ANTIMICROB AGENTS CH, V42, P895, DOI 10.1128/AAC.42.4.895
NR 26
TC 0
Z9 0
U1 0
U2 1
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1120-009X
EI 1973-9478
J9 J CHEMOTHERAPY
JI J. Chemother.
PD AUG
PY 2008
VL 20
IS 4
BP 420
EP 427
DI 10.1179/joc.2008.20.4.420
PG 8
WC Oncology; Infectious Diseases; Pathology; Pharmacology & Pharmacy
SC Oncology; Infectious Diseases; Pathology; Pharmacology & Pharmacy
GA 346ZZ
UT WOS:000259109500002
PM 18676219
DA 2018-10-20
ER

PT J
AU Dekeyser, CM
   Buron, CC
   Mc Evoy, K
   Dupont-Gillain, CC
   Marchand-Brynaert, J
   Jonas, AM
   Rouxhet, PG
AF Dekeyser, C. M.
   Buron, C. C.
   Mc Evoy, K.
   Dupont-Gillain, C. C.
   Marchand-Brynaert, J.
   Jonas, A. M.
   Rouxhet, P. G.
TI Oligo(ethylene glycol) monolayers by silanization of silicon wafers:
   Real nature and stability
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE silane; PEO; XPS; PCA; PBS; stability; OEG
ID SELF-ASSEMBLED MONOLAYERS; RAY PHOTOELECTRON-SPECTROSCOPY; POLY(ETHYLENE
   GLYCOL); PROTEIN ADSORPTION; RESISTANT SURFACES; SILANE MONOLAYERS;
   OXIDE); ALKYLTRICHLOROSILANES; ADHESION; GOLD
AB Grafting silicon wafers with CH3O-(CH2-CH2-O)(n)-C3H6-trimethoxysilane and -trichlorosilane (n = 6 to 9) was performed in different conditions (solvent, reaction time, washing) in order to select procedures compatible with the design of nanostructured surfaces for biomaterial applications, using electron-beam lithography. After a first screening by principal component analysis (PCA), the X-ray photoelectron spectroscopy (XPS) data were analyzed by plotting the carbon to oxygen molar ratio vs the molar ratio of carbon singly bound to oxygen [C-O] over carbon bound only to carbon and hydrogen [C-(C,H)]. This was found to be a convenient method for discarding samples containing free polymerized silane. Such excess occurred as a result of insufficient washing or unsuitable solvent for the reaction (ether), as confirmed by AFM and thickness measured by X-ray reflectometry. Angle resolved XPS analysis indicated that the grafted silane layer had a 1-2 nm thickness and was covered by a thin layer of adventitious contaminant. As a result, the surface chemical composition obtained covered a broad range (O/C of 0.4 to 1.1; C-O/C-(C,H) of 2.5 to 6.5); variations could not be related to the nature of the silane reagent and no significant difference was found between hexane and toluene as solvent for the reaction. The grafted silane layer was not stable upon incubation during 24 h in phosphate buffered saline (PBS) at 37 degrees C, which mimics biological environments. As a consequence, the grafted wafers did not show protein repellent properties. This alteration was not observed at room temperature. XPS analysis demonstrated that silane layer detachment was due to a hydrolysis within the SiO2 layer initially present at the wafer surface.
C1 [Dekeyser, C. M.; Mc Evoy, K.; Dupont-Gillain, C. C.; Rouxhet, P. G.] Univ Catholique Louvain, Unite Chim Interfaces, B-1348 Louvain, Belgium.
   [Dekeyser, C. M.; Marchand-Brynaert, J.] Univ Catholique Louvain, Unite Chim Organ & Med, B-1348 Louvain, Belgium.
   [Buron, C. C.; Jonas, A. M.] Univ Catholique Louvain, Unite Chim & Phys Hauts Polymeres, B-1348 Louvain, Belgium.
RP Rouxhet, PG (reprint author), Univ Catholique Louvain, Unite Chim Interfaces, Croix Sud 2-18, B-1348 Louvain, Belgium.
EM paul.rouxhet@uclouvain.be
RI Jonas, Alain/J-5232-2012
OI Jonas, Alain/0000-0002-4083-0688; Buron, Cedric/0000-0001-9067-7856
CR Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Andrade JD, 1996, ADV CHEM SER, V248, P51
   Arys X, 2001, MACROMOLECULES, V34, P3318, DOI 10.1021/ma010092s
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   BRERETON RG, 2003, CHEMOMETRICS DATA AN
   BRZOSKA JB, 1994, LANGMUIR, V10, P4367, DOI 10.1021/la00023a072
   Cecchet F, 2006, LANGMUIR, V22, P1173, DOI 10.1021/la052507z
   Cheng HL, 1999, J POLYM RES-TAIWAN, V6, P123, DOI 10.1007/s10965-006-0079-y
   Denis FA, 2005, SMALL, V1, P984, DOI 10.1002/smll.200500116
   Denis FA, 2004, LANGMUIR, V20, P9335, DOI 10.1021/la049188g
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   Dewez JL, 1997, J COLLOID INTERF SCI, V191, P1, DOI 10.1006/jcis.1997.4908
   Fadeev AY, 2000, LANGMUIR, V16, P7268, DOI 10.1021/la000471z
   GENET MJ, 2008, MED APPL CO IN PRESS, pCH5
   GERIN PA, 1995, J CHIM PHYS PCB, V92, P1043, DOI 10.1051/jcp/1995921043
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Lee SW, 1998, BIOMATERIALS, V19, P1669, DOI 10.1016/S0142-9612(98)00044-1
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   MARSDEN C, 1954, SOLVENTS MANUAL
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Mougin K, 2004, LANGMUIR, V20, P4302, DOI 10.1021/la049824n
   Onclin S, 2005, ANGEW CHEM INT EDIT, V44, P6282, DOI 10.1002/anie.200500633
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   Pallandre A, 2004, NANO LETT, V4, P365, DOI 10.1021/nl035045n
   Papra A, 2001, LANGMUIR, V17, P1457, DOI 10.1021/la000609d
   Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227
   Rye RR, 1997, LANGMUIR, V13, P2965, DOI 10.1021/la960919p
   Saq'an SA, 2004, OPT MATER, V24, P629, DOI 10.1016/S0925-3467(03)00166-6
   Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la0347531
   Tanuma S, 1997, SURF INTERFACE ANAL, V25, P25, DOI 10.1002/(SICI)1096-9918(199701)25:1<25::AID-SIA207>3.3.CO;2-U
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   Veiseh M, 2004, BIOMATERIALS, V25, P3315, DOI 10.1016/j.biomaterials.2003.10.014
   Vereecke G, 1998, SURF INTERFACE ANAL, V26, P490, DOI 10.1002/(SICI)1096-9918(199806)26:7<490::AID-SIA392>3.0.CO;2-U
   Vitchev RG, 2004, APPL SURF SCI, V235, P21, DOI 10.1016/j.apsusc.2004.05.135
   Wang AF, 2005, J COLLOID INTERF SCI, V291, P438, DOI 10.1016/j.jcis.2005.05.008
   Wang MJ, 2005, LANGMUIR, V21, P1848, DOI 10.1021/la048483y
   WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
NR 40
TC 28
Z9 29
U1 2
U2 27
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD AUG
PY 2008
VL 324
IS 1-2
BP 118
EP 126
DI 10.1016/j.jcis.2008.05.002
PG 9
WC Chemistry, Physical
SC Chemistry
GA 320KJ
UT WOS:000257232100017
PM 18533173
DA 2018-10-20
ER

PT J
AU Mouzakis, DE
   Bouropoulos, N
   Kallidonis, P
   Karnabatidis, D
   Katsanos, K
   Constantinidis, C
   Perimenis, P
   Siamblis, D
   Liatsikos, EN
AF Mouzakis, Dionysios E.
   Bouropoulos, Nikolaos
   Kallidonis, Panagiotis
   Karnabatidis, Dimitrios
   Katsanos, Konstantinos
   Constantinidis, Constantinos
   Perimenis, Petros
   Siamblis, Dimitrios
   Liatsikos, Evangelos N.
TI Viscoelastic property mapping along encrusted polymeric urinary
   catheters
SO JOURNAL OF ENDOUROLOGY
LA English
DT Article
ID URETERAL STENT; DEPOSITION; BACTERIAL
AB Purpose: Mapping of the material viscoelastic property variation along the length axis of polymeric stents.
   Materials and Methods: Five pigtail ureteral stents and five percutaneous stents placed in vivo for different periods were studied. Viscoelastic property changes along the length of polymeric stents were measured using the dynamic mechanical analysis technique. The type of encrustations was identified using FT-IR spectroscopy and their morphology by scanning electron microscopy (SEM).
   Results: Variations in viscoelastic stiffness were confirmed for both types of stents. In a few cases, the variation was quite large (400%). Various encrustation types and/or organic sheathing of the salt were found to be responsible for this effect. In detail, calcium oxalate monohydrate (COM) plaques for percutaneous and COM/organic layer for pigtail stents were recognized by FT-IR spectroscopy and SEM observation to invoke reinforcing effects along the stent axes.
   Conclusions: The phenomenon of stiffness variation along the stent axes requires further study to understand the mechanism behind it and consequently to improve the biomaterial and design of specific areas of stents as well as to avoid encrustations. This further research might lead in the near future to the development of new types of polymer stents for drug-eluting specialized areas.
C1 [Kallidonis, Panagiotis; Perimenis, Petros; Liatsikos, Evangelos N.] Univ Patras, Sch Med, Dept Urol, Patras 26500, Greece.
   [Mouzakis, Dionysios E.; Bouropoulos, Nikolaos] Univ Patras, Dept Mat Sci, Patras 26500, Greece.
   [Karnabatidis, Dimitrios; Katsanos, Konstantinos; Siamblis, Dimitrios] Univ Patras, Sch Med, Dept Radiol, Patras 26500, Greece.
   [Constantinidis, Constantinos] Univ Athens, Sch Med, Laikon Gen Hosp, Dept Urol, GR-11527 Athens, Greece.
RP Liatsikos, EN (reprint author), Univ Patras, Sch Med, Dept Urol, Patras 26500, Greece.
EM liatsikos@yahoo.com
OI Mouzakis, Dionysios E./0000-0001-5842-5202
CR Beiko DT, 2004, J UROLOGY, V171, P2438, DOI 10.1097/01.ju.0000125001.56045.6c
   Beiko DT, 2003, J ENDOUROL, V17, P195, DOI 10.1089/089277903765444294
   Bithelis G, 2004, J ENDOUROL, V18, P550, DOI 10.1089/end.2004.18.550
   Christensen R., 1982, THEORY VISCOELASTICI
   Damiano R, 2002, UROL INT, V69, P136, DOI 10.1159/000065563
   ELSHERIF A, 1995, BRIT J UROL, V76, P108, DOI 10.1111/j.1464-410X.1995.tb07842.x
   GANDERTON L, 1992, EUR J CLIN MICROBIOL, V11, P789, DOI 10.1007/BF01960877
   Kehinde EO, 2002, J UROLOGY, V167, P1334, DOI 10.1016/S0022-5347(05)65294-9
   Lawrentschuk N, 2004, ANZ J SURG, V74, P243, DOI 10.1111/j.1445-2197.2004.02947.x
   Mouzakis DE, 2006, J ENDOUROL, V20, P64, DOI 10.1089/end.2006.20.64
   MOUZAKIS DE, 1999, THESIS BERLIN
   MOUZAKIS DE, 2002, J MATER SCI, V35, P1
   OSWALT GC, 1979, J UROLOGY, V122, P249, DOI 10.1016/S0022-5347(17)56350-8
   REID G, 1995, COLLOID SURFACE B, V5, P171, DOI 10.1016/0927-7765(95)01208-Z
   Richter S, 2000, BJU INT, V85, P408, DOI 10.1046/j.1464-410x.2000.00478.x
   Robert M, 1997, UROL INT, V58, P100, DOI 10.1159/000282959
   Tieszer C, 1998, J UROLOGY, V160, P876, DOI 10.1016/S0022-5347(01)62825-8
NR 17
TC 0
Z9 0
U1 0
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0892-7790
J9 J ENDOUROL
JI J. Endourol.
PD AUG
PY 2008
VL 22
IS 8
BP 1761
EP 1769
DI 10.1089/end.2007.0423
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA 345YP
UT WOS:000259034700036
PM 18721048
DA 2018-10-20
ER

PT J
AU Nagai, N
   Okauchi, M
   Rodriguez, A
   Gunduz, M
   Hu, HL
   Kubota, M
   Nagaoka, N
   Inoue, M
   Nagatsuka, H
   Takagi, T
   Akao, M
AF Nagai, Noriyuki
   Okauchi, Mika
   Rodriguez, Andrea
   Gunduz, Mehmet
   Hu, Hailong
   Kubota, Midori
   Nagaoka, Noriyuki
   Inoue, Miho
   Nagatsuka, Hitoshi
   Takagi, Tohru
   Akao, Masaru
TI Development of New Titanium Coating Material (CaTiO3-aC) with Modified
   Thermal Decomposition Method
SO JOURNAL OF HARD TISSUE BIOLOGY
LA English
DT Article
DE Biomaterial; Titanium; Carbon; HA; Coating material; CaTiO3-aC
AB We developed a novel method for titanium coating material using modified thermal decomposition technique, specifically focusing on presence of CaTiO3 and carbon C. Two layers of thin film coating composed of CaTiO3-amorphous carbon compound (CaTiO3-aC) and hydroxyapatite (HA) were generated on titanium surface. In this method, ratios of Ca/P as well as Ca/Ti, sintering temperature and sintering velocity were carefully planned. Within crystal structure of CaTiO3 granules, 4 atomic % of carbon in amorphous state was included. By our method, inclusion of carbon in HA suggested formation of carbonate apatite. Regarding with attachment-detachment experiment at titanium surface, adhesion strength was 2.5 times stronger in CaTiO(3)aC/FIA coating substrate as compared to HA only coating material. Results of the novel developed modified thermal decomposition method suggested that the 2 layers biomaterial composed of CaTiO3-aC (0.6 mu m) and carbonate apatite-included HA (2.4 mu m) can be used as a coating material on titanium surface.
C1 [Nagai, Noriyuki; Okauchi, Mika; Rodriguez, Andrea; Gunduz, Mehmet; Hu, Hailong; Kubota, Midori; Nagaoka, Noriyuki; Inoue, Miho; Nagatsuka, Hitoshi; Takagi, Tohru] Okayama Univ, Dept Oral Pathol & Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan.
   [Nagai, Noriyuki; Takagi, Tohru; Akao, Masaru] Int Dent Hygienist Coll Okayama, Ctr Oral Hlth Sci, Okayama, Japan.
RP Nagai, N (reprint author), Okayama Univ, Dept Oral Pathol & Med, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikatacho, Okayama 7008525, Japan.
EM nori@md.okayama-u.ac.jp
FU Japan Society for the Promotion of Science [17406027, 19592236]
FX This work was supported by Grant-in-Aid for Scientific Research(B)
   (17406027) and (C) (19592236) from the Japan Society for the Promotion
   of Science.
CR Brossa F., 1993, Bio-Medical Materials and Engineering, V3, P127
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DEBRUIJIN JD, 1992, J BIOMED MATER RES, V26, P1356
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   ELLIES LG, 1992, BIOMATERIALS, V13, P313, DOI 10.1016/0142-9612(92)90055-S
   Fujishiro Y, 1998, J MATER SCI-MATER M, V9, P363, DOI 10.1023/A:1013201627622
   Hasegawa Seiichiro, 1996, Bulletin of Tokyo Medical and Dental University, V43, P25
   Kilpadi DV, 2000, INT J ORAL MAX IMPL, V15, P219
   Kweh SWK, 2002, BIOMATERIALS, V23, P381, DOI 10.1016/S0142-9612(01)00116-8
   LIN JHC, 1994, J BIOMED MATER RES, V28, P723, DOI 10.1002/jbm.820280609
   Lynn AK, 2002, BIOMATERIALS, V23, P1937, DOI 10.1016/S0142-9612(01)00321-0
   OHTSU N, 2007, J MAT SCI MAT MED, V18
   Ohtsu N, 2007, J BIOMED MATER RES A, V82A, P304, DOI 10.1002/jbm.a.31136
   OHTSUKA Y, 1994, SURF COAT TECH, V65, P224, DOI 10.1016/S0257-8972(94)80037-5
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   UKEGAWA Y, 1992, J JPN ORTHOP ASSOC, V66, P688
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
   Webster TJ, 2003, J BIOMED MATER RES A, V67A, P975, DOI 10.1002/jbm.a.10160
   Zhou P, 1997, BIO-MED MATER ENG, V7, P67
NR 20
TC 4
Z9 4
U1 2
U2 3
PU JOURNAL HARD TISSUE BIOLOGY
PI MINATO KU
PA NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO
   106-0031, JAPAN
SN 1341-7649
J9 J HARD TISSUE BIOL
JI J. Hard Tissue Biol.
PD AUG
PY 2008
VL 17
IS 2
BP 47
EP 54
DI 10.2485/jhtb.17.47
PG 8
WC Engineering, Biomedical
SC Engineering
GA V11RY
UT WOS:000207549900002
OA Bronze
DA 2018-10-20
ER

PT J
AU Acharya, C
   Ghosh, SK
   Kundu, SC
AF Acharya, Chitrangada
   Ghosh, Sudip K.
   Kundu, S. C.
TI Silk fibroin protein from mulberry and non-mulberry silkworms:
   cytotoxicity, biocompatibility and kinetics of L929 murine fibroblast
   adhesion
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TROPICAL TASAR SILKWORM; IN-VITRO; ANTHERAEA-MYLITTA; INFLAMMATORY
   RESPONSES; RAW-264.7 MACROPHAGES; CELL-ADHESION; BOMBYX-MORI;
   ATTACHMENT; SERICIN; GROWTH
AB Silks fibers and films fabricated from fibroin protein of domesticated mulberry silkworm cocoon have been traditionally utilized as sutures in surgery and recently as biomaterial films respectively. Here, we explore the possibility of application of silk fibroin protein from non-mulberry silkworm cocoon as a potential biomaterial aid. In terms of direct inflammatory potential, fibroin proteins from Antheraea mylitta and Bombyx mori are immunologically inert and invoke minimal immune response. Stimulation of murine peritoneal macrophages and RAW 264.7 murine macrophages by these fibroin proteins both in solution and in the form of films assayed in terms of nitric oxide and TNF alpha production showed comparable stimulation as in collagen. Kinetics of adhesion of L929 murine fibroblasts, for biocompatibility evaluation, monitored every 4 h from seeding and studied over a period of 24 h, reveal A. mylitta fibroin film to be a better substrate in terms of rapid and easier cellularization. Cell viability studies by MTT assay and flow cytometric analyses indicate the ability of fibroin matrices to support cell growth and proliferation comparable to collagen for long-term culture. This matrix may have potential to serve in those injuries where rapid cellularization is essential.
C1 [Acharya, Chitrangada; Ghosh, Sudip K.; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291
CR ACHARYA C, 2008, BIOTECHNOLOGY J, V3, P2
   Akai H, 2000, INT J WILD SILKMOTHS, V5, P255
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Bruns S, 2007, J BIOTECHNOL, V131, P335, DOI 10.1016/j.jbiotec.2007.06.024
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   Crellin NK, 2007, J IMMUNOL METHODS, V324, P92, DOI 10.1016/j.jim.2007.05.008
   Dash R, 2007, COMP BIOCHEM PHYS B, V147, P129, DOI 10.1016/j.cbpb.2007.01.009
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   Datta A, 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI 10.1016/S0965-1748(01)00049-2
   EGCZKAOSYCZKA A, 1997, BIOMATERIALS, V18, P1243
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Guillou-Buffello D., 2005, BIOMATERIALS, V26, P4197
   Hofer M, 2007, INT IMMUNOPHARMACOL, V7, P1369, DOI 10.1016/j.intimp.2007.06.003
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   HOROWITZ SM, 1995, J BIOMED MATER RES, V29, P477, DOI 10.1002/jbm.820290407
   HUG TS, 2003, ASSAY DRUG DEV TECHN, V1, P1
   LEE Y, 1999, FAO AGR SERICES B, V136, pCH2
   Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010
   MAHENDRAN B, 2006, J GENET, V85, P1
   Mahendran B, 2006, J BIOCHEM MOL BIOL, V39, P522
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Miyatake K, 2007, BIOCHEM BIOPH RES CO, V360, P115, DOI 10.1016/j.bbrc.2007.06.009
   MORI H, 2000, REV MOL BIOTECHNOL, V74, P95, DOI DOI 10.1016/S1389-0352(00)00004-0
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   POSTE G, 1980, NATURE, V309, P30
   Radhika M, 1999, COMP BIOCHEM PHYS C, V124, P131, DOI 10.1016/S0742-8413(99)00042-0
   RAE T, 1986, CRIT REV BIOCOMPAT, V2, P97
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SHAMITHA G, 2000, INT J WILD SILKMOTHS, V5, P274
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   TAMURA T, 1988, INSECT BIOCHEM, V18, P169, DOI 10.1016/0020-1790(88)90021-2
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   VOGLER EA, 1988, BIOPHYS J, V53, P759, DOI 10.1016/S0006-3495(88)83156-4
NR 45
TC 71
Z9 73
U1 1
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2008
VL 19
IS 8
BP 2827
EP 2836
DI 10.1007/s10856-008-3408-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309QZ
UT WOS:000256476600007
PM 18322779
DA 2018-10-20
ER

PT J
AU Mazzocchi, M
   Gardini, D
   Traverso, PL
   Faga, MG
   Bellosi, A
AF Mazzocchi, Mauro
   Gardini, Davide
   Traverso, Pier Luigi
   Faga, Maria Giulia
   Bellosi, Alida
TI On the possibility of silicon nitride as a ceramic for structural
   orthopaedic implants. Part II: chemical stability and wear resistance in
   body environment
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PROCESSING ROUTES; IN-VITRO; WETTABILITY; FRICTION; JOINT;
   BIOCOMPATIBILITY; COMPOSITES; PROTEINS; ADHESION; CONTACT
AB In Part I, the processing, microstructure and mechanical properties of three silicon nitride-based ceramics were examined and their non-toxicity was demonstrated. In this Part II, some features critical to biomedical applications were investigated: (i) the wetting behaviour against aqueous media, including physiological solutions; (ii) the chemical stability in water and in physiological solutions; and (iii) the wear resistance, measured under experimental procedures that simulate the conditions typical of the hip joint prosthesis. The results confirmed that silicon nitride may serve as a biomaterial for bone substitution in load bearing prosthesis.
C1 [Mazzocchi, Mauro; Gardini, Davide; Bellosi, Alida] CNR, Inst Sci & Technol Ceram, I-48018 Faenza, Ravenna, Italy.
   [Traverso, Pier Luigi] CNR, Harine Sci Inst Unit Genova, I-16149 Genoa, Italy.
   [Faga, Maria Giulia] CNR, Inst Sci & Technol Ceram Unit, I-10135 Turin, Italy.
RP Mazzocchi, M (reprint author), CNR, Inst Sci & Technol Ceram, Via Granarolo 64, I-48018 Faenza, Ravenna, Italy.
EM mauro.mazzocchi@istec.cnr.it
RI Mazzocchi, Mauro/D-9631-2016; Gardini, Davide/A-8708-2012; Bellosi,
   Alida/B-6167-2014
OI Mazzocchi, Mauro/0000-0002-0243-6890; Gardini,
   Davide/0000-0002-8879-6044; Faga, Maria Giulia/0000-0003-1290-3314;
   Traverso, Pierluigi/0000-0003-0111-5531
CR ABREAU CS, 2002, KEY ENG MATER, V230, P919
   AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   AGATHOPOULOS S, 1995, EUROCERAMICS 4, V8, P319
   AKAZAWA M, 1988, WEAR, V124, P123, DOI 10.1016/0043-1648(88)90239-6
   Aldini NN, 2002, J BIOMED MATER RES, V61, P282, DOI 10.1002/jbm.10162
   Amaral M, 2002, BIOMATERIALS, V23, P4123, DOI 10.1016/S0142-9612(02)00155-2
   Amaral M, 2002, BIOMATERIALS, V23, P857, DOI 10.1016/S0142-9612(01)00194-6
   Annarelli CC, 1999, J COLLOID INTERF SCI, V213, P386, DOI 10.1006/jcis.1999.6153
   BELLOSI A, 1992, J EUROP CERAM SOC, P983
   BELLOSI A, 1999, NATO ARW SERIES, P285
   Bondanini A, 2001, J MATER SCI, V36, P4851, DOI 10.1023/A:1011890926908
   Galassi C, 2000, J MATER RES, V15, P155, DOI 10.1557/JMR.2000.0026
   Giannoulis CS, 2002, J MATER SCI-MATER M, V13, P75, DOI 10.1023/A:1013646805593
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   HEIMKE G, 2000, BIOMATERIALS ENG DEV, V2, P253
   Howlett C., 1989, CLIN ORTHOP RELAT R, V244, P296
   IKEUCHI K, 2000, J CERAMIC PROCESSING, V1, P53
   JAHANMIR S, 1988, TRIBOL T, V31, P32, DOI 10.1080/10402008808981795
   Krajewski A, 1998, BIOMATERIALS, V19, P637, DOI 10.1016/S0142-9612(97)00153-1
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Kusaka J, 1999, WEAR, V225, P734, DOI 10.1016/S0043-1648(98)00386-X
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   MAIER HR, 2004, CFI-CERAM FORUM INT, V81, P33
   MAZZOCCHI M, J MAT SCI MAT MED
   Murakami T, 2002, KEY ENG MAT, V218-2, P521, DOI 10.4028/www.scientific.net/KEM.218-220.521
   Neumann A, 2004, J MATER SCI-MATER M, V15, P1135, DOI 10.1023/B:JMSM.0000046396.14073.92
   NEUMANN A, 2004, WERKSTOFFTECH, V35, P569
   Rosengren A, 2003, BIOMATERIALS, V24, P147, DOI 10.1016/S0142-9612(02)00272-7
   Silva CCG, 2004, MAT SCI ENG C-BIO S, V24, P643, DOI 10.1016/j.msec.2004.08.007
   SOHRABI A, 2000, J BIOMED MATER RES, V50, P49
   SORRELL CC, 1999, P 5 M SEM IMPL SPIN, P47
   Spriano S, 2005, WEAR, V259, P919, DOI 10.1016/j.wear.2005.02.011
   Willmann G, 2001, ADV ENG MATER, V3, P135, DOI 10.1002/1527-2648(200103)3:3<135::AID-ADEM135>3.3.CO;2-2
   WILLMANN G, 2002, CFI-CERAM FORUM INT, V79, P27
   Zhou YS, 1997, WEAR, V210, P171, DOI 10.1016/S0043-1648(97)00066-5
   ZHOU YS, 1977, MAT SCI ENG C, V5, P125
NR 37
TC 46
Z9 47
U1 0
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2008
VL 19
IS 8
BP 2889
EP 2901
DI 10.1007/s10856-008-3437-y
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309QZ
UT WOS:000256476600015
PM 18415002
DA 2018-10-20
ER

PT J
AU Gellynck, K
   Verdonk, P
   Forsyth, R
   Almqvist, KF
   Van Nimmen, E
   Gheysens, T
   Mertens, J
   Van Langenhove, L
   Kiekens, P
   Verbruggen, G
AF Gellynck, Kris
   Verdonk, Peter
   Forsyth, Ramses
   Almqvist, Karl Fredrik
   Van Nimmen, Els
   Gheysens, Tom
   Mertens, Johan
   Van Langenhove, Lieva
   Kiekens, Paul
   Verbruggen, Gust
TI Biocompatibility and biodegradability of spider egg sac silk
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FIBERS; PROTEINS; FIBROIN; BIOMATERIALS; CARTILAGE; SCAFFOLDS; SEQUENCE;
   BONE
AB Spider egg sac silk (SpESS) were enzymatically cleaned and their biodegradation in vivo and in vitro, as well as their biocompatibility were studied. Proteinase K treatment diminished the tenacity and the strain of the SpESS fibers in proportion to the enzyme concentration. Fibers treated with trypsin were not significantly affected. Tensile properties of Vicryl (R) , SpESS and of silkworm (Bombyx mori) silk fibers (SWS) were measured after incubation in phosphate buffered saline (PBS) at 37 degrees C up to 12 weeks. Biodegradation of SpESS and SWS was insignificant compared to Vicryl (R). Five milligram SpESS fibers from laboratory grown spiders (Araneus diadematus) were treated with proteinases before sterilization and subcutaneously implanted in Wistar rats. After 1, 4 and 7 weeks the immunological reaction was compared to untreated SpESS and polyglactin Vicryl (R) control samples. SpESS samples treated with trypsin only or in combination with a Proteinase K treatment induced less inflammatory reactions than untreated silk fibers. The enzymatical cleaning could diminish the tensile properties, but enhanced the biocompatibility of the SpESS fibers rendering them appropriate for use in biomaterial application where the slow biodegradability is an advantage.
C1 [Gellynck, Kris; Van Nimmen, Els; Van Langenhove, Lieva; Kiekens, Paul] Univ Ghent, Dept Text, Fac Sci Appl, B-9052 Ghent, Belgium.
   [Verdonk, Peter; Almqvist, Karl Fredrik] Ghent Univ Hosp, Dept Orthoped Surg, B-9000 Ghent, Belgium.
   [Forsyth, Ramses] Ghent Univ Hosp, N Goormaghtigh Inst Pathol, B-9000 Ghent, Belgium.
   [Gheysens, Tom; Mertens, Johan] Univ Ghent, Unit Anim Ecol Zoogeog & Nat Conservat, Dept Biol, Fac Sci, B-9000 Ghent, Belgium.
   [Verbruggen, Gust] Ghent Univ Hosp, Dept Rheumatol, B-9000 Ghent, Belgium.
RP Gellynck, K (reprint author), Univ Ghent, Dept Text, Fac Sci Appl, Technol PK 9, B-9052 Ghent, Belgium.
EM k.gellynck@ucl.ac.uk; Johan.mertens@ugent.be
RI gheysens, tom/J-5001-2012
OI gheysens, tom/0000-0002-8185-8986
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   [Anonymous], 1994, 109936 ISO
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   CASTELLI WA, 1978, ORAL SURG ORAL MED O, V45, P179, DOI 10.1016/0030-4220(78)90083-X
   DEBAKKER D, 2002, EUROPEAN ARACHNOLOGY, P356
   Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Gheysens T, 2005, J ARACHNOL, V33, P549, DOI 10.1636/CS05-12.1
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kubik S, 2002, ANGEW CHEM INT EDIT, V41, P2721, DOI 10.1002/1521-3773(20020802)41:15<2721::AID-ANIE2721>3.0.CO;2-3
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   LU L, 2001, CLIN ORTHOP S, V391, pS251
   Madsen B, 2000, NATURWISSENSCHAFTEN, V87, P148, DOI 10.1007/s001140050694
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   POSTLETHWAIT RW, 1975, ANN SURG, V181, P144
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   VANNIMMEN E, 2003, J MAT PROD TECHNOL, V18, P345
   Viney C, 2000, J TEXT I, V91, P2, DOI 10.1080/00405000008659539
   Vollrath F, 2000, J Biotechnol, V74, P67
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   Vollrath F, 2002, IN VIVO, V16, P229
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
NR 29
TC 29
Z9 31
U1 1
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2008
VL 19
IS 8
BP 2963
EP 2970
DI 10.1007/s10856-007-3330-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309QZ
UT WOS:000256476600024
PM 18360800
DA 2018-10-20
ER

PT J
AU Wong, DY
   Leveque, JC
   Brumblay, H
   Krebsbach, PH
   Hollister, SJ
   LaMarca, F
AF Wong, Darice Y.
   Leveque, Jean-Christophe
   Brumblay, Hunter
   Krebsbach, Paul H.
   Hollister, Scott J.
   LaMarca, Frank
TI Macro-architectures in spinal cord scaffold implants influence
   regeneration
SO JOURNAL OF NEUROTRAUMA
LA English
DT Article
DE immunohistochemistry; in vivo studies; neural injury; polycaprolactone;
   regeneration; scaffold architecture; traumatic spinal cord injury
ID PERIPHERAL-NERVE GRAFTS; NEURAL STEM-CELLS; AXONAL REGENERATION;
   GUIDANCE CHANNELS; POLY(2-HYDROXYETHYL METHACRYLATE); FUNCTIONAL
   RECOVERY; BRAIN-STEM; INJURY; TRANSECTION; REPAIR
AB Biomaterial scaffold architecture has not been investigated as a tunable source of influence on spinal cord regeneration. This study compared regeneration in a transected spinal cord within various designed-macro-architecture scaffolds to determine if these architectures alone could enhance regeneration. Three-dimensional (3D) designs were created and molds were built on a 3-D printer. Salt-leached porous poly(epsilon-caprolactone) was cast in five different macro-architectures: cylinder, tube, channel, open-path with core, and open-path without core. The two open-path designs were created in this experiment to compare different supportive aspects of architecture provided by scaffolds and their influence on regeneration. Rats received T8 transections and implanted scaffolds for 1 and 3 months. Overall morphology and orientation of sections were characterized by H&E, luxol fast blue, and cresyl violet staining. Borders between intact gray matter and non-regenerated defect were observed from GFAP immunolabeling. Nerve fibers and regenerating axons were identified with Tuj-1 immunolabeling. The open-path designs allowed extension of myelinated fibers along the length of the defect both exterior to and inside the scaffolds and maintained their original defect length up to 3 months. In contrast, the cylinder, tube, and channel implants had a doubling of defect length from secondary damage and large scar and cyst formation with no neural tissue bridging. The open-path scaffold architectures enhanced spinal cord regeneration compared to the three other designs without the use of biological factors.
C1 [Leveque, Jean-Christophe; Brumblay, Hunter; Hollister, Scott J.; LaMarca, Frank] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.
   [Wong, Darice Y.; Krebsbach, Paul H.; Hollister, Scott J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Hollister, SJ (reprint author), Univ Michigan, Dept Neurosurg, 1101 Beal Ave,2149 LBME, Ann Arbor, MI 48109 USA.
EM scottho@umich.edu
RI Leveque, Jean-Christophe/L-6367-2017
OI Leveque, Jean-Christophe/0000-0003-2465-444X
FU NIH [T32 DE-007057-31]
FX Thanks go to Alex Garnepudi for all his assistance. Funding was provided
   by NIH (training grant T32 DE-007057-31 to D.Y.W.).
CR Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Barnett SC, 2007, NAT CLIN PRACT NEURO, V3, P152, DOI 10.1038/ncpneuro0447
   Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006
   Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004
   Carone TW, 2006, J BIOMED MATER RES B, V78B, P274, DOI 10.1002/jbm.b.30483
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   Dinh P, 2007, SPINE, V32, P943, DOI 10.1097/01.brs.0000261408.61303.77
   El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103
   Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X
   Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024
   Fukunaga S, 2004, J ORTHOP SCI, V9, P605, DOI 10.1007/s00776-004-0833-0
   Gelain F, 2007, J NANOSCI NANOTECHNO, V7, P424, DOI 10.1166/jnn.2007.154
   Goldner JS, 2006, BIOMATERIALS, V27, P460, DOI 10.1016/j.biomaterials.2005.06.035
   Hadlock T, 2006, EXPERT OPIN BIOL TH, V6, P1105, DOI 10.1517/14712598.6.11.1105
   Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133
   HOULE JD, 1994, J NEURAL TRANSP PLAS, V5, P115, DOI 10.1155/NP.1994.115
   Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006
   Huang YC, 2005, J BIOMED MATER RES B, V74B, P659, DOI 10.1002/jbm.b.30267
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jones LL, 2003, J NEUROSCI, V23, P9276
   Kaegi S, 2002, EUR J NEUROSCI, V16, P249, DOI 10.1046/j.1460-9568.2002.02076.x
   Kuo HS, 2007, BIOCHEM BIOPH RES CO, V357, P1, DOI 10.1016/j.bbrc.2007.02.167
   Levi ADO, 2002, J NEUROSURG, V96, P197, DOI 10.3171/spi.2002.96.2.0197
   Li XG, 2006, PROG NAT SCI, V16, P1051
   Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890
   Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646
   MORI S, 1992, BRAIN DEV-JPN, V14, pS109
   NOGA BR, 1991, J NEUROSCI, V11, P1691
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2006, NEUROSURGERY, V59, P183, DOI 10.1227/NEU.0000219859.35349.EF
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Oudega M, 1999, EUR J NEUROSCI, V11, P2453, DOI 10.1046/j.1460-9568.1999.00666.x
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909
   Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004
   Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Yoshii S, 2003, SPINE, V28, P2346, DOI 10.1097/01.BRS.0000085302.95413.16
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
NR 49
TC 36
Z9 38
U1 0
U2 22
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0897-7151
J9 J NEUROTRAUM
JI J. Neurotrauma
PD AUG
PY 2008
VL 25
IS 8
BP 1027
EP 1037
DI 10.1089/neu.2007.0473
PG 11
WC Critical Care Medicine; Clinical Neurology; Neurosciences
SC General & Internal Medicine; Neurosciences & Neurology
GA 343ZT
UT WOS:000258895700009
PM 18721107
OA Green Published
DA 2018-10-20
ER

PT J
AU Jeon, JH
   Piepgrass, WT
   Lin, YL
   Thornas, MV
   Puleo, DA
AF Jeon, Ju Hyeong
   Piepgrass, Ward T.
   Lin, Yi-Ling
   Thornas, Mark V.
   Puleo, David A.
TI Localized intermittent delivery of simvastatin hydroxyacid stimulates
   bone formation in rats
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE controlled release; osteogenesis; simvastatin; simvastatin hydroxyacid;
   sustained release
ID BIOMATERIAL OG-PLG; IN-VITRO; MORPHOGENETIC PROTEINS; STATINS; RELEASE;
   CELLS; DIFFERENTIATION; REGENERATION; INDUCTION; MC3T3-E1
AB Background: The cholesterol-lowering drug simvastatin promotes bone formation in cell cultures and animal models. In previous studies, devices for the controlled, localized delivery of simvastatin hydroxyacid enhanced osteoblastic activity in vitro. The objective of this investigation was to determine bioactivity,of the delivery system in vivo.
   Methods: Devices for sustained or intermittent release of simvastatin hydroxyacid were formed using a blend of cellulose acetate phthalate and a poly(ethylene oxide) and poly(propylene oxide) block copolymer, and they were implanted directly over the calvarium of young male rats. Drug-free devices were used as controls. After 9, 18, or 28 days, specimens were histologically evaluated for new bone formation.
   Results: All three groups showed some level of new bone formation, but the extent of osteogenesis depended on the type of implant. Devices delivering simvastatin hydroxyacid were associated witha 77.5% to 133% increase in new woven bone thickness compared to control devices without a drug (P < 0.05). Furthermore, intermittent release stimulated a 32.3% greater response in bone thickness and a 74.1% greater bone area than did sustained delivery (P < 0.05). Although a minimal thickness of woven bone was formed directly under the device (up to 36 mu m), a significantly thicker layer was observed at the periphery (up to 205 mu m), implying mechanical and/or chemical effects directly under the implant. The percentage of lamellar bone area for intermittent and sustained release was higher than that for the control group (P < 0.05).
   Conclusion: Based on the present results of enhanced bone formation, these devices for the intermittent delivery of simvastatin hydroxyacid merit further attention for localized osteogenesis.
C1 [Puleo, David A.] Univ Kentucky, Ctr Biomed Engn, Wenner Gren Lab, Lexington, KY 40506 USA.
   [Piepgrass, Ward T.; Thornas, Mark V.] Univ Kentucky, Coll Dent, Div Periodontol, Lexington, KY 40506 USA.
   [Lin, Yi-Ling] Univ Kentucky, Coll Dent, Div Oral Pathol, Lexington, KY 40506 USA.
RP Puleo, DA (reprint author), Univ Kentucky, Ctr Biomed Engn, Wenner Gren Lab, Lexington, KY 40506 USA.
EM puleo@uky.edu
FU NIAMS NIH HHS [AR048700]
CR ADAMI S, 1987, CALCIFIED TISSUE INT, V41, P326, DOI 10.1007/BF02556671
   Andriano KP, 2000, J BIOMED MATER RES, V53, P36, DOI 10.1002/(SICI)1097-4636(2000)53:1<36::AID-JBM5>3.0.CO;2-H
   Carson JS, 2007, INJURY, V38, pS33, DOI 10.1016/j.injury.2007.02.008
   Cochran DL, 1999, J PERIODONTOL, V70, P139, DOI 10.1902/jop.1999.70.2.139
   Garrett IR, 2007, J ORTHOP RES, V25, P1351, DOI 10.1002/jor.20391
   Garrett IR, 2001, CURR PHARM DESIGN, V7, P715, DOI 10.2174/1381612013397762
   GOLDRING MB, 1990, CLIN ORTHOP RELAT R, P245
   Grasser W. A., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P53
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Hughes A, 2007, CALCIFIED TISSUE INT, V81, P403, DOI 10.1007/s00223-007-9078-1
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   Ismail FA, 2006, DRUG DEV IND PHARM, V32, P1199, DOI 10.1080/03639040600751886
   Jeon JH, 2007, INT J PHARM, V340, P6, DOI 10.1016/j.ijpharm.2007.03.007
   Kirker-Head CA, 2007, JAVMA-J AM VET MED A, V231, P1039, DOI 10.2460/javma.231.7.1039
   Kureishi Y, 2000, NAT MED, V6, P1004
   Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20072
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Nkenke E, 2001, CLIN ORAL IMPLAN RES, V12, P495, DOI 10.1034/j.1600-0501.2001.120510.x
   Nyan M, 2007, J PHARMACOL SCI, V104, P384, DOI 10.1254/jphs.SC0070184
   OHMORI Y, 1988, BIOCHIM BIOPHYS ACTA, V970, P22, DOI 10.1016/0167-4889(88)90218-2
   Oxlund H, 2001, CALCIFIED TISSUE INT, V69, P299, DOI 10.1007/s00223-001-2027-5
   Parhami F, 2002, J BONE MINER RES, V17, P1997, DOI 10.1359/jbmr.2002.17.11.1997
   Raiche AT, 2003, IEEE ENG MED BIOL, V22, P35, DOI 10.1109/MEMB.2003.1256270
   Skoglund B, 2002, J BONE MINER RES, V17, P2004, DOI 10.1359/jbmr.2002.17.11.2004
   Staal A, 2003, J BONE MINER RES, V18, P88, DOI 10.1359/jbmr.2003.18.1.88
   Stein D, 2005, J PERIODONTOL, V76, P1861, DOI 10.1902/jop.2005.76.11.1861
   Sugiyama M, 2000, BIOCHEM BIOPH RES CO, V271, P688, DOI 10.1006/bbrc.2000.2697
   Thylin MR, 2002, J PERIODONTOL, V73, P1141, DOI 10.1902/jop.2002.73.10.1141
   TODD PA, 1990, DRUGS, V40, P583, DOI 10.2165/00003495-199040040-00007
   Toh S, 2007, PHARMACOEPIDEM DR S, V16, P627, DOI 10.1002/pds.1363
   Veillard N. R., 2002, CMLS Cellular and Molecular Life Sciences, V59, P1771, DOI 10.1007/PL00012505
   Whang KM, 2005, J BIOMED MATER RES A, V74A, P237, DOI 10.1002/jbm.a.30309
   Whang KM, 2005, J BIOMED MATER RES A, V74A, P247, DOI 10.1002/jbm.a.30370
   Wong RWK, 2003, BRIT J ORAL MAX SURG, V41, P244, DOI 10.1016/S0266-4356(03)00081-0
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 36
TC 26
Z9 27
U1 0
U2 5
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD AUG
PY 2008
VL 79
IS 8
BP 1457
EP 1464
DI 10.1902/jop.2008.080004
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 336DY
UT WOS:000258345700019
PM 18672996
DA 2018-10-20
ER

PT J
AU Park, SJ
AF Park, Su-Jung
TI Chemical observation of anodic TiO2 for biomaterial application
SO METALS AND MATERIALS INTERNATIONAL
LA English
DT Article
DE anodic TiO2; chemical states; electrolyte; XPS; osteoblast-like cells
ID TITANIUM; FILMS; NANOTUBES
AB Anodic TiO2 film on Ti a substrate was fabricated at 170 V in sulfuric acid solutions containing phosphoric acid and hydrogen peroxide. The pores in the oxide layer were not uniform in size, shape, or direction of growth, particularly near the interface between the substrate and the oxide layer, compared with those of the surface layer. The formation of an irregular type of pores seemed to be caused by the spark discharge phenomena, which occurred extensively when the anodic voltage was increased. The pore diameter and the cell size increased and the number of cells per unit area decreased over time. From the analysis of chemical states in the XPS spectrum, the incorporated phosphate species were found mostly in the forms of HPO4-, PO4-, and PO3-. In addition, Ti, O, and P were well dispersed in TiO2 oxide film, as shown in the results of element mapping analyses by an energy dispersive X-ray spectrometer. An SGM observation of osteoblast-likes cells grown on treated TiO2 oxide film samples for 24 h showed clear differences in cell density and spreading pattern. MC3T3 osteoblast-like cells were flat with a polygonal configuration and were attached to the substrate by cellular extensions.
C1 Chosun Univ, Dept Dent Mat, Coll Dent, Kwangju 501759, South Korea.
RP Park, SJ (reprint author), Chosun Univ, Dept Dent Mat, Coll Dent, BK21,375 Seosuk Dong, Kwangju 501759, South Korea.
EM iamred@chosun.ac.kr
CR Afshar A, 2004, SURF COAT TECH, V186, P398, DOI 10.1016/j.surfcoat.2004.01.003
   Allred DB, 2007, ELECTROCHIM ACTA, V53, P193, DOI 10.1016/j.electacta.2007.06.019
   ASOH H, 2006, ELECTROCHEM COMMUN, V12, P1817
   BAN S, 2006, DENT MATER, V12, P1115
   Bestetti M, 2007, THIN SOLID FILMS, V515, P5253, DOI 10.1016/j.tsf.2006.12.180
   Chen JJ, 2006, J ELECTROANAL CHEM, V590, P26, DOI 10.1016/j.jelechem.2006.02.016
   Dewidar MM, 2006, MET MATER INT, V12, P193, DOI 10.1007/BF03027531
   Kohn J, 2007, BIOMATERIALS, V28, P4171, DOI 10.1016/j.biomaterials.2007.06.022
   Macak JM, 2005, ELECTROCHEM COMMUN, V7, P1133, DOI 10.1016/j.elecom.2005.08.013
   MASUMOTO K, 2006, MAT SCI ENG A-STRUCT, V25, P835
   Matykina E, 2006, ELECTROCHIM ACTA, V51, P4709, DOI 10.1016/j.electacta.2006.01.021
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   Oliveira NTC, 2006, ELECTROCHIM ACTA, V51, P3506, DOI 10.1016/j.electacta.2005.10.007
   SENTHIL EK, 2007, BONE, V41, P733
   Tanvir MT, 2007, ELECTROCHIM ACTA, V52, P6834, DOI 10.1016/j.electacta.2007.04.113
   Xu JW, 2007, ELECTROCHIM ACTA, V52, P8044, DOI 10.1016/j.electacta.2007.06.077
   ZENG P, 2007, CHINA PART, V15, P169
NR 17
TC 12
Z9 12
U1 1
U2 12
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA POSCO CENTER, 4TH FL (EAST WING), 892 DAECHI-4-DONG, KANGNAM-KU, SEOUL
   135-777, SOUTH KOREA
SN 1598-9623
J9 MET MATER-INT
JI Met. Mater.-Int.
PD AUG
PY 2008
VL 14
IS 4
BP 449
EP 455
DI 10.3365/met.mat.2008.08.449
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 344YE
UT WOS:000258962400010
DA 2018-10-20
ER

PT J
AU Andreaus, U
   Colloca, M
   Toscano, A
AF Andreaus, U.
   Colloca, M.
   Toscano, A.
TI Mechanical behaviour of physiological and prosthesized human femurs
   during stair climbing: a comparative analysis via 3D numerical
   simulation
SO MINERVA ORTOPEDICA E TRAUMATOLOGICA
LA English
DT Article
DE finite element analysis; arthroplasty, replacement, hip; femur
ID PRIMARY STABILITY; BONE; RESORPTION; STEMS
AB Aim The aim of this study was to perform finite element investigation of the mechanical behaviour of a prosthesized human femur during stair climbing. in order to numerically analyze the stress shielding phenomenon in a femoral bone with an artificial hip replacement, the strain and stress distributions both in the femur and in the stem were evaluated by using the finite element method.
   Methods. From a set of computed tomography (CT) images the geometry of the femur was recovered and me-shed. An operation of virtual surgery allowed to insert the metal stem (constructed by a CAD code) in the medullary canal.
   Results. Numerical simulation showed evidence that stresses and strain energy density increase in the distal zone of the stem-bone interface of the prosthesized femur; and hence a load transfer is determined from proximal zones to distal ones. As expected, lateral and medial zones are subjected to, respectively, tensile and compressive normal stresses in z-direction, absolute maxima being attained at the distal part of the diaphysis.
   Conclusion. The development of a computational model allowed to deal with the complexity of the biomechanical problem and to describe quantitatively the mechanical behaviour of bone tissue in contact with the metal stem. The calculated results motivate the performed analyses because they are sufficient to activate the mechanisms of deposition and resorption in the bone tissue at contact with the artificial biomaterial. Thus, stair climbing confirms to be a critical task for primary stability of the prosthesized femur.
C1 [Andreaus, U.] Univ Roma La Sapienza, Dept Struct & Geotecn Engn, I-00184 Rome, Italy.
RP Andreaus, U (reprint author), Univ Roma La Sapienza, Dept Struct & Geotecn Engn, Via Eudossiana 18, I-00184 Rome, Italy.
EM ugo.andreaus@uniroma1.it
RI Andreaus, Ugo/A-8780-2010
CR ANDREAUS U, 2005, SCI COSTRUZIONI MECC
   ANDREAUS U, 2006, G I O T, V32, P198
   ANDRIACCHI TP, 1980, J BONE JOINT SURG AM, V62, P749, DOI 10.2106/00004623-198062050-00008
   Carter DR, 2001, SKELETAL FUNCTION FO
   Chae SW, 2006, JSME INT J A-SOLID M, V49, P147, DOI 10.1299/jsmea.49.147
   *COMSON AB, 2006, COMSOL MULT 3 3 COMP
   Cowin SC., 2000, BONE MECH HDB
   DIBELLO C, 2004, BIOMATERIALI INTRODU
   Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003
   FUNG YC, 1990, BIOMECHANICS MECH PR
   GUO XE, 2001, BONE MECH HDB
   HART R, 2001, BONE MECH HDB
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   JEBSEN KJ, 2001, BONE MECH HDB
   Kassi JP, 2005, J BIOMECH, V38, P1143, DOI 10.1016/j.jbiomech.2004.05.023
   KAUFMAN KR, 2000, BIOMEDICAL ENG HDB
   Nordin M., 2001, BASIC BIOMECHANICS M
   Ozkaya N., 1999, FUNDAMENTALS BIOMECH
   Pancanti A, 2003, J BIOMECH, V36, P777, DOI 10.1016/S0021-9290(03)00011-3
   PIETRABISSA R, 2000, BIOMATERIALI PROTESI
   RUBIN PJ, 1993, J BIOMECH, V26, P725, DOI 10.1016/0021-9290(93)90035-D
   Spears IR, 2000, J BIOMECH, V33, P1471, DOI 10.1016/S0021-9290(00)00096-8
   VANRIETBERGEN B, 1993, J BIOMECH, V26, P369, DOI 10.1016/0021-9290(93)90001-U
   Wirtz DC, 1998, Z ORTHOP GRENZGEB, V136, P310, DOI 10.1055/s-2008-1053743
   Zannoni C, 1998, MED ENG PHYS, V20, P653, DOI 10.1016/S1350-4533(98)00076-9
   ZIENKIEWICZ OC, 2000, FINTE ELEMENT METHOD, V1
   STEM MODEL
   CT DATA SET FEMUR
NR 28
TC 2
Z9 2
U1 0
U2 1
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0026-4911
J9 MINERVA ORTOP TRAUMA
JI Minerva Ortop. Traumatol.
PD AUG
PY 2008
VL 59
IS 4
BP 213
EP 220
PG 8
WC Orthopedics
SC Orthopedics
GA 333JI
UT WOS:000258148400002
DA 2018-10-20
ER

PT J
AU Jayabalan, P
   Bal, BS
AF Jayabalan, P.
   Bal, B. Sonny
TI Review of biomaterials in total knee arthroplasty
SO MINERVA ORTOPEDICA E TRAUMATOLOGICA
LA English
DT Review
DE arthroplasty, replacement, knee; biocompatible materials; polyethylene;
   ceramics
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL HIP-ARTHROPLASTY; CROSS-LINKED
   POLYETHYLENE; POROUS TANTALUM BIOMATERIAL; CERAMIC BEARING SURFACES;
   TOTAL JOINT ARTHROPLASTY; UHMWPE WEAR DEBRIS; TERM FOLLOW-UP; FEMORAL
   COMPONENTS; IN-VITRO
AB Important advancements have come over the past 15 years in our knowledge of the fabrication of total knee implants, resulting in optimistic projections of the long-term results from total knee arthroplasty. At present, one of the principal reasons for failure of total knee arthroplasty (TKA) is wear the ultra-high molecular weight polyethylene (PE) insert. Attempts to alleviate this problem have focused on highly on improved biomaterials such as highly crosslinked PE, ceramic materials, and alternative metals such as tantalum. The authors review recent developments in the field of biomaterials as applied to total TKA.
C1 [Bal, B. Sonny] Univ Missouri, Dept Orthoped Surg, Columbia, MO 65212 USA.
   [Jayabalan, P.] Univ Missouri, Comparat Orthoped Lab, Columbia, MO 65212 USA.
RP Bal, BS (reprint author), Univ Missouri, Dept Orthoped Surg, MC213,DC053-00,1 Hosp Dr, Columbia, MO 65212 USA.
EM balb@health.missouri.edu
OI Bal, B. Sonny/0000-0002-9615-8632
CR Affatato S, 2005, BIOMATERIALS, V26, P3259, DOI 10.1016/j.biomaterials.2004.07.070
   Ahn NU, 2001, J ARTHROPLASTY, V16, P136, DOI 10.1054/arth.2001.9052
   Archibeck MJ, 2000, CLIN ORTHOP RELAT R, P12
   Atsui Kaoru, 1997, Bulletin Hospital for Joint Diseases, V56, P233
   Bal B Sonny, 2006, J Knee Surg, V19, P89
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   BARTEL DL, 1986, J BONE JOINT SURG AM, V68A, P1041, DOI 10.2106/00004623-198668070-00010
   Bell CJ, 1998, J ARTHROPLASTY, V13, P280, DOI 10.1016/S0883-5403(98)90173-5
   Bizot P, 2004, J BONE JOINT SURG BR, V86B, P190, DOI 10.1302/0301-620X.86B2.14026
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Boehler M, 2000, CLIN ORTHOP RELAT R, P85
   BOS I, 1995, ACTA ORTHOP SCAND, V66, P1, DOI 10.3109/17453679508994628
   Boutin P, 2000, CLIN ORTHOP RELAT R, V379, P3
   Buechel FF, 2002, CLIN ORTHOP RELAT R, P40, DOI 10.1097/01.blo.0000036529.46246.88
   Cales B, 2000, CLIN ORTHOP RELAT R, P94
   Chiu R, 2008, J INVEST MED, V56, P243
   CHRISTEL PS, 1992, CLIN ORTHOP RELAT R, P10
   CLARKE C, 1992, ASTM STP, V1144, P7
   Conditt MA, 2004, J BONE JOINT SURG AM, V86A, P1031, DOI 10.2106/00004623-200405000-00022
   Conditt MA, 2005, J BONE JOINT SURG AM, V87A, P326, DOI 10.2106/JBJS.C.01308
   CONNELLY G M, 1984, Journal of Orthopaedic Research, V2, P119, DOI 10.1002/jor.1100020202
   COOPER JR, 1991, J MED ENG TECHNOL, V15, P63, DOI 10.3109/03091909109009970
   D'Antonio J, 2005, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000162995.50971.39
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P213
   DOBBS HS, 1980, BIOMATERIALS, V1, P193, DOI 10.1016/0142-9612(80)90016-2
   DORRE E, 1983, CERAMICS SURG, P61
   Ezzet KA, 2004, CLIN ORTHOP RELAT R, P120, DOI 10.1097/01.blo.000048576.70780.13
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Fisher J, 2004, CLIN ORTHOP RELAT R, P114, DOI 10.1097/01.blo.0000148783.20469.4c
   Fisher J, 1995, Proc Inst Mech Eng H, V209, P263, DOI 10.1243/PIME_PROC_1995_209_353_02
   Font-Rodriguez DE, 1997, CLIN ORTHOP RELAT R, P79
   Germain MA, 2003, BIOMATERIALS, V24, P469, DOI 10.1016/S0142-9612(02)00360-5
   Glyn-Jones S, 2008, J ARTHROPLASTY, V23, P337, DOI 10.1016/j.arth.2006.12.117
   Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Hamada Y, 1999, J BIOMED MATER RES, V48, P301, DOI 10.1002/(SICI)1097-4636(1999)48:3<301::AID-JBM14>3.0.CO;2-9
   Hamadouche M, 2000, REV CHIR ORTHOP, V86, P474
   HARMS J, 1979, J BIOMED MATER RES, V13, P67, DOI 10.1002/jbm.820130109
   HARRIS WH, 1994, ACTA ORTHOP SCAND, V65, P113, DOI 10.3109/17453679408993734
   Harris WH, 2001, CLIN ORTHOP RELAT R, P66
   Hashiguchi T, 1999, ARCH ORTHOP TRAUM SU, V119, P30, DOI 10.1007/s004020050350
   Hatton A, 2003, BIOMATERIALS, V24, P1193, DOI 10.1016/S0142-9612(02)00510-0
   Huang CH, 2002, J ORTHOPAED RES, V20, P1038, DOI 10.1016/S0736-0266(02)00015-3
   Jacobs JJ, 1999, CLIN ORTHOP RELAT R, P173
   JACOBS JJ, 1995, CLIN ORTHOP RELAT R, P94
   Jacobs JJ, 2003, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000096810.78689.62
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   JAYABALAN PFB, 2006, HOSP SPECIAL SURG J, V3, P30
   JOHANSSON CB, 1990, BIOMATERIALS, V11, P277, DOI 10.1016/0142-9612(90)90010-N
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Keating EM, 2002, CLIN ORTHOP RELAT R, P34, DOI 10.1097/01.blo.0000030485.77561.57
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Knight JL, 1995, J ARTHROPLASTY, V10, P748, DOI 10.1016/S0883-5403(05)80070-1
   Kokubo T, 2004, J MATER SCI-MATER M, V15, P99, DOI 10.1023/B:JMSM.0000011809.36275.0c
   Koshino T, 2002, J ARTHROPLASTY, V17, P1009, DOI 10.1054/arth.2002.35826
   Kovacik MW, 2000, CLIN ORTHOP RELAT R, P186
   Lakdawala A, 2005, J BONE JOINT SURG BR, V87B, P796, DOI 10.1302/0301-620X.87B6.15776
   LASKIN, 2007, TECH KNEE SURG, V6, P220
   Lerouge S, 1997, J BONE JOINT SURG BR, V79B, P135, DOI 10.1302/0301-620X.79B1.6621
   Li S, 2002, CLIN ORTHOP RELAT R, P75, DOI 10.1097/01.blo.0000036538.462646.74
   MALKANI AL, 1995, J BONE JOINT SURG AM, V77A, P423, DOI 10.2106/00004623-199503000-00012
   Martell JM, 2003, J ARTHROPLASTY, V18, P55, DOI 10.1054/S0883-5403(03)00341-3
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   McEwen HMJ, 2005, J BIOMECH, V38, P357, DOI 10.1016/j.jbiomech.2004.02.015
   McKellop H, 2000, J BONE JOINT SURG AM, V82A, P1708, DOI 10.2106/00004623-200012000-00004
   Meneghini R Michael, 2005, Instr Course Lect, V54, P481
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   MICHEL R, 1991, ARCH ORTHOP TRAUM SU, V110, P61, DOI 10.1007/BF00393876
   Miyazaki T, 2000, J BIOMED MATER RES, V50, P35, DOI 10.1002/(SICI)1097-4636(200004)50:1<35::AID-JBM6>3.0.CO;2-8
   Mochida Y, 2002, J ARTHROPLASTY, V17, P121, DOI 10.1054/arth.2002.29330
   Muratoglu OK, 2004, CLIN ORTHOP RELAT R, P108, DOI 10.1097/01.blo.0000143801.41885.8b
   NASSER S, 1990, CLIN ORTHOP RELAT R, P171
   Nasser S, 2004, J ARTHROPLASTY, V19, P562, DOI 10.1016/j.arth.2004.02.025
   Naudie Douglas D, 2004, Instr Course Lect, V53, P251
   Nelson CL, 2003, J ARTHROPLASTY, V18, P37, DOI 10.1054/S0883-5403(03)00290-0
   Nevelos J, 2004, KNEE, V11, P163, DOI 10.1016/j.knee.2004.01.004
   OONISHI H, 1992, J LONG-TERM EFF MED, V2, P37
   Oonishi H, 2002, KEY ENG MAT, V218-2, P499, DOI 10.4028/www.scientific.net/KEM.218-220.499
   Oonishi H., 1981, ORTHOPAEDIC CERAMIC, VI
   PARIKH AMM, 2007, T ORTHOPAEDIC RES SO, V33
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   POGGIE RA, 1992, AM SOC TEST MATER, V1145, P65, DOI 10.1520/STP15333S
   Que L, 2000, J BIOMED MATER RES, V53, P111, DOI 10.1002/(SICI)1097-4636(2000)53:1<111::AID-JBM15>3.0.CO;2-Y
   Rader CP, 1999, J ARTHROPLASTY, V14, P840, DOI 10.1016/S0883-5403(99)90035-9
   Radnay CS, 2006, CLIN ORTHOP RELAT R, P83, DOI 10.1097/01.blo.0000214437.57151.41
   Rahbek O, 2005, INT ORTHOP, V29, P368, DOI 10.1007/s00264-005-0008-4
   RANAWAT CS, 1993, CLIN ORTHOP RELAT R, P94
   RANAWAT CS, 1988, CLIN ORTHOP RELAT R, P6
   Ries MD, 1996, J ARTHROPLASTY, V11, P974, DOI 10.1016/S0883-5403(96)80143-4
   RIES MD, 1999, EFFECT FEMORAL COMPO, V3
   RIMNAC CM, 1994, J BONE JOINT SURG AM, V76A, P1052, DOI 10.2106/00004623-199407000-00014
   Ritter MA, 2001, CLIN ORTHOP RELAT R, P94
   RUSSELL AL, 2001, T ORTHOP RES SOC, V26, P1101
   Shanbhag AS, 2000, J BIOMED MATER RES, V53, P100, DOI 10.1002/(SICI)1097-4636(2000)53:1<100::AID-JBM14>3.0.CO;2-4
   Sharkey PF, 2002, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000036002.13841.32
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   SHIRAZIADL A, 1993, J BIOMED MATER RES, V27, P167, DOI 10.1002/jbm.820270205
   Skinner HB, 1999, CLIN ORTHOP RELAT R, P83
   STULBERG BN, 1994, J APPL BIOMATER, V5, P9, DOI 10.1002/jab.770050103
   Subbarao E.C., 1981, ADV CERAM, V3, P1
   Thomas P, 2003, BIOMATERIALS, V24, P959, DOI 10.1016/S0142-9612(02)00432-5
   TSAO A, 1993, J BONE JOINT SURG AM, V75A, P19, DOI 10.2106/00004623-199301000-00004
   VINCE KG, 1988, ORTHOP CLIN N AM, V19, P575
   Wang A, 1998, J ARTHROPLASTY, V13, P615, DOI 10.1016/S0883-5403(98)80002-8
   WHITE SE, 1994, CLIN ORTHOP RELAT R, P176
   WRIGHT TM, 1992, CLIN ORTHOP RELAT R, P126
   Yasuda K, 2007, TECH KNEE SURG, V6, P213
   Yasuda Kazunori, 1993, Bulletin Hospital for Joint Diseases, V53, P15
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   ZHANG Y, 1999, J MUSCULOSKELET RES, V27, P167
   Zou XN, 2003, APMIS, V111, P127
NR 115
TC 0
Z9 0
U1 1
U2 10
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0026-4911
J9 MINERVA ORTOP TRAUMA
JI Minerva Ortop. Traumatol.
PD AUG
PY 2008
VL 59
IS 4
BP 241
EP 252
PG 12
WC Orthopedics
SC Orthopedics
GA 333JI
UT WOS:000258148400006
DA 2018-10-20
ER

PT J
AU Zhang, X
   Sharma, KK
   Boeglin, M
   Ogier, J
   Mainard, D
   Voegel, JC
   Mely, Y
   Benkirane-Jessel, N
AF Zhang, Xin
   Sharma, Kamal Kant
   Boeglin, Marcel
   Ogier, Joelle
   Mainard, Didier
   Voegel, Jean-Claude
   Mely, Yves
   Benkirane-Jessel, Nadia
TI Transfection ability and intracellular DNA pathway of nanostructured
   gene-delivery systems
SO NANO LETTERS
LA English
DT Article
ID POLYELECTROLYTE MULTILAYERS; BETA-CYCLODEXTRIN; THIN-FILMS;
   THERAPEUTICS; FLUORESCENCE; ARCHITECTURE; TRAFFICKING; DEPOSITION;
   COMPLEXES; POLYMERS
AB Considerable efforts have been devoted to the design of structured materials with functional properties. Polyelectrolyte multilayer films are now a well-established nanostructured concept with numerous potential applications, in particular as biomaterial coatings. This technique allows the preparation of nanostructured architectures exhibiting specific properties for cell-activation control and local drug delivery. In this study, we used a multilayered system made of poly-(L-lysine)/hyaluronic acid (PLL/HA) as a reservoir for active DNA complexes with nonviral gene-delivery vectors, PLL, beta-cyclodextrin (CD), and PLL-CD. When embedded into the multilayered films, the transfection efficiencies of the DNA complexes and the cell viability were improved. The highest transfection efficiency was obtained with the PLL-CD/plasmid DNA (pDNA) complexes. We found that this high transfection efficiency was related to an efficient internalization of the complexes in the cell cytoplasm and selected nuclei domains through a nonendocytotic pathway. For the first time, we report the intracellular pathway of the pDNA in complexes incorporated into the multilayered system.
C1 [Zhang, Xin; Sharma, Kamal Kant; Mely, Yves] Univ Strasbourg 1, Dept Pharmacol & Physicochim, Equipe Photophys Interact Biomol, Inst Gilbert Laustriat,UMR 7175,Fac Pharm, F-67401 Illkirch Graffenstaden, France.
   [Zhang, Xin; Ogier, Joelle; Voegel, Jean-Claude; Benkirane-Jessel, Nadia] Fac Med, INSERM, U595, F-67085 Strasbourg, France.
   [Zhang, Xin; Ogier, Joelle; Voegel, Jean-Claude; Benkirane-Jessel, Nadia] Univ Strasbourg 1, Fac Chirurg Dent, F-67000 Strasbourg, France.
   [Boeglin, Marcel] ULP, CNRS, INSERM, IGBMC,Coll France, F-67404 Strasbourg, France.
   [Mainard, Didier] CHU Nancy, Hop Cent, F-54000 Nancy, France.
   [Mainard, Didier] Univ Nancy 1, CNRS, UMR 7561, Fac Med, Vandoeuvre Les Nancy, France.
RP Mely, Y (reprint author), Univ Strasbourg 1, Dept Pharmacol & Physicochim, Equipe Photophys Interact Biomol, Inst Gilbert Laustriat,UMR 7175,Fac Pharm, BP 60024, F-67401 Illkirch Graffenstaden, France.
EM mely@pharma.u-strasbg.fr; nnadia.jessel@medecine.u-strasbg.fr
RI Benkirane-Jessel, Nadia/H-6438-2016
OI Benkirane-Jessel, Nadia/0000-0003-3059-3559
FU Agence Nationale de la Recherche [ANR06-BLAN-0197-01/CartilSpray];
   Fondation Avenir; Ligue contre le Cancer, du haut Rhin, Region Alsace;
   Canceropole du Grand Est; Faculte de Chirurgie Dentaire of Strasbourg
FX This work was supported by the project ANR06-BLAN-0197-01/CartilSpray,
   from the "Agence Nationale de la Recherche", the "Fondation Avenir", the
   "Ligue contre le Cancer, du haut Rhin, Region Alsace" and "Canceropole
   du Grand Est". X.Z thanks the Faculte de Chirurgie Dentaire of
   Strasbourg for financial support. N.J is indebted to CHU de Nancy
   (Contrat d'interface vers l'hopital).
CR Akinc A, 2002, BIOTECHNOL BIOENG, V78, P503, DOI 10.1002/bit.20215
   Arima H, 2001, BIOCONJUGATE CHEM, V12, P476, DOI 10.1021/bc000111n
   Berth G, 2002, BIOMACROMOLECULES, V3, P579, DOI 10.1021/bm0200130
   Boon EM, 2000, NAT BIOTECHNOL, V18, P1096, DOI 10.1038/80301
   Clamme JP, 2003, BBA-BIOMEMBRANES, V1617, P52, DOI 10.1016/j.bbamem.2003.09.002
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Garza JM, 2005, LANGMUIR, V21, P12372, DOI 10.1021/la051465b
   Gonzalez H, 1999, BIOCONJUGATE CHEM, V10, P1068, DOI 10.1021/bc990072j
   Hartwich G, 1999, J AM CHEM SOC, V121, P10803, DOI 10.1021/ja9920664
   Hiller J, 2002, NAT MATER, V1, P59, DOI 10.1038/nmat719
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   JESSEL N, 2004, ADV MATER, V16, P1507
   Jessel N., 2004, ADV FUNCT MATER, V14, P174
   Jessel N., 2005, ADV FUNCT MATER, V15, P648
   Jessel NB, 2004, ADV FUNCT MATER, V14, P963, DOI 10.1002/adfm.200305089
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Kempf M, 2003, J DRUG TARGET, V11, P11, DOI 10.1080/1061186031000072978
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   Krishnamoorthy G, 2002, BIOCHEMISTRY-US, V41, P15277, DOI 10.1021/bi020440y
   LVOV Y, 1993, MACROMOLECULES, V26, P5396, DOI 10.1021/ma00072a016
   Mannisto M, 2007, J GENE MED, V9, P479, DOI 10.1002/jgm.1035
   Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7
   Meyer F, 2006, BBA-BIOMEMBRANES, V1758, P419, DOI 10.1016/j.bbamem.2005.11.015
   Remy-Kristensen A, 2001, BBA-BIOMEMBRANES, V1514, P21, DOI 10.1016/S0005-2736(01)00359-5
   Ren KF, 2005, COLLOID SURFACE B, V46, P63, DOI 10.1016/j.colsurfb.2005.09.004
   Rimann M, 2008, BIOCONJUGATE CHEM, V19, P548, DOI 10.1021/bc7003439
   Schouten S, 1999, LANGMUIR, V15, P8133, DOI 10.1021/la990162c
   Strand SP, 2005, BIOMACROMOLECULES, V6, P3357, DOI 10.1021/bm0503726
   Wang DY, 2002, NANO LETT, V2, P857, DOI 10.1021/nl025624c
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
   ZHANG X, 2008, J GENE MED
NR 33
TC 37
Z9 38
U1 2
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD AUG
PY 2008
VL 8
IS 8
BP 2432
EP 2436
DI 10.1021/nl801379y
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 337MR
UT WOS:000258440700055
PM 18611056
DA 2018-10-20
ER

PT J
AU Cao, Y
   Li, HB
AF Cao, Yi
   Li, Hongbin
TI Engineered elastomeric proteins with dual elasticity can be controlled
   by a molecular regulator
SO NATURE NANOTECHNOLOGY
LA English
DT Article
ID FORCE-SPECTROSCOPY; MECHANICAL-PROPERTIES; BIOLOGICAL ROLES; BINDING;
   DOMAINS; STABILITY; TOPOLOGY; DESIGN; TITINS
AB Elastomeric proteins are molecular springs that confer excellent mechanical properties(1-5) to many biological tissues and biomaterials. Depending on the role performed by the tissue or biomaterial, elastomeric proteins can behave as molecular springs(1,2,6,7) or shock absorbers(3-5,8-10). Here we combine single-molecule atomic force microscopy and protein engineering techniques to create elastomeric proteins that can switch between two distinct types of mechanical behaviour in response to the binding of a molecular regulator. The proteins are mechanically labile by design and behave as entropic springs with an elasticity that is governed by their configurational entropy. However, when a molecular regulator binds to the protein, it switches into a mechanically stable state and can act as a shock absorber. These engineered proteins effectively mimic and combine the two extreme forms of elastic behaviour found in natural elastomeric proteins, and thus represent a new type of smart nanomaterial that will find potential applications in nanomechanics and material sciences.
C1 [Cao, Yi; Li, Hongbin] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada.
RP Cao, Y (reprint author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.
EM Hongbin@chem.ubc.ca
RI Cao, Yi/A-4200-2011; Li, Hongbin/G-2949-2012
OI Li, Hongbin/0000-0001-7813-1332; Cao, Yi/0000-0003-1493-7868
CR Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034
   Brockwell DJ, 2005, BIOPHYS J, V89, P506, DOI 10.1529/biophysj.105.061465
   Bullard B, 2006, P NATL ACAD SCI USA, V103, P4451, DOI 10.1073/pnas.0509016103
   Bustanji Y, 2002, ANGEW CHEM INT EDIT, V41, P1546, DOI 10.1002/1521-3773(20020503)41:9<1546::AID-ANIE1546>3.0.CO;2-U
   Cao Y, 2008, J MOL BIOL, V378, P1132, DOI 10.1016/j.jmb.2008.03.046
   Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104
   Cao Y, 2007, NAT MATER, V6, P109, DOI 10.1038/nmat1825
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1
   Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600
   Klimov DK, 2000, P NATL ACAD SCI USA, V97, P7254, DOI 10.1073/pnas.97.13.7254
   LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293
   Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437
   Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697
   Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00398
   Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098
   Li PC, 2004, J PHYS CHEM B, V108, P745, DOI 10.1021/jp0363895
   Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4
   Oberhauser AF, 1998, NATURE, V393, P181
   Paci E, 2000, P NATL ACAD SCI USA, V97, P6521, DOI 10.1073/pnas.100124597
   Sagawa T, 2005, MOL IMMUNOL, V42, P9, DOI 10.1016/j.molimm.2004.07.004
   SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Tatham AS, 2000, TRENDS BIOCHEM SCI, V25, P567, DOI 10.1016/S0968-0004(00)01670-4
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003
NR 29
TC 46
Z9 49
U1 3
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1748-3387
J9 NAT NANOTECHNOL
JI Nat. Nanotechnol.
PD AUG
PY 2008
VL 3
IS 8
BP 512
EP 516
DI 10.1038/nnano.2008.168
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 335WZ
UT WOS:000258325800018
PM 18685641
DA 2018-10-20
ER

PT J
AU Ni, Y
   Zhao, X
   Zhou, L
   Shao, ZZ
   Yan, WH
   Chen, X
   Cao, ZB
   Xue, Z
   Jiang, JJ
AF Ni, Yusu
   Zhao, Xia
   Zhou, Liang
   Shao, Zhengzhong
   Yan, Wenhong
   Chen, Xin
   Cao, Zhengbing
   Xue, Zhen
   Jiang, Jack J.
TI Radiologic and histologic characterization of silk fibroin as scaffold
   coating for rabbit tracheal defect repair
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Article
ID CARTILAGE; MORI; RECONSTRUCTION; PROSTHESIS; EXPERIENCE; HEAVY
AB OBJECTIVES: To explore the feasibility of silk fibroin as a biomaterial coating used in tracheal defect reconstruction.
   METHODS: Silk fibroin was subcutaneously embedded in three rabbits and as an artificial implant material coating to reconstruct 12 rabbits' tracheal defects. The postoperative radiologic and histologic characterization was summarized.
   RESULTS: The thickness of the fibroblasts layer covering the porus and nonporus silk fibroin film was 240.4 +/- 9.9 and 302.3 +/- 10.5 mu m, respectively, and there was no statistical difference (P > 0.05) within each group. There was no foreign-body granuloma or macrophagocyte infiltration around the silk film. The tracheal reconstruction study showed a normal mucous membrane with normal cilial growth on the artificial implant and no visible granulation tissue in the reconstructed tracheal cavity.
   CONCLUSIONS: Silk fibroin is a potential new biomaterial coating for tracheal defect reconstruction. The mechanism of silk fibroin appears to promote tracheal mucous membrane, which may be related to its molecular structure and biology. (C) 2008 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
C1 [Zhao, Xia; Yan, Wenhong; Xue, Zhen] Fudan Univ, Huashan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200040, Peoples R China.
   [Ni, Yusu; Zhou, Liang; Jiang, Jack J.] Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Otolaryngol, Shanghai 200040, Peoples R China.
   [Shao, Zhengzhong; Chen, Xin; Cao, Zhengbing] Fudan Univ, Key Lab Mol Engn Polymer MOE, Shanghai 200040, Peoples R China.
   [Shao, Zhengzhong; Chen, Xin; Cao, Zhengbing] Fudan Univ, Dept Macromol Sci, Shanghai 200040, Peoples R China.
   [Jiang, Jack J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI USA.
RP Zhao, X (reprint author), Fudan Univ, Huashan Hosp, Dept Otorhinolaryngol Head & Neck Surg, 12 Wulumuqi Middle Rd, Shanghai 200040, Peoples R China.
EM zhaoxiaabc@126.com
RI cao, zhengbing/F-4544-2010; Chen, Xin/F-6802-2015
OI Chen, Xin/0000-0001-7706-4166
CR CHEN X, Patent No. 1483866
   CHEN X, Patent No. 031422012
   COTTON RT, 1989, LARYNGOSCOPE, V99, P1111
   Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   JINGSONG C, 2003, BIOMATERIALS, V24, P401
   KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583
   Kushibe K, 2001, ANN THORAC SURG, V71, P1666, DOI 10.1016/S0003-4975(01)02530-9
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   LIU XY, 2002, CHIN J HEMORHEOL, V12, P266
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Murai K, 1999, ANN THORAC SURG, V67, P776, DOI 10.1016/S0003-4975(98)01142-4
   NEVILLE WE, 1990, J THORAC CARDIOV SUR, V99, P604
   Ni Yu-su, 2005, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V40, P887
   Ning L, 2000, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V14, P44
   NING L, 1998, SPECIAL FUNCTIONAL M, V8, P217
   PIHUAN J, 2000, MED STAT, P413
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
   Wu F, 1999, ANN NY ACAD SCI, V875, P405, DOI 10.1111/j.1749-6632.1999.tb08523.x
   [谢宇锋 Xie Yufeng], 2004, [苏州大学学报. 医学版, Suzhou University Journal of Medical Science], V24, P1
   Yildirim G, 2000, ANN OTO RHINOL LARYN, V109, P981
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 22
TC 19
Z9 21
U1 2
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0194-5998
EI 1097-6817
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD AUG
PY 2008
VL 139
IS 2
BP 256
EP 261
DI 10.1016/j.otohns.2008.03.028
PG 6
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 332WM
UT WOS:000258113800015
PM 18656725
DA 2018-10-20
ER

PT J
AU Zou, J
   Asukas, J
   Inha, T
   Toppila, E
   Kellomaki, M
   Pyykko, I
AF Zou, Jing
   Asukas, Jonna
   Inha, Taija
   Toppila, Esko
   Kellomaki, Minna
   Pyykko, Ilmari
TI Biocompatibility of different biopolymers after being implanted into the
   rat cochlea
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE biomaterial; biocompatibility; cochlea; implant
ID DRUG-DELIVERY SYSTEMS; LONG-TERM EVALUATION; IN-VITRO; NEUROTROPHIC
   FACTOR; PHOTOCROSSLINKABLE CHITOSAN; CONTROLLED-RELEASE; ACID
   MICROSPHERES; MOLECULAR-WEIGHT; POLY(EPSILON-CAPROLACTONE);
   NANOPARTICLES
AB Objective: To assess the biocompatibility of different biopolymers with cochlea implant.
   Materials and Methods: Six bioabsorbable polymers and biostable silicone were used for testing histologic reactions in the cochlea of the rat. The samples were prepared from three 50/50 poly(DL-lactide-co-glycolide) PDLLGA having different inherent viscosity (IV) values and 75/25 poly(DL-lactide-co-epsilon-caprolactone) P(DLLA/CL), poly-epsilon-caprolactone PCL, silicone, and chitosan by extruding the biomaterial as a rod using melt molding (for 50/50 PDLLGAs and 75/25 P(DLLA/CL) and PCL), blending (for silicone), and solving (for chitosan). The rods were cut into samples of diameter of 0.5 mm and length of 2 mm. All the samples were packed and sterilized by gamma irradiation (18 kGy, less than 42 degrees C). Twenty-two male and female Sprague-Dawley rats were used in the study. Four months after the implantation, the animals were killed for histologic observation.
   Results: Chitosan does not degrade in the cochlea 4 months after implantation and, therefore, stimulates very weak inflammatory reaction. The 50/50 PDLLGA (IV, 0.83 dL/g) degrades in the cochlea 4 months after implantation and does not stimulate inflammatory reaction. The 50/50 PDLLGA (IV, 0.41 dL/g; IV, 0.37 dL/g), 75/25 P(DLLA/CL), PCL, and silicone might induce strong inflammatory reaction in the cochlea.
   Conclusion: Different degradation property of biomaterials in the cochlea indicates diverse drug releasing time in a controlled way. Chitosan is suitable for long-lasting drug delivery, whereas 50/50 PDLLGA (IV, 0.83 dL/g) favors quicker releasing. Both chitosan and 50/50 PDLLGA (IV, 0.83 dL/g) are ideal materials for cochlear drug delivery.
C1 [Zou, Jing; Toppila, Esko; Pyykko, Ilmari] Univ Tampere, Sch Med, Dept Otolaryngol, Tampere 33520, Finland.
   [Asukas, Jonna; Inha, Taija; Kellomaki, Minna] Tampere Univ Technol, Inst Biomat, FIN-33101 Tampere, Finland.
RP Zou, J (reprint author), Univ Tampere, Sch Med, Dept Otolaryngol, Biokatu 6, Tampere 33520, Finland.
EM Jing.Zou@uta.fi
RI Kellomaki, Minna/G-6190-2010
OI Kellomaki, Minna/0000-0003-4321-1820
CR Aarnisalo AA, 2000, ORL-J OTO-RHIN-LARYN, V62, P330, DOI 10.1159/000027764
   Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o
   Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117
   Bessho K, 2002, J BIOMED MATER RES, V61, P61, DOI 10.1002/jbm.10169
   Carrasquillo KG, 2003, INVEST OPHTH VIS SCI, V44, P290, DOI 10.1167/iovs.01-1156
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   Cui ZR, 2001, J CONTROL RELEASE, V75, P409, DOI 10.1016/S0168-3659(01)00407-2
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   Denkbas EB, 2004, J BIOMATER APPL, V18, P291, DOI 10.1177/0885328204041510
   Felt O, 1999, INT J PHARM, V180, P185, DOI 10.1016/S0378-5173(99)00003-4
   GIORDANO GG, 1995, CURR EYE RES, V14, P761, DOI 10.3109/02713689508995797
   Guerra GD, 1999, J MATER SCI-MATER M, V10, P659, DOI 10.1023/A:1008948010636
   Hinojosa R, 2001, LARYNGOSCOPE, V111, P1797, DOI 10.1097/00005537-200110000-00025
   Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jiao YY, 2002, CIRCULATION, V105, P230, DOI 10.1161/hc0202.101988
   Kanzaki S, 2002, J COMP NEUROL, V454, P350, DOI 10.1002/cne.10480
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Lalwani AK, 2002, LARYNGOSCOPE, V112, P1325, DOI 10.1097/00005537-200208000-00001
   Li S, 1999, ENCY CONTROLLED DRUG, P71
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Meek MF, 1999, MICROSURG, V19, P247, DOI 10.1002/(SICI)1098-2752(1999)19:5<247::AID-MICR7>3.0.CO;2-E
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Miura M, 2002, ANN OTO RHINOL LARYN, V111, P1059, DOI 10.1177/000348940211101201
   MORITERA T, 1991, INVEST OPHTH VIS SCI, V32, P1785
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1979, J PHARM SCI, V68, P1534, DOI 10.1002/jps.2600681219
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Shinohara T, 2002, P NATL ACAD SCI USA, V99, P1657, DOI 10.1073/pnas.032677999
   SPELMAN FA, 1980, ANN OTO RHINOL LARYN, V89, P8
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Valente M, 2002, INT J ARTIF ORGANS, V25, P777
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
NR 39
TC 1
Z9 1
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1531-7129
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD AUG
PY 2008
VL 29
IS 5
BP 714
EP 719
DI 10.1097/MAO.0b013e31817d874b
PG 6
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA 333ZZ
UT WOS:000258193400025
PM 18580700
DA 2018-10-20
ER

PT J
AU Astala, R
   Stottt, MJ
AF Astala, R.
   Stottt, M. J.
TI First-principles study of hydroxyapatite surfaces and water adsorption
SO PHYSICAL REVIEW B
LA English
DT Article
ID STABILIZED TRICALCIUM PHOSPHATE; SYNTHETIC HYDROXYAPATITE; POTENTIAL
   MODEL; BONE; FLUORAPATITE; DISSOLUTION; CHARGE; SPECTROSCOPY; IONS
AB Hydroxyapatite (HA) is the main mineral component of natural bone and an important synthetic biomaterial. The surfaces of this material are critical as the biological action takes place at the interface between the HA and the biological medium. Ab initio total energy methods are used to study the atomic structure and surface chemistry of HA. Low index HA surfaces in vacuum, the adsorption of water on these surfaces, and the loss of Ca from them are considered. All surfaces are found to react strongly with water, and after adsorption of water (001) and Ca-rich (010), surfaces are found to be energetically favored. The loss of Ca from the surface in exchange for two H is also very favorable. The calculated energies of the various surfaces shed light on the morphologies of HA crystallites found in dissolution studies.
C1 [Astala, R.; Stottt, M. J.] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada.
EM astala@physics.queensu.ca; stott@mjs.phy.queensu.ca
FU NSERC; Millenium Biologix Corp.
FX The support of the NSERC and Millenium Biologix Corp. is gratefully
   acknowledged. R.A. also acknowledges the hospitality of E. Kaxiras of
   Department of Physics, Harvard University.
CR Arsic J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.245406
   Artacho E, 1999, PHYS STATUS SOLIDI B, V215, P809, DOI 10.1002/(SICI)1521-3951(199909)215:1<809::AID-PSSB809>3.0.CO;2-0
   Astala R, 2006, CHEM MATER, V18, P413, DOI 10.1021/cm051989x
   Astala R, 2005, CHEM MATER, V17, P4125, DOI 10.1021/cm050523b
   Bazaraa M. S., 1993, NONLINEAR PROGRAMMIN
   BELL LC, 1973, J COLLOID INTERF SCI, V42, P250, DOI 10.1016/0021-9797(73)90288-9
   Brown PW, 1999, J PHYS CHEM B, V103, P1671, DOI 10.1021/jp982554i
   Calderin L, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.134106
   CHANDER S, 1979, J COLLOID INTERF SCI, V70, P506, DOI 10.1016/0021-9797(79)90058-4
   de Leeuw NH, 2004, PHYS CHEM CHEM PHYS, V6, P1860, DOI 10.1039/b313242k
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Dorozhkin SV, 1997, J COLLOID INTERF SCI, V191, P489, DOI 10.1006/jcis.1997.4942
   DRY ME, 1960, J PHYS CHEM-US, V64, P1300, DOI 10.1021/j100838a042
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Harding IS, 2005, BIOMATERIALS, V26, P6818, DOI 10.1016/j.biomaterials.2005.04.060
   HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864
   ISHIKAWA T, 1989, LANGMUIR, V5, P140, DOI 10.1021/la00085a025
   KAXIRAS E, 1987, PHYS REV B, V35, P9625, DOI 10.1103/PhysRevB.35.9625
   KAXIRAS E, 1986, PHYS REV LETT, V56, P2819, DOI 10.1103/PhysRevLett.56.2819
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133
   LAKS DB, 1991, PHYS REV LETT, V66, P648, DOI 10.1103/PhysRevLett.66.648
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Matsunaga K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014102
   Mkhonto D, 2002, J MATER CHEM, V12, P2633, DOI 10.1039/b204111a
   MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188
   Ordejon P, 1996, PHYS REV B, V53, P10441, DOI 10.1103/PhysRevB.53.R10441
   Park CY, 2004, AM MINERAL, V89, P1647, DOI 10.2138/am-2004-11-1209
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Pietak AM, 2006, BIOMATERIALS, V27, P3, DOI 10.1016/j.biomaterials.2005.05.093
   POSNER AS, 1985, J BIOMED MATER RES, V19, P241, DOI 10.1002/jbm.820190307
   ROOTARE HM, 1977, J DENT RES, V56, P1437, DOI 10.1177/00220345770560120101
   Rulis P, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245410
   SMITH AN, 1974, J COLLOID INTERF SCI, V48, P442, DOI 10.1016/0021-9797(74)90188-X
   Troullier N., 1991, PHYS REV B, V43
   Tuck L, 2008, J MATER SCI-MATER M, V19, P917, DOI 10.1007/s10856-007-0172-8
   Vandiver J, 2005, BIOMATERIALS, V26, P271, DOI 10.1016/j.biomaterials.2004.02.053
   WEINER S, 1992, FASEB J, V6, P879
   WHALLEY E, 1957, T FARADAY SOC, V53, P1578, DOI 10.1039/tf9575301578
   Yin XL, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2178800
   Yin XL, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.205205
   Zahn D, 2003, PHYS CHEM CHEM PHYS, V5, P4004, DOI 10.1039/b306358e
NR 44
TC 54
Z9 54
U1 3
U2 46
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 1098-0121
EI 1550-235X
J9 PHYS REV B
JI Phys. Rev. B
PD AUG
PY 2008
VL 78
IS 7
AR 075427
DI 10.1103/PhysRevB.78.075427
PG 11
WC Physics, Condensed Matter
SC Physics
GA 351EG
UT WOS:000259406700108
DA 2018-10-20
ER

PT J
AU Lawal, OS
   Lechner, MD
   Kulicke, WM
AF Lawal, O. S.
   Lechner, M. D.
   Kulicke, W. M.
TI The synthesis conditions, characterizations and thermal degradation
   studies of an etherified starch from an unconventional source
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE pigeon pea; carboxymethyl starch; characterization; thermal stability
ID CARBOXYMETHYL CASSAVA STARCH; PHYSICOCHEMICAL CHARACTERISTICS; REACTION
   PARAMETERS; POTATO STARCH; HYBRID MAIZE; DERIVATIVES; HEMICELLULOSES;
   ORIGIN; AGENT
AB Starch isolated from an under-utilized legume plant (pigeon pea) was carboxymethylated. influences of reaction parameters were investigated on the degree of substitution (DS) and the reaction efficiency (RE). Studies showed that optimal DS of 1.12 could be reached at reaction efficiency of 80.6% in isopropanolwater reaction medium (40 degrees C, 3 h). Scanning electron microscopy showed that after carboxymethylation, the granular appearance of the native starch was distorted. Wide-angle X-ray diffractometry revealed that crystallinity was reduced significantly after carboxymethylation. The infrared spectra revealed new bands in the carboxymethyl starch at nu = 1600, 1426 and 1324 cm(-1) which were attributed to carbonyl functional groups vibration, -CH2 scissoring and OH bending vibration, respectively. Broad-band C-13 NMR of carboxymethyl starch showed an intense peak at delta = 180.3 ppm which was assigned to carbonyl carbon on the carboxymethyl substituent on the AGU (Anhydroglucose Unit). DEPT (Distortionless Enhancement by Polarization Transfer) 135 NMR showed negative signals which correspond to methylene carbons on the AGU. Differential Scanning Calorimetry (DSC) suggests loss of crystallinity after carboxymethylation. Thermogravimetry (TG), Derivative Thermogravimetry (DTG) and Differential Thermal Analysis (DTA) show that thermal stability improved after carboxymethylation. The study provides information on the preparation and characterization of a biomaterial from a new source which could be used alone or in the preparation of other functional polymers for diverse polymer applications. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Lawal, O. S.] Olabisi Onabanjo Univ, Dept Chem Sci, Ago Iwoye, Ogun, Nigeria.
   [Lawal, O. S.; Kulicke, W. M.] Univ Hamburg, Inst Tech & Macromol Chem, D-20146 Hamburg, Germany.
   [Lechner, M. D.] Univ Osnabruck, Inst Phys Chem, D-49069 Osnabruck, Germany.
RP Lawal, OS (reprint author), Olabisi Onabanjo Univ, Dept Chem Sci, PMB 2002, Ago Iwoye, Ogun, Nigeria.
EM laidelawal2@yahoo.com
FU Alexander von Humboldt foundation of Germany; Abdus Salaam International
   Centre for Theoretical Physics, Trieste, Italy
FX OSL is grateful to the Alexander von Humboldt foundation of Germany for
   the award of postdoctoral fellowship with Professor Dr. W.-M. Kulicke
   and the Abdus Salaam International Centre for Theoretical Physics,
   Trieste, Italy for the award of associate of biophysics of the living
   state.
CR Adebowale KO, 2003, FOOD HYDROCOLLOID, V17, P265, DOI 10.1016/S0268-005X(02)00076-0
   Adebowale KO, 2002, NAHRUNG, V46, P311, DOI 10.1002/1521-3803(20020901)46:5<311::AID-FOOD311>3.0.CO;2-Z
   *AOAC, 1996, OFF METH AN
   Bhattacharyya D, 1995, CARBOHYD POLYM, V27, P247, DOI 10.1016/0144-8617(95)00083-6
   De Graaf RA, 2003, ADV POLYM TECH, V22, P56, DOI 10.1002/adv.10034
   Filho G. R., 2007, POLYM DEGRAD STABIL, V92, P205
   GERNAT C, 1990, STARCH-STARKE, V42, P175, DOI 10.1002/star.19900420504
   Guo MY, 2005, J APPL POLYM SCI, V96, P2132, DOI 10.1002/app.21140
   HEBEISH A, 1988, STARCH-STARKE, V40, P104, DOI 10.1002/star.19880400306
   Hebeish A., 2006, STARCH, V42, P185
   Heinze T, 2004, CELLULOSE, V11, P239, DOI 10.1023/B:CELL.0000025386.68486.a4
   Heinze T, 1999, STARCH-STARKE, V51, P11, DOI 10.1002/(SICI)1521-379X(199901)51:1<11::AID-STAR11>3.0.CO;2-2
   HIZUKURI S, 1983, BIOCHIM BIOPHYS ACTA, V760, P188, DOI 10.1016/0304-4165(83)90142-3
   HIZUKURI S, 1986, CARBOHYD RES, V141, P299
   KHALIL MI, 1990, STARCH-STARKE, V42, P60, DOI 10.1002/star.19900420209
   Kittipongpatana OS, 2006, STARCH-STARKE, V58, P587, DOI 10.1002/star.200600528
   KITTIPONGPATANA OS, 2006, STARCH, V63, P105
   Lawal OS, 2008, INT J BIOL MACROMOL, V42, P429, DOI 10.1016/j.ijbiomac.2008.02.006
   Lawal OS, 2007, STARCH-STARKE, V59, P224, DOI 10.1002/star.200600594
   Lawal OS, 2004, CARBOHYD RES, V339, P2673, DOI 10.1016/j.carres.2004.08.015
   Lawal OS, 2005, CARBOHYD POLYM, V60, P331, DOI 10.1016/j.carbpol.2005.01.011
   Lawal OS, 2004, FOOD CHEM, V87, P205, DOI 10.1016/j.foodchem.2003.11.013
   Lawal OS, 2005, INT J BIOL MACROMOL, V35, P71, DOI 10.1016/j.ijbiomac.2004.12.004
   Menard K. P., 2000, PERFORMANCE PLASTICS
   Mostafa KM, 2004, STARCH-STARKE, V56, P254, DOI 10.1002/star.200300203
   Pal S, 2005, CARBOHYD POLYM, V59, P417, DOI 10.1016/j.carbpol.2004.06.047
   PURSEGLOVE JW, 1968, TROPICAL CROPS DICOT
   Qiu HY, 1999, POLYM ADVAN TECHNOL, V10, P468, DOI 10.1002/(SICI)1099-1581(199907)10:7<468::AID-PAT898>3.3.CO;2-N
   Ren JL, 2008, POLYM DEGRAD STABIL, V93, P786, DOI 10.1016/j.polymdegradstab.2008.01.011
   Sangseethonga K, 2005, STARCH-STARKE, V57, P84, DOI 10.1002/star.200400302
   Seidel C, 2004, STARCH-STARKE, V56, P157, DOI 10.1002/star.200200165
   Shirzad-Semsar M, 2007, J PHYS CHEM B, V111, P8641, DOI 10.1021/jp0702705
   Silva GA, 2005, MAT SCI ENG C-BIO S, V25, P237, DOI 10.1016/j.msec.2005.01.012
   Singh RP, 2003, CARBOHYD RES, V338, P1759, DOI 10.1016/S0008-6215(03)00236-2
   Tijsen CJ, 2001, CARBOHYD POLYM, V45, P219, DOI 10.1016/S0144-8617(00)00243-5
   Wu ZW, 2006, J APPL POLYM SCI, V101, P2210, DOI 10.1002/app.23479
   Xiao B, 2001, POLYM DEGRAD STABIL, V74, P307, DOI 10.1016/S0141-3910(01)00163-X
   Zohuriaan MJ, 2004, POLYM TEST, V23, P575, DOI 10.1016/j.polymertesting.2003.11.001
NR 38
TC 53
Z9 57
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD AUG
PY 2008
VL 93
IS 8
BP 1520
EP 1528
DI 10.1016/j.polymdegradstab.2008.05.010
PG 9
WC Polymer Science
SC Polymer Science
GA 350YD
UT WOS:000259388900016
DA 2018-10-20
ER

PT J
AU Lee, SJ
   Van Dyke, M
   Atala, A
   Yoo, JJ
AF Lee, Sang Jin
   Van Dyke, Mark
   Atala, Anthony
   Yoo, James J.
TI Host cell mobilization for in situ tissue regeneration
SO REJUVENATION RESEARCH
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; INFLAMMATORY RESPONSES; CLINICAL-APPLICATIONS;
   DIFFERENTIATION; BIOMATERIALS; EXPANSION; THERAPY
AB Although small, localized injuries can be healed through the body's normal reparative process, large traumatic injury overwhelms this system and may result in a deficit of functional recovery, despite the use of conventional reconstructive modalities. Cell-based approaches using tissue engineering and regenerative medicine techniques have offered new opportunities for treatment. Although the fundamental principles of cell-based therapies have been demonstrated clinically on multiple tissue systems, usually a donor tissue biopsy and ex vivo cell manipulation prior to implantation in vivo are necessary. The goal of the present study was to investigate whether host biologic resources and environmental conditions could be used for in situ tissue regeneration, which may eliminate the need for donor cell procurement and subsequent in vitro cell manipulation. To address this aim, we implanted a common biomaterial into mice and characterized the infiltrating cells to determine their regenerative potential. We showed that host cell infiltrates are not entirely comprised of inflammatory and fibroblast-like cells and the normal inflammatory process can be altered by incorporating anti-inflammatory agents that influence the formation of scar tissue. In addition, the infiltrating cells are capable of differentiating into multiple cell lineages, including osteogenic, myogenic, adipogenic, and endothelial lineages, if appropriate conditions are provided. These results suggest that it is possible to recruit a predominance of cells with multilineage potential into a biomaterial scaffold. Therefore, it may be possible to enrich the infiltrate with such cell types and control their fate, provided the proper substrate-mediated signaling can be imparted into the scaffold for in situ tissue regeneration.
C1 [Lee, Sang Jin; Van Dyke, Mark; Atala, Anthony; Yoo, James J.] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Yoo, JJ (reprint author), Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM jyoo@wfubmc.edu
RI Yoo, James/L-4850-2017
OI Atala, Anthony/0000-0001-8186-2160; Lee, Sang Jin/0000-0002-3899-1909
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2006, CURR OPIN PEDIATR, V18, P167, DOI 10.1097/01.mop.0000193294.94646.be
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337
   Broughton George 2nd, 2006, Plast Reconstr Surg, V117, p1e, DOI 10.1097/01.prs.0000222562.60260.f9
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Cotran RS, 1999, ROBBINS PATHOLOGIC B
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   De Ugarte DA, 2003, ANN PLAS SURG, V50, P215, DOI 10.1097/01.SAP.0000029661.38066.15
   Deasy BM, 2002, CURR OPIN MOL THER, V4, P382
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Guillot PV, 2007, J CELL MOL MED, V11, P935, DOI 10.1111/j.1582-4934.2007.00106.x
   Harty M, 2003, DEV DYNAM, V226, P268, DOI 10.1002/dvdy.10239
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu JW, 2007, J THROMB HAEMOST, V5, P826, DOI 10.1111/j.1538-7836.2007.02381.x
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   MOREHEAD JM, 1994, OTOLARYNG CLIN N AM, V27, P195
   Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180
   Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Williams D. J., 2005, IEE Proceedings Nanobiotechnology, V152, P207, DOI 10.1049/ip-nbt:20050001
   Zhang Y, 2003, WORLD J GASTROENTERO, V9, P201, DOI 10.3748/wjg.v9.i2.201
NR 28
TC 30
Z9 30
U1 0
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
J9 REJUV RES
JI Rejuv. Res.
PD AUG
PY 2008
VL 11
IS 4
BP 747
EP 756
DI 10.1089/rej.2008.0691
PG 10
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA 351XT
UT WOS:000259459900005
PM 18729807
DA 2018-10-20
ER

PT J
AU Nain, AS
   Phillippi, JA
   Sitti, M
   MacKrell, J
   Campbell, PG
   Amon, C
AF Nain, Amritider S.
   Phillippi, Julie A.
   Sitti, Metin
   MacKrell, James
   Campbell, Phil G.
   Amon, Cristina
TI Control of cell behavior by aligned micro/nanofibrous biomaterial
   scaffolds fabricated by spinneret-based tunable engineered parameters
   (STEP) technique
SO SMALL
LA English
DT Article
DE biomaterials; dry spinning; polymer nanofibers; tissue engineering;
   tissue scaffolds
ID GENE-EXPRESSION; FIBER FORMATION; BETA-RECEPTORS; TISSUE; MUSCLE;
   INTEGRINS; PHOSPHORYLATION; DIFFERENTIATION; MORPHOGENESIS; TRANSDUCTION
C1 [Nain, Amritider S.] Carnegie Mellon Univ, ICES, Pittsburgh, PA 15213 USA.
   [Phillippi, Julie A.; MacKrell, James; Campbell, Phil G.] Carnegie Mellon Univ, MBIC, Pittsburgh, PA 15213 USA.
   [Nain, Amritider S.; Sitti, Metin] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.
   [Amon, Cristina] Univ Toronto, Dept Mech & Ind Engn, Fac Appl Sci & Engn, Toronto, ON M5S 1A4, Canada.
RP Nain, AS (reprint author), Carnegie Mellon Univ, ICES, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.
EM anain@andrew.cmu.edu
RI Nain, Amrinder/F-2789-2014
FU Pennsylvania Infrastructure Technology Alliance (PITA: ASN, PGC, and
   MS); Pittsburgh Tissue Engineering Initiative; NSF CAREER [NSF
   IIS-0448042]
FX A. S. Nain and J. A. Phillippi contributed equally to this work. The
   authors gratefully acknowledge Eric Miller, Bahareh Behkam, Franklin
   Chung, Jason Smith, James Fitzpatrick, Greg Fisher, and Joseph Suhan for
   scaffold preparation and imaging assistance, Alan Waggoner, director of
   the Molecular Biosensor and Imaging Center (CMU) for use of the
   facilities, and Jonathan Jarvik for providing the GFP-alpha-tubulin
   vector. The authors are thankful to Purac Biochem, The Netherlands for
   supplying experimental polymeric samples. This work was supported in
   part by the Pennsylvania Infrastructure Technology Alliance (PITA: ASN,
   PGC, and MS), the Pittsburgh Tissue Engineering Initiative (JAP), and
   the NSF CAREER program (MS, NSF IIS-0448042).
CR Damsky CH, 1997, KIDNEY INT, V51, P1427, DOI 10.1038/ki.1997.195
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021
   Gustafson T, 1999, EXP CELL RES, V253, P288, DOI 10.1006/excr.1999.4744
   Jarvik JW, 1996, BIOTECHNIQUES, V20, P896
   Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Langer R, 2007, TISSUE ENG, V13, P1, DOI 10.1089/ten.2006.0219
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   McKee MG, 2004, MACROMOLECULES, V37, P1760, DOI 10.1021/ma035689h
   Milasincic DJ, 1996, IN VITRO CELL DEV-AN, V32, P90
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nain AS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2372694
   Nain AS, 2007, IEEE INT CONF ROBOT, P1918, DOI 10.1109/ROBOT.2007.363602
   Nain AS, 2006, IEEE T NANOTECHNOL, V5, P499, DOI 10.1109/TNANO.2006.880453
   NAIN AS, 2007, THESIS CARNEGIE MELL
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Papenburg BJ, 2007, BIOMATERIALS, V28, P1998, DOI 10.1016/j.biomaterials.2006.12.023
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600
   Silver F. H., 1999, BIOMATERIALS SCI BIO
   Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   Xu JT, 2004, BIOMED MICRODEVICES, V6, P117, DOI 10.1023/B:BMMD.0000031748.13353.10
   YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
   Ziabicki A, 1976, FUNDAMENTALS FIBER F
NR 35
TC 37
Z9 37
U1 0
U2 24
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1613-6810
J9 SMALL
JI Small
PD AUG
PY 2008
VL 4
IS 8
BP 1153
EP 1159
DI 10.1002/smll.200800101
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 339GP
UT WOS:000258566400024
PM 18651720
DA 2018-10-20
ER

PT J
AU Kim, BS
   Atala, A
   Yoo, JJ
AF Kim, Byung-Soo
   Atala, Anthony
   Yoo, James J.
TI A collagen matrix derived from bladder can be used to engineer smooth
   muscle tissue
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE collagen matrix; bladder submucosa; smooth muscle
ID SMALL-INTESTINAL SUBMUCOSA; REPAIR; BIOMATERIAL; ALLODERM; CELLS
AB We have previously demonstrated that a collagen matrix derived from lamina propria, commonly known as bladder submucosa (BSM matrix), is a suitable biomaterial for several urologic applications, including reconstruction of the bladder and urethra in experimental models and clinical trials. In the present study, we evaluated the physical properties of BSM as well as its biocompatibility, cellular interactions, and ability to support the formation of functional tissue in order to determine whether this biomaterial could serve as a matrix for urinary smooth muscle tissue engineering. BSM matrix resembles the extracellular matrix of bladder submucosa in its native structure, composition, and mechanical properties. BSM matrix supported normal mitochondrial metabolic and proliferative functions of human urinary smooth muscle cells and did not induce cytotoxic effects in vitro. When implanted in vivo, BSM matrix promoted the regeneration of urinary smooth muscle tissues with contractility, which is a smooth muscle-specific tissue function. These results suggest that BSM matrix would be a useful biomaterial for urinary smooth muscle reconstruction.
C1 [Atala, Anthony; Yoo, James J.] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
   [Kim, Byung-Soo] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
RP Yoo, JJ (reprint author), Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM jyoo@wfubmc.edu
RI Yoo, James/L-4850-2017; Kim, Byung-Soo/O-2352-2013
OI Atala, Anthony/0000-0001-8186-2160
CR Abenavoli FM, 2001, ANN PLAS SURG, V46, P354, DOI 10.1097/00000637-200103000-00039
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   Atala A, 2001, Curr Urol Rep, V2, P83, DOI 10.1007/s11934-001-0030-z
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Desgrandchamps F, 2000, Curr Opin Urol, V10, P201, DOI 10.1097/00042307-200005000-00003
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   El-Kassaby AW, 2003, J UROLOGY, V169, P31
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   OZTURK SS, 1990, BIOTECHNOL PROGR, V6, P121, DOI 10.1021/bp00002a005
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   UPHILL PF, 1990, MED DEVICE TECHN NOV, P24
   WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I
   Wilson G J, 1990, ASAIO Trans, V36, pM340
   WILSON GJ, 1995, ANN THORAC SURG, V60, pS353, DOI 10.1016/0003-4975(95)98967-Y
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 21
TC 14
Z9 25
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-4983
J9 WORLD J UROL
JI World J. Urol.
PD AUG
PY 2008
VL 26
IS 4
BP 307
EP 314
DI 10.1007/s00345-008-0300-1
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 339LB
UT WOS:000258578000004
PM 18594823
DA 2018-10-20
ER

PT J
AU Harrington, DA
   Sharma, AK
   Erickson, BA
   Cheng, EY
AF Harrington, Daniel A.
   Sharma, Arun K.
   Erickson, Bradley A.
   Cheng, Earl Y.
TI Bladder tissue engineering through nanotechnology
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE bladder; tissue engineering; regenerative medicine; nanotechnology;
   self-assembly; supramolecular; scaffold; biomaterial; top-down;
   bottom-up; stem cell
ID SMALL-INTESTINAL SUBMUCOSA; FIBROBLAST-GROWTH-FACTOR;
   SMOOTH-MUSCLE-CELLS; URINARY-BLADDER; EXTRACELLULAR-MATRIX; STEM-CELLS;
   IN-VITRO; NANOFIBERS; DIFFERENTIATION; RECONSTRUCTION
AB The field of tissue engineering has developed in phases: initially researchers searched for "inert" biomaterials to act solely as replacement structures in the body. Then, they explored biodegradable scaffolds-both naturally derived and synthetic-for the temporary support of growing tissues. Now, a third phase of tissue engineering has developed, through the subcategory of "regenerative medicine." This renewed focus toward control over tissue morphology and cell phenotype requires proportional advances in scaffold design. Discoveries in nanotechnology have driven both our understanding of cell-substrate interactions, and our ability to influence them. By operating at the size regime of proteins themselves, nanotechnology gives us the opportunity to directly speak the language of cells, through reliable, repeatable creation of nanoscale features. Understanding the synthesis of nanoscale materials, via "top-down" and "bottom-up" strategies, allows researchers to assess the capabilities and limits inherent in both techniques. Urology research as a whole, and bladder regeneration in particular, are well-positioned to benefit from such advances, since our present technology has yet to reach the end goal of functional bladder restoration. In this article, we discuss the current applications of nanoscale materials to bladder tissue engineering, and encourage researchers to explore these interdisciplinary technologies now, or risk playing catch-up in the future.
C1 [Harrington, Daniel A.; Sharma, Arun K.; Cheng, Earl Y.] Childrens Mem Hosp, Div Pediat Urol, Chicago, IL 60614 USA.
   [Harrington, Daniel A.; Sharma, Arun K.; Erickson, Bradley A.; Cheng, Earl Y.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.
   [Harrington, Daniel A.; Sharma, Arun K.; Cheng, Earl Y.] Northwestern Univ, Inst BioNanotechnol Med IBNAM, Chicago, IL 60611 USA.
RP Cheng, EY (reprint author), Childrens Mem Hosp, Div Pediat Urol, Chicago, IL 60614 USA.
EM echeng@childrensmemorial.org
OI Harrington, Daniel/0000-0003-2505-0349
FU NIH [DK072450, T32DK62716]; DAH
FX We would like to acknowledge our ongoing collaboration with the
   laboratory of S. Stupp in the PA work, and the laboratory of K. Shull in
   the triblock copolymer work, especially the contributions of M.
   Guvendiren toward synthesis and imaging. We would like to thank K.
   Haberstroh and J. Southgate for providing high-resolution images for
   Fig. 2. This work was partially funded under NIH Award DK072450 and
   T32DK62716. DAH was supported by the Baxter-Northwestern Early Career
   Development Award in Bioengineering, and by the Dr. Ralph and Marian C.
   Falk Medical Research Trust.
CR Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Behanna HA, 2005, J AM CHEM SOC, V127, P1193, DOI 10.1021/ja044863u
   Beqaj SH, 2005, J UROLOGY, V174, P1699, DOI 10.1097/01.ju.0000176633.92150.4e
   Cao Zheng-Guo, 2004, Ai Zheng, V23, P1105
   Chung SY, 2005, J UROLOGY, V174, P353, DOI 10.1097/01.ju.0000161592.00434.c1
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047
   Estrada CR, 2006, CANCER RES, V66, P3078, DOI 10.1158/0008-5472CAN-05-3391
   FUJIYAMA C, 1995, J UROLOGY, V153, P2060, DOI 10.1016/S0022-5347(01)67402-0
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gurocak S, 2007, INDIAN J UROL, V23, P452, DOI 10.4103/0970-1591.36721
   Guvendiren M, 2007, SOFT MATTER, V3, P619, DOI 10.1039/b615412c
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hasirci V, 2006, J BIOMAT SCI-POLYM E, V17, P1241, DOI 10.1163/156856206778667442
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Hurst SJ, 2006, ANGEW CHEM INT EDIT, V45, P2672, DOI 10.1002/anie.200504025
   Hwang JJ, 2002, P NATL ACAD SCI USA, V99, P9662, DOI 10.1073/pnas.152667399
   HWANG JJ, 2001, METHODS TISSUE ENG, P741
   Imamura M, 2007, AM J PHYSIOL-RENAL, V293, pF1007, DOI 10.1152/ajprenal.00107.2007
   Jack GS, 2005, J UROLOGY, V174, P2041, DOI 10.1097/01.ju.0000176489.96993.84
   Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X
   Kanematsu A, 2007, INT J UROL, V14, P673, DOI 10.1111/j.1442-2042.2007.01768.x
   Kreunin P, 2007, J PROTEOME RES, V6, P2631, DOI 10.1021/pr0700807
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968
   Lewis JM, 2007, THESCIENTIFICWORLDJO, V7, P1230, DOI 10.1100/tsw.2007.178
   Lu Z, 2004, CLIN CANCER RES, V10, P7677, DOI 10.1158/1078-0432.CCR-04-1443
   McManus M, 2007, BIOMED MATER, V2, P257, DOI 10.1088/1748-6041/2/4/008
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Oehr P, 2003, ANTICANCER RES, V23, P805
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Sheng J., 1995, Yaoxue Xuebao, V30, P706
   Shergill IS, 2006, BJU INT, V97, P219, DOI 10.1111/j.1464-410X.2006.06020.06021.05879.05881.x
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Song YS, 2007, NEUROUROL URODYNAM, V26, P584, DOI 10.1002/nau.20351
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Tyagi P, 2006, MOL PHARMACEUT, V3, P369, DOI 10.1021/mp060001j
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhou J, 2005, CHINESE MED J-PEKING, V118, P50
NR 43
TC 35
Z9 37
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-4983
EI 1433-8726
J9 WORLD J UROL
JI World J. Urol.
PD AUG
PY 2008
VL 26
IS 4
BP 315
EP 322
DI 10.1007/s00345-008-0273-0
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 339LB
UT WOS:000258578000005
PM 18536880
DA 2018-10-20
ER

PT J
AU Niinomi, M
AF Niinomi, M.
TI Improvement in mechanical performance of low-modulus beta-Ti-Nb-Ta-Zr
   system alloys by microstructural control via thermomechanical processing
SO INTERNATIONAL JOURNAL OF MODERN PHYSICS B
LA English
DT Article
DE TNTZ; fatigue strength; tensile properties; Young's modulus; cytotoxiciy
ID BIOMEDICAL APPLICATIONS; TI-29NB-13TA-4.6ZR
AB Mechanical performance parameters such as the fatigue strength, tensile strength, ductility and Young's modulus of newly developed Ti-29Nb-13Ta-4.6Zr, referred to as TNTZ, can be improved considerably by microstructural control via thermomechanical processing. Thermomechanical processing including severe cold wire drawing can generate functionalities such as super elasticity in TNTZ. The abovementioned improvement in the mechanical performance and functionality of TNTZ is associated with its nanosize structure. The cytotoxicity of TNTZ is very low and equivalent to that of pure titanium. It is expected that TNTZ will be used as a structural biomaterial.
C1 Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Niinomi, M (reprint author), Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM niinomi@imr.tohoku.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2007, MAT SCI ENG C-BIO S, V27, P154, DOI 10.1016/j.msec.2006.04.008
NR 4
TC 2
Z9 2
U1 0
U2 8
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0217-9792
J9 INT J MOD PHYS B
JI Int. J. Mod. Phys. B
PD JUL 30
PY 2008
VL 22
IS 18-19
BP 2787
EP 2795
DI 10.1142/S0217979208047602
PG 9
WC Physics, Applied; Physics, Condensed Matter; Physics, Mathematical
SC Physics
GA 343SZ
UT WOS:000258876700002
DA 2018-10-20
ER

PT J
AU Ohtsu, N
   Abe, C
   Ashino, T
   Semboshi, S
   Wagatsuma, K
AF Ohtsu, Naofumi
   Abe, Chikage
   Ashino, Tetsuya
   Semboshi, Satoshi
   Wagatsuma, Kazuaki
TI Calcium-hydroxide slurry processing for bioactive calcium-titanate
   coating on titanium
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE calcium titanate coating; surface modification; calcium hydroxide
   slurry; biomaterial application
ID PHOSPHATE COATINGS; THIN-FILMS; BONE; SURFACE
AB The present study investigates the relationships between the treatment conditions and characteristics of the surface layer in a surface treatment process using calcium-hydroxide slurry. Furthermore, the appropriate treatment conditions for preparing the bioactive coating are also investigated by soaking the specimens in a simulated body fluid. The treatment process using calcium-hydroxide slurry is as follows: a titanium substrate is buried in calcium hydroxide slurry, and the slurry is then heated at 873 K in air. The calcium hydroxide slurry was prepared by mixing 1 g of calcium hydroxide powder per 1, 1.2,1.5, or 2 mL of water. The slurry was heated to 873 K with various heating rates from 100 to 600 K h(-1) and held at 873 K for 1 and 2 h. As the ratio of water in the slurry increased or the heating rate decreased, the atomic ratio of calcium to titanium in the surface layer decreased. A surface treatment using slurry containing a mixture of 1.0-mL water per 1.0-g calcium hydroxide powder, a heating rate of 600 K h(-1), and a holding time of 2 h produces a crystallized stoichionnetric calcium titanate layer on the titanium substrate. Treatment using slurry of a higher water ratio or a slower heating ratio results in the formation of a dioxide layer containing locally formed calcium titanate. On the crystallized calcium titanate layer, calcium phosphate is formed faster in a simulated body fluid than in the TiO(2) layer containing calcium titanate; therefore, the treatment conditions forming the crystallized calcium titanate layer are appropriate for the bioactive coating. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Ohtsu, Naofumi] Kitami Inst Technol, Instrumental Anal Ctr, Kitami, Hokkaido 0908507, Japan.
   [Abe, Chikage; Ashino, Tetsuya; Wagatsuma, Kazuaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Semboshi, Satoshi] Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan.
RP Ohtsu, N (reprint author), Kitami Inst Technol, Instrumental Anal Ctr, Kitami, Hokkaido 0908507, Japan.
EM nohtsu@mail.kitami-it.ac.jp
RI Semboshi, Satoshi/A-8291-2011; Wagatsuma, Kazuaki/B-3079-2012; Ashino,
   Tetsuya/B-9979-2011; Ohtsu, Naofumi/L-6021-2018
OI Ohtsu, Naofumi/0000-0001-7935-3949
CR Asami K, 2003, SURF INTERFACE ANAL, V35, P483, DOI 10.1002/sia.1554
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Hamada K, 2002, BIOMATERIALS, V23, P2265, DOI 10.1016/S0142-9612(01)00361-1
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   Narushima T, 2005, MATER TRANS, V46, P2246, DOI 10.2320/matertrans.46.2246
   Ohba Y, 1999, J CERAM SOC JPN, V107, P907, DOI 10.2109/jcersj.107.907
   Ohtsu N, 2006, SURF COAT TECH, V200, P5455, DOI 10.1016/j.surfcoat.2005.07.003
   Ohtsu N, 2004, MATER TRANS, V45, P1778, DOI 10.2320/matertrans.45.1778
   Ohtsu N., 2007, MAT T, V45, P105
   Ohtsu N, 2007, J BIOMED MATER RES A, V82A, P304, DOI 10.1002/jbm.a.31136
   Ohtsu N, 2007, SURF COAT TECH, V201, P7686, DOI 10.1016/j.surfcoat.2007.02.043
   Ohtsu N, 2007, J MATER SCI-MATER M, V18, P1009, DOI 10.1007/s10856-006-0114-x
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   Takadama H, 2001, J BIOMED MATER RES, V55, P185, DOI 10.1002/1097-4636(200105)55:2<185::AID-JBM1005>3.3.CO;2-G
   vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6
   Wei M, 2002, BIOMATERIALS, V23, P167, DOI 10.1016/S0142-9612(01)00092-8
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
NR 24
TC 19
Z9 21
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 30
PY 2008
VL 202
IS 21
BP 5110
EP 5115
DI 10.1016/j.surfcoat.2008.05.035
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 339PB
UT WOS:000258588400006
DA 2018-10-20
ER

PT J
AU Aliofkhazraee, M
   Rouhaghdam, AS
   Shahrabi, T
AF Aliofkhazraee, M.
   Rouhaghdam, A. Sabour
   Shahrabi, T.
TI Pulsed nanocrystalline plasma electrolytic carburising for corrosion
   protection of a gamma-TiAl alloy - Part 1. Effect of frequency and duty
   cycle
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE gamma-TiAl alloy; corrosion; pulsed nanocrystallme plasma electrolytic
   carburising; scanning electron microscopy; Ringer's solution
ID STAINLESS-STEEL; ION-IMPLANTATION; PARAMETERS
AB Tafel polarization and electrochemical impedance spectroscopy were employed in Ringer's solution to test carburised Ti-48Al-2Cr-2Nb, treated by a novel method called pulsed nanocrystalline plasma electrolytic carburising. The results show excellent corrosion resistance for modified Ti-48Al-2Cr-2Nb. The effect of frequency and duty cycle of pulsed current was investigated. It was found that frequency and duty cycle of pulsed current affect the size and porosity of nanocrystalline carbides. This surface modification with controlled effective parameters can render the Ti-48Al-2Cr-2Nb material extremely corrosion resistant as a biomaterial. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Aliofkhazraee, M.; Rouhaghdam, A. Sabour; Shahrabi, T.] Tarbiat Modares Univ, Dept Mat Engn, Fac Engn, Tehran, Iran.
RP Rouhaghdam, AS (reprint author), Tarbiat Modares Univ, Dept Mat Engn, Fac Engn, POB 14115-143, Tehran, Iran.
EM sabour01@gmail.com
CR Ahangarani S, 2006, VACUUM, V80, P1032, DOI 10.1016/j.vacuum.2006.01.013
   ALIOFKHAZRAEI M, MAT SCI IN PRESS
   ALIOFKHAZRAEI M, J MAT SCI T IN PRESS, V23
   Baldwin MJ, 1998, SURF COAT TECH, V98, P1187, DOI 10.1016/S0257-8972(97)00150-3
   Baldwin MJ, 1999, THIN SOLID FILMS, V345, P108, DOI 10.1016/S0040-6090(99)00066-8
   Camps E, 1998, VACUUM, V51, P385, DOI 10.1016/S0042-207X(98)00119-5
   COLLINS GA, 1991, MAT SCI ENG A-STRUCT, V139, P171, DOI 10.1016/0921-5093(91)90613-R
   HANNULA SP, 1989, THIN SOLID FILMS, V181, P343, DOI 10.1016/0040-6090(89)90502-6
   MELETIS EI, 1993, J VAC SCI TECHNOL A, V11, P25, DOI 10.1116/1.578712
   SMITH PP, 1994, J VAC SCI TECHNOL B, V12, P940, DOI 10.1116/1.587332
   Tarakci M, 2005, SURF COAT TECH, V199, P205, DOI 10.1016/j.surfcoat.2005.02.117
   Williamson DL, 1997, NUCL INSTRUM METH B, V127, P930, DOI 10.1016/S0168-583X(97)00033-5
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
NR 13
TC 19
Z9 20
U1 1
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD JUL 28
PY 2008
VL 460
IS 1-2
BP 614
EP 618
DI 10.1016/j.jallcom.2007.06.007
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 320DA
UT WOS:000257212700110
DA 2018-10-20
ER

PT J
AU Muller, WEG
   Jochum, KP
   Stoll, B
   Wang, XH
AF Mueller, Werner E. G.
   Jochum, Klaus Peter
   Stoll, Brigitte
   Wang, Xiaohong
TI Formation of giant spicule from quartz glass by the deep sea sponge
   Monorhaphis
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID DEMOSPONGE SUBERITES-DOMUNCULA; SILICEOUS SPICULES; HEXACTINELLID
   MONORHAPHIS; DIATOM FRUSTULE; SILICATEIN; PROTEIN; MATRIX; BIOSILICA;
   PORIFERA; BIOMINERALIZATION
AB The skeleton of the oldest multicellular animals, the spicules from siliceous sponges (the classes of Hexactinellida and Demospongiae), is composed of amorphous hydrated silica. The most outstanding feature of these spicules is that they are synthesized by the enzyme silicatein. After having studied the largest biosilica structures on earth, the up to 3 in long (diameter of 8.5 mm) spicules from the deep-sea hexactinellid Monorhaphis chuni, we describe that this silica material has the quality of glass. Although such silica can be produced chemically only at high temperature and with aggressive chemicals, the animals fabricate this biomaterial physiologically and at low temperature (around 4 degrees C). These giant spicules are composed of almost pure silica. Likewise surprising is the fact that this biosilica contains a proteinaceous, matrix, which is silicatein. Because these composite structured spicules also function as excellent light waveguides, out- results may open new perspectives for the production of nanostructured materials and devices in the opto- and microelectronics industry.
C1 [Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Angew Mol Biol Abt, D-55099 Mainz, Germany.
   [Jochum, Klaus Peter; Stoll, Brigitte] Max Planck Inst Chem, D-55128 Mainz, Germany.
   [Wang, Xiaohong] Natl Res Ctr Geoanal, Beijing 100037, Peoples R China.
RP Muller, WEG (reprint author), Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Angew Mol Biol Abt, Duesbergweg 6, D-55099 Mainz, Germany.
EM wmueller@uni-mainz.de; kpj@mpch-mainz.mpg.de
CR Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101
   Brasier M, 1997, GEOLOGY, V25, P303, DOI 10.1130/0091-7613(1997)025<0303:ESSCFS>2.3.CO;2
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   COMPTON SJ, 1985, ANAL BIOCHEM, V151, P369, DOI 10.1016/0003-2697(85)90190-3
   Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345
   Deane CM, 2001, PROTEIN SCI, V10, P599, DOI 10.1110/ps.37601
   EHRLICH H, 2008, NANOMATERIA IN PRESS
   Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156
   FELSENSTEIN J, 1993, PHYLIP VERSION 3 5
   Foissy A, 1998, SURFACE PROPERTIES OF SILICAS, P365
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0
   HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902
   Hyman L.H., 1940, INVERTEBRATES PROTOZ
   Jochum KP, 2007, J ANAL ATOM SPECTROM, V22, P112, DOI 10.1039/b609547j
   KENNISH MJ, 1994, PRACTICAL HDB MARINE
   Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x
   Lee LP, 2005, SCIENCE, V310, P1148, DOI 10.1126/science.1115248
   LEVI C, 1989, J MATER SCI LETT, V8, P337, DOI 10.1007/BF00725516
   Lobel KD, 1996, MAR BIOL, V126, P353, DOI 10.1007/BF00354617
   Lobel KD, 1996, J MATER SCI LETT, V15, P648, DOI 10.1007/BF00264101
   Maldonado M, 1999, NATURE, V401, P785, DOI 10.1038/44560
   Maldonado M, 2005, LIMNOL OCEANOGR, V50, P799, DOI 10.4319/lo.2005.50.3.0799
   MICHIN EA, 1909, ERG FORTSCHR ZOOL, V2, P171
   Miserez A, 2008, ADV FUNCT MATER, V18, P1241, DOI 10.1002/adfm.200701135
   Muller WEG, 2007, BIOGEOSCIENCES, V4, P219, DOI 10.5194/bg-4-219-2007
   Muller WEG, 2008, J STRUCT BIOL, V161, P188, DOI 10.1016/j.jsb.2007.10.009
   Muller WEG, 2008, FEBS J, V275, P362, DOI 10.1111/j.1742-4658.2007.06206.x
   Muller WEG, 2007, BIOMATERIALS, V28, P4501, DOI 10.1016/j.biomaterials.2007.06.030
   Muller WEG, 2007, CELL TISSUE RES, V329, P363, DOI 10.1007/s00441-007-0402-x
   Muller WEG, 2007, GENE, V395, P62, DOI 10.1016/j.gene.2007.02.014
   Muller W. E. G., 2005, ENCY MOL CELL BIOL M, V13, P269
   Muller WEG, 1999, TRANSPLANTATION, V68, P1215
   Muller WEG, 2006, BIOSENS BIOELECTRON, V21, P1149, DOI 10.1016/j.bios.2005.04.017
   Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5
   Muller WEG, 2004, INT REV CYTOL, V235, P53, DOI 10.1016/S0074-7696(04)35002-3
   Muller WEG, 2003, PROG MOLEC, V33, P195
   Pancer Z, 1996, CELL ADHES COMMUN, V4, P327, DOI 10.3109/15419069609010776
   Pilcher H, 2005, NATURE, V435, P1022, DOI 10.1038/4351022a
   Pisera A, 2003, MICROSC RES TECHNIQ, V62, P312, DOI 10.1002/jemt.10398
   RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6
   ROBINSON PN, 2007, JAVA PROGRAM DRAWING
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Sandford F, 2003, MICROSC RES TECHNIQ, V62, P336, DOI 10.1002/jemt.10400
   Schacke H, 1994, USE OF AQUATIC INVERTEBRATES AS TOOLS FOR MONITORING OF ENVIRONMENTAL HAZARDS, P201
   Schroder HC, 2006, J BIOL CHEM, V281, P12001, DOI 10.1074/jbc.M512677200
   Schroder HC, 2004, BIOCHEM J, V381, P665, DOI 10.1042/BJ20040463
   SCHULZE FE, 1904, HEXACTINELLIDA WISSE, P1
   Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234
   SIMPSON TL, 1984, CELL BIOL SPONGES
   Tahir MN, 2005, CHEM COMMUN, P5533, DOI 10.1039/b510113a
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   Weaver JC, 2007, J STRUCT BIOL, V158, P93, DOI 10.1016/j.jsb.2006.10.027
   Woesz A, 2006, J MATER RES, V21, P2068, DOI 10.1557/JMR.2006.0251
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
NR 55
TC 31
Z9 34
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD JUL 22
PY 2008
VL 20
IS 14
BP 4703
EP 4711
DI 10.1021/cm800734q
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 326NN
UT WOS:000257666300026
DA 2018-10-20
ER

PT J
AU Ponader, S
   Brandt, H
   Vairaktaris, E
   von Wilmowsky, C
   Nkenke, E
   Schlegel, KA
   Neukam, FW
   Holst, S
   Muller, FA
   Greil, P
AF Ponader, Sabine
   Brandt, Heike
   Vairaktaris, Eleftherios
   von Wilmowsky, Cornelius
   Nkenke, Emeka
   Schlegel, Karl A.
   Neukam, Friedrich W.
   Holst, Stefan
   Mueller, Frank A.
   Greil, Peter
TI In vitro response of hFOB cells to pamidronate modified sodium silicate
   coated cellulose scaffolds
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE bisphosphonates; cellulose sodium silicate; human osteoblasts; in vitro
   cell response; sol-gel coating
ID ENHANCE SCREW FIXATION; SIMULATED BODY-FLUID; BIOACTIVE GLASS;
   CALCIUM-PHOSPHATE; OSTEOBLAST DIFFERENTIATION; GENERAL-PROPERTIES;
   APATITE FORMATION; BONE; BISPHOSPHONATES; PROLIFERATION
AB The aim of the present study was to evaluate the suitability of cellulose-based scaffolds coated with pure sodium silicate gel and sodium silicate gels accumulated with different concentrations of the bisphosphonate pamidronate as scaffolds for attachment, proliferation and differentiation of' human fetal osteoblasts (hFOB 1.19).
   Human osteoblasts were cultured in vitro for a period up to 14 days on different cellulose scaffolds. Unmodified and sodium silicate coated cellulose scaffolds were used as control. Two surface-coated modifications of cellulose were applied. The scaffolds were coated in a modified two-step dip coating process with pure sodium silicate gel and pamidronate enriched sodium silicate gel, respectively. In order to investigate the influence of the pamidronate, concentrations of 0.667 mg Na-pamidronate/ml sodium silicate solution, 0.333 mg Na-pamidronate/ml sodium silicate solution and 3.33 x 10(-3) mg Na-pamidronate/ml sodium silicate solution were used for the coating process. Cell proliferation, vitality and attachment were examined by means of cell counting, WST-1 test, fluorescence and scanning electron microscopy. The relative grade of' differentiation of hFOB cells was examined by using quantitative real-time polymerase chain reaction (qRT-PCR) analysis for the gene expression of alkaline phosphatase and osteocalcin.
   Proliferation and differentiation of human osteoblasts was enhanced by the sodium silicate coatings accumulated with pamidronate compared to pure sodium silicate coatings. There was a reciprocal correlation of vitality with the concentration of pamidronate. The highest vitality was found on surfaces with the lowest pamidronate accumulation. Alkaline phosphatase, an early differentiation marker, was overexpressed after 7 days in cells on all pamidronate-containing surfaces (up to 350% compared to untreated cellulose). Osteocalcin, a late differentiation marker, was overexpressed after 14 days in cells on all coated surfaces (up to 300,000% compared to untreated cellulose).
   The results indicate that due to the modified coating procedure a homogeneous coating and thus, an enhancement of cell attachment and subsequent cellular functions can be achieved. Low concentrations of pamidronate seem to have a relevant effect on cell proliferation and vitality and, therefore, can be recommended for the improvement of the properties of a biomaterial. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Ponader, Sabine; von Wilmowsky, Cornelius; Nkenke, Emeka; Schlegel, Karl A.; Neukam, Friedrich W.] Univ Erlangen Nurnberg, Dept Oral & Maxillofacial Surg, Erlangen, Germany.
   [Brandt, Heike; Mueller, Frank A.; Greil, Peter] Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram Biomat, Erlangen, Germany.
   [Vairaktaris, Eleftherios] Univ Athens, Dept Oral & Maxillofacial Surg, Athens, Greece.
   [Holst, Stefan] Univ Erlangen Nurnberg, Dept Prosthodont, Erlangen, Germany.
RP Ponader, S (reprint author), Univ Erlangen Nurnberg, Dept Oral & Maxillofacial Surg, Erlangen, Germany.
EM sabine.ponader@uk-erlangen.de
RI Schlegel, Karl Andreas/D-1015-2010; Nkenke, Emeka/A-1064-2014
OI Nkenke, Emeka/0000-0001-9591-9359; Brandt, Heike/0000-0002-3724-5568
CR Boss JH, 1999, J LONG-TERM EFF MED, V9, P1
   Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   DAMEN JJM, 1989, J DENT RES, V68, P1355, DOI 10.1177/00220345890680091301
   DAMEN JJM, 1992, J DENT RES, V71, P453, DOI 10.1177/00220345920710030601
   Day RM, 2005, J BIOMED MATER RES A, V75A, P778, DOI 10.1002/jbm.a.30433
   DECORREIA VF, 2006, DENT TRAUMATOL, V22, P312
   DUCHEYNE P, 1994, J BONE JOINT SURG BR, V76B, P861
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   Fromigue O, 2002, J ENDOCRINOL INVEST, V25, P539, DOI 10.1007/BF03345497
   Giuliani N, 1998, BONE, V22, P455, DOI 10.1016/S8756-3282(98)00033-7
   Granja PL, 2001, J MATER SCI-MATER M, V12, P785, DOI 10.1023/A:1013960601330
   Hattar S, 2005, BIOMATERIALS, V26, P839, DOI 10.1016/j.biomaterials.2004.03.026
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jonasova L, 2004, KEY ENG MAT, V254-2, P1013, DOI 10.4028/www.scientific.net/KEM.254-256.1013
   KARLSSON KH, 1989, J NON-CRYST SOLIDS, V112, P69, DOI 10.1016/0022-3093(89)90495-X
   Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P783
   Knoblich B, 2001, J NON-CRYST SOLIDS, V283, P109, DOI 10.1016/S0022-3093(01)00356-8
   Laurence S, 2005, J BIOMED MATER RES A, V73A, P422, DOI 10.1002/jbm.a.30280
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Li XW, 2006, J MATER SCI-MATER M, V17, P573, DOI 10.1007/s10856-006-8942-2
   Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231
   Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Meraw SJ, 1999, J PERIODONTOL, V70, P1228, DOI 10.1902/jop.1999.70.10.1228
   Meraw SJ, 1999, J PERIODONTOL, V70, P151, DOI 10.1902/jop.1999.70.2.151
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Muller FA, 2006, KEY ENG MAT, V309-311, P1173
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Muller L, 2006, ACTA BIOMATER, V2, P181, DOI 10.1016/j.actbio.2005.11.001
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800
   Poustis J., 1994, Clinical Materials, V16, P119, DOI 10.1016/0267-6605(94)90106-6
   Reinholz GG, 2000, CANCER RES, V60, P6001
   Rodan GA, 1996, J CLIN INVEST, V97, P2692, DOI 10.1172/JCI118722
   Rodan GA, 1998, ANNU REV PHARMACOL, V38, P375, DOI 10.1146/annurev.pharmtox.38.1.375
   Roether JA, 2002, J MATER SCI-MATER M, V13, P1207, DOI 10.1023/A:1021166726914
   Rogers MJ, 1997, CANCER, V80, P1652, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1652::AID-CNCR15>3.0.CO;2-Z
   SAHNI M, 1993, J CLIN INVEST, V91, P2004, DOI 10.1172/JCI116422
   Scriba G K, 2000, Pharm Unserer Zeit, V29, P50, DOI 10.1002/(SICI)1615-1003(200001)29:1<50::AID-PAUZ50>3.3.CO;2-F
   Shi HQ, 2000, J BIOMED MATER RES, V49, P1
   Skoglund B, 2004, J ORTHOP RES, V22, P1108, DOI 10.1016/j.orthres.2003.12.015
   Sparidans RW, 1998, PHARM WORLD SCI, V20, P206, DOI 10.1023/A:1008626026484
   Stangl R., 2001, European Cells & Materials, V2, P1
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Valilmaki VV, 2006, BONE, V38, P432, DOI 10.1016/j.bone.2005.09.016
   Viitala R, 2005, J NON-CRYST SOLIDS, V351, P3225, DOI 10.1016/j.jnoncrysol.2005.08.023
   von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059
   WERMELIN K, 2007, J BIOMED MATER RES A, V86, P220
   WERMELIN K, 2007, BONE, V42, P365
   Wermelin K, 2007, ACTA ORTHOP, V78, P385, DOI 10.1080/17453670710013979
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yang XBB, 2006, BIOCHEM BIOPH RES CO, V342, P1098, DOI 10.1016/j.bbrc.2006.02.021
   Yoshinari M, 2002, BIOMATERIALS, V23, P2879, DOI 10.1016/S0142-9612(01)00415-X
NR 63
TC 14
Z9 14
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 15
PY 2008
VL 64
IS 2
BP 275
EP 283
DI 10.1016/j.colsurfb.2008.02.002
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 326JV
UT WOS:000257655700017
PM 18346882
DA 2018-10-20
ER

PT J
AU Fundeanu, I
   van der Mei, HC
   Schouten, AJ
   Busscher, HJ
AF Fundeanu, Irina
   van der Mei, Henny C.
   Schouten, Arend J.
   Busscher, Henk J.
TI Polyacrylamide brush coatings preventing microbial adhesion to silicone
   rubber
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE biomaterial; biocompatibility; polyacrylamide brush; coating stability;
   microbial adhesion
ID IN-VIVO; POLYMER; STABILITY; SURFACES
AB Silicone rubber is a frequently used biomaterial in biomedical devices and implants, yet highly prone to microbial adhesion and the development of a biomaterial-centered infection. Effective coating of silicone rubber to discourage microbial adhesion has thus far been impossible due to the hydrophobic character of its surface, surface deterioration upon treatment and instability of coatings Linder physiological conditions. Here we present a method to successfully grow polyacrylamide (PAAm) brushes from silicone rubber surfaces after removal of low molecular weight organic molecules (LMWOM), such as silane oligomers. PAAm brush coating did not cause any surface deterioration and discouraged microbial adhesion, even after 1-month exposure to physiological fluids. The method presented opens many new avenues for the use of silicone rubber as a biomaterial, without the risk of developing a biomaterial-centered infection. (c) 2008 Elsevier B.V. All rights reserved.
C1 [van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Fundeanu, Irina; Schouten, Arend J.] Univ Groningen, Dept Polymer Chem, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.
   [van der Mei, Henny C.; Busscher, Henk J.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, POB 196, NL-9700 AD Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
CR BOHDANECKY M, 1983, MAKROMOL CHEM, V184, P2061
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   Briseno AL, 2006, J AM CHEM SOC, V128, P3880, DOI 10.1021/ja058226v
   Cringus-Fundeanu I, 2007, LANGMUIR, V23, P5120, DOI 10.1021/la063531v
   CRINGUSFUNDEANU I, UNPUB
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   CURRIE EPK, 2000, THESIS U WAGENINGEN, pCH8
   Efimenko K, 2005, POLYMER, V46, P9329, DOI 10.1016/j.polymer.2005.07.046
   Efimenko K, 2002, J COLLOID INTERF SCI, V254, P306, DOI 10.1006/jcis.202.8594
   EVERAERT EP, 1995, J ADHES SCI TECHNOL, V9, P1263, DOI 10.1163/156856195X01030
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   Glasmastar K, 2003, LANGMUIR, V19, P5475, DOI 10.1021/1a026558x
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Keefer LK, 2003, NAT MATER, V2, P357, DOI 10.1038/nmat913
   Lykissa ED, 1997, ANAL CHEM, V69, P4912, DOI 10.1021/ac970710w
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   MCMILLIN CR, 1994, RUBBER CHEM TECHNOL, V67, P417, DOI 10.5254/1.3538684
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   SPERLING LH, 1992, CONFORMATION POLYM C, P175
   ZAFONTE L, 1984, P SOC PHOTO-OPT INST, V470, P164
NR 25
TC 35
Z9 37
U1 3
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 15
PY 2008
VL 64
IS 2
BP 297
EP 301
DI 10.1016/j.colsurfb.2008.02.005
PG 5
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 326JV
UT WOS:000257655700019
PM 18356029
DA 2018-10-20
ER

PT J
AU Vondran, JL
   Sun, W
   Schauer, CL
AF Vondran, Jennifer L.
   Sun, Wei
   Schauer, Caroline L.
TI Crosslinked, electrospun chitosan-poly(ethylene oxide) nanofiber mats
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biopolymers; crosslinking; fibers; mechanical properties
ID TISSUE-ENGINEERING SCAFFOLDS; HYALURONATE POLYELECTROLYTE COMPLEXES;
   CHITOSAN-CHONDROITIN SULFATE; POLY(ETHYLENE OXIDE); ACETIC-ACID;
   LINKING; MEMBRANES; FIBERS; MATRIX; CHITIN
AB Mechanical characterization of nanofiber mats is an underexplored area in biomaterial engineering. In this study, a chitosan-poly(ethylene oxide) copolymer blend was electrospun and crosslinked with glutaraldehyde (GA) for various time periods. The tensile and compressive mechanical integrity of the nanofibers was analyzed with increasing exposure to vapor crosslinking. Solubility, scanning electron microscopy characterization, Fourier transform infrared, uniaxial tensile tests, and nanoindentation analyses were used to identify these trends. The mechanical studies confirmed that the GA vapor crosslinking increased the stiffness and decreased the ductility of the electrospun mats. Increased exposure time to crosslinking led to changes in the mat surface color and resistance to dissolution. Scanning electron microscopy fiber counts verified that exposure to GA vapor crosslinking increased the average fiber diameter. By the use of vapor phase deposition, mechanical properties continued to change throughout the study. The crosslinking exposure time could be chosen to accommodate in vivo mechanical loading. (C) 2008 Wiley Periodicals, Inc.
C1 [Vondran, Jennifer L.; Schauer, Caroline L.] Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Sun, Wei] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Schauer, CL (reprint author), Drexel Univ, Dept Mat Sci & Engn, 3141 Chestnut St, Philadelphia, PA 19104 USA.
EM cschauer@coe.drexel.edu
RI Schauer, Caroline/D-5350-2013
CR Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Arguelles-Monal W, 1998, POLYM GELS NETW, V6, P429, DOI 10.1016/S0966-7822(98)00032-X
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Brandrup J., 2005, POLYM HDB
   Butler MF, 2003, J POLYM SCI POL CHEM, V41, P3941, DOI 10.1002/pola.10960
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Denuziere A, 1996, CARBOHYD POLYM, V29, P317, DOI 10.1016/S0144-8617(96)00035-5
   Duan B, 2004, J BIOMAT SCI-POLYM E, V15, P797, DOI 10.1163/156856204774196171
   Feng Q, 2005, COLLOID SURFACE A, V257-58, P85, DOI 10.1016/j.colsurfa.2004.10.099
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Ge JJ, 2000, J MEMBRANE SCI, V165, P75, DOI 10.1016/S0376-7388(99)00228-8
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   Knaul JZ, 1999, J POLYM SCI POL PHYS, V37, P1079, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1079::AID-POLB4>3.0.CO;2-O
   Koide SS, 1998, NUTR RES, V18, P1091, DOI 10.1016/S0271-5317(98)00091-8
   KOYAMA Y, 1986, J APPL POLYM SCI, V31, P1951, DOI 10.1002/app.1986.070310636
   Krajewska B, 2005, SEP PURIF TECHNOL, V41, P305, DOI 10.1016/j.seppur.2004.03.019
   Krajewska B, 2001, J CHEM TECHNOL BIOT, V76, P636, DOI 10.1002/jctb.429.abs
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Lannutti J, 2007, MAT SCI ENG C-BIO S, V27, P504, DOI 10.1016/j.msec.2006.05.019
   Li F, 2002, BIOMATERIALS, V23, P343, DOI 10.1016/S0142-9612(01)00111-9
   Li L, 2006, CARBOHYD RES, V341, P374, DOI 10.1016/j.carres.2005.11.028
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Marguerite R., 2006, PROG POLYM SCI, V31, P603, DOI DOI 10.1016/J.PROGPOLYMSCI.2006.06.001
   Mi FL, 2005, J POLYM SCI POL CHEM, V43, P1985, DOI 10.1002/pla.20669
   Mi FL, 2002, CARBOHYD POLYM, V48, P61, DOI 10.1016/S0144-8617(01)00212-0
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Monteiro OAC, 1999, INT J BIOL MACROMOL, V26, P119, DOI 10.1016/S0141-8130(99)00068-9
   Musale DA, 2000, SEP PURIF TECHNOL, V21, P27, DOI 10.1016/S1383-5866(00)00188-X
   Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   Neto CGT, 2005, CARBOHYD RES, V340, P2630, DOI 10.1016/j.carres.2005.09.011
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   QIN Y, 2004, MED DEVICE TECHN JAN, P34
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Saltzman W. M., 2004, TISSUE ENG ENG PRINC
   Schauer CL, 2003, THIN SOLID FILMS, V434, P250, DOI 10.1016/S0040-6090(03)00055-5
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P594, DOI 10.1021/bm060804s
   Silva RM, 2004, J MATER SCI-MATER M, V15, P1105, DOI 10.1023/B:JMSM.0000046392.44911.46
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   SPASOVA M, 2004, E-POLYMERS, V56, P1
   Sridhar S, 2001, POLYM INT, V50, P1156, DOI 10.1002/pi.761
   Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489
   Subramanian A, 2005, J BIOMAT SCI-POLYM E, V16, P861, DOI 10.1163/1568562054255682
   Tual C, 2000, J POLYM SCI POL PHYS, V38, P1521, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1521::AID-POLB120>3.0.CO;2-#
   Wang XH, 2003, INT J BIOL MACROMOL, V33, P95, DOI 10.1016/S0141-8130(03)00072-2
   Wang XP, 2000, J APPL POLYM SCI, V75, P740, DOI 10.1002/(SICI)1097-4628(20000207)75:6<740::AID-APP2>3.0.CO;2-3
   Welsh ER, 2002, BIOMACROMOLECULES, V3, P1370, DOI 10.1021/bm025625z
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
NR 55
TC 38
Z9 39
U1 3
U2 47
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 15
PY 2008
VL 109
IS 2
BP 968
EP 975
DI 10.1002/app.28107
PG 8
WC Polymer Science
SC Polymer Science
GA 306SD
UT WOS:000256267200037
DA 2018-10-20
ER

PT J
AU Tarasova, A
   Griesser, HJ
   Meagher, L
AF Tarasova, Anna
   Griesser, Hans J.
   Meagher, Laurence
TI AFM study of the stability of a dense affinity-bound liposome layer
SO LANGMUIR
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; QUARTZ-CRYSTAL MICROBALANCE; PHOTON-CORRELATION
   SPECTROSCOPY; SURFACE-IMMOBILIZED LAYERS; FRICTIONAL-PROPERTIES; INTACT
   LIPOSOMES; CHAIN-LENGTH; ADSORPTION; VESICLES; MONOLAYERS
AB Liposomes that are surface-bound to a biomaterial such as a contact lens are of interest for localized delivery of therapeutic agents, but it is not known whether such liposome layers are sufficiently robust. The stability of a dense, PEG-functionalized layer of liposomes, affinity-bound onto a multilayer coated surface, was tested under various stress conditions using colloid-probe atomic force miscroscopy (AFM). The different stress effects were generated by varying the applied normal load of the probe and the impinging fluid shear through different approach velocities and by varying the applied lateral forces by scanning under increasing force loads. The effect of applied forces (normal and lateral) was further investigated by coating the probe with a layer of albumin. The liposomes remained intact following the ramping of both protein-coated and uncoated probes under the normal and lateral loads. The low-fouling nature of these liposomes, with respect to nonspecific protein adsorption, was also demonstrated from the interaction force measurements which showed only weak adhesion from the protein layer during the contact period of the albumin-coated probe. The observed adhesive interactions were concluded to be a direct result of the applied load from the probe, during the force measurements, rather than from attraction of the protein molecules for the surface-bound liposomes. The low frictional response of the liposome layer indicated the viscoelastic nature of these molecules, which enabled liposome structure retention during the continuous load application. The demonstrated stability of the liposomes presents a system of viable and localized drug delivery in, for example, ophthalmic applications.
C1 [Tarasova, Anna; Meagher, Laurence] CSIRO Mol & Hlth Technol, Clayton, Vic 3168, Australia.
   [Tarasova, Anna; Meagher, Laurence] Univ New S Wales, Vis CRC, Kensington, NSW 2052, Australia.
   [Griesser, Hans J.] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
RP Tarasova, A (reprint author), CSIRO Mol & Hlth Technol, Bag 10,Bayview Ave, Clayton, Vic 3168, Australia.
EM anna.tarasova@csiro.au
RI Griesser, Hans/E-5628-2011; Meagher, Laurence/G-1412-2012
OI Griesser, Hans/0000-0003-1072-7863; Meagher,
   Laurence/0000-0002-2055-6159
CR ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P29, DOI 10.1016/0005-2736(91)90246-5
   Bremmell KE, 2006, LANGMUIR, V22, P313, DOI 10.1021/la052143a
   Brewer NJ, 2001, LANGMUIR, V17, P1970, DOI 10.1021/la001568o
   Brochu H, 2008, LANGMUIR, V24, P2009, DOI 10.1021/la702382d
   Brochu H, 2007, LANGMUIR, V23, P7679, DOI 10.1021/la7003547
   Bushell GR, 1999, CYTOMETRY, V36, P254, DOI 10.1002/(SICI)1097-0320(19990701)36:3<254::AID-CYTO16>3.0.CO;2-4
   CHAN DYC, 1994, AFM ANAL, V2
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   Danion A, 2007, J BIOMED MATER RES A, V82A, P41, DOI 10.1002/jbm.a.31147
   DESOUZA EF, 2003, REV ADV MATER SCI, V5, P41
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   Grant LM, 2002, BIOPHYS J, V82, P1373, DOI 10.1016/S0006-3495(02)75492-1
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Hahner G, 1997, TRIBOL LETT, V3, P359, DOI 10.1023/A:1019153726944
   HOH JH, 1994, J CELL SCI, V107, P1105
   Ji JA, 2004, COLLOID SURFACE B, V34, P185, DOI 10.1016/j.colsurfb.2003.12.015
   Kalyankar ND, 2006, LANGMUIR, V22, P5403, DOI 10.1021/la0602719
   Kanno T, 2002, ANAL BIOCHEM, V309, P196, DOI 10.1016/S0003-2697(02)00291-9
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Kim HI, 1999, LANGMUIR, V15, P3179, DOI 10.1021/la981497h
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kirby AR, 1996, BIOPOLYMERS, V38, P355, DOI 10.1002/(SICI)1097-0282(199603)38:3<355::AID-BIP8>3.0.CO;2-T
   KLEIN J, 1994, NATURE, V370, P634, DOI 10.1038/370634a0
   KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H
   Kohli N, 2006, J COLLOID INTERF SCI, V301, P461, DOI 10.1016/j.jcis.2006.05.048
   Liang XM, 2004, COLLOID SURFACE B, V34, P41, DOI 10.1016/j.colsurfb.2003.10.017
   Liu YH, 1996, LANGMUIR, V12, P1235, DOI 10.1021/la950504o
   Muller MT, 2005, MACROMOLECULES, V38, P3861, DOI 10.1021/ma047468x
   Oncins G, 2005, LANGMUIR, V21, P7373, DOI 10.1021/la050644q
   Park JS, 2006, CHEM MATER, V18, P6147, DOI 10.1021/cm0606732
   Patel AR, 2006, LANGMUIR, V22, P7587, DOI 10.1021/la0610452
   Pignataro B, 2000, BIOPHYS J, V78, P487, DOI 10.1016/S0006-3495(00)76611-2
   Rixman MA, 2003, LANGMUIR, V19, P9357, DOI 10.1021/la0340571
   Rossi C, 2007, J PHYS CHEM B, V111, P7567, DOI 10.1021/jp0686792
   Ruozi B, 2005, EUR J PHARM SCI, V25, P81, DOI 10.1016/j.ejps.2005.01.020
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   Sittig C, 1999, J MATER SCI-MATER M, V10, P191, DOI 10.1023/A:1008997726370
   Teschke O, 2002, LANGMUIR, V18, P6513, DOI 10.1021/la025689v
   Thomson NH, 2000, LANGMUIR, V16, P4813, DOI 10.1021/la991256p
   Vermette P, 2004, BIOMACROMOLECULES, V5, P1496, DOI 10.1021/bm049941k
   Vermette P, 2002, LANGMUIR, V18, P505, DOI 10.1021/la0109967
   Vermette P, 2002, J CONTROL RELEASE, V80, P179, DOI 10.1016/S0168-3659(02)00023-8
   Viitala T, 2007, LANGMUIR, V23, P609, DOI 10.1021/la060923t
   Wei ZQ, 2001, LANGMUIR, V17, P3945, DOI 10.1021/la001185q
   Willemsen OH, 1998, BIOPHYS J, V75, P2220, DOI 10.1016/S0006-3495(98)77666-0
   Xiao XD, 1996, LANGMUIR, V12, P235, DOI 10.1021/la950771u
   Yan XP, 2004, LANGMUIR, V20, P423, DOI 10.1021/la035785b
NR 47
TC 12
Z9 12
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 15
PY 2008
VL 24
IS 14
BP 7371
EP 7377
DI 10.1021/la8002959
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 323SI
UT WOS:000257468300047
PM 18547080
DA 2018-10-20
ER

PT J
AU Szili, EJ
   Kumar, S
   Smart, RSC
   Lowe, R
   Saiz, E
   Voelcker, NH
AF Szili, Endre J.
   Kumar, Sunil
   Smart, Roger St. C.
   Lowe, Rachel
   Saiz, Eduardo
   Voelcker, Nicolas H.
TI Plasma enhanced chemical vapour deposition of silica onto titanium:
   Analysis of surface chemistry, morphology and hydroxylation
SO SURFACE SCIENCE
LA English
DT Article
DE biomaterial; hydroxyl groups; plasma enhanced chemical vapour;
   deposition; silica films; titanium
ID SIMULATED BODY-FLUID; GLASS; IMMOBILIZATION; SILANE; GROWTH
AB We have been developing and characterising a procedure for the deposition of thin silica films by a plasma enhanced chemical vapour deposition (PECVD) procedure using tetraethoxysilane (TEOS) as the main precursor. The silica coatings were used for improving the corrosion resistance of metals and as bioactive coatings on biomedical metallic implants. We have improved the PECVD method for producing high quality and reproducible PECVD-silica (PECVD-SiO2) coatings on metals, primarily for biomaterial applications. In order to understand the interaction of the PECVD-SiO2 coatings with biological species (such as proteins and cells), it is important to first analyse the properties of the silica films deposited using the optimised parameters. Therefore, the work presented and discussed in this paper was carried out to analyse the characteristic features of PECVD-SiO2 deposited on titanium (Ti) substrates (PECVDSiO2-Ti). We determined that the PECVD-SiO2 Coatings on Ti were conformal to the substrate surface, strongly adhered to the underlying substrate and were resistant to delamination. The PECVD-SiO2 surface was composed of stoichiometric SiO2, showed a low carbon content (below 10 at.%) and was very hydrophilic (contact angle <10 degrees). Finally, we also showed that the PECVD-Si coatings contain surface hydroxyl groups. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Kumar, Sunil] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
   [Szili, Endre J.; Lowe, Rachel; Voelcker, Nicolas H.] Flinders Univ S Australia, Sch Chem Phys & Earth Sci, Bedford Pk, SA 5042, Australia.
   [Smart, Roger St. C.] Univ S Australia, Appl Ctr Struct & Synchrotron Studies, Mawson Lakes, SA 5095, Australia.
   [Saiz, Eduardo] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.
RP Kumar, S (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
EM sunil.kumar@unisa.edu.au; nico.voelcker@flinders.edu.au
RI Voelcker, Nicolas/D-6199-2012; Smart, Roger/D-1786-2009
OI Voelcker, Nicolas/0000-0002-1536-7804; 
FU NIH/NIDCR [1R01 DE11289]; TGR BioSciences Pty Ltd; Australian Research
   Council
FX This work was supported by TGR BioSciences Pty Ltd and the Australian
   Research Council. Eduardo Saiz acknowledges the support from NIH/NIDCR
   Grant No. 1R01 DE11289.
CR ABBOTT JR, 2001, J CRANIOFAC SURG, V8, P17
   Arora PS, 1996, SURF INTERFACE ANAL, V24, P539, DOI 10.1002/(SICI)1096-9918(19960916)24:9<539::AID-SIA162>3.0.CO;2-5
   BIERBAUM K, 1995, LANGMUIR, V11, P2143, DOI 10.1021/la00006a049
   Coreno J, 2001, J BIOMED MATER RES, V57, P119, DOI 10.1002/1097-4636(200110)57:1<119::AID-JBM1150>3.0.CO;2-P
   DANG TA, 1990, SURF INTERFACE ANAL, V15, P113, DOI 10.1002/sia.740150209
   DAVIES JE, 2000, BONE ENG
   Halliwell CM, 2001, ANAL CHEM, V73, P2476, DOI 10.1021/ac0010633
   Heiney PA, 2000, LANGMUIR, V16, P2651, DOI 10.1021/1a990557w
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Hou PY, 2005, OXID MET, V63, P113, DOI 10.1007/s11085-005-1954-3
   HU SM, 1980, J APPL PHYS, V51, P5945, DOI 10.1063/1.327512
   Iler R.K., 1995, COLLOID CHEM SILICA
   Jesionowski T, 2001, APPL SURF SCI, V172, P18, DOI 10.1016/S0169-4332(00)00828-X
   Kim T, 2002, J VAC SCI TECHNOL A, V20, P413, DOI 10.1116/1.1448506
   Kumar S, 2007, SURF COAT TECH, V202, P1242, DOI 10.1016/j.surfcoat.2007.07.075
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Moon JH, 1996, LANGMUIR, V12, P4621, DOI 10.1021/la9604339
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Sakai N, 2003, J PHYS CHEM B, V107, P1028, DOI 10.1021/jp022105p
   Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P279, DOI 10.1016/S0304-3991(03)00053-6
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
   Stevens N, 2003, LANGMUIR, V19, P3272, DOI 10.1021/la020660c
   Teghil R, 2002, J MATER SCI LETT, V21, P379, DOI 10.1023/A:1014903117057
   Zhang HL, 2006, COLLOID SURFACE A, V291, P128, DOI 10.1016/j.colsurfa.2006.07.057
NR 25
TC 12
Z9 12
U1 4
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD JUL 15
PY 2008
VL 602
IS 14
BP 2402
EP 2411
DI 10.1016/j.susc.2008.05.027
PG 10
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 346IN
UT WOS:000259062200018
PM 19809536
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Pyda, M
   Hu, X
   Cebe, P
AF Pyda, M.
   Hu, Xiao
   Cebe, Peggy
TI Heat capacity of silk fibroin based on the vibrational motion of
   poly(amino acid)s in the presence and absence of water
SO MACROMOLECULES
LA English
DT Article
ID THERMAL-PROPERTIES; CRYSTAL-STRUCTURE; STATE; PROTEINS; COLLAGEN; FILMS;
   SPECTROSCOPY; TRANSITION; BIOMATERIALS; CONFORMATION
AB The heat capacities in the solid state, below the glass transition, of Bombyx mori silk fibroin with and without water have been determined based on the contribution of vibrational motions of the components: poly(amino acid)s and water. These vibrational heat capacities were constructed using the Advanced Thermal Analysis System (ATHAS) Data Bank. The heat capacities, C-p, of dry silk and silk-water were linked to their vibrational spectra based on the group and skeletal vibration contributions. For dry silk, the experimental and calculated C-p agree to better than +/- 3% between 200 and 435 K. The heat capacity of the solid silk-water system, below the glass transition, was estimated from a sum of linear combinations of the molar fractions of the vibrational heat capacities of dry silk and glassy water. The approach presented allows one to predict the low-temperature vibrational heat capacity for dry silk and for the silk-water system down to 0 K and, together with an extension to higher temperatures, above the glass transition. This can be used as a reference baseline for quantitative thermal analysis of this biomaterial.
C1 [Pyda, M.] Univ Technol Rzeszow, Dept Chem, PL-35959 Rzeszow, Poland.
   [Pyda, M.] ATHAS MP, Knoxville, TN 37922 USA.
   [Hu, Xiao; Cebe, Peggy] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
RP Pyda, M (reprint author), Univ Technol Rzeszow, Dept Chem, PL-35959 Rzeszow, Poland.
EM mpyda@utk.edu; peggy.cebe@tufts.edu
RI Hu, Xiao/F-2403-2012
OI Hu, Xiao/0000-0002-2579-2820; Cebe, Peggy/0000-0002-8721-644X
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Debye P, 1912, ANN PHYS-BERLIN, V39, P789
   Di Lorenzo ML, 1999, J POLYM SCI POL PHYS, V37, P2093, DOI 10.1002/(SICI)1099-0488(19990815)37:16<2093::AID-POLB12>3.0.CO;2-2
   Drummy LF, 2005, BIOMACROMOLECULES, V6, P3328, DOI 10.1021/bm0503524
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   FUNG BM, 1979, BIOPOLYMERS, V18, P489, DOI 10.1002/bip.1979.360180222
   HU X, 2005, AM CHEM SOC DIV POLY, V93, P652
   HU X, 2008, MACROMOLECULES, P41
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Huang J, 2007, POLYM REV, V47, P29, DOI 10.1080/15583720601109560
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   KAPLAN D, 1994, ACS S SERIES, V544
   Kim YS, 2003, MACROMOLECULES, V36, P6281, DOI 10.1021/ma0301451
   Lee KY, 1999, POLYMER, V40, P4131, DOI 10.1016/S0032-3861(98)00611-9
   MAGOSHI J, 1977, J POLYM SCI POL PHYS, V15, P1675, DOI 10.1002/pol.1977.180150915
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   MCGRATH K, 1996, PROTEIN BASED MAT
   Mijovic J, 2005, MACROMOLECULES, V38, P10812, DOI 10.1021/ma051854c
   MINIAKOV AA, 2007, REV SCI INSTRUM, V78, P111
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Pyda M, 2005, MACROMOLECULES, V38, P10472, DOI 10.1021/ma051611k
   Pyda M., 2004, The nature of biological systems as revealed by thermal methods, P307
   Pyda M, 2002, MACROMOLECULES, V35, P4009, DOI 10.1021/ma0118466
   Pyda M, 2001, J POLYM SCI POL PHYS, V39, P3038, DOI 10.1002/polb.10060
   Pyda M, 1998, J THERM ANAL CALORIM, V52, P631, DOI 10.1023/A:1010188110516
   PYDA M, 2007, ATHAS DATA BANK
   Ray VV, 2007, POLYMER, V48, P2404, DOI 10.1016/j.polymer.2007.02.055
   ROLES KA, 1991, BIOPOLYMERS, V31, P477, DOI 10.1002/bip.360310503
   ROLES KA, 1993, BIOPOLYMERS, V33, P753, DOI 10.1002/bip.360330505
   SUGISAKI M, 1968, B CHEM SOC JPN, V41, P2591, DOI 10.1246/bcsj.41.2591
   Tarasov VV, 1950, ZH FIZ KHIM+, V24, P111
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Ur'yash VF, 2006, RUSS J GEN CHEM+, V76, P1363, DOI 10.1134/S1070363206090039
   Valluzzi R, 1997, BIOPOLYMERS, V42, P705, DOI 10.1002/(SICI)1097-0282(199711)42:6<705::AID-BIP8>3.0.CO;2-Y
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   WUNDERLICH B, 1995, PURE APPL CHEM, V67, P1019, DOI 10.1351/pac199567061019
   Wunderlich B, 2003, PROG POLYM SCI, V28, P383, DOI 10.1016/S0079-6700(02)00085-0
   Wunderlich B, 2005, THERMAL ANAL POLYM M
   Yamane T, 2003, MACROMOLECULES, V36, P6766, DOI 10.1021/ma034466o
NR 43
TC 27
Z9 27
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUL 8
PY 2008
VL 41
IS 13
BP 4786
EP 4793
DI 10.1021/ma8003357
PG 8
WC Polymer Science
SC Polymer Science
GA 322HQ
UT WOS:000257366200036
DA 2018-10-20
ER

PT J
AU Philibert, RA
   Sandhu, H
   Hollenbeck, N
   Gunter, T
   Adams, W
   Madan, A
AF Philibert, Robert A.
   Sandhu, Harinder
   Hollenbeck, Nancy
   Gunter, Tracy
   Adams, William
   Madan, Anup
TI The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA
   expression and liability to major depression and alcohol dependence in
   subjects from the Iowa Adoption Studies
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
LA English
DT Article
DE serotonin transporter; serotonin; mRNA; methylation; epigenetics; major
   depression; alcohol dependence
ID SEROTONIN TRANSPORTER GENE; PROMOTER POLYMORPHISM; AFFECTIVE-DISORDERS;
   ASSOCIATION; VARIANTS; DNA; METAANALYSIS; LINES
AB Serotonin Transporter (5HTT or SLC6A4) mRNA transcription is regulated by both genetic and epigenetic mechanisms. Unfortunately, despite intense scrutiny, the exact identity and contribution of each of these regulatory mechanisms, and their relationship to behavioral illness remain unknown. This lack of knowledge is critical because alterations in SLC6A4 function are posited to be central to a wide variety of CNS disorders. In order to address this shortcoming, we quantified 5HTTLPR genotype, SLC6A4 mRNA production and CpG methylation using biomaterial from 192 lymphoblast cell lines derived from subjects who participated in the latest wave of the Iowa Adoption Studies. We then analyzed the resulting data with respect to clinical characteristics. We confirmed prior findings that the short (s) 5HTTLPR allele is associated with lower amounts of mRNA transcription, but there was no significant effect of the "Long G" allele on mRNA transcription. We also found that CpG methylation was higher (P < 0.0008) and mRNA production (P < 0.0001) was lower in females as compared to males. Those subjects with a lifetime history of Alcohol Dependence had higher levels of SLC6A4 mRNA. There was a trend for an association of increased overall methylation with lifetime history of major depression. Finally, we confirm our prior findings that the exact levels of 5HTT mRNA expression are dependent on how it is measured. We conclude that both genetic variation and epigenetic modifications contribute to the regulation of SLC6A4 function and that more in-depth studies of the molecular mechanisms controlling gene activity and the relationship of these mechanisms to behavioral illness are indicated. (C) 2007 Wiley-Liss, Inc.
C1 [Philibert, Robert A.; Sandhu, Harinder; Hollenbeck, Nancy; Gunter, Tracy; Adams, William] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA.
   [Philibert, Robert A.] Univ Iowa, Neurosci & Genet Program, Iowa City, IA 52242 USA.
   [Madan, Anup] Inst Syst Biol, Seattle, WA USA.
RP Philibert, RA (reprint author), MEB Psychiat Res, Rm 2-126, Iowa City, IA 52242 USA.
EM robert-philibert@uiowa.edu
FU NIDA NIH HHS [R01 DA015789, DA 015789]
CR Arenas M, 2007, BBA-MOL BASIS DIS, V1772, P96, DOI 10.1016/j.bbadis.2006.10.006
   *ASS AP, 1994, DIAGN STAT MAN MENT
   Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874
   Bradley SL, 2005, AM J MED GENET B, V136B, P58, DOI 10.1002/ajmg.b.30185
   BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Collier DA, 1996, MOL PSYCHIATR, V1, P453
   Conroy J, 2004, MOL PSYCHIATR, V9, P587, DOI 10.1038/sj.mp.4001459
   Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102
   Ehrich M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1134
   Enoch Mary-Anne, 2003, Am J Pharmacogenomics, V3, P217, DOI 10.2165/00129785-200303040-00001
   Feinn R, 2005, AM J MED GENET B, V133B, P79, DOI 10.1002/ajmg.b.30132
   Fleiss JL, 1981, STAT METHODS RATES P
   GLOVER V, 1993, J PSYCHIATR RES, V27, P223, DOI 10.1016/0022-3956(93)90010-Y
   Heils A, 1996, J NEUROCHEM, V66, P2621
   Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029
   Hu XZ, 2007, ARCH GEN PSYCHIAT, V64, P783, DOI 10.1001/archpsyc.64.7.783
   Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850
   Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62
   Kaufman J, 2007, BIOL PSYCHIAT, V61, P1228, DOI 10.1016/j.biopsych.2006.06.039
   Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529
   KLAUS GGB, 1987, LYMPHOCYTES PRACTICA
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001
   Martin J, 2007, MOL PSYCHIATR, V12, P421, DOI 10.1038/sj.mp.4001952
   Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473
   PHILIBERT RA, 2007, U IOWA ASSIGNEE COMP
   Philibert Robert, 2006, Ann Clin Psychiatry, V18, P219, DOI 10.1080/10401230600948399
   Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414
   Philibert RA, 2007, AM J MED GENET B, V144B, P674, DOI 10.1002/ajmg.b.30502
   Philibert RA, 2007, AM J MED GENET B, V144B, P683, DOI 10.1102/ajmg.b.30512
   Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918
   Shukla SJ, 2005, PHARMACOGENOMICS, V6, P303, DOI 10.1517/14622416.6.3.303
   Sipos L, 2005, FEBS J, V272, P3253, DOI 10.1111/j.1742-4658.2005.04757.x
   Stein MB, 2006, PSYCHOPHARMACOLOGY, V187, P68, DOI 10.1007/s00213-006-0349-8
   Stoltenberg SF, 2002, AM J MED GENET, V114, P230, DOI 10.1002/ajmg.10187
   Surtees PG, 2006, BIOL PSYCHIAT, V59, P224, DOI 10.1016/j.biopsych.2005.07.014
   Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8
   Yates W., 1998, WAY INDIVIDUALITY ME, P95
NR 41
TC 157
Z9 164
U1 1
U2 23
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4841
J9 AM J MED GENET B
JI Am. J. Med. Genet. B
PD JUL 5
PY 2008
VL 147B
IS 5
BP 543
EP 549
DI 10.1002/ajmg.b.30657
PG 7
WC Genetics & Heredity; Psychiatry
SC Genetics & Heredity; Psychiatry
GA 323LG
UT WOS:000257447000001
PM 17987668
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wang, Q
   Xian, WJ
   Li, SF
   Liu, C
   Padua, GW
AF Wang, Qin
   Xian, Wujing
   Li, Shifeng
   Liu, Chang
   Padua, Graciela W.
TI Topography and biocompatibility of patterned hydrophobic/hydrophilic
   zein layers
SO ACTA BIOMATERIALIA
LA English
DT Article
DE biocompatibility; biomolecules structure and function; cell adhesion;
   surface modification
ID SURFACE-PLASMON RESONANCE; SELF-ASSEMBLED MONOLAYERS; CELL-SHAPE; SOFT
   LITHOGRAPHY; PROTEINS; ADSORPTION; MAIZE; BIOMATERIAL; FILMS; GOLD
AB The topography and biocompatibility of zein layers adsorbed on patterned templates containing hydrophilic and hydrophobic regions were investigated. Nanopatterned templates consisting of hydrophilic lines on a hydrophobic background were drawn by dip-pen nanolithography (DPN) on gold-coated surfaces. 16-Mercaptohexadecanoic acid (COOH(CH(2))(15)SH, MHA) was used as primary ink to generate hydrophilic lines. Unpattemed surfaces were backfilled with 18-octadecanethiol (CH(3)(CH(2))(17)SH, ODT), which generated hydrophobic regions. Zein was allowed to adsorb on patterned surfaces from alcohol-water solutions. The topography of zein deposits was observed by atomic force microscopy (AFM). Height profiles from AFM measurements revealed that zein deposits followed closely the nanopattemed templates. The biocompatibility of zein layers assembled over hydrophilic/hydrophobic micropatterned templates was investigated. Templates containing MHA lines and ODT regions were generated by micro-contact printing (mu CP). Mouse fibroblasts seeded on patterned zein layers proliferated on zein deposited over MHA lines, but not on zein over ODT. The experiment indicated that fibroblast cells were able to respond to variations in the underlying surface chemistry, transmitted by the different orientation adopted by zein on the different substrates. This property may be useful in controlling the spatial distribution of cells on patterned protein layers. (c) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wang, Qin; Padua, Graciela W.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.
   [Xian, Wujing] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
   [Li, Shifeng; Liu, Chang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.
RP Wang, Q (reprint author), Univ Illinois, Dept Food Sci & Human Nutr, 382-D AESB,1304 W Penn Ave, Urbana, IL 61801 USA.
EM qinwang@uiuc.edu
RI Liu, Chang/B-7249-2009
OI Xian, Wujing/0000-0001-5074-0304
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   ARGOS P, 1982, J BIOL CHEM, V257, P9984
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Djalali R, 2002, J AM CHEM SOC, V124, P13660, DOI 10.1021/ja028261r
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514
   GEISSLER M, 2003, LANGMUIR, V19, P6111
   GENNADIOS A, 1990, FOOD TECHNOL-CHICAGO, V44, P63
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   HEIDECKER G, 1991, GENOMICS, V10, P719, DOI 10.1016/0888-7543(91)90456-O
   Jiang FZ, 2004, J STRUCT BIOL, V148, P268, DOI 10.1016/j.jsb.2004.07.001
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   LEE KB, 2004, NANO LETT, V4, P1872
   Libioulle L, 1999, LANGMUIR, V15, P300, DOI 10.1021/la980978y
   Lin CC, 2005, BIOMATERIALS, V26, P3655, DOI 10.1016/j.biomaterials.2004.09.051
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   Matsushima N, 1997, BBA-PROTEIN STRUCT M, V1339, P14, DOI 10.1016/S0167-4838(96)00212-9
   Nam Y, 2004, IEEE T BIO-MED ENG, V51, P158, DOI 10.1109/TBME.2003.820336
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Pomes A. F., 1971, ENCY POLYM SCI TECHN, V15, P125
   Rozhok S, 2003, J PHYS CHEM B, V107, P751, DOI 10.1021/jp021550h
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Shotwell M.A., 1989, BIOCH PLANTS COMPREH, V15, P297
   SINGH A, 1986, ABSTR PAP ACS, V27
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Smith JC, 2003, NANO LETT, V3, P883, DOI 10.1021/nl025956h
   TATHAM AS, 1993, J BIOL CHEM, V268, P26253
   THOMPSON GA, 1992, PLANT MOL BIOL, V18, P827, DOI 10.1007/BF00020030
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang Q, 2004, BIOMACROMOLECULES, V5, P1356, DOI 10.1021/bm049965r
   Wang Q, 2003, J AGR FOOD CHEM, V51, P7439, DOI 10.1021/jf0340658
   Wang Y, 2003, MACROMOL MATER ENG, V288, P886, DOI 10.1002/mame.200300069
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WORCH H, 1998, METALS BIOMATERIALS
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhu FY, 2007, J AGR FOOD CHEM, V55, P3843, DOI 10.1021/jf063622y
NR 41
TC 27
Z9 29
U1 2
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2008
VL 4
IS 4
BP 844
EP 851
DI 10.1016/j.actbio.2008.01.017
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 320WQ
UT WOS:000257266300009
PM 18325861
DA 2018-10-20
ER

PT J
AU Sundaram, J
   Durance, TD
   Wang, RZ
AF Sundaram, Jaya
   Durance, Timothy D.
   Wang, Rizhi
TI Porous scaffold of gelatin-starch with nanohydroxyapatite composite
   processed via novel microwave vacuum drying
SO ACTA BIOMATERIALIA
LA English
DT Article
DE nanohydroxyapatite; gelatin; starch; microwave vacuum drying; porous
   scaffold composite
ID HYDROXYAPATITE NANOCRYSTALS; IN-VITRO; MORPHOLOGY; FOAMS; BIOCERAMICS;
   DEGRADATION; RECOMBINANT; POLYMERS; DELIVERY; BEHAVIOR
AB Hydroxyapatite (HA) is a fundamental mineral-based biomaterial, used for preparing composites for bone repair and regeneration. Gelatin blended with starch results in scaffold composites with enhanced mechanical properties. A gelatin-starch blend reinforced with HA nanocrystals (nHA) gave biocompatible composites with enhanced mechanical properties. In this study, a porous scaffold of gelatin-starch-nHA composites was fabricated through microwave vacuum drying and crosslinking using trisodium citrate. Three different composite scaffolds were prepared at three different percentages of nHA: 20%, 30% and 40%. The microstructures and compositions of the composites were analyzed. Within the porous structure, the nHA crystals were observed to precipitate. The interaction between the gelatin-starch network film and nHA crystalline material was studied using Fourier transform infrared (FTIR) spectroscopy and X-ray diffraction analysis (XRD). XRD reflections showed that there are two different minerals present in the scaffold composite. There were strong reflection peaks close to the 26 degrees and 32 degrees 2 theta angles of HA, and close to the 8 degrees and 49 degrees 2 theta angles for sodium citrate minerals. The FTIR result suggested that carboxyl groups, C=O and amino groups play crucial roles in HA formation on the surface of a gelatin network. (c) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Sundaram, Jaya; Durance, Timothy D.; Wang, Rizhi] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada.
RP Sundaram, J (reprint author), Univ British Columbia, 2205 E Mall, Vancouver, BC V6T 1Z4, Canada.
EM jayas@interchange.ubc.ca
CR Brown PW, 1994, HYDROXYAPATITE RELAT
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Cui ZW, 2004, J FOOD ENG, V65, P157, DOI 10.1016/j.jfoodeng.2004.01.008
   Curtil A, 1997, CRYOBIOLOGY, V34, P13, DOI 10.1006/cryo.1996.1982
   Di Silvio L, 1999, J MATER SCI-MATER M, V10, P653
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Durance TD, 2002, J FOOD SCI, V67, P2212, DOI 10.1111/j.1365-2621.2002.tb09529.x
   DURANCE TD, 2005, PCTCA2005001192
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   FRANKS F, 1994, BIO-TECHNOL, V12, P253, DOI 10.1038/nbt0394-253
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   JAYA S, 2007, FOOD BIOPROD PRO E C, V85, P1
   Kendrick BS, 1996, J PHARM SCI, V85, P155, DOI 10.1021/js950332f
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   KOREY DJ, 1989, J PARENT SCI TECHN, V43, P80
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   MALAFAYA PB, 1999, P 15 EUR C BIOM BORD, P325
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Murugan R, 2005, CRYST GROWTH DES, V5, P111, DOI 10.1021/cg034227s
   Nindo CI, 2003, LEBENSM-WISS TECHNOL, V36, P507, DOI 10.1016/S0023-6438(03)00046-X
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   REIS RL, PLASTICS MED SURG PI, P195
   REY LR, 1992, DEV BIOLOGICALS, V74, P3
   SCAMAN CH, 2005, COMBINED MICROWAVE V, P507
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   Tanaka S, 2006, SCI TECHNOL ADV MAT, V7, P226, DOI 10.1016/j.stam.2005.11.022
   Wang YJ, 2006, ADV ENG MATER, V8, P97, DOI 10.1002/adem.200500220
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   WORD A. G., 1977, SCI TECHNOLOGY GELAT
   Wu C., 2004, CHIN J CLIN REHABIL, V8, P929
   Xu JL, 2004, MAT SCI ENG A-STRUCT, V374, P101, DOI 10.1016/j.msea.2003.12.040
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 40
TC 54
Z9 56
U1 6
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2008
VL 4
IS 4
BP 932
EP 942
DI 10.1016/j.actbio.2008.01.019
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 320WQ
UT WOS:000257266300017
PM 18325862
DA 2018-10-20
ER

PT J
AU Piedade, AP
   Nunes, J
   Vieira, MT
AF Piedade, A. P.
   Nunes, J.
   Vieira, M. T.
TI Thin films with chemically graded functionality based on fluorine
   polymers and stainless steel
SO ACTA BIOMATERIALIA
LA English
DT Article
DE functionally graded coatings; PTFE; 316L; Stents
ID CORONARY-ARTERY-DISEASE; COATED STENTS; MICROHARDNESS; IMPLANTATION;
   CHROMIUM; SURFACES; HEPARIN; SYSTEM
AB Thin films of stainless steel and poly(tetrafluoroethylene) were co-deposited, by radiofrequency magnetron sputtering, in an inert atmosphere in order to produce a functionally graded material as a coating on a traditional biomaterial, where non-ferromagnetic characteristics and improved wettability must be ensured. These thin films are intended to modify the surface of SS316L used in stents, where the bulk/thin film couple should be regarded as a single material. This requires excellent adhesion of the coating to the substrate. All coatings were deposited with an average thickness of 500 nm. The chemical and phase characterization of the surface revealed that, with the increase in F content, the thin film evolves from a ferritic phase (alpha) to an amorphous phase with dispersion of a new crystalline ceramic phase (FeF2). For intermediate F content values, an austenitic (111) phase (gamma) was present. Bearing in mind the envisaged application, the best results were attained for thin films with a fluorine content between 10 and 20 at.%. (C) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Piedade, A. P.; Nunes, J.; Vieira, M. T.] Univ Coimbra, ICEMS, Dept Engn Mecan, Fac Ciencias & Tecnol, P-3030788 Coimbra, Portugal.
RP Piedade, AP (reprint author), Univ Coimbra, ICEMS, Dept Engn Mecan, Fac Ciencias & Tecnol, Rua Luis Reis Santos, P-3030788 Coimbra, Portugal.
EM ana.piedade@dem.uc.pt
RI Piedade, Ana/K-8637-2012
OI Piedade, Ana/0000-0002-1588-0640; Vieira, Teresa/0000-0001-9981-3826
CR Airoldi F, 2004, AM J CARDIOL, V93, P474, DOI 10.1016/j.amjcard.2003.10.048
   Antunes JM, 2002, SURF COAT TECH, V149, P27, DOI 10.1016/S0257-8972(01)01413-X
   Baker H., 1992, ASM HDB, V3
   Bakhai A, 2005, INT J CARDIOL, V102, P95, DOI 10.1016/j.ijcard.2004.04.001
   Beier F, 2006, CLIN RES CARDIOL, V95, P455, DOI 10.1007/s00392-006-0406-7
   BILLARD A, 1991, MAT SCI ENG A-STRUCT, V140, P802, DOI 10.1016/0921-5093(91)90517-Q
   Duda SH, 2002, MINIM INVASIV THER, V11, P193, DOI 10.1080/136457002760273412
   Elezi S, 2006, Minerva Cardioangiol, V54, P5
   *EN, 2005, 107132005 EN B
   *EN ISO, 2007, 1457742007 EN ISO 4
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   GODBOLE MJ, 1993, SCRIPTA METALL MATER, V28, P1201, DOI 10.1016/0956-716X(93)90454-Z
   GOLDSCHMIDT HJ, 1967, INTERSTITIAL ALLOYS, P92
   Hanamoto K, 1997, NUCL INSTRUM METH B, V129, P228, DOI 10.1016/S0168-583X(97)00227-9
   Hassel T, 2005, MAGNESIUM TECHNOLOGY 2005, P485
   Inoue S, 2002, VACUUM, V66, P257, DOI 10.1016/S0042-207X(02)00151-3
   JEROME C, 2005, J BIOMED MATER RES A, V76, P521
   Kastrati A, 2000, CIRCULATION, V101, P2478, DOI 10.1161/01.CIR.101.21.2478
   Keykamp H., 2001, J ALLOY COMPD, V321, P138
   Koromila G, 2006, BIOMATERIALS, V27, P2525, DOI 10.1016/j.biomaterials.2005.11.017
   Latha G, 1997, J MATER ENG PERFORM, V6, P743, DOI 10.1007/s11665-997-0076-2
   Lau KW, 2004, AM HEART J, V147, P764, DOI 10.1016/j.ahj.2003.12.007
   Lide DR, 2004, HDB CHEM PHYS
   Makimura Y, 2006, APPL SURF SCI, V252, P4587, DOI 10.1016/j.apsusc.2005.06.043
   Morrison ML, 2006, DIAM RELAT MATER, V15, P138, DOI 10.1016/j.diamond.2005.08.031
   Park SJ, 2002, AM J CARDIOL, V89, P872, DOI 10.1016/S0002-9149(02)02206-3
   PIEDADE AP, 2000, THESIS U COIMBRA COI, P78
   Rodgers Campbell D K, 2002, Rev Cardiovasc Med, V3 Suppl 5, pS10
   Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X
   Sketch MH, 2005, AM J CARDIOL, V95, P8, DOI 10.1016/j.amjcard.2004.08.055
   Sprague EA, 2000, J LONG-TERM EFF MED, V10, P97
   Tepe G, 2002, J VASC INTERV RADIOL, V13, P1029, DOI 10.1016/S1051-0443(07)61868-5
   Venkatraman S, 2003, BIOMATERIALS, V24, P2105, DOI 10.1016/S0142-9612(02)00640-3
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Zhang X, 2004, J MATER RES, V19, P1696, DOI 10.1557/JMR.2004.0215
NR 35
TC 12
Z9 12
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2008
VL 4
IS 4
BP 1073
EP 1080
DI 10.1016/j.actbio.2008.02.023
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 320WQ
UT WOS:000257266300032
PM 18406221
OA Green Published
DA 2018-10-20
ER

PT J
AU Henry, S
AF Henry, Sebastien
TI Medpor porous biomaterial
SO ADVANCED MATERIALS & PROCESSES
LA English
DT Article
C1 Porex Surg Inc, Newnan, GA 30265 USA.
RP Henry, S (reprint author), Porex Surg Inc, 15 Dart Rd, Newnan, GA 30265 USA.
EM sebastien.henry@porex.com
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ASM INT
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 0882-7958
J9 ADV MATER PROCESS
JI Adv. Mater. Process.
PD JUL
PY 2008
VL 166
IS 7
BP 65
EP 65
PG 1
WC Materials Science, Multidisciplinary
SC Materials Science
GA 327MN
UT WOS:000257733300054
DA 2018-10-20
ER

PT J
AU Stukel, JM
   Heys, JJ
   Caplan, MR
AF Stukel, Jill M.
   Heys, Jeffrey J.
   Caplan, Michael R.
TI Optimizing delivery of multivalent targeting constructs for detection of
   secondary tumors
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE mathematical model; multivalent; biomaterial; drug delivery
ID CONVECTION-ENHANCED DELIVERY; PHASE-I TRIAL; DRUG-DELIVERY;
   GLIOBLASTOMA-MULTIFORME; CELL-ADHESION; RAT-BRAIN; MULTIMERIC LIGANDS;
   CHOROID-PLEXUS; BREAST-CANCER; TRANSPORT
AB Targeting drugs or imaging molecules to specific cells by conjugating them to antibodies or ligands for cell surface receptors may allow earlier detection of pathology, better localization for intervention, and fewer side effects. Delivery of these molecules to the target is complicated by construct size, which cannot cross typical endothelial barriers such as the vascular wall, and lack of a priori knowledge of the location of secondary tumor sites to which the construct is targeted. Here we develop mathematical models for diffusive and convection-enhanced delivery of a trivalent construct. Results show that delivery of the construct to the tissue does not yield acceptable contrast or specificity; therefore, unbound construct must be removed from the area of interest by allowing diffusion out of the area or a follow-up injection of fluid containing no construct (e.g., saline). The need for this additional step requires weeks to months for diffusive delivery to yield acceptable contrast, but convection-enhanced delivery may be able to achieve acceptable contrast within several days. Thus, convection-enhanced delivery of multivalent constructs may provide a mechanism to locate secondary tumor sites without prior knowledge of their location which would greatly enhance the ability to detect and treat cancer.
C1 [Stukel, Jill M.; Caplan, Michael R.] Arizona State Univ, Harrington Dept Bioengn, Tempe, AZ 85287 USA.
   [Heys, Jeffrey J.] Arizona State Univ, Dept Chem Engn, Tempe, AZ USA.
RP Caplan, MR (reprint author), Arizona State Univ, Harrington Dept Bioengn, POB 879709, Tempe, AZ 85287 USA.
EM Michael.Caplan@asu.edu
FU NIDCR NIH HHS [K22-DE014846]; NINDS NIH HHS [R21-NS051310]
CR Ashby Lynn S, 2006, Neurosurg Focus, V20, pE3, DOI 10.3171/foc.2006.20.4.3
   BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5
   Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013
   Berens ME, 1996, J NEURO-ONCOL, V27, P11, DOI 10.1007/BF00146079
   Berens Michael E., 1999, Neoplasia (New York), V1, P208, DOI 10.1038/sj.neo.7900034
   BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076
   Bradbury M., 1979, CONCEPT BLOOD BRAIN
   Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X
   Caplan MR, 2005, ANN BIOMED ENG, V33, P1113, DOI 10.1007/s10439-005-5779-1
   Chen MY, 1999, J NEUROSURG, V90, P315, DOI 10.3171/jns.1999.90.2.0315
   Dreher MR, 2006, J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070
   DVORAK HF, 1990, PROG CLIN BIOL RES, V354, P317
   DVORAK HF, 1991, CANCER CELL-MON REV, V3, P77
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   Fung LK, 1996, PHARM RES-DORDR, V13, P671, DOI 10.1023/A:1016083113123
   Ghersi-Egea JF, 2001, MICROSC RES TECHNIQ, V52, P83, DOI 10.1002/1097-0029(20010101)52:1<83::AID-JEMT10>3.0.CO;2-N
   GINGRAS MC, 1995, J NEUROIMMUNOL, V57, P143, DOI 10.1016/0165-5728(94)00178-Q
   Gonzalez AL, 2004, TISSUE ENG, V10, P1775, DOI 10.1089/ten.2004.10.1775
   Groothuis DR, 2000, BRAIN RES, V856, P281, DOI 10.1016/S0006-8993(99)02089-2
   Guerin C, 2004, INVEST NEW DRUG, V22, P27, DOI 10.1023/B:DRUG.0000006172.65135.3e
   Hall Walter A, 2003, Neurosurg Focus, V14, pe2
   Haller MF, 1998, PHARM RES-DORDR, V15, P377, DOI 10.1023/A:1011911912174
   Handl HL, 2004, EXPERT OPIN THER TAR, V8, P565, DOI 10.1517/14728222.8.6.565
   JAIN RK, 1995, MOL MED TODAY, V1, P4, DOI 10.1016/1357-4310(95)80005-0
   Johanson CE, 2005, PHARM RES-DORDR, V22, P1011, DOI 10.1007/s11095-005-6039-0
   Khan A, 2005, J NEUROSURG, V102, P53, DOI 10.3171/ped.2005.102.1.0053
   Kioi M, 2006, CANCER, V107, P1407, DOI 10.1002/cncr.22134
   Limentani SA, 2005, J NEURO-ONCOL, V72, P241, DOI 10.1007/s11060-004-2339-1
   Mak M, 1995, J NEURO-ONCOL, V26, P91, DOI 10.1007/BF01060215
   Mammen Mathai, 1998, Angew Chem Int Ed Engl, V37, P2754, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   MORRISON PF, 1986, J PHARM SCI, V75, P120, DOI 10.1002/jps.2600750204
   Morrison PF, 1999, AM J PHYSIOL-REG I, V277, pR1218, DOI 10.1152/ajpregu.1999.277.4.R1218
   MORRISON PF, 1994, AM J PHYSIOL, V266, pR292
   Nakada M, 2005, AM J PATHOL, V167, P565, DOI 10.1016/S0002-9440(10)62998-7
   Nakahara H, 1996, J BIOL CHEM, V271, P27221, DOI 10.1074/jbc.271.44.27221
   NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338
   Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90
   Patchell RA, 2002, J NEURO-ONCOL, V60, P37, DOI 10.1023/A:1020291229317
   Proescholdt MG, 2000, NEUROSCIENCE, V95, P577
   Raghavan Raghu, 2006, Neurosurg Focus, V20, pE12, DOI 10.3171/foc.2006.20.4.7
   SALTZMAN WM, 1991, CHEM ENG SCI, V46, P2429, DOI 10.1016/0009-2509(91)80036-X
   Saltzman WM, 1997, ADV DRUG DELIV REV, V26, P209
   Sarntinoranont M, 2003, ANN BIOMED ENG, V31, P327, DOI 10.1114/1.1554923
   Sarntinoranont M, 2003, ANN BIOMED ENG, V31, P448, DOI 10.1114/1.1558032
   Shadidi M, 2003, DRUG RESIST UPDATE, V6, P363, DOI 10.1016/j.drup.2003.11.002
   Shadidi Mohsen, 2003, FASEB Journal, V17, P256
   Sharma G, 2006, J DRUG TARGET, V14, P301, DOI 10.1080/10611860600809112
   Shimamura Takeshi, 2006, Neurosurg Focus, V20, pE11, DOI 10.3171/foc.2006.20.4.6
   Sinha R, 2006, MOL CANCER THER, V5, P1909, DOI 10.1158/1535-7163.MCT-06-0141
   Vagner J, 2004, BIOORG MED CHEM LETT, V14, P211, DOI 10.1016/j.bmcl.2003.09.079
   Walker WL, 1996, B MATH BIOL, V58, P1047
   Wang Y, 2006, ANN BIOMED ENG, V34, P114, DOI 10.1007/s10439-005-9007-2
   Wein LM, 2002, CELL PROLIFERAT, V35, P343, DOI 10.1046/j.1365-2184.2002.00246.x
   Westphal M, 2006, ACTA NEUROCHIR, V148, P269, DOI 10.1007/s00701-005-0707-z
   Woiciechowsky C, 2004, MED SCI MONITOR, V10, pBR325
   WOOLSEY TA, 2003, BRAIN ATLAS VISUAL G, P124
   Yezhelyev MV, 2006, LANCET ONCOL, V7, P657, DOI 10.1016/S1470-2045(06)70793-8
NR 58
TC 5
Z9 5
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2008
VL 36
IS 7
BP 1291
EP 1304
DI 10.1007/s10439-008-9498-8
PG 14
WC Engineering, Biomedical
SC Engineering
GA 307KQ
UT WOS:000256318200018
PM 18425582
DA 2018-10-20
ER

PT J
AU Nagel, MD
   Verhoef, R
   Schols, H
   Morra, M
   Knox, JP
   Ceccone, G
   Della Volpe, C
   Vigneron, P
   Bussy, C
   Gallet, M
   Velzenberger, E
   Vayssade, M
   Cascardo, G
   Cassinelli, C
   Haeger, A
   Gilliland, D
   Liakos, I
   Rodriguez-Valverde, MA
   Siboni, S
AF Nagel, Marie-Danielle
   Verhoef, Rene
   Schols, Henk
   Morra, Marco
   Knox, J. Paul
   Ceccone, Giacomo
   Della Volpe, Claudio
   Vigneron, Pascale
   Bussy, Cyrill
   Gallet, Marlene
   Velzenberger, Elodie
   Vayssade, Muriel
   Cascardo, Giovanna
   Cassinelli, Clara
   Haeger, Ash
   Gilliland, Douglas
   Liakos, Ioannis
   Rodriguez-Valverde, Miguel Angel
   Siboni, Stefano
TI Enzymatically-tailored pectins differentially influence the morphology,
   adhesion, cell cycle progression and survival of fibroblasts
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE pectin modified hairy region bioactivity; pectin/fibronectin
   interaction; pectin grafted-biomaterial
ID HAIRY RAMIFIED REGIONS; GROWTH-FACTOR RECEPTORS; SURFACE-CHEMISTRY;
   FIBRONECTIN CONFORMATION; ARABINOGALACTAN-PROTEINS;
   MONOCLONAL-ANTIBODIES; HUMAN KERATINOCYTES; INTEGRIN BINDING; ADSORBED
   FIBRONECTIN; RHAMNOGALACTURONAN-I
AB Improved biocompatibility and performance of biomedical devices can be achieved through the incorporation of bioactive molecules on device surfaces. Five structurally distinct pectic polysaccharides (modified hairy regions (MHRs)) were obtained by enzymatic liquefaction of apple (MHR-B, MHR-A and MHR-alpha), carrot (MHR-C) and potato (MHR-P) cells. Polystyrene (PS) Petri dishes, aminated by a plasma deposition process, were surface modified by the covalent linking of the MHRs. Results clearly demonstrate that MHR-B induces cell adhesion, proliferation and survival, in contrast to the other MHRs. Moreover, MHR-alpha causes cells to aggregate, decrease proliferation and enter into apoptosis. Cells cultured in standard conditions with 1% soluble MHR-B or MHR-alpha show the opposite behaviour to the one observed on MHR-B and -alpha-grafted PS. Fibronectin was similarly adsorbed onto MHR-B and tissue culture polystyrene (TCPS) control, but poorly on MHR-alpha. The Fn cell binding site (RGD sequence) was more accessible on MHR-B than on TCPS control, but poorly on MHR-alpha. The disintegrin echistatin inhibited fibroblast adhesion and spreading on MHR-B-grafted PS, which suggests that MHRs control fibroblast behaviour via serum-adhesive proteins. This study provides a basis for the design of intelligently-tailored biomaterial coatings able to induce specific cell functions. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Nagel, Marie-Danielle; Vigneron, Pascale; Bussy, Cyrill; Gallet, Marlene; Velzenberger, Elodie; Vayssade, Muriel] Univ Technol Compiegne, CNRS, UMR 6600, BP 20529, F-60205 Compiegne, France.
   [Verhoef, Rene; Schols, Henk] Univ Wageningen & Res Ctr, Dept Agrotechnol & Food Sci, Food Chem Lab, NL-6700 EV Wageningen, Netherlands.
   [Morra, Marco; Cascardo, Giovanna; Cassinelli, Clara] Nobil Bio Ric Srl, I-14018 Villafranca Dasti, AT, Italy.
   [Knox, J. Paul; Haeger, Ash] Univ Leeds, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England.
   [Ceccone, Giacomo; Gilliland, Douglas; Liakos, Ioannis] BMS, Commiss European Communities, Inst Hlth & Consumer Protect, I-21020 Ispra, VA, Italy.
   [Della Volpe, Claudio; Rodriguez-Valverde, Miguel Angel; Siboni, Stefano] Univ Trent, Dept Mat Engn & Ind Technol, I-38100 Povo, TN, Italy.
RP Nagel, MD (reprint author), Univ Technol Compiegne, CNRS, UMR 6600, BP 20529, F-60205 Compiegne, France.
EM marie-danielle.nagel@utc.fr
RI bussy, cyrill/C-7190-2008; Schols, Henk/A-1742-2009; Rodriguez-Valverde,
   Miguel Angel/B-7938-2009; della volpe, claudio/D-6733-2014; Liakos,
   Ioannis/C-5847-2014; Knox, Paul/H-4577-2012
OI bussy, cyrill/0000-0001-8870-443X; Rodriguez-Valverde, Miguel
   Angel/0000-0003-4361-6721; della volpe, claudio/0000-0002-3473-8092;
   Liakos, Ioannis/0000-0001-6403-1058; Knox, Paul/0000-0002-9231-6891
CR Briggs D., 1990, AUGER XRAY PHOTOELEC
   Brunold C, 2004, PLANTA MED, V70, P370, DOI 10.1055/s-2004-818952
   Bussy C, 2008, J BIOMED MATER RES A, V86A, P597, DOI 10.1002/jbm.a.31729
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CLARKE AE, 1979, PHYTOCHEMISTRY, V18, P521, DOI 10.1016/S0031-9422(00)84255-7
   Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   Deters AM, 2005, J ETHNOPHARMACOL, V102, P391, DOI 10.1016/j.jep.2005.06.038
   Deters AM, 2005, PLANTA MED, V71, P33, DOI 10.1055/s-2005-837748
   Deters AM, 2005, J CELL PHYSIOL, V202, P717, DOI 10.1002/jcp.20161
   Ding K, 2003, J NAT PROD, V66, P7, DOI 10.1021/np020118o
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Hsieh Tze-chen, 2006, BMC Complement Altern Med, V6, P30, DOI 10.1186/1472-6882-6-30
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Immerzeel P, 2004, PHYSIOL PLANTARUM, V122, P181, DOI 10.1111/j.1399-3054.2004.00395.x
   Immerzeel P, 2006, PHYSIOL PLANTARUM, V128, P18, DOI 10.1111/j.1399-3054.2006.00712.x
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Jackson CL, 2007, GLYCOBIOLOGY, V17, P805, DOI 10.1093/glycob/cwm054
   Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405
   Kaur M, 2006, MOL CANCER THER, V5, P1265, DOI 10.1158/1535-7163.MCT-06-0014
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kniep B, 2006, INT J CANCER, V119, P67, DOI 10.1002/ijc.21788
   Kokkonen HE, 2007, BIOMACROMOLECULES, V8, P509, DOI 10.1021/bm060614h
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   LAU JM, 1987, CARBOHYD RES, V168, P245, DOI 10.1016/0008-6215(87)80029-0
   Malisan F, 2002, J EXP MED, V196, P1535, DOI 10.1084/jem.20020960
   Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065
   Manton KJ, 2007, J MOL HISTOL, V38, P415, DOI 10.1007/s10735-007-9121-6
   Manton KJ, 2006, J CELL PHYSIOL, V209, P219, DOI 10.1002/jcp.20727
   McCann MC, 2001, PHYTOCHEMISTRY, V57, P811, DOI 10.1016/S0031-9422(01)00144-3
   McLane MA, 1996, FEBS LETT, V391, P139, DOI 10.1016/0014-5793(96)00716-8
   MCNEIL M, 1982, PLANT PHYSIOL, V70, P1586, DOI 10.1104/pp.70.6.1586
   Morra M, 2004, BIOMACROMOLECULES, V5, P2094, DOI 10.1021/bm049834q
   Morra M, 2003, J COLLOID INTERF SCI, V259, P236, DOI 10.1016/S0021-9797(02)00204-7
   Morra M, 2007, EXPERT REV MED DEVIC, V4, P361, DOI 10.1586/17434440.4.3.361
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Nergard CS, 2006, BIOMACROMOLECULES, V7, P71, DOI 10.1021/bm050355g
   Olano-Martin E, 2003, ANTICANCER RES, V23, P341
   Oomen R. J. F. J., 2003, ADV PECTIN PECTINASE, P15
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   PLATT D, 1992, J NATL CANCER I, V84, P438, DOI 10.1093/jnci/84.6.438
   Popov SV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P108
   Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3
   Sakurai MH, 1999, IMMUNOLOGY, V97, P540, DOI 10.1046/j.1365-2567.1999.00774.x
   Schols H. A, 2002, PECTINS THEIR MANIPU, P1
   SCHOLS HA, 1994, CARBOHYD RES, V256, P97, DOI 10.1016/0008-6215(94)84230-2
   SCHOLS HA, 1994, CARBOHYD RES, V256, P83, DOI 10.1016/0008-6215(94)84229-9
   Schols HA, 1995, CARBOHYD RES, V279, P265, DOI 10.1016/0008-6215(95)00287-1
   SCHOLS HA, 1990, CARBOHYD RES, V206, P117, DOI 10.1016/0008-6215(90)84011-I
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   VORAGEN AG, 2006, FOOD POLYSACCHARRIDE, P287
   Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6
   Wu SC, 2006, J BIOMED MATER RES A, V79A, P557, DOI 10.1002/jbm.a.30845
   Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131
NR 60
TC 23
Z9 25
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD JUL-AUG
PY 2008
VL 1780
IS 7-8
BP 995
EP 1003
DI 10.1016/j.bbagen.2008.04.002
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 321MJ
UT WOS:000257309000008
PM 18485917
DA 2018-10-20
ER

PT J
AU Wang, AY
   Foss, CA
   Leong, S
   Mo, X
   Pomper, MG
   Yu, SM
AF Wang, Allen Y.
   Foss, Catherine A.
   Leong, Shirley
   Mo, Xiao
   Pomper, Martin G.
   Yu, Seungju M.
TI Spatio-temporal modification of collagen scaffolds mediated by triple
   helical propensity
SO BIOMACROMOLECULES
LA English
DT Article
ID I COLLAGEN; EXTRACELLULAR-MATRIX; MIMETIC PEPTIDE; BINDING-SITES;
   STABILITY; PROTEIN; ATHEROSCLEROSIS; LOCALIZATION; BIOMATERIAL;
   FIBRONECTIN
AB Functionalized collagen that incorporates exogenous compounds may offer new and improved biomaterials applications, especially in drug-delivery, multifunctional implants, and tissue engineering. To that end, we developed a specific and reversible collagen modification technique utilizing associative chain interactions between synthetic collagen mimetic peptide (CMP) [(ProHypGly)(x); Hyp = hydroxyproline] and type I collagen. Here we show temperature-dependent collagen binding and subsequent release of a series of CMPs with varying chain lengths indicating a triple helical propensity driven binding mechanism. The binding took place when melted, single-strand CMPs were allowed to fold while in contact with reconstituted type I collagens. The binding affinity is highly specific to collagen as labeled CMP bound to nanometer scale periodic positions on type I collagen fibers and could be used to selectively image collagens in ex vivo human liver tissue. When heated to physiological temperature, bound CMPs discharged from the collagen at a sustained rate that correlated with CMP's triple helical propensity, suggesting that sustainability is mediated by dynamic collagen-CMP interactions. We also report on the spatially defined modification of collagen film with linear and multi-arm poly(ethylene glycol)CMP conjugates; at 37 degrees C, these PEG-CMP conjugates exhibited temporary cell repelling activity lasting up to 9 days. These results demonstrate new opportunities for targeting pathologic collagens for diagnostic or therapeutic applications and for fabricating multifunctional collagen coatings and scaffolds that can temporally and spatially control the behavior of cells associated with the collagen matrices.
C1 [Wang, Allen Y.; Mo, Xiao; Yu, Seungju M.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
   [Leong, Shirley; Yu, Seungju M.] Johns Hopkins Univ, Dept Biomol & Chem Engn, Baltimore, MD 21218 USA.
   [Pomper, Martin G.; Yu, Seungju M.] Johns Hopkins Univ, Inst NanoBiotechnol, Baltimore, MD 21218 USA.
   [Foss, Catherine A.; Pomper, Martin G.] Johns Hopkins Med Inst, Dept Radiol, Baltimore, MD 21231 USA.
RP Yu, SM (reprint author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
EM yu@jhu.edu
RI Yu, Michael/A-3332-2010
FU NIGMS NIH HHS [R21 GM074812, R21 GM074812-02, R21GM-74812]
CR Ackerman MS, 1999, J BIOL CHEM, V274, P7668, DOI 10.1074/jbc.274.12.7668
   AMENTA PS, 1986, COLLAGEN REL RES, V6, P125
   Berisio R, 2004, BIOPOLYMERS, V73, P682, DOI 10.1002/bip.20017
   Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v
   CHAPMAN JA, 1974, CONNECT TISSUE RES, V2, P137, DOI 10.3109/03008207409152099
   CHRISTINA LA, 2006, FUTURE ONCOL, V2, P417
   Davies JR, 2006, J AM COLL CARDIOL, V47, pC57, DOI 10.1016/j.jacc.2005.11.049
   DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Dorweiler B, 2006, THROMB HAEMOSTASIS, V95, P182, DOI 10.1160/TH05-05-0357
   Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818
   Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640
   Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Jaffer FA, 2006, J AM COLL CARDIOL, V47, P1328, DOI 10.1016/j.jacc.2006.01.029
   JAKEMAN LB, 1992, J CLIN INVEST, V89, P244, DOI 10.1172/JCI115568
   Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Koide T, 2005, CONNECT TISSUE RES, V46, P131, DOI 10.1080/03008200591008518
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Kwak J, 2002, J AM CHEM SOC, V124, P14085, DOI 10.1021/ja0209621
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241
   Melacini G, 1996, J AM CHEM SOC, V118, P10725, DOI 10.1021/ja9617193
   Melacini G, 2000, J MOL BIOL, V300, P1041, DOI 10.1006/jmbi.2000.3919
   Miles CA, 2001, MICRON, V32, P325, DOI 10.1016/S0968-4328(00)00034-2
   Mo X, 2006, ANGEW CHEM INT EDIT, V45, P2267, DOI 10.1002/anie.200504529
   Myles JL, 2000, J BIOMAT SCI-POLYM E, V11, P69, DOI 10.1163/156856200743508
   Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Nishi Y, 2005, BIOCHEMISTRY-US, V44, P6034, DOI 10.1021/bi047887m
   O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   PEFFER NJ, 1993, P NATL ACAD SCI USA, V90, P10648, DOI 10.1073/pnas.90.22.10648
   Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Sasano Y, 2000, HISTOCHEM J, V32, P591, DOI 10.1023/A:1026720003564
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   Teshima R, 2004, J ORTHOP SCI, V9, P270, DOI 10.1007/s00776-004-0769-4
   Tiller JC, 2001, BIOTECHNOL BIOENG, V73, P246, DOI 10.1002/bit.1057
   VAPORCIYAN AA, 1993, SCIENCE, V262, P1580, DOI 10.1126/science.8248808
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
   Wang AY, 2005, J AM CHEM SOC, V127, P4130, DOI 10.1021/ja0431915
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
NR 52
TC 46
Z9 47
U1 1
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL
PY 2008
VL 9
IS 7
BP 1755
EP 1763
DI 10.1021/bm701378k
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 326DX
UT WOS:000257639500007
PM 18547103
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Shin, YM
   Kim, KS
   Lim, YM
   Nho, YC
   Shin, H
AF Shin, Young Min
   Kim, Kyung-Soo
   Lim, Youn Mook
   Nho, Young Chang
   Shin, Heungsoo
TI Modulation of spreading, proliferation, and differentiation of human
   mesenchymal stem cells on gelatin-immobilized
   poly(L-lactide-co-epsilon-caprolactone) substrates
SO BIOMACROMOLECULES
LA English
DT Article
ID SURFACE MODIFICATION; ACRYLIC-ACID; PLCL SCAFFOLDS; COLLAGEN; ADHESION;
   MATRIX; GROWTH; BONE; BIOMATERIAL; OSTEOBLASTS
AB Controlled adhesion and continuous growth of human mesenchymal stem cells (hMSCs) are essential for scaffold-based delivery of hMSCs in tissue engineering applications. The main goal of this study is to develop biofunctionalized synthetic substrates to actively control adhesion, spreading, and proliferation of hMSCs. gamma-Ray irradiation was employed to graft acrylic acid (AAc) to biodegeradable poly(L-lactide-co-epsilon-caprolactone) (PLCL) films. Gelatin, a natural polymer, was then immobilized on the AAc grafted PLCL film (AAc-PLCL) to induce biomimetic interactions with the cells. The graft yield of AAc increased as the irradiation dose and AAc concentration increased, and the presence of gelatin (gelatin-AAc-PLCL) following immobilization was confirmed using ESCA. To investigate cell responses, hMSCs isolated from a human mandible were cultured on the various substrates and their adhesion, spreading, and proliferation were examined. After three days of culture, the DNA concentration from the cells cultured on gelatin-AAc-PLCL film was 2.9-fold greater than that on the PLCL film. Immunofluorescent staining of hMSCs cultured on the gelatin-AAc-PLCL films demonstrated homogeneous localization of F-Actin and vinculin in their cytoplasm, while mature adhesive structure was not observed from the cells cultured on other substrates. Furthermore, the ratio of projected area of adherent single cells on gelatin-AAc-PLCL films was significantly larger (116.80 +/- 12.78%) than that on the PLCL films (30.11 +/- 5.07%). Our results suggest that gelatin-immobilized PLCL substrates may be potentially used in tissue engineering, particularly as a stem cell delivery carrier for the regeneration of target tissue.
C1 [Shin, Young Min; Shin, Heungsoo] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
   [Kim, Kyung-Soo] Hanyang Univ, Dept Internal Med, Div Cardiol, Seoul 133791, South Korea.
   [Lim, Youn Mook; Nho, Young Chang] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Radiat Res Ctr Ind & Environm, Jeongeup Si 580185, Jeollabuk Do, South Korea.
RP Shin, H (reprint author), Hanyang Univ, Dept Bioengn, 17 Haengdang Dong, Seoul 133791, South Korea.
EM hshin@hanyang.ac.kr
OI Shin, Young Min/0000-0002-8818-454X
CR Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380
   Amato I, 2007, BIOMATERIALS, V28, P3668, DOI 10.1016/j.biomaterials.2007.04.038
   Betz VM, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2724
   Carlisle ES, 2000, TISSUE ENG, V6, P45, DOI 10.1089/107632700320883
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Choi JS, 2007, J BIOACT COMPAT POL, V22, P508, DOI 10.1177/0883911507081101
   Cui YL, 2003, J BIOMED MATER RES A, V66A, P770, DOI 10.1002/jbm.a.10071
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fan HB, 2008, BIOMATERIALS, V29, P1017, DOI 10.1016/j.biomaterials.2007.10.048
   Garkhal K, 2007, J BIOMED MATER RES A, V82A, P747, DOI 10.1002/bjm.a.31150
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   Guillot PV, 2007, J CELL MOL MED, V11, P935, DOI 10.1111/j.1582-4934.2007.00106.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hinrichs WLJ, 1997, J CONTROL RELEASE, V45, P163, DOI 10.1016/S0168-3659(96)01571-4
   Ho MH, 2007, MACROMOL BIOSCI, V7, P467, DOI 10.1002/mabi.200600241
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Jeong SI, 2004, J BIOMAT SCI-POLYM E, V15, P645, DOI 10.1163/156856204323046906
   Jeong SI, 2005, BIOMATERIALS, V26, P1405, DOI 10.1016/j.biomaterials.2004.04.036
   Jones E, 2008, RHEUMATOLOGY, V47, P126, DOI 10.1093/rheumatology/kem206
   Kenar H, 2008, J BIOMED MATER RES A, V85A, P1001, DOI 10.1002/jbm.a.31638
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Ng KW, 2005, TISSUE ENG, V11, P182, DOI 10.1089/ten.2005.11.182
   NHO Y, 2004, RADIAT PHYS CHEM, P237
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028
   Rutnakornpituk M, 2006, POLYMER, V47, P7909, DOI 10.1016/j.polymer.2006.09.028
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Teraoka F, 2006, DENT MATER J, V25, P560, DOI 10.4012/dmj.25.560
   Vashi AV, 2008, BIOMATERIALS, V29, P573, DOI 10.1016/j.biomaterials.2007.10.017
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   YAMAGUCHI M, 2004, J ARTIF ORGANS, V7, P187
   Yang J, 2003, J BIOMED MATER RES A, V67A, P1139, DOI 10.1002/jbm.a.10034
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Yen AHH, 2008, CELL TISSUE RES, V331, P359, DOI 10.1007/s00441-007-0467-6
   Ying L, 2003, BIOMACROMOLECULES, V4, P157, DOI 10.1021/bm025676w
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
NR 47
TC 74
Z9 74
U1 0
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL
PY 2008
VL 9
IS 7
BP 1772
EP 1781
DI 10.1021/bm701410g
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 326DX
UT WOS:000257639500009
PM 18558737
DA 2018-10-20
ER

PT J
AU Hsiong, SX
   Huebsch, N
   Fischbach, C
   Kong, HJ
   Mooney, DJ
AF Hsiong, Susan X.
   Huebsch, Nathaniel
   Fischbach, Claudia
   Kong, Hyun Joon
   Mooney, David J.
TI Integrin-adhesion ligand bond formation of preosteoblasts and stem cells
   in three-dimensional RGD presenting matrices
SO BIOMACROMOLECULES
LA English
DT Article
ID RESONANCE ENERGY-TRANSFER; MARROW STROMAL CELLS; OSTEOBLAST
   DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX;
   SIGNALING PATHWAYS; ALGINATE HYDROGELS; COLLAGEN-SYNTHESIS;
   GENE-EXPRESSION; MC3T3-E1 CELLS
AB Cell-interactive polymers have been widely used as synthetic extracellular matrices to regulate cell function and promote tissue regeneration. However, there is a lack of quantitative understanding of the cell-material interface. In this study, integrin-adhesion ligand bond formation of preosteoblasts and D1 stem cells with RGD presenting alginate matrices were examined using FRET and flow cytometry. Bond number increased with adhesion ligand density but did not change with RGD island spacing for both cell types. Integrin expression varied with cell type and substrate in 2D culture, but the integrin expression profiles of both cell types were similar when cultured in 3D RGD presenting substrates and distinct from 2D culture. In summary, combining a FRET technique to quantify bond formation with flow cytometry to elucidate integrin expression can define specific cell-material interactions for a given material system and may be useful for informing biomaterial design strategies for cell-based therapies.
C1 [Mooney, David J.] Harvard Univ, Engn Sci Lab, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Hsiong, Susan X.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Huebsch, Nathaniel] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Fischbach, Claudia] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA.
   [Kong, Hyun Joon] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Engn Sci Lab, Sch Engn & Appl Sci, SEAS 325 Pierce Hall Cambridge, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
RI Fischbach, Claudia/C-8550-2009
OI Fischbach, Claudia/0000-0002-9368-0150; Huebsch,
   Nathaniel/0000-0002-3329-0214
FU NIDCR NIH HHS [R37 DE13033, R37 DE013033, R37 DE013033-12]
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Bennett JH, 2001, ARCH ORAL BIOL, V46, P229, DOI 10.1016/S0003-9969(00)00114-X
   Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1
   Chen HF, 2007, BIOPHYS J, V92, P1399, DOI 10.1529/biophysj.106.094896
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7
   Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7
   DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012
   FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235
   Fromigue O, 1997, CYTOKINE, V9, P613, DOI 10.1006/cyto.1997.0209
   Gilbert M, 2003, J BIOMED MATER RES A, V67A, P69, DOI 10.1002/jbm.a.10053
   Goennenwein S, 2003, BIOPHYS J, V85, P646, DOI 10.1016/S0006-3495(03)74508-1
   Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264
   HSIONG SX, 2007, J BIOMED MATER RES A, V4, P1501
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   KUBITSCHECK U, 1991, BIOPHYS J, V60, P307, DOI 10.1016/S0006-3495(91)82055-0
   Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110
   Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Li XD, 2005, OSTEOPOROSIS INT, V16, P101, DOI 10.1007/s00198-004-1649-7
   Li XD, 2003, BONE, V33, P652, DOI 10.1016/S8756-3282(03)00239-4
   Moursi AM, 1997, J CELL SCI, V110, P2187
   NAKATANI Y, 1984, BIOCHEM BIOPH RES CO, V123, P894, DOI 10.1016/S0006-291X(84)80219-3
   Oyajobi BO, 1999, J BONE MINER RES, V14, P351, DOI 10.1359/jbmr.1999.14.3.351
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Pistone M, 1996, CELL BIOL INT, V20, P471, DOI 10.1006/cbir.1996.0062
   PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Sun S, 2006, BIOELECTROCHEMISTRY, V69, P133, DOI 10.1016/j.bioelechem.2005.11.007
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Titushkin I, 2006, BIOPHYS J, V90, P2582, DOI 10.1529/biophysj.105.073775
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
NR 39
TC 46
Z9 46
U1 2
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL
PY 2008
VL 9
IS 7
BP 1843
EP 1851
DI 10.1021/bm8000606
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 326DX
UT WOS:000257639500018
PM 18540674
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Petrie, TA
   Raynor, JE
   Reyes, CD
   Burns, KL
   Collard, DM
   Garcia, AJ
AF Petrie, Timothy A.
   Raynor, Jenny E.
   Reyes, Catherine D.
   Burns, Kellie L.
   Collard, David M.
   Garcia, Andres J.
TI The effect of integrin-specific bioactive coatings on tissue healing and
   implant osseointegration
SO BIOMATERIALS
LA English
DT Article
DE bone; fibronectin; cell adhesion; RGD; FAK; integrins
ID TOTAL JOINT ARTHROPLASTY; IN-VIVO EVALUATION; BONE-FORMATION;
   CELL-ADHESION; OSTEOBLAST DIFFERENTIATION; BIOMATERIAL SURFACES;
   TITANIUM IMPLANTS; BINDING; ALPHA-V-BETA-3; HYDROXYAPATITE
AB Implant osseointegration, defined as bone apposition and functional fixation, is a requisite for clinical success in orthopaedic and dental applications, many of which are restricted by implant loosening. Modification of implants to present bioactive motifs such as the RGD cell-adhesive sequence from fibronectin (FN) represents a promising approach in regenerative medicine. However, these biomimetic strategies have yielded only marginal enhancements in tissue healing in vivo. In this study, clinical-grade titanium implants were grafted with a non-fouling oligo(ethylene glycol)-substituted polymer coating functionalized with controlled densities of ligands of varying specificity for target integrin receptors. Biomaterials presenting the alpha(5)beta(1)-integrin-specific FN fragment FNIII7-10 enhanced osteoblastic differentiation in bone marrow stromal cells compared to unmodified titanium and RGD-presenting surfaces. Importantly, FNIII7-10-functionalized titanium significantly improved functional implant osseointegration compared to RGD-functionalized and unmodified titanium in vivo. This study demonstrates that bioactive coatings that promote integrin binding specificity regulate marrow-derived progenitor osteoblastic differentiation and enhance healing responses and functional integration of biomedical implants. This work identifies an innovative strategy for the rational design of biomaterials for regenerative medicine. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Petrie, Timothy A.; Reyes, Catherine D.; Burns, Kellie L.; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Petrie, Timothy A.; Reyes, Catherine D.; Burns, Kellie L.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Raynor, Jenny E.; Collard, David M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr,Room 2314 IBB, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
FU NIBIB NIH HHS [R01 EB004496, R01 EB004496-04, R01 EB-004496]
CR *AM AC ORTH SURG, 2003, ARTHR TOT JOINT REPL
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Arthritis Foundation Association of State and Territorial Health Officials Centers for Disease Control and Prevention, 1999, NAT ARTHR ACT PLAN P
   Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Bauer TW, 1999, SKELETAL RADIOL, V28, P423, DOI 10.1007/s002560050541
   Carron CP, 2000, J ENDOCRINOL, V165, P587, DOI 10.1677/joe.0.1650587
   Cheng SL, 2000, J CELL BIOCHEM, V77, P265, DOI 10.1002/(SICI)1097-4644(20000501)77:2<265::AID-JCB9>3.0.CO;2-6
   Cheng SL, 2001, CALCIFIED TISSUE INT, V68, P87, DOI 10.1007/BF02678146
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Engleman V. Wayne, 1997, Journal of Clinical Investigation, V99, P2284, DOI 10.1172/JCI119404
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114
   Hubbell JA, 2004, NAT BIOTECHNOL, V22, P828, DOI 10.1038/nbt0704-828
   Hutchinson JH, 2003, J MED CHEM, V46, P4790, DOI 10.1021/jm030306r
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Nakamura I, 1999, J CELL SCI, V112, P3985
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Pilliar RM, 2005, ORTHOP CLIN N AM, V36, P113, DOI 10.1016/j.ocl.2004.08.001
   Rammelt S, 2007, J ORTHOP RES, V25, P1052, DOI 10.1002/jor.20403
   Raynor JE, 2007, ADV MATER, V19, P1724, DOI 10.1002/adma.200602129
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Siebers MC, 2007, CLIN ORAL IMPLAN RES, V18, P354, DOI 10.1111/j.1600-0501.2006.01314.x
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   Wang H, 2006, BIOMATERIALS, V27, P4192, DOI 10.1016/j.biomaterials.2006.03.034
NR 35
TC 149
Z9 153
U1 2
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2008
VL 29
IS 19
BP 2849
EP 2857
DI 10.1016/j.biomaterials.2008.03.036
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 304YL
UT WOS:000256144900003
PM 18406458
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Williams, DF
AF Williams, David F.
TI On the mechanisms of biocompatibility
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT Ratner Symposium 2006
CY 2006
CL Maui, HI
DE foreign body response; inflammation; implant; scaffold; biodegradation
ID SILICONE BREAST IMPLANTS; CENTRAL VENOUS CATHETERS; TOTAL
   HIP-ARTHROPLASTY; VASCULAR GRAFTS; IN-VIVO; ALKYLENE
   BIS(DILACTOYL)-METHACRYLATE; POLYTETRAFLUOROETHYLENE GRAFTS;
   FEMOROPOPLITEAL BYPASS; SCREW AUGMENTATION; TISSUE-RESPONSE
AB The manner in which a mutually acceptable co-existence of biomaterials and tissues is developed and sustained has been the focus of attention in biomaterials science for many years, and forms the foundation of the subject of biocompatibility. There are many ways in which materials and tissues can be brought into contact such that this co-existence may be compromised, and the search for biomaterials that are able to provide for the best performance in devices has been based upon the understanding of all the interactions within biocompatibility phenomena. Our understanding of the mechanisms of biocompatibility has been restricted whilst the focus of attention has been long-term implantable devices. In this paper, over 50 years of experience with such devices is analysed and it is shown that, in the vast majority of circumstances, the sole requirement for biocompatibility in a medical device intended for long-term contact with the tissues of the human body is that the material shall do no harm to those tissues, achieved through chemical and biological inertness. Rarely has an attempt to introduce biological activity into a biomaterial been clinically successful in these applications. This essay then turns its attention to the use of biomaterials in tissue engineering, sophisticated cell, drug and gene delivery systems and applications in biotechnology, and shows that here the need for specific and direct interactions between biomaterials and tissue components has become necessary, and with this a new paradigm for biocompatibility has emerged. It is believed that once the need for this change is recognised, so our understanding of the mechanisms of biocompatibility will markedly improve. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Williams, David F.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England.
   [Williams, David F.] Tsinghua Univ, Beijing 100084, Peoples R China.
RP Williams, DF (reprint author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.
EM dfw@liv.ac.uk
FU Medical Research Council; Biotechnology and Biological Sciences Research
   Council
CR Adams TST, 2007, J PLAST RECONSTR AES, V60, P210, DOI 10.1016/j.bjps.2006.01.012
   ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030
   Astion DJ, 1996, J BONE JOINT SURG AM, V78A, P755, DOI 10.2106/00004623-199605000-00016
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Bauer TW, 1999, SKELETAL RADIOL, V28, P423, DOI 10.1007/s002560050541
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bhattarai SR, 2006, J BIOMED MATER RES A, V78A, P247, DOI 10.1002/jbm.a.30695
   Bonzani IC, 2007, BIOMATERIALS, V28, P423, DOI 10.1016/j.biomaterials.2006.08.026
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Bottio T, 2007, CARDIOVASC PATHOL, V16, P1, DOI 10.1016/j.carpath.2006.09.008
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   Butany J, 2006, J CARDIAC SURG, V21, P530, DOI 10.1111/j.1540-8191.2006.00323.x
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   CRAGG A, 1983, RADIOLOGY, V147, P261, DOI 10.1148/radiology.147.1.6828742
   Crossley George H., 2000, Cardiology Clinics, V18, P95, DOI 10.1016/S0733-8651(05)70130-2
   Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215
   D'Antonio J, 2005, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000162995.50971.39
   de Voogt WG, 1999, AM J CARDIOL, V83, p187D
   DELBUFALO AGA, 1993, PACE, V16, P1240
   Devine C, 2004, J VASC SURG, V40, P924, DOI 10.1016/j.jvs.2004.08.033
   DI MA, 2005, BIOMATERIALS, V26, P5983
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Donaldson K, 2006, NANOMEDICINE-UK, V1, P229, DOI 10.2217/17435889.1.2.229
   DOTTER CT, 1964, CIRCULATION, V30, P654, DOI 10.1161/01.CIR.30.5.654
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Dumbleton J, 2004, J BONE JOINT SURG AM, V86A, P2526, DOI 10.2106/00004623-200411000-00028
   Dush DM, 2001, ANN RHEUM DIS, V60, P653, DOI 10.1136/ard.60.7.653
   Edworthy SM, 1998, J RHEUMATOL, V25, P254
   EFSING HO, 1983, WORLD J SURG, V7, P419, DOI 10.1007/BF01658094
   Eicken A, 2006, INT J CARDIOL, V107, P30, DOI 10.1016/j.ijcard.2005.02.048
   Elgohary MA, 2006, J CATARACT REFR SURG, V32, P1188, DOI 10.1016/j.jcrs.2006.01.106
   FILLINGER MF, 1990, J VASC SURG, V11, P556, DOI 10.1067/mva.1990.18322
   Fournier E, 2006, BIOMATERIALS, V27, P4963, DOI 10.1016/j.biomaterials.2006.04.045
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   GEESINK RGT, 1995, J BONE JOINT SURG BR, V77B, P534
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248
   Gong G, 1993, J Heart Valve Dis, V2, P684
   Goodman S, 2005, ORTHOP CLIN N AM, V36, P41, DOI 10.1016/j.ocl.2004.06.015
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V117, P1425
   Grossterlinden L, 2006, BIOMATERIALS, V27, P3379, DOI 10.1016/j.biomaterials.2006.01.051
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065
   Hering D, 2005, NAT CLIN PRACT CARD, V2, P415, DOI 10.1038/ncpcardio0271
   Heyligers JMM, 2006, J VASC SURG, V43, P587, DOI 10.1016/j.jvs.2005.10.038
   Hicks CR, 2003, EYE, V17, P385, DOI 10.1038/sj.eye.6700333
   Hua W, 1997, PACE, V20, P17, DOI 10.1111/j.1540-8159.1997.tb04807.x
   Human P, 2001, J Long Term Eff Med Implants, V11, P199
   Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582
   Ignatius AA, 2005, J BIOMED MATER RES B, V75B, P128, DOI 10.1002/jbm.b.30274
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   Janowsky EC, 2000, NEW ENGL J MED, V342, P781, DOI 10.1056/NEJM200003163421105
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   Jones CA, 2005, CLIN GERIATR MED, V21, P527, DOI 10.1016/j.cger.2005.02.005
   Kirkpatrick WNA, 2002, BRIT J PLAST SURG, V55, P479, DOI 10.1054/bjps.2002.3903
   Klement P, 2006, BIOMATERIALS, V27, P5107, DOI 10.1016/j.biomaterials.2006.05.005
   KLEPETKO W, 1989, J THORAC CARDIOV SUR, V97, P90
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Lau H, 2001, ANN VASC SURG, V15, P383, DOI 10.1007/s100160010085
   Le Visage C, 2001, BIOMATERIALS, V22, P2229, DOI 10.1016/S0142-9612(00)00411-7
   Lemson MS, 2000, EUR J VASC ENDOVASC, V19, P336, DOI 10.1053/ejvs.1999.1040
   Long DA, 2006, ANAESTH INTENS CARE, V34, P481
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934
   Mamode N, 2000, COCHRANE DB SYST REV
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Marotta JS, 2002, ANN PLAS SURG, V49, P227, DOI 10.1097/00000637-200209000-00001
   Marrey RV, 2006, BIOMATERIALS, V27, P1988, DOI 10.1016/j.biomaterials.2005.10.012
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   McKellop H, 2000, J BONE JOINT SURG AM, V82A, P1708, DOI 10.2106/00004623-200012000-00004
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   MONREAL M, 1994, THROMB HAEMOSTASIS, V72, P548
   Montanaro L, 2007, BIOMATERIALS, V28, P5155, DOI 10.1016/j.biomaterials.2007.08.003
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Muller K M, 1994, Curr Top Pathol, V86, P273
   Nilsen AR, 1996, ACTA ORTHOP SCAND, V67, P57, DOI 10.3109/17453679608995610
   Norlin A, 2002, BIOMOL ENG, V19, P67, DOI 10.1016/S1389-0344(02)00013-8
   OHLIN A, 1990, ACTA ORTHOP SCAND, V61, P7, DOI 10.3109/17453679008993055
   Olson RJ, 2003, AM J OPHTHALMOL, V136, P146, DOI 10.1016/S0002-9394(03)00226-5
   Peeters P, 2006, J CARDIOVASC SURG, V47, P407
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Pinchuk L, 2008, BIOMATERIALS, V29, P448, DOI 10.1016/j.biomaterials.2007.09.041
   Poeppl N, 2007, AESTHET PLAST SURG, V31, P133, DOI 10.1007/s00266-006-0091-y
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Porter Judith A, 2005, Gen Dent, V53, P423
   Puleo David A, 2006, Dent Clin North Am, V50, P323, DOI 10.1016/j.cden.2006.03.001
   Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Ren WP, 2003, BIOMATERIALS, V24, P4819, DOI 10.1016/S0142-9612(03)00384-3
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Rizkalla M, 2001, BRIT J PLAST SURG, V54, P125, DOI 10.1054/bjps.2000.3490
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Rosenberg NL, 1996, NEUROLOGY, V46, P308, DOI 10.1212/WNL.46.2.308
   Salzmann DL, 1999, CARDIOVASC PATHOL, V8, P63, DOI 10.1016/S1054-8807(98)00003-9
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091
   Shanbhag AS, 2006, J AM ACAD ORTHOP SUR, V14, P215, DOI 10.5435/00124635-200604000-00003
   Shiiya N, 2006, EUR J CARDIO-THORAC, V30, P402, DOI 10.1016/j.ejcts.2006.05.014
   SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   STEINERT R, 2003, CATARACT SURG
   Stone GW, 2006, MAYO CLIN PROC, V81, P641, DOI 10.4065/81.5.641
   Tanzer M, 2004, CLIN ORTHOP RELAT R, P153, DOI 10.1097/01.blo.0000128282.05708.9a
   Taylor PM, 2007, PHILOS T R SOC B, V362, P1313, DOI 10.1098/rstb.2007.2117
   Tornos P, 2005, HEART, V91, P571, DOI 10.1136/hrt.2003.032128
   Van Damme H, 2005, ACTA CHIR BELG, V105, P249
   Van Rooden CJ, 2005, J THROMB HAEMOST, V3, P2409, DOI 10.1111/j.1538-7836.2005.01398.x
   VAN ZD, 2004, ACTA CHIR BELG, V104, P158
   Venkatraman SS, 2006, BIOMATERIALS, V27, P1573, DOI 10.1016/j.biomaterials.2005.09.002
   VERT M, 1994, BIOMATERIALS, V15, P1209, DOI 10.1016/0142-9612(94)90271-2
   Wahlgren CM, 2006, CARDIOVASC INTER RAD, V29, P530, DOI 10.1007/s00270-005-0159-0
   Walluscheck KP, 2006, ITAL J VASC ENDOVASC, V13, P137
   Wang K, 1996, J INVASIVE CARDIOL, V8, P357
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Washizuka T, 2005, INT HEART J, V46, P909, DOI 10.1536/ihj.46.909
   Wejde G, 2003, J CATARACT REFR SURG, V29, P1556, DOI 10.1016/S0886-3350(03)00342-0
   WILLERT HG, 1976, BIOCOMPATIBILITY IMP, P40
   Williams D. F., 1987, DEFINITIONS BIOMATER
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   Williams D, 2008, BIOMATERIALS, V29, P1737, DOI 10.1016/j.biomaterials.2008.01.003
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   WILLIAMS DF, NAT MAT IN PRESS
   WILLIAMS DF, 2003, IMPLANT TISSUE INTER, P407
   Wolfram Dolores, 2004, J Autoimmun, V23, P81
   Wu LB, 2005, J BIOMED MATER RES A, V75A, P767, DOI 10.1002/jbm.a.30487
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
NR 135
TC 965
Z9 1005
U1 34
U2 474
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2008
VL 29
IS 20
BP 2941
EP 2953
DI 10.1016/j.biomaterials.2008.04.023
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 312FS
UT WOS:000256655100001
PM 18440630
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Hennessy, KM
   Clem, WC
   Phipps, MC
   Sawyer, AA
   Shaikh, FM
   Bellis, SL
AF Hennessy, Kristin M.
   Clem, Will C.
   Phipps, Matthew C.
   Sawyer, Amber A.
   Shaikh, Faheem M.
   Bellis, Susan L.
TI The effect of RGD peptides on osseointegration of hydroxyapatite
   biomaterials
SO BIOMATERIALS
LA English
DT Article
DE bioadsorption; bone tissue engineering; cell adhesion; hydroxyapatite;
   osseointegration; RGD peptide
ID COATED TITANIUM IMPLANTS; MESENCHYMAL STEM-CELLS; FORMATION IN-VIVO;
   BONE-FORMATION; SIGNALING PATHWAYS; OSTEOGENIC DIFFERENTIATION;
   OSTEOBLAST ADHESION; PROTEIN ADSORPTION; SYNTHETIC PEPTIDE;
   SERUM-PROTEINS
AB Given that hydroxyrapatite (HA) biomaterials are highly efficient at adsorbing proadhesive proteins, we questioned whether functionalizing HA with RGD peptides would have any benefit. In this study, we implanted uncoated or RGD-coated HA disks into rat tibiae for 30 min to allow endogenous protein adsorption, and then evaluated mesenchymal stem cell (MSC) interactions with the retrieved disks. These experiments revealed that RGD, when presented in combination with adsorbed tibial proteins (including fibronectin, vitronectin and fibrinogen), has a markedly detrimental effect on MSC adhesion and survival. Moreover, analyses of HA disks implanted for 5 days showed that RGD significantly inhibits total bone formation as well as the amount of new bone directly contacting the implant perimeter. Thus, RGD, which is widely believed to promote cell/biomaterial interactions, has a negative effect on HA implant performance. Collectively these results suggest that, for biomaterials that are highly interactive with the tissue microenvironment, the ultimate effects of RGD will depend upon how signaling from this peptide integrates with endogenous processes such as protein adsorption. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Hennessy, Kristin M.; Shaikh, Faheem M.; Bellis, Susan L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA.
   [Clem, Will C.; Bellis, Susan L.] Univ Alabama, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Phipps, Matthew C.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.
   [Sawyer, Amber A.] ASTAR, Inst Mol & Cell Biol, Stem Cells & Tissue Repair Grp, Singapore 138673, Singapore.
RP Bellis, SL (reprint author), Room 982A,MCLM,1918 Univ Bldg, Birmingham, AL 35294 USA.
EM bellis@physiology.uab.edu
FU NIAMS NIH HHS [R01 AR051539-03, R01 AR051539, R01AR51539]; NCI NIH HHS
   [P30 CA13148, P30 CA013148]
CR Akiyama S K, 1996, Hum Cell, V9, P181
   Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   BAGAMBISA FB, 1994, J CRANIO MAXILL SURG, V22, P12, DOI 10.1016/S1010-5182(05)80290-2
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927
   Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO;2-J
   Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X
   Deligianni D, 2005, J SPINAL DISORD TECH, V18, P257
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Elmengaard B, 2005, J BIOMED MATER RES A, V75A, P249, DOI 10.1002/jbm.a.30301
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   FUJISAWA R, 1997, MATRIX BIOL, V16, P28
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   Gilbert M, 2003, J BIOMED MATER RES A, V67A, P69, DOI 10.1002/jbm.a.10053
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   HAUTANEN A, 1989, J BIOL CHEM, V264, P1437
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ho JE, 2007, J BIOMED MATER RES A, V81A, P720, DOI 10.1002/jbm.a.31008
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126
   Kamarajan P, 2007, APOPTOSIS, V12, P2221, DOI 10.1007/s10495-007-0138-9
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Kroese-Deutman HC, 2005, TISSUE ENG, V11, P1867, DOI 10.1089/ten.2005.11.1867
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021
   Okamoto K, 1998, J DENT RES, V77, P481, DOI 10.1177/00220345980770030701
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cb.07.110191.001423
   Roessler S, 2001, J MATER SCI-MATER M, V12, P871, DOI 10.1023/A:1012807621414
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Salasznyk RM, 2004, CELL COMMUN ADHES, V11, P137, DOI 10.1080/15419060500242836
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Woo KM, 2007, BIOMATERIALS, V28, P2622, DOI 10.1016/j.biomaterials.2007.02.004
NR 44
TC 76
Z9 78
U1 4
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2008
VL 29
IS 21
BP 3075
EP 3083
DI 10.1016/j.biomaterials.2008.04.014
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 312FT
UT WOS:000256655200004
PM 18440064
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Jones, KS
AF Jones, Kim S.
TI Biomaterials as vaccine adjuvants
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article; Proceedings Paper
CT 57th Annual Meeting of the Canadian-Society-for-Chemical-Engineering
CY OCT 28-31, 2007
CL Edmonton, CANADA
SP Canadian Soc Chem Engn
DE vaccine; adjuvant; biomaterials; innate immunity
ID TOLL-LIKE RECEPTORS; TARGETING DENDRITIC CELLS; PATTERN-RECOGNITION
   RECEPTORS; ANTIGEN-CONTAINING LIPOSOMES; MEDIATED GENE DELIVERY;
   REGULATORY T-CELLS; IMMUNE-RESPONSE; POLY(LACTIC-CO-GLYCOLIC ACID);
   ANTITUMOR IMMUNITY; INNATE IMMUNITY
AB Biomaterials are promising candidate adjuvants to enhance vaccine efficacy. Through adjuvant design, we can broaden the use of vaccines to diseases such as AIDS, malaria, and cancer. This review addresses the fundamentals of vaccine and adjuvant function in order to determine guidelines for adjuvant design, including aspects of the vaccine such as disease target, antigen formulation, and delivery route. An ideal biomaterial adjuvant will perform three functions. (1) It will deliver the antigen selectively to dendritic cells. This has been accomplished through release of chemokines or cytokines, use of antidendritic cell antibodies, and even through particle size selection. (2) It will activate the dendritic cells, improving antigen presentation. Biomaterials themselves have been shown to activate innate immunity, but specific innate-activating ligands have also been included in adjuvant formulations. Finally, (3) it will release the antigen appropriately into the dendritic cell. Tuning release to be pH sensitive and engineering endosomal release are strategies that have been used. There is a real opportunity to rationally design better biomaterial adjuvants that will significantly expand and improve vaccine function.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
RP Jones, KS (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
EM kjones@mcmaster.ca
CR Ajdary S, 2007, VACCINE, V25, P4595, DOI 10.1016/j.vaccine.2007.03.039
   Albiger B, 2007, J INTERN MED, V261, P511, DOI 10.1111/j.1365-2796.2007.01821.x
   Altin JG, 2004, EXPERT OPIN BIOL TH, V4, P1735, DOI 10.1517/14712598.4.11.1735
   Arnold R, 2006, EUR J IMMUNOL, V36, P1654, DOI 10.1002/eji.200636197
   Ataman-Onal Y, 2006, J CONTROL RELEASE, V112, P175, DOI 10.1016/j.jconrel.2006.02.006
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164
   Bijker MS, 2007, EXPERT REV VACCINES, V6, P591, DOI 10.1586/14760584.6.4.591
   Blander JM, 2007, TRENDS IMMUNOL, V28, P19, DOI 10.1016/j.it.2006.11.001
   Blanks Deidra A, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P281, DOI 10.1097/MOO.0b013e32825a67a2
   Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598
   Boonyo W, 2007, J CONTROL RELEASE, V121, P168, DOI 10.1016/j.jconrel.2007.05.025
   Bosshart H, 2007, ANN NY ACAD SCI, V1096, P1, DOI 10.1196/annals.1397.064
   Bramwell VW, 2006, J PHARM PHARMACOL, V58, P717, DOI 10.1211/jpp.56.6.0002
   Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002
   Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971
   Cao W, 2007, CURR OPIN IMMUNOL, V19, P24, DOI 10.1016/j.coi.2006.11.004
   Carcaboso AM, 2004, VACCINE, V22, P1423, DOI 10.1016/j.vaccine.2003.10.020
   Chabalgoity JA, 2007, CYTOKINE GROWTH F R, V18, P195, DOI 10.1016/j.cytogfr.2007.01.016
   Chatchawalsaisin J, 2004, INT J PHARM, V275, P41, DOI 10.1016/j.ijpharm.2004.01.025
   Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016
   Chen WR, 2005, PHOTOCHEM PHOTOBIOL, V81, P190, DOI 10.1562/2004-07-20-RA-236.1
   Chiarella P, 2007, EXPERT OPIN BIOL TH, V7, P1551, DOI 10.1517/14712598.7.10.1551
   Christensen D, 2007, EXPERT REV VACCINES, V6, P785, DOI 10.1586/14760584.6.5-785
   COMBADIERE M, 2008, COMP IMMUNOL MICROB, V31, P293
   Copland MJ, 2003, VACCINE, V21, P883, DOI 10.1016/S0264-410X(02)00536-4
   CRITCHFIELD JM, 1995, CELL IMMUNOL, V160, P71, DOI 10.1016/0008-8749(95)80011-7
   Cui CJ, 2007, VACCINE, V25, P500, DOI 10.1016/j.vaccine.2006.07.055
   Daubenberger CA, 2007, CURR OPIN MOL THER, V9, P45
   Diebold Sandra S., 2002, Somatic Cell and Molecular Genetics, V27, P65, DOI 10.1023/A:1022975705406
   Diwan Manish, 2003, J Drug Target, V11, P495
   Ehlers M, 2007, TRENDS IMMUNOL, V28, P74, DOI 10.1016/j.it.2006.12.006
   Elamanchili P, 2007, J IMMUNOTHER, V30, P378, DOI 10.1097/CJI.0b013e31802cf3e3
   ELDRIDGE JH, 1991, INFECT IMMUN, V59, P2978
   Ertl HCJ, 1996, VACCINE, V14, P879, DOI 10.1016/0264-410X(96)00005-9
   Espuelas S, 2005, MOL IMMUNOL, V42, P721, DOI 10.1016/j.molimm.2004.09.022
   Feng L, 2006, J CONTROL RELEASE, V112, P35, DOI 10.1016/j.jconrel.2006.01.012
   Firpo EJ, 2002, IMMUNOLOGY, V107, P480, DOI 10.1046/j.1365-2567.2002.01540.x
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   Fritz JH, 2005, J ENDOTOXIN RES, V11, P390, DOI 10.1179/096805105X76850
   Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6
   Gatza E, 2002, J IMMUNOL, V169, P5227, DOI 10.4049/jimmunol.169.9.5227
   Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318
   Gogev S, 2004, VACCINE, V22, P1946, DOI 10.1016/j.vaccine.2003.11.011
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Greenland JR, 2007, VACCINE, V25, P3731, DOI 10.1016/j.vaccine.2007.01.120
   GUPTA RK, 1995, VACCINE, V13, P1276
   Gutierro I, 2002, VACCINE, V21, P67, DOI 10.1016/S0264-410X(02)00435-8
   Gutierro I, 2002, VACCINE, V20, P2181, DOI 10.1016/S0264-410X(02)00146-9
   Hamdy S, 2007, J BIOMED MATER RES A, V81A, P652, DOI 10.1002/jbm.a.31019
   Hauser H, 2004, GENE THER, V11, P924, DOI 10.1038/sj.gt.3302160
   Heit A, 2007, EUR J IMMUNOL, V37, P2063, DOI 10.1002/eji.200737169
   Hem SL, 2007, EXPERT REV VACCINES, V6, P685, DOI 10.1586/14760584.6.5.685
   Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jechlinger W, 2006, EXPERT REV VACCINES, V5, P803, DOI 10.1586/14760584.5.6.803
   Jiang WW, 2007, J BIOMED MATER RES A, V82A, P492, DOI 10.1002/jbm.a.31175
   Jones KS, 2006, TRANSPLANTATION, V82, P415, DOI 10.1097/01.tp.0000228917.57323.ec
   Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P1, DOI 10.1016/j.coi.2006.11.018
   Kaiser-Schulz G, 2007, J IMMUNOL, V179, P2797, DOI 10.4049/jimmunol.179.5.2797
   Kaparakis M, 2007, IMMUNOL CELL BIOL, V85, P495, DOI 10.1038/sj.icb.7100105
   Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246
   Kerkmann M, 2006, OLIGONUCLEOTIDES, V16, P313, DOI 10.1089/oli.2006.16.313
   Khaja SD, 2007, BIOMACROMOLECULES, V8, P1391, DOI 10.1021/bm061234z
   Kim TH, 2006, J NANOSCI NANOTECHNO, V6, P2796, DOI 10.1166/jnn.2006.434
   Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703
   Kwissa M, 2007, EXPERT REV VACCINES, V6, P673, DOI 10.1586/14760584.6.5.673
   Kwon YJ, 2005, P NATL ACAD SCI USA, V102, P18264, DOI 10.1073/pnas.0509541102
   Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758
   Leaver SK, 2007, CRIT CARE MED, V35, P1404, DOI 10.1097/01.CCM.0000261883.16943.4B
   Lee HK, 2007, SEMIN IMMUNOL, V19, P48, DOI 10.1016/j.smim.2006.12.001
   Lee JW, 2008, BIOMATERIALS, V29, P2113, DOI 10.1016/j.biomaterials.2007.12.048
   Lee MS, 2007, MOL CELLS, V23, P1
   Lee S, 2007, BIOCONJUGATE CHEM, V18, P4, DOI 10.1021/bc060259s
   Lim DG, 2002, CELL IMMUNOL, V217, P36, DOI 10.1016/S0008-8749(02)00511-7
   Little SR, 2005, ADV BIOCHEM ENG BIOT, V99, P93, DOI 10.1007/10_004
   Little SR, 2005, J CONTROL RELEASE, V107, P449, DOI 10.1016/j.jconrel.2005.04.022
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Lu DM, 2007, EXPERT REV VACCINES, V6, P213, DOI 10.1586/14760584.6.2.213
   Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008
   Mahnke K, 2005, CANCER RES, V65, P7007, DOI 10.1158/0008-5472.CAN-05-0938
   Mandal B, 2004, INT J PHARM, V269, P259, DOI 10.1016/j.ijpharm.2003.09.023
   Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   McDevitt H, 2004, P NATL ACAD SCI USA, V101, P14627, DOI 10.1073/pnas.0405235101
   McNeela EA, 2000, VACCINE, V19, P1188, DOI 10.1016/S0264-410X(00)00309-1
   Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246
   Meng WS, 2005, EXPERT OPIN BIOL TH, V5, P1019, DOI 10.1517/14712598.5.8.1019
   Miller LH, 2005, TRENDS PARASITOL, V21, P412, DOI 10.1016/j.pt.2005.07.005
   Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002
   Mutwiri G, 2007, REV SCI TECH OIE, V26, P147, DOI 10.20506/rst.26.1.1731
   Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333
   OHAGAN DT, 1991, IMMUNOLOGY, V73, P239
   OHAGAN DT, 1991, VACCINE, V9, P768, DOI 10.1016/0264-410X(91)90295-H
   Oussoren C, 1997, BBA-BIOMEMBRANES, V1328, P261, DOI 10.1016/S0005-2736(97)00122-3
   Padovan E, 2007, TRENDS IMMUNOL, V28, P308, DOI 10.1016/j.it.2007.05.002
   Palmer K, 2001, GENE THER, V8, P282, DOI 10.1038/sj.gt.3301386
   Park JH, 2006, PHARM RES, V23, P1008, DOI 10.1007/s11095-006-0028-9
   Parker LC, 2007, CLIN EXP IMMUNOL, V147, P199, DOI 10.1111/j.1365-2249.2006.03203.x
   Partidos CD, 1996, MOL IMMUNOL, V33, P485, DOI 10.1016/0161-5890(96)00032-6
   Raimondi Giorgio, 2007, Methods Mol Biol, V380, P1
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005
   Reddy ST, 2006, J APPL PHYSIOL, V101, P1162, DOI 10.1152/japplphysiol.00389.2006
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019
   Rezaei N, 2006, INT IMMUNOPHARMACOL, V6, P863, DOI 10.1016/j.intimp.2006.02.005
   Romagne F, 2007, DRUG DISCOV TODAY, V12, P80, DOI 10.1016/j.drudis.2006.11.007
   Rouse BT, 2007, EXPERT OPIN BIOL TH, V7, P1301, DOI 10.1517/14712598.7.9.1301
   Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004
   Sapin A, 2006, INT J PHARM, V309, P1, DOI 10.1016/j.ijpharm.2005.10.046
   Schiller M, 2006, EXP DERMATOL, V15, P331, DOI 10.1111/j.0906-6705.2006.00414.x
   Schmidt CS, 2007, EXPERT REV VACCINES, V6, P391, DOI 10.1586/14760584.6.3.391
   Seya T, 2006, EVID-BASED COMPL ALT, V3, P31, DOI 10.1093/ecam/nek010
   Shakweh M, 2006, J NANOSCI NANOTECHNO, V6, P2811, DOI 10.1166/jnn.2006.438
   Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x
   Singh M, 2001, PHARM RES-DORDR, V18, P1476, DOI 10.1023/A:1012269226066
   Standley SM, 2004, BIOCONJUGATE CHEM, V15, P1281, DOI 10.1021/bc049956f
   Sutterwala FS, 2007, J LEUKOCYTE BIOL, V82, P259, DOI 10.1189/jlb.1206755
   Tafaghodi M, 2006, INT J PHARM, V319, P37, DOI 10.1016/j.ijpharm.2006.03.047
   Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517
   Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038
   UCHIDA T, 1995, J PHARM PHARMACOL, V47, P556, DOI 10.1111/j.2042-7158.1995.tb06713.x
   UCHIDA T, 1994, BIOL PHARM BULL, V17, P1272
   van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138
   van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005
   Villadangos JA, 2007, TRENDS IMMUNOL, V28, P45, DOI 10.1016/j.it.2006.12.008
   Waeckerle-Men Y, 2005, ADV DRUG DELIVER REV, V57, P475, DOI 10.1016/j.addr.2004.09.007
   Wagstaff KM, 2007, BIOCHEM J, V406, P185, DOI 10.1042/BJ20070505
   Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
   Wang RF, 2002, NAT BIOTECHNOL, V20, P149, DOI 10.1038/nbt0202-149
   Wu KY, 2006, BIOMED ENVIRON SCI, V19, P87
   Xie Y, 2007, WORLD J GASTROENTERO, V13, P1547, DOI 10.3748/wjg.v13.i10.1547
   Xing Z, 2005, CURR GENE THER, V5, P485, DOI 10.2174/156652305774329230
   YANG D, 2008, J BIOMED MAT RES A
   Yang TC, 2006, J IMMUNOL, V176, P200, DOI 10.4049/jimmunol.176.1.200
   Yates SF, 2007, J IMMUNOL, V179, P967, DOI 10.4049/jimmunol.179.2.967
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2007, J BIOMED MATER RES A, V80A, P7, DOI 10.1002/jbm.a.30832
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034
   Zhu BD, 2007, EUR J PHARM BIOPHARM, V66, P318, DOI 10.1016/j.ejpb.2006.11.028
NR 145
TC 27
Z9 28
U1 0
U2 13
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD JUL-AUG
PY 2008
VL 24
IS 4
BP 807
EP 814
DI 10.1002/btpr.10
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 348KA
UT WOS:000259208200003
PM 19194892
OA Bronze
DA 2018-10-20
ER

PT J
AU Depprich, R
   Handschel, J
   Wiesmann, HP
   Jasche-Meyer, J
   Meyer, U
AF Depprich, Rita
   Handschel, Joerg
   Wiesmann, Hans-Peter
   Jaesche-Meyer, Janine
   Meyer, Ulrich
TI Use of bioreactors in maxillofacial tissue engineering
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Review
DE bioreactor; tissue engineering; reconstruction
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; ARTICULAR-CARTILAGE; MECHANICAL
   STIMULI; BONE-FORMATION; FLUID-FLOW; SYSTEM; GROWTH; PRINCIPLES; CULTURE
AB Engineering of various oral tissues is a challenging issue in contemporary maxillofacial reconstructive research. In contrast to the classic biomaterial approach, tissue engineering is based on the understanding of cell driven tissue formation, and aims to generate new functional tissues, rather than just to implant non-living space holders. Researchers hope to reach this goal by combining knowledge from biology. physics, materials science, engineering, and medicine in an integrated manner. Several major technical advances have been made in this field during the last decade, and clinical application is at the stage of first clinical trials. A recent limitation of extracorporally engineered cellular substitutes is the problem of growing enlarged tissues ex vivo. One of the main research topics is therefore to scale up artificial tissue constructs for use in extended defect Situations. To overcome the monolayer inherent two-dimensional cell assembly, efforts have been made to grow cells in a three-dimensional space. Bioreactors have therefore been in focus for a considerable time to build tip enlarged tissues. The shift from the ex vivo approach of cell multiplication to the generation of a real tissue growth is mirrored by the development of bioreactors, enabling scientists to grow more complex tissue constructs. This present review intends to provide an overview of the current state of art in maxillofacial tissue engineering by the use of bioreactors, its limitations and hopes, as well as the future research trends. (C) 2008 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Depprich, Rita; Handschel, Joerg; Meyer, Ulrich] Westdeutsch Kieferklin, Clin Maxillofacial & Facial Plast Surg, D-40225 Dusseldorf, Germany.
   [Wiesmann, Hans-Peter] Univ Munster, Clin Cranio Maxillofacial Surg, D-18149 Munster, Germany.
   [Jaesche-Meyer, Janine] Univ Munster, Clin Orthodont, D-18149 Munster, Germany.
RP Meyer, U (reprint author), Westdeutsch Kieferklin, Clin Maxillofacial & Facial Plast Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM ulrich.meyer@med.uni-duesseldorf.de
CR Abukawa H, 2004, J ORAL MAXIL SURG, V62, P601, DOI 10.1016/j.joms.2003.11.010
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Bottlang M, 1997, BIOMED TECH, V42, P305, DOI 10.1515/bmte.1997.42.11.305
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   CASSERBETTE M, 1990, CALCIFIED TISSUE INT, V46, P46, DOI 10.1007/BF02555824
   Cheng GC, 1997, CIRC RES, V80, P28, DOI 10.1161/01.RES.80.1.28
   Cheng MZ, 1996, J BONE MINER RES, V11, P502
   Curtis A, 2001, PHYS MED BIOL, V46, pR47, DOI 10.1088/0031-9155/46/4/201
   Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492
   Domen J, 2000, IMMUNOL RES, V22, P83, DOI 10.1385/IR:22:2-3:83
   DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070
   Freed LE, 1997, IN VITRO CELL DEV-AN, V33, P381
   Frost H. M., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P5
   Granet C, 1998, MED BIOL ENG COMPUT, V36, P513, DOI 10.1007/BF02523224
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hartig M, 2000, EUR BIOPHYS J BIOPHY, V29, P499, DOI 10.1007/s002490000100
   HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706
   Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42
   Jones D, 1995, BIOCHEM CELL BIOL, V73, P525, DOI 10.1139/o95-058
   Jones D. B., 2003, European Cells & Materials, V5, P48
   Jones D. B., 2003, EUR CELLS MATER, V5, P59
   Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JB, 1996, ENG OPTIMIZ, V27, P1, DOI 10.1080/03052159608941397
   Malda J, 2003, CRIT REV BIOTECHNOL, V23, P175, DOI 10.1080/714037688
   Martin I, 2000, BIORHEOLOGY, V37, P141
   MASI L, 1992, CALCIFIED TISSUE INT, V51, P202, DOI 10.1007/BF00334548
   Meyer U, 2006, BRIT J ORAL MAX SURG, V44, P289, DOI 10.1016/j.bjoms.2005.06.026
   Meyer U, 2004, INT J ORAL MAX SURG, V33, P635, DOI 10.1016/j.ijom.2004.04.006
   Meyer U, 2006, BRIT J ORAL MAX SURG, V44, P134, DOI 10.1016/j.bjoms.2005.05.001
   MEYER U, 1993, CELL MATER, V3, P129
   Meyer Ulrich, 2005, Head Face Med, V1, P2, DOI 10.1186/1746-160X-1-2
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Ogata T, 2000, J CELL BIOCHEM, V76, P529, DOI 10.1002/(SICI)1097-4644(20000315)76:4<529::AID-JCB1>3.0.CO;2-5
   Pavalko F. M., 1998, AM J PHYSIOL, V275, P1591
   Plate Ulrich, 2006, Head Face Med, V2, P6, DOI 10.1186/1746-160X-2-6
   Ratcliffe A, 2002, ANN NY ACAD SCI, V961, P210, DOI 10.1111/j.1749-6632.2002.tb03087.x
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217
   Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182
   Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Toma CD, 1997, J BONE MINER RES, V12, P1626, DOI 10.1359/jbmr.1997.12.10.1626
   Vunjak-Novakovic Gordana, 2003, Novartis Found Symp, V249, P34
   Vunjak-Novakovics G, 2003, NOVART FDN SYMP, V249, P170
   VUNJAKNOVAKOVIC G, 2003, NOVART FDN SYMP, V249, P46
   VUNJAKNOVAKOVIC G, 2003, NOVART FDN SYMP, V249, P239
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Wiesmann HP, 2001, BBA-MOL CELL RES, V1538, P28, DOI 10.1016/S0167-4889(00)00135-X
   WINSTON FK, 1989, J APPL PHYSIOL, V67, P397
   Wu W, 2007, BRIT J ORAL MAX SURG, V45, P272, DOI 10.1016/j.bjoms.2006.09.004
NR 53
TC 13
Z9 13
U1 0
U2 7
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD JUL
PY 2008
VL 46
IS 5
BP 349
EP 354
DI 10.1016/j.bjoms.2008.01.012
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 326EB
UT WOS:000257639900001
PM 18343545
DA 2018-10-20
ER

PT J
AU Artzi, Z
   Weinreb, M
   Carmeli, G
   Lev-Dor, R
   Dard, M
   Nemcovsky, CE
AF Artzi, Zvi
   Weinreb, Miron
   Carmeli, Guy
   Lev-Dor, Rony
   Dard, Michel
   Nemcovsky, Carlos E.
TI Histomorphometric assessment of bone formation in sinus augmentation
   utilizing a combination of autogenous and hydroxyapatite/biphasic
   tricalcium phosphate graft materials: at 6 and 9 months in humans
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE alloplasts; bone regeneration; hydroxyapatite; tricalcium phosphate;
   osteoconduction; sinus augmentation
ID MARROW STROMAL CELLS; BIPHASIC CALCIUM-PHOSPHATE; NEWLY FORMED BONE;
   INJECTABLE BONE; GUIDED BONE; FLOOR AUGMENTATION; GRINDING TECHNIQUE;
   IN-VIVO; UNDECALCIFIED BONES; IMPLANT PLACEMENT
AB Objective: The aim of this study was to examine the efficacy of a new biphasic hydroxyapatite/tricalcium phosphate (HA/TCP) bone substitute in combination with particulate autogenous bone in sinus floor augmentation procedures.
   Material and methods: A simultaneous or a two-stage sinus augmentation and implant placement were conducted in 28 patients. A mixture of HA/TCP and autogenous bone chips in a 1 : 1 ratio was used as the grafting biomaterial. Cylindrical specimen bone retrieval was performed in all patients except one. Specimens were harvested either at 6 (n=14) or 9 (n=13) months post-augmentation. For histologic and histomorphometric evaluations, the non-decalcified tissue processing (Donath's technique) was performed.
   Results: Newly formed bone around the grafted particles was found in all samples. The encircling, highly cellular bone followed the outline of the grafted particles in direct contact. Both woven and lamellar types of bone were observed.
   Morphometrically, the total mean bone area fraction of all sections was 34.8 +/- 10.3%, increasing from 28.6 +/- 7.8% at 6 months to 41.6 +/- 8.3% at 9 months (P < 0.001). Mean particle area fraction average was 25.5 +/- 11.6% and 23.5 +/- 9.3% at 6 and 9 months, respectively, with a total mean of 24.5 +/- 10.4%. The increase in bone area fraction was not significantly correlated to the decrease of the grafted particles area fraction.
   Conclusions: The biphasic HA/TCP showed biocompatible and osteoconductive properties. This alloplast as a composite with autogenous bone chips promotes newly formed bone, which increases in its fraction along an extended healing period.
C1 [Artzi, Zvi; Carmeli, Guy; Lev-Dor, Rony; Nemcovsky, Carlos E.] Tel Aviv Univ, Sch Dent Med, Dept Periodontol, IL-69978 Tel Aviv, Israel.
   [Weinreb, Miron] Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Biol, IL-69978 Tel Aviv, Israel.
   [Dard, Michel] Inst Straumann AG, Basel, Switzerland.
RP Artzi, Z (reprint author), Tel Aviv Univ, Sch Dent Med, Dept Periodontol, IL-69978 Tel Aviv, Israel.
EM zviartzi@post.tau.ac.il
CR Artzi Z, 2005, J CLIN PERIODONTOL, V32, P193, DOI 10.1111/j.1600-051X.2005.00656.x
   Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Artzi Z, 2003, INT J PERIODONT REST, V23, P381
   Artzi Z, 2001, J PERIODONTOL, V72, P911, DOI 10.1902/jop.2001.72.7.911
   Blouin S, 2006, J BIOMED MATER RES A, V78A, P570, DOI 10.1002/jbm.a.30721
   Boeck-Neto R, 2002, J PERIODONTOL, V73, P266, DOI 10.1902/jop.2002.73.3.266
   Boix D, 2006, J MATER SCI-MATER M, V17, P1145, DOI 10.1007/s10856-006-0542-7
   Boix D, 2004, J PERIODONTOL, V75, P663, DOI 10.1902/jop.2004.75.5.663
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   BROOK IM, 1991, BIOMATERIALS, V12, P179, DOI 10.1016/0142-9612(91)90197-I
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   BURR DB, 1993, J BIOMED MATER RES, V27, P645, DOI 10.1002/jbm.820270512
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   DAVIS WH, 1984, J ORAL MAXIL SURG, V42, P606, DOI 10.1016/0278-2391(84)90092-2
   De Kok IJ, 2005, INT J ORAL MAX IMPL, V20, P511
   De Kok IJ, 2003, CLIN ORAL IMPLAN RES, V14, P481, DOI 10.1034/j.1600-0501.2003.110770.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   DONATH K, 1985, PATHOL RES PRACT, V179, P631, DOI 10.1016/S0344-0338(85)80209-0
   Emery SE, 1996, SPINE, V21, P2713, DOI 10.1097/00007632-199612010-00003
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   Fleckenstein KB, 2006, J PERIODONTOL, V77, P39, DOI 10.1902/jop.2006.77.1.39
   Garg AK, 1999, TISSUE ENGINEERING, P83
   Gauthier O, 2001, J MATER SCI-MATER M, V12, P385, DOI 10.1023/A:1011284517429
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Hallman Mats, 2004, Clin Implant Dent Relat Res, V6, P82, DOI 10.1111/j.1708-8208.2004.tb00030.x
   HASHIMOTOUOSHIMA M, 1995, INT J PERIODONT REST, V15, P205
   Hellem Solve, 2003, Clin Implant Dent Relat Res, V5, P233, DOI 10.1111/j.1708-8208.2003.tb00206.x
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P401, DOI 10.1034/j.1600-0501.1997.080507.x
   Jensen OT, 1999, SINUS BONE GRAFT, P49
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Jung RE, 2006, CLIN ORAL IMPLAN RES, V17, P426, DOI 10.1111/j.1600-0501.2005.01228.x
   Kirsch A, 1999, SINUS BONE GRAFT, P79
   LAURENCIN CT, 1999, BONE ENG, P462
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Lee TM, 2001, J BIOMED MATER RES, V55, P360, DOI 10.1002/1097-4636(20010605)55:3<360::AID-JBM1040>3.0.CO;2-Q
   Lynch SE, 1999, TISSUE ENGINEERING, pXI
   Mankani MH, 2006, STEM CELLS, V24, P2140, DOI 10.1634/stemcells.2005-0567
   Mankani MH, 2006, AM J PATHOL, V168, P542, DOI 10.2353/ajpath.2006.050407
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Merkx MAW, 2000, CLIN ORAL IMPLAN RES, V11, P422, DOI 10.1034/j.1600-0501.2000.011005422.x
   Misch C E, 1994, J Oral Implantol, V20, P100
   MISCH CE, 1999, CONT IMPLANT DENT, P469
   Ohnishi H, 2000, J PERIODONTOL, V71, P341, DOI 10.1902/jop.2000.71.3.341
   Peleg M, 2006, INT J ORAL MAX IMPL, V21, P551
   ROHRER MD, 1992, ORAL SURG ORAL MED O, V74, P73, DOI 10.1016/0030-4220(92)90218-F
   RUSSOTTI GM, 1987, HIP, V15, P120
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   St John Kenneth R., 1993, Clinical Materials, V12, P49, DOI 10.1016/0267-6605(93)90027-5
   Stewart M, 2004, J BIOMED MATER RES A, V69A, P1, DOI 10.1002/jbm.a.20071
   Tal H, 2008, CLIN ORAL IMPLAN RES, V19, P295, DOI 10.1111/j.1600-0501.2007.01424.x
   Tan YF, 2007, J BIOMED MATER RES A, V82A, P152, DOI 10.1002/jbm.a.31125
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Temenoff J.S., 1999, BONE ENG, P454
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
   Tulasne JF, 1999, SINUS BONE GRAFT, P107
   Watzek G, 1998, INT J ORAL MAX SURG, V27, P428, DOI 10.1016/S0901-5027(98)80031-3
   Zubery Y, 2007, J PERIODONTOL, V78, P112, DOI 10.1902/jop.2007.060055
NR 58
TC 52
Z9 55
U1 0
U2 4
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUL
PY 2008
VL 19
IS 7
BP 686
EP 692
DI 10.1111/j.1600-0501.2008.01539.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 309YM
UT WOS:000256496100008
PM 18492077
DA 2018-10-20
ER

PT J
AU Wang, X
   Lennartz, MR
   Loegering, DJ
   Stenken, JA
AF Wang, Xiangdan
   Lennartz, Michelle R.
   Loegering, Daniel J.
   Stenken, Julie A.
TI Multiplexed cytokine detection of interstitial fluid collected from
   polymeric hollow tube implants - A feasibility study
SO CYTOKINE
LA English
DT Article
DE cytokine; polyurethane; foreign body response; rat
ID IN-VIVO; BIOMATERIALS; MACROPHAGE; RESPONSES; EXPRESSION;
   BIOCOMPATIBILITY; CHEMOKINE; PRESSURE; INFLAMMATION; GENERATION
AB Cytokines are important cellular signaling proteins involved in inflammation, wound heating and are thought to direct the foreign body response to implanted materials. In this work, polyurethane tubes (25 mm length, 1.02 mm i.d., and 1.65 mm o.d.) were implanted into subcutaneous tissue of male Sprague-Dawley rats. The tubes served as the biontaterial and a means to collect the interstitial fluid that would be exchanged within the tube lumen and the surrounding tissue. After 3 and 7 days, the tubes were explanted and cytokines in the fluid were quantified with a multiplexed cytokine immunoassay. Six cytokines, interleukin-1 beta (IL-1 beta), IL-4, IL-6, IL-10, macrophage chemoattractant protein-1 (MCP-1), and tumor necrosis factor-alpha (TNF-alpha), were simultaneously quantified. All cytokine concentrations with the exception of IL-4 and TNF-a ranged between low pg/mL to mid ng/mL levels. Neither TNF-alpha nor IL-4 was detected from any sample. These results illustrate the potential of using the tube materials combined with bead-based immunoassays as a direct method for in vivo collection of multiple cytokines in low microliter sample volumes for fixed day biomaterial implant studies. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Wang, Xiangdan; Stenken, Julie A.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA.
   [Lennartz, Michelle R.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.
   [Loegering, Daniel J.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA.
RP Stenken, JA (reprint author), Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.
EM jstenken@uark.edu
FU NIBIB NIH HHS [R01 EB001441, R01 EB001441-04, EB001441]
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Ao XP, 2006, J PHARMACEUT BIOMED, V40, P915, DOI 10.1016/j.jpba.2005.07.044
   Ao XP, 2005, J MICROBIOL METH, V62, P327, DOI 10.1016/j.mimet.2005.04.016
   Baldwin L, 2008, CYTOKINE, V41, P217, DOI 10.1016/j.cyto.2007.11.015
   BREIT SN, 2001, TGF BETA RELATED CYT
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1
   Clough GF, 2007, J INVEST DERMATOL, V127, P2799, DOI 10.1038/sj.jid.5700930
   COETZEE JH, 1982, COMP BIOCHEM PHYS A, V72, P173, DOI 10.1016/0300-9629(82)90028-7
   DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020
   Ferreira AM, 2005, CYTOKINE, V30, P64, DOI 10.1016/j.cyto.2004.12.00
   Gouwy M, 2005, CYTOKINE GROWTH F R, V16, P561, DOI 10.1016/j.cytogfr.2005.03.005
   Grant V, 2005, BIOCHEM BIOPH RES CO, V331, P187, DOI 10.1016/j.bbrc.2005.03.137
   Griffiths Marie M., 1996, Methods (Orlando), V9, P295, DOI 10.1006/meth.1996.0034
   Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456
   Hunt JA, 1997, J BIOMED MATER RES, V36, P542
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   KOSSOVSKY N, 1993, IMMUNOMETHODS, V3, P43
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lefkowitz DL, 2001, IMMUNOL CELL BIOL, V79, P502, DOI 10.1046/j.1440-1711.2001.01020.x
   Li YW, 2005, BIOMATERIALS, V26, P1081, DOI 10.1016/j.biomaterials.2004.04.018
   Lord R, 2001, CYTOKINE, V13, P155, DOI 10.1006/cyto.2000.0815
   MAHIOUT A, 1989, ARTIF ORGANS, V13, P251, DOI 10.1111/j.1525-1594.1989.tb02872.x
   Marois Y, 1996, BIOMATERIALS, V17, P1835, DOI 10.1016/0142-9612(95)00245-6
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   RAYMOND TL, 1983, J LIPID RES, V24, P113
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   RUTILI G, 1977, ACTA PHYSIOL SCAND, V99, P1, DOI 10.1111/j.1748-1716.1977.tb10345.x
   SCHOLANDER PF, 1968, SCIENCE, V161, P321, DOI 10.1126/science.161.3839.321
   Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6
   Wang XD, 2007, ANAL CHEM, V79, P1816, DOI 10.1021/ac061503b
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wiig H, 2000, AM J PHYSIOL-HEART C, V278, pH1627
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
NR 35
TC 16
Z9 16
U1 3
U2 9
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
J9 CYTOKINE
JI Cytokine
PD JUL
PY 2008
VL 43
IS 1
BP 15
EP 19
DI 10.1016/j.cyto.2008.04.009
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 328UI
UT WOS:000257823300002
PM 18519165
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Orecchio, S
   Gianguzza, A
   Culotta, L
AF Orecchio, Santino
   Gianguzza, Antonio
   Culotta, Loredana
TI Absorption of polycyclic aromatic hydrocarbons by Pinus bark: Analytical
   method and use for environmental pollution monitoring in the Palermo
   area (Sicily, Italy)
SO ENVIRONMENTAL RESEARCH
LA English
DT Article
DE PAH; bark; Pinus; bioaccumulator; GC/MS; air quality; Palermo
ID AIR; QUALITY; BIOMONITORS; LEAVES; PAHS; CITY; EXTRACTION; SAMPLERS;
   PLANTS; SOILS
AB In the light of using biomaterial as pollutants sorbents for the environmental biomonitoring, we report here the results of the absorption of polycyclic aromatic hydrocarbons (PAHs) by pine bark. Quantitative analysis of 19 different polycyclic aromatic compounds was performed, after Soxhlet extraction in dichloromethane, by means GC-MS technique. Pinus was chosen due to its wide distribution in the Mediterranean area. The passive absorption of PAH by pine bark in the metropolitan areas allowed us to evaluate the air quality of Palermo. The obtained results showed a very high range of PAHs concentrations, from 33 mu g/kg (bark dry weight), as Sigma PAHs, at the control site to 1015 mu g/kg along a road with high traffic flow. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Orecchio, Santino; Gianguzza, Antonio; Culotta, Loredana] Univ Palermo, Dipartimento Chim Inorgan & Analit, I-90128 Palermo, Italy.
RP Orecchio, S (reprint author), Univ Palermo, Dipartimento Chim Inorgan & Analit, Parco Orleans 2, I-90128 Palermo, Italy.
EM orecchio@unipa.it
OI Gianguzza, Antonio/0000-0003-3993-6167; Orecchio,
   Santino/0000-0002-5429-5188
CR Alaimo MG, 2000, AEROBIOLOGIA, V16, P47
   Baumard P, 1998, MAR POLLUT BULL, V36, P577, DOI 10.1016/S0025-326X(98)00014-9
   BIDLEMAN TF, 1988, ATMOS PROCESSES ENV, V21, P361
   Bohm P, 1998, ENVIRON POLLUT, V102, P243, DOI 10.1016/S0269-7491(98)00082-7
   Caricchia AM, 1999, ATMOS ENVIRON, V33, P3731, DOI 10.1016/S1352-2310(99)00199-5
   CATSKY J, 2001, PHOTOSYNTHETICA, V39, P196
   Cortes E, 2004, J RADIOANAL NUCL CH, V262, P269
   Culotta L, 2005, POLYCYCL AROMAT COMP, V25, P327, DOI 10.1080/10406630500227262
   Culotta L, 2002, ANN CHIM-ROME, V92, P837
   DUMBAR JC, 2001, SCI TOTAL ENVIRON, V279, P1
   Gao YZ, 2004, CHEMOSPHERE, V55, P1169, DOI 10.1016/j.chemosphere.2004.01.037
   Giacalone A, 2004, POLYCYCL AROMAT COMP, V24, P135, DOI 10.1080/10406630490433223
   GIOVENCO A, 1996, INQUINAMENTO, V3, P48
   Howsam M., 1998, HDB ENV CHEM 1, P137
   IARC-International Agency for Research on Cancer, 1991, MON EV CARC RISKS HU, P43
   Kim EJ, 2003, SCI TOTAL ENVIRON, V311, P177, DOI 10.1016/S0048-9697(03)00095-0
   LANE DA, 1988, ANAL POLYCYCLIC AROM, V101, P31
   Larsen J. C., 1998, AIR POLLUTION HLTH, P33, DOI DOI 10.1039/9781847550095-00033
   LAW RJ, 1994, MAR POLLUT BULL, V29, P235, DOI 10.1016/0025-326X(94)90415-4
   Lombardo M, 2001, ATMOS ENVIRON, V35, P6435, DOI 10.1016/S1352-2310(01)00348-X
   Macaluso A, 2000, ANN CHIM-ROME, V90, P83
   Madejon P, 2006, ENVIRON POLLUT, V143, P1, DOI 10.1016/j.envpol.2005.11.008
   Malcom H. M., 1994, CALCULATION ENV ASSE
   MCVEETY B, 1967, ATMOS ENVIRON, V22, P511
   Neff J.M, 1979, POLYCYCL AROMAT COMP, P1
   Neilson A. H., 1998, HDB ENV CHEM PAHS RE, V3-J, P265
   Nielsen T, 1996, ATMOS ENVIRON, V30, P3481, DOI 10.1016/1352-2310(96)00096-9
   NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X
   RAFFAELLI D, 1996, J EXP MAR BIOL ECOL, V198, P151
   RUHLING A, 1968, Botaniska Notiser, V121, P321
   Schneider K, 2002, J APPL TOXICOL, V22, P73, DOI 10.1002/jat.828
   Schulz H, 2001, ENVIRON MONIT ASSESS, V69, P283, DOI 10.1023/A:1010705907525
   Schulz H, 1999, SCI TOTAL ENVIRON, V232, P49, DOI 10.1016/S0048-9697(99)00109-6
   Simonich S.L., 1995, ENVIRON SCI TECHNOL, V29, P2095, DOI DOI 10.1021/ES00012A004
   TURKAN I, 1995, SCI TOTAL ENVIRON, V166, P61, DOI 10.1016/0048-9697(95)04518-6
   Walkenhorst A., 1993, Plants as biomonitors: indicators for heavy metals in the terrestrial environment., P523
   WILD SR, 1992, SCI TOTAL ENVIRON, V119, P85, DOI 10.1016/0048-9697(92)90258-T
NR 37
TC 28
Z9 32
U1 2
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0013-9351
J9 ENVIRON RES
JI Environ. Res.
PD JUL
PY 2008
VL 107
IS 3
BP 371
EP 379
DI 10.1016/j.envres.2008.02.010
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA 316PA
UT WOS:000256961000011
PM 18417111
DA 2018-10-20
ER

PT J
AU Khan, IM
   Gilbert, SJ
   Singhrao, SK
   Duance, VC
   Archer, CW
AF Khan, I. M.
   Gilbert, S. J.
   Singhrao, S. K.
   Duance, V. C.
   Archer, C. W.
TI CARTILAGE INTEGRATION: EVALUATION OF THE REASONS FOR FAILURE OF
   INTEGRATION DURING CARTILAGE REPAIR. A REVIEW
SO EUROPEAN CELLS & MATERIALS
LA English
DT Review
DE cartilage; integration; repair; autologous chondrocyte implantation
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; TISSUE-ENGINEERED CARTILAGE;
   FULL-THICKNESS DEFECTS; CONTINUOUS PASSIVE MOTION; HUMAN
   ARTICULAR-CARTILAGE; MESENCHYMAL STEM-CELLS; IN-VITRO; OSTEOCHONDRAL
   DEFECTS; CHONDRAL DEFECTS; ENZYMATIC TREATMENT
AB Articular cartilage is a challenging tissue to reconstruct or replace principally because of its avascular nature; large chondral lesions in the tissue do not spontaneously heal. Where lesions do penetrate the bony subchondral plate, formation of hematomas and the migration of mesenchymal stem cells provide an inferior and transient fibrocartilagenous replacement for hyaline cartilage. To circumvent the poor intrinsic reparative response of articular cartilage several surgical techniques based on tissue transplantation have emerged. One characteristic shared by intrinsic reparative processes and the new surgical therapies is an apparent lack of lateral integration of repair or graft tissue with the host cartilage that can lead to poor prognosis. Many factors have been cited as impeding cartilage: cartilage integration including; chondrocyte cell death, chondrocyte dedifferentiation, the nature of the collagenous and proteoglycan networks that constitute the extracellular matrix, the type of biomaterial scaffold employed in repair and the origin of the cells used to repopulate the defect or lesion. This review addresses the principal intrinsic and extrinsic factors that impede integration and describe how manipulation of these factors using a host of strategies can positively influence cartilage integration.
C1 [Khan, I. M.; Gilbert, S. J.; Singhrao, S. K.; Duance, V. C.; Archer, C. W.] Cardiff Univ, Connect Tissue Biol Labs, Sch Biosci, Cardiff CF10 3US, S Glam, Wales.
RP Archer, CW (reprint author), Cardiff Univ, Connect Tissue Biol Labs, Sch Biosci, Museum Ave, Cardiff CF10 3US, S Glam, Wales.
EM archer@cardiff.ac.uk
OI Khan, Ilyas/0000-0002-3886-1987
FU Department for Business Enterprise & Regulatory Reform
FX Funding: Department for Business Enterprise & Regulatory Reform.
CR Allen RG, 1999, J ORTHOPAED RES, V17, P430, DOI 10.1002/jor.1100170320
   AMIEL D, 1985, J BONE JOINT SURG AM, V67A, P911, DOI 10.2106/00004623-198567060-00013
   Archer CW, 2006, J ANAT, V209, P481, DOI 10.1111/j.1469-7580.2006.00624.x
   Balint L, 2005, CLIN ORTHOP RELAT R, P208, DOI 10.1097/01.blo.0000145888.86652.e9
   Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Blaney DE, 2005, ARTHRITIS RES THER, V7, pR1338, DOI DOI 10.1186/AR1833
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   Bos PK, 2002, ARTHRITIS RHEUM, V46, P976, DOI 10.1002/art.10208
   Bravenboer JV, 2004, ARTHRITIS RES THER, V6, pR469, DOI 10.1186/ar1216
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   COHEN I, 2006, ARCH ORTHOP TRAUMA S, V127, P763
   Cohen Ilan, 2005, Iowa Orthop J, V25, P102
   Coleman S H, 2001, Ortop Traumatol Rehabil, V3, P224
   COOK SD, 2001, CLIN ORTHOP S, V391, pS231
   Costouros JG, 2007, KNEE, V14, P107, DOI 10.1016/j.knee.2006.10.013
   D'Lima DD, 2001, J BONE JOINT SURG AM, V83A, P25, DOI 10.2106/00004623-200100021-00006
   DARABI R, 2008, CELL CYCLE, V7
   Dell'Accio F, 2003, J ORTHOPAED RES, V21, P123, DOI 10.1016/S0736-0266(02)00090-6
   DiMicco MA, 2002, OSTEOARTHR CARTILAGE, V10, P218, DOI 10.1053/joca.2001.0502
   DiMicco MA, 2001, J ORTHOPAED RES, V19, P1105, DOI 10.1016/S0736-0266(01)00037-7
   Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912
   Dowthwaite GP, 2003, MATRIX BIOL, V22, P311, DOI 10.1016/S0945-053X(03)00037-4
   Emans PJ, 2005, TISSUE ENG, V11, P1789, DOI 10.1089/ten.2005.11.1789
   Englert C, 2005, ARTHRITIS RHEUM-US, V52, P1091, DOI 10.1002/art.20986
   Englert C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2202
   Englert C, 2006, ARTHRITIS RHEUM, V54, P3890, DOI 10.1002/art.22250
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345
   Gebauer D, 2005, ULTRASOUND MED BIOL, V31, P1391, DOI 10.1016/j.ultrasmedbio.2005.06.002
   Geutjes PJ, 2006, ADV EXP MED BIOL, V585, P279
   Giurea A, 2002, J ORTHOPAED RES, V20, P1274, DOI 10.1016/S0736-0266(02)00084-0
   Gobbi A, 2006, AM J SPORT MED, V34, P1763, DOI 10.1177/0363546506288853
   Gooch KJ, 2002, TISSUE ENG, V8, P591, DOI 10.1089/107632702760240517
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Gratz KR, 2006, J BIOMECH, V39, P138, DOI 10.1016/j.jbiomech.2004.10.016
   Haisch A, 2000, MED BIOL ENG COMPUT, V38, P686, DOI 10.1007/BF02344876
   Hayes AJ, 2001, ANAT EMBRYOL, V203, P469, DOI 10.1007/s004290100178
   Heyde M, 2007, J PHARM PHARMACOL, V59, P329, DOI 10.1211/jpp.59.3.0002
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   Horas U, 2003, J BONE JOINT SURG AM, V85A, P185, DOI 10.2106/00004623-200302000-00001
   Huntley JS, 2005, J BONE JOINT SURG AM, V87A, P351, DOI 10.2106/JBJS.D.02086
   Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hunziker EB, 1998, J BONE JOINT SURG BR, V80B, P144, DOI 10.1302/0301-620X.80B1.7531
   Hunziker EB, 2003, J BONE JOINT SURG AM, V85A, P85, DOI 10.2106/00004623-200300002-00011
   Isogai N, 2006, TISSUE ENG, V12, P691, DOI 10.1089/ten.2006.12.691
   Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008
   Jia Xiao-lin, 2005, Chin J Traumatol, V8, P175
   Johnson TS, 2004, TISSUE ENG, V10, P1308, DOI 10.1089/1076327042500445
   Jurgensen K, 1997, J BONE JOINT SURG AM, V79A, P185, DOI 10.2106/00004623-199702000-00004
   Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285
   Kiviranta P, 2008, OSTEOARTHR CARTILAGE, V16, P796, DOI 10.1016/j.joca.2007.10.016
   Kleemann RU, 2005, OSTEOARTHR CARTILAGE, V13, P958, DOI 10.1016/j.joca.2005.06.008
   Knudson W, 2000, ARTHRITIS RHEUM, V43, P1165, DOI 10.1002/1529-0131(200005)43:5<1165::AID-ANR27>3.0.CO;2-H
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Kuettner KE, 2005, OSTEOARTHR CARTILAGE, V13, P93, DOI 10.1016/j.joca.2004.11.006
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Lee D A, 1994, Osteoarthritis Cartilage, V2, P175, DOI 10.1016/S1063-4584(05)80067-6
   Lee D A, 1993, Osteoarthritis Cartilage, V1, P137, DOI 10.1016/S1063-4584(05)80029-9
   Lee MC, 2000, CLIN ORTHOP RELAT R, P286
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Liao CJ, 2007, J BIOMED MATER RES A, V81A, P567, DOI 10.1002/jbm.a.31035
   LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Martin JA, 2002, BIORHEOLOGY, V39, P145
   Martin JA, 2002, J GERONTOL A-BIOL, V57, pB48, DOI 10.1093/gerona/57.2.B48
   MATSUSUE Y, 1993, ARTHROSCOPY, V9, P318, DOI 10.1016/S0749-8063(05)80428-1
   McGowan KB, 2005, J ORTHOP RES, V23, P594, DOI 10.1016/j.orthres.2004.02.015
   MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208
   Munirah S, 2007, J BONE JOINT SURG BR, V89B, P1099, DOI 10.1302/0301-620X.89B8
   Namba RS, 1998, J BONE JOINT SURG AM, V80A, P4, DOI 10.2106/00004623-199801000-00003
   Nixon AJ, 2007, ANN NY ACAD SCI, V1117, P310, DOI 10.1196/annals.1402.065
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   ODRISCOLL SW, 1986, CLIN ORTHOP RELAT R, P131
   Parsch D, 2002, ARTHRITIS RHEUM, V46, P2911, DOI 10.1002/art.10626
   Pearce R H, 1991, J Rheumatol Suppl, V27, P42
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   Peretti GM, 2006, CONNECT TISSUE RES, V47, P190, DOI 10.1080/03008200600809935
   Peretti GM, 1998, J ORTHOPAED RES, V16, P89, DOI 10.1002/jor.1100160115
   Perka C, 2000, CLIN EXP RHEUMATOL, V18, P13
   PETERFY CG, 1994, RADIOLOGY, V191, P413, DOI 10.1148/radiology.191.2.8153315
   Qiu W, 2000, WOUND REPAIR REGEN, V8, P383
   Ravn P, 2004, BONE, V35, P1216, DOI 10.1016/j.bone.2004.07.017
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Redman SN, 2004, OSTEOARTHR CARTILAGE, V12, P106, DOI 10.1016/j.joca.2002.12.001
   Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613
   Russlies M, 2002, ANN ANAT, V184, P317, DOI 10.1016/S0940-9602(02)80045-0
   Schaefer DB, 2004, BIORHEOLOGY, V41, P503
   Schulze-Tanzil G, 2002, CELL TISSUE RES, V308, P371, DOI 10.1007/s00441-002-0562-7
   Schumann D, 2006, BIO-MED MATER ENG, V16, pS37
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Silverman RP, 2000, PLAST RECONSTR SURG, V105, P1393, DOI 10.1097/00006534-200004040-00019
   Singh NK, 2007, J VET MED A, V54, P210, DOI 10.1111/j.1439-0442.2007.00941.x
   Srbely John Z, 2008, J Can Chiropr Assoc, V52, P30
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Szeparowicz P, 2006, FOLIA HISTOCHEM CYTO, V44, P201
   Tatebe M, 2005, CYTOTHERAPY, V7, P520, DOI 10.1080/14653240500361350
   Tew S, 2001, CLIN ORTHOP RELAT R, pS142
   Tew SR, 2000, ARTHRITIS RHEUM-US, V43, P215, DOI 10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P129, DOI 10.1016/j.joca.2004.10.015
   Tognana E, 2007, CELLS TISSUES ORGANS, V186, P97, DOI 10.1159/000102539
   Trattnig S, 2006, EUR J RADIOL, V57, P9, DOI 10.1016/j.ejrad.2005.08.006
   Trattnig S, 2005, MAGN RESON IMAGING, V23, P779, DOI 10.1016/j.mri.2005.04.010
   Uhl M, 2005, ACTA RADIOL, V46, P875, DOI 10.1080/02841850500335127
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Walker EA, 2000, J ORTHOPAED RES, V18, P25, DOI 10.1002/jor.1100180105
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wilke MM, 2007, J ORTHOP RES, V25, P913, DOI 10.1002/jor.20382
   Yan H, 2007, ARTHROSCOPY, V23, P178, DOI 10.1016/j.arthro.2006.09.005
   ZARNETT R, 1987, CLIN ORTHOP RELAT R, P267
   Zhang ZJ, 2005, J ORTHOP RES, V23, P433, DOI 10.1016/j.orthres.2004.08.028
   ZWILLING E, 1968, DEV BIOL, V2, pS184
NR 117
TC 99
Z9 107
U1 1
U2 22
PU SWISS SOC BIOMATERIALS, AO RESEARCH INST
PI DAVOS
PA BIO-PERFORMANCE MATERIALS & DEVICES, AO RESEARCH INST, CLAVADELERSTRASSE
   8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2008
VL 16
BP 26
EP 39
DI 10.22203/eCM.v016a04
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 442UX
UT WOS:000265867200006
PM 18770504
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Saxena, AK
   Willital, GH
AF Saxena, Amulya K.
   Willital, Guenter H.
TI Infrared thermography: Experience from a decade of pediatric imaging
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Article
DE thermography; children; infrared; newborns; surgery
ID PULSED DYE-LASER; PORT-WINE STAINS; DIGITAL REPLANTATION; HEMANGIOMAS;
   CHILDHOOD; ARGON
AB The aim of this study was to evaluate the feasibility of clinical application of infrared thermography (IRT) in the pediatric population and to identify pathological states that can be diagnosed as well as followed up using this non-invasive technique. In real time computer-assisted IRT, 483 examinations were performed over a period of 10 years from 1990-2000 on 285 patients in the pediatric age group (range 1 week-16 years) presenting with a wide range of pathologies. The temperature was measured in centigrade (degrees C), and color images obtained were computer analyzed and stored on floppy discs. IRT was found to be an excellent noninvasive tool in the follow-up of hemangiomas, vascular malformations and digit amputations related to reimplantation, burns as well as skin and vascular growth after biomaterial implants in newborns with gastroschisis and giant omphaloceles. In the emergency room, it was a valuable tool for rapid diagnosis of extremity thrombosis, varicoceles, inflammation, abscesses, gangrene and wound infections. In conclusion, IRT can be performed in the pediatric age group, is non-invasive, without any biological side effects, requires no sedation or anesthesia and can be repeated as desired for follow-ups, with objective results that can demonstrated as colored images. Periodic thermographic studies to follow progression of lesions seem to be a useful and reproducible method for repeated and long-term examination.
C1 [Saxena, Amulya K.] Med Univ Graz, Dept Pediat Surg, A-8036 Graz, Austria.
   [Willital, Guenter H.] Univ Munster, Dept Pediat Surg, Munster, Germany.
RP Saxena, AK (reprint author), Med Univ Graz, Dept Pediat Surg, Auenbruggerpl 34, A-8036 Graz, Austria.
EM amulya.saxena@meduni-graz.at
CR ASHINOFF R, 1991, J AM ACAD DERMATOL, V24, P467, DOI 10.1016/0190-9622(91)70075-D
   ASHINOFF R, 1993, PEDIATR DERMATOL, V10, P77, DOI 10.1111/j.1525-1470.1993.tb00021.x
   Astner Susanne, 2005, Dermatol Ther, V18, P267, DOI 10.1111/j.1529-8019.2005.05025.x
   Batta K, 2002, LANCET, V360, P521, DOI 10.1016/S0140-6736(02)09741-6
   Chang CJ, 2001, ANN PLAS SURG, V46, P577, DOI 10.1097/00000637-200106000-00001
   COOKE E D, 1982, British Journal of Sexual Medicine, V9, P16
   ENGELS JM, 1985, APPL THERMOLOGY, P269
   GERSHONCOHEN J, 1964, ANN NY ACAD SCI, V121, P4, DOI 10.1111/j.1749-6632.1964.tb13679.x
   HACKETT MEJ, 1974, BRIT J PLAST SURG, V27, P311, DOI 10.1016/0007-1226(74)90028-9
   IKEDA K, 1990, MICROSURG, V11, P261, DOI 10.1002/micr.1920110402
   ISOGAI N, 1995, MICROSURG, V16, P556, DOI 10.1002/micr.1920160810
   IWATA G, 1992, EUR J PEDIATR SURG, V2, P308, DOI 10.1055/s-2008-1063468
   JIMENEZM.M, 1970, SURGERY, V67, P929
   Liddington MI, 1996, BURNS, V22, P26, DOI 10.1016/0305-4179(95)00076-3
   MORDON S, 1993, LASER SURG MED, V13, P124, DOI 10.1002/lsm.1900130119
   ROBICSEK F, 1984, THORAC CARDIOV SURG, V32, P260, DOI 10.1055/s-2007-1023400
   Samaras C A, 1983, Contemp Surg, V22, P31
   Saxena A, 2002, Hernia, V6, P73
   Saxena AK, 1999, PEDIATR SURG INT, V15, P75, DOI 10.1007/s003830050519
   Saxena AK, 2002, PEDIATR SURG INT, V18, P420, DOI 10.1007/s00383-002-0799-y
   Saxena AK, 1999, LANGENBECK ARCH SURG, V384, P187, DOI 10.1007/s004230050190
   Saxena AK, 1999, INT SURG, V84, P326
   SAXENA AK, 2001, ACTA CHIR AUSTRIACA, V33, P16
   SAXENA AK, 1995, 3 INT C NEW TECHN AD
   SAXENA AK, 1999, INT J SURG SCI, V6, P156
   SCHAARSCHMIDT K, 1995, LANGENBECKS ARCH CHI, P138
   STUTTGEN G, 1985, APPL THERMOLOGY, P13
   TROILIUS A, 1992, ACTA DERM-VENEREOL, V72, P6
   Tucker AT, 2000, FERTIL STERIL, V74, P802, DOI 10.1016/S0015-0282(00)01532-6
   Watanabe Yuji, 2002, Curr Opin Urol, V12, P149, DOI 10.1097/00042307-200203000-00012
   YANG W-J, 1992, Bio-Medical Materials and Engineering, V2, P7
NR 31
TC 47
Z9 48
U1 1
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-6199
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD JUL
PY 2008
VL 167
IS 7
BP 757
EP 764
DI 10.1007/s00431-007-0583-z
PG 8
WC Pediatrics
SC Pediatrics
GA 304BL
UT WOS:000256084900008
PM 17762940
DA 2018-10-20
ER

PT J
AU Marchiori-Silva, V
   Han, SW
   Novikoff, S
   Semedo, P
   Reis, RL
   Correlo, V
   Lisboa, BCG
   Camara, NOS
AF Marchiori-Silva, V.
   Han, S. W.
   Novikoff, S.
   Semedo, P.
   Reis, R. L.
   Correlo, V.
   Lisboa, B. C. G.
   Camara, N. O. S.
TI POLYHYDROXYBUTYRATE (PHB) FROM SUGAR CANE AS BIOMATERIAL FOR BONE TISSUE
   ENGINEERING USING MESENCHYMAL STEM CELLS DERIVED FROM HUMAN DENTAL PULP
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 [Marchiori-Silva, V.; Han, S. W.; Novikoff, S.; Lisboa, B. C. G.] Univ Fed Sao Paulo, Ctr Interdisciplinar Terapia Gen, CINTERGEN, Sao Paulo, Brazil.
   [Reis, R. L.; Correlo, V.] 3Bs UMINHO, Braga, Portugal.
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Camara,
   Niels/G-8336-2011; Correlo, Vitor/O-4227-2015; Lisboa,
   Bianca/N-6649-2013
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456;
   Camara, Niels/0000-0001-5436-1248; Correlo, Vitor/0000-0002-5516-7583;
   Lisboa, Bianca/0000-0002-2687-5011
NR 0
TC 0
Z9 0
U1 0
U2 5
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 2008
VL 31
IS 7
BP 600
EP 601
PG 2
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 351TV
UT WOS:000259449700073
DA 2018-10-20
ER

PT J
AU Nakayama, Y
   Takamizawa, K
   Ishibashi-Ueda, H
   Kanda, K
AF Nakayama, Y.
   Takamizawa, K.
   Ishibashi-Ueda, H.
   Kanda, K.
TI BIOMATERIAL SURFACE CHEMISTRY CONTROL OF FABRICATION OF BIOTUBE VASCULAR
   GRAFTS IN VIVO
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 [Ishibashi-Ueda, H.] Natl Cardiovasc Ctr Hosp & Res Inst, Osaka, Japan.
   [Kanda, K.] Kyoto Prefectural Univ Med, Kyoto, Japan.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 2008
VL 31
IS 7
BP 631
EP 631
PG 1
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 351TV
UT WOS:000259449700192
DA 2018-10-20
ER

PT J
AU Martuscelli, R
   Maltarello, MC
   Maraldi, NM
   Sbordone, C
   Sbordone, L
AF Martuscelli, R.
   Maltarello, M. C.
   Maraldi, N. M.
   Sbordone, C.
   Sbordone, L.
TI HISTOLOGICAL AND CLINICAL SURVEY OF POLYLACTIC-POLYGLYCOLIC ACID AND
   DEXTRANE COPOLYMER IN MAXILLARY SINUS LIFT: A PILOT IN VIVO STUDY
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE sinus lift; PLA-GLA-dextrane copolymer; histomorphometric analysis;
   microhardness; X-ray microanalysis
ID BONE; AUGMENTATION; IMPLANTS; FLOOR
AB Of various proposed alternatives to autogenous bone, a synthetic, degradable copolymer of PLA-GLA and dextrane seems to be a promising biomaterial for maxillary sinus lift. Consecutive partially edentulous patients showing severe monolateral posterior maxillary atrophy were treated via sinus lift using PLA-GLA-dextrane copolymer as the sole filler. Delayed implant positioning was performed and cores of regenerated tissues and native bone controls were retrieved and evaluated by light and electron microscopy, histomorphometry, microhardness and qualitative X-ray analysis. Seven sinuses in 7 patients were augmented with PLA-GLA-dextrane copolymer. Six to nine months after the copolymer 'graft', 47 bone cores were retrieved: all histological sections contained newly synthesized, mineralized material and new bone in various stages of development. Histomorphometry revealed average Trabecular Bone Volume (TBV) values ranging from 51% (6 months) to 77% (9 months). Backscattered scanning electron microscopy (BSE) in experimental and control samples confirmed histology findings. Microhardness values suggested newly formed bone at nine months was not as hard as native bone. Ca and P content was similar in 9-month regenerated and native bone. Seventeen implants were inserted in the second stage of surgery: resulting Implant Success (SR) and Cumulative Success (CSR) up to 3 years were 100% following Albrektsson's criteria. Sinus lift augmentation using PLA-GLA-dextrane copolymer as the sole filler resulted in uneventful surgeries. New bone formation was evident histologically and its maturation was still in progress after 9 months. Successful, staged implant positioning was achieved in regenerated tissue.
C1 [Sbordone, L.] Univ Pisa, Dept Surg, I-56100 Pisa, Italy.
   [Martuscelli, R.] Univ Naples Federico 2, Dept Oral Sci & Maxillofacial Surg, Naples, Italy.
   [Maltarello, M. C.; Maraldi, N. M.] IOR, Lab Cell Biol & Electron Microscopy, Bologna, Italy.
   [Maraldi, N. M.] Univ Bologna, Dept Anat Sci, Bologna, Italy.
   [Sbordone, C.] Univ Naples Federico 2, Dept Maxillofacial Surg, Naples, Italy.
RP Sbordone, L (reprint author), Univ Pisa, Dept Surg, Via Roma 67, I-56100 Pisa, Italy.
EM lsbordon@med.unipi.it
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Banse X, 2005, MICRON, V36, P710, DOI 10.1016/j.micron.2005.07.012
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   CHANAVAZ M, 1990, Journal of Oral Implantology, V16, P199
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P136, DOI 10.1111/j.1600-0501.2006.01357.x
   Dickson GR, 1984, METHODS CALCIFIED TI, P79
   Fini M, 2003, BIOMATERIALS, V24, P4929, DOI 10.1016/S0142-9612(03)00416-2
   Giavaresi G, 2004, BIOMATERIALS, V25, P5583, DOI 10.1016/j.biomaterials.2004.01.017
   GROWER MF, 1989, BIOMATER ARTIF CELL, V17, P291, DOI 10.3109/10731198909118286
   Huja SS, 2000, MECH TESTING BONE BO, P247
   Johansson B, 1999, INT J ORAL MAX IMPL, V14, P811
   Mangano C, 2003, INT J ORAL MAX IMPL, V18, P23
   NAKAMURA T, 1989, J BIOMED MATER RES, V23, P1115, DOI 10.1002/jbm.820231003
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P503, DOI 10.1034/j.1600-0501.2001.120511.x
   ROOMANS GM, 1988, J ELECTRON MICR TECH, V9, P19, DOI 10.1002/jemt.1060090104
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   THEUNS HM, 1993, BONE, V14, P545, DOI 10.1016/8756-3282(93)90193-E
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   VISSCHER GE, 1985, J BIOMED MATER RES, V19, P349, DOI 10.1002/jbm.820190315
   von Arx T, 2005, CLIN ORAL IMPLAN RES, V16, P432, DOI 10.1111/j.1600-0501.2005.01138.x
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   WIPPOLD FJ, 1995, ALLERGY PROC, V16, P165, DOI 10.2500/108854195778666801
   Zaffe D, 2005, J MATER SCI-MATER M, V16, P789, DOI 10.1007/s10856-005-3574-5
NR 26
TC 3
Z9 3
U1 0
U2 3
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JUL-SEP
PY 2008
VL 21
IS 3
BP 687
EP 695
DI 10.1177/039463200802100323
PG 9
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA 359KR
UT WOS:000259986100023
PM 18831937
OA Bronze
DA 2018-10-20
ER

PT J
AU Spear, RL
   Cameron, RE
AF Spear, Rose L.
   Cameron, Ruth E.
TI Carbon nanotubes for orthopaedic implants
SO INTERNATIONAL JOURNAL OF MATERIAL FORMING
LA English
DT Review
DE Nanotechnology; Carbon nanotubes; Bioengineering; Biomaterial;
   Nanocomposite
AB The physical and biological limitations of current orthopaedic implant materials are a major challenge for bone tissue engineering. Nanotechnology has introduced new materials and methods for meeting this challenge. The application of nanotechnology to engineering new bone substitutes finds a model in the nanoscale components of natural bone tissue. Carbon nanotubes are a macromolecular form of carbon with exceptional properties and similar morphology and dimensions to the nanoscale collagen fibers of natural bone tissue. Carbon nanotubes have been used in two main areas of bone tissue engineering: for structural and electrical enhancement of polymer and ceramic composites and for nanostructured coatings to improve the bioactivity of implant surfaces. By incorporating carbon nanotubes into the design and engineering of bone tissue substitutes, researchers have attempted to overcome limitations in the structural and biological compatibility of traditional orthopaedic implant materials.
C1 [Spear, Rose L.; Cameron, Ruth E.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Spear, RL (reprint author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.
EM rs489@cam.ac.uk
RI Spear, Rose/H-1921-2011
OI Wedgbury, Rose/0000-0002-7192-5401; Cameron, Ruth/0000-0003-1573-4923
FU Gates Trust
FX Rose L. Spear is grateful to the Gates Trust for financial support for a
   PhD studentship.
CR Akasaka T, 2006, MAT SCI ENG C-BIO S, V26, P675, DOI 10.1016/j.msec.2005.03.009
   An JW, 2003, WEAR, V255, P677, DOI 10.1016/S0043-1648(03)00216-3
   Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   Bacakova L, 2007, DIAM RELAT MATER, V16, P2133, DOI 10.1016/j.diamond.2007.07.015
   Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Boccaccini AR, 2007, ADV FUNCT MATER, V17, P2815, DOI 10.1002/adfm.200600887
   Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Chen Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1951054
   Chen Y, 2006, CARBON, V44, P37, DOI 10.1016/j.carbon.2005.07.011
   Daniel S, 2007, SENSOR ACTUAT B-CHEM, V122, P672, DOI 10.1016/j.snb.2006.06.014
   Davis JJ, 1998, INORG CHIM ACTA, V272, P261, DOI 10.1016/S0020-1693(97)05926-4
   De Nicola M, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/39/395013
   Dumortier H, 2006, NANO LETT, V6, P1522, DOI 10.1021/nl061160x
   Falvo MR, 1997, NATURE, V389, P582
   Gabay T, 2005, PHYSICA A, V350, P611, DOI 10.1016/j.physa.2004.11.007
   Gilmore KJ, 2007, CARBON, V45, P402, DOI 10.1016/j.carbon.2006.09.015
   Gutwein LG, 2004, 26 ANN AM CER SOC M
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hirsch A, 2002, ANGEW CHEM INT EDIT, V41, P1853, DOI 10.1002/1521-3773(20020603)41:11<1853::AID-ANIE1853>3.0.CO;2-N
   Hirsch A, 2006, PHYS STATUS SOLIDI B, V243, P3209, DOI 10.1002/pssb.200669191
   Hutchison JL, 2001, CARBON, V39, P761, DOI 10.1016/S0008-6223(00)00187-1
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Kealley C, 2006, PHYSICA B, V385, P496, DOI 10.1016/j.physb.2006.05.254
   Klumpp C, 2006, BBA-BIOMEMBRANES, V1758, P404, DOI 10.1016/j.bbamem.2005.10.008
   Li GY, 2005, CARBON, V43, P1239, DOI 10.1016/j.carbon.2004.12.017
   Liu Y, 2007, CHEM MATER, V19, P2721, DOI 10.1021/cm070002j
   Ma RZ, 1998, J MATER SCI, V33, P5243, DOI 10.1023/A:1004492106337
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437
   Peigney A, 2000, CERAM INT, V26, P677, DOI 10.1016/S0272-8842(00)00004-3
   Polizu S, 2006, J NANOSCI NANOTECHNO, V6, P1883, DOI 10.1166/jnn.2006.197
   Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b
   RUOFF RS, 1995, CARBON, V33, P925, DOI 10.1016/0008-6223(95)00021-5
   Salvetat JP, 1999, ADV MATER, V11, P161, DOI 10.1002/(SICI)1521-4095(199902)11:2<161::AID-ADMA161>3.0.CO;2-J
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   Spear RL, 2008, WORLD BIOMATERIAL C
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Tencer AF, 1994, BIOMECHANICS ORTHOPE, P18
   Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wenrong Y, 2007, NANOTECHNOL IN PRESS
   White AA, 2007, INT J APPL CERAM TEC, V4, P1, DOI 10.1111/j.1744-7402.2007.02113.x
   Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971
   Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zhao B, 2005, CHEM MATER, V17, P3235, DOI 10.1021/cm0500399
NR 54
TC 15
Z9 15
U1 0
U2 11
PU SPRINGER FRANCE
PI PARIS
PA 22 RUE DE PALESTRO, PARIS, 75002, FRANCE
SN 1960-6206
EI 1960-6214
J9 INT J MATER FORM
JI Int. J. Mater. Form.
PD JUL
PY 2008
VL 1
IS 2
BP 127
EP 133
DI 10.1007/s12289-008-0374-8
PG 7
WC Engineering, Manufacturing; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Engineering; Materials Science; Metallurgy & Metallurgical Engineering
GA V27IZ
UT WOS:000208608200011
DA 2018-10-20
ER

PT J
AU Kokubo, S
   Nozaki, K
   Fukushima, S
   Takahashi, K
   Miyata, K
   Fujimoto, R
   Yokota, S
AF Kokubo, Satoshi
   Nozaki, Kazutoshi
   Fukushima, Shinji
   Takahashi, Koichiro
   Miyata, Keiji
   Fujimoto, Ryuhei
   Yokota, Shoji
TI Recombinant human bone morphogenetic protein-2 as an osteoinductive
   biomaterial and a biodegradable carrier in a rabbit ulnar defect model
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE rhBMP-2; PLGA; gelatin sponge; rabbit; segmental bone defect;
   biodegradable carrier; recombinant human bone; morphogenetic protein-2;
   osteoinductive biomaterial; rabbit ulnar; defect model
ID ENDOTHELIAL GROWTH-FACTOR; STIMULATES CHEMOTACTIC MIGRATION;
   OSTEOBLASTIC DIFFERENTIATION; FRACTURE REPAIR; SKELETAL-MUSCLE;
   ANGIOGENESIS; CELLS; REGENERATION; PATHWAY; MACROPHAGES
AB We investigated early local changes induced by recombinant human bone morphogenetic protein (rhBMP)-2 and a novel carrier, poly[L-lactide-co-glycolide] copolymer-coated gelatin sponge (PGS). A 1.5 cm segmental bone defect was created in the diaphysis of the right ulna of male Japanese white rabbit. Defects received PGS with or without rhBMP-2 (0, 0.4, or 1 mg/cm(3)) and were harvested at 3, 7, 14, 21, or 28 days post implantation for histological examination. Immuno-staining for vascular endothelial growth factor (VEGF) was also performed. Spindle-shaped cells were observed in the rhBMP-2-treated groups 3 and 7 days after implantation. Bone regeneration was detected after 14 days in the rhBMP-2-treated groups and the bone area increased with time and dose. Expression of VEGF was observed in all groups at 3 days and was maintained by 14 days only in the defects treated with rhBMP-2 at a dose of 1 mg. These results indicate that rhBMP-2 exert its osteo-inductive activities via the promotion of osteogenic cell mobilization, and possibly via angiogenesis based on VEGF induction. Foreign-body reactions to the implanted PGS were similar to those observed when either poly[L-lactide-co-glycolide] copolymer or gelatin was individually implanted. These results indicate that the PGS is a useful and safe carrier for rhBMP-2.
C1 [Kokubo, Satoshi; Nozaki, Kazutoshi; Fukushima, Shinji; Takahashi, Koichiro; Miyata, Keiji] Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan.
   [Fujimoto, Ryuhei] Yamanouchi Pharmaceut Co Ltd, Inst Drug Dev Res, Itabashi Ku, Tokyo 1748511, Japan.
   [Yokota, Shoji] Yamanouchi Pharmaceut Co Ltd, Inst Drug Dev Res, Shizuoka 4250072, Japan.
RP Kokubo, S (reprint author), Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.
EM satoshi.kokubo@jp.astellas.com
CR Bax BE, 1999, CALCIFIED TISSUE INT, V65, P83, DOI 10.1007/s002239900662
   Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613
   Bostrom M, 1996, CLIN ORTHOP RELAT R, P272
   Bouxsein ML, 2001, J BONE JOINT SURG AM, V83A, P1219, DOI 10.2106/00004623-200108000-00012
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5
   Fujii T, 2006, ARTERIOSCL THROM VAS, V26, P2483, DOI 10.1161/01.ATV.0000244684.23499.bf
   Gerber HP, 1999, NAT MED, V5, P623
   Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8
   Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010
   GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311
   Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1
   Hay E, 1999, J CELL BIOCHEM, V72, P81, DOI 10.1002/(SICI)1097-4644(19990101)72:1<81::AID-JCB9>3.0.CO;2-N
   Itoh T, 1998, J VET MED SCI, V60, P451, DOI 10.1292/jvms.60.451
   Iwaki A, 1997, J BONE MINER RES, V12, P96, DOI 10.1359/jbmr.1997.12.1.96
   Kakudo N, 2006, LIFE SCI, V79, P1847, DOI 10.1016/j.lfs.2006.06.033
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
   Kokubo S, 2003, BIOMATERIALS, V24, P1643, DOI 10.1016/S0142-9612(02)00551-3
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   Luppen CA, 2002, J BONE MINER RES, V17, P301, DOI 10.1359/jbmr.2002.17.2.301
   Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1
   MEIKLE MC, 1994, BIOMATERIALS, V15, P513, DOI 10.1016/0142-9612(94)90017-5
   MIYAMOTO S, 1993, CLIN ORTHOP RELAT R, P333
   MIYAMOTO S, 1992, CLIN ORTHOP RELAT R, P274
   Nagao H, 2002, INT J ORAL MAX SURG, V31, P66, DOI 10.1054/ijom.2001.0133
   Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708
   Ranne T, 2007, J BIOACT COMPAT POL, V22, P249, DOI 10.1177/0883911507078270
   Rissanen TT, 2002, AM J PATHOL, V160, P1393, DOI 10.1016/S0002-9440(10)62566-7
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X
   THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318
   Verhoeckx KCM, 2006, INT IMMUNOPHARMACOL, V6, P1, DOI 10.1016/j.intimp.2005.05.013
   Welch RD, 1998, J BONE MINER RES, V13, P1483, DOI 10.1359/jbmr.1998.13.9.1483
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Xiong M, 1998, AM J PATHOL, V153, P587, DOI 10.1016/S0002-9440(10)65601-5
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411
   Yokota S, 2001, INT J PHARMACEUT, V223, P69, DOI 10.1016/S0378-5173(01)00728-1
   Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003
   Zhou DS, 2006, J BIOACT COMPAT POL, V21, P373, DOI 10.1177/0883911506068554
NR 43
TC 13
Z9 13
U1 1
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2008
VL 23
IS 4
BP 348
EP 366
DI 10.1177/0883911508092791
PG 19
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 318BA
UT WOS:000257064500004
DA 2018-10-20
ER

PT J
AU Pappalardo, S
   Mastrangelo, F
   Marroccia, DR
   Cappello, V
   Ciampoli, C
   Carlino, V
   Tanteri, L
   Costanzo, M
   Sinatra, F
   Tete, S
AF Pappalardo, S.
   Mastrangelo, F.
   Marroccia, D. Reale
   Cappello, V.
   Ciampoli, C.
   Carlino, V.
   Tanteri, L.
   Costanzo, M.
   Sinatra, F.
   Tete, S.
TI BONE REGENERATION: IN VITRO EVALUATION OF THE BEHAVIOUR OF
   OSTEOBLAST-LIKE MG63 CELLS PLACED IN CONTACT WITH POLYLACTIC-CO-GLYCOLIC
   ACID, DEPROTEINIZED BOVINE BONE AND DEMINERALIZED FREEZE-DRIED BONE
   ALLOGRAFT
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE bone; osteoblast-like cells; mg63 cells; polylactic-co-glycolic acid;
   deproteinized bovine bone; demineralized freeze-dried bone; allograft
ID AUTOGENOUS BONE; OXIDATIVE STRESS; STEM-CELLS; MATRIX; HYDROXYAPATITE;
   GRAFTS; DIFFERENTIATION; INFLAMMATION; AUGMENTATION; SUBSTITUTES
AB Insufficient bone density of the alveolar crests, caused by loss of the dental elements, sometimes impedes the primary stability of an integrated bone implant. The techniques of bone regeneration allow to obtain a sufficient quantity of alveolar bone to permit the implant rehabilitation of the edentulous crests. Today several grafting materials are available and they have different characteristics, according to their structure, which influence the different behaviour of the grafting materials to the bone and the implant surface. The aim of this study is to evaluate the interaction between a human osteosarcoma MG63 cell line and three different biomaterials: polylactic-co-glycolic acid (PLAGA), deproteinized bovine bone and demineralised freeze-dried bone allograft (DFDBA). From this study a different behaviour emerges of the osteoblast-like MG63 cells in relation to the sublayer on which these cells were placed in culture. The results of the study, in fact, demonstrate that the most osteoconductive material of the three analysed is the DFDBA, followed by DPBB. On the contrary, the PLGA, because of its roughness, does not seem to represent a valid support for cell growth, and does not encourage any morphologic modification in tumoral cells. Furthermore, deproteinized bovine bone shows a differentiating effect which could lead to hypothesise an osteoconductive capacity of this biomaterial. Further studies should be carried out with the aim of explaining the results obtained.
C1 [Mastrangelo, F.; Ciampoli, C.; Tanteri, L.; Tete, S.] Univ G dAnnunzio, Dept Oral Sci, I-66100 Chieti, Italy.
   Catania Univ, Oral Sci Sect 2, Dept Specialised Med Surg, Catania, Italy.
   [Costanzo, M.] Catania Univ, Dept Microbiol Sci & Gynaecol Sci, Catania, Italy.
   [Sinatra, F.] Catania Univ, Dept Biomed Sci, Gen Cellular & Genet Mol Biol Sect, Catania, Italy.
RP Tete, S (reprint author), Univ G dAnnunzio, Dept Oral Sci, Via Vestini 31, I-66100 Chieti, Italy.
EM tete@unich.it
OI MASTRANGELO, Filiberto/0000-0002-3746-5675
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   Banche G, 2007, INT J IMMUNOPATH PH, V20, P129, DOI 10.1177/039463200702000115
   Barbaro MPF, 2007, INT J IMMUNOPATH PH, V20, P753, DOI 10.1177/039463200702000411
   Boyan Barbara D, 2006, Dent Clin North Am, V50, P217, DOI 10.1016/j.cden.2005.11.007
   Boyan BD, 2006, J PERIODONTOL, V77, P1555, DOI 10.1902/jop.2006.060019
   Bruzzese V, 2008, EUR J INFLAMM, V6, P93, DOI 10.1177/1721727X0800600207
   Capodiferro S, 2007, EUR J INFLAMM, V5, P51, DOI 10.1177/1721727X0700500109
   Carinci F, 2006, ARCH ORAL BIOL, V51, P154, DOI 10.1016/j.archoralbio.2005.06.006
   Chen TM, 2002, ANN PLAS SURG, V49, P272, DOI 10.1097/01.SAP.0000015488.91165.B8
   Constantino PD, 1994, OTOLARYNGOL CLIN N A, V27, P1037
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd
   *EUR AG EV MED PRO, 2002, DIB ALF SCI DISC EUR
   EWERS R, 2004, CLIN ORAL IMPLAN RES, V96, P100
   Ferdinande L, 2008, INT J IMMUNOPATH PH, V21, P289, DOI 10.1177/039463200802100205
   GAMRADT SC, 2003, CLIN ORTHOP RELAT R, V183, P94
   GAO Y, 2001, MAT SCI MAT MED, V7, P815
   Gigante A, 2008, J BIOL REG HOMEOS AG, V22, P35
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hammerle CHF, 2003, PERIODONTOL 2000, V33, P36, DOI 10.1046/j.0906-6713.2003.03304.x
   Hu ZM, 2005, J CRANIOFAC SURG, V16, P1006, DOI 10.1097/01.scs.0000170449.72040.ee
   Ingber A, 2007, INT J IMMUNOPATH PH, V20, P191, DOI 10.1177/039463200702000123
   Inoue K, 2008, INT J IMMUNOPATH PH, V21, P197, DOI 10.1177/039463200802100122
   KARABUDA C, 2001, J PERIODONTOL, V39, P89
   Katsanos GS, 2008, EUR J INFLAMM, V6, P59, DOI 10.1177/1721727X0800600202
   Lavagno L, 2007, J BIOL REG HOMEOS AG, V21, P5
   Marins Lucele Vieira, 2004, J. Appl. Oral Sci., V12, P62, DOI 10.1590/S1678-77572004000100012
   Minenna L, 2005, J CLIN PERIODONTOL, V32, P456, DOI 10.1111/j.1600-051X.2005.00696.x
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Mott David A, 2002, J Oral Implantol, V28, P57, DOI 10.1563/1548-1336(2002)028<0057:EOOPIV>2.3.CO;2
   Mushipe MT, 2002, BIOMATERIALS, V23, P365, DOI 10.1016/S0142-9612(01)00114-4
   Nishimura Y, 2007, INT J IMMUNOPATH PH, V20, P661, DOI 10.1177/039463200702000402
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P514, DOI 10.1034/j.1600-0501.2002.130511.x
   Nkenke E, 2001, CLIN ORAL IMPLAN RES, V12, P495, DOI 10.1034/j.1600-0501.2001.120510.x
   OLIVEIRA RC, 2004, BRAZ DENT J, V15, P3
   Pannone G, 2007, INT J IMMUNOPATH PH, V20, P317, DOI 10.1177/039463200702000211
   Pautke C, 2004, ANTICANCER RES, V24, P3743
   Peters K, 2007, INT J IMMUNOPATH PH, V20, P685, DOI 10.1177/039463200702000404
   Piancatelli D, 2008, INT J IMMUNOPATH PH, V21, P359, DOI 10.1177/039463200802100213
   PIATTELLI A, 2003, IMPLANTOLOGIA ORALE, V4, P77
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Sailer H F, 2000, Mund Kiefer Gesichtschir, V4 Suppl 1, pS384, DOI 10.1007/PL00014562
   SAMPATH T, 2003, BONE GRAFT SUBSTITUT, P194
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   Schwartz-Arad D, 2002, Refuat Hapeh Vehashinayim (1993), V19, P35
   Serino G, 2003, CLIN ORAL IMPLAN RES, V14, P651, DOI 10.1034/j.1600-0501.2003.00970.x
   Suzuki T, 2000, J BIOSCI BIOENG, V89, P18, DOI 10.1016/S1389-1723(00)88045-7
   Tete S, 2007, INT J IMMUNOPATH PH, V20, P819, DOI 10.1177/039463200702000418
   Thorwarth M, 2005, ORAL SURG ORAL MED O, V100, P278, DOI 10.1016/j.tripleo.2004.12.017
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vallejo LF, 2002, J BIOTECHNOL, V94, P185, DOI 10.1016/S0168-1656(01)00425-4
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Zimmermann R, 2001, TRANSFUSION, V41, P1217, DOI 10.1046/j.1537-2995.2001.41101217.x
NR 54
TC 4
Z9 4
U1 0
U2 2
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD JUL-SEP
PY 2008
VL 22
IS 3
BP 175
EP 183
PG 9
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA 363LS
UT WOS:000260269400005
PM 18842171
DA 2018-10-20
ER

PT J
AU Fu, Q
   Rahaman, MN
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
   Li, HF
AF Fu, Qiang
   Rahaman, Mohamed N.
   Zhou, Nai
   Huang, Wenhai
   Wang, Deping
   Zhang, Liying
   Li, Haifeng
TI In vitro study on different cell response to spherical hydroxyapatite
   nanoparticles
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE nanocrystalline hydroxyapatite; cell proliferation; cell responses;
   biomaterials; L929 cell line
ID HUMAN MONOCYTES; COLORIMETRIC ASSAY; PARTICLE-SIZE; BONE-CEMENT;
   PHOSPHATE; GROWTH; CYTOKINES; TOXICITY; PROLIFERATION; CYTOTOXICITY
AB Hydroxyapatite (HA) is widely used in filling of bone defects and coating on metal parts of prosthetic implants due to its excellent biocompatibility, bioactivity, and bone-bonding properties. It has been demonstrated that micro-sized HA particles cause inflammatory reaction, especially for the needle shaped particles. However, little effort has been concentrated on the cell responses of the spherical HA nanoparticles. The aim of the present work is to chemically and physically characterize the synthesized HA nanoparticles and to investigate the in vitro cell responses. X-ray diffraction, electron microscopy, nitrogen adsorption, and Fourier transform infrared spectroscopy revealed that the particles consisted of nearly spherical crystallites of carbonate-substituted HA with size of 20-40nm and specific surface area of 75 m(2)/g. L929 cell proliferation experiments demonstrate that the spherical HA nanoparticles is more biocompatible than commercially available HA. On the other hand, U2-OS cell test results show that the inhibition rate of the spherical HA nanoparticles increases with time and concentration. The half effective inhibitory concentration (IC50) of the nanoparticles was determined to be 50.8 mu g/mL at 72 h. All these data indicated that the synthesized spherical nanocrystalline HA particles can function as an effective biomaterial for bone tumorectomy repair, while having little adverse effect.
C1 [Fu, Qiang; Rahaman, Mohamed N.] Univ Missouri, Dept Mat Sci & Engn, Rolla, MO 65409 USA.
   [Fu, Qiang; Zhou, Nai; Huang, Wenhai; Wang, Deping; Zhang, Liying] Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
   [Huang, Wenhai] Univ Missouri, Mat Res Ctr, Rolla, MO 65409 USA.
   [Li, Haifeng] Tongji Univ, Tongji Hosp, Shanghai 200065, Peoples R China.
RP Fu, Q (reprint author), Univ Missouri, Dept Mat Sci & Engn, 223 McNutt Hall, Rolla, MO 65409 USA.
EM qf7r9@umr.edu; whhuang@mail.tongji.edu.cn
RI Fu, Qiang/B-1972-2013
CR AKAO M, 1993, J MATER SCI-MATER M, V4, P569, DOI 10.1007/BF00125595
   BASLE MF, 1993, J MATER SCI-MATER M, V4, P273, DOI 10.1007/BF00122280
   Ben-Nissan B, 2004, BIOMATERIALS, V25, P4971, DOI 10.1016/j.biomaterials.2004.02.006
   Blake T, 1998, J TOXICOL ENV HEAL A, V54, P243
   Cao LY, 2005, CERAM INT, V31, P1041, DOI 10.1016/j.ceramint.2004.11.002
   EVANS EJ, 1991, BIOMATERIALS, V12, P574, DOI 10.1016/0142-9612(91)90054-E
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   Fu Q, 2005, J BIOMED MATER RES A, V74A, P156, DOI 10.1002/jbm.a.30322
   Fu QN, 2004, J MATER SCI-MATER M, V15, P1333, DOI 10.1007/s10856-004-5742-4
   GARVEY BT, 1994, J APPL BIOMATER, V5, P39, DOI 10.1002/jab.770050106
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Grandjean-Laquerriere A, 2004, BIOMATERIALS, V25, P5921, DOI 10.1016/j.biomaterials.2004.02.003
   Guthrie GD, 1997, ENVIRON HEALTH PERSP, V105, P1003, DOI 10.2307/3433501
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HEO DS, 1990, CANCER RES, V50, P3681
   Huang J, 2004, J MATER SCI-MATER M, V15, P441, DOI 10.1023/B:JMSM.0000021117.67205.cf
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   JANSEN JA, 1993, J MATER SCI-MATER M, V4, P466, DOI 10.1007/BF00120126
   KIM CY, 1989, J NON-CRYST SOLIDS, V113, P195, DOI 10.1016/0022-3093(89)90011-2
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9
   Laquerriere P, 2003, COLLOID SURFACE B, V30, P207, DOI 10.1016/S0927-7765(03)00083-3
   LEGEROS RZ, 1984, PHOSPHATE MINERALS, P352
   Li S., 1996, BIOCERAMICS, V9, P225
   Liu ZS, 2003, WORLD J GASTROENTERO, V9, P1968, DOI 10.3748/wjg.v9.i9.1968
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Ninomiya JT, 2001, J ORTHOPAED RES, V19, P621, DOI 10.1016/S0736-0266(00)00061-9
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Phillips MJ, 2003, J MATER SCI-MATER M, V14, P875, DOI 10.1023/A:1025682626383
   Posner A. S., 1984, Phosphate Minerals, P330
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192
   SCHULLER HM, 1990, CANCER RES, V50, P1645
   STROBL JS, 1992, J PHARMACOL EXP THER, V263, P186
   Suchanek W, 1998, J MATER RES, V13, P84
   Sun JS, 1997, BIOMATERIALS, V18, P683, DOI 10.1016/S0142-9612(96)00183-4
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   WEHANCED TJ, 2000, BIOMATERIALS, V21, P1803
   WEI JW, 1982, CANCER RES, V42, P2571
   WILKE A, 1993, J MATER SCI-MATER M, V4, P260, DOI 10.1007/BF00122278
NR 42
TC 20
Z9 20
U1 0
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2008
VL 23
IS 1
BP 37
EP 50
DI 10.1177/0885328207081350
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 321SK
UT WOS:000257326600002
PM 18194997
DA 2018-10-20
ER

PT J
AU Jell, G
   Notingher, I
   Tsigkou, O
   Notingher, P
   Polak, JM
   Hench, LL
   Stevens, MM
AF Jell, G.
   Notingher, I.
   Tsigkou, O.
   Notingher, P.
   Polak, J. M.
   Hench, L. L.
   Stevens, M. M.
TI Bioactive glass-induced osteoblast differentiation: A noninvasive
   spectroscopic study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE osteoblasts; Raman spectroscopy; differentiation; bioactive glass; gene
   expression
ID CONFOCAL RAMAN MICROSPECTROSCOPY; IN-VITRO; GENE-EXPRESSION; BIOGLASS(R)
   45S5; IONIC PRODUCTS; CELL-CULTURES; LIVING CELLS; STEM-CELLS; SITU;
   DISSOLUTION
AB Here, we report on a rapid, noninvasive biophotonics system using Raman spectroscopy to detect realtime biochemical changes in foetal osteoblasts (17013s) following exposure to 45S5 Bioglass (R) (BG)-conditioned media. Bio-Raman spectroscopy, combined with multivariate statistical analysis techniques (principal component analysis and least squares analysis), was able to noninvasively identify biochemical differences in FOBs cultured for different time periods and between FOBs exposed/or not to BG-conditioned media. Gene and protein expression studies were also performed for known markers of osteoblastic differentiation, namely, alkaline phosphatase, bone sialoprotein, and collagen type I. Quantitative RT-PCR confirmed upregulation of genes associated with osteoblast differentiation after exposure to BG-conditioned media. These results suggest that Raman spectroscopy can noninvasively detect biochemical changes in FOBs associated with differentiation. This technique could have important applications in the field of regenerative medicine by enabling rapid characterization of cell or organoid behavior on novel bioactive scaffolds without damage to either cell or biomaterial. (C) 2007 Wiley Periodicals, Inc.
C1 [Jell, G.; Tsigkou, O.; Notingher, P.; Hench, L. L.; Stevens, M. M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Notingher, I.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England.
   [Tsigkou, O.; Polak, J. M.; Hench, L. L.] Univ London Imperial Coll Sci Technol & Med, London SW10 9NH, England.
   [Stevens, M. M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
RP Stevens, MM (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
EM m.stevens@imperial.ac.uk
RI Jell, Gavin/C-4893-2009; Jell, Gavin/B-7855-2010
OI Notingher, Ioan/0000-0002-5360-230X; Tsigkou, Olga/0000-0002-5250-8610
FU Medical Research Council
CR Bhattacharya N, 2004, Clin Exp Obstet Gynecol, V31, P167
   Buschman HP, 2001, CARDIOVASC PATHOL, V10, P69, DOI 10.1016/S1054-8807(01)00064-3
   Caspers PJ, 2001, J INVEST DERMATOL, V116, P434, DOI 10.1046/j.1523-1747.2001.01258.x
   Christodoulou I, 2005, J BIOMED MATER RES B, V74B, P529, DOI 10.1002/jbm.b.30249
   Coelho MJ, 2000, BIOMATERIALS, V21, P1087, DOI 10.1016/S0142-9612(99)00284-7
   Crow P, 2005, BRIT J CANCER, V92, P2166, DOI 10.1038/sj.bjc.6602638
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Fuchs JR, 2003, J PEDIATR SURG, V38, P1188, DOI 10.1016/S0022-3468(03)00265-3
   Golan-Mashiach M, 2004, FASEB J, V18, P147, DOI 10.1096/fj.04-2417fje
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   Haka AS, 2002, CANCER RES, V62, P5375
   Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9
   Jones JR, 2005, KEY ENG MAT, V284-286, P623, DOI 10.4028/www.scientific.net/KEM.284-286.623
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   Krafft C, 2003, VIB SPECTROSC, V32, P75, DOI 10.1016/S0924-2031(03)00049-3
   Krupnick AS, 2004, TISSUE ENG, V10, P723, DOI 10.1089/1076327041348419
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Maquelin K, 2003, J CLIN MICROBIOL, V41, P324, DOI 10.1128/JCM.41.1.324-329.2003
   Maquelin K, 2000, ANAL CHEM, V72, P12, DOI 10.1021/ac991011h
   Montjovent MO, 2004, BONE, V35, P1323, DOI 10.1016/j.bone.2004.07.001
   Notingher I, 2004, J R SOC INTERFACE, V1, P79, DOI 10.1098/rsif.2004.0008
   Notingher I, 2004, J CELL BIOCHEM, V92, P1180, DOI 10.1002/jcb.20136
   Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720
   NOTINGHER J, 2003, BIOPOLYMERS, V72, P230
   Notingher L, 2005, J MOL STRUCT, V744, P179, DOI 10.1016/j.molstruc.2004.12.046
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   Owen CA, 2006, J CELL BIOCHEM, V99, P178, DOI 10.1002/jcb.20884
   PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0
   Shafer-Peltier KE, 2002, J CELL BIOCHEM, P125, DOI 10.1002/jcb.10418
   Short KW, 2005, BIOPHYS J, V88, P4274, DOI 10.1529/biophysj.103.038604
   Stone N, 2000, LARYNGOSCOPE, V110, P1756, DOI 10.1097/00005537-200010000-00037
   Thian ES, 2006, J BIOMED MATER RES B, V76B, P326, DOI 10.1002/jbm.b.30368
   Tsigkou O, 2007, J BIOMED MATER RES A, V80A, P837, DOI 10.1002/jbm.a.30910
   Uzunbajakava N, 2003, BIOPHYS J, V84, P3968, DOI 10.1016/S0006-3495(03)75124-8
   Verrier S, 2004, BIOPOLYMERS, V74, P157, DOI 10.1002/bip.20063
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
NR 40
TC 56
Z9 55
U1 2
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 31
EP 40
DI 10.1002/jbm.a.31542
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500004
PM 17941016
DA 2018-10-20
ER

PT J
AU Kim, JG
   Lee, KR
   Yang, SJ
AF Kim, Jung-Gu
   Lee, Kwang-Ryeol
   Yang, Seok-Jo
TI Wear-corrosion performance of Si-DLC coatings on Ti-6Al4V substrate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE wear; corrosion; DLC; biomaterial; Ti
ID TIN COATINGS; CARBON-FILMS; BEHAVIOR; DEPOSITION; RESISTANCE; TI-6A1-4V;
   EROSION; STEEL; ALLOY
AB Si-incorporated diamond-like carbon (Si-DLC) coatings ranging from 0 to 2 at % Si were deposited on Ti-alloy substrate by means of radio frequency plasma-assisted chemical vapor deposition (r.f. PACVD) technique, using a mixture of benzene (C6H6) and silane (SiH4) as the reaction gas. The synergy in wear and corrosion of Si-DLC coatings was investigated by tribological and electrochemical techniques. The electrolyte used in this test to simulate the corrosive environment of body fluid was a 0.89 wt % NaCl solution of pH 7.4 at 37 degrees C. This study provides quantitative data for the assessment of the effect of Si incorporation on the synergistic effect between wear and corrosion in the simulated body fluid environment. In conclusion, tribological and electrochemical measurements showed that the Si-DLC films could improve wear-corrosion resistance in the simulated body fluid environment owing to the lower friction coefficient, corrosion rate, delamination area, and water uptake. (C) 2007 Wiley Periodicals, Inc.
C1 [Kim, Jung-Gu] Sungkyunkwan Univ, Dept Adv Mat Engn, Suwon 440746, South Korea.
   [Lee, Kwang-Ryeol] Korea Inst Sci & Technol, Future Technol Res Div, Seoul 130650, South Korea.
   [Yang, Seok-Jo] Chungnam Natl Univ, Dept Mechatron Engn, Taejon 305764, South Korea.
RP Kim, JG (reprint author), Sungkyunkwan Univ, Dept Adv Mat Engn, 300 Chunchun Dong, Suwon 440746, South Korea.
EM kimjg@skku.ac.kr
RI Lee, Kwang-Ryeol/E-1242-2011
OI Lee, Kwang-Ryeol/0000-0002-8211-3257
CR *ASTM, 1994, G10290 ASTM
   Barril S, 2001, TRIBOL INT, V34, P599, DOI 10.1016/S0301-679X(01)00052-4
   Choi J, 2007, DIAM RELAT MATER, V16, P1361, DOI 10.1016/j.diamond.2006.11.088
   Choi YS, 2000, CORROSION, V56, P1202, DOI 10.5006/1.3280508
   Damasceno JC, 2000, SURF COAT TECH, V133, P247, DOI 10.1016/S0257-8972(00)00932-4
   Eisenbarth E, 2002, BIOMOL ENG, V19, P243, DOI 10.1016/S1389-0344(02)00032-1
   Guleryuz H, 2004, BIOMATERIALS, V25, P3325, DOI 10.1016/j.biomaterials.2003.10.009
   Kim HG, 2005, THIN SOLID FILMS, V482, P299, DOI 10.1016/j.tsf.2004.11.164
   Lee KR, 1997, THIN SOLID FILMS, V308, P263, DOI 10.1016/S0040-6090(97)00411-2
   Liang H, 2004, VACUUM, V73, P317, DOI 10.1016/j.vacuum.2003.12.160
   LIU H, 1995, DIAMOND CHEM VAPOR D, P44
   MADSEN BW, 1988, WEAR, V123, P127, DOI 10.1016/0043-1648(88)90095-6
   Rudenja S, 1999, SURF COAT TECH, V114, P129, DOI 10.1016/S0257-8972(99)00033-X
   TSAI CH, 1993, CORROSION, V49, P726, DOI 10.5006/1.3316106
   Wan GJ, 2004, SURF COAT TECH, V186, P136, DOI 10.1016/j.surfcoat.2004.04.037
   Zhou S, 1996, CORROSION, V52, P934, DOI 10.5006/1.3292087
NR 16
TC 15
Z9 16
U1 0
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 41
EP 47
DI 10.1002/jbm.a.31632
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500005
PM 17941020
DA 2018-10-20
ER

PT J
AU Lu, PL
   Lai, JY
   Tabata, Y
   Hsiue, GH
AF Lu, Pei-Lin
   Lai, Jui-Yang
   Tabata, Yasuhiko
   Hsiue, Ging-Ho
TI A methodology based on the "anterior chamber of rabbit eyes" model for
   noninvasively determining the biocompatibility of biomaterials in an
   immune privileged site
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE methodology; biocompatibility; biomaterials; immune privileged site;
   animal model
ID OLIGO(POLY(ETHYLENE GLYCOL) FUMARATE); AMNIOTIC MEMBRANE; IN-VITRO;
   INTRAOCULAR-PRESSURE; DIBLOCK COPOLYMERS; CONTROLLED-RELEASE;
   MOLECULAR-WEIGHT; DRUG-DELIVERY; CANINE MODEL; GELATIN
AB In this study, a novel methodology based on the anterior chamber of rabbit eyes model was developed to evaluate the in vivo biocompatibility of biomaterials in an immune privileged site. The 7-mm-diameter membrane implants made from either a biological tissue material (amniotic membrane, AM group) or a biomedical polymeric material (gelatin, GM group) were inserted in rabbit anterior chamber for 36 months and characterized by biomicroscopic examinations, intraocular pressure measurements, and corneal thickness measurements. The noninvasive ophthalmic parameters were scored to provide a quantitative grading system. In this animal model, both AM and GM implants were visible in an ocular immune privileged site during clinical observations. The implants of the AM group appeared as soft tissue patches and have undergone a slow dissolution process resulting in a partial reduction of their size. Additionally, the AM implants did not induce any foreign body reaction or change in ocular tissue response for the studied period. By contrast, in the GM groups, significant corneal edema, elevated intraocular pressure, and increased corneal thickness were noted in the early postoperative phase (within 3 days), but resolved rapidly with in vivo dissolution of the gelatin. The results from the ocular grading system showed that both implants had good long-term biocompatibility in an ocular immune privileged site for up to 3 years. It is concluded that the anterior chamber of rabbit eyes model is an efficient method for noninvasively determining the immune privileged fissue/biomaterial interactions. (C) 2007 Wiley Periodicals, Inc.
C1 [Lu, Pei-Lin; Lai, Jui-Yang; Hsiue, Ging-Ho] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 33302, Taiwan.
   [Tabata, Yasuhiko] Kyoto Univ, Dept Biomat Field Tissue Engn, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
RP Lai, JY (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
EM jylai@mail.cgu.edu.tw; ghhsiue@che.nthu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
CR Choi TH, 2001, CORNEA, V20, P197, DOI 10.1097/00003226-200103000-00019
   Connon CJ, 2006, AM J OPHTHALMOL, V141, P190, DOI 10.1016/j.ajo.2005.08.027
   Ehlers N, 2004, EXP EYE RES, V78, P543, DOI 10.1016/j.exer.2003.09.017
   Fernandes M, 2005, CORNEA, V24, P643, DOI 10.1097/01.ico.0000151501.80952.c5
   Foster PJ, 2000, OPHTHALMOLOGY, V107, P1816, DOI 10.1016/S0161-6420(00)00343-2
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Fournier E, 2006, BIOMATERIALS, V27, P4963, DOI 10.1016/j.biomaterials.2006.04.045
   Fukunaka Y, 2002, J CONTROL RELEASE, V80, P333, DOI 10.1016/S0168-3659(02)00026-3
   Hashizoe M, 1997, CURR EYE RES, V16, P633, DOI 10.1076/ceyr.16.7.633.5063
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Hsiue GH, 2006, TRANSPLANTATION, V81, P473, DOI 10.1097/01.tp.0000194864.13539.2c
   Hsiue GH, 2006, BIOCONJUGATE CHEM, V17, P781, DOI 10.1021/bi050317u
   Hsiue GH, 2002, J BIOMED MATER RES, V61, P19, DOI 10.1002/jbm.2000
   Hsiue GH, 2002, BIOMATERIALS, V23, P457, DOI 10.1016/S0142-9612(01)00127-2
   Kasper FK, 2006, J BIOMED MATER RES A, V78A, P823, DOI 10.1002/jbm.a.30736
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Liu Y, 2006, BIOMACROMOLECULES, V7, P1819, DOI 10.1021/bm060160o
   Lo CL, 2006, ADV FUNCT MATER, V16, P2309, DOI 10.1002/adfm.200500627
   MELAMED S, 1980, BRIT J OPHTHALMOL, V64, P164, DOI 10.1136/bjo.64.3.164
   Miyagawa S, 2005, TRANSPLANTATION, V80, P1586, DOI 10.1097/01.tp.0000181163.69108.dd
   Nicita G, 2005, UROL INT, V75, P314, DOI 10.1159/000089165
   Okamoto T, 2004, J THORAC CARDIOV SUR, V127, P329, DOI 10.1016/j.jtcvs.2003.08.017
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Sakai S, 2006, J BIOMED MATER RES A, V78A, P394, DOI 10.1002/jbm.a.30676
   SETALA K, 1979, ACTA OPHTHALMOL, V57, P1004
   Sethuraman S, 2006, J BIOMED MATER RES A, V77A, P679, DOI 10.1002/jbm.a.30620
   Shim WS, 2006, BIOMACROMOLECULES, V7, P1935, DOI 10.1021/bm0600567
   Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Tsapanos VS, 2002, J BIOMED MATER RES, V63, P10, DOI 10.1002/jbm.10040
   Uzzo RG, 1999, J UROLOGY, V161, P1344, DOI 10.1016/S0022-5347(01)61681-1
   Ventura L, 2006, PHYS MED BIOL, V51, P3085, DOI 10.1088/0031-9155/51/12/006
   Wang DY, 2003, INVEST OPHTH VIS SCI, V44, P4698, DOI 10.1167/iovs.03-0272
   Watanabe J, 2005, BIOMACROMOLECULES, V6, P1797, DOI 10.1021/bm050138f
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   WILLIAMS D. F., 1987, P BIOCH, P49
   Yasukawa T, 2005, ADV DRUG DELIVER REV, V57, P2033, DOI 10.1016/j.addr.2005.09.005
   YOSHIDA M, 1987, BIOMATERIALS, V8, P124, DOI 10.1016/0142-9612(87)90101-3
   Zhong ZY, 2005, BIOMACROMOLECULES, V6, P3440, DOI 10.1021/bm050505n
NR 41
TC 34
Z9 34
U1 0
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 108
EP 116
DI 10.1002/jbm.a.31619
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500011
PM 17941023
DA 2018-10-20
ER

PT J
AU Kasahara, Y
   Iwasaki, N
   Yamane, S
   Igarashi, T
   Majima, T
   Nonaka, S
   Harada, K
   Nishimura, SI
   Minami, A
AF Kasahara, Yasuhiko
   Iwasaki, Norimasa
   Yamane, Shintaro
   Igarashi, Tatsuya
   Majima, Tokifumi
   Nonaka, Sachiko
   Harada, Kazuo
   Nishimura, Shin-Ichiro
   Minami, Akio
TI Development of mature cartilage constructs using novel three-dimensional
   porous scaffolds for enhanced repair of osteochondral defects
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitosan; cartilage; tissue engineering; hyaluronic acid/hyaluronan;
   animal model
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; FIBROBLAST-GROWTH-FACTOR;
   ARTICULAR-CARTILAGE; II COLLAGEN; TISSUE; TRANSPLANTATION; KNEE;
   REGENERATION; BIOMATERIAL; CULTURE
AB In this study, we successfully developed two types of volume-reduced three-dimensional scaffolds, including cushion- and cylinder-shape scaffolds, fabricated from chitosan-based hyaluronic acid hybrid polymer fibers. Using these scaffolds combined with a bioreactor system, we regenerated histologically and mechanically mature cartilage constructs. The final goal of this study was to clarify the ability of this engineered cartilage construct to induce cartilage repair in osteochondral defects. The mature cartilage constructs regenerated with two types of scaffolds were implanted into 5-mm diameter osteochondral defects in the patellar groove of rabbits. At 12 weeks after implantation, the reparative tissues consisted of hyaline-like cartilage with evidence of stable fusion to adjacent native cartilage and normal reconstitution of subchondral bone. The histological score of these tissues significantly outranked the value of untreated tissue. Biomechanically, compression modulus of reparative tissue at 12 weeks postoperatively was comparative to that of normal articular cartilage. Our results indicate that the implantation of constructs with mature cartilage have potential as a better approach for joint resurfacing. (C) 2007 Wiley Periodicals, Inc.
C1 [Kasahara, Yasuhiko; Iwasaki, Norimasa; Yamane, Shintaro; Igarashi, Tatsuya; Majima, Tokifumi; Minami, Akio] Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   [Kasahara, Yasuhiko; Iwasaki, Norimasa; Igarashi, Tatsuya; Majima, Tokifumi; Nishimura, Shin-Ichiro] Hokkaido Univ, Frontier Res Ctr Post Genom Sci & Technol, Sapporo, Hokkaido, Japan.
   [Nonaka, Sachiko; Harada, Kazuo] Inst Biol Chem, Sapporo, Hokkaido, Japan.
   [Nishimura, Shin-Ichiro] Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Lab Biomacromol Chem, Sapporo, Hokkaido, Japan.
RP Iwasaki, N (reprint author), Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.
EM niwasaki@med.hokudai.ac.jp
RI Iwasaki, Norimasa/D-6448-2012; Majima, Tokifumi/E-2412-2012; Nishimura,
   Shinichiro/F-5277-2011
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   BELL E, 2000, PRINCIPLES TISSUE EN, P35
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1999, CLIN ORTHOP S, V367, P46
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Fu FH, 2005, AM J SPORT MED, V33, P1658, DOI 10.1177/0363546505275148
   Fukuda A, 2005, BIOMATERIALS, V26, P4301, DOI 10.1016/j.biomaterials.2004.11.007
   Funakoshi T, 2005, J BIOMED MATER RES A, V74A, P338, DOI 10.1002/jbm.a.30237
   HANKEMEIER S, 2003, J ORTHOP RES, V21, P132
   Horas U, 2003, J BONE JOINT SURG AM, V85A, P185, DOI 10.2106/00004623-200302000-00001
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Kandel RA, 2006, BIOMATERIALS, V27, P4120, DOI 10.1016/j.biomaterials.2006.03.005
   KASAHARA Y, 2007, J BIOMED MATER RES, V81, P586
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Minas T, 2005, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000171916.40245.5d
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Otsuka Y, 1997, DEV GROWTH DIFFER, V39, P143
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   SHARPIO F, 1993, J BONE JOINT SURG AM, V75, P532
   Toolan BC, 1996, J BIOMED MATER RES, V31, P273, DOI 10.1002/(SICI)1097-4636(199606)31:2<273::AID-JBM15>3.0.CO;2-M
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   YAMANE S, J BIOMED MA IN PRESS
NR 31
TC 23
Z9 24
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 127
EP 136
DI 10.1002/jbm.a.31259
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500013
PM 17957716
DA 2018-10-20
ER

PT J
AU Lindholm-Sethson, B
   Ardlin, BI
AF Lindholm-Sethson, B.
   Ardlin, B. I.
TI Effects of pH and fluoride concentration on the corrosion of titanium
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium; dental materials; fluoride; electrochemical techniques; pH;
   brushing
ID ELECTROCHEMICAL-BEHAVIOR; IMPEDANCE SPECTROSCOPY; PURE TITANIUM; AC
   IMPEDANCE; RESISTANCE; ALLOYS; MEDIA
AB The aim of this investigation was to confirm and summarize the corrosion behavior of titanium in saline solution at different pH and fluoride concentration, and to characterize the surface films and the stability of a passive and aged titanium surface using open circuit potential measurements, electrochemical impedance spectroscopy, and anodic polarization curves. The results from the electrochemical measurements were related to titanium released after 2-min brushing with saline solutions with different pH and fluoride concentration, that is, simulating tooth brushing with fluoride containing prophylactic substances. Titanium was analyzed using atomic adsorption spectrophotometry. The pH in the saline solution was varied between 4 and 7 with additions of sodium fluoride up to 1.0 wt %. The presence of fluoride in solution was unfavorable for the stability of titanium and led to corrosion and the release of titanium especially at low pH. The combination of low pH and presence of fluoride ions in solution destroyed a passive film on the titanium surface even after aging for 170 h in neutral saline solution. The results do not necessarily imply the occurrence of biological soft tissue related effects even if a physical contact between titanium and the surrounding milieu is prevalent. To provide a general understanding of electrochemical techniques in biomaterial research, much effort was put in the qualitative description of the results, with the intention to provide a broader understanding of especially the impedance method to other researchers. (C) 2007 Wiley Periodicals, Inc.
C1 [Lindholm-Sethson, B.] Umea Univ, Dept Chem Biophys Chem, SE-90187 Umea, Sweden.
   [Lindholm-Sethson, B.] Umea Univ, Ctr Biomed Engn & Phys, SE-90187 Umea, Sweden.
   [Ardlin, B. I.] Umea Univ, Dept Odontol, Dent Mat Sci & Dent Technician Program, SE-90187 Umea, Sweden.
RP Lindholm-Sethson, B (reprint author), Umea Univ, Dept Chem Biophys Chem, SE-90187 Umea, Sweden.
EM britta.sethson@chem.umu.se
CR ARCHER WI, 1980, ELECTROCHEMISTRY, V7, P157
   Armstrong R. D., 1978, ELECTROCHEM-SPR, V6, P98
   Blackwood DJ, 2003, CORROS REV, V21, P97
   BOERE G, 1995, J APPL BIOMATER, V6, P283, DOI 10.1002/jab.770060409
   de Mele MFL, 2000, J APPL ELECTROCHEM, V30, P95
   DONACHIE MJ, 1988, TITANIUM TECHNICAL G, pCH12
   Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659
   Fovet Y, 2001, TALANTA, V53, P1053, DOI 10.1016/S0039-9140(00)00592-0
   Fraker A. C., 1983, ASTM STP, V786, P206
   Huang HH, 2002, ELECTROCHIM ACTA, V47, P2311, DOI 10.1016/S0013-4686(02)00079-8
   Huang HH, 2002, BIOMATERIALS, V23, P59, DOI 10.1016/S0142-9612(01)00079-5
   Ibris N, 2002, J ELECTROANAL CHEM, V526, P53, DOI 10.1016/S0022-0728(02)00814-8
   KEDDAM M, 1984, J ELECTROCHEM SOC, V131, P2016, DOI 10.1149/1.2116010
   Lemons J E, 1992, Implant Dent, V1, P107, DOI 10.1097/00008505-199205000-00002
   LUNDE L, 1985, IFEKRE85004, P4
   Mabilleau G, 2006, ACTA BIOMATER, V2, P121, DOI 10.1016/j.actbio.2005.09.004
   MACDONALD JR, 1992, ANN BIOMED ENG, V20, P289, DOI 10.1007/BF02368532
   Nakagawa M, 2002, DENT MATER J, V21, P83, DOI 10.4012/dmj.21.83
   Nakagawa M, 1999, J DENT RES, V78, P1568, DOI 10.1177/00220345990780091201
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Probster L, 1992, INT J ORAL MAXILLOF, V7, P390
   Reclaru L, 1998, BIOMATERIALS, V19, P85, DOI 10.1016/S0142-9612(97)00179-8
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   SHARP M, 1989, J ELECTROANAL CHEM, V274, P35, DOI 10.1016/0022-0728(89)87028-7
   Siirila H S, 1991, Int J Oral Maxillofac Implants, V6, P50
   Strub JR, 2006, J AM DENT ASSOC, V137, P1289, DOI 10.14219/jada.archive.2006.0389
   ToumelinChemla F, 1996, J DENT, V24, P109, DOI 10.1016/0300-5712(95)00033-X
   Tschernitschek H, 2005, QUINTESSENCE INT, V36, P523
NR 28
TC 24
Z9 25
U1 3
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 149
EP 159
DI 10.1002/jbm.a.31415
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500015
PM 17957718
DA 2018-10-20
ER

PT J
AU Wang, Y
   Zhang, LH
   Hu, M
   Liu, HC
   Wen, WS
   Xiao, HX
   Niu, Y
AF Wang, Yan
   Zhang, Lihai
   Hu, Min
   Liu, Hongchen
   Wen, Weisheng
   Xiao, Hongxi
   Niu, Yu
TI Synthesis and characterization of collagen-chitosan-hydroxyapatite
   artificial bone matrix
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen; hydroxyapatite; chitosan; artificial bone matrix
ID CHONDROITIN SULFATE; TISSUE; COMPOSITE; BIOMATERIAL; SCAFFOLDS
AB In this study, anew artificial bone matrix was constructed with collagen and Ca(5)(PO(4))(3)OH (hydroxyapatite/HA) which are the main components of natural bone. To improve the property of the artificial bone matrix, chitosan (CS), a kind of positive charged polysaccharide, was crosslinked into the scaffolds. Solid-liquid phase separation method was used to shape 3D porous structure benefited for cells growing into. The artificial bone matrix was investigated by transmission electron microscopy, scanning electron microscopy, and electron spectroscopy for chemical analysis, etc. for structures and characteristics. And its ability of bone repair was investigated by orthotope bone defect reparation in vivo. The results showed that the artificial bone matrix was a porous scaffold with three-dimension interconnected fiber microstructure. HA particles were dispersed evenly among collagen fiber and CS was modified on the surface of collagen fiber. It was indicated that this artificial bone matrix could be used as a bone substitute with outstanding properties. (C) 2007 Wiley Periodicals, Inc.
C1 [Hu, Min; Liu, Hongchen; Wen, Weisheng; Xiao, Hongxi; Niu, Yu] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China.
   [Wang, Yan; Zhang, Lihai] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100853, Peoples R China.
RP Hu, M (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China.
EM zhanglihai@gmail.com
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   [Anonymous], 2003, MAT SCI
   Barbani N, 1999, J APPL POLYM SCI, V72, P971, DOI 10.1002/(SICI)1097-4628(19990516)72:7<971::AID-APP13>3.0.CO;2-N
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Kersteen EA, 2001, BIOPOLYMERS, V59, P24, DOI 10.1002/1097-0282(200107)59:1<24::AID-BIP1002>3.0.CO;2-N
   Knott L, 1997, BIOCHEM J, V322, P535, DOI 10.1042/bj3220535
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282
   Liu LR, 2003, ARTIF CELL BLOOD SUB, V31, P435, DOI 10.1081/BIO-120025414
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Ohta M, 2001, RADIAT PROT DOSIM, V94, P385, DOI 10.1093/oxfordjournals.rpd.a006515
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   SENA LA, 2003, ACTA MICROSC, V12, P45
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Yang HY, 2001, J MATER SCI TECHNOL, V17, P495
   Zhang LH, 2005, ARTIF CELL BLOOD SUB, V33, P215, DOI 10.1081/BIO-200055912
   Zhang LH, 2002, ARTIF CELL BLOOD SUB, V30, P319, DOI 10.1081/BIO-120006122
   Zhang QQ, 1997, J MATER SCI TECHNOL, V13, P179
NR 23
TC 25
Z9 27
U1 2
U2 25
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 244
EP 252
DI 10.1002/jbm.a.31758
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500024
PM 18080313
DA 2018-10-20
ER

PT J
AU Jones, JA
   Qin, LA
   Meyerson, H
   Kwon, IK
   Matsuda, T
   Anderson, JM
AF Jones, Jacqueline A.
   Qin, L. Abby
   Meyerson, Howard
   Kwon, Il Keun
   Matsuda, Takehisa
   Anderson, James M.
TI Instability of self-assembled monolayers as a model material system for
   macrophage/FBGC cellular behavior
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE self-assembled monolayers; instability; macrophage; foreign body giant
   cell; contact angles
ID BIOMATERIAL SURFACE-CHEMISTRY; IN-VIVO; MICROPATTERNED SURFACES;
   ALKANETHIOL MONOLAYERS; ADHERENT MACROPHAGES; ALBUMIN ADSORPTION;
   PROTEIN ADSORPTION; SOFT LITHOGRAPHY; INTEGRIN BINDING; GOLD SURFACES
AB Novel self-assembled monolayers (SAMs) designed to present homogenous surface chemistries were utilized to further investigate the material surface chemistry dependent macrophage and foreign-body giant cell (FBGC) behaviors, including macrophage adhesion, fusion, and apoptosis. Contact angle analysis revealed instabilities in the -CH3 and -COOH terminated SAM surfaces upon incubation in serum-free media (SFM) at 37 degrees C or under dry, room temperature conditions. Further analysis indicated that the -CH3 terminated SAM surface degraded rapidly within 2 h and loss of sufficient SAM units to be comparable to the gold (Au) control surface, within 24 h of incubation in SFM at 37 degrees C. After 5 days of incubation in SFM at 37 degrees C, the contact angles for the -COOH terminated SAM surfaces increased markedly. AFM analysis confirmed the desorption of -CH3 terminated SAM molecules from the surface with increased roughness and marked appearance of peaks and valleys within 2 h. A decrease in the thickness of the -COOH terminated SAM surface also suggests molecular desorption over time. No significant changes in contact angle or AFM analyses were observed on the -OH terminated SAM surfaces. Cellular adhesion decreased more rapidly on the Au control and -CH3 terminated SAM surfaces in comparison to the other surfaces. However by day 10, cellular adhesion, fusion, and apoptosis were comparable on all SAM surfaces and the Au control. These studies suggest that SAM surfaces may not be suitable for long-term studies where material dependent properties are investigated. (c) 2008 Wiley Periodicals, Inc.
C1 [Jones, Jacqueline A.; Qin, L. Abby; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Meyerson, Howard; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Meyerson, Howard] Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA.
   [Kwon, Il Keun] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA.
   [Kwon, Il Keun] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   [Matsuda, Takehisa] Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU NIBIB NIH HHS [EB-000275, R01 EB000275, R37 EB000275]
CR Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Datwani SS, 2004, LANGMUIR, V20, P4970, DOI 10.1021/la030140x
   Flynn NT, 2003, LANGMUIR, V19, P10909, DOI 10.1021/la035331e
   Garg N, 2002, LANGMUIR, V18, P2717, DOI 10.1021/la0115278
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102
   Jiang XY, 2004, ANAL CHEM, V76, P6116, DOI 10.1021/ac049152t
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kondoh H, 1999, J CHEM PHYS, V111, P1175, DOI 10.1063/1.479302
   Lahiri J, 1999, ANAL CHEM, V71, P777, DOI 10.1021/ac980959t
   Latour RA, 2002, J BIOMED MATER RES, V60, P564, DOI 10.1002/jbm.10052
   Li LY, 2003, LANGMUIR, V19, P3266, DOI 10.1021/la026323l
   Li LY, 2003, LANGMUIR, V19, P2974, DOI 10.1021/la0262957
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Martin MCL, 2003, J MATER SCI-MATER M, V14, P945, DOI 10.1023/A:1026394431100
   Martins MCL, 2003, BIOMATERIALS, V24, P3697, DOI 10.1016/S0142-9612(03)00244-8
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   Nelson CM, 2003, LANGMUIR, V19, P1493, DOI 10.1021/la026178b
   Noh J, 2001, LANGMUIR, V17, P7280, DOI 10.1021/la0100441
   Prathima N, 2005, LANGMUIR, V21, P2364, DOI 10.1021/la048654z
   Sayre CN, 1997, LANGMUIR, V13, P714, DOI 10.1021/la960420v
   Schoenfisch MH, 1998, J AM CHEM SOC, V120, P4502, DOI 10.1021/ja974301t
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Shyue JJ, 2004, LANGMUIR, V20, P8693, DOI 10.1021/la049247q
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   Slaughter GE, 2004, LANGMUIR, V20, P7189, DOI 10.1021/la049492s
   TANAHASKI M, 1997, J BIOMED MATER RES, V34, P314
   Wang AF, 2007, J BIOMED MATER RES A, V81A, P363, DOI 10.1002/jbm.a.31034
   Wang H., 2005, LANGMUIR, V21, P2634
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Yang GH, 2004, LANGMUIR, V20, P3995, DOI 10.1021/la0499160
   Zhang F, 2001, J BIOMAT SCI-POLYM E, V12, P515, DOI 10.1163/156856201300194252
   Zhang YM, 1998, J AM CHEM SOC, V120, P2654, DOI 10.1021/ja9714853
NR 48
TC 11
Z9 11
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2008
VL 86A
IS 1
BP 261
EP 268
DI 10.1002/jbm.a.31660
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309KO
UT WOS:000256459500026
PM 18412136
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ma, W
   Wei, JH
   Li, YZ
   Wang, XM
   Shi, HY
   Tsutsumi, S
   Li, DH
AF Ma, Wei
   Wei, Jian-Hua
   Li, Ying-Zhe
   Wang, Xin-Mu
   Shi, Hui-Ying
   Tsutsumi, Sadami
   Li, De-Hua
TI Histological evaluation and surface componential analysis of modified
   micro-arc oxidation-treated titanium implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE titanium (alloys); surface modification; biocompatibility/hard tissue;
   osteogenesis
ID ANODIC OXIDE-FILMS; BONE RESPONSE; IN-VITRO; CA; COATINGS; BIOMATERIAL;
   BIOACTIVITY; INTERFACE; METAL
AB The objective of this study is to investigate soft tissue and bone tissue reaction to titanium implants treated by a modified micro arc oxidation (MAO) technique, and analyze the surface components and implant-bone contact ratio by animal experiments to evaluate the osseointegration condition of implants with this modified MAO surface. MAO titanium plates were installed subcutaneously in rabbits. Tissue reaction was evaluated by HE sections. MAO titanium implants designed for endosseous examination were installed in Beagles' femurs. Bone tissue surrounding implants was analyzed histologically. Surfaces of retrieved implants were observed and examined by SEM and EDX. All procedures were performed under the control of untreated pure titanium implants. Thin homogeneous fibrous envelope could be found without apparent inflammation cells infiltration around the subcutaneously imbedded MAO titanium plates, which was almost same as control group. Fast osteoid deposition comprising high content of calcium, phosphor, carbon, and nitrogen elements was found on the retrieved MAO implant surfaces, while comparatively less amount of carbon and nitrogen elements were found on the retrieved implants of control group. Matured bone tissue comprising bone trabeculae and Haversian canals appeared in 8 weeks, while it took 12 weeks needed to form matured bone tissue in control group. In conclusion, MAO titanium materials shows good biocompatibility and calcium phosphate inducement capability in vivo and could accelerate bone tissue growth and shorten the osseointegration time. (C) 2007 Wiley Periodicals, Inc.
C1 [Wei, Jian-Hua; Wang, Xin-Mu] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Peoples R China.
   [Ma, Wei; Li, De-Hua] Fourth Mil Med Univ, Sch Stomatol, Dept Dent Implant, Xian 710032, Peoples R China.
   [Li, Ying-Zhe; Tsutsumi, Sadami] Kyoto Univ, Inst Frontier Med Sci, Dept Med Simulat Engn, Kyoto 6068507, Japan.
   [Shi, Hui-Ying] Xian Univ Technol, Sch Mat Sci & Engn, Xian 710048, Peoples R China.
RP Wei, JH (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Peoples R China.
EM weiyoyo@fmmu.edu.cn
CR Albrektsson T, 1998, J ORAL MAXIL SURG, V56, P1312, DOI 10.1016/S0278-2391(98)90616-4
   ALBREKTSSON T, 1987, J PROSTHET DENT, V57, P597, DOI 10.1016/0022-3913(87)90344-1
   CHAE JC, 1992, J BIOMED MATER RES, V26, P93, DOI 10.1002/jbm.820260109
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   Hamadouche M, 2001, J BIOMED MATER RES, V54, P560, DOI 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.3.CO;2-A
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   IKARASHI Y, 1992, J BIOMED MATER RES, V26, P339, DOI 10.1002/jbm.820260306
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1459, DOI 10.1002/jbm.820291118
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Ong J L, 2000, Crit Rev Biomed Eng, V28, P667
   ONISHI H, 2000, J BIOMED MATER RES, V51, P37
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   STEFLIK DE, 1994, J ORAL IMPLANTOL, V20, P198
   Suh JY, 2003, BIOMATERIALS, V24, P347, DOI 10.1016/S0142-9612(02)00325-3
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Sul YT, 2001, J MATER SCI-MATER M, V12, P1025, DOI 10.1023/A:1012837905910
   TISEL CL, 1994, J BONE JOINT SURG AM, V76, P139
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 25
TC 24
Z9 32
U1 1
U2 21
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2008
VL 86B
IS 1
BP 162
EP 169
DI 10.1002/jbm.b.31002
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315PJ
UT WOS:000256891600020
PM 18098194
DA 2018-10-20
ER

PT J
AU Sicca, CM
   Corotti, MV
   Sgarbosa, SHPV
   Cestari, TM
   Cavalcanti, MGP
   Ferreira, PM
   Taga, R
   Granjeiro, JM
AF Sicca, Cristina Miguel
   Corotti, Mauro Vinicius
   Pereira Vergili Sgarbosa, Silvia Helena
   Cestari, Tania Mary
   Paraiso Cavalcanti, Marcelo Gusmao
   Ferreira, Paulo Martins
   Taga, Rumio
   Granjeiro, Jose Mauro
TI Comparative histomorphometric and tomographic analysis of maxillary
   sinus floor augmentation in rabbits using autografts and xenografts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE sinus augmentation; xenograft; autogenous bone; maxillary sinus; rabbits
ID DEPROTEINIZED BONE PARTICLES; ANORGANIC BOVINE BONE; AUTOGENOUS BONE;
   ENDOSSEOUS IMPLANTS; ATROPHIC MAXILLA; BIO-OSS; GRAFTS; HUMANS;
   HYDROXYAPATITE; SUBSTITUTE
AB Our goal was to evaluate bone neoformation promoted by a bovine xenograft composite (XC) compared with autogenous graft for maxillary sinus augmentation in a rabbit model. The left maxillary sinus of 18 male rabbits was filled with 200 mg of cortical and cancellous autogenous bone and the right sinus was filled with 200 mg of a composite comprised organic and inorganic bovine matrices, pool of bBMPs and collagen. Postoperative implant intervals of 2, 4, and 8 weeks were analyzed. Differences in the bone optical density among the groups and experimental periods were evaluated by computed tomography analysis. The tissue response was evaluated by histomorphometric analysis of the newly formed bone, connective tissue and/or granulation tissue, residual material, and bone marrow. The tomographic analyses showed a maximum optical density in the 4-week period for both groups. Histologically, an inflammatory infiltrate was observed at 2 weeks in the XC group but exclusively around the organic particles of the biomaterial. Regarding to the amount of newly formed bone, no statistical differences (p > 0.05) were observed among the two treatments throughout the implant intervals. However, by the end of the 8 weeks, the quantity of bone marrow was two times greater (p < 0.05) in the control group than in the XC group. In conclusion, the xenograft composite promotes formation of new bone in a similar fashion to autogenous bone and could therefore be considered a biomaterial with potential applications as a bone substitute in maxillary sinus floor augmentation. (C) 2007 Wiley Periodicals, Inc.
C1 [Granjeiro, Jose Mauro] Univ Fed Fluminense, Inst Biol, Dept Cell & Mol Biol, Niteroi, RJ, Brazil.
   [Ferreira, Paulo Martins] Univ Sao Paulo, Bauru Dent Sch, Dept Prosthet Rehabil, BR-05508 Sao Paulo, Brazil.
   [Paraiso Cavalcanti, Marcelo Gusmao] Univ Iowa, Coll Med, Dept Radiol, Iowa City, IA 52242 USA.
   [Paraiso Cavalcanti, Marcelo Gusmao] Univ Sao Paulo, Sao Paulo Dent Sch, Dept Stomatol, FOUSP, BR-05508 Sao Paulo, Brazil.
   [Sicca, Cristina Miguel; Corotti, Mauro Vinicius; Pereira Vergili Sgarbosa, Silvia Helena; Cestari, Tania Mary; Taga, Rumio] Univ Sao Paulo, Bauru Dent Sch, Dept Biol Sci, BR-05508 Sao Paulo, Brazil.
RP Granjeiro, JM (reprint author), Univ Fed Fluminense, Inst Biol, Dept Cell & Mol Biol, Niteroi, RJ, Brazil.
EM jmgranjeiro@vm.uff.br
RI Granjeiro, Jose/D-8289-2012; Cestari, Tania/E-7060-2012; Taga,
   Rumio/E-5794-2012
OI Granjeiro, Jose/0000-0002-8027-8293; 
CR ASAI S, 2002, CLIN ORAL IMPLAN RES, V13, P420
   BECKER J, 1992, INT J ORAL MAX SURG, V21, P243, DOI 10.1016/S0901-5027(05)80229-2
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Boeck-Neto R, 2002, J PERIODONTOL, V73, P266, DOI 10.1902/jop.2002.73.3.266
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   FREDERIKSEN NL, 2003, ORAL RADIOLOGY PRINC, P250
   Froum S J, 1998, Int J Periodontics Restorative Dent, V18, P528
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Hallman M, 2004, INT J ORAL MAX IMPL, V19, P222
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hanisch O, 1999, INT J ORAL MAX IMPL, V14, P329
   HASS R, 2002, CLIN ORAL IMPLAN RES, V13, P396
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Indovina A, 2002, J ORAL MAXIL SURG, V60, P53, DOI 10.1053/joms.2002.0000
   Johansson B, 2001, DENTOMAXILLOFAC RAD, V30, P157, DOI 10.1038/sj.dmfr.4600601
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Joshi A, 2004, BRIT DENT J, V196, P215, DOI 10.1038/sj.bdj.4810987
   KirkerHead CA, 1997, INT J ORAL MAX IMPL, V12, P403
   LeGeros R. Z., 1995, ENCY HDB BIOMATERI A, V2, P1429
   Luna L. G., 1968, MANUAL HISTOLOGIC ST, P36
   MORSE A, 1945, J DENT RES, V24, P143, DOI 10.1177/00220345450240030501
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P514, DOI 10.1034/j.1600-0501.2002.130511.x
   OLIVARES J, 1999, PSICOL CONDUCT, V7, P85
   OLIVEIRA RC, 2003, REV BRAS ORTOP, V38, P551
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   PEETZ M, 1997, OSSEOUS RECONSTRUCTI, P87
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P503, DOI 10.1034/j.1600-0501.2001.120511.x
   Salata Luiz A, 2002, Clin Implant Dent Relat Res, V4, P27, DOI 10.1111/j.1708-8208.2002.tb00148.x
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schultze-Mosgau S, 2001, BRIT J ORAL MAX SURG, V39, P439, DOI 10.1054/bjom.2001.0617
   Sicca Cm, 2000, REV FAC ODONTOL BAUR, V8, P1
   TAGA R, 1997, REV BRAS IMPLANT, V3, P13
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   Ueda M, 2001, ARTIF ORGANS, V25, P164, DOI 10.1046/j.1525-1594.2001.025003164.x
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556
   van den Bergh JPA, 2000, J CLIN PERIODONTOL, V27, P627, DOI 10.1034/j.1600-051x.2000.027009627.x
   Wada K, 2001, Int J Periodontics Restorative Dent, V21, P252
   Watanabe K, 1999, ORAL SURG ORAL MED O, V88, P26, DOI 10.1016/S1079-2104(99)70189-7
   Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X
   Xu H, 2005, BRIT J ORAL MAX SURG, V43, P40, DOI 10.1016/j.bjoms.2004.10.004
   Xu H, 2004, CLIN ORAL IMPLAN RES, V15, P126, DOI 10.1111/j.1600-0501.2004.01003.x
   Xu H, 2003, CLIN ORAL IMPLAN RES, V14, P548, DOI 10.1034/j.1600-0501.2003.00933.x
   Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 48
TC 7
Z9 8
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2008
VL 86B
IS 1
BP 188
EP 196
DI 10.1002/jbm.b.31005
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315PJ
UT WOS:000256891600023
PM 18161780
DA 2018-10-20
ER

PT J
AU Ghosh, SK
   Nandi, SK
   Kundu, B
   Datta, S
   De, DK
   Roy, SK
   Basu, D
AF Ghosh, Samir K.
   Nandi, Samit K.
   Kundu, Biswanath
   Datta, Someswar
   De, Dipak K.
   Roy, Sujit K.
   Basu, Debabrata
TI In vivo response of porous hydroxyapatite and beta-tricalcium phosphate
   prepared by aqueous solution combustion method and comparison with
   bioglass scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE solution combustion; calcium phosphate; bioglass; push-out test;
   vascularization
ID SCANNING-ELECTRON-MICROSCOPY; SEGMENTAL DEFECTS; BONE TISSUE; CERAMICS;
   MECHANISM; GLASS; OSTEOINDUCTION; RECONSTRUCTION; SUBSTITUTES; POROSITY
AB Pure hydroxyapatite (HAp) and a biphasic calcium phosphate [containing 90% of beta-tri-calcium phosphate (beta-TCP) and 10% HAp] were tailored through an aqueous solution combustion synthesis. Porous struts were prepared using all the powders along with bioglass, a known bioactive material, and subsequently characterized. Sterilized struts were implanted to the lateral side of radius bone of 24 black Bengal goats of either sex, in which a blank hole was left unfilled in a group of six specimens to act as control. The bone formation response of the three implanting materials in vivo has been studied using scanning electron microscope and histological analysis in contrast with positive controls. Push-out tests were used to assess the mechanical strength at the bone-biomaterial interface. It was observed that interfacial response was strongly dependent on combinations of different physical and chemical parameters. The surface of beta-TCP exhibited similar characteristics of bone and was distinct from those of intervening apatite layer of bioglass. Lower bone ingrowth and reduced strength was observed with HAp compared to beta-TCP/bioglass-based implants. Bone formation response of the Ca-P material varied according to the composition of the implanting material, which could be tailored through this novel synthesis. (C) 2007 Wiley Periodicals, Inc.
C1 [Ghosh, Samir K.; Kundu, Biswanath; Datta, Someswar; Roy, Sujit K.; Basu, Debabrata] Cent Glass & Ceram Res Inst, Kolkata, India.
   [Nandi, Samit K.; De, Dipak K.] W Bengal Univ Anim & Fishery Sci, Kolkata, India.
RP Kundu, B (reprint author), Cent Glass & Ceram Res Inst, Kolkata, India.
EM biswa_kundu@rediffmail.com
CR ALEXANDER H, 1987, CRIT REV BIOCOMPAT, V4, P43
   Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   Asada M., 1987, Yogyo-Kyokai-Shi, V95, P703
   BASSETT CAL, 1962, J BONE JOINT SURG AM, V44, P842, DOI 10.2106/00004623-196244050-00002
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   BOLANDER ME, 1986, J BONE JOINT SURG AM, V68A, P1264, DOI 10.2106/00004623-198668080-00018
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   BRANEMARK PI, 1983, BIOMATERIALS, V4, P25, DOI 10.1016/0142-9612(83)90065-0
   Chang CS, 1999, J BIOMED MATER RES, V48, P411, DOI 10.1002/(SICI)1097-4636(1999)48:4<411::AID-JBM3>3.0.CO;2-H
   Cutright D E, 1972, Oral Surg Oral Med Oral Pathol, V33, P850, DOI 10.1016/0030-4220(72)90457-4
   CZITROM AA, 1992, ALLOGRAFTS ORTHOPAED, P147
   De Aza PN, 2003, BIOMATERIALS, V24, P1437, DOI 10.1016/S0142-9612(02)00530-6
   ELLINGER RF, 1986, INT J PERIODONT REST, V3, P223
   FERREIRA VM, 1992, FERROELECTRICS, V133, P127, DOI 10.1080/00150199208217987
   Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2
   FUJITA Y, 1991, J BIOMED MATER RES, V25, P991, DOI 10.1002/jbm.820250806
   Ghosh SK, 2004, T INDIAN CERAM SOC, V63, P27, DOI 10.1080/0371750X.2004.11012125
   Gil-Albarova J, 2004, BIOMATERIALS, V25, P4639, DOI 10.1016/j.biomaterials.2003.12.009
   GROSS U, 1988, CRC CRIT R BIOCOMP, V4, P25
   HATTORI T, 1988, ADV CERAM MATER, V3, P426
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   JAIN SR, 1981, COMBUST FLAME, V40, P71, DOI 10.1016/0010-2180(81)90111-5
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   KINGSLEY JJ, 1990, J MATER SCI, V25, P1305
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KLUG HP, 1974, XRAY DIFFRACTION PRO, P364
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   LEGEROS RZ, 1990, CRC HDB BIOACTIVE CE, P17
   Lin TC, 1997, J BIOMED MATER RES, V36, P91, DOI 10.1002/(SICI)1097-4636(199707)36:1<91::AID-JBM11>3.0.CO;2-M
   Meeder P J, 1994, Injury, V25 Suppl 1, pA2
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   OSAKA A, 1991, J MATER SCI-MATER M, V2, P51, DOI 10.1007/BF00701687
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   SHIMAZAKI K, 1985, J ORTHOPAED RES, V3, P301, DOI 10.1002/jor.1100030306
   Singh S, 2000, INDIAN J ANIM SCI, V70, P276
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 42
TC 78
Z9 80
U1 0
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2008
VL 86B
IS 1
BP 217
EP 227
DI 10.1002/jbm.b.31009
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315PJ
UT WOS:000256891600026
PM 18161811
DA 2018-10-20
ER

PT J
AU Macario, DK
   Entersz, I
   Bolikal, D
   Kohn, J
   Nackman, GB
AF Macario, Danielle K.
   Entersz, Ildiko
   Bolikal, Durgadas
   Kohn, Joachim
   Nackman, Gary B.
TI Iodine inhibits antiadhesive effect of PEG: Implications for tissue
   engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell-material interactions; in vitro; polymer; vascular; protein
   adsorption
ID CORONARY-ARTERY DISEASE; IN-STENT RESTENOSIS; PROTEIN ADSORPTION;
   DEGRADABLE BIOMATERIALS; BALLOON ANGIOPLASTY; MULTICENTER TRIAL;
   CELL-ADHESION; SURFACES; POLYETHYLENE; IMPLANTATION
AB Background: The success of a biomaterial implant may be affected by the surface chemistry's impact on protein adsorption. We have developed a series of poly(ethylene glycol) (PEG) containing, tyrosine-derived polycarbonates, which have been rendered radio-opaque by the iodination of tyrosine units in the copolymer backbone for use in resorbable biomedical implants including vascular stents and grafts. We tested the hypothesis that protein adsorption along with seeding, growth, and migration of human aortic smooth muscle cells (SMC) and human aortic endothelial cells (EC) will be modified by the presence of iodine and PEG within the polymer composition. Methods: Thin films of these polymers were prepared for the protein-material and cell-material interaction studies. Dot blot, SDS-PAGE, and XPS were used to evaluate relative protein adsorption. Cell adhesion and growth studies were performed using an NITS assay. Cell migration was evaluated using an injury model. Results: The presence of PEG attenuated protein adsorption, cell adhesion, and growth. With the subsequent incorporation of iodine, protein adsorption markedly increased while the antiadhesive effect of PEG was counteracted by iodine for EC and SMC adhesion and SMC growth. Conclusion: Iodine incorporation into the polymer resulted in increased protein adsorption thus counteracting the effect of PEG. (C) 2007 Wiley Periodicals, Inc.
C1 [Macario, Danielle K.; Entersz, Ildiko; Nackman, Gary B.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Vasc Surg, New Brunswick, NJ 08901 USA.
   [Bolikal, Durgadas; Kohn, Joachim] Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA.
   [Bolikal, Durgadas; Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
RP Nackman, GB (reprint author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Vasc Surg, New Brunswick, NJ 08901 USA.
EM gary.nackman@umdnj.edu
FU NIBIB NIH HHS [EB003057]
CR Benzina A, 1996, J BIOMED MATER RES, V32, P459, DOI 10.1002/(SICI)1097-4636(199611)32:3<459::AID-JBM20>3.0.CO;2-A
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Garza L, 2002, CURR OPIN CARDIOL, V17, P518, DOI 10.1097/01.HCO.0000024183.40973.4E
   Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6
   HOPER KA, 1995, J BIOACT COMPAT POLY, V10, P327
   JAKOBSEN RJ, 1978, ARTIF ORGANS, V2, P183, DOI 10.1111/j.1525-1594.1978.tb03449.x
   LARSEN AA, 1956, J AM CHEM SOC, V78, P3210, DOI 10.1021/ja01594a066
   Lazos D, 2005, LANGMUIR, V21, P8774, DOI 10.1021/la051049r
   Lowe HC, 2002, J AM COLL CARDIOL, V39, P183, DOI 10.1016/S0735-1097(01)01742-9
   Martin EC, 1995, J VASC INTERV RADIOL, V6, P843, DOI 10.1016/S1051-0443(95)71198-8
   Muathen H.A., 1994, J CHEM RES SYNOP, V11, P405
   PALMAZ JC, 1992, CARDIOVASC INTER RAD, V15, P291, DOI 10.1007/BF02733953
   Popat KC, 2004, LANGMUIR, V20, P8035, DOI 10.1021/la049075x
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   SILVER JH, 1994, BIOMATERIALS, V15, P695, DOI 10.1016/0142-9612(94)90168-6
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Wagner MS, 2003, BIOMATERIALS, V24, P1897, DOI 10.1016/S0142-9612(02)00612-9
   Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Yu C, 1999, BIOMATERIALS, V20, P253, DOI 10.1016/S0142-9612(98)00169-0
NR 24
TC 6
Z9 6
U1 1
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2008
VL 86B
IS 1
BP 237
EP 244
DI 10.1002/jbm.b.31011
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315PJ
UT WOS:000256891600028
PM 18161808
DA 2018-10-20
ER

PT J
AU Huang, TH
   Chang, FL
   Lin, SC
   Liu, SH
   Hsieh, SS
   Yang, RS
AF Huang, Tsang-Hai
   Chang, Feng-Ling
   Lin, Shang-Chih
   Liu, Shing-Hwa
   Hsieh, Sandy S.
   Yang, Rong-Sen
TI Endurance treadmill running training benefits the biomaterial quality of
   bone in growing male Wistar rats
SO JOURNAL OF BONE AND MINERAL METABOLISM
LA English
DT Article
DE treadmill running; biomechanics; intermittent endurance; continuous
   endurance; bone mineral density
ID MINERAL DENSITY; GROWTH-HORMONE; MECHANICAL-PROPERTIES; VOLUNTARY
   EXERCISE; CORTICAL BONE; F344 RATS; STRENGTH; MASS; COLLAGEN; TURNOVER
AB This study investigated the effects of endurance running training on the bones of growing rats. Thirty-two male Wistar rats (7 weeks old) were assigned to a sedentary control group (CON, n = 10), a continuous endurance running group (CEN, n = 10), or an intermittent endurance running group (IEN, n = 12). After an 8-week training period, both exercise groups had significantly less body weight (BW) gain but higher aerobic capacity, shown by increased muscle citrate synthase (CS) activity. Bone area (BA), areal bone mineral density (aBMD), and bone mineral content (BMC) were measured by dual-energy Xray absorptiometry (DXA) in the total femur and sections of femora. Except for showing a significantly higher aBMD in total femora, the CON group was only slightly and nonsignificantly higher in other DXA measurements. In tissue weight measurements, the CON group showed a nonsignificantly higher tissue dry weight (P = 0.146), but a significantly lower tissue water content ratio (WCR, %) as compared to the exercise group. Despite having nonsignificantly lower long bone cross-sectional parameters, both exercise groups showed significantly better biomaterial properties, as measured by a three-point bending test. In extrinsic analysis, femora of the two exercise groups showed no difference in bending load and stiffness, but were significantly higher in post-yield bending energy and total ultimate bending energy (P < 0.05). Similar phenomena were revealed in tissue-level measurements; the CEN and IEN groups were significantly higher in ultimate toughness and post-yield toughness (P < 0.05). Higher post-yield energy shown by two exercise groups implied a change in bone matrix organization. In conclusion, this study demonstrated that two endurance treadmill training modes benefit bone, with subjects showing better tissue biomaterial properties without significantly increasing aBMD, BMC, or bone dimension. Further study would be valuable to investigate the effects of endurance running on other components of bone, such as organization of bone matrix and its relationship with bone biomaterial properties.
C1 [Yang, Rong-Sen] Natl Taiwan Univ & Hosp, Dept Orthopaed, Taipei 100, Taiwan.
   [Huang, Tsang-Hai] Natl Cheng King Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan, Taiwan.
   [Huang, Tsang-Hai; Chang, Feng-Ling] Natl Taiwan Normal Univ, Dept Phys Educ, Taipei, Taiwan.
   [Lin, Shang-Chih] Natl Cent Univ, Dept Mech Engn, Tao Yuan, Taiwan.
   [Liu, Shing-Hwa] Natl Taiwan Univ, Inst Toxicol, Taipei 10764, Taiwan.
   [Hsieh, Sandy S.] Natl Taiwan Normal Univ, Grad Inst Exercise & Sport Sci, Taipei, Taiwan.
RP Yang, RS (reprint author), Natl Taiwan Univ & Hosp, Dept Orthopaed, 7 Chung Shan S Rd, Taipei 100, Taiwan.
EM rsyang@ntuh.gov.tw
OI Yang, Rong-Sen/0000-0002-0553-4779; LIU, SHING-HWA/0000-0002-9976-1197
CR Banu MJ, 1999, BONE, V25, P469, DOI 10.1016/S8756-3282(99)00195-7
   Boskey AL, 1999, J BONE MINER RES, V14, P330, DOI 10.1359/jbmr.1999.14.3.330
   BOURRIN S, 1995, J BONE MINER RES, V10, P1745
   Burr DB, 2002, BONE, V31, P8, DOI 10.1016/S8756-3282(02)00815-3
   Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889
   CURREY JD, 1979, J BIOMECH, V12, P459, DOI 10.1016/0021-9290(79)90031-9
   CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1
   Davicco MJ, 1999, MECH AGEING DEV, V109, P83, DOI 10.1016/S0047-6374(99)00026-3
   Fahey TD, 2005, EXERCISE PHYSL HUMAN
   FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Hagihara Y, 2005, J BONE MINER METAB, V23, P289, DOI 10.1007/s00774-005-0601-z
   Honda A, 2001, J BONE MINER RES, V16, P1688, DOI 10.1359/jbmr.2001.16.9.1688
   Huang TH, 2003, J APPL PHYSIOL, V95, P300, DOI 10.1152/japplphysiol.01076.2002
   Huang TH, 2002, BONE, V30, P293, DOI 10.1016/S8756-3282(01)00659-7
   Iwamoto J, 2005, EXP ANIM TOKYO, V54, P1, DOI 10.1538/expanim.54.1
   Iwamoto J, 2004, J BONE MINER METAB, V22, P26, DOI 10.1007/s00774-003-0443-5
   Joo YI, 2003, BONE, V33, P485, DOI 10.1016/S8756-3285(03)00212-6
   Jurimae Toivo, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P579, DOI 10.2114/jpa.24.579
   Kiuchi A, 1998, INT J SPORTS MED, V19, P245, DOI 10.1055/s-2007-971912
   KOPP J, 1989, Matrix, V9, P443
   LIN YS, 1995, MED SCI SPORT EXER, V27, P73
   MAROTTI G, 1994, CLIN RHEUMATOL, V13, P63
   Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254
   Mazess R B, 1998, Arch Intern Med, V158, P300, DOI 10.1001/archinte.158.3.298-a
   Mosekilde L, 1999, BONE, V24, P71, DOI 10.1016/S8756-3282(98)00169-0
   NORDSLETTEN L, 1993, J BONE MINER RES, V8, P1089
   Notomi T, 2000, EUR J APPL PHYSIOL, V83, P469, DOI 10.1007/s004210000316
   Nyman JS, 2006, J BIOMECH, V39, P931, DOI 10.1016/j.jbiomech.2005.01.012
   Puustjarvi K, 1999, J BONE MINER RES, V14, P321, DOI 10.1359/jbmr.1999.14.3.321
   RICO H, 1991, MINER ELECTROL METAB, V17, P321
   SAKAMOTO K, 1987, J NUTR, V117, P390
   SHEPHERD D, 1969, METHOD ENZYMOL, V13, P11, DOI DOI 10.1016/0076-6879(69)13006-2
   SIEMON NJ, 1973, NATURE, V243, P541, DOI 10.1038/243541a0
   Skedros JG, 2006, J EXP BIOL, V209, P3025, DOI 10.1242/jeb.02304
   Soot T, 2005, J BONE MINER METAB, V23, P401, DOI 10.1007/s00774-005-0620-9
   TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K
   Umemura Y, 1997, J BONE MINER RES, V12, P1480, DOI 10.1359/jbmr.1997.12.9.1480
   Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9
   Wallace JD, 2000, J CLIN ENDOCR METAB, V85, P124, DOI 10.1210/jc.85.1.124
   Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4
   Wang XD, 2001, J ORTHOPAED RES, V19, P1021, DOI 10.1016/S0736-0266(01)00047-X
   Webb AA, 2003, BEHAV BRAIN RES, V144, P143, DOI 10.1016/S0166-4328(03)00076-7
   Welch JM, 2004, J APPL PHYSIOL, V97, P1859, DOI 10.1152/japplphysiol.00438.2004
   Welsh L, 1997, INT J SPORTS MED, V18, P247, DOI 10.1055/s-2007-972628
   WHEELER DL, 1995, MED SCI SPORT EXER, V27, P520
   YEH JK, 1993, AM J PHYSIOL, V264, pE182
   Zittermann A, 2002, EUR J NUTR, V41, P189, DOI 10.1007/s00394-002-0375-1
   Zonderland ML, 1999, EUR J APPL PHYSIOL O, V79, P391, DOI 10.1007/s004210050527
NR 49
TC 19
Z9 24
U1 0
U2 1
PU SPRINGER TOKYO
PI TOKYO
PA 1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN
SN 0914-8779
J9 J BONE MINER METAB
JI J. Bone Miner. Metab.
PD JUL
PY 2008
VL 26
IS 4
BP 350
EP 357
DI 10.1007/s00774-007-0831-3
PG 8
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA 322RG
UT WOS:000257392400007
PM 18600401
DA 2018-10-20
ER

PT J
AU Li, D
   Yang, W
   Li, GY
AF Li, Dong
   Yang, Wei
   Li, Guo-Ying
TI Extraction of native collagen from limed bovine split wastes through
   improved pretreatment methods
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE native collagen; pretreatment; limed bovine split wastes;
   physicochemical properties; collagen yield
ID DECALCIFICATION; BIOMATERIAL; PRODUCTS
AB BACKGROUND: The large amount of limed bovine split wastes discharged by the leather industry has raised concerns regarding their environmental effect. The objective of this work was to perform pilot plant trials to extract high-value native collagen from these wastes through improved pretreatment methods.
   RESULTS: EDTA- and HCl-pretreatment gave similar removal percentages of inorganic substances. Owing to the open structure of fibers, the collagen yield of HCl-pretreated splits (HPS) (41.31%) was higher than that of EDTA-pretreated splits (EPS) (10.42%). Furthermore, HCl-pretreated split collagen (HPC) had a more acidic isoelectric point, lower content of primary amino groups, larger Z-average particle size and higher relative viscosity than EDTA-pretreated split collagen (EPC). Electrophoretic analysis and circular dichroism spectra revealed the maintenance of polypeptide and triple helix conformation, respectively. In addition, the transition temperatures of EPC (34.7 degrees C) and HPC (34.6 degrees C) detected by differential scanning calorimetry (DSC) were close to that of commercial collagen from calfskin (CCC) (35.7 degrees C).
   CONCLUSION: A process of native collagen extraction from limed bovine split wastes was proposed. While both EPC and HPC represented similar physicochemical properties to those of CCC, the collagen yield of HPS was much higher than that of EPS. (C) 2008 Society of Chemical Industry.
C1 [Li, Dong; Yang, Wei; Li, Guo-Ying] Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Peoples R China.
RP Li, GY (reprint author), Sichuan Univ, Key Lab Leather Chem & Engn, Minist Educ, Chengdu 610065, Peoples R China.
EM liguoyings@163.com
CR Alexander KTW, 1991, J SOC LEATHER TECHNO, V76, P17
   *ASS OFF AGR CHEM, 1990, OFF TENT METH AN
   BALATON AJ, 1989, ANN PATHOL, V9, P140
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Cabeza LF, 1998, WASTE MANAGE, V18, P211, DOI 10.1016/S0956-053X(98)00032-4
   CASSEL JM, 1966, BIOPOLYMERS, V4, P989, DOI 10.1002/bip.1966.360040904
   Dias JCCA, 2002, ARQ BRAS MED VET ZOO, V54, P618, DOI 10.1590/S0102-09352002000600010
   FAN GT, 1993, PRODUCTS RAW HIDES
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GAYATRI R, 2001, BIOCHEM BIOPH RES CO, V283, P299
   Hattori S, 1999, J BIOCHEM-TOKYO, V125, P676, DOI 10.1093/oxfordjournals.jbchem.a022336
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Leammli U. K., 1970, NATURE, V277, P680, DOI DOI 10.1038/227680A0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LI G. Y., 2003, J SOC LEATHER TECHNO, V88, P66
   Li GY, 2003, J AM LEATHER CHEM AS, V98, P224
   MAIRE MS, 1980, J AM LEATHER CHEM AS, V75, P16
   Morimura S, 2002, PROCESS BIOCHEM, V37, P1403, DOI 10.1016/S0032-9592(02)00024-9
   *NEW ENGL TANN CLU, 1973, LEATH FACTS
   NG KH, 1992, EUR J MORPHOL, V30, P150
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Peng Y, 2004, J COSMET SCI, V55, P327
   ROBERT F, 1971, BIOCHEM J, V124, P581
   RONCAROLI F, 1991, Pathologica (Genoa), V83, P307
   SAMLOFF IM, 2004, AM J MED, V79, P15
   Santos LM, 2007, J CLEAN PROD, V15, P12, DOI 10.1016/j.jclepro.2006.01.025
   Taylor MM, 2004, J AM LEATHER CHEM AS, V99, P133
   WIRSIGWIECHMANN CR, 1994, J NEUROSCI METH, V51, P213, DOI 10.1016/0165-0270(94)90013-2
   Yang L, 2003, J INORG BIOCHEM, V93, P197, DOI 10.1016/S0162-0134(02)00573-1
NR 30
TC 9
Z9 9
U1 1
U2 21
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0268-2575
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD JUL
PY 2008
VL 83
IS 7
BP 1041
EP 1048
DI 10.1002/jctb.1912
PG 8
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA 320RO
UT WOS:000257252900012
DA 2018-10-20
ER

PT J
AU Indrizzi, E
   Moricca, LM
   Pellacchia, V
   Leonardi, A
   Buonaccorsi, S
   Fini, G
AF Indrizzi, Elena
   Moricca, Luca Maria
   Pellacchia, Valentina
   Leonardi, Alessandra
   Buonaccorsi, Sara
   Fini, Giuseppina
TI Biomaterial implantation in facial esthetic diseases: Ultrasonography
   monitor follow-up
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE biomaterial; reconstruction; ultrasonography
ID SURGERY
AB Facial deficit diseases are corrected by biomaterial implantation. The ideal biomaterial should be easy to implant and remove and simple to be identified by a low-dose radiation and low-cost radiologic technique. The purpose of this work was to evaluate ultrasonography (US) as a technique in monitoring biomaterial status after operation.
   In the last 3 years, for this study we used polyethylene porosus and polyacrylamide. Our study included 300 patients grouped accordingly as follows: malformative syndromes, degenerative syndromes, and esthetic problems, results of skull-facial traumas, and whether they are treated in the early phase and or the late phase. In this paper, we describe the better 15 clinical cases for their excellent result and for their variety of US images.
   Ultrasonography has been shown as an excellent way to visualize clinical features and a possible pathologic process of an implanted biomaterial; it is a noninvasive, low-radiation and low-cost dose radiologic technique.
   Reconstruction in facial deficit diseases needs adequate biomaterial to implant and a careful patients observation, that is, both clinical and radiologic. Ultrasonography is a fundamental component of the follow up of implanted biomaterial patients.
C1 [Indrizzi, Elena; Moricca, Luca Maria; Pellacchia, Valentina; Leonardi, Alessandra; Buonaccorsi, Sara; Fini, Giuseppina] Univ Roma La Sapienza, Sch Med & Surg, Cattedra Chirurg Maxillo, Rome, Italy.
RP Moricca, LM (reprint author), Via Rose,6-C, I-01036 Viterbo, Italy.
EM luca_maria@infinito.it
CR ANDREWS JM, 1966, PLAST RECONSTR SURG, V38, P581, DOI 10.1097/00006534-196638060-00017
   BEN-HUR N, 1963, Isr Med J, V22, P15
   BRALY S, 1967, PLAST RECONSTR SURG, V51, P3
   BROWN JB, 1954, AMA ARCH SURG, V68, P744, DOI 10.1001/archsurg.1954.01260050746003
   Cenzi R, 1995, Minerva Stomatol, V44, P559
   Chin E, 1968, Keisei Geka, V11, P177
   CONLEY J, 1985, ARCH OTOLARYNGOL, V111, P241
   GRUSS JS, 1985, PLAST RECONSTR SURG, V75, P303
   GUTIERREZ C, 1982, ARCH OTOLARYNGOL, V108, P243
   HELL B, 1989, J CRANIO MAXILL SURG, V17, P39, DOI 10.1016/S1010-5182(89)80126-X
   HELL B, 1993, INT J ORAL MAX SURG, V22, P173, DOI 10.1016/S0901-5027(05)80247-4
   MAAS CS, 1990, ARCH OTOLARYNGOL, V116, P551
   Meyer R, 1997, AESTHET PLAST SURG, V21, P159, DOI 10.1007/s002669900103
   Pacini S, 2003, PLAST RECONSTR SURG, V111, P489, DOI 10.1097/00006534-200301000-00092
   Pacini Stefania, 2002, Italian Journal of Anatomy and Embryology, V107, P209
   Rocher P., 1995, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V96, P281
   Sengezer M, 1992, J Craniofac Surg, V3, P125, DOI 10.1097/00001665-199211000-00003
   STOSIC S, 1991, Deutsche Stomatologie, V41, P166
   Wellisz T, 1992, J Craniofac Surg, V3, P101, DOI 10.1097/00001665-199209000-00009
   WELLISZ T, 1993, AESTHET PLAST SURG, V17, P339, DOI 10.1007/BF00437109
NR 20
TC 4
Z9 4
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JUL
PY 2008
VL 19
IS 4
BP 1098
EP 1103
DI 10.1097/SCS.0b013e3181763633
PG 6
WC Surgery
SC Surgery
GA 330EC
UT WOS:000257921300041
PM 18650740
DA 2018-10-20
ER

PT J
AU Neethling, WML
   Yadav, S
   Hodge, AJ
   Glancy, R
AF Neethling, William M. L.
   Yadav, Sumit
   Hodge, Andrew J.
   Glancy, Ross
TI Enhanced biostability and biocompatibility of decellularized bovine
   pericardium, crosslinked with an ultra-low concentration monomeric
   aldehyde and treated with ADAPT (R)
SO JOURNAL OF HEART VALVE DISEASE
LA English
DT Article; Proceedings Paper
CT 4th Biennial Meeting of the Society-for-Heart-Valve-Disease
CY JUN 15-18, 2007
CL New York, NY
SP Soc Heart Valve Dis
ID PORCINE HEART-VALVES; IN-VITRO; TISSUE; GLUTARALDEHYDE; CALCIFICATION;
   LINKING; MATRIX; BIOPROSTHESES; MODEL; RECELLULARIZATION
AB Background and aim of the study: Matrix preparation remains controversial due to incomplete cell removal, inflammatory responses, reabsorption and thrombocyte activation. Previously, crosslinked matrices have been considered unsatisfactory due to cytotoxicity. In the present study, the biostability, biocompatibility and calcification potential of a decellularized matrix crosslinked with a low concentration of monomeric glutaraldehyde (GA) and treated with the ADAPT (R) anti-calcification process were examined.
   Methods: Bovine pericardium was decellularized with Triton X-100, deoxycholate, IgePal CA-630 (R) and ribonuclease. The resulting matrices were allocated to either group I (control, n = 5), crosslinked in 0.2% polymeric GA + ADAPT (R), or to group 11 (treatment, n = 5), crosslinked in 0.05% monomeric GA + ADAPT (R). The physical properties, enzymatic degradation, histology and immunohistochemical staining of the tissues were monitored. The matrices were also implanted in the jugular vein of juvenile sheep for 200 days.
   Results: Complete acellularity was achieved. Biostability was significantly (p < 0.01) enhanced in group II, but inflammatory responses were limited in both groups. Host fibroblasts infiltrated the periphery in group I and the entire matrix in group II. The luminal surfaces were free from thrombotic depositions and covered with endothelial cells. Both groups tested positive for Factor VIII, smooth muscle alpha-actin and vimentin. Tissue extractable calcium levels were low (group I = 1.02 +/- 0.39, group II = 0.86 +/- 0.22 mu g Ca/mg tissue).
   Conclusion: Low-concentration GA-crosslinked matrices proved to be stable. The immunoreactivity of both groups was low, with host cell infiltration, migration and trans-differentiation being optimized in those grafts crosslinked with an ultra-low monomeric GA concentration. Calcification levels were close to zero in both groups. Enhanced crosslinking and effective anti-calcification produce a biomaterial with advanced in-vivo tissue-engineering properties.
C1 [Neethling, William M. L.] Univ Western Australia, Fremantle Heart Inst, Nedlands, WA 6009, Australia.
   [Neethling, William M. L.] Univ Western Australia, Sch Surg & Pathol, Nedlands, WA 6009, Australia.
   [Yadav, Sumit; Hodge, Andrew J.] Fremantle Hosp, Dept Cardiothorac Surg, Fremantle, WA 6160, Australia.
   [Glancy, Ross] Fremantle Hosp, Dept Histopathol, Fremantle, WA 6160, Australia.
RP Neethling, WML (reprint author), Fremantle Hosp, Fremantle Heart Inst, Cell Biol Res Unit, Z Block,Alma St, Fremantle, WA 6160, Australia.
EM Leon.Neethling@health.wa.gov.au
CR Chang Y, 2004, J BIOMED MATER RES A, V69A, P323, DOI 10.1002/jbm.a.30003
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   Deiwick M, 1998, ANN THORAC SURG, V66, pS206, DOI 10.1016/S0003-4975(98)01125-4
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Girardot JMD, 1996, J HEART VALVE DIS, V5, P518
   Goissis G, 1998, ARTIF ORGANS, V22, P210, DOI 10.1046/j.1525-1594.1998.06006.x
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Hoerstrup S P, 1998, Swiss Surg, VSuppl 2, P23
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Hughes H, 1994, J Heart Valve Dis, V3, P111
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Ketchedjian A, 2005, ANN THORAC SURG, V79, P888, DOI 10.1016/j.athorascur.2004.09.033
   Kim KM, 2002, J BIOMED MATER RES, V59, P639, DOI 10.1002/jbm.10038
   KOK LP, 1990, J MICROSC-OXFORD, V158, P291, DOI 10.1111/j.1365-2818.1990.tb03003.x
   MESSIER RH, 1994, J SURG RES, V57, P1, DOI 10.1006/jsre.1994.1102
   NEETHLIN WML, 1992, J CARDIOVASC SURG, V3, P285
   Neethling WML, 2006, J CARDIOVASC SURG, V47, P711
   Neethling WML, 2004, J HEART VALVE DIS, V13, P689
   Neethling WML, 2003, J BIOMED MATER RES B, V66B, P356, DOI 10.1002/jbm.b.10015
   RASMUSSEN KE, 1974, HISTOCHEMISTRY, V38, P19, DOI 10.1007/BF00490216
   RICHARDS FM, 1968, J MOL BIOL, V37, P231, DOI 10.1016/0022-2836(68)90086-7
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   ROSSI MA, 1990, J EXP PATHOL, V71, P187
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SHIN M, 1995, J CLIN LAB ANAL, V9, P424, DOI 10.1002/jcla.1860090615
   Shinoka T, 1996, CIRCULATION, V94, P164
   Singla A, 2002, J BIOMED MATER RES, V60, P368, DOI 10.1002/jbm.10077
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Valente M, 1998, J HEART VALVE DIS, V7, P180
   WOODROOF EA, 1978, J BIOENG, V2, P1
NR 33
TC 13
Z9 13
U1 0
U2 6
PU I C R PUBLISHERS
PI NORTHWOOD
PA CRISPIN HOUSE, 12/A SOUTH APPROACH, MOOR PARK, NORTHWOOD HA6 2ET,
   ENGLAND
SN 0966-8519
J9 J HEART VALVE DIS
JI J. Heart Valve Dis.
PD JUL
PY 2008
VL 17
IS 4
BP 456
EP 463
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 331LX
UT WOS:000258014800019
PM 18751476
DA 2018-10-20
ER

PT J
AU Ramanath, HS
   Chua, CK
   Leong, KF
   Shah, KD
AF Ramanath, H. S.
   Chua, C. K.
   Leong, K. F.
   Shah, K. D.
TI Melt flow behaviour of poly-epsilon-caprolactone in fused deposition
   modelling
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 5th Asian-Australian Conference on Composite Materials (ACCM-5_
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
ID POROUS STRUCTURES; SCAFFOLDS; FABRICATION; COMPOSITES; BIOPOLYMER;
   EXTRUSION; DESIGN
AB Fused deposition modelling (FDM) is an extrusion based Rapid prototyping (RP) technique which can be used to fabricate tissue engineering scaffolds. The present work focuses on the study of the melt flow behaviour (MFB) of Poly-epsilon-caprolactone (PCL) as a representative biomaterial, on the FDM. The MFB significantly affects the quality of the scaffold which depends not only on the pressure gradient, its velocity, and the temperature gradients but also physical properties like the melt temperature and rheology. The MFB is studied using two methods: mathematical modelling and finite element analysis (FEA) using Ansys (R). The MFB is studied using accurate channel geometry by varying filament velocity at the entry and by varying nozzle diameters and angles at the exit. The comparative results of both mathematical modelling and FEA suggest that the pressure drop and the velocities of the melt flow depend on the flow channel parameters. One inference of particular interest is the temperature gradient of the PCL melt, which shows that it liquefies within 35% of the channel length. These results are invaluable to better understand the MFB of biomaterials that affects the quality of the scaffold built via FDM and can also be used to predict the MFB of other biomaterials.
C1 [Ramanath, H. S.] Singapore Inst Mfg Technol, Singapore 638075, Singapore.
   [Chua, C. K.; Leong, K. F.] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
   [Shah, K. D.] Vellore Inst Technol, Sch Mech & Bldg Engn, Vellore, Tamil Nadu, India.
RP Ramanath, HS (reprint author), Singapore Inst Mfg Technol, Singapore 638075, Singapore.
EM ramanath@simtech.a-star.edu.sg
RI Chua, Chee Kai/B-6171-2009; Leong, Kah-Fai/B-6183-2009
CR Ang KC, 2007, J BIOMED MATER RES A, V80A, P655, DOI 10.1002/jbm.a.30996
   Ang KC, 2006, RAPID PROTOTYPING J, V12, P100, DOI 10.1108/135525406106524471
   *ANS INC, 2004, ANSYS EL REF MAN
   *ASM INT, 1991, ASM HDB, V2
   BELLINI A, 2002, THESIS DREXEL U US
   Chita C. K, 2003, RAPID PROTOTYPING PR
   Ciardelli G, 2004, J MATER SCI-MATER M, V15, P305, DOI 10.1023/B:JMSM.0000021092.03087.d4
   Darling AL, 2004, J BIOMED MATER RES B, V70B, P311, DOI 10.1002/jbm.b.30050
   Grosvenor MP, 1996, INT J PHARM, V135, P103, DOI 10.1016/0378-5173(95)04404-3
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   Jiang KY, 2004, KEY ENG MAT, V259-2, P667, DOI 10.4028/www.scientific.net/KEM.259-260.667
   Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   MICHAELI W, 1984, EXTRUSION DIES DESIG, P10
   Pingping Z, 1998, EUR POLYM J, V34, P91
   Ramanath HS, 2007, KEY ENG MATER, V334-335, P1241, DOI 10.4028/www.scientific.net/KEM.334-335.1241
   RAUWENDAAL C, 1994, POLYM EXTRUSION, P182
   *START INC, 2001, FDM 3000 SYST DOC
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Too MH, 2002, INT J ADV MANUF TECH, V19, P217, DOI 10.1007/s001700200016
   Wang CG, 2001, CHINESE J ELECTRON, V10, P42
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 25
TC 77
Z9 77
U1 4
U2 91
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2008
VL 19
IS 7
BP 2541
EP 2550
DI 10.1007/s10856-007-3203-6
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 301EL
UT WOS:000255879100003
PM 17619957
DA 2018-10-20
ER

PT J
AU Couet, F
   Mantovani, D
AF Couet, Frederic
   Mantovani, Diego
TI Experimental validation of a new approach for the development of
   mechano-compatible composite scaffolds for vascular tissue engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 5th Asian-Australian Conference on Composite Materials (ACCM-5_
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
AB The clinical need for the design of small-diameter vascular substitutes with high patency rates has never been so urgent as nowadays. Mechano-compatibility is widely known as one of the main key parameter for the design and the development of highly-patent vascular substitutes independently of their nature, i.e., arterial prostheses, arterial grafts or tissue-engineered blood-vessel. In this work, we attempt to target mechano-compatibility of cylindrical scaffolds for vascular tissue engineering by a computational model based on the composite theory associated with finite element and genetic algorithm. Then, cylindrical composite scaffolds were fabricated from gelatine (matrix) and silk (reinforcement) to experimentally validate theoretical results obtained by the implemented computational model. Finally, the compliance of the scaffolds was measured by an in-house developed specific device. Results show that the computational predictions from numerical simulation are in good agreement with the measurements obtained form the experimental tests. Therefore, the proposed computational model represents a valid tool to assist biomaterial scientists during the design of composite scaffolds, and especially in targeting their mechanical properties.
C1 [Mantovani, Diego] Univ Laval, Quebec Univ Hosp, Dept Mat Engn, Lab Biomat & Bioengn, Quebec City, PQ G1K 7P4, Canada.
   Univ Laval, Quebec Univ Hosp, Res Ctr, Quebec City, PQ G1K 7P4, Canada.
RP Mantovani, D (reprint author), Univ Laval, Quebec Univ Hosp, Dept Mat Engn, Lab Biomat & Bioengn, Pavillon Pouliot 1745-E, Quebec City, PQ G1K 7P4, Canada.
EM diego.mantovani@gmn.ulaval.ca
OI Mantovani, Diego/0000-0001-9672-895X
CR *AM HEART ASS, 2005, INT CARD DIS STAT
   *AM HEART ASS, 2005, HEART DIS STROK STAT
   Bailon J.-P., 2000, DES MATERIAUX
   COUET F, 2007, UNPUB REV SCI INSTRU
   COUET F, 2007, KEY ENG MATER, V335, P1169
   Couet F, 2007, MACROMOL BIOSCI, V7, P701, DOI 10.1002/mabi.200700002
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Lehoux S, 2003, J BIOMECH, V36, P631, DOI 10.1016/S0021-9290(02)00441-4
   Lehoux S, 2006, CARDIOVASC RES, V71, P269, DOI 10.1016/j.cardiores.2006.05.008
   MEGERMAN J, 1983, VASCULAR GRAFTING, P344
   Pries AR, 2005, AM J PHYSIOL-HEART C, V288, pH1010, DOI 10.1152/ajpheart.00752.2004
   ROSATELLA G, 2003, ENG MED BIOL SOC, V4, P17
   Tranquillo RT, 1996, BIOMATERIALS, V17, P349, DOI 10.1016/0142-9612(96)85573-6
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
NR 14
TC 5
Z9 5
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2008
VL 19
IS 7
BP 2551
EP 2554
DI 10.1007/s10856-007-3242-z
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 301EL
UT WOS:000255879100004
PM 17914629
DA 2018-10-20
ER

PT J
AU Lin, CJ
   Han, HJ
   Zhang, F
   Li, AM
AF Lin, Changjian
   Han, Huijuan
   Zhang, Fang
   Li, Aimin
TI Electrophoretic deposition of HA/MWNTs composite coating for biomaterial
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 5th Asian-Australian Conference on Composite Materials (ACCM-5_
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
ID HYDROXYAPATITE COATINGS; CARBON NANOTUBES; TITANIUM; FIBERS;
   BIOCERAMICS; PARTICLES; SURFACE; LAYER
AB A composite coating of hydroxyapatite (HA)/multi-walled carbon nanotubes (MWNTs) has been fabricated by electrophoretic deposition (EPD). The nano powders of HA and MWNTs were dispersed in ethanol with total concentration of 0.005 g/mL and MWNTs 20% and 30% contents (wt). And the pH value of suspension was adjusted in a range from 4 to 5. After stabilization the mixture was ultrasonically treated for 3 h to form a stable suspension. Prior to the electrophoretic deposition, the titanium substrate was hydrothermally treated at 140 in NaOH (10 mol/L) solution for 6 h. A titanium sheet and circinal net of stainless steel were used as a cathode and an anode respectively, and a constant deposition voltage of 30 V was applied for 50-60 s in the EPD process. The thickness of the coatings was controlled from 10 mu m to 20 mu m. The samples of composite coating were then sintered in a resistance tube furnace in flowing argon at 700 for 2 h. The structure of the as prepared coating was characterized by SEM and XRD, and the bonding force of the coating/substrate was measured by an interfacial shear strength test. It is shown that the bonding strengths between the coating and the titanium substrate is as high as 35 MPa. The cell culture experiments indicate that the prepared composite coating of HA/MWNTs possesses good biocompatibility.
C1 [Lin, Changjian; Han, Huijuan; Zhang, Fang; Li, Aimin] Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, State Key Lab Phys Chem Solid Surface, Xiamen 361005, Peoples R China.
   [Li, Aimin] Shandong Univ, Coll Mat Sci & Engn, Jinan 250061, Peoples R China.
RP Li, AM (reprint author), Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, State Key Lab Phys Chem Solid Surface, Xiamen 361005, Peoples R China.
EM cjlin@xmu.edu.cn
RI Lin, CJ/G-3392-2010
CR Bae JC, 2002, PHYSICA B, V323, P168, DOI 10.1016/S0921-4526(02)00890-6
   BRENDEL T, 1992, J MATER SCI-MATER M, V3, P175, DOI 10.1007/BF00713445
   Chen F, 2005, KEY ENG MAT, V288-289, P183, DOI 10.4028/www.scientific.net/KEM.288-289.183
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   CHEN F, 2004, THESIS XIAMEN U
   Chen Hong, 2002, CARBON NANOTUBES SYN
   CHEN Y, 2005, J APPL PHYS LETT, V86, P51905
   der Biest O. O. V., 1999, ANNU REV MATER SCI, V29, P327
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   Du CS, 2002, J MATER SCI LETT, V21, P565, DOI 10.1023/A:1015417206987
   GAO B, 2001, ADV MATER, V13, P23
   Gomez-Vega JM, 2000, BIOMATERIALS, V21, P105, DOI 10.1016/S0142-9612(99)00131-3
   Gong HJ, 2005, ACTA POLYM SIN, P297
   Gross KA, 2002, J BIOMED MATER RES, V63, P106, DOI 10.1002/jbm.10090
   Haddon RC, 2002, ACCOUNTS CHEM RES, V35, P997, DOI 10.1021/ar020259h
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Huang HH, 2005, SCRIPTA MATER, V53, P1037, DOI 10.1016/j.scriptamat.2005.07.006
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Ma J, 2003, BIOMATERIALS, V24, P3505, DOI 10.1016/S0142-9612(03)00203-5
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   NIEH TG, 1991, SCRIPTA METALL MATER, V25, P955, DOI 10.1016/0956-716X(91)90256-Z
   Poulin P, 2002, CARBON, V40, P1741, DOI 10.1016/S0008-6223(02)00042-8
   SHIRKHANZADEH M, 1991, J MATER SCI LETT, V10, P1415, DOI 10.1007/BF00735695
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
   Wei M, 2005, J MATER SCI-MATER M, V16, P319, DOI 10.1007/s10856-005-0630-0
   Wei M, 2001, J SOL-GEL SCI TECHN, V21, P39, DOI 10.1023/A:1011201414651
   Wei M, 1999, J MATER SCI-MATER M, V10, P401, DOI 10.1023/A:1008923029945
   Zhao B, 2005, CHEM MATER, V17, P3235, DOI 10.1021/cm0500399
   Zhao LP, 2004, CARBON, V42, P423, DOI 10.1016/j.carbon.2003.10.024
   Zhitomirsky I, 1998, J EUR CERAM SOC, V18, P849, DOI 10.1016/S0955-2219(97)00213-6
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
NR 32
TC 37
Z9 40
U1 0
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2008
VL 19
IS 7
BP 2569
EP 2574
DI 10.1007/s10856-007-3196-1
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 301EL
UT WOS:000255879100007
PM 17619960
DA 2018-10-20
ER

PT J
AU Kundu, J
   Dewan, M
   Ghoshal, S
   Kundu, SC
AF Kundu, Joydip
   Dewan, Moumita
   Ghoshal, Sarani
   Kundu, S. C.
TI Mulberry non-engineered silk gland protein vis-a-vis silk cocoon protein
   engineered by silkworms as biomaterial matrices
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 5th Asian-Australian Conference on Composite Materials (ACCM-5_
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
ID BOMBYX-MORI; CONTROLLED-RELEASE; AQUEOUS-SOLUTIONS; FIBROIN FILMS;
   SPIDER SILK; SCAFFOLDS; POLYMER; GENE; FIBERS; REGENERATION
AB Silk fibroin from silk gland of Bombyx mori 5th instar larvae was utilized to fabricate films, which may find possible applications as two-dimensional matrices for tissue engineering. Bombyx mori cocoon fibroin is well characterized as potential biomaterial by virtue of its good mechanical strength, water stability, thermal properties, surface roughness and biocompatibility. The present study aims to characterize the biophysical, thermal, mechanical, rheological, swelling properties along with spectroscopic analysis, surface morphology and biocompatibility of the silk gland fibroin films compared with cocoon fibroin. Fibroin solutions showed increased turbidity and shear thinning at higher concentration. The films after methanol treatment swelled moderately and were less hydrophilic compared to the untreated. The spectroscopic analysis of the films illustrated the presence of various amide peaks and conformational transition from random coil to beta sheet on methanol treatment. X-ray diffraction studies also confirmed the secondary structure. Thermogravimetric analysis showed distinct weight loss of the films. The films were mechanically stronger and AFM studies showed surfaces were rougher on methanol treatment. The matrices were biocompatible and supported L929 mouse fibroblast cell growth and proliferation. The results substantiate the silk gland fibroin films as potential biomaterial matrices.
C1 [Kundu, Joydip; Dewan, Moumita; Ghoshal, Sarani; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016
OI Kundu, Subhas/0000-0002-7170-2291
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   ASTM, 1993, ANN BOOK ASTM STAND, P59
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Feng XX, 2007, INT J BIOL MACROMOL, V40, P105, DOI 10.1016/j.ijbiomac.2006.06.011
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   GAMO T, 1982, BIOCHEM GENET, V20, P165, DOI 10.1007/BF00484944
   GIMENES ML, 2007, J MEMB SCI, V29, P71
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   GRZELAK K, 1995, COMP BIOCHEM PHYS B, V110, P671, DOI 10.1016/0305-0491(94)00215-G
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hu K, 2006, J BIOACT COMPAT POL, V21, P23, DOI 10.1177/0883911506060455
   Hwang JS, 2001, BIOTECHNOL LETT, V23, P1321, DOI 10.1023/A:1010542011150
   Iliescu T, 2005, CHEM PHYS, V310, P189, DOI 10.1016/j.chemphys.2004.10.034
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Inoue SI, 2000, J POLYM SCI POL PHYS, V38, P1436, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1436::AID-POLB30>3.0.CO;2-8
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KAPLAN DL, 1992, MRS BULL, V17, P41
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Malay O, 2007, INT J BIOL MACROMOL, V40, P387, DOI 10.1016/j.ijbiomac.2006.09.017
   MANDAL BB, IN PRESS BIOTECHNOL
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   MICHAILLE JJ, 1986, BIOCHIMIE, V68, P1165, DOI 10.1016/S0300-9084(86)80060-8
   MINIURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   SHIOZAKI H, 2003, ANGEW MAKROMOLEKULAR, V64, P1
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sun YY, 1997, J APPL POLYM SCI, V65, P959, DOI 10.1002/(SICI)1097-4628(19970801)65:5<959::AID-APP14>3.0.CO;2-N
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   TELLEZGARAY AM, 1999, THESIS TEXAS A M U C
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P237, DOI 10.1016/S0141-8130(99)00002-1
   van Egmond JW, 1998, CURR OPIN COLLOID IN, V3, P385, DOI 10.1016/S1359-0294(98)80054-X
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011
   Wang WB, 2005, J BIOSCIENCES, V30, P605, DOI 10.1007/BF02703560
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhu JX, 2007, INT J BIOL MACROMOL, V41, P469, DOI 10.1016/j.ijbiomac.2007.06.006
NR 55
TC 28
Z9 28
U1 1
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2008
VL 19
IS 7
BP 2679
EP 2689
DI 10.1007/s10856-008-3398-1
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 301EL
UT WOS:000255879100021
PM 18283532
DA 2018-10-20
ER

PT J
AU Biggs, MJP
   Richards, RG
   Wilkinson, CDW
   Dalby, MJ
AF Biggs, M. J. P.
   Richards, R. G.
   Wilkinson, C. D. W.
   Dalby, M. J.
TI Focal adhesion interactions with topographical structures: a novel
   method for immuno-SEM labelling of focal adhesions in S-phase cells
SO JOURNAL OF MICROSCOPY
LA English
DT Article
DE cell cycle; focal adhesions; immunocytochemistry; osteoblast; scanning
   electron microscopy; S-phase
ID SCANNING ELECTRON-MICROSCOPY; SUBSTRATUM ADHESION; CONTACT GUIDANCE;
   PROLIFERATION; ENHANCEMENT; BIOMATERIALS; UNDERSURFACE; FIBROBLASTS;
   MARKERS; GROWTH
AB Current understanding of the mechanisms involved in osseointegration following implantation of a biomaterial has led to adhesion quantification being implemented as an assay of cytocompatibility. Such measurement can be hindered by intra-sample variation owing to morphological changes associated with the cell cycle. Here we report on a new scanning electron microscopical method for the simultaneous immunogold labelling of cellular focal adhesions and S-phase nuclei identified by BrdU incorporation. Prior to labelling, cellular membranes are removed by tritonization and antigens of non-interest blocked by serum incubation. Adhesion plaque-associated vinculin and S-phase nuclei were both separately labelled with a 1.4 nm gold colloid and visualized by subsequent colloid enhancement via silver deposition. This study is specifically concerned with the effects microgroove topographies have on adhesion formation in S-phase osteoblasts. By combining backscattered electron (BSE) imaging with secondary electron (SE) imaging it was possible to visualize S-phase nuclei and the immunogold-labelled adhesion sites in one energy 'plane' and the underlying nanotopography in another. Osteoblast adhesion to these nanotopographies was ascertained by quantification of adhesion complex formation.
C1 [Biggs, M. J. P.; Wilkinson, C. D. W.; Dalby, M. J.] Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
RP Biggs, MJP (reprint author), Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.
EM m.biggs.1@research.gla.ac.uk
RI Messier, Claude/A-2322-2008; Dalby, Matthew/G-2426-2012; Richards,
   Robert/I-8235-2015
OI Messier, Claude/0000-0002-4791-1763; Richards,
   Robert/0000-0002-7778-2480; Dalby, Matthew/0000-0002-0528-3359; Biggs,
   Manus/0000-0003-4699-1025
FU Biotechnology and Biological Sciences Research Council
CR BEISKER W, 1987, CYTOMETRY, V8, P235, DOI 10.1002/cyto.990080218
   Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001
   Besser A, 2006, BIOPHYS J, V90, P3469, DOI 10.1529/biophysj.105.074377
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   BIGGS MJ, 2006, J ORTHOP RES, V25, P273, DOI DOI 10.1002/JOR.20319
   CHRISTENSEN MM, 1992, HISTOCHEMISTRY, V97, P207, DOI 10.1007/BF00267629
   DAVIES PF, 1993, J CLIN INVEST, V91, P2640, DOI 10.1172/JCI116503
   EVERHART LP, 1974, J CELL BIOL, V60, P434, DOI 10.1083/jcb.60.2.434
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Gadegaard N, 2003, MACROMOL MATER ENG, V288, P76, DOI 10.1002/mame.200290037
   GADEGAARD N, 2003, MICROELECTRON ENG, V67, P126
   HALL PA, 1990, CELL TISSUE KINET, V23, P505, DOI 10.1111/j.1365-2184.1990.tb01343.x
   HOWARD A, 1951, NATURE, V167, P599, DOI 10.1038/167599a0
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z
   LORZ M, 1994, EUR ARCH OTO-RHINO-L, V251, P91
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   Meredith DO, 2004, EXP CELL RES, V293, P58, DOI 10.1016/j.yexcr.2003.10.005
   Mokry J, 1995, Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove, V38, P107
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Oleschuk RD, 2000, BIOMATERIALS, V21, P1701, DOI 10.1016/S0142-9612(00)00054-5
   Owen GR, 2002, J MICROSC-OXFORD, V207, P27, DOI 10.1046/j.1365-2818.2002.01035.x
   Owen GRH, 2001, CELL BIOL INT, V25, P1251, DOI 10.1006/cbir.2001.0846
   PELC SR, 1952, BRIT MED BULL, V8, P132
   RICHARDS RG, 1993, J MICROSC-OXFORD, V171, P205, DOI 10.1111/j.1365-2818.1993.tb03377.x
   RICHARDS RG, 1995, J MICROSC-OXFORD, V177, P43, DOI 10.1111/j.1365-2818.1995.tb03532.x
   Richards RG, 2001, CELL BIOL INT, V25, P1237, DOI 10.1006/cbir.2001.0807
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Weipoltshammer K, 2000, HISTOCHEM CELL BIOL, V114, P489
   Yanai T, 1996, J COMP PATHOL, V114, P265, DOI 10.1016/S0021-9975(96)80048-X
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005
NR 35
TC 22
Z9 22
U1 1
U2 9
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc..
PD JUL
PY 2008
VL 231
IS 1
BP 28
EP 37
DI 10.1111/j.1365-2818.2008.02013.x
PG 10
WC Microscopy
SC Microscopy
GA 324CH
UT WOS:000257494800004
PM 18638187
OA Bronze
DA 2018-10-20
ER

PT J
AU Intini, G
   Andreana, S
   Buhite, RJ
   Bobek, LA
AF Intini, Giuseppe
   Andreana, Sebastiano
   Buhite, Robert J.
   Bobek, Libuse A.
TI A comparative analysis of bone formation induced by human demineralized
   freeze-dried bone and enamel matrix derivative in rat calvaria
   critical-size bone defects
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE bone morphogenetic protein 2; bone regeneration; demineralized bone
ID PERIODONTAL DEFECTS; MORPHOGENETIC PROTEIN-2; IN-VIVO; REGENERATION;
   EMDOGAIN(R); ALLOGRAFTS; SITES; MODEL; BMP; OSTEOINDUCTION
AB Background: Human demineralized freeze-dried bone allograft (DFDBA) and enamel matrix derivative (EMD) have been used with varying success for the treatment of bone and periodontal defects. The purpose of this study was to compare qualitatively and quantitatively the bone formation induced by DFDBA and EMD to that of a positive control, recombinant human bone morphogenetic protein 2 (rhBMP-2), in the 8-mm rat calvaria critical-size bone defect.
   Methods: Five groups of five rats each were used. The two test groups were DFDBA and EMD. A negative control consisted of a defect without any biomaterial implanted, a positive control consisted of a defect filled with collagen carrying rhBMP-2, and a non-surgical control consisted of the intact rat calvaria. Eight weeks after implantation of the biomaterials, histologic analysis was used for qualitative assessments and microcomputed tomography was used for quantitative assessments of bone formation. Statistical evaluation was performed by analysis of variance followed by the Fisher's least significant difference multiple-comparison test.
   Results: In the negative control and EMD groups, the histologic analysis showed no bone formation within the center of the defect and limited bone repair at its margins. In the DFDBA group, granules of DFDBA were still present 8 weeks after implantation, and a limited degree of osteoinduction was seen at the center of the defect. The microcomputed tomography quantitative analysis showed a limited capacity of DFDBA and EMD to induce bone formation, and no statistically significant difference was detected among DFDBA, EMD, and the negative control. On the contrary, the positive control (rhBMP-2) consistently showed regeneration of bone throughout the critical-size defects.
   Conclusion: Unlike rhBMP-2, DFDBA and EMD had limited ability to induce bone formation in the rat calvaria critical-size bone defect; therefore, they may not be effective as bone-regenerative therapy for critical-size defects.
C1 [Intini, Giuseppe; Buhite, Robert J.] SUNY Buffalo, Dept Periodont & Endodont, Buffalo, NY 14260 USA.
   [Intini, Giuseppe; Bobek, Libuse A.] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.
   [Andreana, Sebastiano] Loma Linda Univ, Dept Periodont, Loma Linda, CA 92350 USA.
   [Buhite, Robert J.] SUNY Buffalo, Dept Restorat Dent, Buffalo, NY 14260 USA.
   [Buhite, Robert J.] SUNY Buffalo, Dept Oral Maxillofacial Surg, Buffalo, NY 14260 USA.
RP Intini, G (reprint author), Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave,REB 513, Boston, MA 02115 USA.
EM giuseppe_intini@hsdm.harvard.edu
FU NIDCR NIH HHS [R01 DE 009820]
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   *AM ASS TISS BANKS, 2006, STAND TISS BANK
   AN YH, 1999, ANIMAL MODELS ORTHOP, P241
   Becker W, 1998, J PERIODONTOL, V69, P414, DOI 10.1902/jop.1998.69.4.414
   BECKER W, 1995, J PERIODONTOL, V66, P822, DOI 10.1902/jop.1995.66.9.822
   Becker W, 1996, J PERIODONTOL, V67, P1025, DOI 10.1902/jop.1996.67.10.1025
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bostrom MPG, 1999, ORTHOP CLIN N AM, V30, P647, DOI 10.1016/S0030-5898(05)70117-6
   Boyan BD, 2000, J PERIODONTOL, V71, P1278, DOI 10.1902/jop.2000.71.8.1278
   Cochran D, 2001, J PERIODONTOL, V72, P834, DOI 10.1902/jop.2001.72.6.834
   Cortellini P, 1995, Int J Periodontics Restorative Dent, V15, P128
   Donos N, 2006, CLIN ORAL IMPLAN RES, V17, P434, DOI 10.1111/j.1600-0501.2006.01260.x
   Edwards JT, 1998, CLIN ORTHOP RELAT R, P219
   Feighan JE, 1995, J ORTHOP RES, V13, P881, DOI 10.1002/jor.1100130612
   Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Heden G, 1999, J CLIN PERIODONTOL, V26, P855
   Heden G, 2006, J PERIODONTOL, V77, P295, DOI 10.1902/jop.2006.050071
   Heijl L, 1997, J CLIN PERIODONTOL, V24, P705, DOI 10.1111/j.1600-051X.1997.tb00253.x
   Intini G, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-13
   Iwata T, 2002, J DENT RES, V81, P387, DOI 10.1177/154405910208100606
   Kawana F, 2001, ANAT REC, V264, P438, DOI 10.1002/ar.10016
   Kawase T, 2001, J PERIODONTAL RES, V36, P367, DOI 10.1034/j.1600-0765.2001.360604.x
   Laurell L, 1998, J PERIODONTOL, V69, P303, DOI 10.1902/jop.1998.69.3.303
   LIBIN BM, 1975, J PERIODONTOL, V46, P51, DOI 10.1902/jop.1975.46.1.51
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Machtei E E, 1995, Int J Periodontics Restorative Dent, V15, P146
   MARDEN LJ, 1994, J BIOMED MATER RES, V28, P1127, DOI 10.1002/jbm.820281003
   Oliver RC, 1998, J PERIODONTOL, V69, P269, DOI 10.1902/jop.1998.69.2.269
   Ozturk A, 2006, INT ORTHOP, V30, P147, DOI 10.1007/s00264-006-0079-x
   Pacaccio Douglas J, 2005, Clin Podiatr Med Surg, V22, P599, DOI 10.1016/j.cpm.2005.07.001
   PINHOLT EM, 1992, SCAND J DENT RES, V100, P361
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   Rosen P S, 1997, Int J Periodontics Restorative Dent, V17, P516
   Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   SCHMITZ JP, 1990, ACTA ANAT, V138, P185
   Schwartz Z, 1996, J PERIODONTOL, V67, P918, DOI 10.1902/jop.1996.67.9.918
   Stevenson S, 1998, CLIN ORTHOP RELAT R, pS239
   Suzuki S, 2005, J DENT RES, V84, P510, DOI 10.1177/154405910508400605
   Szpalski Marek, 2005, Acta Orthop Belg, V71, P133
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P1367, DOI 10.2106/JBJS.D.02585
   Turonis James W, 2006, J Oral Implantol, V32, P55, DOI 10.1563/780.1
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Yoneda S, 2003, J PERIODONTAL RES, V38, P333, DOI 10.1034/j.1600-0765.2003.00667.x
   Zetterstrom O, 1997, J CLIN PERIODONTOL, V24, P697, DOI 10.1111/j.1600-051X.1997.tb00252.x
NR 48
TC 20
Z9 23
U1 0
U2 6
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD JUL
PY 2008
VL 79
IS 7
BP 1217
EP 1224
DI 10.1902/jop.2008.070435
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 326FJ
UT WOS:000257643600014
PM 18597604
DA 2018-10-20
ER

PT J
AU Traini, T
   Degidi, M
   Sammons, R
   Stanley, P
   Piattelli, A
AF Traini, Tonino
   Degidi, Marco
   Sammons, Rachel
   Stanley, Paul
   Piattelli, Adriano
TI Histologic and elemental microanalytical study of anorganic bovine bone
   substitution following sinus floor augmentation in humans
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE bio-oss; bone regeneration; electron microscopy; histology; sinus
ID PLATELET-RICH PLASMA; PROTEIN-KINASE-A; MAXILLARY SINUS; EXTRACELLULAR
   CALCIUM; BIO-OSS; SURFACE-ROUGHNESS; IMPLANT PLACEMENT; DENTAL IMPLANTS;
   2003 UPDATE; FLUID-FLOW
AB Background: Histologic data regarding the use of anorganic bovine bone (ABB) in humans are scarce. This study was a histologic evaluation and an examination of the elemental composition of ABB particles and adjacent bone in humans.
   Methods: Ten biopsies were retrieved 20 months after maxillary sinus augmentation in five patients. The investigation was carried out using light microscopy in brightfield, fluorescence, and circularly polarized light and scanning electron microscopy (SEM) with energy-dispersive x-ray spectroscopy.
   Results: The regenerated tissue consisted of 38% +/- 2.1% newly formed bone, 36% +/- 1.3% marrow spaces, and 29% +/- 1.8% residual ABB particles. Under polarized light, the newly formed bone was characterized by randomly oriented collagen fibers. Under fluorescence, the biomaterial showed close apposition to bone; under SEM, several projections of newly formed bone were seen penetrating the ABB particles. ABB and bone were distinguished by the lighter gray color of the biomaterial in back-scattered electron images; ABB particles were surrounded and linked by newly formed bone. Elemental analysis gave average calcium/phosphorus ratios (atomic %) similar to 1.9 for ABB and 1.4 for bone. Relatively high concentrations of calcium and phosphorus in the biomaterial decreased gradually toward the interface with bone.
   Conclusion: The persistence of ABB in the human tissue after 20 months might have been related to the relatively high calcium content of the biomaterial as well as the absence of proteins.
C1 [Traini, Tonino; Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   [Sammons, Rachel] Univ Birmingham, Sch Dent, Birmingham, W Midlands, England.
   [Stanley, Paul] Univ Birmingham, Electron Microscopy Unit, Birmingham B15 2TT, W Midlands, England.
RP Piattelli, A (reprint author), Via F Sciucchi 63, I-66100 Chieti, Italy.
EM apiattelli@unich.it
OI Traini, Tonino/0000-0002-0265-8709; Sammons, Rachel/0000-0002-4787-048X
CR Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   Blomqvist JE, 1998, ORAL SURG ORAL MED O, V86, P268, DOI 10.1016/S1079-2104(98)90170-6
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   Burr DB, 2002, BONE, V30, P2, DOI 10.1016/S8756-3282(01)00619-6
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DEGROOT K, 1981, BIOCOMPATIBILITY CLI, P199
   Friedmann A, 2002, CLIN ORAL IMPLAN RES, V13, P587, DOI 10.1034/j.1600-0501.2002.130603.x
   Frost HM, 2004, ANGLE ORTHOD, V74, P3
   Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119
   Froum SJ, 1998, INT J PERIODONT REST, V18, P529
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   Haas R, 2002, INT J ORAL MAX IMPL, V17, P337
   HALL TJ, 1994, BIOCHEM BIOPH RES CO, V202, P456, DOI 10.1006/bbrc.1994.1950
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   JENSEN OT, 1992, TISSUE INTEGRATION IN ORAL, ORTHOPEDIC, AND MAXILLOFACIAL RECONSTRUCTION, P321
   Landi L, 2000, INT J PERIODONT REST, V20, P575
   LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P
   Lorget F, 2000, BIOCHEM BIOPH RES CO, V268, P899, DOI 10.1006/bbrc.2000.2229
   Maiorana C, 2003, INT J PERIODONT REST, V23, P227
   Martin RB, 2002, BONE, V30, P8, DOI 10.1016/S8756-3282(01)00620-2
   MCDOWELL H, 1977, J RES NBS A PHYS CH, V81, P273, DOI 10.6028/jres.081A.017
   Merkx MAW, 2003, INT J ORAL MAX SURG, V32, P1, DOI 10.1054/ijom.2002.0346
   Merkx MAW, 1999, BIOMATERIALS, V20, P2029, DOI 10.1016/S0142-9612(99)00105-2
   Misch C E, 1990, Int J Oral Implantol, V6, P23
   MIYAUCHI A, 1990, J CELL BIOL, V111, P2543, DOI 10.1083/jcb.111.6.2543
   Noble BS, 1997, BONE, V20, P273, DOI 10.1016/S8756-3282(96)00365-1
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Ozaki W, 1998, PLAST RECONSTR SURG, V102, P291, DOI 10.1097/00006534-199808000-00001
   Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Ramaswamy Y, 2005, J MATER SCI-MATER M, V16, P1199, DOI 10.1007/s10856-005-4729-0
   Rodriguez A, 2003, J ORAL MAXIL SURG, V61, P157, DOI 10.1053/joms.2003.50041
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   Schwartz Z, 2001, BIOMATERIALS, V22, P731, DOI 10.1016/S0142-9612(00)00241-6
   SHIMIZU H, 1989, BONE MINER, V6, P261, DOI 10.1016/0169-6009(89)90033-0
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Smit TH, 2002, J BONE MINER RES, V17, P2021, DOI 10.1359/jbmr.2002.17.11.2021
   Tadjoedin ES, 2003, J CLIN PERIODONTOL, V30, P261, DOI 10.1034/j.1600-051X.2003.01099.x
   Tami AE, 2002, J BONE MINER RES, V17, P2030, DOI 10.1359/jbmr.2002.17.11.2030
   Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308
   Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Wheeler SL, 1997, J ORAL MAXIL SURG, V55, P1287, DOI 10.1016/S0278-2391(97)90186-5
   You LD, 2004, ANAT REC PART A, V278A, P505, DOI 10.1002/ar.a.20050
NR 52
TC 35
Z9 39
U1 0
U2 4
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD JUL
PY 2008
VL 79
IS 7
BP 1232
EP 1240
DI 10.1902/jop.2008.070504
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 326FJ
UT WOS:000257643600016
PM 18597606
DA 2018-10-20
ER

PT J
AU Giannoni, P
   Mastrogiacomo, M
   Alini, M
   Pearce, SG
   Corsi, A
   Santolini, F
   Muraglia, A
   Bianco, P
   Cancedda, R
AF Giannoni, P.
   Mastrogiacomo, M.
   Alini, M.
   Pearce, S. G.
   Corsi, A.
   Santolini, F.
   Muraglia, A.
   Bianco, P.
   Cancedda, R.
TI Regeneration of large bone defects in sheep using bone marrow stromal
   cells
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE bone repair; bone tissue engineering; cell differentiation; ceramic
   scaffold; in vivo test; mesenchymal stem cells
ID MESENCHYMAL STEM-CELLS; GRAFT HARVEST; TISSUE-REPAIR; RABBIT MODEL;
   IN-VIVO; DIFFERENTIATION; HYDROXYAPATITE; RECONSTRUCTION;
   MICROTOMOGRAPHY; DISTRACTION
AB Bone repair was addressed in a critical-sized defect model in sheep, combining a ceramic biomaterial and mesenchymal progenitor cells. The defects in the tibial mid-diaphysis were treated with autologous bone or with a silicon-stabilized tricalcium phosphate biomaterial, implemented cor not by the addition of expanded bone marrow stromal cells. An internal locking compression plate and an external fixator were applied for stabilization. Radiographies were taken during the 8 months follow-up: the pixel grey levels of the lesion areas were determined to evaluate the repair process radiologically. Microradiography, histology and vascular density tests were performed. The autologous bone-treated group performed best, as assessed radiologically, within 20-24 weeks after surgery. Very limited healing was detected in the other experimental group: a partial bone deposition occurred at the periphery of the bony stumps only in the cell-seeded scaffolds. Interestingly, this effect ended within 20-24 weeks, as for the autologous bone, suggesting similar kinetics of the repair processes involved. Moreover, bone deposition was located where a significant reduction of the ceramic scaffold was detected. Faxitron microradiography and histology data confirmed these results. Vascular density analysis evidenced that cell-seeded scaffolds supported an increased vascular ingrowth. Thus, the interactions with the proper microenvironment and the oxygen and nutrient supply in the inner part of the constructs seem fundamental to initiate scaffold substitution and to improve cell performance in tissue-engineered approaches to bone repair. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Mastrogiacomo, M.; Cancedda, R.] Natl Inst Canc Res, Adv Biotechnol Ctr, Stem Cell Lab, I-16132 Genoa, Italy.
   [Giannoni, P.; Muraglia, A.] Biorigen SRL, I-16149 Genoa, Italy.
   [Mastrogiacomo, M.; Cancedda, R.] Univ Genoa, Dept Oncol Biol & Genet, I-16132 Genoa, Italy.
   [Alini, M.; Pearce, S. G.] AO Res Inst, CH-7270 Davos, Switzerland.
   [Corsi, A.; Bianco, P.] Univ Roma La Sapienza, Expt Med & Pathol Dept, I-00169 Rome, Italy.
   [Santolini, F.] Azienda Ospedaliera San Martino, I-16132 Genoa, Italy.
RP Giannoni, P (reprint author), Natl Inst Canc Res, Adv Biotechnol Ctr, Stem Cell Lab, Largo R Benzi 10, I-16132 Genoa, Italy.
EM paolo.giannoni@cba-biotecnologie.it
CR Bensaid W, 2005, TISSUE ENG, V11, P814, DOI 10.1089/ten.2005.11.814
   Brawley SC, 2006, ORTHOPEDICS, V29, P342
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014
   Chen YC, 2006, HEAD NECK-J SCI SPEC, V28, P496, DOI 10.1002/hed.20452
   Choong PFM, 2003, CLIN ORTHOP RELAT R, pS19, DOI 10.1097/01.blo.0000093839.72468.da
   Chou LB, 2007, FOOT ANKLE INT, V28, P199, DOI 10.3113/FAI.2007.0199
   Delloye C, 2003, Chir Organi Mov, V88, P335
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Follmar KE, 2007, ANN PLAS SURG, V58, P561, DOI 10.1097/01.sap.0000245119.74126.09
   Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018
   Hall N R, 1992, Surg Oncol, V1, P223, DOI 10.1016/0960-7404(92)90068-V
   HEIPLE KG, 1987, ORTHOP CLIN N AM, V18, P179
   HEISE U, 1990, INT ORTHOP, V14, P329
   Hu ZM, 2005, J CRANIOFAC SURG, V16, P1006, DOI 10.1097/01.scs.0000170449.72040.ee
   Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518
   Khosla S, 2006, ANN NY ACAD SCI, V1068, P489, DOI 10.1196/annals.1346.022
   Komlev VS, 2006, TISSUE ENG, V12, P3449, DOI 10.1089/ten.2006.12.3449
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Lee SY, 2007, J CELL PHYSIOL, V210, P561, DOI 10.1002/jcp.20890
   Lisignoli G, 2006, J CELL PHYSIOL, V207, P364, DOI 10.1002/jcp.20572
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583
   Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539
   Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001
   Mastrogiacomo M, 2004, TISSUE ENG, V10, P1767, DOI 10.1089/ten.2004.10.1767
   Matsushita T, 1998, ACTA ORTHOP SCAND, V69, P95, DOI 10.3109/17453679809002365
   MODDER UI, 2007, J CELL BIOCHEM, V103, P393
   Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Potier E, 2007, TISSUE ENG, V13, P1325, DOI 10.1089/ten.2006.0325
   Richards M, 1998, CLIN ORTHOP RELAT R, pS191
   Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172
   SARTORIS D J, 1992, Journal of Foot Surgery, V31, P301
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Soucacos PN, 2006, INJURY, V37, pS41, DOI 10.1016/j.injury.2006.02.040
   Tate MLK, 2007, J BONE JOINT SURG AM, V89A, P307, DOI 10.2106/JBJS.E.00512
   Weiss ML, 2006, STEM CELL REV, V2, P155, DOI 10.1007/s12015-006-0022-y
   Wheeler D L, 2001, Biomed Sci Instrum, V37, P251
   Wheeler DL, 2005, CLIN ORTHOP RELAT R, P36, DOI 10.1097/01.blo.0000165850.58583.50
   Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806
NR 43
TC 57
Z9 61
U1 1
U2 7
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUL
PY 2008
VL 2
IS 5
BP 253
EP 262
DI 10.1002/term.90
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 328OG
UT WOS:000257807100002
PM 18537203
DA 2018-10-20
ER

PT J
AU Hunt, JA
   Callaghan, JT
AF Hunt, John A.
   Callaghan, Jill T.
TI Polymer-hydroxyapatite composite versus polymer interference screws in
   anterior cruciate ligament reconstruction in a large animal model
SO KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
LA English
DT Article
DE anterior cruciate ligament; bioabsorbable implants;
   hydroxyapatite-tricalciumphosphate composite;
   hydroxyapatite-polylactide; medical device
ID ANKLE FRACTURES; INTRAARTICULAR MIGRATION; FIXATION DEVICES; IMPLANTS;
   GRAFT; POLYGLYCOLIDE
AB The aim of the study was to assess the hard tissue response of a composite hydroxyapatite/poly L-lactic acid (HA/PLLA) interference screw for anterior cruciate ligament (ACL) reconstruction compared to a standard PLLA screw. Twelve skeletally mature rams underwent unilateral ACL reconstruction using an autologous bone-patellar tendon graft. Each animal received either two test HA/PLLA interference screws or two control PLLA interference screws. Animals were sacrificed at 6 and 12 months post-implantation and the operated knees excised. Undecalcified sections of the screw and surrounding tissues were cut from resin embedded samples and stained; sections were approximately parallel to the longitudinal axis of the screws. A quantitative assessment of bone formation between each screw type (PLLA vs. HA/PLLA) and adjacent tissue in both the tibia and femur was undertaken using automated image analysis (KS400, Zeiss, UK). The inflammatory response of each screw type was assessed by histological evaluation. New bone formation along the perimeter of the screw threads was statistically significantly higher with the HA/PLLA than the PLLA alone. The inflammatory response as assessed semi-quantitatively by histologically determining the number of inflammatory cells present in the tissue adjacent to the implant, was higher for PLLA than HA/PLLA. Significantly increased new bone formation and decreased inflammatory cells were observed in vivo with the composite screw in comparison with the standard polymer. A novel HA/PLLA composite biomaterial in the form of an interference screw demonstrated an improved hard-tissue response compared to PLLA in a large animal ACL reconstruction. This study determined the differences in the tissue response between PLLA and a composite material of HA/PLLA. The improved tissue related outcomes observed in vivo, may be of benefit clinically in ACL reconstruction.
C1 [Hunt, John A.; Callaghan, Jill T.] Univ Liverpool, Sch Clin Sci, UK Ctr Tissue Engn, Liverpool L69 3GA, Merseyside, England.
RP Hunt, JA (reprint author), Univ Liverpool, Sch Clin Sci, UK Ctr Tissue Engn, Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.
EM huntja@liv.ac.uk
RI Hunt, John/G-6366-2012
OI Hunt, John/0000-0002-5168-4778; Callaghan, Jill T/0000-0002-5147-7218
FU Medical Research Council [MC_QA137917]
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Barber FA, 2006, ARTHROSCOPY, V22, P820, DOI 10.1016/j.arthro.2006.04.096
   Baums MH, 2006, KNEE SURG SPORT TR A, V14, P865, DOI 10.1007/s00167-006-0049-2
   BOSTMAN OM, 1992, CLIN ORTHOP RELAT R, P193
   Bostman OM, 2000, CLIN ORTHOP RELAT R, P216
   Brand J, 2000, AM J SPORT MED, V28, P761, DOI 10.1177/03635465000280052501
   Bush-Joseph C A, 1998, Am J Knee Surg, V11, P32
   Ciccone W J 2nd, 2001, J Am Acad Orthop Surg, V9, P280
   FROKJAER J, 1992, ACTA ORTHOP SCAND, V63, P434, DOI 10.3109/17453679209154762
   Gefen A, 2002, MED ENG PHYS, V24, P337, DOI 10.1016/S1350-4533(02)00027-9
   Goetzen N, 2005, J BIOMECH, V38, P595, DOI 10.1016/j.jbiomech.2004.01.023
   Han I, 2005, AM J SPORT MED, V33, P1742, DOI 10.1177/0363546505275150
   Hovis WD, 1997, FOOT ANKLE INT, V18, P128, DOI 10.1177/107110079701800303
   Krappel FA, 2006, ARCH ORTHOP TRAUM SU, V126, P615, DOI 10.1007/s00402-006-0101-1
   Macarini Luca, 2004, Radiol Med, V107, P47
   Marumo K, 2006, J ORTHOP SCI, V11, P154, DOI 10.1007/s00776-005-0989-2
   MATTHEWS L S, 1989, Arthroscopy, V5, P225, DOI 10.1016/0749-8063(89)90177-1
   Middleton JC, 1998, MED PLASTICS BIO MAR, P31
   Moonot P, 2006, KNEE SURG SPORT TR A, V14, P1004, DOI 10.1007/s00167-005-0010-9
   Park MC, 2006, ARTHROSCOPY, V22
   Pihlajamaki H, 1997, BIOMATERIALS, V18, P1311, DOI 10.1016/S0142-9612(97)00068-9
   Resinger C, 2005, ARTHROSCOPY, V21, P1398, DOI 10.1016/j.arthro.2005.08.0351398
   Sassmannshausen Greg, 2003, Arthroscopy, V19, pE133, DOI 10.1016/j.arthro.2003.09.017
   SHELLOCK FG, 1992, JMRI-J MAGN RESON IM, V2, P225, DOI 10.1002/jmri.1880020217
   Sidhu DS, 1997, AM J SPORT MED, V25, P268, DOI 10.1177/036354659702500223
   Weiler A, 2000, ARTHROSCOPY, V16, P305, DOI 10.1016/S0749-8063(00)90055-0
   Wilson TC, 2004, AM J SPORT MED, V32, P543, DOI 10.1177/0363546504263151
   Zantop T, 2006, ARTHROSCOPY, V22, P1204, DOI 10.1016/j.arthro.2006.06.015
NR 29
TC 19
Z9 19
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0942-2056
J9 KNEE SURG SPORT TR A
JI Knee Surg. Sports Traumatol. Arthrosc.
PD JUL
PY 2008
VL 16
IS 7
BP 655
EP 660
DI 10.1007/s00167-008-0528-8
PG 6
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 320IV
UT WOS:000257227800006
PM 18418577
DA 2018-10-20
ER

PT J
AU Wettero, J
   Hellerstedt, T
   Nygren, P
   Broo, K
   Aili, D
   Liedberg, B
   Magnusson, KE
AF Wettero, Jonas
   Hellerstedt, Tobias
   Nygren, Patrik
   Broo, Klas
   Aili, Daniel
   Liedberg, Bo
   Magnusson, Karl-Eric
TI Immobilized chemoattractant peptides mediate adhesion and distinct
   calcium-dependent cell signaling in human neutrophils
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; LEUKOCYTE CHEMOSENSORY MIGRATION; VASCULAR
   PROSTHETIC BIOMATERIAL; POLYMORPHONUCLEAR LEUKOCYTES; CHEMOTACTIC
   FACTORS; AMINO-ACIDS; RECEPTOR; BINDING; SPECTROSCOPY; COMPLEMENT
AB Chemotaxis is the stimulated directional migration of cells in response to chemotactic factors, manifested for instance during leukocyte interaction with chemoattractants in inflammation. The N-formyl-Met-Leu-Phe (fMLF) bacterial peptide family is particularly potent in attracting and activating neutrophilic granulocytes. To accomplish defined circumstances for recruitment and activation of cells, we fabricated semitransparent gold-coated glass coverslips functionalized with chemoattractant fMLF receptor peptide agonist analogues. Peptides based on a common leading four-amino-acid sequence Gly-Gly-Gly-Cys were thus coupled to two potent fMLF receptor agonists, N-formyl-Tyr-Nle-Phe-Leu-Nle-Gly-Gly-Gly-Cys and N-formyl-Met-Leu-Phe-Gly-Gly-Gly-Cys, and a formylated control peptide, N-formyl-Gly-Gly-Gly-Cys. They were anchored via the SH group of Cys either directly to the gold surface or a mixed self-assembled monolayer composed of maleimide- and hydroxyl-terminated oligo(ethylene glycol) alkyldisulfides. The overall peptide immobilization procedure was characterized with ellipsometry, contact angle measurement, and infrared spectroscopy. When exposed to granulocytes, the agonist surface rapidly recruited neutrophils and the cells responded with extensive spreading and intracellular calcium transients within minutes. The reference peptide generated no such activation, and the cells maintained a more spherical morphology, suggesting that we have been able to immobilize chemoattractant receptor agonist peptides with retained bioactivity. This is a crucial step in designing surfaces with specific effects on cellular behavior.
C1 [Wettero, Jonas] Linkoping Univ, Dept Clin & Expt Med, Rheumatol AIR, Linkoping, Sweden.
   [Hellerstedt, Tobias; Nygren, Patrik; Aili, Daniel; Liedberg, Bo] Linkoping Univ, Dept Phys Biol & Chem, Div Mol Phys, Linkoping, Sweden.
   [Broo, Klas] Univ Gothenburg, Sahlgrenska Univ Hosp, Gothenburg, Sweden.
RP Wettero, J (reprint author), Linkoping Univ, Dept Clin & Expt Med, Rheumatol AIR, Linkoping, Sweden.
EM jonwe@imk.liu.se
RI Liedberg, Bo/N-6093-2014; Nygren, Patrik/B-7319-2015; Aili,
   Daniel/L-2668-2013; Wettero, Jonas/C-9578-2009
OI Nygren, Patrik/0000-0002-9233-2859; Aili, Daniel/0000-0002-7001-9415;
   Wettero, Jonas/0000-0002-6916-5490; Magnusson,
   Karl-Eric/0000-0002-7809-8437
CR ANDERSON DC, 1986, J IMMUNOL, V137, P15
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Chang CC, 2000, J MATER SCI-MATER M, V11, P337, DOI 10.1023/A:1008925722623
   Chang CC, 2000, BIOMATERIALS, V21, P2305, DOI 10.1016/S0142-9612(00)00157-5
   CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002
   Cohen M, 2004, CHEMBIOCHEM, V5, P1393, DOI 10.1002/cbic.200400162
   DAHLGREN C, 1984, J IMMUNOL METHODS, V75, P23, DOI 10.1016/0022-1759(84)90221-7
   Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5
   Ekeroth J, 2002, J COLLOID INTERF SCI, V254, P322, DOI 10.1006/cjis.2002.8576
   EKEROTH J, 2002, THESIS LINKOPING U L
   Entschladen F, 2005, EXP CELL RES, V307, P418, DOI 10.1016/j.yexcr.2005.03.029
   FERRANTE A, 1980, J IMMUNOL METHODS, V36, P109, DOI 10.1016/0022-1759(80)90036-8
   Frow Emma K, 2004, Med Res Rev, V24, P276, DOI 10.1002/med.10062
   Fu HM, 2008, J IMMUNOL METHODS, V331, P50, DOI 10.1016/j.jim.2007.11.005
   Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Houseman BT, 2003, LANGMUIR, V19, P1522, DOI 10.1021/la0262304
   IHS A, 1990, J COLLOID INTERF SCI, V140, P192, DOI 10.1016/0021-9797(90)90335-L
   ISLAM LN, 1985, J IMMUNOL METHODS, V85, P137, DOI 10.1016/0022-1759(85)90282-0
   ISSEKUTZ A, 1983, J IMMUNOL METHODS, V59, P19, DOI 10.1016/0022-1759(83)90141-2
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   JOHANSSON B, 1993, J CELL BIOL, V121, P1281, DOI 10.1083/jcb.121.6.1281
   Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006
   KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6
   Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d
   Lang K, 2003, SCAND J IMMUNOL, V57, P350, DOI 10.1046/j.1365-3083.2003.01247.x
   LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   LIEDBERG B, 1986, J COLLOID INTERF SCI, V114, P386, DOI 10.1016/0021-9797(86)90424-8
   Loitto VM, 2001, J LEUKOCYTE BIOL, V69, P762
   McCrackin F. L., 1969, 479 NBS
   Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5
   MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   NIEDEL J, 1979, J BIOL CHEM, V254, P700
   Panaro MA, 1999, IMMUNOPHARM IMMUNOT, V21, P397, DOI 10.3109/08923979909007117
   PARIKH AN, 1992, J CHEM PHYS, V96, P927, DOI 10.1063/1.462847
   REMES JJ, 1993, EXP CELL RES, V209, P26, DOI 10.1006/excr.1993.1280
   Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034
   SHOWELL HJ, 1976, J EXP MED, V143, P1154, DOI 10.1084/jem.143.5.1154
   Simon SI, 2005, ANNU REV BIOMED ENG, V7, P151, DOI 10.1146/annurev.biomed.7.060804.100423
   Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200
   SOON L, 2007, J MICROSC RES TECH, V70, P252
   Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4
   TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7
   UHING JR, 1999, INFLANUNATION BASIC, P607
   Valiokas R, 1999, LANGMUIR, V15, P3390, DOI 10.1021/la981647o
   Wettero J, 2003, J BIOMED MATER RES A, V66A, P162, DOI 10.1002/jbm.a.10591
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9
   Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003
   ZICHA D, 1991, J CELL SCI, V99, P769
   ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606
   ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387
NR 58
TC 10
Z9 10
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 1
PY 2008
VL 24
IS 13
BP 6803
EP 6811
DI 10.1021/la703502y
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 318OI
UT WOS:000257101100057
PM 18507416
DA 2018-10-20
ER

PT J
AU Wirth, C
   Grosgogeat, B
   Lagneau, C
   Jaffrezic-Renault, N
   Ponsonnet, L
AF Wirth, Carine
   Grosgogeat, Brigitte
   Lagneau, Christelle
   Jaffrezic-Renault, Nicole
   Ponsonnet, Laurence
TI Biomaterial surface properties modulate in vitro rat calvaria
   osteoblasts response: Roughness and or chemistry?
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 5th Maghreb/Europe Meeting on Materials and Their Applications for
   Devices and Physical, Chemical and Biological Sensors (MADICA 2006)
CY OCT 30-NOV 01, 2006
CL Mahdia, TUNISIA
DE nickel-titanium; roughness; chemistry; wettability; osteoblast
ID NICKEL-TITANIUM ALLOY; SHAPE-MEMORY ALLOY; CELL RESPONSE;
   HISTOMORPHOMETRIC ANALYSIS; BONE; ADHESION; BEHAVIOR; BIOCOMPATIBILITY;
   NITINOL; MINERALIZATION
AB The aim of this study was a better understanding of the regulation mechanisms of in vitro osteoblast activity on biomaterials. Rat osteoblast behaviour on different surfaces was studied. Surfaces with different roughness (and a similar surface chemistry) or with different surface chemistry (and a similar roughness) were compared. Cellular morphology was observed by scanning electron microscopy and cell adhesion was quantified using an image analysis system. Osteoblast proliferation was quantified by a MTT test and total protein content and alkaline phosphatase (ALP) activity were evaluated by spectrophotometry. Data were compared by statistical analysis.
   Results showed that NiTi surface roughness did not influence osteoblasts morphology, adhesion, total protein content and ALP activity whereas it modulated cell proliferation. Roughness was shown to stimulate cell proliferation. For smooth surfaces exhibiting two different chemical compositions, adhesion rate was found to be higher on Thermanox (R) than on NiTi whereas proliferation was shown to be smaller. ALP activity was also modulated by surface chemistry. Thus, cell adhesion and ALP activity were found to be more governed by surface chemistry than by roughness whereas cell proliferation was shown to be modulated by roughness (this effect increasing during cell culture) and by chemistry (this effect remaining stable in time) together. Total protein content and cell morphology were found to be independent of both parameters (roughness and chemistry). Effects of surface chemistry were discussed in terms of wettability and electron acceptor/donor properties of the surfaces of interest. Immunofluorescence images of adhesion proteins could not demonstrate differences between the three surfaces. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Ponsonnet, Laurence] Univ Rouen, Lab Polymeres Biopolymeres & Membranes, CNRS, UMR 6522, F-76821 Mont St Aignan, France.
   [Wirth, Carine; Grosgogeat, Brigitte; Lagneau, Christelle] Univ Lyon 1, Lab Etud Interfaces & Biofilms Odontol, F-69372 Lyon, France.
   [Grosgogeat, Brigitte] Univ Lyon 1, CNRS, UMR 5615, Lab Multimat & Interfaces, F-69622 Lyon, France.
   [Jaffrezic-Renault, Nicole] Univ Lyon 1, CNRS, UMR 5180, Sci Analyt Lab, F-69622 Lyon, France.
RP Ponsonnet, L (reprint author), Univ Rouen, Lab Polymeres Biopolymeres & Membranes, CNRS, UMR 6522, F-76821 Mont St Aignan, France.
EM laurence.ponsonnet@galilee.univ-paris13.fr
CR Ahmad M, 1999, J BIOMED MATER RES, V46, P121, DOI 10.1002/(SICI)1097-4636(199907)46:1<121::AID-JBM14>3.0.CO;2-P
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   Bierbaum S, 2003, J BIOMED MATER RES A, V67A, P431, DOI 10.1002/jbm.a.10084
   BOUVIER M, 1994, CELL MATER, V4, P135
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   BRAUN G, 1995, CLIN ORAL IMPLAN RES, V6, P1, DOI 10.1034/j.1600-0501.1995.060101.x
   BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Castellani R, 1999, CLIN ORAL IMPLAN RES, V10, P369, DOI 10.1034/j.1600-0501.1999.100504.x
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   Chou LS, 1996, J BIOMED MATER RES, V31, P209
   Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G
   Dubois JC, 1999, BIOMATERIALS, V20, P1841, DOI 10.1016/S0142-9612(99)00082-4
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   HEAD WC, 1995, CLIN ORTHOP RELAT R, V311, P85
   Kapanen A, 2001, BIOMATERIALS, V22, P2475, DOI 10.1016/S0142-9612(00)00435-X
   Kapanen A, 2002, BIOMATERIALS, V23, P645, DOI 10.1016/S0142-9612(01)00143-0
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Ku CH, 2002, BIOMATERIALS, V23, P4193, DOI 10.1016/S0142-9612(02)00161-8
   Kulkarni RP, 1999, BJU INT, V83, P755
   KUNETSOV MV, 1992, J ELECT SPECTROSC RE, V58, P169
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   Mabboux F, 2004, COLLOID SURFACE B, V39, P199, DOI 10.1016/j.colsurfb.2004.08.002
   Mailhot JM, 1998, CLIN ORAL IMPLAN RES, V9, P43, DOI 10.1034/j.1600-0501.1998.090106.x
   Marks L S, 1999, Tech Urol, V5, P226
   Matsuzaka K, 2004, J BIOMED MATER RES A, V68A, P227, DOI 10.1002/jbm.a.10158
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Maxian SH, 1998, J BIOMED MATER RES, V40, P171, DOI 10.1002/(SICI)1097-4636(199805)40:2<171::AID-JBM1>3.0.CO;2-I
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mueller L, 2003, J SURG RES, V114, P146, DOI 10.1016/S0022-4804(03)00252-X
   Mustafa K, 2000, CLIN ORAL IMPLAN RES, V11, P116, DOI 10.1034/j.1600-0501.2000.011002116.x
   Nattrass C, 1998, EUR J ORTHODONT, V20, P169, DOI 10.1093/ejo/20.2.169
   NEFUSSI JR, 1985, DIFFERENTIATION, V29, P160, DOI 10.1111/j.1432-0436.1985.tb00310.x
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   PONSONNET L, 2003, MAT SCI ENG C-BIO S, V23, P467
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   ROBEY PG, 1972, DISORDERS BONE MINER, P241
   Rosa AL, 2003, CLIN ORAL IMPLAN RES, V14, P43, DOI 10.1034/j.1600-0501.2003.140106.x
   Ryhanen J, 1999, J BIOMED MATER RES, V47, P472, DOI 10.1002/(SICI)1097-4636(19991215)47:4<472::AID-JBM3>3.0.CO;2-Z
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   Schneevoigt R, 1999, MED ENG PHYS, V21, P119, DOI 10.1016/S1350-4533(99)00034-X
   SIMON A, 2002, INTERET AFM BIOFONCT
   Skjodt H, 1994, CYTOKINES BONE METAB, P1
   Sun JS, 2004, BIOMATERIALS, V25, P607, DOI 10.1016/S0142-9612(03)00567-2
   Takeshita F, 1997, BIOMATERIALS, V18, P21, DOI 10.1016/S0142-9612(96)00051-8
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   Trepanier C, 1999, J BIOMED MATER RES, V48, P165, DOI 10.1002/(SICI)1097-4636(1999)48:2<165::AID-JBM11>3.0.CO;2-#
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
   Wirth C, 2005, MAT SCI ENG C-BIO S, V25, P51, DOI 10.1016/j.msec.2004.06.001
   Yang YZ, 2002, BIOMATERIALS, V23, P1383, DOI 10.1016/S0142-9612(01)00259-9
NR 61
TC 51
Z9 56
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JUL 1
PY 2008
VL 28
IS 5-6
SI SI
BP 990
EP 1001
DI 10.1016/j.msec.2007.10.085
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 332IG
UT WOS:000258076100075
DA 2018-10-20
ER

PT J
AU Moscato, S
   Mattii, L
   D'Alessandro, D
   Cascone, MG
   Lazzeri, L
   Serino, LP
   Dolfi, A
   Bernardini, N
AF Moscato, Stefania
   Mattii, Letizia
   D'Alessandro, Delfo
   Cascone, Maria Grazia
   Lazzeri, Luigi
   Serino, Lorenzo Pio
   Dolfi, Arnelio
   Bernardini, Nunzia
TI Interaction of human gingival fibroblasts with PVA/gelatine
SO MICRON
LA English
DT Review
DE tissue engineering; biomimetic scaffolds; PVA; gelatine; human
   fibroblasts; extracellular matrix molecules; TGF-beta 1; RhoA;
   immunocytochemistry; ultrastructure
ID ACTIVATED PROTEIN-KINASE; CELL-CYCLE PROGRESSION; TRANSFORMING
   GROWTH-FACTOR-BETA-1; POLYMERIC SCAFFOLDS; STEM-CELLS; IN-VITRO;
   FIBRONECTIN; EXPRESSION; COLLAGENASE-3; ANGIOGENESIS
AB Tissue engineering scaffolds should be able to reproduce optimal microenvironments in order to support cell attachment, three-dimensional growth, migration and, regarding fibroblasts, must also promote extracellular matrix production. Various bioactive molecules are employed in the preparation of spongy scaffolds to obtain biomimetic matrices by either surface-coating or introducing them into the bulk composition of the biomaterial. The biomimetic properties of a spongy matrix composed of PVA combined with the natural component gelatine were evaluated by culturing human gingival fibroblasts on the scaffold. Cell adhesion, morphology and distribution within the scaffold were assessed by histology and electron microscopy; viability and metabolic activity as well as extracellular matrix production were analyzed by MTT assay, cytochemistry and immunocytochemistry. Fibroblasts interacted positively with PVA/gelatine. They adhered to the PVA/gelatine matrix in which they had good spreading activity and active metabolism; fibroblasts were also able to produce extracellular matrix molecules (type I collagen, fibronectin and laminin) compared to bi-dimensionally grown cells. The in situ creation of a biological matrix by human fibroblasts together with the ability to produce growth factor TGF-beta 1 and the intracellular signal transduction molecule RhoA, suggests that this kind of PVA/gelatine sponge may represent a suitable support for in vitro extracellular matrix production and connective tissue regeneration. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Moscato, Stefania; Mattii, Letizia; D'Alessandro, Delfo; Serino, Lorenzo Pio; Dolfi, Arnelio; Bernardini, Nunzia] Univ Pisa, Fac Med, Med Histol & Embriol Sect, Dept Human Morphol & Appl Biol, I-56126 Pisa, Italy.
   [Cascone, Maria Grazia; Lazzeri, Luigi] Univ Pisa, Dept Chem Engn, Fac Engn, I-56100 Pisa, Italy.
RP Bernardini, N (reprint author), Univ Pisa, Fac Med, Med Histol & Embriol Sect, Dept Human Morphol & Appl Biol, Via Roma 55, I-56126 Pisa, Italy.
EM n.bernardini@med.unipi.it
RI Moscato, Stefania/B-6151-2018; Mattii, Letizia/B-6123-2018
OI Moscato, Stefania/0000-0001-9283-6902; Mattii,
   Letizia/0000-0001-6835-7987
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Alberts B., 2002, MOL BIOL CELL
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Bernardini N, 1999, NEPHRON, V81, P289, DOI 10.1159/000045295
   Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267
   Danen EHJ, 2000, J CELL BIOL, V151, P1413, DOI 10.1083/jcb.151.7.1413
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Fried K, 2005, EXP CELL RES, V307, P329, DOI 10.1016/j.yexcr.2005.04.009
   Konttinen YT, 2000, ARTHRITIS RES, V2, P348, DOI 10.1186/ar111
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Lee DY, 2005, ARCH DERMATOL RES, V296, P296, DOI 10.1007/s00403-004-0529-5
   Moscato S, 2006, J BIOMED MATER RES A, V76A, P214, DOI 10.1002/jbm.a.30538
   OVERALL CM, 1991, J BIOL CHEM, V266, P14064
   Patel N, 1998, FASEB J, V12, P1447
   Pierce RA, 1998, AM J RESP CELL MOL, V19, P237, DOI 10.1165/ajrcmb.19.2.3087
   Ravanti L, 1999, J BIOL CHEM, V274, P2446, DOI 10.1074/jbc.274.4.2446
   Reed MJ, 2003, MICROVASC RES, V65, P9, DOI 10.1016/S0026-2862(02)00026-2
   Reed MJ, 1998, AM J PATHOL, V152, P113
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   Shah M, 1999, AM J PATHOL, V154, P1115, DOI 10.1016/S0002-9440(10)65364-3
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048
   Specchia N, 2001, J ORTHOPAED RES, V19, P294, DOI 10.1016/S0736-0266(00)00026-7
   Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769
   Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yoshinouchi T, 1999, EUR RESPIR J, V14, P579, DOI 10.1034/j.1399-3003.1999.14c16.x
   Zavan B, 2005, BIOMATERIALS, V26, P7038, DOI 10.1016/j.biomaterials.2005.04.067
NR 30
TC 36
Z9 41
U1 2
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD JUL
PY 2008
VL 39
IS 5
BP 569
EP 579
DI 10.1016/j.micron.2007.06.016
PG 11
WC Microscopy
SC Microscopy
GA 324QF
UT WOS:000257532400008
PM 17702585
DA 2018-10-20
ER

PT J
AU Noth, U
   Steinert, AF
   Tuan, RS
AF Noeth, Ulrich
   Steinert, Andre F.
   Tuan, Rocky S.
TI Technology Insight: adult mesenchymal stem cells for osteoarthritis
   therapy
SO NATURE CLINICAL PRACTICE RHEUMATOLOGY
LA English
DT Review
DE articular cartilage; biomaterial scaffold; gene delivery;
   osteoarthritis; mesenchymal stem cell
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; GENE-THERAPY; ARTICULAR-CARTILAGE;
   BONE-MARROW; CHONDROGENIC DIFFERENTIATION; OSTEOCHONDRAL DEFECTS; JOINT
   DISEASES; STROMAL CELLS; KNEE; REPAIR
AB Despite the high prevalence and morbidity of osteoarthritis (OA), an effective treatment for this disease is currently lacking. Restoration of the diseased articular cartilage in patients with OA is, therefore, a challenge of considerable appeal to researchers and clinicians. Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate into cells of the chondrogenic lineage have led to a variety of experimental strategies to investigate whether MSCs instead of chondrocytes can be used for the regeneration and maintenance of articular cartilage. MSC-based strategies should provide practical advantages for the patient with OA. These strategies include use of MSCs as progenitor cells to engineer cartilage implants that can be used to repair chondral and osteochondral lesions, or as trophic producers of bioactive factors to initiate endogenous regenerative activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs. Delivery of MSCs might be attained by direct intra-articular injection or by graft of engineered constructs derived from cell-seeded scaffolds; this latter approach could provide a three dimensional construct with mechanical properties that are congruous with the weight-bearing function of the joint. Promising experimental and clinical data are beginning to emerge in support of the use of MSCs for regenerative applications.
C1 [Tuan, Rocky S.] NIAMSD, Cartilage Biol & Orthoped Branch, NIH, Bethesda, MD 20892 USA.
   [Noeth, Ulrich] Univ Wurzburg, Orthoped Ctr Musculoskeletal Res, Div Tissue Engn, Wurzburg, Germany.
RP Tuan, RS (reprint author), NIAMSD, Cartilage Biol & Orthoped Branch, NIH, Bldg 50,Room 1523,50 S Dr MSC 8022, Bethesda, MD 20892 USA.
EM tuanr@mail.nih.gov
RI Steinert, Prof. Dr., Andre/P-4559-2015
OI Steinert, Prof. Dr., Andre/0000-0002-4397-8434
FU Intramural NIH HHS
CR Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534
   Barry Frank P., 2003, Birth Defects Research, V69, P250, DOI 10.1002/bdrc.10021
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   Bert JM, 2002, ARTHROSCOPY, V18, P107, DOI 10.1053/jars.2002.36513
   Brooks PM, 2002, CURR OPIN RHEUMATOL, V14, P573, DOI 10.1097/01.BOR.0000025200.21474.83
   Buckwalter JA, 2006, BIORHEOLOGY, V43, P603
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216
   Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x
   De Bari C, 2007, CLIN SCI, V113, P339, DOI 10.1042/CS20070126
   Deschner J, 2003, CURR OPIN CLIN NUTR, V6, P289, DOI 10.1097/01.mco.0000068964.34812.2b
   Elders MJ, 2000, J RHEUMATOL, V27, P6
   Evans CH, 2005, P NATL ACAD SCI USA, V102, P8698, DOI 10.1073/pnas.0502854102
   Evans CH, 2004, GENE THER, V11, P379, DOI 10.1038/sj.gt.3302196
   Evans CH, 1996, HUM GENE THER, V7, P1261, DOI 10.1089/hum.1996.7.10-1261
   Evans CH, 2006, NAT CLIN PRACT RHEUM, V2, P344, DOI 10.1038/ncprheum0215
   Frisbie DD, 2002, GENE THER, V9, P12, DOI 10.1038/sj.gt.3301608
   Gelse K, 2003, ARTHRITIS RHEUM, V48, P430, DOI 10.1002/art.10759
   Gerwin N, 2006, ADV DRUG DELIVER REV, V58, P226, DOI 10.1016/j.addr.2006.01.018
   Gouze E, 2007, MOL THER, V15, P1114, DOI 10.1038/sj.mt.6300151
   Gunther JP, 2001, BEST PRACT RES CL RH, V15, P627, DOI 10.1053/berh.2001.0178
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   Haupt JL, 2005, J ORTHOP RES, V23, P118, DOI 10.1016/j.orthres.2004.06.020
   Henderson I, 2005, KNEE, V12, P209, DOI 10.1016/j.knee.2004.07.002
   HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104
   Hollander AP, 2006, TISSUE ENG, V12, P1787, DOI 10.1089/ten.2006.12.1787
   Im GI, 2006, TISSUE ENG, V12, P527, DOI 10.1089/ten.2006.12.527
   Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285
   Kan I., 2007, V180, P219
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311
   Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Li WJ, 2005, J BIOMED NANOTECHNOL, V1, P259, DOI 10.1166/jbn.2005.032
   Martin JA, 2004, CLIN ORTHOP RELAT R, pS96, DOI 10.1097/01.blo.0000143818.74887.b1
   Mi Z, 2003, ARTHRITIS RES THER, V5, pR132, DOI 10.1186/ar745
   Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259
   Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Murphy JM, 2002, ARTHRITIS RHEUM, V46, P704, DOI 10.1002/art.10118
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Nesic D, 2006, ADV DRUG DELIVER REV, V58, P300, DOI 10.1016/j.addr.2006.01.012
   Nixon AJ, 2005, GENE THER, V12, P177, DOI 10.1038/sj.gt.3302396
   Noth U, 2007, J BIOMED MATER RES A, V83A, P626, DOI 10.1002/jbm.a.31254
   Noth U, 2002, TISSUE ENG, V8, P131, DOI 10.1089/107632702753503126
   NOTH U, 2006, EUROPEAN MUSCULOSKEL, P62
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Robbins PD, 2003, GENE THER, V10, P902, DOI 10.1038/sj.gt.3302040
   Scharstuhl A, 2007, STEM CELLS, V25, P3244, DOI 10.1634/stemcells.2007.0300
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   Terada S, 2005, J BIOMED MATER RES A, V75A, P907, DOI 10.1002/jbm.a.30505
   Trippel SB, 2004, GENE THER, V11, P351, DOI 10.1038/sj.gt.3302201
   Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991
   Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001
   Verbruggen G, 2006, RHEUMATOLOGY, V45, P129, DOI 10.1093/rheumatology/kei171
   Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747
NR 63
TC 155
Z9 161
U1 5
U2 35
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1745-8382
J9 NAT CLIN PRACT RHEUM
JI Nat. Clin. Pract. Rheumatol.
PD JUL
PY 2008
VL 4
IS 7
BP 371
EP 380
DI 10.1038/ncprheum0816
PG 10
WC Rheumatology; Social Issues
SC Rheumatology; Social Issues
GA 320XP
UT WOS:000257268800013
PM 18477997
DA 2018-10-20
ER

PT J
AU Waese, EYL
   Kandel, RR
   Stanford, WL
AF Waese, Elaine Y. L.
   Kandel, Rita R.
   Stanford, William L.
TI Application of stem cells in bone repair
SO SKELETAL RADIOLOGY
LA English
DT Review
DE bone repair; osteoprogenitors; mesenchymal stromal cells; embryonic stem
   cells; pluripotent; scaffold
ID MARROW STROMAL CELLS; SEVERE OSTEOGENESIS IMPERFECTA; THERAPY POSITION
   STATEMENT; REGIONAL GENE-THERAPY; MESENCHYMAL STEM; IN-VITRO;
   INTERNATIONAL-SOCIETY; ARTICULAR-CARTILAGE; PROGENITOR CELLS; HUMAN FAT
AB Bone has the ability to repair minor injuries through remodeling. However, when the host source of osteoprogenitors is compromised at the defect site, one effective treatment may be cell-based therapy, as it replenishes the area of bone loss with cells possessing osteogenic potential. This review is a concise comparison of different types of stem cells that have the potential to be used in tissue-engineered scaffolds for bone repair. The clinical use of mesenchymal stem or stromal cells isolated from the bone marrow for treating various diseases has been well documented. However, the scarcity of these cells prompts the search for alternative sources of multipotential cells such as amniotic fluid stem cells and umbilical cord perivascular cells. Embryonic stem cells are another controversial source of cells with osteogenic potential. These cells have the ability to differentiate into all cell types of the adult body. Issues such as the use of human embryos and the risk of contamination from animal-derived culture components continue to prevent the therapeutic use of ESCs. As a result, abundant research has been carried out to design defined culture conditions for culturing ESCs, and alternative strategies such as the generation of induced pluripotent stem cells are being developed to eliminate the need for using embryos for cell derivation. In addition to the cell source, the ability to control stem cell differentiation into functional bone and the choice of biomaterial are also paramount objectives that are being examined in research and clinical trials.
C1 [Waese, Elaine Y. L.; Kandel, Rita R.; Stanford, William L.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Kandel, Rita R.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada.
   [Waese, Elaine Y. L.; Stanford, William L.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G9, Canada.
RP Stanford, WL (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St, Toronto, ON M5S 3G9, Canada.
EM william.stanford@utoronto.ca
RI Kandel, Rita/E-2149-2017
OI Kandel, Rita/0000-0003-4047-3913; Stanford, William/0000-0002-5813-8016
CR Ahmed N, 2007, SKELETAL RADIOL, V36, P909, DOI 10.1007/s00256-007-0333-3
   Ahn SE, 2006, BIOCHEM BIOPH RES CO, V340, P403, DOI 10.1016/j.bbrc.2005.12.020
   Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518
   Boden SD, 2005, ORTHOP NURS, V24, P49
   Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14
   Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bruder SP, 1999, CLIN ORTHOP RELAT R, pS68
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Cao T, 2005, TISSUE CELL, V37, P325, DOI 10.1016/j.tice.2005.03.008
   Chiavegato A, 2007, J MOL CELL CARDIOL, V42, P746, DOI 10.1016/j.yjmcc.2006.12.008
   Chin ACP, 2007, J BIOTECHNOL, V130, P320, DOI 10.1016/j.jbiotec.2007.04.013
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Dallari D, 2007, J BONE JOINT SURG AM, V89A, P2413, DOI 10.2106/JBJS.F.01026
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dragoo JL, 2003, J ORTHOP RES, V21, P622, DOI 10.1016/S0736-0266(02)00238-3
   Dragoo JL, 2005, PLAST RECONSTR SURG, V115, P1665, DOI 10.1097/01.PRS.0000161459.90856.AB
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Galotto M, 1999, EXP HEMATOL, V27, P1460, DOI 10.1016/S0301-472X(99)00076-4
   Gazit D, 1999, J GENE MED, V1, P121, DOI 10.1002/(SICI)1521-2254(199903/04)1:2<121::AID-JGM26>3.0.CO;2-J
   Gertow K, 2004, STEM CELLS DEV, V13, P421, DOI 10.1089/1547328041797499
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234
   Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399
   Horwitz EM, 2001, BLOOD, V97, P1227, DOI 10.1182/blood.V97.5.1227
   Hyslop Louise A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009804
   Jankowski RJ, 2002, GENE THER, V9, P642, DOI 10.1038/sj/gt/3301719
   Karp JM, 2006, STEM CELLS, V24, P835, DOI 10.1634/stemcells.2005-0383
   Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542
   Kitoh H, 2004, BONE, V35, P892, DOI 10.1016/j.bone.2004.06.013
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Muschler GF, 2003, CLIN ORTHOP RELAT R, P102, DOI 10.1097/01.blo.0000030504.43495.46
   NAKAHARA H, 1990, BONE, V11, P181, DOI 10.1016/8756-3282(90)90212-H
   O'Shea KS, 1999, ANAT REC, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2
   OFLAHERTY E, 1995, BONE MARROW TRANSPL, V15, P207
   Oreffo ROC, 1998, SCAND J RHEUMATOL, V27, P415
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prusa Andrea-Romana, 2002, Med Sci Monit, V8, pRA253
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Rodriguez JP, 2000, J CELL BIOCHEM, V79, P557, DOI 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H
   Rodriguez JP, 2004, J CELL BIOCHEM, V92, P745, DOI 10.1002/jcb.20119
   Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166
   Schnutgen F, 2006, METHOD ENZYMOL, V420, P100, DOI 10.1016/S0076-6879(06)20007-7
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takigami H, 2007, J ORTHOP RES, V25, P1333, DOI 10.1002/jor.20411
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tu Q, 2007, TISSUE ENG, V13, P2431, DOI 10.1089/ten.2006.0406
   Tu QS, 2006, BIOCHEM BIOPH RES CO, V341, P1257, DOI 10.1016/j.bbrc.2006.01.092
   Wang JC, 2003, J BONE JOINT SURG AM, V85A, P905, DOI 10.2106/00004623-200305000-00020
   Wu L, 2007, MOL CELL BIOCHEM, V301, P83, DOI 10.1007/s11010-006-9399-9
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zhang X, 2006, CALCIFIED TISSUE INT, V79, P169, DOI 10.1007/s00223-006-0083-6
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 73
TC 38
Z9 43
U1 0
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-2348
J9 SKELETAL RADIOL
JI Skeletal Radiol.
PD JUL
PY 2008
VL 37
IS 7
BP 601
EP 608
DI 10.1007/s00256-007-0438-8
PG 8
WC Orthopedics; Radiology, Nuclear Medicine & Medical Imaging
SC Orthopedics; Radiology, Nuclear Medicine & Medical Imaging
GA 304EF
UT WOS:000256092100002
PM 18193216
DA 2018-10-20
ER

PT J
AU Mok, JM
   Durrani, SK
   Piper, SL
   Hu, SS
   Deviren, V
   Berven, SH
   Burch, S
AF Mok, James M.
   Durrani, Salim K.
   Piper, Samantha L.
   Hu, Serena S.
   Deviren, Vedat
   Berven, Sigurd H.
   Burch, Shane
TI Extravasation of rhBMP-2 with use of postoperative drains after
   posterolateral spinal fusion
SO SPINE
LA English
DT Article
DE bone morphogenetic protein; rhBMP-2; BMP-2; leakage; extravasation;
   drains; posterolateral spinal fusion; collagen sponge
ID BONE MORPHOGENETIC PROTEIN-2; ANTERIOR INTERBODY FUSION; RAT ECTOPIC
   MODEL; NONHUMAN PRIMATE; BIOMATERIAL CARRIERS; GRAFT SUBSTITUTE;
   COLLAGEN SPONGES; IN-VIVO; ARTHRODESIS; SAFETY
AB Study Design. Prospective measurement of rhBMP-2 from drains in a cohort of patients undergoing posterolateral spinal fusion.
   Objective. To quantify the amount of rhBMP-2 that extravasates into drains after posterolateral fusion using its current commercially available form, rhBMP-2 within an absorbable collagen sponge.
   Summary of Background Data. Retention of rhBMP-2 at the fusion site is essential for clinical efficacy and avoidance of unintentional bony growth in other areas of the spine. In vitro studies have shown a large degree of rhBMP-2 release from the sponge within the first 48 hours. It is unknown what effect drainage may have on changing the local concentration of BMP at the posterolateral site.
   Methods. The entire contents of drains were collected for 48 hours after surgery from 9 patients who underwent instrumented posterolateral fusion with rhBMP-2. The total amount collected was calculated from the concentration of BMP-2 as measured by enzyme-linked immunosorbent assay.
   Results. A median 68 mu g of BMP-2 ( range, 13-498) was recovered from drains, representing a median 0.58% ( range, 0.21%-4.2%) of the amount implanted; adjusted for yield rate, a median 1.08% was recovered. No significant relationships were found between percentage of BMP-2 extravasation and amount implanted, number of levels, blood loss, and drainage output. A mean 54% of the total amount recovered was in the drain within the first 6 hours.
   Conclusion. The greater bleeding and muscular compression associated with posterolateral fusion did not result in a substantial amount of rhBMP-2 extravasation into postoperative drains. Based on the small rates of recovery, suction drains may be placed after even complex surgeries involving large blood loss without the loss of significant amounts of the implanted rhBMP-2 into the drain.
C1 [Mok, James M.; Durrani, Salim K.; Piper, Samantha L.; Hu, Serena S.; Deviren, Vedat; Berven, Sigurd H.; Burch, Shane] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA.
RP Burch, S (reprint author), Univ Calif San Francisco, Dept Orthopaed Surg, 500 Parnassus,MU320-W,Box 0728, San Francisco, CA 94143 USA.
EM burchs@orthosurg.ucsf.edu
CR Barnes B, 2005, SPINE, V30, P1127, DOI 10.1097/01.brs.0000162623.48058.8c
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 1998, J SPINAL DISORD, V11, P95
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   Bouxsein ML, 2001, J BONE JOINT SURG AM, V83A, P1219, DOI 10.2106/00004623-200108000-00012
   COOK SD, 1994, SPINE, V19, P1655, DOI 10.1097/00007632-199408000-00002
   Dimar J, 2006, SPINE, V31, P2540
   Dimar JR, 2006, SPINE, V31, P2534, DOI 10.1097/01.brs.0000240715.78657.81
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   GLASSMAN SD, 2007, SPINE J, V8, P443
   Glassman SD, 2007, SPINE J, V7, P44, DOI 10.1016/j.spinee.2006.06.381
   Haid Jr RW, 2004, SPINE J, V4, P38
   Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025
   Hecht BP, 1999, SPINE, V24, P629, DOI 10.1097/00007632-199904010-00004
   Kwon Brian, 2005, Spine J, V5, p224S, DOI 10.1016/j.spinee.2005.02.007
   Li G, 1998, ACTA ORTHOP SCAND, V69, P420, DOI 10.3109/17453679808999060
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   Martin GJ, 1999, J SPINAL DISORD, V12, P179, DOI 10.1097/00002517-199906000-00001
   Meyer RA, 1999, SPINE, V24, P747, DOI 10.1097/00007632-199904150-00004
   MUSCHLER GF, 1994, CLIN ORTHOP RELAT R, P229
   Patel Vikas V, 2006, Spine J, V6, P397, DOI 10.1016/j.spinee.2005.11.006
   Patel VV, 2006, SPINE, V31, P1201, DOI 10.1097/01.brs.0000217650.90861.99
   Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/01.BRS.0000020734.34957.6A
   Sandhu HS, 2002, SPINE, V27, P567, DOI 10.1097/00007632-200203150-00003
   Sandhu HS, 1995, SPINE, V20, P2669, DOI 10.1097/00007632-199512150-00008
   SCHIMANDLE JH, 1995, SPINE, V20, P1326, DOI 10.1097/00007632-199506000-00002
   Sciadini MF, 2000, J ORTHOPAED RES, V18, P289, DOI 10.1002/jor.1100180218
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Singh K, 2006, J SPINAL DISORD TECH, V19, P416, DOI 10.1097/00024720-200608000-00008
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   Yoon ST, 2004, SPINE, V29, P2603, DOI 10.1097/01.brs.0000146103.94600.85
NR 36
TC 7
Z9 7
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
J9 SPINE
JI SPINE
PD JUL 1
PY 2008
VL 33
IS 15
BP 1668
EP 1674
DI 10.1097/BRS.0b013e31817b6229
PG 7
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 322RS
UT WOS:000257393600009
PM 18594460
DA 2018-10-20
ER

PT J
AU Nettles, DL
   Kitaoka, K
   Hanson, NA
   Flahiff, CM
   Mata, BA
   Hsu, EW
   Chilkoti, A
   Setton, LA
AF Nettles, Dana L.
   Kitaoka, Kenichi
   Hanson, Neil A.
   Flahiff, Charlene M.
   Mata, Brian A.
   Hsu, Edward W.
   Chilkoti, Ashutosh
   Setton, Lori A.
TI In situ crosslinking elastin-like polypeptide gels for application to
   articular cartilage repair in a goat osteochondral defect model
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; TISSUE-ENGINEERED CARTILAGE;
   FULL-THICKNESS DEFECTS; PROTEIN-BASED POLYMERS; CULTURED CHONDROCYTES;
   HYDROGELS; MATRIX; SCAFFOLD; VITRO
AB The objective of this study was to evaluate an injectable, in situ crosslinkable elastin-like polypeptide (ELP) gel for application to cartilage matrix repair in critically sized defects in goat knees. One cylindrical, osteochondral defect in each of seven animals was filled with an aqueous solution of ELP and a biocompatible, chemical crosslinker, while the contralateral defect remained unfilled and served as an internal control. Joints were sacrificed at 3 (n=3) or 6 (n=4) months for MRI, histological, and gross evaluation of features of biomaterial performance, including integration, cellular infiltration, surrounding matrix quality, and new matrix in the defect. At 3 months, ELP-filled defects scored significantly higher for integration by histological and gross grading compared to unfilled defects. ELP did not impede cell infiltration but appeared to be partly degraded. At 6 months, new matrix in unfilled defects outpaced that in ELP-filled defects and scored significantly better for MRI evidence of adverse changes, as well as integration and proteoglycan-containing matrix via gross and histological grading. The ELP-crosslinker solution was easily delivered and formed stable, well-integrated gels that supported cell infiltration and matrix synthesis; however, rapid degradation suggests that ELP formulation modifications should be optimized for longer-term benefits in cartilage repair applications.
C1 [Nettles, Dana L.; Flahiff, Charlene M.; Chilkoti, Ashutosh; Setton, Lori A.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Kitaoka, Kenichi] Kochi Med Sch, Dept Orthopaed Surg, Kochi, Japan.
   [Hanson, Neil A.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27708 USA.
   [Mata, Brian A.; Setton, Lori A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27708 USA.
   [Hsu, Edward W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Setton, LA (reprint author), Duke Univ, Dept Biomed Engn, 136 Hudson Hall,Box 90281,Sci Dr, Durham, NC 27708 USA.
EM setton@duke.edu
FU NIBIB NIH HHS [R01 EB002263-08, R01 EB002263, EB002263]
CR Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021
   BUCKWALTER JA, 1983, INSTR COURSE LECT, V32, P349
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   HANSON NA, 2006, T ORTHOP RES SOC, V31
   Henderson IJP, 2003, J BONE JOINT SURG BR, V85B, P1060, DOI 10.1302/0301-620X.85B7.13782
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Huber M, 2000, INVEST RADIOL, V35, P573, DOI 10.1097/00004424-200010000-00003
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008
   Lee J, 2001, BIOMACROMOLECULES, V2, P170, DOI 10.1021/bm0000900
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007
   Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208
   Nagapudi K, 2002, MACROMOLECULES, V35, P1730, DOI 10.1021/ma011429t
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Ong SR, 2006, BIOMATERIALS, V27, P1930, DOI 10.1016/j.biomaterials.2005.10.018
   Passaretti D, 2001, TISSUE ENG, V7, P805, DOI 10.1089/107632701753337744
   Recht M, 2003, SKELETAL RADIOL, V32, P185, DOI 10.1007/s00256-003-0631-3
   Saim AB, 2000, LARYNGOSCOPE, V110, P1694, DOI 10.1097/00005537-200010000-00023
   SANDBERG LB, 1981, NEW ENGL J MED, V304, P566, DOI 10.1056/NEJM198103053041004
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001
   Sims CD, 1996, PLAST RECONSTR SURG, V98, P843, DOI 10.1097/00006534-199610000-00015
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   URRY DW, 1992, PROG BIOPHYS MOL BIO, V57, P23, DOI 10.1016/0079-6107(92)90003-O
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   Verstraete KL, 2004, CLIN RADIOL, V59, P674, DOI 10.1016/j.crad.2004.01.012
NR 43
TC 58
Z9 58
U1 1
U2 19
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUL
PY 2008
VL 14
IS 7
BP 1133
EP 1140
DI 10.1089/ten.tea.2007.0245
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 327WR
UT WOS:000257759700002
PM 18433311
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Pehlivan, E
   Altun, T
AF Pehlivan, Erol
   Altun, Tuerkan
TI Biosorption of chromium(VI) ion from aqueous solutions using walnut,
   hazelnut and almond shell
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE shell; low-cost adsorbent; batch model; chromium; adsorption; Walnut;
   Hazelnut; Almond
ID SULFURIZED ACTIVATED CARBON; AGRICULTURAL BY-PRODUCTS; HEXAVALENT
   CHROMIUM; WASTE-WATER; METAL-IONS; HEAVY-METALS; EXCHANGE-RESINS;
   CITRIC-ACID; BROWN COALS; REMOVAL
AB The potential to remove Cr(VI) ion from aqueous solutions through biosorption using, the shells of Walnut (WNS) (Juglans regia), Hazelnut (HNS) (Corylus avellana) and Almond (AS) (Prunus dulcis) was investigated in batch experiments. The equilibrium adsorption level was determined to be a function of the solution contact time and concentration. Kinetic experiments revealed that the dilute chromium solutions reached equilibrium within 100 min. The biosorptive capacity of the shells was dependent on the pH of the chromium solution, with pH 3.5 being optimal. Adsorption of Cr(VI) ion uptake is in all cases pH-dependent showing a maximum at equilibrium pH values between 2.0 and 3.5, depending on the biomaterial, that correspond to equilibrium pH values of 3.5 for (WNS), 3.5 for (HNS) and 3.2 for (AS). The adsorption data fit well with the Langmuir isotherm model. The sorption process conformed to the Langmuir isotherm with maximum Cr(VI) ion sorption capacities of 8.01, 8.28, and 3.40 mg/g for WNS, HNS and AS, respectively. Percentage removal by WNS, HNS and AS was 85.32, 88.46 and 55.00%, respectively at a concentration of 0.5 mM. HNS presented the highest adsorption capacities for the Cr(VI) ion. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Pehlivan, Erol; Altun, Tuerkan] Selcut Univ, Dept Chem Engn, TR-42079 Konya, Turkey.
RP Altun, T (reprint author), Selcut Univ, Dept Chem Engn, TR-42079 Konya, Turkey.
EM erolpehlivan@gmail.com
CR Agarwal GS, 2006, BIORESOURCE TECHNOL, V97, P949, DOI 10.1016/j.biortech.2005.04.030
   Bai S, 2001, BIORESOURCE TECHNOL, V79, P73, DOI 10.1016/S0960-8524(00)00107-3
   Boddu VM, 2003, ENVIRON SCI TECHNOL, V37, P4449, DOI 10.1021/es021013a
   Brown PA, 2000, WATER RES, V34, P3907, DOI 10.1016/S0043-1354(00)00152-4
   CHAKRAVARTI AK, 1995, COLLOID SURFACE A, V103, P59, DOI 10.1016/0927-7757(95)03201-N
   Chubar N, 2003, COLLOID SURFACE A, V230, P57, DOI 10.1016/j.colsurfa.2003.09.014
   CieslakGolonka M, 1996, POLYHEDRON, V15, P3667, DOI 10.1016/0277-5387(96)00141-6
   CIMINO G, 1990, BIOL WASTE, V33, P201, DOI 10.1016/0269-7483(90)90005-D
   Cimino G, 2000, WATER RES, V34, P2955, DOI 10.1016/S0043-1354(00)00048-8
   Dean SA, 1999, RESOUR CONSERV RECY, V27, P151, DOI 10.1016/S0921-3449(98)00095-0
   DEFILIPPIS LF, 1994, ALGAE WATER POLLUTIO, P31
   Donmez G, 2002, PROCESS BIOCHEM, V38, P751, DOI 10.1016/S0032-9592(02)00204-2
   Espinola A., 1999, P TMS FALL EXTR PROC, V3, P2057
   Gloaguen V, 1997, J ENVIRON SCI HEAL A, V32, P901, DOI 10.1080/10934529709376585
   Gode F, 2006, ENERG SOURCE PART A, V28, P447, DOI 10.1080/009083190927156
   Gode F, 2005, FUEL PROCESS TECHNOL, V86, P875, DOI 10.1016/j.fuproc.2004.10.006
   Gode F, 2005, J HAZARD MATER, V119, P175, DOI 10.1016/j.jhazmat.2004.12.004
   Gode F, 2003, J HAZARD MATER, V100, P231, DOI 10.1016/S0304-3894(03)00110-9
   Gomez-Serrano V, 1998, WATER RES, V32, P1, DOI 10.1016/S0043-1354(97)00203-0
   Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8
   HO YS, 1995, WATER RES, V29, P1327, DOI 10.1016/0043-1354(94)00236-Z
   Iqbal M, 2002, BIORESOURCE TECHNOL, V81, P151, DOI 10.1016/S0960-8524(01)00126-2
   Juang RS, 2000, J MEMBRANE SCI, V165, P159, DOI 10.1016/S0376-7388(99)00235-5
   Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2
   Kapoor A, 1995, BIORESOURCE TECHNOL, V53, P195, DOI 10.1016/0960-8524(95)00072-1
   Kawamura Y, 1997, WATER SCI TECHNOL, V35, P97, DOI 10.1016/S0273-1223(97)00119-4
   Klimmek S, 2001, ENVIRON SCI TECHNOL, V35, P4283, DOI 10.1021/es010063x
   Lakatos J, 2002, FUEL, V81, P691, DOI 10.1016/S0016-2361(01)00159-4
   Lalvani SB, 1998, CARBON, V36, P1219, DOI 10.1016/S0008-6223(98)00102-X
   Lalvani SB, 2000, ENERG SOURCE, V22, P45, DOI 10.1080/00908310050014207
   LASZLO JA, 1994, J APPL POLYM SCI, V52, P531, DOI 10.1002/app.1994.070520408
   Lee B. G., 2004, Journal of Natural Fibers, V1, P97, DOI 10.1300/J395v01n01_07
   Lee MY, 2005, J APPL POLYM SCI, V96, P44, DOI 10.1002/app.21356
   Lu AH, 2006, ENVIRON SCI TECHNOL, V40, P3064, DOI 10.1021/es052057x
   MaciasGarcia A, 1995, AN QUIM, V91, P547
   MACIASGARCIA A, 1993, CARBON, V31, P1249, DOI 10.1016/0008-6223(93)90083-M
   Maddalone RF, 1996, WATER AIR SOIL POLL, V90, P163, DOI 10.1007/BF00619278
   Madoni P, 1996, WATER RES, V30, P135, DOI 10.1016/0043-1354(95)00124-4
   Madronova L, 2001, REACT FUNCT POLYM, V47, P119, DOI 10.1016/S1381-5148(00)00077-8
   Mahvi A. H., 2005, American Journal of Applied Sciences, V2, P372
   MALTERER T, 1996, MINING ENG, V48, P53
   Marathe RM, 2002, FOOD HYDROCOLLOID, V16, P423, DOI 10.1016/S0268-005X(01)00118-7
   Marshall WE, 2000, ENVIRON TECHNOL, V21, P601, DOI 10.1080/09593332108618075
   MARSHALL WE, 1995, J ENVIRON SCI HEAL A, V30, P241, DOI 10.1080/10934529509376198
   McKay G, 1997, J CHEM TECHNOL BIOT, V69, P309, DOI 10.1002/(SICI)1097-4660(199707)69:3<309::AID-JCTB724>3.0.CO;2-W
   Namasivayam C, 1999, CARBON, V37, P79, DOI 10.1016/S0008-6223(98)00189-4
   Ozdemir G, 2004, CHEM ENG J, V102, P249, DOI 10.1016/j.cej.2004.01.032
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Rengaraj S, 2001, J HAZARD MATER, V87, P273, DOI 10.1016/S0304-3894(01)00291-6
   Ricou-Hoeffer P, 2001, WATER RES, V35, P965, DOI 10.1016/S0043-1354(00)00341-9
   Saeed Asma, 2002, Pakistan Journal of Scientific and Industrial Research, V45, P206
   SHARMA DC, 1994, BIORESOURCE TECHNOL, V47, P257, DOI 10.1016/0960-8524(94)90189-9
   TAN WT, 1993, ENVIRON TECHNOL, V14, P277, DOI 10.1080/09593339309385290
   TEIXER AC, 1999, ENVIRON SCI TECHNOL, V33, P489
   UDAYBHASKAR P, 1990, J APPL POLYM SCI, V39, P739, DOI 10.1002/app.1990.070390322
   VOLESKY B, 1994, FEMS MICROBIOL REV, V14, P291, DOI 10.1111/j.1574-6976.1994.tb00102.x
   Wartelle LH, 2000, ADV ENVIRON RES, V4, P1, DOI 10.1016/S1093-0191(00)00002-2
   Wasay SA, 1999, WATER AIR SOIL POLL, V116, P449, DOI 10.1023/A:1005115820429
   Yan GY, 2001, BIORESOURCE TECHNOL, V78, P243, DOI 10.1016/S0960-8524(01)00020-7
   Yates LM, 1999, ENVIRON SCI TECHNOL, V33, P2076, DOI 10.1021/es980408k
NR 60
TC 124
Z9 137
U1 1
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD JUN 30
PY 2008
VL 155
IS 1-2
BP 378
EP 384
DI 10.1016/j.jhazmat.2007.11.071
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 310TH
UT WOS:000256552800048
PM 18179865
DA 2018-10-20
ER

PT J
AU Song, YW
   Shan, DY
   Han, EH
AF Song, Y. W.
   Shan, D. Y.
   Han, E. H.
TI Electrodeposition of hydroxyapatite coating on AZ91D magnesium alloy for
   biomaterial application
SO MATERIALS LETTERS
LA English
DT Article
DE deposition; hydroxyapatite; coating; biodegradable property; magnesium
   alloy
ID SIMULATED BODY-FLUID; IN-VIVO CORROSION; CALCIUM-PHOSPHATE; BEHAVIOR;
   TI-6AL-4V
AB Magnesium and its alloys are potential biodegradable implant materials due to their attractive biological property. But their poor corrosion resistance may result in the sudden failure of the implants. The bioactive hydroxyapatite (HA) coating was electrodeposited on AZ91D magnesium alloy surface to improve its biodegradation performance. The biodegradable behavior of HA coating was investigated by electrochemical tests and immersion tests. The experimental results indicated that the as-deposited coating consisting of dicalcium phosphate dehydrate ((DCPD, CaHPO4 center dot 2H(2)O) and beta-tricalcium phosphate (beta-TCP, Ca-3 (PO4)(2)) was transformed into uniforryl hydroxyapatite (HA, Calo (PO4)(6)(OH)(2)) coating after immersion in 1 M NaOH solution for 2 h. The HA coating can obviously slow down the biodegradation rate of AZ91 D magnesium alloy in stimulated body fluid (SBF). (c) 2008 Elsevier B.V. All rights reserved.
C1 [Song, Y. W.; Shan, D. Y.; Han, E. H.] Chinese Acad Sci, Inst Met Res, Environm Corros Ctr, Shenyang 110016, Peoples R China.
RP Song, YW (reprint author), Chinese Acad Sci, Inst Met Res, Environm Corros Ctr, 62 Wencui Rd, Shenyang 110016, Peoples R China.
EM ywsong@imr.ac.cn
CR Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cao C.N., 2004, PRINCIPLE CORROSION
   Cao C. N., 2002, INTRO ELECTROCHEMICA
   Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Liu CL, 2007, THIN SOLID FILMS, V516, P422, DOI 10.1016/j.tsf.2007.05.048
   Liu CL, 2007, MAT SCI ENG A-STRUCT, V456, P350, DOI 10.1016/j.msea.2006.12.020
   Narayanan R, 2006, SURF COAT TECH, V200, P4720, DOI 10.1016/j.surfcoat.2005.04.040
   Narayanan R, 2007, SCRIPTA MATER, V56, P229, DOI 10.1016/j.scriptamat.2006.10.004
   Park JH, 2005, SURF COAT TECH, V195, P252, DOI 10.1016/j.surfcoat.2004.08.185
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YW, 2008, ELECTROCHIM ACTA, V53, P2135, DOI 10.1016/j.electacta.2007.09.026
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Yen S. K., 2002, MAT SCI ENG C-BIO S, V20, P153
   Zhang EL, 2005, T NONFERR METAL SOC, V15, P1199
NR 17
TC 323
Z9 351
U1 16
U2 189
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUN 30
PY 2008
VL 62
IS 17-18
BP 3276
EP 3279
DI 10.1016/j.matlet.2008.02.048
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 314AI
UT WOS:000256780700204
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Cejas, MA
   Kinnney, WA
   Chen, C
   Vinter, JG
   Almond, HR
   Balss, KM
   Maryanoff, CA
   Schmidt, U
   Breslav, M
   Mahan, A
   Lacy, E
   Maryanoff, BE
AF Cejas, Mabel A.
   Kinnney, William A.
   Chen, Cailin
   Vinter, Jeremy G.
   Almond, Harold R.
   Balss, Karin M.
   Maryanoff, Cynthia A.
   Schmidt, Ute
   Breslav, Michael
   Mahan, Andrew
   Lacy, Eilyn
   Maryanoff, Bruce E.
TI Thrombogenic collagen-mimetic peptides: Self-assembly of triple
   helix-based fibrils driven by hydrophobic interactions
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; platelets; structure-function; supramolecular triplex
ID STACKING INTERACTIONS; MOLECULAR-STRUCTURE; FORCE-FIELD; STABILITY;
   ACTIVATION; PROTEINS; INTEGRIN; STRANDS; FLOW; GPVI
AB Collagens are integral structural proteins in animal tissues and play key functional roles in cellular modulation. We sought to discover collagen model peptides (CmPs) that would form triple helices and self-assemble into supramolecular fibrils exhibiting collagen-like biological activity without preorganizing the peptide chains by covalent linkages. This challenging objective was accomplished by placing aromatic groups on the ends of a representative 30-mer CMP, (GPO)(10), as with L-phenylalanine and L-pentafluorophenylalanine in 32-mer la. Computational studies on homologous 29-mers 1a'-d' (one less GPO), as pairs of triple helices interacting head-to-tail, yielded stabilization energies in the order 1a' > 1b, > 1c' > 1d', supporting the hypothesis that hydrophobic aromatic groups can drive CMP self-assembly. Peptides 1a-d were studied comparatively relative to structural properties and ability to stimulate human platelets. Although each 32-mer formed stable triple helices (CID) spectroscopy, only 1a and 1b self-assembled into micrometer-scale fibrils. Light microscopy images for 1a depicted long collagen-like fibrils, whereas images for Id did not. Atomic force microscopy topographical images indicated that 1a and 1b self-organize into microfibrillar species, whereas 1 c and 1d do not. Peptides 1a and 1b induced the aggregation of human blood platelets with a potency similar to type I collagen, whereas 1c was much less effective, and 1d was inactive (EC50 potency: 1a/1b >> 1c > 1d). Thus, 1a and 1b spontaneously self-assemble into thrombogenic collagen-mimetic materials because of hydrophobic aromatic interactions provided by the special end-groups. These findings have important implications for the design of biofunctional CmPs.
C1 [Cejas, Mabel A.; Kinnney, William A.; Chen, Cailin; Almond, Harold R.; Breslav, Michael; Mahan, Andrew; Maryanoff, Bruce E.] Johnson & Johnson Pharmaceut Res & Dev, Res & Early Dev, Spring House, PA 19477 USA.
   [Vinter, Jeremy G.] Cresset BioMol Discovery Ltd, Welwyn Garden City AL7 3AX, Herts, England.
   [Balss, Karin M.; Maryanoff, Cynthia A.] Johnson & Johnson Co, Convergent Product Dev, Spring House, PA 19477 USA.
   [Schmidt, Ute] WITec GmbH, D-89081 Ulm, Germany.
   [Lacy, Eilyn] Centocor Res & Dev, Prot Engn, Radnor, PA 19087 USA.
RP Kinnney, WA (reprint author), Johnson & Johnson Pharmaceut Res & Dev, Res & Early Dev, Spring House, PA 19477 USA.
EM wak@pei3.com; bmaryano@prdus.jnj.com
CR Ajayaghosh A, 2007, ACCOUNTS CHEM RES, V40, P644, DOI 10.1021/ar7000364
   BASELT DR, 1993, BIOPHYS J, V65, P2644, DOI 10.1016/S0006-3495(93)81329-8
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Binder WH, 2006, ANGEW CHEM INT EDIT, V45, P7324, DOI 10.1002/anie.200602001
   Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200
   Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f
   Chakravarti S, 2006, DEV DYNAM, V235, P2493, DOI 10.1002/dvdy.20868
   Chan WC, 2000, FMOC SOLID PHASE PEP, P41
   Chessari G, 2002, CHEM-EUR J, V8, P2860, DOI 10.1002/1521-3765(20020703)8:13<2860::AID-CHEM2860>3.0.CO;2-N
   Cole DJ, 1999, SURGERY, V126, P510, DOI 10.1067/msy.2099.99675
   Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W
   Gdaniec M, 2003, ANGEW CHEM INT EDIT, V42, P3903, DOI 10.1002/anie.200351432
   HELSETH DL, 1981, J BIOL CHEM, V256, P7118
   Hoekstra WJ, 1999, J MED CHEM, V42, P5254, DOI 10.1021/jm990418b
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   KAR K, 2006, J BIOL CHEM, V282, P33283
   Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200
   Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s
   Lecut C, 2005, THROMB HAEMOSTASIS, V94, P107, DOI 10.1160/TH04-12-0783
   Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063
   Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007
   Lozman OR, 2001, J CHEM SOC PERK T 2, P1446, DOI 10.1039/b103390p
   McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458
   MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337
   Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882
   Nishi Y, 2005, BIOCHEMISTRY-US, V44, P6034, DOI 10.1021/bi047887m
   Oshovsky GV, 2007, ANGEW CHEM INT EDIT, V46, P2366, DOI 10.1002/anie.200602815
   Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Rele S, 2007, J AM CHEM SOC, V129, P14780, DOI 10.1021/ja0758990
   Ricard-Blum S, 2005, TOP CURR CHEM, V247, P35, DOI 10.1007/b103819
   RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   Sarratt KL, 2005, BLOOD, V106, P1268, DOI 10.1182/blood-2004-11-4434
   Savage B, 1999, BLOOD, V94, P2704
   TRAUB W, 1978, FEBS LETT, V92, P114, DOI 10.1016/0014-5793(78)80734-0
   VINTER JG, 1994, J COMPUT AID MOL DES, V8, P653, DOI 10.1007/BF00124013
   Wess TJ, 2005, ADV PROTEIN CHEM, V70, P341, DOI 10.1016/S0065-3233(05)70010-3
   WHITE P. D., 2000, FMOC SOLID PHASE PEP, P9
   YANG C, 2003, J BIOMED MATER RES B, V69, P18
NR 47
TC 91
Z9 94
U1 2
U2 33
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 24
PY 2008
VL 105
IS 25
BP 8513
EP 8518
DI 10.1073/pnas.0800291105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 319TA
UT WOS:000257185700007
PM 18559857
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Yang, SH
   Wu, XH
   Mei, RC
   Yang, C
   Li, J
   Xu, WH
   Ye, SN
AF Yang, Shuhua
   Wu, Xinghuo
   Mei, Rongcheng
   Yang, Cao
   Li, Jin
   Xu, Weihua
   Ye, Shunan
TI Biomaterial-loaded allograft threaded cage for the treatment of femoral
   head osteonecrosis in a goat model
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE osteonecrosis; core decompression; allograft threaded cage; decalcified
   bone matrix; goat
ID DEMINERALIZED BONE-MATRIX; DONOR-SITE MORBIDITY; CORE DECOMPRESSION;
   AVASCULAR NECROSIS; FIBULAR GRAFTS; HIP; CARTILAGE; REPAIR
AB The purpose of this study was to evaluate the efficacy of core decompression with a biomaterial-loaded allograft threaded cage (ATC) for the treatment of femoral head osteonecrosis in an established goat model. First, bilateral early-stage osteonecrosis was induced. After core decompression, the remaining goats were randomly divided into three groups: Group A, the goats were left without any treatment; Group B, the goats were treated with implanting a composite of autologous bone and decalcified bone matrix (DBM); Group C, the goats were treated using insertion of ATC loaded with DBM and autogenous bone graft. Then radiographic, histological and biomechanical analysis were taken in each group at 5, 10, and 20 weeks postoperation. In Group A, the classical signs of osteonecrosis of the femoral head were identified 10 weeks after the induction. Twenty weeks later, the density, surface and biomechanical stability of the femoral head were normal in Group C, while an irregular surface and an inhomogeneous microstructure or variation of density/hardness were identified in Group B. The specimens revealed a continuous trabaecular bone structure throughout the cage and extensive bone ingrowth and remodeling in Group C, while fibrous tissue was evident in Group B. Core decompression with a biomaterial loaded ATC almost uniformly delays or arrests the progression of the disease before articular collapse, and it could help to get the balance between bone resorption and new bone formation, strengthen structural mechanics of the femoral head, provide structure support of articular cartilage.
C1 [Yang, Shuhua; Wu, Xinghuo; Mei, Rongcheng; Yang, Cao; Li, Jin; Xu, Weihua; Ye, Shunan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
RP Yang, SH (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
EM shuhua196@yahoo.com.cn
CR AARON RK, 1989, CLIN ORTHOP RELAT R, P209
   Aaron RK, 1998, ADULT HIP, P451
   Aldridge J Mack 3rd, 2004, Am J Orthop (Belle Mead NJ), V33, P327
   Aluisio FV, 1998, CLIN ORTHOP RELAT R, P192
   ASSOULINEDAYAN Y, 2002, BIOTECHNOL BIOENG, V92, P189
   Babyn PS, 1998, J MAGN RESON IMAGING, V8, P717, DOI 10.1002/jmri.1880080331
   Bejar J, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-24
   Beltrame F, 2005, BIOTECHNOL BIOENG, V92, P189, DOI 10.1002/bit.20591
   Conzemius MG, 2002, J ORTHOPAED RES, V20, P303, DOI 10.1016/S0736-0266(01)00108-5
   Han B, 2003, J ORTHOPAED RES, V21, P648, DOI 10.1016/S0736-0266(03)00005-6
   Hungerford DS, 2007, J ARTHROPLASTY, V22, P91, DOI 10.1016/j.arth.2007.02.009
   Kim SY, 2005, J BONE JOINT SURG AM, V87A, P2012, DOI 10.2106/JBJS.D.02593
   Lavernia CJ, 2000, J ARTHROPLASTY, V15, P171, DOI 10.1016/S0883-5403(00)90132-3
   Lieberman Jay R, 2003, Instr Course Lect, V52, P337
   Lieberman JR, 2004, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000150312.53937.6f
   Magnussen RA, 2005, J ORTHOP RES, V23, P576, DOI 10.1016/j.orthres.2004.12.006
   McCarthy J, 2003, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.0000043045.84315.d9
   Mont MA, 1998, J BONE JOINT SURG BR, V80B, P56, DOI 10.1302/0301-620X.80B1.7989
   Mont MA, 2003, CLIN ORTHOP RELAT R, P84, DOI 10.1097/01.blo.0000096826.67494.38
   MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018
   Mont MA, 2004, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000150128.57777.8e
   Mont MA, 1996, CLIN ORTHOP RELAT R, P169
   Mont Michael A, 2007, Instr Course Lect, V56, P213
   Ranly DM, 2005, J BONE JOINT SURG AM, V87A, P2052, DOI 10.2106/JBJS.D.02752
   ROSENWASSER MP, 1994, INSTR COURSE LECT, V306, P17
   Russell JL, 2000, TISSUE ENG, V6, P435, DOI 10.1089/107632700418137
   Scully SP, 1998, J BONE JOINT SURG AM, V80A, P1270, DOI 10.2106/00004623-199809000-00004
   Steinberg ME, 2001, CLIN ORTHOP RELAT R, P71
   STEINBERG ME, 1997, OSTEONECROSIS ETIOLO, P293
   TAKAOKA K, 1981, ARCH ORTHOP TRAUM SU, V99, P109, DOI 10.1007/BF00389746
   Tang CL, 1998, MICROSURG, V18, P383, DOI 10.1002/(SICI)1098-2752(1998)18:6<383::AID-MICR8>3.0.CO;2-5
   Vail TP, 1996, J BONE JOINT SURG AM, V78A, P204, DOI 10.2106/00004623-199602000-00006
   Veillette CJH, 2006, J BONE JOINT SURG AM, V88A, P48, DOI 10.2106/JBJS.F.00538
NR 33
TC 6
Z9 9
U1 1
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUN 15
PY 2008
VL 100
IS 3
BP 560
EP 566
DI 10.1002/bit.21792
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 301GE
UT WOS:000255883600016
PM 18438884
DA 2018-10-20
ER

PT J
AU Schopper, C
   Moser, D
   Spassova, E
   Goriwoda, W
   Lagogiannis, G
   Hoering, B
   Ewers, R
   Redl, H
AF Schopper, C.
   Moser, D.
   Spassova, E.
   Goriwoda, W.
   Lagogiannis, G.
   Hoering, B.
   Ewers, R.
   Redl, H.
TI Bone regeneration using a naturally grown HA/TCP carrier loaded with
   rhBMP-2 is independent of barrier-membrane effects
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE BMP; bone regeneration; hydroxyapatite composite; membrane; scaffold
ID MORPHOGENETIC PROTEIN FAMILY; GUIDED TISSUE REGENERATION; TRICALCIUM
   PHOSPHATE; IMPLANTS; RAT; NEOGENESIS; REGULATORS; DEFECTS; MONKEYS;
   SURFACE
AB The present study investigated whether bone regeneration and biomaterial replacement would be improved by loading of biogenous biphasic biomaterial scaffolds (HA/TCP ratio 30/70) with rhBMP-2, and whether the placement of three barrier membranes differing in structure and porosity (prototyped SLA Ti specimens, GORE RESOLUT Adapt specimens, and titanized TiMESH light specimens) would have a synergistic effect. A rabbit calvarial model was used for the implantation studies. Histological specimens were obtained after 12 weeks and evaluated quantitatively for differences between the various material combinations. Loading of the biomaterials with rhBMP-2 significantly enhanced the amount of regenerated bone and caused a pronounced biomaterial replacement. While BMP-induced bone had formed uniformly over the surgical defects, bone regeneration in the absence of BMP depends on bone promotion from the margins of the defects toward the center. No positive effect on bone regeneration was seen for any of the placed barrier membranes. While the present study had shown that rhBMP-2 loading significantly increases bone regeneration using the investigated biomaterial, barrier-membrane placement may be useful in predetermining the final shape of the regenerative site but provides no additional beneficial impact on the amount and quality of the bone regeneration induced by rhBMP-2. (C) 2007 Wiley Periodicals, Inc.
C1 [Schopper, C.; Moser, D.; Goriwoda, W.; Lagogiannis, G.; Ewers, R.] Med Univ Vienna, Hosp Craniomaxillofacial & Oral Surg, Vienna, Austria.
   [Spassova, E.] AlgOss Biotechnol GmbH, Vienna, Austria.
   [Hoering, B.; Redl, H.] Ludwig Boltzmann Inst Expt & Clin Traumatol, Res Ctr Traumatol, Vienna, Austria.
RP Schopper, C (reprint author), Med Univ Vienna, Hosp Craniomaxillofacial & Oral Surg, Vienna, Austria.
EM christian.schopper@meduniwien.ac.at
CR ASPENBERG P, 1991, J ORTHOPAED RES, V9, P20, DOI 10.1002/jor.1100090104
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Buser D., 2001, TITANIUM MED, p[876, 888]
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   DONATH K, 1982, J ORAL PATHOL, V11, P198
   ELIMA K, 1993, ANN MED, V25, P395, DOI 10.3109/07853899309147302
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   HARDWICK R, 1995, J PERIODONTOL, V66, P495, DOI 10.1902/jop.1995.66.6.495
   Hay E, 2004, J BIOL CHEM, V279, P1650, DOI 10.1074/jbc.M300969200
   Hoffmann A, 2001, APPL MICROBIOL BIOT, V57, P294
   Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P245, DOI 10.1034/j.1600-0501.1994.050408.x
   Laffargue P, 1999, BONE, V25, p55S, DOI 10.1016/S8756-3282(99)00134-9
   LINDE A, 1993, J PERIODONTOL, V64, P1116, DOI 10.1902/jop.1993.64.11s.1116
   LYONS KM, 1991, TRENDS GENET, V7, P408, DOI 10.1016/0168-9525(91)90265-R
   MIYAMOTO S, 1993, J BONE JOINT SURG BR, V75, P107
   Namikawa T, 2005, SPINE, V30, P1717, DOI 10.1097/01.brs.0000172155.17239.fa
   Ono I, 1999, J BIOMED MATER RES, V45, P337
   Pecora G, 1997, Dent Clin North Am, V41, P585
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   RENGACHARY SS, 2002, NEUROSURG FOCUS, V13, P1
   SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129, DOI 10.1902/jop.1993.64.11s.1129
   SCHMID J, 1994, CLIN ORAL IMPLAN RES, V5, P125, DOI 10.1034/j.1600-0501.1994.050302.x
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Schopper Christian, 2003, Clin Oral Implants Res, V14, P743
   SEEHERMAN H, 2002, SPINE, V27, P16
   STEENBERGHE D, 2003, CLIN ORAL IMPLAN RES, V14, P63
   Takeishi H, 2001, ORAL DIS, V7, P281, DOI 10.1034/j.1601-0825.2001.00725.x
   URIST MR, 1965, SCIENCE, V150, P839
   VUKICEVIC S, 1995, EUR J CLIN CHEM CLIN, V33, P661
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
   Wozney JM, 1998, EUR J ORAL SCI, V106, P160, DOI 10.1111/j.1600-0722.1998.tb02170.x
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zellin G, 1996, BIOMATERIALS, V17, P695, DOI 10.1016/0142-9612(96)86739-1
NR 41
TC 22
Z9 24
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2008
VL 85A
IS 4
BP 954
EP 963
DI 10.1002/jbm.a.31525
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 302VW
UT WOS:000255999000011
PM 17896771
DA 2018-10-20
ER

PT J
AU van Minnen, B
   van Leeuwen, MBM
   Kors, G
   Zuidema, J
   van Kooten, TG
   Bos, RRM
AF van Minnen, B.
   van Leeuwen, M. B. M.
   Kors, G.
   Zuidema, J.
   van Kooten, T. G.
   Bos, R. R. M.
TI In vivo resorption of a biodegradable polyurethane foam, based on
   1.4-butanediisocyanate: A three-year subcutaneous implantation study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyurethane; biodegradation; bioresorption; in vivo test
ID FOREIGN-BODY REACTION; ALIPHATIC POLYESTERS; DEGRADATION; BONE; ACID;
   BIOCOMPATIBILITY; POLY(L-LACTIDE); SCAFFOLDS; FIXATION; RABBITS
AB Degradable polyurethanes (PUs), based on aliphatic diisocyanates, can be very useful in tissue regeneration applications. Their long-term in vivo degradation has not been extensively investigated. In this study a biodegradable PU with copolyester soft segments Of DL-lactide/ F-caprolactone and hard segments synthesized from 1,4-butanediisocyanate was evaluated with regard to tissue response during degradation and, ultimately, the resorption of the material. Highly porous PU foam discs were subcutaneously implanted in rats and rabbits for intervals up to 3 years. A copolymer foam Of DL-lactide and c-caprolactone served as a control. The foams, the surrounding tissues and the draining lymph nodes were evaluated with light and electron microscopy. In the first stages of degradation the number of macrophages and giant cells increased. As the resorption stage set in their numbers gradually decreased. Electron microscopy showed macrophages containing pieces of PU. The size of the intracellular PU particles diminished and cells containing these remnants gradually disappeared after periods from I to 3 years. After 3 years an occasional, isolated macrophage with biomaterial remnants could be traced in both PU and copolymer explants. Single macrophages with biomaterial remnants were observed in the lymph nodes between 39 weeks and 1.5 years following implantation. It is concluded that the PU foam is biocompatible during degradation. After 3 years PU samples had been resorbed almost completely. These results indicate that the PU foam can be safely used as a biodegradable implant. (C) 2007 Wiley Periodicals, Inc.
C1 [van Leeuwen, M. B. M.; van Kooten, T. G.] Univ Groningen, Univ Med Ctr Groningen, Sect Biocompatibil & Biomat, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [van Minnen, B.; Bos, R. R. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, NL-9700 RB Groningen, Netherlands.
   [Kors, G.] Univ Groningen, Univ Med Ctr Groningen, Sect Electron Microscopy, Dept Cell Biol, NL-9713 AV Groningen, Netherlands.
   [Zuidema, J.] Polyganics BV, NL-9713 GX Groningen, Netherlands.
RP van Kooten, TG (reprint author), Univ Groningen, Univ Med Ctr Groningen, Sect Biocompatibil & Biomat, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM kooten@med.umcg.nl
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   AN HA, 2000, BIOMATERIALS, V21, P2635
   AWANG MN, 1988, INT J ORAL MAX SURG, V17, P110, DOI 10.1016/S0901-5027(88)80162-0
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P1169, DOI 10.1002/jbm.820231006
   Cordewener FW, 2000, TISSUE ENG, V6, P413, DOI 10.1089/107632700418119
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   Edwards RC, 2001, J ORAL MAXIL SURG, V59, P19, DOI 10.1053/joms.2001.19267
   Ganta SR, 2003, J BIOMED MATER RES A, V64A, P242, DOI 10.1002/jbm.a.10402
   GETTER L, 1972, J ORAL SURG, V30, P344
   Groot J. H., 1996, BIOMATERIALS, V17, P163
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   Labow RS, 2002, J BIOMAT SCI-POLYM E, V13, P651, DOI 10.1163/156856202320269148
   Laitinen O, 2002, J BIOMED MATER RES, V61, P33, DOI 10.1002/jbm.10115
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Pietrzak WS, 1997, J CRANIOFAC SURG, V8, P87, DOI 10.1097/00001665-199703000-00004
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Spaans CJ, 2000, BIOMATERIALS, V21, P2453, DOI 10.1016/S0142-9612(00)00113-7
   SPAANS CJ, 2000, THESIS STATE U GRONI
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   van Minnen B, 2007, J ORAL MAXIL SURG, V65, P218, DOI 10.1016/j.joms.2005.11.120
   van Tienen T, 2004, AM J SPORTS MED, V32, P1182
   VANMINNEN B, 2006, UNPUB 3 YEAR IN VITR
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P1115, DOI 10.1002/jbm.820270817
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
NR 32
TC 21
Z9 21
U1 1
U2 27
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2008
VL 85A
IS 4
BP 972
EP 982
DI 10.1002/jbm.a.31574
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 302VW
UT WOS:000255999000013
PM 17907243
DA 2018-10-20
ER

PT J
AU Faxalv, L
   Tengvall, P
   Lindahl, TL
AF Faxaelv, Lars
   Tengvall, Pentti
   Lindahl, Tomas L.
TI Imaging of blood plasma coagulation and its propagation at surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE coagulation; propagation; image processing; surface; biomaterial
ID QUARTZ-CRYSTAL MICROBALANCE; FREE OSCILLATION RHEOMETRY; WHOLE-BLOOD;
   ARTIFICIAL SURFACES; TIME; ACTIVATION; RESONANCE
AB A new method utilizing image capture and processing was developed for the analysis of blood plasma coagulation at surfaces. The coagulation was detected in a cuvette by time-lapse image capture of light scattering from the developing fibrin network. By image processing and computer analysis of the captured image data, both early detection of coagulation at the surface and the propagation phase of coagulation could be measured in the same experiment. It is possible to use both platelet-rich plasma (PRP) and platelet-free plasma (PFP) with the method, and thereby study the platelet contribution to both surface coagulation and propagation of coagulation. Two well-known model surfaces, hydrophilic and hydrophobic glass, were used in combination with PRP and PFP to illustrate the method. Hydrophilic glass activated coagulation significantly faster (PRP: 7.0 +/- 1.7 min, PFP: 5.9 +/- 1.2 min, n = 16) than hydrophobic glass (PRP: 50 +/- 14 min, PFP: 65+/-32 min, n = 16) in both PRP and PFP. Hydrophilic surfaces showed a faster initial propagation of coagulation adjacent to the surface (mean velocity: 0.14 +/- 0.05 min/minute) compared with the propagation observed further out from the surface (mean velocity: 0.05 +/- 0.01 mm/min). The method is very flexible and can be suitable for screening hemocompatibility of biomaterials. (C) 2007 Wiley Periodicals, Inc.
C1 [Faxaelv, Lars; Lindahl, Tomas L.] Linkoping Univ Hosp, Dept Clin Chem, Lab Med, SE-58185 Linkoping, Sweden.
   [Tengvall, Pentti] Linkoping Univ, Dept Phys Chem & Biol, Appl Phys Lab, SE-58183 Linkoping, Sweden.
RP Faxalv, L (reprint author), Linkoping Univ Hosp, Dept Clin Chem, Lab Med, SE-58185 Linkoping, Sweden.
EM lars.faxalv@ibk.liu.se
CR Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   Hansson KM, 2002, BIOSENS BIOELECTRON, V17, P747, DOI 10.1016/S0956-5663(02)00048-9
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   Ranby M, 2003, SCAND J CLIN LAB INV, V63, P397, DOI 10.1080/00365510310002095
   Sanchez J, 2002, THROMB RES, V105, P407, DOI 10.1016/S0049-3848(02)00051-8
   Vikinge TP, 2000, BIOSENS BIOELECTRON, V15, P605, DOI 10.1016/S0956-5663(00)00125-1
   WALSH PN, 2006, HEMOSTASIS THROMBOSI, P1827
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 8
TC 8
Z9 8
U1 1
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2008
VL 85A
IS 4
BP 1129
EP 1134
DI 10.1002/jbm.a.31529
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 302VW
UT WOS:000255999000030
PM 17907239
DA 2018-10-20
ER

PT J
AU Nakai, M
   Niinomi, M
   Akahori, T
   Ohtsu, N
   Nishimura, H
   Toda, H
   Fukui, H
   Ogawa, M
AF Nakai, Masaaki
   Niinomi, Mitsuo
   Akahori, Toshikazu
   Ohtsu, Naofumi
   Nishimura, Hideki
   Toda, Hiroyuki
   Fukui, Hisao
   Ogawa, Michiharu
TI Surface hardening of biomedical Ti-29Nb-13Ta-4.6Zr and Ti-6Al-4V ELI by
   gas nitriding
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE biomaterial; titanium alloy; Ti-29Nb-13Ta-4.6Zr; Ti-6Al-4V; surface
   hardening; nitriding
ID TITANIUM-ALLOY; PERFORMANCE
AB The microstructure and hardness near the surface of a biomedical titanium alloy, Ti-29Nb-13Ta-4.6Zr (TNTZ), subjected to gas nitriding at 1023-1223 K was investigated in comparison with the conventional biomedical Ti-6Al-4V ELI (Ti64). After gas nitriding, the microstructure near the specimen surface was observed by optical microscopy, X-ray diffraction (XRD), Auger electron spectroscopy (AES), and X-ray photoelectron spectroscopy (XPS). In both alloys, two types of titanium nitrides (TiN and Ti(2)N) are formed and the a phase is precipitated by gas nitriding. Furthermore, the oxygen impurity in the gas nitriding atmosphere reacts with the titanium nitrides; thus, TiO(2) is formed at the outermost titanium nitride layer. The surface hardening was also evaluated by Vickers hardness measurement. The Vickers hardness near the surface of TNTZ and Ti64 increases significantly by gas nitriding. (c) 2007 Published by Elsevier B.V.
C1 [Nakai, Masaaki; Niinomi, Mitsuo; Akahori, Toshikazu; Ohtsu, Naofumi] Tohoku Univ, Mat Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan.
   [Nishimura, Hideki; Toda, Hiroyuki] Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   [Fukui, Hisao] Aichi Gakuin Univ, Sch Dent, Chikusa Ku, Nagoya, Aichi 4648650, Japan.
   [Ogawa, Michiharu] Daido Steel Co Ltd, R&D Lab, Minami Ku, Nagoya, Aichi 4578545, Japan.
RP Nakai, M (reprint author), Tohoku Univ, Mat Res Inst, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM nakai@imr.tohoku.ac.jp
RI Ohtsu, Naofumi/L-6021-2018; Nakai, Masaaki/C-1919-2009; Niinomi,
   Mitsuo/B-5965-2011
OI Ohtsu, Naofumi/0000-0001-7935-3949; 
CR Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   BARIN I., 1989, THERMOCHEMICAL DATA
   BERTOTI I, 1995, APPL SURF SCI, V84, P357, DOI 10.1016/0169-4332(94)00545-1
   DESMAISON J, 1979, OXID MET, V13, P505, DOI 10.1007/BF00812775
   Dong H, 2000, WEAR, V238, P131, DOI 10.1016/S0043-1648(99)00359-2
   Hanawa T, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P145
   HUTCHINGS R, 1983, WEAR, V92, P143, DOI 10.1016/0043-1648(83)90014-5
   Ikeda M, 2002, METALL MATER TRANS A, V33, P487, DOI 10.1007/s11661-002-0110-9
   KOFSTAD P, 1972, NONSTOICHIOMETRY DIF, P137
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MIZUTA S, 2001, KOTAIDENKIKAGAKU JIK, P84
   MURALEEDHARAN TM, 1992, THIN SOLID FILMS, V221, P104, DOI 10.1016/0040-6090(92)90802-I
   NAKAYAMA T, 1996, KINZOKU, V66, P986
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2002, TETSU TO HAGANE, V88, P567, DOI 10.2355/tetsutohagane1955.88.9_567
   Ohtsu N, 2007, MATER TRANS, V48, P105, DOI 10.2320/matertrans.48.105
   SWIFT P, 1982, SURF INTERFACE ANAL, V4, P47, DOI 10.1002/sia.740040204
   Wilson AD, 1999, SURF COAT TECH, V114, P70, DOI 10.1016/S0257-8972(99)00024-9
NR 21
TC 29
Z9 32
U1 0
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUN 15
PY 2008
VL 486
IS 1-2
BP 193
EP 201
DI 10.1016/j.msea.2007.08.065
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 306RX
UT WOS:000256266600029
DA 2018-10-20
ER

PT J
AU Zhou, YL
   Niinomi, M
   Akahori, T
AF Zhou, Ying-Long
   Niinomi, Mitsuo
   Akahori, Toshikazu
TI Changes in mechanical properties of Ti alloys in relation to alloying
   additions of Ta and Hf
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT 14th International Conference on the Strength of Materials (ICSMA 14)
CY JUN 04-09, 2006
CL Xian Jiaotong Univ, Xian, PEOPLES R CHINA
SP Inst Met Res, CAS
HO Xian Jiaotong Univ
DE dynamic Young's modulus; tensile property; Ti-Ta alloy; Ti-Hf alloy;
   metallic biomaterial
ID TITANIUM-ALLOYS; YOUNGS MODULUS
AB The effects of Ta and Hf on the dynamic Young's moduli and tensile properties of Ti-Ta and Ti-Hf alloys for biomedical applications are comparatively studied in this paper. It is found that with increasing Hf content, the dynamic Young's modulus of the Ti-Hf alloy gently decreases and its tensile strength keeps on increasing. In contrast, with increasing Ta content, the dynamic Young's modulus of the Ti-Ta alloys first decreases, reaches a minimum value of 69 GPa and then increases. In parallel, the tensile strength first increases, reaches a maximum value of 587 MPa, and then slightly decreases. It is shown that the addition of Hf has a slight influence on the dynamic Young's modulus and a strong influence on the tensile properties of the Ti-Hf alloy, while an increase of Ta content has a strong effect on both the dynamic Young's modulus and tensile properties of the Ti-Ta alloy. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Zhou, Ying-Long] Foshan Univ, Sch Mechatron & Informat Engn, Dept Mechatron Engn, Foshan 528000, Peoples R China.
   [Niinomi, Mitsuo; Akahori, Toshikazu] Tohoku Univ, Inst Mat Res, Dept Biomat Sci, Sendai, Miyagi 9808577, Japan.
RP Zhou, YL (reprint author), Foshan Univ, Sch Mechatron & Informat Engn, Dept Mechatron Engn, Foshan 528000, Peoples R China.
EM ylzhou_2@yahoo.com
RI Niinomi, Mitsuo/B-5965-2011
CR BOYER R, 1994, MAT PROPERTIES HDB T
   CUI XZ, 2000, METALLOGRAPHY HEAT T
   Dieter G. E., 1976, MECH METALLURGY
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   LEE YT, 1990, MAT SCI ENG A-STRUCT, V128, P77, DOI 10.1016/0921-5093(90)90097-M
   MACK DJ, 1946, T AM I MIN MET ENG, V166, P68
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Song Y, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P273
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
NR 12
TC 44
Z9 48
U1 0
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUN 15
PY 2008
VL 483-84
SI SI
BP 153
EP 156
DI 10.1016/j.msea.2006.09.173
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 303WH
UT WOS:000256071100037
DA 2018-10-20
ER

PT J
AU Hsiong, SX
   Cooke, PH
   Kong, HJ
   Fishman, ML
   Ericsson, M
   Mooney, DJ
AF Hsiong, Susan X.
   Cooke, Peter H.
   Kong, Hyun-Joon
   Fishman, Marshall L.
   Ericsson, Maria
   Mooney, David J.
TI AFM imaging of RGD presenting synthetic extracellular matrix using gold
   nanoparticles
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE atomic force microscopy (AFM); biomaterials; electron microscopy;
   hydrogels; TEM
ID ATOMIC-FORCE MICROSCOPY; TEMPERATURE ELECTRON-MICROSCOPY; CELL-ADHESION;
   POLYSACCHARIDE ULTRASTRUCTURES; ALGINATE HYDROGELS; STEM-CELLS;
   DIFFERENTIATION; GELS; ORGANIZATION; SURFACES
AB Several high-resolution imaging techniques such as FESEM, TEM and AFM are compared with respect to their application on alginate hydrogels, a widely used polysaccharide biomaterial. A new AFM method applicable to RGD peptides covalently conjugated to alginate hydrogels is described. High-resolution images of RGD adhesion ligand distribution were obtained by labeling biotinylated RGD peptides with streptavidin-labeled gold nanoparticles. This method may broadly provide a useful tool for sECM characterization and design for tissue regeneration strategies.
C1 [Hsiong, Susan X.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Engn Sci Lab, SEAS, Cambridge, MA 02138 USA.
   [Hsiong, Susan X.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Cooke, Peter H.; Fishman, Marshall L.] Agr Res Serv, Eastern Reg Res Ctr, USDA, Wyndmoor, PA USA.
   [Kong, Hyun-Joon] Univ Illinois, Dept Chem & Biomol Engn, Champaign, IL 61820 USA.
   [Ericsson, Maria] Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Engn Sci Lab, SEAS, 325 Pierce Hall, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Comisar WA, 2006, BIOMATERIALS, V27, P2322, DOI 10.1016/j.biomaterials.2005.10.037
   DANILOV YN, 1989, EXP CELL RES, V182, P186, DOI 10.1016/0014-4827(89)90290-5
   Decho AW, 1999, CARBOHYD RES, V315, P330, DOI 10.1016/S0008-6215(99)00006-3
   Dufrane D, 2006, TRANSPLANTATION, V81, P1345, DOI 10.1097/01.tp.0000208610.75997.20
   Dupres V, 2007, BIOMATERIALS, V28, P2393, DOI 10.1016/j.biomaterials.2006.11.011
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   Fishman ML, 2007, BIOMACROMOLECULES, V8, P573, DOI 10.1021/bm0607729
   Fishman ML, 2004, BIOMACROMOLECULES, V5, P334, DOI 10.1021/bm0300655
   Franz C M, 2007, SCI STKE, P15
   Harrison D, 1997, Biomed Sci Instrum, V34, P41
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   LIU H, 2006, BIOMATERIALS, V28, P354
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Mierisch CM, 2003, J BONE JOINT SURG AM, V85A, P1757, DOI 10.2106/00004623-200309000-00015
   MORRIS VJ, 2004, ATOMIC FORCE MICROSC
   Park Y, 2005, OSTEOARTHR CARTILAGE, V13, P527, DOI 10.1016/j.joca.2005.02.006
   Reese S, 2007, MICROSC RES TECHNIQ, V70, P816, DOI 10.1002/jemt.20471
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Santos NC, 2004, BIOPHYS CHEM, V107, P133, DOI 10.1016/j.bpc.2003.09.001
   Serp D, 2002, BIOTECHNOL BIOENG, V79, P253, DOI 10.1002/bit.10287
   Serp D, 2002, BIOTECHNOL BIOENG, V79, P243, DOI 10.1002/bit.10286
   Shao ZF, 1995, ANNU REV CELL DEV BI, V11, P241, DOI 10.1146/annurev.cb.11.110195.001325
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   SMALL JV, 1986, J CELL BIOL, V102, P210, DOI 10.1083/jcb.102.1.210
   Spagnoli C, 2005, CARBOHYD RES, V340, P929, DOI 10.1016/j.carres.2005.01.024
   Tanaka H, 2004, J CELL BIOCHEM, V93, P454, DOI 10.1002/jcb.20171
   Wong M, 2002, TISSUE ENG, V8, P979, DOI 10.1089/107632702320934074
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yang HY, 2007, EXP CELL RES, V313, P3497, DOI 10.1016/j.yexcr.2007.08.001
NR 43
TC 4
Z9 4
U1 7
U2 21
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUN 11
PY 2008
VL 8
IS 6
BP 469
EP 477
DI 10.1002/mabi.200700313
PG 9
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 315QX
UT WOS:000256895600001
PM 18383570
DA 2018-10-20
ER

PT J
AU Yang, Y
   Bolikal, D
   Becker, ML
   Kohn, J
   Zeiger, DN
   Simon, CG
AF Yang, Yanyin
   Bolikal, Durgadas
   Becker, Matthew L.
   Kohn, Joachim
   Zeiger, Diana N.
   Simon, Carl G., Jr.
TI Combinatorial polymer scaffold libraries for screening cell-biomaterial
   interactions in 3D
SO ADVANCED MATERIALS
LA English
DT Article
ID TYROSINE-DERIVED POLYCARBONATES; DEGRADABLE BIOMATERIALS; STEM-CELLS;
   DIFFERENTIATION; MICROARRAYS; SURFACES; CULTURE; BLENDS; LINE
AB A combinatorial method for screening cell-biomaterial interactions in 3D is presented; polymeric, salt-leached scaffolds with varied composition and properties are present in a 96-well plate. Previous high-throughput approaches for screening cell-material interactions have focused on planar 2D surfaces or films. However, biomaterials are commonly used in a 3D scaffold format and cells behave more physiologically when cultured in 3D.
C1 [Yang, Yanyin; Becker, Matthew L.; Zeiger, Diana N.; Simon, Carl G., Jr.] Natl Inst Stand & Technol, Div Polymers, Gaithersburg, MD 20899 USA.
   [Bolikal, Durgadas; Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
RP Simon, CG (reprint author), Natl Inst Stand & Technol, Div Polymers, 100 Bur Dr, Gaithersburg, MD 20899 USA.
EM carl.simon@nist.gov
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Anderson DG, 2006, ADV MATER, V18, P2614, DOI 10.1002/adma.200600529
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Bailey LO, 2006, J BIOMED MATER RES A, V76A, P491, DOI 10.1002/jbm.a.30527
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Disney MD, 2004, CHEM BIOL, V11, P1701, DOI 10.1016/j.chembiol.2004.10.011
   DOOLEY CT, 1994, SCIENCE, V266, P2019, DOI 10.1126/science.7801131
   Eidelman N, 2004, J RES NATL INST STAN, V109, P219, DOI 10.6028/jres.109.014
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672
   HORBETT TA, 1982, BIOMATERIALS INTERFA, P233
   ISHIYAMA M, 1993, CHEM PHARM BULL, V41, P1118
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KOHN J, 2006, MED DEVICE DEV, V1, P35
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Rohrer SP, 1998, SCIENCE, V282, P737, DOI 10.1126/science.282.5389.737
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Simon CG, 2002, J ORTHOPAED RES, V20, P473, DOI 10.1016/S0736-0266(01)00140-1
   SIMON CG, 2007, REV SCI INSTRUM, V78
   Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Tweedie CA, 2005, ADV MATER, V17, P2599, DOI 10.1002/adma.200501142
   Urquhart AJ, 2007, ADV MATER, V19, P2486, DOI 10.1002/adma.200700949
   Webb K, 2003, BIOMATERIALS, V24, P4681, DOI 10.1016/S0142-9612(03)00368-5
   Weber N, 2005, J BIOMED MATER RES A, V72A, P420, DOI 10.1002/jbm.a.30272
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
NR 33
TC 43
Z9 43
U1 1
U2 27
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD JUN 4
PY 2008
VL 20
IS 11
BP 2037
EP +
DI 10.1002/adma.200702088
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 317UC
UT WOS:000257044600002
DA 2018-10-20
ER

PT J
AU Yang, TL
   Young, TH
AF Yang, Tsung-Lin
   Young, Tai-Horng
TI The enhancement of submandibular gland branch formation on chitosan
   membranes
SO BIOMATERIALS
LA English
DT Article
DE salivary glands; submandibular gland (SMG); biomaterials; chitosan;
   collagen; branching morphogenesis
ID SALIVARY EPITHELIAL-CELLS; IN-VITRO; ACINAR-CELLS; MORPHOGENESIS;
   COLLAGEN; TISSUE; CHITIN; SULFATE; GROWTH; PROLIFERATION
AB Many glandular organs are developed by branching morphogenesis, an efficient and ubiquitous process for creating a larger cellular area for metabolic requirement. To regenerate a glandular organ, such as salivary glands, recapitulation of branching processes may be requisite. At present, the roles of biomaterials in regenerative branching have never been thoroughly explored. By culturing the embryonal submandibular gland (SMG) on different substrata, including polyvinyl alcohol (PVA), chitosan, and polycarbonate (PC), this study demonstrated for the first time that chitosan was capable of providing a more preferential environment for salivary gland branch formation. After culturing SMG explants on chitosan membranes, secreted extracellular matrices distributed in a reticular manner and formed thicker fibers beyond the extents of cell attachment, which were not found in PVA and PC. In the subsequent culture of explants just on the used chitosan substrates, these conditioned membranes were able to further enhance SMG branching. The fact that the promoting effects were eliminated with collagenase treatment and type I and type III collagen were identified within the adherent fibrillar extracellular matrix raised the possibility that the stimulating factors were collagen-originated. This indicates that, for SMG, chitosan is a bioactive substratum which enables cells to synthesize and deposit essential extracellular matrix, paving an important way for ensuing branch formation. Accordingly, the current study provides a larger scope to use chitosan as a biomaterial for recapitulating branching, which might be useful for the scaffold design of salivary gland regeneration. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Yang, Tsung-Lin; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Yang, Tsung-Lin] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
EM thyoung@ntu.edu.tw
OI YANG, TSUNG-LIN/0000-0001-6521-8631
CR Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380
   Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o
   BARD JBL, 1977, J CELL BIOL, V74, P816, DOI 10.1083/jcb.74.3.816
   Chen MH, 2005, J BIOMED MATER RES A, V74A, P254, DOI 10.1002/jbm.a.30376
   Chen MH, 2005, TISSUE ENG, V11, P526, DOI 10.1089/ten.2005.11.526
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   DOANE KJ, 1992, EXP CELL RES, V202, P113, DOI 10.1016/0014-4827(92)90410-A
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   GRINNELL F, 1979, CELL, V17, P117, DOI 10.1016/0092-8674(79)90300-3
   GROBSTEIN C, 1965, SCIENCE, V150, P626, DOI 10.1126/science.150.3696.626
   Hamilton V, 2006, J MATER SCI-MATER M, V17, P1373, DOI 10.1007/s10856-006-0613-9
   Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172
   Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0
   Jaskoll T, 2001, BMC Dev Biol, V1, P5, DOI 10.1186/1471-213X-1-5
   Joraku A, 2005, LARYNGOSCOPE, V115, P244, DOI 10.1097/01.mlg.0000154726.77915.cc
   Joraku A, 2007, DIFFERENTIATION, V75, P318, DOI 10.1111/j.1432-0436.2006.00138.x
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kojima K, 2004, J VET MED SCI, V66, P1595, DOI 10.1292/jvms.66.1595
   Kojima K, 1998, CARBOHYD POLYM, V37, P109, DOI 10.1016/S0144-8617(98)00055-1
   KRATOCHWIL K, 1986, DEV BIOL, V117, P596, DOI 10.1016/0012-1606(86)90328-3
   Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717
   NAKANISHI Y, 1993, DEV GROWTH DIFFER, V35, P371
   NAKANISHI Y, 1986, J EMBRYOL EXP MORPH, V96, P65
   NAKANISHI Y, 1988, DEVELOPMENT, V104, P51
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   TAKAHASHI Y, 1991, DEVELOPMENT, V111, P327
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Umeda Y, 2001, DEV BIOL, V237, P202, DOI 10.1006/dbio.2001.0351
   Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305
   Warde P, 2002, INT J RADIAT ONCOL, V54, P9, DOI 10.1016/S0360-3016(02)02890-0
   Wei C, 2007, TISSUE ENG, V13, P721, DOI 10.1089/ten.2006.0123
NR 40
TC 26
Z9 28
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2008
VL 29
IS 16
BP 2501
EP 2508
DI 10.1016/j.biomaterials.2008.02.014
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 294TG
UT WOS:000255428100007
PM 18316118
DA 2018-10-20
ER

PT J
AU Kelly, S
   Regan, EM
   Uney, JB
   Dick, AD
   McGeehan, JP
   Mayer, EJ
   Claeyssens, F
AF Kelly, Stephen
   Regan, Edward M.
   Uney, James B.
   Dick, Andrew D.
   McGeehan, Joseph P.
   Mayer, Eric J.
   Claeyssens, Frederik
CA Bristol Biochip Grp
TI Patterned growth of neuronal cells on modified diamond-like carbon
   substrates
SO BIOMATERIALS
LA English
DT Article
DE laser ablation; neural cell; carbon; diamond; micropatterning
ID IMMERSION ION-IMPLANTATION; AMORPHOUS RED PHOSPHORUS; PULSED-LASER
   ABLATION; IN-VITRO; THIN-FILMS; DLC COATINGS; BLOOD COMPATIBILITY;
   ENDOTHELIAL-CELLS; PLATELET-ADHESION; RAMAN-SPECTRA
AB Diamond-like carbon (DLC) has been explored as a biomaterial with potential use for coating implantable devices and surgical instruments. In this study the interaction of DLC with mammalian neuronal cells has been studied along with its modifications to improve its function as a biomaterial. We describe the use of DLC, oxidised DLC and phosphorus-doped DLC to support the growth and survival of primary central nervous system neurones and neuroblastoma cells. None of these substrates were cytotoxic and primary neurones adhered better to phosphorus-doped DLC than unmodified DLC. This property was used to culture cortical neurones in a predetermined micropattern. This raises the potential of DLC as a biomaterial for central nervous system (CNS) implantation. Furthermore, patterned DLC and phosphorus-doped DLC can direct neuronal growth, generating a powerful tool to study neuronal networks in a spatially distinct way. This study reports the generation of nerve cell patterns via patterned deposition of DLC. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Claeyssens, Frederik] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England.
   [McGeehan, Joseph P.] Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1TH, Avon, England.
   [Regan, Edward M.; Dick, Andrew D.; Mayer, Eric J.] Univ Bristol, Bristol Eye Hosp, Bristol BS1 2LX, Avon, England.
   [Kelly, Stephen; Regan, Edward M.; Uney, James B.] Univ Bristol, Clin Sci S Bristol, Henry Wellcome LINE, Bristol BS8 1TH, Avon, England.
   Univ Bristol, Dept Clin Sci, Bristol BS8 1TH, Avon, England.
   Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1TH, Avon, England.
   [Bristol Biochip Grp] Univ Bristol, Sch Chem, Bristol BS8 1TH, Avon, England.
RP Claeyssens, F (reprint author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.
EM e.mayer@bristol.ac.uk; f.claeyssens@bristol.ac.uk
RI Kelly, Stephen/A-8307-2010; Claeyssens, Frederik/E-4781-2011
OI Claeyssens, Frederik/0000-0002-1030-939X
FU Engineering and Physical Sciences Research Council [EP/C532066/1];
   Wellcome Trust
CR Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   ANTONIUCCI D, 2000, AM J CARDIOL, V86, P171
   Ashfold MNR, 2004, CHEM SOC REV, V33, P23, DOI 10.1039/b207644f
   Ball M, 2004, J BIOMED MATER RES A, V70A, P380, DOI 10.1002/jbm.a.30066
   Bartorelli AL, 2002, CATHETER CARDIO INTE, V55, P150, DOI 10.1002/ccd.10037
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chu PK, 2007, SURF COAT TECH, V201, P8076, DOI 10.1016/j.surfcoat.2005.12.053
   Claeyssens F, 2004, DALTON T, P3085, DOI 10.1039/b402740j
   Claeyssens F, 2004, APPL PHYS A-MATER, V79, P1237, DOI 10.1007/s00339-004-2726-7
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   FASOL G, 1984, SOLID STATE COMMUN, V52, P307, DOI 10.1016/0038-1098(84)90832-9
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Fuge GM, 2004, DIAM RELAT MATER, V13, P1442, DOI 10.1016/j.diamond.2003.11.069
   GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539
   Gorham J, 2005, J PHYS CHEM B, V109, P20379, DOI 10.1021/jp0521196
   Gross GW, 1999, J INTEL MAT SYST STR, V10, P558, DOI 10.1106/XC9U-BMJ8-FE1A-EUNQ
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   Huang LCL, 2004, LANGMUIR, V20, P5879, DOI 10.1021/la0495736
   Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.3.CO;2-N
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Kumar R.R., 2007, J BIOMEDICAL MAT R B, V83B, P72
   Kumari TV, 2002, BIO-MED MATER ENG, V12, P329
   Kwok SCH, 2006, DIAM RELAT MATER, V15, P893, DOI 10.1016/j.diamond.2005.10.062
   Kwok SCH, 2006, NEW DIAM FRONT C TEC, V16, P39
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Kwok SCH, 2004, J BIOMED MATER RES A, V70A, P107, DOI 10.1002/jbm.a.30070
   Leng YX, 2003, SURF SCI, V531, P177, DOI 10.1016/S0039-6028(03)00487-4
   Logothetidis S, 2005, THIN SOLID FILMS, V482, P126, DOI 10.1016/j.tsf.2004.11.131
   Ma WJ, 2007, BIOMATERIALS, V28, P1620, DOI 10.1016/j.biomaterials.2006.12.010
   Maguire PD, 2005, DIAM RELAT MATER, V14, P1277, DOI 10.1016/j.diamond.2004.12.023
   Nebel CE, 2007, J R SOC INTERFACE, V4, P439, DOI 10.1098/rsif.2006.0196
   Nurdin N., 2003, European Cells & Materials, V5, P17
   Nurdin N., 2003, EUR CELLS MATER, V5, P26
   Okpalugo TIT, 2004, J BIOMED MATER RES A, V71A, P201, DOI 10.1002/jbm.a.30104
   Okpalugo TIT, 2004, BIOMATERIALS, V25, P239, DOI 10.1016/S0142-9612(03)00494-0
   OLEGO DJ, 1984, SOLID STATE COMMUN, V52, P311, DOI 10.1016/0038-1098(84)90833-0
   Ong SE, 2007, BIOMATERIALS, V28, P4033, DOI 10.1016/j.biomaterials.2007.05.031
   Prawer S, 1996, DIAM RELAT MATER, V5, P433, DOI 10.1016/0925-9635(95)00363-0
   Salahas A, 2007, ANGIOLOGY, V58, P203, DOI 10.1177/0003319707300360
   Schaefer O, 2004, CLIN RADIOL, V59, P1128, DOI 10.1016/j.crad.2004.05.016
   Singh A, 2003, BIOMATERIALS, V24, P5083, DOI 10.1016/S0142-9612(03)00424-1
   Tran HS, 1999, J INVEST SURG, V12, P133
   Xiao XC, 2006, J BIOMED MATER RES B, V77B, P273, DOI 10.1002/jbm.b.30448
NR 46
TC 46
Z9 47
U1 1
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2008
VL 29
IS 17
BP 2573
EP 2580
DI 10.1016/j.biomaterials.2008.03.001
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 307JE
UT WOS:000256314400002
PM 18359076
DA 2018-10-20
ER

PT J
AU Peyton, SR
   Kim, PD
   Ghajar, CM
   Seliktar, D
   Putnam, AJ
AF Peyton, Shelly R.
   Kim, Peter D.
   Ghajar, Cyrus M.
   Seliktar, Dror
   Putnam, Andrew J.
TI The effects of matrix stiffness and RhoA on the phenotypic plasticity of
   smooth muscle cells in a 3-D biosynthetic hydrogel system
SO BIOMATERIALS
LA English
DT Article
DE ECM (extracellular matrix); hydrogel; mechanical properties;
   polyethylene oxide; smooth muscle cell
ID PEG HYDROGELS; COLLAGEN MATRIX; MC3T3-E1 CELLS; TISSUE; MIGRATION;
   FIBRINOGEN; ADHESION; TENSION; GTPASES; KINASE
AB Studies using 2-D cultures have shown that the mechanical properties of the extracellular matrix (ECM) influence cell migration, spreading, proliferation, and differentiation; however, cellular mechanosensing in 3-D remains under-explored. To investigate this topic, a unique biomaterial system based on poly(ethylene glycol)-conjugated fibrinogen was adapted to study phenotypic plasticity in smooth muscle cells (SMCs) as a function of ECM mechanics in 3-D. Tuning the compressive modulus between 448 and 5804 Pa modestly regulated SMC cytoskeletal assembly in 3-D3, with spread cells in stiff matrices having a slightly higher degree of F-actin bundling after prolonged culture. However, vinculin expression in all 3-D conditions was qualitatively low and was not assembled into the classic focal adhesions typically seen in 2-D cultures. Given the evidence that RhoA-mediated cytoskeletal contractility represents a critical node in mechanosensing, we molecularly upregulated contractility by inducing SMCs to express constitutively active RhoA. In these cells, F-actin bundling and total vinculin expression increased, and focal adhesion-like structures began to emerge, consistent with RhoA' mechanism of action in cells cultured on 2-D substrates. Furthermore, SMC proliferation in 3-D did not depend significantly on matrix stiffness, and was reduced by constitutive activation of RhoA irrespective of ECM mechanical properties. Conversely, the expression of contractile markers globally increased with constitutive RhoA activation and depended on 3-D matrix stiffness only in cells with heightened RhoA activity. Combined, these data suggest that the synergistic effects of ECM mechanics and RhoA activity on SMC phenotype in 3-D are distinct from those in 2-D, and highlight the importance of studying the mechanical role of cell-matrix interactions in tunable 3-D environments. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Kim, Peter D.; Ghajar, Cyrus M.; Putnam, Andrew J.] Univ Calif Irvine, Dept Biomed Engn, Henry Samueli Sch Engn, Irvine, CA 92697 USA.
   [Peyton, Shelly R.; Putnam, Andrew J.] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Henry Samueli Sch Engn, Irvine, CA 92697 USA.
   [Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
RP Putnam, AJ (reprint author), Univ Calif Irvine, Dept Biomed Engn, Henry Samueli Sch Engn, 3107 Nat Sci 2, Irvine, CA 92697 USA.
EM aputnam@uci.edu
RI Peyton, Shelly/F-5340-2012; Putnam, Andrew/E-8643-2010
OI Putnam, Andrew/0000-0002-1262-4377; Peyton, Shelly/0000-0002-7364-8727;
   Seliktar, Dror/0000-0001-6964-8567
FU NCRR NIH HHS [P41 RR001192, P41 RR001192-20, #P41-RR01192]
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Bi D, 2005, CIRC RES, V96, P890, DOI 10.1161/01.RES.0000163018.66460.85
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Chapados R, 2006, CIRC RES, V99, P837, DOI 10.1161/01.RES.0000246172.77441.f1
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   DIKOVSKY D, 2008, BIOPHYS J
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Kamiyama Masumi, 2003, J Atheroscler Thromb, V10, P117
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974
   Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200
   Mallat Z, 2003, CIRC RES, V93, P884, DOI 10.1161/01.RES.0000099062.55042.9A
   Nikolovski J, 2003, FASEB J, V17, P455, DOI 10.1096/fj.02-0459fje
   OSOL G, 1995, J VASC RES, V32, P275, DOI 10.1159/000159102
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578
   Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104
   Sawada N, 2000, CIRCULATION, V101, P2030, DOI 10.1161/01.CIR.101.17.2030
   Schmidt O, 2006, BIOTECHNOL BIOENG, V95, P1061, DOI 10.1002/bit.21072
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   THYBERG J, 1990, ARTERIOSCLEROSIS, V10, P966, DOI 10.1161/01.ATV.10.6.966
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
   Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010
   Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
   Zuckerbraun BS, 2007, AM J PHYSIOL-CELL PH, V292, pC824, DOI 10.1152/ajpcell.00592.2005
NR 47
TC 142
Z9 143
U1 4
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2008
VL 29
IS 17
BP 2597
EP 2607
DI 10.1016/j.biomaterials.2008.02.005
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 307JE
UT WOS:000256314400005
PM 18342366
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Pham, QP
   Kasper, FK
   Baggett, LS
   Raphael, RM
   Jansen, JA
   Mikos, AG
AF Pham, Quynh P.
   Kasper, F. Kurtis
   Baggett, L. Scott
   Raphael, Robert M.
   Jansen, John A.
   Mikos, Antonios G.
TI The influence of an in vitro generated bone-like extracellular matrix on
   osteoblastic gene expression of marrow stromal cells
SO BIOMATERIALS
LA English
DT Article
DE extracellular matrix; gene expression; growth factors; osteoblast;
   scaffold
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTORS; MC3T3-E1 CELLS; DIFFERENTIATION;
   PHENOTYPE; PROTEINS; DECORIN; BINDING; REPAIR; TISSUE
AB The function and development of cells rely heavily on the signaling interactions with the surrounding extracellular matrix (ECM). Therefore, a tissue engineering scaffold should mimic native ECM to recreate the in vivo environment. Previously, we have shown that an in vitro generated ECM secreted by cultured cells enhances the mineralized matrix deposition of marrow stromal cells (MSCs). in this study, MSC expression of 45 bone-related genes using real-time reverse transcriptase polymerase chain reaction (RT-PCR) was determined. Upregulation of osteoblastic markers such as collagen type 1, matrix extracellular phosphoglycoprotein with ASARM motif, parathyroid hormone receptor, and osteocalcin, indicated that the MSCs on plain titanium scaffolds differentiated down the osteoblastic lineage and deposited a mineralized matrix on day 12. Significant mineralized matrix deposition was observed as early as day 4 on ECM-containing scaffolds and was associated with the enhancement in expression of a subset of osteoblast-specific genes that included a 2-fold increase in osteopontin expression at day 1 and a 6.5-fold increase in osteocalcin expression at day 4 as well as downregulation of chondrogenic gene markers. These results were attributed to the cellular interactions with growth factors and matrix molecules that are likely present in the in vitro generated ECM since the genes for insulin-like growth factor 1, insulin-like growth factor 2, vascular endothelial growth factor, dentin matrix protein, collagen type IV, cartilage oligomeric protein, and matrix metalloproteinase 13 were significantly upregulated during ECM construct generation. Overall, the data demonstrate that modulation of MSC differentiation occurs at the transcriptional level and gene expression of bone-related proteins is differentially regulated by the ECM. This study presents enormous implications for tissue engineering strategies, as it demonstrates that modification of a biomaterial with an in vitro generated ECM containing cell-generated bioactive signaling molecules can effectively direct gene expression and differentiation of seeded progenitor cell populations. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Pham, Quynh P.; Kasper, F. Kurtis; Raphael, Robert M.; Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   [Baggett, L. Scott] Rice Univ, Dept Stat, Houston, TX 77251 USA.
   [Jansen, John A.] Radboud Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, NL-6500 HB Nijmegen, Netherlands.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, MS-142,POB 1892, Houston, TX 77251 USA.
EM mikos@rice.edu
RI Jansen, John/H-8055-2014; Kasper, Fred/H-5719-2011
FU NCI NIH HHS [CA-16672]; NIAMS NIH HHS [(R01-AR42639]; NIBIB NIH HHS [5
   R01 EB005173-02]; NIDDK NIH HHS [5 T90 DK070121-03]
CR Argiro L, 2001, GENOMICS, V74, P342, DOI 10.1006/geno.2001.6558
   Aubin JE, 1995, BONE, V17, P77
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047
   BI Y, 2005, J BIOL CHEM
   Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   Chen GP, 2003, J BIOMED MATER RES A, V67A, P1170, DOI 10.1002/jbm.a.10164
   Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.0.CO;2-A
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   Fogel P, 2007, BIOINFORMATICS, V23, P44, DOI 10.1093/bioinformatics/btl550
   Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201
   Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603
   Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   HEDBOM E, 1993, J BIOL CHEM, V268, P27307
   Hoshi K, 1999, J BONE MINER RES, V14, P273, DOI 10.1359/jbmr.1999.14.2.273
   HUANG Z, 2007, TISSUE ENG
   Kondo H, 1997, J BONE MINER RES, V12, P2089, DOI 10.1359/jbmr.1997.12.12.2089
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P407, DOI 10.3109/17453679609002342
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marvanova M, 2004, NEUROPSYCHOPHARMACOL, V29, P1070, DOI 10.1038/sj.npp.1300398
   Matheson S, 2005, J PERIODONTAL RES, V40, P312, DOI 10.1111/j.1600-0765.2005.00800.x
   Matsuura T, 2005, EUR J ORAL SCI, V113, P225, DOI 10.1111/j.1600-0722.2005.00208.x
   Monticone M, 2004, J CELL BIOCHEM, V92, P733, DOI 10.1002/jcb.20120
   Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447
   Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198
   Ninomiya K, 2007, BIOCHEM BIOPH RES CO, V362, P460, DOI 10.1016/j.bbrc.2007.07.193
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   ROBEY PG, 2002, PRINCIPLES BONE BIOL, P225
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Schiavi SC, 2006, NAT GENET, V38, P1230, DOI 10.1038/ng1106-1230
   Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748
   Sommarin Y, 1998, J BIOL CHEM, V273, P16723, DOI 10.1074/jbc.273.27.16723
   Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Wang PP, 2004, BIOCHEM BIOPH RES CO, V320, P712, DOI 10.1016/j.bbrc.2004.05.213
   Xu MF, 2004, CIRCULATION, V110, P2658, DOI 10.1161/01.CIR.0000145609.20435.36
NR 45
TC 98
Z9 102
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2008
VL 29
IS 18
BP 2729
EP 2739
DI 10.1016/j.biomaterials.2008.02.025
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 304YF
UT WOS:000256144300004
PM 18367245
DA 2018-10-20
ER

PT J
AU Bera, T
   Vivek, AN
   Saraf, SK
   Ramachandrarao, P
AF Bera, Tanmay
   Vivek, A. N.
   Saraf, S. K.
   Ramachandrarao, P.
TI Characterization of biomimetically synthesized Hap-Gel nanocomposites as
   bone substitute
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID TRICALCIUM PHOSPHATE; DEFICIENT APATITE; BIOCERAMICS
AB There is an increasing demand for an affordable and easy-to-fabricate material to help patients having a long bone gap. In this paper, we describe the biomimetic synthesis of Hap-Gel in situ nanocomposite powders with varied proportions. Their biocompatibility and bone regeneration abilities were assessed on a rabbit model. The use of Hap crystals and Gel molecule, the soluble form of bone protein, makes the nanocomposites comparable to natural bone in constituents. The application of biomimetic principles improves crystal morphology and the interaction of Hap crystals with the Gel molecules as seen through in vitro characterizations. Out of the various compositions studied, one with 80: 20 proportions of Hap to Gel proved to be closest to the characteristics of natural bone. The immunological response to this composite, assessed through intradermal inoculation, did not reveal any reaction. The in vivo implantation studies in the femoral condyle of the animals, as assessed by serial post-operative follow-up radiography and the histological evaluation, revealed a good biocompatibility and bone-regeneration ability of the material. Thus, nanocomposites of Hap-Gel have a great potential for serving as an effective and affordable biomaterial for bone grafting applications.
C1 [Bera, Tanmay] Banaras Hindu Univ, Inst Technol, Dept Met Engn, Varanasi 221005, Uttar Pradesh, India.
   [Vivek, A. N.; Saraf, S. K.] Banaras Hindu Univ, Inst Med Sci, Dept Orthoped, Varanasi 221005, Uttar Pradesh, India.
   [Ramachandrarao, P.] Int Adv Res Ctr Powder Metallurgy & New Mat ARCI, Hyderabad 500005, Andhra Pradesh, India.
RP Bera, T (reprint author), Banaras Hindu Univ, Inst Technol, Dept Met Engn, Varanasi 221005, Uttar Pradesh, India.
EM pramachandra_rao@yahoo.com
CR BERMAN A, 1988, NATURE, V331, P546
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Gilbert PUPA, 2005, REV MINERAL GEOCHEM, V59, P157, DOI 10.2138/rmg.2005.59.7
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Hao H, 2004, BIOMATERIALS, V25, P431, DOI 10.1016/S0142-9612(03)00550-7
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KATTHAGEN BD, 1987, BONE REGENERATION BO
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Liou SC, 2004, BIOMATERIALS, V25, P189, DOI 10.1016/S0142-9612(03)00479-4
   Liu GP, 2007, BIOMED MATER, V2, P78, DOI 10.1088/1748-6041/2/2/004
   MANN S, 1988, NATURE, V334, P692, DOI 10.1038/334692a0
   MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Oudadesse H, 2007, BIOMED MATER, V2, pS59, DOI 10.1088/1748-6041/2/1/S09
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   RAMACHANDRARAO P, 2003, SADHNA, V28, P657, DOI DOI 10.1007/BF02706452
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Wilson RM, 2005, BIOMATERIALS, V26, P1317, DOI 10.1016/j.biomaterials.2004.04.038
NR 21
TC 9
Z9 9
U1 0
U2 4
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2008
VL 3
IS 2
AR 025001
DI 10.1088/1748-6041/3/2/025001
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 309IN
UT WOS:000256454000002
PM 18458374
DA 2018-10-20
ER

PT J
AU Huang, TH
   Muhlbauer, RC
   Tang, CH
   Chen, HI
   Chang, GL
   Huang, YW
   Lai, YT
   Lin, HS
   Yang, WT
   Yang, RS
AF Huang, Tsang-Hai
   Muehlbauer, Roman C.
   Tang, Chih-Hsin
   Chen, Hsiun-Ing
   Chang, Guan-Liang
   Huang, Yi-Wei
   Lai, Yu-Ting
   Lin, Hsin-Shi
   Yang, Wei-Ting
   Yang, Rong-Sen
TI Onion decreases the ovariectomy-induced osteopenia in young adult rats
SO BONE
LA English
DT Article
DE osteoporosis; phytotherapy; alendronate; osteoclast; menopause
ID BONE-MINERAL DENSITY; MECHANICAL-PROPERTIES; VEGETABLE CONSUMPTION;
   ALENDRONATE TREATMENT; DIETARY PATTERNS; FRUIT; OSTEOPOROSIS;
   METABOLISM; MASS; STRENGTH
AB It has been suggested that fruit and vegetable consumption are associated with good bone health. Onion, in particular, has been verified in its efficacy in bone resorption activity. In this study, we further investigated the effects of an onion-containing diet on ovariectomy-induced bone loss using methods of serum marker assay, bistomorphometric analysis and biomechanical tests. Sixty-four female Wistar rats (14-week-old) with sham operations or ovariectomy were assigned to 6 groups: CON, sham-operated control group; OVX, ovariectomized group; ALN, ovariectomized rats treated with alendronate (1 mg/kg/day, p.o.); and 3% ON, 7% ON and 14% ON, ovariectomized rats fed with diets containing 3%, 7% and 14% (wt/wt) onion powder, respectively. Animals were sacrificed after a six-week treatment course. In the serum marker assay, alendronate and all three onion-enriched diets significantly decreased serum calcium level (p<0.05). Both 14% ON group and the ALN group even showed similarly lower level of serum osteocalcin (p<0.05), suggesting a down-regulation of bone turnover. The histomorphometric analysis showed that ovariectomy markedly decrease bone trabeculae. The ALN and 14% ON rats were 80% and 46% higher, respectively, in BV/TV than the OVX rats (p<0.05), and the rats fed with onion-enriched food showed a lesser ovariectomy-induced bone loss in a dose-dependent manner. Additionally, both ALN and 14% ON groups had significantly more trabecular number, less separated trabeculae, and fewer osteoclasts (p<0.05), but the protective efficacy from the 14% onion-enriched diet was slightly inferior to that of alendronate. Ovariectomy also significantly decreased tissue weight and biomechanical strength in the OVX group (p<0.05). The ALN and 14% ON groups equivalently showed a lesser decrease in tissue weight, though the difference was not significant. On the other hand, both the ALN and 14% ON groups represented similar biomaterial properties of femurs, and both reduced the ovariectomy-induced decrease in bending load and bending energy (p<0.05). The present study further verified that an onion-enriched diet could counteract ovariectomy-induced bone loss and deterioration of biomechanical properties. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Yang, Rong-Sen] Natl Taiwan Univ & Hosp, Coll Med, Dept Orthopaed, Taipei 100, Taiwan.
   [Huang, Tsang-Hai; Lin, Hsin-Shi] Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan 701, Taiwan.
   [Chen, Hsiun-Ing] Natl Cheng Kung Univ, Dept Physiol, Tainan 701, Taiwan.
   [Chang, Guan-Liang; Yang, Wei-Ting] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 701, Taiwan.
   [Huang, Yi-Wei; Lai, Yu-Ting] Natl Cheng Kung Univ, Dept Life Sci, Tainan 701, Taiwan.
   [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung 404, Taiwan.
   [Muehlbauer, Roman C.] Univ Bern, Dept Clin Res, Bone Biol Grp, CH-3010 Bern, Switzerland.
RP Yang, RS (reprint author), Natl Taiwan Univ & Hosp, Coll Med, Dept Orthopaed, 7 Chung-Shan S Rd, Taipei 100, Taiwan.
EM rsyang@ntuh.gov.tw
RI Tang, Chih Hsin/O-5212-2015
OI Tang, Chih Hsin/0000-0002-7113-8352; Yang, Rong-Sen/0000-0002-0553-4779
CR Alatalo SL, 2003, J BONE MINER RES, V18, P134, DOI 10.1359/jbmr.2003.18.1.134
   Arjmandi BH, 2002, J WOMEN HEALTH GEN-B, V11, P61, DOI 10.1089/152460902753473471
   Arjmandi BH, 1996, J NUTR, V126, P161
   Azuma Y, 1998, J PHARMACOL EXP THER, V286, P128
   Bagi CM, 1997, CALCIFIED TISSUE INT, V61, P336, DOI 10.1007/s002239900344
   Cai DJ, 2005, J BONE MINER RES, V20, P828, DOI 10.1359/JBMR.041236
   Chachra D, 2000, BIOMED SCI INSTRUM, V36, P123
   Chen YM, 2006, BRIT J NUTR, V96, P745, DOI 10.1079/BJN20061883
   da Paz LHBC, 2001, BRAZ J MED BIOL RES, V34, P1015, DOI 10.1590/S0100-879X2001000800007
   Deyhim F, 2005, MENOPAUSE, V12, P755, DOI 10.1097/01.gme.0000185486.55758.5b
   Draper CR, 1997, J NUTR, V127, P1795
   Friedman AW, 2006, JCR-J CLIN RHEUMATOL, V12, P70, DOI 10.1097/01.rhu.0000208612.33819.8c
   Frolik CA, 1996, BONE, V18, P621, DOI 10.1016/8756-3282(96)00085-3
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916
   Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148
   Honda A, 2001, J BONE MINER RES, V16, P1688, DOI 10.1359/jbmr.2001.16.9.1688
   Horcajada-Molteni MN, 2000, J BONE MINER RES, V15, P2251, DOI 10.1359/jbmr.2000.15.11.2251
   Huang TH, 2003, J APPL PHYSIOL, V95, P300, DOI 10.1152/japplphysiol.01076.2002
   Huang TH, 2002, BONE, V30, P293, DOI 10.1016/S8756-3282(01)00659-7
   Ito M, 2002, JPN J PHARMACOL, V89, P255, DOI 10.1254/jjp.89.255
   Iwamoto J, 2006, EXP ANIM TOKYO, V55, P357, DOI 10.1538/expanim.55.357
   KALU DN, 1989, ENDOCRINOLOGY, V124, P7, DOI 10.1210/endo-124-1-7
   Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064
   Lindsay R, 1997, OSTEOPOROSIS INT, V7, P1
   Martiniakova M, 2006, J FORENSIC SCI, V51, P1235, DOI 10.1111/j.1556-4029.2006.00260.x
   McGartland CP, 2004, AM J CLIN NUTR, V80, P1019
   MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902
   Melton LJ, 1998, J BONE MINER RES, V13, P1915, DOI 10.1359/jbmr.1998.13.12.1915
   Muhlbauer R. C., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P137
   Muhlbauer RC, 1999, NATURE, V401, P343, DOI 10.1038/43824
   Muhlbauer RC, 2003, J NUTR, V133, P3592
   Muhlbauer RC, 2002, J BONE MINER RES, V17, P1230, DOI 10.1359/jbmr.2002.17.7.1230
   Muhlbauer RC, 2001, J BONE MINER RES, V16, P970, DOI 10.1359/jbmr.2001.16.5.970
   New SA, 2000, AM J CLIN NUTR, V71, P142
   Ogawa K, 2005, J BONE MINER METAB, V23, P351, DOI 10.1007/s00774-005-0612-9
   Okubo H, 2006, AM J CLIN NUTR, V83, P1185
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Peng ZQ, 1997, BONE, V20, P207, DOI 10.1016/S8756-3282(96)00369-9
   Prynne CJ, 2006, AM J CLIN NUTR, V83, P1420
   Reid Ian R, 2002, Expert Opin Drug Saf, V1, P93, DOI 10.1517/14740338.1.1.93
   RUTH EB, 1953, AM J ANAT, V93, P429, DOI 10.1002/aja.1000930306
   Tucker KL, 2002, AM J CLIN NUTR, V76, P245
   Tucker KL, 1999, AM J CLIN NUTR, V69, P727
   TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K
   Tylavsky FA, 2004, AM J CLIN NUTR, V79, P311
   van der Meulen MCH, 2001, BONE, V29, P101, DOI 10.1016/S8756-3282(01)00491-4
   Vatanparast H, 2005, AM J CLIN NUTR, V82, P700
   Wetli HA, 2005, J AGR FOOD CHEM, V53, P3408, DOI [10.1021/jf040457i, 10.1021/jf040457l]
   Ye She-Fang, 2003, Endocr Regul, V37, P145
   Yeh IT, 2007, ADV ANAT PATHOL, V14, P17, DOI 10.1097/PAP.0b013e31802ef00f
NR 51
TC 17
Z9 19
U1 1
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD JUN
PY 2008
VL 42
IS 6
BP 1154
EP 1163
DI 10.1016/j.bone.2008.01.032
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 307PE
UT WOS:000256330000018
PM 18387868
DA 2018-10-20
ER

PT J
AU Nie, M
   Zhang, TP
   Pei, CX
   Quan, DX
   Chen, N
AF Nie Min
   Zhang TianPeng
   Pei ChangXing
   Quan DongXiao
   Chen Nan
TI The U/Omega effect of electricity parameters of the lotus root silk in
   the liquor with different pH values
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE silk of lotus root; biomedicine engineering material; U/Omega effect; pH
   value of liquor
ID TISSUE; CELLS
AB The silk of lotus root is a kind of natural biomaterial with the advantages of easy absorbing and dissolving and poisonless. It may become a new engineering material for clinic and tissue engineering. However, the relationship between its electricity parameters and the pH values of the liquor that the silk is dipped in is unknown presently. The electricity parameters of inductance, capacitance and impedance of the silk were measured in the environment with the temperature ranging from 23 degrees C to 25 degrees C and the humidity ranging from 45% to 55% when it was dipped in the liquor with different pH values for 24 h. The results show that the inductance and impedance vary in Omega shape curves with the liquor pH value, and the capacitance varies in Omega shape curve. The minimal value of the Omega curves and the maximal value of the Omega curve appear at the point where the pH value equals to Omega. The phenomena are called the U/Omega effect. It means that the silk has perfect biocompatibility with human tissues. The study results may imply that the silk have broader potential applications in biomedicine, tissue engineering and bioelectronics.
C1 [Nie Min; Zhang TianPeng; Pei ChangXing; Quan DongXiao; Chen Nan] Xidian Univ, State Key Lab ISN, Xian 710071, Peoples R China.
   [Nie Min] Xian Inst Post & Telecommun, Xian 710061, Peoples R China.
RP Nie, M (reprint author), Xidian Univ, State Key Lab ISN, Xian 710071, Peoples R China.
EM mnie@xidian.edu.cn
CR BLAU HM, 2001, CELL, V105, P8292
   BRIEN FJ, 2005, BIOMATERIALS, V26, P433
   Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025
   Fujita M, 2005, TISSUE ENG, V11, P1346, DOI 10.1089/ten.2005.11.1346
   HAYNES CA, 1992, J PHYS CHEM-US, V96, P905, DOI 10.1021/j100181a069
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin YZ, 2001, ACTA CHIM SINICA, V59, P2110
   MA L, 2001, SPACE MED ENG, V15, P199
   PATRICIA YW, 2005, NAT MATER, V4, P568
   Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91
   Scott J., 2005, NAT MATER, V4, P518
   VINCENT LV, 1981, J COLLOID INTERF SCI, V79, P548
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   WU L, 2005, THESIS NW U AGR FORE
NR 16
TC 0
Z9 0
U1 0
U2 5
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD JUN
PY 2008
VL 53
IS 12
BP 1924
EP 1928
DI 10.1007/s11434-008-0260-2
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 316PU
UT WOS:000256963000019
DA 2018-10-20
ER

PT J
AU Tang, CY
   Chen, DZ
   Yue, TM
   Chan, KC
   Tsui, CP
   Yu, PHF
AF Tang, C. Y.
   Chen, D. Z.
   Yue, T. M.
   Chan, K. C.
   Tsui, C. P.
   Yu, Peter H. F.
TI Water absorption and solubility of PHBHV/HA nanocomposites
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE polymer-matrix composites (PMCs); nanostructures; ceramics; thermal
   properties; water absorption
ID MECHANICAL-PROPERTIES; MOISTURE ABSORPTION; COMPOSITES; HYDROXYAPATITE;
   DIFFUSION; NANOINDENTATION; TEMPERATURE; POLYMERS; SORPTION; RESINS
AB A thorough understanding of the influence of bioceramic phase on the water absorption and solubility of biomaterial is of importance in tailoring its degradation and the formation of bone-like apatite for clinical implant applications in a wet environment. The objective of this study was to characterize and quantify the water transport properties and solubility of biomaterial incorporating poly(3-hydroxy-butyrate-co-3-hydroxyvalerate) (PHBHV) and nano-hydroxyapatite (nano-HA) modified with a silane coupling agent. Solubility and transport parameters such as diffusion, permeability, and sorption coefficients were determined at three different temperatures using the weighing method. When the environmental temperature reached 60 degrees C, the water uptake of the nanocomposite reaches equilibrium after a normally fast absorption process, and then decreases as the immersion time is prolonged due to the solubility of the material. Moreover, this phenomenon becomes more significant with increasing the volume fraction of nano-HA. Compared to those for the base resin, the diffusion coefficients for the nanocomposite decrease, whereas the sorption coefficients and the solubility show an opposite tendency. All of the transportation parameters are temperature sensitive and obey the Arrhenius or the van't Hoff relationship. Results from thermodynamic analysis imply that when using a high filler loading level (>= 20 vol%) the sorption of the nanocomposite is mainly dominated by a Langmuir sorption mode giving an exothermic process. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Tang, C. Y.; Chen, D. Z.; Yue, T. M.; Chan, K. C.; Tsui, C. P.] Hong Kong Polytech Univ, Dept Ind & Syst Engn, Kowloon, Hong Kong, Peoples R China.
   [Yu, Peter H. F.] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.
RP Chen, DZ (reprint author), Hong Kong Polytech Univ, Dept Ind & Syst Engn, Kowloon, Hong Kong, Peoples R China.
EM mfdazhu@polyu.edu.hk
RI Chan, K.C./A-2311-2014; TSUI, CP/A-4087-2009
OI Chan, K.C./0000-0002-6173-5532; YUE, Tai Man/0000-0001-9380-5067; TSUI,
   Chi Pong/0000-0001-9239-9386; Tang, Chak Yin/0000-0003-2577-024X
CR Aminabhavi TM, 1996, EUR POLYM J, V32, P1117, DOI 10.1016/0014-3057(96)00021-3
   ANDRIANO KP, 1992, J APPL BIOMATER, V3, P197, DOI 10.1002/jab.770030306
   Balac I, 2006, MATER SCI FORUM, V518, P501, DOI 10.4028/www.scientific.net/MSF.518.501
   Bao LR, 2002, POLYMER, V43, P3987, DOI 10.1016/S0032-3861(02)00189-1
   Becker O, 2004, EUR POLYM J, V40, P187, DOI 10.1016/j.eurpolymj.2003.09.008
   Bond DA, 2005, J COMPOS MATER, V39, P2113, DOI 10.1177/0021998305052030
   BRADEN M, 1976, J DENT RES, V55, P730, DOI 10.1177/00220345760550050501
   Chen DZ, 2007, COMPOS SCI TECHNOL, V67, P1617, DOI 10.1016/j.compscitech.2006.07.034
   Chow CPL, 2007, COMPOS SCI TECHNOL, V67, P306, DOI 10.1016/j.compscitech.2006.08.005
   Chuang T. H., 2004, INT J POLYM MATER, V53, P553
   CRANK J, 1957, MATH DIFFUSION, P45
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P531
   Hashimoto M, 2006, MATER RES BULL, V41, P515, DOI 10.1016/j.materresbull.2005.09.014
   Hodzic A, 2004, COMPOS SCI TECHNOL, V64, P2185, DOI 10.1016/j.compscitech.2004.03.011
   Kim JK, 2005, COMPOS SCI TECHNOL, V65, P805, DOI 10.1016/j.compscitech.2004.10.014
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P293, DOI 10.1016/S0142-9612(99)00180-5
   Li HY, 2005, COMPOS SCI TECHNOL, V65, P2226, DOI 10.1016/j.compscitech.2005.04.051
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Malacarne J, 2006, DENT MATER, V22, P973, DOI 10.1016/j.dental.2005.11.020
   Mathieu LM, 2006, COMPOS SCI TECHNOL, V66, P1606, DOI 10.1016/j.compscitech.2005.11.012
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Santos C, 2002, BIOMATERIALS, V23, P1897, DOI 10.1016/S0142-9612(01)00331-3
   Shanahan MER, 1998, POLYMER, V39, P1155, DOI 10.1016/S0032-3861(97)00277-2
   Sideridou I, 2004, BIOMATERIALS, V25, P367, DOI 10.1016/S0142-9612(03)00529-5
   Sreekala MS, 2002, COMPOS PART A-APPL S, V33, P763, DOI 10.1016/S1359-835X(02)00032-5
   Tang CY, 2006, J APPL POLYM SCI, V102, P5388, DOI 10.1002/app.25016
   Uskokovic PS, 2007, J EUR CERAM SOC, V27, P1559, DOI 10.1016/j.jeurceramsoc.2006.04.122
   Vallittu PK, 1999, J ORAL REHABIL, V26, P666, DOI 10.1046/j.1365-2842.1999.00431.x
   Wang YJ, 2007, MATER LETT, V61, P1071, DOI 10.1016/j.matlet.2006.06.042
   Wu LB, 2006, J BIOMED MATER RES A, V76A, P264, DOI 10.1002/jbm.a.30544
   Yoon JS, 2000, J APPL POLYM SCI, V77, P1716, DOI 10.1002/1097-4628(20000822)77:8<1716::AID-APP8>3.3.CO;2-6
   Zhao JL, 2004, MATER LETT, V58, P163, DOI 10.1016/S0167-577X(03)00437-3
NR 33
TC 27
Z9 29
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD JUN
PY 2008
VL 68
IS 7-8
BP 1927
EP 1934
DI 10.1016/j.compscitech.2007.12.003
PG 8
WC Materials Science, Composites
SC Materials Science
GA 304US
UT WOS:000256135200043
DA 2018-10-20
ER

PT J
AU Laib, S
   Petit, M
   Bodio, E
   Fatimi, A
   Weiss, P
   Bujoli, B
AF Laib, Samia
   Petit, Marc
   Bodio, Ewen
   Fatimi, Ahmed
   Weiss, Pierre
   Bujoli, Bruno
TI Labeling of a self-hardening bone substitute using ruthenium
   tris-bipyridine complexes, for the analysis of its in vivo metabolism
SO COMPTES RENDUS CHIMIE
LA English
DT Article; Proceedings Paper
CT GECOM-CONCOORD Conference
CY MAY 20-25, 2007
CL Plancoet, FRANCE
DE labeling; bipyridine; ruthenium; hydrogel; biomaterial; cellulose;
   self-setting scaffold
ID SOLID-PHASE SYNTHESIS; GENERAL-PROPERTIES; REDOX DERIVATIVES;
   BIOMATERIALS; SEPARATION; INGROWTH; LYSINE
AB A self-setting cellulose scaffold, used as a component of an injectable bone substitute, was labeled with ruthenium tris-bipyridine complexes functionalized by triethoxysilane groups. The labeling yield was found to vary according to the number and location of Si(OR)(3) groups present on the ruthenium complex backbone. For label loadings, less than similar to 0.1 wt%, no significant modification of the theological properties of the gel was observed.
C1 [Laib, Samia; Petit, Marc; Bodio, Ewen; Bujoli, Bruno] Univ Nantes, CEISAM, Fac Sci & Tech, F-44322 Nantes 3, France.
   [Laib, Samia; Fatimi, Ahmed; Weiss, Pierre] Univ Nantes, LIOAD, INSERM, UMRS 791, F-44042 Nantes 1, France.
   [Laib, Samia; Petit, Marc; Bodio, Ewen; Bujoli, Bruno] CNRS, UMR 6230, F-44322 Nantes 3, France.
RP Bujoli, B (reprint author), Univ Nantes, CEISAM, Fac Sci & Tech, 2 Rue Houssiniere,BP 92208, F-44322 Nantes 3, France.
EM bruno.bujoli@univ-nantes.fr
RI Fatimi, Ahmed/F-2936-2012; petit, marc/C-8828-2015; Weiss,
   Pierre/P-1372-2014
OI petit, marc/0000-0001-6298-2087; Weiss, Pierre/0000-0002-6159-8590
CR Arnosti C, 2000, MAR CHEM, V71, P321, DOI 10.1016/S0304-4203(00)00061-X
   BARD AJ, 1993, Patent No. 8602734
   Berg KE, 2001, EUR J INORG CHEM, P1019
   Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   Daculsi G, 1999, BONE, V25, P59
   Fraser CL, 1997, J ORG CHEM, V62, P9314, DOI 10.1021/jo971685x
   FURUE M, 1991, B CHEM SOC JPN, V64, P1632, DOI 10.1246/bcsj.64.1632
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   GHOSH PK, 1980, J AM CHEM SOC, V102, P5543, DOI 10.1021/ja00537a021
   Hu X, 2000, INORG CHEM, V39, P2500, DOI 10.1021/ic991078n
   Jones JR, 2006, MATER TODAY, V9, P34, DOI 10.1016/S1369-7021(06)71741-2
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Loiseau A, 2006, MACROMOLECULES, V39, P9185, DOI 10.1021/ma061324w
   MCCAFFERTY DG, 1995, TETRAHEDRON, V51, P1093, DOI 10.1016/0040-4020(94)01018-U
   Nordmark TS, 2000, FOOD HYDROCOLLOID, V14, P579, DOI 10.1016/S0268-005X(00)00037-0
   O'Shea MG, 1998, CARBOHYD RES, V307, P1, DOI 10.1016/S0008-6215(97)10085-4
   PEEK BM, 1991, INT J PEPT PROT RES, V38, P114
   Savage SA, 1998, J ORG CHEM, V63, P10048, DOI 10.1021/jo981505z
   Schubert US, 1998, TETRAHEDRON LETT, V39, P8643, DOI 10.1016/S0040-4039(98)02041-3
   Smith AP, 2000, TETRAHEDRON LETT, V41, P2787, DOI 10.1016/S0040-4039(00)00264-1
   Telfer SG, 2003, DALTON T, P435, DOI 10.1039/b208934c
   TELSER J, 1989, J AM CHEM SOC, V111, P7221, DOI 10.1021/ja00200a049
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   TRAMP H, 2001, FOOD RES INT, V34, P931
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Will G, 1999, J PHYS CHEM B, V103, P8067, DOI 10.1021/jp990414i
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
NR 28
TC 3
Z9 3
U1 0
U2 10
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1631-0748
J9 CR CHIM
JI C. R. Chim.
PD JUN-JUL
PY 2008
VL 11
IS 6-7
BP 641
EP 649
DI 10.1016/j.crci.2008.01.013
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 313IX
UT WOS:000256735400008
DA 2018-10-20
ER

PT J
AU Yamada, M
   Amoo, M
AF Yamada, Masanori
   Amoo, Mariko
TI Enzymatic collapse of artificial polymer composite material containing
   double-stranded DNA
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE DNA; enzymatic collapse; Micrococcal nuclease; composite materials;
   artificial polymer
ID METAL-IONS; UV-IRRADIATION; ACID; CELLULOSE; COMPLEX
AB Large amounts of DNA-enriched biomaterials, such as salmon milts and shellfish gonads, are discarded as industrial waste around the world. Therefore, the utilizations of DNA with the specific function are important for the biomaterial science and the curce technology. We could convert the discarded DNA to an enzymatic collapsible material by the addition of DNA to the artificial polymer material, such as nylon. Although these DNA-artificial polymer composite materials were stable in water, these materials indicated the collapsibility at the DNA-hydrolyzed enzyme, such as Micrococcal nuclease, condition. Additionally, these collapsibilities under enzyme condition were controlled by the number of imino groups in the components of the artificial polymer. Furthermore, these composite materials could create the fiber form with a highly ordered molecular orientation by the reaction at the liquid/liquid interface. The DNA-artificial polymer composite materials may have the potential utility as a novel bio-, medical-, and environmental materials with the enzymatic collapsibility and degraclability. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Yamada, Masanori; Amoo, Mariko] Okayama Univ Sci, Dept Chem, Fac Sci, Okayama 7000005, Japan.
RP Yamada, M (reprint author), Okayama Univ Sci, Dept Chem, Fac Sci, Okayama 7000005, Japan.
EM myamada@chem.ous.ac.jp
CR Alberts B., 1971, METHOD ENZYMOL, V21, P198
   Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8
   Bozkurt A, 2001, SOLID STATE IONICS, V138, P259, DOI 10.1016/S0167-2738(00)00779-7
   Fugetsu B, 2004, B CHEM SOC JPN, V77, P1945, DOI 10.1246/bcsj.77.1945
   Hackl EV, 2005, INT J BIOL MACROMOL, V35, P175, DOI 10.1016/j.ijbiomac.2005.01.011
   Kawahara M, 2000, ELECTROCHIM ACTA, V45, P1395, DOI 10.1016/S0013-4686(99)00349-7
   LITMAN RM, 1968, J BIOL CHEM, V243, P6222
   Liu XD, 2007, ADV POLYM SCI, V209, P149, DOI 10.1007/12_2006_106
   NAIR LS, 2006, PROG POLYM SCI, V31, P576
   Nakayama H, 2001, CHEM COMMUN, P2300, DOI 10.1039/b107228e
   Niemeyer CM, 2007, NANO TODAY, V2, P42, DOI 10.1016/S1748-0132(07)70058-0
   Nishida A, 2004, B CHEM SOC JPN, V77, P1783, DOI 10.1246/bcsj.77.1783
   SAENGER W, 1987, PRINCIPLES NUCL ACID
   Seeman NC, 2003, BIOCHEMISTRY-US, V42, P7259, DOI 10.1021/bi030079v
   Silverstein R. M., 1998, SPECTROMETRIC IDENTI
   Simmel FC, 2005, SMALL, V1, P284, DOI 10.1002/smll.200400111
   TAJMIRRIAHI HA, 1993, BIOPOLYMERS, V33, P1819, DOI 10.1002/bip.360331208
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Yamada M, 2005, POLYMER, V46, P10102, DOI 10.1016/j.polymer.2005.07.086
   Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r
   Yamada M, 2001, BIOMATERIALS, V22, P3121, DOI 10.1016/S0142-9612(01)00061-8
   Yang KG, 2005, DESALINATION, V175, P297, DOI 10.1016/j.desal.2004.08.046
   YU L, 2007, PROG POLYM SCI, V32, P762
   Zhao BD, 2005, INT J BIOL MACROMOL, V37, P143, DOI 10.1016/j.ijbiomac.2005.10.002
NR 24
TC 3
Z9 3
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUN 1
PY 2008
VL 42
IS 5
BP 478
EP 482
DI 10.1016/j.ijbiomac.2008.03.005
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 317SI
UT WOS:000257039600012
PM 18457870
DA 2018-10-20
ER

PT J
AU Xu, L
   Sun, R
   Zhang, LF
   Yang, DJ
   Tan, YF
   Xiong, CD
AF Xu, Liang
   Sun, Rui
   Zhang, Li-Fang
   Yang, De-Juan
   Tan, Yan-Fei
   Xiong, Cheng-Dong
TI Studies on Poly(D, L-lactic acid)/wollastonite composites as a
   blomaterial
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE polylactic acid; wollastonite; biomaterial; mechanical properties;
   biocompatibility
ID WOLLASTONITE MICRO-FIBERS; IN-VITRO; MECHANICAL-PROPERTIES; BONE
   REGENERATION; APATITE FORMATION; SCAFFOLDS; HYDROXYAPATITE;
   BIOMATERIALS; BIOCERAMICS; FABRICATION
AB The aim of the study was to prepare bioactive and bioabsorbable composites of polylactide/wollastonite (PDLLA/W) and evaluate their mechanical properties and biocompatibility in vitro. PDLLA and wollastonite were physically mixed and the mechanical properties of the composition showed the influence of wollastonite, and that a partial composite, e.g., a PDLLA/wollastonite composition with 15 wt% wollastonite (PW-15) has similar mechanical properties compared to pure PDLLA. However, an in vitro biocompatibility testing showed that the composite has no deleterious effects on the osteoblast cells and facilitates both adhesion and proliferation of the osteoblast cells on the PDLLA/wollastonite film surface. The introduction of wollastonite could also induce the deposition of hydroxyapatite (HA) on the surface of the composite in simulated body fluids (SBF) which has important implications on bone regeneration. These mechanical and biocompatibility properties represent PDLLA/wollastonite composites as potential biomaterials.
C1 [Xu, Liang; Sun, Rui; Zhang, Li-Fang; Yang, De-Juan; Xiong, Cheng-Dong] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
   [Tan, Yan-Fei] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Xiong, CD (reprint author), Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
EM luanshikedou@sina.com
CR Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   DUCHEYNE P, 1988, BIOCERAMICS MAT CHAR, V523
   Durucan C, 2001, ADV ENG MATER, V3, P227, DOI 10.1002/1527-2648(200104)3:4<227::AID-ADEM227>3.3.CO;2-T
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2001, Z METALLKD, V92, P145
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kim HM, 1999, J BIOMED MATER RES, V46, P228, DOI 10.1002/(SICI)1097-4636(199908)46:2<228::AID-JBM12>3.0.CO;2-J
   KOKUBO T, 1993, J MATER SCI-MATER M, V4, P1, DOI 10.1007/BF00122969
   Kokubo T., 1990, J BIOMED MATER RES, V24, P723
   Li HY, 2005, J CONTROL RELEASE, V107, P463, DOI 10.1016/j.jconrel.2005.05.019
   Li HY, 2005, POLYM DEGRAD STABIL, V87, P301, DOI 10.1016/j.polymdegradstab.2004.09.001
   Li HY, 2004, J MATER SCI-MATER M, V15, P1089, DOI 10.1023/B:JMSM.0000046390.09540.c2
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   Linhart W, 2001, J BIOMED MATER RES, V54, P162, DOI 10.1002/1097-4636(200102)54:2<162::AID-JBM2>3.0.CO;2-3
   LOW NMP, 1994, CEMENT CONCRETE RES, V24, P650, DOI 10.1016/0008-8846(94)90189-9
   LOW NMP, 1994, CEMENT CONCRETE RES, V24, P874, DOI 10.1016/0008-8846(94)90007-8
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Mohammadi Y, 2007, IRAN POLYM J, V16, P57
   Molly M S, 2004, BIOMATERIALS, V25, P887
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   NIIAREN H, 1999, J MATER SCI-MATER M, V10, P707
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   SCHLIEPHAKE H, 1994, J ORAL MAXIL SURG, V52, P57, DOI 10.1016/0278-2391(94)90016-7
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Tong J, 2003, WEAR, V255, P734, DOI 10.1016/S0043-1648(03)00221-7
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Ye LZ, 2008, J BIOMATER APPL, V22, P465, DOI 10.1177/0885328207079670
   Zhang FM, 2008, J MATER SCI-MATER M, V19, P167, DOI 10.1007/s10856-006-0056-3
   Zhang LF, 2008, MAT SCI ENG C-BIO S, V28, P141, DOI 10.1016/j.msec.2007.01.005
NR 33
TC 8
Z9 9
U1 0
U2 5
PU POLYMER RESEARCH CENTER IRAN
PI TEHRAN
PA PO BOX 14185-515, TEHRAN, IRAN
SN 1026-1265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD JUN
PY 2008
VL 17
IS 6
BP 407
EP 418
PG 12
WC Polymer Science
SC Polymer Science
GA 324PC
UT WOS:000257529500002
DA 2018-10-20
ER

PT J
AU Arslan, H
   Celikkan, H
   Ornek, N
   Ozan, O
   Ersoy, AE
   Aksu, ML
AF Arslan, Halit
   Celikkan, Hueseyin
   Oernek, Nisa
   Ozan, Oguz
   Ersoy, A. Ersan
   Aksu, M. Levent
TI Galvanic corrosion of titanium-based dental implant materials
SO JOURNAL OF APPLIED ELECTROCHEMISTRY
LA English
DT Article
DE galvanic corrosion; Ti-based dental materials; Tafel plots;
   electrochemical impedance spectroscopy
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; PASSIVE OXIDE-FILM; SURGICAL
   IMPLANTS; ALLOYS; FLUORIDE; BEHAVIOR; BIOMATERIAL; WEAR; TI
AB This paper describes an investigation of the corrosion behavior of Ti-based dental materials with Au, CrNi and CoCr in Ringer solution by the use of Tafel plots, Evans diagrams and EIS Nyguist diagrams. The galvanic potentials and currents obtained for various implant couples are as follows: For, Ti6Al4V/CrNi couple -0.030 V (Ag/AgCl (3 M NaCl)) and 7.94 mu A cm(-2); for Ti6Al4V/CoCr couple -0.020 V (Ag/AgCl (3 M NaCl)) and 7.08 mu A cm(-2); for Ti6Al4V/Au couple -0.020 V (Ag/AgCl (3 M NaCl)) and 5.62 mu A cm(-2). The Ti6Al4V/Au couple was found to be the most suitable one against galvanic corrosion according to both the Tafel method and mixed potential theory. The corrosion behaviors of Ti6Al4V/CoCr and Ti6Al4V/CrNi couples were found to be similar.
C1 [Aksu, M. Levent] Gazi Univ, Gazi Educ Fac, Dept Chem Educ, TR-06500 Ankara, Turkey.
   [Arslan, Halit] Gazi Univ, Arts Sci Fac, Dept Chem, TR-06500 Ankara, Turkey.
   [Celikkan, Hueseyin] Mineral Res & Explorat Inst, Ankara, Turkey.
   [Oernek, Nisa; Ozan, Oguz; Ersoy, A. Ersan] Ankara Univ, Fac Dent, TR-06500 Ankara, Turkey.
RP Aksu, ML (reprint author), Gazi Univ, Gazi Educ Fac, Dept Chem Educ, TR-06500 Ankara, Turkey.
EM maksu@gazi.edu.tr
RI ARSLAN, Halit/A-4121-2016
OI Celikkan, Huseyin/0000-0002-8016-3082
CR BADAWY WA, 1993, J BR CORR, V28, P136
   Bianco PD, 1996, J BIOMED MATER RES, V31, P227
   Blackwood DJ, 2000, CORROS SCI, V42, P481, DOI 10.1016/S0010-938X(99)00103-1
   BLACKWOOD DJ, 1988, ELECTROCHIM ACTA, V33, P1143, DOI 10.1016/0013-4686(88)80206-8
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Frateur I, 2000, J ELECTROANAL CHEM, V482, P202, DOI 10.1016/S0022-0728(00)00050-4
   Gurappa I, 2002, MATER CHARACT, V49, P73, DOI 10.1016/S1044-5803(02)00320-0
   HANSON M, 1958, CONSTITUTION BINARY
   HILLE GH, 1966, J MATER, V1, P373
   Hsu RWW, 2004, MATER CHEM PHYS, V86, P269, DOI 10.1016/j.matchemphys.2004.02.025
   Jacobs JJ, 1999, CLIN ORTHOP RELAT R, P173
   Katzer A, 2003, TOXICOLOGY, V190, P145, DOI 10.1016/S03000-483X(03)00147-1
   KOLMAN DG, 1994, J ELECTROCHEM SOC, V141, P2633, DOI 10.1149/1.2059146
   LUCKEY HA, 1983, 796 STP AM SOC TEST
   MACDONALD D, 1981, ASTM SPEC TECH PUB
   MACDONALD DD, 1981, ASTM STP, V727, P110
   Mansfeld F., 1993, 26 SOL SCHLUMB
   Nakagawa M, 2002, DENT MATER J, V21, P83, DOI 10.4012/dmj.21.83
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   POPA MV, 1997, ADV MAT PROCESSING T, V2, P737
   POPA MV, 1997, 9 P INT MET MAT C, V1
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   RECLARU L, 1994, J DENT, V22, P159, DOI 10.1016/0300-5712(94)90200-3
   Reclaru L, 2002, BIOMATERIALS, V23, P3479, DOI 10.1016/S0142-9612(02)00055-8
   Reclaru L, 1998, BIOMATERIALS, V19, P85, DOI 10.1016/S0142-9612(97)00179-8
   ROSCA MJC, 1997, 7 EUR C APPL SURF IN
   SCHUTZ RW, 1986, TITANIUM PROCESS IND
   Souza MEP, 2007, SURF COAT TECH, V201, P7775, DOI 10.1016/j.surfcoat.2007.03.005
   TOMASHOV ND, 1974, ELECTROCHIM ACTA, V19, P159, DOI 10.1016/0013-4686(74)85012-7
   ToumelinChemla F, 1996, J DENT, V24, P109, DOI 10.1016/0300-5712(95)00033-X
   WILLIAMS DF, 1981, BIOCOMPATIBILITY CLI, V2
NR 32
TC 23
Z9 23
U1 3
U2 33
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0021-891X
J9 J APPL ELECTROCHEM
JI J. Appl. Electrochem.
PD JUN
PY 2008
VL 38
IS 6
BP 853
EP 859
DI 10.1007/s10800-008-9523-5
PG 7
WC Electrochemistry
SC Electrochemistry
GA 299JO
UT WOS:000255752100016
DA 2018-10-20
ER

PT J
AU Tamimi, F
   Torres, J
   Bettini, R
   Ruggera, F
   Rueda, C
   Lopez-Ponce, M
   Lopez-Cabarcos, E
AF Tamimi, Faleh
   Torres, Jesus
   Bettini, Ruggero
   Ruggera, Francesca
   Rueda, Carmen
   Lopez-Ponce, Manuel
   Lopez-Cabarcos, Enrique
TI Doxycycline sustained release from brushite cements for the treatment of
   periodontal diseases
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE doxycycline; brushite cement; periodontal pathogens; solid state
   fluorescence; controlled release
ID CALCIUM-PHOSPHATE CEMENTS; DELIVERED DOXYCYCLINE; CREVICULAR FLUID;
   BONE-CEMENT; TETRACYCLINE; SYSTEM; FLUORESCENCE; THERAPY; TEETH
AB Doxycycline (DOXY) is a wide spectrum antibiotic used in the treatment of dental, periodontal, and bone infections. Brushite cements are calcium phosphate biomaterials especially interesting for bone regeneration processes. In this work, we describe the preparation of a brushite cement containing DOXY and the drug release from the cement. DOXY solutions were mixed with the cement powder and after a 50% burst release in the first 12 h, a slow and controlled release was achieved over 3.5 days. The release of DOXY hyclate was controlled by both, diffusion and Ca2+ interaction. Formation of DOXY-Ca2+ chelates was detected in the cement structure using solid state fluorescence. The brushite cement loaded with DOXY hyclate had antibacterial activity against periodontal pathogens: Actinobacilhis actinomycetemcomitans, Porphyromonas gingivalis, and Bacteroides frosthytus. This new biomaterial may be helpful for the treatment of periodontal diseases. (C) 2007 Wiley Periodicals, Inc.
C1 [Tamimi, Faleh; Rueda, Carmen; Lopez-Ponce, Manuel; Lopez-Cabarcos, Enrique] Univ Complutense Madrid, Dept Quim Fis 2, E-28040 Madrid, Spain.
   [Torres, Jesus] Univ Rey Juan Carlos I, Dept Ciencias Salud 3, Madrid, Spain.
   [Bettini, Ruggero; Ruggera, Francesca] Univ Parma, Dipartimento Farmaceut, I-43100 Parma, Italy.
RP Tamimi, F (reprint author), Univ Complutense Madrid, Dept Quim Fis 2, E-28040 Madrid, Spain.
EM fdamimim@farm.ucm.es
RI Bettini, Ruggero/O-2693-2013; Lopez Cabarcos, Enrique/L-5802-2014
OI Lopez Cabarcos, Enrique/0000-0003-2939-4130; TORRES GARCIA DENCHE,
   JESUS/0000-0002-8310-9209; Bettini, Ruggero/0000-0002-3857-7476
CR Albandar Jasim M, 2005, Dent Clin North Am, V49, P517, DOI 10.1016/j.cden.2005.03.003
   Barralet JE, 2004, BIOMATERIALS, V25, P2197, DOI 10.1016/j.biomaterials.2003.09.085
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Bokor-Bratic M, 2000, Med Pregl, V53, P266
   CASWELL AH, 1971, BIOCHEM BIOPH RES CO, V43, P625, DOI 10.1016/0006-291X(71)90660-7
   Choi DH, 2004, J PERIODONTAL RES, V39, P20, DOI 10.1111/j.1600-0765.2004.00696.x
   Ciancio Sebastian G., 1999, General Dentistry, V47, P172
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   DAVIES AK, 1985, J DENT RES, V64, P936, DOI 10.1177/00220345850640061701
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   Hanes Philip J, 2003, Ann Periodontol, V8, P79, DOI 10.1902/annals.2003.8.1.79
   HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018
   Jacinto RC, 2003, ORAL MICROBIOL IMMUN, V18, P285, DOI 10.1034/j.1399-302X.2003.00078.x
   Johnson L R, 1999, Compend Contin Educ Dent, V20, P19
   KAITILA I, 1971, BIOCHIM BIOPHYS ACTA, V244, P584, DOI 10.1016/0304-4165(71)90075-4
   Parfitt K, 1999, COMPLETE DRUG REFERE, P203
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Ramamurthy NS, 2002, J PERIODONTOL, V73, P726, DOI 10.1902/jop.2002.73.7.726
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   Schneider S, 2003, PHOTOCH PHOTOBIO SCI, V2, P1107, DOI 10.1039/b304523b
   Slots J, 1986, Oral Microbiol Immunol, V1, P48, DOI 10.1111/j.1399-302X.1986.tb00318.x
   SLOTS J, 1982, J CLIN MICROBIOL, V16, P1148
   Song Zhiguo, 2003, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V20, P586
   Stoller NH, 1998, J PERIODONTOL, V69, P1085, DOI 10.1902/jop.1998.69.10.1085
   Tomasi C, 2004, J CLIN PERIODONTOL, V31, P589, DOI 10.1111/j.1600-051X.2004.00524.x
   Walker C, 1999, Compend Contin Educ Dent, V20, P4
NR 28
TC 54
Z9 57
U1 4
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2008
VL 85A
IS 3
BP 707
EP 714
DI 10.1002/jbm.a.31610
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 296GC
UT WOS:000255530500017
PM 17876778
DA 2018-10-20
ER

PT J
AU Ahmad, Z
   Huang, J
   Thian, ES
   Edirisinghe, MJ
   Jayasinghe, SN
   Best, SM
   Bonfield, W
   Brooks, RA
   Rushton, N
AF Ahmad, Z.
   Huang, J.
   Thian, E. S.
   Edirisinghe, M. J.
   Jayasinghe, S. N.
   Best, S. M.
   Bonfield, W.
   Brooks, R. A.
   Rushton, N.
TI Freeform fabrication of nano-biomaterials using 3D electrohydrodynamic
   print-patterning
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE freeforming; hydroxyapatite; biomaterials; printing; patterning
ID INK-JET PRINTER; ELECTROSTATIC ATOMIZATION; HYDROXYAPATITE SCAFFOLDS;
   IMPLANT MATERIALS; BONE-FORMATION; SUSPENSION; CELLS; CERAMICS;
   DROPLETS; VITRO
AB An electrohydrodynamic jet in conjunction with a computer-controlled collecting device has been used to form micro-scale structures. From a nano-scale particle suspension of a biomaterial a variety of patterning was produced in the x,y axis by the collection of fine droplets resulting from the jetting process. By over-printing these patterns repeatedly, whilst controlling the deposition in the z axis, structures can be formed to the desired height. The merits and limiting factors of this freeform fabrication method are discussed alongside some of the key developments and future aims in this area.
C1 [Ahmad, Z.; Huang, J.; Edirisinghe, M. J.; Jayasinghe, S. N.] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Thian, E. S.; Best, S. M.; Bonfield, W.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   [Brooks, R. A.; Rushton, N.] Addenbrookes Hosp, Orthopaed Res Unit, Cambridge CB2 2QQ, England.
RP Ahmad, Z (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.
RI Jayasinghe, Suwan/C-1799-2008
OI Ahmad, Zeeshan/0000-0001-8863-6211; Thian, Eng San/0000-0001-6925-6811;
   Jayasinghe, Suwan/0000-0002-7125-2219
CR AHAMD Z, 2006, J BIOMED NANOTECHNOL, V2, P201
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   CLOUPEAU M, 1994, J AEROSOL SCI, V25, P1021, DOI 10.1016/0021-8502(94)90199-6
   de Sousa FCG, 2005, ADV APPL CERAM, V104, P30, DOI 10.1179/174367605225011025
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   Dimitrov D, 2006, RAPID PROTOTYPING J, V12, P136, DOI 10.1108/13552540610670717
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Eagles PAM, 2006, BIOCHEM J, V394, P375, DOI 10.1042/BJ20051838
   Gao C, 2004, J INORG MATER, V19, P714
   Gray C, 1996, BONE, V18, P115, DOI 10.1016/8756-3282(95)00456-4
   Gupta A, 2007, J BIOACT COMPAT POL, V22, P265, DOI 10.1177/0883911507078268
   HARTMAN RPA, 1999, ELECTROSTATICS 1999, V163, P115
   Huang J, 2004, J MATER SCI, V39, P1029, DOI 10.1023/B:JMSC.0000012937.85880.7b
   Jayasinghe SN, 2002, J MATER SCI LETT, V21, P371, DOI 10.1023/A:1014998916149
   Jayasinghe SN, 2002, MATER RES INNOV, V6, P92, DOI 10.1007/s10019-002-0192-4
   Lee DY, 2006, APPL PHYS A-MATER, V82, P671, DOI 10.1007/s00339-005-3452-5
   Limpanuphap S, 2002, J MATER SCI-MATER M, V13, P1163, DOI 10.1023/A:1021146106442
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   MEESTERS GMH, 1992, J AEROSOL SCI, V23, P37, DOI 10.1016/0021-8502(92)90316-N
   Michna S, 2005, BIOMATERIALS, V26, P5632, DOI 10.1016/j.biomaterials.2005.02.040
   Moon J, 2002, J AM CERAM SOC, V85, P755
   NEDOVIC V, 2002, LANDBAUFORSCH VOLK, VSH 241, P11
   Notz PK, 1999, J COLLOID INTERF SCI, V213, P218, DOI 10.1006/jcis.1999.6136
   Park J, 2006, LANGMUIR, V22, P3506, DOI 10.1021/la053450j
   Park JU, 2007, NAT MATER, V6, P782, DOI 10.1038/nmat1974
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Rea SM, 2004, J BIOMED MATER RES B, V70B, P250, DOI 10.1002/jbm.b.30039
   Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07
   Samarasinghe SR, 2006, GOLD BULL, V39, P48, DOI 10.1007/BF03215276
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Sirringhaus H, 2003, MRS BULL, V28, P802, DOI 10.1557/mrs2003.228
   Sirringhaus H, 2001, MRS BULL, V26, P539, DOI 10.1557/mrs2001.127
   Smay JE, 2002, ADV MATER, V14, P1279, DOI 10.1002/1521-4095(20020916)14:18<1279::AID-ADMA1279>3.0.CO;2-A
   STANKUS JJ, 2006, BIOMATERIALS, V27, P744
   Stevens MM, 2005, BIOMATERIALS, V26, P7636, DOI 10.1016/j.biomaterials.2005.05.001
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Tay BY, 2003, INT MATER REV, V48, P341, DOI 10.1179/095066003225010263
   Thian ES, 2008, J BIOMED MATER RES A, V85A, P188, DOI 10.1002/jbm.a.31564
   Thian ES, 2007, J BIONANOSCI, V1, P60, DOI DOI 10.1166/JBNS.2007.004
   Wang DZ, 2006, J AM CERAM SOC, V89, P1727, DOI 10.1111/j.1551-2916.2006.00936.x
   Wang DZ, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1942531
   Wang DZ, 2005, J NANOPART RES, V7, P301, DOI 10.1007/s11051-004-7772-8
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Yeo LY, 2005, BIOMATERIALS, V26, P6122, DOI 10.1016/j.biomaterials.2005.03.033
   Zhao X, 2003, CERAM INT, V29, P887, DOI 10.1016/S0272-8842(03)00032-4
NR 50
TC 11
Z9 11
U1 1
U2 50
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD JUN
PY 2008
VL 4
IS 2
BP 185
EP 195
DI 10.1166/jbn.2008.017
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 328JH
UT WOS:000257794200007
DA 2018-10-20
ER

PT J
AU Tanzer, M
   Bobyn, JD
   Krygier, JJ
   Karabasz, D
AF Tanzer, M.
   Bobyn, J. D.
   Krygier, J. J.
   Karabasz, D.
TI Histopathologic retrieval analysis of clinically failed porous tantalum
   osteonecrosis implants
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article
ID FEMORAL-HEAD; BIOMATERIAL
AB Background: An Osteonecrosis Intervention Implant made of porous tantalum was recently developed to provide structural support and a compatible surface for tissue ingrowth in osteonecrotic femoral heads. From an investigational device exemption study that comprised 113 implants, we carried out a retrieval analysis of clinically failed implants.
   Methods: Seventeen porous tantalum implants that had been used for the treatment of Steinberg stage-II osteonecrosis of the hip were retrieved at the time of conversion to a total hip arthroplasty. Fifteen implants that had been transected near the base of the femoral neck with the proximal portion left in situ within the femoral head underwent histopathologic analysis at an average of 13.4 months (range, three to thirty-six months) after implantation.
   Results: Residual osteonecrosis was present in fourteen of the fifteen specimens. Fracture of the subchondral bone of the femoral head was present in all instances, and collapse of the femoral head was present in nine instances (60%). Backscattered scanning electron microscopy confirmed the presence of bone ingrowth in thirteen (87%) of the fifteen specimens. The mean extent of bone ingrowth was 1.9% (range, 0% to 4.4%).
   Conclusions: The retrieved implants were associated with little bone ingrowth and insufficient mechanical support of subchondral bone. The implant design, the surgical technique, its application, and the clinical characteristics of candidates for this procedure should continue to be monitored closely.
   Level of Evidence: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.
C1 [Tanzer, M.] McGill Univ, Div Orthopaed, Dept Surg, Miller Orthopaed Res Lab, Montreal, PQ H3G 1A4, Canada.
RP Tanzer, M (reprint author), McGill Univ, Div Orthopaed, Dept Surg, Miller Orthopaed Res Lab, 1650 Cedar Ave B5-159, Montreal, PQ H3G 1A4, Canada.
CR Beris AE, 2001, CLIN ORTHOP RELAT R, P64
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BORGSTEDE LL, 2006, T ORTHOP RES SOC, V31, P640
   BUGBEE WD, 1998, ADULT HIP, V2, P1023
   Della Valle AG, 2005, J ARTHROPLASTY, V20, P331, DOI 10.1016/j.arth.2004.05.006
   Mont MA, 1996, CLIN ORTHOP RELAT R, P169
   Peters CL, 1998, ADULT HIP, VII, P993
   Plakseychuk AY, 2003, J BONE JOINT SURG AM, V85A, P589, DOI 10.2106/00004623-200304000-00001
   STEINBERG ME, 1995, J BONE JOINT SURG BR, V77B, P34
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Urbaniak J R, 1998, J Am Acad Orthop Surg, V6, P44
   Vail TP, 1996, J BONE JOINT SURG AM, V78A, P204, DOI 10.2106/00004623-199602000-00006
   ZIMMER, 2005, SURG TECHNIQUES BROC
NR 15
TC 34
Z9 56
U1 0
U2 3
PU JOURNAL BONE JOINT SURGERY INC
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02192 USA
SN 0021-9355
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PD JUN
PY 2008
VL 90A
IS 6
BP 1282
EP 1289
DI 10.2106/JBJS.F.00847
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 309JL
UT WOS:000256456400015
PM 18519322
DA 2018-10-20
ER

PT J
AU Busscher, HJ
   Dijkstra, RJB
   Langworthy, DE
   Collias, DI
   Bjorkquist, DW
   Mitchell, MD
   Van der Mei, HC
AF Busscher, Henk J.
   Dijkstra, Rene J. B.
   Langworthy, Don E.
   Collias, Dimitris I.
   Bjorkquist, David W.
   Mitchell, Michael D.
   Van der Mei, Henny C.
TI Interaction forces between waterborne bacteria and activated carbon
   particles
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE AFM; activated carbon; bacterial adhesion; water filtration; interaction
   force; Raoutella terrigena; Escherichiae coli; EPS
ID ADHESION FORCES; STAPHYLOCOCCUS-EPIDERMIDIS; MICROSCOPY; SURFACES;
   BIOFILMS; BIOMATERIAL; ADSORPTION; STRAINS; BINDING; GLASS
AB Activated carbons remove waterborne bacteria from potable water systems through attractive Lifshitz-van der Waals forces despite electrostatic repulsion between negatively charged cells and carbon surfaces. In this paper we quantify the interaction forces between bacteria with negatively and positively charged, mesoporous wood-based carbons, as well as with a microporous coconut carbon. To this end, we glued carbon particles to the cantilever of an atomic force microscope and measured the interaction forces upon approach and retraction of thus made tips. Waterborne Raoultella terrigena and Escherichia coli adhered weakly (1-2 nN) to different activated carbon particles, and the main difference between the activated carbons was the percentage of curves with attractive sites revealed upon traversing of a carbon particle through the bacterial EPS layer. The percentage of curves showing adhesion forces upon retraction varied between 21% and 69%, and was highest for R. terrigena with positively charged carbon (66%) and a coconut carbon (69%). Macroscopic bacterial removal by the mesoporous carbon particles increased with increasing percentages of attractive sites revealed upon traversing a carbon particle through the outer bacterial surface layer. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Busscher, Henk J.; Dijkstra, Rene J. B.; Van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Busscher, Henk J.; Dijkstra, Rene J. B.; Van der Mei, Henny C.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Busscher, Henk J.] SASA BV, NL-9797 PC Thesinge, Netherlands.
   [Langworthy, Don E.; Bjorkquist, David W.] Procter & Gamble Co, Cincinnati, OH USA.
   [Collias, Dimitris I.; Mitchell, Michael D.] Procter & Gamble Co, Corp Res & Dev, W Chester, OH 45069 USA.
RP Van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
CR BIFULCO JM, 1989, APPL ENVIRON MICROB, V55, P2214
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Busscher HJ, 2006, ENVIRON SCI TECHNOL, V40, P6799, DOI 10.1021/s061282r
   Chaw KC, 2005, ANTIMICROB AGENTS CH, V49, P4853, DOI 10.1128/AAC.49.12.4853-4859.2005
   Dufrene YF, 2002, J BACTERIOL, V184, P5205, DOI 10.1128/JB.184.19.5205-5213.2002
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2
   Flemming HC, 2001, WATER SCI TECHNOL, V43, P1
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   KASAS S, 1995, BIOPHYS J, V68, P1678, DOI 10.1016/S0006-3495(95)80344-9
   Liu XL, 2005, RADIOCHIM ACTA, V93, P305, DOI 10.1524/ract.93.5.305.64276
   MENDEZVILAS A, IN PRESS COLLOIDS SU
   Neu T R, 1990, J Biomater Appl, V5, P107, DOI 10.1177/088532829000500203
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   PAYMENT P, 1988, CAN J MICROBIOL, V34, P1304, DOI 10.1139/m88-228
   Percival SL, 1999, BIOFOULING, V14, P99, DOI 10.1080/08927019909378402
   PerezGiraldo C, 1997, J ANTIMICROB CHEMOTH, V39, P643, DOI 10.1093/jac/39.5.643
   Quinlivan PA, 2005, WATER RES, V39, P1663, DOI 10.1016/j.watres.2005.01.029
   Rabinovich YI, 2000, J COLLOID INTERF SCI, V232, P17, DOI 10.1006/jcis.2000.7168
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Schmitt J, 1999, WATER SCI TECHNOL, V39, P77, DOI 10.1016/S0273-1223(99)00153-5
   Shellenberger K, 2002, ENVIRON SCI TECHNOL, V36, P184, DOI 10.1021/es015515k
   Shi ZL, 2007, IND ENG CHEM RES, V46, P439, DOI 10.1021/ie0608096
   Tang GY, 2004, ARCH ORAL BIOL, V49, P727, DOI 10.1016/j.archoralbio.2004.04.003
   Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004
   Vadillo-Rodriguez V, 2005, COLLOID SURFACE B, V41, P33, DOI 10.1016/j.colsurfb.2004.10.028
   Vadillo-Rodriguez V, 2004, MICROBIOL-SGM, V150, P1015, DOI 10.1099/mic.0.26828-0
   van der Mei HC, 2000, BIOPHYS J, V78, P2668, DOI 10.1016/S0006-3495(00)76810-X
   van Hoogmoed CG, 2006, J DENT RES, V85, P54, DOI 10.1177/154405910608500109
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Yongsunthon R, 2007, LANGMUIR, V23, P2289, DOI 10.1021/la063117v
NR 31
TC 14
Z9 14
U1 3
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JUN 1
PY 2008
VL 322
IS 1
BP 351
EP 357
DI 10.1016/j.jcis.2008.03.018
PG 7
WC Chemistry, Physical
SC Chemistry
GA 303FY
UT WOS:000256027600046
PM 18405910
DA 2018-10-20
ER

PT J
AU Kramer, FJ
   Sinikovic, B
   Mueller, M
   Rahmstorf, M
   Schierle, H
AF Kramer, Franz-Josef
   Sinikovic, Branko
   Mueller, Michal
   Rahmstorf, Meike
   Schierle, Hannes
TI Experimental application of a biomaterial in bifocal transport
   osteogenesis for craniofacial reconstruction
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE craniofacial; reconstruction; distraction; bifocal transport
   osteogenesis; biomaterial
ID MANDIBULAR DISTRACTION OSTEOGENESIS; DEFECTS
AB Purpose: Bifocal transport osteogenesis is an alternative technique of callus distraction, in which movement of a transport segment results in the formation of new bone in order to close a continuity defect. The aim of this experimental pilot study was to replace a bone graft by a biomaterial as a transport segment. Material and methods: Critical size defects of the calvaria in four adult sheep were treated with transport segments consisting either of an autogenous free bone graft of the calvaria (n = 2) or of the biomaterial (deproteinized bovine cancellous bone; n = 2). Latency period was 5 days; the rate of distraction was I mm per day and was planned for 40 days. The consolidation period was 28 days. Specimens were investigated by conventional radiography, CT-scans and histologically, including immunofluorescence. Results: In both groups, transport osteogenesis resulted in a "de novo" formation of bone, indicating that this biomaterial may contribute successfully to bone formation in bifocal transport osteogenesis. However, volume and thickness of the newly formed bone at the defect site were smaller when using the biomaterial than when using autogenous bonegrafts. Conclusion: The application of a biomaterial as transport segments in bifocal transport osteogenesis in cranial critical size defects resulted in the formation of new bone thus excluding bone graft donor site morbidity. (C) 2008 European Association for Cranio-Maxillofacial Surgery.
C1 [Kramer, Franz-Josef] Univ Gottingen, Dept Oral & Maxillofacial Surg, D-37099 Gottingen, Germany.
   [Sinikovic, Branko] Hannover Med Sch, Dept Oral & Maxillofacial Surg, Hannover, Germany.
RP Kramer, FJ (reprint author), Univ Gottingen, Dept Oral & Maxillofacial Surg, Robert Koch Str 40, D-37099 Gottingen, Germany.
EM franz-josef.kramer@med.uni-goettingen.de
CR Aronson J, 1990, Clin Orthop Relat Res, P43
   Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P1074, DOI 10.1097/00006534-200203000-00046
   Bouletreau PJ, 2002, J CRANIO MAXILL SURG, V30, P1, DOI 10.1054/jems.2001.0263
   Clokie CML, 2002, J CRANIOFAC SURG, V13, P111, DOI 10.1097/00001665-200201000-00026
   Costantino PD, 1996, J CRANIOFAC SURG, V7, P404, DOI 10.1097/00001665-199611000-00002
   COSTANTINO PD, 1990, ARCH OTOLARYNGOL, V116, P535
   Costantino Peter D, 2002, Facial Plast Surg, V18, P13, DOI 10.1055/s-2002-19823
   ENNEKING WF, 1972, CLIN ORTHOP RELAT R, P28
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   ILIZAROV GA, 1980, ACTA CHIR PLAST, V22, P32
   ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249
   Kondoh T, 2002, INT J ORAL MAX SURG, V31, P675, DOI 10.1054/ijom.2002.0249
   McCarthy JG, 2002, PLAST RECONSTR SURG, V110, P1704, DOI 10.1097/01.PRS.0000036260.60746.1B
   MOLINA F, 1995, PLAST RECONSTR SURG, V96, P825, DOI 10.1097/00006534-199509001-00010
   Paccione MF, 2001, J CRANIOFAC SURG, V12, P175, DOI 10.1097/00001665-200103000-00015
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   SCHMITZ JP, 1990, ACTA ANAT, V138, P185
   StuckiMcCormick SU, 1997, J CRANIOFAC SURG, V8, P48, DOI 10.1097/00001665-199701000-00016
   Swennen G, 2002, INT J ORAL MAX SURG, V31, P123, DOI 10.1054/ijom.2002.0225
NR 19
TC 3
Z9 3
U1 0
U2 2
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD JUN
PY 2008
VL 36
IS 4
BP 218
EP 226
DI 10.1016/j.jcms.2007.12.001
PG 9
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 312BQ
UT WOS:000256644500005
PM 18314339
DA 2018-10-20
ER

PT J
AU Santos, DT
   Sarrouh, BF
   Rivaldi, JD
   Converti, A
   Silva, SS
AF Santos, Diego T.
   Sarrouh, Boutros F.
   Rivaldi, Juan D.
   Converti, Attilio
   Silva, Silvio S.
TI Use of sugarcane bagasse as biomaterial for cell immobilization for
   xylitol production
SO JOURNAL OF FOOD ENGINEERING
LA English
DT Article
DE sugarcane bagasse fibers; biomaterial; cell immobilization;
   bioconversion; xylitol production
ID CANDIDA-GUILLIERMONDII CELLS; FLUIDIZED-BED REACTOR; CA-ALGINATE;
   D-XYLOSE; HEMICELLULOSE HYDROLYSATE; POROUS-GLASS; YEAST-CELLS;
   FERMENTATION; BIOREACTOR; HYDROLYZATE
AB This study provides a preliminary contribution to the development of a bioprocess for the contintious production of xylitol from hemicellulosic hydrolyzate utilizing Candida guilliermondii cells immobilized onto natural sugarcane bagasse fibers. To this purpose, cells of this yeast were submitted to batch tests of "in situ" adsorption onto crushed and powdered sugarcane bagasse after treatment with 0.5 M NaOH. The results obtained on a xylose-based semi-synthetic medium were evaluated in terms of immobilization efficiency, cell retention and specific growth rates of suspended, immobilized and total cells. The first two parameters were shown to increase along the immobilization process, reached maximum values of 50.5% and 0.31 g immobilized cells/g bagasse after 21 h and then sharply decreased. The specific growth rate of suspended cells continuously increased during the immobilization tests, while that of the immobilized ones, after an initial growth, exhibited decreasing values. Under the conditions selected for cell immobilization, fermentation also took place with promising results. The yields of xylitol and biomass on consumed xylose were 0.65 and 0.18 g/g, respectively, xylitol and biomass productivities 0.66 and 0.13 g L-1 h(-1), and the efficiency of xylose-to-xylitol bioconversion was 70.8%. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Santos, Diego T.; Sarrouh, Boutros F.; Rivaldi, Juan D.; Silva, Silvio S.] Univ Sao Paulo, Dept Biotechnol, Sch Engn Lorena, BR-12602810 Lorena, SP, Brazil.
   [Converti, Attilio] Univ Genoa, Dept Chem & Proc Engn, I-16145 Genoa, Italy.
   [Silva, Silvio S.] FATEA, Lorena, SP, Brazil.
RP Silva, SS (reprint author), Univ Sao Paulo, Dept Biotechnol, Sch Engn Lorena, Estrada Municipal Campinho S-N,Cx Postal 116, BR-12602810 Lorena, SP, Brazil.
EM silvio@debiq.eel.usp.br
RI Oliveira, Nadir/H-3532-2015; Converti, Attilio/C-4368-2013; da Silva,
   Silvio/H-8960-2012; Santos, Diego/G-2922-2011; RIVALDI, JUAN/I-6610-2012
OI Converti, Attilio/0000-0003-2488-6080; da Silva,
   Silvio/0000-0003-0669-2784; Santos, Diego/0000-0003-1551-3012; RIVALDI,
   JUAN/0000-0002-2296-2791
CR ABSOLOM SR, 1985, COMPREHENSIVE BIOTEC, V4, P433
   BARBOSA MFS, 1988, J IND MICROBIOL, V3, P241, DOI 10.1007/BF01569582
   Branyik T, 2001, BIOTECHNOL LETT, V23, P1073, DOI 10.1023/A:1010558407475
   Carvalho W, 2005, BIOCHEM ENG J, V25, P25, DOI 10.1016/j.bej.2005.03.006
   Carvalho W, 2003, ENZYME MICROB TECH, V32, P553, DOI 10.1016/S0141-0229(03)00007-3
   CORCORAN E, 1985, TOPICS ENZYME FERMEN, V10, P12
   Cunha M, 2006, WORLD J MICROB BIOT, V22, P65, DOI 10.1007/s11274-005-6812-6
   Dominguez JM, 1996, APPL BIOCHEM BIOTECH, V57-8, P49, DOI 10.1007/BF02941687
   FACCHINI PJ, 1988, APPL MICROBIOL BIOT, V29, P346, DOI 10.1007/BF00265818
   GRANSTROM T, 2002, THESIS HELSINKI U TE
   Granstrom TB, 2007, APPL MICROBIOL BIOT, V74, P273, DOI 10.1007/s00253-006-0760-4
   Guo C, 2006, J APPL MICROBIOL, V101, P1096, DOI 10.1111/j.1365-2672.2006.02994.x
   GURGEL PV, 1998, BRAZ J CHEM ENG, V15, P309
   JONES HC, 1969, J BACTERIOL, V99, P316
   Kontiokari T, 1998, J ANTIMICROB CHEMOTH, V41, P563, DOI 10.1093/jac/41.5.563
   Kwon SG, 2006, J BIOSCI BIOENG, V101, P13, DOI 10.1263/jbb.101.13
   Lopez F, 2004, ANTON LEEUW INT J G, V85, P281, DOI 10.1023/B:ANTO.0000020368.37876.1c
   Masako K, 2005, J DERMATOL SCI, V38, P207, DOI 10.1016/j.jdermsci.2005.01.003
   Masako K, 2005, J DERMATOL SCI, V38, P197, DOI 10.1016/j.jdermsci.2005.01.006
   Mathew S, 2005, ENZYME MICROB TECH, V36, P565, DOI 10.1016/j.enzmictec.2004.12.003
   McLean R. J. C., 1994, IMMOBILIZED BIOSYSTE, P289
   MOZES N, 1985, APPL MICROBIOL BIOT, V22, P92
   Naaber P, 1996, FEMS IMMUNOL MED MIC, V14, P205, DOI 10.1016/0928-8244(96)00031-4
   NAVARRO JM, 1977, EUR J APPL MICROBIOL, V4, P243, DOI 10.1007/BF00931261
   NORTON S, 1994, ENZYME MICROB TECH, V16, P365, DOI 10.1016/0141-0229(94)90150-3
   Park JK, 2000, BIOTECHNOL ADV, V18, P303, DOI 10.1016/S0734-9750(00)00040-9
   Pilkington PH, 1998, J I BREWING, V104, P19, DOI 10.1002/j.2050-0416.1998.tb00970.x
   Ramakrishna SV, 1999, CURR SCI INDIA, V77, P87
   ROBERTO IC, 1994, BIOTECHNOL LETT, V16, P1211, DOI 10.1007/BF01020853
   Rodrigues RCLB, 2006, CURR MICROBIOL, V53, P53, DOI 10.1007/s00284-005-0242-4
   Sampaio FC, 2005, PROCESS BIOCHEM, V40, P3600, DOI 10.1016/j.procbio.2005.03.039
   Santos JC, 2005, BIOCHEM ENG J, V23, P1, DOI 10.1016/j.bej.2004.10.001
   Santos JC, 2005, PROCESS BIOCHEM, V40, P113, DOI 10.1016/j.procbio.2003.11.045
   Santos JC, 2003, BIOTECHNOL PROGR, V19, P1210, DOI 10.1021/bp034042d
   Sarrouh Boutros Fouad, 2007, Biotechnology Journal, V2, P759, DOI 10.1002/biot.200600207
   Sene L, 2002, BIORESOURCE TECHNOL, V83, P153, DOI 10.1016/S0960-8524(01)00192-4
   Silva CJSM, 2006, J FOOD ENG, V75, P115, DOI 10.1016/j.jfoodeng.2005.04.001
   SILVA SS, 1994, THESIS U SAO PAULO, P219
   SIMEONOVA DD, 2004, THESIS L PASTEUR U S, P155
   Tischler AS, 1996, TOXICOL APPL PHARM, V140, P115, DOI 10.1006/taap.1996.0204
   Veliky IA, 1994, IMMOBILIZED BIOSYSTE
   WANG YM, 1981, ANNU REV NUTR, V1, P435
   Winkelhausen E, 1998, J FERMENT BIOENG, V86, P1, DOI 10.1016/S0922-338X(98)80026-3
   Zabner J, 2000, P NATL ACAD SCI USA, V97, P11614, DOI 10.1073/pnas.97.21.11614
NR 44
TC 50
Z9 50
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0260-8774
J9 J FOOD ENG
JI J. Food Eng.
PD JUN
PY 2008
VL 86
IS 4
BP 542
EP 548
DI 10.1016/j.jfoodeng.2007.11.004
PG 7
WC Engineering, Chemical; Food Science & Technology
SC Engineering; Food Science & Technology
GA 273GV
UT WOS:000253919300009
DA 2018-10-20
ER

PT J
AU Palsule, AS
   Clarson, SJ
   Widenhouse, CW
AF Palsule, Aniruddha S.
   Clarson, Stephen J.
   Widenhouse, Christopher W.
TI Gamma irradiation of silicones
SO JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS
LA English
DT Review
DE silicones; polysiloxanes; PDMS; gamma irradiation; gamma sterilization
ID RADIATION-INDUCED POLYMERIZATION; SOLID-STATE POLYMERIZATION;
   ELECTRON-SPIN-RESONANCE; LIQUID-STATE; POLY(DIMETHYL SILOXANE);
   IONIZING-RADIATION; CROSS-LINKING; CHEMISTRY;
   OCTAMETHYLCYCLOTETRASILOXANE; HEXAMETHYLCYCLOTRISILOXANE
AB Silicones in various forms have been utilized in biomedical applications over the past several decades. While silicone elastomers are currently the most common silicone biomaterial, low molar mass cyclic silicones, low molar mass linear silicones, silicone oligomers, silicone polymers and silicone gels have each found applications as biomaterials. For the biomedical applications of silicones, it is required that the materials be sterilized prior to application or implantation. Common methods of sterilization include steam sterilization, ethylene oxide sterilization, electron beam sterilization and gamma sterilization. In this review we will describe the behavior of various silicones upon exposure to gamma radiation.
C1 [Clarson, Stephen J.] Univ Cincinnati, Dept Chem & Mat Engn, Cincinnati, OH 45221 USA.
   [Palsule, Aniruddha S.] Univ Cincinnati, Dept Chem & Mat Engn, Cincinnati, OH 45221 USA.
   [Widenhouse, Christopher W.] Ethicon Endo Surg, Cincinnati, OH 45242 USA.
RP Clarson, SJ (reprint author), Univ Cincinnati, Dept Chem & Mat Engn, 601b ERC,ML 0012, Cincinnati, OH 45221 USA.
EM Stephen.Clarson@UC.Edu
CR ARKLES B, 1983, CHEMTECH, V13, P542
   Basfar AA, 1997, RADIAT PHYS CHEM, V50, P607, DOI 10.1016/S0969-806X(97)00123-0
   Brook M. A., 2000, SILICON ORGANIC ORGA, P459
   BRUCK S D, 1971, Journal of Biomedical Materials Research, V5, P139, DOI 10.1002/jbm.820050303
   BRUCK SD, 1988, J BIOMED MATER RES-A, V22, P133, DOI 10.1002/jbm.820221306
   BUECHE AM, 1956, J POLYM SCI, V19, P297, DOI 10.1002/pol.1956.120199206
   CHARLESBY A, 1955, PROC R SOC LON SER-A, V230, P120, DOI 10.1098/rspa.1955.0116
   CHARLESBY A, 1963, PROC R SOC LON SER-A, V273, P117, DOI 10.1098/rspa.1963.0078
   CHAWLA AS, 1972, J POLYM SCI A1, V10, P2691, DOI 10.1002/pol.1972.150100915
   CHAWLA AS, 1972, J APPL POLYM SCI, V16, P1887, DOI 10.1002/app.1972.070160802
   Chien A, 2000, RADIAT PHYS CHEM, V59, P493, DOI 10.1016/S0969-806X(00)00305-4
   Clarson S.J., 1996, POLYM MAT ENCY, V10, P7663
   Clarson S. J., 1993, SILOXANE POLYM
   CLARSON SJ, 2003, ACM S SERIES, V838, P2
   Colas A., 1996, BIOMATERIALS SCI INT, p[80, 697]
   CORFIELD GC, 1984, AM CHEM SOC, V24, P473
   DELIDES CG, 1980, RADIAT PHYS CHEM, V16, P345, DOI 10.1016/0146-5724(80)90228-9
   DEWHURST HA, 1960, J PHYS CHEM-US, V64, P1063, DOI 10.1021/j100837a025
   Hill DJT, 2002, POLYMER, V43, P1051, DOI 10.1016/S0032-3861(01)00711-X
   Hill DJT, 2001, RADIAT PHYS CHEM, V62, P11, DOI 10.1016/S0969-806X(01)00416-9
   HILL DJT, 2000, MACROMOL S, V195, P95
   KNAAP B, 1996, SILICON
   Kowalski JB, 1996, BIOMATERIALS SCI INT, P415
   LAWTON EJ, 1956, J POLYM SCI, V19, P455, DOI 10.1002/pol.1956.120199306
   LAZURKIN IS, 1958, ATOM ENERGY, V4, P365
   LEBRUN JJ, 1984, RADIAT PHYS CHEM, V24, P239, DOI 10.1016/0146-5724(84)90058-X
   LIEBHAFSKY HA, 1978, SILICONES MONOGRAM S
   MARK JE, 1998, RUB CHEM TECH, V71, P941
   Maxwell RS, 2003, POLYM DEGRAD STABIL, V80, P443, DOI 10.1016/S0141-3910(03)00028-4
   MCGREGOR RR, 1954, PHYSL RESPONSE SILIC, P188
   MENHOFER H, 1987, RADIAT PHYS CHEM, V29, P243
   MENHOFER H, 1986, RADIAT PHYS CHEM, V33, P561
   MILLER AA, 1961, J AM CHEM SOC, V83, P31, DOI 10.1021/ja01462a006
   MILLER AA, 1960, J AM CHEM SOC, V82, P3519, DOI 10.1021/ja01499a011
   NAYLOR DM, 1986, J POLYM SCI POL LETT, V24, P319, DOI 10.1002/pol.1986.140240704
   NAYLOR DM, 1991, POLYMER, V32, P1084, DOI 10.1016/0032-3861(91)90596-B
   NAYLOR DM, 1990, POLYMER, V31, P954, DOI 10.1016/0032-3861(90)90063-5
   NAYLOR DM, 1994, POLYMER, V35, P1764, DOI 10.1016/0032-3861(94)90853-2
   Noll W., 1968, CHEM TECHNOLOGY SILI
   NOLL W, 1968, PHYSL BEHAV CHEM TEC, P516
   ORMEROD MG, 1963, POLYMER, V4, P459, DOI 10.1016/0032-3861(63)90059-4
   PARK JB, 1992, STERILIZATION EFFECT, P162
   RICHOW EG, 1946, INTRO CHEM SILICONES
   Rochow E. G., 1987, SILICON SILICONES
   Rogero SO, 2005, NUCL INSTRUM METH B, V236, P521, DOI 10.1016/j.nimb.2005.04.031
   SEMLYEN JA, LARGE RING MOL, P3
   Stevenson I, 2001, POLYMER, V42, P9287, DOI 10.1016/S0032-3861(01)00470-0
   STPIERRE LE, 1960, J PHYS CHEM-US, V64, P1060
   THOMAS J, 2002, ELEMENTS SILICON
   VanDyke ME, 2003, INTRO POLYM BIOMATER, P109
   VISSER SA, 1996, BIOMATERIALS SCI INT, P59
   WARRICK EL, 1990, 40 YEARS 1 RECOLLECT, P184
   WARRICK EL, 1955, IND ENG CHEM, V24, P842
   WARRICK EL, 1990, 40 YEARS 1 RECOLLECT
   WOLF CJ, 1962, J PHYS CHEM-US, V66, P1119
   ZACK JF, 1961, J CHEM ENG DATA, V6, P279
NR 56
TC 35
Z9 35
U1 1
U2 40
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1574-1443
J9 J INORG ORGANOMET P
JI J. Inorg. Organomet. Polym. Mater.
PD JUN
PY 2008
VL 18
IS 2
BP 207
EP 221
DI 10.1007/s10904-008-9205-0
PG 15
WC Polymer Science
SC Polymer Science
GA 285KL
UT WOS:000254775600001
DA 2018-10-20
ER

PT J
AU Yamauchi, K
   Takahashi, T
   Funaki, K
   Yamashita, Y
AF Yamauchi, Kensuke
   Takahashi, Tetsu
   Funaki, Katsuyuki
   Yamashita, Yoshihiro
TI Periosteal expansion osteogenesis using highly purified beta-tricalcium
   phosphate blocks: A pilot study in dogs
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE alveolar augmentation; biomaterial; distraction osteogenesis; periosteum
ID DISTRACTION OSTEOGENESIS; BONE-FORMATION; POROUS HYDROXYAPATITE; RIDGE
   AUGMENTATION; ALVEOLAR RIDGE; LONG-TERM; RECONSTRUCTION; IMPLANTS;
   FRACTURE; DEFECTS
AB Background: In highly atrophic edentulous jaws, the augmentation of the alveolar process is standard treatment for dental implantation because of the lack of alveolar bone height and width. Our aim was to examine periosteal expansion osteogenesis in a dog model, based on the concept of distraction osteogenesis, using a highly purified beta-tricalcium phosphate (beta-TCP) block instead of an original bone segment.
   Methods: Three beagle dogs weighing 10 to 12 kg were used. The beta-TCP block was placed at the lateral surface of the mandibular bone. Two titanium screws were inserted from the lingual aspect to push the block to the buccal side. After a latency period of 8 days, during which primary wound healing occurred, the lingual screws were advanced by similar to 0.5 mm/day for 8 days. Specimens were taken 8 weeks after lingual screw adjustments ceased and were analyzed by hematoxylin and eosin, tartrate-resistant acid phosphatase (TRAP), and Villanueva bone staining.
   Results: The alveolar form at the experimental region was changed dramatically following lateral expansion with the beta-TCP block. Newly formed bone was observed in the gap between the bone and the beta-TCP block, as well as on the lateral surface of the block. Moreover, the replacement of large parts of beta-TCP with newly formed bone was observed in the beta-TCP block area. However, newly formed bone was not observed over the upper parts of the block, and multinucleated TRAP-positive cells were attached to the beta-TCP in the periphery of this area.
   Conclusion: The highly purified beta-TCP block worked as an activator for the soft tissue, including the periosteum, as well as a space maker to induce an osteoblastic response in the periosteum.
C1 [Yamauchi, Kensuke; Takahashi, Tetsu; Funaki, Katsuyuki; Yamashita, Yoshihiro] Kyushu Dent Coll, Dept Oral & Maxillofacial Surg, Div Oral & Maxillofacial Reconstruct Surg, Fukuoka, Japan.
RP Yamauchi, K (reprint author), 2-6-1 Manazuru,Kokurakita Ku, Fukuoka 8038580, Japan.
EM k-yama@kyu-dent.ac.jp
CR Estrada JIC, 2007, BRIT J ORAL MAX SURG, V45, P402, DOI 10.1016/j.bjoms.2006.02.005
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   DELLOYE C, 1990, CLIN ORTHOP RELAT R, P34
   Dortbudak O, 2002, J ORAL REHABIL, V29, P835, DOI 10.1046/j.1365-2842.2002.00918.x
   EYREBROOK AL, 1984, CLIN ORTHOP RELAT R, P300
   Fujita R, 2003, J ORAL MAXIL SURG, V61, P1045, DOI 10.1016/S0278-2391(03)00317-3
   Hikiji H, 2000, J ORAL MAXIL SURG, V58, P1270, DOI 10.1053/joms.2000.16628
   Hirata M, 2006, INT ORTHOP, V30, P510, DOI 10.1007/s00264-006-0156-1
   HOLBEIN O, 1995, J ORTHOP RES, V13, P629, DOI 10.1002/jor.1100130420
   HOOGENDOORN HA, 1984, CLIN ORTHOP RELAT R, P281
   Ilizarov G A, 1989, Clin Orthop Relat Res, P263
   Kanno T, 2005, J ORAL MAXIL SURG, V63, P499, DOI 10.1016/j.joms.2004.07.023
   Kessler P, 2007, BRIT J ORAL MAX SURG, V45, P284, DOI 10.1016/j.bjoms.2006.09.010
   Koepp HE, 2004, J BIOMED MATER RES B, V70B, P209, DOI 10.1002/jbm.b.30034
   Kondo N, 2006, BIOMATERIALS, V27, P4419, DOI 10.1016/j.biomaterials.2006.04.016
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   KOSTOPOULOS L, 1995, J CLIN PERIODONTOL, V22, P247
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205
   Ogose A, 2002, J BIOMED MATER RES, V63, P601, DOI 10.1002/jbm.10380
   Ogose A, 2006, BIOMATERIALS, V27, P1542, DOI 10.1016/j.biomaterials.2005.08.034
   Ozerdem OR, 1998, ANN PLAS SURG, V41, P148
   POSTACCHINI F, 1995, CLIN ORTHOP RELAT R, P218
   SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008
   Schmidt BL, 2002, J ORAL MAXIL SURG, V60, P1170, DOI 10.1053/joms.2002.34993
   Sencimen M, 2007, INT J ORAL MAX SURG, V36, P235, DOI 10.1016/j.ijom.2006.08.016
   Simion M, 2001, CLIN ORAL IMPLAN RES, V12, P35, DOI 10.1034/j.1600-0501.2001.012001035.x
   Takahashi T, 2004, INT J ORAL MAX IMPL, V19, P291
   Uckan S, 2002, BRIT J ORAL MAX SURG, V40, P393, DOI 10.1016/S0266-4356(02)00211-5
   Yamatuchi K, 2006, INT J ORAL MAX SURG, V35, P493, DOI 10.1016/j.ijom.2006.01.008
NR 30
TC 18
Z9 18
U1 0
U2 5
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD JUN
PY 2008
VL 79
IS 6
BP 999
EP 1005
DI 10.1902/jop.2008.070536
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 312CK
UT WOS:000256646500007
PM 18533776
DA 2018-10-20
ER

PT J
AU Molly, L
   Vandromme, H
   Quirynen, M
   Schepers, E
   Adams, JL
   van Steenberghe, D
AF Molly, Liene
   Vandromme, Heleen
   Quirynen, Marc
   Schepers, Evert
   Adams, Jessica L.
   van Steenberghe, Daniel
TI Bone formation following implantation of bone biomaterials into
   extraction sites
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE biomaterials; bone; case series; dental implants; tooth extraction;
   tooth socket
ID TOOTH EXTRACTION; SINUS AUGMENTATION; RIDGE PRESERVATION; HUMANS;
   DEFECTS; MEMBRANE; REGENERATION; BIO-OSS(R); DIMENSIONS; LESIONS
AB Background: Adequate bone volume is imperative for the osseointegration of endosseous implants, but post-extraction resorption and remodeling may challenge implant placement. The use of bone biomaterials has been advocated to fill extraction sites and to enhance primary implant stability during osseointegration. The objective of the case series was to evaluate bone formation histologically and biomechanically in extraction sites following implantation of three commercially available bone biomaterials to compare their ability to allow guided bone regeneration.
   Methods: Thirty-six periodontally involved teeth were extracted from eight healthy non-smoking subjects. At least two bone biomaterials, a synthetic sponge based on poly lactic-polyglycolic acid technology (FIS), bovine porous bone mineral (BPBM), Ora natural coral derivative physically and chemically transformed into a calcium carbonate ceramic (COR), and one non-grafted control were applied to the extraction sockets within each subject and were covered by an expanded polytetrafluoroethylene device. The devices were removed after 2 months, and trephine biopsies were obtained from each site 4 months later. At that time, endosseous implants were placed in 25 of the sites, and healing abutments were placed; measurements were taken 4 to 6 months later with an electronic mobility testing device.
   Results: The percentage of residual biomaterial was 5.6% +/- 8.9% for FIS (P<0.001), 20.2% +/- 17.0% for BPBM (P<0.05), and 12.0% +/- 16.4% for COR (P<0.001). The amount of residual biomaterial after 6 months showed a significant relationship with the insertion torque measurements during the first third of implant insertion (P<0.05) and with values of the electronic mobility testing device at the abutment connection (P = 0.05). Histologically, new bone apposition was seen on BPBM particles. FIS sites showed similar ingrowth of blood vessels and osteocytes as empty controls.
   Conclusion: All sites revealed good primary stability at implant insertion and proper implant rigidity at abutment placement, indicating that early implant osseointegration was not influenced by the application of bone biomaterials used in this study.
C1 [Molly, Liene; Quirynen, Marc; van Steenberghe, Daniel] Catholic Univ Louvain, Dept Periodontol, Sch Dent Oral Pathol & Maxillofacial Surg, Fac Med, B-3000 Louvain, Belgium.
   [Molly, Liene; Adams, Jessica L.] Univ Maryland, Sch Dent, Dept Periodontol, Baltimore, MD USA.
   [Vandromme, Heleen] Catholic Univ Louvain, Fac Psychol & Educ Sci, Ctr Psychol Learning & Expt Psychopathol, B-3000 Louvain, Belgium.
   [Schepers, Evert] Catholic Univ Louvain, Dept Prosthet Dent, Sch Dent Oral Pathol & Maxillofacial Surg, Fac Med, B-3000 Louvain, Belgium.
RP Molly, L (reprint author), Catholic Univ Louvain, Dept Periodontol, Sch Dent Oral Pathol & Maxillofacial Surg, Fac Med, Kapucijnenvoer 7, B-3000 Louvain, Belgium.
EM lienemolly@yahoo.com
CR Assenza B, 2001, J Oral Implantol, V27, P287, DOI 10.1563/1548-1336(2001)027<0287:LRAUTM>2.3.CO;2
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Castellon Paulino, 2004, Implant Dent, V13, P42, DOI 10.1097/01.ID.0000116451.04676.7B
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Kainulainen VT, 2004, INT J ORAL MAX SURG, V33, P786, DOI 10.1016/j.ijom.2004.01.007
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   Mecall R A, 1991, Int J Periodontics Restorative Dent, V11, P8
   MORA F, 1995, J CLIN PERIODONTOL, V22, P877, DOI 10.1111/j.1600-051X.1995.tb01787.x
   Nair PNR, 2004, ORAL SURG ORAL MED O, V97, P559, DOI 10.1016/j.tripleo.2003.10.013
   Penarrocha Miguel, 2004, Med Oral, V9, P234
   Saldanha JB, 2006, J ORAL MAXIL SURG, V64, P1359, DOI 10.1016/j.joms.2006.05.021
   Sandor GKB, 2003, DENT TRAUMATOL, V19, P221, DOI 10.1034/j.1600-9657.2003.00164.x
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Serino G, 2003, CLIN ORAL IMPLAN RES, V14, P651, DOI 10.1034/j.1600-0501.2003.00970.x
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   Simion M, 1998, Int J Periodontics Restorative Dent, V18, P8
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   Tatakis DN, 1999, J PERIODONTOL, V70, P542, DOI 10.1902/jop.1999.70.5.542
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   van Steenberghe D, 2003, CLIN ORAL IMPLAN RES, V14, P63, DOI 10.1034/j.1600-0501.2003.140109.x
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Zitzmann N U, 2001, Int J Periodontics Restorative Dent, V21, P288
NR 27
TC 51
Z9 52
U1 1
U2 11
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD JUN
PY 2008
VL 79
IS 6
BP 1108
EP 1115
DI 10.1902/jop.2008.070476
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 312CK
UT WOS:000256646500022
PM 18533791
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI AFM techniques for understanding cell-biomaterial interactions
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT News Item
CR MOONEY DJ, MACROMOL BIOSCI, DOI DOI 10.1002/MABI.200700313
NR 1
TC 0
Z9 0
U1 1
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-624X
EI 1099-0518
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JUN 1
PY 2008
VL 46
IS 11
BP A3
EP A3
DI 10.1002/mabi.200700313
PG 1
WC Polymer Science
SC Polymer Science
GA 308KY
UT WOS:000256390100005
DA 2018-10-20
ER

PT J
AU Shyang, CW
   Khim, LY
   Ariffin, A
   Arifin, Z
   Ishak, M
AF Shyang, Chow Wen
   Khim, Loo Yok
   Ariffin, Azlan
   Arifin, Zainal
   Ishak, Mohd
TI Flexural properties of hydroxyapatite reinforced poly(methyl
   methacrylate) composites
SO JOURNAL OF REINFORCED PLASTICS AND COMPOSITES
LA English
DT Article
DE poly(methyl methacrylate); hydroxyapatite; composites
ID POLYETHYLENE COMPOSITES; MECHANICAL-PROPERTIES
AB Poly(methyl methacrylate) (PMMA) filled with hydroxyapatite (HA) filler has been widely used in biomaterial application. Acrylic denture base material was prepared from PMMA filled with HA. This research work attempted to investigate the effects of hydroxyapatite (HA) on the flexural properties of poly(methyl methacrylate). PMMA powder was mixed with a monomer of methyl methacrylate (MMA) stabilized with hydroquinone. Benzoyl peroxide (BPO) and ethylene glycol dimethacrylate (EGDMA) were used as initiator and crosslinking agent, respectively. The PMMA/HA composites were prepared by using heat-processing polymers powder and liquid method. The flexural modulus of PMMA was increased by the addition of HA. This is attributed to the reinforcement effects of HA. However, the flexural strength and strain was decreased in the presence of HA. Experimental data of flexural modulus for PMMA/HA composites was compared with several theoretical models and equations. It was found that the experimental data could be relatively predicted by Hirsch's model.
C1 [Shyang, Chow Wen; Khim, Loo Yok; Ariffin, Azlan; Arifin, Zainal; Ishak, Mohd] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong Tebal 14300, Penang, Malaysia.
RP Shyang, CW (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Engn Campus, Nibong Tebal 14300, Penang, Malaysia.
EM chowwenshyang@yahoo.com
CR Balac I, 2001, COMP MATER SCI, V20, P275, DOI 10.1016/S0927-0256(00)00182-8
   Balamurugan A, 2004, TRENDS BIOMATER ARTI, V18, P41
   Cheang P, 2003, MAT SCI ENG A-STRUCT, V345, P47, DOI 10.1016/S0921-5093(02)00284-8
   Fang LM, 2006, BIOMATERIALS, V27, P3701, DOI 10.1016/j.biomaterials.2006.02.023
   Ferris CF, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-10
   John J, 2001, J PROSTHET DENT, V86, P424, DOI 10.1067/mpr.2001.118564
   LAWRENCE EN, 1994, MECH PROPERTIES POLY, P386
   MCCABE JF, 1998, APPL DENT MAT, P96
   NIDAL WE, 2006, THESIS U SAINS MALAY, P79
   OBRIEN WJ, 2002, DENTAL MAT THEIR SEL, P77
   ONFIELD, 2003, BIOMATERIALS RES DEV, P72
   Pereira Marivalda de Magalhães, 2003, Mat. Res., V6, P311, DOI 10.1590/S1516-14392003000300002
   SAIED HM, 2006, THESIS U SAINS MALAY, P90
   Sakaguchi RL, 2004, DENT MATER, V20, P397, DOI 10.1016/j.dental.2003.11.003
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   Yan W, 2006, COMPOS SCI TECHNOL, V66, P2080, DOI 10.1016/j.compscitech.2005.12.022
NR 16
TC 5
Z9 6
U1 1
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0731-6844
J9 J REINF PLAST COMP
JI J. Reinf. Plast. Compos.
PD JUN
PY 2008
VL 27
IS 9
BP 945
EP 952
DI 10.1177/0731684407086506
PG 8
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 311GJ
UT WOS:000256588400005
DA 2018-10-20
ER

PT J
AU Safran, MR
   Kim, H
   Zaffagnini, S
AF Safran, Marc R.
   Kim, Hubert
   Zaffagnini, Stefano
TI The use of scaffolds in the management of art articular cartilage injury
SO JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; TISSUE-ENGINEERED CARTILAGE; BOVINE
   CHONDROCYTES; REPAIR; DEFECTS; POLYMER; REDIFFERENTIATION; BIOMATERIAL;
   CONSTRUCTS; SURFACES
AB Managing articular cartilage injury continues to be a difficult challenge for the clinician. Although the short- and intermediateterm results of autologous chondrocyte implantation appear to be favorable, resources are being directed toward research to improve the technology. One promising area of investigation is the combination of cultured chondrocytes with scaffolds. Clinicians desire techniques that may be implanted easily, reduce surgical morbidity, do not require harvesting of other tissues, exhibit enhanced cell proliferation and maturation, have easier phenotype maintenance, and allow for efficient and complete integration with surrounding articular cartilage. The characteristics that make scaffolds optimal for clinical use are that they be biocompatible, biodegradable, permeable, reproducible, mechanically stable, noncytotoxic, and capable of serving as a temporary support for the cells while allowing for eventual replacement by matrix components synthesized by the implanted cells. Clinical experience is growing with three scaffold-based cartilage repair techniques, each using a different type of scaffold material: matrix-induced autologous chondrocyte implantation, a hyaluronic acid-based scaffold, and a composite polylactic/polyglycolic acid polymer fleece. Clinical results are encouraging. Future directions in scaffold-based cartilage repair include bioactive and spatially oriented scaffolds.
C1 [Safran, Marc R.; Kim, Hubert] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA.
   [Zaffagnini, Stefano] Rizzoli Orthopaed Inst, Biomech Lab, Bologna, Italy.
RP Safran, MR (reprint author), Stanford Univ, 300 Pasteur Dr,Edwards R105, Stanford, CA 94305 USA.
CR Allemann M, 2001, J BIOMED MATER RES, V55, P13
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Chen G, 2003, FEBS LETT, V542, P95, DOI 10.1016/S0014-5793(03)00354-5
   Chou CH, 2006, J BIOMED MATER RES B, V77B, P338, DOI 10.1002/jbm.b.30432
   Erggelet C, 2003, ARTHROSCOPY, V19, P108, DOI 10.1053/jars.2003.50025
   GOTI GK, 2003, ARCH OTOLARYNGOL, V129, P889
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   GUILLEN P, 2005, FINAL PROGRAM, P145
   Haddo O, 2004, KNEE, V11, P51, DOI 10.1016/S0968-0160(03)00041-3
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Kim HT, 2006, J ORTHOP SPORT PHYS, V36, P765, DOI 10.2519/jospt.2006.2284
   Lee DA, 2003, ACTA ORTHOP SCAND, V74, P6, DOI 10.1080/00016470310013581
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Marcacci M., 2005, ANN M AM ORTH SOC SP
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Mizuno S, 2001, J BIOMED MATER RES, V56, P368, DOI 10.1002/1097-4636(20010905)56:3<368::AID-JBM1105>3.0.CO;2-V
   Rahman MS, 2001, TISSUE ENG, V7, P781, DOI 10.1089/107632701753337726
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Strauss EJ, 2005, AM J SPORT MED, V33, P1647, DOI 10.1177/0363546505275487
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   Zehbe R, 2005, BIO-MED MATER ENG, V15, P445
NR 27
TC 42
Z9 43
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1067-151X
EI 1940-5480
J9 J AM ACAD ORTHOP SUR
JI J. Am. Acad. Orthop. Surg.
PD JUN
PY 2008
VL 16
IS 6
BP 306
EP 311
DI 10.5435/00124635-200806000-00002
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 306XC
UT WOS:000256280600002
PM 18524981
DA 2018-10-20
ER

PT J
AU Dutra, CEA
   Pereira, MM
   Serakides, R
   Rezende, CAF
AF Dutra, Carlos E. A.
   Pereira, Marivalda M.
   Serakides, Rogeria
   Rezende, Cleuza A. F.
TI In vivo evaluation of bioactive glass foams associated with
   platelet-rich plasma in bone defects
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biomaterials; bioactive glass foam; sol-gel; bone; osteoconduction
ID REGENERATION; SCAFFOLDS; CERAMICS; GRAFTS; GROWTH
AB The objective of this study was to evaluate the use of bioactive glass foams produced by the sol-gel process, associated or not with platelet-rich plasma (PRP), in the regeneration of bone defects. Mongrel dogs (n = 14) were divided into two groups after having their superior first premolar removed. A small piece of vestibular bone from the alveolus was intentionally removed. The area was filled with bioactive glass foam produced by the sol-gel method. Two groups were tested: group A was the glass foam; group B was the same material associated with PRP, prepared from each animal. The other side of alveolar bone was used as a control group, in which the bone defect did not receive any biomaterial. The thickness of the bone area was measured before and after the intervention. After a period of 60 days implantation, the right and left bones were measured again, and a bone biopsy on both regions was conducted for histological analysis. The findings show an increase of bone thickness for both materials implanted compared to the control group. Group B, implanted with bioactive glass foam associated with PRP, showed a thicker bone area compared to Group A. Histological results indicate bone formation for both materials used. However, the bioactive glass associated with PRP gave rise to a more mature bone formation. These results show that bioactive glass foams processed by a sol-gel method is effective in maintaining the thickness of the alveolar ridge, and the use of PRP associated with the foams improve bone formation. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Dutra, Carlos E. A.] Univ Fed Minas Gerais, Dept Clin Patol & Cirurgia Odontol, Fac Odontol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pereira, Marivalda M.] Univ Fed Minas Gerais, Escola Engn, Dept Engn Met, BR-31270901 Belo Horizonte, MG, Brazil.
   [Serakides, Rogeria; Rezende, Cleuza A. F.] Univ Fed Minas Gerais, Escola Med Vet, Dept Clin & Cirurgia Vet, BR-31270901 Belo Horizonte, MG, Brazil.
RP Dutra, CEA (reprint author), Univ Fed Minas Gerais, Dept Clin Patol & Cirurgia Odontol, Fac Odontol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM kkdut@hotmail.com
RI Serakides, Rogeria/C-7571-2016
OI Serakides, Rogeria/0000-0001-5374-6242
CR BARTLEY PM, 2001, REV ADM, V5, P283
   BELL E, 1997, PRINCIPLES TISSUE EN, P181
   Choi BH, 2005, INT J ORAL MAX SURG, V34, P420, DOI 10.1016/j.ijom.2004.10.018
   Coelho MD, 2005, J BIOMED MATER RES B, V75B, P451, DOI 10.1002/jbm.b.30354
   Cunningham N, 1992, BONE GRAFTS BONE SUB, P93
   Dugrillon A, 2002, INT J ORAL MAX SURG, V31, P615, DOI 10.1054/ijom.2002.0322
   Froum SJ, 2002, INT J PERIODONT REST, V22, P45
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   GRENNSPAN DC, 1998, P 11 INT S CER MED B, P345
   HAMMADOUCHE M, 2001, J BIOMED MATER RES, V4, P560
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   Langer R, 1997, PHARMACEUT RES, V14, P840, DOI 10.1023/A:1012131329148
   Leonetti J A, 2000, Implant Dent, V9, P177, DOI 10.1097/00008505-200009020-00012
   LYNCH SE, 1994, PERIODONTAL REGENERA
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Nevins M L, 2000, Int J Periodontics Restorative Dent, V20, P458
   PEREIRA MM, 1994, THESIS GRADUATE SCH
   PUTNAM JA, 1996, NAT MED, V7, P824
   Radin S, 2005, BIOMATERIALS, V26, P1043, DOI 10.1016/j.biomaterials.2004.04.004
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Tadjoedin ES, 2000, CLIN ORAL IMPLAN RES, V11, P334, DOI 10.1034/j.1600-0501.2000.011004334.x
   URIST MR, 1972, CLIN ORTHOP RELAT R, P132
   XINUS ID, 2000, BIOCHEM BIOPH RES CO, V276, P461
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
NR 27
TC 18
Z9 22
U1 0
U2 2
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2008
VL 2
IS 4
BP 221
EP 227
DI 10.1002/term.86
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 317UI
UT WOS:000257045200007
PM 18493909
DA 2018-10-20
ER

PT J
AU Arias, JI
   Gonzalez, A
   Fernandez, MS
   Gonzalez, C
   Saez, D
   Arias, JL
AF Arias, J. I.
   Gonzalez, A.
   Fernandez, M. S.
   Gonzalez, C.
   Saez, D.
   Arias, J. L.
TI Eggshell membrane as a biodegradable bone regeneration inhibitor
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE eggshell membrane; bone; regeneration; radius curvus; biomaterial; type
   X collagen
ID MOLECULAR WEIGHT COLLAGEN; DISTAL ULNAR PHYSIS; X COLLAGEN; ENDOCHONDRAL
   OSSIFICATION; PREMATURE CLOSURE; CRANIAL DEFECTS; NONUNION MODEL;
   CHONDROCYTES; CARTILAGE; MATRIX
AB The efficiency of chicken eggshell membranes combined with a minimally invasive small osteotomy procedure of the ulna to accomplish an efficient release of the radius so that it can continue to grow in an unstressed manner was tested in rabbits. Eggshell membranes were extracted from chicken eggs, rinsed, dried and sterilized with ethylene oxide for 24 h. For reactivity testing, four separate subcutaneous pockets were created in 10 rats in the paravertebral region by blunt dissection and eggshell membranes were implanted in two of them. After 1-16 weeks, the implants were retrieved with the surrounding soft tissues and submitted to histological examination. Subsequently, 10 rabbits were anaesthetized and a complete 0.5 mm. wide osteotomy was performed in both the right and the left distal ulna. A piece of eggshell membranes was interposed in the osteotomy site of one ulna. The opposite osteotomized ulna was left as a negative control. The rabbits were injected with oxytetracycline at the time of surgery and this was repeated every 7 days for labelling new bone formation. After 1-16 weeks, ulnar osteotomized regions were histologically examined. After histological, fluorescence microcopy and radiological evaluation, we demonstrate here for the first time that eggshell membranes as interpositional material in rabbit osteotomized ulnar experiments acted as an active barrier against bone bridging. The degradation of the eggshell membrane, due to host reaction, appeared sufficiently late to cause the desirable delay of bone healing that is compatible with the time needed for a corrective response. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Arias, J. I.] Univ Austral Chile, Inst Ciencias Clin Vet, Fac Ciencias Vet, Valdivia, Chile.
   [Gonzalez, A.; Fernandez, M. S.; Saez, D.; Arias, J. L.] Univ Chile, Fac Ciencias Vet & Pecuarias, Santiago, Chile.
   [Fernandez, M. S.; Arias, J. L.] Univ Chile, Fac Vet Sci, Ctr Adv Interdisciplinary Res Mat Sci, Santiago, Chile.
   [Gonzalez, C.] Univ Andres Bello, Fac Ecol & Recursos Nat, Escuela Med Vet, Santiago, Chile.
RP Arias, JL (reprint author), Univ Chile, Fac Vet Sci, Ctr Adv Interdisciplinary Res Mat Sci, Santa Rosa 11735, Santiago, Chile.
EM jarias@uchile.cl
RI ARIAS, JOSE/H-5489-2013; Arias, Jose/E-1206-2011
OI Arias, Jose Ignacio/0000-0001-6518-2229
CR [Anonymous], 2003, F198399 ASTM INT
   Arias JL, 1997, CONNECT TISSUE RES, V36, P21, DOI 10.3109/03008209709160211
   ARIAS JL, 1991, MATRIX, V11, P313, DOI 10.1016/S0934-8832(11)80202-7
   ARIAS JL, 1991, CONNECT TISSUE RES, V26, P37, DOI 10.3109/03008209109152162
   ARIAS JL, 2007, HDB BIOMINERALIZATIO, V2, P109
   *ASTM INT, 2004, F98104 ASTM INT
   Bodde EWH, 2008, J BIOMED MATER RES A, V85A, P206, DOI 10.1002/jbm.a.31549
   CAPASSO O, 1984, MOL CELL BIOL, V4, P1163, DOI 10.1128/MCB.4.6.1163
   CAPASSO O, 1982, EXP CELL RES, V142, P194
   DEBOER HH, 1989, J BONE JOINT SURG BR, V71, P374
   Dupoirieux L, 2001, J CRANIOFAC SURG, V12, P53, DOI 10.1097/00001665-200101000-00009
   Dupoirieux L, 2001, INT J ORAL MAX SURG, V30, P58, DOI 10.1054/ijom.2000.0011
   Durmus E, 2003, J INT MED RES, V31, P223, DOI 10.1177/147323000303100309
   EGGER EL, 1978, J AM ANIM HOSP ASSOC, V14, P690
   Fernandez MS, 2001, MATRIX BIOL, V19, P793
   Fox DB, 2006, VET SURG, V35, P67, DOI 10.1111/j.1532-950X.2005.00114.x
   GIBSON GJ, 1984, J CELL BIOL, V99, P208, DOI 10.1083/jcb.99.1.208
   GRANT WT, 1987, J BIOL CHEM, V262, P9844
   HABUCHI H, 1985, J BIOL CHEM, V260, P13026
   HAN CS, 1992, J BONE JOINT SURG AM, V74A, P1441, DOI 10.2106/00004623-199274100-00002
   JACENKO O, 1991, CRIT REV EUKAR GENE, V1, P3217
   JIA J, 2007, J BIOMED MAT RES
   KIELTY CM, 1985, BIOCHEM J, V227, P545, DOI 10.1042/bj2270545
   Kim G, 2007, BIOMED MATER, V2, P250, DOI 10.1088/1748-6041/2/4/007
   KIRSCH T, 1992, DIFFERENTIATION, V52, P89, DOI 10.1111/j.1432-0436.1992.tb00503.x
   Kokubu T, 2003, J ORTHOP RES, V21, P503, DOI 10.1016/S0736-0266(02)00209-7
   KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597
   LAU RE, 1977, J AM ANIM HOSP ASSOC, V13, P609
   LEBOY PS, 1988, J BIOL CHEM, V263, P8515
   LUVALLE P, 1992, MATRIX, V12, P404, DOI 10.1016/S0934-8832(11)80037-5
   MAY JW, 1989, J BONE JOINT SURG AM, V71A, P1422, DOI 10.2106/00004623-198971090-00027
   NEWTON CD, 1974, J AM VET MED ASSOC, V164, P479
   Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191
   Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003
   PIERMATEI DL, 1997, HDB SMALL ANIMAL ORT, P696
   POOLE AR, 1989, ANAT REC, V224, P167
   POOLE AR, 1989, J CELL BIOL, V109, P2547, DOI 10.1083/jcb.109.5.2547
   Russell G, 2007, J INVEST SURG, V20, P249, DOI 10.1080/08941930701481312
   SCHMID TM, 1985, DEV BIOL, V107, P373, DOI 10.1016/0012-1606(85)90319-7
   SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598
   SCHMID TM, 1982, J BIOL CHEM, V257, P2444
   SCHMID TM, 1983, J BIOL CHEM, V258, P9504
   Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x
   SOLURSH M, 1986, DEV BIOL, V117, P90, DOI 10.1016/0012-1606(86)90351-9
   TACCHETTI C, 1989, DEV BIOL, V132, P442, DOI 10.1016/0012-1606(89)90240-6
   Upman PJ, 2003, LAB ANIMAL, V32, P26, DOI 10.1038/laban0303-26
   VANDEWATER A, 1982, VET SURG, V11, P92, DOI 10.1111/j.1532-950X.1982.tb00675.x
   Viateau V, 2006, VET SURG, V35, P445, DOI 10.1111/j.1532-950X.2006.00173.x
   WALKER GD, 1995, J ORTHOPAED RES, V13, P4, DOI 10.1002/jor.1100130104
   Zadik Y, 2007, WILD ENVIRON MED, V18, P230, DOI 10.1580/06-WEME-LE-082R1.1
NR 50
TC 13
Z9 13
U1 0
U2 19
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2008
VL 2
IS 4
BP 228
EP 235
DI 10.1002/term.87
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 317UI
UT WOS:000257045200008
PM 18493912
DA 2018-10-20
ER

PT J
AU Hiromoto, S
   Yamamoto, A
   Maruyama, N
   Somekawa, H
   Mukai, T
AF Hiromoto, Sachiko
   Yamamoto, Akiko
   Maruyama, Norio
   Somekawa, Hidetoshi
   Mukai, Toshiji
TI Polarization behavior of pure magnesium under a controlled flow in a
   NaCl solution
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE pure magnesium; controlled flow; polarization behavior; impedance
   behavior; biomaterial
ID ABSORBABLE METAL; ALLOYS; CORROSION; STENTS
AB Magnesium and its alloys are potential candidates for bioabsorbable stents. The degradation rate of an indwelled magnesium stent is expected to be controlled under a blood flow. The influence of the controlled flow on the polarization and impedance behavior of pure Mg was thus investigated in a 0.6 mass% NaCl solution using a rotating electrode. The existence of a flow caused an increase in the anodic current density as well as a decrease in the impedance for a few hours of immersion, indicating the acceleration of Mg dissolution and the retardation of the growth of the surface hydroxide film. Interestingly, the existence of a flow retarded the breakdown of the surface film. After the surface film was broken down, the impedance did not depend on the rotation speed. To precisely evaluate the degradation rate of magnesium and its alloys for use in stents, the flow rate of the test solution should be controlled.
C1 [Hiromoto, Sachiko; Yamamoto, Akiko; Maruyama, Norio] Natl Inst Mat Sci, Ctr Biomat, Biomet Grp, Tsukuba, Ibaraki 3050044, Japan.
   [Somekawa, Hidetoshi; Mukai, Toshiji] Natl Inst Mat Sci, Struct Met Ctr, Lightweight Alloys Grp, Tsukuba, Ibaraki 3050047, Japan.
RP Hiromoto, S (reprint author), Natl Inst Mat Sci, Ctr Biomat, Biomet Grp, Tsukuba, Ibaraki 3050044, Japan.
EM HIROMOTO.Sachiko@nims.go.jp
RI Mukai, Toshiji/F-9570-2014; HIROMOTO, Sachiko/H-2686-2011; Kobe Univ,
   Engineering/D-2028-2017
OI Mukai, Toshiji/0000-0002-9628-5762; 
CR Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   GULBRANDSEN E, 1992, ELECTROCHIM ACTA, V37, P1403, DOI 10.1016/0013-4686(92)87014-Q
   Hara N, 2007, CORROS SCI, V49, P166, DOI 10.1016/j.corsci.2006.05.033
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hillis J., 2006, MAGNESIUM TECHNOLOGY, P469
   KAIBARA M, 1999, BIORHEOLOGY, P78
   Levesque J, 2003, MATER SCI FORUM, V426-4, P521, DOI 10.4028/www.scientific.net/MSF.426-432.521
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   McCord Carey P., 1942, INDUST MED [BELOIT], V11, P71
   Peeters P, 2005, J ENDOVASC THER, V12, P1, DOI 10.1583/04-1349R.1
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA, P139
   Stroganov G. B., 1972, [No title captured], Patent No. [3687135, 3, 687, 135]
   SUGAWARA M, 2003, HEMORHEOLOGY BLOOD F, P75
   Takatani Y., 2005, Journal of Japan Institute of Light Metals, V55, P357, DOI 10.2464/jilm.55.357
   TANAKA H, 1995, CHEM REV Q, V27, P3
   WADA G, 1957, DENKI KAGAKU ELECTRO, V25, P164
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
NR 19
TC 15
Z9 15
U1 0
U2 12
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUN
PY 2008
VL 49
IS 6
BP 1456
EP 1461
DI 10.2320/matertrans.MRA2008011
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 333OD
UT WOS:000258160900041
OA Bronze
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI AFM techniques for understanding cell-biomaterial interactions
SO PHYSICA STATUS SOLIDI-RAPID RESEARCH LETTERS
LA English
DT News Item
CR MOONEY DJ, MACROMOL BIOSCI, DOI DOI 10.1002/MABI.200700313
NR 1
TC 0
Z9 0
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1862-6254
EI 1862-6270
J9 PHYS STATUS SOLIDI-R
JI Phys. Status Solidi-Rapid Res. Lett.
PD JUN
PY 2008
VL 2
IS 3
BP A3
EP A3
PG 1
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 317TQ
UT WOS:000257043400010
DA 2018-10-20
ER

PT J
AU Man, I
   Pirvu, C
   Demetrescu, I
AF Man, Isabela
   Pirvu, Cristian
   Demetrescu, Ioana
TI Enhancing Titanium stability in Fusayama Saliva using electrochemical
   elaboration of TiO(2) nanotubes
SO REVISTA DE CHIMIE
LA English
DT Article
DE TO(2) nanotubes; Fusayama saliva; cyclic voltametry; atomic force
   microscopy
ID SURFACE OXIDE-FILM; PHYSIOLOGICAL ENVIRONMENT; DENTAL ALLOYS; BEHAVIOR;
   LAYERS; MOCVD
AB Titanium having low density, stability and biocompatibility, is one of the most promising biomaterial of the century even with the natural passive stratum [1,2], but building a nano-tube structure in the last decade using various procedure could lead also to an improvement of a quite large range of properties important in applied chemistry. The aim of the paper is to elaborate electrochemically TiO(2) nanotubes and to evaluate the stability increase of Titanium in Fusayama saliva changing the surface morphology from micro TiO(2) to TiO(2) nanotubes. Anodization at room temperature in a mixture of (NH(4))(2)SO(4) and NH(4)F, was the choice of nanotubes structures elaboration, and cyclic voltammetry was the procedure of stability evaluation. The surface analysis was performed using scanning electron microscopy (SEM), energy-dispersive X-ray microanalysis (EDAX), and atomic force microscopy before and after anodization.
C1 [Man, Isabela; Pirvu, Cristian; Demetrescu, Ioana] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
RP Demetrescu, I (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, 1-3 Polizu Str, Bucharest 011061, Romania.
EM l_demetrescu@chim.upb.ro
RI Demetrescu, Ioana/C-5325-2013
OI Pirvu, Cristian/0000-0003-0339-6146
CR Balaur E, 2005, J MATER CHEM, V15, P4488, DOI 10.1039/b509672c
   Balaur E, 2005, ELECTROCHEM COMMUN, V7, P1066, DOI 10.1016/j.elecom.2005.07.014
   Brunette D. M., 2001, TITANIUM MED
   de Assis SL, 2006, ELECTROCHIM ACTA, V51, P1815, DOI 10.1016/j.electacta.2005.02.121
   Duffo GS, 2004, CORROSION-US, V60, P594, DOI 10.5006/1.3287764
   DYER CK, 1978, J ELECTROCHEM SOC, V125, P23, DOI 10.1149/1.2131391
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   HANAVA T, 1998, BIOMATERIALS, V19, P85
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Hazra SK, 2006, MAT SCI ENG B-SOLID, V131, P135, DOI 10.1016/j.mseb.2006.04.004
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   Macak JM, 2005, ELECTROCHIM ACTA, V50, P3679, DOI 10.1016/j.electacta.2005.01.014
   Macak JM, 2005, ANGEW CHEM INT EDIT, V44, P2100, DOI 10.1002/anie.200462459
   Popa MV, 2004, ELECTROCHIM ACTA, V49, P2113, DOI 10.1016/j.electacta.2003.12.036
   Popa MV, 2003, MATER CORROS, V54, P215, DOI 10.1002/maco.200390049
   Popescu S, 2007, REV CHIM-BUCHAREST, V58, P880
   Popescu S, 2007, J MATER SCI-MATER M, V18, P2075, DOI 10.1007/s10856-007-3133-3
   Reclaru L, 1998, BIOMATERIALS, V19, P85, DOI 10.1016/S0142-9612(97)00179-8
   Takeuchi M, 2003, BIOMATERIALS, V24, P1821, DOI 10.1016/S0142-9612(02)00576-8
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
NR 22
TC 30
Z9 30
U1 1
U2 6
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD JUN
PY 2008
VL 59
IS 6
BP 615
EP 617
PG 3
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 325QY
UT WOS:000257604600002
DA 2018-10-20
ER

PT J
AU Ganio, E
   Marino, F
   Giani, I
   Luc, AR
   Clerico, G
   Novelli, E
   Trompetto, M
AF Ganio, E.
   Marino, F.
   Giani, I.
   Luc, A. Realis
   Clerico, G.
   Novelli, E.
   Trompetto, M.
TI Injectable synthetic calcium hydroxylapatite ceramic microspheres
   (Coaptite) for passive fecal incontinence
SO TECHNIQUES IN COLOPROCTOLOGY
LA English
DT Article
DE Fecal incontinence; Bulking agents; Calcium hydroxylapatite; Coaptite
ID RADIOFREQUENCY ENERGY DELIVERY; STRESS URINARY-INCONTINENCE;
   ANAL-SPHINCTER DYSFUNCTION; SILICONE BIOMATERIAL; VESICOURETERAL REFLUX;
   ENDOSCOPIC TREATMENT; PERIANAL INJECTION; BULKING AGENT; COLLAGEN;
   MANAGEMENT
AB Background Passive fecal incontinence is a disabling condition caused by internal anal sphincter dysfunction. The aim of the study was to assess prospectively the effects of calcium hydroxylapatite ceramic microspheres (Coaptite) as a bulking agents to treat patients with passive fecal incontinence. Methods Ten patients with passive fecal incontinence were recruited. All patients were assessed by clinical examination, anal ultrasonography and anal manometry. The severity of incontinence and quality of life were assessed using the Fecal Incontinence Scoring System (FISS) and Fecal Incontinence Quality of Life (FIQoL) questionnaire at baseline and at 3, 6 and 12 months after the Coaptite injection. Results Eight patients (80%) had a marked improvement in continence, with a significant reduction in FISS from 85.6 +/- 9.4 to 28.0 +/- 29.0 (p=0.008) at 12 months. There was an improvement in global quality of life scores, which was significant in three subscales ( lifestyle, coping/behaviour and embarrassment). Manometry showed a significant improvement from baseline in the mean resting anal canal pressure after the Coaptite injection (p=0.018). Conclusions Coaptite is a promising and safe bulking agent for the treatment of passive fecal incontinence.
C1 [Ganio, E.; Marino, F.; Giani, I.; Luc, A. Realis; Clerico, G.; Novelli, E.; Trompetto, M.] Clin S Rita, Colorectal Eporediensis Ctr, Vercelli, Italy.
RP Marino, F (reprint author), Clin S Rita, Colorectal Eporediensis Ctr, Vercelli, Italy.
EM fabio.marino@virgilio.it
CR Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Efron JE, 2003, DIS COLON RECTUM, V46, P1606, DOI 10.1097/01.DCR.0000098927.47914.D0
   Hetzer FH, 2006, BRIT J SURG, V93, P1411, DOI 10.1002/bjs.5491
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kumar D, 1998, BRIT J SURG, V85, P978
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   MAEDA Y, 2007, COLORECTAL DIS, V10, P268
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Mayer R, 2001, UROLOGY, V57, P434, DOI 10.1016/S0090-4295(00)01098-0
   Mayer RD, 2007, UROLOGY, V69, P876, DOI 10.1016/j.urology.2007.01.050
   Merrot T, 2005, PROG UROL, V15, P1114
   Mevorach RA, 2006, J UROLOGY, V175, P288, DOI 10.1016/S0022-5347(05)00013-3
   Mora Durban Miguel Julian, 2006, Archivos Espanoles de Urologia, V59, P493
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   Nijhuis PH, 1998, DIS COLON RECTUM, V41, P624, DOI 10.1007/BF02235272
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Takahashi T, 2003, DIS COLON RECTUM, V46, P711, DOI 10.1097/01.DCR.0000070342.56449.4A
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
NR 22
TC 21
Z9 22
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1123-6337
J9 TECH COLOPROCTOL
JI Tech. Coloproctology
PD JUN
PY 2008
VL 12
IS 2
BP 99
EP 102
DI 10.1007/s10151-008-0406-x
PG 4
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 385VU
UT WOS:000261842500003
PM 18545883
DA 2018-10-20
ER

PT J
AU El-Ayoubi, R
   Eliopoulos, N
   Diraddo, R
   Jacques, G
   Yousef, AM
AF El-Ayoubi, Rouwayda
   Eliopoulos, Nicoletta
   Diraddo, Robert
   Galipeau, Jacques
   Yousefi, Azizeh-Mitra
TI Design and fabrication of 3D porous scaffolds to facilitate cell-based
   gene therapy
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; TISSUE ENGINEERING
   SCAFFOLDS; BIODEGRADABLE POLYMER; POLY(D,L-LACTIC-CO-GLYCOLIC ACID);
   SYSTEMIC DELIVERY; PHASE-SEPARATION; SPINAL-CORD; PORE-SIZE;
   ERYTHROPOIETIN
AB Biomaterials capable of efficient gene delivery by embedded cells provide a fundamental tool for the treatment of acquired or hereditary diseases. A major obstacle is maintaining adequate nutrient and oxygen diffusion to cells within the biomaterial. In this study, we combined the solid free-form fabrication and porogen leaching techniques to fabricate three-dimensional scaffolds, with bimodal pore size distribution, for cell-based gene delivery. The objective of this study was to design micro-/macroporous scaffolds to improve cell viability and drug delivery. Murine bone marrow-derived mesenchymal stromal cells (MSCs) genetically engineered to secrete erythropoietin (EPO) were seeded onto poly-L-lactide (PLLA) scaffolds with different microporosities. Over a period of 2 weeks in culture, an increase in cell proliferation and metabolic activity was observed with increasing scaffold microporosity. The concentration of EPO detected in supernatants also increased with increasing microporosity level. Our study shows that these constructs can promote cell viability and release of therapeutic proteins, and clearly demonstrates their capacity for a dual role as scaffolds for tissue regeneration and as delivery systems for soluble gene products.
C1 [El-Ayoubi, Rouwayda; Diraddo, Robert; Yousefi, Azizeh-Mitra] Natl Res Council Canada, Inst Ind Mat, Boucherville, PQ J4B 6Y4, Canada.
   [Eliopoulos, Nicoletta; Galipeau, Jacques] McGill Univ, Lady Davis Inst Med Res, Dept Med, Montreal, PQ H3A 2T5, Canada.
   [Eliopoulos, Nicoletta; Galipeau, Jacques] McGill Univ, Lady Davis Inst Med Res, Dept Oncol, Montreal, PQ H3A 2T5, Canada.
RP Yousef, AM (reprint author), Natl Res Council Canada, Inst Ind Mat, 75 Mortagne Blvd, Boucherville, PQ J4B 6Y4, Canada.
EM Azizeh.Yousefi@imi.cnrc-nrc.gc.ca
CR Bibby SRS, 2004, EUR SPINE J, V13, P695, DOI 10.1007/s00586-003-0616-x
   Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Bursac PM, 1999, J BIOMECH, V32, P1125, DOI 10.1016/S0021-9290(99)00105-0
   Cao L, 2004, BRAIN, V127, P535, DOI 10.1093/brain/awh072
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Chang PL, 1998, ADV DRUG DELIVER REV, V33, P31, DOI 10.1016/S0169-409X(98)00018-0
   Crow BB, 2005, TISSUE ENG, V11, P1077, DOI 10.1089/ten.2005.11.1077
   Cui YL, 2003, J BIOMED MATER RES A, V66A, P770, DOI 10.1002/jbm.a.10071
   Dealy J M, 1990, MELT RHEOLOGY ITS RO
   Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3
   Diez S, 2006, EUR J PHARM BIOPHARM, V63, P188, DOI 10.1016/j.ejpb.2006.03.007
   Eliopoulos N, 2006, J AM SOC NEPHROL, V17, P1576, DOI 10.1681/ASN.2005101035
   Eliopoulos N, 2004, MOL THER, V10, P741, DOI 10.1016/j.ymthe.2004.07.004
   Eliopoulos N, 2003, GENE THER, V10, P478, DOI 10.1038/sj.gt.3301919
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Gerson SL, 1999, NAT MED, V5, P262, DOI 10.1038/6470
   Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z
   Hirata K, 2003, BONE, V32, P502, DOI 10.1016/S8756-3282(03)00054-1
   Horwitz EM, 2003, ARCH MED RES, V34, P600, DOI 10.1016/j.arcmed.2003.09.006
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   Jelkmann W, 1996, ANN ANAT, V178, P391, DOI 10.1016/S0940-9602(96)80124-5
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim SS, 1998, ANN SURG, V228, P8, DOI 10.1097/00000658-199807000-00002
   Kim SY, 2002, KOREAN J CHEM ENG, V19, P190, DOI 10.1007/BF02706894
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Leclerc E, 2004, MAT SCI ENG C-BIO S, V24, P349, DOI 10.1016/j.msec.2003.12.004
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Liu H, 2006, BIOMATERIALS, V27, P5978, DOI 10.1016/j.biomaterials.2006.05.053
   Ma ZW, 2002, J BIOMED MATER RES, V63, P838, DOI 10.1002/jbm.10470
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Margarett D.M.E., 1998, J BIOMED MATER RES, V40, P621
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mikos AG, 1994, POLYMER, V35, P1069
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Newman KD, 2004, BIOMATERIALS, V25, P5763, DOI 10.1016/j.biomaterials.2004.01.027
   Paek HJ, 2006, TISSUE ENG, V12, P1733, DOI 10.1089/ten.2006.12.1733
   Pfister A, 2004, J POLYM SCI POL CHEM, V42, P624, DOI 10.1002/pola.10807
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pochampally RR, 2005, GENE THER, V12, P1119, DOI 10.1038/sj.gt.3302514
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Ranucci CS, 1999, TISSUE ENG, V5, P407, DOI 10.1089/ten.1999.5.407
   Razaq S, 2003, EUR SPINE J, V12, P341, DOI 10.1007/s00586-003-0582-3
   Regulier E, 1998, GENE THER, V5, P1014, DOI 10.1038/sj.gt.3300687
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   Rose FR, 2004, BIOMATERIALS, V25, P5507, DOI 10.1016/j.biomaterials.2004.01.012
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   VACANTI JP, 1999, LANCET S1, V354, pS132
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   WEISS L, 1997, INT TECHNOLOGY RES I, V5, P5
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   XU SL, 2001, ANN NY ACAD SCI, V944, P144
   Yamamoto M, 2006, ADV DRUG DELIVER REV, V58, P535, DOI 10.1016/j.addr.2006.03.003
   Yousefi AM, 2007, POLYM ENG SCI, V47, P608, DOI 10.1002/pen.20732
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 68
TC 22
Z9 24
U1 2
U2 16
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUN
PY 2008
VL 14
IS 6
BP 1037
EP 1048
DI 10.1089/ten.tea.2006.0418
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 316SK
UT WOS:000256969800009
PM 19230126
DA 2018-10-20
ER

PT J
AU Pokrywczynska, M
   Drewa, T
   Jundzill, A
   Lysik, J
AF Pokrywczynska, M.
   Drewa, T.
   Jundzill, A.
   Lysik, J.
TI Alginate is not a good material for growth of rapidly proliferating
   cells
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article
ID VESICOURETERAL REFLUX; ENDOSCOPIC TREATMENT; FOLLOW-UP; CHONDROCYTES;
   ISLETS; HYDROGELS; SCAFFOLDS
AB Introduction. Alginate scaffolds are widely used in tissue engineering. The aim of this study was to evaluate alginate as a scaffold for 3D cultures of rapidly proliferating cells.
   Materials and Methods. Murine 3T3 fibroblasts were cultured in an alginate scaffold for 30 days. Cells growing in alginate were observed under the inverted microscope. Pathologic examination by hematoxylin and eosin staining was done at the end of the experiment.
   Results. Migration of rapidly proliferating cells from the 3D scaffold and an inappropriate growth pattern were observed during the experiment. Cells and scaffold did not form a solid graft.
   Conclusions. The results obtained in this study indicated that alginate is not a good biomaterial for a durable implant.
C1 Nicholas Copernicus Univ, Coll Med, Chair Med Biol, Dept Tissue Engn, PL-85090 Bydgoszcz, Poland.
   Ctr Oncol, Dept Oncol & Brachytherapy, Bydgoszcz, Poland.
RP Drewa, T (reprint author), Nicholas Copernicus Univ, Coll Med, Chair Med Biol, Dept Tissue Engn, Karlowicza 24 Str, PL-85090 Bydgoszcz, Poland.
EM tomaszdrewa@wp.pl
RI Pokrywczynska, Marta/E-9323-2014
OI Pokrywczynska, Marta/0000-0003-3259-087X
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Bent AE, 2001, NEUROUROL URODYNAM, V20, P157, DOI 10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO;2-A
   Calafiore R, 2006, TRANSPLANT P, V38, P1156, DOI 10.1016/j.transproceed.2006.03.014
   Chertin B, 2002, J UROLOGY, V167, P1443, DOI 10.1016/S0022-5347(05)65340-2
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103
   Diamond DA, 1999, J UROLOGY, V162, P1185, DOI 10.1016/S0022-5347(01)68124-2
   Elliott RB, 2005, TRANSPL P, V37, P466, DOI 10.1016/j.transproceed.2004.12.198
   Fu SH, 2003, TRANSPLANT P, V35, P496, DOI 10.1016/S0041-1345(02)03902-7
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Kamishina H, 2006, J VET MED SCI, V68, P1239, DOI 10.1292/jvms.68.1239
   Lackgren G, 2001, J UROLOGY, V166, P1887, DOI 10.1016/S0022-5347(05)65713-8
   Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Stabler C, 2001, BIOMATERIALS, V22, P1301, DOI 10.1016/S0142-9612(00)00282-9
   WENG Y, 2006, TISSUE ENG, V6, P1503
   Zhang WJ, 2001, TRANSPLANT P, V33, P3517, DOI 10.1016/S0041-1345(01)02419-8
NR 20
TC 18
Z9 19
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
J9 TRANSPL P
JI Transplant. Proc.
PD JUN
PY 2008
VL 40
IS 5
BP 1664
EP 1667
DI 10.1016/j.transproceed.2008.03.135
PG 4
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 326YJ
UT WOS:000257695300090
PM 18589169
DA 2018-10-20
ER

PT J
AU Nagele, U
   Kuczyk, MA
   Horstmann, M
   Hennenlotter, J
   Sievert, KD
   Schilling, D
   Walcher, U
   Stenzl, A
   Anastasiadis, AG
AF Nagele, Udo
   Kuczyk, Markus A.
   Horstmann, Marcus
   Hennenlotter, Joerg
   Sievert, Karl-Dietrich
   Schilling, David
   Walcher, Ute
   Stenzl, Arnulf
   Anastasiadis, Aristotelis G.
TI Initial clinical experience with full-length metal ureteral stents for
   obstructive ureteral stenosis
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE ureteral obstruction; endourology; metal stent
ID BIOMATERIAL ENCRUSTATION; WALLSTENTS; MODEL
AB Objectives Long-term ureteral stenting is used to ensure urinary drainage if a reconstructive approach or a release of an extrinsic obstruction is not possible. In this contribution, a long-term experience with a new full-length, metal indwelling stent is presented.
   Methods Fourteen patients with ureteral obstruction received full metal indwelling stents in 18 collecting systems (benign disease in 5 and malignant disease in 13). Stent placement was performed cystoscopically under fluoroscopic guidance. Follow-up was done every 3 months with ultrasonographic examination, creatinine levels, and a visual analog pain score.
   Results Eight stents were removed, whereas eight are still in situ. One patient without stent-related problems died because of progressive rectal cancer 9 months after bilateral stent insertion. Mean stent duration (8 stents still in situ) is 8.6 months, whereas mean stent duration for benign and malignant disease is 11.8 (median 13) and 7.3 (median 6) months, respectively (p < 0.05). All removed stents were extracted endoscopically without any problems and had no incrustation except two. Neither migration nor mechanical damage was observed.
   Conclusion This novel stent is easy to insert and remove. It is an option for patients in which a surgical reconstruction of the obstructed ureter is not possible. Stents have been developed further and are now available in various lengths. This might result in a reduction of problems associated with inadequate stent length and should increase patient comfort and stent durability.
C1 [Nagele, Udo; Kuczyk, Markus A.; Horstmann, Marcus; Hennenlotter, Joerg; Sievert, Karl-Dietrich; Schilling, David; Walcher, Ute; Stenzl, Arnulf; Anastasiadis, Aristotelis G.] Univ Tubingen, Dept Urol, D-72076 Tubingen, Germany.
RP Nagele, U (reprint author), Univ Tubingen, Dept Urol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.
EM Udo.Nagele@med.uni-tuebingen.de
CR Barbalias GA, 2002, EUR UROL, V42, P276, DOI 10.1016/S0302-2838(02)00281-6
   Borin JF, 2006, J ENDOUROL, V20, P300, DOI 10.1089/end.2006.20.300
   Chung SY, 2004, J UROLOGY, V172, P592, DOI 10.1097/01.ju.0000130510.28768.f5
   DOCIMO SG, 1989, J UROLOGY, V142, P277, DOI 10.1016/S0022-5347(17)38729-3
   Hekimoglu B, 1996, EUR RADIOL, V6, P675
   JOSHI HB, 2001, EUR UROL, V39, P6
   Klarskov P, 2005, SCAND J UROL NEPHROL, V39, P169, DOI 10.1080/00365590510007720
   KU JH, 2004, UROLOGY, V64, P5
   Liatsikos EN, 2007, J UROLOGY, V178, P169, DOI 10.1016/j.juro.2007.03.061
   Lugmayr HF, 1996, RADIOLOGY, V198, P105, DOI 10.1148/radiology.198.1.8539359
   PAUER W, 1992, J UROLOGY, V148, P281, DOI 10.1016/S0022-5347(17)36573-4
   THIJSSEN AM, 1994, J UROLOGY, V151, P268, DOI 10.1016/S0022-5347(17)34930-3
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1996, BIOMATERIALS, V17, P1025, DOI 10.1016/0142-9612(96)84679-5
NR 14
TC 42
Z9 42
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-4983
J9 WORLD J UROL
JI World J. Urol.
PD JUN
PY 2008
VL 26
IS 3
BP 257
EP 262
DI 10.1007/s00345-008-0245-4
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 304EH
UT WOS:000256092300010
PM 18324407
DA 2018-10-20
ER

PT J
AU Bodnar, M
   Kjoniksen, AL
   Molnar, RM
   Hartmann, JF
   Daroczi, L
   Nystrom, B
   Borbely, J
AF Bodnar, MagdoIna
   Kjoniksen, Anna-Lena
   Molnar, Reka M.
   Hartmann, John F.
   Daroczi, Lajos
   Nystrom, Bo
   Borbely, Janos
TI Nanoparticles formed by complexation of poly-gamma-glutamic acid with
   lead ions
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE gamma-PGA; lead binding; nanoparticles; complexation
ID POLY(GAMMA-GLUTAMIC ACID); FLOCCULATING ACTIVITY; WASTE-WATER; CHEMICAL
   MODIFICATION; BACILLUS-SUBTILIS; AQUEOUS-SOLUTIONS; ULTRAFILTRATION;
   ASSOCIATION; SURFACTANT; SUSPENSION
AB The present investigation describes the preparation and characterization of novel biodegradable nanoparticles based on complexation of polygarnma-glutamic acid (gamma-PGA) with bivalent lead ion. The prepared nano-systems were stable in aqueous media at low pH, neutral and mild alkaline conditions. The particle size and the size of the complexes were identified by dynamic light scattering (DLS) and transmission electron microscopy (TEM) measurements. It was found that the size of the complexes depended on the pH and concentrations of gamma-PGA and lead ions. Particle sizes measured by TEM revealed that at low concentrations, nanosized particles were formed, however, at high concentrations of gamma-PGA and lead ions, the formation of large aggregates with a broad size distribution was promoted. The size of individual particles was in the range of 40-100 nm measured by TEM. The results from the DLS measurements showed that the low and high pH values in mixtures with high concentrations of gamma-PGA and Pb2+ ions favored the growth of large complexes. The gamma-PGA nanoparticles, composed of a biodegradable biomaterial with high flocculating and heavy metal binding activity, may be useful for various water treatment applications. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Bodnar, MagdoIna; Molnar, Reka M.; Borbely, Janos] Univ Debrecen, Dept Colloid & Environm Chem, H-4010 Debrecen, Hungary.
   [Kjoniksen, Anna-Lena; Nystrom, Bo] Univ Oslo, Dept Chem, N-0315 Oslo, Norway.
   [Hartmann, John F.] ElizaNor Polymer LLC, Princeton Jct, NJ 08550 USA.
   [Daroczi, Lajos] Univ Debrecen, H-4010 Debrecen, Hungary.
   [Borbely, Janos] BBS Nanotechnol Ltd, H-4225 Debrecen 16, Hungary.
RP Borbely, J (reprint author), Univ Debrecen, Dept Colloid & Environm Chem, H-4010 Debrecen, Hungary.
EM jborbely@delfin.unideb.hu
RI Kjoniksen, Anna-Lena/B-9603-2011
OI Kjoniksen, Anna-Lena/0000-0003-4864-4043
CR BORBELY M, 1994, POLYM BULL, V32, P127, DOI 10.1007/BF00306378
   DEARFIELD KL, 1988, MUTAT RES, V195, P45, DOI 10.1016/0165-1110(88)90015-2
   Denizli A, 2005, MAT SCI ENG C-BIO S, V25, P448, DOI 10.1016/j.msec.2004.12.001
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   Kjoniksen AL, 1998, LANGMUIR, V14, P5039, DOI 10.1021/la980391j
   Krecz A, 2001, FOLIA MICROBIOL, V46, P183, DOI 10.1007/BF02818530
   Lauten RA, 2003, COLLOID SURFACE A, V219, P45, DOI 10.1016/S0927-7757(03)00030-X
   Lin WC, 2006, COLLOID SURFACE B, V47, P43, DOI 10.1016/j.colsurfb.2005.11.013
   Llorens J, 2004, J MEMBRANE SCI, V239, P173, DOI 10.1016/j.memsci.2004.02.034
   Maleki A, 2005, J PHYS CHEM B, V109, P12329, DOI 10.1021/jp0514271
   Mark SS, 2006, BIOTECHNOL PROGR, V22, P523, DOI 10.1021/bp060040s
   Molinari R, 2004, WATER RES, V38, P593, DOI 10.1016/j.watres.2003.10.024
   Qi LF, 2004, COLLOID SURFACE A, V251, P183, DOI 10.1016/j.colsurfa.2004.10.010
   Ramelow US, 1996, J HAZARD MATER, V46, P37, DOI 10.1016/0304-3894(95)00104-2
   Rattanakawin C, 2001, COLLOID SURFACE A, V177, P87, DOI 10.1016/S0927-7757(00)00662-2
   Rivas BL, 2003, PROG POLYM SCI, V28, P173, DOI 10.1016/S0079-6700(02)00028-X
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   Shih IL, 2001, BIORESOURCE TECHNOL, V78, P267, DOI 10.1016/S0960-8524(01)00027-X
   Solpan D, 2005, COLLOID SURFACE A, V268, P12, DOI 10.1016/j.colsurfa.2005.04.035
   Taniguchi M, 2005, J BIOSCI BIOENG, V100, P207, DOI 10.1263/jbb.100.207
   Taniguchi M, 2005, J BIOSCI BIOENG, V99, P245, DOI 10.1263/jbb.99.245
   Taniguchi M, 2005, J BIOSCI BIOENG, V99, P130, DOI 10.1263/jbb.99.130
   Xu H, 2005, PROCESS BIOCHEM, V40, P519, DOI 10.1016/j.procbio.2003.09.025
   Yang WY, 2004, J COLLOID INTERF SCI, V273, P400, DOI 10.1016/j.jcis.2004.02.002
   Yokoi H, 1996, J FERMENT BIOENG, V82, P84, DOI 10.1016/0922-338X(96)89461-X
NR 25
TC 17
Z9 19
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD MAY 30
PY 2008
VL 153
IS 3
BP 1185
EP 1192
DI 10.1016/j.jhazmat.2007.09.080
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 296LG
UT WOS:000255544300037
PM 17997032
DA 2018-10-20
ER

PT J
AU Salvay, DM
   Rives, CB
   Zhang, XM
   Chen, F
   Kaufman, DB
   Lowe, WL
   Shea, LD
AF Salvay, David M.
   Rives, Christopher B.
   Zhang, Xiaomin
   Chen, Fei
   Kaufman, Dixon B.
   Lowe, William L., Jr.
   Shea, Lonnie D.
TI Extracellular matrix protein-coated scaffolds promote the reversal of
   diabetes after extrahepatic islet transplantation
SO TRANSPLANTATION
LA English
DT Article
DE islet transplantation; biomaterial; diabetes; PLG; scaffold;
   microenvironment
ID HUMAN PANCREATIC-ISLETS; CELL-MATRIX; BETA-CELLS; INSULIN; APOPTOSIS;
   SECRETION; MELLITUS; TERM; REVASCULARIZATION; MICROENVIRONMENTS
AB Background. The survival and function of transplanted pancreatic islets is limited, owing in part to disruption of islet-matrix attachments during the isolation procedure. Using polymer scaffolds as a platform for islet transplantation, we investigated the hypothesis that replacement of key extracellular matrix components known to surround islets in vivo would improve graft function at an extrahepatic implantation site.
   Methods. Microporous polymer scaffolds fabricated from copolymers of lactide and glycolide were adsorbed with collagen IV, fibronectin, laminin-332 or serum proteins before seeding with 125 mouse islets. Islet-seeded scaffolds were then implanted onto the epididymal fat pad of syngeneic mice with streptozotocin-induced diabetes. Nonfasting glucose levels, weight gain, response to glucose challenges, and histology were used to assess graft function for 10 months after transplantation.
   Results. Mice transplanted with islets seeded onto scaffolds adsorbed with collagen IV achieved euglycemia fastest and their response to glucose challenge was similar to normal mice. Fibronectin and laminin similarly promoted euglycemia, yet required more time than collagen IV and less time than serum. Histopathological assessment of retrieved grafts demonstrated that coating scaffolds with specific extracellular matrix proteins increased total islet area in the sections and vessel density within the transplanted islets, relative to controls.
   Conclusions. Extracellular matrix proteins adsorbed to microporous scaffolds can enhance the function of transplanted islets, with collagen IV maximizing graft function relative to the other proteins tested. These scaffolds enable the creation of well-defined microenvironments that promote graft efficacy at extrahepatic sites.
C1 [Salvay, David M.; Rives, Christopher B.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Zhang, Xiaomin; Kaufman, Dixon B.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Transplant Surg, Chicago, IL 60611 USA.
   [Chen, Fei; Lowe, William L., Jr.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,Tech E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIBIB NIH HHS [F31 EB 007118, R01 EB003806, F31 EB007118, R01
   EB003806-04, F31 EB007118-02, R01 EB 003806]; NIDDK NIH HHS [R01 DK
   52919, R21 DK 067833, R21 DK062641, R01 DK 063439, R21 DK067833, R21
   DK063439, R01 DK 062641]
CR Baker SE, 1996, EXP CELL RES, V228, P262, DOI 10.1006/excr.1996.0325
   Balamurugan AN, 2006, PANCREAS, V32, P231, DOI 10.1097/01.mpa.0000203961.16630.2f
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233
   Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103
   Chen XJ, 2007, TRANSPLANTATION, V84, P122, DOI 10.1097/01.tp.0000266909.58117.e3
   Cheung BWY, 2005, FUND CLIN PHARMACOL, V19, P347, DOI 10.1111/j.1472-8206.2005.00329.x
   Dufrane D, 2006, TRANSPLANTATION, V81, P36, DOI 10.1097/01.tp.0000189712.74495.82
   Eiselein L, 2004, ILAR J, V45, P231, DOI 10.1093/ilar.45.3.231
   EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360
   Hamalainen Anu-Maaria, 2002, Curr Diab Rep, V2, P347, DOI 10.1007/s11892-002-0025-2
   Hamamoto Y, 2003, HORM METAB RES, V35, P460
   Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034
   HAYEK A, 1989, IN VITRO CELL DEV B, V25, P146
   Hering BJ, 2005, TRANSPLANTATION, V79, P1296, DOI 10.1097/01.TP.0000157321.55375.86
   Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830
   Ihm SH, 2006, DIABETES, V55, P1361, DOI 10.2337/005-1333
   Jang JH, 2006, J BIOMED MATER RES A, V77A, P50, DOI 10.1002/jbm.a.30643
   Jiang FX, 2002, MOL MED, V8, P763, DOI 10.1007/BF03402081
   Jiang FX, 2002, J HISTOCHEM CYTOCHEM, V50, P1625, DOI 10.1177/002215540205001206
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200
   Kaido T, 2006, DIABETES, V55, P2723, DOI 10.2337/db06-0120
   Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65
   LUCASCLERC C, 1993, MOL CELL ENDOCRINOL, V94, P9, DOI 10.1016/0303-7207(93)90046-M
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mattsson G, 2003, TRANSPLANTATION, V75, P736, DOI 10.1097/01.TP.0000052592.92966.FE
   Mohsin F, 2005, DIABETES CARE, V28, P1974, DOI 10.2337/diacare.28.8.1974
   Nathan D M, 1992, Drugs, V44 Suppl 3, P39
   NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306
   Olsson R, 2006, TRANSPLANTATION, V82, P340, DOI 10.1097/01.tp.0000229418.60236.87
   Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
   Thomas F, 2001, SURGERY, V130, P333, DOI 10.1067/msy.2001.116413
   Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1016/S0039-6060(99)70169-8
   Tian B, 2005, J CANCER RES CLIN, V131, P80, DOI 10.1007/s00432-004-0614-3
   Wilson DB, 2005, NATURE, V438, pE5, DOI 10.1038/nature04423
   Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63
NR 41
TC 82
Z9 83
U1 0
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD MAY 27
PY 2008
VL 85
IS 10
BP 1456
EP 1464
DI 10.1097/TP.0b013e31816fc0ea
PG 9
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 305LS
UT WOS:000256180500017
PM 18497687
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Adamov, GE
   Devyatkov, AG
   Gnatyuk, LN
   Goldobin, IS
   Grebennikov, EP
AF Adamov, G. E.
   Devyatkov, A. G.
   Gnatyuk, L. N.
   Goldobin, I. S.
   Grebennikov, E. P.
TI Bacteriorhodopsin - Perspective biomaterial for molecular nanophotonics
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY
LA English
DT Article; Proceedings Paper
CT International Symposium on Molecular Photonics
CY JUN 28-JUL 02, 2006
CL St Petersburg, RUSSIA
DE molecular nanophotonics; bacteriorhodopsin; neural networks; multilayer
   structures
ID RECEPTIVE-FIELDS
AB Results of investigation of photochromic protein bacteriorhodopsin (BR) extracted from cellular membranes of Halobacterium salinarum are represented. Basic processes and original approaches of neural networks realization based on bacteriorhodopsin in composition of multilayer structures. Requirements of BR-containing functional films are determined and results of investigation of layers modifications are represented for the purpose of stabilization of extremely high photochromic sensitivity of BR-containing media. The modification of BR-films using bifunctional crosslinking reagents to increase of technological parameters of BR is applied. The influence of 1,4-diaminobenzene, glutaric dialdehyde and lysine on photochromic proper-ties of the bacteriorhodopsin films is investigated. Shown that addition of bifunctional crosslinking reagents increase technological parameters of materials based on bacteriorhodopsin. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Adamov, G. E.; Devyatkov, A. G.; Gnatyuk, L. N.; Goldobin, I. S.; Grebennikov, E. P.] OJSC CSRIT Technomash, Moscow 121108, Russia.
RP Adamov, GE (reprint author), OJSC CSRIT Technomash, Ivan Franko Str 4, Moscow 121108, Russia.
EM ntc_technology@socket.ru
CR ALEXEEV AS, 1992, IOFAN P, V38, P133
   Birge RR, 1999, J PHYS CHEM B, V103, P10746, DOI 10.1021/jp991883n
   CHINAROV V, 1995, 5 INT S BIOEL MOL EL, P243
   DMITRIEV AS, 1993, RADIO ENG ELECT, V38, P18
   GREBENNIKOV EP, 2000, P 2 C MOL PHYS NON S, P235
   GREBENNIKOV EP, 1997, P SOC PHOTO-OPT INS, V3402, P460
   GROSS RB, 1992, P SOC PHOTO-OPT INS, V1662, P186, DOI 10.1117/12.58502
   HARONIAN D, 1991, APPL OPTICS, V30, P597, DOI 10.1364/AO.30.000597
   HWANG SB, 1978, BIOCHIM BIOPHYS ACTA, V509, P300, DOI 10.1016/0005-2736(78)90049-4
   KORCHEMSKAYA EY, 1990, QUANTUM ELECTRON+, V17, P448
   KOYAMA K, 1994, SCIENCE, V265, P762, DOI 10.1126/science.265.5173.762
   MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020
   MIYASAKA T, 1992, SCIENCE, V255, P342, DOI 10.1126/science.255.5042.342
   OESTERHELT D, 1991, Q REV BIOPHYS, V24, P425, DOI 10.1017/S0033583500003863
   PRIGOZHIN I, 1985, EXISTENT INCIPIENT T
   RODIECK RW, 1965, J NEUROPHYSIOL, V28, P833, DOI 10.1152/jn.1965.28.5.833
   SHELTON DP, 1977, OPT LETT, V22, P1728
   SIEBERT F, 1982, FEBS LETT, V141, P82, DOI 10.1016/0014-5793(82)80021-5
   TAKEI H, 1991, APPL OPTICS, V30, P500, DOI 10.1364/AO.30.000500
   VSEVOLODOV NN, 1988, PHOTOMATERIAL BASED, P224
   Wasserman F., 1992, NEUROCOMPUTER TECHNI, P240
   Zeisel D., 1992, J PHYS CHEM-US, V96, P7787
NR 22
TC 5
Z9 5
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1010-6030
J9 J PHOTOCH PHOTOBIO A
JI J. Photochem. Photobiol. A-Chem.
PD MAY 20
PY 2008
VL 196
IS 2-3
BP 254
EP 261
DI 10.1016/j.jphotochem.2007.07.027
PG 8
WC Chemistry, Physical
SC Chemistry
GA 302ZM
UT WOS:000256008700020
DA 2018-10-20
ER

PT J
AU Arami, M
   Limaee, NY
   Mahmoodi, NM
AF Arami, Mokhtar
   Limaee, Nargess Yousefi
   Mahmoodi, Niyaz Mohammad
TI Evaluation of the adsorption kinetics and equilibrium for the potential
   removal of acid dyes using a biosorbent
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE biosorbent; acid dye; ESM; isotherms; kinetics; dye removal
ID LOW-COST ADSORBENTS; ACTIVATED CARBON; AQUEOUS-SOLUTIONS; PHOTOCATALYTIC
   DEGRADATION; IMMOBILIZED NANOPARTICLES; FUNDAMENTAL PROPERTIES;
   TITANIUM-DIOXIDE; REACTIVE DYES; ORANGE PEEL; CONGO RED
AB The adsorption of Acid Red 14 (AR14) and Acid Blue 92 (AB92) onto the microporous and mesoporous egg shell membrane (ESM) was investigated in aqueous solution in a batch system with respect to initial dye concentration, pH, contact time, particle size and biosorbent doses at 20 +/- 1 degrees C. The surface area, Fourier transform infrared (FTIR) and scanning electron microscopy (SEM) of ESM were obtained. The surface area of ESM was found to be 2.2098 m(2)/g. The pseudo-first-order, pseudo-second-order kinetics and the intraparticle diffusion models were used to describe the kinetics data. The rate constants at different pH values (2-12) were evaluated. The experimental data fitted well to the pseudo-second-order kinetics model at pH values of 2-8 and pseudo-first-order kinetics model at pH values of 10 and 12 for both dyes. Equilibrium isotherms were analyzed by Langmuir, Freundlich and Redlich-Peterson adsorption models. Maximum desorption of >= 89.6% was achieved for AR14 and 82.8% for AB92 in aqueous solution at pH 12. The results indicate that ESM could be fruitfully employed as effective biomaterial for the removal of residual color from effluents. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Arami, Mokhtar] Amir Kabir Univ Technol, Dept Text Engn, Tehran, Iran.
   [Arami, Mokhtar; Limaee, Nargess Yousefi; Mahmoodi, Niyaz Mohammad] Inst Colorants Paint & Coatings, Dept Organ Colorants, Tehran, Iran.
RP Arami, M (reprint author), Amir Kabir Univ Technol, Dept Text Engn, Tehran, Iran.
EM mokhtar-arami@yahoo.com; nm_-mahmoodi@yahoo.com
OI Mahmoodi, Niyaz Mohammad/0000-0002-3349-3732
CR Akbari A, 2002, CHEM ENG PROCESS, V41, P601, DOI 10.1016/S0255-2701(01)00181-7
   Allen SJ, 2004, J COLLOID INTERF SCI, V280, P322, DOI 10.1016/j.jcis.2004.08.078
   ALLEN SJ, 2000, P 2 PAC BAS C ADS SC, P46
   ALLEY ER, 2000, WATER QUALITY CONTRO, P125
   Annadurai G, 2002, ADV ENVIRON RES, V6, P191, DOI 10.1016/S1093-0191(01)00050-8
   Annadurai G, 2002, J HAZARD MATER, V92, P263, DOI 10.1016/S0304-3894(02)00017-1
   Arami M, 2005, J COLLOID INTERF SCI, V288, P371, DOI 10.1016/j.jcis.2005.03.020
   Arami M, 2006, J HAZARD MATER, V135, P171, DOI 10.1016/j.jhazmat.2005.11.044
   Benefield LD, 1982, PROCESS CHEM WATER W, P191
   Chakraborty S, 2005, DESALINATION, V174, P73, DOI 10.1016/j.desal.2004.08.040
   Chen BN, 2001, CHEM ENG J, V84, P77, DOI 10.1016/S1385-8947(01)00193-0
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   El-Geundi MS, 1997, ADSORPT SCI TECHNOL, V15, P777, DOI 10.1177/026361749701501004
   Fernandes A, 2004, DYES PIGMENTS, V61, P287, DOI 10.1016/j.jdyepig.2003.11.008
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   He J, 2002, APPL CATAL B-ENVIRON, V39, P211, DOI 10.1016/S0926-3373(02)00085-1
   Ho YS, 1998, CHEM ENG J, V70, P115, DOI 10.1016/S0923-0467(98)00076-1
   Ho YS, 2004, SCIENTOMETRICS, V59, P171
   Ho YS, 2002, PROCESS BIOCHEM, V37, P1421, DOI 10.1016/S0032-9592(02)00036-5
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Ho YS, 2001, ADSORPTION, V7, P139, DOI 10.1023/A:1011652224816
   HO YS, 1995, THESIS U BIRMINGHAM
   Hoda N, 2006, J HAZARD MATER, V137, P344, DOI 10.1016/j.jhazmat.2006.02.009
   Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0
   Kim MS, 2006, INT J ENVIRON POLLUT, V27, P247, DOI 10.1504/IJEP.2006.010467
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Langmuir I, 1917, J AM CHEM SOC, V39, P1848, DOI 10.1021/ja02254a006
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Mahmoodi NM, 2007, J HAZARD MATER, V145, P65, DOI 10.1016/j.jhazmat.2006.10.089
   Mahmoodi NM, 2007, J PHOTOCH PHOTOBIO A, V189, P1, DOI 10.1016/j.jphotochem.2006.12.025
   Mahmoodi NM, 2007, MATER RES BULL, V42, P797, DOI 10.1016/j.materresbull.2006.08.031
   Mahmoodi NM, 2006, J PHOTOCH PHOTOBIO A, V182, P60, DOI 10.1016/j.jphotochem.2006.01.014
   Mahmoodi NM, 2006, COLLOID SURFACE A, V290, P125, DOI 10.1016/j.colsurfa.2006.05.012
   Mahmoodi NM, 2006, J HAZARD MATER, V133, P113, DOI 10.1016/j.jhazmat.2005.09.057
   Mahmoodi NM, 2006, J COLLOID INTERF SCI, V295, P159, DOI 10.1016/j.jcis.2005.08.007
   Mahmoodi NM, 2005, CHEM ENG J, V112, P191, DOI 10.1016/j.cej.2005.07.008
   Mall ID, 2005, CHEMOSPHERE, V61, P492, DOI 10.1016/j.chemosphere.2005.03.065
   Meshko V, 2001, WATER RES, V35, P3357, DOI 10.1016/S0043-1354(01)00056-2
   Morais LC, 1999, WATER RES, V33, P979, DOI 10.1016/S0043-1354(98)00294-2
   Namasivayam C, 2002, DYES PIGMENTS, V54, P47, DOI 10.1016/S0143-7208(02)00025-6
   Ozcan A, 2005, J HAZARD MATER, V125, P252, DOI 10.1016/j.jhazmat.2005.05.039
   Park SC, 2006, EUR PHYS J B, V50, P327, DOI 10.1140/epjb/e2006-00126-9
   Pavia D. L., 1987, INTRO SPECTROSCOPY G
   Ravikumar K, 2007, DYES PIGMENTS, V72, P66, DOI 10.1016/j.dyepig.2005.07.018
   REDLICH O, 1959, J PHYS CHEM-US, V63, P1024, DOI 10.1021/j150576a611
   Sanghi R, 2002, COLOR TECHNOL, V118, P256
   Senthilkumaar S, 2006, BIORESOURCE TECHNOL, V97, P1618, DOI 10.1016/j.biortech.2005.08.001
   Sivaraj R, 2001, WASTE MANAGE, V21, P105, DOI 10.1016/S0956-053X(00)00076-3
   Wang SB, 2005, WATER RES, V39, P129, DOI 10.1016/j.watres.2004.09.011
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Woodard F, 2001, IND WASTE TREATMENT, P376
   Yuzhu F., 2002, ADV ENVIRON RES, V7, P239
NR 54
TC 95
Z9 109
U1 1
U2 19
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
J9 CHEM ENG J
JI Chem. Eng. J.
PD MAY 15
PY 2008
VL 139
IS 1
BP 2
EP 10
DI 10.1016/j.cej.2007.07.060
PG 9
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 302WZ
UT WOS:000256002000002
DA 2018-10-20
ER

PT J
AU Sarkar, D
   Yang, JC
   Lopina, ST
AF Sarkar, Debanjan
   Yang, Jui-Chen
   Lopina, Stephanie T.
TI Structure-property relationship of L-tyrosine-based polyurethanes for
   biomaterial applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polyurethane; L-tyrosine; FTIR; hydrolytic degradation; morphology
ID CHAIN EXTENDER; ELASTOMERS; COPOLYMERS; RELEASE; DESIGN
AB The structure-property relationship of L-tyrosine-based polyurethanes was demonstrated by using different polyols and diisocyanates. L-tyrosine-based chain extender, desaminotyrosyl tyrosine hexyl ester (DTH), was used, to synthesize a series of polyurethanes. Polyethylene glycol (PEG) or poly caprolactone diol (PCL) was used as the soft segment and hexamethylene diisocyanate (HDI) or dicyclohexylmethane 4,4'-diisocyanate (HMDI) was used with DTH as the hard segment. The polyurethanes were characterized to investigate the effect of structure on different polyurethane properties. From FTIR and DSC, these polyurethanes exhibit a wide range of morphology from phase-mixed to phase-separated structure. The decreasing molecular weight of the PEG soft segment leads to relatively more phase mixed morphology whereas for PCL-based polyurethanes the extent of phase mixing is less with decreasing PCL molecular weight. Results show that PCL-based polyurethanes are mechanically stronger than PEG-based polyurethanes but PCL-based polyurethanes degrade slower and absorb less water compared with PEG-based polyurethanes. The HMDI-based polyurethanes are less crystalline and comparatively more hydrophobic than HDI-based polyurethartes. The characterization results show that the polyurethane properties are directly related to the structure and can be varied easily for a different set of properties that are pertinent for biomaterial applications. (C) 2008 Wiley Periodicals, Inc.
C1 [Sarkar, Debanjan; Yang, Jui-Chen; Lopina, Stephanie T.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
RP Lopina, ST (reprint author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
EM lopina@uakron.edu
RI Sarkar, Debanjan/C-6093-2017
OI Sarkar, Debanjan/0000-0002-6666-3152
CR Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Hepburn C., 1993, POLYURETHANE ELASTOM
   HESKETH TR, 1980, POLYM ENG SCI, V20, P190, DOI 10.1002/pen.760200304
   Iskakov R, 2000, J APPL POLYM SCI, V75, P35, DOI 10.1002/(SICI)1097-4628(20000103)75:1<35::AID-APP5>3.0.CO;2-2
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LI F, 2000, J APPL POLYM SCI, V75, P1522
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Liaw DJ, 1997, J APPL POLYM SCI, V66, P1251, DOI 10.1002/(SICI)1097-4628(19971114)66:7<1251::AID-APP5>3.0.CO;2-F
   Mallapragada SK, 1997, J BIOMED MATER RES, V36, P125, DOI 10.1002/(SICI)1097-4636(199707)36:1<125::AID-JBM15>3.0.CO;2-H
   Petrovic Z., 1991, J PROG POLYM SCI, V16, P695
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   Rao C. N. R., 1963, CHEM APPL INFRARED S
   SARKAR D, IN PRESS J BIOMED MA
   Sen Gupta A, 2004, POLYMER, V45, P4653, DOI 10.1016/j.polymer.2004.04.052
   Shen E, 2001, BIOMATERIALS, V22, P201, DOI 10.1016/S0142-9612(00)00175-7
   SIEGMANN A, 1987, POLYM ENG SCI, V27, P1187, DOI 10.1002/pen.760271512
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   SPECKHARD TA, 1986, RUBBER CHEM TECHNOL, V59, P405, DOI 10.5254/1.3538208
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Yeganeh H, 2007, POLYM INT, V56, P41, DOI 10.1002/pi.2107
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
NR 27
TC 31
Z9 35
U1 1
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAY 15
PY 2008
VL 108
IS 4
BP 2345
EP 2355
DI 10.1002/app.27637
PG 11
WC Polymer Science
SC Polymer Science
GA 283YQ
UT WOS:000254672800038
DA 2018-10-20
ER

PT J
AU Ban, L
   Chai, XS
   Guo, JQ
   Ban, WP
   Lucia, LA
AF Ban, Lan
   Chai, Xinsheng
   Guo, Jiqiang
   Ban, Weiping
   Lucia, Lucian A.
TI Chemical response of hardwood oligosaccharides as a statistical function
   of isolation protocol
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE hardwoods; hemicelluloses; extraction; pH; temperature
ID XYLAN; EXTRACTION; LIGNOCELLULOSE; HYDROLYSIS
AB Hardwoods contain a substantial amount of hemicellulose-type oligosaccharides, the chemical structures of which are typically categorized in the xylan saccharide class. The efficient and selective isolation of these hemicelluloses is regarded as one of the most critical obstacles to overcome for their eventual biomaterial and bioenergy utilization. Therefore, the objective of the current work was to perform a fundamental exploration of the function of extraction pH, temperature, and time on the final chemical properties of the extracted hemicelluloses. The extraction chemistries employed varied pH and showed that acidic conditions provided a higher extractive yield versus alkaline conditions. An alkaline environment gave higher yields than an acidic environment and also resulted in much higher lignin removal from wood, especially at high temperature. In general, control of the pH chemistry leads to a change in the carboxylic acid groups present in the extracts. When the extraction pH changed from acidic to alkaline, the total carboxylic acid group content in the hemicelluloses removed significantly increased due to more acetic acid group hydrolysis and increased lignin degradation.
C1 [Lucia, Lucian A.] N Carolina State Univ, Dept Wood & Paper Sci, Raleigh, NC 27695 USA.
   [Ban, Lan; Chai, Xinsheng] Georgia Inst Technol, Inst Paper Sci & Technol, Atlanta, GA 03320 USA.
   [Guo, Jiqiang; Ban, Weiping] Dalian Polytech Univ, Dalian 116034, Peoples R China.
RP Lucia, LA (reprint author), N Carolina State Univ, Dept Wood & Paper Sci, Campus Box 8005, Raleigh, NC 27695 USA.
EM lucian.lucia@ncsu.edu
CR Azuma J., 1986, WOOD RES, V72, P1
   BENNANI A, 1991, BIOMASS BIOENERG, V1, P289, DOI 10.1016/0961-9534(91)90041-A
   BIERMANN CJ, 1984, J WOOD CHEM TECHNOL, V4, P111, DOI 10.1080/02773818408062286
   BUCHERT J, 1995, TAPPI J, V78, P125
   Chai XS, 2005, IND ENG CHEM RES, V44, P10013, DOI 10.1021/ie050921o
   Chai XS, 2003, J PULP PAP SCI, V29, P204
   DAVID N, 2001, WOOD CELLULOSIC CHEM
   Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542
   Fang JM, 2000, CELLULOSE, V7, P87, DOI 10.1023/A:1009245100275
   Hromadkova Z, 2005, CHEM PAP-CHEM ZVESTI, V59, P223
   Hromadkova Z, 1999, IND CROP PROD, V9, P101, DOI 10.1016/S0926-6690(98)00020-X
   JUNEL L, 1999, THESIS LUTKDH LUND U
   JUSLIN M, 1984, PHARM PHARM, V36, P256
   LAMPTEY J, 1985, BIOTECHNOL LETT, V7, P531, DOI 10.1007/BF01199874
   Lindstrom T, 1992, NORD PULP PAP RES J, V7, P181
   MAGARA K, 1988, MOKUZAI GAKKAISHI, V34, P462
   OKAMOTO Y, 1984, J AM CHEM SOC, V106, P5357, DOI 10.1021/ja00330a057
   PASZNER L, 1993, ENERGY BIOMASS WASTE, V16, P629
   Prade RA, 1996, BIOTECHNOL GENET ENG, V13, P101, DOI 10.1080/02648725.1996.10647925
   PULS J, 1993, 2 TRICEL93 S TRICH R, V8, P51
   Schultz T., 1984, ENERGY BIOMASS WASTE, V8, P1171
   Sjostrom E, 1989, NORD PULP PAP RES J, V4, P90, DOI DOI 10.3183/NPPRJ-1989-04-02-P090-093
   Tenkanen M, 1999, J PULP PAP SCI, V25, P306
   VAZQUEZ MJ, 2001, TRENDS FOOD SCI TECH, V11, P387
NR 24
TC 6
Z9 6
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAY 14
PY 2008
VL 56
IS 9
BP 2953
EP 2959
DI 10.1021/jf0727037
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 297ZJ
UT WOS:000255655600014
PM 18407651
DA 2018-10-20
ER

PT J
AU Berglin, M
   Olsson, A
   Elwing, H
AF Berglin, Mattias
   Olsson, Adam
   Elwing, Hans
TI The interaction between model biomaterial coatings and nylon
   microparticles as measured with a quartz crystal microbalance with
   dissipation monitoring
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE adhesion; biomaterials; cell attachment; quartz crystal microbalance
   (QCM)
ID IMMUNE COMPLEMENT ACTIVATION; SURFACE-PLASMON RESONANCE; PROTEIN
   ADSORPTION; CELL-ADHESION; CROSS-LINKING; MULTILAYER FILMS; COUPLED
   WATER; BLOOD-PLASMA; QCM-D; QUANTIFICATION
AB The interaction between cells and biomaterials has been mimicked using nylon microparticles as pseudo-cells and PLMA and PIBMA as biomaterial model acrylate polymers. The shift of fundamental resonance frequencies was negative for both polymers, indicating mass-coupling to the sensor surface. The shifts of the 3(rd), 5(th) and 7(th) overtone frequencies were initially positive for both polymers, indicating a particle slip or wobbling on the surface. The OCM technique could discriminate between the two different polymers, showing increased interaction between microparticle and PLMA. The dissipation shift was positive for all overtones on both polymers, but again with faster and more prominent response for PLMA.
C1 [Berglin, Mattias; Olsson, Adam; Elwing, Hans] Univ Gothenburg, Dept Cell & Mol Biol, SE-40530 Gothenburg, Sweden.
RP Berglin, M (reprint author), Univ Gothenburg, Dept Cell & Mol Biol, SE-40530 Gothenburg, Sweden.
EM mattias.berglin@cmb.gu.se
CR Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   Andersson M, 2002, J BIOMAT SCI-POLYM E, V13, P907, DOI 10.1163/156856202320401951
   Berglin M, 2005, J ADHESION, V81, P805, DOI 10.1080/00218460500189059
   Berglin M, 2004, BIOMACROMOLECULES, V5, P2376, DOI 10.1021/bm0496864
   Berglin M, 2004, BIOMATERIALS, V25, P4581, DOI 10.1016/j.biomaterials.2003.11.050
   Bowen WR, 1999, J MEMBRANE SCI, V154, P205
   Cans AS, 2001, ANAL CHEM, V73, P5805, DOI 10.1021/ac010777q
   de Kerchove AJ, 2007, BIOMACROMOLECULES, V8, P113, DOI 10.1021/bm060670i
   Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Graneli A, 2004, CHEMPHYSCHEM, V5, P729, DOI 10.1002/cphc.200301061
   Holland NB, 1999, J BIOMED MATER RES, V45, P167, DOI 10.1002/(SICI)1097-4636(19990605)45:3<167::AID-JBM2>3.0.CO;2-7
   Hong S, 2006, BIOMATERIALS, V27, P5813, DOI 10.1016/j.biomaterials.2006.07.031
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 2002, ENCY SURFACE COLLOID, P774
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Li J, 2005, BIOSENS BIOELECTRON, V20, P1333, DOI 10.1016/j.bios.2004.05.004
   Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006
   Olofsson AC, 2005, APPL ENVIRON MICROB, V71, P2705, DOI 10.1128/AEM.71.5.2705-2712.2005
   Reimhult E, 2004, ANAL CHEM, V76, P7211, DOI 10.1021/ac0492970
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Schakenraad J M, 1996, BIOMATERIALS SCI
   Sellborn A, 2005, MOL IMMUNOL, V42, P569, DOI 10.1016/j.molimm.2004.09.015
   Sellborn A, 2003, COLLOID SURFACE B, V27, P295, DOI 10.1016/S0927-7765(02)00066-8
   Shah AK, 1999, BONE, V24, P499, DOI 10.1016/S8756-3282(99)00077-0
   Welle A, 2004, J BIOMAT SCI-POLYM E, V15, P357, DOI 10.1163/156856204322977238
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
NR 31
TC 21
Z9 21
U1 1
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY 13
PY 2008
VL 8
IS 5
BP 410
EP 416
DI 10.1002/mabi.200700218
PG 7
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 311WZ
UT WOS:000256632400005
PM 18167626
DA 2018-10-20
ER

PT J
AU Ketteler, G
   Ashby, P
   Mun, BS
   Ratera, I
   Bluhm, H
   Kasemo, B
   Salmeron, M
AF Ketteler, G.
   Ashby, P.
   Mun, B. S.
   Ratera, I.
   Bluhm, H.
   Kasemo, B.
   Salmeron, M.
TI In situ photoelectron spectroscopy study of water adsorption on model
   biomaterial surfaces
SO JOURNAL OF PHYSICS-CONDENSED MATTER
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; RAY-INDUCED DAMAGE; ALKANETHIOLATE
   MONOLAYERS; ORGANIC-SURFACES; PHOTOEMISSION; MEMBRANE; GOLD;
   IRRADIATION; ELECTRON; POLYMER
AB Using in situ photoelectron spectroscopy at near ambient conditions, we compare the interaction of water with four different model biomaterial surfaces: self-assembled thiol monolayers on Au(111) that are functionalized with methyl, hydroxyl, and carboxyl groups, and phosphatidylcholine (POPC) lipid films on silicon. We show that the interaction of water with biomaterial surfaces is mediated by polar functional groups that interact strongly with water molecules through hydrogen bonding, resulting in adsorption of 0.2-0.3 ML water on the polar thiol films in 700 mTorr water pressure and resulting in characteristic N 1s and P 2p shifts for the POPC films. Provided that beam damage is carefully controlled, in situ electron spectroscopy can give valuable information about water adsorption which is not accessible under ultrahigh vacuum conditions.
C1 [Ketteler, G.; Kasemo, B.] Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden.
   [Mun, B. S.] Lawrence Berkeley Natl Labs, Adv Light Source, Berkeley, CA 94720 USA.
   [Mun, B. S.] Hanyang Univ, Dept Appl Phys, Ansan 426791, Kyunggi Do, South Korea.
   [Ratera, I.; Salmeron, M.] Lawrence Berkeley Natl Labs, Div Mat Sci, Berkeley, CA 94720 USA.
   [Bluhm, H.] Lawrence Berkeley Natl Labs, Div Chem Sci, Berkeley, CA 94720 USA.
RP Ketteler, G (reprint author), Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden.
RI Ratera, Imma/E-2353-2014; Mun, Bongjin/G-1701-2013
OI Ratera, Imma/0000-0002-1464-9789; 
CR BAIN CD, 1989, ANGEW CHEM INT EDIT, V28, P506, DOI 10.1002/anie.198905061
   Bluhm H, 2006, J ELECTRON SPECTROSC, V150, P86, DOI 10.1016/j.elspec.2005.07.005
   DUWEZ AS, 2004, J ELECT SPECTROSC RE, V97, P134
   GRAHAM RL, 1993, J PHYS CHEM-US, V97, P9456, DOI 10.1021/j100139a033
   He Q, 2006, J NANOSCI NANOTECHNO, V6, P1838, DOI 10.1166/jnn.2006.208
   Heister K, 2003, SURF SCI, V529, P36, DOI 10.1016/S0039-6028(03)00299-1
   Heister K, 2001, LANGMUIR, V17, P8, DOI 10.1021/la001101d
   ISRAELICHVILI J, 1992, NATURE, V379, P219
   Lorusso GF, 1997, J PHYS D APPL PHYS, V30, P1794, DOI 10.1088/0022-3727/30/12/017
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Maccarini M, 2005, APPL SURF SCI, V252, P1941, DOI 10.1016/j.apsusc.2005.03.157
   Methivier C, 2003, LANGMUIR, V19, P8807, DOI 10.1021/la0345789
   NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012
   Ogletree DF, 2002, REV SCI INSTRUM, V73, P3872, DOI 10.1063/1.1512336
   OTTOVALEITMANNOVA A, 1992, PROG SURF SCI, V41, P337, DOI 10.1016/0079-6816(92)90012-7
   Pertsin AJ, 2000, LANGMUIR, V16, P8829, DOI 10.1021/1a000340y
   Pijpers AP, 1999, CHEM SOC REV, V28, P233
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Schreiber F, 2000, PROG SURF SCI, V65, P151, DOI 10.1016/S0079-6816(00)00024-1
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang RY, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1869414
   Wang T, 2005, COLLOID SURFACE B, V46, P233, DOI 10.1016/j.colsurfb.2005.07.010
   Wen XG, 2004, J PHYS CHEM A, V108, P9673, DOI 10.1021/jp047922z
   Willey TM, 2004, LANGMUIR, V20, P2746, DOI 10.1021/la036073o
   Yang ZH, 1999, LANGMUIR, V15, P1731, DOI 10.1021/la980839g
   Ye SH, 2005, J MEMBRANE SCI, V249, P133, DOI 10.1016/j.memsci.2004.10.006
   YEH JJ, 1985, ATOM DATA NUCL DATA, V32, P1, DOI 10.1016/0092-640X(85)90016-6
   Zerulla D, 1999, LANGMUIR, V15, P5285, DOI 10.1021/la980300i
   Zharnikov M, 2002, J VAC SCI TECHNOL B, V20, P1793, DOI 10.1116/1.1514665
   Zharnikov M, 1999, PHYS CHEM CHEM PHYS, V1, P3163, DOI 10.1039/a902013f
   Zubavichus Y, 2004, LANGMUIR, V20, P11022, DOI 10.1021/la047980b
   Zubavichus Y, 2004, RADIAT RES, V161, P346, DOI 10.1667/RR3114.1
NR 33
TC 17
Z9 17
U1 2
U2 18
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0953-8984
J9 J PHYS-CONDENS MAT
JI J. Phys.-Condes. Matter
PD MAY 7
PY 2008
VL 20
IS 18
AR 184024
DI 10.1088/0953-8984/20/18/184024
PG 7
WC Physics, Condensed Matter
SC Physics
GA 298BL
UT WOS:000255661200026
DA 2018-10-20
ER

PT J
AU Deupree, SM
   Schoenfisch, MH
AF Deupree, Susan M.
   Schoenfisch, Mark H.
TI Quantitative method for determining the lateral strength of bacterial
   adhesion and application for characterizing adhesion kinetics
SO LANGMUIR
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPE; STAPHYLOCOCCUS-AUREUS ADHESION; SUBSTRATUM
   SURFACE-TOPOGRAPHY; MEDIATED CELL ATTACHMENT; DETACHMENT KINETICS;
   STREPTOCOCCUS-THERMOPHILUS; BIOMATERIAL SURFACES; SOL-GELS; FLOW;
   FIBRINOGEN
AB A quantitative method for measuring the shear force required to detach individual adhered bacteria using atomic force microscopy (AFM) was developed. By determining the total compression of the cantilever during cell detachment events, a more accurate means of calculating the applied lateral force necessary to remove individual cells was achieved compared to previous methods. In addition, a tunable assay for monitoring the dynamics of Pseudomonas aeruginosa and Staphylococcus aureus adhesion strength was employed. The accumulation of force measurements over time allowed for the characterization of adhesion strength kinetics. P. aeruginosa reinforced its adhesion to the surface at a rate 7-fold faster than for S. aureus; the average adhesion strength of P. aeruginosa was larger than that of S. aureus at corresponding time points. Adhered cells of the same species and strain demonstrated a range of adhesion forces that broadened with time, indicating that the change in adhesion strength does not proceed uniformly.
C1 [Deupree, Susan M.; Schoenfisch, Mark H.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.
RP Schoenfisch, MH (reprint author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.
EM schoenfisch@unc.edu
CR An Y. H, 2000, HDB BACTERIAL ADHESI, P1
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Bowen WR, 2002, BIOTECHNOL BIOENG, V79, P170, DOI 10.1002/bit.10321
   Boyd RD, 2002, LANGMUIR, V18, P2343, DOI 10.1021/la011142p
   CHEUNG AL, 1990, J INFECT DIS, V161, P1177, DOI 10.1093/infdis/161.6.1177
   Chin MYH, 2006, J BIOMED MATER RES B, V78B, P401, DOI 10.1002/jbm.b.30501
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P841, DOI 10.1016/S0006-3495(90)82430-9
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P857, DOI 10.1016/S0006-3495(90)82431-0
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   DUDDRIDGE JE, 1982, BIOTECHNOL BIOENG, V24, P153, DOI 10.1002/bit.260240113
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HERMANN M, 1988, J INFECT DIS, V158, P693
   Hetrick EM, 2007, BIOMATERIALS, V28, P1948, DOI 10.1016/j.biomaterials.2007.01.006
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   Katsaros D, 2004, IEEE INTERNET COMPUT, V8, P37, DOI 10.1109/MIC.2004.1297272
   KUUSELA P, 1978, NATURE, V276, P718, DOI 10.1038/276718a0
   Kwon KD, 2006, GEOCHIM COSMOCHIM AC, V70, P3803, DOI 10.1016/j.gca.2006.05.016
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Marshall K.C., 1985, BACTERIAL ADHESION M, P133
   Marxer SM, 2003, CHEM MATER, V15, P4193, DOI 10.1021/cm034347n
   McWhirter MJ, 2002, COLLOID SURFACE B, V26, P365, DOI 10.1016/S0927-7765(02)00017-6
   MEINDERS JM, 1994, J COLLOID INTERF SCI, V164, P355, DOI 10.1006/jcis.1994.1177
   Montanaro L., 2000, HDB BACTERIAL ADHESI, P331
   MORRIS EJ, 1984, INFECT IMMUN, V43, P656
   Nablo BJ, 2003, J BIOMED MATER RES A, V67A, P1276, DOI 10.1002/jbm.a.20030
   ORSTAVIK D, 1977, ACTA PATH MICRO IM B, V85, P38
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   SATERBAK A, 1993, BIOPHYS J, V65, P243, DOI 10.1016/S0006-3495(93)81077-4
   Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002
   Senechal A, 2004, LANGMUIR, V20, P4172, DOI 10.1021/la035847y
   Tang H., 2006, J BIOMED MATER RES A, V80, P885
   Vacheethasanee K., 2000, HDB BACTERIAL ADHESI, P73
   Vadillo-Rodriguez V, 2006, ENVIRON SCI TECHNOL, V40, P2983, DOI 10.1021/es052365v
   Vadillo-Rodriguez V, 2004, J COLLOID INTERF SCI, V278, P251, DOI 10.1016/j.jcis.2004.05.045
   Vaudaux P, 1990, J Biomater Appl, V5, P134, DOI 10.1177/088532829000500204
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   Walker SL, 2005, ENVIRON SCI TECHNOL, V39, P6405, DOI 10.1021/es050077t
   Whitehead KA, 2006, COLLOID SURFACE B, V51, P44, DOI 10.1016/j.colsurfb.2006.05.003
   Xu LC, 2006, LANGMUIR, V22, P4720, DOI 10.1021/la053443v
   Xu LC, 2006, COLLOID SURFACE B, V48, P84, DOI 10.1016/j.colsurfb.2006.01.012
   Xu LC, 2005, ENVIRON SCI TECHNOL, V39, P3592, DOI 10.1021/es048377i
NR 45
TC 13
Z9 13
U1 3
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 6
PY 2008
VL 24
IS 9
BP 4700
EP 4707
DI 10.1021/la800417g
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 294UP
UT WOS:000255432000045
PM 18399690
DA 2018-10-20
ER

PT J
AU Yang, ZG
   Ding, JD
AF Yang, Zigang
   Ding, Jiandong
TI A thermosensitive and biodegradable physical gel with chemically
   crosslinked nanogels as the building block
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE biodegradable; block copolymers; gelation; hydrogels; sol-gel transition
ID CONTROLLED DRUG-DELIVERY; POLY(ETHYLENE OXIDE); TRIBLOCK COPOLYMERS;
   AQUEOUS-SOLUTIONS; DIBLOCK COPOLYMERS; ALPHA-CYCLODEXTRIN;
   PHASE-TRANSITIONS; HYDROGELS; GELATION; POLYMERIZATION
AB A triblock copolymer, poly(ethylene glycol)-poly(propylene glycol)--poly(ethylene glycol) was end-capped by acryloyl groups using a biodegradable oligolactide as spacer, and such biodegradable amphiphilic macromers could form micelles in water. A nanogel was prepared via polymerizing macromers in a micelle, and a macroscopic physical gelation was found upon heating a concentrated aqueous nanogel suspension. Such a sol-gel transition with a chemically crosslinked nanogel as the building block was thermoreversible. While the hydrogel affords a promising injectable biomaterial; this research reveals new physics of the thermogelling mechanism of amphiphilic block copolymers.
C1 [Yang, Zigang; Ding, Jiandong] Fudan Univ, Key Lab Mol Engn Polymers, Minist Educ, Dept Macromol Sci,Adv Mat Lab, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Key Lab Mol Engn Polymers, Minist Educ, Dept Macromol Sci,Adv Mat Lab, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
CR ASTAFIEVA I, 1993, MACROMOLECULES, V26, P7339, DOI 10.1021/ma00078a034
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   Chen L, 2002, MACROMOL RAPID COMM, V23, P171, DOI 10.1002/1521-3927(20020201)23:3<171::AID-MARC171>3.0.CO;2-P
   Deng W, 2007, ANGEW CHEM INT EDIT, V46, P5144, DOI 10.1002/anie.200701272
   Edwards EW, 2007, MACROMOL CHEM PHYSIC, V208, P439, DOI 10.1002/macp.200600655
   Graeter SV, 2007, NANO LETT, V7, P1413, DOI 10.1021/nl070098g
   Guo K, 2007, BIOMATERIALS, V28, P3284, DOI 10.1016/j.biomaterials.2007.03.031
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   Hu ZB, 2000, ADV MATER, V12, P1173, DOI 10.1002/1521-4095(200008)12:16<1173::AID-ADMA1173>3.0.CO;2-Z
   Hu ZB, 2004, ADV MATER, V16, P305, DOI 10.1002/adma.200305560
   Huang M, 2007, MACROMOLECULES, V40, P6658, DOI 10.1021/ma062482q
   ITO K, 1991, MACROMOLECULES, V24, P2348, DOI 10.1021/ma00009a035
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khattak SF, 2005, TISSUE ENG, V11, P974, DOI 10.1089/ten.2005.11.974
   Kissel T, 2002, ADV DRUG DELIVER REV, V54, P99, DOI 10.1016/S0169-409X(01)00244-7
   Kretschmann O, 2006, ANGEW CHEM INT EDIT, V45, P4361, DOI 10.1002/anie.200504539
   Kuroda K, 2002, LANGMUIR, V18, P3780, DOI 10.1021/la011454s
   Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Loh XJ, 2007, EXPERT OPIN THER PAT, V17, P965, DOI 10.1517/13543776.17.8.965
   Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933
   Lu WQ, 2006, MACROMOLECULES, V39, P7433, DOI 10.1021/ma061356j
   Lu Y, 2007, MACROMOL CHEM PHYSIC, V208, P254, DOI 10.1002/macp.200600534
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutz JF, 2007, MACROMOLECULES, V40, P2503, DOI 10.1021/ma062925q
   Nagasaki Y, 2001, MACROMOL RAPID COMM, V22, P1124, DOI 10.1002/1521-3927(20011001)22:14<1124::AID-MARC1124>3.0.CO;2-4
   Namkung S, 2007, J BIOMAT SCI-POLYM E, V18, P901, DOI 10.1163/156856207781367701
   Oh JK, 2007, J AM CHEM SOC, V129, P5939, DOI 10.1021/ja069150l
   Park SY, 2007, MACROMOL RAPID COMM, V28, P1172, DOI 10.1002/marc.200600914
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Sugihara S, 2004, MACROMOLECULES, V37, P336, DOI 10.1021/ma035037t
   Tanodekaew S, 1997, MACROMOL CHEM PHYSIC, V198, P3385, DOI 10.1002/macp.1997.021981105
   Tomatsu I, 2006, MACROMOL RAPID COMM, V27, P238, DOI 10.1002/marc.200500793
   Van Tomme SR, 2006, BIOMATERIALS, V27, P4141, DOI 10.1016/j.biomaterials.2006.03.023
   Wang B, 2007, MACROMOL RAPID COMM, V28, P567, DOI 10.1002/marc.200600730
   Wang C, 2004, ADV MATER, V16, P1074, DOI 10.1002/adma.200306516
   Wehnert F, 2006, MACROMOL RAPID COMM, V27, P1865, DOI 10.1002/marc.200600482
   Wenzel JGW, 2002, J CONTROL RELEASE, V85, P51, DOI 10.1016/S0168-3659(02)00271-7
   Yamamoto N, 1996, MACROMOL RAPID COMM, V17, P313, DOI 10.1002/marc.1996.030170505
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang Y, 2005, J CONTROL RELEASE, V105, P260, DOI 10.1016/j.jconrel.2005.04.001
NR 47
TC 34
Z9 36
U1 4
U2 43
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1336
EI 1521-3927
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD MAY 2
PY 2008
VL 29
IS 9
BP 751
EP 756
DI 10.1002/marc.200700872
PG 6
WC Polymer Science
SC Polymer Science
GA 306EL
UT WOS:000256231000008
DA 2018-10-20
ER

PT J
AU Balas, F
   Manzano, M
   Colilla, M
   Vallet-Regi, M
AF Balas, Francisco
   Manzano, Miguel
   Colilla, Montserrat
   Vallet-Regi, Maria
TI L-Trp adsorption into silica mesoporous materials to promote bone
   formation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE bioactive silica; bone-healing; peptides; adsorption; controlled release
ID RAY PHOTOELECTRON-SPECTROSCOPY; HORMONE-RELATED PROTEIN; DRUG-DELIVERY;
   CONTROLLED-RELEASE; MOLECULAR-SIEVES; DISSOLUTION; COPOLYMER; TRIBLOCK;
   MATRICES; SYSTEM
AB The properties of ordered mesoporous silicas as bioactive materials, able to induce bone-tissue regeneration, have been combined with their abilities to host and release specific biomolecules in a controlled fashion. The possibility of locally deliver peptides and proteins is of great scientific importance because it opens new paths for the design of implantable biomaterials than can promote bone formation where needed. These biomaterials can host such biofactors, and their adsorption can be enhanced by chemically modifying the silica surface, with the aim of encouraging host-guest interaction and, thereby, increasing the loading capacity of the biomaterial matrix. L-Tryptophan (L-Trp) is a hydrophobic amino acid present in the three-dimensional structure of numerous proteins, and it is used here as model system to predict peptide delivery systems. Unmodified, silanol-rich, bioactive SBA-15 ordered mesoporous silica has been found to be incapable of confining L-Trp in its mesopores due to the hydrophobic character of this molecule. Organically modifying SBA-15 with quaternary amines results in approximately two-thirds of the silica surface being functionalized, increases the surface hydrophobicity allowing an increased L-Trp loading, and also induces different release kinetics. The control of the L-Trp release is the first step in controlled and localized protein delivery technologies, and opens novel perspectives for designing bioactive silica-based devices suitable for bone-healing applications. (c) 2007 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Balas, Francisco; Manzano, Miguel; Colilla, Montserrat; Vallet-Regi, Maria] Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
EM vallet@farm.ucm.es
RI Colilla, Montserrat/N-4628-2014; Manzano, Miguel/K-3719-2014;
   Vallet-Regi, Maria/M-3378-2014; Balas, Francisco/K-7799-2014
OI Colilla, Montserrat/0000-0003-1961-4160; Manzano,
   Miguel/0000-0001-6238-6111; Vallet-Regi, Maria/0000-0002-6104-4889;
   Balas, Francisco/0000-0001-5512-0075
CR Balas F, 2006, J AM CHEM SOC, V128, P8116, DOI 10.1021/ja062286z
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   Crank J., 1975, MATH DIFFUSION
   Cuthbertson RM, 1999, BBA-PROTEIN STRUCT M, V1432, P64, DOI 10.1016/S0167-4838(99)00078-3
   Doadrio JC, 2006, J MATER CHEM, V16, P462, DOI 10.1039/b510101h
   ESCARD J, 1974, INORG CHEM, V13, P695, DOI 10.1021/ic50133a036
   Frenning G, 2003, INT J PHARM, V250, P137, DOI 10.1016/S0378-5173(02)00539-2
   GREGG SJ, 1982, ADSORPTION SURFACE A
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hernandez R, 2004, J AM CHEM SOC, V126, P3370, DOI 10.1021/ja039424u
   Horcajada P, 2006, SOLID STATE SCI, V8, P1243, DOI 10.1016/j.solidstatesciences.2006.04.016
   Ikeo N., 1991, HDB XRAY PHOTOELECTR
   Iler R. K., 1979, CHEM SILICA
   Inagaki S., 1993, CHEM COMMUN, P680
   KALLURY KMR, 1994, LANGMUIR, V10, P492, DOI 10.1021/la00014a025
   Koyano KA, 1997, J PHYS CHEM B, V101, P9436, DOI 10.1021/jp9724941
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Kruk M, 2000, MICROPOR MESOPOR MAT, V35-6, P545, DOI 10.1016/S1387-1811(99)00249-8
   Kruk M, 2002, J PHYS CHEM B, V106, P4732, DOI 10.1021/jp0137423
   Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l
   Lei CH, 2002, J AM CHEM SOC, V124, P11242, DOI 10.1021/ja026855o
   Maria Chong AS, 2003, J PHYS CHEM B, V107, P12650
   MOSES PR, 1978, ANAL CHEM, V50, P576, DOI 10.1021/ac50026a010
   MULYE NV, 1995, DRUG DEV IND PHARM, V21, P943, DOI 10.3109/03639049509026658
   SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618
   Thomas JM, 2003, ACCOUNTS CHEM RES, V36, P20, DOI 10.1021/ar990017q
   Valin A, 1997, J CELL PHYSIOL, V170, P209, DOI 10.1002/(SICI)1097-4652(199702)170:2<209::AID-JCP13>3.3.CO;2-Y
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Vallet-Regi MA, 2006, J MATER CHEM, V16, P26, DOI 10.1039/b509744d
   Vallet-Regi M, 2007, SOLID STATE SCI, V9, P768, DOI 10.1016/j.solidstatesciences.2007.03.026
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   VALLETREGI M, 2007, PROG SOLID STATE CHE
   VANDENBERG ET, 1991, J COLLOID INTERF SCI, V147, P103, DOI 10.1016/0021-9797(91)90139-Y
   Walcarius A, 2003, CHEM MATER, V15, P2161, DOI 10.1021/cm021310e
   Wei Q, 2006, J SOL-GEL SCI TECHN, V39, P103, DOI 10.1007/s10971-006-9171-3
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i
NR 38
TC 62
Z9 64
U1 2
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2008
VL 4
IS 3
BP 514
EP 522
DI 10.1016/j.actbio.2007.11.009
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 299YC
UT WOS:000255790500006
PM 18234569
DA 2018-10-20
ER

PT J
AU Le Guehennec, L
   Lopez-Heredia, MA
   Enkel, B
   Weiss, P
   Amouriq, Y
   Layrolle, P
AF Le Guehennec, Laurent
   Lopez-Heredia, Marco-Antonio
   Enkel, Benedicte
   Weiss, Pierre
   Amouriq, Yves
   Layrolle, Pierre
TI Osteoblastic cell behaviour on different titanium implant surfaces
SO ACTA BIOMATERIALIA
LA English
DT Article
DE cell-biomaterial interaction; osteoblasts; surface roughness; titanium;
   dental implant
ID ENHANCED BONE APPOSITION; IN-VITRO; ENDOSSEOUS IMPLANTS;
   OSSEOINTEGRATION; PROLIFERATION; ROUGHNESS; TOPOGRAPHY; ENERGY;
   ACTIVATION; ATTACHMENT
AB The osseointegration of oral implants is related to the early interactions between osteoblastic cells and titanium surfaces. The behaviour of osteoblastic MC3T3-E1 cells was compared on four different titanium surfaces: mirror-polished (Smooth-Ti), alumina grit-blasted (Alumina-Ti) or biphasic calcium phosphate ceramic grit-blasted (BCP-Ti) and a commercially available implant surface (SLA). Scanning electron microscopy and profilometry showed distinct microtopographies. The BCP-Ti group had higher average surface roughness (R-a = 2.5 mu m) than the other grit-blasted groups. Hydrophilicity and surfaces energies were determined on the different substrates by dynamic contact angle measurements. The most hydrophilic surface was the Alumina-Ti discs, while SLA was the most hydrophobic. The titanium surfaces were all oxidized as TiO2 and polluted by carbon contaminants, as determined by X-ray photoelectron spectroscopy. Alumina-Ti samples also exhibited aluminium peaks as a result of the blasting. The BCP-Ti discs contained traces of calcium and phosphorus. MC3T3-E1 cells attached, spread and proliferated on the substrates. For both the SLA and BCP-Ti groups, the entire surface was covered with a layer of osteoblastic cells after 2 days. At high magnification, the cells exhibited cytoplasmic extensions and filopodia. Compared with plastic, cell viability was similar with the Smooth-Ti, slightly lower with the Alumina-Ti and superior with the SLA and BCP-Ti groups. Alkaline phosphatase activity increased with the culture time whatever the substrate. This study shows that BCP-blasting produces rough titanium implants without surface contaminants. (c) 2007 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Le Guehennec, Laurent; Lopez-Heredia, Marco-Antonio; Enkel, Benedicte; Weiss, Pierre; Amouriq, Yves; Layrolle, Pierre] Univ Nantes, INSERM, U791, Lab Osteoarticular & Dent Tissue Engn,Fac Dent Su, F-44042 Nantes, France.
RP Layrolle, P (reprint author), Univ Nantes, INSERM, U791, Lab Osteoarticular & Dent Tissue Engn,Fac Dent Su, 1 Pl Alexis Ricordeau, F-44042 Nantes, France.
EM pierre.layrolle@nantes.inserm.fr
RI LABOUX, OLIVIER/A-8270-2015; LE GUEHENNEC, Laurent/P-6301-2014; Weiss,
   Pierre/P-1372-2014; Layrolle, Pierre/K-9257-2015
OI Weiss, Pierre/0000-0002-6159-8590; Layrolle, Pierre/0000-0001-9800-5210
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P544
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Citeau A, 2005, BIOMATERIALS, V26, P157, DOI 10.1016/j.biomaterials.2004.02.033
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Esposito Marco, 2005, Eur J Prosthodont Restor Dent, V13, P15
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   Giordano C, 2006, INT J ARTIF ORGANS, V29, P772
   Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060
   Ivanoff CJ, 2003, INT J ORAL MAX IMPL, V18, P341
   Kim MJ, 2006, J BIOMED MATER RES A, V79A, P1023, DOI 10.1002/jbm.a.31040
   Kim MJ, 2006, BIOMATERIALS, V27, P5502, DOI 10.1016/j.biomaterials.2006.06.023
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   MARINUCCI L, 2007, INT J ORAL MAXILLOF, V22, P19
   Marinucci L, 2006, INT J ORAL MAX IMPL, V21, P719
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Novaes AB, 2002, INT J ORAL MAX IMPL, V17, P377
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Puleo David A, 2006, Dent Clin North Am, V50, P323, DOI 10.1016/j.cden.2006.03.001
   Sader MS, 2005, CLIN ORAL IMPLAN RES, V16, P667, DOI 10.1111/j.1600-0501.2005.01135.x
   Sanz A, 2001, Implant Dent, V10, P126
   Schuler M, 2006, NANOMEDICINE-UK, V1, P449, DOI 10.2217/17435889.1.4.449
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Sul YT, 2005, INT J ORAL MAX IMPL, V20, P349
   Suzuki A, 2002, BONE, V30, P91, DOI 10.1016/S8756-3282(01)00660-3
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Xavier SP, 2003, J DENT, V31, P173, DOI 10.1016/S0300-5712(03)00027-7
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 42
TC 123
Z9 123
U1 1
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2008
VL 4
IS 3
BP 535
EP 543
DI 10.1016/j.actbio.2007.12.002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 299YC
UT WOS:000255790500008
PM 18226985
DA 2018-10-20
ER

PT J
AU Yang, ZP
   Si, SH
   Zeng, XM
   Zhang, CJ
   Dai, HJ
AF Yang, Zhengpeng
   Si, Shihui
   Zeng, Xiaoming
   Zhang, Chunjing
   Dai, Hongjuan
TI Mechanism and kinetics of apatite formation on nanocrystalline TiO2
   coatings: A quartz crystal microbalance study
SO ACTA BIOMATERIALIA
LA English
DT Article
DE nanocrystalline TiO2 coatings; apatite; QCM; mechanism; kinetics
ID SIMULATED BODY-FLUID; BIOMIMETIC DEPOSITION; BIOACTIVE MATERIALS;
   TITANIUM-DIOXIDE; ADSORPTION; GROWTH; BIOSENSOR; SURFACES; ALLOY; QCM
AB Apatite (Ca-5(PO4)(3)OH) has long been considered as an excellent biomaterial to promote bone repairs and implant. Apatite formation induced by negatively charged nanocrystalline TiO2 coatings soaked in simulated body fluid (SBF) was investigated using in situ quartz crystal microbalance (QCM), scanning electron microscopy (SEM), Fourier-transformed infrared spectroscopy (FTIR), X-ray diffraction (XRD) and energy-dispersive X-ray spectroscopy (EDX) techniques, and factors affecting its formation such as pH, size of TiO2 particles and thickness of TiO2 coatings, were discussed in detail. Two different stages were clearly observed in the process of apatite precipitation, indicating two different kinetic processes. At the first stage, the calcium ions in SBF were initially attracted to the negatively charged TiO2 surface, and then the calcium titanate formed at the interface combined with phosphate ions, consequently forming apatite nuclei. After the nucleation, the calcium ions, phosphate ions and other minor ions (i.e. CO32- and Mg2+) in supersaturated SBF deposited spontaneously on the original apatite coatings to form apatite precipitates. In terms of the in situ frequency shifts, the growth-rate constants of apatite (K-1 and K-2) were estimated, respectively, at two different stages, and the results were (1.96 +/- 0.14) x 10(-3) s(-1) and (1.28 +/- 0.10) x 10(-4) s(-1), respectively, in 1.5 SBF solution. It was found that the reaction rate at the first stage is obviously higher than that at the second stage. (c) 2007 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Yang, Zhengpeng; Si, Shihui; Zhang, Chunjing; Dai, Hongjuan] Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Peoples R China.
   [Zeng, Xiaoming] Hunan Bur Qual & Tech Supervis, Changsha 410007, Peoples R China.
RP Si, SH (reprint author), Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Peoples R China.
EM sishihui@mail.esu.edu.cn
CR Areva S, 2002, CHEM MATER, V14, P1614, DOI 10.1021/cm0107272
   BenDov I, 1997, ANAL CHEM, V69, P3506, DOI 10.1021/ac970216s
   Cosnier S, 1999, J ELECTROANAL CHEM, V469, P176, DOI 10.1016/S0022-0728(99)00223-5
   Cui CX, 2005, MATER LETT, V59, P3144, DOI 10.1016/j.matlet.2005.05.037
   Dutta PK, 2004, J COLLOID INTERF SCI, V278, P270, DOI 10.1016/j.jcis.2004.06.015
   FAWCETT NC, 1998, ANAL CHEM, V70, P287
   Gu YW, 2005, BIOMATERIALS, V26, P6916, DOI [10.1016/j.biomaterials.2005.04.051, 10.1016/j.biomaterials.2005.04.51]
   Hayakawa S, 2000, J NON-CRYST SOLIDS, V263, P409, DOI 10.1016/S0022-3093(99)00649-3
   He YR, 2007, INT J HEAT MASS TRAN, V50, P2272, DOI 10.1016/j.ijheatmasstransfer.2006.10.024
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hianik T, 2005, BIOORG MED CHEM LETT, V15, P291, DOI 10.1016/j.bmcl.2004.10.083
   JOOS P, 1995, J COLLOID INTERF SCI, V171, P399, DOI 10.1006/jcis.1995.1196
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   Keshmiri M, 2003, J NON-CRYST SOLIDS, V324, P289, DOI 10.1016/S0022-3093(03)00363-6
   Koenig Bernd, 1994, Analytical Chemistry, V66, P341, DOI 10.1021/ac00075a005
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOSSLINGER C, 1992, BIOSENS BIOELECTRON, V7, P397, DOI 10.1016/0956-5663(92)85038-C
   Lin CM, 2006, MAT SCI ENG C-BIO S, V26, P54, DOI 10.1016/j.msec.2005.06.048
   Liu JX, 2003, THIN SOLID FILMS, V429, P225, DOI 10.1016/S0040-6090(03)00146-9
   Liu SQ, 2005, LANGMUIR, V21, P8409, DOI 10.1021/la050875x
   Liu XY, 2005, BIOMATERIALS, V26, P6143, DOI 10.1016/j.biomaterials.2005.04.035
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Lori JA, 2001, CORROS SCI, V43, P2111, DOI 10.1016/S0010-938X(01)00003-8
   Nunalee FN, 2006, ANAL CHEM, V78, P1158, DOI 10.1021/ac0515226
   Oliva FY, 2003, J COLLOID INTERF SCI, V261, P299, DOI 10.1016/S0021-9797(03)00029-8
   Park IS, 2004, BIOSENS BIOELECTRON, V19, P667, DOI 10.1016/S0956-5663(03)00268-9
   Ratner B. D., 2001, TITANIUM MED, P1
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Shen ZH, 2007, ANAL CHEM, V79, P2312, DOI 10.1021/ac061986j
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Stanley S, 2003, ANAL CHEM, V75, P1573, DOI 10.1021/ac0257546
   Su XL, 2005, BIOSENS BIOELECTRON, V21, P840, DOI 10.1016/j.bios.2005.01.021
   SURI CR, 1994, BIOSENS BIOELECTRON, V9, P325, DOI 10.1016/0956-5663(94)80031-6
   Tanahashi M, 1996, J BIOMED MATER RES, V31, P243, DOI 10.1002/(SICI)1097-4636(199606)31:2<243::AID-JBM11>3.0.CO;2-M
   Towery RB, 2001, BIOSENS BIOELECTRON, V16, P1, DOI 10.1016/S0956-5663(00)00126-3
   Wang CX, 2003, BIOMATERIALS, V24, P3069, DOI 10.1016/S0142-9612(03)00154-6
   Wang XX, 2003, BIOMATERIALS, V24, P4631, DOI 10.1016/S0142-9612(03)00357-0
   Wu WJ, 1997, COLLOID SURFACE B, V10, P87, DOI 10.1016/S0927-7765(97)00054-4
   Xie Y., 2006, SURF SCI, V600, P651
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
   Yang ZP, 2007, THIN SOLID FILMS, V515, P3344, DOI 10.1016/j.tsf.2006.09.018
   Zhang HZ, 1999, J PHYS CHEM B, V103, P4656, DOI 10.1021/jp984574q
   Zhu PX, 2003, J AM CERAM SOC, V86, P782, DOI 10.1111/j.1151-2916.2003.tb03375.x
NR 43
TC 42
Z9 45
U1 1
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2008
VL 4
IS 3
BP 560
EP 568
DI 10.1016/j.actbio.2007.10.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 299YC
UT WOS:000255790500011
PM 18053780
DA 2018-10-20
ER

PT J
AU Gomes, PS
   Santos, JD
   Fernandes, MH
AF Gomes, P. S.
   Santos, J. D.
   Fernandes, M. H.
TI Cell-induced response by tetracyclines on human bone marrow colonized
   hydroxyapatite and Bonelike (R)
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tetracyclines; osteoblasts; hydroxyapatite; bonelike
ID GLASS-REINFORCED-HYDROXYAPATITE; OSTEOBLAST PHENOTYPE; TISSUE
   REGENERATION; INDUCED OSTEOPENIA; DIFFERENTIATION; DOXYCYCLINE;
   PROLIFERATION; COMPOSITES; SCAFFOLDS; GROWTH
AB Semi-synthetic tetracyclines are commonly used antibiotics that also seem to play an important role in the modulation of the immuno-inflammatory imbalance, verified in several bone diseases. The association of a therapeutic agent (that prevents bacterial infection and induces tissue formation) to a biomaterial aiming to repair/regenerate bone defects could contribute to a more predictable clinical outcome. The present study intends to evaluate the proliferation and functional activity of osteoblast-induced human bone marrow cells, cultured on the surface of hydroxyapatite (HA) and Bonelike (R), in the presence of therapeutic concentrations of doxycycline and minocycline. First passage bone marrow cells were cultured for 35 days on the surface of HA and Bonelike (R) discs, in the absence or presence of 1 mu g ml(-1) doxycycline and minocycline. Cultures performed in standard tissue culture plates were used as control.
   Doxycycline or minocycline induced cell proliferation and increased the extent of matrix mineralization in osteoblastic cell cultures established in the three substrates. Also, an improved biological behavior was verified in seeded Bonelike (R) compared with HA. The results suggest that the local delivery of tetracyclines might associate the antimicrobial activity in implant-related bone infection with an eventual induction of osteoblastic proliferation and maintenance of the characteristic biological activity of these cells. (c) 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Gomes, P. S.; Fernandes, M. H.] Univ Porto FMDUP, Fac Med Dent, Lab Farmacol & Biocompatibilidade Celular, P-4200392 Oporto, Portugal.
   [Santos, J. D.] Univ Porto, Seccao Mat, DEMM, Fac Engn, P-4200465 Oporto, Portugal.
   [Santos, J. D.] Inst Engn Biomed INEB, Lab Biomat, P-4150180 Oporto, Portugal.
RP Fernandes, MH (reprint author), Univ Porto FMDUP, Fac Med Dent, Lab Farmacol & Biocompatibilidade Celular, Rua Dr Manuel Pereira Silva,S-N, P-4200392 Oporto, Portugal.
EM mhrf@portugalmail.pt
RI Fernandes, Maria Helena/K-6917-2014; Gomes, Pedro/K-2433-2014
OI Gomes, Pedro/0000-0001-5365-2123; Santos, Jose
   Domingos/0000-0002-6871-9850; Fernandes, Maria
   Helena/0000-0001-9391-9574
CR Alkan A, 2002, J ORAL MAXIL SURG, V60, P898, DOI 10.1053/jams.2002.33859
   Beardmore AA, 2005, J BONE JOINT SURG AM, V87A, P107, DOI 10.2106/JBJS.C.01670
   Bettany J T, 1998, Adv Dent Res, V12, P136
   Brause BD, 2000, MANDELL DOUGLAS BENN, P1196
   BUCHTER A, 2004, BRIT J ORAL MAX SURG, V42, P452
   Carson JS, 2007, INJURY, V38, pS33, DOI 10.1016/j.injury.2007.02.008
   Caton J G, 1999, Compend Contin Educ Dent, V20, P451
   Chambers HF, 2006, GOODMAN GILMANS PHAR, P1173
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Costa MA, 2004, KEY ENG MAT, V254-2, P821, DOI 10.4028/www.scientific.net/KEM.254-256.821
   Darley ESR, 2004, J ANTIMICROB CHEMOTH, V53, P928, DOI 10.1093/jac/dkh191
   DUARTE F, 2004, MATER SCI FORUM, V370, P455
   Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05
   GERSTENFELD LC, 1988, J CELL BIOL, V106, P979, DOI 10.1083/jcb.106.3.979
   GIANNOUDIS P, 2005, INT J CARE INJURED, V365, P220
   GOLUB LM, 1984, J PERIODONTAL RES, V19, P651, DOI 10.1111/j.1600-0765.1984.tb01334.x
   GOLUB LM, 1994, J AM DENT ASSOC, V125, P163, DOI 10.14219/jada.archive.1994.0261
   GOLUB LM, 1990, RES COMMUN CHEM PATH, V68, P27
   Gomes PS, 2007, ARCH ORAL BIOL, V52, P251, DOI 10.1016/j.archoralbio.2006.10.005
   Gurkan A, 2005, J CLIN PERIODONTOL, V32, P244, DOI 10.1111/j.1600-051X.2005.00663.x
   Gutierres M, 2006, J ORTHOP RES, V24, P953, DOI 10.1002/jor.20117
   GUTIERRES M, 2005, KEY ENG MATER, V1041, P284
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Holmes SG, 2004, BONE, V35, P471, DOI 10.1016/j.bone.2004.02.028
   Jorgensen NR, 2004, STEROIDS, V69, P219, DOI 10.1016/j.steroids.2003.12.005
   KARIMBUX N, 1998, J PERIODONTOL, V69, P39
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   KIMA HW, 2005, BIOMATERIALS, V26, P4395
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li SH, 2002, J BIOMED MATER RES, V61, P109, DOI 10.1002/jbm.10163
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lin LY, 2001, J CARDIOVASC ELECTR, V12, P26, DOI 10.1046/j.1540-8167.2001.00026.x
   Lopes MA, 2001, J BIOMED MATER RES, V54, P463, DOI 10.1002/1097-4636(20010315)54:4<463::AID-JBM10>3.0.CO;2-Y
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   POLSON A, 2005, J APPL RES CLIN DENT, P32
   Pytlik M, 2004, CALCIFIED TISSUE INT, V75, P225, DOI 10.1007/s00223-004-0097-x
   RAMAMURTHY N, 2003, P 10 WORLD C NEW YOR, P236
   Ramamurthy N, 2005, J PERIODONTOL, V73, P726
   Sakellari D, 2000, J CLIN PERIODONTOL, V27, P53, DOI 10.1034/j.1600-051x.2000.027001053.x
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Santos JD, 1996, J MATER SCI-MATER M, V7, P187, DOI 10.1007/BF00121259
   SANTOS JD, 1995, J MATER SCI-MATER M, V6, P348, DOI 10.1007/BF00120303
   Schwartz Z, 2000, J PERIODONTOL, V71, P586, DOI 10.1902/jop.2000.71.4.586
   Shirtliff ME, 2002, CLIN MICROBIOL REV, V15, P527, DOI 10.1128/CMR.15.4.527-544.2002
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sundar M, 2005, TRENDS BIOMATER ARTI, V18, P213
   Vallet Regi M, 2007, DRUG METABOL LETT, V1, P37
   Williams S, 1999, ANN NY ACAD SCI, V878, P191, DOI 10.1111/j.1749-6632.1999.tb07684.x
   Williams S, 1998, Adv Dent Res, V12, P71
   Williams S, 1996, BONE, V19, P637, DOI 10.1016/S8756-3282(96)00302-X
   WOESSNER JF, 2000, MATRIX METALLOPROTEI, P109
   YAMAGUCHI A, 1990, J BIOL CHEM, V265, P4809
   YU Z, 1993, J PERIODONTAL RES, V28, P420
   Yukna R A, 1982, Int J Periodontics Restorative Dent, V2, P8
   ZHANG Y, 2001, KEY ENG MATER, V192, P643
   Zucchelli G, 1999, J PERIODONTOL, V70, P239, DOI 10.1902/jop.1999.70.3.239
NR 58
TC 29
Z9 30
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2008
VL 4
IS 3
BP 630
EP 637
DI 10.1016/j.actbio.2007.12.006
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 299YC
UT WOS:000255790500018
PM 18291737
DA 2018-10-20
ER

PT J
AU Kelch, S
   Choi, NY
   Wang, ZG
   Lendlein, A
AF Kelch, Steffen
   Choi, Nok-Young
   Wang, Zhonggang
   Lendlein, Andreas
TI Amorphous, elastic AB copolymer networks from acrylates and
   poly[(L-lactide)-ran-glycolide]dimethacrylates
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID SHAPE-MEMORY POLYMER; OLIGO(EPSILON-CAPROLACTONE) SEGMENTS;
   ANGIOGENESIS; IMPLANTATION; BIOMATERIAL; DEGRADATION; MICE
C1 [Kelch, Steffen] Sik Technol AG, CH-8048 Zurich, Switzerland.
   [Lendlein, Andreas] GKSS Forschungszentrum Geesthacht GmbH, Polymer Res Inst, D-14513 Teltow, Germany.
   [Choi, Nok-Young] BASF AG, D-67056 Ludwigshafen, Germany.
   [Wang, Zhonggang] Dalian Univ Technol, Sch Chem Engn, Dept Polymer Sci & Mat, Dalian 116012, Peoples R China.
RP Kelch, S (reprint author), Sik Technol AG, Tuffenwies 16, CH-8048 Zurich, Switzerland.
EM andreas.lendlein@gkss.de
RI Wang, Zhonggang/L-1555-2014; Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Alcoutlabi M, 1999, J MATER SCI, V34, P2361, DOI 10.1023/A:1004546228825
   Bellin I, 2006, P NATL ACAD SCI USA, V103, P18043, DOI 10.1073/pnas.0608586103
   Bertmer M, 2005, MACROMOLECULES, V38, P3793, DOI 10.1021/ma0501489
   Binzen E, 2004, CLIN HEMORHEOL MICRO, V30, P283
   Binzen E, 2003, CLIN HEMORHEOL MICRO, V28, P183
   Buckley PR, 2006, IEEE T BIO-MED ENG, V53, P2075, DOI 10.1109/TBME.2006.877113
   Charlesby A, 1960, ATOMIC RAD POLYM
   Choi NY, 2007, SOFT MATTER, V3, P901, DOI 10.1039/b702515g
   Choi NY, 2006, ADV ENG MATER, V8, P439, DOI 10.1002/adem.200600020
   GRULKE EA, 1989, POLYM HDB
   Jeong HM, 2000, J MATER SCI, V35, P279, DOI 10.1023/A:1004728814128
   Kagami Y, 1996, MACROMOL RAPID COMM, V17, P539, DOI 10.1002/marc.1996.030170806
   Kelch S, 2007, BIOMACROMOLECULES, V8, P1018, DOI 10.1021/bm0610370
   KINE BB, 1985, ENCY POLYM SCI ENG, V1, P274
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, J POLYM SCI POL CHEM, V43, P1369, DOI 10.1002/pola.20598
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A., 2005, ENCY MAT SCI TECHNOL
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   Min CC, 2005, POLYM ADVAN TECHNOL, V16, P608, DOI 10.1002/pat.624
   Mohr R, 2006, P NATL ACAD SCI USA, V103, P3540, DOI 10.1073/pnas.0600079103
   Reyntjens WG, 1999, MACROMOL RAPID COMM, V20, P251, DOI 10.1002/(SICI)1521-3927(19990501)20:5<251::AID-MARC251>3.0.CO;2-2
   Rickert D, 2005, CLIN HEMORHEOL MICRO, V32, P117
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
NR 26
TC 53
Z9 53
U1 1
U2 26
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD MAY
PY 2008
VL 10
IS 5
BP 494
EP 502
DI 10.1002/adem.200700339
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 310VF
UT WOS:000256558100013
DA 2018-10-20
ER

PT J
AU Ignjatovic, N
   Uskokovic, D
AF Ignjatovic, N.
   Uskokovic, D.
TI Biodegradable composites based on nanocrystalline calcium phosphate and
   bioresorbable polymers
SO ADVANCES IN APPLIED CERAMICS
LA English
DT Article
DE composite biomaterials; injectable paste; nanocrystalline calcium
   phosphate; resorbable polymer
ID HARD-TISSUE REPLACEMENT; BONE TISSUE; HAP/PLLA COMPOSITE; IN-VIVO;
   BIOMATERIALS; BIOCOMPOSITE; RECONSTRUCTION; OSTEOGENESIS; SUBSTITUTION;
   SPECTROSCOPY
AB Nanocrystalline calcium phosphates (NC CP) are suitable for the synthesis of CP/bioresorbable polymer composite biomaterials for the application in bone engineering. There are different forms of NC CP/ bioresorbable polymers composite biomaterials. Calcium phosphate was synthesised in highly NC form. A NC calcium phosphate/poly-DL-lactide-co-glycolide (CP/DLPLG) composite biomaterial in filler forms was synthesised in the shape of spherical granules (150-200 mu m in diameter) and nanoparticles (30-40 nm in diameter). Each CP granule or nanoparticle was coated with amorphous DLPLG polymer. Using NC and nanosized CP/ DLPLG composite materials, an injectable composite biomaterial was prepared. By hot pressing of highly porous NC CP/ bioresorbable polymer composite biomaterials at the polymer's melting temperature, blocks were obtained with relatively uniform distribution of phases. Designing of the properties of CP/ bioresorbable polymers composite biomaterial block was provided by combining high pressure, temperature and time.
C1 [Ignjatovic, N.; Uskokovic, D.] Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade 11000, Serbia.
RP Uskokovic, D (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, Knez Mihailova 35-IV, Belgrade 11000, Serbia.
EM uskok@itn.sanu.ac.yu
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968
CR Aho AJ, 2004, J MATER SCI-MATER M, V15, P1165, DOI 10.1023/B:JMSM.0000046401.50406.9b
   Ajdukovic Z, 2007, J BIOMATER APPL, V21, P317, DOI 10.1177/0885328207073760
   Albee FH, 1920, ANN SURG, V71, P32
   Daculsi G, 1999, BONE, V25, p59S, DOI 10.1016/S8756-3282(99)00135-0
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.3.CO;2-C
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   GERLACH KI, 2004, QUINTESSENZ, V66, P603
   Grigor'ian A S, 2000, Stomatologiia (Mosk), V79, P9
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2005, MATER SCI FORUM, V494, P519, DOI 10.4028/www.scientific.net/MSF.494.519
   Ignjatovic N, 2005, J MATER SCI-MATER M, V16, P621, DOI 10.1007/s10856-005-2532-6
   Ignjatovic N, 2004, SPECTROSC-INT J, V18, P553, DOI 10.1155/2004/917656
   Ignjatovic N, 2004, APPL SURF SCI, V238, P314, DOI 10.1016/j.apsusc.2004.05.227
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   Ignjatovic N, 2003, BIO-MED MATER ENG, V13, P401
   Ignjatovic N, 2001, Z METALLKD, V92, P145
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Ignjatovic NL, 2007, ACTA BIOMATER, V3, P927, DOI 10.1016/j.actbio.2007.04.001
   Ignjatovic N, 2007, J EUR CERAM SOC, V27, P1589, DOI 10.1016/j.jeurceramsoc.2006.04.104
   Ignjatovic N, 2006, MICROSC RES TECHNIQ, V69, P976, DOI 10.1002/jemt.20374
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   Kandic L, 2006, MATER SCI FORUM, V518, P507, DOI 10.4028/www.scientific.net/MSF.518.507
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Le Nihouannen D, 2006, BIOMATERIALS, V27, P2716, DOI 10.1016/j.biomaterials.2005.11.038
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lu LC, 1996, MRS BULL, V21, P28
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Meneghini C, 2003, BIOPHYS J, V84, P2021, DOI 10.1016/S0006-3495(03)75010-3
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Ooms EM, 2003, BIOMATERIALS, V24, P749, DOI 10.1016/S0142-9612(02)00408-8
   Osman MA, 2006, POLYMER, V47, P2357, DOI 10.1016/j.polymer.2006.01.085
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   Shi XF, 2005, NANOTECHNOLOGY, V16, pS531, DOI 10.1088/0927-4484/16/7/030
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Soriano I, 2000, J CONTROL RELEASE, V68, P121, DOI 10.1016/S0168-3659(00)00251-0
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   YAMAMURA K, 1992, J BIOMED MATER RES, V26, P1053, DOI 10.1002/jbm.820260807
NR 46
TC 8
Z9 9
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-6753
EI 1743-6761
J9 ADV APPL CERAM
JI Adv. Appl. Ceram.
PD MAY
PY 2008
VL 107
IS 3
BP 142
EP 147
DI 10.1179/174367608X263421
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 333EY
UT WOS:000258137000004
DA 2018-10-20
ER

PT J
AU Du, CL
   Wang, MQ
   Liu, JY
   Pan, ML
   Cai, YR
   Yao, JM
AF Du, Chunling
   Wang, Mingqi
   Liu, Jinying
   Pan, Mingli
   Cai, Yurong
   Yao, Juming
TI Improvement of thermostability of recombinant collagen-like protein by
   incorporating a foldon sequence
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE collagen; recombinant protein; fibritin; foldon; thermostability; cell
   biocompatibility
ID BACTERIOPHAGE-T4 FIBRITIN; TERMINAL DOMAIN; EXPRESSION; PEPTIDES; CHAIN
AB Collagen is a popular biomaterial in many specific biological interactions as well as a structural element. In this work, the recombinant collagen-like proteins were synthesized using Escherichia coli expression system. A foldon sequence, GYIPEAPRDGQAYVRKDGEWVLLSTFL, derived from the native T4 phage fibritin was incorporated at the C-terminal of collagen-like protein molecules to stabilize the triple helix formed in the proteins. The differential scanning calorimetry and thermogravimetric analysis measurements showed that the thermostability of the recombinant collagen-like proteins was significantly improved when compared with those without the foldon sequence at the C-terminal. Fourier transform infrared and scanning electron microscopy observations indicated that the collagen-like proteins forms the triple helix structure and prefer to aggregate as fibrils, same as the native collagen. Moreover, the mice fibroblasts L929 cells could attach and grew very well on the recombinant collage-like proteins. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that the cell biocompatibility of collagen-like proteins produced in this work was even better than that of native collagen, suggesting that the collagen-like proteins may be a satisfactory candidate for the future applications as a biomaterial.
C1 [Du, Chunling; Wang, Mingqi; Liu, Jinying; Pan, Mingli; Cai, Yurong; Yao, Juming] Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
RP Yao, JM (reprint author), Zhejiang Sci Tech Univ, Coll Mat & Text, Minist Educ, Key Lab Adv Text Mat & Mfg Technol, Hangzhou 310018, Peoples R China.
EM yaoj@zstu.edu.cn
RI Yao, Juming/N-7886-2014
CR Baez J, 2005, APPL MICROBIOL BIOT, V69, P245, DOI 10.1007/s00253-005-0180-x
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   EYRE DR, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P119
   Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083
   GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532
   PERRIS R, 1993, J CELL SCI, V106, P1357
   Plepis AMD, 1996, POLYM ENG SCI, V36, P2932
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Saito M, 2001, EUR J BIOCHEM, V268, P2817, DOI 10.1046/j.1432-1327.2001.02160.x
   SERGEI PB, 2002, EUR J BIOCHEM, V269, P833
   STAATZ WD, 1990, J BIOL CHEM, V265, P4778
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Valluzzi R, 2000, BIOPOLYMERS, V53, P350, DOI 10.1002/(SICI)1097-0282(20000405)53:4<350::AID-BIP7>3.0.CO;2-O
   VANDERZEE E, 1995, J CELL SCI, V108, P3307
   Wang Y, 2006, MAT SCI ENG C-BIO S, V26, P635, DOI 10.1016/j.msec.2005.07.019
   Yao JM, 2004, J BIOCHEM, V136, P643, DOI 10.1093/jb/mvh172
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
NR 22
TC 17
Z9 18
U1 1
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0175-7598
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD MAY
PY 2008
VL 79
IS 2
BP 195
EP 202
DI 10.1007/s00253-008-1427-0
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 292FZ
UT WOS:000255253200004
PM 18379779
DA 2018-10-20
ER

PT J
AU Rice, WL
   Firdous, S
   Gupta, S
   Hunter, M
   Foo, CWP
   Wang, Y
   Kim, HJ
   Kaplan, DL
   Georgakoudi, I
AF Rice, William L.
   Firdous, Shamaraz
   Gupta, Sharad
   Hunter, Martin
   Foo, Cheryl W. P.
   Wang, Yongzhong
   Kim, Hyeon Joo
   Kaplan, David L.
   Georgakoudi, Irene
TI Non-invasive characterization of structure and morphology of silk
   fibroin biomaterials using non-linear microscopy
SO BIOMATERIALS
LA English
DT Article
DE silk; fibroin; two photon excited fluorescence; second harmonic
   generation; spectral analysis; non-invasive characterization
ID TRYPTOPHAN FLUORESCENCE-SPECTRA; MESENCHYMAL STEM-CELLS; LOG-NORMAL
   COMPONENTS; MARROW STROMAL CELLS; SPIDER DRAGLINE SILK; IN-VIVO
   EVALUATION; 2ND-HARMONIC GENERATION; OSTEOGENIC DIFFERENTIATION;
   MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX
AB Designing biomaterial scaffolds remains a major challenge in tissue engineering. Key to this challenge is improved understanding of the relationships between the scaffold properties and its degradation kinetics, as well as the cell interactions and the promotion of new matrix deposition. Here we present the use of non-linear spectroscopic imaging as a non-invasive method to characterize not only morphological, but also structural aspects of silkworm silk fibroin-based biomaterials, relying entirely on endogenous optical contrast. We demonstrate that two photon excited fluorescence and second harmonic generation are sensitive to the hydration, overall sheet content and molecular orientation of the sample. Thus, the functional content and high resolution afforded by these non-invasive approaches offer promise for identifying important connections between biomaterial design and functional engineered tissue development. The strategies described also have broader implications for understanding and tracking the remodeling of degradable biomaterials under dynamic conditions both ill vitro and ill vivo. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Rice, William L.; Gupta, Sharad; Hunter, Martin; Foo, Cheryl W. P.; Wang, Yongzhong; Kim, Hyeon Joo; Kaplan, David L.; Georgakoudi, Irene] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Firdous, Shamaraz] Pakistan Inst Engn & Appl Sci, Dept Phys & Appl Math, Laser Lab, Islamabad, Pakistan.
RP Georgakoudi, I (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St,Room 229, Medford, MA 02155 USA.
EM rene.georgakoudi@tufts.edu
RI Firdous, Shamaraz/I-8028-2015; Gupta, Sharad/C-3481-2013
OI Gupta, Sharad/0000-0003-2521-0170
FU NIBIB NIH HHS [P41 EB002520, P41 EB002520-03]
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Asakura T, 2005, BIOMACROMOLECULES, V6, P468, DOI 10.1021/bm049487k
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Behravesh E, 1999, CLIN ORTHOP RELAT R, pS118
   Bell FI, 2002, NATURE, V416, P37, DOI 10.1038/416037a
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Brehmer B, 2007, UROL INT, V78, P23, DOI 10.1159/000096930
   Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879
   Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7
   Chandra M, 2006, OPT EXPRESS, V14, P6157, DOI 10.1364/OE.14.006157
   Edwards GA, 1997, J BIOMED MATER RES, V34, P291
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P193, DOI 10.1007/s00339-005-3425-8
   Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892
   Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043
   Gonzalez S, 2003, CLIN DERMATOL, V21, P359, DOI 10.1016/j.clindermatol.2003.08.007
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gubler U, 2002, NAT MATER, V1, P209, DOI 10.1038/nmat781
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Ko HJ, 2006, TISSUE ENG, V12, P63, DOI 10.1089/ten.2006.12.63
   LEE HS, 2006, TISSUE ENG
   Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmet1534
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mauney JR, 2006, J BIOMED MATER RES A, V79A, P464, DOI 10.1002/jbm.a.30876
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Ntziachristos V, 2001, BREAST CANCER RES, V3, P41, DOI 10.1186/bcr269
   Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8
   Ramanujam N, 2000, NEOPLASIA, V2, P89, DOI 10.1038/sj.neo.7900077
   Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0
   Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   Shao ZZ, 1999, INT J BIOL MACROMOL, V24, P295, DOI 10.1016/S0141-8130(98)00093-2
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tan W, 2004, TISSUE ENG, V10, P1747, DOI 10.1089/ten.2004.10.1747
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Xu C. C., 2006, TISSUE ENG
   Zhao CH, 2003, BIOPOLYMERS, V69, P253, DOI 10.1002/bip.10350
   Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899
   Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100
   Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799
NR 58
TC 48
Z9 50
U1 1
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2008
VL 29
IS 13
BP 2015
EP 2024
DI 10.1016/j.biomaterials.2007.12.049
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 315BO
UT WOS:000256853100003
PM 18291520
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, XH
   Baughman, CB
   Kaplan, DL
AF Zhang, Xiaohui
   Baughman, Cassandra B.
   Kaplan, David L.
TI In vitro evaluation of electrospun silk fibroin scaffolds for vascular
   cell growth
SO BIOMATERIALS
LA English
DT Article
DE silk; electrospinning; endothelial cells; smooth muscle cells; vascular
ID BIODEGRADABLE POLYMER; PULMONARY-ARTERY; TUBE FORMATION; COLLAGEN;
   ANGIOGENESIS; CONSTRUCTS; FIBROBLAST; NANOFIBER; INVITRO; TISSUES
AB Human aortic endothelial (HAEC) and human coronary artery smooth muscle cell (HCASMC) responses on electrospun silk fibroin scaffolds were studied to evaluate potential for vascular tissue engineering. Cell proliferation studies supported the utility of this biomaterial matrix by both HAECs and HCASMCs. Alignment and elongation of HCASMCs on random non-woven nanofibrous silk scaffolds was observed within 5 days after seeding based on SEM and confocal microscopy. Short cord-like structures formed from HAECs on the scaffolds by day 4, and a complex interconnecting network of capillary tubes with identifiable lumens was demonstrated by day 7. The preservation of cell phenotype on the silk fibroin scaffolds was confirmed by the presence of cell-specific markers, including CD 146, VE-cadherin, PECAM-1 and vWF for HAECs, and SM-MHC2 and SM-actin for HCASMCs at both protein and transcription levels using immunocytochemistry and real-time RT-PCR, respectively. Formation of ECM was also demonstrated for the HCASMCs, based on the quantification of collagen type I expression at protein and transcription levels. The results indicate a favorable interaction between vascular cells and electrospun silk fibroin scaffolds. When these results are factored into the useful mechanical properties and slow degradability of this protein biomaterial matrix, potential utility in tissue-engineered blood vessels can be envisioned. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Zhang, Xiaohui; Kaplan, David L.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Zhang, Xiaohui; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Baughman, Cassandra B.; Kaplan, David L.] Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem & Biol Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Zhang, Xiaohui/C-4569-2013
FU PHS HHS [P41]; NIBIB NIH HHS [P41 EB002520, P41 EB002520-05]
CR AUERBACH R, 1991, PHARMACOL THERAPEUT, V51, P1, DOI 10.1016/0163-7258(91)90038-N
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Collen A, 1998, Angiogenesis, V2, P153, DOI 10.1023/A:1009240522808
   Conte MS, 1998, FASEB J, V12, P43
   DAVIE EW, 1995, THROMB HAEMOSTASIS, V74, P1
   GAMBLE JR, 1993, J CELL BIOL, V121, P931, DOI 10.1083/jcb.121.4.931
   HERRING MB, 1991, J VASC SURG, V13, P731
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   LEAH S, IN PRESS J BIOMATER
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Montanez Eloi, 2002, Angiogenesis, V5, P167, DOI 10.1023/A:1023837821062
   Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 31
TC 206
Z9 239
U1 3
U2 122
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2008
VL 29
IS 14
BP 2217
EP 2227
DI 10.1016/j.biomaterials.2008.01.022
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289PH
UT WOS:000255065900007
PM 18279952
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zeugolis, DI
   Khew, ST
   Yew, ESY
   Ekaputra, AK
   Tong, YW
   Yung, LYL
   Hutmacher, DW
   Sheppard, C
   Raghunath, M
AF Zeugolis, Dimitrios I.
   Khew, Shih T.
   Yew, Elijah S. Y.
   Ekaputra, Andrew K.
   Tong, Yen W.
   Yung, Lin-Yue L.
   Hutmacher, Dietmar W.
   Sheppard, Colin
   Raghunath, Michael
TI Electro-spinning of pure collagen nano-fibres - Just an expensive way to
   make gelatin?
SO BIOMATERIALS
LA English
DT Editorial Material
DE collagen denaturation; gelatin; denaturation temperature; second
   harmonic generation; transmission electron microscopy; circular
   dichroism
ID TISSUE ENGINEERING SCAFFOLDS; 2ND-HARMONIC GENERATION; FIBRIL FORMATION;
   MECHANICAL-PROPERTIES; CIRCULAR-DICHROISM; MOLECULAR PACKING; I
   COLLAGEN; CROSS-LINKING; RAT TENDON; INVITRO
AB Scaffolds manufactured from biological materials promise better clinical functionality, providing that characteristic features are preserved. Collagen, a prominent biopolymer, is used extensively for tissue engineering applications, because its signature biological and physico-chemical properties are retained in in vitro preparations. We show here for the first time that the very properties that have established collagen as the leading natural biomaterial are lost when it is electro-spun into nano-fibres out of fluoroalcohols such as 1,1,1,3,3,3-hexafluoro-2-propanol or 2,2,2-trifluoroethanol. We further identify the use of fluoroalcohols as the major culprit in the process. The resultant nano-scaffolds lack the unique ultra-structural axial periodicity that confirms quarter-staggered supramolecular assemblies and the capacity to generate second harmonic signals, representing the typical crystalline triple-helical structure. They were also characterised by low denaturation temperatures, similar to those obtained from gelatin preparations (p > 0.05). Likewise, circular dichroism spectra revealed extensive denaturation of the electro-spun collagen. Using pepsin digestion in combination with quantitative SDS-PAGE, we corroborate great losses of up to 99% of triple-helical collagen. In conclusion, electro-spinning of collagen out of fluoroalcohols effectively denatures this biopolymer, and thus appears to defeat its purpose, namely to create biomimetic scaffolds emulating the collagen structure and function of the extracellular matrix. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Zeugolis, Dimitrios I.; Raghunath, Michael] Natl Univ Singapore, Tissue Modulat Lab, Singapore 117510, Singapore.
   [Zeugolis, Dimitrios I.; Yew, Elijah S. Y.; Ekaputra, Andrew K.; Tong, Yen W.; Hutmacher, Dietmar W.; Sheppard, Colin; Raghunath, Michael] Natl Univ Singapore, Fac Engn, Div Bioengn, Singapore 117576, Singapore.
   [Zeugolis, Dimitrios I.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Immunol Programme, Singapore 117456, Singapore.
   [Khew, Shih T.; Tong, Yen W.; Yung, Lin-Yue L.] Natl Univ Singapore, Fac Engn, Dept Chem & Biomol Engn, Singapore 117576, Singapore.
   [Hutmacher, Dietmar W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 117597, Singapore.
   [Raghunath, Michael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore.
RP Raghunath, M (reprint author), Natl Univ Singapore, Tissue Modulat Lab, Singapore 117510, Singapore.
EM bierm@nus.edu.sg
RI Khew, Shih Tak/H-1828-2011; Sheppard, Colin/B-9593-2008; Yung,
   Lanry/B-6515-2009; Tong, Yen Wah/D-4602-2009; Raghunath,
   Michael/E-6483-2010
OI Sheppard, Colin/0000-0002-0792-4607; Yung, Lanry/0000-0001-7579-6347;
   Tong, Yen Wah/0000-0002-6004-6284; Raghunath,
   Michael/0000-0002-2138-6614; zeugolis, dimitrios/0000-0002-7599-5191;
   Hutmacher, Dietmar Werner/0000-0001-5678-2134
CR BAILEY AJ, 1992, J SOC LEATH TECH CH, V76, P111
   Bailey AJ, 1998, J SOC LEATH TECH CH, V82, P104
   Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292
   BEAR RS, 1952, ADV PROTEIN CHEM, V7, P69, DOI 10.1016/S0065-3233(08)60018-2
   Bigi A, 2004, BIOMATERIALS, V25, P5675, DOI 10.1016/j.biomaterials.2004.01.033
   BIRK DE, 1990, J CELL SCI, V95, P649
   BRODSKYDOYLE B, 1976, BIOCHEM J, V159, P279, DOI 10.1042/bj1590279
   BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   CHU FH, 1974, BIOPOLYMERS, V13, P1427, DOI 10.1002/bip.1974.360130713
   COMPER WD, 1977, BIOPOLYMERS, V16, P2113, DOI 10.1002/bip.1977.360161004
   Cort JR, 1997, BIOCHEM BIOPH RES CO, V233, P687, DOI 10.1006/bbrc.1997.6524
   Cox G, 2003, J STRUCT BIOL, V141, P53, DOI 10.1016/S1047-8477(02)00576-2
   COX G, 2003, P SPIE
   DANIELSEN CC, 1981, MECH AGEING DEV, V15, P269, DOI 10.1016/0047-6374(81)90135-4
   DOYLE BB, 1978, BIOCHIM BIOPHYS ACTA, V535, P25
   FINCH A, 1974, BIOCHIM BIOPHYS ACTA, V365, P400, DOI 10.1016/0005-2795(74)90012-9
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   GELMAN RA, 1979, J BIOL CHEM, V254, P1741
   GROSS J, 1954, P NATL ACAD SCI USA, V40, P679, DOI 10.1073/pnas.40.8.679
   GROSS J, 1955, P NATL ACAD SCI USA, V41, P1, DOI 10.1073/pnas.41.1.1
   HIGHBERGER JH, 1951, P NATL ACAD SCI USA, V37, P286, DOI 10.1073/pnas.37.5.286
   Holmes DF, 2001, MICRON, V32, P273, DOI 10.1016/S0968-4328(00)00040-8
   HOLMES DF, 1986, INT J BIOL MACROMOL, V8, P161, DOI 10.1016/0141-8130(86)90020-6
   Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t
   HORMANN H, 1971, BIOCHEMISTRY-US, V10, P932
   HSU S, 1994, BIORHEOLOGY, V31, P21
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huang YF, 2001, EXP EYE RES, V73, P521, DOI 10.1006/exer.2001.1057
   Hulmes DJS, 1992, ESSAYS BIOCHEM, V27, P49
   HULMES DJS, 1985, J MOL BIOL, V184, P473, DOI 10.1016/0022-2836(85)90295-5
   HULMES DJS, 1979, NATURE, V282, P878, DOI 10.1038/282878a0
   HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7
   HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1
   Jarvinen TAH, 2004, J ORTHOP RES, V22, P1303, DOI 10.1016/j.orthres.2004.04.003
   JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   Kielty CM, 2002, CONNECTIVE TISSUE IT, P159
   Kim BM, 2000, LASER SURG MED, V27, P329, DOI 10.1002/1096-9101(2000)27:4<329::AID-LSM5>3.0.CO;2-C
   KOPP J, 1989, Matrix, V9, P443
   Kundu A, 2004, BIOPOLYMERS, V73, P405, DOI 10.1002/bip.20014
   Kwon IK, 2005, BIOMACROMOLECULES, V6, P2096, DOI 10.1021/bm050086u
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   LIGHT ND, 1985, METHODS SKIN RES, P559
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mentink CJAL, 2002, CLIN CHIM ACTA, V321, P69, DOI 10.1016/S0009-8981(02)00097-9
   Paul R Gordon, 2003, ScientificWorldJournal, V3, P138
   Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976
   RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   SILVER FH, 1984, INT J BIOL MACROMOL, V6, P125, DOI 10.1016/0141-8130(84)90052-7
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Theodossiou TA, 2006, BIOPHYS J, V91, P4665, DOI 10.1529/biophysj.106.093740
   Tsereteli G. I., 1991, POLYM SCI, V33, P2112
   Usha R, 2004, THERMOCHIM ACTA, V409, P201, DOI 10.1016/S0040-6031(03)00335-6
   Van Der Rest Michel, 1993, V6, P1
   VEIS A, 1961, ARCH BIOCHEM BIOPHYS, V94, P20, DOI 10.1016/0003-9861(61)90005-4
   WANG MC, 1994, BIOMATERIALS, V15, P507
   Wess TJ, 1998, J MOL BIOL, V275, P255, DOI 10.1006/jmbi.1997.1449
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   ZEUGOLIS DI, J BIOMEDICAL MAT R A
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang ZK, 2006, J SOC LEATH TECH CH, V90, P23
   Zhong SP, 2007, MAT SCI ENG C-BIO S, V27, P262, DOI 10.1016/j.msec.2006.05.010
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
NR 78
TC 299
Z9 305
U1 7
U2 108
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2008
VL 29
IS 15
BP 2293
EP 2305
DI 10.1016/j.biomaterials.2008.02.009
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289YB
UT WOS:000255088700001
PM 18313748
DA 2018-10-20
ER

PT J
AU Gupta, S
   Hunter, M
   Cebe, P
   Levitt, JM
   Kaplan, DL
   Georgakoudi, I
AF Gupta, Sharad
   Hunter, Martin
   Cebe, Peggy
   Levitt, Jonathan M.
   Kaplan, David L.
   Georgakoudi, Irene
TI Non-invasive optical characterization of biomaterial mineralization
SO BIOMATERIALS
LA English
DT Article
DE silk; fibroin; tissue engineering; polarization; light scattering
ID MORI SILK FIBROIN; LIGHT-SCATTERING SPECTROSCOPY; AIR-WATER-INTERFACE;
   BIOLOGICAL TISSUE; CRYSTAL-STRUCTURE; TRANSITION; DYSPLASIA; PROTEINS;
   MINERALS; APATITE
AB Current approaches to study biomaterial mineralization are invasive and prevent dynamic characterization of this process within the same sample. Polarized light scattering spectroscopy (LSS) may offer a non-invasive alternative for assessing the levels of mineralization as well as some aspects of the organization of the mineral deposits. Specifically, we used LSS to characterize the formation of hydroxyapatite deposits on three types of silk films (water-annealed, methanol-treated and polyaspartic acid (PAA)-mixed) following 1, 3, 5 and 7 cycles of mineralization. We found that the total light scattering intensity provided a quantitative measure of the degree of mineralization as confirmed by thermal gravimetric analysis (TGA). The PAA-mixed silk films yielded the highest level of mineral deposition and the water-annealed ones the least, consistent with the beta sheet content of the films prior to the onset of mineralization. The wavelength dependence of the singly backscattered light was consistent with a self-affine fractal morphology of the deposited films within scales in the range of 150-300 nm; this was confirmed by Fourier analysis of scanning electron microscopy (SEM) images of the corresponding films. The deposits of minerals in the water-annealed films were predominantly flake-like, with positively correlated density fluctuations (Hurst parameter, H > 0.5), whereas methanol-treated and PAA-mixed silk films resulted in densely-packed, bulk mineral deposits with negatively correlated density fluctuations (H < 0.5). Therefore, LSS could serve as a valuable tool for understanding the role of biomaterial properties in mineral formation, and, ultimately, for optimizing biomaterial designs that yield mineral deposits with the desired organization. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Gupta, Sharad; Hunter, Martin; Levitt, Jonathan M.; Kaplan, David L.; Georgakoudi, Irene] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Cebe, Peggy] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
RP Georgakoudi, I (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colgby St, Medford, MA 02155 USA.
EM Irene.Georgakoudi@tufts.edu
RI Gupta, Sharad/C-3481-2013
OI Gupta, Sharad/0000-0003-2521-0170; Cebe, Peggy/0000-0002-8721-644X
FU NIBIB NIH HHS [P41 EB002520, P41 EB002520-04]
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Backman V, 1999, IEEE J SEL TOP QUANT, V5, P1019, DOI 10.1109/2944.796325
   Backman V, 2000, NATURE, V406, P35
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Dougherty G, 2001, MED ENG PHYS, V23, P369, DOI 10.1016/S1350-4533(01)00057-1
   Drezek R, 2001, PHOTOCHEM PHOTOBIOL, V73, P636, DOI 10.1562/0031-8655(2001)073<0636:AMOFCT>2.0.CO;2
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Frankel RB, 2003, REV MINERAL GEOCHEM, V54, P95, DOI 10.2113/0540095
   Gil ES, 2006, BIOMACROMOLECULES, V7, P728, DOI 10.1021/bm050622i
   Gurjar RS, 2001, NAT MED, V7, P1245, DOI 10.1038/nm1101-1245
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hunter M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.138102
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Kim YL, 2003, IEEE J SEL TOP QUANT, V9, P243, DOI 10.1109/JSTQE.2003.814183
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Li CM, 2005, J MATER RES, V20, P3374, DOI 10.1557/JMR.2005.0425
   LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198
   Mandelbrot B B, 2000, FRACTAL GEOMETRY NAT
   MANN S, 1983, STRUCT BOND, V54, P125
   MANN S, 2001, BIORNINERALIZATION P
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Perelman LT, 1998, PHYS REV LETT, V80, P627, DOI 10.1103/PhysRevLett.80.627
   POWER WL, 1991, J GEOPHYS RES-SOLID, V96, P415, DOI 10.1029/90JB02107
   Schmitt JM, 1996, OPT LETT, V21, P1310, DOI 10.1364/OL.21.001310
   SIMUKANGA S, 1995, FERT RES, V41, P159, DOI 10.1007/BF00750758
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Valluzzi R, 1997, BIOPOLYMERS, V42, P705, DOI 10.1002/(SICI)1097-0282(199711)42:6<705::AID-BIP8>3.0.CO;2-Y
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   VOSS RF, 1986, PHYS SCRIPTA, VT13, P27, DOI 10.1088/0031-8949/1986/T13/004
   Wallace MB, 2000, GASTROENTEROLOGY, V119, P677, DOI 10.1053/gast.2000.16511
   Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001
   YOUNGJUAN R, 2007, FRONT MAT SCI CHINA, V1, P258
NR 35
TC 10
Z9 10
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2008
VL 29
IS 15
BP 2359
EP 2369
DI 10.1016/j.biomaterials.2008.01.034
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289YB
UT WOS:000255088700007
PM 18313137
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yang, Q
   Peng, J
   Guo, QY
   Huang, JX
   Zhang, L
   Yao, J
   Yang, F
   Wang, SG
   Xu, WJ
   Wang, AY
   Lu, SB
AF Yang, Qiang
   Peng, Jiang
   Guo, Quanyi
   Huang, Jingxiang
   Zhang, Li
   Yao, Jun
   Yang, Fei
   Wang, Shenguo
   Xu, Wenjing
   Wang, Aiyuan
   Lu, Shibi
TI A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo
   cartilage tissue engineering with PKH26-labeled chondrogenic bone
   marrow-derived mesenchymal stem cells
SO BIOMATERIALS
LA English
DT Article
DE cartilage tissue engineering; ECM (extracellular matrix); fluorescence;
   decellularization; scaffolds
ID ARTICULAR-CARTILAGE; CROSS-LINKING; MODEL; REPAIR; DIFFERENTIATION;
   RECONSTRUCTION; BIOMATERIALS; IMPLANTATION
AB We developed a natural, acellular, 3-D interconnected porous scaffold derived from cartilage extracellular matrix (ECM). Human cartilage was physically shattered, then decellularized sequentially with use of hypotonic buffer, TritonX-100, and a nuclease solution and made into a suspension. The scaffold was fabricated by simple freeze-drying and cross-linking techniques. On histology, scaffolds showed most of the ECM components after removal of the cell fragments, and scanning electron microscopy revealed a 3-D interconnected porous structure. Cellular viability assay revealed no cytotoxic effects. In vitro study showed that the novel scaffold could provide a suitable 3-D environment to support the adheration, proliferation and differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) to chondrocytes in culture with chondrogenic medium after 21 days. Chondrogenically induced BMSCs labeled with fluorescent dye PKH26 were then grown on scaffolds and implanted subcutaneously into nude mice. Four weeks later, cartilage-like tissue formed, with positive staining for Safranin 0, tuoluidine blue and collagen H. Cells in the samples seemed to confirm that they originated from the labeled BMSCs, as confirmed by in vivo fluorescent imaging and immunofluorescence examination. In conclusion, the cartilage ECM-derived porous scaffold shows potential as biomaterial for cartilage tissue engineering, and PKH26 fluorescent labeling and in vivo fluorescent imaging can be useful for cell tracking and analyzing cell-scaffold constructs in vivo. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Yang, Qiang; Peng, Jiang; Guo, Quanyi; Huang, Jingxiang; Zhang, Li; Yao, Jun; Xu, Wenjing; Wang, Aiyuan; Lu, Shibi] Chinese Peoples Liberat Army Gen Hosp, Inst Orthoped, Key Lab People Liberat Army, Beijing 100853, Peoples R China.
   [Yang, Fei; Wang, Shenguo] Chinese Acad Sci, Inst Chem, BNLMS State Key Lab Polymer Phys & Chem, Beijing 100080, Peoples R China.
RP Lu, SB (reprint author), Chinese Peoples Liberat Army Gen Hosp, Inst Orthoped, Key Lab People Liberat Army, 28 Fuxing Rd, Beijing 100853, Peoples R China.
EM shibilu301@gmail.com
CR Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Blum JS, 2004, BIOMATERIALS, V25, P5809, DOI 10.1016/j.biomaterials.2004.01.035
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Chen JW, 2005, CELL TISSUE RES, V319, P429, DOI 10.1007/s00441-004-1025-0
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   de Boer J, 2006, BIOMATERIALS, V27, P1851, DOI 10.1016/j.biomaterials.2005.09.034
   Dell'Accio F, 2003, J ORTHOPAED RES, V21, P123, DOI 10.1016/S0736-0266(02)00090-6
   Flynn L, 2007, BIOMATERIALS, V28, P3834, DOI 10.1016/j.biomaterials.2007.05.002
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Grogan SP, 2002, J PATHOL, V198, P5, DOI 10.1002/path.1169
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Iyer M, 2002, MOL THER, V6, P555, DOI 10.1006/mthe.2002.0700
   Kamelger FS, 2004, BIOMATERIALS, V25, P1649, DOI 10.1016/S0142-9612(03)00520-9
   Kelley TF, 2002, OTOLARYNG HEAD NECK, V127, P265, DOI 10.1067/mhn.2002.128344
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Quintavalla J, 2002, BIOMATERIALS, V23, P109, DOI 10.1016/S0142-9612(01)00086-2
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   Roman I, 2007, BIOMATERIALS, V28, P2718, DOI 10.1016/j.biomaterials.2007.02.011
   Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006
   Song L, 2004, CYTOTHERAPY, V6, P596, DOI 10.1080/14653240410005276
   Spector M, 2006, SWISS MED WKLY, V136, P293
   Tatebe M, 2005, CYTOTHERAPY, V7, P520, DOI 10.1080/14653240500361350
   Uematsu K, 2005, BIOMATERIALS, V26, P4273, DOI 10.1016/j.biomaterials.2004.10.037
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6
   Wu JC, 2002, CIRCULATION, V105, P1631, DOI 10.1161/01.CIR.0000014984.95520.AD
   Zhou GD, 2006, TISSUE ENG, V12, P3209, DOI 10.1089/ten.2006.12.3209
NR 32
TC 155
Z9 185
U1 7
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2008
VL 29
IS 15
BP 2378
EP 2387
DI 10.1016/j.biomaterials.2008.01.037
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289YB
UT WOS:000255088700009
PM 18313139
DA 2018-10-20
ER

PT J
AU Park, KM
   Bae, JW
   Joung, YK
   Shin, JW
   Park, KD
AF Park, Kyung Min
   Bae, Jin Woo
   Joung, Yoon Ki
   Shin, Jung Woog
   Park, Ki Dong
TI Nanoaggregate of thermosensitive chitosan-pluronic for sustained release
   of hydrophobic drug
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE chitosan; pluronic; nanoaggregate; sustained release; indomethacin
ID POLYMERIC MICELLES; POLY(ETHYLENE GLYCOL); BLOCK-COPOLYMERS; IN-VITRO;
   DELIVERY; BEHAVIOR; NANOPARTICLES; BIOMATERIAL; CARRIERS; DESIGN
AB A thermo-sensitive chitosan-Pluromic copolymer (CP) was prepared by grafting mono-carboxyl Pluronic onto the chitosan using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and N-hydroxysuccinimide (NHS). Indomethacin (IMC)-loaded nanoaggregate (NA) was prepared using the synthesized CP by the direct dissolution method. The critical aggregate concentration (CAC), hydrodynamic size and surface morphology of the prepared CP nanoaggregate (CPNA) were characterized by fluorescence spectroscopy, dynamic light scattering (DLS), and transmission electron microscopy (TEM), respectively. The resulting CAC and the average diameter of CPNA were about 0.31 g/l and 120 nm, indicating high structural stability of CPNA and size favorable for intravenous delivery of drugs. In vitro release test of the IMC encapsulated into CPNA showed sustained release rate of IMC as compared with that from Pluronic micelle. Therefore, we can conclude that our CPNA can be a novel type of superior drug carrier for sustained delivery of hydrophobic drugs. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Park, Kyung Min; Bae, Jin Woo; Joung, Yoon Ki; Park, Ki Dong] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
   [Shin, Jung Woog] Inje Univ, Dept Biomed Engn, Gimhae 621749, South Korea.
RP Park, KD (reprint author), Ajou Univ, Dept Mol Sci & Technol, 5 Wonchon, Suwon 443749, South Korea.
EM kdp@ajou.ac.kr
OI joung, yoon ki/0000-0001-8661-481X
CR ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
   Allen C, 1999, COLLOID SURFACE B, V16, P3, DOI 10.1016/S0927-7765(99)00058-2
   Bae JW, 2006, MACROMOL RES, V14, P461, DOI 10.1007/BF03219111
   Cha J, 2006, MACROMOL RES, V14, P573, DOI 10.1007/BF03218726
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chung HJ, 2005, CURR APPL PHYS, V5, P485, DOI 10.1016/j.cap.2005.01.015
   Chung JE, 1999, J CONTROL RELEASE, V62, P115, DOI 10.1016/S0168-3659(99)00029-2
   Gan ZH, 1999, MACROMOLECULES, V32, P590, DOI 10.1021/ma981121a
   Hong SW, 2005, MACROMOL RES, V13, P397, DOI 10.1007/BF03218472
   KABANOV AV, 1995, MACROMOLECULES, V28, P2303, DOI 10.1021/ma00111a026
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Kalyanasundoram K., 1988, J AM CHEM SOC, V99, P2039
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kim IS, 2000, INT J PHARM, V205, P165, DOI 10.1016/S0378-5173(00)00501-9
   Kim SY, 1998, J CONTROL RELEASE, V51, P13, DOI 10.1016/S0168-3659(97)00124-7
   KOSSOVSK N, 1997, BIOL TECHNOL, V11, P1534
   Lee JH, 2003, INT J PHARM, V251, P23, DOI 10.1016/S0378-5173(02)00582-3
   Lee JY, 2004, J CONTROL RELEASE, V94, P323, DOI 10.1016/j.conrel.2003.10.012
   Liu SQ, 2005, BIOMATERIALS, V26, P5064, DOI 10.1016/j.biomaterials.2005.01.030
   Martin H., 2005, J CONTROL RELEASE, V103, P137
   MIYAZAKI S, 1981, CHEM PHARM BULL, V29, P3067
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   PRASAD KN, 1982, J COLLOID INTERF SCI, V90, P303
   Soga O, 2005, J CONTROL RELEASE, V103, P341, DOI 10.1016/j.jconrel.2004.12.009
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   Sugimoto H, 2005, POLYMER, V46, P10800, DOI 10.1016/j.polymer.2005.09.005
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   WILHELM M, 1991, MACROMOLECULES, V24, P1033, DOI 10.1021/ma00005a010
   Yokoyama M, 1998, J CONTROL RELEASE, V50, P79, DOI 10.1016/S0168-3659(97)00115-6
   YOKOYAMA M, 1991, CANCER RES, V51, P3229
NR 30
TC 48
Z9 50
U1 3
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2008
VL 63
IS 1
BP 1
EP 6
DI 10.1016/j.colsurfb.2007.10.024
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 293JU
UT WOS:000255332400001
PM 18314312
DA 2018-10-20
ER

PT J
AU Goda, T
   Matsuno, R
   Konno, T
   Takai, M
   Ishihara, K
AF Goda, Tatsuro
   Matsuno, Ryosuke
   Konno, Tomohiro
   Takai, Madoka
   Ishihara, Kazuhiko
TI Photografting of 2-methacryloyloxyethyl phosphorylcholine from
   polydimethylsiloxane: Tunable protein repellency and lubrication
   property
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE polydimethylsiloxane; phosphorylcholine; photografting; protein
   adsorption; lubrication
ID LIVING GRAFT-POLYMERIZATION; PDMS MICROFLUIDIC CHANNELS;
   POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE); PHOSPHOLIPID POLYMER;
   MOLECULAR-DYNAMICS; WATER INTERACTION; ADHERENT CELLS; SURFACE;
   ADSORPTION; COPOLYMERS
AB The phosphorylcholine group functional methacrylate monomer, 2-methacryloyloxyethyl phosphory1choline (MPC), was graft polymerized from the polydimethylsiloxane (PDMS) substrate using ultraviolet irradiation and using benzophenone as a photoinitiator. The varying monomer concentrations and irradiation times were investigated in order to verify the relationships between graft density and protein resistance under specific biological conditions. The ellipsometry analysis revealed that the layer thickness of the grafted polymer depended on the monomer concentrations after the irradiation for 1 min, however, it stabilized thereafter in all the specified conditions. The curve fitting of the C Is spectrum obtained by X-ray photoelectron spectroscopy analysis showed that the amount of grafted polymer increased with an increase in both monomer concentration and irradiation time. Atomic force microscopic images revealed that the terminations among the graft chains became dominant due to magnified chain mobility followed by growth of their length. In vitro albumin and fibrinogen adsorption results indicated that the resistance to protein adsorption was easily tuned by the specified conditions due to the controlled graft density. Lubrication was dramatically enhanced by the grafting and it was further promoted by an increase in the graft density in good solvents, indicating that the interactions between the graft chains and the solvents resulted in the lubrication system. These basic findings regarding the grafted PDMS surface are important for versatile applications, including its use as a biomaterial and microfluidic device. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Goda, Tatsuro; Matsuno, Ryosuke; Konno, Tomohiro; Takai, Madoka; Ishihara, Kazuhiko] Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Goda, Tatsuro; Matsuno, Ryosuke; Konno, Tomohiro; Takai, Madoka; Ishihara, Kazuhiko] Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan.
   [Ishihara, Kazuhiko] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Ishihara, K (reprint author), Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ishihara@mpc.t.u-tokyo.ac.jp
RI Goda, Tatsuro/B-6484-2011; Konno, Tomohiro/E-5244-2011
OI Goda, Tatsuro/0000-0003-2688-8186; Konno, Tomohiro/0000-0002-7814-3306
CR BEAMSON G, 1992, HDB HIGH RESOLUTION, pCH15
   Bhattacharya A, 2004, PROG POLYM SCI, V29, P767, DOI 10.1016/j.progpolymsci.2004.05.002
   Christman KL, 2006, SOFT MATTER, V2, P928, DOI 10.1039/b611000b
   Ebara M, 2006, LAB CHIP, V6, P843, DOI 10.1039/b515128g
   Eteshola E, 2001, SENSOR ACTUAT B-CHEM, V72, P129, DOI 10.1016/S0925-4005(00)00640-7
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Feng W, 2006, BIOINTERPHASES, V1, P50, DOI 10.1116/1.2187495
   Goda T, 2007, COLLOID SURFACE B, V54, P67, DOI 10.1016/j.colsurfb.2006.09.006
   Goda T, 2006, BIOMATERIALS, V27, P5151, DOI 10.1016/j.biomaterials.2006.05.046
   Ho SP, 2003, BIOMATERIALS, V24, P5121, DOI 10.1016/S0142-9612(03)00450-2
   Hu SW, 2004, ANAL CHEM, V76, P1865, DOI 10.1021/ac049937z
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Ishihara K, 2000, COLLOID SURFACE B, V18, P325, DOI 10.1016/S0927-7765(99)00158-7
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Iwasaki Y, 2007, COLLOID SURFACE B, V57, P226, DOI 10.1016/j.colsurfb.2007.02.007
   Iwata R, 2004, BIOMACROMOLECULES, V5, P2308, DOI 10.1021/bm049613k
   Kato K, 2003, PROG POLYM SCI, V28, P209, DOI 10.1016/S0079-6700(02)00032-1
   Kiritoshi Y, 2002, J BIOMAT SCI-POLYM E, V13, P213, DOI 10.1163/156856202317414384
   KIRITOSHI Y, 2003, ADV MATER, V4, P93
   Kitano H, 2005, LANGMUIR, V21, P11932, DOI 10.1021/la0515571
   Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673
   Kitano H, 2000, J PHYS CHEM B, V104, P11425, DOI 10.1021/jp000429c
   Kyomoto M, 2007, J BIOMED MATER RES A, V82A, P10, DOI 10.1002/jbm.a.31134
   Kyomoto M, 2007, BIOMATERIALS, V28, P3121, DOI 10.1016/j.biomaterials.2007.03.010
   Lam JKW, 2004, J CONTROL RELEASE, V100, P293, DOI 10.1016/j.jconrel.2004.08.028
   Ma HM, 2000, MACROMOLECULES, V33, P331, DOI 10.1021/ma990821s
   Matsuda Y, 2006, CHEM LETT, V35, P1310, DOI 10.1246/cl.2006.1310
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   Muller MT, 2005, MACROMOLECULES, V38, P3861, DOI 10.1021/ma047468x
   OGIWARA Y, 1981, J POLYM SCI POL LETT, V19, P457, DOI 10.1002/pol.1981.130190905
   OSTER G, 1957, J POLYM SCI, V26, P233, DOI 10.1002/pol.1957.1202611311
   Patel JD, 2005, J BIOMED MATER RES A, V73A, P359, DOI 10.1002/jbm.a.30302
   Pu QS, 2007, LANGMUIR, V23, P1577, DOI 10.1021/la062662t
   Ruiz L, 1998, BIOMATERIALS, V19, P987, DOI 10.1016/S0142-9612(97)00197-X
   Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433
   Sawada SI, 2006, J BIOMED MATER RES A, V79A, P476, DOI 10.1002/jbm.a.30820
   SEIBER RP, 1975, J APPL POLYM SCI, V19, P2187, DOI 10.1002/app.1975.070190812
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   SMITH PK, 1985, ANAL BIOCHEM, V150, P6
   Tamai Y, 1996, MACROMOLECULES, V29, P6750, DOI 10.1021/ma951635z
   Tamai Y, 1996, MACROMOLECULES, V29, P6761, DOI 10.1021/ma960961r
   UCHIDA E, 1993, J APPL POLYM SCI, V47, P417, DOI 10.1002/app.1993.070470305
   UEDA T, 1995, J BIOMED MATER RES, V29, P381, DOI 10.1002/jbm.820290313
   Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084
   Ulbricht M, 1997, J MEMBRANE SCI, V136, P25, DOI 10.1016/S0376-7388(97)00151-8
   Wang YL, 2006, LANGMUIR, V22, P2719, DOI 10.1021/la053188e
   WRIGHT AN, 1967, NATURE, V215, P953, DOI 10.1038/215953a0
   Yang WT, 1996, MACROMOLECULES, V29, P3308, DOI 10.1021/ma9515543
   YAO ZP, 1990, J APPL POLYM SCI, V41, P1469, DOI 10.1002/app.1990.070410710
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
NR 55
TC 36
Z9 37
U1 2
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2008
VL 63
IS 1
BP 64
EP 72
DI 10.1016/j.colsurfb.2007.11.014
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 293JU
UT WOS:000255332400010
PM 18226507
DA 2018-10-20
ER

PT J
AU Ma, LJ
   Wen, HP
AF Ma, Lijuan
   Wen, Jianping
TI Biocomposite of double-walled carbon nanotube-doped alginate gel for
   biomaterial immobilization
SO COMPOSITES SCIENCE AND TECHNOLOGY
LA English
DT Article
DE carbon nanotubes; hybrid composites; mechanical properties; scanning
   electron microscopy (SEM); transmission electron microscopy (TEM)
ID ENZYME IMMOBILIZATION; BIOCOMPATIBILITY; MICROCAPSULES; ADSORPTION;
   MECHANISM
AB An efficient support for biomaterial immobilization, double-walled carbon nanotube-doped alginate gel (DWCNT-ALG) hybrid composite, was studied in this work. DWCNTs were cut by mixed acids to get a homogeneous dispersion in an aqueous solution. Fourier transform infrared spectroscopy (FTIR) was employed to analyze the structure of shortened DWCNTs. Bovine serum albumin (BSA), the model biomaterial, was immobilized in DWCNT-ALG composites. Mixture of DWCNTs and BSA were suspended in ALG homogenously and then added into a calcium chloride solution dropwise to form biocomposite beads. Transmission and scanning electron microscope (TEM and SEM) images confirmed the adsorption of BSA on DWCNTs and the uniform distribution of DWCNTs in ALG, respectively. Water loss and BSA leakage from the BSA-DWCNT-ALG biocomposites were reduced to 46.48% and 19.28%, respectively, compared with those from BSA-ALG biocomposites. These DWCNT-ALG biocomposites showed high efficiency in BSA immobilization. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Ma, Lijuan; Wen, Jianping] Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300072, Peoples R China.
RP Wen, HP (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300072, Peoples R China.
EM jpwen@tju.edu.cn
CR Asuri P, 2006, J AM CHEM SOC, V128, P1046, DOI 10.1021/ja0573965
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Bunger CM, 2003, J BIOMED MATER RES A, V67A, P1219, DOI 10.1002/jbm.a.10094
   Cheng H, 2001, J AM CHEM SOC, V123, P5845, DOI 10.1021/ja0155231
   Endo M, 2004, NANO LETT, V4, P1451, DOI 10.1021/nl0492483
   Jiang ZY, 2006, J BIOMAT SCI-POLYM E, V17, P21, DOI 10.1163/156856206774879144
   Karajanagi SS, 2004, LANGMUIR, V20, P11594, DOI 10.1021/la047994h
   Kim YJ, 2000, J APPL POLYM SCI, V78, P1797, DOI 10.1002/1097-4628(20001205)78:10<1797::AID-APP110>3.0.CO;2-M
   King A, 2003, J BIOMED MATER RES A, V64A, P533, DOI 10.1002/jbm.a.10276
   Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253
   Marshall MW, 2006, CARBON, V44, P1137, DOI 10.1016/j.carbon.2005.11.010
   Miyamoto J, 2006, J AM CHEM SOC, V128, P12636, DOI 10.1021/ja064744+
   Ren WC, 2005, J PHYS CHEM B, V109, P7169, DOI 10.1021/jp0448088
   Seifert DB, 1997, BIOTECHNOL PROGR, V13, P562, DOI 10.1021/bp9700723
   Simpson NE, 2004, BIOMATERIALS, V25, P2603, DOI 10.1016/j.biomaterials.2003.09.046
   Tang DS, 2006, CARBON, V44, P2155, DOI 10.1016/j.carbon.2006.03.023
   Tapia C, 2005, BIOMACROMOLECULES, V6, P2389, DOI 10.1021/bm050227s
   Taqieddin E, 2004, BIOMATERIALS, V25, P1937, DOI 10.1016/j.biomaterials.2003.08.034
   Wang Q, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045403
   Wang YJ, 2005, CHEM MATER, V17, P953, DOI 10.1021/cm0483137
   Wei JQ, 2006, ADV MATER, V18, P1695, DOI 10.1002/adna.200501841
   Xu SW, 2006, J MOL CATAL B-ENZYM, V43, P68, DOI 10.1016/j.molcatb.2006.06.026
   Zhang J, 2003, J PHYS CHEM B, V107, P3712, DOI 10.1021/jp027500u
   Zhang L, 2004, J APPL POLYM SCI, V92, P878, DOI 10.1002/app.13708
NR 24
TC 11
Z9 11
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-3538
J9 COMPOS SCI TECHNOL
JI Compos. Sci. Technol.
PD MAY
PY 2008
VL 68
IS 6
BP 1297
EP 1303
DI 10.1016/j.compscitech.2007.12.009
PG 7
WC Materials Science, Composites
SC Materials Science
GA 300AQ
UT WOS:000255797100007
DA 2018-10-20
ER

PT J
AU Sato, H
   Yamada, K
   Pezzotti, G
   Nawa, M
   Ban, S
AF Sato, Hideo
   Yamada, Kiyotaka
   Pezzotti, Giuseppe
   Nawa, Masahiro
   Ban, Seiji
TI Mechanical properties of dental zirconia ceramics changed with
   sandblasting and heat treatment
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE zirconia; sandblasting; heat treatment
ID RAMAN MICROPROBE SPECTROSCOPY; TETRAGONAL ZIRCONIA; FLEXURAL STRENGTH;
   RESIDUAL-STRESSES; SURFACE; TRANSFORMATION; RELIABILITY; NANOCOMPOSITE;
   POLYCRYSTALS; BIOMATERIAL
AB Two types of tetragonal zirconia polycrystals (TZP), a ceria-stabilized TZP/Al2O3 nanocomposite (CZA) and a conventional yttria-stabilized TZP (Y-TZP), were sandblasted with 70-mu m alumina and 125-mu m SiC powders, then partially annealed at 500-1200 degrees C for five minutes. Monoclinic ZrO2 content was determined by X-ray diffractometry and Raman spectroscopy. Biaxial flexure test was conducted on the specimens before and after the treatments. Monoclinic ZrO2 content and biaxial flexure strength increased after sandblasting, but decreased after heat treatment. However, in both cases, the strength of CZA was higher than that of Y-TZP. Raman spectroscopy showed that a compressive stress field was introduced on the sample surface after sandblasting. It was concluded that sandblasting induced tetragonal-to-monoclinic phase transformation and that the volume expansion associated with such a phase transformation gave rise to an increase in compressive stress on the surface of CZA. With the occurrence of such a strengthening mechanism in the microstructure, it was concluded that CZA was more susceptible to stress-induced transformation than Y-TZP.
C1 [Sato, Hideo; Ban, Seiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biomat Sci, Kagoshima 8908544, Japan.
   [Yamada, Kiyotaka; Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068585, Japan.
   [Yamada, Kiyotaka; Pezzotti, Giuseppe] Kyoto Inst Technol, Res Inst Nanosci, Sakyo Ku, Kyoto 6068585, Japan.
   [Nawa, Masahiro] Matsushita Elect Works Ltd, Cent Res Lab, Osaka 5718686, Japan.
RP Ban, S (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biomat Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.
EM sban@denta.hal.kagoshima-u.ac.jp
CR ANUSAVICE KJ, 2003, PHILIPS SCI DENT MAT, P680
   Ban S, 2007, KEY ENG MATER, V330-332, P353, DOI 10.4028/www.scientific.net/KEM.330-332.353
   BAN S, 1990, J DENT RES, V69, P1791, DOI 10.1177/00220345900690120201
   Chevalier J, 1999, J AM CERAM SOC, V82, P3129
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Denry IL, 2006, J BIOMED MATER RES B, V76B, P440, DOI 10.1002/jbm.b.30382
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Filser F, 2001, Int J Comput Dent, V4, P89
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Hasegawa H, 2003, J CERAM SOC JPN, V111, P252, DOI 10.2109/jcersj.111.252
   Katagiri G, 1988, ADV CERAM, V24, P537
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   Kosmac T, 2004, KEY ENG MAT, V254-2, P683, DOI 10.4028/www.scientific.net/KEM.254-256.683
   KOSMAC T, 1981, J AM CERAM SOC, V64, pC72
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   MIYAZAKI T, 2007, DENTISTRY JAPAN, V43, P189
   Nawa M, 1998, CERAM INT, V24, P497, DOI 10.1016/S0272-8842(97)00048-5
   Pezzotti G, 2003, J BIOMED MATER RES A, V65A, P229, DOI 10.1002/jbm.a.10447
   Pezzotti G, 1999, J RAMAN SPECTROSC, V30, P867
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   REED JS, 1977, MATER RES BULL, V12, P949, DOI 10.1016/0025-5408(77)90017-4
   SATO T, 1985, AM CERAM SOC BULL, V64, P1382
   Studart AR, 2007, BIOMATERIALS, V28, P2695, DOI 10.1016/j.biomaterials.2006.12.033
   SWAIN MV, 1980, J MATER SCI, V15, P1577, DOI 10.1007/BF00752140
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   Yamada K, 2007, KEY ENG MATER, V330-332, P373, DOI 10.4028/www.scientific.net/KEM.330-332.373
   Yu MQ, 2003, KEY ENG MAT, V249, P167, DOI 10.4028/www.scientific.net/KEM.249.167
   VITA VM9 WORKING INS
NR 31
TC 124
Z9 132
U1 0
U2 23
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KAMAGOME TS BDG, KOMAGONE, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD MAY
PY 2008
VL 27
IS 3
BP 408
EP 414
DI 10.4012/dmj.27.408
PG 7
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 330XV
UT WOS:000257977000011
PM 18717169
OA Bronze
DA 2018-10-20
ER

PT J
AU Jakubowicz, J
AF Jakubowicz, J.
TI Formation of porous TiOx biomaterials in H3PO4 electrolytes
SO ELECTROCHEMISTRY COMMUNICATIONS
LA English
DT Article
DE titanium oxide; biomaterials; atomic force microscopy; corrosion;
   etching
ID NANOTUBES; ALLOYS
AB In this work, formation of porous TiOx layers and theirs corrosion behavior were studied. Application of H3PO4 electrolytes results in porous TiOx formation. The process is enhanced by small amount of HF content in the electrolyte. The HF results in higher current density, enhancing dissolution. Small 0.5% HF concentration results in nanopores formation, with pore diameter of about 45 nm. Increase of HF concentration up to 10% results in pores with average diameter of about 5.2 mu m. An increase of etching time results in larger pore diameter, but between large 2-5 mu m diameter pores smallest ones were observed with diameter below 200 nm. In the initial etching process a remnants of the flat surface are presents with initial cracks in the surface, indicating places for growth of the pores.
   The TiOx layers can be used as a biomaterial. The corrosion behavior of the layer investigated in Ringer's solution, revealed an excellent corrosion resistance, with respect to pure Ti. (C) 2008 Elsevier B.V. All rights reserved.
C1 Poznan Tech Univ, Inst Mat Sci & Engn, PL-60965 Poznan, Poland.
RP Jakubowicz, J (reprint author), Poznan Tech Univ, Inst Mat Sci & Engn, M Sklodowska Curie 5 Sq, PL-60965 Poznan, Poland.
EM jaroslawjakubowicz@put.poznan.pl
RI Jakubowicz, Jaroslaw/F-7836-2014
OI Jakubowicz, Jaroslaw/0000-0001-6339-0796
CR Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   Brusatori MA, 2003, BIOSENS BIOELECTRON, V18, P1269, DOI 10.1016/S0956-5663(03)00079-4
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Macak JM, 2005, ELECTROCHIM ACTA, V50, P3679, DOI 10.1016/j.electacta.2005.01.014
   Munoz AG, 2007, ELECTROCHIM ACTA, V52, P4167, DOI 10.1016/j.electacta.2006.11.035
   Sgambato A, 2003, MAT SCI ENG C-BIO S, V23, P419, DOI 10.1016/S0928-4931(02)00314-4
   Tsuchiya H, 2005, ELECTROCHEM COMMUN, V7, P576, DOI 10.1016/j.elecom.2005.04.008
   Tsuchiya H, 2006, ELECTROCHIM ACTA, V52, P94, DOI 10.1016/j.electacta.2006.03.087
   Varghese OK, 2003, SENSOR ACTUAT B-CHEM, V93, P338, DOI 10.1016/S0925-4005(03)00222-3
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
NR 10
TC 33
Z9 35
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1388-2481
J9 ELECTROCHEM COMMUN
JI Electrochem. Commun.
PD MAY
PY 2008
VL 10
IS 5
BP 735
EP 739
DI 10.1016/j.elecom.2008.02.027
PG 5
WC Electrochemistry
SC Electrochemistry
GA 311BN
UT WOS:000256575100014
DA 2018-10-20
ER

PT J
AU Merle, M
   Lallemand, B
   Lim, A
   Gantois, G
AF Merle, M.
   Lallemand, B.
   Lim, A.
   Gantois, G.
TI Experimental and clinical evaluation of an absorbable biomaterial
   inducing an anti-adhesive barrier (Divide (R))
SO EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY
LA English
DT Article
ID OXIDIZED REGENERATED CELLULOSE; POTENTIAL MECHANISM; PREVENT ADHESIONS;
   INTERCEED; REDUCTION; MACROPHAGES; SURGERY
AB We evaluated the efficacy of a biomaterial composed of oxidised regenerated cellulose ( Divide) in decreasing the formation of peri-tendinous adhesions in an experimental and clinical study. The experimental study was carried out in 47 New Zealand white rabbits whose Achilles tendons were subjected to a crush injury. The left Achilles tendon served as a control, while the right tendon was wrapped in a sheet of Divide (R). Six weeks later the range of motion at the ankle was measured, the tendons were histologically analysed for peri-tendinous adhesions, the tendon sheath was examined using a scanning electron microscope for determining resorption of the biomaterial and the mechanical properties evaluated. The clinical study was performed on 22 patients; 16 requiring post-traumatic extensor tenolysis and six who underwent dorsal synovectomy for rheumatoid arthritis. A sheet of Divide (R) was placed either between the periosteum and the tendon or around the tendon in all patients. Total active motion and grip strength was evaluated in all patients pre-operatively and at regular intervals post-operatively. The experimental study showed that ankle range of motion was similar between the control and Divide (R) treated groups in two rabbits, better in the Divide (R) group in seven rabbits and better in the control group in two rabbits. The results were not statistically significant (P <= 0.262) since the numbers were quite low. Histological analysis showed that the treated tendon had a better gliding surface and minimal inflammation/reaction compared to the control group. Scanning electron microscopy on the 10th post-operative day revealed the formation of a new tendon sheath in the Divide (R) group. The mechanical properties of both the control and experimental Achilles tendon were similar and comparable to a human tendon. The clinical study demonstrated that Divide (R) was completely resorbed, perfectly biocompatible and non-allergenic. The mean T. A. M. improved from 159.4 degrees to 187.3 degrees (P <= 0.074) and grip strength from -26.7 kgF to 10.7 kgF on the 84th post-op day in the extensor tenolysis group ( 16 digits), while mean return of function to pre-operation level was achieved at 42nd post-operative day and grip strength increased from -3.4 kgF in the immediate, post-operative period to +5.7 kgF at the 84th day in the rheumatoid arthritis group.
C1 [Merle, M.; Lallemand, B.] Inst Europeen Main, F-54320 Maxeville Nancy, France.
   [Merle, M.; Lim, A.; Gantois, G.] Univ Henri Poincare, Inst Europeen Biomat & Microchirurg, F-54506 Vandoeuvre Les Nancy, France.
   [Lim, A.] Natl Univ Singapore, Natl Univ Hosp, Dept Orthopaed Surg, Yong Loo Lin Sch Med, Singapore 119074, Singapore.
RP Merle, M (reprint author), Inst Europeen Main, 13 Rue Blaise Pascal, F-54320 Maxeville Nancy, France.
EM mmerle@pt.lu
CR Diamond MP, 1997, AM J OBSTET GYNECOL, V177, P1320
   DIAMOND MP, 1991, J GYNECOL SURG, V7, P1, DOI 10.1089/gyn.1991.7.1
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V195, P247
   GELBERMAN RH, 1986, J ORTHOPAED RES, V4, P119, DOI 10.1002/jor.1100040116
   Hwang JM, 1999, BRIT J OPHTHALMOL, V83, P788, DOI 10.1136/bjo.83.7.788
   IKEDA K, 2002, J HAND SURG, V7, P11
   Loick J, 1997, Handchir Mikrochir Plast Chir, V29, P209
   MAINARD D, 1988, PROGR RECENT BIOMATE, P193
   MEISLIN RJ, 1990, J APPL BIOMATER, V1, P13, DOI 10.1002/jab.770010104
   Merle M, 1995, 6TH CONGRESS OF THE INTERNATIONAL FEDERATION OF SOCIETIES FOR SURGERY OF THE HAND (IFSSH), P1025
   MERLE M, 1997, HAND SURG CURRENT CO, P33
   Reddy S, 1997, AM J OBSTET GYNECOL, V177, P1315, DOI 10.1016/S0002-9378(97)70070-X
   SEIFER DB, 1990, J GYNECOL SURG, V6, P3, DOI 10.1089/gyn.1990.6.3
   STANLEY JT, COMMUNICATION
   STICKLAND JW, 2000, J HAND SURG-AM, V25, P214
   TEMIZ A, 2007, INT ORTHOP      0309
   Yeo Y, 2007, ANN SURG, V245, P819, DOI 10.1097/01.sla.0000251519.49405.55
NR 17
TC 7
Z9 7
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1633-8065
J9 EUR J ORTHOP SURG TR
JI Eur. J. Orthop. Surg. Traumatol.
PD MAY
PY 2008
VL 18
IS 4
BP 255
EP 263
DI 10.1007/s00590-008-0294-9
PG 9
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 315FG
UT WOS:000256862900001
OA Other Gold
DA 2018-10-20
ER

PT J
AU Luo, YF
   Wang, YH
   Niu, XF
   Shang, JF
AF Luo, Yanfeng
   Wang, Yuanhang
   Niu, Xufeng
   Shang, Juanfang
TI Evaluation of the cytocompatibility of butanediamine- and RGDS-grafted
   poly(DL-lactic acid)
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE poly(DL-lactic acid); biomimetic material; butanediamine; RGDS;
   cytocompatibility
ID OSTEOBLAST ADHESION; SURFACE-CHEMISTRY; MEDIATED ADHESION;
   GENE-EXPRESSION; CELL-GROWTH; BONE-MATRIX; POLYMER; DIFFERENTIATION;
   BIOMATERIALS; HYALURONAN
AB Butanediamine-grafted polylactic acid (BDPLA) is a well-established poly(DL-lactic acid) (PDLLA) based biomaterial with pendant carboxyl groups and amino groups. It has been proved out that BDPLA possesses highly improved hydrophilicity and reduced acidity of degrading products compared with PDLLA. RGDS-PLA is a BDPLA-based biomimetic material obtained by covalently incorporating RGDS adhesion peptide. The objective of this study was to evaluate the cytocompatibility of BDPLA and RGDS-PLA with PDLLA as control. Rat calvarial osteoblasts (ROBs) were seeded on various polymer films, and the morphology, adhesion and spreading, and viability and proliferation of ROBs were assessed by scanning electronic microscopy (SEM), micropipette aspiration system and methylthiazolyl tetrazolium assay (MTT assay), respectively. ALP activity and extracellular calcium production were exploited to characterize the differentiation of ROBs on various polymer films. The affecting mechanisms of BDPLA and RGDS-PLA on the cytocompatibility were extensively explained. The results revealed that the introduction of butanediamine to PDLLA is obviously beneficial to the adhesion, spreading, growth and differentiation of ROB, and the introduction of RGDS adhesive peptide can further improve the cytocompatibility of PDLLA. These results suggest that, in terms of cytocompatibility, BDPLA and RGDS-PLA are promising biomaterials for tissue engineering and other biomedical applications, and RGDS-PLA is a better one. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Luo, Yanfeng; Wang, Yuanhang; Niu, Xufeng; Shang, Juanfang] Chongqing Univ, Res Ctr Bioinspired Mat Sci & Engn, Dept Bioengn, Chongqing 400030, Peoples R China.
   [Niu, Xufeng] Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing 100084, Peoples R China.
RP Luo, YF (reprint author), Chongqing Univ, Res Ctr Bioinspired Mat Sci & Engn, Dept Bioengn, Chongqing 400030, Peoples R China.
EM yfluo@cqu.edu.cn
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 1999, J MATER SCI-MATER M, V10, P815, DOI 10.1023/A:1008992109670
   ARVANITOYANNIS I, 1995, POLYMER, V36, P2947, DOI 10.1016/0032-3861(95)94344-S
   BOHNER M, 2002, J BIOMAT SCI-POLYM E, V13, P732
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Carlisle ES, 2000, TISSUE ENG, V6, P45, DOI 10.1089/107632700320883
   Cohen M, 2006, EMBO J, V25, P302, DOI 10.1038/sj.emboj.7600960
   CURTIS A, 1987, J CELL SCI, V87, P609
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   Elisseeff J, 1997, MACROMOLECULES, V30, P2182, DOI 10.1021/ma961411w
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Igarashi M, 2004, J MOL HISTOL, V35, P3
   Ji J, 2004, BIOMATERIALS, V25, P1859, DOI 10.1016/j.biometerials.2003.08.031
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594
   Kim H, 2003, J BONE MINER METAB, V21, P311, DOI 10.1007/s00774-003-0426-6
   Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R
   Luo YF, 2007, EUR POLYM J, V43, P3856, DOI 10.1016/j.eurpolymj.2007.06.022
   Luo YF, 2004, CHINESE CHEM LETT, V15, P521
   MASSIA SP, 1992, J BIOL CHEM, V267, P10133
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402
   NEBE B, 2007, BIOMOL ENG, DOI DOI 10.1016/J.BIOENG.2007.07.004
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Niu XF, 2005, CHINESE CHEM LETT, V16, P1035
   NIU XF, 2005, J MATER SCI TECHNOL, V20, P571
   Perinpanayagam H, 2006, ARCH ORAL BIOL, V51, P406, DOI 10.1016/j.archoralbio.2005.09.004
   Ponec M, 2002, ADV DRUG DELIVER REV, V54, pS19, DOI 10.1016/S0169-409X(02)00112-6
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Salih V, 2001, BIOMATERIALS, V22, P2817, DOI 10.1016/S0142-9612(01)00026-6
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   Taguchi K, 1988, MACROMOLECULES, V21, P3338
   WHITSON SW, 1992, J BONE MINER RES, V7, P727
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
   Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 51
TC 18
Z9 23
U1 2
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
J9 EUR POLYM J
JI Eur. Polym. J.
PD MAY
PY 2008
VL 44
IS 5
BP 1390
EP 1402
DI 10.1016/j.eurpolymj.2008.01.043
PG 13
WC Polymer Science
SC Polymer Science
GA 306MR
UT WOS:000256253000012
DA 2018-10-20
ER

PT J
AU Bordenave, L
   Menu, P
   Baquey, C
AF Bordenave, Laurence
   Menu, Patrick
   Baquey, Charles
TI Developments towards tissue-engineered, small-diameter arterial
   substitutes
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biomaterial; bioreactor; endothelial cell; scaffold; small-diameter
   vascular substitution; stem cell; vascular graft; vascular tissue
   engineering
ID KNEE FEMOROPOPLITEAL BYPASS; EMBRYONIC STEM-CELLS; VASCULAR GRAFTS;
   IN-VITRO; ENDOTHELIAL-CELLS; BLOOD-VESSELS; PROGENITOR CELLS;
   SHEAR-STRESS; MECHANICAL-PROPERTIES; CLINICAL-EXPERIENCE
AB This article reviews the present state of small-diameter vascular substitution, the mechanisms of graft failure and the ongoing matters of graft design, with particular attention to small-caliber grafts. Tissue engineering of blood vessels with the mechanical properties of native vessels and with the antithrombotic properties required is really a great challenge. Recent advances, however, indicate that the goal of providing a tissue-engineered vascular graft that will remain patent in vivo for substantial periods of time, is achievable. This review describes the specific requirements of the successful replacement artery from a biomaterial- and tissue-engineering perspective, as well as various approaches in vascular tissue engineering including cells and cell sources, scaffolds and their improvements as well as bioreactors and signaling.
C1 [Bordenave, Laurence] Univ Bordeaux 2, INSERM, U577, F-33076 Bordeaux, France.
   [Bordenave, Laurence] CHU Bordeaux, F-33604 Pessac, France.
   [Bordenave, Laurence] INSERM, CIC IT 802, Bordeaux, France.
   [Menu, Patrick] Nancy Univ, UMR 7563, F-54505 Vandoeuvre Les Nancy, France.
RP Bordenave, L (reprint author), Univ Bordeaux 2, INSERM, U577, F-33076 Bordeaux, France.
EM laurence.bordenave@u-bordeaux2.fr; patrick.menu@medecine.uhp-nancy.fr;
   charles.baquey@bordeaux.inserm.fr
CR Abbott W M, 1995, Semin Vasc Surg, V8, P236
   Abbott WM, 1997, J VASC SURG, V25, P19, DOI 10.1016/S0741-5214(97)70317-3
   ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   Adham M, 1996, J SURG RES, V64, P32, DOI 10.1006/jsre.1996.0302
   Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Amiel GE, 2006, TISSUE ENG, V12, P2355, DOI 10.1089/ten.2006.12.2355
   Ao PY, 2000, EUR J VASC ENDOVASC, V20, P241, DOI 10.1053/ejvs.2000.1177
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   BAQUEY C, 1989, C INSERM, P177
   Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   BOCK AK, 2003, 21000 JRCIPTS EUR EN
   Bordenave L, 2005, CLIN HEMORHEOL MICRO, V33, P227
   Bordenave L, 1999, ENDOTHELIUM-J ENDOTH, V6, P267, DOI 10.3109/10623329909078494
   Bos GW, 1998, ARCH PHYSIOL BIOCHEM, V106, P100, DOI 10.1076/apab.106.2.100.4384
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Campbell JH, 1999, CIRC RES, V85, P1173
   CHIEN S, 2005, J PHYSL HEART CIRC P, V292, pH1209
   Conte MS, 1998, FASEB J, V12, P43
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   Evans ND, 2006, MATER TODAY, V9, P26, DOI 10.1016/S1369-7021(06)71740-0
   Farber A, 2003, J VASC SURG, V38, P15, DOI 10.1016/S0741-5214(03)00330-6
   Fernandez P, 2006, TISSUE ENG, V12, P1, DOI 10.1089/ten.2006.12.1
   Fernandez P, 2005, BIOMATERIALS, V26, P5042, DOI 10.1016/j.biomaterials.2005.01.011
   Fernandez P, 2007, TISSUE ENG, V13, P1607, DOI 10.1089/ten.2006.0399
   Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201
   Flanagan TC, 2007, BIOMATERIALS, V28, P3388, DOI 10.1016/j.biomaterials.2007.04.012
   FOSTER ED, 1989, CIRCULATION, V79, P34
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Hamilton DW, 2004, TISSUE ENG, V10, P361, DOI 10.1089/107632704323061726
   Harris DT, 2007, EXPERT OPIN BIOL TH, V7, P1311, DOI 10.1517/14712598.7.9.1311
   HERRING M, 1985, J VASC SURG, V2, P727, DOI 10.1067/mva.1985.avs0020727
   HERRING M, 1978, SURGERY, V84, P498
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   HONGDEWU MH, 1995, J VASC SURG, V21, P862
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kashyap Vikram S, 2002, Vasc Endovascular Surg, V36, P255
   Kerdjoudj H, 2007, CLIN HEMORHEOL MICRO, V37, P89
   Kerdjoudj H, 2007, ADV FUNCT MATER, V17, P2667, DOI 10.1002/adfm.200600795
   Kirkpatrick CJ, 1997, INT J MICROCIRC, V17, P231, DOI 10.1159/000179235
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 2007, TISSUE ENG, V13, P1, DOI 10.1089/ten.2006.0219
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Levenberg S, 2005, CURR OPIN BIOTECH, V16, P516, DOI 10.1016/j.copbio.2005.08.007
   Levenberg S, 2007, BLOOD, V110, P806, DOI 10.1182/blood-2006-08-019190
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marois Y, 1999, ANN VASC SURG, V13, P130, DOI 10.1007/s100169900231
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   McManus MC, 2006, ACTA BIOMATER, V2, P19, DOI 10.1016/j.actbio.2005.09.008
   Meinhart JG, 2005, TISSUE ENG, V11, P887, DOI 10.1089/ten.2005.11.887
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Moby V, 2007, BIOMACROMOLECULES, V8, P2156, DOI 10.1021/bm070348n
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Naito Y, 2003, J THORAC CARDIOV SUR, V125, P419, DOI 10.1067/mtc.2003.134
   NEREM RM, 1984, BIORHEOLOGY, V21, P565
   NIKLASON LE, 1985, SURGERY, V98, P816
   Opitz F, 2007, TISSUE ENG, V13, P2505, DOI 10.1089/ten.2006.0424
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Quinones-Baldrich W J, 1991, Ann Vasc Surg, V5, P163, DOI 10.1007/BF02016750
   Rabkin E, 2002, CARDIOVASC PATHOL, V11, P305, DOI 10.1016/S1054-8807(02)00130-8
   Riha GM, 2005, TISSUE ENG, V11, P1535, DOI 10.1089/ten.2005.11.1535
   ROBERTS PN, 1977, BRIT MED J, V2, P1190, DOI 10.1136/bmj.2.6096.1190-a
   Salacinski HJ, 2002, J BIOMED MATER RES, V59, P207
   Sales KM, 2005, TRENDS BIOTECHNOL, V23, P461, DOI 10.1016/j.tibtech.2005.06.006
   SAUVAGE LR, 1975, ANN SURG, V182, P749, DOI 10.1097/00000658-197512000-00017
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Shi Q, 1997, J VASC SURG, V25, P736, DOI 10.1016/S0741-5214(97)70303-3
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   Song YC, 2000, NAT BIOTECHNOL, V18, P296
   SPARKS CH, 1972, AM J SURG, V124, P244, DOI 10.1016/0002-9610(72)90021-9
   Stanke F, 1998, J VASC SURG, V28, P273, DOI 10.1016/S0741-5214(98)70163-6
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Tassiopoulos AK, 2000, J BIOMAT SCI-POLYM E, V11, P1275, DOI 10.1163/156856200744200
   Teo Wee-Eong, 2006, Biotechnology Journal, V1, P918, DOI 10.1002/biot.200600044
   Thomas AC, 2003, CARDIOVASC PATHOL, V12, P271, DOI 10.1016/S1054-8807(03)00086-3
   Tiaw KS, 2007, BIOMACROMOLECULES, V8, P807, DOI 10.1021/bm060832a
   Tiwari A, 2002, CARDIOVASC SURG, V10, P191, DOI 10.1016/S0967-2109(02)00004-2
   Trommelmans L, 2007, TISSUE ENG, V13, P667, DOI 10.1089/ten.2006.0089
   Vacanti JP, 2007, TISSUE ENG, V13, P231, DOI 10.1089/ten.2006.0351
   Vara DS, 2005, PATHOL BIOL, V53, P599, DOI 10.1016/j.patbio.2004.12.006
   Venkatasubramanian RT, 2006, ANN BIOMED ENG, V34, P823, DOI 10.1007/s10439-005-9044-x
   Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f
   Vunjak-Novakovic G, 2006, TISSUE ENG, V12, P3261, DOI 10.1089/ten.2006.12.3261
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WILSON GJ, 1983, T AM SOC ART INT ORG, V29, P260
   Wusteman M. C., 2000, Cell and Tissue Banking, V1, P295, DOI 10.1023/A:1010167604609
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003
   Yow KH, 2006, BRIT J SURG, V93, P652, DOI 10.1002/bjs.5343
NR 102
TC 44
Z9 49
U1 0
U2 22
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD MAY
PY 2008
VL 5
IS 3
BP 337
EP 347
DI 10.1586/17434440-5.3-337
PG 11
WC Engineering, Biomedical
SC Engineering
GA 343FB
UT WOS:000258837200018
PM 18452384
DA 2018-10-20
ER

PT J
AU Santin, M
   Ambrosio, L
AF Santin, Matteo
   Ambrosio, Luigi
TI Soybean-based biornaterials: preparation, properties and tissue
   regeneration potential
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biodegradable biomaterial; bone filler; isoflavone; soybean; wound
   dressing
ID HEPATOCYTE GROWTH-FACTOR; BONE FILLERS; GLYCINE-MAX; GENISTEIN; CELLS;
   DIFFERENTIATION; EXTRACTION; EXPRESSION; INHIBITOR; VARIETIES
AB Future successes in regenerative medicine will depend on the development of new biodegradable biomaterials able to control tissue regeneration in vitro and in vivo. None of the products currently available to surgeons can combine all the essential characteristics for biodegradable biomaterials, which are tunable degradation rate, controlled inflammatory reaction, no toxicity and stimulation of tissue regeneration. These clinical features should be provided, together with ease of handling during surgery and cost-effective production. Here, an overview is presented of a novel class of soybean-based biomaterials, which can be manufactured as different hydrogel formulations, all tailored for specific clinical applications. In vitro and in vivo studies have ascertained their activity on various biochemical and cellular components of regenerating tissues. Beyond their use, the ascertained bioactivity of some of the soybean components may open new investigations and commercial routes in regenerative medicine.
C1 [Santin, Matteo] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
   [Ambrosio, Luigi] Inst Composite & Biomed Mat IMCB CNR, I-80130 Naples, Italy.
RP Santin, M (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Cockcroft Bldg Lewes Rd, Brighton BN2 4GJ, E Sussex, England.
EM m.santin@brighton.ac.uk; ambrosio@unina.it
OI AMBROSIO, LUIGI/0000-0002-8367-2405
CR AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
   Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13
   Andersson H, 2001, J APPL ELECTROCHEM, V31, P1, DOI 10.1023/A:1004105622558
   Brynin Rona, 2002, Altern Med Rev, V7, P317
   Deak NA, 2007, J AM OIL CHEM SOC, V84, P137, DOI 10.1007/s11746-006-1017-1
   Demirbas A, 2007, INT J GREEN ENERGY, V4, P15, DOI 10.1080/15435070601015395
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   FINI M, 2007, P 21 EUR SOC BIOM C
   Fiorellini JP, 2007, INT J PERIODONT REST, V27, P287
   Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176
   Fu CJJ, 2007, J AGR FOOD CHEM, V55, P4014, DOI 10.1021/jf070211o
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   Hollung K, 2005, J AGR FOOD CHEM, V53, P9112, DOI 10.1021/jf051438r
   Hwang K, 2001, J HISTOTECHNOL, V24, P95
   ILLSLEY MS, 2007, P 21 EUR SOC BIOM C
   Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8
   Kanellakis P, 2004, ATHEROSCLEROSIS, V176, P63, DOI 10.1016/j.atherosclerosis.2004.05.003
   KESANI AK, 2007, ORTHOPAEDICS REL RES, V464, P210
   Klein SL, 2002, MOL MED, V8, P742, DOI 10.1007/BF03402038
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Lee JH, 2006, FOOD SCI BIOTECHNOL, V15, P392
   Lee Kenneth J H, 2005, Spine J, V5, p217S, DOI 10.1016/j.spinee.2005.02.006
   LHORCINE L, 2007, CRIT REV FOOD SCI NU, V47, P127
   Lligadas G, 2007, BIOMACROMOLECULES, V8, P1858, DOI 10.1021/bm070157k
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   *MED HEALTHC PROD, 2004, MDA2004047 MED HEALT
   *MED HEALTHC PROD, 1999, AN199901 MED HEALTHC
   *MED HEALTHC PROD, 2000, 200005 HN MED HEALTH
   Middleton E, 2000, PHARMACOL REV, V52, P673
   Mo XQ, 2006, J AGR FOOD CHEM, V54, P7589, DOI 10.1021/jf060780g
   Morris C, 2006, J NUTR, V136, P1166
   Newman SA, 2003, J PERIODONTOL, V74, P1191, DOI 10.1902/jop.2003.74.8.1191
   Ni YW, 2007, PLANTA MED, V73, P1260, DOI 10.1055/s-2007-990225
   Nodar MD, 2002, FOOD SCI TECHNOL INT, V8, P337, DOI 10.1106/108201302031651
   Okada M, 2000, J HYPERTENS, V18, P1825, DOI 10.1097/00004872-200018120-00017
   Pandjaitan N, 2000, J FOOD SCI, V65, P399, DOI 10.1111/j.1365-2621.2000.tb16015.x
   Pesic MB, 2007, SENSORS-BASEL, V7, P67, DOI 10.3390/s7010067
   Ramirez-Suarez JC, 2003, MEAT SCI, V65, P899, DOI 10.1016/S0309-1740(02)00297-8
   Rickard DJ, 2003, J CELL BIOCHEM, V89, P633, DOI 10.1002/jcb.10539
   SANTIN M, 2005, P 19 EUR C BIOM SORR
   Santin M, 2007, BIOMACROMOLECULES, V8, P2706, DOI 10.1021/bm0703362
   Schmidt V, 2005, POLYM DEGRAD STABIL, V87, P25, DOI 10.1016/j.polymdegradstab.2004.07.003
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   Smith PC, 2004, J PERIODONTAL RES, V39, P380, DOI 10.1111/j.1600-0765.2004.00753.x
   STANDEN G, 2005, P 19 EUR SOC BIOM C
   Vaz CM, 2003, J BIOMED MATER RES A, V65A, P60, DOI 10.1002/jbm.a.10416
   Vignes JR, 2007, J CRANIO MAXILL SURG, V35, P185, DOI 10.1016/j.jcms.2007.04.002
   World Health Organization, GLOB STRAT DIET PHYS
   Zhang EJ, 2007, J AGR FOOD CHEM, V55, P6940, DOI 10.1021/jf0708903
   Zhang LX, 2002, AGRON J, V94, P1163, DOI 10.2134/agronj2002.1163
NR 50
TC 33
Z9 37
U1 1
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD MAY
PY 2008
VL 5
IS 3
BP 349
EP 358
DI 10.1586/17434440.5.3.349
PG 10
WC Engineering, Biomedical
SC Engineering
GA 343FB
UT WOS:000258837200019
PM 18452385
DA 2018-10-20
ER

PT J
AU Wei, N
   Wang, M
   Lin, Y
   Gong, P
   Yao, YY
   Li, XY
   Lin, YH
   Wu, DC
   Man, Y
AF Wei, Na
   Wang, Min
   Lin, Yi
   Gong, Ping
   Yao, Yong-Yi
   Li, Xiao-Yu
   Lin, Yin-He
   Wu, Da-Cheng
   Man, Yi
TI Cyto-compatibility of polyethersulphone nanofibres prepared by
   gas-jet/electrospinning
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE electrospinning; polyethersulphone; gas-jet; cyto-compatibility;
   nanofibres
ID NORMAL HUMAN KERATINOCYTES; HOLLOW-FIBER MEMBRANES; SMOOTH-MUSCLE-CELL;
   IN-VITRO; SCAFFOLDS; COLLAGEN; HEMODIALYSIS; FIBROBLASTS; ADHESION;
   MATRIX
AB Polymeric nanofibres that mimic the structure and function of the natural extracellular matrix (ECM) are produced by electrospinning and have attracted great interests in biomedical applications in the last several years. Electrospinning is an efficient process whereby polymeric nanofibres are formed in a high-voltage electrostatic field. Compared to the conventional electrospinning, the gas-jet/electrospinning method can generate thinner and more uniform nanofibres with higher efficiency. Recently, polyethersulphone (PES) has drawn significant attention as a commercially available material with unique properties, which make it extremely suitable for fabrication of some biomedical materials. In this paper, the cyto-compatibility of a novel nanofibrous scaffold made of PIES was examined by culturing human umbilical vein endothelial cells and rat osteoblasts. This scaffold was prepared by gas-jet/electrospinning and was made up of ultrafine fibres with the average diameter 126 nm and well-interconnected pores. Cell attachment and proliferation and cell-matrix interaction were assayed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) analysis, Vi CELL automated cell counter and scanning electron microscopy (SEM) imaging. The results of cell behaviour on the nanofibrous structure showed that both ECV-304 endothelial cells and osteoblasts adhered and proliferated well on the PIES nanofibrous matrix. In addition, the cells maintained a normal phenotypic shape on the nanofibres. This may result from the cyto-compatibility of PES and the three-dimensional structure of electrospun nanofibres. Overall, these results strongly support the cyto-compatibility of the gas-jet/electrospun PES nanofibrous structure and suggest potential uses of this biomaterial matrix as scaffolds for biomedical applications.
C1 [Wei, Na; Wang, Min; Gong, Ping; Lin, Yin-He; Man, Yi] Sichuan Univ, W China Coll Stomatol, Chengdu 610064, Peoples R China.
   [Lin, Yi; Yao, Yong-Yi; Wu, Da-Cheng] Sichuan Univ, Textile Coll, Chengdu 610065, Peoples R China.
   [Li, Xiao-Yu] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
RP Gong, P (reprint author), Sichuan Univ, W China Coll Stomatol, Chengdu 610064, Peoples R China.
EM gp602002@163.com
CR Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   David S, 2003, CONTRIB NEPHROL, V138, P43
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Duan B, 2006, EUR POLYM J, V42, P2013, DOI 10.1016/j.eurpolymj.2006.04.021
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Jalili R, 2005, IRAN POLYM J, V14, P1074
   Khulbe KC, 2000, J MEMBRANE SCI, V167, P263, DOI 10.1016/S0376-7388(99)00296-3
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Locatelli F, 2003, CONTRIB NEPHROL, V138, P55
   Long L, 2006, J BIOMED MATER RES B, V78B, P409, DOI 10.1002/jbm.b.30502
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Min BM, 2004, CARBOHYD POLYM, V57, P285, DOI 10.1016/j.carbpol.2004.05.007
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Moce-Llivina L, 2003, J VIROL METHODS, V109, P99, DOI 10.1016/S0166-0934(03)00046-6
   Mohammadi Y, 2007, IRAN POLYM J, V16, P57
   Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   PAUL D, 2002, TRIVANDRUM RES SIGNP, P179
   SOURIRAJAN S, 1985, 24188 NAT RES COUNC
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   WAN JL, 2006, ACTA BIOMATER, V2, P377
   Wan YQ, 2006, IRAN POLYM J, V15, P265
   YAO YY, 2005, ACTA POLYM SIN, V5, P687
   ZHONG S, 2006, MATER SCI ENG, V27, P262
   ZHU DD, 2005, J YUNNAN U, V27, P231
NR 34
TC 5
Z9 5
U1 0
U2 2
PU POLYMER RESEARCH CENTER IRAN
PI TEHRAN
PA PO BOX 14185-515, TEHRAN, IRAN
SN 1026-1265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD MAY
PY 2008
VL 17
IS 5
BP 333
EP 343
PG 11
WC Polymer Science
SC Polymer Science
GA 312RZ
UT WOS:000256689800003
DA 2018-10-20
ER

PT J
AU Koc, A
   Emin, N
   Elcin, AE
   Elcin, YM
AF Koc, Aysel
   Emin, Nuray
   Elcin, A. Eser
   Elcin, Y. Murat
TI In vitro osteogenic differentiation of rat mesenchymal stem cells in a
   microgravity bioreactor
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE bone tissue engineering; mesencyhmal stem cells; stroma; MSCs; PLGA;
   mineralization; osteogenic differentiation; microgravity bioreactor
ID PERIODONTAL-LIGAMENT FIBROBLASTS; MARROW STROMAL CELLS; BONE-MARROW;
   EXTRACELLULAR-MATRIX; BIOMIMETIC PROCESS; PERFUSION CULTURE;
   GENE-EXPRESSION; SCAFFOLDS; PROLIFERATION; MICROSPHERES
AB Mesenchymal stem cells (MSCs) are multipotent progenitor cells with the ability to differentiate into osteoblasts, chondroblasts, myocytes, and adipocytes. They have potential for bone tissue engineering by the utilization of in vitro expanded cells with osteogenic capacity and their delivery to the appropriate sites via biomaterial scaffolds. The objective was to evaluate the potential of rat bone marrow MSCs to form 3D bone-like tissue by the use of mineralized poly(DL-lactic-co-glycolic acid) (PLGA) foam and osteoinductive medium under rotating culture conditions. PLGA foams were prepared by solvent casting and particulate leaching, then mineralized by incubating in simulated body fluid. MSCs isolated from the bone marrow of young Wistar rats were expanded and seeded on the mineralized scaffolds. The cell-polymer constructs were then cultured in a slow turning lateral vessel-type rotating bioreactor for 4 weeks under the effect of osteogenic inducers, P-glycerophosphate, ascorbic acid and dexamethasone. Mineralization was evaluated using FT-IR and increases in dry mass; morphology changes of the mineralized foams and cell adhesion was characterized by SEM; cell viability was monitored by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide). Osteogenic differentiation was determined by using immunohistochemistry (anti-osteopontin). Results indicate the feasibility of bone tissue engineering with MSCs and mineralized PLGA scaffolds supporting cell adhesion, viability and osteogenic differentiation properties of cells in hybrid structures under appropriate bioreactor conditions.
C1 [Koc, Aysel; Emin, Nuray; Elcin, A. Eser; Elcin, Y. Murat] Ankara Univ, Fac Sci, TR-06100 Ankara, Turkey.
   [Koc, Aysel; Emin, Nuray; Elcin, A. Eser; Elcin, Y. Murat] Ankara Univ, Inst Biotechnol, Tissue Engn & Biomat Lab, TR-06100 Ankara, Turkey.
   [Elcin, A. Eser] Gazi Univ, GEF, Div Biol Educ, TR-06100 Ankara, Turkey.
RP Elcin, YM (reprint author), Ankara Univ, Fac Sci, TR-06100 Ankara, Turkey.
EM elcin@science.ankara.edu.tr
RI Koc Demir, Aysel/G-7889-2016; Emin, Nuray/H-1546-2017
OI Emin, Nuray/0000-0002-0859-2536; Elcin, Yasar Murat/0000-0003-1037-0825
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   BURG KJL, 2000, J BIOMED MATER RES, V51, P562
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Carmeliet G, 1999, FASEB J, V13, pS129
   Chaubey A, 2008, J BIOACT COMPAT POL, V23, P20, DOI 10.1177/0883911507085534
   Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040
   Chen HC, 2006, BIOTECHNOL LETT, V28, P1415, DOI 10.1007/s10529-006-9111-x
   Chen X, 2006, STEM CELLS, V24, P2052, DOI 10.1634/stemcells.2005-0591
   Conconi MT, 2006, TISSUE ENG, V12, P811, DOI 10.1089/ten.2006.12.811
   Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dominici M, 2001, J BIOL REG HOMEOS AG, V15, P28
   Elcin YM, 2003, TISSUE ENG, V9, P1047, DOI 10.1089/107632703322495682
   ELCIN YM, 2003, TISSUE ENG STEM CELL, V534
   *FDA, 1997, DIV GEN REST DEV CAL
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Harris SA, 2000, BONE, V26, P325, DOI 10.1016/S8756-3282(00)00234-9
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P1387, DOI 10.1016/j.biomaterials.2005.08.017
   Inanc B, 2006, TISSUE ENG, V12, P257, DOI 10.1089/ten.2006.12.257
   Inanc B, 2007, J BIOMED MATER RES A, V82A, P917, DOI 10.1002/jbm.a.31213
   Jiao YP, 2007, J BIOACT COMPAT POL, V22, P492, DOI 10.1177/0883911507082161
   KASEMO B, 1991, BONE-BIOMATERIAL INTERFACE, P19
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee H, 2007, J BIOACT COMPAT POL, V22, P89, DOI 10.1177/0883911506073363
   Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771
   Li Y, 2001, BIOTECHNOL PROGR, V17, P935, DOI 10.1021/bp0100878
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marks S. C., 2002, PRINCIPLES BONE BIOL, V1, P3
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Merzlikina N. V., 2004, J GRAVIT PHYSL, V11, P193
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164
   Rucci N, 2002, J CELL BIOCHEM, V85, P167, DOI 10.1002/jcb.10120
   Sibonga JD, 2000, BONE, V27, P535, DOI 10.1016/S8756-3282(00)00352-5
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Simon CG, 2002, J ORTHOPAED RES, V20, P473, DOI 10.1016/S0736-0266(01)00140-1
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   Zhou DS, 2006, J BIOACT COMPAT POL, V21, P373, DOI 10.1177/0883911506068554
NR 42
TC 22
Z9 24
U1 0
U2 26
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2008
VL 23
IS 3
BP 244
EP 261
DI 10.1177/0883911508091828
PG 18
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 299UQ
UT WOS:000255780900003
DA 2018-10-20
ER

PT J
AU Maus, U
   Andereya, S
   Gravius, S
   Ohnsorge, JAK
   Niedhart, C
AF Maus, Uwe
   Andereya, Stefan
   Gravius, Sascha
   Ohnsorge, Joerg A. K.
   Niedhart, Christopher
TI BMP-2 incorporated in a tricalcium phosphate bone substitute enhances
   bone remodeling in sheep
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE BMP-2; bone substitute; TCP; calcium phosphate; osteogenesis;
   osteoinduction; osseous defect
ID RAT ECTOPIC MODEL; MORPHOGENETIC PROTEIN-2; NORIAN SRS;
   HISTOLOGICAL-EVALUATION; BIOMATERIAL CARRIERS; GRAFT SUBSTITUTES;
   CALCIUM; CEMENT; DEFECTS; RHBMP-2
AB Bone morphogenetic protein-2 (BMP-2) is a well-known osteoinductive protein, which requires a carrier for local application. As an alternative to the previously described carriers, an in situ hardening, resorbable, and osteoconductive beta-tricalcium phosphate cement (TCP) is tested. Trepanation defects in the bovine distal femoral epiphysis are filled with a composite consisting of TCP and 200 mu g rhBMP-2 per cm(3) TCP, autologous bone graft, pure TCP, or left empty. A radiological follow-up is performed after 7 weeks and 3 months. The sheep are euthanized and bone samples are analyzed by microradiography, histology, and histomorphometry. Microradiography and histology show similar results for pure TCP and the composite. The defects are filled with trabecular bone and newly formed bone is in close contact with the remaining TCP-particles. The majority of the cement is resorbed, in the composite group the amount of remaining cement particles is reduced. Defects treated with autologous bone graft are filled completely, while untreated defects shows only a small amount of bone originating from the rim of the defect. Histomorphometry of the defects treated with pure TCP shows a significantly increased bone content in comparison to defects treated with the composite or autologous bone graft. Analysis of the remaining cement particles shows significantly less cement in the TCP/rhBMP-2 group in comparison to pure TCP. The sum of bone and cement content in the rhBMP-2 group shows amounts comparable to the calcified structures found following autologous bone grafting. The addition of rhBMP-2 to the TCP leads to faster remodeling of the defect comparable to autologous bone graft, while defects treated with pure TCP are not completely remodeled.
C1 [Maus, Uwe; Andereya, Stefan; Gravius, Sascha; Ohnsorge, Joerg A. K.; Niedhart, Christopher] Univ Aachen, Dept Orthoped Surg, D-52074 Aachen, Germany.
RP Maus, U (reprint author), Univ Aachen, Dept Orthoped Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
EM umaus@ukaachen.de
CR AGRAWAL CM, 1995, BIOMATERIALS, V16, P1255, DOI 10.1016/0142-9612(95)98133-Y
   Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003
   Allegrini S, 2004, J BIOMED MATER RES B, V68B, P127, DOI 10.1002/jbm.b.20006
   Barnes B, 2005, SPINE, V30, P1127, DOI 10.1097/01.brs.0000162623.48058.8c
   BROWN CE, 1987, CEMENTS RES PROGR 19, P352
   Cassidy C, 2003, J BONE JOINT SURG AM, V85A, P2127, DOI 10.2106/00004623-200311000-00010
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   FRIEDLAENDER G E, 1987, Journal of Bone and Joint Surgery American Volume, V69, P786
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   GOULET A, 1997, CLIN ORTHOP RELAT R, V339, P76
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hoshino M, 2006, BIOMATERIALS, V27, P4934, DOI 10.1016/j.biomaterials.2006.04.044
   ISHKAWA K, 1995, J MATL SCI MATL MED, V6, P528
   Jubel A, 2004, ORTHOPADE, V33, P919, DOI 10.1007/s00132-004-0664-x
   Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.0.CO;2-J
   Levine JP, 1997, ANN PLAS SURG, V39, P158, DOI 10.1097/00000637-199708000-00008
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Manjubala I, 2005, J BIOMATER APPL, V19, P341, DOI 10.1177/0885328205048633
   MARDEN LJ, 1994, J BIOMED MATER RES, V28, P1127, DOI 10.1002/jbm.820281003
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   Niedhart C, 2004, J BIOMED MATER RES B, V71B, P123, DOI 10.1002/jbm.b.30071
   Niedhart C, 2003, J BIOMED MATER RES A, V65A, P17, DOI 10.1002/jbm.a.10362
   Ohyama T, 2004, NEUROL MED-CHIR, V44, P234, DOI 10.2176/nmc.44.234
   Ooms EM, 2003, BIOMATERIALS, V24, P989, DOI 10.1016/S0142-9612(02)00438-6
   Parikh SN, 2002, ORTHOPEDICS, V25, P1301
   Paul W, 2003, J BIOMATER APPL, V17, P253, DOI 10.1177/088532803030571
   PELTIER LF, 1978, J BONE JOINT SURG AM, V60, P820, DOI 10.2106/00004623-197860060-00017
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Simpson D, 2004, INJURY, V35, P913, DOI 10.1016/S0020-1383(03)00109-8
   Tomford William W., 2000, Cell and Tissue Banking, V1, P105, DOI 10.1023/A:1010158731885
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1987, CLIN ORTHOP RELAT R, P295
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Weibrich G, 1999, Mund Kiefer Gesichtschir, V3, P92, DOI 10.1007/s100060050103
   Welkerling H, 2003, J BONE JOINT SURG BR, V85B, P238, DOI 10.1302/0301-620X.85B2.13255
   Wolff KD, 2004, J CRANIO MAXILL SURG, V32, P71, DOI 10.1016/S1010-5182(03)00134-3
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
NR 44
TC 34
Z9 36
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2008
VL 22
IS 6
BP 559
EP 576
DI 10.1177/0885328207083311
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 296VG
UT WOS:000255573300005
PM 18194994
DA 2018-10-20
ER

PT J
AU Ng, AMH
   Tan, KK
   Phang, MY
   Aziyati, O
   Tan, GH
   Isa, MR
   Aminuddin, BS
   Naseem, M
   Fauziah, O
   Ruszymah, BHI
AF Ng, Angela M. H.
   Tan, K. K.
   Phang, M. Y.
   Aziyati, O.
   Tan, G. H.
   Isa, M. R.
   Aminuddin, B. S.
   Naseem, M.
   Fauziah, O.
   Ruszymah, B. H. I.
TI Differential osteogenic activity of osteoprogenitor cells on HA and
   TCP/HA scaffold of tissue engineered bone
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone tissue engineering; hydroxyapatite; tricalcium phosphate; fibrin;
   periosteum
ID CALCIUM-PHOSPHATE BIOCERAMICS; MESENCHYMAL STEM-CELLS; PHYSICOCHEMICAL
   CHARACTERIZATION; CERAMICS; HYDROXYAPATITE; REGENERATION; IMPLANTATION;
   SUBSTITUTES; POROSITY; SURFACE
AB Biomaterial, an essential component of tissue engineering, serves as a scaffold for cell attachment, proliferation, and differentiation; provides the three dimensional (313) structure and, in some applications, the mechanical strength required for the engineered tissue. Both synthetic and naturally occurring calcium phosphate based biomaterial have been used as bone fillers or bone extenders in orthopedic and reconstructive surgeries. This study aims to evaluate two popular calcium phosphate based biomaterial i.e., hydroxyapatite (HA) and tricalcium phosphate/hydroxyapatite (TCP/HA) granules as scaffold materials in bone tissue engineering. In our strategy for constructing tissue engineered bone, human osteoprogenitor cells derived from periosteum were incorporated with human plasma-derived fibrin and seeded onto HA or TCP/HA forming 3D tissue constructs and further maintained in osteogenic medium for 4 weeks to induce osteogenic differentiation. Constructs were subsequently implanted intramuscularly in nude mice for 8 weeks after which mice were euthanized and constructs harvested for evaluation. The differential cell response to the biomaterial (HA or TCP/HA) adopted as scaffold was illustrated by the histology of undecalcified constructs and evaluation using SEM and TEM. Both HA and TCP/HA constructs showed evidence of cell proliferation, calcium deposition, and collagen bundle formation albeit lesser in the former. Our findings demonstrated that TCP/HA is superior between the two in early bone formation and hence is the scaffold material of choice in bone tissue engineering. (C) 2007 Wiley Periodicals, Inc.
C1 [Ng, Angela M. H.; Ruszymah, B. H. I.] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia.
   [Ng, Angela M. H.; Ruszymah, B. H. I.] Hosp Univ Kebangsaan Malaysia, Tissue Engn Lab, Kuala Lumpur, Malaysia.
   [Tan, K. K.; Tan, G. H.] Univ Kebangsaan Malaysia, Fac Med, Dept Orthoped & Traumatol, Kuala Lumpur, Malaysia.
   [Phang, M. Y.; Aziyati, O.; Fauziah, O.] Univ Putra Malaysia, Microscopy Imaging & Nanosci Unit, Inst Biosci, Selangor, Malaysia.
   [Phang, M. Y.; Aziyati, O.; Fauziah, O.] Univ Putra Malaysia, Fac Med & Hlth Sci, Selangor, Malaysia.
   [Isa, M. R.] Univ Kebangsaan Malaysia, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia.
   [Aminuddin, B. S.] Ampang Puteri Specialist Hosp, Ear Nose & Throat Consultant Clin, Kuala Lumpur, Malaysia.
   [Naseem, M.] Inst Med Res, Lab Anim Resource Unit, Kuala Lumpur 50588, Malaysia.
RP Ruszymah, BHI (reprint author), Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia.
EM ruszy@medic.ukm.my
RI Idrus, Ruszymah/F-1521-2010; Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR ANGELA MH, 2005, J ORTHO SCI, V10, P192
   ANGELA MH, 2005, P 8 ANN M TISS ENG S
   ANGELA MH, 2005, 4 MAL IND MED SCI C
   Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   Culling C. F. A., 1974, HDB HISTOPATHOLOGICA
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Ferrera D, 2002, BONE, V30, P718, DOI 10.1016/S8756-3282(02)00691-9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   Hoshi K, 2000, CALCIFIED TISSUE INT, V66, P430, DOI 10.1007/s002230010087
   Kwon SH, 2003, J EUR CERAM SOC, V23, P1039, DOI 10.1016/S0955-2219(02)00263-7
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Leng Y, 2003, BIOMATERIALS, V24, P2125, DOI 10.1016/S0142-9612(03)00036-X
   Livingston AT., 2005, BIOMATERIALS, V26, P3631
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   Ogose A, 2005, J BIOMED MATER RES B, V72B, P94, DOI 10.1002/jbm.b.30136
   OHTSUKI C, 1991, J BIOMED MATER RES, V25, P1363, DOI 10.1002/jbm.820251105
   Phang M.Y., 2004, J MICROSC-OXFORD, V1, P73
   Tan K K, 2004, Med J Malaysia, V59 Suppl B, P43
   TEMENOFF JS, 2004, ORTHOPAEDIC TISSUE E, P77
NR 27
TC 44
Z9 44
U1 0
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 301
EP 312
DI 10.1002/jbm.a.31324
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700003
PM 17688285
DA 2018-10-20
ER

PT J
AU Ricci, JL
   Grew, JC
   Alexander, H
AF Ricci, John L.
   Grew, John C.
   Alexander, Harold
TI Connective-tissue responses to defined biomaterial surfaces. I. Growth
   of rat fibroblast and bone marrow cell colonies on microgrooved
   substrates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE microgroove; in vitro; cell-surface interactions; fibroblasts; bone
   marrow
ID OSTEOBLAST-LIKE CELLS; TITANIUM IMPLANT MATERIALS; TOTAL JOINT
   ARTHROPLASTY; HUMAN-ENDOTHELIAL CELLS; LACTIC ACID IMPLANTS; GROOVED
   SUBSTRATA; EPITHELIAL TISSUE; MICROSCOPIC OBSERVATION; MICROTEXTURED
   SURFACES; TOPOGRAPHICAL CONTROL
AB Surface microgeometry plays a role in tissue-implant surface interactions, but our understanding of its effects is incomplete. Substrate microgrooves strongly influence cells in vitro, as evidenced by contact guidance and cell alignment. We studied "dot" colonies of primary fibroblasts and bone marrow cells that were grown on titanium-coated, microgrooved polystyrene surfaces that we designed and produced. Rat tendon fibroblast and rat bone marrow colony growth and migration varied (p < 0.01) by microgroove dimension and slightly by cell type. We observed profoundly altered morphologies, reduced growth rates, and directional growth in colonies grown on microgrooved substrates, when compared with colonies grown on flat, control surfaces (p < 0.01). The cells in our colonies grown on microgrooved surfaces were well aligned and elongated in the direction parallel to the grooves and colonies. Our "dot" colony is an easily reproduced, easily measured and artificial explant model of tissue-implant interactions that better approximates in vivo implant responses than culturing isolated cells on biomaterials. Our results correlate well with in vivo studies of titanium dioxide-coated polystyrene, titanium, and titanium alloy implants with controlled microgeometries. Microgrooves and other surface features appear to directionally or spatially organize cells and matrix molecules in ways that contribute to improved stabilization and osseointegration of implants. (C) 2007 Wiley Periodicals, Inc.
C1 [Grew, John C.] New Jersey City Univ, Dept Biol, Jersey City, NJ 07305 USA.
   [Ricci, John L.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10003 USA.
   [Alexander, Harold] Orthogen Corp, Springfield, NJ 07081 USA.
RP Grew, JC (reprint author), New Jersey City Univ, Dept Biol, 2039 Kennedy Blvd, Jersey City, NJ 07305 USA.
EM jGrew@NJCU.edu
CR ALBREKTSSON T, 1985, BIOMATERIALS, V6, P97, DOI 10.1016/0142-9612(85)90070-5
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   ALBREKTSSON T, 1986, BIOMATERIALS, V7, P201, DOI 10.1016/0142-9612(86)90103-1
   Albrektsson Tomas, 2005, J Can Dent Assoc, V71, P327
   ALEXANDER H, 2007, J BIOMED MAT  B 0423
   ALHABBAB R, 2005, T SOC BIOMATER, V28, P123
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Batzer R, 1998, J BIOMED MATER RES, V41, P489
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Bauer TW, 1999, SKELETAL RADIOL, V28, P423, DOI 10.1007/s002560050541
   Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Cameron HU, 1997, CAN J SURG, V40, P278
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Chehroudi B., 1995, P813
   CHEHROUDI B, 1992, J BIOMED MATER RES, V26, P493, DOI 10.1002/jbm.820260407
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   Curtis A S G, 2005, Eur Cell Mater, V9, P50
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   denBraber ET, 1997, J BIOMED MATER RES, V37, P539, DOI 10.1002/(SICI)1097-4636(19971215)37:4<539::AID-JBM13>3.0.CO;2-3
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   DUVAL JL, 1988, BIOMATERIALS, V9, P155, DOI 10.1016/0142-9612(88)90115-9
   Evans MDM, 2005, BIOMATERIALS, V26, P1703, DOI 10.1016/j.biomaterials.2004.05.023
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Frenkel SR, 2002, J BIOMED MATER RES, V63, P706, DOI 10.1002/jbm.10408
   FRENKEL SR, 1998, T SOC BIOMATER, V21, P66
   FRENKEL SR, 1999, T ORTHOP RES SOC, V22, P891
   Gemmell CH, 2000, BONE ENG, P108
   Glass-Brudzinski JT, 2002, J BIOMED MATER RES, V61, P608, DOI 10.1002/jbm.10243
   Goessl A, 2001, J BIOMED MATER RES, V57, P15, DOI 10.1002/1097-4636(200110)57:1<15::AID-JBM1136>3.0.CO;2-N
   GREW JC, IN PRESS J BIOMED MA
   GREW JC, 1998, T SOC BIOMATER, V21, P40
   GREW JC, 1997, T SOC BIOMATER, V20, P32
   HADDAD RJ, 1987, J BONE JOINT SURG AM, V69A, P1459
   Healy K E, 1991, ASAIO Trans, V37, pM150
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   HONG HL, 1987, J CELL SCI, V87, P259
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   KELLER JC, 1994, J BIOMED MATER RES, V28, P939, DOI 10.1002/jbm.820280813
   Kenar H, 2006, BIOMATERIALS, V27, P885, DOI 10.1016/j.biomaterials.2005.07.001
   Khakbaznejad A, 2004, J BIOMED MATER RES A, V70A, P206, DOI 10.1002/jbm.a.30058
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   LENK TJ, 1989, J BIOMED MATER RES, V23, P549, DOI 10.1002/jbm.820230603
   LINDER L, 1988, J BONE JOINT SURG BR, V70, P550
   Loesberg WA, 2005, J BIOMED MATER RES A, V75A, P723, DOI 10.1002/jbm.a.30480
   LOM B, 1993, J NEUROSCI METH, V50, P385, DOI 10.1016/0165-0270(93)90044-R
   Lu X, 2003, J BIOMED MATER RES A, V66A, P677, DOI 10.1002/jbm.a.10022
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Matsuzaka K, 2004, J BIOMED MATER RES A, V68A, P227, DOI 10.1002/jbm.a.10158
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   McClary KB, 1999, BIOMATERIALS, V20, P2435, DOI 10.1016/S0142-9612(99)00171-4
   McDevitt TC, 2002, J BIOMED MATER RES, V60, P472, DOI 10.1002/jbm.1292
   Millenium Research Group, 2003, IMPLANT DENT, V12, P108
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   *NAT CTR HLTH STAT, 2003, NUMB RAT SURG NONS P
   Ozawa N, 2002, J BIOMED MATER RES, V62, P579, DOI 10.1002/jbm.10281
   Parker JATC, 2003, TISSUE ENG, V9, P117, DOI 10.1089/107632703762687591
   Parker JATC, 2002, J BIOMED MATER RES, V61, P91, DOI 10.1002/jbm.10170
   Parker JATC, 2002, BIOMATERIALS, V23, P3887, DOI 10.1016/S0142-9612(02)00134-5
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   Ricci J, 2000, BONE ENG, P282
   RICCI JL, 1990, B HOSP JOINT DIS ORT, V50, P126
   RICCI JL, 1984, J BIOMED MATER RES, V18, P1073, DOI 10.1002/jbm.820180910
   RICCI JL, 1991, J BIOMED MATER RES, V25, P651, DOI 10.1002/jbm.820250508
   RICCI JL, 1995, T SOC BIOMATER, V18, P115
   RICCI JL, 1992, TISSUE INDUCING BIOM, P221
   Ricci JL, 1994, SURFACE MODIFICATION, VVII, P491
   RICCI JL, 1996, T WORLD BIOMATER C, V6, P937
   ROVENSKY YA, 1971, EXP CELL RES, V65, P193, DOI 10.1016/S0014-4827(71)80066-6
   Salvi GE, 2001, CRIT REV ORAL BIOL M, V12, P262, DOI 10.1177/10454411010120030501
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   Saneinejad S, 2000, J BIOMED MATER RES, V50, P465, DOI 10.1002/(SICI)1097-4636(20000615)50:4<465::AID-JBM1>3.3.CO;2-B
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Schwartz Zvi, 2005, Alpha Omegan, V98, P9
   Sennerby L, 1998, INT J PROSTHODONT, V11, P408
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Soboyejo WO, 2002, J BIOMED MATER RES, V62, P56, DOI 10.1002/jbm.10221
   Steigenga Jennifer T, 2003, Implant Dent, V12, P306, DOI 10.1097/01.ID.0000091140.76130.A1
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tan J, 2001, BIOPHYS J, V81, P2569, DOI 10.1016/S0006-3495(01)75901-2
   Tan J, 2000, J BIOMED MATER RES, V51, P694, DOI 10.1002/1097-4636(20000915)51:4<694::AID-JBM18>3.3.CO;2-E
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P1317, DOI 10.1002/jbm.820211104
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
   Walboomers XF, 2005, J BIOMED MATER RES A, V74A, P381, DOI 10.1002/jbm.a.30337
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 2000, BIOMATERIALS, V21, P629, DOI 10.1016/S0142-9612(99)00230-6
   Walboomers XF, 2002, J BIOMED MATER RES, V60, P445, DOI 10.1002/jbm.1290
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037
   WEINER S, IN PRESS IMPLANT DEN
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Yoshinari M, 2003, J BIOMED MATER RES A, V65A, P359, DOI 10.1002/jbm.a.10521
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 115
TC 36
Z9 36
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 313
EP 325
DI 10.1002/jbm.a.31379
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700004
PM 17688290
DA 2018-10-20
ER

PT J
AU Grew, JC
   Ricci, JL
   Alexander, H
AF Grew, John C.
   Ricci, John L.
   Alexander, Harold
TI Connective-tissue responses to defined biomaterial surfaces. II.
   Behavior of rat and mouse fibroblasts cultured on microgrooved
   substrates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE microgroove; in vitro; cell-surface interactions; fibroblasts;
   cytoskeleton
ID OSTEOBLAST-LIKE CELLS; CAPILLARY ENDOTHELIAL-CELLS; MESSENGER-RNA
   EXPRESSION; QUANTITATIVE-ANALYSIS; GROOVED SUBSTRATA; CYCLE PROGRESSION;
   CONTACT GUIDANCE; MICROSCOPIC OBSERVATION; DIFFERENT DIMENSIONS;
   TITANIUM SUBSTRATA
AB Surface microgeometry strongly influences the shapes, orientations, and growth characteristics of cultured cells, but in-depth, quantitative studies of these effects are lacking. We investigated several contact guidance effects in cells within "dot" colonies of primary fibroblasts and in cultures of a transformed fibroblast cell line, employing titanium-coated, microgrooved polystyrene surfaces that we designed and produced. The aspect ratios, orientations, densities, and attachment areas of rat tendon fibroblasts (RTF) colony cells, in most cases, varied (p < 0.01) by microgroove dimension. We observed profoundly altered cell morphologies, reduced attachment areas, and reduced cell densities within colonies grown on microgrooved substrates, compared with cells of colonies grown on flat, control surfaces. 3T3 fibroblasts cultured on microgrooved surfaces demonstrated similarly altered morphologies. Fluorescence microscopy revealed that microgrooves alter the distribution and assembly of cytoskeletal and attachment proteins within these cells. These findings are consistent with previous results, and taken together with the results of our in vivo and cell colony growth studies, enable us to propose a unified hypothesis of how microgrooves induce contact guidance. (C) 2007 Wiley Periodicals, Inc.
C1 [Grew, John C.] New Jersey City Univ, Dept Biol, Jersey City, NJ 07305 USA.
   [Ricci, John L.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10003 USA.
   [Alexander, Harold] Orthogen Corp, Springfield, NJ 07081 USA.
RP Grew, JC (reprint author), New Jersey City Univ, Dept Biol, 2039 Kennedy Blvd, Jersey City, NJ 07305 USA.
EM jGrew@NJCU.edu
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   ALEXANDER H, 2007, IN PRESS J BIOMED MA
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Assoian RK, 1997, CURR OPIN CELL BIOL, V9, P93, DOI 10.1016/S0955-0674(97)80157-3
   BRITLAND S, 1992, EXP CELL RES, V198, P124, DOI 10.1016/0014-4827(92)90157-4
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1988, J BIOMED MATER RES, V22, P459, DOI 10.1002/jbm.820220603
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chicurel ME, 1998, NATURE, V392, P730
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   Curtis A S G, 2004, Eur Cell Mater, V8, P27
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Dike LE, 1996, J CELL SCI, V109, P2855
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   DUNN GA, 1986, J CELL SCI, V83, P313
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Frenkel SR, 2002, J BIOMED MATER RES, V63, P706, DOI 10.1002/jbm.10408
   Freshney RI, 2000, CULTURE ANIMAL CELLS
   Glass-Brudzinski JT, 2002, J BIOMED MATER RES, V61, P608, DOI 10.1002/jbm.10243
   GREW JC, 1998, T SOC BIOMATER, V21, P40
   GREW JC, 1997, T SOC BIOMATER, V20, P32
   HONG HL, 1987, J CELL SCI, V87, P259
   Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   INGBER DE, 1986, ENDOCRINOLOGY, V119, P1768, DOI 10.1210/endo-119-4-1768
   Kato S, 2001, J BIOMED MATER RES, V54, P366, DOI 10.1002/1097-4636(20010305)54:3<366::AID-JBM80>3.3.CO;2-I
   Khakbaznejad A, 2004, J BIOMED MATER RES A, V70A, P206, DOI 10.1002/jbm.a.30058
   Loesberg WA, 2005, J BIOMED MATER RES A, V75A, P723, DOI 10.1002/jbm.a.30480
   Lu X, 2003, J BIOMED MATER RES A, V66A, P677, DOI 10.1002/jbm.a.10022
   Matsuzaka K, 2004, J BIOMED MATER RES A, V68A, P227, DOI 10.1002/jbm.a.10158
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537
   Ricci J, 2000, BONE ENG, P282
   RICCI JL, 1990, B HOSP JOINT DIS ORT, V50, P126
   RICCI JL, 1995, T SOC BIOMATER, V18, P115
   Ricci JL, 1994, SURFACE MODIFICATION, VVII, P491
   RICCI JL, 1996, T WORLD BIOMATER C, P937
   RICCI JL, IN PRESS J BIOMED MA
   ROVENSKY YA, 1971, EXP CELL RES, V65, P193, DOI 10.1016/S0014-4827(71)80066-6
   SARBER R, 1981, MECH AGEING DEV, V17, P107, DOI 10.1016/0047-6374(81)90077-4
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Soboyejo WO, 2002, J BIOMED MATER RES, V62, P56, DOI 10.1002/jbm.10221
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   Walboomers X F, 2001, Odontology, V89, P2, DOI 10.1007/s10266-001-8178-z
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Walboomers XF, 2000, J BIOMED MATER RES, V51, P529, DOI 10.1002/1097-4636(20000905)51:3<529::AID-JBM30>3.0.CO;2-R
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   WEINER S, IN PRESS IMPLANT DEN
   Yoshinari M, 2003, J BIOMED MATER RES A, V65A, P359, DOI 10.1002/jbm.a.10521
   Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391
NR 69
TC 27
Z9 28
U1 1
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 326
EP 335
DI 10.1002/jbm.a.31378
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700005
PM 17688289
DA 2018-10-20
ER

PT J
AU Rousseau, M
   Boulzaguet, H
   Biagianti, J
   Duplat, D
   Milet, C
   Lopez, E
   Bedouet, L
AF Rousseau, Marthe
   Boulzaguet, Helene
   Biagianti, Julie
   Duplat, Denis
   Milet, Christian
   Lopez, Evelyne
   Bedouet, Laurent
TI Low molecular weight molecules of oyster nacre induce mineralization of
   the MC3T3-E1 cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE MC3T3-E1 preosteoblast; mineralization; nacre; metabolites; osteopontin;
   Runx2
ID OSTEOBLASTS MAINTAINED INVITRO; MESENCHYMAL STEM-CELLS; GENE-EXPRESSION;
   TRANSCRIPTIONAL REGULATION; SIGNALING PATHWAY; PINCTADA-MAXIMA; ORGANIC
   MATRIX; BONE-FORMATION; IN-VIVO; DIFFERENTIATION
AB The nacre layer from the pearl oyster shell is considered as a promising osteoinductive biomaterial. Nacre contains one or more signal molecules capable of stimulating bone formation. The identity and the mode of action of these molecules on the osteoblast differentiation were analyzed. Water-soluble molecules from nacre were fractionated according to dialysis, solvent extraction, and reversed-phase HPLC. The activity of a fraction composed of low molecular weight molecules in the mineralization of the MC3T3-E1 extracellular matrix was investigated. Mineralization of the preosteoblast cells was monitored according to alizarin red staining, Raman spectroscopy, scanning electron microscopy, and quantitative RT-PCR. Molecules isolated from nacre, ranging from 50 to 235 Da, induced a red alizarin staining of the preosteoblasts extracellular matrix after 16 days of culture. Raman spectroscopy demonstrated the presence of hydroxyapatite (HA) in samples treated with these molecules. Scanning electron microscopy pictures showed at the surface of the treated cells the occurrence of clusters of spherical particles resembling to HA. The treatment of cells with nacre molecules accelerated expression of collagen I and increased the mRNA expression of Runx2 and osteopontin. This study indicated that the nacre molecules efficient in bone cell differentiation are certainly different from proteins, and could be useful for in vivo bone repair. (C) 2007 Wiley Periodicals, Inc.
C1 [Rousseau, Marthe; Boulzaguet, Helene; Biagianti, Julie; Duplat, Denis; Milet, Christian; Lopez, Evelyne; Bedouet, Laurent] Museum Natl Hist Nat, CNRS MNHN Biol Organismes Marine & Ecosyst, ERT Valorisat Mol Bioact Origine Marine, Dept Milieux & Peuplements Aquat,UMR 5178, F-75231 Paris 05, France.
RP Rousseau, M (reprint author), Museum Natl Hist Nat, CNRS MNHN Biol Organismes Marine & Ecosyst, ERT Valorisat Mol Bioact Origine Marine, Dept Milieux & Peuplements Aquat,UMR 5178, CP 26,43 Rue Cuvier, F-75231 Paris 05, France.
EM rousseam@gmx.net
RI MNHN/CNRS/UPMC/IRD, UMR BOREA/B-2312-2012
CR Almeida MJ, 2001, J BIOMED MATER RES, V57, P306, DOI 10.1002/1097-4636(200111)57:2<306::AID-JBM1172>3.0.CO;2-H
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Bedouet L, 2006, COMP BIOCHEM PHYS B, V144, P532, DOI 10.1016/j.cbpb.2006.05.012
   BEVELANDER G, 1969, CALC TISS RES, V3, P84, DOI 10.1007/BF02058648
   Bidwell JP, 1998, J BONE MINER RES, V13, P155, DOI 10.1359/jbmr.1998.13.2.155
   CARIOLOU MA, 1988, J COMP PHYSIOL B, V157, P717, DOI 10.1007/BF00691002
   Carter EA, 2001, INFRARED RAMAN SPECT, P421
   Cho HH, 2005, J CELL BIOCHEM, V96, P533, DOI 10.1002/jcb.20544
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200
   Javed A, 1999, MOL CELL BIOL, V19, P7491
   Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0180
   Kim SW, 2005, BONE, V37, P359, DOI 10.1016/j.bone.2005.04.020
   Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0
   Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958
   Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   Lamghari M, 2001, J BONE MINER RES, V16, P2232, DOI 10.1359/jbmr.2001.16.12.2232
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lopez E., 2004, ARGOS SPINE NEWS, V8, P32
   MATSUMOTO T, 1991, BONE, V12, P27, DOI 10.1016/8756-3282(91)90051-J
   McKee MD, 1996, CONNECT TISSUE RES, V35, P197, DOI 10.3109/03008209609029192
   Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004
   Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x
   PEREIRAMOURIES L, 2002, COMP BIOCH PHYSL, V132, P217
   Rousseau M, 2003, COMP BIOCHEM PHYS A, V135, P271, DOI 10.1016/S1095-6433(03)00070-9
   Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064
   Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   SUDO H, 1983, J CELL BIOL, V96, P194
   VANDESOMPELE J, 2002, GENOME BIOL, V3, DOI [DOI 10.1186/GB-2002-3-7-RESEARCH0034, DOI 10.1186/GB-2002-2-7-RESEARCH0034]
   Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
NR 36
TC 30
Z9 31
U1 0
U2 17
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 487
EP 497
DI 10.1002/jbm.a.31553
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700023
PM 17729263
DA 2018-10-20
ER

PT J
AU Broekhuizen, CAN
   de Boer, L
   Schipper, K
   Jones, CD
   Quadir, S
   Vandenbroucke-Grauls, CMJE
   Zaat, SAJ
AF Broekhuizen, Corine A. N.
   de Boer, Leonie
   Schipper, Kim
   Jones, Christopher D.
   Quadir, Shan
   Vandenbroucke-Grauls, Christina M. J. E.
   Zaat, Sebastian A. J.
TI Staphylococcus epidermidis is cleared from biomaterial implants but
   persists in peri-implant tissue in mice despite rifampicin/vancomycin
   treatment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Staphylococcus epidermidis; experimental biomaterial-associated
   infection; vancomycin; rifampicin; tissue colonization
ID FOREIGN-BODY INFECTION; SUBCUTANEOUS ABSCESS FORMATION; CATHETER-RELATED
   INFECTIONS; IN-VIVO; POUCH MODEL; VANCOMYCIN; RIFAMPIN; AUREUS;
   BIOFILMS; SUSCEPTIBILITY
AB Infections associated with implanted biomedical devices (BAI) are predominantly caused by Staphylococcus epidermidis. We previously observed in murine experimental BAI that S. epidermidis persists in peri-implant tissue rather than on the implanted biomaterial itself (Boelens et al., J Infect Dis 2000;181:1337-1349; Broekhuizen et al., Infect Immun 2007;75:1129-1136). To investigate the efficacy of rifampicin/vancomycin to clear S. epidermidis from implants and peri-implant tissues, mice with two implants were challenged with 10(7) cfu S. epidermidis per implant and received daily injections of rifampicin (25 mg/kg) and vancomycin (50 mg/kg). On the day of termination, implants and peri-implant tissue were collected and processed for culture and histology. After 1 and 8 days, implants of control mice were culture positive in 14/18 and 5/16 cases, respectively, and tissue biopsies were all culture positive. In the antibiotic-treated mice, bacteria were recovered from only 1/18 and 1/16 implants after 1 and 8 days, respectively, whereas the tissues were culture positive in 14/18 and 7/16 biopsies, respectively. In microscopy, bacteria were seen in the tissue at a distance of several cell layers from the tissue-implant interface, colocalized with host cells. Thus, although a regimen of rifampicin/vancomycin sterilized the implants, S. epidermidis persisted in peri-implant tissue, which might be an as yet unrecognized reservoir in the pathogenesis of BAI (C) 2007 Wiley Periodicals, Inc.
C1 [Broekhuizen, Corine A. N.; de Boer, Leonie; Schipper, Kim; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Inflammat Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.
   [Jones, Christopher D.; Quadir, Shan] Emergent Prod Dev UK Ltd Microsci Ltd, Wokingham RG41 5TU, Berks, England.
RP Zaat, SAJ (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Inflammat Amsterdam CINIMA, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.
EM s.a.zaat@amc.uva.nl
CR BLASER J, 1995, ANTIMICROB AGENTS CH, V39, P1134, DOI 10.1128/AAC.39.5.1134
   Boelens JJ, 2000, J INFECT DIS, V181, P1167, DOI 10.1086/315344
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   BROEKHUIZEN CAN, 2006, 106 ASM GEN M WASH D
   BROEKHUIZEN CAN, 2007, UNPUB TISSUE CATHETE
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Burns CA, 2006, SCAND J INFECT DIS, V38, P133, DOI 10.1080/00365540500277292
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Chuard C, 1997, J ANTIMICROB CHEMOTH, V39, P603, DOI 10.1093/jac/39.5.603
   CHUARD C, 1991, ANTIMICROB AGENTS CH, V35, P2611, DOI 10.1128/AAC.35.12.2611
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Crnich CJ, 2002, CLIN INFECT DIS, V34, P1232, DOI 10.1086/339863
   DAROUICHE RO, 1994, ANTIMICROB AGENTS CH, V38, P1059, DOI 10.1128/AAC.38.5.1059
   DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522
   DWORKIN R, 1990, ANTIMICROB AGENTS CH, V34, P1014, DOI 10.1128/AAC.34.6.1014
   El-Azizi Mohamed, 2005, Ann Clin Microbiol Antimicrob, V4, P2, DOI 10.1186/1476-0711-4-2
   Gagnon R F, 1992, ASAIO J, V38, pM596, DOI 10.1097/00002480-199207000-00106
   Garrison JR, 1997, ASAIO J, V43, P8, DOI 10.1097/00002480-199701000-00003
   Ghiselli R, 2002, EUR J VASC ENDOVASC, V24, P230, DOI 10.1053/ejvs.2002.1713
   Giacometti A, 2003, J ANTIMICROB CHEMOTH, V52, P724, DOI 10.1093/jac/dkg396
   HEBERT GA, 1985, J CLIN MICROBIOL, V22, P409
   Isiklar Z U, 1999, Bull Hosp Jt Dis, V58, P79
   KARCHMER AW, 1983, ANN INTERN MED, V98, P447, DOI 10.7326/0003-4819-98-4-447
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P107, DOI 10.1007/s00430-002-0125-2
   LUCET JC, 1990, ANTIMICROB AGENTS CH, V34, P2312, DOI 10.1128/AAC.34.12.2312
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001
   Monzon M, 2002, DIAGN MICR INFEC DIS, V44, P319, DOI 10.1016/S0732-8893(02)00464-9
   Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74
   RAAD I, 1995, ANTIMICROB AGENTS CH, V39, P2397, DOI 10.1128/AAC.39.11.2397
   SCHAAD HJ, 1994, ANTIMICROB AGENTS CH, V38, P1703, DOI 10.1128/AAC.38.8.1703
   Stein GE, 2005, ANN PHARMACOTHER, V39, P427, DOI 10.1345/aph.1E484
   Stevens DL, 2006, CLIN INFECT DIS, V42, pS51, DOI 10.1086/491714
   Vandecasteele SJ, 2003, CLIN MICROBIOL INFEC, V9, P114, DOI 10.1046/j.1469-0691.2003.00544.x
   Vesely JJK, 1998, PHARMACOTHERAPY, V18, P345
   VIRDEN CP, 1992, AESTHET PLAST SURG, V16, P173, DOI 10.1007/BF00450610
   von Eiff C, 1999, INFECTION, V27, pS7, DOI 10.1007/BF02561610
   Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487
   Walsh C., 2003, ANTIBIOTICS ACTIONS
   WEHRLI W, 1983, REV INFECT DIS S, V3, pS407
   Wilcox MH, 2001, J ANTIMICROB CHEMOTH, V47, P171, DOI 10.1093/jac/47.2.171
   Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 48
TC 17
Z9 17
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 498
EP 505
DI 10.1002/jbm.a.31528
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700024
PM 17729261
DA 2018-10-20
ER

PT J
AU Rodriguez, A
   Voskerician, G
   Meyerson, H
   MacEwan, SR
   Anderson, JM
AF Rodriguez, Analiz
   Voskerician, Gabriela
   Meyerson, Howard
   MacEwan, Sarah R.
   Anderson, James M.
TI T cell subset distributions following primary and secondary implantation
   at subcutaneous biomaterial implant sites
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE rat cage system; flow cytometry; T cell; synthetic biomaterials;
   secondary host response
ID IN-VIVO BIOCOMPATIBILITY; FOREIGN-BODY RESPONSE; IMMUNE-RESPONSE;
   VASCULAR PROSTHESES; SURFACE-CHEMISTRY; ANTIBODY-RESPONSE; ADHESION;
   VITRO; RATS; MECHANISMS
AB Synthetic biomaterials are considered to be non-immunogenic. Therefore, the role that adaptive immunity may play in the host response to implanted synthetic biomaterials has not been extensively studied. Cardinal features of adaptive immunity include specificity and T cell responses, which are greater and more effective with upregulation of activation receptors upon rechallenge. We compared the primary and secondary in vivo host response to three synthetic biomaterials: Elasthane 80A, silicone rubber, and polyethylene terephthalate using a cage implant model in Sprague Dawley rats. The synthetic biomedical polymers were subcutaneously implanted in cages for 14 days. Following explantation of the cages and a 2 week healing period, rats were implanted with cages containing the biomedical polymers for an additional 2 weeks. The cellular exudates within the cages were analyzed 4, 7, and 14 days post primary and secondary implantation by flow cytometry for the following cell types: T cells (inclusive of CD8(+), CD4(+), and CD4(+)/CD25(+) subsets), B cells, granulocytes, and macrophages. At day 14 following secondary implantation, there was an increase in T cells, granulocytes, and macrophages in the exudates when compared with primary implantation for all groups inclusive of the empty cage control. However, CD4(+)/CD8(+) ratios, the percentage of CD4(+)CD25(+) T cells, and the macrophage surface adhesion/fusion did not vary significantly upon secondary implantation. Despite a quantitative increase in T cells following secondary biomaterial exposure, T cell subset distribution did not change, indicating nonspecific recruitment rather than an adaptive immune response. (C) 2007 Wiley Periodicals, Inc.
C1 [Rodriguez, Analiz; Meyerson, Howard; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Voskerician, Gabriela] Proxy Biomed Ltd, Galway, Ireland.
   [MacEwan, Sarah R.; Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), 2103 Cornell Rd,Wolstein Res Bldg 5104, Cleveland, OH 44106 USA.
EM jma6@case.edu
OI MacEwan, Sarah/0000-0002-4365-6232
FU NIBIB NIH HHS [R01 EB000282, EB-000282]
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Budinger L, 2000, ALLERGY, V55, P108, DOI 10.1034/j.1398-9995.2000.00107.x
   D'Ambrosio D, 2006, SEMIN CANCER BIOL, V16, P91, DOI 10.1016/j.semcancer.2005.11.002
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   DJIKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x
   Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263
   Granchi D, 2002, BIOMATERIALS, V23, P1033, DOI 10.1016/S0142-9612(01)00215-0
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUANG B, 1992, BIOMATERIALS, V13, P209, DOI 10.1016/0142-9612(92)90186-R
   Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016
   JEFFERIES WA, 1985, J EXP MED, V162, P117, DOI 10.1084/jem.162.1.117
   Jiang H, 2006, NEW ENGL J MED, V354, P1166, DOI 10.1056/NEJMra055446
   JONES JA, 2007, J BIOMED MAT RE 0514
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   LANZAVECCHIA A, 2000, SCIENCE, V290, P8063
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245
   Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003
   RHODES NP, 1994, J MATER SCI-MATER M, V5, P666, DOI 10.1007/BF00120353
   Rozalska B, 1996, IMMUNOL LETT, V49, P99, DOI 10.1016/0165-2478(95)02489-1
   SANTAVIRTA S, 1990, J BONE JOINT SURG BR, V72, P597
   Schlosser M, 2002, J BIOMED MATER RES, V61, P450, DOI 10.1002/jbm.10096
   SCHLOSSER M, 1994, HORM METAB RES, V26, P534, DOI 10.1055/s-2007-1001751
   Schuster M, 2001, TRANSPLANT P, V33, P1960, DOI 10.1016/S0041-1345(00)02754-8
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   van Luyn MJA, 2001, BIOMATERIALS, V22, P1385, DOI 10.1016/S0142-9612(00)00295-7
   Yi HF, 2006, CELL MOL IMMUNOL, V3, P189
   ZIEGLER M, 1994, BIOMATERIALS, V15, P859, DOI 10.1016/0142-9612(94)90043-4
   Zippel R, 2001, EUR J VASC ENDOVASC, V21, P202, DOI 10.1053/ejvs.2000.1298
NR 37
TC 26
Z9 26
U1 1
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2008
VL 85A
IS 2
BP 556
EP 565
DI 10.1002/jbm.a.31562
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 285UM
UT WOS:000254801700030
PM 17729264
DA 2018-10-20
ER

PT J
AU Zhu, AP
   Pan, YN
   Liao, TQ
   Zhao, F
   Chen, T
AF Zhu, Aiping
   Pan, Yingnan
   Liao, Tianqing
   Zhao, Feng
   Chen, Tian
TI The synthesis and characterization of polymerizable and Biocompatible
   N-maleic acyl-chitosan
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE chitosan; maleic acyl-chitosan; polymeric activity; cytocompatibility
ID ADHESION CONTACT DYNAMICS; O-CARBOXYMETHYLCHITOSAN; POLY(ETHYLENE
   GLYCOL); PCL DIACRYLATE; CELL VIABILITY; ACID; SCAFFOLDS; HYDROGELS;
   POLYSACCHARIDES; COMPATIBILITY
AB Biocompatible and polymerizable natural macromolecules have been found to provide great advantages in the preparation of hydrogels, which have wide applications in the fields of tissue engineering and polymeric drug delivery systems. To develop a new biocompatible polymerizable chitosan derivative, N-maleic acyl-chitosan (NMCS) was synthesized in this study. This novel biomaterial was designed from the N-acylation of chitosan with maleic anhydride introducing functional carboxyl and vinylated (-C=C-) groups. The structure of NMCS was characterized by FTIR, H-1 NMR, element analysis, and X-ray diffraction (XRD). NMCS can be dissolved into water because of its decreased crystallinity compared with chitosan. The NMCS's multiporous and microgel morphology was revealed by transmission electron microscope (TEM). Crosslinked hydrogel films can be successfully obtain through the macromolecular polymerization of NMCS. Subsequently, 3T3 fibroblasts were cultured onto the surface of the polymerized NMCS (P-NMCS) films to examine the capability of cell attachment and proliferation. Results from the cell culture demonstrate that P-NMCS films provide significant improvement in cell attachment and proliferation over unmodified chitosan. The improved P-NMCS cytocompatibility is expected to provide substantial contributions to tissue engineering in the future.(c) 2007 Wiley Periodicals, Inc.
C1 [Zhu, Aiping; Pan, Yingnan; Chen, Tian] Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225002, Peoples R China.
   [Liao, Tianqing; Zhao, Feng] Florida State Univ, Dept Chem & Biomed Engn, Tallahassee, FL 32310 USA.
RP Zhu, AP (reprint author), Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225002, Peoples R China.
EM apzhu@yzu.edu.cn
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Dureja H, 2001, INT J PHARM, V213, P193, DOI 10.1016/S0378-5173(00)00666-9
   Fang N, 2005, MACROMOL BIOSCI, V5, P1022, DOI 10.1002/mabi.200500123
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hoshikawa A, 2006, TISSUE ENG, V12, P2333, DOI 10.1089/ten.2006.12.2333
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim SH, 2000, J BIOMED MATER RES, V49, P517, DOI 10.1002/(SICI)1097-4636(20000315)49:4<517::AID-JBM10>3.0.CO;2-8
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Ma ZW, 2003, BIOMATERIALS, V24, P3725, DOI 10.1016/S0142-9612(03)00247-3
   Matsuda T, 2002, BIOMACROMOLECULES, V3, P942, DOI 10.1021/bm0200229
   PARK JW, 1983, B KOR CHEM SOC, V4, P68
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Tanaka M, 2007, J NANOSCI NANOTECHNO, V7, P763, DOI 10.1166/jnn.2007.514
   Vachoud L, 1997, CARBOHYD RES, V302, P169, DOI 10.1016/S0008-6215(97)00126-2
   VYAVAHARE N, 1994, J POLYM SCI POL CHEM, V32, P1271, DOI 10.1002/pola.1994.080320708
   Zhu AP, 2006, BIOMATERIALS, V27, P2566, DOI 10.1016/j.biomaterials.2005.11.039
   Zhu AP, 2006, J BIOMED MATER RES B, V76B, P76, DOI 10.1002/jbm.b.30348
   Zhu AP, 2006, CARBOHYD POLYM, V63, P89, DOI 10.1016/j.carbpol.2005.08.006
   Zhu AP, 2005, BIOMACROMOLECULES, V6, P2607, DOI 10.1021/bm050328q
   Zhu AP, 2005, COLLOID SURFACE B, V43, P143, DOI 10.1016/j.colsurfb.2005.04.009
   Zhu AP, 2005, J BIOMAT SCI-POLYM E, V16, P301, DOI 10.1163/1568562053654149
   Zhu AP, 2003, POLYM INT, V52, P81, DOI 10.1002/pi.1026
   Zhu YB, 2003, J BIOMED MATER RES A, V67A, P1367, DOI 10.1002/jbm.a.20058
NR 25
TC 14
Z9 14
U1 0
U2 23
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2008
VL 85B
IS 2
BP 489
EP 495
DI 10.1002/jbm.b.30970
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 291GB
UT WOS:000255180900022
PM 18161835
DA 2018-10-20
ER

PT J
AU Lyu, S
   Schley, J
   Loy, B
   Luo, L
   Hobot, C
   Sparer, R
   Untereker, D
   Krzeszak, J
AF Lyu, SuPing
   Schley, James
   Loy, Brian
   Luo, Lian
   Hobot, Chris
   Sparer, Randall
   Untereker, Darrel
   Krzeszak, Jason
TI In vitro biostability evaluation of polyurethane composites in acidic,
   basic, oxidative, and neutral solutions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE composite; biostabillity; oxidation; chemical resistance; hydration;
   biomaterial
ID MATRIX INTERFACIAL BOND; STRUCTURAL BIOMATERIALS; STRESS CRACKING;
   SURFACE DAMAGE; BIODEGRADATION; CARBON; ENVIRONMENTS; REPLACEMENT;
   COMPONENTS; DEGRADATION
AB New and improved properties can often be achieved by compounding two or more different but compatible materials. But, can failure possibility also be increased by such a compounding strategy? In this article, we compared the in vitro biostability of composites with that of the pure polymer. We tested three model composites in oxidative, acidic, basic, and neutral solutions. We found that oxidation degradation was much more profound in the composites than in the corresponding pure polymer. This degradation seemed to be an intrinsic property of composite materials. We also observed the well documented interfacial debonding between filler and matrix and its effects on the mechanical reinforcement of the hydrated composites. The improvements in acid and base resistance were also observed. (c) 2007 Wiley Periodicals, Inc.
C1 [Lyu, SuPing; Schley, James; Loy, Brian; Luo, Lian; Hobot, Chris; Sparer, Randall; Untereker, Darrel; Krzeszak, Jason] Medtron Corp Sci & Technol, Minneapolis, MN 55432 USA.
RP Lyu, S (reprint author), Medtron Corp Sci & Technol, 710 Medtron Pkwy, Minneapolis, MN 55432 USA.
EM suping.lyu@medtronic.com
CR ADAMS D, 1978, J BIOMED MATER RES, V12, P35, DOI 10.1002/jbm.820120104
   Byrd C L, 1983, Pacing Clin Electrophysiol, V6, P869
   Casas J, 1999, J BIOMED MATER RES, V46, P475, DOI 10.1002/(SICI)1097-4636(19990915)46:4<475::AID-JBM5>3.0.CO;2-J
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   COURY A, 2004, BIOMATERIALS SCI INT, P411
   HALCOMB FJ, 1981, T AM SOC ART INT ORG, V27, P364
   LATOUR RA, 1992, J BIOMED MATER RES, V26, P593, DOI 10.1002/jbm.820260504
   LATOUR RA, 1993, J BIOMED MATER RES, V27, P1281, DOI 10.1002/jbm.820271008
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   MEYER MR, 1994, J BIOMED MATER RES, V28, P1221, DOI 10.1002/jbm.820281012
   Migliaresi C., 2004, BIOMATERIALS SCI INT, P181
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Stokes KS, 1988, J BIOMATER APPL, V3, P229
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Wiggins MJ, 2003, J BIOMED MATER RES A, V66A, P463, DOI 10.1002/jbm.a.10584
   Wiggins MJ, 2003, J BIOMED MATER RES A, V65A, P524, DOI 10.1002/jbm.a.10565
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   WRIGHT TM, 1986, CLIN ORTHOP RELAT R, P67
   WRIGHT TM, 1988, J BONE JOINT SURG AM, V70A, P1312, DOI 10.2106/00004623-198870090-00006
   WRIGHT TM, 1988, J BONE JOINT SURG AM, V70A, P926, DOI 10.2106/00004623-198870060-00019
   Wright-Charlesworth DD, 2006, J BIOMED MATER RES A, V78A, P541, DOI 10.1002/jbm.a.30767
   ZHAO QH, 1995, J BIOMED MATER RES, V29, P467, DOI 10.1002/jbm.820290406
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 24
TC 6
Z9 6
U1 2
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2008
VL 85B
IS 2
BP 509
EP 518
DI 10.1002/jbm.b.30973
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 291GB
UT WOS:000255180900025
PM 18076092
DA 2018-10-20
ER

PT J
AU Batory, D
   Blaszczyk, T
   Clapa, M
   Mitura, S
AF Batory, D.
   Blaszczyk, T.
   Clapa, M.
   Mitura, S.
TI Investigation of anti-corrosion properties of Ti : C gradient layers
   manufactured in hybrid deposition system
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT International Conference on Surfaces, Coatings and Nanostructured
   Materials (NanoSMat)
CY 2007
CL Algarve, PORTUGAL
SP Soc Nanosci & Nanotechnol
ID STAINLESS-STEEL; MAGNESIUM ALLOY; DLC COATINGS; CORROSION; WEAR;
   BIOMATERIAL; FRICTION; BEHAVIOR; FILMS
AB Excellent properties of hard carbon layers and especially, the unique combination of tribological, chemical and physical properties make them a popular coating material for use on surgical prosthesis, biomedical implants, and machine tools. However, their well-known poor adhesion and high internal stress disqualifies them in many possibilities of industrial applications. These drawbacks were improved by deposition of Ti buffer layer. By a combination of Radio Frequency Plasma Assisted Chemical Vapor Deposition (RFPACVD) and DC magnetron sputtering methods, thick carbon films were manufactured on Rex 734 steel. Structure and chemical composition of deposited layers was determined by scanning electron microscope and energy dispersive spectrometer analysis. The main purpose of this work was to determine the corrosion properties of Rex 734 alloy in a typical 0.5 M NaCl solution and to find the influence of Ti:C gradient layers on these properties. Anti-corrosion behavior was measured by the detection of corrosion potential in open circuit and the registration of potentiodynamic characteristics according to Stern-Geary and Tafel methods. Five different types of samples were studied: for full analysis the investigation was conducted for every structural component of the layer: for pure Ti deposited on Rex 734 as well as for Ti containing carbon layer and carbon layer deposited subsequently, and finally the corrosion resistance of Rex 734 steel was measured for comparison. As a result of the investigation it was noticed that the Ti-C interlayer enables to maximize the thickness of DLC films and Ti:C gradient layers have the good influence on the corrosion features of Rex 734 alloy.
C1 [Batory, D.; Clapa, M.; Mitura, S.] Tech Univ Lodz, Inst Mat Sci & Engn, PL-90924 Lodz, Poland.
   [Blaszczyk, T.] Univ Lodz, Dept Gen & Inorgan Chem, PL-90136 Lodz, Poland.
RP Batory, D (reprint author), Tech Univ Lodz, Inst Mat Sci & Engn, 1 Stefanowskiego St, PL-90924 Lodz, Poland.
EM damian.batory@p.lodz.pl
RI Mitura, Stanislaw/L-6013-2014
OI Mitura, Stanislaw/0000-0001-9280-3748
CR Batoty D., 2006, INZYNIERIA MATERIALO, V5, P868
   BLASZCZYK T, 2006, ENG BIOMATER, V65, P58
   BURNAT B, 2007, ENG BIOMATER RYTRO, P66621
   Choi J, 2007, DIAM RELAT MATER, V16, P1361, DOI 10.1016/j.diamond.2006.11.088
   Clapa M., 2007, J ACHIEVEMENTS MAT M, V20, P415
   COUVRAT P, 1995, DIAM RELAT MATER, V4, P1251, DOI 10.1016/0925-9635(95)00307-X
   Dorner-Reisel A, 2004, SURF COAT TECH, V177, P830, DOI 10.1016/j.surfcoat.2003.06.015
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Huang GF, 2003, DIAM RELAT MATER, V12, P1406, DOI 10.1016/S0925-9635(03)00168-7
   Huang LY, 2001, DIAM RELAT MATER, V10, P1448, DOI 10.1016/S0925-9635(00)00501-X
   Mitura E, 1996, DIAM RELAT MATER, V5, P998, DOI 10.1016/0925-9635(95)00469-6
   MITURA S, 2000, NANOTECHNOLOGY MAT S, P66621
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   Pan J, 2000, J ELECTROCHEM SOC, V147, P1021, DOI 10.1149/1.1393307
   Reclaru L, 2002, BIOMATERIALS, V23, P3479, DOI 10.1016/S0142-9612(02)00055-8
   SCHOLL H, 2006, NEW TECHNOLOGIES MED, P66621
   SUNDARAM VS, 2006, DIAM RELAT MATER, V201, P2707
   Yamauchi N, 2005, SURF COAT TECH, V193, P277, DOI 10.1016/j.surfcoat.2004.07.056
   Yamauchi N, 2003, SURF COAT TECH, V174, P465, DOI 10.1016/S0257-8972(03)00406-7
   2004, G10289, P66621
NR 20
TC 12
Z9 12
U1 5
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD MAY
PY 2008
VL 43
IS 10
BP 3385
EP 3391
DI 10.1007/s10853-007-2393-0
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 288CQ
UT WOS:000254964200005
DA 2018-10-20
ER

PT J
AU Pan, YS
   Xiong, DS
   Gao, F
AF Pan, Yusong
   Xiong, Dangsheng
   Gao, Fei
TI Viscoelastic behavior of nano-hydroxyapatite reinforced poly(vinyl
   alcohol) gel biocomposites as an articular cartilage
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FRICTION CHARACTERISTICS; PVA-HYDROGEL; STARCH GELS; BIOMATERIAL
AB Nanohydroxyapatite reinforced poly(vinyl alcohol) gel (nano-HA/PVA gel) composites has been proposed as an articular cartilage repair biomaterial. In this paper, nano-HA/PVA gel composites were prepared by in situ synthesis nano-HA particles in PVA solution and accompanied with freeze/thaw method. The influence of nano-HA content, PVA concentration, test frequency and freeze/thaw cycle times on the viscoelastic behavior of nano-HA/PVA gel composites were evaluated using dynamic mechanical thermal analysis (DMTA). The results showed that both storage modulus and loss modulus firstly increased and then presented decreasing trend with the rise of nano-HA content. Their maximum values were obtained while nano-HA content was 6%. Furthermore, the G' and G '' of the composites improve with the increase of PVA concentrations and freeze/thaw cycle times. This effect was more distinct at low freeze/thaw cycles. The phase angle (tan delta) of the pure PVA gel is larger than that of the nano-HA/PVA composites at the test frequency spectra, but all the phase angle values of the tested composites were close to that of nature bone.
C1 [Pan, Yusong; Xiong, Dangsheng; Gao, Fei] Nan Jing Univ Sci & Technol, Dept Mat Sci & Engn, Nan Jing 21009, Peoples R China.
RP Pan, YS (reprint author), Nan Jing Univ Sci & Technol, Dept Mat Sci & Engn, Nan Jing 21009, Peoples R China.
EM xiongds@163.com
CR Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Arvind S., 2007, MAT SCI ENG C, V27, P70
   Buechner PM, 2001, ANN BIOMED ENG, V29, P719, DOI 10.1114/1.1385813
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   Hernandez R, 2002, POLYMER, V43, P5661, DOI 10.1016/S0032-3861(02)00470-6
   Hisatoshi K., 2004, MAT SCI ENG C, V24, P729
   Huang H. Y., 1997, CLIN NEUROL NEUROSUR, V99, P20
   JOAO FM, 2005, MAT SCI ENG C-BIO S, V25, P145
   Karen JLB, 2000, BIOMATERIALS, V21, P2347
   KONG LX, 2005, SYNTHETIC MET, V152, P25
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   Michailova V, 1999, COLLOID SURFACE A, V149, P515, DOI 10.1016/S0927-7757(98)00608-6
   Mondragon M, 2006, CARBOHYD POLYM, V65, P314, DOI 10.1016/j.carbpol.2006.01.011
   Moresi M, 2004, J FOOD ENG, V64, P179, DOI 10.1016/j.jfoodeng.2003.09.030
   Nebahat D., 2006, COLLOID SURFACE B, V48, P42
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   PAN YS, 2007, MAT SCI, V42, P5129
   [潘育松 Pan Yusong], 2006, [摩擦学学报, Tribology], V26, P188
   Pan YS, 2007, KEY ENG MATER, V330-332, P1297, DOI 10.4028/www.scientific.net/KEM.330-332.1297
   REBECA H, 2004, POLYMER, V46, P5543
   REBECCAH JC, 2003, WEAR, V25, P1064
   Rosa R., 2003, POLYMER, V44, P3375
   SHIGO M, 2004, MAT SCI ENG C-BIO S, V24, P425
   SU FL, 2005, ACTA MAT COMPOSITES, V22, P27
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   Xu FL, 2004, J MATER SCI, V39, P5669, DOI 10.1023/B:JMSC.0000040074.64787.b3
   ZHANG P, 2004, SYNTHETIC MET, V152, P25
   Zheng-Qiu G, 1998, BIO-MED MATER ENG, V8, P75
NR 29
TC 34
Z9 39
U1 4
U2 40
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2008
VL 19
IS 5
BP 1963
EP 1969
DI 10.1007/s10856-007-3280-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 277HC
UT WOS:000254202300013
PM 17943417
DA 2018-10-20
ER

PT J
AU Venugopal, J
   Low, S
   Choon, AT
   Kumar, TSS
   Ramakrishna, S
AF Venugopal, J.
   Low, Sharon
   Choon, Aw Tar
   Kumar, T. S. Sampath
   Ramakrishna, S.
TI Mineralization of osteoblasts with electrospun collagen/hydroxyapatite
   nanofibers
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE; HUMAN BONE; HYDROXYAPATITE; COLLAGEN; MATRIX; CELLS;
   COMPOSITE; SCAFFOLDS; IMPLANTS; BIOMATERIALS
AB Regeneration of fractured or diseased bones is the challenge faced by current technologies in tissue engineering. The major solid components of human bone consist of collagen and hydroxyapatite. Collagen (Col) and hydroxyapatite (HA) have potential in mimicking natural extracellular matrix and replacing diseased skeletal bones. More attention has been focused on HA because of its crystallographic structure similar to inorganic compound found in natural bone and extensively investigated due to its excellent biocompatibility, bioactivity and osteoconductivity properties. In the present study, electrospun nanofibrous scaffolds are fabricated with collagen (80 mg/ml) and Col/HA (1:1). The diameter of the collagen nanofibers is around 265 +/- 0.64 nm and Col/HA nanofibers are 293 +/- 1.45 nm. The crystalline HA (29 +/- 7.5 nm) loaded into the collagen nanofibers are embedded within nanofibrous matrix of the scaffolds. Osteoblasts cultured on both scaffolds and show insignificant level of proliferation but mineralization was significantly (p < 0.001) increased to 56% in Col/HA nanofibrous scaffolds compared to collagen. Energy dispersive X-ray analysis (EDX) spectroscopy results proved the presence of higher level of calcium and phosphorous in Col/HA nanocomposites than collagen nanofibrous scaffolds grown osteoblasts. The results of the present study suggested that the designed electrospun nanofibrous scaffold (Col/HA) have potential biomaterial for bone tissue engineering.
C1 [Venugopal, J.; Ramakrishna, S.] Natl Univ Singapore, Div Bioengn, Singapore 117576, Singapore.
   [Low, Sharon; Choon, Aw Tar] StemLife Sdn BhD, Kuala Lumpur 50450, Malaysia.
   [Kumar, T. S. Sampath] Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
RP Venugopal, J (reprint author), Natl Univ Singapore, Div Bioengn, Block E3,05-14,9 Engn Dr 1, Singapore 117576, Singapore.
EM engjrv@nus.edu.sg
OI Jayarama Reddy, Venugopal/0000-0001-5867-8007
CR Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Boskey AL, 1996, CONNECT TISSUE RES, V35, P357, DOI 10.3109/03008209609029212
   Carlson GA, 2004, BIOCHEM BIOPH RES CO, V321, P472, DOI 10.1016/j.bbrc.2004.06.165
   CLARKE KI, 1993, J MATER SCI-MATER M, V4, P107, DOI 10.1007/BF00120378
   De Bruijn J. D., 1998, BIOMATERIALS SURG, P77
   Derkx P, 1998, BONE, V22, P367, DOI 10.1016/S8756-3282(97)00299-8
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GEORGE J, 2006, BIOTECHNOL BIOENG, V95, P405
   GLOWACKI J, 1981, CALCIFIED TISSUE INT, V33, P71, DOI 10.1007/BF02409414
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Hsu SH, 2007, J BIOMED MATER RES B, V80B, P519, DOI 10.1002/jbm.b.30626
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   JOHANSEN E, 1960, J BIOPHYS BIOCHEM CY, V7, P743, DOI 10.1083/jcb.7.4.743
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Li Xiang-Ru, 2005, Journal of Software, V16, P365, DOI 10.1360/jos160365
   Mendes SC, 2004, J MATER SCI-MATER M, V15, P1123, DOI 10.1023/B:JMSM.0000046394.53153.21
   MENDES SC, 2000, BONE ENG, P505
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   MIZUNO M, 2001, J BIOCHEM-TOKYO, V129, P129
   MURUGAN R, 2002, BIOCH BIOPHYS RES, V292, P1
   Nishikawa Tetsunari, 2005, Implant Dent, V14, P252, DOI 10.1097/01.id.0000173628.00705.d0
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Porter A, 2005, J MATER SCI-MATER M, V16, P899, DOI 10.1007/s10856-005-4424-1
   ROBINSON RA, 1952, J BONE JOINT SURG AM, V34-A, P389, DOI 10.2106/00004623-195234020-00013
   Sachlos E, 2006, TISSUE ENG, V12, P2479, DOI 10.1089/ten.2006.12.2479
   Scabbia A, 2004, J CLIN PERIODONTOL, V31, P348, DOI 10.1111/j.1600-051X.2004.00483.x
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
   WEINER S, 1989, TISSUE RES, V221, P589
   WEINREB M, 1990, J BONE MINER RES, V5, P831
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Xie JW, 2004, J BIOMED MATER RES A, V71A, P108, DOI 10.1002/jbm.a.30140
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
NR 41
TC 114
Z9 114
U1 1
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2008
VL 19
IS 5
BP 2039
EP 2046
DI 10.1007/s10856-007-3289-x
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 277HC
UT WOS:000254202300022
PM 17957448
DA 2018-10-20
ER

PT J
AU Mangano, C
   Piattelli, A
   Perrotti, V
   Iezzi, G
AF Mangano, Carlo
   Piattelli, Adriano
   Perrotti, Vittoria
   Iezzi, Giovanna
TI Dense hydroxyapatite inserted into postextraction sockets: A histologic
   and histomorphometric 20-year case report
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE case report; histology; hydroxyapatite; long-term study
ID LONG-TERM; POROUS HYDROXYAPATITE; ALVEOLAR RIDGE; TRICALCIUM PHOSPHATE;
   EXTRACTION SOCKETS; CERAMIC IMPLANTS; MAXILLARY SINUS; DOG FEMORA;
   IN-VIVO; BONE
AB Background: The biologic behavior, i.e., the degradation of hydroxyapatite (HA) in the human body, is of relevance for clinicians. The present investigation is a long-term (20-year) histologic and histomorphometric evaluation of dense HA used in postextraction sockets.
   Methods: Dense HA particles were used in a patient in postextraction alveolar sockets to maintain the alveolar ridge height. The patient returned after 20 years for implant treatment. A ridge remodeling was necessary during implant insertion surgery, and the HA/bone tissue was harvested with bone-cutting forceps from the canine and premolar area. The specimen was processed for histology and histomorphometry at the Implant Retrieval Centre, Dental School, University of Chieti-Pescara.
   Results: Most of the particles (56%) were surrounded partially by bone, whereas some particles (39%) were surrounded completely. At higher magnification, bone was in close contact with the particles, and neither gaps nor flbrous tissues were present at the bone-biomaterial interface. Microscopically, the particles had a dense appearance. In only a few fields, it was possible to observe that the outer part of some particles had detached from the original particles' surface. Histomorphometry showed that bone represented 25.4% +/- 3.2%, marrow spaces represented 41.3% +/- 5.2%, and residual HA particles represented 38.1% +/- 4.1%.
   Conclusions: Intimate binding between bone and HA particles was present after a long-term implantation period (20 years). The fact that HA particles were surrounded closely by bone is very promising for the long-term stability of the augmentation.
C1 [Mangano, Carlo] Univ Varese, Sch Dent, Dept Biomat Sci, Varese, Italy.
   [Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Dept Oral Med & Pathol, Chieti, Italy.
   [Perrotti, Vittoria; Iezzi, Giovanna] Univ G dAnnunzio, Sch Dent, Dept Stomatol & Oral Sci, Chieti, Italy.
RP Piattelli, A (reprint author), Via F Sciucchi 63, I-66100 Chieti, Italy.
EM apiattelli@unich.it
CR Ayers RA, 1998, J ORAL MAXIL SURG, V56, P1297, DOI 10.1016/S0278-2391(98)90613-9
   BELL R, 1988, J ORAL MAXIL SURG, V46, P589, DOI 10.1016/0278-2391(88)90150-4
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   CARRANZA FA, 1987, J PERIODONTOL, V58, P682, DOI 10.1902/jop.1987.58.10.682
   DENISSEN HW, 1984, J BIOMED MATER RES, V18, P147, DOI 10.1002/jbm.820180205
   DENISSEN HW, 1985, HYDROXYAPATITE IMPLA, P63
   DONATH K, 1987, ORAL SURG ORAL MED O, V63, P651, DOI 10.1016/0030-4220(87)90362-8
   DONATH K, 1990, OSSEOINTEGRATED IMPL, P99
   ELDEEB M, 1991, J ORAL MAXIL SURG, V49, P257, DOI 10.1016/0278-2391(91)90215-8
   Goto T, 2001, J Orthop Sci, V6, P444, DOI 10.1007/s007760170013
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   Haas R, 2003, INT J ORAL MAX IMPL, V18, P691
   HOOGENDOORN HA, 1984, CLIN ORTHOP RELAT R, P281
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KENT JN, 1986, DENT CLIN N AM, V30, P231
   KLEIN CPAT, 1989, BIOMATERIALS, V10, P59
   KWONG CH, 1989, BIOMATERIALS, V10, P579, DOI 10.1016/0142-9612(89)90110-5
   Liljensten Elisabeth, 2003, Clin Implant Dent Relat Res, V5, P95, DOI 10.1111/j.1708-8208.2003.tb00190.x
   Mangano C, 2003, INT J ORAL MAX IMPL, V18, P23
   Mercier P, 1996, J ORAL MAXIL SURG, V54, P960, DOI 10.1016/S0278-2391(96)90392-4
   OGUCHI H, 1995, BIOMATERIALS, V16, P33, DOI 10.1016/0142-9612(95)91093-E
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   Proussaefs P, 2002, J PROSTHET DENT, V87, P481, DOI 10.1037/mpr.2002.122961
   Ramaswamy Y, 2005, J MATER SCI-MATER M, V16, P1199, DOI 10.1007/s10856-005-4729-0
   SCHEER P, 1987, J AM DENT ASSOC, V114, P594
   SHERER AD, 1987, J PROSTHET DENT, V57, P331, DOI 10.1016/0022-3913(87)90308-8
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   Ye F, 2007, J MATER SCI-MATER M, V18, P2173, DOI 10.1007/s10856-007-3215-2
NR 29
TC 17
Z9 17
U1 0
U2 0
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD MAY
PY 2008
VL 79
IS 5
BP 929
EP 933
DI 10.1902/jop.2008.070245
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 302IH
UT WOS:000255961500021
PM 18454673
DA 2018-10-20
ER

PT J
AU Schoenfeld, AJ
   Battula, S
   Sahai, V
   Vrabec, GA
   Corman, S
   Burton, L
   Njus, GO
AF Schoenfeld, Andrew J.
   Battula, Suneel
   Sahai, Vivek
   Vrabec, Gregory A.
   Corman, Steven
   Burton, Lyndsey
   Njus, Glen O.
TI Pullout strength and load to failure properties of self-tapping cortical
   screws in synthetic and cadaveric environments representative of healthy
   and osteoporotic bone
SO JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
LA English
DT Article
DE osteoporosis; biomaterial properties; self-tapping screws; biomechanical
   testing
AB Background: The parameters of self-tapping screw (STS) performance in normal and osteoporotic bone have been defined in representative environments, but the question remains as to the clinical application of such findings. The goal of this study was to analyze the biomechanical performance of STSs in cadaveric and synthetic environments representative of healthy and osteoporotic bone.
   Methods: Ninety-six Synthes STSs were inserted into cadaveric and synthetic models representative of osteoporotic and healthy bone. Screws were inserted to depths of 1 mm short of the far cortex, flush and 1 nun and 2 mm beyond the far cortex. Screws were tested with an Instron 8511 material testing system utilizing axial pullout forces. A SAS procedure was used to conduct analysis of variance for unbalanced datasets.
   Results: Substantial differences were appreciated with respect to screw performance between osteoporotic and healthy bone specimens. Although a similar pattern of increased pullout strength and loading energy with increasing depth of insertion was demonstrated, absolute values were lower in osteoporotic specimens. Although performance trends were similar in cadaveric and synthetic testing models for both osteoporotic and healthy bone, values obtained during testing were different. Incomplete insertion of STSs resulted in a 21.5% and 37% reduction of biomechanical properties in osteoporotic and normal bone, respectively.
   Conclusions: These results indicate that previously published findings on the performance of STSs in synthetic models cannot reasonably be applied to the clinical realm. Although trends may be similar, screw performance in synthetic, as compared with cadaveric, models is markedly different.
C1 [Schoenfeld, Andrew J.; Vrabec, Gregory A.] Northeastern Ohio Univ Coll Med & Pharm, Dept Orthopaed Surg, Akron, OH USA.
   [Schoenfeld, Andrew J.; Sahai, Vivek; Vrabec, Gregory A.; Corman, Steven] Akron Gen Med Ctr, Dept Orthopaed Surg, Akron, OH USA.
   [Battula, Suneel; Njus, Glen O.] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
   [Burton, Lyndsey] Northeastern Ohio Univ Coll Med & Pharm, Rootstown, OH USA.
RP Schoenfeld, AJ (reprint author), Northeastern Ohio Univ Coll Med & Pharm, Dept Orthopaed Surg, 400 Wabash Ave, Akron, OH USA.
EM ajschoen@neoucom.edu
OI Schoenfeld, Andrew/0000-0002-3691-1215
CR *ASTM, 1996, BOOK ASTM STAND, P1
   Battula S, 2006, CLIN BIOMECH, V21, P533, DOI 10.1016/j.clinbiomech.2005.12.020
   Berkowitz R, 2005, J ORTHOP TRAUMA, V19, P462, DOI 10.1097/01.bot.0000161544.72757.95
   CHANDLER RW, 2001, ROCKWOOD GREENS FRAC, P181
   Cornell Charles N, 2003, J Am Acad Orthop Surg, V11, P109
   Gonzalez J V, 1997, J Foot Ankle Surg, V36, P422
   LANE J, 2003, SKELETAL TRAUMA, P287
   MAZZOCCA AD, 2003, SKELETAL TRAUMA BASI, P195
   MCDONALD DE, 1994, VET SURG, V23, P488, DOI 10.1111/j.1532-950X.1994.tb00510.x
   Murphy TP, 2001, VET SURG, V30, P253, DOI 10.1053/jvet.2001.23344
   ROSEN H, 1990, ORTHOP CLIN N AM, V21, P725
   Yerby S, 2001, J ORTHOP TRAUMA, V15, P216, DOI 10.1097/00005131-200103000-00012
NR 12
TC 24
Z9 24
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5282
J9 J TRAUMA
JI J. Trauma-Injury Infect. Crit. Care
PD MAY
PY 2008
VL 64
IS 5
BP 1302
EP 1307
DI 10.1097/TA.0b013e318169cd71
PG 6
WC Critical Care Medicine; Surgery
SC General & Internal Medicine; Surgery
GA 301SH
UT WOS:000255915400027
PM 18469654
DA 2018-10-20
ER

PT J
AU Roller, J
   Laschke, MW
   Sethi, S
   Herrmann, M
   Menger, MD
AF Roller, Jonas
   Laschke, Matthias W.
   Sethi, Shneh
   Herrmann, Mathias
   Menger, Michael D.
TI Prolene-Monocryl-composite meshes do not increase microvascular
   Staphylococcus aureus adherence and do not sensitize for leukocytic
   inflammation
SO LANGENBECKS ARCHIVES OF SURGERY
LA English
DT Article
DE surgical mesh; infection; Staphylococcus aureus; dorsal skinfold
   chamber; intravital fluorescence microscopy
ID COMPARATIVE IN-VIVO; FIBRONECTIN-BINDING PROTEINS; HERNIA REPAIR;
   INGUINAL-HERNIA; STRIATED-MUSCLE; POLYPROPYLENE MESH; INCISIONAL HERNIA;
   CHAMBER TECHNIQUE; STAINLESS-STEEL; INFECTION
AB Background and aims Mesh implantation for hernia repair bears the risk of bacterial mesh infection. In this study, we analyzed whether this complication is supported by an increased interaction of bacteria and leukocytes with the microvascular endothelium at the implantation site.
   Materials and methods Ultrapro meshes were implanted into the dorsal skinfold chamber of Syrian golden hamsters. After 12 days, fluorescein isothiocyanate (FITC)-labeled staphylococci were injected in the animals. Subsequently, we analyzed bacterial adherence, leukocyte-endothelial cell interaction, and microhemodynamics in venules of the mesh border zone and of distant control tissue under baseline conditions and during TNF-alpha-induced inflammation using intravital fluorescence microscopy. The results were compared to animals which did not receive any bacteria.
   Results Under baseline conditions, leukocyte-endothelial cell interaction and bacterial adherence were not affected by the implanted biomaterial. TNF-alpha-induced inflammation significantly increased numbers of adherent leukocytes and bacteria in venules located in direct vicinity to the mesh however without any differences to control tissue. Comparable results were found for the leukocyte-endothelial cell interaction when animals were not exposed to bacteria.
   Conclusion Implanted Ultrapro meshes do neither increase microvascular Staphylococcus aureus adherence nor sensitize for leukocytic inflammation. Thus, we suggest that a mesh-induced increase of bacterial adherence in vessels of the implantation site cannot be considered as a primary cause for the development of mesh infection.
C1 [Roller, Jonas; Laschke, Matthias W.; Menger, Michael D.] Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
   [Sethi, Shneh; Herrmann, Mathias] Univ Saarland, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany.
RP Laschke, MW (reprint author), Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
EM matthias.laschke@uniklinik-saarland.de
RI Herrmann, Mathias/B-6475-2013; Sethi, Shneh/F-1796-2013
CR AINSCOW DAP, 1984, J BONE JOINT SURG BR, V66, P580
   BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0
   BELLON JM, 1994, EUR SURG RES, V26, P46, DOI 10.1159/000129317
   Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461
   Burger JWA, 2004, ANN SURG, V240, P578
   Cobb WS, 2003, AM SURGEON, V69, P784
   Collaboration EH, 2000, BRIT J SURG, V87, P854
   Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005
   Delikoukos S, 2007, Hernia, V11, P15, DOI 10.1007/s10029-006-0131-1
   Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a..20016
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   Falagas ME, 2005, CLIN MICROBIOL INFEC, V11, P3, DOI 10.1111/j.1469-0691.2004.01014.x
   Foschi D, 1998, SURG ENDOSC-ULTRAS, V12, P455, DOI 10.1007/s004649900704
   Harrell A G, 2006, Hernia, V10, P120, DOI 10.1007/s10029-005-0056-0
   Hoffmann JN, 2004, CRIT CARE MED, V32, P1011, DOI 10.1097/01.CCM.0000120058.88975.42
   Holzheimer RG, 2007, EUR J MED RES, V12, P1
   HOMER V, 2007, INT J INFECT DIS SUP, V11, pS17
   Jezupors A, 2006, WORLD J SURG, V30, P2270, DOI 10.1007/s00268-006-0130-5
   Kerdudou S, 2006, THROMB HAEMOSTASIS, V96, P183, DOI 10.1160/TH-06-02-0116
   Klosterhalfen B, 2003, EUR SURG, V35, P16
   Kraft CN, 2005, J BIOMED MATER RES A, V75A, P31, DOI 10.1002/jbm.a.30407
   Kraft CN, 2001, J BIOMED MATER RES, V57, P404, DOI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   Laschke MW, 2005, J BIOMED MATER RES A, V74A, P696, DOI 10.1002/jbm.a.30371
   Laschke MW, 2005, J INFECT DIS, V191, P435, DOI 10.1086/427193
   LASCHKE MW, 2007, IN PRESS J BIOMED MA
   LEHR HA, 1993, AM J PATHOL, V143, P1055
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   MALMROS C, 1994, WORLD J SURG, V18, P811, DOI 10.1007/BF00299071
   Mann DV, 1998, AM J SURG, V176, P12, DOI 10.1016/S0002-9610(98)00094-4
   Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663
   Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093
   Nienhuijs S, 2007, AM J SURG, V194, P394, DOI 10.1016/j.amjsurg.2007.02.012
   PAPENFUSS HD, 1979, MICROVASC RES, V18, P311, DOI 10.1016/0026-2862(79)90039-6
   Rios A, 2001, Hernia, V5, P148
   Rosch R, 2003, EUR SURG RES, V35, P161, DOI 10.1159/000070045
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4
   Shaw JP, 2003, J SURG RES, V109, P37, DOI 10.1006/jsre.2002.6559
   Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x
   Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Taylor SG, 1999, BRIT J SURG, V86, P562
   Vallien G, 2000, MICROCIRCULATION, V7, P249, DOI 10.1080/713773980
   Yerdel MA, 2001, ANN SURG, V233, P26, DOI 10.1097/00000658-200101000-00005
NR 47
TC 12
Z9 12
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1435-2443
J9 LANGENBECK ARCH SURG
JI Langenbecks Arch. Surg.
PD MAY
PY 2008
VL 393
IS 3
BP 349
EP 357
DI 10.1007/s00423-008-0295-5
PG 9
WC Surgery
SC Surgery
GA 278CH
UT WOS:000254260600015
PM 18322695
DA 2018-10-20
ER

PT J
AU Yaguchi, S
   Nishihara, H
   Kambhiranond, W
   Stanley, D
   Apple, DJ
AF Yaguchi, Shigeo
   Nishihara, Hitoshi
   Kambhiranond, Waraporn
   Stanley, Daniel
   Apple, David J.
TI Light scatter on the surface of AcrySof (R) intraocular lenses: Part II.
   Analysis of lenses following hydrolytic stability testing
SO OPHTHALMIC SURGERY LASERS & IMAGING
LA English
DT Article
AB BACKGROUND AND OBJECTIVE: To investigate the surface light scatter and optical quality of AcrySof lenses (Alcon Laboratories, Inc., Fort Worth, TX) following simulated aging of 20 years.
   MATERIALS AND METHODS: AcrySof lenses were exposed to exaggerated thermal conditions to simulate up to 20 years of aging and were tested for surface light scatter and optical quality (modulation transfer function).
   RESULTS: There were no significant differences from baseline for either the surface light scatter or optical quality of the lenses over time.
   CONCLUSION: The current study demonstrated that surface light scatter on AcrySof lenses did not increase under conditions simulating 20 years of aging. Because the simulated aging environment contained no protein, this work indirectly supports the finding that surface light scatter is due to the deposition of a biomaterial on the lens surface rather than changes in the material. Optical performance integrity of the test lenses was maintained under severe environmental conditions.
C1 [Yaguchi, Shigeo; Nishihara, Hitoshi] Showa Univ, Fujigaoka Hosp, Dept Ophthalmol, Kanagawa 2278501, Japan.
   [Kambhiranond, Waraporn; Stanley, Daniel] Alcon Res Ltd, Ft Worth, TX USA.
   [Apple, David J.] Univ Utah, Moran Eye Ctr, Salt Lake City, UT USA.
RP Yaguchi, S (reprint author), Showa Univ, Fujigaoka Hosp, Dept Ophthalmol, 1-30 Fujigaoka, Kanagawa 2278501, Japan.
CR *INT ORG STAND, 1197922000 ISO 2
   *INT ORG STAND, 1197962000 ISO 6
   Learning DV, 2004, J CATARACT REFR SURG, V30, P892
   Nishihara H, 2003, J CATARACT REFR SURG, V29, P1385, DOI 10.1016/S0886-3350(02)01994-6
   Yaguchi S, 2008, OPHTHAL SURG LAS IM, V39, P209, DOI 10.3928/15428877-20080501-22
NR 5
TC 7
Z9 7
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 1542-8877
J9 OPHTHAL SURG LAS IM
JI Ophthalmic Surg. Lasers Imaging
PD MAY-JUN
PY 2008
VL 39
IS 3
BP 214
EP 216
PG 3
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 299QE
UT WOS:000255769300007
PM 18556942
DA 2018-10-20
ER

PT J
AU Patel, M
   Fisher, JP
AF Patel, Minal
   Fisher, John P.
TI Biomaterial scaffolds in pediatric tissue engineering
SO PEDIATRIC RESEARCH
LA English
DT Review
ID BONE-MARROW-CELLS; RANDOMIZED-TRIAL; THICKNESS BURNS; HEART-VALVES;
   CARTILAGE; REGENERATION; DEGRADATION; REPAIR; TRANSPLANTATION; EXPANDERS
AB This article reviews recent developments and major issues in the use and design of biomaterials for use as scaffolds in pediatric tissue engineering. A brief history of tissue engineering and the limitations of current tissue-engineering research with respect to pediatric patients have been introduced. An overview of the characteristics of an ideal tissue-engineering scaffold for pediatric applications has been presented, including a description of the different types of scaffolds. Applications of scaffolds materials have been highlighted in the fields of drug delivery, bone, cardiovascular, and skin tissue engineering with respect to the pediatric population. This review highlights biomaterials as scaffolds as an alternative treatment method for pediatric surgeries due to the ability to create a functional cell-scaffold environment.
C1 [Patel, Minal; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg 225, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
OI Fisher, James/0000-0001-7851-9222
CR Andriani E, 2000, Minerva Pediatr, V52, P15
   Bendoriene Jolanta, 2006, Eye Contact Lens, V32, P104, DOI 10.1097/01.icl.0000174755.50802.15
   Cassidy C, 2005, BURNS, V31, P890, DOI 10.1016/j.burns.2005.04.029
   Chalasani R, 2007, SURV OPHTHALMOL, V52, P145, DOI 10.1016/j.survophthal.2006.12.007
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Cohen AJ, 2004, J CRANIOFAC SURG, V15, P469, DOI 10.1097/00001665-200405000-00025
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Demann Eric T K, 2005, J Long Term Eff Med Implants, V15, P687
   Drewa T, 2005, J PEDIATR SURG, V40, P317, DOI 10.1016/j.jpedsurg.2004.10.019
   Earthman James C, 2006, Dent Clin North Am, V50, P229, DOI 10.1016/j.cden.2005.11.010
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P850, DOI 10.1097/01.FRS.0000132856.69391.43
   Esposito G, 2007, PLAST RECONSTR SURG, V119, P2346, DOI 10.1097/01.prs.0000261076.40549.cf
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   Frimberger D, 2006, REGEN MED, V1, P425, DOI 10.2217/17460751.1.4.425
   Gilbert TW, 2007, BIOMATERIALS, V28, P147, DOI 10.1016/j.biomaterials.2006.08.022
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Idrus RBH, 2005, INT J PEDIATR OTORHI, V69, P1489, DOI 10.1016/j.ijporl.2005.04.026
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kobus KF, 2007, J PLAST RECONSTR AES, V60, P414, DOI 10.1016/j.bjps.2006.01.053
   Kumar RJ, 2004, ANZ J SURG, V74, P622, DOI 10.1111/j.1445-1433.2004.03106.x
   Lang EM, 2005, ANN PLAS SURG, V55, P485, DOI 10.1097/01.sap.0000182652.88669.a6
   Langer R, 2000, MOL THER, V1, P12, DOI 10.1006/mthe.1999.0003
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040
   Martinez L, 2002, Cir Pediatr, V15, P97
   Maurer BJ, 2007, CLIN CANCER RES, V13, P3079, DOI 10.1158/1078-0432.CCR-06-1889
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Nakabayashi N, 2003, BIOMATERIALS, V24, P2437, DOI 10.1016/S0142-9612(03)00112-1
   Nikitin A A, 2005, Stomatologiia (Mosk), V84, P40
   Norbury WB, 2005, CRIT CARE, V9, P533, DOI 10.1186/cc3881
   Ozawa T, 2004, CELL TRANSPLANT, V13, P169, DOI 10.3727/000000004773301852
   Patel M, 2006, TISSUE ENG, V12, P3189, DOI 10.1089/ten.2006.12.3189
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Perry TE, 2003, ANN THORAC SURG, V75, P761, DOI 10.1016/S0003-4975(02)03776-1
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Richards SK, 2005, PEDIATR TRANSPLANT, V9, P627, DOI 10.1111/j.1399-3046.2005.00312.x
   Roh JD, 2007, J PEDIATR SURG, V42, P198, DOI 10.1016/j.jpedsurg.2006.09.054
   Schittkowski MP, 2006, BRIT J OPHTHALMOL, V90, P1173, DOI 10.1136/bjo.2006.092478
   Schmidt D, 2004, ANN THORAC SURG, V78, P2094, DOI 10.1016/j.athoracsur.2004.06.052
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Sodian R, 2006, ANN THORAC SURG, V81, P2207, DOI 10.1016/j.athoracsur.2005.12.073
   STUART JD, 1987, AM FAM PHYSICIAN, V36, P139
   Sumita Y, 2006, BIOMATERIALS, V27, P3238, DOI 10.1016/j.biomaterials.2006.01.055
   SUNIL B, 2006, J PEDIATR SURG, V41, pE5
   Thornton AJ, 2004, J UROLOGY, V172, P763, DOI 10.1097/01.ju.0000130466.84214.f7
   Tuggle DW, 2004, J PEDIATR SURG, V39, P626, DOI 10.1016/j.jpedsurg.2003.12.032
   Vacanti JP, 1999, LANCET, V354, pSI32
   van Amerongen MJ, 2006, BIOMATERIALS, V27, P2247, DOI 10.1016/j.biomaterials.2005.11.002
   Velardi F, 2006, CHILD NERV SYST, V22, P1158, DOI 10.1007/s00381-006-0100-0
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoon DM, 2006, ADV EXP MED BIOL, V585, P67
   Yoon DM, 2007, BIOMATERIALS, V28, P299, DOI 10.1016/j.biomaterials.2006.08.039
NR 56
TC 38
Z9 41
U1 0
U2 16
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD MAY
PY 2008
VL 63
IS 5
BP 497
EP 501
DI 10.1203/01.PDR.0b013e318165eb3e
PG 5
WC Pediatrics
SC Pediatrics
GA 293CH
UT WOS:000255311900008
PM 18427294
OA Bronze
DA 2018-10-20
ER

PT J
AU Gunaydin, S
   McCusker, K
   Sari, T
   Onur, MA
   Gurpinar, A
   Sevim, H
   Atasoy, P
   Yorgancioglu, C
   Zorlutuna, Y
AF Gunaydin, S.
   McCusker, K.
   Sari, T.
   Onur, M. A.
   Gurpinar, A.
   Sevim, H.
   Atasoy, P.
   Yorgancioglu, C.
   Zorlutuna, Y.
TI Clinical impact and biomaterial evaluation of autologous platelet gel in
   cardiac surgery
SO PERFUSION-UK
LA English
DT Article; Proceedings Paper
CT Annual Seminar of the American-Academy-of-Cardiovascular-Perfusion
CY JAN 25-28, 2008
CL Orlando, FL
SP Amer Acad Cardiovasc Perfus
DE extracorporeal circulation; platelet activation; platelet gel; platelet
   rich plasma; surgical hemostasis
ID RICH PLASMA; GLUE
AB We compared the clinical efficacy of autologous platelet gel (APG) and gelatine (CONT), including biomaterial evaluation. In a prospective, randomized, controlled trial, 64 patients undergoing complex coronary artery bypass graft (CABG) surgery and/ or aortic surgery, in whom the surgeon was able to identify a bleeding site for which conventional means to stop bleeding were impractical or proved unsuccessful, were enrolled. Aortic punch biopsy from each patient was harvested in explant cell (EC) culture media. Hemostasis success for the "oozing" category was 89% in APG and 60% in CONT (p < 0.05). For the "heavy bleeding" category, the success rates were 92% in APG and 45% in CONT (p < 0.01). Contact of gelatine inhibited EC proliferation and APG increased cell cycling and EC quantity. Phagocytic capacity (PC) was significantly higher in the APG group (p < 0.001). APG was significantly better than CONT with respect to hemostatic success rate, effects on wound healing and increased resistance to infection (PC). Perfusion (2008) 23, 179-186.
C1 [McCusker, K.] New York Med Coll, New York, NY USA.
   [Onur, M. A.; Gurpinar, A.; Yorgancioglu, C.] Hacettepe Univ, Ankara, Turkey.
RP Gunaydin, S (reprint author), Univ K Kale, Dept CV Surg, Angora Evleri G-8 Bl 1, TR-06800 Beysukent Ankara, Turkey.
EM sgunaydin@isnet.net.tr
RI ONUR, MEHMET/G-9137-2013
OI ONUR, MEHMET/0000-0002-3630-7982
CR Beck LH, 2004, DIFFERENTIATION, V72, P162, DOI 10.1111/j.1432-0436.2004.07204004.x
   Borzini P, 2005, CURR OPIN HEMATOL, V12, P473, DOI 10.1097/01.moh.0000177831.70657.e8
   Borzini P, 2005, TRANSFUSION, V45, P1759, DOI 10.1111/j.1537-2995.2005.00600.x
   EVERTS, 2006, JECT, V38, P174
   Everts PA, 2007, SURG ENDOSC, V21, P2063, DOI 10.1007/s00464-007-9293-x
   Everts PAM, 2006, GROWTH FACTORS, V24, P165, DOI 10.1080/08977190600821327
   Giannini G, 2004, TRANSFUS APHER SCI, V30, P139, DOI 10.1016/j.transci.2003.11.009
   Green DM, 1998, PLAST RECONSTR SURG, V101, P1161, DOI 10.1097/00006534-199804040-00067
   Khatafi RS, 2008, EUR J CARDIO-THORAC, V34, P360, DOI 10.1016/j.ejcts.2008.04.026
   Krasna M, 2007, ACTA DERMATOVEN ALP, V16, P105
   Pietrzak WS, 2005, J CRANIOFAC SURG, V16, P1043, DOI 10.1097/01.scs.0000186454.07097.bf
   Trowbridge Cody C, 2005, J Extra Corpor Technol, V37, P381
   Vang See N, 2007, J Extra Corpor Technol, V39, P31
NR 13
TC 10
Z9 12
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0267-6591
EI 1477-111X
J9 PERFUSION-UK
JI Perfusion-UK
PD MAY
PY 2008
VL 23
IS 3
BP 179
EP 186
DI 10.1177/0267659108097783
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 375KY
UT WOS:000261114000007
PM 19029269
DA 2018-10-20
ER

PT J
AU Yao, L
   Liu, JY
   Andreadis, ST
AF Yao, Lan
   Liu, Jinyu
   Andreadis, Stelios T.
TI Composite fibrin scaffolds increase mechanical strength and preserve
   contractility of tissue engineered blood vessels
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE cardiovascular tissue engineering; composite materials; contractility;
   fibrin; smooth muscle
ID SMOOTH-MUSCLE-CELLS; ACTIVATED PROTEIN-KINASE; IN-VITRO; GROWTH-FACTOR;
   MEDIA-EQUIVALENTS; CYCLIC STRAIN; VASCULAR CONSTRUCTS;
   CONTROLLED-RELEASE; ENDOTHELIAL-CELLS; PULMONARY-ARTERY
AB Purpose: We recently demonstrated that fibrin-based tissue engineered blood vessels (TEV) exhibited vascular reactivity, matrix remodeling and sufficient strength for implantation into the veins of an ovine animal model, where they remained patent for 15 weeks. Here we present an approach to improve the mechanical properties of fibrin-based TEV and examine the relationship between mechanical strength and smooth muscle cell (SMC) function.
   Materials and Methods: To this end, we prepared TEV that were composed of two layers: a cellular layer containing SMC embedded in fibrin hydrogel to provide contractility and matrix remodeling; and a second cell-free fibrin layer composed of high concentration fibrinogen to provide mechanical strength.
   Results: The ultimate tensile force of double-layered TEV increased with FBG concentration in the cell-free layer in a dose-dependent manner. Double-layered TEV exhibited burst pressure that was ten-fold higher than single-layered tissues but vascular reactivity remained high even though the cells were constricting an additional tissue layer.
   Conclusions: These results showed that mechanical strength results largely from the biomaterial but contractility requires active cellular machinery. Consequently, they may suggest novel approaches for engineering biomaterials that satisfy the requirement for high mechanical strength while preserving SMC function.
C1 [Yao, Lan; Liu, Jinyu; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, Buffalo, NY 14260 USA.
   [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA.
RP Andreadis, ST (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, 908 Furnas Hall, Buffalo, NY 14260 USA.
EM sandread@eng.buffalo.edu
CR Bader A, 2000, TRANSPLANTATION, V70, P7
   Barocas VH, 1998, J BIOMECH ENG-T ASME, V120, P660, DOI 10.1115/1.2834759
   Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   BROWN SL, 1994, CARDIOVASC RES, V28, P1815, DOI 10.1093/cvr/28.12.1815
   Chen QH, 2003, J VASC SURG, V37, P660, DOI 10.1067/mva.2003.95
   CLARK RAF, 1995, J CELL SCI, V108, P1251
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Drury J K, 1987, Ann Vasc Surg, V1, P542, DOI 10.1016/S0890-5096(06)61437-4
   DVORAK HF, 1987, LAB INVEST, V57, P673
   GAUDINO M, 2005, CIRCULATION, V112, P265
   Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4
   Geer DJ, 2004, TISSUE ENG, V10, P1006, DOI 10.1089/ten.2004.10.1006
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Higgins SP, 2003, J BIOMED MATER RES A, V67A, P295, DOI 10.1002/jbm.a.10599
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hudlett P, 2005, J HYPERTENS, V23, P1559, DOI 10.1097/01.hjh.0000174607.18780.62
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662
   Ishibashi K, 1994, ASAIO J, V40, pM284, DOI 10.1097/00002480-199407000-00009
   Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Li W, 2003, J CELL PHYSIOL, V195, P202, DOI 10.1002/jcp.10230
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Martineau Laurie, 2007, Angiogenesis, V10, P269, DOI 10.1007/s10456-007-9079-8
   MATSUDA T, 1995, J THORAC CARDIOV SUR, V110, P988, DOI 10.1016/S0022-5223(05)80166-7
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747
   Nikolovski J, 2003, FASEB J, V17, P455, DOI 10.1096/fj.02-0459fje
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   PASIC M, 1995, CIRCULATION, V92, P2605, DOI 10.1161/01.CIR.92.9.2605
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359
   Seliktar D, 2001, ANN BIOMED ENG, V29, P923, DOI 10.1114/1.1415522
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Smith JD, 2001, ENDOTHELIUM-NEW YORK, V8, P41, DOI 10.3109/10623320109063156
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   TAKEI A, 1995, IN VITRO CELL DEV-AN, V31, P467
   THIE M, 1991, EUR J CELL BIOL, V55, P295
   Tuan TL, 1996, EXP CELL RES, V223, P127, DOI 10.1006/excr.1996.0065
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481
   Yao L, 2005, TISSUE ENG, V11, P991, DOI 10.1089/ten.2005.11.991
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 60
TC 24
Z9 24
U1 0
U2 11
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD MAY
PY 2008
VL 25
IS 5
BP 1212
EP 1221
DI 10.1007/s11095-007-9499-6
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 286MJ
UT WOS:000254849700024
PM 18092140
DA 2018-10-20
ER

PT J
AU Yu, O
   Jez, JM
AF Yu, Oliver
   Jez, Joseph M.
TI Nature's assembly line: biosynthesis of simple phenylpropanoids and
   polyketides
SO PLANT JOURNAL
LA English
DT Review
DE phenylpropanoid; polyketide; metabolic engineering; stilbene;
   isoflavone; catechin
ID SOYBEAN ISOFLAVONE SYNTHASE; PHENYLALANINE AMMONIA-LYASE; CHAIN-LENGTH
   CONTROL; CHALCONE SYNTHASE; PROANTHOCYANIDIN BIOSYNTHESIS; ENZYMATIC
   FORMATION; REACTION-MECHANISM; PLANT POLYKETIDES; CELL-CULTURES;
   LIFE-SPAN
AB Plants produce large amounts of phenylpropanoids, both in terms of molecular diversity and absolute quantity of these compounds. The phenylpropanoids, and the related plant polyketides, have multiple biological functions. They serve to attract pollinators, support secondary cell-wall growth, provide protection against various plant diseases, and interact with beneficial soil microbes. Their basic chemical properties also make them useful in the biofuel and biomaterial industries. Phenylpropanoid metabolism begins with the amino acid phenylalanine, which feeds into various biosynthetic pathways that generate a wide range of structurally related polyphenolic compounds. This review focuses on four sub-groups of these polyphenolic compounds - polyketides, stilbenes, isoflavones and catechins. We discuss the biosynthesis of these molecules, their physiological role in plants, and their striking pharmacological and physiological effects on humans. This review also highlights metabolic engineering efforts aimed at increasing or decreasing the amounts of each class of compound in various model plants and crops.
C1 [Yu, Oliver; Jez, Joseph M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.
RP Yu, O (reprint author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.
EM oyu@danforthcenter.org
CR Abe I, 2006, ORG LETT, V8, P499, DOI 10.1021/ol052912h
   Abe I, 2006, FEBS J, V273, P208, DOI 10.1111/j.1742-4658.2005.05059.x
   Abe I, 2005, J AM CHEM SOC, V127, P12709, DOI 10.1021/ja053945v
   Abe I, 2005, J AM CHEM SOC, V127, P1362, DOI 10.1021/ja0431206
   Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x
   Abe I, 2004, PHYTOCHEMISTRY, V65, P2447, DOI 10.1016/j.phytochem.2004.08.005
   Abe I, 2004, FEBS LETT, V562, P171, DOI 10.1016/S0014-5793(04)00230-3
   Abe I, 2003, ORG LETT, V5, P1277, DOI 10.1021/ol0300165
   Abe I, 2002, ORG LETT, V4, P3623, DOI 10.1021/ol0201409
   Abe I, 2007, J AM CHEM SOC, V129, P5976, DOI 10.1021/ja0703751
   Akashi T, 2005, PLANT PHYSIOL, V137, P882, DOI 10.1104/pp.104.056747
   Akiyama T, 1999, EUR J BIOCHEM, V263, P834, DOI 10.1046/j.1432-1327.1999.00562.x
   Albertazzi P, 2002, CLIMACTERIC, V5, P190, DOI 10.1080/713605224
   Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X
   Aruoma OI, 2006, BIOFACTORS, V27, P245, DOI 10.1002/biof.5520270121
   Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5
   Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024
   Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Bomati EK, 2005, J BIOL CHEM, V280, P30496, DOI 10.1074/jbc.M502239200
   Bringmann G, 2007, J ORG CHEM, V72, P3247, DOI 10.1021/jo062566x
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Cos P, 2004, CURR MED CHEM, V11, P1345, DOI 10.2174/0929867043365288
   Das S, 2006, J NAT PROD, V69, P499, DOI 10.1021/np0504659
   Dayan FE, 2003, J BIOL CHEM, V278, P28607, DOI 10.1074/jbc.M304185200
   Dewick Paul M., 2002, MED NATURAL PRODUCTS
   Dixon RA, 1998, ADV EXP MED BIOL, V439, P55
   Dixon RA, 1996, GENE, V179, P61, DOI 10.1016/S0378-1119(96)00327-7
   Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x
   Eckermann C, 2003, PHYTOCHEMISTRY, V62, P271, DOI 10.1016/S0031-9422(02)00554-X
   Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652
   Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775
   Graham TL, 2007, PLANT PHYSIOL, V144, P728, DOI 10.1104/pp.107.097865
   HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0
   Halls C, 2008, TRENDS BIOTECHNOL, V26, P77, DOI 10.1016/j.tibtech.2007.11.002
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Hwang IK, 2004, LIFE SCI, V75, P1989, DOI 10.1016/j.lfs.2004.05.013
   Jeandet P, 2002, J AGR FOOD CHEM, V50, P2731, DOI 10.1021/jf011429s
   Jez JM, 2000, NAT STRUCT BIOL, V7, P786, DOI 10.1038/79025
   Jez JM, 2002, BIOCHEMISTRY-US, V41, P5168, DOI 10.1021/bi0255266
   Jez JM, 2001, J IND MICROBIOL BIOT, V27, P393, DOI 10.1038/sj.jim.7000188
   Jez JM, 2002, J BIOL CHEM, V277, P1361, DOI 10.1074/jbc.M109224200
   Jez JM, 2002, P NATL ACAD SCI USA, V99, P5319, DOI 10.1073/pnas.082590499
   Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7
   Jez JM, 2000, J BIOL CHEM, V275, P39640, DOI 10.1074/jbc.M008569200
   Jez JM, 2001, BIOCHEMISTRY-US, V40, P14829, DOI 10.1021/bi015621z
   Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f
   Jung W, 2000, NAT BIOTECHNOL, V18, P208, DOI 10.1038/72671
   Klingauf P, 2005, PHYTOCHEMISTRY, V66, P139, DOI 10.1016/j.phytochem.2004.11.003
   Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772
   Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668
   Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x
   Liu BY, 2004, PLANTA, V218, P492, DOI 10.1007/s00425-003-1144-y
   Liu BY, 2003, PLANT J, V34, P847, DOI 10.1046/j.1365-313X.2003.01771.x
   Liu CJ, 2002, P NATL ACAD SCI USA, V99, P14578, DOI 10.1073/pnas.212522099
   Lozovaya VV, 2007, PLANTA, V225, P665, DOI 10.1007/s00425-006-0368-z
   Lukacin R, 2005, PHYTOCHEMISTRY, V66, P277, DOI 10.1016/j.phytochem.2004.11.023
   MacDonald MJ, 2007, BIOCHEM CELL BIOL, V85, P273, DOI 10.1139/O07-018
   MACLAGAN TJ, 1876, LANCET, V1, P342, DOI DOI 10.1016/S0140-6736(02)46434-3
   Marles MAS, 2003, PHYTOCHEMISTRY, V64, P367, DOI 10.1016/S0031-9422(03)00377-7
   Martin Jan H J, 2007, Future Oncol, V3, P307, DOI 10.2217/14796694.3.3.307
   Medina-Bolivar F, 2007, PHYTOCHEMISTRY, V68, P1992, DOI 10.1016/j.phytochem.2007.04.039
   Messina MJ, 2001, J NUTR, V131, p3095S, DOI 10.1093/jn/131.11.3095S
   Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003
   NONOMURA S, 1963, Yakugaku Zasshi, V83, P988
   Oguro S, 2004, BIOCHEM BIOPH RES CO, V325, P561, DOI 10.1016/j.bbrc.2004.10.057
   Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326
   Paniego NB, 1999, EUR J BIOCHEM, V262, P612, DOI 10.1046/j.1432-1327.1999.00444.x
   Penning TM, 2001, CHEM REV, V101, P3027, DOI 10.1021/cr000049n
   Peters D, 2007, ADV BIOCHEM ENG BIOT, V105, P1, DOI 10.1007/10_031
   Ralston L, 2005, PLANT PHYSIOL, V137, P1375, DOI 10.1104/pp.104.054502
   Rosler J, 1997, PLANT PHYSIOL, V113, P175, DOI 10.1104/pp.113.1.175
   Sawada Y, 2002, PLANT J, V31, P555, DOI 10.1046/j.1365-313X.2002.01378.x
   Schroder G, 2004, PHYTOCHEMISTRY, V65, P1085, DOI 10.1016/j.phytochem.2004.02.010
   Schroder J, 1998, BIOCHEMISTRY-US, V37, P8417, DOI 10.1021/bi980204g
   Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x
   Schwekendiek A, 2007, J AGR FOOD CHEM, V55, P7002, DOI 10.1021/jf070509e
   Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4839, DOI 10.2741/2432
   Shomura Y, 2005, PROTEINS, V60, P803, DOI 10.1002/prot.20584
   SPAINK HP, 1994, ANTON LEEUW INT J G, V65, P81, DOI 10.1007/BF00871750
   Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k
   Springob K, 2007, FEBS J, V274, P406, DOI 10.1111/j.1742-4658.2006.05588.x
   Sreevidya VS, 2006, J EXP BOT, V57, P1957, DOI 10.1093/jxb/erj143
   Steele CL, 1999, ARCH BIOCHEM BIOPHYS, V367, P146, DOI 10.1006/abbi.1999.1238
   Stevens JF, 2004, PHYTOCHEMISTRY, V65, P1317, DOI 10.1016/j.phytochem.2004.04.025
   Stuart EC, 2006, LIFE SCI, V79, P2329, DOI 10.1016/j.lfs.2006.07.036
   Subramanian S, 2005, PLANT PHYSIOL, V137, P1345, DOI 10.1104/pp.104.057257
   Subramanian S, 2007, TRENDS PLANT SCI, V12, P282, DOI 10.1016/j.tplants.2007.06.006
   Subramanian S, 2006, PLANT J, V48, P261, DOI 10.1111/j.1365-313X.2006.02874.x
   Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x
   Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200
   Tian L, 2006, PLANTA, V224, P496, DOI 10.1007/s00425-006-0233-0
   TROPF S, 1994, J MOL EVOL, V38, P610
   Turck D, 2007, CURR OPIN CLIN NUTR, V10, P360, DOI 10.1097/MCO.0b013e3280fa821b
   Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038
   van Beilen JB, 2008, PLANT J, V54, P684, DOI 10.1111/j.1365-313X.2008.03431.x
   Vatanparast H, 2007, NUTR REV, V65, P294, DOI 10.1301/nr.2007jun.294-299
   Wanibuchi K, 2007, FEBS J, V274, P1073, DOI 10.1111/j.1742-4658.2007.05656.x
   Wellmann F, 2006, FEBS LETT, V580, P1642, DOI 10.1016/j.febslet.2006.02.004
   Wilmouth RC, 2002, STRUCTURE, V10, P93, DOI 10.1016/S0969-2126(01)00695-5
   Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x
   Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5
   Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789
   Xie DY, 2006, PLANT J, V45, P895, DOI 10.1111/j.1365-313X.2006.026553.x
   Xie DY, 2005, PHYTOCHEMISTRY, V66, P2127, DOI 10.1016/j.phytochem.2005.01.008
   Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540
   Yu O, 2000, PLANT PHYSIOL, V124, P781, DOI 10.1104/pp.124.2.781
   Yu O, 2003, PHYTOCHEMISTRY, V63, P753, DOI 10.1016/S0031-9422(03)00345-5
   Zhang YS, 2006, J AM CHEM SOC, V128, P13030, DOI 10.1021/ja0622094
NR 110
TC 64
Z9 68
U1 1
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7412
EI 1365-313X
J9 PLANT J
JI Plant J.
PD MAY
PY 2008
VL 54
IS 4
BP 750
EP 762
DI 10.1111/j.1365-313X.2008.03436.x
PG 13
WC Plant Sciences
SC Plant Sciences
GA 299KR
UT WOS:000255755000017
PM 18476876
OA Bronze
DA 2018-10-20
ER

PT J
AU Bhatti, IA
   Lee, J
   Jang, YD
   Kim, KS
   Kwon, JH
AF Bhatti, Ijaz A.
   Lee, Jeongeun
   Jang, Yun-Deuk
   Kim, Kyong-Su
   Kwon, Joong-Ho
TI Analysis of shellfish by thermoluminescence and X-ray diffraction
   methods: Knowledge of gamma-ray treatment and mineral characterization
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
DE shellfish; irradiation; thermoluminescence; minerals; X-ray diffraction
ID INTERNATIONAL INTERLABORATORY TRIAL; CONTAMINATING MINERALS; IRRADIATED
   SHELLFISH; LUMINESCENCE; FOODS; IDENTIFICATION; ORIGINS
AB To investigate the detection of irradiated shellfish, seven kinds of shellfish samples were gamma irradiated at 3 and 6 kGy. The first-glow curves for all the control and irradiated shellfish samples were recorded between temperatures of 50 and 400 degrees C at I heating rate of 5 degrees C/s. All the samples, the first glow curves (TL1) of which have been recorded, were re-irradiated at 1 kGy for the normalization of results. Their second glow curves (TL,) were obtained at the same conditions in order to achieve the thermoluminescence (TL) ratios (TL1/TL2). The TL method proactively identified the whole shellfish samples by using the calcite, aragonite and quartz minerals that are present in the shells. The X-ray diffraction spectroscopy has been used as all analytical tool for the characterization of minerals that are present in the shells as inorganic materials along with biomaterial. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Lee, Jeongeun; Kwon, Joong-Ho] Kyungpook Natl Univ, Dept Food Sci & Technol, Taegu 702701, South Korea.
   [Bhatti, Ijaz A.] Univ Agr Faisalabad, Dept Chem, Faisalabad, Pakistan.
   [Jang, Yun-Deuk] Kyungpook Natl Univ, Dept Geol, Taegu 702701, South Korea.
   [Kim, Kyong-Su] Chosun Univ, Dept Food Sci & Nutr, Kwangju 501759, South Korea.
RP Kwon, JH (reprint author), Kyungpook Natl Univ, Dept Food Sci & Technol, Taegu 702701, South Korea.
EM jhkwon@knu.ac.kr
RI Bhatti, Ijaz Ahmad/I-8043-2015; Kim, Kyong Su/F-8576-2014
OI Kim, Kyong Su/0000-0002-2394-857X
CR ANGEL JP, 1992, RECENT ADV DETECTION, P186
   [Anonymous], 1996, 1788 EN EUR COMM STA
   Carmichael LA, 2000, FOOD CHEM, V68, P233, DOI 10.1016/S0308-8146(99)00200-9
   Choi ID, 2004, FOOD SCI BIOTECHNOL, V13, P151
   DAVID C, 1994, ENV INDICATORS SHELL, P1
   Engin B, 2000, RADIAT MEAS, V32, P253, DOI 10.1016/S1350-4487(99)00284-X
   FIELDS P, 1996, METHYL BROMIDE ALTER
   Khan HM, 1999, J RADIOANAL NUCL CH, V242, P739, DOI 10.1007/BF02347388
   Khan HM, 1998, RADIAT PHYS CHEM, V52, P145, DOI 10.1016/S0969-806X(98)00064-4
   Kwon JH, 2002, RADIAT PHYS CHEM, V63, P415, DOI 10.1016/S0969-806X(01)00590-4
   Pinnioja S, 1999, RADIAT PHYS CHEM, V54, P505, DOI 10.1016/S0969-806X(97)00284-3
   Pinnioja S, 1999, RADIAT PHYS CHEM, V55, P743, DOI 10.1016/S0969-806X(99)00222-4
   Pinnioja S, 1998, RADIAT MEAS, V29, P651, DOI 10.1016/S1350-4487(98)00073-0
   Sanderson D. C. W., 1996, DETECTION METHODS IR, P139
   SANDERSON DCW, 1989, RADIAT PHYS CHEM, V34, P915
   Sanderson DCW, 2003, J AOAC INT, V86, P983
   Sanderson DCW, 2003, J AOAC INT, V86, P976
   Sanderson DCW, 2003, J AOAC INT, V86, P971
   SANDERSON DCW, 1990, PUBLICATION ROYAL SO, V86, P25
   Thayer DW, 1996, RAD PASTEURIZATION F
   Urbina M, 1998, J LUMIN, V79, P21, DOI 10.1016/S0022-2313(98)00015-5
   2006, FOOD IRRADIATION UPD
   2005, IRRADIATION OYSTERS
NR 23
TC 7
Z9 9
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD MAY
PY 2008
VL 77
IS 5
BP 663
EP 668
DI 10.1016/j.radphyschem.2007.12.009
PG 6
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 291PU
UT WOS:000255210100020
DA 2018-10-20
ER

PT J
AU Benesch, J
   Hungerfod, G
   Suhling, K
   Tavares, C
   Lewitt, JA
   Mano, JF
   Reis, RL
AF Benesch, J.
   Hungerfod, G.
   Suhling, K.
   Tavares, C.
   Lewitt, J. A.
   Mano, J. F.
   Reis, R. L.
TI Application of fluorescence techniques to the study of protein
   adsorption and packing on biomaterial surfaces
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Benesch, J.; Mano, J. F.; Reis, R. L.] Univ Minho, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, Braga, Portugal.
   [Benesch, J.; Mano, J. F.; Reis, R. L.] IBB Inst Biotechnol & Bioengn, PT Govt Associated lab, Braga, Portugal.
   [Hungerfod, G.; Suhling, K.; Lewitt, J. A.] Kings Coll London, Dept Phys, London WC2R 2LS, England.
   [Tavares, C.] Univ Minho, Dept Phys, Guimaraes, Portugal.
RI Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Benesch,
   Johan/C-6593-2014; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765; Benesch,
   Johan/0000-0003-3991-7433; Reis, Rui L./0000-0002-4295-6129
NR 0
TC 0
Z9 0
U1 1
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA OP18
BP 700
EP 700
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800030
DA 2018-10-20
ER

PT J
AU Longin, F
   Schwach-Abdellaoui, K
AF Longin, F.
   Schwach-Abdellaoui, K.
TI New biosynthetic bacillus-derived hyaluronic acid as an attractive
   potential biomaterial for tissue engineering applications
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Longin, F.; Schwach-Abdellaoui, K.] Novozymes Biopolymer AS, DK-2880 Bagsvaerd, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA OP203
BP 760
EP 761
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800215
DA 2018-10-20
ER

PT J
AU Marcacci, M
   Kon, E
   Zaffagnini, S
   Filardo, G
   Pressato, D
   Arcangeli, E
   Quarto, R
   Parma, B
   Tampieri, A
   Delcogliano, M
AF Marcacci, M.
   Kon, E.
   Zaffagnini, S.
   Filardo, G.
   Pressato, D.
   Arcangeli, E.
   Quarto, R.
   Parma, Bruna
   Tampieri, A.
   Delcogliano, M.
TI Novel nano-composite biomaterial for osteochondral tissue engineering:
   Pilot clinical study
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Marcacci, M.; Kon, E.; Zaffagnini, S.; Filardo, G.; Delcogliano, M.] Ist Ortoped Rizzoli, Bologna, Italy.
   [Pressato, D.; Arcangeli, E.] Fin Ceram SPA, Faenza, Italy.
   [Quarto, R.] Univ Genoa, Adv Biotechnol Ctr, Stem Cells Lab, Genoa, Italy.
   [Parma, Bruna] Opocrin SpA, Modena, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA OP214
BP 764
EP 764
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800226
DA 2018-10-20
ER

PT J
AU Alves, A
   Pinho, ED
   Neves, NM
   Mano, JF
   Sousa, RA
   Reis, RL
AF Alves, A.
   Pinho, E. D.
   Neves, N. M.
   Mano, J. F.
   Sousa, R. A.
   Reis, R. L.
TI Ulvan: a new natural derived biomaterial obtained from renewable marine
   resources
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN 22-26, 2008
CL Oporto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Alves, A.; Pinho, E. D.; Neves, N. M.; Mano, J. F.; Sousa, R. A.; Reis, R. L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4710057 Braga, Portugal.
   [Alves, A.; Pinho, E. D.; Neves, N. M.; Mano, J. F.; Sousa, R. A.; Reis, R. L.] Inst Biotechnol & Bioengn, Braga, Portugal.
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Alves,
   Anabela/C-2729-2011; Mano, Joao/A-4418-2009; Neves, Nuno/B-4685-2008
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Alves,
   Anabela/0000-0002-6878-0766; Mano, Joao/0000-0002-2342-3765; Neves,
   Nuno/0000-0003-3041-0687
NR 0
TC 0
Z9 0
U1 0
U2 8
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA OP305
BP 793
EP 793
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800317
DA 2018-10-20
ER

PT J
AU Edwards, FC
   Di, Y
   Dann, SC
   Clayton, EA
   Dye, JF
AF Edwards, F. C.
   Di, Y.
   Dann, S. C.
   Clayton, E. A.
   Dye, J. F.
TI Calcium phosphate formation causes an inflammatory response to a
   prototype biomaterial scaffold
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
NR 0
TC 1
Z9 1
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA P57
BP 816
EP 817
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800388
DA 2018-10-20
ER

PT J
AU Caissie, R
   Tomasetig, F
   Grenier, M
   Landry, PE
   Berthod, F
AF Caissie, R.
   Tomasetig, F.
   Grenier, M.
   Landry, P. E.
   Berthod, F.
TI Evaluation of nerve regeneration across using a fibroblast nerve conduit
   filled with a collagen-based biomaterial to bridge peripheral nerve gaps
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Caissie, R.; Tomasetig, F.; Grenier, M.; Berthod, F.] Hop St Sacrement, CHAUQ, LOEX, Quebec City, PQ, Canada.
   [Caissie, R.; Landry, P. E.] Univ Laval, Dept Chirurg, Quebec City, PQ, Canada.
   [Caissie, R.; Landry, P. E.] Hop Enfants Jesus, CHAUQ, Dept Oral & Maxillofacial Surg, Quebec City, PQ, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA P162
BP 850
EP 850
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800493
DA 2018-10-20
ER

PT J
AU Myllymaa, K
   Myllymaa, S
   Korhonen, H
   Kouri, VP
   Konttinen, YT
   Lappalainen, R
AF Myllymaa, K.
   Myllymaa, S.
   Korhonen, H.
   Kouri, V-P.
   Konttinen, Y. T.
   Lappalainen, R.
TI Osteoblast attachment studied using microtextured thin film biomaterial
   surfaces
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Myllymaa, K.; Myllymaa, S.; Korhonen, H.; Lappalainen, R.] Univ Kuopio, Dept Phys, Kuopio, Finland.
   [Kouri, V-P.; Konttinen, Y. T.] Univ Helsinki, Biomedicum, Helsinki, Finland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA P303
BP 894
EP 894
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800633
DA 2018-10-20
ER

PT J
AU Scaglione, S
   Zerega, B
   Cavaliere, A
   De Faveri, S
   Ilengo, C
   Quarto, R
AF Scaglione, S.
   Zerega, B.
   Cavaliere, A.
   De Faveri, S.
   Ilengo, C.
   Quarto, R.
TI Three-dimensional system (bioreactor-biomaterial) to engineer ligament
   tissue
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT Annual
   Tissue-Engineering-and-Regenerative-Medicine-International-Society-Europ
   ean-Chapter Meeting
CY JUN, 2008
CL Porto, PORTUGAL
SP Tissue Engn & Regenerat Med Int Soc, European Chap
C1 [Scaglione, S.; Zerega, B.; Ilengo, C.; Quarto, R.] Adv Biotechnol Ctr, Stem Cell Lab, Genoa, Italy.
   [Scaglione, S.; Cavaliere, A.; De Faveri, S.] Univ Genoa, Dept Commun Comp & Syst Sci, Genoa, Italy.
   [Quarto, R.] Univ Genoa, Dept Chem & Food & Pharmaceut Technol, Genoa, Italy.
RI Scaglione, Silvia/B-7124-2014
OI Scaglione, Silvia/0000-0002-9464-3554
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY
PY 2008
VL 14
IS 5
MA P383
BP 919
EP 920
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 306HV
UT WOS:000256239800713
DA 2018-10-20
ER

PT J
AU Kluge, JA
   Rabotyagova, U
   Leisk, GG
   Kaplan, DL
AF Kluge, Jonathan A.
   Rabotyagova, Uena
   Leisk, Gary G.
   Kaplan, David L.
TI Spider silks and their applications
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID GENETICALLY-ENGINEERED SILK; DRAGLINE SILK; MECHANICAL-PROPERTIES;
   ESCHERICHIA-COLI; PROTEIN; FIBROIN; EXPRESSION; BIOMATERIAL; SCAFFOLDS;
   FIBERS
AB Spider silks are characterized by remarkable diversity in their chemistry, structure and functions, ranging from orb web construction to adhesives and cocoons. These unique materials have prompted efforts to explore potential applications of spider silk equivalent to those of silkworm silks, which have undergone 5000 years of domestication and have a variety of uses, from textiles to biomedical materials. Recent progress in genetic engineering of spider silks and the development of new chimeric spider silks with enhanced functions and specific characteristics have advanced spider silk technologies. Further progress in yields of expressed spider-silk proteins, in the control of self-assembly processes and in the selective exploration of material applications is anticipated in the future. The unique features of spider silks, the progress and challenges in the cloning and expression of these silks, environmentally triggered silk assembly and disassembly and the formation of fibers, films and novel chimeric composite materials from genetically engineered spider silks will be reviewed.
C1 [Kluge, Jonathan A.; Rabotyagova, Uena; Leisk, Gary G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn Chem & Mech Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn Chem & Mech Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
FU NIDCR NIH HHS [R01 DE017207]; NIBIB NIH HHS [R01 EB014283]
CR Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Barr LA, 2004, MOL BREEDING, V13, P345, DOI 10.1023/B:MOLB.0000034089.92263.ff
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Corsini P, 2007, J POLYM SCI POL PHYS, V45, P2568, DOI 10.1002/polb.21255
   Exler JH, 2007, ANGEW CHEM INT EDIT, V46, P3559, DOI 10.1002/anie.200604718
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P193, DOI 10.1007/s00339-005-3425-8
   Garb JE, 2007, MOL BIOL EVOL, V24, P2454, DOI 10.1093/molbev/msm179
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Gellynck K., 2005, EUR CELLS MATER, V10, P45
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Junghans F, 2006, APPL PHYS A-MATER, V82, P253, DOI 10.1007/s00339-005-3432-9
   Kaplan D, 1994, SILK POLYM MAT SCI B
   Kaplan DL, 1997, PROTEIN BASED MAT, P103
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karatzas C. N., 2003, BIOPOLYMERS POLYAMID, P500
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee KS, 2007, J BIOSCIENCES, V32, P705, DOI 10.1007/s12038-007-0070-8
   Lewis R, 1996, BIOSCIENCE, V46, P636, DOI 10.2307/1312891
   McGrath K. P., 1997, PROTEIN BASED MAT
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Miao YG, 2006, APPL MICROBIOL BIOT, V71, P192, DOI 10.1007/s00253-005-0127-2
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   Sutherland TD, 2007, MOL BIOL EVOL, V24, P2424, DOI 10.1093/molbev/msm171
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Xu Y, 2005, J MATER SCI, V40, P5355, DOI 10.1007/s10853-005-4301-9
   Yang JJ, 2005, TRANSGENIC RES, V14, P313, DOI 10.1007/s11248-005-0272-5
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zuo BQ, 2007, J APPL POLYM SCI, V106, P53, DOI 10.1002/app.26653
NR 62
TC 150
Z9 168
U1 5
U2 195
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD MAY
PY 2008
VL 26
IS 5
BP 244
EP 251
DI 10.1016/j.tibtech.2008.02.006
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 300MJ
UT WOS:000255827600004
PM 18367277
DA 2018-10-20
ER

PT J
AU Kim, HS
   Park, WI
   Kim, Y
   Jin, HJ
AF Kim, H. -S.
   Park, W. -I.
   Kim, Y.
   Jin, H. -J.
TI Silk fibroin films crystallized by multiwalled carbon nanotubes
SO INTERNATIONAL JOURNAL OF MODERN PHYSICS B
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Impact Engineering
CY SEP 16-19, 2007
CL Daejeon, SOUTH KOREA
DE silk fibroins; carbon nanotubes; nanocomposites; crystallization
ID MECHANICAL-PROPERTIES; COMPOSITES; NUCLEATION; REINFORCEMENT; NYLON-6
AB Silk films prepared from regenerated silk fibroin are normally stabilized by beta-sheet formation through the use of solvents (methanol, water etc.). Herein, we report a new method of preparing water-stable films without a beta-sheet conformation from regenerated silk fibroin solutions by incorporating a small amount (0.2 wt%) of multiwalled carbon nanotubes (MWCNTs). To extend the biomaterial utility of silk proteins, forming water-stable silk-based materials with enhanced mechanical properties is essential. Scanning electron microscopy and transmission electron microscopy were used to observe the morphology of the MWCNT-incorporated silk films. The wide-angle X-ray diffraction provided clear evidence of the crystallization of the silk fibroin induced by MWCNT in the composite films without any additional annealing processing. The tensile modulus and strength of the composite films were improved by 108% and 51%, respectively, by the incorporation of 0.2 wt% of MWCNTs, as compared with those of the pure silk films. The method described in this study will provide an alternative means of crystallizing silk fibroin films without using an organic solvent or blending with any other polymers, which may be important in biomedical applications.
C1 [Kim, H. -S.; Park, W. -I.; Kim, Y.; Jin, H. -J.] Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
RP Jin, HJ (reprint author), Inha Univ, Dept Polymer Sci & Engn, Inchon 402751, South Korea.
EM hjjin@inha.ac.kr
CR ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Assouline E, 2003, J POLYM SCI POL PHYS, V41, P520, DOI 10.1002/polb.10394
   Cadek M, 2004, NANO LETT, V4, P353, DOI 10.1021/nl035009o
   Esumi K, 1996, CARBON, V34, P279, DOI 10.1016/0008-6223(96)83349-5
   Grady BP, 2002, J PHYS CHEM B, V106, P5852, DOI 10.1021/jp014622y
   Jin HJ, 2005, CHEM MATER, V17, P4034, DOI 10.1021/cm050500x
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kang M, 2006, POLYMER, V47, P3961, DOI 10.1016/j.polymer.2006.03.073
   Kim HS, 2006, MACROMOL RAPID COMM, V27, P146, DOI 10.1002/marc.200500617
   Kim JY, 2006, POLYMER, V47, P1379, DOI 10.1016/j.polymer.2005.12.042
   Liu TX, 2004, MACROMOLECULES, V37, P7214, DOI 10.1021/ma049132t
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Ryan KP, 2006, SYNTHETIC MET, V156, P332, DOI 10.1016/j.synthmet.2005.12.015
   Ryan KP, 2004, CHEM PHYS LETT, V391, P329, DOI 10.1016/j.cplett.2004.05.025
   Shen Y, 1998, MACROMOLECULES, V31, P8857, DOI 10.1021/ma980281j
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Wang M, 2005, POLYMER, V46, P11510, DOI 10.1016/j.polymer.2005.10.007
   Yoon SH, 2006, BIOMACROMOLECULES, V7, P1280, DOI 10.1021/bm050597g
NR 19
TC 5
Z9 5
U1 1
U2 16
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0217-9792
J9 INT J MOD PHYS B
JI Int. J. Mod. Phys. B
PD APR 30
PY 2008
VL 22
IS 9-11
BP 1807
EP 1812
DI 10.1142/S0217979208047456
PG 6
WC Physics, Applied; Physics, Condensed Matter; Physics, Mathematical
SC Physics
GA 312WH
UT WOS:000256702600120
DA 2018-10-20
ER

PT J
AU Jia, XT
   He, W
   Yang, W
   Zhao, HS
   Zhang, XD
AF Jia, Xingtao
   He, Wen
   Yang, Wei
   Zhao, Hongshi
   Zhang, Xudong
TI Nanomorphological anatase TiO(2): From spongy network to porous
   nanoparticles
SO MATERIALS LETTERS
LA English
DT Article
DE spongy network structure; nanomaterials; sol-gel preparation; TiO(2);
   biomaterial
ID PHOTOCATALYTIC ACTIVITY; NANOTUBE ARRAYS; METAL-OXIDES; THIN-FILMS
AB Nanomorphological anatase TiO(2) from spongy network to porous nanoparticles was synthesized by a modified sol-gel preparation and a post microwave-assisted combustion treatment. The TEM studies showed that the spongy network texture was resulted in sample calcined at lower temperature (360 degrees C) and the structure partially collapsed into solid and porous nanoparticles when calcined at higher temperature (400 degrees C). The photocatalysis study showed that the lower calcinations sample is photo-inactive large adsorbed of methyl orange than P25. The special texture, large adsorption of organ molecular and photo-inactivity of the lower calcinations sample indicated that the materials maybe served as a kind of promising biomimetic material. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Jia, Xingtao; He, Wen; Zhao, Hongshi; Zhang, Xudong] Shandong Inst Light Ind, Dept Mat Sci & Engn, Jinan 250353, Peoples R China.
   [Jia, Xingtao; Yang, Wei] China Univ Petr, Coll Chem & Chem Engn, Dongying 257061, Peoples R China.
RP He, W (reprint author), Shandong Inst Light Ind, Dept Mat Sci & Engn, Jinan 250353, Peoples R China.
EM jiaxingtao@126.com; hewen_sdili@yahoo.com.cn; yangwei@hdpu.edu.cn;
   zhaohongshi@126.com; xdzhang@icm.sdu.edu.cn
RI jia, xingtao/C-8829-2013
CR Alvaro M, 2006, J PHYS CHEM B, V110, P6661, DOI 10.1021/jp0573240
   Chen J, 2003, J AM CHEM SOC, V125, P5284, DOI 10.1021/ja034601c
   Frindell KL, 2004, CHEM MATER, V16, P3524, DOI 10.1021/cm0341989
   GEDYE R, 1986, TETRAHEDRON LETT, V27, P279, DOI 10.1016/S0040-4039(00)83996-9
   HOFFMANN MR, 1995, CHEM REV, V95, P96
   Karvinen SM, 2003, IND ENG CHEM RES, V42, P1035, DOI 10.1021/ie020358z
   Kunst M, 2006, SUPERLATTICE MICROST, V39, P376, DOI 10.1016/j.spmi.2005.08.062
   Mitchell JW, 2006, MATER LETT, V60, P1524, DOI 10.1016/j.matlet.2005.11.063
   Mor GK, 2005, NANO LETT, V5, P191, DOI 10.1021/nl048301k
   Nadagouda MN, 2006, SMART MATER STRUCT, V15, P1260, DOI 10.1088/0964-1726/15/5/015
   Park JH, 2006, NANO LETT, V6, P24, DOI 10.1021/nl051807y
   Popovici N, 2006, J NON-CRYST SOLIDS, V352, P1486, DOI 10.1016/j.jnoncrysol.2005.10.036
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Toma SH, 2006, SURF SCI, V600, P4591, DOI 10.1016/j.susc.2006.07.027
   Yang PD, 1998, NATURE, V396, P152
   Yu JC, 2005, CHEM COMMUN, P2704, DOI 10.1039/b502493e
   Zhao D, 1998, ADV MATER, V10, P1380, DOI 10.1002/(SICI)1521-4095(199811)10:16<1380::AID-ADMA1380>3.0.CO;2-8
NR 17
TC 5
Z9 5
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD APR 30
PY 2008
VL 62
IS 12-13
BP 1896
EP 1898
DI 10.1016/j.matlet.2007.10.034
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 297JG
UT WOS:000255612400043
DA 2018-10-20
ER

PT J
AU Liu, HT
   Xu, WL
   Zou, HT
   Ke, GZ
   Li, WB
   Ouyang, CX
AF Liu, Hongtao
   Xu, Weilin
   Zou, Hantao
   Ke, Guizhen
   Li, Wenbin
   Ouyang, Chenxi
TI Feasibility of wet spinning of silk-inspired polyurethane elastic
   biofiber
SO MATERIALS LETTERS
LA English
DT Article
DE polyurethane; spandex; silk fibroin; superfine powder; elastic biofiber
ID FIBERS; MORPHOLOGY; BEHAVIOR; FIBROIN
AB Two types of water-insoluble protein from Bombyx mori silkworm, degummed and undegummed superfine silk powders, were prepared through a physical method. Water-soluble superfine silk fibroin powder was obtained from salt-dissolved, dialyzed and freeze-dried silk fibroin. These three types of superfine silk powders were blended with solution of commercially available biomedical grade segmented polyurethane (PU) to prepare elastic biofiber by a wet-spinning process. The objective of the current study was to identify the feasibility of wet spinning of polyurethane/superfine silk powder blend elastic biofiber, and analyse and compare the mechanical properties of the as-spun biofibers. Superfine silk fibroin powders and PU were dispersed in dimethyl formamide (DMF) and the dope solution exhibited good fiber formation in a warm distilled water coagulation bath. The superfine silk powder/PU blend fiber had a smooth surface, dense structure, and considerably high strength with a circular cross-section. The future further investigation will be carried out to analyse in detail the structure and morphology of the as-spun fiber. The silk-inspired biomedical polyurethane biofiber showed potential as a biomaterial for small-diameter artificial vascular scaffolds. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Liu, Hongtao; Xu, Weilin; Zou, Hantao; Ke, Guizhen; Li, Wenbin] Wuhan Univ Sci & Engn, Textile Res Ctr, Wuhan 430073, Peoples R China.
   [Liu, Hongtao] DongHua Univ, Coll Text, Shanghai 201620, Peoples R China.
   [Ouyang, Chenxi] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Vasc Surg, Wuhan 430022, Hubei, Peoples R China.
RP Xu, WL (reprint author), Wuhan Univ Sci & Engn, Textile Res Ctr, Wuhan 430073, Peoples R China.
EM weilin-xu@hotmail.com
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bhat G, 2001, THERMOCHIM ACTA, V367, P161, DOI 10.1016/S0040-6031(00)00673-0
   Chattopadhyay DK, 2007, PROG POLYM SCI, V32, P352, DOI 10.1016/j.progpolymsci.2006.05.003
   Jiang P, 2006, MATER LETT, V60, P919, DOI 10.1016/j.matlet.2005.10.056
   Ke GZ, 2004, ACTA POLYM SIN, P103
   Ki CS, 2007, INT J BIOL MACROMOL, V41, P346, DOI 10.1016/j.ijbiomac.2007.05.005
   Lee KH, 2007, INT J BIOL MACROMOL, V41, P168, DOI 10.1016/j.ijbiomac.2007.01.011
   Li Y., 2006, US. Patent, Patent No. 7000858
   Novak S, 2004, POWDER TECHNOL, V139, P140, DOI 10.1016/j.powtec.2003.11.007
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   Sanders JE, 2005, BIOMATERIALS, V26, P813, DOI 10.1016/j.biomaterials.2004.03.030
   Smeenk JM, 2005, MACROMOL SYMP, V225, P1, DOI 10.1002/masy.200550701
   Wei YP, 2004, J APPL POLYM SCI, V92, P351, DOI 10.1002/app.20023
   Xia YY, 2007, MATER LETT, V61, P4321, DOI 10.1016/j.matlet.2007.01.095
   Xu WL, 2004, POWDER TECHNOL, V140, P136, DOI 10.1016/j.powtec.2003.12.010
   XU WL, 2006, Patent No. 1268434
NR 16
TC 25
Z9 28
U1 3
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD APR 30
PY 2008
VL 62
IS 12-13
BP 1949
EP 1952
DI 10.1016/j.matlet.2007.10.061
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 297JG
UT WOS:000255612400058
DA 2018-10-20
ER

PT J
AU Sander, B
   Raabe, D
AF Sander, B.
   Raabe, D.
TI Texture inhomogeneity in a Ti-Nb-based beta-titanium alloy after warm
   rolling and recrystallization
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE texture; rolling; biomaterial; titanium; crystal plasticity; goss;
   recrystallization; recovery; shear texture
ID AUSTENITIC STAINLESS-STEEL; BIMODAL IMI-834 BILLET; LOW-CARBON STEELS;
   CRYSTALLOGRAPHIC TEXTURE; BCC METALS; GRAIN-GROWTH; ORIENTATION
   DEPENDENCE; MECHANICAL-PROPERTIES; VARIANT SELECTION; ALPHA-PHASE
AB The crystallographic microtexture and microstructure of a beta-titanium, alloy (Ti-35 wt.% Nb-7 wt.% Zr-5 wt.% Ta) is studied after warm rolling and recrystallization. The main observations are the evolution of partially recrystallized microstructures during warm rolling and the formation of strong through-thickness texture and microstructure gradients at larger strains. Both, the recrystallized volume fraction and the texture depend on the thickness reduction. At small reductions (<= 50%) texture gradients are also small showing some alpha(bcc)-fiber (crystallographic axis < 110 > parallel to the rolling direction) and gamma-fiber (crystallographic axis < 111 > parallel to the normal direction) texture components. At larger strains (70-90%) the texture and microstructure gradients are characterized by shear texture components and dynamic recrystallization particularly close to the surface layers and plane strain texture components which are typical of recovered grains in the center layer. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Sander, B.; Raabe, D.] Max Planck Inst Eisenforsch GmbH, D-40237 Dusseldorf, Germany.
RP Raabe, D (reprint author), Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, D-40237 Dusseldorf, Germany.
EM b.sander@mpie.de; d.raabe@mpie.de
RI Raabe, Dierk/A-6470-2009
OI Raabe, Dierk/0000-0003-0194-6124
CR Aernoudt E, 1993, MATER SCI TECHNOL, V6, P89
   Bache M.R., 2001, INT J FATIGUE, V23, P153
   Bache MR, 2003, INT J FATIGUE, V25, P1079, DOI 10.1016/S0142-1123(03)00145-2
   Bache MR, 2001, MAT SCI ENG A-STRUCT, V319, P409, DOI 10.1016/S0921-5093(00)02034-7
   BEYNON JH, 1988, PROCESS MODEL MET FO, V321
   BOWEN AW, 1977, MATER SCI ENG, V29, P19, DOI 10.1016/0025-5416(77)90141-0
   Bridier F, 2005, ACTA MATER, V53, P555, DOI 10.1016/j.actamat.2004.09.040
   Chen N, 2003, ACTA MATER, V51, P1755, DOI 10.1016/S1359-6454(02)00574-8
   De Gelas B., 1982, TITANIUM TITANIUM AL
   FEDOSSEEV AI, 1994, SCRIPTA METALL MATER, V30, P1, DOI 10.1016/0956-716X(94)90348-4
   Germain L, 2005, ACTA MATER, V53, P3535, DOI 10.1016/j.actamat.2005.03.043
   Gey N, 2000, SCRIPTA MATER, V42, P525, DOI 10.1016/S1359-6462(99)00396-6
   Glavicic MG, 2004, MAT SCI ENG A-STRUCT, V385, P372, DOI 10.1016/j.msea.2004.07.036
   Glavicic MG, 2003, MAT SCI ENG A-STRUCT, V351, P258, DOI 10.1016/S0921-5093(02)00844-4
   HOLSCHER M, 1991, STEEL RES, V62, P567
   HOLSCHER M, 1994, ACTA METALL MATER, V42, P879, DOI 10.1016/0956-7151(94)90283-6
   Humbert M, 2006, MAT SCI ENG A-STRUCT, V430, P157, DOI 10.1016/j.msea.2006.05.047
   Hutchinson W. B., 1984, International Metals Reviews, V29, P25
   HUTCHINSON WB, 1989, ACTA METALL MATER, V37, P1047, DOI 10.1016/0001-6160(89)90101-6
   Inamura T, 2006, MAT SCI ENG A-STRUCT, V438, P865, DOI 10.1016/j.msea.2006.02.092
   Ivasishin OM, 2002, MAT SCI ENG A-STRUCT, V332, P343, DOI 10.1016/S0921-5093(01)01755-5
   Kalinyuk AN, 2003, MAT SCI ENG A-STRUCT, V346, P178, DOI 10.1016/S0921-5093(02)00518-X
   Karasevskaya OP, 2003, MAT SCI ENG A-STRUCT, V354, P121, DOI 10.1016/S0921-5093(02)00935-8
   Karthikeyan T, 2005, MAT SCI ENG A-STRUCT, V393, P294, DOI 10.1016/j.msea.2004.10.044
   Kocks U. F., 1998, TEXTURE ANISOTROPY
   Lebensohn RA, 1997, ACTA MATER, V45, P3687, DOI 10.1016/S1359-6454(97)00067-0
   MCLAREN AJ, 1993, P INT C STRIP CAST H, V107
   Peeters B, 2001, SCRIPTA MATER, V45, P1349, DOI 10.1016/S1359-6462(01)01168-X
   Ponsonnet L, 1999, MAT SCI ENG A-STRUCT, V262, P50, DOI 10.1016/S0921-5093(98)01016-8
   RAABE D, 1993, MATER SCI TECH SER, V9, P302, DOI 10.1179/mst.1993.9.4.302
   RAABE D, 1995, MATER SCI TECH SER, V11, P455, DOI 10.1179/mst.1995.11.5.455
   Raabe D, 2007, ACTA MATER, V55, P4475, DOI 10.1016/j.actamat.2007.04.024
   RAABE D, 1994, Z METALLKD, V85, P302
   RAABE D, 1995, PHILOS MAG A, V71, P805, DOI 10.1080/01418619508236221
   RAABE D, 1992, SCRIPTA METALL MATER, V27, P211, DOI 10.1016/0956-716X(92)90115-U
   RAABE D, 1995, SCRIPTA METALL MATER, V33, P735, DOI 10.1016/0956-716X(95)00276-2
   RAABE D, 1993, J PHYS IV, V3, P523, DOI 10.1051/jp4:1993784
   RAABE D, 1995, STEEL RES, V66, P222, DOI 10.1002/srin.199501116
   RAABE D, 1994, MATER SCI FORUM, V157-, P841, DOI 10.4028/www.scientific.net/MSF.157-162.841
   Raabe D, 2002, ACTA MATER, V50, P421, DOI 10.1016/S1359-6454(01)00323-8
   RAABE D, 1995, J MATER SCI, V30, P47, DOI 10.1007/BF00352130
   RAABE D, 1995, METALL MATER TRANS A, V26, P991, DOI 10.1007/BF02649096
   RAABE D, 1992, SCRIPTA METALL MATER, V26, P1221, DOI 10.1016/0956-716X(92)90567-X
   RAABE D, 1995, MAT SCI ENG A-STRUCT, V197, P31, DOI 10.1016/0921-5093(94)09770-4
   RAABE D, 1995, MATER SCI TECH SER, V11, P461, DOI 10.1179/mst.1995.11.5.461
   Raabe D., 1994, MATER SCI TECHNOL, V10, P229
   RAPHANEL JL, 1985, ACTA METALL MATER, V33, P1481, DOI 10.1016/0001-6160(85)90049-5
   Roters F, 2005, MATER SCI FORUM, V495-497, P937, DOI 10.4028/www.scientific.net/MSF.495-497.937
   Semiatin SL, 2001, MAT SCI ENG A-STRUCT, V299, P225, DOI 10.1016/S0921-5093(00)01371-X
   SINGH AK, 1999, MAT SCI ENG A-STRUCT, P225
   Stanford N, 2004, ACTA MATER, V52, P5215, DOI 10.1016/j.actamat.2004.07.034
   Suwas S, 1999, ACTA MATER, V47, P4585, DOI 10.1016/S1359-6454(99)00327-4
   Thomas I, 2003, ADV ENG MATER, V5, P566, DOI 10.1002/adem.200300373
   Toth LS, 1997, METALL MATER TRANS A, V28, P2343, DOI 10.1007/s11661-997-0191-6
   USHIODA K, 1986, MATER SCI TECH SER, V2, P807, DOI 10.1179/mst.1986.2.8.807
   Van Houtte P., 1999, TEXTURE MICROSTRUCT, V31, P109
   Zaefferer S, 2003, MAT SCI ENG A-STRUCT, V344, P20, DOI 10.1016/S0921-5093(02)00421-5
   Zeng L, 2005, MAT SCI ENG A-STRUCT, V392, P403, DOI 10.1016/j.msea.2004.09.072
NR 58
TC 58
Z9 65
U1 1
U2 49
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD APR 25
PY 2008
VL 479
IS 1-2
BP 236
EP 247
DI 10.1016/j.msea.2007.06.077
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 292HE
UT WOS:000255256300028
DA 2018-10-20
ER

PT J
AU Tiwari, A
   Singh, SP
AF Tiwari, Ashutosh
   Singh, S. P.
TI Synthesis and characterization of biopolymer-based electrical conducting
   graft copolymers
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polyaniline-graft-guar gum; water soluble; electrical conductivity;
   sensor application
ID MICROWAVE IRRADIATION; SEED-GUMS; POLYANILINE; POLYMERIZATION; POLYMERS;
   ANILINE; POLYACRYLAMIDE; ACID
AB The naturally occurring Guar gum (GG) was chemically modified with polyaniline (PANI) using ammonium persulfate (APS) as oxidant/initiator in acidic condition. The representative graft copolymer was characterized using UV-vis, FTIR, H-1 NMR, XRD, TGA, and SEM taking GG and PANI as reference. The affinity of the upper limit for the graft copolymerization has been extensively studied by varying different chemical and physical parameters. All the findings have been discussed, and proposed a plausible mechanism for the graft copolymerization. The grafted GG exhibited hybrid properties of biopoly- mer as well as PANI, and has electrical conductivity in the range of 1.6 X 10(-2) S/cm at room temperature. The electrical conductivity of the grafted biomaterial was quite sensitive with pH, and it could be interesting to combine a biopolymer, isolated from the natural resources with synthetic polymer from petrochemical origin, and yielded an eco-friendly material of high performance. (C) 2008 Wiley Periodicals, Inc.
C1 [Tiwari, Ashutosh; Singh, S. P.] Natl Phys Lab, Dept Mat Engn, New Delhi 110012, India.
RP Tiwari, A (reprint author), Natl Phys Lab, Dept Mat Engn, New Delhi 110012, India.
EM ashunpl@gmail.com
CR Ahmeda A. A., 2004, SYNTHETIC MET, V144, P29
   Anbarasan R, 2003, J APPL POLYM SCI, V90, P3827, DOI 10.1002/app.13115
   Beadle PM, 1998, SYNTHETIC MET, V95, P29, DOI 10.1016/S0379-6779(98)00028-9
   CAO Y, 1986, SYNTHETIC MET, V16, P305, DOI 10.1016/0379-6779(86)90167-0
   CAO Y, 1992, SYNTHETIC MET, V48, P91, DOI 10.1016/0379-6779(92)90053-L
   GANG L, 1997, MACROMOLECULES, V30, P5660
   Gospodinova N, 1998, PROG POLYM SCI, V23, P1443, DOI 10.1016/S0079-6700(98)00008-2
   Hosseini SH, 2001, POLYM ADVAN TECHNOL, V12, P482, DOI 10.1002/pat.107
   Kim SJ, 2005, J APPL POLYM SCI, V96, P867, DOI 10.1002/app.21524
   KOBAYASHI T, 1984, J ELECTROANAL CHEM, V161, P419, DOI 10.1016/S0022-0728(84)80201-6
   LI Z, 1992, ELECTROCHIM ACTA, V37, P1003, DOI 10.1016/0013-4686(92)85215-7
   MacDiarmid AG, 2001, REV MOD PHYS, V73, P701, DOI 10.1103/RevModPhys.73.701
   MACDIARMID AG, 1989, FARADAY DISCUSS, P317
   MANOHAR SK, 1991, SYNTHETIC MET, V41, P711, DOI 10.1016/0379-6779(91)91165-7
   Peniche C, 1999, BIOMATERIALS, V20, P1869, DOI 10.1016/S0142-9612(99)00048-4
   Singh V, 2007, EXPRESS POLYM LETT, V1, P51, DOI 10.3144/expresspolymlett.2007.10
   Singh V, 2006, POLYMER, V47, P254, DOI 10.1016/j.polymer.2005.10.101
   Singh V, 2005, BIOMACROMOLECULES, V6, P453, DOI 10.1021/bm049518b
   Singh V, 2004, CARBOHYD POLYM, V58, P1, DOI 10.1016/j.carbpol.2004.04.010
   Singh V, 2004, J APPL POLYM SCI, V92, P1569, DOI 10.1002/app.20099
   Singh V, 2003, CARBOHYD POLYM, V54, P523, DOI 10.1016/j.carbpol.2003.05.003
   SINGH V, 2005, R J APPL POLYM SCI, V98, P1652
   Singh V, 2006, REACT FUNCT POLYM, V66, P1306, DOI 10.1016/j.reactfunctpolym.2006.03.013
   SKOTHEIM TA, 1997, HDB CONDUCTING POLYM
   Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113
   Takeda S, 1999, THIN SOLID FILMS, V343, P313, DOI 10.1016/S0040-6090(98)01591-0
   Tiwari A, 2007, J MACROMOL SCI A, V44, P735, DOI 10.1080/10601320701353116
   Trivedi D. C., 1997, HDB ORGANIC CONDUCTI, V2
   TRIVEDI DC, 1993, POLYM ADVAN TECHNOL, V4, P335
   Wan Y, 2004, MACROMOL BIOSCI, V4, P882, DOI 10.1002/mabi.200400044
   Yang YS, 2005, POLYM ADVAN TECHNOL, V16, P24, DOI 10.1002/pat.541
NR 31
TC 34
Z9 34
U1 3
U2 14
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD APR 15
PY 2008
VL 108
IS 2
BP 1169
EP 1177
DI 10.1002/app.27789
PG 9
WC Polymer Science
SC Polymer Science
GA 265IO
UT WOS:000253352500060
DA 2018-10-20
ER

PT J
AU Oliveira, WE
   Franca, AS
   Oliveira, LS
   Rocha, SD
AF Oliveira, Waleska E.
   Franca, Adriana S.
   Oliveira, Leandro S.
   Rocha, Sonia D.
TI Untreated coffee husks as biosorbents for the removal of heavy metals
   from aqueous solutions
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE biosorption; agricultural waste; toxic pollutants
ID ACTIVATED CARBON; WASTE-WATER; AGRICULTURAL WASTE; HEXAVALENT CHROMIUM;
   BIOSORPTION; ADSORPTION; SORPTION; CADMIUM; BIOMASS; EQUILIBRIUM
AB The objective of this work was to propose an altemative use for coffee husks (CH), a coffee processing residue, as untreated sorbents for the removal of heavy metal ions from aqueous solutions. Biosorption studies were conducted in a batch system as a function of contact time, initial metal ion concentration, biosorbent concentration and pH of the solution. A contact time of 72 It assured attainment of equilibrium for Cu(II), Cd(II) and Zn(II). The sorption efficiency after equilibrium was higher for Cu(II) (89-98% adsorption), followed by Cd(II) (65-85%) and Zn(II) (48-79%). Even though equilibrium was not attained in the case of Cr(VI) ions, sorption efficiency ranged from 79 to 86%. Sorption performance improved as metal ions concentrations were lowered. The experimental sorption equilibrium data were fitted by both Langmuir and Freundlich sorption models, with Langmuir providing the best fit (R-2 > 0.95). The biosorption kinetics was determined by fitting first and second-order kinetic models to the experimental data, being better described by the pseudo-second-order model (R-2 > 0.99). The amount of metal ions sorbed increased with the biosorbent concentration in the case of Cu(H) and Cr(VI) and did not present significant variations for the other metal ions. The effect of the initial pH in the biosorption efficiency was verified in the pH range of 4-7, and the results showed that the highest adsorption capacity occurred at distinct pH values for each metal ion. A comparison of the maximum sorption capacity of several untreated biomaterial-based residues showed that coffee husks are suitable candidates for use as biosorbents in the removal of heavy metals from aqueous solutions. (C) 2007 Elsevier B.V All rights reserved.
C1 [Oliveira, Waleska E.; Franca, Adriana S.; Oliveira, Leandro S.; Rocha, Sonia D.] Univ Fed Minas Gerais, Dept Engn Quim, BR-30160030 Belo Horizonte, MG, Brazil.
RP Oliveira, LS (reprint author), Univ Fed Minas Gerais, Dept Engn Quim, 35 Sexto Andar, BR-30160030 Belo Horizonte, MG, Brazil.
EM leandro@deq.ufmg.br
RI Franca, Adriana/N-8870-2013; Oliveira, Leandro/O-2671-2017
OI Franca, Adriana/0000-0003-0967-8451; Oliveira,
   Leandro/0000-0001-6977-7625
CR Agrawal A, 2004, COLLOID SURFACE A, V237, P133, DOI 10.1016/j.colsurfa.2004.01.034
   Al-Degs YS, 2006, WATER RES, V40, P2645, DOI 10.1016/j.watres.2006.05.018
   Annadurai A., 2002, WATER SCI TECHNOL, V47, P185
   Bansal RC, 1988, ACTIVE CARBON
   Basci N, 2004, DESALINATION, V164, P135, DOI 10.1016/S0011-9164(04)00172-9
   Brown P, 2000, ADV ENVIRON RES, V4, P19, DOI 10.1016/S1093-0191(00)00004-6
   Chen JP, 2005, IND ENG CHEM RES, V44, P9931, DOI 10.1021/ie050678t
   Chubar N, 2003, COLLOID SURFACE A, V230, P57, DOI 10.1016/j.colsurfa.2003.09.014
   Conrad K, 2007, BIORESOURCE TECHNOL, V98, P89, DOI 10.1016/j.biortech.2005.11.018
   Dakiky M, 2002, ADV ENVIRON RES, V6, P533, DOI 10.1016/S1093-0191(01)00079-X
   Doyurum S, 2006, J HAZARD MATER, V138, P22, DOI 10.1016/j.jhazmat.2006.03.071
   Evans MJB, 1999, CARBON, V37, P269, DOI 10.1016/S0008-6223(98)00174-2
   Garg UK, 2007, J HAZARD MATER, V140, P60, DOI 10.1016/j.jhazmat.2006.06.056
   Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8
   Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2
   Kumar U, 2006, BIORESOURCE TECHNOL, V97, P104, DOI 10.1016/j.biortech.2005.02.027
   Kumar YP, 2006, J HAZARD MATER, V137, P1211, DOI 10.1016/j.jhazmat.2006.04.006
   Leyva-Ramos R, 2005, SEP PURIF TECHNOL, V45, P41, DOI 10.1016/j.seppur.2005.02.005
   Lodeiro P, 2005, BIORESOURCE TECHNOL, V96, P1796, DOI 10.1016/j.biortech.2005.01.002
   Malkoc E, 2006, J HAZARD MATER, V138, P142, DOI 10.1016/j.jhazmat.2006.05.051
   Meunier N, 2003, BIORESOURCE TECHNOL, V90, P255, DOI 10.1016/S0960-8524(03)00129-9
   Mohan D, 2002, WATER RES, V36, P2304, DOI 10.1016/S0043-1354(01)00447-X
   Mohan D, 2005, IND ENG CHEM RES, V44, P1027, DOI 10.1021/ie0400898
   Montanher SF, 2005, J HAZARD MATER, V117, P207, DOI 10.1016/j.jhazmat.2004.09.015
   Namane A, 2005, J HAZARD MATER, V119, P189, DOI 10.1016/j.jhazmat.2004.12.006
   Nasernejad B, 2005, PROCESS BIOCHEM, V40, P1319, DOI 10.1016/j.procbio.2004.06.010
   Nuhoglu Y, 2003, PROCESS BIOCHEM, V38, P1627, DOI 10.1016/S0032-9592(03)00055-4
   Pagnanelli F, 2002, WASTE MANAGE, V22, P901, DOI 10.1016/S0956-053X(02)00086-7
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   PINTO LC, 2003, QUANTIKOV IMAGE ANAL
   POLLARD SJT, 1992, SCI TOTAL ENVIRON, V116, P31, DOI 10.1016/0048-9697(92)90363-W
   Puigdom'enech I., 2004, MEDUSA
   Rajeshwarisivaraj, 2001, BIORESOURCE TECHNOL, V80, P233
   Saeed A, 2005, SEP PURIF TECHNOL, V45, P25, DOI 10.1016/j.seppur.2005.02.004
   Saenger M, 2001, RENEW ENERG, V23, P103, DOI 10.1016/S0960-1481(00)00106-3
   Singh KK, 2006, BIORESOURCE TECHNOL, V97, P994, DOI 10.1016/j.biortech.2005.04.043
   Singh KK, 2005, J HAZARD MATER, V121, P51, DOI 10.1016/j.jhazmat.2004.11.002
   Titus E, 2003, COLLOID SURFACE A, V223, P55, DOI 10.1016/S0927-7757(03)00131-6
   Valdes H, 2002, LANGMUIR, V18, P2111, DOI 10.1021/la010920a
   Yu LJ, 2003, J HAZARD MATER, V100, P53, DOI 10.1016/S0304-3894(03)00008-6
NR 40
TC 121
Z9 128
U1 1
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD APR 15
PY 2008
VL 152
IS 3
BP 1073
EP 1081
DI 10.1016/j.jhazmat.2007.07.085
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 291FZ
UT WOS:000255180600024
PM 17804159
DA 2018-10-20
ER

PT J
AU Jewrajka, SK
   Kennedy, JP
AF Jewrajka, Suresh K.
   Kennedy, J. P.
TI Networks and conetworks of PIB-based cyanoacrylate-telechelic
   prepolymers: Synthesis, characterization, and properties
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE biomaterial; bulk polymerization; conetwork; crosslinking;
   cyanoacrylate; network; polyisobutylene; reaction injection molding
ID ETHYL CYANOACRYLATE; COPOLYMERIZABILITY; POLYMERIZABILITY;
   POLYISOBUTYLENE
AB Novel networks and conetworks were prepared by the instantaneous polymerization of cyanoacrylate-telechelic three-arm star polyisobutylene [phi(PIB-CA)(3)] and the copolymerization of phi(PIB-CA)(3)/2,4,4-trimethylpentane cyanoacrylate (TMP-CA) mixtures, respectively, by means of strong nucleophiles, such as NEt2-telechleic linear or three-arm star PIBs [phi(PIB-NEt2)(2) or 3]. The reactants were combined in the bulk in double-barrel syringes by reaction injection molding (RIM). The chemical and mechanical properties of products prepared in the bulk and by conventional solution techniques were characterized by various techniques (swelling, extractables, FTIR and NMR spectroscopies, Instron, microhardness, oxidative resistance, DSC, DMTA). Conditions for the preparation of rubbery materials for possible biomedical applications were developed. (c) 2008 Wiley Periodicals, Inc.
C1 [Jewrajka, Suresh K.; Kennedy, J. P.] Univ Akron, Inst Polymer Sci, Akron, OH 44325 USA.
RP Kennedy, JP (reprint author), Univ Akron, Inst Polymer Sci, Akron, OH 44325 USA.
EM josep19@uakron.edu
CR Costa G, 1997, MACROMOL RAPID COMM, V18, P891, DOI 10.1002/marc.1997.030180918
   FICHT K, 1993, MAKROMOL CHEM-RAPID, V14, P6669
   Fox G., 1956, B AM PHYS SOC, V1, P123
   JEWRAJKA SK, IN PRESS J BIOMED A
   JEWRAJKA SK, UNPUB
   Klemarczyk P, 2001, POLYMER, V42, P2837, DOI 10.1016/S0032-3861(00)00618-2
   Kwon Y, 2007, POLYM ADVAN TECHNOL, V18, P800, DOI 10.1002/pat.969
   Kwon Y, 2007, POLYM ADVAN TECHNOL, V18, P808, DOI 10.1002/pat.968
   MATSUMOTO T, 1972, MED EXAMINATION PUBL, P5
   PAPATHEOFANIS FJ, 1989, J BIOMED MATER RES, V23, P661, DOI 10.1002/jbm.820230609
   TUNCEL A, 1995, J BIOMED MATER RES, V29, P721, DOI 10.1002/jbm.820290608
   ZUMPANO BJ, 1982, SURG NEUROL, V18, P452, DOI 10.1016/0090-3019(82)90186-0
NR 12
TC 9
Z9 9
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD APR 15
PY 2008
VL 46
IS 8
BP 2612
EP 2623
DI 10.1002/pola.22591
PG 12
WC Polymer Science
SC Polymer Science
GA 288IB
UT WOS:000254978600002
DA 2018-10-20
ER

PT J
AU Pishko, MV
AF Pishko, Michael V.
TI POLY 630-Hyperbranched polymer thin films on nanostructured biomaterial
   surfaces
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 235th American-Chemical-Society National Meeting
CY APR 06-10, 2008
CL New Orleans, LA
C1 [Pishko, Michael V.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77845 USA.
EM mpishko@tamu.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 6
PY 2008
VL 235
MA 630-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 519XJ
UT WOS:000271802800338
DA 2018-10-20
ER

PT J
AU Wang, S
   Bao, HM
   Yang, PY
   Chen, G
AF Wang, Sheng
   Bao, Huimin
   Yang, Pengyuan
   Chen, Gang
TI Immobilization of trypsin in polyaniline-coated nano-Fe3O4/carbon
   nanotube composite for protein digestion
SO ANALYTICA CHIMICA ACTA
LA English
DT Article
DE composite; Fe3O4; polyaniline; carbon nanotube; proteomics; trypsin
ID CARBON NANOTUBES; SOL-GEL; NANOPARTICLES; REACTOR; MICROCHIP; ANILINE;
   POLYMERIZATION; IDENTIFICATION; SEPARATION; PROTEOMICS
AB In this report, a four-component nanocomposite, trypsin-immobilized polyaniline-coated Fe3O4/carbon nanotube composite, was synthesized for highly efficient protein digestion. Fe3O4 was deposited by the chemical coprecipitation of Fe2+ and Fe3+ in an alkaline solution containing carbon nanotubes (CNTs) to prepare nano-Fe3O4/CNT composite. Subsequently, polyaniline (PA) was assembled on the Fe3O4/CNT composite by the in situ polymerization of aniline in the presence of trypsin to obtain trypsin-immobilized PA/Fe3O4/CNT nanocomposite. The novel 1D superparamagnetic biomaterial has been characterized by TEM, SEM, XRD, and magnetometric analysis. The feasibility and performance of the unique magnetic biomaterial have been demonstrated by the tryptic digestion of bovine serum albumin, myoglobin, and lysozyme within 5 min. The digests were identified by MALDI-TOF MS with sequence coverages that were comparable to those obtained from the conventional in-solution tryptic digestion. The present biocomposite offers considerable promise for protein analysis due to its high magnetic responsivity and excellent dispersibility. it can be easily isolated from the digests with the aid of an external magnetic field. Because the enzyme-immobilized nanocomposite can be prepared by a simple two-step deposition approach at low cost, it may find a wide range of biological applications including proteome research. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Chen, Gang] Fudan Univ, Sch Pharm, Shanghai 200032, Peoples R China.
   Fudan Univ, Dept Chem, Shanghai 200032, Peoples R China.
RP Chen, G (reprint author), Fudan Univ, Sch Pharm, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.
EM gangchen@fudan.edu.cn
RI Wang, Sheng/I-2066-2015
CR Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   AMANKWA LN, 1993, ANAL CHEM, V65, P2693, DOI 10.1021/ac00067a025
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   BIKOVA Z, 2006, ELECTROPHORESIS, V27, P1811
   Choi JW, 2002, LAB CHIP, V2, P27, DOI [10.1039/b107540n, 10.1039/b1077540n]
   Cooper JW, 2003, ANAL CHEM, V75, P1067, DOI 10.1021/ac025768b
   Deng JG, 2003, SYNTHETIC MET, V139, P295, DOI 10.1016/S0379-6779(03)00166-8
   Deng YH, 2005, COLLOID SURFACE A, V262, P87, DOI 10.1016/j.colsurfa.2005.04.009
   Ding Y, 1999, J POLYM SCI POL CHEM, V37, P2569, DOI 10.1002/(SICI)1099-0518(19990715)37:14<2569::AID-POLA30>3.0.CO;2-N
   Downs C, 1999, ADV MATER, V11, P1028, DOI 10.1002/(SICI)1521-4095(199908)11:12<1028::AID-ADMA1028>3.0.CO;2-N
   Fan HZ, 2007, PROTEOMICS, V7, P3445, DOI 10.1002/pmic.200700505
   Ghosh P, 1999, EUR POLYM J, V35, P699, DOI 10.1016/S0014-3057(98)00157-8
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kryszewski M, 1998, SYNTHETIC MET, V94, P99, DOI 10.1016/S0379-6779(97)04152-0
   Li Y, 2007, J PROTEOME RES, V6, P2367, DOI 10.1021/pr060558r
   Li YM, 1998, ACTA POLYM SIN, P177
   Lion N, 2003, ELECTROPHORESIS, V24, P3533, DOI 10.1002/elps.200305629
   Liu Y, 2006, ANAL CHEM, V78, P801, DOI 10.1021/ac051463w
   Lu XF, 2005, NANOTECHNOLOGY, V16, P1660, DOI 10.1088/0957-4484/16/9/043
   Lu XF, 2006, J SOLID STATE CHEM, V179, P2609, DOI 10.1016/j.jssc.2006.04.029
   Peng XJ, 2005, CARBON, V43, P880, DOI 10.1016/j.carbon.2004.11.009
   Qu HY, 2004, ANAL CHEM, V76, P6426, DOI 10.1021/ac049466g
   Qu S, 2007, TALANTA, V71, P1096, DOI 10.1016/j.talanta.2006.06.003
   Righetti PG, 2004, EUR J MASS SPECTROM, V10, P335, DOI 10.1255/ejms.600
   Sakai-Kato K, 2003, ANAL CHEM, V75, P388, DOI 10.1021/ac026240+
   Slysz GW, 2005, ANAL CHEM, V77, P1572, DOI 10.1021/ac048698c
   Xu XQ, 2007, J PROTEOME RES, V6, P3849, DOI 10.1021/pr070132s
   Zengin H, 2002, ADV MATER, V14, P1480, DOI 10.1002/1521-4095(20021016)14:20<1480::AID-ADMA1480>3.0.CO;2-O
   Zhu WZ, 2003, MATER CHEM PHYS, V82, P638, DOI 10.1016/S0254-0584(03)00341-9
NR 29
TC 61
Z9 66
U1 2
U2 88
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2670
EI 1873-4324
J9 ANAL CHIM ACTA
JI Anal. Chim. Acta
PD APR
PY 2008
VL 612
IS 2
BP 182
EP 189
DI 10.1016/j.aca.2008.02.035
PG 8
WC Chemistry, Analytical
SC Chemistry
GA 289IX
UT WOS:000255049300009
PM 18358864
DA 2018-10-20
ER

PT J
AU Meek, MF
   Coert, JH
AF Meek, M. F.
   Coert, J. H.
TI US Food and Drug Administration/Conformit Europe-approved absorbable
   nerve conduits for clinical repair of peripheral and cranial nerves
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
DE NeuraGen; NeuroMatrix; Neurotube; Neurolac; absorbable nerve conduit;
   clinical
ID POLYGLYCOLIC ACID CONDUITS; RAT SCIATIC-NERVE; COLLAGEN TUBE;
   REGENERATION; RECONSTRUCTION; GUIDE; TUBULIZATION; BIOMATERIAL; DEFECTS
AB Several absorbable nerve conduits are approved by the US Food and Drug Administration (FDA) and Conformit Europe (CE) for clinical repair of peripheral and cranial nerves. Surgeons are often not aware of the different (bio)materials of these conduits when performing nerve repair. An overview of these FDA- and CE-approved absorbable nerve conduits for clinical use is presented. PubMed. MEDLINE, and the companies selling the conduits were consulted. The available FDA and CE absorbable nerve conduits for peripheral and cranial nerve repair are 2 collagen- and 2 synthetic-polyester-based conduits. The available clinical data, the price, the length, and the composition of the tube show significant differences. Based on the available data in this paper at this moment, we favor the PGA (Neurotube) nerve conduit for repair of peripheral and cranial nerve defects because of its advantages in length, price, and availability of clinical data. However, no prospective studies comparing the available nerve conduits have been published.
C1 [Meek, M. F.] Derbyshire Royal Infirm, Pulvertaft Hand Ctr, Derby DE1 2QY, England.
   [Coert, J. H.] Erasmus Univ, Med Ctr, Dept Plast Reconstruct & Hand Surg, Rotterdam, Netherlands.
RP Meek, MF (reprint author), Derbyshire Royal Infirm, Pulvertaft Hand Ctr, London Rd, Derby DE1 2QY, England.
EM marcelfineek@hotmail.com
CR Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   Ashley WW, 2006, J NEUROSURG, V105, P452, DOI 10.3171/ped.2006.105.6.452
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Berger A, 1994, Handchir Mikrochir Plast Chir, V26, P44
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   BUNGE MB, 1989, DEV NEUROSCI-BASEL, V11, P348, DOI 10.1159/000111911
   Casanas J, 2000, J HAND SURG B, V25, P44
   Chamberlain LJ, 2000, J COMP NEUROL, V417, P415, DOI 10.1002/(SICI)1096-9861(20000221)417:4<415::AID-CNE3>3.0.CO;2-9
   CRAWLEY WA, 1992, PLAST RECONSTR SURG, V90, P300, DOI 10.1097/00006534-199290020-00022
   Dellon AL, 2006, J HAND SURG-AM, V31A, P1495, DOI 10.1016/j.jhsa.2006.07.003
   DENDUNNEN WFA, 1996, THESIS U GRONINGEN
   Donoghoe N, 2007, MICROSURG, V27, P595, DOI 10.1002/micr.20408
   Ducic I, 2005, J RECONSTR MICROSURG, V21, P29, DOI 10.1055/s-2005-862777
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Hagiwara Akeo, 2002, Gan To Kagaku Ryoho, V29, P2202
   Inada Y, 2005, PAIN, V117, P251, DOI 10.1016/j.pain.2005.05.033
   Inada Y, 2004, NEUROSURGERY, V55, P640, DOI 10.1227/01.NEU.0000134388.86603.11
   Itoh S, 2002, BIOMATERIALS, V23, P4475, DOI 10.1016/S0142-9612(02)00166-7
   Jansen K, 2004, J BIOMED MATER RES A, V69A, P334, DOI 10.1002/jbm.a.30004
   KEELEY RD, 1991, J RECONSTR MICROSURG, V7, P93, DOI 10.1055/s-2007-1006766
   Kim J, 2001, J Foot Ankle Surg, V40, P318
   LAQUERRIERE A, 1994, MICROSURG, V15, P203, DOI 10.1002/micr.1920150312
   LaRosa G, 2003, RIV ITAL CHIR PLASTI, V35, P125
   LI S-T, 1992, Clinical Materials, V9, P195, DOI 10.1016/0267-6605(92)90100-8
   LOHMEYER J, 2007, DER CHIRURG, V78, P142
   LUNDBORG G, 1994, J RECONSTR MICROSURG, V10, P345, DOI 10.1055/s-2007-1006604
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   MATHUR A, 1983, SCAN ELECT MICROSC, V2, P975
   Meek M F, 2003, Ned Tijdschr Geneeskd, V147, P717
   Meek MF, 2007, BIO-MED MATER ENG, V17, P329
   Meek MF, 2006, J RECONSTR MICROSURG, V22, P149, DOI 10.1055/s-2006-939959
   Meek MF, 2004, J BIOMED MATER RES A, V68A, P43, DOI 10.1002/jbm.a.10157
   Meek MF, 2002, J RECONSTR MICROSURG, V18, P97, DOI 10.1055/s-2002-19889
   MEEK MF, 2007, DER CHIRUR, V78, P1152
   MEEK MF, 2000, THESIS U GRONINGEN
   MERRELL JC, 1986, ANN PLAS SURG, V17, P49, DOI 10.1097/00000637-198607000-00010
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Navissano M, 2005, MICROSURG, V25, P268, DOI 10.1002/micr.20128
   ROSEN J M, 1989, Journal of Rehabilitation Research and Development, V26, P1
   ROSEN JM, 1983, ANN PLAS SURG, V11, P397, DOI 10.1097/00000637-198311000-00007
   Rosner BI, 2003, ANN BIOMED ENG, V31, P1383, DOI 10.1114/1.1626118
   Scherman P, 2001, J NEUROSURG, V95, P316, DOI 10.3171/jns.2001.95.2.0316
   Strauch B, 2000, HAND CLIN, V16, P123
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Yuen D., 2003, T SOC BIOMATERIALS, P228
NR 46
TC 101
Z9 105
U1 1
U2 41
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD APR
PY 2008
VL 60
IS 4
BP 466
EP 472
DI 10.1097/SAP.0b013e31804d441c
PG 7
WC Surgery
SC Surgery
GA 281ML
UT WOS:000254501600028
PM 18437784
DA 2018-10-20
ER

PT J
AU Rodas, ACD
   Maizato, MJS
   Leirner, AA
   Pitombo, RNM
   Polakiewicz, B
   Beppu, MM
   Higa, OZ
AF Rodas, Andrea C. D.
   Maizato, Marina J. S.
   Leirner, Adolfo A.
   Pitombo, Ronaldo N. M.
   Polakiewicz, Bronislaw
   Beppu, Marisa M.
   Higa, Olga Z.
TI Cytotoxicity and genotoxicity of bovine pericardium preserved in
   glycerol
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 4th Latin American Congress for Artificial Organs and Biomaterials
CY AUG 08-11, 2006
CL Caxambu, BRAZIL
DE cytotoxicity; genotoxicity; glycerol; pericardium
ID MECHANISMS
AB Bovine pericardium is a widely utilized biomaterial. Usually, after harvesting, it is advantageous that the pericardium be immersed in glycerol to improve its shelf life. This can induce some degree of toxicity in the material. The studies were performed in compliance with the rules of ISO 10993 and OECD 487, in the biological evaluation of medical devices. The material was prepared without previous washing. After sterilization by gamma radiation the pericardium was immersed in RPMI 1640 culture medium to fulfill the extraction condition. The same extract was employed in the cytotoxic and genotoxic tests. The procedures were carried out with Chinese hamster ovary cell line and to determine the cytotoxicity, a colorimetric method with the tetrazolium compound MTS was used. For the genotoxicity, following the in vitro micronucleus assay, the test was developed with and without metabolic activation. The Cytotoxicity Index was graphically estimated at the extract concentration of 78%. In the genotoxicity test, the average value of cell proliferation index was found to be 1.62 +/- 0.02 with S9 metabolic activator and 1.91 +/- 0.01 without S9 metabolic activator. Both values are similar to the negative control value in the micronucleus assay. We observed that although the pericardium preserved in glycerol shows a certain level of cytotoxicity, it does not show any genotoxicity.
C1 [Rodas, Andrea C. D.; Higa, Olga Z.] IPEN CNEN SP, Ctr Biotechnol, BR-05508900 Sao Paulo, Brazil.
   [Maizato, Marina J. S.; Leirner, Adolfo A.] HC FMUSP, Inst Coracao InCor, Div Bioengn, Sao Paulo, Brazil.
   [Pitombo, Ronaldo N. M.; Polakiewicz, Bronislaw] Univ Sao Paulo, FCF, Dept Tecnol Bioquim Farmaceut, Sao Paulo, Brazil.
   [Beppu, Marisa M.] Univ Estadual Campinas, Escola Engn Quim, Campinas, Brazil.
RP Rodas, ACD (reprint author), IPEN CNEN SP, Ctr Biotechnol, Av Prof Lineu Prestes,2242 Cidade Univ, BR-05508900 Sao Paulo, Brazil.
EM arodas@ipen.br
RI Biofabris, Inct/I-2418-2013; Rodas, Andrea/E-1130-2012; BEPPU,
   MARISA/E-1057-2012
CR BRAILE DM, 1990, THESIS EPM SP
   CORY AH, 1991, CANCER COMMUN, V3, P207
   DIDISHEIM P, 1996, BIOMATERIALS SCI
   Garriott ML, 2002, MUTAT RES-GEN TOX EN, V517, P123, DOI 10.1016/S1383-5718(02)00059-1
   Groth T, 1995, ATLA-ALTERN LAB ANIM, V23, P790
   INTERNATIONAL ORGANIZATION FOR STANDARDIZATION-ISO, 1992, 109933 ISO
   International Standardization Organization, 1992, 109935 ISO
   MAIZATO MJS, 2003, THESIS UNICAMP CAMPI
   *ORG EC COOP DEV, 487 OECD
NR 9
TC 7
Z9 7
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD APR
PY 2008
VL 32
IS 4
BP 272
EP 276
DI 10.1111/j.1525-1594.2008.00542.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 280GE
UT WOS:000254412900004
PM 18370940
DA 2018-10-20
ER

PT J
AU Theiszova, M
   Jantova, S
   Letasiova, S
   Valik, L
   Palou, MT
AF Theiszova, Marica
   Jantova, Sona
   Letasiova, Silvia
   Valik, Lubos
   Palou, Martin T.
TI Comparative study of a new composite biomaterial fluor-hydroxyapatite on
   fibroblast cell line NIH-3T3 by direct test
SO BIOLOGIA
LA English
DT Article
DE fluor-hydroxyapatite composite; fluorapatite; hydroxyapatite; NIH-3T3
   fibroblasts; contact basal cytotoxicity
ID IN-VITRO CYTOTOXICITY; CALCIUM-PHOSPHATE; HYDROXYLAPATITE; INVITRO;
   TISSUE; DAMAGE
AB The number of biomaterials used in biomedical applications has rapidly increased in the past two decades. Fluorapatite (FA) is one of the inorganic constituents of bone or teeth used for hard tissue repairs and replacements. Fluor-hydroxyapatite (FHA) is a new synthetically prepared composite that in its structure contains the same molecular concentration of OH- groups and F- ions. The aim of this experimental investigation was to use the embryonal mouse fibroblast cell line NIH-3T3 for comparative study of basal cytotoxicity of fluoridated biomaterials FHA and FA discs. Hydroxyapatite (HA) disc, high-density polyethylene as negative control and polyvinyl chloride (PVC) containing organotin stabilizer as positive control were used as standard biomaterials. The appropriateness of the use of NIH-3T3 cells and their sensitivity for tested biomaterials were evaluated on the basis of five cytotoxic end points: cell proliferation, cell morphology, lactate dehydrogenase (LDH) released, protein and DNA cell content. The basal cytotoxicity of FHA, FA and HA discs was measured by direct contact method. FHA composite, FA and HA demonstrated in cell line NIH-3T3 nearly similar basal cytotoxicity increasing with the time of treatment. After 72 h of biomaterials treatment, about 25% inhibition of cell number, unchanged morphology of dividing cells, 6.31-0.16% increase of released LDH, about 10% inhibition of cell protein content and about 20% inhibition of DNA content was found. On the other hand, from the growth rates it resulted that NIH-3T3 cells, affected by tested biomaterials, divided about 20% slowlier than the control (untreated cells). Using the linear regression analysis we found out that deviations in measurements of cytotoxicity by four methods were as follows: less than 10% for cell number, protein and DNA content methods and 12.4% for released LDH method. Based on a good correlation of the cytotoxicity of biomaterials obtained from all end points we could conclude that fibroblast NIH-3T3 cell line was appropriate for measuring the basal cytoxicity of tested biomaterials.
C1 [Theiszova, Marica; Jantova, Sona; Letasiova, Silvia; Valik, Lubos] Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Biochem Nutr & Hlth Protect, SK-81237 Bratislava, Slovakia.
   [Palou, Martin T.] Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Inorgan Chem Technol & Mat, SK-81237 Bratislava, Slovakia.
RP Theiszova, M (reprint author), Slovak Univ Technol Bratislava, Fac Chem & Food Technol, Inst Biochem Nutr & Hlth Protect, Radlinskeho 9, SK-81237 Bratislava, Slovakia.
EM marica.theiszova@stuba.sk
RI Valik, Lubomir/A-9971-2008
OI Valik, Lubomir/0000-0001-8681-3616
CR ASTERN P, 1998, PHARM WORLD SCI, V20, P214
   BARANYI J, 1993, FOOD MICROBIOL, V10, P43, DOI 10.1006/fmic.1993.1005
   BARILE FA, 1994, INTRO VITRO CYTOTOXI
   Bergmeier H. U., 1970, METHODEN ENZYMATISCH
   FARLEY JR, 1983, SCIENCE, V222, P330
   Gineste L, 1999, J BIOMED MATER RES, V48, P224, DOI 10.1002/(SICI)1097-4636(1999)48:3<224::AID-JBM5>3.0.CO;2-A
   HONGSLO JK, 1974, J DENT RES, V53, P410, DOI 10.1177/00220345740530023801
   IGNAJATOVIC N, 2006, MICROSC RES TECHNIQ, V69, P976
   JARCHO M, 1977, J BIOENG, V1, P79
   Karen JLB, 2000, BIOMATERIALS, V21, P2347
   KUZIELOVA E, 2006, BOOK ABSTR, V28, P99
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   LANG H, 1990, J ORAL MAXIL SURG, V48, P606, DOI 10.1016/S0278-2391(10)80475-6
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Leroy N., 2001, European Cells & Materials, V2, P36
   Lickorish D, 2004, J BIOMED MATER RES A, V68A, P19, DOI 10.1002/jbm.a..20031
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARUGAN R, 2002, MATER LETT, V57, P429
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Nablo BJ, 2005, BIOMATERIALS, V26, P4405, DOI 10.1016/j.biomaterials.2004.11.015
   Ning Congqin, 2003, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V20, P550
   OGURO A, 1983, J DENT HLTH, V31, P453
   Pereira MM, 2005, ADV APPL CERAM, V104, P35, DOI 10.1179/174367605225011034
   Qu HB, 2006, ACTA BIOMATER, V2, P113, DOI 10.1016/j.actbio.2005.09.003
   REJDA BV, 1977, J BIOENG, V1, P93
   Ribeiro Daniel Araki, 2006, Braz. Dent. J., V17, P91, DOI 10.1590/S0103-64402006000200001
   Ribeiro Daniel Araki, 2004, Braz. oral res., V18, P192, DOI 10.1590/S1806-83242004000300003
   RICE RM, 1978, J BIOMED MATER RES, V12, P43, DOI 10.1002/jbm.820120105
   Shan KR, 2004, TOXICOLOGY, V200, P169, DOI 10.1016/j.tox.2004.03.013
   Tadashi K, 2003, BIOMATERIALS, V24, P2161
   Vallittu PK, 1999, J ORAL REHABIL, V26, P666, DOI 10.1046/j.1365-2842.1999.00431.x
   Wang AG, 2004, BIOMED ENVIRON SCI, V17, P217
   Xu W, 2006, MATER LETT, V60, P1575, DOI 10.1016/j.matlet.2005.11.072
NR 34
TC 4
Z9 4
U1 1
U2 12
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0006-3088
EI 1336-9563
J9 BIOLOGIA
JI Biologia
PD APR
PY 2008
VL 63
IS 2
BP 273
EP 281
DI 10.2478/s11756-008-0043-x
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 275BA
UT WOS:000254045700025
OA Other Gold
DA 2018-10-20
ER

PT J
AU Coutinho, DF
   Pashkuleva, IH
   Alves, CM
   Marques, AP
   Neves, NM
   Reis, RL
AF Coutinho, Daniela F.
   Pashkuleva, Iva H.
   Alves, Catarina M.
   Marques, Alexandra P.
   Neves, Nuno M.
   Reis, Rui L.
TI The effect of chitosan on the in vitro biological performance of
   chitosan-poly(butylene succinate) blends
SO BIOMACROMOLECULES
LA English
DT Article
ID OSTEOBLAST ADHESION; BIOMATERIALS; FIBRONECTIN; ADSORPTION; SCAFFOLDS;
   PROTEINS; SURFACES; BINDING; CHITIN; ENERGY
AB Chitosan blends with synthetic biodegradable polymers have been proposed for various biomedical applications due to their versatile mechanical properties and easier processing. However, details regarding the main surface characteristics that may benefit from the blending of these two types of materials are still missing. Hence, this work aims at investigating the surface properties of chitosan-based blends, illustrating the way these properties determine the material-proteins interactions and ultimately the behavior of osteoblast-like cells. The surface characteristics of modified and nonmodified blends were assessed using complimentary techniques such as optical microscopy, scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR-ATR), X-ray photoelectron spectroscopy (XPS), contact angle measurements and surface energy calculations. The adsorption of human serum albumin (HSA) and human plasma fibronectin (HFN) onto the different surfaces was quantified by association of an indirect method with a colorimetric assay. It was found that the presence of chitosan on the surface promoted the adsorption of proteins. Moreover, a preferential adsorption of albumin over fibronectin was registered. The in vitro biological performance of the studied materials was further investigated by a direct contact assay with an osteoblastic-like cell line (SaOs-2). A synergistic effect of the two components of the blend was observed. While the synthetic polyester promoted the adhesion of SaOs-2, the presence of chitosan significantly enhanced the osteoblastic activity of these cells. This work further confirmed the interest in designing polymeric blends with natural polymers as a successful strategy to enhance the biological performance of a biomaterial.
C1 [Coutinho, Daniela F.; Pashkuleva, Iva H.; Alves, Catarina M.; Marques, Alexandra P.; Neves, Nuno M.; Reis, Rui L.] Univ Minho, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4710057 Braga, Portugal.
   [Coutinho, Daniela F.; Pashkuleva, Iva H.; Alves, Catarina M.; Marques, Alexandra P.; Neves, Nuno M.; Reis, Rui L.] IBB, PT Govt Assoc Lab, Braga, Portugal.
RP Coutinho, DF (reprint author), Univ Minho, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, Campus Gualtar, P-4710057 Braga, Portugal.
EM d.coutinho@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Alves, Catarina/B-3632-2018; Pashkuleva,
   Iva/B-5590-2008; Neves, Nuno/B-4685-2008; Marques,
   Alexandra/B-1238-2012; Reis, Rui L./A-8938-2008
OI Group, 3Bs/0000-0002-5195-3456; Alves, Catarina/0000-0001-6003-9159;
   Pashkuleva, Iva/0000-0001-6818-3374; Neves, Nuno/0000-0003-3041-0687;
   Marques, Alexandra/0000-0002-3222-0310; Reis, Rui L./0000-0002-4295-6129
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Briggs D., 1998, SURFACE ANAL POLYM X
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chatterjee S, 2005, J COLLOID INTERF SCI, V288, P30, DOI 10.1016/j.jcis.2005.02.055
   Correlo VM, 2007, MACROMOL BIOSCI, V7, P354, DOI 10.1002/mabi.200600233
   Correlo VM, 2005, MAT SCI ENG A-STRUCT, V403, P57, DOI 10.1016/j.msea.2005.04.055
   Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   KAELBLE DH, 1970, J ADHESION, V2, P66, DOI 10.1080/0021846708544582
   Lee I. -S., 2007, Current Applied Physics, V7, pe6, DOI 10.1016/j.cap.2006.11.004
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lopez-Perez PM, 2007, J MATER CHEM, V17, P4064, DOI 10.1039/b707326g
   Lyon M, 2000, J BIOL CHEM, V275, P4599, DOI 10.1074/jbc.275.7.4599
   MacDonald DE, 1998, COLLOID SURFACE B, V11, P131, DOI 10.1016/S0927-7765(98)00030-7
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Rege PR, 1999, CARBOHYD RES, V321, P235, DOI 10.1016/S0008-6215(99)00172-X
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 27
TC 43
Z9 47
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2008
VL 9
IS 4
BP 1139
EP 1145
DI 10.1021/bm701268s
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 288JP
UT WOS:000254983000009
PM 18330991
DA 2018-10-20
ER

PT J
AU Lawrence, BD
   Cronin-Golomb, M
   Georgakoudi, I
   Kaplan, DL
   Omenetto, FG
AF Lawrence, Brian D.
   Cronin-Golomb, Mark
   Georgakoudi, Irene
   Kaplan, David L.
   Omenetto, Fiorenzo G.
TI Bioactive silk protein biomaterial systems for optical devices
SO BIOMACROMOLECULES
LA English
DT Article
ID BOMBYX-MORI SILK; PHOTONIC CRYSTAL FIBERS; SENSITIVE HOLOGRAPHIC
   SENSORS; MECHANICAL-PROPERTIES; ABSORPTION-SPECTRA; FIBROIN MEMBRANE;
   GLUCOSE-OXIDASE; HEME-PROTEINS; IN-VITRO; IMMOBILIZATION
AB Silk-based biomaterial systems have been previously explored for a variety of medical and nonmedical materials needs. The unique biophysical features of silks provide options to generate highly tailored structures and morphologies with this unique family of fibrous proteins. To exploit these features, we have optimized the all aqueous processing of silk fibroin into novel surface nanopatterned protein materials. We have exploited control of this nanomorphology to optimize the optical features of these silk protein systems. We demonstrate control of surface morphology down to 125 nm, with fidelity over large length scales. This surface nanopatterning allows the silk protein to be formed into diffractive optics such as diffraction gratings, pattern generators, and lenses due to novel aqueous processing into optically clear materials via control of beta sheet crystallinity. Further, we incorporate biological components, such as hemoglobin and the enzyme peroxidase, during the process of forming the silk diffraction gratings. The ambient processing of the silk protein in water, in combination with these bioactive components, allows these entrained molecules to retain activity and provide added functions and selectivity to the optically active silk films. Thus, combinations of biochemical and optical readout is feasible and provides in a single, disposable/all degradable element with both spectral discrimination and biological function. These new surface nanopatterned, bioactive silk protein-based material systems offer a unique combination of features potentially useful for a range of biosensor needs, particularly when considered in concert with the remarkable mechanical properties of these proteins, their biocompatibility, and controllable biodegradation.
C1 [Lawrence, Brian D.; Cronin-Golomb, Mark; Georgakoudi, Irene; Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Ctr Sci & Technol, Dept Biomed Engn, Medford, MA 01225 USA.
   [Omenetto, Fiorenzo G.] Tufts Univ, Ctr Sci & Technol, Dept Phys, Medford, MA 01225 USA.
RP Omenetto, FG (reprint author), Tufts Univ, Ctr Sci & Technol, Dept Biomed Engn, 4 Colby St, Medford, MA 01225 USA.
EM fiorenzo.omenetto@tufts.edu
RI Cronin-Golomb, Mark/A-5430-2012
OI Cronin-Golomb, Mark/0000-0002-8936-4358
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   DEMURA M, 1989, BIOTECHNOL BIOENG, V33, P598, DOI 10.1002/bit.260330513
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   DEMURA M, 1989, J BIOTECHNOL, V10, P113, DOI 10.1016/0168-1656(89)90033-3
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Horecker BL, 1943, J BIOL CHEM, V148, P173
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Lee MC, 2004, ANAL CHEM, V76, P5748, DOI 10.1021/ac049334n
   LLEWELLYNSMITH IJ, 1993, J NEUROSCI METH, V46, P27, DOI 10.1016/0165-0270(93)90138-H
   Marshall AJ, 2003, ANAL CHEM, V75, P4423, DOI 10.1021/ac020730k
   MIYAIRI S, 1978, AGR BIOL CHEM TOKYO, V42, P1661, DOI 10.1080/00021369.1978.10863228
   Omenetto FG, 2006, OPT EXPRESS, V14, P4928, DOI 10.1364/OE.14.004928
   PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022
   Russell P, 2003, SCIENCE, V299, P358, DOI 10.1126/science.1079280
   Sartain FK, 2006, ANAL CHEM, V78, P5664, DOI 10.1021/ac060416g
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Wadsworth WJ, 2002, J OPT SOC AM B, V19, P2148, DOI 10.1364/JOSAB.19.002148
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   WEINBERG RJ, 1991, J HISTOCHEM CYTOCHEM, V39, P1143, DOI 10.1177/39.8.1906909
   WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2
   Wu YH, 2006, ANAL CHIM ACTA, V558, P179, DOI 10.1016/j.aca.2005.11.031
   Xia YN, 1996, CHEM MATER, V8, P1558, DOI 10.1021/cm9602196
   Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
NR 32
TC 174
Z9 181
U1 5
U2 128
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2008
VL 9
IS 4
BP 1214
EP 1220
DI 10.1021/bm701235f
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 288JP
UT WOS:000254983000019
PM 18370418
DA 2018-10-20
ER

PT J
AU Pan, H
   Jiang, HL
   Chen, WL
AF Pan, Hui
   Jiang, Hongliang
   Chen, Weiliam
TI The biodegradability of electrospun Dextran/PLGA scaffold in a
   fibroblast/macrophage co-culture
SO BIOMATERIALS
LA English
DT Article
DE fibroblasts; macrophages; co-culture; biodegradation; enzyme; receptor
ID MACROPHAGE ACTIVATION; ALVEOLAR MACROPHAGES; BETA-GLUCOSIDASE;
   GAUCHER-DISEASE; IN-VIVO; DEGRADATION; POLYURETHANES; FIBROBLASTS;
   PARTICLES; LYSOZYME
AB Fibroblast and macrophage are 2 dominant cell types respond cooperatively to degrade implanted biomaterials. Using an electrospun Dextran/Poly-lactide-co-glycolide (PLGA) scaffold as a model, an in vitro fibroblast/macrophage co-culture system was developed to investigate the degradability of implantable biodegradable materials. SEM showed that both fibroblasts and macrophages were able to degrade the scaffold, separately or cooperatively. Under the synergistic coordination of macrophages and fibroblasts, scaffolds showed faster degradation rate than their counterparts incubated with a single type of cells as well as in PBS or cell culture medium. Lysozyme, non-specific esterase (NSE), gelatinase, hyaluronidase-1 and alpha-glucosidase were up-regulated in the presence of the scaffold, suggesting their roles in the cell-mediated scaffold degradation. In addition, the expressions of cell surface receptors CD204 and Toll like receptor 4 (TLR4) were elevated I week after cell seeding, implying that these receptors might be involved in scaffold degradation. The results of in vivo subdermal implantation of the scaffold further confirmed the biodegradability of the Dextran/PLGA scaffold. The fibroblast/macrophage co-culture model adequately mimicked the in vivo environment and could be further developed into an in vitro tool for initial biomaterial evaluation. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Pan, Hui] SUNY Stony Brook, Dept Biomed Engn, Hlth Sci Ctr, Stony Brook, NY 11794 USA.
   [Jiang, Hongliang] Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Chen, WL (reprint author), SUNY Stony Brook, Dept Biomed Engn, Hlth Sci Ctr, T18-030, Stony Brook, NY 11794 USA.
EM weiliam.chen@stonybrook.edu
FU NIDDK NIH HHS [DK068401, R01 DK068401, R01 DK068401-04]
CR ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283
   Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Arlein WJ., 1998, AM J PHYSIOL, V275, P1041
   Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058
   BRANCHAUD RM, 1993, PATHOBIOLOGY, V61, P154, DOI 10.1159/000163784
   Calvo P, 1997, BIOMATERIALS, V18, P1305, DOI 10.1016/S0142-9612(97)00061-6
   Chellat F, 2005, BIOMATERIALS, V26, P7260, DOI 10.1016/j.biomaterials.2005.05.044
   Chiu RK, 1995, J NEURO-ONCOL, V26, P231, DOI 10.1007/BF01052626
   Christenson EM, 2004, J BIOMED MATER RES A, V69A, P407, DOI 10.1002/jbm.a.30002
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091
   Fujikawa Yosuke, 2005, Mod Rheumatol, V15, P346
   Girard N, 2002, BRIT J HAEMATOL, V119, P199, DOI 10.1046/j.1365-2141.2002.03733.x
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Hamilton RF, 2006, J BIOL CHEM, V281, P34218, DOI 10.1074/jbc.M605229200
   HASILIK A, 1980, J BIOL CHEM, V255, P4937
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   LEE JS, 2006, AM J PATHOL, V168, P290
   Lord MS, 2006, BIOMATERIALS, V27, P1341, DOI 10.1016/j.biomaterials.2005.09.007
   MANO JF, 2007, J R SOC INTERFAC, P999
   MEIER B, 1990, BIOL CHEM H-S, V371, P1021, DOI 10.1515/bchm3.1990.371.2.1021
   Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497
   Palecanda Aiyappa, 2001, Current Molecular Medicine (Hilversum), V1, P589, DOI 10.2174/1566524013363384
   Pan H, 2006, BIOMATERIALS, V27, P3209, DOI 10.1016/j.biomaterials.2006.01.032
   PAN H, UNPUB FIBROBLAST MAC
   RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899
   Shockman GD, 1996, MICROB DRUG RESIST, V2, P95, DOI 10.1089/mdr.1996.2.95
   Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200
   Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816
   Wang W, 1997, J BONE JOINT SURG BR, V79B, P849, DOI 10.1302/0301-620X.79B5.7780
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Xia Z, 2006, BIOMED MATER, V1, P1
   YOMOTA C, 1990, YAKUGAKU ZASSHI, V110, P442, DOI 10.1248/yakushi1947.110.6_442
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 42
TC 44
Z9 47
U1 1
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2008
VL 29
IS 11
BP 1583
EP 1592
DI 10.1016/j.biomaterials.2007.12.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 268ZS
UT WOS:000253619900004
PM 18192003
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Scuderi, N
   Onesti, MG
   Bistoni, G
   Ceccarelli, S
   Rotolo, S
   Angeloni, A
   Marchese, C
AF Scuderi, Nicolo
   Onesti, Maria G.
   Bistoni, Giovanni
   Ceccarelli, Simona
   Rotolo, Sabrina
   Angeloni, Antonio
   Marchese, Cinzia
TI The clinical application of autologous bioengineered skin based on a
   hyaluronic acid scaffold
SO BIOMATERIALS
LA English
DT Article
DE autologous cell; co-culture; hyaluronic acid scaffold; transplantation
ID FULL-THICKNESS BURNS; CONGENITAL NEVOCELLULAR NEVUS; MALIGNANT-MELANOMA;
   MELANOCYTIC NEVI; ARTIFICIAL SKIN; SUBSTITUTES; TISSUE; RISK;
   BIOCOMPATIBILITY; RECONSTRUCTION
AB The aim of this work was to generate an in vitro skin substitute harbouring autologous fibroblasts, keratinocytes and melanocytes, to establish a new one-step clinical method in problems associated with skin disorders. Here we present a case of a nine-year-old girl with a congenital giant nevus treated by surgical approach, with primary co-cultures of keratinocytes, melanocytes and fibroblasts obtained from autologous skin biopsy. Generally these lesions need to be removed to avoid the risk of transformation into malignant melanoma. With this purpose we analyzed the melanocytes contained in the new skin substitute for the presence of genetic alterations correlated to increased risk for melanoma. The organotypical cultures were designed including an engineered scaffold of a non-woven mesh of hyaluronic acid (HYAFF (R) 11). This biomaterial has been previously demonstrated to be the most suitable to maintain polarity and to support the in vitro constructs. Six dermal-epidermal skin substitutes were transplanted and 14 days after surgery the re-epithelialized area was about 90%. Our results suggest that this new dermal-epidermal construct not only reduces hospitalization time and ameliorates scar retraction, but might also represent a solution for the high risk of developing a tumour derived from the original nevus. (c) 2007 Elsevier Ltd. All fights reserved.
C1 [Ceccarelli, Simona; Rotolo, Sabrina; Angeloni, Antonio; Marchese, Cinzia] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy.
   [Scuderi, Nicolo; Onesti, Maria G.; Bistoni, Giovanni] Univ Roma La Sapienza, Dept Plast & Reconstruct Surg, I-00161 Rome, Italy.
RP Marchese, C (reprint author), Univ Roma La Sapienza, Dept Expt Med, Viale Regina Elena 324, I-00161 Rome, Italy.
EM cinzia.marchese@uniromal.it
RI Scuderi, Nicolo/J-2711-2018; Angeloni, Antonio/J-9392-2018; Ceccarelli,
   Simona/J-4086-2018
OI Scuderi, Nicolo/0000-0002-2458-0498; Angeloni,
   Antonio/0000-0003-4969-9548; Ceccarelli, Simona/0000-0001-8789-7719;
   MARCHESE, CINZIA/0000-0002-9280-8917; ONESTI, Maria
   Giuseppina/0000-0003-3403-2433
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   ARONS MS, 1983, PLAST RECONSTR SURG, V72, P355, DOI 10.1097/00006534-198309000-00019
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   Boyce ST, 2002, ANN SURG, V235, P269, DOI 10.1097/00000658-200202000-00016
   Boyce ST, 1999, J BURN CARE REHABIL, V20, P453, DOI 10.1097/00004630-199920060-00006
   Brun P, 1999, J BIOMED MATER RES, V46, P337, DOI 10.1002/(SICI)1097-4636(19990905)46:3<337::AID-JBM5>3.3.CO;2-H
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766
   DONATI L, 1994, P WORKSH HELD ANN M, P52
   DONATI L, 1995, WOUND REPAIR REGEN, V3, P363
   Earle SA, 2005, J CRANIOFAC SURG, V16, P904, DOI 10.1097/01.scs.0000180485.20043.d5
   Fargnoli MC, 1998, J INVEST DERMATOL, V111, P1202, DOI 10.1046/j.1523-1747.1998.00412.x
   Flores JF, 1996, CANCER RES, V56, P5023
   Galassi G, 2000, BIOMATERIALS, V21, P2183, DOI 10.1016/S0142-9612(00)00147-2
   KAPLAN EN, 1974, PLAST RECONSTR SURG, V53, P421, DOI 10.1097/00006534-197404000-00007
   Liu Y, 2007, CELL BIOL INT, V31, P985, DOI 10.1016/j.cellbi.2007.03.009
   Marghoob AA, 1996, ARCH DERMATOL, V132, P170, DOI 10.1001/archderm.132.2.170
   Myers S. R., 1997, Journal of Burn Care and Rehabilitation, V18, P214, DOI 10.1097/00004630-199705000-00007
   Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021
   Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054
   QUABA AA, 1986, PLAST RECONSTR SURG, V78, P174, DOI 10.1097/00006534-198608000-00004
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   RHODES AR, 1981, PLAST RECONSTR SURG, V67, P782, DOI 10.1097/00006534-198106000-00012
   Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009
   RUDOLPH R, 1976, SURG GYNECOL OBSTET, V142, P49
   RUIZMALDONADO R, 1992, J PEDIATR-US, V120, P906, DOI 10.1016/S0022-3476(05)81958-4
   Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074
   SIMONETTI O, 1995, ARCH DERMATOL RES, V287, P465, DOI 10.1007/BF00373430
   SOBER AJ, 1995, CANCER, V75, P645, DOI 10.1002/1097-0142(19950115)75:2+<645::AID-CNCR2820751405>3.0.CO;2-1
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Stark HJ, 2004, EUR J CELL BIOL, V83, P631, DOI 10.1078/0171-9335-00435
   Stark HJ, 2004, BIOL PROCED ONLINE, V6, P55, DOI DOI 10.1251/BP072
   Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com
   Tannous ZS, 2005, J AM ACAD DERMATOL, V52, P197, DOI 10.1016/j.jaad.2004.07.020
   Tonello C, 2005, FASEB J, V19, P1546, DOI 10.1096/fj.05-3804fje
   Walker GJ, 1998, GENE CHROMOSOME CANC, V22, P157, DOI 10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 39
TC 33
Z9 35
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2008
VL 29
IS 11
BP 1620
EP 1629
DI 10.1016/j.biomaterials.2007.12.024
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 268ZS
UT WOS:000253619900008
PM 18201759
DA 2018-10-20
ER

PT J
AU Rebollar, E
   Frischauf, I
   Olbrich, M
   Peterbauer, T
   Hering, S
   Preiner, J
   Hinterdorfer, P
   Romanin, C
   Heitz, J
AF Rebollar, Esther
   Frischauf, Irene
   Olbrich, Michael
   Peterbauer, Thomas
   Hering, Steffen
   Preiner, Johannes
   Hinterdorfer, Peter
   Romanin, Christoph
   Heitz, Johannes
TI Proliferation of aligned mammalian cells on laser-nanostructured
   polystyrene
SO BIOMATERIALS
LA English
DT Article
DE cell proliferation; cell morphology; laser manufacturing;
   nanotopography; polystyrene
ID SMOOTH-MUSCLE-CELLS; IN-VITRO; POLYETHYLENE-TEREPHTHALATE;
   SURFACE-CHEMISTRY; CONTACT GUIDANCE; EPITHELIAL-CELLS; PLASMA TREATMENT;
   ADHESION; GROWTH; TOPOGRAPHY
AB Biomaterial surface chemistry and nanoscale topography are important for many potential applications in medicine and biotechnology as they strongly influence cell function, adhesion and proliferation. In this work, we present periodic surface structures generated by linearly polarized KrF laser light (248 nm) on polystyrene (PS) foils. These structures have a periodicity of 200-430 nm and a depth of 30-100 nm, depending on the angle of incidence of the laser beam. The changes in surface topography and chemistry were analysed by atomic force microscopy (AFM), advancing water contact-angle measurements, Fourier-transform infrared spectroscopy using an attenuated total reflection device (ATR-FTIR) and X-ray photoelectron spectroscopy (XPS). We show that the surface laser modification results in a significantly enhanced adhesion and proliferation of human embryonic kidney cells (HEK-293) compared to the unmodified polymer foil. Furthermore, we report on the alignment of HEK-293 cells, Chinese hamster ovary (CHO-K1) cells and skeletal myoblasts along the direction of the structures. The results indicate that the presence of nanostructures on the substrates can guide cell alignment along definite directions, and more importantly, in our opinion, that this alignment is only observed when the periodicity is above a critical periodicity value that is cell-type specific. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Rebollar, Esther; Olbrich, Michael; Heitz, Johannes] Johannes Kepler Univ Linz, Inst Appl Phys, A-4040 Linz, Austria.
   [Frischauf, Irene; Preiner, Johannes; Hinterdorfer, Peter; Romanin, Christoph] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria.
   [Peterbauer, Thomas; Hering, Steffen] Univ Vienna, Dept Pharmacol & Toxicol, A-1090 Vienna, Austria.
RP Heitz, J (reprint author), Johannes Kepler Univ Linz, Inst Appl Phys, A-4040 Linz, Austria.
EM johannes.heitz@jku.at
RI Romanin, Christoph/D-5399-2009; Hinterdorfer, Peter/C-4235-2013;
   Peterbauer, Thomas/A-8001-2008; Rebollar, Esther/N-4065-2014; Heitz,
   Johannes/O-8637-2015
OI Romanin, Christoph/0000-0003-3756-4136; Peterbauer,
   Thomas/0000-0002-2362-5711; Rebollar, Esther/0000-0002-1144-7102; Heitz,
   Johannes/0000-0002-5608-5133; Frischauf, Irene/0000-0003-0661-2932;
   Preiner, Johannes/0000-0002-6755-6543
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   ARENHOLZ E, 1996, SPIE P, V2777, P90
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Baquey C, 1999, NUCL INSTRUM METH B, V151, P255, DOI 10.1016/S0168-583X(99)00106-8
   BAROFFIO A, 1993, MUSCLE NERVE, V16, P498, DOI 10.1002/mus.880160511
   Bauerle D., 2000, LASER PROCESSING CHE
   Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   BOLLE M, 1992, APPL PHYS LETT, V60, P674, DOI 10.1063/1.106588
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Charest JL, 2005, J VAC SCI TECHNOL B, V23, P3011, DOI 10.1116/1.2127951
   CLARK P, 1991, J CELL SCI, V99, P73
   Clark P, 2002, INT J BIOCHEM CELL B, V34, P816, DOI 10.1016/S1357-2725(01)00180-7
   Csete M, 1998, APPL SURF SCI, V133, P5, DOI 10.1016/S0169-4332(98)00192-5
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Cyster LA, 2004, BIOMATERIALS, V25, P97, DOI 10.1016/S0142-9612(03)00480-0
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Duncan AC, 2007, COLLOID SURFACE B, V54, P150, DOI 10.1016/j.colsurfb.2006.09.013
   Gejo JL, 2006, PHOTOCH PHOTOBIO SCI, V5, P948, DOI 10.1039/b611874g
   Gumpenberger T, 2003, BIOMATERIALS, V24, P5139, DOI 10.1016/S0142-9612(03)00460-5
   Harrison RG, 1912, ANAT REC, V6, P181, DOI 10.1002/ar.1090060404
   Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450
   Kim KH, 2001, NUCL INSTRUM METH B, V175, P542, DOI 10.1016/S0168-583X(00)00650-9
   LAZARE S, 1993, J APPL PHYS, V74, P4953, DOI 10.1063/1.354333
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Lopez-Gejo J, 2005, PHOTOCHEM PHOTOBIOL, V81, P777, DOI 10.1562/2004-11-30-RA-387R.1
   Lu HW, 2004, MATER LETT, V58, P29, DOI 10.1016/S0167-577X(03)00408-7
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Mikulikova R, 2005, BIOMATERIALS, V26, P5572, DOI 10.1016/j.biomaterials.2005.02.010
   Mirzadeh H, 2003, RADIAT PHYS CHEM, V67, P381, DOI 10.1016/S0969-806X(03)00071-9
   Morra M, 2002, PLASMAS POLYM, V7, P89, DOI 10.1023/A:1016250718123
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   ONYIRIUKA EC, 1994, J ADHES SCI TECHNOL, V8, P1, DOI 10.1163/156856194X00014
   Peterbauer T, 2006, LAB CHIP, V6, P857, DOI 10.1039/b601803c
   Rademacher A, 2001, INT J ARTIF ORGANS, V24, P235
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Recknor JB, 2004, BIOMATERIALS, V25, P2753, DOI 10.1016/j.biomaterials.2003.11.045
   Rockova-Hlavackova K, 2004, NUCL INSTRUM METH B, V225, P275, DOI 10.1016/j.nimb.2004.05.004
   Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104
   Schindler M, 2005, BIOMATERIALS, V26, P5624, DOI 10.1016/j.biomaterials.2005.02.014
   Svorcik V, 2004, NUCL INSTRUM METH B, V217, P307, DOI 10.1016/j.nimb.2003.09.036
   Svorcik V, 2004, NUCL INSTRUM METH B, V215, P366, DOI 10.1016/j.nimb.2003.08.030
   Svorcik V, 2001, J MATER SCI LETT, V20, P1941, DOI 10.1023/A:1013130617983
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Thakar RG, 2003, BIOCHEM BIOPH RES CO, V307, P883, DOI 10.1016/S0006-291X(03)01285-3
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang XF, 2006, J BIOMED MATER RES A, V78A, P746, DOI 10.1002/jbm.a.30764
   WOJCIAKSTOTHARD B, 1995, CELL MOTIL CYTOSKEL, V31, P147, DOI 10.1002/cm.970310207
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhu BS, 2004, J BIOMED MATER RES B, V70B, P43, DOI 10.1002/jbm.b.30011
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
NR 58
TC 151
Z9 151
U1 7
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2008
VL 29
IS 12
BP 1796
EP 1806
DI 10.1016/j.biomaterials.2007.12.039
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 284TV
UT WOS:000254729800007
PM 18237776
DA 2018-10-20
ER

PT J
AU Velzenberger, E
   Vayssade, M
   Legeay, G
   Nagel, MD
AF Velzenberger, Elodie
   Vayssade, Muriel
   Legeay, Gilbert
   Nagel, Marie-Danielle
TI Study of cell behaviour on a cellulose anti-adhesive substratum
SO CELLULOSE
LA English
DT Article
DE carboxymethylcellulose; hydroxypropylmethylcellulose; three-dimensional
   culture; cell adhesion; cell proliferation; apoptosis
ID ANCHORAGE-INDEPENDENT GROWTH; MELANOMA-CELLS; DIFFERENTIAL EXPRESSION;
   EXTRACELLULAR-MATRIX; APOPTOTIC CELLS; DRUG-DELIVERY; T-LYMPHOCYTES;
   IN-VITRO; SURVIVAL; ADHESION
AB Carboxymethylcellulose (CMC) is used as an anti-adhesive in several biomaterial applications. We have shown that an original bi-layered hydroxypropylmethylcellulose (HPMC)-CMC-coated substratum (CEL) is suitable for studying the molecular mechanisms underlying cell-substratum and cell-cell interactions. The present work was carried out to assess the anti-adhesive properties of a CEL substratum by analysing the behaviour of three types of adherent cells (Swiss 3T3 fibroblasts, MC-3T3-E1 pre-osteoblasts and B16F10 highly metastatic melanoma cells). Tissue culture polystyrene (tPS) was used as an adhesive control and poly(2-hydroxyethyl methacrylate) PolyHEMA as an anti-adhesive control. Cell morphology, growth, cell cycle analysis and apoptosis were compared. The proliferation of cells on CEL was significantly decreased, cells were arrested in the G1 phase and underwent apoptosis (except for melanoma cells) 48 h post-seeding. We conclude that CEL is an effective anti-adhesive cellulose biomaterial that gives reproducible and demonstratable results, especially for apoptosis. Its advantage as a coating for culture devices is its long shelf-live. It may therefore also be a very good candidate for other biomedical applications requiring adhesion-resistant substrata.
C1 [Velzenberger, Elodie; Vayssade, Muriel; Nagel, Marie-Danielle] Univ Technol Compiegne, CNRS, UMR Domaine Biomat Biocompatibil 6600, F-60205 Compiegne, France.
   [Legeay, Gilbert] Ctr Transfert Technol Mans, Dept Mat, Le Mans, France.
RP Nagel, MD (reprint author), Univ Technol Compiegne, CNRS, UMR Domaine Biomat Biocompatibil 6600, 20529, F-60205 Compiegne, France.
EM marie-danielle.nagel@utc.fr
CR Barbucci R, 2004, J BIOMAT SCI-POLYM E, V15, P607, DOI 10.1163/156856204323046870
   Beck D E, 1997, Eur J Surg Suppl, P49
   Bottaro DP, 2002, ANN NY ACAD SCI, V961, P143, DOI 10.1111/j.1749-6632.2002.tb03068.x
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   Bretland AJ, 2001, CELL PROLIFERAT, V34, P199, DOI 10.1046/j.1365-2184.2001.00198.x
   Buckenmaier CC, 2000, AM SURGEON, V66, P1041
   Caruso DM, 2006, J BURN CARE RES, V27, P298, DOI 10.1097/01.BCR.0000216741.21433.66
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chiumiento A, 2006, J MATER SCI-MATER M, V17, P427, DOI 10.1007/s10856-006-8470-0
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   DEPAUWGILLET MCAJ, 1988, ANTICANCER RES, V8, P153
   Diaz-Montero CM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-39
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   FADOK VA, 1992, J IMMUNOL, V148, P2207
   Faucheux N, 2004, BIOMATERIALS, V25, P2501, DOI 10.1016/j.biomaterials.2003.09.036
   Faucheux N, 2001, BIOMATERIALS, V22, P2993, DOI 10.1016/S0142-9612(01)00045-X
   FAUCHEUX N, 2006, BEHAV CELLS CULTURED, P35
   FEDERMENGUS C, 2007, BR J CANC
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Frankfurt OS, 2001, J HISTOCHEM CYTOCHEM, V49, P369, DOI 10.1177/002215540104900311
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Gekas J, 2004, FEBS LETT, V563, P103, DOI 10.1016/S0014-5793(04)00276-5
   Ghosh S, 2005, ANN SURG, V242, P851, DOI 10.1097/01.sla.0000189571.84213.b0
   Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723
   Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431
   Goldmann WH, 2002, CELL BIOL INT, V26, P313, DOI 10.1006/cbir.2002.0857
   Guest JF, 2005, CURR MED RES OPIN, V21, P281, DOI 10.1185/030079905X25532
   Guest JF, 2005, CURR MED RES OPIN, V21, P81, DOI 10.1185/030079904X15219
   Hindie A, 2005, BIOMOL ENG, V22, P205, DOI 10.1016/j.bioeng.2005.07.002
   Hindie M, 2006, J CELL BIOCHEM, V99, P96, DOI 10.1002/jcb.20833
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   Jorgensen K, 2005, BIOCHEM BIOPH RES CO, V329, P266, DOI 10.1016/j.bbrc.2005.01.143
   Krylov SN, 2000, ELECTROPHORESIS, V21, P767, DOI 10.1002/(SICI)1522-2683(20000301)21:4<767::AID-ELPS767>3.3.CO;2-5
   LaRue KEA, 2004, CANCER RES, V64, P1621, DOI 10.1158/0008-5472.CAN-2902-2
   Liu LS, 2007, CELLULOSE, V14, P15, DOI 10.1007/s10570-006-9095-7
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Mousavi-Shafaei P, 2006, ANTI-CANCER DRUG, V17, P1031, DOI 10.1097/01.cad.0000231474.77159.e3
   Ravenscroft MJ, 2006, ANN ROY COLL SURG, V88, P18, DOI 10.1308/003588406X82989
   Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shiras A, 2002, CLIN EXP METASTAS, V19, P445, DOI 10.1023/A:1016305611858
   Szabo A, 2000, EUR SURG RES, V32, P125, DOI 10.1159/000008751
   Tsuchimochi K, 2005, MOL CELL BIOL, V25, P7344, DOI 10.1128/MCB.25.16.7344-7356.2005
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
   VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Wang LH, 2004, MT SINAI J MED, V71, P361
   Wu PC, 1998, DRUG DEV IND PHARM, V24, P179, DOI 10.3109/03639049809085604
   Zhan M, 2004, HISTOL HISTOPATHOL, V19, P973, DOI 10.14670/HH-19.973
   Zhang XD, 2004, MOL CANCER THER, V3, P187
NR 55
TC 11
Z9 11
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
J9 CELLULOSE
JI Cellulose
PD APR
PY 2008
VL 15
IS 2
BP 347
EP 357
DI 10.1007/s10570-007-9182-4
PG 11
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA 267QR
UT WOS:000253524800017
DA 2018-10-20
ER

PT J
AU Islek, C
   Sinag, A
   Akata, I
AF Islek, Cemil
   Sinag, Ali
   Akata, Ilgaz
TI Investigation of biosorption behavior of methylene blue on Pleurotus
   ostreatus (Jacq.) P. Kumm.
SO CLEAN-SOIL AIR WATER
LA English
DT Article
DE Pleurotus ostreatus (Jacq.) P. Kumm.; methylene blue; adsorption;
   Langmuir; biosorption; wastewater
ID ACTIVATED CARBON; HEAVY-METALS; ADSORPTION; KINETICS; REMOVAL;
   MECHANISM; SORPTION; DYES; EQUILIBRIUM; COPPER
AB The effect of varying parameters such as dye concentration, adsorbent dose, pH and temperature on the adsorption capacity of Pleurotus ostreatus is investigated. The commonly available white rot fungus Pleurotus ostreatus is investigated as a viable biomaterial for the biological treatment of synthetic basic methylene blue effluents. The results obtained from the batch experiments reveal the ability of the fungus to remove methylene blue. The performance is dependent on the dye concentration, pH, and fungal biomass. The equilibrium and kinetics of adsorption are investigated and the Langmuir equation is used to fit the equilibrium isotherm. The adsorption isotherm of methylene blue follows only the Langmuir model with a correlation coefficient of ca. 0.96-0.99. The maximum adsorption capacity is ca. 70 mg of dye per g of dry fungus at pH 11, 70 mg L(-1) dye, and 0.1 g L(-1) fungus concentration, respectively. This study demonstrates that the fungus could be used as an effective biosorbent for the treatment of dye-containing wastewater streams.
C1 [Sinag, Ali] Ankara Univ, Fac Sci, Dept Chem, TR-06100 Ankara, Turkey.
   [Islek, Cemil; Akata, Ilgaz] Ankara Univ, Fac Sci, Dept Biol, TR-06100 Ankara, Turkey.
RP Sinag, A (reprint author), Ankara Univ, Fac Sci, Dept Chem, TR-06100 Ankara, Turkey.
EM sinag@science.ankara.edu.tr
OI Akata, Ilgaz/0000-0002-1731-1302
CR CEDENO VMA, 2002, WORLD J MICROB BIOT, V18, P201
   Dogan M, 2004, J HAZARD MATER, V109, P141, DOI 10.1016/j.jhazmat.2004.03.003
   El Qada EN, 2006, CHEM ENG J, V124, P103, DOI 10.1016/j.cej.2006.08.015
   FINDON A, 1993, J ENVIRON SCI HEAL A, VA28, P173, DOI 10.1080/10934529309375870
   Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0
   Kargi F, 2004, ENZYME MICROB TECH, V35, P267, DOI 10.1016/j.enzmictec.2004.05.002
   Kratochvil D, 1998, TRENDS BIOTECHNOL, V16, P291, DOI 10.1016/S0167-7799(98)01218-9
   Meshko V, 2001, WATER RES, V35, P3357, DOI 10.1016/S0043-1354(01)00056-2
   Minamisawa M, 2004, J AGR FOOD CHEM, V52, P5606, DOI 10.1021/jf0496402
   Namasivayam C, 1996, BIORESOURCE TECHNOL, V57, P37, DOI 10.1016/0960-8524(96)00044-2
   PLATT MW, 1984, APPL MICROBIOL BIOT, V20, P150
   Quek SY, 1998, WATER SA, V24, P251
   Sarin V., 2006, BIORESOURCE TECHNOL, V97, P5
   Shaobin W., 2005, J COLLOID INTERF SCI, V284, P440
   SOLAK H, 1996, THESIS DOKUZ EYLUL U
   Soo SK, 1998, BIOTECHNOL LETT, V20, P569
   Vadivelan V, 2005, J COLLOID INTERF SCI, V286, P90, DOI 10.1016/j.jcis.2005.01.007
   Vasanth KK, 2005, BIOCH ENG J, V27, P83, DOI DOI 10.1016/J.BEJ.2005.08.004
   Walker GM, 1999, WATER RES, V33, P1895, DOI 10.1016/S0043-1354(98)00388-1
   Walker GM, 1997, WATER RES, V31, P2093, DOI 10.1016/S0043-1354(97)00039-0
   Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6
   WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204
NR 22
TC 15
Z9 15
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1863-0650
J9 CLEAN-SOIL AIR WATER
JI Clean-Soil Air Water
PD APR
PY 2008
VL 36
IS 4
BP 387
EP 392
DI 10.1002/clen.200700167
PG 6
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Environmental Sciences; Marine
   & Freshwater Biology; Water Resources
SC Science & Technology - Other Topics; Environmental Sciences & Ecology;
   Marine & Freshwater Biology; Water Resources
GA 293OP
UT WOS:000255344900021
DA 2018-10-20
ER

PT J
AU Oliveira, NTC
   Guastaldi, AC
AF Oliveira, N. T. C.
   Guastaldi, A. C.
TI Electrochemical behavior of Ti-Mo alloys applied as biomaterial
SO CORROSION SCIENCE
LA English
DT Article
DE titanium alloys; cyclic voltammetry; passivation; anodic films; pitting
   corrosion
ID IN-VITRO CORROSION; TITANIUM-ALLOYS; BIOCOMPATIBLE ALLOYS; ANODIC
   OXIDES; FILM; STABILITY; ZIRCONIUM; LAYERS; MEDIA; WEAR
AB Electrochemical investigation on the as-cast Ti-Mo alloys (4-20 Mo wt.%) applied as biomaterials in Na2SO4 and Ringer physiological solutions is reported. Analyses of the open-circuit potential indicated that all alloys present spontaneous passivation. SEM and cyclic voltammograms obtained in the Ringer solution showed that the samples studied do not present pitting corrosion at potentials up to 8 V (SCE), indicating high corrosion resistance. Open-circuit potential profiles of the anodic oxides growth in both solutions show that the presence of chloride ions during the anodization does not influence the oxides' chemical stability, and also clearly indicate that adding Mo to pure Ti improves the stability of the anodic oxides. All these results suggest Ti-Mo alloys promissory to be applied as biomaterials. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Oliveira, N. T. C.; Guastaldi, A. C.] Univ Estadual Paulista, Grp Biomat, Dept Quim Fis, Inst Quim, BR-14081970 Araraquara, SP, Brazil.
RP Guastaldi, AC (reprint author), Univ Estadual Paulista, Grp Biomat, Dept Quim Fis, Inst Quim, Rua Francisco Degni S-N,POB 355, BR-14081970 Araraquara, SP, Brazil.
EM guastald@iq.unesp.br
RI Oliveira, Nilson/G-4429-2015; Guastaldi, Antonio/O-7379-2014
OI Guastaldi, Antonio/0000-0002-6433-3555
CR ARVIA AJ, 1979, ISRAEL J CHEM, V18, P89
   BANEMARK PI, 1997, OSSEOINTEGRATED IMPL
   BLACKWOOD DJ, 1988, ELECTROCHIM ACTA, V33, P1143, DOI 10.1016/0013-4686(88)80206-8
   CAMARA OR, 1984, ELECTROCHIM ACTA, V29, P1111, DOI 10.1016/0013-4686(84)87163-7
   DAlkaine CV, 1997, J ELECTROCHEM SOC, V144, P3331, DOI 10.1149/1.1838014
   DALKAINE CV, 1993, CORROS SCI, V34, P129, DOI 10.1016/0010-938X(93)90264-H
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Guastaldi A. C., 2003, METALURGIA MAT, V59, P442
   Guo H, 2002, ACTA MATER, V50, P929, DOI 10.1016/S1359-6454(01)00392-5
   Habazaki H, 2003, SURF COAT TECH, V169, P151, DOI 10.1016/S0257-8972(03)00216-0
   HEAKAL FE, 1987, CORROS SCI, V27, P453, DOI 10.1016/0010-938X(87)90089-8
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   Kuroda D., 1995, J BIOMED MATER RES, V29, P943
   Lavos-Valereto IC, 2004, J MATER SCI-MATER M, V15, P55, DOI 10.1023/B:JMSM.0000010097.86245.74
   LIU Y, 2003, J CENTRAL S U TECHNO, V2, P81
   Lopez MF, 2002, ELECTROCHIM ACTA, V47, P1359, DOI 10.1016/S0013-4686(01)00860-X
   Lopez MF, 2002, SURF INTERFACE ANAL, V33, P570, DOI 10.1002/sia.1422
   Lopez MF, 2001, SURF SCI, V482, P300, DOI 10.1016/S0039-6028(00)01005-0
   Marcus P, 1998, ELECTROCHIM ACTA, V43, P109, DOI 10.1016/S0013-4686(97)00239-9
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Maurice V, 1996, J ELECTROCHEM SOC, V143, P1182, DOI 10.1149/1.1836616
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Oliveira EM, 2000, ELECTROCHEM COMMUN, V2, P254, DOI 10.1016/S1388-2481(00)00018-7
   Oliveira NTC, 2006, ELECTROCHIM ACTA, V51, P2068, DOI 10.1016/j.electacta.2005.07.015
   Oliveira NTC, 2005, J BIOMED MATER RES A, V74A, P397, DOI 10.1002/jbm.a.30352
   Oliveira NTC, 2004, ELECTROCHIM ACTA, V49, P4563, DOI 10.1016/j.electacta.2004.04.042
   Oliveira NTC, 2002, J BRAZIL CHEM SOC, V13, P463, DOI 10.1590/S0103-50532002000400009
   OLIVEIRA NTC, 2007, J MAT SCI ENG A, V452, P727
   Popa MV, 2005, REV CHIM-BUCHAREST, V56, P908
   SAKAGUCHI S, 1999, MET MATER INT, V2, P193
   Schmidt H, 1998, MATER SCI TECH-LOND, V14, P592, DOI 10.1179/mst.1998.14.6.592
   Sugano M., 1998, MAT SCI ENG A-STRUCT, V1-2, P163
   WILLIAMS DF, 1981, CRC SERIES BIOCOMPAT, V1, P24
   Yoshimitsu D, 2003, MAT SCI ENG A-STRUCT, V1-3, P133
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
   Yun YH, 1996, J BIOMED MATER RES, V32, P77, DOI 10.1002/(SICI)1097-4636(199609)32:1<77::AID-JBM9>3.0.CO;2-M
   Zhang LC, 2005, J MATER SCI, V40, P2833, DOI 10.1007/s10853-005-2426-5
   ZHANG LC, 2005, APPL PHYS LETT, V87, P3
NR 41
TC 89
Z9 92
U1 2
U2 41
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0010-938X
J9 CORROS SCI
JI Corrosion Sci.
PD APR
PY 2008
VL 50
IS 4
BP 938
EP 945
DI 10.1016/j.corsci.2007.09.009
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 293JA
UT WOS:000255330400004
DA 2018-10-20
ER

PT J
AU Oilo, M
   Gjerdet, NR
   Tvinnereim, HM
AF Oilo, Marit
   Gjerdet, Nils Roar
   Tvinnereim, Helene M.
TI The firing procedure influences properties of a zirconia core ceramic
SO DENTAL MATERIALS
LA English
DT Article
DE dental ceramics; zirconia; heat treatment; flexural strength;
   microhardness; fractography
ID FIXED PARTIAL DENTURES; Y-TZP-ZIRCONIA; FRACTURE-SURFACE-ANALYSIS;
   DENTIN THICKNESS RATIO; FLEXURAL STRENGTH; HEAT-TREATMENT; IN-VITRO;
   RELIABILITY; PERFORMANCE; BIOMATERIAL
AB Objectives. High-strength ceramics for dental restoration are used as an understructure (core) that subsequently is covered by veneering ceramic. The veneering process involves a firing procedure at high temperatures at least once, usually two to five times. The aim of this study was to investigate whether these firing procedures affect the mechanical properties of a zirconia ceramic.
   Methods. Thirty-three specimens of an industrially sintered yttria -stabilized zirconia ceramic (DC Zircon, DCS Dental AG, Allschwil, Switzerland) were cut into bars (1.2 mm x 4 mm x 20 mm). one set of specimens (n = 13) remained untreated (controls). Another set of specimens (n = 10) was heat-treated once, corresponding to the first step of the veneering process. The third set of specimens (n = 10) was heat-treated five times to mimic the full veneering process. Flexural strength, microhardness, dimensions and surface roughness were measured. The fracture patterns were assessed by light microscopy.
   Results. The untreated specimens showed a statistically significant higher flexural strength (20%) and microhardness (9%) than both of the test groups (p <= 0.001). No significant differences were found for fracture patterns, dimensions or surface roughness.
   Significance. The heat treatment associated with the veneering procedure on a zirconia core material reduced the flexural strength of the core after the first firing. Subsequent firings were not detrimental to the properties measured. (C) 2007 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Oilo, Marit; Gjerdet, Nils Roar; Tvinnereim, Helene M.] Univ Bergen, Dept Oral Sci, N-5009 Bergen, Norway.
RP Oilo, M (reprint author), Univ Bergen, Dept Oral Sci, Arstadveien 17, N-5009 Bergen, Norway.
EM marit.oilo@odont.uib.no
OI Oilo, Marit/0000-0002-7134-6485
CR Alcala J, 2000, J AM CERAM SOC, V83, P1977
   ALCALA J, 1977, J AM CERAM SOC, V80, P2759
   [Anonymous], 1995, 6872 ISO
   BADWAL SPS, 1995, SOLID STATE IONICS, V76, P67, DOI 10.1016/0167-2738(94)00236-L
   Balkaya MC, 2005, J PROSTHET DENT, V93, P346, DOI 10.1016/j.prosdent.2005.02.003
   Cattell MJ, 2002, J DENT, V30, P161, DOI 10.1016/S0300-5712(02)00013-1
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Curtis AR, 2006, J DENT, V34, P195, DOI 10.1016/j.jdent.2005.06.006
   Deng Y, 2002, J BIOMED MATER RES, V63, P137, DOI 10.1002/jbm.10091
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Fleming GJP, 2006, DENT MATER, V22, P771, DOI 10.1016/j.dental.2005.11.005
   Fleming GJP, 2005, DENT MATER, V21, P164, DOI 10.1016/j.dental.2004.01.005
   Fleming GJP, 2004, DENT MATER, V20, P142, DOI 10.1016/S0109-5641(03)00085-X
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Guazzato M, 2004, INT J PROSTHODONT, V17, P142
   Guazzato M, 2004, BIOMATERIALS, V25, P2153, DOI 10.1016/j.biomaterials.2003.08.056
   Hull D., 1999, FRACTOGRAPHY OBSERVI
   Hummel R E, 2004, UNDERSTANDING MAT SC
   Isgro G, 2005, DENT MATER, V21, P557, DOI 10.1016/j.dental.2004.08.006
   KELLY JR, 1989, J PROSTHET DENT, V62, P536, DOI 10.1016/0022-3913(89)90075-9
   KELLY JR, 1995, J DENT RES, V74, P1253, DOI 10.1177/00220345950740060301
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   Luthardt RG, 2004, DENT MATER, V20, P655, DOI 10.1016/j.dental.2003.08.007
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Quinn JB, 2005, DENT MATER, V21, P920, DOI 10.1016/j.dental.2005.01.006
   Studart AR, 2007, DENT MATER, V23, P115, DOI 10.1016/j.dental.2005.12.009
   STUDART AR, 2006, DENT MATER, V23, P177
   Sundh A, 2005, DENT MATER, V21, P476, DOI 10.1016/j.dental.2004.07.013
   Taskonak B, 2006, J DENT RES, V85, P277, DOI 10.1177/154405910608500314
   WHALEN PJ, 1989, J AM CERAM SOC, V72, P319, DOI 10.1111/j.1151-2916.1989.tb06124.x
   Zhang Y, 2004, J BIOMED MATER RES B, V71B, P381, DOI 10.1002/jbm.b.30097
NR 33
TC 24
Z9 28
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD APR
PY 2008
VL 24
IS 4
BP 471
EP 475
DI 10.1016/j.dental.2007.04.008
PG 5
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 279TM
UT WOS:000254377600005
PM 17651794
DA 2018-10-20
ER

PT J
AU Salgueiredo, E
   Vila, M
   Silva, MA
   Lopes, MA
   Santos, JD
   Costa, FM
   Silva, RF
   Gomes, PS
   Femandes, MH
AF Salgueiredo, E.
   Vila, M.
   Silva, M. A.
   Lopes, M. A.
   Santos, J. D.
   Costa, F. M.
   Silva, R. F.
   Gomes, P. S.
   Femandes, M. H.
TI Biocompatibility evaluation of DLC-coated Si3N4 substrates for
   biomedical applications
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT International Conference on New Diamond and Nano Carbons
CY MAY 28-31, 2007
CL Osaka, JAPAN
SP New Energy & Ind Technol Dev Org, Japan New Diamond Forum, Elsevier, Seki Technotron, Natl Inst Ind Sci & Technol, Element Six
DE DLC coatings; biomedical applications; cell cultures
ID DIAMOND-LIKE CARBON; SURFACE FREE-ENERGY; FILMS; OSTEOBLASTS; COATINGS;
   PROTEINS; BEHAVIOR
AB DLC coatings are of enormous interest for biotribological applications due to their biocompatibility, auto-lubricious, and non-stick properties. The most demanding implant is the hip joint. Alternative materials to metal alloys are being increasingly investigated aiming low wear debris volume, in any case innocuous wear particles. Silicon nitride (Si3N4) ceramics are light, tough, mechanical resistant, inert materials, turning them suitable for high-load medical applications. In this study, Si3N4 polished substrates were coated with adherent DLC coatings grown by DC magnetron sputtering to reduce of the friction forces against any antagonist material. Surface characterization results showed that the developed material is quite hydrophobic, with a total surface tension of 45.7 mN/m (polar component: 9.1 mN/m; dispersive component: 36.6 mN/m), and a zeta potential of -35.0 +/- 1.3 mV. In vitro testing using an acellular simulated body fluid (SBF) showed no apatite layer formation ability, as confirmed by SEM observation and analysis of the solution ions concentration with immersion time. MG63 osteoblast-like cells showed poor adhesion on the DLC films but the adherent cells displayed a normal morphology and, as compared to standard polystyrene tissue culture plates, exhibited a higher cell growth rate, suggesting no indication of cytotoxicity. Results suggested that the novel DLC-coated Si3N4 biomaterial should be adequate to be used for articular prostheses medical application. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Salgueiredo, E.; Vila, M.; Silva, R. F.] Univ Aveiro, Glass & Ceram Eng Dept, CICECO, P-3810193 Aveiro, Portugal.
   [Silva, M. A.; Lopes, M. A.; Santos, J. D.] Inst Biomed Engn, Lab Biomat, Oporto, Portugal.
   [Lopes, M. A.; Santos, J. D.] Univ Porto, Fac Engn, Dep Eng Met & Mat, Oporto, Portugal.
   [Costa, F. M.] Univ Aveiro, Dept Phys, P-3810193 Aveiro, Portugal.
   [Gomes, P. S.; Femandes, M. H.] Univ Porto, Fac Med Dent, Lab Farmacol & Biocompatibilidade Celular, Oporto, Portugal.
RP Silva, RF (reprint author), Univ Aveiro, Glass & Ceram Eng Dept, CICECO, P-3810193 Aveiro, Portugal.
EM rsilva@cv.ua.pt
RI Universidade Aveiro, Departamento Fisica/E-4128-2013; Lopes,
   Cristina/A-4241-2010; Costa, Florinda/J-4345-2013; Lopes, Maria
   A./P-4442-2014; Gomes, Pedro/K-2433-2014; Silva, Rui/B-8208-2008
OI Costa, Florinda/0000-0001-8729-714X; Lopes, Maria
   A./0000-0003-4105-8148; Gomes, Pedro/0000-0001-5365-2123; Silva,
   Rui/0000-0002-2584-1792; Silva, Marta/0000-0002-4833-3686; Santos, Jose
   Domingos/0000-0002-6871-9850; Vila, Mercedes/0000-0002-8473-0881;
   Fernandes, Maria Helena/0000-0001-9391-9574
CR Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Fairbrother F., 1924, J CHEM SOC, V75, P2318
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Narayan RJ, 2005, MAT SCI ENG C-BIO S, V25, P405, DOI 10.1016/j.msec.2005.01.026
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Petzow G., 2002, HIGH PERFORMANCE NON, P47
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   Schulz H, 2005, SURF COAT TECH, V200, P1123, DOI 10.1016/j.surfcoat.2005.02.019
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   STROM G, 1987, J COLLOID INTERF SCI, V119, P352, DOI 10.1016/0021-9797(87)90280-3
   Vila M, 2006, THIN SOLID FILMS, V515, P2192, DOI 10.1016/j.tsf.2006.07.083
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zhao Q, 2004, J COLLOID INTERF SCI, V280, P174, DOI 10.1016/j.jcis.2004.07.004
NR 16
TC 54
Z9 58
U1 3
U2 37
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR-MAY
PY 2008
VL 17
IS 4-5
SI SI
BP 878
EP 881
DI 10.1016/j.diamond.2007.08.019
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 312BE
UT WOS:000256643300103
DA 2018-10-20
ER

PT J
AU Kaplan, D
AF Kaplan, David
TI Protein biomaterial systems for tissue engineering strategies
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Kaplan, David] Tufts Univ, Dept Bioengn, Melfor, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2008
VL 22
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA V25GZ
UT WOS:000208467800743
DA 2018-10-20
ER

PT J
AU Kaplan, DL
AF Kaplan, David L.
TI Protein Biomaterial Systems for Tissue Engineering Strategies
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Kaplan, David L.] Tufts Univ, Medford, MA 02155 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2008
VL 22
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA V25GZ
UT WOS:000208467800741
DA 2018-10-20
ER

PT J
AU Shah, M
   Kelso, BG
   Caplan, MR
AF Shah, Miti
   Kelso, Bret G.
   Caplan, Michael R.
TI Mathematical modeling and systems biology approach to study biomaterial
   composition-mediated inflammatory signals in endothelial cells
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Shah, Miti; Kelso, Bret G.; Caplan, Michael R.] Arizona State Univ, Dept Bioengn, Tempe, AZ USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2008
VL 22
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA V25GZ
UT WOS:000208467803017
DA 2018-10-20
ER

PT J
AU Stoop, R
AF Stoop, Reinout
TI Smart biomaterials for tissue engineering of cartilage
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Review
DE biomaterials; tissue engineering; drug delivery; chondrocytes
ID MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2 RHBMP-2; FULL-THICKNESS
   DEFECTS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; POLY(ETHYLENE GLYCOL)
   HYDROGELS; FIBROBLAST-GROWTH-FACTOR; SCAFFOLDS IN-VITRO;
   ARTICULAR-CARTILAGE; OSTEOCHONDRAL DEFECTS; CONTROLLED-RELEASE
AB Biological regeneration using cartilage tissue engineering in which cells are grown on biomaterial scaffolds and then implanted into the cartilage defects could provide new treatment options for articular cartilage defects. This review aims to give an overview of the wide variety of biomaterials that are currently developed as scaffolds for cartilage tissue engineering. Emphasis will be placed on the current development of the materials that are able to direct cell differentiation and metabolism. These so-called "smart" biomaterials are produced by modifying the physical properties of the scaffolds using peptide sequences and most importantly by developing materials that can deliver proteins to enhance tissue regeneration. Besides providing drug delivery systems, the materials respond to environmental stimuli or release their cargo on cellular demand. However, critical issues remain, such as the transferability of basic science insights to clinical products and the applicability of certain data sets to human patients.
C1 [Stoop, Reinout] TNO Qual Life, NL-2301 CE Leiden, Netherlands.
   [Stoop, Reinout] Univ Tubingen, NMI Nat & Med Sci Inst, Reutlingen, Germany.
RP Stoop, R (reprint author), TNO Qual Life, POB 2215, NL-2301 CE Leiden, Netherlands.
EM reinout.stoop@tno.nl
OI , Reinout/0000-0002-8773-8248
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   ALTMAN RD, 1992, ANN RHEUM DIS, V51, P1056, DOI 10.1136/ard.51.9.1056
   Andereya S, 2006, Z ORTHOP GRENZGEB, V144, P272, DOI 10.1055/s-2006-933445
   Appel B, 2006, INT J PHARM, V314, P170, DOI 10.1016/j.ijpharm.2005.11.049
   Barbucci R, 2005, BIOMATERIALS, V26, P7596, DOI 10.1016/j.biomaterials.2005.05.090
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   BRANDSTEDT S, 1980, EUR SURG RES, V12, P12, DOI 10.1159/000128105
   Brittberg M, 1997, BIOMATERIALS, V18, P235, DOI 10.1016/S0142-9612(96)00117-2
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Burrage PS, 2007, CURR DRUG TARGETS, V8, P293, DOI 10.2174/138945007779940098
   Chen JP, 2006, MACROMOL BIOSCI, V6, P1026, DOI 10.1002/mabi.200600142
   Cherubino P, 2003, J Orthop Surg (Hong Kong), V11, P10
   CHOU CH, 2007, J BIOMED MAT RES A
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Cook SD, 2003, J BONE JOINT SURG AM, V85A, P116, DOI 10.2106/00004623-200300003-00018
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Dedhar S, 2000, CURR OPIN CELL BIOL, V12, P250, DOI 10.1016/S0955-0674(99)00083-6
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   DEFRERE J, 1992, ACTA CHIR BELG, P217
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   DURR J, 1993, EXP CELL RES, V207, P235, DOI 10.1006/excr.1993.1189
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   ENOMOTO M, 1993, EXP CELL RES, V205, P276, DOI 10.1006/excr.1993.1087
   Facchini A, 2006, BIORHEOLOGY, V43, P471
   Fan H, 2006, INT J ARTIF ORGANS, V29, P602
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Fujisato T, 1996, BIOMATERIALS, V17, P155, DOI 10.1016/0142-9612(96)85760-7
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   GARCIA AJ, 2002, BIOMIMETIC MAT DESIG, P29
   Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397
   Gille J, 2005, TISSUE CELL, V37, P339, DOI 10.1016/j.tice.2005.05.004
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Gobbi A, 2006, AM J SPORT MED, V34, P1763, DOI 10.1177/0363546506288853
   Gordon TD, 2004, TISSUE ENG, V10, P1287, DOI 10.1089/1076327041887763
   HANFF G, 1990, SCAND J PLAST RECONS, V24, P217, DOI 10.3109/02844319009041282
   Harbers G. M., 2002, BIOMIMETIC MAT DESIG, P55
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   HOFMANN S, 2006, TISSUE ENG
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hollander AP, 2006, TISSUE ENG, V12, P1787, DOI 10.1089/ten.2006.12.1787
   HOMMINGA GN, 1993, ACTA ORTHOP SCAND, V64, P441, DOI 10.3109/17453679308993663
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS171
   HUNZIKER EB, 2001, CLIN ORTHOP S, V391, pS182
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Im GI, 2001, J BONE JOINT SURG BR, V83B, P289, DOI 10.1302/0301-620X.83B2.10495
   Kang SW, 2006, J BIOMAT SCI-POLYM E, V17, P925, DOI 10.1163/156856206777996862
   Kang Y, 2006, J BIOMED MATER RES A, V77A, P331, DOI 10.1002/jbm.a.30607
   KAPLONYI G, 1988, INJURY, V19, P267, DOI 10.1016/0020-1383(88)90043-5
   Kawamura S, 1998, ACTA ORTHOP SCAND, V69, P56, DOI 10.3109/17453679809002358
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kim MR, 2002, J CONTROL RELEASE, V80, P69, DOI 10.1016/S0168-3659(01)00557-0
   Kuo AC, 2006, OSTEOARTHR CARTILAGE, V14, P1126, DOI 10.1016/j.joca.2006.04.004
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LARNO S, 1985, LIFE SCI, V36, P2069, DOI 10.1016/0024-3205(85)90458-8
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lee KY, 2000, NATURE, V408, P998
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   LOESER RF, 1993, ARTHRITIS RHEUM, V36, P1103, DOI 10.1002/art.1780360811
   Lohmann CH, 2000, BIOMATERIALS, V21, P49, DOI 10.1016/S0142-9612(99)00132-5
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma PX, 1999, J BIOMED MATER RES, V44, P217
   Mahmood TA, 2005, TISSUE ENG, V11, P1244, DOI 10.1089/ten.2005.11.1244
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Marlovits S, 2005, KNEE SURG SPORT TR A, V13, P451, DOI 10.1007/s00167-004-0535-3
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   Miot S, 2006, J ORTHOP RES, V24, P1078, DOI 10.1002/jor.20098
   Na K, 2007, J BIOTECHNOL, V128, P412, DOI 10.1016/j.jbiotec.2006.09.025
   Na K, 2006, BIOMATERIALS, V27, P5951, DOI 10.1016/j.biomaterials.2006.08.012
   Nehrer S, 2006, EUR J RADIOL, V57, P3, DOI 10.1016/j.ejrad.2005.08.005
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   POOLE CA, 1990, CONNECT TISSUE RES, V24, P319, DOI 10.3109/03008209009152158
   Pulkkinen H, 2006, BIO-MED MATER ENG, V16, pS29
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Segat D, 2002, J BIOL CHEM, V277, P31612, DOI 10.1074/jbc.M203471200
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002
   Sellers RS, 2000, J BONE JOINT SURG AM, V82A, P151, DOI 10.2106/00004623-200002000-00001
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Solchaga LA, 2002, TISSUE ENG, V8, P333, DOI 10.1089/107632702753725085
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   STOOP R, 2004, CELL BIOMATERIAL REA
   Tamai N, 2005, OSTEOARTHR CARTILAGE, V13, P405, DOI 10.1016/j.joca.2004.12.014
   TERRELL TG, 1993, INT REV EXP PATHOL, V34, P43
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   van Susante JLC, 1998, BIOMATERIALS, V19, P2367, DOI 10.1016/S0142-9612(98)00158-6
   van Susante JLC, 1999, BIOMATERIALS, V20, P1167, DOI 10.1016/S0142-9612(97)00190-7
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279
   Veilleux N, 2005, OSTEOARTHR CARTILAGE, V13, P278, DOI 10.1016/j.joca.2004.12.013
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   WANG TW, 2007, J BIOMED MAT RES B
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
NR 119
TC 44
Z9 47
U1 0
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD APR
PY 2008
VL 39
SU 1
BP S77
EP S87
DI 10.1016/j.injury.2008.01.036
PG 11
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 293UW
UT WOS:000255361900011
PM 18313475
DA 2018-10-20
ER

PT J
AU Araujo, M
   Linder, E
   Wennstrom, J
   Lindhe, J
AF Araujo, Mauricio
   Linder, Elena
   Wennstrom, Jan
   Lindhe, Jan
TI The influence of Bio-Oss Collagen on healing of an extraction socket: An
   experimental study in the dog
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID MAXILLARY SINUS AUGMENTATION; DIFFERENT GRAFTING MATERIALS; GUIDED BONE
   REGENERATION; TOOTH EXTRACTION; DENTAL IMPLANTS; BIOACTIVE GLASS; PART
   1; TISSUE; BIO-OSS(R); PLACEMENT
AB The objective of the present experiment was to evaluate the effect on hard tissue modeling and remodeling of the placement of a xenograft in fresh extraction sockets in dogs. Five mongrel dogs were used. Two mandibular premolars (P-4(4)) were hemisected in each dog, and the distal roots were carefully removed. In one socket, a graft consisting of Bio-Oss Collagen (Geistlich) was placed, whereas the contralateral site was left without grafting. After 3 months of healing, the dogs were euthanized and biopsies sampled. From each experimental site, four ground sections (two from the mesial root and two from the healed socket) were prepared, stained, and examined under the microscope. The presence of Bio-Oss Collagen failed to inhibit the processes of modeling and remodeling that took place in the socket walls following tooth extraction. However, it apparently promoted de novo hard tissue formation, particularly in the cortical region of the extraction site. Thus, the dimension of the hard tissue was maintained and the profile of the ridge was better preserved. The placement of a biomaterial in an extraction socket may promote bone modeling and compensate, at least temporarily, for marginal ridge contraction.
C1 [Araujo, Mauricio] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
   [Linder, Elena; Wennstrom, Jan; Lindhe, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Gothenburg, Sweden.
RP Araujo, M (reprint author), Rua Silva Jardim,15 Sala 03, BR-87013010 Maringa, Parana, Brazil.
EM odomar@hotmail.com
CR AMLER MH, 1960, J AM DENT ASSOC, V61, P46
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Araujo MG, 2001, J CLIN PERIODONTOL, V28, P73, DOI 10.1034/j.1600-051x.2001.280111.x
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Becker W, 1998, J PERIODONTOL, V69, P414, DOI 10.1902/jop.1998.69.4.414
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Botticelli D, 2004, CLIN ORAL IMPLAN RES, V15, P285, DOI 10.1046/j.1600-0501.2003.01008.x
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Donath K., 1988, PRAPARATOR, V34, P197
   Donath K, 1993, PREPARATION HISTOLOG
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Mellonig J T, 1993, Int J Periodontics Restorative Dent, V13, P108
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Norton MR, 2002, INT J ORAL MAX IMPL, V17, P249
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P244, DOI 10.1034/j.1600-0501.1997.080311.x
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P198
   Slotte C, 1999, CLIN ORAL IMPLAN RES, V10, P468, DOI 10.1034/j.1600-0501.1999.100605.x
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
NR 35
TC 159
Z9 169
U1 0
U2 14
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD APR
PY 2008
VL 28
IS 2
BP 123
EP 135
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 292FO
UT WOS:000255252100003
PM 18546808
DA 2018-10-20
ER

PT J
AU Sawa, Y
   Tatsumi, E
   Funakubo, A
   Horiuchi, T
   Iwasaki, K
   Kishida, A
   Masuzawa, T
   Matsuda, K
   Nishimura, M
   Nishimura, T
   Tomizawa, Y
   Yamaoka, T
   Watanabe, H
AF Sawa, Y.
   Tatsumi, E.
   Funakubo, A.
   Horiuchi, T.
   Iwasaki, K.
   Kishida, A.
   Masuzawa, T.
   Matsuda, K.
   Nishimura, M.
   Nishimura, T.
   Tomizawa, Y.
   Yamaoka, T.
   Watanabe, H.
TI Journal of Artificial Organs 2007: the year in review
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE artificial heart (basic); artificial heart (clinical); cardiopulmonary
   bypass; artificial lung; blood vessel prosthesis; pacemaker; artificial
   valve; biomaterial; tissue engineering; dialysis; apheresis; artificial
   liver; artificial pancreas; artificial skin; artificial muscle;
   artificial bone; artificial neuron
ID VENTRICULAR ASSIST DEVICE; EXTRACORPOREAL MEMBRANE-OXYGENATION;
   CORONARY-ARTERY-BYPASS; FULMINANT MYOCARDITIS; VALVE; SYSTEM; PUMP;
   IMPLANTATION; CYTOTOXICITY; PATIENT
C1 [Sawa, Y.] Osaka Univ, Div Cardiovasc Surg, Dept Surg, Grad Sch Med, Suita, Osaka 5650871, Japan.
   [Tatsumi, E.] Natl Cardiovasc Ctr, Res Inst, Dept Artificial Organs, Adv Med Engn Ctr, Suita, Osaka 565, Japan.
   [Funakubo, A.] Tokyo Denki Univ, Dept Elect & Comp Engn, Sch Sci & Engn, Tokyo 101, Japan.
   [Horiuchi, T.] Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie 514, Japan.
   [Iwasaki, K.] Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan.
   [Kishida, A.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
   [Masuzawa, T.] Ibaraki Univ, Dept Mech Engn, Hitachi, Ibaraki, Japan.
   [Matsuda, K.] Univ Yamanashi Hosp, Chuo, Japan.
   [Nishimura, M.] Tottori Univ, Fac Med, Div Organ Regenerat Surg, Yonago, Tottori 683, Japan.
   [Nishimura, T.] Tokyo Univ Hosp, Tokyo 113, Japan.
   [Tomizawa, Y.] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Tokyo, Japan.
   [Yamaoka, T.] Natl Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka 565, Japan.
   [Watanabe, H.] Niigata Univ, Div Thorac & Cardiovasc Surg, Grad Sch Med & Dent Sci, Niigata, Japan.
RP Sawa, Y (reprint author), Osaka Univ, Div Cardiovasc Surg, Dept Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM sawa@surg1.medo.osaka-u.ac.jp
CR Abe Y, 2007, J ARTIF ORGANS, V10, P60, DOI 10.1007/s10047-006-0368-6
   Aiba M, 2007, J ARTIF ORGANS, V10, P165, DOI 10.1007/s10047-007-0387-y
   Akagawa E, 2007, J ARTIF ORGANS, V10, P85, DOI 10.1007/s10047-007-0378-z
   Bayrakci B, 2007, J ARTIF ORGANS, V10, P6, DOI 10.1007/s10047-006-0359-7
   Fukunaga K, 2007, J ARTIF ORGANS, V10, P77, DOI 10.1007/s10047-007-0375-2
   Hata K, 2007, J ARTIF ORGANS, V10, P129, DOI 10.1007/s10047-006-0371-y
   Hirata I, 2007, J ARTIF ORGANS, V10, P212, DOI 10.1007/s10047-007-0391-2
   Hoshino A, 2007, J ARTIF ORGANS, V10, P149, DOI 10.1007/s10047-007-0379-y
   Ishiguro H, 2007, J ARTIF ORGANS, V10, P133, DOI 10.1007/s10047-007-0381-4
   Iwai S, 2007, J ARTIF ORGANS, V10, P29, DOI 10.1007/s10047-006-0360-1
   Journal of Artificial Organs Editorial Committee, 2006, J ARTIF ORGANS, V9, P1
   Kataoka G, 2007, J ARTIF ORGANS, V10, P218, DOI 10.1007/s10047-007-0392-1
   Kato T, 2007, J ARTIF ORGANS, V10, P42, DOI 10.1007/s10047-006-0362-z
   Kimura T, 2007, J ARTIF ORGANS, V10, P104, DOI 10.1007/s10047-006-0367-7
   Komoda T, 2007, J ARTIF ORGANS, V10, P124, DOI 10.1007/s10047-007-0374-3
   Lee H, 2007, J ARTIF ORGANS, V10, P181, DOI 10.1007/s10047-007-0382-3
   Lee Hwansung, 2006, J Artif Organs, V9, P154, DOI 10.1007/s10047-006-0332-5
   Liu HJ, 2007, J ARTIF ORGANS, V10, P223, DOI 10.1007/s10047-007-0395-y
   Mitsumune N, 2007, J ARTIF ORGANS, V10, P231, DOI 10.1007/s10047-007-0388-x
   Morsi YS, 2007, J ARTIF ORGANS, V10, P109, DOI 10.1007/s10047-006-0369-5
   Morsi YS, 2007, J ARTIF ORGANS, V10, P96, DOI 10.1007/s10047-006-0365-9
   Nakayama Y, 2007, J ARTIF ORGANS, V10, P171, DOI 10.1007/s10047-007-0376-1
   Ninomiya S, 2007, J ARTIF ORGANS, V10, P201, DOI 10.1007/s10047-007-0396-x
   NISHINAKA T, 151 DAYS CONTINUOUS, V40
   Nishinaka T, 2007, J ARTIF ORGANS, V10, P236, DOI 10.1007/s10047-007-0389-9
   Niwayama J, 2007, J ARTIF ORGANS, V10, P36, DOI 10.1007/s10047-006-0357-9
   Ohata T, 2007, J ARTIF ORGANS, V10, P92, DOI 10.1007/s10047-007-0377-0
   Ohata T, 2007, J ARTIF ORGANS, V10, P228, DOI 10.1007/s10047-007-0393-0
   Okamoto E, 2007, J ARTIF ORGANS, V10, P158, DOI 10.1007/s10047-007-0380-5
   Reiss N, 2007, J ARTIF ORGANS, V10, P195, DOI 10.1007/s10047-007-0394-z
   Sacar M, 2007, J ARTIF ORGANS, V10, P177, DOI 10.1007/s10047-007-0383-2
   Saito S, 2007, J ARTIF ORGANS, V10, P118, DOI 10.1007/s10047-007-0373-4
   Sakamoto Y, 2007, J ARTIF ORGANS, V10, P206, DOI 10.1007/s10047-007-0397-9
   Sawa Y, 2007, J ARTIF ORGANS, V10, P53, DOI 10.1007/s10047-007-0386-z
   Sugiki Hiroshi, 2006, J Artif Organs, V9, P42, DOI 10.1007/s10047-005-0319-7
   Sugiki H, 2007, J ARTIF ORGANS, V10, P16, DOI 10.1007/s10047-006-0364-x
   Tamai M, 2007, J ARTIF ORGANS, V10, P22, DOI 10.1007/s10047-006-0363-y
   Tatsumi E, 2007, J ARTIF ORGANS, V10, P1, DOI 10.1007/s10047-006-0356-x
   Tatsumi E, 2007, J ARTIF ORGANS, V10, P187, DOI 10.1007/s10047-007-0384-1
   Tokunaga S, 2007, J ARTIF ORGANS, V10, P115, DOI 10.1007/s10047-006-0366-8
   Tomizawa Y, 2007, J ARTIF ORGANS, V10, P122, DOI 10.1007/s10047-006-0372-x
   Tomo T, 2007, J ARTIF ORGANS, V10, P47, DOI 10.1007/s10047-006-0358-8
   Tsutsui N, 2007, J ARTIF ORGANS, V10, P143, DOI 10.1007/s10047-007-0385-0
   Watanabe T, 2007, J ARTIF ORGANS, V10, P10, DOI 10.1007/s10047-006-0361-0
   YAMANE Y, 2007, J ARTIF ORGANS, V10, P71
NR 45
TC 13
Z9 13
U1 2
U2 7
PU SPRINGER TOKYO
PI TOKYO
PA 1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN
SN 1434-7229
J9 J ARTIF ORGANS
JI J. Artif. Organs
PD APR
PY 2008
VL 11
IS 1
BP 4
EP 11
DI 10.1007/s10047-008-0404-9
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 290MH
UT WOS:000255126400002
PM 18414986
DA 2018-10-20
ER

PT J
AU Stark, Y
   Bruns, S
   Stahl, F
   Kasper, C
   Wesemann, M
   Grothe, C
   Scheper, T
AF Stark, Yvonne
   Bruns, Stephanie
   Stahl, Frank
   Kasper, Cornelia
   Wesemann, Maike
   Grothe, Claudia
   Scheper, Thomas
TI A study on polysialic acid as a biomaterial for cell culture
   applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE peripheral nerve regeneration; polysialic acid; surface coating;
   biomaterials; differentiation
ID ADHESION MOLECULE; INTERNEURON PRECURSORS; NERVE REGENERATION;
   BETA-GLUCAN; GROWTH; NCAM; ATTACHMENT; POLYMER; AXONS; POLYSIALYLATION
AB Polysialic acid (PSA) was investigated for its applicability as coating material for mammalian cell cultivation. PSA is involved in post-translational modification of the vertebrate neural cell adhesion molecule (NCAM). It is biocompatible and degradation-controlled. Thus, it becomes interesting for use as a coating and scaffold material for tissue engineering applications, especially for peripheral nerve regeneration. As a preliminary study of the use of PSA as scaffold material it was tested in its soluble form as coating material. The cytotoxicity was investigated and compared to another polysaccharide beta-glucan, to widely used coating substances (collagen 1, poly-L-lysine, hyaluronic acid) and uncoated tissue culture plastic material. The interactions between the modified cell culture surface and the cells were investigated using a model liver cell line Hep-G2 and a neurobiological cell line PC-12. The PSA coating itself was analyzed by immunoanalysis. Viability of the cells was investigated by the MTT assay. The number and distribution of adhered cells were studied by cell nuclei staining. Furthermore, the differentiation status of the PC-12 cells was monitored, as well as glucose and lactate levels in the cell culture medium from the Hep-G2 cells. Comparable viability and similar numbers of attached cells were observed. Growth in cell clusters was observed for PSA, P-glucan, and hyaluronic acid coated materials. In general, the results indicate that PSA is comparable to other well-established coating materials (e.g. collagen I, hyaluronic acid, and poly-L-lysine). Moreover, as a key substance in vertebrate development it offers interesting features for nerve regeneration, especially as an insoluble, modified scaffold material. (c) 2007 Wiley Periodicals, Inc.
C1 [Stark, Yvonne; Bruns, Stephanie; Stahl, Frank; Kasper, Cornelia; Scheper, Thomas] Leibniz Univ Hannover, Inst Tech Chem, D-30167 Hannover, Germany.
   [Wesemann, Maike; Grothe, Claudia] Hannover Med Sch, Inst Neuroanat, D-30623 Hannover, Germany.
RP Scheper, T (reprint author), Leibniz Univ Hannover, Inst Tech Chem, Callinstr 3, D-30167 Hannover, Germany.
EM scheper@iftc.uni-hannover.de
RI Scheper, Thomas/H-8143-2013
CR ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143
   Aykin-Burns N, 2005, ARCH ENVIRON CON TOX, V49, P119, DOI 10.1007/s00244-004-0025-0
   Bini TB, 2005, J MATER SCI-MATER M, V16, P367, DOI 10.1007/s10856-005-0637-6
   Bork K, 2005, FEBS LETT, V579, P5079, DOI 10.1016/j.febslet.2005.08.013
   Cai J, 2005, J BIOMED MATER RES A, V75A, P374, DOI 10.1002/jbm.a.30432
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Hu HY, 2000, J NEUROSCI RES, V61, P480, DOI 10.1002/1097-4547(20000901)61:5<480::AID-JNR2>3.0.CO;2-M
   Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X
   Hwang JJ, 2005, J BIOMAT SCI-POLYM E, V16, P237, DOI 10.1163/1568562053115480
   JACOBSON BS, 1977, SCIENCE, V195, P302, DOI 10.1126/science.831278
   Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349
   KOIZUMI N, 1993, ANTIVIR RES, V21, P1, DOI 10.1016/0166-3542(93)90063-O
   LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J
   Leckband D, 2004, CURR OPIN STRUC BIOL, V14, P524, DOI 10.1016/j.sbi.2004.09.002
   MATSUMOTO S, 1981, J MOL BIOL, V152, P501, DOI 10.1016/0022-2836(81)90255-2
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   MITCHELL JD, 1994, J THORAC CARDIOV SUR, V107, P1481
   Miura T, 1999, FEMS IMMUNOL MED MIC, V24, P131
   Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8
   Nagai M, 2002, DENT MATER J, V21, P250, DOI 10.4012/dmj.21.250
   Oberdoerster J, 1998, J PHARMACOL EXP THER, V287, P359
   ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0
   Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807
   RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842
   RUTISHAUSER U, 1991, TRENDS NEUROSCI, V14, P528, DOI 10.1016/0166-2236(91)90006-G
   SAKAGAMI H, 1989, In Vivo (Attiki), V3, P243
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x
   TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W
   TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5
   Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23
   Verheye S, 2000, ARTERIOSCL THROM VAS, V20, P1168, DOI 10.1161/01.ATV.20.4.1168
   WANG KK, 1993, J RECONSTR MICROSURG, V9, P39, DOI 10.1055/s-2007-1006637
   Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   WOLK M, 1985, MED BIOL, V63, P73
   Yashiki S, 2001, J BIOSCI BIOENG, V92, P385, DOI 10.1263/jbb.92.385
   YIN XH, 1995, DEVELOPMENT, V121, P3439
   Yun CH, 2003, FEMS IMMUNOL MED MIC, V35, P67, DOI 10.1016/S0928-8244(02)00460-1
NR 42
TC 5
Z9 5
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2008
VL 85A
IS 1
BP 1
EP 13
DI 10.1002/jbm.a.31406
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 270UF
UT WOS:000253745000001
PM 17618519
DA 2018-10-20
ER

PT J
AU de Guzman, RC
   VandeVord, PJ
AF de Guzman, Roche C.
   VandeVord, Pamela J.
TI Variations in astrocyte and fibroblast response due to biomaterial
   particulates in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE reactive astrocyte; fibroblast; proliferation; cytotoxicity; biomaterial
   particles
ID CENTRAL-NERVOUS-SYSTEM; HUMAN BREAST-CANCER; SPINAL-CORD-INJURY;
   UP-REGULATION; REACTIVE ASTROCYTES; DOSE-RESPONSE; GLIAL SCAR;
   ADULT-RATS; BRAIN; EXPRESSION
AB The possible involvement of orthopedic biomaterial particles such as cobalt-chrome alloy (Co-Cr), ultrahigh molecular weight polyethylene (UHMWPE), titanium alloy (Ti-6Al-4V), and polymethyl methacrylate (PMMA) in the formation of glial and meningeal scars was investigated using an in vitro system. Cell lines were used as models for astrocytes and meningeal fibroblasts. They were incubated with varying concentrations of particle suspensions, after which proliferative and cytotoxic responses were quantified using MTT assay and Live/Dead microscopy. It was determined that relative particulate toxicity (arranged in decreasing order) to astrocytes is Co-Cr > Ti-6AI-4V > PMMA > UHMWPE, and toxicity to fibroblasts is PMMA > Co-Cr > Ti-6AI-4V > UHMWPE. Cell death caused by PMMA was mainly due to necrosis, while the rest of the particles induced apoptosis. Low quantities of Co-Cr and Ti-6Al-4V stimulate increased astrocyte proliferation rate. However, only the cells treated with titanium alloy caused upregulated transcription of reactive astrocyte markers such as glial fibrillary acidic protein, vimentin, nestin, and type IV collagen, suggesting the potential of titanium alloy alone to trigger glial scarring. None of the biomaterials tested promoted proliferation in fibroblasts implying that biomaterial particles are not directly involved in meningeal scar development. (c) 2007 Wiley Periodicals, Inc.
C1 [de Guzman, Roche C.; VandeVord, Pamela J.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.
RP de Guzman, RC (reprint author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.
EM roche@wayne.edu
RI VandeVord, Pamela/B-4606-2012; de Guzman, Roche/K-8832-2015
OI de Guzman, Roche/0000-0001-6051-4765
CR AlAli SY, 1996, J ANAT, V188, P257
   Anteby EY, 2005, EUR J OBSTET GYN R B, V118, P174, DOI 10.1016/j.ejogrb.2004.04.029
   BURKE JM, 1987, ARCH OPHTHALMOL-CHIC, V105, P404, DOI 10.1001/archopht.1987.01060030124041
   Cazaubon S, 1997, J NEUROSCI, V17, P6203
   Chang GHF, 2000, NEURO-ONCOLOGY, V2, P174, DOI 10.1093/neuonc/2.3.174
   CHUANG CF, 1994, FEBS LETT, V346, P229, DOI 10.1016/0014-5793(94)00480-3
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515
   Hirano S, 2004, BIOCHEM BIOPH RES CO, V317, P437, DOI 10.1016/j.bbrc.2004.03.049
   Kalmar B, 2001, NEUROCHEM INT, V38, P453, DOI 10.1016/S0197-0186(00)00090-5
   Kawai K, 2002, VIRCHOWS ARCH, V441, P584, DOI 10.1007/s00428-002-0636-7
   Kim JK, 1999, J TOXICOL ENV HEAL A, V58, P437, DOI 10.1080/009841099157160
   KRUGER S, 1986, J COMP NEUROL, V249, P103, DOI 10.1002/cne.902490108
   LEIBNITZ L, 1985, J HIRNFORSCH, V26, P601
   Li MS, 1996, GLIA, V18, P306, DOI 10.1002/(SICI)1098-1136(199612)18:4<306::AID-GLIA5>3.0.CO;2-V
   Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x
   Liesi P, 2002, EXP NEUROL, V173, P31, DOI 10.1006/exnr.2001.7800
   Lightfoot HM, 2004, BREAST CANCER RES TR, V88, P109, DOI 10.1007/s10549-004-1022-8
   Liu F, 2003, SPINE, V28, P1666, DOI 10.1097/00007632-200308010-00007
   Mhawech-Fauceglia P, 2006, EJSO, V32, P439, DOI 10.1016/j.ejso.2006.01.018
   Mofid MM, 1997, PLAST RECONSTR SURG, V100, P14, DOI 10.1097/00006534-199707000-00003
   Mohanty M, 2003, J BIOMATER APPL, V18, P109, DOI 10.1177/088532803034746
   Murai Nozomu, 1997, Neurologia Medico-Chirurgica, V37, P201, DOI 10.2176/nmc.37.201
   Nicholas AP, 2002, NEUROSCI LETT, V323, P85, DOI 10.1016/S0304-3940(01)02534-4
   Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005
   Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207
   Pentreath VW, 2000, HUM EXP TOXICOL, V19, P641, DOI 10.1191/096032700676221595
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Renner R, 2004, ENVIRON SCI TECHNOL, V38, p90A, DOI 10.1021/es040410d
   SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7
   Scholl FA, 2005, CANCER LETT, V230, P1, DOI 10.1016/j.canlet.2004.12.013
   Schulte-Hermann R, 2000, MUTAT RES-GEN TOX EN, V464, P13, DOI 10.1016/S1383-5718(99)00162-X
   Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   Tansey FA, 1998, NEUROSCI LETT, V248, P159, DOI 10.1016/S0304-3940(98)00373-5
   Teixeira A, 2000, J NEUROCHEM, V74, P1034, DOI 10.1046/j.1471-4159.2000.0741034.x
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236
   Verlaan JJ, 2006, BIOMATERIALS, V27, P290, DOI 10.1016/j.biomaterials.2005.07.028
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
   Wu VW, 1998, J NEUROSCI RES, V51, P675, DOI 10.1002/(SICI)1097-4547(19980315)51:6<675::AID-JNR2>3.0.CO;2-8
   Yao Qing, 2004, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V20, P328
   Yip SS, 2000, INT J CANCER, V88, P363, DOI 10.1002/1097-0215(20001101)88:3<363::AID-IJC7>3.3.CO;2-W
   YTURRASPE DJ, 1975, J NEUROSURG, V42, P47, DOI 10.3171/jns.1975.42.1.0047
   YUEN TGH, 1987, BIOMATERIALS, V8, P138, DOI 10.1016/0142-9612(87)90103-7
NR 45
TC 7
Z9 7
U1 2
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2008
VL 85A
IS 1
BP 14
EP 24
DI 10.1002/jbm.a.31516
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 270UF
UT WOS:000253745000002
PM 17668862
DA 2018-10-20
ER

PT J
AU Tanihara, M
   Kajiwara, K
   Ida, K
   Suzuki, Y
   Kamitakahara, M
   Ogata, S
AF Tanihara, Masao
   Kajiwara, Kazumi
   Ida, Keiko
   Suzuki, Yoshihisa
   Kamitakahara, Masanobu
   Ogata, Shin-ichi
TI The biodegradability of poly(Pro-Hyp-Gly) synthetic polypeptide and the
   promotion of a dermal wound epithelialization using a poly(Pro-Hyp-Gly)
   sponge
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE synthetic polypeptide; poly(Pro-Hyp-Gly); biodegradability; wound
   repair; epithelialization
ID COLLAGEN GEL; IN-VIVO; REGENERATION; PEPTIDES; BIOMATERIAL; STABILITY;
   SCAFFOLDS; DELIVERY; ELASTIN; LAMININ
AB Collagens are widely used in medical applications, but animal-derived collagens have several drawbacks, such as low thermal stability, nonspecific cell attachment, and susceptibility to contamination by infectious pathogens, such as prions, which may transfect humans. We have previously reported the chemical synthesis of polypeptides consisting of a Pro-Hyp-Gly sequence and the high thermostability of their triple-helical structure. To clarify the biomaterial characteristics of the poly(Pro-Hyp-Gly) polypeptide, we assessed its biodegradability and its capability for skin regeneration. Eight weeks after implantation, a poly(Pro-Hyp-Gly) freeze-dried sponge embedded subcutaneously into a rat dorsal area degraded at the same rate as Terudermis (R)), which is made from bovine type I atelocollagen and is used as an artificial dermis. Surprisingly, compared with Terudermis, the poly(Pro-Hyp-Gly) sponge significantly promoted epithelialization of a full-thickness wound on a rabbit's ear pad. This chemically synthesized polypeptide may be useful as a scaffold for tissue engineering and tissue regeneration. (c) 2007 Wiley Periodicals, Inc.
C1 [Tanihara, Masao; Kajiwara, Kazumi; Ida, Keiko; Kamitakahara, Masanobu; Ogata, Shin-ichi] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan.
   [Suzuki, Yoshihisa] Kyoto Univ, Grad Sch Med, Div Surg, Sakyo Ku, Kyoto 6068507, Japan.
RP Tanihara, M (reprint author), Nara Inst Sci & Technol, Grad Sch Mat Sci, 8916-5 Takayama, Nara 6300192, Japan.
EM mtanihar@ms.naist.jp
CR Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   BRODSKY B, 1992, BIOPOLYMERS, V32, P447, DOI 10.1002/bip.360320423
   Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3
   Hashimoto T, 2004, BIOMATERIALS, V25, P1407, DOI 10.1016/j.biomaterials.2003.07.004
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Kane J. B., 1996, BIOMATERIALS SCI INT, P360
   Kishimoto T, 2005, BIOPOLYMERS, V79, P163, DOI 10.1002/bip.20348
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Matsui R, 1996, BIOMATERIALS, V17, P989, DOI 10.1016/0142-9612(96)84673-4
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P3
   Morihara Y, 2005, J POLYM SCI POL CHEM, V43, P6048, DOI 10.1002/pola.21097
   Ochi K, 2003, J CELL PHYSIOL, V194, P45, DOI 10.1002/jcp.10185
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Rothenburger M, 2002, ASAIO J, V48, P586, DOI 10.1097/01.MAT.0000033637.90113.1E
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   Scherer F, 2002, J GENE MED, V4, P634, DOI 10.1002/jgm.298
   Suzuki Y, 1999, J BIOMED MATER RES, V48, P522, DOI 10.1002/(SICI)1097-4636(1999)48:4<522::AID-JBM18>3.0.CO;2-O
   Toba T, 2002, INT J ARTIF ORGANS, V25, P230
   Ushida T, 2002, CELL TRANSPLANT, V11, P489
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Yoshii S, 2002, BRAIN RES, V949, P202, DOI 10.1016/S0006-8993(02)03149-9
NR 26
TC 16
Z9 16
U1 0
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2008
VL 85A
IS 1
BP 133
EP 139
DI 10.1002/jbm.a.31496
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 270UF
UT WOS:000253745000013
PM 17688259
DA 2018-10-20
ER

PT J
AU Hsiong, SX
   Carampin, P
   Kong, HJ
   Lee, KY
   Mooney, DJ
AF Hsiong, Susan X.
   Carampin, Paolo
   Kong, Hyun-Joon
   Lee, Kuen-Yong
   Mooney, David J.
TI Differentiation stage alters matrix control of stem cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; extracellular matrix; cell differentiation; stem cells;
   osteoblasts
ID MARROW STROMAL CELLS; CONTROLLED SCAFFOLD DEGRADATION; BONE-MARROW;
   OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; EXTRACELLULAR-MATRIX;
   ALGINATE HYDROGELS; FOCAL ADHESIONS; SUBSTRATE; TISSUE
AB Cues from the material to which a cell is adherent (e.g., adhesion ligand presentation, substrate elastic modulus) clearly influence the phenotype of differentiated cells. However, it is currently unclear if stem cells respond similarly to these cues. This study examined how the overall density and nanoscale organization of a model cell adhesion ligand (arginine-glycine-aspartic acid [RGD] containing peptide) presented from hydrogels of varying stiffness regulated the proliferation of a clonally derived stem cell line (D1 cells) and preostcoblasts (MC3T3-E1). While the growth rate of MC3T3-E1 preosteoblasts was responsive to nanoscale RGD ligand organization and substrate stiffness, the D1 stem cells were less sensitive to these cues in their uncommitted state. However, once the D1 cells were differentiated towards the osteoblast lineage, they became more responsive to these signals. These results demonstrate that the cell response to material cues is dependent on the stage of cell commitment or differentiation, and these findings will likely impact the design of biomaterials for tissue regeneration. (c) 2007 Wiley Periodicals, Inc.
C1 [Hsiong, Susan X.; Carampin, Paolo; Kong, Hyun-Joon; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Hsiong, Susan X.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Kong, Hyun-Joon] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Lee, Kuen-Yong] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
OI Lee, Kuen Yong/0000-0002-5759-5952
CR Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Comisar WA, 2006, BIOMATERIALS, V27, P2322, DOI 10.1016/j.biomaterials.2005.10.037
   Devine MJ, 2002, J ORTHOP RES, V20, P1232, DOI 10.1016/S0736-0266(02)00051-7
   DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Eaglstein WH, 1997, CLIN THER, V19, P894, DOI 10.1016/S0149-2918(97)80043-4
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Hansbrough John F., 1992, Journal of Burn Care and Rehabilitation, V13, P519, DOI 10.1097/00004630-199209000-00004
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Kato M, 2004, BIOCHEMISTRY-US, V43, P2699, DOI 10.1021/bi0352670
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Koo LY, 2002, J CELL SCI, V115, P1423
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Li XD, 2005, OSTEOPOROSIS INT, V16, P101, DOI 10.1007/s00198-004-1649-7
   Li XD, 2003, BONE, V33, P652, DOI 10.1016/S8756-3282(03)00239-4
   Lian JB, 1997, ENDOCRINOLOGY, V138, P2117, DOI 10.1210/en.138.5.2117
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Malaval L, 1999, J CELL BIOCHEM, V74, P616
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   MASSIA SP, 1993, J BIOL CHEM, V268, P8053
   NAKATANI Y, 1984, BIOCHEM BIOPH RES CO, V123, P894, DOI 10.1016/S0006-291X(84)80219-3
   Patel N, 1998, FASEB J, V12, P1447
   Pelham RJ, 1998, BIOL BULL, V194, P348, DOI 10.2307/1543109
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603
   VACANTI JP, 1998, ADV DRUG DELIV REV, V33, P165, DOI DOI 10.1016/SO169-409X(98)00025-8
   Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Yanai T, 2001, J BONE MINER METAB, V19, P345, DOI 10.1007/s007740170003
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103
NR 52
TC 68
Z9 69
U1 2
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2008
VL 85A
IS 1
BP 145
EP 156
DI 10.1002/jbm.a.31521
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 270UF
UT WOS:000253745000015
PM 17688260
DA 2018-10-20
ER

PT J
AU Narayanan, R
   Seshadri, SK
   Kwon, TY
   Kim, KH
AF Narayanan, R.
   Seshadri, S. K.
   Kwon, T. Y.
   Kim, K. H.
TI Calcium phosphate-based coatings on titanium and its alloys
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE titanium; calcium phosphate; hydroxyapatite; coating
ID SPRAYED HYDROXYAPATITE COATINGS; SIMULATED BODY-FLUID; PULSED-LASER
   DEPOSITION; BONELIKE APATITE FORMATION; METAL-ION RELEASE; OXIDE-FILMS;
   IN-VITRO; ELECTROPHORETIC DEPOSITION; OSTEOBLAST ADHESION; POROUS
   TITANIUM
AB Use of titanium as biomaterial is possible because of its very favorable biocompatibility with living tissue. Titanium implants having calcium phosphate coatings on their surface show good fixation to the bone. This review covers briefly the requirements of typical biomaterials and narrowly focuses on the works on titanium. Calcium phosphate ceramics for use in implants are introduced and various methods of producing calcium phosphate coating on titanium substrates are elaborated. Advantages and disadvantages of each type of coating from the view point of process simplicity, cost-effectiveness, stability of the coatings, coating integration with the bone, cell behavior, and so forth are highlighted. Taking into account all these factors, the efficient method(s) of producing these coatings are indicated finally. (c) 2007 Wiley Periodicals, Inc.
C1 [Narayanan, R.; Seshadri, S. K.] Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
   [Narayanan, R.; Kwon, T. Y.; Kim, K. H.] Kyungpook Natl Univ, Sch Dent, Dept Dent Biomat, Taegu, South Korea.
RP Narayanan, R (reprint author), Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
EM rnarayan69@hotmail.com
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Ban S, 1998, BIOMATERIALS, V19, P1245, DOI 10.1016/S0142-9612(98)00032-5
   Ban S, 1998, J BIOMED MATER RES, V42, P387, DOI 10.1002/(SICI)1097-4636(19981205)42:3<387::AID-JBM6>3.3.CO;2-Q
   BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   Bao QH, 2006, MAT SCI ENG A-STRUCT, V429, P25, DOI 10.1016/j.msea.2006.04.003
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Baszkiewicz J, 2003, VACUUM, V70, P163, DOI 10.1016/S0042-207X(02)00636-X
   Bigi A, 2005, BIOMATERIALS, V26, P4085, DOI 10.1016/j.biomaterials.2004.10.034
   Bow JS, 2004, BIOMATERIALS, V25, P3155, DOI 10.1016/j.biomaterials.2003.10.046
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BROWN PW, 1992, J AM CERAM SOC, V75, P17, DOI 10.1111/j.1151-2916.1992.tb05435.x
   Cabrini M, 1997, BIOMATERIALS, V18, P783, DOI 10.1016/S0142-9612(96)00205-0
   Cao Y, 1996, BIOMATERIALS, V17, P419, DOI 10.1016/0142-9612(96)89658-X
   Chen MF, 2007, SURF COAT TECH, V201, P5688, DOI 10.1016/j.surfcoat.2006.07.057
   Chou BY, 2001, SCRIPTA MATER, V45, P487, DOI 10.1016/S1359-6462(01)01064-8
   Cleries L, 2000, BIOMATERIALS, V21, P1861, DOI 10.1016/S0142-9612(00)00060-0
   Cleries L, 2000, J BIOMED MATER RES, V49, P43, DOI 10.1002/(SICI)1097-4636(200001)49:1<43::AID-JBM6>3.0.CO;2-G
   Cleries L, 2000, BIOMATERIALS, V21, P967, DOI 10.1016/S0142-9612(99)00240-9
   CORTEZ PM, 2005, MATER LETT, V58, P1336
   de Andrade MC, 2002, J EUR CERAM SOC, V22, P505
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   DEARNALEY G, 1986, VACUUM, V36, P807, DOI 10.1016/0042-207X(86)90116-8
   Dearnley PA, 2004, WEAR, V256, P469, DOI 10.1016/S0043-1648(03)00557-X
   DELPLANCKE JL, 1982, SURF TECHNOL, V16, P153, DOI 10.1016/0376-4583(82)90033-4
   Deram V, 2003, SURF COAT TECH, V166, P153, DOI 10.1016/S0257-8972(02)00855-1
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   DUNN D, 1992, SURF COAT TECH, V50, P223, DOI 10.1016/0257-8972(92)90005-U
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Erkmen ZE, 1999, J BIOMED MATER RES, V48, P861, DOI 10.1002/(SICI)1097-4636(1999)48:6<861::AID-JBM15>3.0.CO;2-H
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Feng B, 2002, J BIOMED MATER RES, V59, P12, DOI 10.1002/jbm.1211
   Fernandez-Pradas JM, 2000, APPL PHYS A-MATER, V71, P37
   Fernandez-Pradas JM, 1999, J MATER RES, V14, P4715, DOI 10.1557/JMR.1999.0638
   Fernandez-Pradas JM, 2001, BIOMATERIALS, V22, P2171, DOI 10.1016/S0142-9612(00)00408-7
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.3.CO;2-D
   Fujihara T, 2004, VACUUM, V73, P629, DOI 10.1016/j.vacuum.2003.12.082
   FUJIU T, 1984, J BIOMED MATER RES, V18, P845, DOI 10.1002/jbm.820180714
   GarciaSanz FJ, 1997, J MATER SCI-MATER M, V8, P861, DOI 10.1023/A:1018549720873
   Gledhill HC, 2001, BIOMATERIALS, V22, P695, DOI 10.1016/S0142-9612(00)00232-5
   Gledhill HC, 2001, BIOMATERIALS, V22, P1233, DOI 10.1016/S0142-9612(00)00273-8
   Gledhill HC, 1999, BIOMATERIALS, V20, P315, DOI 10.1016/S0142-9612(98)00166-5
   Grassmann O, 2000, J BIOMED MATER RES, V53, P685, DOI 10.1002/1097-4636(2000)53:6<685::AID-JBM11>3.3.CO;2-2
   Gross KA, 2002, BIOMATERIALS, V23, P4731, DOI 10.1016/S0142-9612(02)00222-3
   Hamagami J, 2004, SOLID STATE IONICS, V172, P331, DOI 10.1016/j.ssi.2004.02.046
   Han Y, 2001, J BIOMED MATER RES, V54, P96, DOI 10.1002/1097-4636(200101)54:1<96::AID-JBM11>3.0.CO;2-U
   He G, 2003, BIOMATERIALS, V24, P5115, DOI 10.1016/S0142-9612(03)00440-X
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1988, BIOCERAMICS MAT CHAR, P54
   Herranen M, 2001, CORROS SCI, V43, P365, DOI 10.1016/S0010-938X(00)00079-2
   -Hukovic M. M., 2003, SURF COAT TECH, V165, P40
   HUTCHINGS R, 1983, WEAR, V92, P143, DOI 10.1016/0043-1648(83)90014-5
   HWANG BJ, 1993, J APPL ELECTROCHEM, V23, P1056, DOI 10.1007/BF00266129
   Ichinose S, 2003, J MATER SCI-MATER M, V14, P79, DOI 10.1023/A:1021557605458
   Inagaki M, 2001, THIN SOLID FILMS, V382, P69, DOI 10.1016/S0040-6090(00)01772-7
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Ishizawa H, 1999, J MATER SCI, V34, P5893, DOI 10.1023/A:1004739108534
   Ishizawa H, 1996, J MATER SCI, V31, P6279, DOI 10.1007/BF00354450
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1459, DOI 10.1002/jbm.820291118
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   Kameyama T, 1999, B MATER SCI, V22, P641, DOI 10.1007/BF02749980
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Khor KA, 2000, MAT SCI ENG A-STRUCT, V281, P221, DOI 10.1016/S0921-5093(99)00717-0
   Kido H, 1996, J LONG-TERM EFF MED, V6, P119
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Krupa D, 2003, J MATER PROCESS TECH, V143, P158, DOI 10.1016/S0924-0136(03)00398-4
   Krupa D, 2001, VACUUM, V63, P715, DOI 10.1016/S0042-207X(01)00263-9
   Kumar M, 1999, J BIOMED MATER RES, V45, P302, DOI 10.1002/(SICI)1097-4636(19990615)45:4<302::AID-JBM4>3.0.CO;2-A
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Latysh V, 2006, CURR APPL PHYS, V6, P262, DOI 10.1016/j.cap.2005.07.053
   Lausmaa J, 1996, J ELECTRON SPECTROSC, V81, P343, DOI 10.1016/0368-2048(95)02530-8
   Lee IS, 2002, MAT SCI ENG C-BIO S, V22, P15, DOI 10.1016/S0928-4931(02)00107-8
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Li F, 2002, SURF COAT TECH, V154, P88, DOI 10.1016/S0257-8972(01)01710-8
   Liang B, 2003, BIOMATERIALS, V24, P4959, DOI 10.1016/S0142-9612(03)00421-6
   Liang FH, 2003, SURF COAT TECH, V165, P133, DOI 10.1016/S0257-8972(02)00735-1
   Lin HY, 2004, APPL SURF SCI, V225, P21, DOI 10.1016/j.apsusc.2003.09.027
   Liou SC, 2004, BIOMATERIALS, V25, P189, DOI 10.1016/S0142-9612(03)00479-4
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Liu YL, 2001, J BIOMED MATER RES, V57, P327, DOI 10.1002/1097-4636(20011205)57:3<327::AID-JBM1175>3.0.CO;2-J
   Lo WJ, 2000, J BIOMED MATER RES, V50, P536, DOI 10.1002/(SICI)1097-4636(20000615)50:4<536::AID-JBM9>3.3.CO;2-L
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Maitz MF, 2002, SURF COAT TECH, V158, P151, DOI 10.1016/S0257-8972(02)00189-5
   Mangano C, 2003, INT J ORAL MAX IMPL, V18, P23
   Marcelo H., 2003, J MATER SCI-MATER M, V14, P511
   Massaro C, 2001, J BIOMED MATER RES, V58, P651, DOI 10.1002/jbm.1065
   MCKELLOP H, 1981, J BIOMED MATER RES, V15, P619, DOI 10.1002/jbm.820150503
   Meng XW, 2006, KEY ENG MAT, V309-311, P639, DOI 10.4028/www.scientific.net/KEM.309-311.639
   Milella E, 2001, BIOMATERIALS, V22, P1425, DOI 10.1016/S0142-9612(00)00300-8
   Mohammadi Z, 2007, APPL SURF SCI, V253, P4960, DOI 10.1016/j.apsusc.2006.11.002
   Montenero A, 2000, J MATER SCI, V35, P2791, DOI 10.1023/A:1004738900778
   MORONI A, 1994, BIOMATERIALS, V15, P926, DOI 10.1016/0142-9612(94)90119-8
   Murugan R, 2004, MATER LETT, V58, P230, DOI 10.1016/S0167-577X(03)00451-8
   Narayanan R, 2006, SURF COAT TECH, V200, P4720, DOI 10.1016/j.surfcoat.2005.04.040
   Narayanan R, 2007, SCRIPTA MATER, V56, P229, DOI 10.1016/j.scriptamat.2006.10.004
   Nie X, 2001, J BIOMED MATER RES, V57, P612, DOI 10.1002/1097-4636(20011215)57:4<612::AID-JBM1208>3.0.CO;2-H
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Okido M, 2002, SOLID STATE IONICS, V151, P47, DOI 10.1016/S0167-2738(02)00603-3
   Ong JL, 2002, J BIOMED MATER RES, V59, P184, DOI 10.1002/jbm.1232
   Onoki T, 2006, SURF COAT TECH, V200, P6801, DOI 10.1016/j.surfcoat.2005.10.016
   Peng P, 2006, J BIOMED MATER RES A, V76A, P347, DOI 10.1002/jbm.a.30514
   Pezzatini S, 2006, J BIOMED MATER RES A, V76A, P656, DOI 10.1002/jbm.a.30524
   Pham MT, 2000, J MATER SCI LETT, V19, P1029, DOI 10.1023/A:1006782818468
   Pham MT, 2000, J MATER SCI LETT, V19, P443, DOI 10.1023/A:1006759309358
   Pham MT, 2000, SURF COAT TECH, V128, P313, DOI 10.1016/S0257-8972(00)00593-4
   Piveteau LD, 2000, BIOMATERIALS, V21, P2193, DOI 10.1016/S0142-9612(00)00160-5
   Redepenning J, 1996, J BIOMED MATER RES, V30, P287
   Rossler S, 2003, J BIOMED MATER RES A, V64A, P655, DOI 10.1002/jbm.a.10330
   ROSTLUND T, 1989, BIOMATERIALS, V10, P176, DOI 10.1016/0142-9612(89)90020-3
   ROYER P, 1991, SURF COAT TECH, V45, P171, DOI 10.1016/0257-8972(91)90220-Q
   Sam Z, 2006, SURF COAT TECH, V200, P6350, DOI 10.1016/j.surfcoat.2005.11.033
   Sampathkumaran U, 2001, ADV ENG MATER, V3, P401, DOI 10.1002/1527-2648(200106)3:6<401::AID-ADEM401>3.0.CO;2-L
   Scharnweber D, 2002, J MATER SCI-MATER M, V13, P1215, DOI 10.1023/A:1021118811893
   SHARMA AK, 1992, THIN SOLID FILMS, V208, P48, DOI 10.1016/0040-6090(92)90946-9
   SHIRKHANZADEH M, 1995, J MATER SCI-MATER M, V6, P90, DOI 10.1007/BF00120414
   SHIRKHANZADEH M, 1991, J MATER SCI LETT, V10, P1415, DOI 10.1007/BF00735695
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   SILVA MHP, 2001, SURF COAT TECH, V137, P270
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Sousa SR, 1996, BIOMATERIALS, V17, P397, DOI 10.1016/0142-9612(96)89655-4
   Stewart M, 2004, J BIOMED MATER RES A, V69A, P1, DOI 10.1002/jbm.a.20071
   Stoch A, 2001, J MOL STRUCT, V596, P191, DOI 10.1016/S0022-2860(01)00716-5
   Suh JY, 2003, BIOMATERIALS, V24, P347, DOI 10.1016/S0142-9612(02)00325-3
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   Thian ES, 2007, MAT SCI ENG C-BIO S, V27, P251, DOI 10.1016/j.msec.2006.05.016
   Thian ES, 2001, BIOMATERIALS, V22, P1225, DOI 10.1016/S0142-9612(00)00272-6
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
   Wang CX, 2002, MATER LETT, V54, P30, DOI 10.1016/S0167-577X(01)00532-8
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   WEBSTER T, 2005, NANOMED-NANOTECHNOL, V1, P251
   Webster TJ, 2003, J BIOMED MATER RES A, V67A, P975, DOI 10.1002/jbm.a.10160
   Wen HB, 1997, BIOMATERIALS, V18, P1471, DOI 10.1016/S0142-9612(97)82297-1
   Wen J, 2000, BIOMATERIALS, V21, P1339, DOI 10.1016/S0142-9612(99)00273-2
   Wie H, 1998, INT J ORAL MAX IMPL, V13, P837
   WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, V1, P11
   Willmann G, 1999, ADV ENG MATER, V1, P95
   WOLKE JGC, 1992, J THERM SPRAY TECHN, V1, P75
   Xue WC, 2005, J BIOMED MATER RES A, V74A, P553, DOI 10.1002/jbm.a.30323
   YAMASHITA K, 1994, J AM CERAM SOC, V77, P2401, DOI 10.1111/j.1151-2916.1994.tb04611.x
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yang Y, 2003, J Oral Implantol, V29, P270, DOI 10.1563/1548-1336(2003)029<0270:CADBOS>2.3.CO;2
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Yang YZ, 2003, BIOMATERIALS, V24, P5131, DOI 10.1016/S0142-9612(03)00459-9
   Yen SK, 2003, MATER CHEM PHYS, V77, P70, DOI 10.1016/S0254-0584(01)00562-4
   Yousefpour M, 2006, J ELECTROANAL CHEM, V589, P96, DOI 10.1016/j.jelechem.2006.01.020
   Zaffe D, 2004, BIOMATERIALS, V25, P3837, DOI 10.1016/j.biomaterials.2003.10.020
   Zhang CG, 2001, BIOMATERIALS, V22, P1357, DOI 10.1016/S0142-9612(00)00289-1
   Zhang YM, 2002, BIOMOL ENG, V19, P57, DOI 10.1016/S1389-0344(02)00011-4
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
   Zhu XL, 2003, J MATER SCI-MATER M, V14, P629, DOI 10.1023/A:1024079109073
NR 164
TC 172
Z9 176
U1 6
U2 74
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2008
VL 85B
IS 1
BP 279
EP 299
DI 10.1002/jbm.b.30932
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 280SB
UT WOS:000254445400036
PM 17853421
DA 2018-10-20
ER

PT J
AU Wollensak, G
   Iomdina, E
AF Wollensak, Gregor
   Iomdina, Elena
TI Crosslinking of scleral collagen in the rabbit using glyceraldehyde
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID MYOPIA PROGRESSION; MAILLARD REACTION; KERATOCONUS; RIBOFLAVIN;
   GLYCATION; PRODUCTS; DELIVERY; UVA
AB PURPOSE: To strengthen rabbit sclera in vivo using chemical crosslinking with glyceraldehyde for a scleral-based treatment of progressive myopia.
   SETTING: Department of Ophthalmology, Martin-Luther-University, Halle, Germany.
   METHODS: Five chinchilla rabbits were treated with sequential sub-Tenon injections of 0.15 mL 0.5 M glyceraldehyde into the superonasal quadrant of the right eye 5 times during 14 days. The rabbits were humanely killed and biomechanical stress-strain measurements of scleral strips from the treatment area were performed and compared with nontreated contralateral control sclera using a microcomputer-controlled biomaterial tester. The treated eyes were examined histologically by light microscopy to exclude possible adverse effects.
   RESULTS: Following the crosslinking treatment, the ultimate stress was 15.8 MPa +/- 6.0 (SD) versus 3.1 +/- 0.3 MPa in the controls (increase of 409.7%; P<.02), the Young modulus was 129.6 +/- 53.7 MPa versus 11.5 +/- 1.8 MPa in the controls (increase of 1027%, P<.01), and ultimate strain was 19.8% +/- 2.6% MPA versus 38.2% +/- 5.1% MPA in the controls (decrease of 48.2% P<.05). Histologically, mild side effects were found in the peripheral cornea adjacent to the treatment area, with some inflammatory infiltrate and moderate loss of keratocytes.
   CONCLUSIONS: Glyceraldehyde crosslinking of scleral collagen increased the scleral biomechanical rigidity efficiently. Glyceraldehyde can be easily applied by sequential parabulbar injections. There were no side effects on the retina, so the new method might become a treatment modality for strengthening scleral tissue to prevent progressive myopia.
C1 [Wollensak, Gregor] Univ Halle Wittenberg, Dept Ophthalmol, Halle, Germany.
   [Iomdina, Elena] Moscow Helmholtz Res Inst Eye Dis, Moscow, Russia.
RP Wollensak, G (reprint author), Wildentensteig 4, D-14195 Berlin, Germany.
EM gwollens@hotmail.com
CR Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618
   AWETISSOW ES, 1980, KLIN MONATSBL AUGENH, V176, P777, DOI 10.1055/s-2008-1057552
   Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5
   Bell G R, 1993, J Am Optom Assoc, V64, P332
   Bergman L, 1996, OPHTHALMIC SURG LAS, V27, P106
   Bullimore MA, 2002, INVEST OPHTH VIS SCI, V43, P2110
   Edwards MH, 1996, ACTA OPHTHALMOL SCAN, V74, P213
   FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314
   Gerrard JA, 2002, FOOD CHEM, V79, P343, DOI 10.1016/S0308-8146(02)00174-7
   Iomdina E.N., 1993, P 14 C BIOM PAR INT, P616
   KATO Y, 1994, PHOTOCHEM PHOTOBIOL, V59, P343, DOI 10.1111/j.1751-1097.1994.tb05045.x
   Kumar CM, 2003, EYE, V17, P1003, DOI 10.1038/sj.eye.6700501
   MCBRIEN BA, 2003, PROG RETIN EYE RES, V22, P307
   MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133
   MECHANIC G, 1972, BIOCHEM BIOPH RES CO, V47, P267, DOI 10.1016/S0006-291X(72)80038-X
   Paul RG, 1996, INT J BIOCHEM CELL B, V28, P1297, DOI 10.1016/S1357-2725(96)00079-9
   Pierro L, 1999, RETINA-J RET VIT DIS, V19, P401, DOI 10.1097/00006982-199909000-00005
   Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009
   Robinson MR, 2006, EXP EYE RES, V82, P479, DOI 10.1016/j.exer.2005.08.007
   SADY C, 1995, BIOCHEM BIOPH RES CO, V214, P793, DOI 10.1006/bbrc.1995.2356
   Saw SM, 2002, OPHTHALMOLOGY, V109, P415, DOI 10.1016/S0161-6420(01)00972-1
   Saw SM, 2002, OPHTHALMOLOGY, V109, P422
   Seiler T, 2000, GRAEF ARCH CLIN EXP, V238, P822, DOI 10.1007/s004179900111
   SNYDER AA, 1972, AM J OPHTHALMOL, V74, P73
   Spoerl E, 2005, INVEST OPHTH VIS SCI, V46, P1286, DOI 10.1167/iovs.040978
   Taylor CR, 1999, ARCH DERMATOL, V135, P540, DOI 10.1001/archderm.135.5.540
   Tessier FJ, 2003, BIOCHEM J, V369, P705, DOI 10.1042/BJ20020668
   Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P1201, DOI 10.1167/iovs.06-0737
   Touzeau O, 2004, J FR OPHTALMOL, V27, P765, DOI 10.1016/S0181-5512(04)96211-0
   Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5
   Wildsoet CF, 1999, OPTOMETRY VISION SCI, V76, P341, DOI 10.1097/00006324-199906000-00001
   Wollensak G, 2005, ACTA OPHTHALMOL SCAN, V83, P477, DOI 10.1111/j.1600-0420.2005.00447.x
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
NR 34
TC 27
Z9 31
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD APR
PY 2008
VL 34
IS 4
BP 651
EP 656
DI 10.1016/i.jcrs.2007.12.030
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 283TW
UT WOS:000254660400027
PM 18361989
DA 2018-10-20
ER

PT J
AU Pedraza, CE
   Chien, YC
   Mckee, MD
AF Pedraza, Claudio E.
   Chien, Yung-Ching
   Mckee, Marc D.
TI Calcium oxalate crystals in fetal bovine serum: Implications for cell
   culture, phagocytosis and biomineralization studies in vitro
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE fetal bovine serum; calcium oxalate; cell culture; biomineralization;
   phagocytosis
ID RENAL EPITHELIAL-CELLS; MONOHYDRATE CRYSTALS; ETHYLENE-GLYCOL; VASCULAR
   CALCIFICATION; GLYCOPROTEIN/FETUIN-A; DIHYDRATE CRYSTALS; PROTEIN;
   MATRIX; URINE; ACID
AB Cell culture methods and models are key investigative tools for cell and molecular biology studies. Fetal bovine serum (FBS) is commonly used as an additive during cell culture since its constituents promote cell survival, proliferation and differentiation. Here we report that commercially available FBS from different major suppliers consistently contain precipitated, calcium oxalate crystals-either in the monohydrate (COM) or dihydrate (COD) form. Mineral structure and phase identification of the crystals were determined by X-ray diffraction, chemical composition by energy-dispersive X-ray microanalysis, and imaging and measurement of crystal growth steps by atomic force microscopy-all identified and confirmed crystallographic parameters for COM and COD. Proteins binding to the crystals were identified by immunoblotting, revealing the presence of osteopontin and fetuin-A (alpha 2HS-glycoprotein)-known regulators of crystal growth found in serum. Macrophage cell cultures exposed to calcium oxalate crystals showed internalization of the crystals by phagocytosis in a process that induced disruption of cell-cell adhesion, release of reactive oxygen species and membrane damage, events that may be linked to the release of inflammatory cytokines by these cells into the culture media. in conclusion, calcium oxalate crystals found in commercially available FBS are toxic to cells, and their presence may confound results from in vitro studies where, amongst others, phagocytosis, biomineralization, renal cell and molecular biology, and drug and biomaterial testing are being examined.
C1 [Pedraza, Claudio E.; Chien, Yung-Ching; Mckee, Marc D.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   [Mckee, Marc D.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada.
RP Mckee, MD (reprint author), McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.
EM marc.mckee@mcgill.ca
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   AKBARIEH M, 1987, SCANNING MICROSCOPY, V1, P1397
   Bautista DS, 1996, J CELL BIOCHEM, V61, P402, DOI 10.1002/(SICI)1097-4644(19960601)61:3<402::AID-JCB7>3.0.CO;2-X
   Belliveau J, 2001, ANAL BIOCHEM, V291, P69, DOI 10.1006/abio.2001.5002
   Bratosin D, 2005, CYTOM PART A, V66A, P78, DOI 10.1002/cyto.a.20152
   BURNS JR, 1980, INVEST UROL, V18, P174
   Cerini C, 1999, KIDNEY INT, V55, P1776, DOI 10.1046/j.1523-1755.1999.00426.x
   Cheung HS, 2005, CURR OPIN RHEUMATOL, V17, P336, DOI 10.1097/01.bor.0000155362.83990.80
   CHIRIBOGA J, 1963, BIOCHEM BIOPH RES CO, V11, P277, DOI 10.1016/0006-291X(63)90557-6
   de Water R, 2001, AM J KIDNEY DIS, V38, P331, DOI 10.1053/ajkd.2001.26098
   El-Shall H, 2004, CRYST RES TECHNOL, V39, P222, DOI 10.1002/crat.200310174
   ELLIOT JS, 1980, J UROLOGY, V123, P324, DOI 10.1016/S0022-5347(17)55918-2
   FINKLEA HO, 1992, J AM CHEM SOC, V114, P3173, DOI 10.1021/ja00035a001
   FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235
   Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106
   Greene EL, 2005, UROL RES, V33, P340, DOI 10.1007/s00240-005-0491-5
   Hassoun EA, 1999, J BIOCHEM MOL TOXIC, V13, P179, DOI 10.1002/(SICI)1099-0461(1999)13:3/4<179::AID-JBT8>3.0.CO;2-4
   Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200
   HONN KV, 1975, P SOC EXP BIOL MED, V149, P344
   KASHTOCK M, 1980, J ASSOC OFF ANA CHEM, V63, P168
   Ketteler M, 2002, BLOOD PURIFICAT, V20, P473, DOI 10.1159/000063554
   Khan SR, 2004, NEPHRON EXP NEPHROL, V98, pE55, DOI 10.1159/000080257
   KNIGHT AP, 2003, GUIDE PLANT POISONIN
   Konya E, 2003, EUR UROL, V43, P564, DOI 10.1016/S0302-2838(03)00088-5
   Koul HK, 2002, J BIOL CHEM, V277, P36845, DOI 10.1074/jbc.M200832200
   LASAGA AC, 1998, THEORY CRYSTALS GROW
   LEPAGE L, 1982, J PHARM SCI, V71, P1059, DOI 10.1002/jps.2600710927
   LIESKE JC, 1994, P NATL ACAD SCI USA, V91, P6987, DOI 10.1073/pnas.91.15.6987
   LIESKE JC, 1992, AM J PHYSIOL, V262, pF622
   MARSH ME, 1995, J BONE MINER RES, V10, P1635
   MCKEE MD, 1995, J BONE MINER RES, V10, P1913
   McMartin KE, 2005, TOXICOL SCI, V84, P195, DOI 10.1093/toxsci/kfi062
   Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98
   Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101
   Olton D, 2007, BIOMATERIALS, V28, P1267, DOI 10.1016/j.biomaterials.2006.10.026
   Price PA, 2004, J BIOL CHEM, V279, P1594, DOI 10.1074/jbc.M305199200
   Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200
   Rolleston W B, 1999, Dev Biol Stand, V99, P79
   Ryall RL, 2005, BJU INT, V96, P654, DOI 10.1111/j.1464-410X.2005.05701.x
   Ryall RL, 2004, NEPHRON PHYSIOL, V98, pp37
   Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI200317202
   Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789
   SORENSEN ES, 1993, J DAIRY RES, V60, P535, DOI 10.1017/S0022029900027886
   STAINES D, 2003, MANAGING SERUM REQUI, P1
   Thamilselvan S, 2000, J UROLOGY, V164, P224, DOI 10.1016/S0022-5347(05)67499-X
   THRALL MA, 1985, VET PATHOL, V22, P625, DOI 10.1177/030098588502200618
   Umekawa T, 2003, NEPHROL DIAL TRANSPL, V18, P664, DOI 10.1093/ndt/gfg140
   Walton RC, 2005, BBA-GEN SUBJECTS, V1723, P175, DOI 10.1016/j.bbagen.2005.02.014
   Webb MA, 1999, PLANT CELL, V11, P751
NR 49
TC 15
Z9 15
U1 0
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD APR 1
PY 2008
VL 103
IS 5
BP 1379
EP 1393
DI 10.1002/jcb.21515
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 285HP
UT WOS:000254768200005
PM 17879965
DA 2018-10-20
ER

PT J
AU Lauto, A
   Mawad, D
   Foster, LJR
AF Lauto, Antonio
   Mawad, Damia
   Foster, L. John R.
TI Adhesive biomaterials for tissue reconstruction
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE glues; tissue engineering; lasers; wound closure; biomaterials
ID POLY(ETHYLENE GLYCOL) DIACRYLATE; RANDOMIZED MULTICENTER TRIAL;
   AUTOLOGOUS FIBRIN GLUE; POLYGLYCOLIC ACID MESH; SOLID PROTEIN SOLDER;
   RAT SCIATIC-NERVE; IN-VITRO; DURAL REPAIR; PHYSICOCHEMICAL
   CHARACTERISTICS; PHOTOCROSSLINKABLE CHITOSAN
AB Tissue reconstruction and wound closure rely on sutures, staples and clips in current surgical procedures. These traditional devices are nonetheless unable to prevent leakage of fluids from a variety of tissue including blood vessels and dura mater. Furthermore, sutures are usually difficult to apply during minimal invasive surgery and often induce detrimental scarring that may impair healing. To overcome these disadvantages, biocompatible and biodegradable glues based on fibrin, polyethylene glycol (PEG) and cyanoacrylate have recently been used in patients to seal and repair tissue wounds. Cyanoacrylate glues create typically very strong tissue bonds but have mostly been applied externally for skin wound closure because of their residual cytotoxicity. Other adhesive biomaterials are also emerging; these glues and adhesives are usually based on proteins such as albumin and collagen or polysaccharides like chitosan; these are irradiated with coherent or non-coherent light to trigger their adhesion to tissue. These biomaterial based devices offer significant advantages over sutures, such as their sealing or repairing ability, easy application modality and delivery in situ of compounds for accelerating wound healing. This paper reviews different tissue reconstruction strategies employing adhesive biomaterials currently used in surgical and experimental procedures. (c) 2007 Society of Chemical Industry.
C1 [Lauto, Antonio] Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymers Res Grp, Sydney, NSW 2052, Australia.
   [Mawad, Damia] Univ Lyon, ESCPE, UMR 5007, Lab Automat & Genie Procedes,LAGEP, F-69622 Villeurbanne, France.
RP Lauto, A (reprint author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Bio Polymers Res Grp, Sydney, NSW 2052, Australia.
EM J.Foster@unsw.edu.au
CR Aigner C, 2006, ANN THORAC SURG, V81, P1275, DOI 10.1016/j.athoracsur.2005.11.037
   BASS LS, 1994, SURGERY, V115, P398
   Belboul A, 2004, EUR J CARDIO-THORAC, V26, P1187, DOI 10.1016/j.ejcts.2004.08.009
   Berger A, 2001, BREAST CANCER RES TR, V67, P9, DOI 10.1023/A:1010671209279
   BREASTED JH, 2006, E SMITH SURG PAPYRUS
   Chelala E, 2007, SURG ENDOSC, V21, P391, DOI 10.1007/s00464-006-9014-x
   Christenson JT, 2004, THORAC CARDIOV SURG, V52, P225, DOI 10.1055/s-2004-821078
   Cimador M, 2004, UROL INT, V73, P320, DOI 10.1159/000081592
   Cooley BC, 1996, MICROSURG, V17, P198, DOI 10.1002/(SICI)1098-2752(1996)17:4<198::AID-MICR6>3.0.CO;2-H
   Cosgrove GR, 2007, J NEUROSURG, V106, P52, DOI 10.3171/jns.2007.106.1.52
   Cuomo BE, 2000, J UROLOGY, V163, P634, DOI 10.1016/S0022-5347(05)67949-9
   DUBUISSON AS, 1993, MICROSURG, V14, P398, DOI 10.1002/micr.1920140609
   EIFERMAN RA, 1983, ARCH OPHTHALMOL-CHIC, V101, P958
   Fasol R, 2004, ANN THORAC SURG, V77, P1070, DOI 10.1016/S0003-4975(03)01175-5
   Forer B, 2006, LARYNGOSCOPE, V116, P1002, DOI 10.1097/01.mlg.0000217241.01388.2d
   Gades MD, 2003, OBES RES, V11, P683, DOI 10.1038/oby.2003.97
   Grayeli AB, 2005, EUR ARCH OTO-RHINO-L, V262, P404, DOI 10.1007/s00405-004-0829-6
   Hida K, 2006, SURG NEUROL, V65, P136, DOI 10.1016/j.surneu.2005.07.059
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Hwang K, 2005, J CRANIOFAC SURG, V16, P1102, DOI 10.1097/01.scs.0000179740.60671.e5
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   JACKSON RM, 2001, AM J SURG, V182, pS36
   Kawahara M, 1996, DIS COLON RECTUM, V39, P556, DOI 10.1007/BF02058711
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kirman I, 1999, LASER SURG MED, V25, P438, DOI 10.1002/(SICI)1096-9101(1999)25:5<438::AID-LSM11>3.0.CO;2-T
   Kirsch AJ, 1996, UROLOGY, V48, P616, DOI 10.1016/S0090-4295(96)00243-9
   Kirsch AJ, 2001, J UROLOGY, V165, P574, DOI 10.1097/00005392-200102000-00073
   KJAERGARD HK, 1994, EUR SURG RES, V26, P273, DOI 10.1159/000129346
   Lauto A, 2007, LASER SURG MED, V39, P19, DOI 10.1002/lsm.20418
   Lauto A, 2005, LASER SURG MED, V36, P193, DOI 10.1002/lsm.20145
   Lauto A, 2004, LASER SURG MED, V35, P140, DOI 10.1002/lsm.20081
   Lauto A, 1997, LASER SURG MED, V21, P134, DOI 10.1002/(SICI)1096-9101(1997)21:2<134::AID-LSM4>3.0.CO;2-R
   Lauto A, 1998, LASER SURG MED, V22, P120, DOI 10.1002/(SICI)1096-9101(1998)22:2<120::AID-LSM8>3.0.CO;2-R
   Li CL, 2003, J BIOMED MATER RES B, V66B, P439, DOI 10.1002/jbm.b.10025
   Loose HW, 1998, BRIT J RADIOL, V71, P1255, DOI 10.1259/bjr.71.852.10318997
   Lumsden AB, 2006, J VASC SURG, V44, P1002, DOI 10.1016/j.jvs.2006.06.039
   Maitz PKM, 1999, PLAST RECONSTR SURG, V104, P1726, DOI 10.1097/00006534-199911000-00017
   Manzano RPD, 2006, CORNEA, V25, P350
   Marcovich R, 2001, UROLOGY, V57, P806, DOI 10.1016/S0090-4295(00)01075-X
   Martinowitz U, 1996, Curr Opin Hematol, V3, P395
   McNally KM, 2000, LASER SURG MED, V27, P147, DOI 10.1002/1096-9101(2000)27:2<147::AID-LSM6>3.0.CO;2-P
   Menovsky T, 2003, MICROSURG, V23, P109, DOI 10.1002/micr.10100
   Menovsky T, 2001, J NEUROSURG, V95, P694, DOI 10.3171/jns.2001.95.4.0694
   Menovsky T, 1996, LASER SURG MED, V19, P152, DOI 10.1002/(SICI)1096-9101(1996)19:2<152::AID-LSM5>3.0.CO;2-R
   Merrifield BF, 2006, GASTROINTEST ENDOSC, V63, P710, DOI 10.1016/j.gie.2005.11.018
   MILLESI H, 1982, SCAND J PLAST RECONS, P25
   Murray KD, 2002, CHEST, V122, P2146, DOI 10.1378/chest.122.6.2146
   Nageris BI, 2004, OTOLARYNG HEAD NECK, V131, P856, DOI 10.1016/j.otohns.2004.08.002
   Nakamura H, 2005, SPINE, V30, pE347, DOI 10.1097/01.brs.0000167820.54413.8e
   Nakayama Y, 1999, J BIOMED MATER RES, V48, P511, DOI 10.1002/(SICI)1097-4636(1999)48:4<511::AID-JBM17>3.3.CO;2-M
   Okino H, 2002, J BIOMED MATER RES, V59, P233, DOI 10.1002/jbm.1237
   Ong CCP, 2002, PEDIATR SURG INT, V18, P553, DOI 10.1007/s00383-002-0728-0
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Oskoui P, 2003, LASER SURG MED, V32, P346, DOI 10.1002/lsm.10173
   OZ MC, 1990, J VASC SURG, V11, P718, DOI 10.1067/mva.1990.18591
   Paez JMG, 2004, J MATER SCI-MATER M, V15, P109, DOI 10.1023/B:JMSM.0000011810.12031.c6
   Pecha RE, 1998, GASTROINTEST ENDOSC, V48, P299, DOI 10.1016/S0016-5107(98)70196-8
   Petratos PB, 2002, WOUND REPAIR REGEN, V10, P252, DOI 10.1046/j.1524-475X.2002.10409.x
   Pini R, 2001, PROC SPIE, V4244, P266, DOI 10.1117/12.427800
   POPPAS DP, 1988, J UROLOGY, V139, P415, DOI 10.1016/S0022-5347(17)42446-3
   Proano CE, 2004, INVEST OPHTH VIS SCI, V45, P2177, DOI 10.1167/iovs.03-1066
   Pruthi RS, 2004, BJU INT, V93, P813, DOI 10.1111/j.1464-410X.2004.04742.x
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Reece TB, 2001, AM J SURG, V182, p40S, DOI 10.1016/S0002-9610(01)00742-5
   Ren Z, 2004, J CLIN LASER MED SUR, V22, P81, DOI 10.1089/104454704774076118
   Rutgeerts P, 1997, LANCET, V350, P692, DOI 10.1016/S0140-6736(97)03233-9
   SALTZ R, 1991, PLAST RECONSTR SURG, V88, P1005, DOI 10.1097/00006534-199112000-00009
   Schievink WI, 2004, J NEUROSURG, V100, P1098, DOI 10.3171/jns.2004.100.6.1098
   SCHOBER R, 1986, SCIENCE, V232, P1421, DOI 10.1126/science.3715454
   SHAFFREY CI, 1990, NEUROSURGERY, V26, P207, DOI 10.1227/00006123-199002000-00004
   Sharma A, 2003, OPHTHALMOLOGY, V110, P291, DOI 10.1016/S0161-6420(02)01558-0
   Sheffy N, 2006, J AM COLL SURGEONS, V203, P297, DOI 10.1016/j.jamcollsurg.2006.05.010
   Shimada Y, 2006, J ORTHOP SCI, V11, P454, DOI 10.1007/s00776-006-1044-7
   Sierra DH, 2000, J BIOMED MATER RES, V52, P534, DOI 10.1002/1097-4636(20001205)52:3<534::AID-JBM12>3.0.CO;2-7
   Silecchia G, 2006, OBES SURG, V16, P125, DOI 10.1381/096089206775565249
   Sin AH, 2006, J NEUROSURG-SPINE, V5, P224, DOI 10.3171/spi.2006.5.3.224
   Spotnitz WD, 2001, AM J SURG, V182, p8S, DOI 10.1016/S0002-9610(01)00771-1
   Stewart RB, 2002, LASER SURG MED, V31, P36, DOI 10.1002/lsm.10071
   Stone CA, 2000, BRIT J PLAST SURG, V53, P601, DOI 10.1054/bjps.2000.3412
   Sweeney T, 2002, SURGERY, V131, P185, DOI 10.1067/msy.2002.119492
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
   Taylor LM, 2003, J VASC SURG, V38, P766, DOI 10.1016/S0741-5214(03)00474-9
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Torchiana DF, 2003, J CARDIAC SURG, V18, P504, DOI 10.1046/j.0886-0440.2003.00305.x
   TSENG YC, 1990, BIOMATERIALS, V11, P73, DOI 10.1016/0142-9612(90)90055-U
   van den Ende ED, 2004, J PEDIATR SURG, V39, P1249, DOI 10.1016/j.jpedsurg.2004.04.013
   VONSEGESSER LK, 1995, ANN THORAC SURG, V60, P511, DOI 10.1016/0003-4975(95)00536-T
   Vote BJT, 2000, CLIN EXP OPHTHALMOL, V28, P437, DOI 10.1046/j.1442-9071.2000.00351.x
   Wain JC, 2001, ANN THORAC SURG, V71, P1623, DOI 10.1016/S0003-4975(01)02537-1
   Xie H, 2004, LASER SURG MED, V35, P201, DOI 10.1002/lsm.20092
   Yamada K, 2000, BIOMACROMOLECULES, V1, P252, DOI 10.1021/bm0003009
NR 92
TC 46
Z9 46
U1 5
U2 66
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD APR
PY 2008
VL 83
IS 4
BP 464
EP 472
DI 10.1002/jctb.1771
PG 9
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA 285GB
UT WOS:000254764200006
DA 2018-10-20
ER

EF